PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hsu, HJ; Lee, CF; Kaunas, R				Hsu, Hui-Ju; Lee, Chin-Fu; Kaunas, Roland			A Dynamic Stochastic Model of Frequency-Dependent Stress Fiber Alignment Induced by Cyclic Stretch	PLOS ONE			English	Article								Background: Actin stress fibers (SFs) are mechanosensitive structural elements that respond to forces to affect cell morphology, migration, signal transduction and cell function. Cells are internally stressed so that SFs are extended beyond their unloaded lengths, and SFs tend to self-adjust to an equilibrium level of extension. While there is much evidence that cells reorganize their SFs in response to matrix deformations, it is unclear how cells and their SFs determine their specific response to particular spatiotemporal changes in the matrix. Methodology/Principal Findings: Bovine aortic endothelial cells were subjected to cyclic uniaxial stretch over a range of frequencies to quantify the rate and extent of stress fiber alignment. At a frequency of 1 Hz, SFs predominantly oriented perpendicular to stretch, while at 0.1 Hz the extent of SF alignment was markedly reduced and at 0.01 Hz there was no alignment at all. The results were interpreted using a simple kinematic model of SF networks in which the dynamic response depended on the rates of matrix stretching, SF turnover, and SF self-adjustment of extension. For these cells, the model predicted a threshold frequency of 0.01 Hz below which SFs no longer respond to matrix stretch, and a saturation frequency of 1 Hz above which no additional SF alignment would occur. The model also accurately described the dependence of SF alignment on matrix stretch magnitude. Conclusions: The dynamic stochastic model was capable of describing SF reorganization in response to diverse temporal and spatial patterns of stretch. The model predicted that at high frequencies, SFs preferentially disassembled in the direction of stretch and achieved a new equilibrium by accumulating in the direction of lowest stretch. At low stretch frequencies, SFs self-adjusted to dissipate the effects of matrix stretch. Thus, SF turnover and self-adjustment are each important mechanisms that cells use to maintain mechanical homeostasis.	[Hsu, Hui-Ju; Lee, Chin-Fu; Kaunas, Roland] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hsu, HJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	rkaunas@tamu.edu			American Heart Association [0730238N]	American Heart Association(American Heart Association)	The authors were supported by an American Heart Association Grant (0730238N) awarded to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Chen YG, 1998, J ASIAN NAT PROD RES, V1, P125, DOI 10.1080/10286029808039854; Civelekoglu-Scholey G, 2005, J THEOR BIOL, V232, P569, DOI 10.1016/j.jtbi.2004.09.004; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; De R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031923; Deguchi S., 2005, Molecular & Cellular Biomechanics, V2, P125; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kakisis JD, 2004, ENDOTHELIUM-J ENDOTH, V11, P17, DOI 10.1080/10623320490432452; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; KAUNAS R, 2008, J THEORETIC IN PRESS; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; Malek AM, 1996, J CELL SCI, V109, P713; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Na S, 2004, BIOMECH MODEL MECHAN, V3, P75, DOI 10.1007/s10237-004-0051-x; Noria S, 2004, AM J PATHOL, V164, P1211, DOI 10.1016/S0002-9440(10)63209-9; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Sotoudeh M, 2002, AM J PHYSIOL-HEART C, V282, pH1709, DOI 10.1152/ajpheart.00744.2001; Takemasa T, 1998, EUR J CELL BIOL, V77, P91, DOI 10.1016/S0171-9335(98)80076-9; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; WANG DL, 1993, BIOCHEM BIOPH RES CO, V195, P1050, DOI 10.1006/bbrc.1993.2150; WANG DL, 1995, CIRC RES, V77, P294, DOI 10.1161/01.RES.77.2.294; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745; Wille JJ, 2004, J BIOMECH ENG-T ASME, V126, P545, DOI 10.1115/1.1798053; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076	34	96	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4853	10.1371/journal.pone.0004853	http://dx.doi.org/10.1371/journal.pone.0004853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319193	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499200001
J	Kuo, MW; Wang, SH; Chang, JC; Chang, CH; Huang, LJ; Lin, HH; Yu, ALT; Li, WH; Yu, J				Kuo, Ming-Wei; Wang, Sheng-Hung; Chang, Jui-Chin; Chang, Chien-Huei; Huang, Ling-Jyun; Lin, Hsin-Hung; Yu, Alice Lin-Tsing; Li, Wen-Hsiung; Yu, John			A Novel puf-A Gene Predicted from Evolutionary Analysis Is Involved in the Development of Eyes and Primordial Germ-Cells	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; ZEBRAFISH; PUMILIO; EXPRESSION; VISUALIZATION; REVEALS	Although the human genome project has been completed for some time, the issue of the number of transcribed genes with identifiable biological functions remains unresolved. We used zebrafish as a model organism to study the functions of Ka/Ks-predicted novel human exons, which were identified from a comparative evolutionary genomics analysis. In this study, a novel gene, designated as puf-A, was cloned and functionally characterized, and its homologs in zebrafish, mouse, and human were identified as one of the three homolog clusters which were consisted of 14 related proteins with Puf repeats. Computer modeling of human Puf-A structure and a pull-down assay for interactions with RNA targets predicted that it was a RNA-binding protein. Specifically, Puf-A contained a special six Puf-repeat domain, which constituted a unique superhelix half doughnut-shaped Puf domain with a topology similar to, but different from the conventional eight-repeat Pumilio domain. Puf-A transcripts were uniformly distributed in early embryos, but became restricted primarily to eyes and ovaries at a later stage of development. In mice, puf-A expression was detected primarily in retinal ganglion and pigmented cells. Knockdown of puf-A in zebrafish embryos resulted in microphthalmia, a small head, and abnormal primordial germ-cell (PGC) migration. The latter was confirmed by microinjecting into embryos puf-A siRNA containing nanos 39 UTR that expressed in PGC only. The importance of Puf-A in the maturation of germline stem cells was also implicated by its unique expression in the most primitive follicles (stage I) in adult ovaries, followed by a sharp decline of expression in later stages of folliculogenesis. Taken together, our study shows that puf-A plays an important role not only in eye development, but also in PGC migration and the specification of germ cell lineage. These studies represent an exemplary implementation of a unique platform to uncover unknown function(s) of human genes and their roles in development regulation.	[Kuo, Ming-Wei; Wang, Sheng-Hung; Chang, Chien-Huei; Huang, Ling-Jyun; Yu, John] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chang, Jui-Chin; Lin, Hsin-Hung; Yu, Alice Lin-Tsing; Li, Wen-Hsiung; Yu, John] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Li, Wen-Hsiung] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Li, Wen-Hsiung] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; University of Chicago; Academia Sinica - Taiwan	Kuo, MW (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	johnyu@gate.sinica.edu.tw	yu, john/AAA-9255-2021; Lin, Hsin-Hung/J-5254-2013; YU, JOHN/G-8954-2012	Lin, Hsin-Hung/0000-0001-8327-6835; Li, Wen-Hsiung/0000-0003-1086-1456; Yu, John/0000-0002-3237-4272; yu, alice/0000-0003-2444-0505	National Science Council [NSC96-3111-B-001-005]; Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants from the National Science Council (#NSC96-3111-B-001-005) and from Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Fishman MC, 1999, P NATL ACAD SCI USA, V96, P10554, DOI 10.1073/pnas.96.19.10554; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Koprunner M, 2001, GENE DEV, V15, P2877; Kuo MW, 2005, J BIOMED SCI, V12, P629, DOI 10.1007/s11373-005-7457-z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nekrutenko A, 2003, NUCLEIC ACIDS RES, V31, P3564, DOI 10.1093/nar/gkg597; Nekrutenko A, 2003, TRENDS GENET, V19, P306, DOI 10.1016/S0168-9525(03)00114-8; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Saito T, 2006, INT J DEV BIOL, V50, P691, DOI 10.1387/ijdb.062143ts; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zamore PD, 1997, RNA, V3, P1421	37	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4980	10.1371/journal.pone.0004980	http://dx.doi.org/10.1371/journal.pone.0004980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319195	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499200012
J	Greco, D; Volpicelli, F; Di Lieto, A; Leo, D; Perrone-Capano, C; Auvinen, P; di Porzio, U				Greco, Dario; Volpicelli, Floriana; Di Lieto, Antonio; Leo, Damiana; Perrone-Capano, Carla; Auvinen, Petri; di Porzio, Umberto			Comparison of Gene Expression Profile in Embryonic Mesencephalon and Neuronal Primary Cultures	PLOS ONE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; TRANSCRIPTION FACTOR; MOLECULAR-MECHANISMS; NURR1; TARGET; CELLS; INDUCTION; DIFFERENTIATION	In the mammalian central nervous system (CNS) an important contingent of dopaminergic neurons are localized in the substantia nigra and in the ventral tegmental area of the ventral midbrain. They constitute an anatomically and functionally heterogeneous group of cells involved in a variety of regulatory mechanisms, from locomotion to emotional/motivational behavior. Midbrain dopaminergic neuron (mDA) primary cultures represent a useful tool to study molecular mechanisms involved in their development and maintenance. Considerable information has been gathered on the mDA neurons development and maturation in vivo, as well as on the molecular features of mDA primary cultures. Here we investigated in detail the gene expression differences between the tissue of origin and ventral midbrain primary cultures enriched in mDA neurons, using microarray technique. We integrated the results based on different re-annotations of the microarray probes. By using knowledge-based gene network techniques and promoter sequence analysis, we also uncovered mechanisms that might regulate the expression of CNS genes involved in the definition of the identity of specific cell types in the ventral midbrain. We integrate bioinformatics and functional genomics, together with developmental neurobiology. Moreover, we propose guidelines for the computational analysis of microarray gene expression data. Our findings help to clarify some molecular aspects of the development and differentiation of DA neurons within the midbrain.	[Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Volpicelli, Floriana; Leo, Damiana; Perrone-Capano, Carla; di Porzio, Umberto] CNR, Inst Genet & Biophys, Naples, Italy; [Di Lieto, Antonio] Univ Helsinki, Neurosci Ctr, FIN-00014 Helsinki, Finland; [Perrone-Capano, Carla] Univ Naples Federico II, Naples, Italy	University of Helsinki; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Helsinki; University of Naples Federico II	Greco, D (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	dario.greco@helsinki.fi	Auvinen, Petri/AAP-8117-2021; Greco, Dario/T-7113-2019; Perrone-Capano, Carla/O-7708-2015; Auvinen, Petri/D-5044-2009; Perrone-Capano, Carla/AAX-3217-2020	Greco, Dario/0000-0001-9195-9003; Perrone-Capano, Carla/0000-0002-6327-9753; Auvinen, Petri/0000-0002-3947-4778; Perrone-Capano, Carla/0000-0002-6327-9753; di Porzio, Umberto/0000-0002-2139-8754; Leo, Damiana/0000-0001-9219-5498; Volpicelli, Floriana/0000-0003-0618-5504	Institute of Biotechnology, University of Helsinki (Finland); COFIN MIUR/PRIN 2007 (Italy); Suomen Kulttuurirahasto (Finland); Ehrnrooth Foundation (Finland); FEBS [summer fellowship]	Institute of Biotechnology, University of Helsinki (Finland); COFIN MIUR/PRIN 2007 (Italy)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Suomen Kulttuurirahasto (Finland); Ehrnrooth Foundation (Finland); FEBS	This study has been funded by the Institute of Biotechnology, University of Helsinki (Finland) and by COFIN MIUR/PRIN 2007 (Italy). Dario Greco was funded by the Suomen Kulttuurirahasto (Finland) and by the Ehrnrooth Foundation (Finland). Damiana Leo was recipient of a FEBS summer fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUVIER MM, 1995, J NEUROSCI, V15, P7141; Carter SL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-107; Chow S, 2005, EUL DIAGR WORKSH 200; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dailly E, 2004, FUND CLIN PHARMACOL, V18, P601, DOI 10.1111/j.1472-8206.2004.00287.x; DIPORZIO U, 1990, INT J DEV NEUROSCI, V8, P523; DIPORZIO U, 1980, NATURE, V288, P370, DOI 10.1038/288370a0; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hornykiewicz O, 2001, J CHEM NEUROANAT, V22, P3, DOI 10.1016/S0891-0618(01)00100-4; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Lin JC, 2003, SEMIN CELL DEV BIOL, V14, P175, DOI 10.1016/S1084-9521(03)00009-0; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Park CH, 2006, J CELL SCI, V119, P2310, DOI 10.1242/jcs.02955; PARMAN C, 2008, AFFYQCREPORT PACKAGE; Pernas-Alonso R, 1999, BRAIN RES PROTOC, V4, P395, DOI 10.1016/S1385-299X(99)00045-8; Perrone-Capano C, 2008, REND LINCEI-SCI FIS, V19, P271, DOI 10.1007/s12210-008-0019-3; PerroneCapano C, 1996, MOL BRAIN RES, V39, P160, DOI 10.1016/0169-328X(96)00022-8; PERRONECAPANO C, 1994, NEUROREPORT, V5, P1145, DOI 10.1097/00001756-199405000-00031; PROCHIANTZ A, 1979, P NATL ACAD SCI USA, V76, P5387, DOI 10.1073/pnas.76.10.5387; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Sharma N, 2002, NEUROL CLIN, V20, P759, DOI 10.1016/S0733-8619(01)00014-7; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STEEL MC, 1993, MOL PHARMACOL, V43, P694; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Volkow ND, 2001, AM J PSYCHIAT, V158, P383, DOI 10.1176/appi.ajp.158.3.383; Volpicelli F, 2004, J NEUROCHEM, V88, P1283, DOI 10.1046/j.1471-4159.2003.02254.x; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Volpicelli Floriana, 2004, Neural Plasticity, V11, P45, DOI 10.1155/NP.2004.45; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4977	10.1371/journal.pone.0004977	http://dx.doi.org/10.1371/journal.pone.0004977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305503	Green Published, gold			2022-12-27	WOS:000265498800019
J	Scheckhuber, CQ; Grief, J; Boilan, E; Luce, K; Debacq-Chainiaux, F; Rittmeyer, C; Gredilla, R; Kolbesen, BO; Toussaint, O; Osiewacz, HD				Scheckhuber, Christian Q.; Grief, Jurgen; Boilan, Emmanuelle; Luce, Karin; Debacq-Chainiaux, Florence; Rittmeyer, Claudia; Gredilla, Ricardo; Kolbesen, Bernd O.; Toussaint, Olivier; Osiewacz, Heinz D.			Age-Related Cellular Copper Dynamics in the Fungal Ageing Model Podospora anserina and in Ageing Human Fibroblasts	PLOS ONE			English	Article							PLASMID-LIKE DNA; METALLOTHIONEIN GENE; OXIDATIVE STRESS; PRION PROTEIN; LIFE-SPAN; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; TRANSCRIPTION FACTOR; FILAMENTOUS FUNGUS; DELIVERING COPPER	In previous investigations an impact of cellular copper homeostasis on ageing of the ascomycete Podospora anserina has been demonstrated. Here we provide new data indicating that mitochondria play a major role in this process. Determination of copper in the cytosolic fraction using total reflection X-ray fluorescence spectroscopy analysis and eGfp reporter gene studies indicate an age-related increase of cytosolic copper levels. We show that components of the mitochondrial matrix (i.e. eGFP targeted to mitochondria) become released from the organelle during ageing. Decreasing the accessibility of mitochondrial copper in P. anserina via targeting a copper metallothionein to the mitochondrial matrix was found to result in a switch from a copper-dependent cytochrome-c oxidase to a copper-independent alternative oxidase type of respiration and results in lifespan extension. In addition, we demonstrate that increased copper concentrations in the culture medium lead to the appearance of senescence biomarkers in human diploid fibroblasts (HDFs). Significantly, expression of copper-regulated genes is induced during in vitro ageing in medium devoid of excess copper suggesting that cytosolic copper levels also increase during senescence of HDFs. These data suggest that the identified molecular pathway of age-dependent copper dynamics may not be restricted to P. anserina but may be conserved from lower eukaryotes to humans.	[Scheckhuber, Christian Q.; Grief, Jurgen; Luce, Karin; Gredilla, Ricardo; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Boilan, Emmanuelle; Debacq-Chainiaux, Florence; Toussaint, Olivier] Univ Namur, Res Unit Cellular Biol, Namur, Belgium; [Rittmeyer, Claudia; Kolbesen, Bernd O.] Goethe Univ Frankfurt, Inst Inorgan Chem Analyt Chem, D-6000 Frankfurt, Germany	Goethe University Frankfurt; University of Namur; Goethe University Frankfurt	Osiewacz, HD (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany.	osiewacz@bio.uni-frankfurt.de	Scheckhuber, Christian Q./A-6462-2012; Osiewacz, Heinz D./D-3454-2011	Scheckhuber, Christian Q./0000-0002-2924-7547; GREDILLA, RICARDO/0000-0003-4501-1355; Debacq-Chainiaux, Florence/0000-0003-3949-395X	Deutsche Forschungsgemeinschaft, Bonn, Germany [Os75/7-5]; European Commission [FP6-518230]; Spanish Ministry of Education [postdoctoral fellowship]; Belgian FNRS; Belgian FRIA	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Education(Spanish Government); Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian FRIA(Fonds de la Recherche Scientifique - FNRS)	This work is supported by a grant of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/, Bonn, Germany, Os75/7-5) and the European Commission (http://erc.europa.eu/, Integrated Project: PROTEOMAGE, Contract No. FP6-518230). R. Gredilla received a postdoctoral fellowship from the Spanish Ministry of Education. O. Toussaint and F. Debacq-Chainiaux are Research Associate and post-doctoral Researcher, respectively, of the Belgian FNRS. E. Boilan receives a fellowship from the Belgian FRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; ARRETZ M, 1994, J BIOL CHEM, V269, P4959; Averbeck NB, 2001, MOL GEN GENET, V264, P604, DOI 10.1007/s004380000346; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Borghouts C, 2002, INT J BIOCHEM CELL B, V34, P1355, DOI 10.1016/S1357-2725(02)00078-X; Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x; Debacq-Chainiaux F, 2008, FREE RADICAL BIO MED, V44, P1817, DOI 10.1016/j.freeradbiomed.2008.02.001; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Eliseev RA, 2002, MITOCHONDRION, V1, P361, DOI 10.1016/S1567-7249(01)00039-3; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Greco M, 1998, FEBS LETT, V427, P179, DOI 10.1016/S0014-5793(98)00419-0; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hamann A, 2005, CURR GENET, V48, P270, DOI 10.1007/s00294-005-0018-1; Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Himelblau E, 1998, PLANT PHYSIOL, V117, P1227, DOI 10.1104/pp.117.4.1227; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; IGBAVBOA U, 1989, BIOCHEM BIOPH RES CO, V161, P619, DOI 10.1016/0006-291X(89)92644-2; INOUE T, 1993, BIOCHIM BIOPHYS ACTA, V1140, P313, DOI 10.1016/0005-2728(93)90071-M; KARIN M, 1982, NUCLEIC ACIDS RES, V10, P3165, DOI 10.1093/nar/10.10.3165; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; KUCK U, 1981, CURR GENET, V3, P151, DOI 10.1007/BF00365719; Kumar KS, 2005, FEMS MICROBIOL LETT, V242, P45, DOI 10.1016/j.femsle.2004.10.040; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LIAO YCJ, 1986, SCIENCE, V233, P364, DOI 10.1126/science.3014653; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mattie MD, 2004, AM J PHYSIOL-CELL PH, V286, pC293, DOI 10.1152/ajpcell.00293.2003; Mira H, 2002, PLANTA, V214, P939, DOI 10.1007/s00425-001-0706-0; Moraga D, 2005, COMP BIOCHEM PHYS C, V141, P151, DOI 10.1016/j.cca.2005.05.014; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; OSIEWACZ HD, 1984, CURR GENET, V8, P299, DOI 10.1007/BF00419728; OSIEWACZ HD, 1991, APPL MICROBIOL BIOT, V35, P38; Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211; Pierrel F, 2007, BIOMETALS, V20, P675, DOI 10.1007/s10534-006-9052-9; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; RIZET G, 1953, CR HEBD ACAD SCI, V237, P838; SADHU C, 1989, MOL CELL BIOL, V9, P5738, DOI 10.1128/MCB.9.12.5738; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; SCHULTE E, 1988, MOL GEN GENET, V211, P342, DOI 10.1007/BF00330614; Song MO, 2005, MOL CELL BIOCHEM, V279, P141, DOI 10.1007/s11010-005-8286-0; STAHL U, 1982, P NATL ACAD SCI-BIOL, V79, P3641, DOI 10.1073/pnas.79.11.3641; STAHL U, 1978, MOL GEN GENET, V162, P341, DOI 10.1007/BF00268860; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; Treiber Carina, 2008, V459, P161, DOI 10.1007/978-1-59745-234-2_12; Varela-Nallar L, 2006, BIOL RES, V39, P39, DOI 10.4067/S0716-97602006000100005; Varela-Nallar L, 2006, AM J PHYSIOL-CELL PH, V290, pC271, DOI 10.1152/ajpcell.00160.2005; Wittershagen A, 1997, SPECTROCHIM ACTA B, V52, P1033, DOI 10.1016/S0584-8547(96)01639-4; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Zickermann V, 1997, BIOCHEMISTRY-US, V36, P3232, DOI 10.1021/bi962040e; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	82	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4919	10.1371/journal.pone.0004919	http://dx.doi.org/10.1371/journal.pone.0004919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305496	Green Published, Green Submitted, gold			2022-12-27	WOS:000265498800003
J	Taylor, AR				Taylor, Alison R.			A Fast Na+/Ca2+-Based Action Potential in a Marine Diatom	PLOS ONE			English	Article								Background: Electrical impulses in animals play essential roles in co-ordinating an array of physiological functions including movement, secretion, environmental sensing and development. Underpinning many of these electrical signals is a fast Na+-based action potential that has been fully characterised only in cells associated with the neuromuscular systems of multicellular animals. Such rapid action potentials are thought to have evolved with the first metazoans, with cnidarians being the earliest representatives. The present study demonstrates that a unicellular protist, the marine diatom Odontella sinensis, can also generate a fast Na+/Ca2+ based action potential that has remarkably similar biophysical and pharmacological properties to invertebrates and vertebrate cardiac and skeletal muscle cells. Methodology/Principal Findings: The kinetic, ionic and pharmacological properties of the rapid diatom action potential were examined using single electrode current and voltage clamp techniques. Overall, the characteristics of the fast diatom currents most closely resemble those of vertebrate and invertebrate muscle Na+/Ca2+ currents. Conclusions/Significance: This is the first demonstration of voltage-activated Na+ channels and the capacity to generate fast Na+-based action potentials in a unicellular photosynthetic organism. The biophysical and pharmacological characteristics together with the presence of a voltage activated Na+/Ca2+ channel homologue in the recently sequenced genome of the diatom Thalassiosira pseudonana, provides direct evidence supporting the hypothesis that this rapid signalling mechanism arose in ancestral unicellular eukaryotes and has been retained in at least two phylogenetically distant lineages of eukaryotes; opisthokonts and the stramenopiles. The functional role of the fast animal-like action potential in diatoms remains to be elucidated but is likely involved in rapid environmental sensing of these widespread and successful marine protists.	[Taylor, Alison R.] Marine Biol Assoc UK, Plymouth, Devon, England; [Taylor, Alison R.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC USA	Marine Biological Association United Kingdom; University of North Carolina; University of North Carolina Wilmington	Taylor, AR (corresponding author), Marine Biol Assoc UK, Citadel Hill, Plymouth, Devon, England.	taylora@uncw.edu		Berger, Frederic/0000-0002-3609-8260	Marine Biological Association of the UK [Fellowship]; Natural and Environmental Research Council UK; Biotechnology and Biological Sciences Research Council UK; EU Framework 6 [512035]	Marine Biological Association of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural and Environmental Research Council UK; Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Framework 6	ART acknowledges a Marine Biological Association of the UK Fellowship and financial support from both the Natural and Environmental Research Council UK and Biotechnology and Biological Sciences Research Council UK. This paper represents a contribution to the objectives of the Diatomics consortium, a specific targeted research project supported by EU Framework 6 funding (EU contract number 512035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PAV, 1987, J EXP BIOL, V133, P231; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BADEN DG, 1989, FASEB J, V3, P1807, DOI 10.1096/fasebj.3.7.2565840; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BEILBY MJ, 1982, PHILOS T ROY SOC B, V299, P435, DOI 10.1098/rstb.1982.0142; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Boyd CM, 1999, J EXP BOT, V50, P445, DOI 10.1093/jexbot/50.333.445; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Davey MS, 2003, J PHYCOL, V39, P1132, DOI 10.1111/j.0022-3646.2003.02-200.x; ECKERT R, 1979, ANNU REV BIOPHYS BIO, V8, P353, DOI 10.1146/annurev.bb.08.060179.002033; Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; FEBVRECHEVALIER C, 1986, J EXP BIOL, V122, P177; FROMM J, 1994, J EXP BOT, V45, P463, DOI 10.1093/jxb/45.4.463; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 2002, J EXP BIOL, V205, P575; Gradmann D, 2000, J MEMBRANE BIOL, V175, P149, DOI 10.1007/s002320001063; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Kuo CC, 2004, J GEN PHYSIOL, V124, P27, DOI 10.1085/jgp.200409054; Li WI, 2001, P NATL ACAD SCI USA, V98, P7599, DOI 10.1073/pnas.121085898; LUNEVSKY VZ, 1983, J MEMBRANE BIOL, V72, P43, DOI 10.1007/BF01870313; Makita N, 1997, PROTOPLASMA, V197, P86, DOI 10.1007/BF01279887; OAMI K, 1995, J COMP PHYSIOL A, V176, P635, DOI 10.1007/BF01021583; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Stahlberg R, 1997, PLANT PHYSIOL, V113, P209, DOI 10.1104/pp.113.1.209; Taylor AR, 2003, PLANT PHYSIOL, V131, P1391, DOI 10.1104/pp.011791; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; PROTEIN ID 2207	34	36	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4966	10.1371/journal.pone.0004966	http://dx.doi.org/10.1371/journal.pone.0004966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305505	Green Published, Green Submitted, gold			2022-12-27	WOS:000265498800014
J	Rosset, MB; Sacquin, A; Lecollinet, S; Chaigneau, T; Adam, M; Crespeau, F; Eloit, M				Rosset, Martine Bruley; Sacquin, Antoine; Lecollinet, Sylvie; Chaigneau, Thomas; Adam, Micheline; Crespeau, Francois; Eloit, Marc			Dendritic Cell-Mediated-Immunization with Xenogenic PrP and Adenoviral Vectors Breaks Tolerance and Prolongs Mice Survival against Experimental Scrapie	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; HUMORAL IMMUNE-RESPONSE; PRION PROTEIN-PEPTIDES; WILD-TYPE MICE; T-CELLS; MONOCLONAL-ANTIBODIES; VACCINATION; REPLICATION; INDUCTION; INHIBIT	In prion diseases, PrPc, a widely expressed protein, is transformed into a pathogenic form called PrPSc, which is in itself infectious. Antibodies directed against PrPc have been shown to inhibit PrPc to PrPSc conversion in vitro and protect in vivo from disease. Other effectors with potential to eliminate PrPSc-producing cells are cytotoxic T cells directed against PrP-derived peptides but their ability to protect or to induce deleterious autoimmune reactions is not known. The natural tolerance to PrPc makes difficult to raise efficient adaptive responses. To break tolerance, adenovirus (Ad) encoding human PrP (hPrP) or control Ad were administered to wild-type mice by direct injection or by transfer of Ad-transduced dendritic cells (DCs). Control Ad-transduced DCs from Tg650 mice overexpressing hPrP were also used for immunization. DC-mediated but not direct administration of AdhPrP elicited antibodies that bound to murine native PrPc. Frequencies of PrP-specific IFN gamma-secreting T cells were low and in vivo lytic activity only targeted cells strongly expressing hPrP. Immunohistochemical analysis revealed that CD3(+) T cell infiltration was similar in the brain of vaccinated and unvaccinated 139A-infected mice suggesting the absence of autoimmune reactions. Early splenic PrPSc replication was strongly inhibited ten weeks post infection and mean survival time prolonged from 209 days in untreated 139A-infected mice to 246 days in mice vaccinated with DCs expressing the hPrP. The efficacy appeared to be associated with antibody but not with cytotoxic cell-mediated PrP-specific responses.	[Rosset, Martine Bruley; Sacquin, Antoine; Chaigneau, Thomas] INSERM, UMR 938, Paris, France; [Rosset, Martine Bruley; Sacquin, Antoine; Chaigneau, Thomas] Univ Paris 06, Med Ctr, Hop St Antoine, F-75252 Paris, France; [Lecollinet, Sylvie; Adam, Micheline; Eloit, Marc] Ecole Natl Vet Alfort, AFSSA, INRA, UMR1161 Virol, Maisons Alfort, France; [Crespeau, Francois] Ecole Natl Vet Alfort, Lab Anatomopathol, Maisons Alfort, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA)	Rosset, MB (corresponding author), INSERM, UMR 938, Paris, France.	martine.rosset@inserm.fr	Lecollinet, Sylvie/M-1728-2019; sacquin, Antoine/M-5532-2014; Lecollinet, Sylvie/AAV-5276-2021	Lecollinet, Sylvie/0000-0001-8535-2133	INSERM; Neuroprion network of excellence, European FP6; France Alzheimer Association [PhD fellowship]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Neuroprion network of excellence, European FP6; France Alzheimer Association	This work was supported by funds from INSERM and the Neuroprion network of excellence, European FP6. Antoine Sacquin received a PhD fellowship from "France Alzheimer Association". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrabal S, 2001, BIOCHEM BIOPH RES CO, V285, P623, DOI 10.1006/bbrc.2001.5208; Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Bade S, 2006, VACCINE, V24, P1242, DOI 10.1016/j.vaccine.2005.12.051; Ballerini C, 2006, J IMMUNOL, V176, P7254, DOI 10.4049/jimmunol.176.12.7254; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; del Hoyo GM, 2006, J IMMUNOL, V177, P6137, DOI 10.4049/jimmunol.177.9.6137; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fernandez-Borges N, 2006, J VIROL, V80, P9970, DOI 10.1128/JVI.01210-06; Gilch S, 2003, J BIOL CHEM, V278, P18524, DOI 10.1074/jbc.M210723200; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; Gregoire S, 2005, J IMMUNOL, V175, P6443, DOI 10.4049/jimmunol.175.10.6443; Gregoire S, 2004, J LEUKOCYTE BIOL, V76, P125, DOI 10.1189/jlb.1203656; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Handisurya A, 2007, FEBS J, V274, P1747, DOI 10.1111/j.1742-4658.2007.05721.x; Hensley SE, 2005, J IMMUNOL, V175, P6032, DOI 10.4049/jimmunol.175.9.6032; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Holdener M, 2008, J EXP MED, V205, P1409, DOI 10.1084/jem.20071859; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Ishibashi D, 2007, VACCINE, V25, P985, DOI 10.1016/j.vaccine.2006.09.078; Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Levavasseur E, 2007, J GEN VIROL, V88, P2353, DOI 10.1099/vir.0.82816-0; Lewicki H, 2003, J VIROL, V77, P3799, DOI 10.1128/JVI.77.6.3799-3808.2003; Lotscher M, 2003, J IMMUNOL, V170, P6040, DOI 10.4049/jimmunol.170.12.6040; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Magri G, 2005, VACCINE, V23, P2862, DOI 10.1016/j.vaccine.2004.11.067; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mennuni C, 2005, INT J CANCER, V117, P444, DOI 10.1002/ijc.21188; Nikles D, 2005, J VIROL, V79, P4033, DOI 10.1128/JVI.79.7.4033-4042.2005; Nitschke C, 2007, VET MICROBIOL, V123, P367, DOI 10.1016/j.vetmic.2007.03.032; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; PORTER DD, 1973, J IMMUNOL, V111, P1407; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rosset MB, 2004, J IMMUNOL, V172, P5168, DOI 10.4049/jimmunol.172.9.5168; Sacquin A, 2008, J IMMUNOL, V181, P768, DOI 10.4049/jimmunol.181.1.768; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Shibagaki N, 2002, J IMMUNOL, V168, P2393, DOI 10.4049/jimmunol.168.5.2393; Tal Y, 2003, J NEUROSCI RES, V71, P286, DOI 10.1002/jnr.10474; TANG Y, 2008, BLOOD, V104, P2704; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Xiang M, 2006, VIRAL IMMUNOL, V19, P210, DOI 10.1089/vim.2006.19.210; Yamanaka H, 2006, VACCINE, V24, P2815, DOI 10.1016/j.vaccine.2005.12.054; Yang TC, 2007, EXPERT REV VACCINES, V6, P347, DOI 10.1586/14760584.6.3.347	54	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4917	10.1371/journal.pone.0004917	http://dx.doi.org/10.1371/journal.pone.0004917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295917	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496700007
J	Weyermann, P; Dallmann, R; Magyar, J; Anklin, C; Hufschmid, M; Dubach-Powell, J; Courdier-Fruh, I; Hennebohle, M; Nordhoff, S; Mondadori, C				Weyermann, Philipp; Dallmann, Robert; Magyar, Josef; Anklin, Corinne; Hufschmid, Martina; Dubach-Powell, Judith; Courdier-Fruh, Isabelle; Henneboehle, Marco; Nordhoff, Sonja; Mondadori, Cesare			Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice	PLOS ONE			English	Article								Background: Cachexia is among the most debilitating and life-threatening aspects of cancer. It represents a metabolic syndrome affecting essential functional circuits involved in the regulation of homeostasis, and includes anorexia, fat and muscle tissue wasting. The anorexigenic peptide alpha-MSH is believed to be crucially involved in the normal and pathologic regulation of food intake. It was speculated that blockade of its central physiological target, the melanocortin (MC)-4 receptor, might provide a promising anti-cachexia treatment strategy. This idea is supported by the fact that in animal studies, agouti-related protein (AgRP), the endogenous inverse agonist at the MC-4 receptor, was found to affect two hallmark features of cachexia, i.e. to increase food intake and to reduce energy expenditure. Methodology/Principal Findings: SNT207707 and SNT209858 are two recently discovered, non peptidic, chemically unrelated, orally active MC-4 receptor antagonists penetrating the blood brain barrier. Both compounds were found to distinctly increase food intake in healthy mice. Moreover, in mice subcutaneously implanted with C26 adenocarcinoma cells, repeated oral administration (starting the day after tumor implantation) of each of the two compounds almost completely prevented tumor induced weight loss, and diminished loss of lean body mass and fat mass. Conclusions/Significance: In contrast to the previously reported peptidic and small molecule MC-4 antagonists, the compounds described here work by the oral administration route. Orally active compounds might offer a considerable advantage for the treatment of cachexia patients.	[Weyermann, Philipp; Dallmann, Robert; Magyar, Josef; Anklin, Corinne; Hufschmid, Martina; Dubach-Powell, Judith; Courdier-Fruh, Isabelle; Henneboehle, Marco; Nordhoff, Sonja; Mondadori, Cesare] Santhera Pharmaceut Switzerland Ltd, Liestal, Switzerland		Weyermann, P (corresponding author), Santhera Pharmaceut Switzerland Ltd, Liestal, Switzerland.	philipp.weyermann@santhera.com	Dallmann, Bob/AAA-4929-2022	Dallmann, Robert/0000-0002-7490-0218	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd. funded and approved the publication of this work.	Argiles JM, 2008, DRUG DISCOV TODAY, V13, P73, DOI 10.1016/j.drudis.2007.10.008; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Chen C, 2008, BIOORGAN MED CHEM, V16, P5606, DOI 10.1016/j.bmc.2008.03.072; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Foster AC, 2005, IDRUGS, V8, P314; Foster AC, 2007, CURR TOP MED CHEM, V7, P1131; Frost RA, 2005, CURR OPIN CLIN NUTR, V8, P255, DOI 10.1097/01.mco.0000165003.16578.2d; Heinrichs SC, 2001, BEHAV BRAIN RES, V125, P81, DOI 10.1016/S0166-4328(01)00287-X; Hoggard N, 2004, J MOL ENDOCRINOL, V33, P693, DOI 10.1677/jme.1.01632; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Joppa MA, 2005, PEPTIDES, V26, P2294, DOI 10.1016/j.peptides.2005.03.002; Kask A, 1998, ENDOCRINOLOGY, V139, P5006, DOI 10.1210/en.139.12.5006; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Laviano A, 1996, NUTRITION, V12, P358, DOI 10.1016/S0899-9007(96)80061-X; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mak RH, 2006, PEDIATR NEPHROL, V21, P1807, DOI 10.1007/s00467-006-0194-3; Markison S, 2005, ENDOCRINOLOGY, V146, P2766, DOI 10.1210/en.2005-0142; Marks DL, 2001, CANCER RES, V61, P1432; Nicholson JR, 2006, J PHARMACOL EXP THER, V317, P771, DOI 10.1124/jpet.105.097725; O'Riordain MG, 1999, INT J ONCOL, V15, P823; Plauth M, 2002, INT J CARDIOL, V85, P83, DOI 10.1016/S0167-5273(02)00236-X; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; Santhera Pharmaceuticals (Switzerland) AG, 2009, Subsituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators, Patent No. [WO 2009/010299 A1, 2009010299]; Santhera Pharmaceuticals (Switzerland) AG, 2008, Preparation of imidazopyridines as melanocortin-4 receptor antagonists, Patent No. [WO 2008/116665 A1, 2008116665]; Scarlett JM, 2005, EXPERT OPIN INV DRUG, V14, P1233, DOI 10.1517/13543784.14.10.1233; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Trayhurn P, 2006, PHILOS T R SOC B, V361, P1237, DOI 10.1098/rstb.2006.1859; Tung YCL, 2006, ENDOCRINOLOGY, V147, P5940, DOI 10.1210/en.2006-0866; Vos TJ, 2004, J MED CHEM, V47, P1602, DOI 10.1021/jm034244g; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6	34	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4774	10.1371/journal.pone.0004774	http://dx.doi.org/10.1371/journal.pone.0004774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295909	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496700001
J	Serino, A; Giovagnoli, G; Ladavas, E				Serino, Andrea; Giovagnoli, Giulia; Ladavas, Elisabetta			I Feel what You Feel if You Are Similar to Me	PLOS ONE			English	Article							SOMATOSENSORY CORTEX; TACTILE PERCEPTION; EMPATHY; TOUCH; VISION; PAIN; SELF; FACE; CONNECTIONS; ACTIVATION	Social interactions are influenced by the perception of others as similar or dissimilar to the self. Such judgements could depend on physical and semantic characteristics, such as membership in an ethnic or political group. In the present study we tested whether social representations of the self and of others could affect the perception of touch. To this aim, we assessed tactile perception on the face when subjects observed a face being touched by fingers. In different conditions we manipulated the identity of the shown face. In a first experiment, Caucasian and Maghrebian participants viewed a face belonging either to their own or to a different ethnic group; in a second experiment, Liberal and Conservative politically active participants viewed faces of politicians belonging to their own or to the opposite political party. The results showed that viewing a touched face most strongly enhanced the perception of touch on the observer's face when the observed face belonged to his/her own ethnic or political group.	[Serino, Andrea; Ladavas, Elisabetta] Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Serino, Andrea; Giovagnoli, Giulia; Ladavas, Elisabetta] Univ Bologna, Ctr Studi Ricerche Neurosci Cognit, Polo Sci Didattico Cesena, Bologna, Italy	University of Bologna; University of Bologna	Serino, A (corresponding author), Univ Bologna, Dipartimento Psicol, Bologna, Italy.	andrea.serino@unibo.it		LADAVAS, ELISABETTA/0000-0001-8930-725X	M.I.U.R. - Italian Ministry of University and Scientific Research	M.I.U.R. - Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	The study was funded by M.I.U.R. - Italian Ministry of University and Scientific Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2009, NEUROIMAGE, V44, P275, DOI 10.1016/j.neuroimage.2008.08.001; Banissy MJ, 2007, NAT NEUROSCI, V10, P815, DOI 10.1038/nn1926; Bender M.B., 1952, DISORDERS PERCEPTION; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Castelli L, 2004, J PERS SOC PSYCHOL, V86, P373, DOI 10.1037/0022-3514.86.3.373; EBISCH SJ, 2008, J COGN NEUROSCI; Fiorio M, 2005, EUR J NEUROSCI, V22, P773, DOI 10.1111/j.1460-9568.2005.04267.x; Haggard P, 2003, CURR BIOL, V13, pR170, DOI 10.1016/S0960-9822(03)00115-5; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Krebs DL, 1997, EVOLUTIONARY SOCIAL, P21; Ladavas E, 2008, ANN NY ACAD SCI, V1124, P98, DOI 10.1196/annals.1440.008; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lickel B, 2000, J PERS SOC PSYCHOL, V78, P223, DOI 10.1037/0022-3514.78.2.223; LONGO MR, 2008, VISUAL ENHANCEMENT T; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Padberg J, 2005, CEREB CORTEX, V15, P1938, DOI 10.1093/cercor/bhi071; Paladino MP, 2008, PERS SOC PSYCHOL B, V34, P755, DOI 10.1177/0146167208315155; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Schaefer M, 2005, NEUROREPORT, V16, P1101, DOI 10.1097/00001756-200507130-00014; Serino A, 2008, PSYCHOL SCI, V19, P434, DOI 10.1111/j.1467-9280.2008.02105.x; Serino A, 2007, NEUROPSYCHOLOGIA, V45, P1101, DOI 10.1016/j.neuropsychologia.2006.09.013; Serino A, 2009, CORTEX, V45, P602, DOI 10.1016/j.cortex.2008.03.008; Singer T, 2005, NAT NEUROSCI, V8, P845, DOI 10.1038/nn0705-845; Spence C., 2004, CROSSMODAL SPACE CRO; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001	36	64	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4930	10.1371/journal.pone.0004930	http://dx.doi.org/10.1371/journal.pone.0004930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293933	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496600015
J	Aviezer, D; Brill-Almon, E; Shaaltiel, Y; Hashmueli, S; Bartfeld, D; Mizrachi, S; Liberman, Y; Freeman, A; Zimran, A; Galun, E				Aviezer, David; Brill-Almon, Einat; Shaaltiel, Yoseph; Hashmueli, Sharon; Bartfeld, Daniel; Mizrachi, Sarah; Liberman, Yael; Freeman, Arnold; Zimran, Ari; Galun, Eithan			A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme-A Preclinical and Phase I Investigation	PLOS ONE			English	Article								Gaucher disease is a progressive lysosomal storage disorder caused by the deficiency of glucocerebrosidase leading to the dysfunction in multiple organ systems. Intravenous enzyme replacement is the accepted standard of treatment. In the current report, we evaluate the safety and pharmacokinetics of a novel human recombinant glucocerebrosidase enzyme expressed in transformed plant cells (prGCD), administered to primates and human subjects. Short term (28 days) and long term (9 months) repeated injections with a standard dose of 60 Units/kg and a high dose of 300 Units/kg were administered to monkeys (n = 4/sex/dose). Neither clinical drug-related adverse effects nor neutralizing antibodies were detected in the animals. In a phase I clinical trial, six healthy volunteers were treated by intravenous infusions with escalating single doses of prGCD. Doses of up to 60 Units/kg were administered at weekly intervals. prGCD infusions were very well tolerated. Anti-prGCD antibodies were not detected. The pharmacokinetic profile of the prGCD revealed a prolonged half-life compared to imiglucerase, the commercial enzyme that is manufactured in a costly mammalian cell system. These studies demonstrate the safety and lack of immunogenicity of prGCD. Following these encouraging results, a pivotal phase III clinical trial for prGCD was FDA approved and is currently ongoing.	[Aviezer, David; Brill-Almon, Einat; Shaaltiel, Yoseph; Hashmueli, Sharon; Bartfeld, Daniel] Protalix Biotherapeut, Carmiel, Israel; [Mizrachi, Sarah; Liberman, Yael; Freeman, Arnold; Galun, Eithan] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Zimran, Ari] Gaucher Clin, Shaare Zedek Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Aviezer, D (corresponding author), Protalix Biotherapeut, Sci Pk, Carmiel, Israel.	eithang@hadassah.org.il	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702	MOLEDA [LSHB-CT-2004-512034]; LIV-ES [LSHB-CT-2008- 223317]; INTHER [LSHB-CT-2005-018961]; Horowitz Foundation; Wolfson Foundation	MOLEDA; LIV-ES; INTHER; Horowitz Foundation; Wolfson Foundation	This work is supported by the grants LSHB-CT-2004-512034 (MOLEDA), LSHB-CT-2008- 223317 (LIV-ES) and LSHB-CT-2005-018961 (INTHER). Additional support was provided through grants from Barbara Fox Miller, Lille and Alfy Nathan, the Horowitz and the Wolfson Foundations. The study was supported also by a grant of the chief scientist office of the Israeli ministry of Industry and Trade.	Arntzen CJ, 2008, SCIENCE, V321, P1052, DOI 10.1126/science.1163420; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beutler E, 2004, PLOS MED, V1, P118, DOI 10.1371/journal.pmed.0010021; Beutler E, 2006, MOL GENET METAB, V88, P208, DOI 10.1016/j.ymgme.2006.01.010; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Futerman AH, 2004, TRENDS PHARMACOL SCI, V25, P147, DOI 10.1016/j.tips.2004.01.004; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Hellwig S, 2004, NAT BIOTECHNOL, V22, P1415, DOI 10.1038/nbt1027; POLLACK A, 2008, CUTTING DOSAGE COSTL; Ponce E, 1997, BLOOD, V90, P43; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Shaaltiel Y, 2007, PLANT BIOTECHNOL J, V5, P579, DOI 10.1111/j.1467-7652.2007.00263.x; SIJMONS PC, 1990, BIO-TECHNOL, V8, P217, DOI 10.1038/nbt0390-217; Starzyk K, 2007, MOL GENET METAB, V90, P157, DOI 10.1016/j.ymgme.2006.09.003; Travis J, 2008, SCIENCE, V320, P473, DOI 10.1126/science.320.5875.473; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; Weinreb NJ, 2008, EXPERT OPIN PHARMACO, V9, P1987, DOI [10.1517/14656566.9.11.1987, 10.1517/14656566.9.11.1987 ]; Wraith EJ, 2005, BIODRUGS, V19, P1, DOI 10.2165/00063030-200519010-00001; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Zhao HQ, 2003, BLOOD CELL MOL DIS, V30, P90, DOI 10.1016/S1079-9796(03)00012-3; ZIMRAN A, 2006, GAUCHER DIS, pCH22	22	125	135	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4792	10.1371/journal.pone.0004792	http://dx.doi.org/10.1371/journal.pone.0004792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277123	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496100015
J	Carpentier, B; Pierobon, P; Hivroz, C; Henry, N				Carpentier, Benoit; Pierobon, Paolo; Hivroz, Claire; Henry, Nelly			T-Cell Artificial Focal Triggering Tools: Linking Surface Interactions with Cell Response	PLOS ONE			English	Article								T-cell activation is a key event in the immune system, involving the interaction of several receptor ligand pairs in a complex intercellular contact that forms between T-cell and antigen-presenting cells. Molecular components implicated in contact formation have been identified, but the mechanism of activation and the link between molecular interactions and cell response remain poorly understood due to the complexity and dynamics exhibited by whole cell-cell conjugates. Here we demonstrate that simplified model colloids grafted so as to target appropriate cell receptors can be efficiently used to explore the relationship of receptor engagement to the T-cell response. Using immortalized Jurkat T cells, we monitored both binding and activation events, as seen by changes in the intracellular calcium concentration. Our experimental strategy used flow cytometry analysis to follow the short time scale cell response in populations of thousands of cells. We targeted both T-cell receptor CD3 (TCR/CD3) and leukocyte-function-associated antigen (LFA-1) alone or in combination. We showed that specific engagement of TCR/CD3 with a single particle induced a transient calcium signal, confirming previous results and validating our approach. By decreasing anti-CD3 particle density, we showed that contact nucleation was the most crucial and determining step in the cell-particle interaction under dynamic conditions, due to shear stress produced by hydrodynamic flow. Introduction of LFA-1 adhesion molecule ligands at the surface of the particle overcame this limitation and elucidated the low TCR/CD3 ligand density regime. Despite their simplicity, model colloids induced relevant biological responses which consistently echoed whole cell behavior. We thus concluded that this biophysical approach provides useful tools for investigating initial events in T-cell activation, and should enable the design of intelligent artificial systems for adoptive immunotherapy.	[Carpentier, Benoit; Pierobon, Paolo; Henry, Nelly] Univ Paris 06, CNRS, UMR 168, Inst Curie,Lab Phys Chim Curie, Paris, France; [Hivroz, Claire] INSERM, Inst Curie, Lab Immun Canc, U 653, Pavillon Pasteur, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Carpentier, B (corresponding author), Univ Paris 06, CNRS, UMR 168, Inst Curie,Lab Phys Chim Curie, Paris, France.	nelly.henry@curie.fr	Pierobon, Paolo/G-7395-2014; Hivroz, Claire/H-2711-2014	Hivroz, Claire/0000-0002-6794-2890	Agence Nationale de la Recherche (ANR); 'Association de Recherche contre le Cancer (ARC)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); 'Association de Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	The work has been supported by the 'Agence Nationale de la Recherche (ANR)' and by the 'Association de Recherche contre le Cancer (ARC)'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Blanchard N, 2002, BIOL CELL, V94, P345, DOI 10.1016/S0248-4900(02)00007-2; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; GOLDSMITH HL, 1967, RHEOLOGY THEORY APPL, V4, P87; Groves JT, 2003, J IMMUNOL METHODS, V278, P19, DOI 10.1016/S0022-1759(03)00193-5; Guelly C, 2002, EUR J IMMUNOL, V32, P182, DOI 10.1002/1521-4141(200201)32:1<182::AID-IMMU182>3.0.CO;2-P; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hashemi BB, 1996, J IMMUNOL, V156, P3660; Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.smim.2007.02.011; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JEDDITEHRANI M, 1992, CELL IMMUNOL, V141, P1, DOI 10.1016/0008-8749(92)90122-6; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kim JV, 2004, NAT BIOTECHNOL, V22, P403, DOI 10.1038/nbt955; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Leboeuf D, 2006, LANGMUIR, V22, P127, DOI 10.1021/la0518501; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lu XL, 2008, CANCER LETT, V271, P129, DOI 10.1016/j.canlet.2008.05.049; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Randriamampita C, 2004, BIOL CELL, V96, P69, DOI 10.1016/j.biolcel.2003.10.008; RICH RR, 1973, J EXP MED, V137, P649, DOI 10.1084/jem.137.3.649; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sarda S, 2004, BIOPHYS J, V86, P3291, DOI 10.1016/S0006-3495(04)74377-5; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910; [No title captured]	48	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4784	10.1371/journal.pone.0004784	http://dx.doi.org/10.1371/journal.pone.0004784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274104	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496000021
J	Ingold, B; Schraml, P; Heppner, FL; Moch, H				Ingold, Barbara; Schraml, Peter; Heppner, Frank L.; Moch, Holger			Homogeneous MGMT Immunoreactivity Correlates with an Unmethylated MGMT Promoter Status in Brain Metastases of Various Solid Tumors	PLOS ONE			English	Article								The O-6-methylguanine-methyltransferase (MGMT) promoter methylation status is a predictive parameter for the response of malignant gliomas to alkylating agents such as temozolomide. First clinical reports on treating brain metastases with temozolomide describe varying effects. This may be due to the fact that MGMT promoter methylation of brain metastases has not yet been explored in depth. Therefore, we assessed MGMT promoter methylation of various brain metastases including those derived from lung (n = 91), breast (n = 72) kidney (n = 49) and from malignant melanomas (n = 113) by methylation-specific polymerase chain reaction (MS-PCR) and MGMT immunoreactivity. Fifty-nine of 199 brain metastases (29.6%) revealed a methylated MGMT promoter. The methylation rate was the highest in brain metastases derived from lung carcinomas (46.5%) followed by those from breast carcinoma (28.8%), malignant melanoma (24.7%) and from renal carcinoma (20%). A significant correlation of homogeneous MGMT-immunoreactivity (>95% MGMT positive tumor cells) and an unmethylated MGMT promoter was found. Promoter methylation was detected in 26 of 61 (43%) tumors lacking MGMT immunoreactivity, in 17 of 63 (27%) metastases with heterogeneous MGMT expression, but only in 5 of 54 brain metastases (9%) showing a homogeneous MGMT immunoreactivity. Our results demonstrate that a significant number of brain metastases reveal a methylated MGMT-promoter. Based on an obvious correlation between homogeneous MGMT immunoreactivity and unmethylated MGMT promoter, we hypothesize that immunohistochemistry for MGMT may be a helpful diagnostic tool to identify those tumors that probably will not benefit from the use of alkylating agents. The discrepancy between promoter methylation and a lack of MGMT immunoreactivity argues for assessing MGMT promoter methylation both by immunohistochemical as well as by molecular approaches for diagnostic purposes.	[Ingold, Barbara; Schraml, Peter; Moch, Holger] Univ Hosp Zurich, Inst Surg Pathol, Dept Pathol, Zurich, Switzerland; [Heppner, Frank L.] Unive Hosp Zurich, Inst Neuropathol, Dept Pathol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Ingold, B (corresponding author), Charite, Inst Pathol, Campus Mitte, D-13353 Berlin, Germany.	barbara.ingold-heppner@charite.de	Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917	Essex Oncology, Lucerne, Switzerland	Essex Oncology, Lucerne, Switzerland	The study was funded by Essex Oncology, Lucerne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda T, 2003, NEUROL RES, V25, P241, DOI 10.1179/016164103101201445; Antonadou D, 2002, J CLIN ONCOL, V20, P3644, DOI 10.1200/JCO.2002.04.140; Bearzatto A, 2000, CANCER RES, V60, P3262; Bello MJ, 2004, MUTAT RES-FUND MOL M, V554, P23, DOI 10.1016/j.mrfmmm.2004.02.011; Blough MD, 2007, CANCER RES, V67, P580, DOI 10.1158/0008-5472.CAN-06-2782; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; CAPPER D, 2007, ACTA NEUROPATHOL BER; Chinot OL, 2007, J CLIN ONCOL, V25, P1470, DOI 10.1200/JCO.2006.07.4807; Crone TM, 1996, MUTAT RES-DNA REPAIR, V363, P15, DOI 10.1016/0921-8777(95)00058-5; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; *G S, 2006, LEITLINIENPAPIER DIA; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gonzalez-Gomez P, 2004, INT J MOL MED, V13, P93; Grasbon-Frodl EM, 2007, INT J CANCER, V121, P2458, DOI 10.1002/ijc.23020; Grombacher T, 1996, CARCINOGENESIS, V17, P2329, DOI 10.1093/carcin/17.11.2329; Harbeck N, 2008, J CLIN ONCOL, V26, P5036, DOI 10.1200/JCO.2007.14.1697; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LIU LL, 1994, CANCER RES, V54, P4648; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Nakasu S, 2004, J NEURO-ONCOL, V70, P333, DOI 10.1007/s11060-004-9170-6; NELSON JS, 1997, PATHOLOGY GENETICS T, P200; OLSSON M, 1980, J BIOL CHEM, V255, P569; Palmisano WA, 2000, CANCER RES, V60, P5954; Park DK, 2002, CANCER CHEMOTH PHARM, V50, P160, DOI 10.1002/s00280-002-0473-z; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Peereboom DM, 2005, NEUROSURGERY, V57, P54, DOI 10.1227/01.NEU.0000182740.39014.9A; Pollack IF, 2006, J CLIN ONCOL, V24, P3431, DOI 10.1200/JCO.2006.05.7265; PREUSSER M, 2008, BRAIN PATHOL; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Rastetter M, 2007, HISTOL HISTOPATHOL, V22, P1005, DOI 10.14670/HH-22.1005; Richards GM, 2007, CRIT REV ONCOL HEMAT, V61, P70, DOI 10.1016/j.critrevonc.2006.06.012; Rolhion C, 1999, INT J CANCER, V84, P416, DOI 10.1002/(SICI)1097-0215(19990820)84:4<416::AID-IJC15>3.0.CO;2-A; Srivenugopal KS, 2001, CLIN CANCER RES, V7, P1398; Srivenugopal KS, 1996, BIOCHEMISTRY-US, V35, P1328, DOI 10.1021/bi9518205; Stupp R, 2007, J CLIN ONCOL, V25, P1459, DOI 10.1200/JCO.2006.09.7139; Theurillat JP, 2007, CANCER IMMUNOL IMMUN, V56, P1723, DOI 10.1007/s00262-007-0316-1; Verger E, 2005, INT J RADIAT ONCOL, V61, P185, DOI 10.1016/j.ijrobp.2004.04.061; Weller Michael, 2005, Future Oncol, V1, P747, DOI 10.2217/14796694.1.6.747	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4775	10.1371/journal.pone.0004775	http://dx.doi.org/10.1371/journal.pone.0004775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274096	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496000014
J	Michelsen, KS; Thomas, LS; Taylor, KD; Yu, QT; Mei, L; Landers, CJ; Derkowski, C; McGovern, DPB; Rotter, JI; Targan, SR				Michelsen, Kathrin S.; Thomas, Lisa S.; Taylor, Kent D.; Yu, Qi T.; Mei, Ling; Landers, Carol J.; Derkowski, Carrie; McGovern, Dermot P. B.; Rotter, Jerome I.; Targan, Stephan R.			IBD-Associated TL1A Gene (TNFSF15) Haplotypes Determine Increased Expression of TL1A Protein	PLOS ONE			English	Article								Background: The recently identified member of the TNF superfamily TL1A (TNFSF15) increases IFN-gamma production by T cells in peripheral and mucosal CCR9+ T cells. TL1A and its receptor DR3 are up-regulated during chronic intestinal inflammation in ulcerative colitis and Crohn's disease (CD). TL1A gene haplotypes increase CD susceptibility in Japanese, European, and US cohorts. Methodology and Principal Findings: Here we report that the presence of TL1A gene haplotype B increases risk in Jewish CD patients with antibody titers for the E. coli outer membrane porin C (OmpC+) (Haplotype B frequency in Jewish CD patients: 24.9% for OmpC negative and 41.9% for OmpC positive patients, respectively, P <= 0.001). CD14+ monocytes isolated from Jewish OmpC+ patients homozygous for TL1A gene haplotype B express higher levels of TL1A in response to Fc gamma R stimulation, a known inducing pathway of TL1A, as measured by ELISA. Furthermore, the membrane expression of TL1A is increased on peripheral monocytes from Jewish but not non-Jewish CD patients with the risk haplotype. Conclusions and Significance: These findings suggest that TL1A gene variation exacerbates induction of TL1A in response to Fc gamma R stimulation in Jewish CD patients and this may lead to chronic intestinal inflammation via overwhelming T cell responses. Thus, TL1A may provide an important target for therapeutic intervention in this subgroup of IBD patients.	[Michelsen, Kathrin S.; Thomas, Lisa S.; Yu, Qi T.; Landers, Carol J.; Derkowski, Carrie; McGovern, Dermot P. B.; Targan, Stephan R.] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; [Michelsen, Kathrin S.; Thomas, Lisa S.; Yu, Qi T.; Landers, Carol J.; Derkowski, Carrie; McGovern, Dermot P. B.; Targan, Stephan R.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Taylor, Kent D.; Mei, Ling; Rotter, Jerome I.] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Michelsen, KS (corresponding author), Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA.	targans@cshs.org	Rotter, Jerome/AAY-6598-2021		NIH [DK056328, DK046763]; Cedars-Sinai Board of Governor's Chair in Medical Genetics; General Clinical Research Center [RR000425]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK056328, P01DK046763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Board of Governor's Chair in Medical Genetics; General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK056328 (S.R.T.) and DK046763 (S.R.T., J.I.R.) and in part by the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). Genotyping was supported in part by the General Clinical Research Center Genotyping Core (RR000425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; BARRETT JC, 2008, NAT GENET; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Dubinsky MC, 2007, INFLAMM BOWEL DIS, V13, P511, DOI 10.1002/ibd.20126; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Kakuta Y, 2006, GUT, V55, P1527, DOI 10.1136/gut.2006.100297; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Li T, 2005, MOL PSYCHIATR, V10, P1037, DOI 10.1038/sj.mp.4001718; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; MEYLAN F, 2008, IMMUNITY; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; Prehn JL, 2004, CLIN IMMUNOL, V112, P66, DOI 10.1016/j.clim.2004.02.007; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROTH MP, 1989, GASTROENTEROLOGY, V96, P1016, DOI 10.1016/0016-5085(89)91618-1; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Shih DQ, 2008, GASTROENTEROLOGY, V134, pA23; Silverberg MS, 2007, EUR J HUM GENET, V15, P328, DOI 10.1038/sj.ejhg.5201756; Sugimura K, 2003, AM J HUM GENET, V72, P509, DOI 10.1086/367848; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; TAYLOR KD, 2008, INFLAMM BOWEL DIS; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517	41	69	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4719	10.1371/journal.pone.0004719	http://dx.doi.org/10.1371/journal.pone.0004719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262684	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490600029
J	Chaurasia, P; Mezei, M; Zhou, MM; Ossowski, L				Chaurasia, Pratima; Mezei, Mihaly; Zhou, Ming-Ming; Ossowski, Liliana			Computer Aided Identification of Small Molecules Disrupting uPAR/alpha 5 beta 1-Integrin Interaction: A New Paradigm for Metastasis Prevention	PLOS ONE			English	Article								Background: Disseminated dormant cancer cells can resume growth and eventually form overt metastases, but the underlying molecular mechanism responsible for this change remains obscure. We previously established that cell surface interaction between urokinase receptor (uPAR) and alpha 5 beta 1-integrin initiates a sequel of events, involving MAPK-ERK activation that culminates in progressive cancer growth. We also identified the site on uPAR that binds alpha 5 beta 1-integrin. Disruption of uPAR/integrin interaction blocks ERK activation and forces cancer cells into dormancy. Methods and Principle Findings: Using a target structure guided computation docking we identified 68 compounds from a diversity library of 13,000 small molecules that were predicted to interact with a previously identified integrin-binding site on uPAR. Of these 68 chemical hits, ten inhibited ERK activation in a cellular assay and of those, 2 compounds, 2-(Pyridin-2-ylamino)-quinolin-8-ol and, 2,2'-(methylimino)di (8-quinolinol) inhibited ERK activation by disrupting the uPAR/integrins interaction. These two compounds, when applied in vivo, inhibited ERK activity and tumor growth and blocked metastases of a model head and neck carcinoma. Conclusions/Significance: We showed that interaction between two large proteins (uPAR and alpha 5 beta 1-integrin) can be disrupted by a small molecule leading to profound downstream effects. Because this interaction occurs in cells with high uPAR expression, a property almost exclusive to cancer cells, we expect a new therapy based on these lead compounds to be cancer cell specific and minimally toxic. This treatment, rather than killing disseminated metastatic cells, should induce a protracted state of dormancy and prevent overt metastases.	[Chaurasia, Pratima; Ossowski, Liliana] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA; [Mezei, Mihaly; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chaurasia, P (corresponding author), Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA.	Liliana.Ossowski@mssm.edu			USPHS [CA87658, CA80058, CA-40578]; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work was supported by funds from the Dr. Golden and Harold Lamport Chair and USPHS Research Grants CA87658 and CA80058 (to M-M.Z), and USPHS Research Grant CA-40578 and the Samuel Waxman Cancer Research Foundation (to LO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Allgayer H, 2008, APMIS, V116, P602, DOI 10.1111/j.1600-0463.2008.00997.x; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; Duffy MJ, 2004, CLIN BIOCHEM, V37, P541, DOI 10.1016/j.clinbiochem.2004.05.013; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Heiss MM, 2002, J CLIN ONCOL, V20, P2005, DOI 10.1200/jco.2002.08.003; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Laufs S, 2006, CELL CYCLE, V5, P1760; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; OSSOWSKI L, 1980, CANCER RES, V40, P2300; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; Petty HR, 2002, IMMUNOL RES, V25, P75, DOI 10.1385/IR:25:1:75; Pierga JY, 2005, INT J CANCER, V114, P291, DOI 10.1002/ijc.20698; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Romer J, 2004, CURR PHARM DESIGN, V10, P2359, DOI 10.2174/1381612043383962; Tang CH, 2008, CELL MOL LIFE SCI, V65, P1916, DOI 10.1007/s00018-008-7573-9; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x	33	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4617	10.1371/journal.pone.0004617	http://dx.doi.org/10.1371/journal.pone.0004617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242538	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487500018
J	Guedj, F; Sebrie, C; Rivals, I; Ledru, A; Paly, E; Bizot, JC; Smith, D; Rubin, E; Gillet, B; Arbones, M; Delabar, JM				Guedj, Faycal; Sebrie, Catherine; Rivals, Isabelle; Ledru, Aurelie; Paly, Evelyne; Bizot, Jean C.; Smith, Desmond; Rubin, Edward; Gillet, Brigitte; Arbones, Mariona; Delabar, Jean M.			Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A	PLOS ONE			English	Article								Individuals with partial HSA21 trisomies and mice with partial MMU16 trisomies containing an extra copy of the DYRK1A gene present various alterations in brain morphogenesis. They present also learning impairments modeling those encountered in Down syndrome. Previous MRI and histological analyses of a transgenic mice generated using a human YAC construct that contains five genes including DYRK1A reveal that DYRK1A is involved, during development, in the control of brain volume and cell density of specific brain regions. Gene dosage correction induces a rescue of the brain volume alterations. DYRK1A is also involved in the control of synaptic plasticity and memory consolidation. Increased gene dosage results in brain morphogenesis defects, low BDNF levels and mnemonic deficits in these mice. Epigallocatechin gallate ( EGCG) - a member of a natural polyphenols family, found in great amount in green tea leaves - is a specific and safe DYRK1A inhibitor. We maintained control and transgenic mice overexpressing DYRK1A on two different polyphenol-based diets, from gestation to adulthood. The major features of the transgenic phenotype were rescued in these mice.	[Guedj, Faycal; Ledru, Aurelie; Paly, Evelyne; Delabar, Jean M.] Univ Paris 07, Paris, France; [Guedj, Faycal; Ledru, Aurelie; Paly, Evelyne; Delabar, Jean M.] CNRS, Paris, France; [Sebrie, Catherine; Gillet, Brigitte] ICSN, CNRS, Lab RMN Biol, Gif Sur Yvette, France; [Rivals, Isabelle] ESPCI, Equipe Stat Appliquee, Paris, France; [Bizot, Jean C.] Parc Technol Source, Key Obs SA, Orleans, France; [Smith, Desmond; Rubin, Edward] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; LBNL, Dept Genome Sci, Berkeley, CA USA; [Arbones, Mariona] UPF, Ctr Genom Regulat, Barcelona, Spain	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Guedj, F (corresponding author), Univ Paris 07, Paris, France.	delabar@univ-paris-diderot.fr	Arbones, Maria/D-4668-2016; Rivals, Isabelle/AAE-7971-2022	Arbones, Maria/0000-0002-6035-0235; Rivals, Isabelle/0000-0002-8736-7010	EU [FP5, FP6]	EU(European Commission)	This work was supported by EU grants: T21 targets(FP5) and AnEUploidy (FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 2006, BIOCHEMISTRY-US, V45, P12011, DOI 10.1021/bi060632j; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Aldridge K, 2007, AM J MED GENET A, V143A, P1060, DOI 10.1002/ajmg.a.31721; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Chabert C, 2004, BEHAV GENET, V34, P559, DOI 10.1007/s10519-004-5584-3; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Chu KO, 2007, HUM REPROD, V22, P280, DOI 10.1093/humrep/del353; Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2; Dahmane N, 1998, GENOMICS, V48, P12, DOI 10.1006/geno.1997.5146; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hattori M, 2000, NATURE, V407, P110; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Korenberg JR, 1997, CYTOGENET CELL GENET, V79, P22; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Murakami N, 2006, J BIOL CHEM, V281, P23712, DOI 10.1074/jbc.M513497200; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olofsdotter K, 2000, NEUROSCIENCE, V101, P531, DOI 10.1016/S0306-4522(00)00428-0; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Ronan A, 2007, J MED GENET, V44, P448, DOI 10.1136/jmg.2006.047373; Sebrie C, 2008, ANAT REC, V291, P254, DOI 10.1002/ar.20640; Siarey RJ, 1999, NEUROPHARMACOLOGY, V38, P1917, DOI 10.1016/S0028-3908(99)00083-0; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Tanaka T, 1997, J NEUROSCI, V17, P2959; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; VANPRAAG H, 2007, J NEUROSCI, V27, pR2; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; XIE W, 2007, NEUROCHEM RES; Yang DJ, 2007, J CHROMATOGR A, V1156, P312, DOI 10.1016/j.chroma.2006.11.088	47	146	150	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4606	10.1371/journal.pone.0004606	http://dx.doi.org/10.1371/journal.pone.0004606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242551	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487500011
J	Karpinets, TV; Pelletier, DA; Pan, CL; Uberbacher, EC; Melnichenko, GV; Hettich, RL; Samatova, NF				Karpinets, Tatiana V.; Pelletier, Dale A.; Pan, Chongle; Uberbacher, Edward C.; Melnichenko, Galina V.; Hettich, Robert L.; Samatova, Nagiza F.			Phenotype Fingerprinting Suggests the Involvement of Single-Genotype Consortia in Degradation of Aromatic Compounds by Rhodopseudomonas palustris	PLOS ONE			English	Article							NITROGEN-FIXATION; MOLECULAR CHARACTERIZATION; ANAEROBIC DEGRADATION; MARINE ECOSYSTEMS; CARBON SOURCE; FRESH-WATER; EXPRESSION; METABOLISM; SPHAEROIDES; ESTUARINE	Anaerobic degradation of complex organic compounds by microorganisms is crucial for development of innovative biotechnologies for bioethanol production and for efficient degradation of environmental pollutants. In natural environments, the degradation is usually accomplished by syntrophic consortia comprised of different bacterial species. This strategy allows consortium organisms to reduce efforts required for maintenance of the redox homeostasis at each syntrophic level. Cellular mechanisms that maintain the redox homeostasis during the degradation of aromatic compounds by one organism are not fully understood. Here we present a hypothesis that the metabolically versatile phototrophic bacterium Rhodopseudomonas palustris forms its own syntrophic consortia, when it grows anaerobically on p-coumarate or benzoate as a sole carbon source. We have revealed the consortia from large-scale measurements of mRNA and protein expressions under p-coumarate, benzoate and succinate degrading conditions using a novel computational approach referred as phenotype fingerprinting. In this approach, marker genes for known R. palustris phenotypes are employed to determine the relative expression levels of genes and proteins in aromatics versus non-aromatics degrading condition. Subpopulations of the consortia are inferred from the expression of phenotypes and known metabolic modes of the R. palustris growth. We find that p-coumarate degrading conditions may lead to at least three R. palustris subpopulations utilizing p-coumarate, benzoate, and CO2 and H-2. Benzoate degrading conditions may also produce at least three subpopulations utilizing benzoate, CO2 and H-2, and N-2 and formate. Communication among syntrophs and inter-syntrophic dynamics in each consortium are indicated by up-regulation of transporters and genes involved in the curli formation and chemotaxis. The N-2-fixing subpopulation in the benzoate degrading consortium has preferential activation of the vanadium nitrogenase over the molybdenum nitrogenase. This subpopulation in the consortium was confirmed in an independent experiment by consumption of dissolved nitrogen gas under the benzoate degrading conditions.	[Karpinets, Tatiana V.] Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA; [Karpinets, Tatiana V.; Pan, Chongle; Samatova, Nagiza F.] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN USA; [Pelletier, Dale A.; Uberbacher, Edward C.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Pan, Chongle; Hettich, Robert L.] Oak Ridge Natl Lab, Chem Sci Div, Oak Ridge, TN USA; [Karpinets, Tatiana V.] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; [Melnichenko, Galina V.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA; [Samatova, Nagiza F.] N Carolina State Univ, Dept Comp Sci, Raleigh, NC USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of North Carolina; North Carolina State University	Karpinets, TV (corresponding author), Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA.	karpinetstv@ornl.gov	Pelletier, Dale/F-4154-2011; Hettich, Robert L/N-1458-2016; Pan, Chongle/C-6960-2008	Hettich, Robert L/0000-0001-7708-786X; Pan, Chongle/0000-0003-2860-0334; Pelletier, Dale/0000-0002-4321-7918	U.S. Department of Energy (Office of Advanced Scientific Computing Research, Office of Science); Office of Biological and Environmental Research, U.S. Department of Energy; BioEnergy Science Center (BESC); UT-Battelle, LLC [DE-AC05-00OR22725]	U.S. Department of Energy (Office of Advanced Scientific Computing Research, Office of Science)(United States Department of Energy (DOE)); Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE)); BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); UT-Battelle, LLC	This research has been supported by the "Exploratory Data Intensive Computing for Complex Biological Systems" project from U.S. Department of Energy (Office of Advanced Scientific Computing Research, Office of Science). Research also sponsored by the Office of Biological and Environmental Research, U.S. Department of Energy, through the ORNL Genomics:GTL Center for Molecular and Cellular Systems (CMCS). This research was sponsored in part by the BioEnergy Science Center (BESC). The BioEnergy Science Center is a U.S. Department of Energy Bioenergy. Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. Oak Ridge National Laboratory (ORNL) is managed and operated under contract No. DE-AC05-00OR22725 by UT-Battelle, LLC. The work of Nagiza Samatova was partially supported by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory.	BARASSI CA, 1985, J BACTERIOL, V163, P778, DOI 10.1128/JB.163.2.778-782.1985; Barbosa MJ, 2001, J BIOTECHNOL, V85, P25, DOI 10.1016/S0168-1656(00)00368-0; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Becker JG, 2005, ENVIRON HEALTH PERSP, V113, P310, DOI 10.1289/ehp.6933; Boll M, 2005, J MOL MICROB BIOTECH, V10, P132, DOI 10.1159/000091560; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Castonguay MH, 2006, RES MICROBIOL, V157, P471, DOI 10.1016/j.resmic.2005.10.003; Chen LL, 2007, BIOSENS BIOELECTRON, V22, P1487, DOI 10.1016/j.bios.2006.06.038; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; ELDER DJE, 1992, ARCH MICROBIOL, V157, P148, DOI 10.1007/BF00245283; FALCONE DL, 1991, J BACTERIOL, V173, P2099, DOI 10.1128/jb.173.6.2099-2108.1991; Ficker M, 1999, APPL ENVIRON MICROB, V65, P5576; FISHER SH, 1991, ANNU REV MICROBIOL, V45, P107, DOI 10.1146/annurev.mi.45.100191.000543; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; HALLENBECK PL, 1990, J BACTERIOL, V172, P1736, DOI 10.1128/jb.172.4.1736-1748.1990; Harrison FH, 2005, MICROBIOL-SGM, V151, P727, DOI 10.1099/mic.0.27731-0; HARRISON FH, 2005, THESIS U IOWA IOWA C; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Heider J, 1997, EUR J BIOCHEM, V243, P577, DOI 10.1111/j.1432-1033.1997.00577.x; HELRICK K, 1990, OFFICIAL METHODS ANA, V1422, P2; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; Joshi HM, 1996, P NATL ACAD SCI USA, V93, P14515, DOI 10.1073/pnas.93.25.14515; KARL D, 2004, DINITROGEN FIXATION, P47; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kasai Y, 2005, ENVIRON MICROBIOL, V7, P806, DOI 10.1111/j.1462-2920.2005.00754.x; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; MCEWAN AG, 1994, ANTON LEEUW INT J G, V66, P151, DOI 10.1007/BF00871637; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oda Y, 2005, J BACTERIOL, V187, P7784, DOI 10.1128/JB.187.22.7784-7794.2005; OREMLAND RS, 1978, GEOCHIM COSMOCHIM AC, V42, P209, DOI 10.1016/0016-7037(78)90133-3; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; QADRI SM, 1968, J BACTERIOL, V95, P2344, DOI 10.1128/JB.95.6.2344-2357.1968; Qian YL, 1998, J BACTERIOL, V180, P4644, DOI 10.1128/JB.180.17.4644-4649.1998; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Rey FE, 2006, J BACTERIOL, V188, P6143, DOI 10.1128/JB.00381-06; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Sawayama S, 2001, J BIOSCI BIOENG, V91, P195, DOI 10.1263/jbb.91.195; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; Thompson MR, 2008, ANAL CHEM, V80, P9517, DOI 10.1021/ac801707s; VARGA AR, 1983, J BACTERIOL, V154, P1414, DOI 10.1128/JB.154.3.1414-1430.1983; VerBerkmoes NC, 2006, J PROTEOME RES, V5, P287, DOI 10.1021/pr0503230; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; WANG X, 1993, J BACTERIOL, V175, P3372, DOI 10.1128/jb.175.11.3372-3379.1993; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WEBER A, 1986, PLANT SOIL, V90, P419, DOI 10.1007/BF02277413; Wolin M.J., 1982, ASM NEWS, V48, P561; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624; Zwolinski MD, 2000, BIODEGRADATION, V11, P141, DOI 10.1023/A:1011190316012	50	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4615	10.1371/journal.pone.0004615	http://dx.doi.org/10.1371/journal.pone.0004615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242537	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487500017
J	Carrara, VI; Zwang, J; Ashley, EA; Price, RN; Stepniewska, K; Barends, M; Brockman, A; Anderson, T; McGready, R; Phaiphun, L; Proux, S; van Vugt, M; Hutagalung, R; Lwin, KM; Phyo, AP; Preechapornkul, P; Imwong, M; Pukrittayakamee, S; Singhasivanon, P; White, NJ; Nosten, F				Carrara, Verena Ilona; Zwang, Julien; Ashley, Elizabeth A.; Price, Ric N.; Stepniewska, Kasia; Barends, Marion; Brockman, Alan; Anderson, Tim; McGready, Rose; Phaiphun, Lucy; Proux, Stephane; van Vugt, Michele; Hutagalung, Robert; Lwin, Khin Maung; Phyo, Aung Pyae; Preechapornkul, Piyanuch; Imwong, Mallika; Pukrittayakamee, Sasithon; Singhasivanon, Pratap; White, Nicholas J.; Nosten, Francois			Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment	PLOS ONE			English	Article								Background: Artemisinin combination treatments (ACT) are recommended as first line treatment for falciparum malaria throughout the malaria affected world. We reviewed the efficacy of a 3-day regimen of mefloquine and artesunate regimen (MAS(3)), over a 13 year period of continuous deployment as first-line treatment in camps for displaced persons and in clinics for migrant population along the Thai-Myanmar border. Methods and Findings: 3,264 patients were enrolled in prospective treatment trials between 1995 and 2007 and treated with MAS(3). The proportion of patients with parasitaemia persisting on day-2 increased significantly from 4.5% before 2001 to 21.9% since 2002 (p<0.001). Delayed parasite clearance was associated with increased risk of developing gametocytaemia (AOR = 2.29; 95% CI, 2.00-2.69, p = 0.002). Gametocytaemia on admission and carriage also increased over the years (p = 0.001, test for trend, for both). MAS(3) efficacy has declined slightly but significantly (Hazards ratio 1.13; 95% CI, 1.07-1.19, p<0.001), although efficacy in 2007 remained well within acceptable limits: 96.5% (95% CI, 91.0-98.7). The in vitro susceptibility of P. falciparum to artesunate increased significantly until 2002, but thereafter declined to levels close to those of 13 years ago (geometric mean in 2007: 4.2 nM/l; 95% CI, 3.2-5.5). The proportion of infections caused by parasites with increased pfmdr1 copy number rose from 30% (12/40) in 1996 to 53% (24/45) in 2006 (p = 0.012, test for trend). Conclusion: Artesunate-mefloquine remains a highly efficacious antimalarial treatment in this area despite 13 years of widespread intense deployment, but there is evidence of a modest increase in resistance. Of particular concern is the slowing of parasitological response to artesunate and the associated increase in gametocyte carriage.	[Carrara, Verena Ilona; Zwang, Julien; Ashley, Elizabeth A.; Barends, Marion; McGready, Rose; Phaiphun, Lucy; Proux, Stephane; van Vugt, Michele; Hutagalung, Robert; Lwin, Khin Maung; Phyo, Aung Pyae; Nosten, Francois] Shoklo Malaria Res Unit, Tak, Thailand; [Ashley, Elizabeth A.; Stepniewska, Kasia; McGready, Rose; Preechapornkul, Piyanuch; Imwong, Mallika; Pukrittayakamee, Sasithon; Singhasivanon, Pratap; White, Nicholas J.; Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Ashley, Elizabeth A.; Price, Ric N.; Stepniewska, Kasia; McGready, Rose; White, Nicholas J.; Nosten, Francois] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Price, Ric N.; Brockman, Alan] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Anderson, Tim] Southwest Fdn Biomed Res, San Antonio, TX USA	Mahidol University; Mahidol University; University of Oxford; Charles Darwin University; Menzies School of Health Research; Texas Biomedical Research Institute	Carrara, VI (corresponding author), Shoklo Malaria Res Unit, Tak, Thailand.	smru@tropmedres.ac	Phyo, Aung Pyae/K-2413-2019; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Imwong, Mallika/ABE-6493-2020; Phyo, Aung Pyae/GYU-6181-2022; McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019; Carrara, Verena/R-6492-2019	Phyo, Aung Pyae/0000-0002-0383-9624; White, Nick/0000-0002-1897-1978; Phyo, Aung Pyae/0000-0002-0383-9624; McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Carrara, Verena/0000-0002-2758-0872; Stepniewska, Kasia/0000-0002-1713-6209; Singhasivanon, Pratap/0000-0002-9759-1702; Price, Richard/0000-0003-2000-2874	Wellcome Trust of Great Britain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048071] Funding Source: NIH RePORTER	Wellcome Trust of Great Britain(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from the Wellcome Trust of Great Britain. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Ashley EA, 2006, TROP MED INT HEALTH, V11, P1653, DOI 10.1111/j.1365-3156.2006.01724.x; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Chareonviriyaphap Theeraphap, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P225; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46; LUXEMBURGER C, 1994, T ROY SOC TROP MED H, V88, P213, DOI 10.1016/0035-9203(94)90303-4; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Nosten F, 2005, LANCET, V365, P653; PREECHAPORNKUL P, ANTIMICROB IN PRESS; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Rojanawatsirivej C., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P536; Rojanawatsirivet Chaiporn, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P560; Rooney W., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P131; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Thimasarn Krongthong, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P465; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; van Vugt M, 2002, CLIN INFECT DIS, V35, P1498, DOI 10.1086/344901; van Vugt M, 1998, ANTIMICROB AGENTS CH, V42, P135, DOI 10.1128/AAC.42.1.135; Vijaykadga S, 2006, TROP MED INT HEALTH, V11, P211, DOI 10.1111/j.1365-3156.2005.01557.x; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; Wongsrichanalai Chansuda, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P300	33	187	190	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4551	10.1371/journal.pone.0004551	http://dx.doi.org/10.1371/journal.pone.0004551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234601	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487200007
J	Mutoh, H; Perron, A; Dimitrov, D; Iwamoto, Y; Akemann, W; Chudakov, DM; Knopfel, T				Mutoh, Hiroki; Perron, Amelie; Dimitrov, Dimitar; Iwamoto, Yuka; Akemann, Walther; Chudakov, Dmitriy M.; Knoepfel, Thomas			Spectrally-Resolved Response Properties of the Three Most Advanced FRET Based Fluorescent Protein Voltage Probes	PLOS ONE			English	Article								Genetically-encoded optical probes for membrane potential hold the promise of monitoring electrical signaling of electrically active cells such as specific neuronal populations in intact brain tissue. The most advanced class of these probes was generated by molecular fusion of the voltage sensing domain (VSD) of Ci-VSP with a fluorescent protein (FP) pair. We quantitatively compared the three most advanced versions of these probes (two previously reported and one new variant), each involving a spectrally distinct tandem of FPs. Despite these different FP tandems and dissimilarities within the amino acid sequence linking the VSD to the FPs, the amplitude and kinetics of voltage dependent fluorescence changes were surprisingly similar. However, each of these fluorescent probes has specific merits when considering different potential applications.	[Mutoh, Hiroki; Perron, Amelie; Dimitrov, Dimitar; Iwamoto, Yuka; Akemann, Walther; Knoepfel, Thomas] RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama, Japan; [Chudakov, Dmitriy M.] RAS Miklukho Maklaya, Shemyakin and Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	RIKEN; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Mutoh, H (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama, Japan.	tknopfel@brain.riken.jp	Knöpfel, Thomas/B-1128-2008; Iwamoto, Yuka/C-6026-2017; Akemann, Walther/A-7593-2011; Mutoh, Hiroki/D-5240-2009; Chudakov, Dmitriy M/G-7741-2014	Knöpfel, Thomas/0000-0002-5718-0765; Iwamoto, Yuka/0000-0002-1178-0044; Akemann, Walther/0000-0002-4978-4665; Chudakov, Dmitriy M/0000-0003-0430-790X	RIKEN Brain Science Institute; NIH [NS057631]; Japanese Society for the Promotion of Science-Canadian Institutes for Health Research program [fellowship, grant-in-Aid]; MCB RAS [02.513.12.3013]; Rosnauka [02.513.12.3013]	RIKEN Brain Science Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Society for the Promotion of Science-Canadian Institutes for Health Research program(Canadian Institutes of Health Research (CIHR)); MCB RAS; Rosnauka	This work was supported by an intramural grant from the RIKEN Brain Science Institute (TK), by NIH grant NS057631 (under a sub award granted by Yale University to TK), a fellowship from the Japanese Society for the Promotion of Science-Canadian Institutes for Health Research program (AP) and a grant-in-Aid for JSPS Fellows (AP). DMC is supported by MCB RAS and Rosnauka [02.513.12.3013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER BJ, 2008, BRAIN CELL BIOL; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Pham E, 2007, STRUCTURE, V15, P515, DOI 10.1016/j.str.2007.03.009; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; VILLALBAGALEA CA, 2008, P NATL ACAD SCI US; VILLALBAGALEA CA, 2008, BIOPHYS J, V94, P1362	12	57	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4555	10.1371/journal.pone.0004555	http://dx.doi.org/10.1371/journal.pone.0004555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234605	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487200011
J	Brisse, S; Fevre, C; Passet, V; Issenhuth-Jeanjean, S; Tournebize, R; Diancourt, L; Grimont, P				Brisse, Sylvain; Fevre, Cindy; Passet, Virginie; Issenhuth-Jeanjean, Sylvie; Tournebize, Regis; Diancourt, Laure; Grimont, Patrick			Virulent Clones of Klebsiella pneumoniae: Identification and Evolutionary Scenario Based on Genomic and Phenotypic Characterization	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; ESCHERICHIA-COLI; BETA-LACTAMASE; CALYMMATOBACTERIUM-GRANULOMATIS; GENE-CLUSTER; SEROTYPE K1; STRAINS; RECOMBINATION; INFECTIONS; SEQUENCE	Klebsiella pneumoniae is found in the environment and as a harmless commensal, but is also a frequent nosocomial pathogen (causing urinary, respiratory and blood infections) and the agent of specific human infections including Friedlander's pneumonia, rhinoscleroma and the emerging disease pyogenic liver abscess (PLA). The identification and precise definition of virulent clones, i.e. groups of strains with a single ancestor that are associated with particular infections, is critical to understand the evolution of pathogenicity from commensalism and for a better control of infections. We analyzed 235 K. pneumoniae isolates of diverse environmental and clinical origins by multilocus sequence typing, virulence gene content, biochemical and capsular profiling and virulence to mice. Phylogenetic analysis of housekeeping genes clearly defined clones that differ sharply by their clinical source and biological features. First, two clones comprising isolates of capsular type K1, clone CC23(K1) and clone CC82(K1), were strongly associated with PLA and respiratory infection, respectively. Second, only one of the two major disclosed K2 clones was highly virulent to mice. Third, strains associated with the human infections ozena and rhinoscleroma each corresponded to one monomorphic clone. Therefore, K. pneumoniae subsp. ozaenae and K. pneumoniae subsp. rhinoscleromatis should be regarded as virulent clones derived from K. pneumoniae. The lack of strict association of virulent capsular types with clones was explained by horizontal transfer of the cps operon, responsible for the synthesis of the capsular polysaccharide. Finally, the reduction of metabolic versatility observed in clones Rhinoscleromatis, Ozaenae and CC82(K1) indicates an evolutionary process of specialization to a pathogenic lifestyle. In contrast, clone CC23(K1) remains metabolically versatile, suggesting recent acquisition of invasive potential. In conclusion, our results reveal the existence of important virulent clones associated with specific infections and provide an evolutionary framework for research into the links between clones, virulence and other genomic features in K. pneumoniae.	[Brisse, Sylvain; Fevre, Cindy; Passet, Virginie; Issenhuth-Jeanjean, Sylvie; Diancourt, Laure; Grimont, Patrick] Inst Pasteur, Paris, France; [Tournebize, Regis] Inst Pasteur, Unite Pathogen Microbienne Mol, Paris, France; [Tournebize, Regis] Inst Pasteur, INSERM, U786, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brisse, S (corresponding author), Inst Pasteur, Paris, France.	sylvain.brisse@pasteur.fr	Brisse, Sylvain/M-8723-2013; Tournebize, Regis/K-7847-2018	Brisse, Sylvain/0000-0002-2516-2108; Tournebize, Regis/0000-0003-3718-3130; Grimont, Patrick/0000-0002-6264-136X	Institut Pasteur; Conny-Maeva Charitable Foundation	Institut Pasteur(European Commission); Conny-Maeva Charitable Foundation	This work received financial support from Institut Pasteur and from a generous gift by the Conny-Maeva Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; ARAKAWA Y, 1995, J BACTERIOL, V177, P1788, DOI 10.1128/jb.177.7.1788-1796.1995; BISERCIC M, 1991, J BACTERIOL, V173, P3894; BRENNER D J, 1972, International Journal of Systematic Bacteriology, V22, P193; Brisse S, 2005, VET MICROBIOL, V105, P307, DOI 10.1016/j.vetmic.2004.11.010; Brisse S, 2004, J CLIN MICROBIOL, V42, P3388, DOI 10.1128/JCM.42.8.3388-3398.2004; Brisse S, 2001, INT J SYST EVOL MICR, V51, P915, DOI 10.1099/00207713-51-3-915; Brisse S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P159, DOI 10.1007/0-387-30746-x_8; CARPENTER JL, 1990, REV INFECT DIS, V12, P672; Carter JS, 1999, INT J SYST BACTERIOL, V49, P1695, DOI 10.1099/00207713-49-4-1695; Chand MS, 1997, OTOLARYNG HEAD NECK, V116, P554, DOI 10.1016/S0194-5998(97)70311-5; CHENG DL, 1991, ARCH INTERN MED, V151, P1557; Cheng Hsiao-Pei, 2002, Journal of Microbiology Immunology and Infection, V35, P85; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Colodner R, 2004, EUR J CLIN MICROBIOL, V23, P163, DOI 10.1007/s10096-003-1084-2; Dagan T, 2006, MOL BIOL EVOL, V23, P310, DOI 10.1093/molbev/msj036; DARFEUILLE-MICHAUD A, 1992, INFECT IMMUN, V60, P44, DOI 10.1128/IAI.60.1.44-55.1992; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; DIMARTINO P, 1995, INFECT IMMUN, V63, P4336, DOI 10.1128/IAI.63.11.4336-4344.1995; EICKHOFF TC, 1966, ANN INTERN MED, V65, P1163, DOI 10.7326/0003-4819-65-6-1163; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Fang FC, 2005, J CLIN MICROBIOL, V43, P991, DOI 10.1128/JCM.43.2.991-992.2005; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fevre C, 2005, ANTIMICROB AGENTS CH, V49, P5149, DOI 10.1128/AAC.49.12.5149-5152.2005; GOLDSTEIN EJC, 1978, J CLIN MICROBIOL, V8, P413; Grimont P. A. D., 2005, BERGEYS MANUAL SYS B, P685; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hansen DS, 2002, CLIN MICROBIOL INFEC, V8, P397, DOI 10.1046/j.1469-0691.2002.00411.x; Hart CA, 2000, J MED MICROBIOL, V49, P395, DOI 10.1099/0022-1317-49-5-395; HORNICK DB, 1992, INFECT IMMUN, V60, P1577, DOI 10.1128/IAI.60.4.1577-1588.1992; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Kharsany ABM, 1999, J MED MICROBIOL, V48, P841, DOI 10.1099/00222615-48-9-841; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Kohler Jonathan E, 2007, Surg Infect (Larchmt), V8, P227, DOI 10.1089/sur.2006.007; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lai YC, 2003, FEMS MICROBIOL LETT, V218, P121, DOI 10.1016/S0378-1097(02)01120-5; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Lu CH, 2002, J CLIN NEUROSCI, V9, P533, DOI 10.1054/jocn.2001.1032; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; McVean G, 2002, GENETICS, V160, P1231; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; NELSON K, 1994, P NATL ACAD SCI USA, V91, P10227, DOI 10.1073/pnas.91.21.10227; NOUVELLON M, 1994, J CLIN MICROBIOL, V32, P2625, DOI 10.1128/JCM.32.10.2625-2627.1994; OFEK I, 1993, INFECT IMMUN, V61, P4208, DOI 10.1128/IAI.61.10.4208-4216.1993; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; ORSKOV I, 1974, BERGEYS MANUAL DETER, P321; Orskov I., 1984, BERGEYS MANUAL SYSTE, V1, P461; ORSKOV I, 1981, PROCARYOTES HDB HABI, P1160; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Regue M, 2001, J BACTERIOL, V183, P3564, DOI 10.1128/JB.183.12.3564-3573.2001; RICHARD C, 1973, ANN BIOL CLIN-PARIS, V31, P295; RICHARD C, 1989, B SOC PATHOL EXOT, V82, P458; RICHENS J, 1985, PAPUA NEW GUINEA MED, V28, P67; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sarma PS, 2007, INT J INFECT DIS, V11, P86, DOI 10.1016/j.ijid.2005.11.003; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Seidler R. J., 1981, The prokaryotes. A handbook on habitats, isolation, and identification of bacteria. Volumes I and II, P1166; Shehata MA, 1996, AM J OTOLARYNG, V17, P81, DOI 10.1016/S0196-0709(96)90000-9; SIMOONSSMIT AM, 1984, J MED MICROBIOL, V17, P67, DOI 10.1099/00222615-17-1-67; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Struve C, 2005, J MED MICROBIOL, V54, P1111, DOI 10.1099/jmm.0.46165-0; TAINTURIER D, 1986, REV MED VET-TOULOUSE, V137, P49; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Turton JF, 2007, J MED MICROBIOL, V56, P593, DOI 10.1099/jmm.0.46964-0; van Westreenen M, 2003, J ANTIMICROB CHEMOTH, V52, P530, DOI 10.1093/jac/dkg382; VANKREGTEN E, 1984, J CLIN MICROBIOL, V20, P936, DOI 10.1128/JCM.20.5.936-941.1984; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Williams P., 1990, Reviews in Medical Microbiology, V1, P196; Wong CH, 2004, EUR J CLIN MICROBIOL, V23, P403, DOI 10.1007/s10096-004-1125-5; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; YU WL, 2008, DIAGN MICROBIOL INFE	92	299	322	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4982	10.1371/journal.pone.0004982	http://dx.doi.org/10.1371/journal.pone.0004982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319196	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499200013
J	Cheng, L; Pilder, S; Nairn, AC; Ramdas, S; Vijayaraghavan, S				Cheng, Lina; Pilder, Stephen; Nairn, Angus C.; Ramdas, Shandilya; Vijayaraghavan, Srinivasan			PP1 gamma 2 and PPP1R11 Are Parts of a Multimeric Complex in Developing Testicular Germ Cells in which their Steady State Levels Are Reciprocally Related	PLOS ONE			English	Article								Mice lacking the protein phosphatase 1 gamma isoforms, PP1 gamma 1 and PP1 gamma 2, are male-sterile due to defective germ cell morphogenesis and apoptosis. However, this deficiency causes no obvious abnormality in other tissues. A biochemical approach was employed to learn how expression versus deficiency of PP1 gamma 2, the predominant PP1 isoform in male germ cells, affects spermatogenesis. Methods used in this study include column chromatography, western blot and northern blot analyses, GST pull-down assays, immunoprecipitation, non-denaturing gel electrophoresis, phosphatase enzyme assays, protein sequencing, and immunohistochemistry. We report for the first time that in wild-type testis, PP1 gamma 2 forms an inactive complex with actin, protein phosphatase 1 regulatory subunit 7 (PPP1R7), and protein phosphatase 1 regulatory subunit 11 (PPP1R11), the latter, a potent PP1 inhibitor. Interestingly, PPP1R11 protein, but not its mRNA level, falls significantly in PP1 gamma-null testis where mature sperm are virtually absent. Conversely, both mature sperm numbers and the PPP1R11 level increase substantially in PP1 gamma-null testis expressing transgenic PP1 gamma 2. PPP1R11 also appears to be ubiquitinated in PP1 gamma-null testis. The levels of PP1 gamma 2 and PPP1R11 were increased in phenotypically normal PP1 alpha-null testis. However, in PP1 alpha-null spleen, where PP1 gamma 2 normally is not expressed, PPP1R11 levels remained unchanged. Our data clearly show a direct reciprocal relationship between the levels of the protein phosphatase isoform PP1 gamma 2 and its regulator PPP1R11, and suggest that complex formation between these polypeptides in testis may prevent proteolysis of PPP1R11 and thus, germ cell apoptosis.	[Cheng, Lina; Ramdas, Shandilya; Vijayaraghavan, Srinivasan] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Pilder, Stephen] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Yale University	Cheng, L (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	svijayar@kent.edu		Nairn, Angus/0000-0002-7075-0195	NIH [R01 HD38520, HD31164, DA10044]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD031164, R01HD031164, R29HD031164, R01HD038520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01 HD38520 (SV), HD31164 (SP), and DA10044 (ACN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Bennett D, 2006, J MOL BIOL, V364, P196, DOI 10.1016/j.jmb.2006.08.094; CEBRATHOMAS JA, 1991, NATURE, V349, P239, DOI 10.1038/349239a0; Ceulemans H, 1999, EUR J BIOCHEM, V262, P36, DOI 10.1046/j.1432-1327.1999.00344.x; Chakrabarti R, 2007, ASIAN J ANDROL, V9, P445, DOI 10.1111/j.1745-7262.2007.00307.x; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Cohen P, 1978, BIOCHEM SOC T, V6, P17, DOI 10.1042/bst0060017; Dinischiotu A, 1997, FEBS LETT, V402, P141, DOI 10.1016/S0014-5793(96)01514-1; Fardilha M, 2004, ANN NY ACAD SCI, V1030, P468, DOI 10.1196/annals.1329.059; Han YB, 2007, MOL REPROD DEV, V74, P1132, DOI 10.1002/mrd.20631; Helps NR, 1998, FEBS LETT, V438, P131, DOI 10.1016/S0014-5793(98)01286-1; Hrabchak C, 2004, J BIOL CHEM, V279, P37079, DOI 10.1074/jbc.M403710200; Hrabchak C, 2007, BIOCHEMISTRY-US, V46, P4635, DOI 10.1021/bi6025837; Huang HS, 2005, ARCH BIOCHEM BIOPHYS, V443, P33, DOI 10.1016/j.abb.2005.08.021; Huang HS, 2008, J BIOL CHEM, V283, P18135, DOI 10.1074/jbc.M709735200; Huang ZH, 2005, BIOL REPROD, V72, P384, DOI 10.1095/biolreprod.104.034140; Huang ZH, 2004, BIOL REPROD, V71, P177, DOI 10.1095/biolreprod.104.027284; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; Huang ZH, 2002, BIOL REPROD, V67, P1936, DOI 10.1095/biolreprod.102.004093; HUGO VV, 2002, JBC, V277, P47331; Hui L, 2006, BIOL REPROD, V74, P633, DOI 10.1095/biolreprod.105.045963; Kwon J, 2005, BIOL REPROD, V73, P29, DOI 10.1095/biolreprod.104.037077; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Mishra S, 2003, BIOL REPROD, V69, P1572, DOI 10.1095/biolreprod.103.018739; NIMMO GA, 1978, EUR J BIOCHEM, V87, P341, DOI 10.1111/j.1432-1033.1978.tb12383.x; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; Pedelini L, 2007, J BIOL CHEM, V282, P3282, DOI 10.1074/jbc.M607171200; Pilder S H, 2007, Soc Reprod Fertil Suppl, V63, P123; PILDER SH, 1993, DEV BIOL, V159, P631, DOI 10.1006/dbio.1993.1270; PILDER SH, 1991, GENETICS, V129, P237; Puntoni F, 1997, MOL CELL BIOCHEM, V171, P115, DOI 10.1023/A:1006892103306; RENOUF S, 1995, FEBS LETT, V375, P75, DOI 10.1016/0014-5793(95)01180-M; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Strack S, 1999, J COMP NEUROL, V413, P373; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayaraghavan S, 1997, BIOL REPROD, V57, P1517, DOI 10.1095/biolreprod57.6.1517; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vijayaraghavan S, 1997, BIOL REPROD, V56, P1450, DOI 10.1095/biolreprod56.6.1450; Walsh Edmund P., 2007, V365, P235; Zhang J, 1998, BIOCHEMISTRY-US, V37, P16728, DOI 10.1021/bi981169g	42	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4861	10.1371/journal.pone.0004861	http://dx.doi.org/10.1371/journal.pone.0004861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300506	gold, Green Published			2022-12-27	WOS:000265496800002
J	Bond, CE; Zimmermann, M; Greenfield, SA				Bond, Cherie E.; Zimmermann, Martina; Greenfield, Susan A.			Upregulation of alpha 7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; READTHROUGH ACETYLCHOLINESTERASE; MOLECULAR-MECHANISMS; NEURITE GROWTH; T-PEPTIDE; IN-VITRO; CHOLINE; PROTEIN; NEURONS	Background: The alpha-7 nicotinic acetylcholine receptor (alpha 7-nAChR) is well known as a potent calcium ionophore that, in the brain, has been implicated in excitotoxicity and hence in the underlying mechanisms of neurodegenerative disorders such as Alzheimer's disease. Previous research implied that the activity of this receptor may be modified by exposure to a peptide fragment derived from the C-terminal region of the enzyme acetylcholinesterase. This investigation was undertaken to determine if the functional changes observed could be attributed to peptide binding interaction with the alpha 7-nAChR, or peptide modulation of receptor expression. Methodology/Principal Findings: This study provides evidence that two peptides derived from the C-terminus of acetylcholinesterase, not only selectively displace specific bungarotoxin binding at the alpha 7-nAChR, but also alter receptor binding properties for its familiar ligands, including the alternative endogenous agonist choline. Of more long-term significance, these peptides also induce upregulation of alpha 7-nAChR mRNA and protein expression, as well as enhancing receptor trafficking to the plasma membrane. Conclusions/Significance: The results reported here demonstrate a hitherto unknown relationship between the alpha 7-nAChR and the non-enzymatic functions of acetylcholinesterase, mediated independently by its C-terminal domain. Such an interaction may prove valuable as a pharmacological tool, prompting new approaches for understanding, and combating, the process of neurodegeneration.	[Bond, Cherie E.; Greenfield, Susan A.] Univ Oxford, Dept Pharmacol, Inst Future Mind, Oxford OX1 3QT, England; [Zimmermann, Martina] Goethe Univ Frankfurt, Dept Pharmacol, D-6000 Frankfurt, Germany	University of Oxford; Goethe University Frankfurt	Bond, CE (corresponding author), Univ Oxford, Dept Pharmacol, Inst Future Mind, S Parks Rd, Oxford OX1 3QT, England.	cherie.bond@pharm.ox.ac.uk		Zimmermann, Martina/0000-0003-4274-6145	James Martin 21st Century School Foundation	James Martin 21st Century School Foundation	This research was supported by a grant from the James Martin 21st Century School Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PR, 1984, J BIOL CHEM, V259, P5350; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Allen DD, 1997, NEUROSCI LETT, V234, P71; Alvarez A, 1998, J NEUROSCI, V18, P3213; Anderson AA, 2008, J CELL PHYSIOL, V215, P82, DOI 10.1002/jcp.21288; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Bednar I, 2002, MOL CELL NEUROSCI, V20, P354, DOI 10.1006/mcne.2002.1112; Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; Bon CLM, 2003, EUR J NEUROSCI, V17, P1991, DOI 10.1046/j.1460-9568.2003.02648.x; Bond CE, 2007, GLIA, V55, P1348, DOI 10.1002/glia.20547; Bourin M, 2003, CURR MED RES OPIN, V19, P169, DOI 10.1185/030079903125001631; Broide RS, 1996, J NEUROSCI, V16, P2956; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chu LW, 2005, DEMENT GERIATR COGN, V19, P106, DOI 10.1159/000082661; Coleman BA, 1996, J BIOL CHEM, V271, P4410; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Cottingham MG, 2003, BIOCHEMISTRY-US, V42, P10863, DOI 10.1021/bi034768i; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Day T, 2004, EXP BRAIN RES, V155, P500, DOI 10.1007/s00221-003-1757-1; Day T, 2003, EXP BRAIN RES, V153, P334, DOI 10.1007/s00221-003-1567-5; Day T, 2002, NEUROSCIENCE, V111, P649, DOI 10.1016/S0306-4522(02)00031-3; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dori A, 2006, J MOL NEUROSCI, V28, P247, DOI 10.1385/JMN:28:3:247; Dunckley T, 2006, BRAIN RES, V1116, P39, DOI 10.1016/j.brainres.2006.07.111; Emmett SR, 2004, NEUROSCI LETT, V358, P210, DOI 10.1016/j.neulet.2003.12.078; Evron T, 2007, TOXICOLOGY, V233, P97, DOI 10.1016/j.tox.2006.08.018; Fodero LR, 2004, J NEUROCHEM, V88, P1186, DOI 10.1046/j.1471-4159.2003.02296.x; FOSSIER P, 1983, NATURE, V301, P710, DOI 10.1038/301710a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greenfield S, 2002, NEUROSCIENCE, V113, P485, DOI 10.1016/S0306-4522(02)00194-X; GREENFIELD S, 1984, TRENDS NEUROSCI, V7, P364, DOI 10.1016/S0166-2236(84)80055-7; Greenfield SA, 2004, J NEUROCHEM, V90, P325, DOI 10.1111/j.1471-4159.2004.02494.x; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; Hruska M, 2007, J NEUROSCI, V27, P11501, DOI 10.1523/JNEUROSCI.3057-07.2007; Inestrosa NC, 2008, FEBS J, V275, P625, DOI 10.1111/j.1742-4658.2007.06238.x; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jiang H, 2008, FEBS J, V275, P612, DOI 10.1111/j.1742-4658.2007.06236.x; Jin QH, 2004, ACTA PHARMACOL SIN, V25, P1013; Jones IW, 2006, J MOL NEUROSCI, V30, P83, DOI 10.1385/JMN:30:1:83; Jonnala RR, 2001, J NEUROSCI RES, V66, P565, DOI 10.1002/jnr.10022; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kawai H, 2001, J NEUROCHEM, V78, P1367, DOI 10.1046/j.1471-4159.2001.00526.x; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Liu Z, 2007, BIOCHEM PHARMACOL, V74, P1112, DOI 10.1016/j.bcp.2007.05.022; LUKAS RJ, 1980, J BIOL CHEM, V255, P5573; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Massoulie J, 2006, J MOL NEUROSCI, V30, P233, DOI 10.1385/JMN:30:1:233; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Mousavi M, 2004, INT J DEV NEUROSCI, V22, P545, DOI 10.1016/j.ijdevneu.2004.07.005; Novakova J, 2005, BRAIN RES, V1062, P101, DOI 10.1016/j.brainres.2005.09.021; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; Onganer PU, 2006, BBA-GEN SUBJECTS, V1760, P415, DOI 10.1016/j.bbagen.2005.12.016; Papke RL, 2000, EUR J PHARMACOL, V393, P179, DOI 10.1016/S0014-2999(00)00009-1; Papke RL, 1996, NEUROSCI LETT, V213, P201; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Paraoanu LE, 2006, J MOL NEUROSCI, V30, P201, DOI 10.1385/JMN:30:1:201; Park SE, 2008, CARCINOGENESIS, V29, P729, DOI 10.1093/carcin/bgn036; Payette DJ, 2007, BRAIN RES, V1135, P12, DOI 10.1016/j.brainres.2006.12.005; PEREIRA EFR, 1993, J PHARMACOL EXP THER, V265, P1474; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Rees Tina M., 2005, Current Alzheimer Research, V2, P291, DOI 10.2174/1567205054367847; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; Rozen S, 2000, Methods Mol Biol, V132, P365; Salinska E, 2005, FOLIA NEUROPATHOL, V43, P322; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Saxena A, 2003, BIOCHEMISTRY-US, V42, P15292, DOI 10.1021/bi030150x; SCHWARZ M, 1995, MOL BRAIN RES, V31, P101, DOI 10.1016/0169-328X(95)00040-Y; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sharma KV, 2001, J NEUROSCI RES, V63, P165, DOI 10.1002/1097-4547(20010115)63:2<165::AID-JNR1008>3.0.CO;2-O; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; Sternfeld M, 1998, J NEUROSCI, V18, P1240; Svedberg MM, 2002, J MOL NEUROSCI, V18, P211, DOI 10.1385/JMN:18:3:211; TAYLOR P, 1994, BIOCHEM SOC T, V22, P740, DOI 10.1042/bst0220740; Torrao AS, 2000, DEV BRAIN RES, V124, P81, DOI 10.1016/S0165-3806(00)00113-9; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; van Damme P, 2005, NEURODEGENER DIS, V2, P147, DOI 10.1159/000089620; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Yu WF, 2005, EXP NEUROL, V192, P215, DOI 10.1016/j.expneurol.2004.12.015; Zbarsky V, 2004, NEUROBIOL DIS, V16, P283, DOI 10.1016/j.nbd.2004.02.009; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034; Zwart R, 2000, J NEUROCHEM, V75, P2492, DOI 10.1046/j.1471-4159.2000.0752492.x	92	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4846	10.1371/journal.pone.0004846	http://dx.doi.org/10.1371/journal.pone.0004846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287501	gold, Green Published			2022-12-27	WOS:000265496400008
J	Du, ZQ; Zhao, X; Vukasinovic, N; Rodriguez, F; Clutter, AC; Rothschild, MF				Du, Zhi-Qiang; Zhao, Xia; Vukasinovic, Natascha; Rodriguez, Fernanda; Clutter, Archie C.; Rothschild, Max F.			Association and Haplotype Analyses of Positional Candidate Genes in Five Genomic Regions Linked to Scrotal Hernia in Commercial Pig Lines	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; CREMASTER MUSCLES; INGUINAL-HERNIAS; EXPRESSION; ELF5; SUSCEPTIBILITY; SACS; TRAITS	Scrotal hernia in pigs is a complex trait likely affected by genetic and environmental factors. A large-scale association analysis of positional and functional candidate genes was conducted in four previously identified genomic regions linked to hernia susceptibility on Sus scrofa chromosomes 2 and 12, as well as the fifth region around 67 cM on chromosome 2, respectively. In total, 151 out of 416 SNPs discovered were genotyped successfully. Using a family-based analysis we found that four regions surrounding ELF5, KIF18A, COL23A1 on chromosome 2, and NPTX1 on chromosome 12, respectively, may contain the genetic variants important for the development of the scrotal hernia in pigs. These findings were replicated in another case-control dataset. The SNPs around the ELF5 region were in high linkage disequilibrium with each other, and a haplotype containing SNPs from ELF5 and CAT was highly significantly associated with hernia development. Extensive re-sequencing work focused on the KIF18A gene did not detect any further SNPs with extensive association signals. These genes may be involved in the estrogen receptor signaling pathway (KIF18A and NPTX1), the epithelial-mesenchymal transition (ELF5) and the collagen metabolism pathway (COL23A1), which are associated with the important molecular characteristics of hernia pathophysiology. Further investigation on the molecular mechanisms of these genes may provide more molecular clues on hernia development in pigs.	[Du, Zhi-Qiang; Zhao, Xia; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Du, Zhi-Qiang; Zhao, Xia; Rothschild, Max F.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA 50011 USA; [Vukasinovic, Natascha; Clutter, Archie C.] Newsham Choice Genet, Des Moines, IA USA; [Rodriguez, Fernanda] Monsanto Co, St Louis, MO USA	Iowa State University; Iowa State University; Monsanto	Rothschild, MF (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu			Monsanto Choice Genetics and Newsham Choice Genetics; State of Iowa; Hatch Funds; College of Agriculture and Life Science in Iowa State University	Monsanto Choice Genetics and Newsham Choice Genetics; State of Iowa; Hatch Funds; College of Agriculture and Life Science in Iowa State University	We appreciate the financial support by Monsanto Choice Genetics and Newsham Choice Genetics, and the additional financial support provided by State of Iowa and Hatch Funds and the support from the College of Agriculture and Life Science in Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyard J, 2007, CLIN CANCER RES, V13, P2634, DOI 10.1158/1078-0432.CCR-06-2163; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellon JM, 2001, ANN SURG, V233, P287, DOI 10.1097/00000658-200102000-00020; Bendavid Robert, 2004, Hernia, V8, P171; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardini L, 2007, AM J MED GENET A, V143A, P2937, DOI 10.1002/ajmg.a.32092; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Dick DM, 2008, BIOL PSYCHIAT, V63, P1047, DOI 10.1016/j.biopsych.2007.11.005; Diniz G, 2004, PATHOL RES PRACT, V200, P531, DOI 10.1016/j.prp.2004.04.010; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; DU F, 2004, 29 INT C AN GEN ISAG, P123; Du FX, 2004, J DAIRY SCI, V87, P453; Du FX, 2004, J ANIM SCI, V82, P453; Du FX, 2004, POULTRY SCI, V83, P453; Du FX, 2007, INT J BIOL SCI, V3, P166; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Grindflek E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-25; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; Hutson JM, 2005, MED HYPOTHESES, V64, P37, DOI 10.1016/j.mehy.2003.11.046; Jansen PL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-36; Jansen PL, 2004, SURGERY, V136, P1, DOI 10.1016/j.surg.2004.01.004; Klinge U, 2006, Hernia, V10, P472, DOI 10.1007/s10029-006-0145-8; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Koskimies P, 2003, MOL CELL ENDOCRINOL, V206, P159, DOI 10.1016/S0303-7207(02)00425-2; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Luboshits G, 2007, J CELL BIOCHEM, V100, P693, DOI 10.1002/jcb.21000; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Metzger DE, 2008, DEV BIOL, V320, P149, DOI 10.1016/j.ydbio.2008.04.038; MIKAMI H, 1979, CAN J GENET CYTOL, V21, P9, DOI 10.1139/g79-002; Morrison AC, 2008, AM J HYPERTENS, V21, P117, DOI 10.1038/ajh.2007.17; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puri V, 2007, BIOL PSYCHIAT, V61, P873, DOI 10.1016/j.biopsych.2006.06.014; Skandalakis JE, 1997, HERNIA, V1, P45; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Szczesny W, 2006, Hernia, V10, P266, DOI 10.1007/s10029-006-0081-7; Tanyel FC, 2006, UROLOGY, V67, P855, DOI 10.1016/j.urology.2005.10.050; Tanyel FC, 2003, UROL INT, V70, P211, DOI 10.1159/000068765; Tanyel FC, 2001, BJU INT, V87, P251, DOI 10.1046/j.1464-410x.2001.02028.x; Tez M, 2006, MED HYPOTHESES, V66, P1042, DOI 10.1016/j.mehy.2005.12.016; Thaller G, 1996, GENETICS, V143, P1819; Tiranti IN, 2002, J AGR SCI, V138, P333, DOI 10.1017/S0021859602001958; Ulusu NN, 2007, CELL BIOCHEM FUNCT, V25, P515, DOI 10.1002/cbf.1341; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; VOGT DW, 1990, AM J VET RES, V51, P1501; Yasuhara F, 2008, BIOL REPROD, V79, P432, DOI 10.1095/biolreprod.107.067413; ZHAO X, 2008, AM J VET RE IN PRESS; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538; Zhu XF, 2008, ADV GENET, V60, P547, DOI 10.1016/S0065-2660(07)00419-1; Zondervan KT, 2007, NAT PROTOC, V2, P2492, DOI 10.1038/nprot.2007.366	53	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4837	10.1371/journal.pone.0004837	http://dx.doi.org/10.1371/journal.pone.0004837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287495	Green Published, gold			2022-12-27	WOS:000265496400005
J	Gordo, I; Gomes, MGM; Reis, DG; Campos, PRA				Gordo, Isabel; Gomes, M. Gabriela M.; Reis, Daniel G.; Campos, Paulo R. A.			Genetic Diversity in the SIR Model of Pathogen Evolution	PLOS ONE			English	Article							POSITIVE SELECTION; VIRUS; SUBSTITUTIONS; REINFECTION; DYNAMICS; BURSTS	We introduce a model for assessing the levels and patterns of genetic diversity in pathogen populations, whose epidemiology follows a susceptible-infected-recovered model (SIR). We model the population of pathogens as a metapopulation composed of subpopulations (infected hosts), where pathogens replicate and mutate. Hosts transmit pathogens to uninfected hosts. We show that the level of pathogen variation is well predicted by analytical expressions, such that pathogen neutral molecular variation is bounded by the level of infection and increases with the duration of infection. We then introduce selection in the model and study the invasion probability of a new pathogenic strain whose fitness (R-0(1+s)) is higher than the fitness of the resident strain (R0). We show that this invasion probability is given by the relative increment in R-0 of the new pathogen (s). By analyzing the patterns of genetic diversity in this framework, we identify the molecular signatures during the replacement and compare these with those observed in sequences of influenza A.	[Gordo, Isabel; Gomes, M. Gabriela M.; Reis, Daniel G.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Gomes, M. Gabriela M.] Univ Lisbon, Ctr Mat Aplicacoes Fundament, P-1699 Lisbon, Portugal; [Campos, Paulo R. A.] Univ Fed Pernambuco, Dept Fis, Recife, PE, Brazil	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade Federal de Pernambuco	Gordo, I (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	igordo@igc.gulbenkian.pt	Gomes, Gabriela/H-7218-2014; Gordo, Isabel/D-6770-2013; Campos, Paulo/G-2459-2012; Campos, Paulo/AAC-7734-2019	Gomes, Gabriela/0000-0002-1454-4979; Gordo, Isabel/0000-0003-1622-5143; Campos, Paulo/0000-0002-7823-1998; Campos, Paulo/0000-0002-7823-1998	Portuguese Research Council (FCT) [PTDC/BIA-BDE/65276/2006]; Fundacao Calouste Gulbenkian; Instituto Gulbenkian de Ciencia, Oeiras; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); PRONEX/MCT-CNPq-FACEPE; European Commission [MEXT-CT-2004-14338]	Portuguese Research Council (FCT)(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian(European Commission); Instituto Gulbenkian de Ciencia, Oeiras; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); PRONEX/MCT-CNPq-FACEPE; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the Portuguese Research Council (FCT) for financial support through PTDC/BIA-BDE/65276/2006. We thank FCT of Portugal, grants PTDC/BIA-BDE/65276/2006, and, Fundacao Calouste Gulbenkian for the financial support of hermes, a High Performance Computing Centre, hosted in Instituto Gulbenkian de Ciencia, Oeiras. PRAC is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and program PRONEX/MCT-CNPq-FACEPE. MGG and DGR are supported by FCT and the European Commission grant MEXT-CT-2004-14338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bazykin GA, 2006, P NATL ACAD SCI USA, V103, P19396, DOI 10.1073/pnas.0609484103; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Campos PRA, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/12/L12003; Combadao J, 2007, GENET RES, V89, P7, DOI 10.1017/S0016672307008658; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Drake JW, 1998, GENETICS, V148, P1667; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Gokaydin D, 2007, J R SOC INTERFACE, V4, P137, DOI 10.1098/rsif.2006.0159; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Gordo I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-116; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kimura M., 1983, NEUTRAL THEORY MOL E; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Rousset F., 2004, GENETIC STRUCTURE SE; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SLATKIN M, 1981, EVOLUTION, V35, P477, DOI 10.1111/j.1558-5646.1981.tb04911.x; TAJIMA F, 1989, GENETICS, V123, P597; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Wilson DJ, 2005, TRENDS ECOL EVOL, V20, P39, DOI 10.1016/j.tree.2004.10.009; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34	31	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4876	10.1371/journal.pone.0004876	http://dx.doi.org/10.1371/journal.pone.0004876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287490	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400017
J	Kuczenski, B; Ruder, WC; Messner, WC; LeDuc, PR				Kuczenski, Brandon; Ruder, Warren C.; Messner, William C.; LeDuc, Philip R.			Probing Cellular Dynamics with a Chemical Signal Generator	PLOS ONE			English	Article								Observations of material and cellular systems in response to time-varying chemical stimuli can aid the analysis of dynamic processes. We describe a microfluidic "chemical signal generator,'' a technique to apply continuously varying chemical concentration waveforms to arbitrary locations in a microfluidic channel through feedback control of the interface between parallel laminar (co-flowing) streams. As the flow rates of the streams are adjusted, the channel walls are exposed to a chemical environment that shifts between the individual streams. This approach can be used to probe the dynamic behavior of objects or substances adherent to the interior of the channel. To demonstrate the technique, we exposed live fibroblast cells to ionomycin, a membrane-permeable calcium ionophore, while assaying cytosolic calcium concentration. Through the manipulation of the laminar flow interface, we exposed the cells' endogenous calcium handling machinery to spatially-contained discrete and oscillatory intracellular disturbances, which were observed to elicit a regulatory response. The spatiotemporal precision of the generated signals opens avenues to previously unapproachable areas for potential investigation of cell signaling and material behavior.	[Kuczenski, Brandon; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Ruder, Warren C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Messner, WC (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	bmessner@andrew.cmu.edu; prleduc@cmu.edu	LeDuc, Philip/M-1103-2014	LeDuc, Philip/0000-0001-6397-2905; Kuczenski, Brandon/0000-0003-1918-0825	National Institute of Health [T32-EB0003392]; Dowd-ICES [predoctoral fellowship]; National Science Foundation [CMS0555513]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dowd-ICES; National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the National Institute of Health (NIH-NIBIB T32-EB0003392 - WCR), the Dowd-ICES predoctoral fellowship (WCR), and the National Science Foundation (CMS0555513 - WCM and PRL, NSF Early Career faculty fellowship - PRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PR, 1986, AM J PHYSIOL, V251, pC887, DOI 10.1152/ajpcell.1986.251.6.C887; Araujo RP, 2006, CURR OPIN CHEM BIOL, V10, P81, DOI 10.1016/j.cbpa.2006.01.002; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Beta C, 2007, ANAL CHEM, V79, P3940, DOI 10.1021/ac070033y; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; Dode L, 2002, J BIOL CHEM, V277, P45579, DOI 10.1074/jbc.M207778200; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Gu W, 2004, P NATL ACAD SCI USA, V101, P15861, DOI 10.1073/pnas.0404353101; Hofer AM, 1998, EMBO J, V17, P1986, DOI 10.1093/emboj/17.7.1986; Ismagilov RF, 2000, APPL PHYS LETT, V76, P2376, DOI 10.1063/1.126351; Jimenez J, 2005, J FLUID MECH, V535, P245, DOI 10.1017/S0022112005004994; Kamholz AE, 1999, ANAL CHEM, V71, P5340, DOI 10.1021/ac990504j; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Korin N, 2007, LAB CHIP, V7, P611, DOI 10.1039/b702392h; Kuczenski B, 2007, LAB CHIP, V7, P647, DOI 10.1039/b617065j; Lau BW, 2005, GASTROENTEROLOGY, V128, P695, DOI 10.1053/j.gastro.2004.12.046; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; SCARPA A, 1972, J GEN PHYSIOL, V60, P735, DOI 10.1085/jgp.60.6.735; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Walker GM, 2002, BIOMED MICRODEVICES, V4, P161, DOI 10.1023/A:1016088128057; Wang F, 2008, BIOTECHNOL BIOENG, V100, P150, DOI 10.1002/bit.21737; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Yang MS, 2002, ANAL CHEM, V74, P3991, DOI 10.1021/ac025536c	33	52	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4847	10.1371/journal.pone.0004847	http://dx.doi.org/10.1371/journal.pone.0004847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287482	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496400009
J	Gillespie, JJ; Ammerman, NC; Dreher-Lesnick, SM; Rahman, MS; Worley, MJ; Setubal, JC; Sobral, BS; Azad, AF				Gillespie, Joseph J.; Ammerman, Nicole C.; Dreher-Lesnick, Sheila M.; Rahman, M. Sayeedur; Worley, Micah J.; Setubal, Joao C.; Sobral, Bruno S.; Azad, Abdu F.			An Anomalous Type IV Secretion System in Rickettsia Is Evolutionarily Conserved	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS VIRB7; ESSENTIAL VIRULENCE PROTEIN; T-DNA TRANSFER; COMPLEX TRANSPORT APPARATUS; MULTIPLE SEQUENCE ALIGNMENT; MEDIATED CONJUGAL TRANSFER; BRUCELLA-SUIS VIRB8; HELICOBACTER-PYLORI; ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASES	Background: Bacterial type IV secretion systems (T4SSs) comprise a diverse transporter family functioning in conjugation, competence, and effector molecule (DNA and/or protein) translocation. Thirteen genome sequences from Rickettsia, obligate intracellular symbionts/pathogens of a wide range of eukaryotes, have revealed a reduced T4SS relative to the Agrobacterium tumefaciens archetype ( vir). However, the Rickettsia T4SS has not been functionally characterized for its role in symbiosis/virulence, and none of its substrates are known. Results: Superimposition of T4SS structural/functional information over previously identified Rickettsia components implicate a functional Rickettsia T4SS. virB4, virB8 and virB9 are duplicated, yet only one copy of each has the conserved features of similar genes in other T4SSs. An extraordinarily duplicated VirB6 gene encodes five hydrophobic proteins conserved only in a short region known to be involved in DNA transfer in A. tumefaciens. virB1, virB2 and virB7 are newly identified, revealing a Rickettsia T4SS lacking only virB5 relative to the vir archetype. Phylogeny estimation suggests vertical inheritance of all components, despite gene rearrangements into an archipelago of five islets. Similarities of Rickettsia VirB7/VirB9 to ComB7/ComB9 proteins of e-proteobacteria, as well as phylogenetic affinities to the Legionella lvh T4SS, imply the Rickettsiales ancestor acquired a vir-like locus from distantly related bacteria, perhaps while residing in a protozoan host. Modern modifications of these systems likely reflect diversification with various eukaryotic host cells. Conclusion: We present the rvh (Rickettsiales vir homolog) T4SS, an evolutionary conserved transporter with an unknown role in rickettsial biology. This work lays the foundation for future laboratory characterization of this system, and also identifies the Legionella lvh T4SS as a suitable genetic model.	[Gillespie, Joseph J.; Setubal, Joao C.; Sobral, Bruno S.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Gillespie, Joseph J.; Ammerman, Nicole C.; Dreher-Lesnick, Sheila M.; Rahman, M. Sayeedur; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA; [Worley, Micah J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Setubal, Joao C.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; University System of Maryland; University of Maryland Baltimore; University of Louisville; Virginia Polytechnic Institute & State University	Gillespie, JJ (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jgill@vbi.vt.edu	Setubal, Joao Carlos/C-7305-2012; Sobral, Bruno/GVU-7637-2022	Setubal, Joao Carlos/0000-0001-9174-2816; Sobral, Bruno/0000-0003-3908-577X; Gillespie, Joseph/0000-0002-5447-7264; Ammerman, Nicole C./0000-0001-9359-9144	National Institute of Allergy And Infectious Diseases (NIAID) [R01AI017828, R01AI59118, HHSN266200400035C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017828, R01AI059118] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Numbers R01AI017828 and R01AI59118 from the National Institute of Allergy And Infectious Diseases (NIAID) to AFA, and through NIAID contract HHSN266200400035C to BSS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the National Institutes of Health.	Abajy MY, 2007, J BACTERIOL, V189, P2487, DOI 10.1128/JB.01491-06; Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; AMMERMAN NC, 2008, J BACTERIOL; Anderson LB, 1996, P NATL ACAD SCI USA, V93, P8889, DOI 10.1073/pnas.93.17.8889; ANDERSSON SGE, 1995, J BACTERIOL, V177, P4171, DOI 10.1128/jb.177.14.4171-4175.1995; Andersson SGE, 1995, BIOCHEM CELL BIOL, V73, P775, DOI 10.1139/o95-086; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andrzejewska J, 2006, J BACTERIOL, V188, P5865, DOI 10.1128/JB.00060-06; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; Azad AF, 2003, ANN NY ACAD SCI, V990, P734, DOI 10.1111/j.1749-6632.2003.tb07452.x; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Bandyopadhyay P, 2007, INFECT IMMUN, V75, P723, DOI 10.1128/IAI.00956-06; Baron C, 2005, FEMS MICROBIOL LETT, V253, P163, DOI 10.1016/j.femsle.2005.09.030; Baron C, 1997, J BACTERIOL, V179, P1203, DOI 10.1128/jb.179.4.1203-1210.1997; Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Baron C, 2002, MOL MICROBIOL, V43, P1359, DOI 10.1046/j.1365-2958.2002.02816.x; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Bayer M, 2001, J BACTERIOL, V183, P3176, DOI 10.1128/JB.183.10.3176-3183.2001; BAYER M, 1995, J BACTERIOL, V177, P4279, DOI 10.1128/jb.177.15.4279-4288.1995; Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104; Beaupre CE, 1997, J BACTERIOL, V179, P78, DOI 10.1128/jb.179.1.78-89.1997; BEIJERSBERGEN A, 1994, PLASMID, V32, P212, DOI 10.1006/plas.1994.1057; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993; BETZNER AS, 1989, MOL GEN GENET, V219, P489, DOI 10.1007/BF00259625; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Bohne J, 1998, P NATL ACAD SCI USA, V95, P7057, DOI 10.1073/pnas.95.12.7057; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201; Carle A, 2006, INFECT IMMUN, V74, P108, DOI 10.1128/IAI.74.1.108-117.2006; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chao CC, 2004, PROTEOMICS, V4, P1280, DOI 10.1002/pmic.200300775; Chao CC, 2007, BBA-PROTEINS PROTEOM, V1774, P373, DOI 10.1016/j.bbapap.2007.01.001; Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; CHRISTIE PJ, 1989, P NATL ACAD SCI USA, V86, P9677, DOI 10.1073/pnas.86.24.9677; Christie PJ, 1997, J BACTERIOL, V179, P3085, DOI 10.1128/jb.179.10.3085-3094.1997; Citovsky V, 2004, J BIOL CHEM, V279, P29528, DOI 10.1074/jbc.M403159200; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DALE EM, 1993, J BACTERIOL, V175, P887, DOI 10.1128/JB.175.3.887-891.1993; Dang TAT, 1997, J BACTERIOL, V179, P453, DOI 10.1128/jb.179.2.453-462.1997; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das A, 1997, J BACTERIOL, V179, P3404, DOI 10.1128/jb.179.11.3404-3409.1997; De Buck E, 2007, MICROBIOL-SGM, V153, P3948, DOI 10.1099/mic.0.2007/012039-0; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Dozot M, 2006, CELL MICROBIOL, V8, P1791, DOI 10.1111/j.1462-5822.2006.00749.x; Draper O, 2006, J BIOL CHEM, V281, P37628, DOI 10.1074/jbc.M606403200; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Duckely M, 2003, FEMS MICROBIOL LETT, V223, P1, DOI 10.1016/S0378-1097(03)00246-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; Eisenbrandt R, 2000, J BACTERIOL, V182, P6751, DOI 10.1128/JB.182.23.6751-6761.2000; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Fernandez D, 1996, J BACTERIOL, V178, P3168, DOI 10.1128/jb.178.11.3168-3176.1996; FINBERG KE, 1995, J BACTERIOL, V177, P4881, DOI 10.1128/jb.177.17.4881-4889.1995; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; FRITSCHE TR, 1993, J CLIN MICROBIOL, V31, P1122, DOI 10.1128/JCM.31.5.1122-1126.1993; Fullner KJ, 1998, J BACTERIOL, V180, P430, DOI 10.1128/JB.180.2.430-434.1998; FULLNER KJ, 1994, MOL GEN GENET, V245, P704, DOI 10.1007/BF00297277; Fuxelius HH, 2007, RES MICROBIOL, V158, P745, DOI 10.1016/j.resmic.2007.09.008; Fuxelius HH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r42; Ge H, 2004, J BACTERIOL, V186, P556, DOI 10.1128/JB.186.2.556-565.2004; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GUYON P, 1980, P NATL ACAD SCI-BIOL, V77, P2693, DOI 10.1073/pnas.77.5.2693; HALL J, 1985, J PARASITOL, V71, P89, DOI 10.2307/3281982; Hapfelmeier S, 2000, J BACTERIOL, V182, P4505, DOI 10.1128/JB.182.16.4505-4511.2000; Hare S, 2007, EMBO J, V26, P4926, DOI 10.1038/sj.emboj.7601904; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Harris RL, 2001, MOL MICROBIOL, V42, P757, DOI 10.1046/j.1365-2958.2001.02667.x; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Hoppner C, 2005, MICROBIOL-SGM, V151, P3469, DOI 10.1099/mic.0.28326-0; Horn M, 1999, ENVIRON MICROBIOL, V1, P357, DOI 10.1046/j.1462-2920.1999.00045.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; JONES AL, 1994, J BACTERIOL, V176, P5255, DOI 10.1128/JB.176.17.5255-5261.1994; Jones AL, 1996, J BACTERIOL, V178, P5706, DOI 10.1128/jb.178.19.5706-5711.1996; Judd PK, 2005, MICROBIOL-SGM, V151, P3483, DOI 10.1099/mic.0.28337-0; Judd PK, 2005, MOL MICROBIOL, V55, P115, DOI 10.1111/j.1365-2958.2004.04378.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KADO CI, 1994, MOL MICROBIOL, V12, P17, DOI 10.1111/j.1365-2958.1994.tb00990.x; Kalkum M, 2004, CURR PROTEIN PEPT SC, V5, P417, DOI 10.2174/1389203043379639; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; KOCH AL, 1990, RES MICROBIOL, V141, P119, DOI 10.1016/0923-2508(90)90103-W; KOONIN EV, 1994, TRENDS BIOCHEM SCI, V19, P106; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KULDAU GA, 1990, MOL GEN GENET, V221, P256, DOI 10.1007/BF00261729; Kumpar RB, 2001, J BACTERIOL, V183, P3636, DOI 10.1128/JB.183.12.3636-3641.2001; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2002, J BACTERIOL, V184, P327, DOI 10.1128/JB.184.1.327-330.2002; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lehnherr H, 1998, MOL MICROBIOL, V30, P454, DOI 10.1046/j.1365-2958.1998.01069.x; LESSL M, 1994, CELL, V77, P321, DOI 10.1016/0092-8674(94)90146-5; LIN TS, 1993, MOL MICROBIOL, V9, P803, DOI 10.1111/j.1365-2958.1993.tb01739.x; Liu ZY, 2003, J BACTERIOL, V185, P3259, DOI 10.1128/JB.185.11.3259-3269.2003; Llosa M, 2000, J BACTERIOL, V182, P3437, DOI 10.1128/JB.182.12.3437-3445.2000; MAHER D, 1993, J BACTERIOL, V175, P2175, DOI 10.1128/JB.175.8.2175-2183.1993; Malek JA, 2004, NUCLEIC ACIDS RES, V32, P1059, DOI 10.1093/nar/gkh254; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Masui S, 2000, J BACTERIOL, V182, P6529, DOI 10.1128/JB.182.22.6529-6531.2000; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Medini D, 2006, PLOS COMPUT BIOL, V2, P1543, DOI 10.1371/journal.pcbi.0020173; METZGER S, 1989, J BIOL CHEM, V264, P9122; Middleton R, 2005, P NATL ACAD SCI USA, V102, P1685, DOI 10.1073/pnas.0409399102; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P7321, DOI 10.1073/pnas.93.14.7321; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; NORRIS V, 1993, BIOPHYS J, V64, P1691, DOI 10.1016/S0006-3495(93)81541-8; Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2000, SCIENCE, V290, P347, DOI 10.1126/science.290.5490.347; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; OKAMOTO S, 1991, MOL GEN GENET, V228, P24, DOI 10.1007/BF00282443; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Pansegrau W, 1996, PROG NUCLEIC ACID RE, V54, P197, DOI 10.1016/S0079-6603(08)60364-5; Paschos A, 2006, P NATL ACAD SCI USA, V103, P7252, DOI 10.1073/pnas.0600862103; Patey G, 2006, INFECT IMMUN, V74, P4945, DOI 10.1128/IAI.00584-06; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quebatte M, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13068; Rambaut A., 2007, TRACER V1 4; RANCES E, 2008, J BACTERIOL; Rashkova S, 1997, J BACTERIOL, V179, P583, DOI 10.1128/jb.179.3.583-591.1997; Robertus JD, 1998, J EXP ZOOL, V282, P127, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;127::AID-JEZ14&gt;3.0.CO;2-R; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38; Saga G, 1998, TRENDS MICROBIOL, V6, P253, DOI 10.1016/S0966-842X(98)01308-0; Sagulenko V, 2001, J BACTERIOL, V183, P3642, DOI 10.1128/JB.183.12.3642-3651.2001; SALMOND GPC, 1994, ANNU REV PHYTOPATHOL, V32, P181, DOI 10.1146/annurev.py.32.090194.001145; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Sexton JA, 2002, TRAFFIC, V3, P178, DOI 10.1034/j.1600-0854.2002.030303.x; Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004; SHIRASU K, 1993, FEMS MICROBIOL LETT, V111, P287, DOI 10.1111/j.1574-6968.1993.tb06400.x; SHIRASU K, 1990, MOL MICROBIOL, V4, P1153, DOI 10.1111/j.1365-2958.1990.tb00690.x; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Spudich GM, 1996, P NATL ACAD SCI USA, V93, P7512, DOI 10.1073/pnas.93.15.7512; STACHEL SE, 1986, CELL, V46, P325, DOI 10.1016/0092-8674(86)90653-7; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; STOTHARD DR, 1995, SYST APPL MICROBIOL, V18, P52, DOI 10.1016/S0723-2020(11)80448-0; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; THOMPSON DV, 1988, NUCLEIC ACIDS RES, V16, P4621, DOI 10.1093/nar/16.10.4621; THORSTENSON YR, 1994, J BACTERIOL, V176, P1711, DOI 10.1128/jb.176.6.1711-1717.1994; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Tzfira T, 2004, NATURE, V431, P87, DOI 10.1038/nature02857; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Vogel JP, 1999, CURR OPIN MICROBIOL, V2, P30, DOI 10.1016/S1369-5274(99)80005-8; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Ward DV, 2002, TRENDS PLANT SCI, V7, P1, DOI 10.1016/S1360-1385(01)02175-6; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; WARD JE, 1990, J BACTERIOL, V172, P5187, DOI 10.1128/jb.172.9.5187-5199.1990; WARD JE, 1988, J BIOL CHEM, V263, P5804; WARD JE, 1990, J BACTERIOL, V172, P5200, DOI 10.1128/jb.172.9.5200-5210.1990; WARD JE, 1991, P NATL ACAD SCI USA, V88, P9350, DOI 10.1073/pnas.88.20.9350; WARD JE, 1990, J BIOL CHEM, V265, P4768; Watarai M, 2001, MOL MICROBIOL, V39, P313, DOI 10.1046/j.1365-2958.2001.02193.x; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WEISBURG WG, 1989, J BACTERIOL, V171, P4202, DOI 10.1128/JB.171.8.4202-4206.1989; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7; Winiecka-Krusnell J, 2002, SCAND J INFECT DIS, V34, P253, DOI 10.1080/00365540110080052; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2; Winiecka-Krusnell J, 1999, SCAND J INFECT DIS, V31, P383, DOI 10.1080/00365549950163833; Yeo HJ, 2003, P NATL ACAD SCI USA, V100, P15947, DOI 10.1073/pnas.2535211100; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07	216	73	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4833	10.1371/journal.pone.0004833	http://dx.doi.org/10.1371/journal.pone.0004833			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279686	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496200010
J	Longo, C; Patanarut, A; George, T; Bishop, B; Zhou, WD; Fredolini, C; Ross, MM; Espina, V; Pellacani, G; Petricoin, EF; Liotta, LA; Luchini, A				Longo, Caterina; Patanarut, Alexis; George, Tony; Bishop, Barney; Zhou, Weidong; Fredolini, Claudia; Ross, Mark M.; Espina, Virginia; Pellacani, Giovanni; Petricoin, Emanuel F., III; Liotta, Lance A.; Luchini, Alessandra			Core-Shell Hydrogel Particles Harvest, Concentrate and Preserve Labile Low Abundance Biomarkers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IMATINIB MESYLATE; SERUM; TEMPERATURE; TARGET; MARKER; LIGAND; FUTURE; URINE; TRIAL	Background: The blood proteome is thought to represent a rich source of biomarkers for early stage disease detection. Nevertheless, three major challenges have hindered biomarker discovery: a) candidate biomarkers exist at extremely low concentrations in blood; b) high abundance resident proteins such as albumin mask the rare biomarkers; c) biomarkers are rapidly degraded by endogenous and exogenous proteinases. Methodology and Principal Findings: Hydrogel nanoparticles created with a N-isopropylacrylamide based core (365 nm)-shell (167 nm) and functionalized with a charged based bait (acrylic acid) were studied as a technology for addressing all these biomarker discovery problems, in one step, in solution. These harvesting core-shell nanoparticles are designed to simultaneously conduct size exclusion and affinity chromatography in solution. Platelet derived growth factor (PDGF), a clinically relevant, highly labile, and very low abundance biomarker, was chosen as a model. PDGF, spiked in human serum, was completely sequestered from its carrier protein albumin, concentrated, and fully preserved, within minutes by the particles. Particle sequestered PDGF was fully protected from exogenously added tryptic degradation. When the nanoparticles were added to a 1 mL dilute solution of PDGF at non detectable levels (less than 20 picograms per mL) the concentration of the PDGF released from the polymeric matrix of the particles increased within the detection range of ELISA and mass spectrometry. Beyond PDGF, the sequestration and protection from degradation for a series of additional very low abundance and very labile cytokines were verified. Conclusions and Significance: We envision the application of harvesting core-shell nanoparticles to whole blood for concentration and immediate preservation of low abundance and labile analytes at the time of venipuncture.	[Longo, Caterina; Pellacani, Giovanni] Univ Modena, Dept Dermatol, I-41100 Modena, Italy; [Longo, Caterina; George, Tony; Zhou, Weidong; Fredolini, Claudia; Ross, Mark M.; Espina, Virginia; Petricoin, Emanuel F., III; Liotta, Lance A.; Luchini, Alessandra] George Mason Univ, Ctr Appl Proteom & Mol Med, Manassas, VA USA; [Patanarut, Alexis; Bishop, Barney] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA	Universita di Modena e Reggio Emilia; George Mason University; George Mason University	Longo, C (corresponding author), Univ Modena, Dept Dermatol, I-41100 Modena, Italy.	aluchini@gmu.edu	pellacani, giovanni/E-8573-2011; Luchini, Alessandra/M-5340-2014; Longo, Caterina/A-8046-2012	pellacani, giovanni/0000-0002-7222-2951; Luchini, Alessandra/0000-0003-1599-0214; Longo, Caterina/0000-0002-8218-3896; Fredolini, Claudia/0000-0002-7674-2014; Espina, Virginia/0000-0001-5080-5972	George Mason University; Italian Istituto Superiore di Sanita; U.S. Department of Energy [DE-FC52-04NA25455]; NIH [1R21CA137706-01]; NATIONAL CANCER INSTITUTE [R21CA137706] Funding Source: NIH RePORTER	George Mason University; Italian Istituto Superiore di Sanita; U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by 1) George Mason University, 2) the Italian Istituto Superiore di Sanita' in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University, and the Italian Ministry of Public Health, and 3) the U.S. Department of Energy (grant number DE-FC52-04NA25455). The data herein was incorporated in the NIH grant submission number 1R21CA137706-01. The funding organizations did not have any role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ayache S, 2006, AM J CLIN PATHOL, V126, P174, DOI 10.1309/3WM7XJ7RD8BCLNKX; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Borst C, 2008, J CHROMATOGR A, V1204, P191, DOI 10.1016/j.chroma.2008.05.052; BOWENPOPE DF, 1984, BLOOD, V64, P458; Braude E. A., 1955, DETERMINATION ORGANI; Cai WS, 2005, J INCL PHENOM MACRO, V51, P41, DOI 10.1007/s10847-004-5238-3; Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e; Couvreur P, 2008, SMALL, V4, P247, DOI 10.1002/smll.200700731; Denizli A, 2001, J BIOCHEM BIOPH METH, V49, P391, DOI 10.1016/S0165-022X(01)00209-3; Dodziuk H., 2006, CYCLODEXTRINS THEIR; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Elmas B, 2002, COLLOID POLYM SCI, V280, P1137, DOI 10.1007/s00396-002-0740-x; Fortina P, 2005, TRENDS BIOTECHNOL, V23, P168, DOI 10.1016/j.tibtech.2005.02.007; Frederick M J, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003301; Fredolini C, 2008, NANO RES, V1, P502, DOI 10.1007/s12274-008-8054-z; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hennink WE, 2012, ADV DRUG DELIVER REV, V64, P223, DOI 10.1016/j.addr.2012.09.009; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Jahnz-Rozyk K, 2003, ALLERGY, V58, P595, DOI 10.1034/j.1398-9995.2003.00083.x; JIN S, ARCH DERMATOL RES, V8, P451; Jones CD, 2000, MACROMOLECULES, V33, P8301, DOI 10.1021/ma001398m; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kagami S, 2005, J INVEST DERMATOL, V124, P1088, DOI 10.1111/j.0022-202X.2005.23700.x; KATAOKA K, 1994, MACROMOLECULES, V27, P1061, DOI 10.1021/ma00082a028; Kubo T, 2008, CANCER-AM CANCER SOC, V112, P2119, DOI 10.1002/cncr.23437; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Lopez MF, 2005, CLIN CHEM, V51, P1946, DOI 10.1373/clinchem.2005.053090; LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Mader HS, 2008, MICROCHIM ACTA, V162, P1, DOI 10.1007/s00604-008-0947-8; Mathew P, 2004, J CLIN ONCOL, V22, P3323, DOI 10.1200/JCO.2004.10.116; McArthur GA, 2005, J CLIN ONCOL, V23, P866, DOI 10.1200/JCO.2005.07.088; Merrell Karen, 2004, J Biomol Tech, V15, P238; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Nayak S, 2005, SMALL, V1, P416, DOI 10.1002/smll.200400089; Pecora R, 1985, BER BUNSEN PHYS CHEM, DOI DOI 10.1002/BBPC.19870910455; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Robak E, 2007, EUR CYTOKINE NETW, V18, P181, DOI 10.1684/ecn.2007.0103; Sakamoto JH, 2005, TECHNOL CANCER RES T, V4, P627, DOI 10.1177/153303460500400606; Sereikaite J, 2006, BIOMED CHROMATOGR, V20, P195, DOI 10.1002/bmc.552; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Uekama K, 2006, J INCL PHENOM MACRO, V56, P3, DOI 10.1007/s10847-006-9052-y; Yamauchi A., 2006, GLUCOSE SENSING TOPI, P237; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zhang YL, 2006, CHEM-EUR J, V12, P1377, DOI 10.1002/chem.200500982; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	54	77	79	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4763	10.1371/journal.pone.0004763	http://dx.doi.org/10.1371/journal.pone.0004763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274087	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000004
J	Matamales, M; Bertran-Gonzalez, J; Salomon, L; Degos, B; Deniau, JM; Valjent, E; Herve, D; Girault, JA				Matamales, Miriam; Bertran-Gonzalez, Jesus; Salomon, Lucas; Degos, Bertrand; Deniau, Jean-Michel; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine			Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; BASAL GANGLIA; SUBSTANCE-P; DOPAMINE-RECEPTORS; ENKEPHALIN NEURONS; RAT STRIATUM; NEOSTRIATUM; ACTIVATION; DARPP-32; CELLS	Precise identification of neuronal populations is a major challenge in neuroscience. In the striatum, more than 95% of neurons are GABAergic medium-sized spiny neurons (MSNs), which form two intermingled populations distinguished by their projections and protein content. Those expressing dopamine D-1-receptors (D1Rs) project preferentially to the substantia nigra pars reticulata (SNr), whereas those expressing dopamine D-2-receptors (D2Rs) project preferentially to the lateral part of the globus pallidus (LGP). The degree of segregation of these populations has been a continuous subject of debate, and the recent introduction of bacterial artificial chromosome (BAC) transgenic mice expressing fluorescent proteins driven by specific promoters was a major progress to facilitate striatal neuron identification. However, the fraction of MSNs labeled in these mice has been recently called into question, casting doubt on the generality of results obtained with such approaches. Here, we performed an in-depth quantitative analysis of striatal neurons in drd1a-EGFP and drd2-EGFP mice. We first quantified neuronal and non-neuronal populations in the striatum, based on nuclear staining with TO-PRO-3, and immunolabeling for NeuN, DARPP-32 (dopamine- and cAMP-regulated phosphoprotein Mr similar to 32,000), and various markers for interneurons. TO-PRO-3 staining was sufficient to identify MSNs by their typical nuclear morphology and, with a good probability, interneuron populations. In drd1a-EGFP/drd2-EGFP double transgenic mice all MSNs expressed EGFP, which was driven in about half of them by drd1a promoter. Retrograde labeling showed that all MSNs projecting to the SNr expressed D1R and very few D2R (<1%). In contrast, our results were compatible with the existence of some D1R-EGFP-expressing fibers giving off terminals in the LGP. Thus, our study shows that nuclear staining is a simple method for identifying MSNs and other striatal neurons. It also unambiguously confirms the degree of segregation of MSNs in the mouse striatum and allows the full exploitation of results obtained with BAC-transgenic mice.	[Matamales, Miriam; Bertran-Gonzalez, Jesus; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine] INSERM, UMR S 839, Paris, France; [Matamales, Miriam; Bertran-Gonzalez, Jesus; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine] Univ Paris 06, F-75252 Paris, France; [Matamales, Miriam; Bertran-Gonzalez, Jesus; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine] Inst Fer Moulin, Paris, France; [Salomon, Lucas; Degos, Bertrand; Deniau, Jean-Michel] Inserm, Coll France, U667, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Matamales, M (corresponding author), INSERM, UMR S 839, Paris, France.	jean-antoine.girault@inserm.fr	Girault, Jean-Antoine/F-7518-2013; Longo, Kenneth A/A-5631-2010; HERVE, Denis/E-2929-2017; Matamales, Miriam/J-5189-2014; Bertran-Gonzalez, J/L-1410-2017	Girault, Jean-Antoine/0000-0002-7900-1705; HERVE, Denis/0000-0003-1376-1522; Matamales, Miriam/0000-0001-9978-0091; Bertran-Gonzalez, J/0000-0002-3794-1782; Valjent, Emmanuel/0000-0002-1034-606X	Inserm; Agence Nationale de la Recherche [ANR-05-NEUR-020]; Fondation pour la Recherche Medicale; Neuropole de Recherche Francilien (NeRF); Region Ile de France	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Neuropole de Recherche Francilien (NeRF); Region Ile de France(Region Ile-de-France)	This work was supported by Inserm, Agence Nationale de la Recherche (ANR-05-NEUR-020), Fondation pour la Recherche Medicale, and Neuropole de Recherche Francilien (NeRF), Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AUGOOD SJ, 1994, MOL BRAIN RES, V22, P204, DOI 10.1016/0169-328X(94)90048-5; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; BECKSTEAD RM, 1988, NEUROSCIENCE, V27, P851, DOI 10.1016/0306-4522(88)90188-1; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bink K, 2001, HISTOCHEM CELL BIOL, V115, P293; BISHOP GA, 1982, NEUROSCIENCE, V7, P179, DOI 10.1016/0306-4522(82)90159-2; Borgkvist A, 2008, NEUROPHARMACOLOGY, V55, P230, DOI 10.1016/j.neuropharm.2008.05.028; BROWNSTEIN MJ, 1977, BRAIN RES, V135, P315, DOI 10.1016/0006-8993(77)91034-4; DIFIGLIA M, 1986, J COMP NEUROL, V244, P36, DOI 10.1002/cne.902440104; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Gurney K, 2004, TRENDS NEUROSCI, V27, P453, DOI 10.1016/j.tins.2004.06.003; HERRERAMARSCHITZ M, 1984, BRAIN RES, V323, P269, DOI 10.1016/0006-8993(84)90297-X; HONG JS, 1977, NEUROPHARMACOLOGY, V16, P451, DOI 10.1016/0028-3908(77)90089-2; HONG JS, 1977, BRAIN RES, V122, P541, DOI 10.1016/0006-8993(77)90464-4; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; LEMOINE C, 1990, NEUROSCI LETT, V117, P248, DOI 10.1016/0304-3940(90)90671-U; LEMOINE C, 1990, P NATL ACAD SCI USA, V87, P230, DOI 10.1073/pnas.87.1.230; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; MROZ EA, 1977, BRAIN RES, V125, P305, DOI 10.1016/0006-8993(77)90623-0; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; OUIMET CC, 1984, J NEUROSCI, V4, P111; OUIMET CC, 1990, J NEUROCYTOL, V19, P39, DOI 10.1007/BF01188438; Paxinos G., 2001, MOUSE BRAIN STEREOTA; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107; TAKAGI H, 1983, J COMP NEUROL, V214, P1, DOI 10.1002/cne.902140102; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	49	174	175	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4770	10.1371/journal.pone.0004770	http://dx.doi.org/10.1371/journal.pone.0004770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274089	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000010
J	Xu, XJ; Kasembeli, MM; Jiang, XQ; Tweardy, BJ; Tweardy, DJ				Xu, Xuejun; Kasembeli, Moses M.; Jiang, Xueqing; Tweardy, Benjamin J.; Tweardy, David J.			Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation	PLOS ONE			English	Article								Signal transducer and activator of transcription (Stat) 3 is an oncogene constitutively activated in many cancer systems where it contributes to carcinogenesis. To develop chemical probes that selectively target Stat3, we virtually screened 920,000 small drug-like compounds by docking each into the peptide-binding pocket of the Stat3 SH2 domain, which consists of three sites-the pY-residue binding site, the +3 residue-binding site and a hydrophobic binding site, which served as a selectivity filter. Three compounds satisfied criteria of interaction analysis, competitively inhibited recombinant Stat3 binding to its immobilized pY-peptide ligand and inhibited IL-6-mediated tyrosine phosphorylation of Stat3. These compounds were used in a similarity screen of 2.47 million compounds, which identified 3 more compounds with similar activities. Examination of the 6 active compounds for the ability to inhibit IFN-gamma-mediated Stat1 phosphorylation revealed that 5 of 6 were selective for Stat3. Molecular modeling of the SH2 domains of Stat3 and Stat1 bound to compound revealed that compound interaction with the hydrophobic binding site was the basis for selectivity. All 5 selective compounds inhibited nuclear-to-cytoplasmic translocation of Stat3, while 3 of 5 compounds induced apoptosis preferentially of breast cancer cell lines with constitutive Stat3 activation. Thus, virtual ligand screening of compound libraries that targeted the Stat3 pY-peptide binding pocket identified for the first time 3 lead compounds that competitively inhibited Stat3 binding to its pY-peptide ligand; these compounds were selective for Stat3 vs. Stat1 and induced apoptosis preferentially of breast cancer cells lines with constitutively activated Stat3.	[Xu, Xuejun; Kasembeli, Moses M.; Jiang, Xueqing; Tweardy, Benjamin J.; Tweardy, David J.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Xu, XJ (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA.	dtweardy@bcm.edu	Tweardy, David/L-3929-2019		National Cancer Institute of the NIH [CA072261]; NATIONAL CANCER INSTITUTE [R01CA072261] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by grant CA072261 (DJT) from the National Cancer Institute of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chen JY, 2007, BIOORG MED CHEM LETT, V17, P3939, DOI 10.1016/j.bmcl.2007.04.096; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Costantino L, 2008, CURR MED CHEM, V15, P834, DOI 10.2174/092986708783955464; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Dong S, 2003, LEUKEMIA LYMPHOMA, V44, P2023, DOI 10.1080/1042819031000116670; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Jing N, 2003, DNA CELL BIOL, V22, P685, DOI 10.1089/104454903770946665; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; Jing NJ, 2006, MOL CANCER THER, V5, P279, DOI 10.1158/1535-7163.MCT-05-0302; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kato T, 2004, J BIOL CHEM, V279, P31076, DOI 10.1074/jbc.M400637200; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Maloney KN, 2006, ORG LETT, V8, P4067, DOI 10.1021/ol061556f; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Redell Michele S, 2006, Drug Discov Today Technol, V3, P261, DOI 10.1016/j.ddtec.2006.09.010; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; SATYAPRAKASH KL, 1981, CANCER GENET CYTOGEN, V3, P61, DOI 10.1016/0165-4608(81)90057-1; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shao H, 2004, J BIOL CHEM, V279, P18967, DOI 10.1074/jbc.M314037200; Shao H, 2006, J IMMUNOL, V176, P2933, DOI 10.4049/jimmunol.176.5.2933; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Totrov M, 1997, PROTEINS, P215; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; TWEARDY DJ, 1995, BLOOD, V86, P4409, DOI 10.1182/blood.V86.12.4409.bloodjournal86124409; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; ZHANG RD, 1991, INVAS METAST, V11, P204; Zhu QQ, 2007, J COMPUT AID MOL DES, V21, P641, DOI 10.1007/s10822-007-9147-6	49	95	103	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4783	10.1371/journal.pone.0004783	http://dx.doi.org/10.1371/journal.pone.0004783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274102	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000020
J	Baskind, HA; Na, L; Ma, QH; Patel, MP; Geenen, DL; Wang, QT				Baskind, Heather A.; Na, Lucy; Ma, Quanhong; Patel, Mayur P.; Geenen, David L.; Wang, Q. Tian			Functional Conservation of Asxl2, a Murine Homolog for the Drosophila Enhancer of Trithorax and Polycomb Group Gene Asx	PLOS ONE			English	Article							ADDITIONAL-SEX-COMBS; HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEINS; HOX GENE; RESPONSE ELEMENTS; BINDING-PROTEIN; DNA-BINDING; COMPLEX; IDENTIFICATION; METHYLATION	Background: Polycomb-group (PcG) and trithorax-group (trxG) proteins regulate histone methylation to establish repressive and active chromatin configurations at target loci, respectively. These chromatin configurations are passed on from mother to daughter cells, thereby causing heritable changes in gene expression. The activities of PcG and trxG proteins are regulated by a special class of proteins known as Enhancers of trithorax and Polycomb (ETP). The Drosophila gene Additional sex combs (Asx) encodes an ETP protein and mutations in Asx enhance both PcG and trxG mutant phenotypes. The mouse and human genomes each contain three Asx homologues, Asx-like 1, 2, and 3. In order to understand the functions of mammalian Asx-like (Asxl) proteins, we generated an Asxl2 mutant mouse from a gene-trap ES cell line. Methodology/Principal Findings: We show that the Asxl2 gene trap is expressed at high levels in specific tissues including the heart, the axial skeleton, the neocortex, the retina, spermatogonia and developing oocytes. The gene trap mutation is partially embryonic lethal and approximately half of homozygous animals die before birth. Homozygotes that survive embryogenesis are significantly smaller than controls and have a shortened life span. Asxl2(-/-) mice display both posterior transformations and anterior transformation in the axial skeleton, suggesting that the loss of Asxl2 disrupts the activities of both PcG and trxG proteins. The PcG-associated histone modification, trimethylation of histone H3 lysine 27, is reduced in Asxl2(-/-) heart. Necropsy and histological analysis show that mutant mice have enlarged hearts and may have impaired heart function. Conclusions/Significance: Our results suggest that murine Asxl2 has conserved ETP function and plays dual roles in the promotion of PcG and trxG activity. We have also revealed an unexpected role for Asxl2 in the heart, suggesting that the PcG/trxG system may be involved in the regulation of cardiac function.	[Baskind, Heather A.; Na, Lucy; Ma, Quanhong; Patel, Mayur P.; Wang, Q. Tian] Univ Chicago, Dept Biol Sci, Chicago, IL 60637 USA; [Geenen, David L.] Univ Illinois, Dept Med, Sect Cardiol, Chicago, IL 60680 USA; [Geenen, David L.] Univ Illinois, Ctr Cardiovasc Res, Chicago, IL 60680 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Baskind, HA (corresponding author), Univ Chicago, Dept Biol Sci, Chicago, IL 60637 USA.	qtwang@uic.edu			WISER Fund Award; Leukemia Research Foundation [2007-04173]	WISER Fund Award; Leukemia Research Foundation	This work was partially supported by a WISER Fund Award (www.uicwise.org/) to QTW and a Leukemia Research Foundation (www.leukemia-research.org) grant (#2007-04173) to QTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bel S, 1998, DEVELOPMENT, V125, P3543; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Core N, 1997, DEVELOPMENT, V124, P721; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Decoville M, 2001, GENETICS, V157, P237; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Duncan I, 1996, BIOESSAYS, V18, P91, DOI 10.1002/bies.950180203; Durand JB, 1999, CURR OPIN CARDIOL, V14, P225, DOI 10.1097/00001573-199905000-00006; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Gildea JJ, 2000, GENETICS, V156, P645; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Katoh M, 2004, INT J ONCOL, V24, P1617; Katoh M, 2003, INT J ONCOL, V23, P845; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kurzhals RL, 2008, DEV BIOL, V313, P293, DOI 10.1016/j.ydbio.2007.10.025; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Lorente M, 2006, MECH DEVELOP, V123, P312, DOI 10.1016/j.mod.2006.02.003; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Ramocki MB, 2003, EUR J HUM GENET, V11, P527, DOI 10.1038/sj.ejhg.5200995; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shirai M, 2002, J CLIN INVEST, V110, P177, DOI 10.1172/JCI200214839; SINCLAIR DAR, 1992, GENETICS, V130, P817; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4750	10.1371/journal.pone.0004750	http://dx.doi.org/10.1371/journal.pone.0004750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270745	Green Published, gold, Green Submitted			2022-12-27	WOS:000265495900017
J	Meli, ML; Cattori, V; Martinez, F; Lopez, G; Vargas, A; Simon, MA; Zorrilla, I; Munoz, A; Palomares, F; Lopez-Bao, JV; Pastor, J; Tandon, R; Willi, B; Hofmann-Lehmann, R; Lutz, H				Meli, Marina L.; Cattori, Valentino; Martinez, Fernando; Lopez, Guillermo; Vargas, Astrid; Simon, Miguel A.; Zorrilla, Irene; Munoz, Alvaro; Palomares, Francisco; Lopez-Bao, Jose V.; Pastor, Josep; Tandon, Ravi; Willi, Barbara; Hofmann-Lehmann, Regina; Lutz, Hans			Feline Leukemia Virus and Other Pathogens as Important Threats to the Survival of the Critically Endangered Iberian Lynx (Lynx pardinus)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DONANA-NATIONAL-PARK; IMMUNODEFICIENCY VIRUS; BOVINE TUBERCULOSIS; MOLECULAR CHARACTERIZATION; EXPERIMENTAL TRANSMISSION; MYCOBACTERIUM-BOVIS; WILD CARNIVORES; GENE-SEQUENCES; DISEASE AGENTS	Background: The Iberian lynx (Lynx pardinus) is considered the most endangered felid species in the world. In order to save this species, the Spanish authorities implemented a captive breeding program recruiting lynxes from the wild. In this context, a retrospective survey on prevalence of selected feline pathogens in free-ranging lynxes was initiated. Methodology/Principal Findings: We systematically analyzed the prevalence and importance of seven viral, one protozoan (Cytauxzoon felis), and several bacterial (e.g., hemotropic mycoplasma) infections in 77 of approximately 200 remaining free-ranging Iberian lynxes of the Donana and Sierra Morena areas, in Southern Spain, between 2003 and 2007. With the exception of feline immunodeficiency virus (FIV), evidence of infection by all tested feline pathogens was found in Iberian lynxes. Fourteen lynxes were feline leukemia virus (FeLV) provirus-positive; eleven of these were antigenemic (FeLV p27 positive). All 14 animals tested negative for other viral infections. During a six-month period in 2007, six of the provirus-positive antigenemic lynxes died. Infection with FeLV but not with other infectious agents was associated with mortality (p < 0.001). Sequencing of the FeLV surface glycoprotein gene revealed a common origin for ten of the eleven samples. The ten sequences were closely related to FeLV-A/61E, originally isolated from cats in the USA. Endogenous FeLV sequences were not detected. Conclusions/Significance: It was concluded that the FeLV infection most likely originated from domestic cats invading the lynx's habitats. Data available regarding the time frame, co-infections, and outcome of FeLV-infections suggest that, in contrast to the domestic cat, the FeLV strain affecting the lynxes in 2007 is highly virulent to this species. Our data argue strongly for vaccination of lynxes and domestic cats in and around lynx's habitats in order to prevent further spread of the virus as well as reduction the domestic cat population if the lynx population is to be maintained.	[Meli, Marina L.; Cattori, Valentino; Tandon, Ravi; Willi, Barbara; Hofmann-Lehmann, Regina; Lutz, Hans] Univ Zurich, Clin Lab, Vetsuisse Fac, Zurich, Switzerland; [Martinez, Fernando; Vargas, Astrid] Espac Nat Donana, Programa Conservac Ex Situ Lince Iberico, Matalascanas, Spain; [Lopez, Guillermo; Simon, Miguel A.] Egmasa Consejeria Medio Ambiente, Cordoba, Spain; [Zorrilla, Irene; Munoz, Alvaro] Ctr Anal Diagnost, Malaga, Spain; [Palomares, Francisco; Lopez-Bao, Jose V.] CSIC, Dept Biol Conservac, Estn Biol Donana, Seville, Spain; [Pastor, Josep] Univ Autonoma Barcelona, Fac Vet, Dept Med Cirurg Anim, Barcelona, Spain	University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Autonomous University of Barcelona	Meli, ML (corresponding author), Univ Zurich, Clin Lab, Vetsuisse Fac, Zurich, Switzerland.	mmeli@vetclinics.uzh.ch	Zorrilla, Irene/G-2885-2014; Pastor, Josep/J-9990-2015; Palomares, Francisco/F-5327-2016; Hofmann-Lehmann, Regina/C-6528-2009; Willi, Barbara/B-7636-2018; Willi, Barbara/AAZ-8136-2021	Pastor, Josep/0000-0003-1702-9531; Palomares, Francisco/0000-0002-4655-7205; Hofmann-Lehmann, Regina/0000-0001-9750-4296; Willi, Barbara/0000-0002-8010-1180; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Cattori, Valentino/0000-0001-6856-1347	Spanish Ministry of Education and Science [CGL2004-00346/BOS]; Spanish Ministry of the Environment [17/2005]; FPU [fellow]; Swiss National Science Foundation [PP00B 102866, PP00P3-119136]; University of Zurich, Switzerland	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of the Environment(Spanish Government); FPU(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich, Switzerland	The authors are indebted to the Environmental Council of the government of Andalusia, southern Spain, for providing the Iberian lynx samples. Some of the lynxes used in the present study were trapped and radio-tracked under research projects CGL2004-00346/BOS of the Spanish Ministry of Education and Science, and 17/2005 of the Spanish Ministry of the Environment under the National Parks research program, with the collaboration of Land Rover Espana S.A. JVLB is an FPU fellow (Ministry of Education). Laboratory work was performed using the logistics of the Center for Clinical Studies at the Vetsuisse Faculty of the University of Zurich. RHL is the recipient of a professorship by the Swiss National Science Foundation (PP00B 102866 and PP00P3-119136). The project was supported by the University of Zurich, Switzerland, by financing the operational activities of the Clinical laboratory of the Vetsuisse Faculty, Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Arjona A, 2000, J CLIN MICROBIOL, V38, P3448, DOI 10.1128/JCM.38.9.3448-3449.2000; Briones V, 2000, EMERG INFECT DIS, V6, P189, DOI 10.3201/eid0602.000214; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; Brown MA, 2008, EMERG INFECT DIS, V14, P252, DOI 10.3201/eid1402.070981; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Cattori V, 2006, MOL CELL PROBE, V20, P172, DOI 10.1016/j.mcp.2005.11.007; Chandhasin C, 2005, J VIROL, V79, P5278, DOI 10.1128/JVI.79.9.5278-5287.2005; Chandhasin C, 2005, J VIROL, V79, P1351, DOI 10.1128/JVI.79.3.1351-1360.2005; Chandhasin C, 2004, J GEN VIROL, V85, P2937, DOI 10.1099/vir.0.80149-0; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coelho FM, 2008, J GEN VIROL, V89, P2799, DOI 10.1099/vir.0.2008/003855-0; Delibes M., 2000, ACTION PLAN CONSERVA; EVERMANN JF, 1988, ARCH VIROL, V102, P155, DOI 10.1007/BF01310822; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreras P, 1997, J ZOOL, V243, P163, DOI 10.1111/j.1469-7998.1997.tb05762.x; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; GAONA P, 1998, ECOL MONOGR, P349; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gut M, 1999, J VIROL METHODS, V77, P37, DOI 10.1016/S0166-0934(98)00129-3; GUZMAN JN, 2002, IBERIAN LYNX LYNX PA; HEENEY JL, 1990, J VIROL, V64, P1964, DOI 10.1128/JVI.64.5.1964-1972.1990; Helps C, 2002, J VIROL METHODS, V106, P241, DOI 10.1016/S0166-0934(02)00167-2; Helps C, 2001, J CLIN MICROBIOL, V39, P2675, DOI 10.1128/JCM.39.7.2675-2676.2001; Hofmann-Lehmann R, 2007, VACCINE, V25, P5531, DOI 10.1016/j.vaccine.2006.12.022; HofmannLehmann R, 1997, CLIN DIAGN LAB IMMUN, V4, P33, DOI 10.1128/CDLI.4.1.33-42.1997; HofmannLehmann R, 1996, CLIN DIAGN LAB IMMUN, V3, P554, DOI 10.1128/CDLI.3.5.554-562.1996; HOOVER EA, 1991, J AM VET MED ASSOC, V199, P1287; HOOVER EA, 1987, BLOOD, V70, P1880; IUCN, 2007, IUCN RED LIST THREAT; Jackson P., 1996, BIOL CONSERVATION; Jimenez MA, 2008, VET IMMUNOL IMMUNOP, V121, P34, DOI 10.1016/j.vetimm.2007.07.018; Johnson WE, 2004, J HERED, V95, P19, DOI 10.1093/jhered/esh006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leutenegger CM, 1999, J VIROL METHODS, V78, P105, DOI 10.1016/S0166-0934(98)00166-9; LOPEZ G, ANIMAL CONSERV UNPUB; Lopez-Bao JV, 2008, MAMM BIOL, V73, P404, DOI 10.1016/j.mambio.2007.10.012; Luaces I, 2005, J WILDLIFE DIS, V41, P810, DOI 10.7589/0090-3558-41.4.810; Luaces I, 2008, J VET DIAGN INVEST, V20, P381, DOI 10.1177/104063870802000325; LUTZ H, 1983, AM J VET RES, V44, P2054; Martin-Atance P, 2006, J WILDLIFE DIS, V42, P704, DOI 10.7589/0090-3558-42.3.704; MATSUMOTO Y, 1992, VIROLOGY, V189, P745, DOI 10.1016/0042-6822(92)90598-J; Meli M, 2004, J FELINE MED SURG, V6, P69, DOI 10.1016/j.jfms.2003.08.007; Millan J, 2007, PARASITOLOGY, V134, P995, DOI 10.1017/S003118200700248X; Molia S, 2004, VET MICROBIOL, V100, P31, DOI 10.1016/j.vetmic.2004.01.007; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nei M., 2000, MOL EVOLUTION PHYLOG; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NOWELL K, 2002, IUCN SSC CAT SPECIAL; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; Palomares F, 2002, MOL ECOL, V11, P2171, DOI 10.1046/j.1365-294X.2002.01608.x; PALOMARES F, 2001, WILDLIFE MONOGRAPHS; Palomares F, 2003, MEMORIAM PROF ISIDOR, P505; Parra A, 2005, VET MICROBIOL, V110, P293, DOI 10.1016/j.vetmic.2005.07.013; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; Pena L, 2006, COMP IMMUNOL MICROB, V29, P114, DOI 10.1016/j.cimid.2006.01.003; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Pusterla N, 1999, J CLIN MICROBIOL, V37, P1329, DOI 10.1128/JCM.37.5.1329-1331.1999; Ramsauer S, 2007, CLIN VACCINE IMMUNOL, V14, P808, DOI 10.1128/CVI.00307-06; Rodriguez A, 2002, ECOGRAPHY, V25, P314, DOI 10.1034/j.1600-0587.2002.250308.x; Roelke ME, 2008, EUR J WILDLIFE RES, V54, P171, DOI 10.1007/s10344-007-0122-2; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; RoyBurman P, 1995, VIRUS GENES, V11, P147, DOI 10.1007/BF01728655; Ryser-Degiorgis MP, 2005, J WILDLIFE DIS, V41, P58, DOI 10.7589/0090-3558-41.1.58; Sobrino R, 2007, VET PARASITOL, V148, P187, DOI 10.1016/j.vetpar.2007.06.038; Tandon R, 2005, J VIROL METHODS, V130, P124, DOI 10.1016/j.jviromet.2005.06.017; TANDON R, 2008, VIRUS RES; Tandon R, 2007, MOL CELL PROBE, V21, P257, DOI 10.1016/j.mcp.2007.01.003; TARTAGLIA J, 1993, J VIROL, V67, P2370, DOI 10.1128/JVI.67.4.2370-2375.1993; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres J, 1998, J HELMINTHOL, V72, P221, DOI 10.1017/S0022149X00016473; Vicente J, 2004, J HELMINTHOL, V78, P179, DOI 10.1079/JOH2003216; Vogtlin A, 2002, J CLIN MICROBIOL, V40, P519, DOI 10.1128/JCM.40.2.519-523.2002; Willi B, 2006, J CLIN MICROBIOL, V44, P961, DOI 10.1128/JCM.44.3.961-969.2006; Willi B, 2005, J CLIN MICROBIOL, V43, P2581, DOI 10.1128/JCM.43.6.2581-2585.2005; Willi B, 2007, J CLIN MICROBIOL, V45, P1159, DOI 10.1128/JCM.02005-06	79	103	103	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4744	10.1371/journal.pone.0004744	http://dx.doi.org/10.1371/journal.pone.0004744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270739	Green Published, gold			2022-12-27	WOS:000265495900012
J	Wiedemann, T; Loell, E; Mueller, S; Stoeckelhuber, M; Stolte, M; Haas, R; Rieder, G				Wiedemann, Tobias; Loell, Eva; Mueller, Susanna; Stoeckelhuber, Mechthild; Stolte, Manfred; Haas, Rainer; Rieder, Gabriele			Helicobacter pylori cag-Pathogenicity Island-Dependent Early Immunological Response Triggers Later Precancerous Gastric Changes in Mongolian Gerbils	PLOS ONE			English	Article								Infection with Helicobacter pylori, carrying a functional cag type IV secretion system (cag-T4SS) to inject the Cytotoxin associated antigen (CagA) into gastric cells, is associated with an increased risk for severe gastric diseases in humans. Here we studied the pathomechanism of H. pylori and the role of the cag-pathogenicity island (cag-PAI) for the induction of gastric ulcer and precancerous conditions over time (2-64 weeks) using the Mongolian gerbil model. Animals were challenged with H. pylori B128 (WT), or an isogenic B128 Delta cagY mutant-strain that produces CagA, but is unable to translocate it into gastric cells. H. pylori colonization density was quantified in antrum and corpus mucosa separately. Paraffin sections were graded for inflammation and histological changes verified by immunohistochemistry. Physiological and inflammatory markers were quantitated by RIA and RT-PCR, respectively. An early cag-T4SS-dependent inflammation of the corpus mucosa (4-8 weeks) occurred only in WT-infected animals, resulting in a severe active and chronic gastritis with a significant increase of proinflammatory cytokines, mucous gland metaplasia, and atrophy of the parietal cells. At late time points only WT-infected animals developed hypochlorhydria and hypergastrinemia in parallel to gastric ulcers, gastritis cystica profunda, and focal dysplasia. The early cag-PAI-dependent immunological response triggers later physiological and histopathological alterations towards gastric malignancies.	[Wiedemann, Tobias; Loell, Eva; Haas, Rainer; Rieder, Gabriele] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Mueller, Susanna] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Stoeckelhuber, Mechthild] Univ Munich, Inst Anat, D-80539 Munich, Germany; [Stolte, Manfred] Klin Bayreuth GmbH, Inst Pathol, Bayreuth, Germany	University of Munich; University of Munich; University of Munich; Klinikum Bayreuth	Wiedemann, T (corresponding author), Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany.	rieder@mvp.uni-muenchen.de			Deutsche Forschungsgemeinschaft [RI 972/3-1, SFB576]; ERA-NET PathoGenoMics [0313930D]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERA-NET PathoGenoMics	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RI 972/3-1) to GR and (SFB576) to RH and ERA-NET PathoGenoMics (0313930D) to RH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bach S, 1999, EUR J CLIN MICROBIOL, V18, P807, DOI 10.1007/s100960050405; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Beales ILP, 1998, GUT, V43, P176, DOI 10.1136/gut.43.2.176; CORREA P, 1988, CANCER RES, V48, P3554; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Zimaity HMT, 2002, CANCER-AM CANCER SOC, V94, P1428, DOI 10.1002/cncr.10375; Elfvin A, 2005, SCAND J GASTROENTERO, V40, P1313, DOI 10.1080/00365520510023611; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Fox JG, 2003, CANCER RES, V63, P942; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Honda S, 1998, CANCER RES, V58, P4255; International Agency for Research on Cancer, 1994, IARC MONOGR EVAL CAR, V61, P1; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Meining A, 1998, VIRCHOWS ARCH, V432, P311, DOI 10.1007/s004280050171; Miehlke S, 2001, AM J GASTROENTEROL, V96, P1008, DOI 10.1111/j.1572-0241.2001.03685.x; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; Neu B, 2003, BIOCHEM PHARMACOL, V65, P1755, DOI 10.1016/S0006-2952(03)00124-2; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Prinz C, 1997, GASTROENTEROLOGY, V112, P364, DOI 10.1053/gast.1997.v112.pm9024290; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Schmidt PH, 1999, LAB INVEST, V79, P639; Sewald X, 2008, CELL HOST MICROBE, V3, P20, DOI 10.1016/j.chom.2007.11.003; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Sozzi M, 2001, FEMS MICROBIOL LETT, V203, P109, DOI 10.1016/S0378-1097(01)00338-X; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Takaishi S, 2005, GASTROENTEROLOGY, V128, P1965, DOI 10.1053/j.gastro.2005.03.027; Takashima M, 2001, GUT, V48, P765, DOI 10.1136/gut.48.6.765; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Zavros Y, 2003, P NATL ACAD SCI USA, V100, P12944, DOI 10.1073/pnas.2135193100; Zavros Y, 2005, BIOCHEM PHARMACOL, V69, P365, DOI 10.1016/j.bcp.2004.07.043	48	50	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4754	10.1371/journal.pone.0004754	http://dx.doi.org/10.1371/journal.pone.0004754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270747	Green Published, Green Submitted, gold			2022-12-27	WOS:000265495900021
J	Ke, XS; Qu, Y; Rostad, K; Li, WC; Lin, BY; Halvorsen, OJ; Haukaas, SA; Jonassen, I; Petersen, K; Goldfinger, N; Rotter, V; Akslen, LA; Oyan, AM; Kalland, KH				Ke, Xi-Song; Qu, Yi; Rostad, Kari; Li, Wen-Cheng; Lin, Biaoyang; Halvorsen, Ole Johan; Haukaas, Svein A.; Jonassen, Inge; Petersen, Kjell; Goldfinger, Naomi; Rotter, Varda; Akslen, Lars A.; Oyan, Anne M.; Kalland, Karl-Henning			Genome-Wide Profiling of Histone H3 Lysine 4 and Lysine 27 Trimethylation Reveals an Epigenetic Signature in Prostate Carcinogenesis	PLOS ONE			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; MIR-200 FAMILY; CANCER; METHYLATION; PROLIFERATION; SUBGROUPS; PHENOTYPE; CELLS; MARKS	Background: Increasing evidence implicates the critical roles of epigenetic regulation in cancer. Very recent reports indicate that global gene silencing in cancer is associated with specific epigenetic modifications. However, the relationship between epigenetic switches and more dynamic patterns of gene activation and repression has remained largely unknown. Methodology/Principal Findings: Genome-wide profiling of the trimethylation of histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3) was performed using chromatin immunoprecipitation coupled with whole genome promoter microarray (ChIP-chip) techniques. Comparison of the ChIP-chip data and microarray gene expression data revealed that loss and/or gain of H3K4me3 and/or H3K27me3 were strongly associated with differential gene expression, including microRNA expression, between prostate cancer and primary cells. The most common switches were gain or loss of H3K27me3 coupled with low effect on gene expression. The least prevalent switches were between H3K4me3 and H3K27me3 coupled with much higher fractions of activated and silenced genes. Promoter patterns of H3K4me3 and H3K27me3 corresponded strongly with coordinated expression changes of regulatory gene modules, such as HOX and microRNA genes, and structural gene modules, such as desmosome and gap junction genes. A number of epigenetically switched oncogenes and tumor suppressor genes were found overexpressed and underexpressed accordingly in prostate cancer cells. Conclusions/Significance: This work offers a dynamic picture of epigenetic switches in carcinogenesis and contributes to an overall understanding of coordinated regulation of gene expression in cancer. Our data indicate an H3K4me3/H3K27me3 epigenetic signature of prostate carcinogenesis.	[Ke, Xi-Song; Qu, Yi; Rostad, Kari; Li, Wen-Cheng; Akslen, Lars A.; Oyan, Anne M.; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Li, Wen-Cheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan, Peoples R China; [Lin, Biaoyang] Swedish Med Ctr, Seattle, WA USA; [Lin, Biaoyang] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Hangzhou, Peoples R China; [Halvorsen, Ole Johan; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Haukaas, Svein A.] Univ Bergen, Dept Surgical Sci, N-5020 Bergen, Norway; [Haukaas, Svein A.] Haukeland Hosp, Dept Surg, Bergen, Norway; [Jonassen, Inge; Petersen, Kjell] Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, N-5020 Bergen, Norway; [Jonassen, Inge; Petersen, Kjell] Univ Bergen, Dept Informat, N-5020 Bergen, Norway; [Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Oyan, Anne M.; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol & Immunol, Bergen, Norway	University of Bergen; Huazhong University of Science & Technology; Swedish Medical Center; Zhejiang University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Weizmann Institute of Science; University of Bergen; Haukeland University Hospital	Ke, XS (corresponding author), Univ Bergen, Gade Inst, Bergen, Norway.	Xisong.Ke@gades.uib.no; Kalland@gades.uib.no	Lin, Biaoyang/AAA-1258-2020; Akslen, Lars A./AAG-6097-2021; Jonassen, Inge/AAC-7035-2020	Lin, Biaoyang/0000-0002-2189-0407; Akslen, Lars A./0000-0003-2710-9543; Jonassen, Inge/0000-0003-4110-0748	Helse Vest [911005, 911227, 911401]; Research Council of Norway [154942/310, 163920/V50, 185676/V40]; The Norwegian Cancer Society [HS01-2006-0446, HS01-2006-0468, HS02-2008-0188]; European Commission 6th Framework Program [504743]; UroBergen Research Fund	Helse Vest; Research Council of Norway(Research Council of Norway); The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); European Commission 6th Framework Program(European CommissionEuropean Commission Joint Research Centre); UroBergen Research Fund	This work was supported by Helse Vest (grants no. 911005, 911227 and 911401), the Research Council of Norway (grants. no. 154942/310, 163920/V50 and 185676/V40) and The Norwegian Cancer Society (grants no. HS01-2006-0446, HS01-2006-0468, HS02-2008-0188), the European Commission 6th Framework Program Contract 504743 and the UroBergen Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Halvorsen OJ, 2005, INT J ONCOL, V26, P329; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller GJ, 2003, CANCER RES, V63, P5879; Miremadi A, 2007, HUM MOL GENET, V16, pR28, DOI 10.1093/hmg/ddm021; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Petersen K, 2007, ANAL BIOCHEM, V366, P46, DOI 10.1016/j.ab.2007.03.013; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rostad K, 2007, INT J ONCOL, V30, P19; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Shioji G, 2005, J HUM GENET, V50, P507, DOI 10.1007/s10038-005-0285-1; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	43	110	115	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4687	10.1371/journal.pone.0004687	http://dx.doi.org/10.1371/journal.pone.0004687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262738	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490600015
J	Govern, CC; Chakraborty, AK				Govern, Christopher C.; Chakraborty, Arup K.			Signaling Cascades Modulate the Speed of Signal Propagation through Space	PLOS ONE			English	Article							KINASE CASCADE	Background: Cells are not mixed bags of signaling molecules. As a consequence, signals must travel from their origin to distal locations. Much is understood about the purely diffusive propagation of signals through space. Many signals, however, propagate via signaling cascades. Here, we show that, depending on their kinetics, cascades speed up or slow down the propagation of signals through space, relative to pure diffusion. Methodology/Principal Findings: We modeled simple cascades operating under different limits of Michaelis-Menten kinetics using deterministic reaction-diffusion equations. Cascades operating far from enzyme saturation speed up signal propagation; the second mobile species moves more quickly than the first through space, on average. The enhanced speed is due to more efficient serial activation of a downstream signaling module (by the signaling molecule immediately upstream in the cascade) at points distal from the signaling origin, compared to locations closer to the source. Conversely, cascades operating under saturated kinetics, which exhibit zero-order ultrasensitivity, can slow down signals, ultimately localizing them to regions around the origin. Conclusions/Significance: Signal speed modulation may be a fundamental function of cascades, affecting the ability of signals to penetrate within a cell, to cross-react with other signals, and to activate distant targets. In particular, enhanced speeds provide a way to increase signal penetration into a cell without needing to flood the cell with large numbers of active signaling molecules; conversely, diminished speeds in zero-order ultrasensitive cascades facilitate strong, but localized, signaling.	[Govern, Christopher C.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Govern, CC (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu			NIH Director's Pioneer Award; NIH [2 T32 GM008334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008334] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH Director's Pioneer Award; NIH Grant 2 T32 GM008334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2002, TRENDS CELL BIOL, V12, P173, DOI 10.1016/S0962-8924(02)02251-1; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; Markevich NI, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100108; Naka T, 2006, BIOSYSTEMS, V83, P167, DOI 10.1016/j.biosystems.2005.06.015; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Slepchenko BM, 2003, MOL BIOL CELL, V14, P4695, DOI 10.1091/mbc.E03-04-0248; Stelling J, 2009, J MATH BIOL, V58, P35, DOI 10.1007/s00285-008-0162-6; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4639	10.1371/journal.pone.0004639	http://dx.doi.org/10.1371/journal.pone.0004639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247484	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487800020
J	Hans, S; Kaslin, J; Freudenreich, D; Brand, M				Hans, Stefan; Kaslin, Jan; Freudenreich, Dorian; Brand, Michael			Temporally-Controlled Site-Specific Recombination in Zebrafish	PLOS ONE			English	Article								Conventional use of the site-specific recombinase Cre is a powerful technology in mouse, but almost absent in other vertebrate model organisms. In zebrafish, Cre-mediated recombination efficiency was previously very low. Here we show that using transposon-mediated transgenesis, Cre is in fact highly efficient in this organism. Furthermore, temporal control of recombination can be achieved by using the ligand-inducible CreER(T2). Site-specific recombination only occurs upon administration of the drug tamoxifen (TAM) or its active metabolite, 4-hydroxy-tamoxifen (4-OHT). Cre-mediated recombination is detectable already 4 or 2 hours after administration of TAM or 4-OHT, demonstrating fast recombination kinetics. In addition, low doses of TAM allow mosaic labeling of single cells. Combined, our results show that conditional Cre/lox will be a valuable tool for both, embryonic and adult zebrafish studies. Furthermore, single copy insertion transgenesis of Cre/lox constructs suggest a strategy suitable also for other organisms.	[Hans, Stefan; Kaslin, Jan; Freudenreich, Dorian; Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany; [Hans, Stefan; Kaslin, Jan; Freudenreich, Dorian; Brand, Michael] Tech Univ Dresden, Ctr Regenerative Therapies Dresden, D-8027 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Hans, S (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kaslin, Jan/E-7780-2010; Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Kaslin, Jan/0000-0002-6207-1889	EU; ZF-MODELS; Endotrack;  [SFB 655]	EU(European Commission); ZF-MODELS; Endotrack; 	This work was supported by grants from the EU, ZF-MODELS, Endotrack and SFB 655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Driever W, 1996, DEVELOPMENT, V123, P37; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Feil R, 2007, Handb Exp Pharmacol, P3; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feng H, 2007, BRIT J HAEMATOL, V138, P169, DOI 10.1111/j.1365-2141.2007.06625.x; Haffter P, 1996, DEVELOPMENT, V123, P1; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Iyengar A, 1996, TRANSGENIC RES, V5, P147, DOI 10.1007/BF01969704; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Picker A, 2002, DEVELOPMENT, V129, P3227; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STUART GW, 1988, DEVELOPMENT, V103, P403; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	30	144	146	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4640	10.1371/journal.pone.0004640	http://dx.doi.org/10.1371/journal.pone.0004640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247481	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800021
J	Papeo, L; Vallesi, A; Isaja, A; Rumiati, RI				Papeo, Liuba; Vallesi, Antonino; Isaja, Alessio; Rumiati, Raffaella Ida			Effects of TMS on Different Stages of Motor and Non-Motor Verb Processing in the Primary Motor Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; WORD RECOGNITION; MENTAL ROTATION; LANGUAGE; BRAIN; ACTIVATION; MECHANISMS; SYSTEM; REPRESENTATION; COMPATIBILITY	The embodied cognition hypothesis suggests that motor and premotor areas are automatically and necessarily involved in understanding action language, as word conceptual representations are embodied. This transcranial magnetic stimulation (TMS) study explores the role of the left primary motor cortex in action-verb processing. TMS-induced motor-evoked potentials from right-hand muscles were recorded as a measure of M1 activity, while participants were asked either to judge explicitly whether a verb was action-related (semantic task) or to decide on the number of syllables in a verb (syllabic task). TMS was applied in three different experiments at 170, 350 and 500 ms post-stimulus during both tasks to identify when the enhancement of M1 activity occurred during word processing. The delays between stimulus onset and magnetic stimulation were consistent with electrophysiological studies, suggesting that word recognition can be differentiated into early (within 200 ms) and late (within 400 ms) lexical-semantic stages, and post-conceptual stages. Reaction times and accuracy were recorded to measure the extent to which the participants' linguistic performance was affected by the interference of TMS with M1 activity. No enhancement of M1 activity specific for action verbs was found at 170 and 350 ms post-stimulus, when lexical-semantic processes are presumed to occur (Experiments 1-2). When TMS was applied at 500 ms post-stimulus (Experiment 3), processing action verbs, compared with non-action verbs, increased the M1-activity in the semantic task and decreased it in the syllabic task. This effect was specific for hand-action verbs and was not observed for action-verbs related to other body parts. Neither accuracy nor RTs were affected by TMS. These findings suggest that the lexical-semantic processing of action verbs does not automatically activate the M1. This area seems to be rather involved in post-conceptual processing that follows the retrieval of motor representations, its activity being modulated (facilitated or inhibited), in a top-down manner, by the specific demand of the task.	[Papeo, Liuba; Isaja, Alessio; Rumiati, Raffaella Ida] Scuola Int Super Studi Avanzati, Sector Cognit Neurosci, Trieste, Italy; [Vallesi, Antonino] Rotman Res Inst Baycrest, Toronto, ON, Canada	International School for Advanced Studies (SISSA); University of Toronto; University Toronto Affiliates; Baycrest	Papeo, L (corresponding author), Scuola Int Super Studi Avanzati, Sector Cognit Neurosci, Trieste, Italy.	rumiati@sissa.it	Vallesi, Antonino/E-8987-2011; Papeo, Liuba/O-4336-2017	Vallesi, Antonino/0000-0002-4087-2845; 	PRIN	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was supported by a PRIN to RIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Ben Shalom D, 2008, NEUROSCIENTIST, V14, P119, DOI 10.1177/1073858407305726; Berndt RS, 2002, J NEUROLINGUIST, V15, P353, DOI 10.1016/S0911-6044(01)00030-6; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Carreiras M, 2005, J COGNITIVE NEUROSCI, V17, P1803, DOI 10.1162/089892905774589217; DeRenzi E, 1995, CORTEX, V31, P619, DOI 10.1016/S0010-9452(13)80016-0; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; EIMER M, 1995, ACTA PSYCHOL, V90, P301, DOI 10.1016/0001-6918(95)00022-M; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Floel A, 2003, EUR J NEUROSCI, V18, P704, DOI 10.1046/j.1460-9568.2003.02774.x; Fodor J. A, 2001, MIND DOESNT WORK WAY; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; Iwaki S, 1999, NEUROREPORT, V10, P1793, DOI 10.1097/00001756-199906030-00031; Jeannerod M, 1999, Q J EXP PSYCHOL-A, V52, P1, DOI 10.1080/027249899391205; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Kellenbach ML, 2002, J COGNITIVE NEUROSCI, V14, P561, DOI 10.1162/08989290260045819; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; KORNBLUM S, 1992, TUTORIALS MOTOR BEHA, P713; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; LAWS KR, 1995, MEMORY, V3, P397, DOI 10.1080/09658219508253158; LU C, 2005, PSYCHON B RES, V2, P174; Luzzatti C, 2002, BRAIN LANG, V81, P432, DOI 10.1006/brln.2001.2536; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Paivio A, 1971, IMAGERY VERBAL PROCE; PAPAGNO C, 1993, J NEUROL NEUROSUR PS, V56, P286, DOI 10.1136/jnnp.56.3.286; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, J COGNITIVE NEUROSCI, V17, P884, DOI 10.1162/0898929054021111; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2002, PROG NEUROBIOL, V67, P85, DOI 10.1016/S0301-0082(02)00014-X; PULVERMULLER F, 2004, BRAIN LANG, V78, P113; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Reynolds C, 1999, NEUROLOGY, V53, P730, DOI 10.1212/WNL.53.4.730; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; ROBERTSON EM, 2008, J COGNITIVE NEUROSCI, V15, P948; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Southgate V, 2008, COGNITION, V107, P1059, DOI 10.1016/j.cognition.2007.10.002; TALMY L, 1985, WEAVING LEXICON, P57; TAYLOR B., 1977, LINGUIST PHILOS, V1, P199, DOI DOI 10.1007/BF00351103; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tomasino B, 2005, COGN NEUROPSYCHOL, V22, P348, DOI 10.1080/02643290442000185; Tomasino B, 2007, NEUROIMAGE, V36, pT128, DOI 10.1016/j.neuroimage.2007.03.035; Tomasino B, 2008, NEUROPSYCHOLOGIA, V46, P1915, DOI 10.1016/j.neuropsychologia.2008.01.015; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; YENDLER Z, 1957, PHYLOSOPHICAL REV, V66, P143	66	137	138	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4508	10.1371/journal.pone.0004508	http://dx.doi.org/10.1371/journal.pone.0004508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240793	Green Published, Green Submitted, gold			2022-12-27	WOS:000278086700001
J	Roy, SW				Roy, Scott William			Phylogenomics: Gene Duplication, Unrecognized Paralogy and Outgroup Choice	PLOS ONE			English	Article								Comparative genomics has revealed the ubiquity of gene and genome duplication and subsequent gene loss. In the case of gene duplication and subsequent loss, gene trees can differ from species trees, thus frequent gene duplication poses a challenge for reconstruction of species relationships. Here I address the case of multi-gene sets of putative orthologs that include some unrecognized paralogs due to ancestral gene duplication, and ask how outgroups should best be chosen to reduce the degree of non-species tree (NST) signal. Consideration of expected internal branch lengths supports several conclusions: (i) when a single outgroup is used, the degree of NST signal arising from gene duplication is either independent of outgroup choice, or is minimized by use of a maximally closely related post-duplication (MCRPD) outgroup; (ii) when two outgroups are used, NST signal is minimized by using one MCRPD outgroup, while the position of the second outgroup is of lesser importance; and (iii) when two outgroups are used, the ability to detect gene trees that are inconsistent with known aspects of the species tree is maximized by use of one MCRPD, and is either independent of the position of the second outgroup, or is maximized for a more distantly related second outgroup. Overall, these results generalize the utility of closely-related outgroups for phylogenetic analysis.	[Roy, Scott William] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Roy, SW (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	royscott@ncbi.nlm.nih.gov			National Library of Medicine Internal Research Training Award	National Library of Medicine Internal Research Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Library of Medicine Internal Research Training Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYANT D, 2002, LCNS, V242, P375; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Huelsenbeck JP, 1996, SYST BIOL, V45, P92, DOI 10.2307/2413514; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Penny D, 2008, MOL BIOL EVOL, V25, P239, DOI 10.1093/molbev/msm263; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Rogozin IB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-7; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zheng CF, 2008, J COMPUT BIOL, V15, P947, DOI 10.1089/cmb.2008.0118; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	23	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4568	10.1371/journal.pone.0004568	http://dx.doi.org/10.1371/journal.pone.0004568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234600	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487200019
J	Krause, ET; Honarmand, M; Wetzel, J; Naguib, M				Krause, E. Tobias; Honarmand, Mariam; Wetzel, Jennifer; Naguib, Marc			Early Fasting Is Long Lasting: Differences in Early Nutritional Conditions Reappear under Stressful Conditions in Adult Female Zebra Finches	PLOS ONE			English	Article								Conditions experienced during early life can have profound effects on individual development and condition in adulthood. Differences in nutritional provisioning in birds during the first month of life can lead to differences in growth, reproductive success and survival. Yet, under natural conditions shorter periods of nutritional stress will be more prevalent. Individuals may respond differently, depending on the period of development during which nutritional stress was experienced. Such differences may surface specifically when poor environmental conditions challenge individuals again as adults. Here, we investigated long term consequences of differences in nutritional conditions experienced during different periods of early development by female zebra finches (Taeniopygia guttata) on measures of management and acquisition of body reserves. As nestlings or fledglings, subjects were raised under different nutritional conditions, a low or high quality diet. After subjects reached sexual maturity, we measured their sensitivity to periods of food restriction, their exploration and foraging behaviour as well as adult resting metabolic rate (RMR). During a short period of food restriction, subjects from the poor nutritional conditions had a higher body mass loss than those raised under qualitatively superior nutritional conditions. Moreover, subjects that were raised under poor nutritional conditions were faster to engage in exploratory and foraging behaviour. But RMR did not differ among treatments. These results reveal that early nutritional conditions affect adult exploratory behaviour, a representative personality trait, foraging and adult's physiological condition. As early nutritional conditions are reflected in adult phenotypic plasticity specifically when stressful situations reappear, the results suggest that costs for poor developmental conditions are paid when environmental conditions deteriorate.	[Krause, E. Tobias; Honarmand, Mariam; Wetzel, Jennifer; Naguib, Marc] Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany; [Naguib, Marc] Netherlands Inst Ecol, NIOO KNAW, Dept Anim Populat Biol, Heteren, Netherlands	University of Bielefeld; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Krause, ET (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany.	tobias.krause@uni-bielefeld.de	Krause, E. Tobias/A-9900-2009; Naguib, Marc/C-2650-2009	Krause, E. Tobias/0000-0002-8327-3711; Naguib, Marc/0000-0003-0494-4888	German Research Foundation [Na335/6]	German Research Foundation(German Research Foundation (DFG))	The research was funded by a grant from the German Research Foundation (Na335/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 2007, J AVIAN BIOL, V38, P356, DOI 10.1111/j.2007.0908-8857.03818.x; ARNOLD KE, 2007, P ROY SOC LOND B BIO, V274, P2693; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; Blount JD, 2006, IBIS, V148, P509, DOI 10.1111/j.1474-919X.2006.00554.x; Carere C, 2005, BEHAVIOUR, V142, P1329, DOI 10.1163/156853905774539328; Criscuolo F, 2008, P ROY SOC B-BIOL SCI, V275, P1565, DOI 10.1098/rspb.2008.0148; Cuthill Innes C., 1997, P97; Deerenberg C, 1996, J AVIAN BIOL, V27, P321, DOI 10.2307/3677263; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2006, J NEUROBIOL, V66, P1602, DOI 10.1002/neu.20312; Immelmann K., 1965, Journal fuer Ornithologie, V106, P415, DOI 10.1007/BF01673432; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; LEMON WC, 1991, NATURE, V352, P153, DOI 10.1038/352153a0; LEMON WC, 1993, PHYSIOL ZOOL, V66, P946, DOI 10.1086/physzool.66.6.30163748; LEMON WC, 1992, ANIM BEHAV, V44, P851, DOI 10.1016/S0003-3472(05)80581-0; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; MacLeod R, 2007, ECOL LETT, V10, P945, DOI 10.1111/j.1461-0248.2007.01088.x; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Mosseau TA, 1998, MATERNAL EFFECTS ADA; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Nilsson JA, 2001, OECOLOGIA, V128, P187, DOI 10.1007/s004420100653; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Pravosudov VV, 2005, BEHAV NEUROSCI, V119, P1368, DOI 10.1037/0735-7044.119.5.1368; R Core Team, 2018, R LANG ENV STAT COMP; Rickard IJ, 2007, TRENDS ENDOCRIN MET, V18, P94, DOI 10.1016/j.tem.2007.02.004; Roff Derek A., 1992; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Tobler M, 2007, BIOLOGY LETT, V3, P408, DOI 10.1098/rsbl.2007.0127; Verhulst S, 2006, BIOL LETTERS, V2, P478, DOI 10.1098/rsbl.2006.0496; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walling CA, 2007, BEHAV ECOL SOCIOBIOL, V61, P1007, DOI 10.1007/s00265-006-0333-7; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; [No title captured]	41	88	88	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e5015	10.1371/journal.pone.0005015	http://dx.doi.org/10.1371/journal.pone.0005015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325706	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499400006
J	Wang, K; Yu, CS; Xu, LJ; Qin, W; Li, KC; Xu, L; Jiang, TZ				Wang, Kun; Yu, Chunshui; Xu, Lijuan; Qin, Wen; Li, Kuncheng; Xu, Lin; Jiang, Tianzi			Offline Memory Reprocessing: Involvement of the Brain's Default Network in Spontaneous Thought Processes	PLOS ONE			English	Article							STIMULUS-INDEPENDENT THOUGHT; RESTING HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; EPISODIC MEMORY; BASE-LINE; PREFRONTAL CORTEX; PARIETAL CORTEX; WORKING-MEMORY; VISUAL-CORTEX; STATE	Background: Spontaneous thought processes (STPs), also called daydreaming or mind-wandering, occur ubiquitously in daily life. However, the functional significance of STPs remains largely unknown. Methodology/Principal Finding: Using functional magnetic resonance imaging (fMRI), we first identified an STPs-network whose activity was positively correlated with the subjects' tendency of having STPs during a task-free state. The STPs-network was then found to be strongly associated with the default network, which has previously been established as being active during the task-free state. Interestingly, we found that offline reprocessing of previously memorized information further increased the activity of the STPs-network regions, although during a state with less STPs. In addition, we found that the STPs-network kept a dynamic balance between functional integration and functional separation among its component regions to execute offline memory reprocessing in STPs. Conclusion/Significance: These findings strengthen a view that offline memory reprocessing and STPs share the brain's default network, and thus implicate that offline memory reprocessing may be a predetermined function of STPs. This supports the perspective that memory can be consolidated and modified during STPs, and thus gives rise to a dynamic behavior dependent on both previous external and internal experiences.	[Wang, Kun; Xu, Lijuan; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Yu, Chunshui; Qin, Wen; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Lab Learning & Memory, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology	Wang, K (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	jiangtz@nlpr.ia.ac.cn	QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012	QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Xu, Lin/0000-0002-2710-3507; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [30425004, 60121302]; National Key Basic Research and Development Program (973) [2004CB318107]; Beijing Scientific and Technological New Star Program [2005B21]; CAS graduate science and social practice special funding innovative research projects	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China); Beijing Scientific and Technological New Star Program; CAS graduate science and social practice special funding innovative research projects	This work was supported by the Natural Science Foundation of China, Grant Nos. 30425004, and 60121302, the National Key Basic Research and Development Program (973), Grant No. 2004CB318107, Beijing Scientific and Technological New Star Program Grant No. 2005B21, and CAS graduate science and social practice special funding innovative research projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; ANTROBUS JS, 1970, T NEW YORK ACAD SCI, V32, P242, DOI 10.1111/j.2164-0947.1970.tb02056.x; ANTROBUS JS, 1968, BRIT J PSYCHOL, V59, P423, DOI 10.1111/j.2044-8295.1968.tb01157.x; ANTROBUS JS, 1966, PERCEPT MOTOR SKILL, V23, P399, DOI 10.2466/pms.1966.23.2.399; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2004, CORTEX, V40, P623, DOI 10.1016/S0010-9452(08)70158-8; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dalla Barba G, 1998, CORTEX, V34, P547; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRIEDMAN HR, 1994, J NEUROSCI, V14, P2775; GIAMBRA LM, 1979, INT J AGING HUM DEV, V10, P1, DOI 10.2190/01BD-RFNE-W34G-9ECA; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jonides J, 1998, J NEUROSCI, V18, P5026; KEDALL M, 1990, CORRELAION METHODS; Klinger E., 1987, IMAG COGN PERS, V7, P105, DOI [DOI 10.2190/7K24-G343-MTQW-115V, 10.2190/7k24-g343-mtqw-115v]; KLINGER E, 1971, STRUCTURE FUNCTIONAL; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mellet E, 1996, J NEUROSCI, V16, P6504; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Miyamoto Hiroyuki, 2003, Mol Interv, V3, P404, DOI 10.1124/mi.3.7.404; Nadel L, 2001, HIPPOCAMPUS, V11, P56, DOI 10.1002/1098-1063(2001)11:1<56::AID-HIPO1020>3.0.CO;2-O; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; SHANK RC, 1982, DYNAMIC MEMORY; SINGER J L, 1963, Percept Mot Skills, V17, P187; Singer J. L., 1972, FUNCTION NATURE IMAG, P175; SINGER JL, 1961, J CONSULT PSYCHOL, V25, P1, DOI 10.1037/h0048906; Singer JL., 1966, DAYDREAMING; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Stein T, 2000, AM J NEURORADIOL, V21, P1397; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Tulving E, 1972, ORG MEMORY; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	59	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4867	10.1371/journal.pone.0004867	http://dx.doi.org/10.1371/journal.pone.0004867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290044	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496500004
J	Fredembach, B; de Boisferon, AH; Gentaz, E				Fredembach, Benjamin; de Boisferon, Anne Hillairet; Gentaz, Edouard			Learning of Arbitrary Association between Visual and Auditory Novel Stimuli in Adults: The "Bond Effect'' of Haptic Exploration	PLOS ONE			English	Article							CLASSIFICATIONS; AWARENESS; MEMORY	Background: It is well-known that human beings are able to associate stimuli (novel or not) perceived in their environment. For example, this ability is used by children in reading acquisition when arbitrary associations between visual and auditory stimuli must be learned. The studies tend to consider it as an "implicit'' process triggered by the learning of letter/sound correspondences. The study described in this paper examined whether the addition of the visuo-haptic exploration would help adults to learn more effectively the arbitrary association between visual and auditory novel stimuli. Methodology/Principal Findings: Adults were asked to learn 15 new arbitrary associations between visual stimuli and their corresponding sounds using two learning methods which differed according to the perceptual modalities involved in the exploration of the visual stimuli. Adults used their visual modality in the "classic'' learning method and both their visual and haptic modalities in the "multisensory'' learning one. After both learning methods, participants showed a similar above-chance ability to recognize the visual and auditory stimuli and the audio-visual associations. However, the ability to recognize the visual-auditory associations was better after the multisensory method than after the classic one. Conclusion/Significance: This study revealed that adults learned more efficiently the arbitrary association between visual and auditory novel stimuli when the visual stimuli were explored with both vision and touch. The results are discussed from the perspective of how they relate to the functional differences of the manual haptic modality and the hypothesis of a "haptic bond'' between visual and auditory stimuli.	[Fredembach, Benjamin; de Boisferon, Anne Hillairet; Gentaz, Edouard] CNRS, Grenoble, France; [Fredembach, Benjamin; de Boisferon, Anne Hillairet; Gentaz, Edouard] Univ Grenoble 2, F-38040 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gentaz, E (corresponding author), CNRS, Grenoble, France.	Edouard.Gentaz@upmf-grenoble.fr	Hillairet de Boisferon, Anne/H-4655-2019	Hillairet de Boisferon, Anne/0000-0002-7304-6291	CNRS; University of Grenoble 2	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Grenoble 2	The research was supported by CNRS grants and University of Grenoble 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVANEL E, 1973, NEUROPSYCHOLOGIA, V11, P207, DOI 10.1016/0028-3932(73)90009-2; ARISTOTEBAZAN B, 1985, REV SCI PHILOS THEOL, V69, P521; Bara F, 2004, COGNITIVE DEV, V19, P433, DOI 10.1016/j.cogdev.2004.05.003; Bara F, 2007, BRIT J DEV PSYCHOL, V25, P643, DOI 10.1348/026151007X186643; Baranyi J, 2004, FOOD SAF ASSUR VET, V2, P145; BERGER C, 1995, BRIT J DEV PSYCHOL, V13, P143, DOI 10.1111/j.2044-835X.1995.tb00670.x; BERGER C, 1993, COGNITIVE DEV, V8, P495, DOI 10.1016/S0885-2014(05)80006-1; Berger C, 1996, J EXP CHILD PSYCHOL, V63, P447, DOI 10.1006/jecp.1996.0058; BRYANT P, 1985, CHILDRENS READING PR; Bus AG, 1999, J EDUC PSYCHOL, V91, P403, DOI 10.1037/0022-0663.91.3.403; BYRNE B, 1991, J EDUC PSYCHOL, V83, P451, DOI 10.1037/0022-0663.83.4.451; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; DEBOISFERON AH, 2007, ANNE PSYCHOL, V107, P1; DEHEANE S, 2007, NEURONES LECT; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; EVANS PM, 1988, COGNITIVE DEV, V3, P265, DOI 10.1016/0885-2014(88)90012-3; Garner W. R., 1974, PROCESSING INFORM ST; GARVILL J, 1973, SCAND J PSYCHOL, V14, P203, DOI 10.1111/j.1467-9450.1973.tb00111.x; Gentaz E, 2003, ANN PSYCHOL, V103, P561; GENTAZ E, 2009, MAIN CERVEAU TOUCHER; GOODNOW JJ, 1971, NEUROPSYCHOLOGICA, V42, P1187; HATWELL Y, 1994, TRAITE PSYCHOL EXPT, P543; HATWELL Y, 2003, TOUCHING KNOWING; HATWELL Y, 2000, TOUCHER CONNAITRE; HELLER M, 2000, TOUCH REPRESENTATION; HULME C, 1979, Q J EXP PSYCHOL, V31, P249, DOI 10.1080/14640747908400724; HULME C, 1981, READING RETARDATION; Kandel Eric. R., 2006, SEARCH MEMORY EMERGE; Locke J., 1700, ESSAY HUMAN UNDERSTA, V4th; Longcamp M, 2008, J COGNITIVE NEUROSCI, V20, P802, DOI 10.1162/jocn.2008.20504; Millar Susanna, 1994, UNDERSTANDING REPRES, DOI 10.1093/acprof:oso/9780198521426.001.0001; Minogue J, 2006, REV EDUC RES, V76, P317, DOI 10.3102/00346543076003317; ORLIAGUET JP, 1985, CAH PSYCHOL COGN, V5, P609; ORLIAGUET JP, 1983, CAHIERS PSYCHOL COGN, V3, P133; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; SHEPP BE, 1976, J EXP CHILD PSYCHOL, V22, P73, DOI 10.1016/0022-0965(76)90091-6; SMITH LB, 1989, PSYCHOL REV, V7, P811; Sprenger-Charolles L., 2006, READING ACQUISITION; SPRENGERCHAROLL.L, 2003, LECT DYSLEXIE; THORNDIKE EL, 1898, ANIMAL INTELLIGENCE; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	42	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4844	10.1371/journal.pone.0004844	http://dx.doi.org/10.1371/journal.pone.0004844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OI	19287486	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496400006
J	Kotecha, R; Pardos, M; Wang, YY; Wu, T; Horn, P; Brown, D; Rose, D; DeGrauw, T; Xiang, J				Kotecha, Rupesh; Pardos, Maria; Wang, Yingying; Wu, Ting; Horn, Paul; Brown, David; Rose, Douglas; DeGrauw, Ton; Xiang, Jing			Modeling the Developmental Patterns of Auditory Evoked Magnetic Fields in Children	PLOS ONE			English	Article								Background: As magnetoencephalography (MEG) is of increasing utility in the assessment of deficits and development delays in brain disorders in pediatrics, it becomes imperative to fully understand the functional development of the brain in children. Methodology: The present study was designed to characterize the developmental patterns of auditory evoked magnetic responses with respect to age and gender. Sixty children and twenty adults were studied with a 275-channel MEG system. Conclusions: Three main responses were identified at approximately 46 ms (M50), 71 ms (M70) and 106 ms (M100) in latency for children. The latencies of M70 and M100 shortened with age in both hemispheres; the latency of M50 shortened with age only in the right hemisphere. Analysis of developmental lateralization patterns in children showed that the latency of the right hemispheric evoked responses shortened faster than the corresponding left hemispheric responses. The latency of M70 in the right hemisphere highly correlated to the age of the child. The amplitudes of the M70 responses increased with age and reached their peaks in children 12-14 years of age, after which they decreased with age. The source estimates for the M50 and M70 responses indicated that they were generated in different subareas in the Heschl's gyrus in children, while not localizable in adults. Furthermore, gender also affected developmental patterns. The latency of M70 in the right hemisphere was proposed to be an index of auditory development in children, the modeling equation is 85.72-1.240xAge (yrs). Our results demonstrate that there is a clear developmental pattern in the auditory cortex and underscore the importance of M50 and M70 in the developing brain.	[Kotecha, Rupesh; Pardos, Maria; Wang, Yingying; Wu, Ting; Horn, Paul; Rose, Douglas; DeGrauw, Ton; Xiang, Jing] Cincinnati Childrens Hosp, MEG Ctr, Dept Neurol, Med Ctr, Cincinnati, OH USA; [Horn, Paul] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA; [Brown, David] Cincinnati Childrens Hosp Med Ctr, Ear & Hearing Ctr, Cincinnati, OH USA; [Brown, David] Cincinnati Childrens Hosp Med Ctr, Div Audiol, Cincinnati, OH USA; [Rose, Douglas] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Otolaryngol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Xiang, J (corresponding author), Cincinnati Childrens Hosp, MEG Ctr, Dept Neurol, Med Ctr, Cincinnati, OH USA.	jing.xiang@cchmc.org	Xiang, Jing/AAA-5326-2020; Wang, Yingying/I-2705-2018	Xiang, Jing/0000-0003-0242-5590; Wang, Yingying/0000-0001-6502-1388	Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA	Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA	This study was supported by a Trustee Grant from Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Cardy JEO, 2008, INT J PSYCHOPHYSIOL, V68, P170, DOI 10.1016/j.ijpsycho.2007.10.015; Cardy JEO, 2004, NEUROREPORT, V15, P1867, DOI 10.1097/00001756-200408260-00006; EGGERMONT JJ, 1988, ELECTROEN CLIN NEURO, V70, P293, DOI 10.1016/0013-4694(88)90048-X; FUCHIGAMI T, 1993, DEV MED CHILD NEUROL, V35, P230; Gage NM, 2003, DEV BRAIN RES, V144, P201, DOI 10.1016/S0165-3806(03)00172-X; Godey B, 2001, CLIN NEUROPHYSIOL, V112, P1850, DOI 10.1016/S1388-2457(01)00636-8; Gomes H, 2001, DEV BRAIN RES, V129, P147, DOI 10.1016/S0165-3806(01)00196-1; Kanno A, 2000, NEUROSCI LETT, V293, P187, DOI 10.1016/S0304-3940(00)01525-1; KOTECHA R, 2008, INT J PSYCHOPHYSIOL; Lajiness-O'Neill R, 2007, NEUROCASE, V13, P390, DOI 10.1080/13554790701851544; McGee T, 1996, EAR HEARING, V17, P419, DOI 10.1097/00003446-199610000-00008; Nakasato N, 1997, J NEUROSURG, V86, P610, DOI 10.3171/jns.1997.86.4.0610; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAETAU R, 1995, J CLIN NEUROPHYSIOL, V12, P177, DOI 10.1097/00004691-199503000-00008; Pang EW, 2003, INT J PSYCHOPHYSIOL, V51, P27, DOI 10.1016/S0167-8760(03)00150-8; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; Papanicolaou AC, 2005, J CLIN NEUROPHYSIOL, V22, P231, DOI 10.1097/01.WNP.0000172255.62072.E8; Pekkonen E, 2007, NEUROIMAGE, V35, P1547, DOI 10.1016/j.neuroimage.2007.01.036; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; REITE M, 1994, COGNITIVE BRAIN RES, V2, P13, DOI 10.1016/0926-6410(94)90016-7; REITE M, 1988, ELECTROEN CLIN NEURO, V70, P490, DOI 10.1016/0013-4694(88)90147-2; REITE M, 1989, ARCH GEN PSYCHIAT, V46, P565; Roberts TPL, 2000, J CLIN NEUROPHYSIOL, V17, P114, DOI 10.1097/00004691-200003000-00002; Rojas DC, 1998, NEUROREPORT, V9, P1543, DOI 10.1097/00001756-199805110-00055; Salmelin R, 1996, ANN NEUROL, V40, P157, DOI 10.1002/ana.410400206; SCHEUNEMAN D, 1991, BRAIN RES BULL, V26, P747, DOI 10.1016/0361-9230(91)90170-O; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Takeshita K, 2002, CLIN NEUROPHYSIOL, V113, P1470, DOI 10.1016/S1388-2457(02)00202-X; Teale P, 1996, IEEE T BIO-MED ENG, V43, P967, DOI 10.1109/10.532131; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; Thoma RJ, 2008, PSYCHOPHYSIOLOGY, V45, P926, DOI 10.1111/j.1469-8986.2008.00692.x; TONNQUISTUHLEN I, 1995, ELECTROEN CLIN NEURO, V95, P34, DOI 10.1016/0013-4694(95)00044-Y; Tovar-Spinoza ZS, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E16; Toyoda K, 1998, J NEUROL NEUROSUR PS, V64, P777, DOI 10.1136/jnnp.64.6.777; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008; Xiang J, 2003, PEDIATR RADIOL, V33, P321, DOI 10.1007/s00247-003-0883-z; Xiang J, 2002, CLIN NEUROPHYSIOL, V113, P1, DOI 10.1016/S1388-2457(01)00709-X; Xiang J, 2001, NEUROREPORT, V12, P3923, DOI 10.1097/00001756-200112210-00014; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	42	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4811	10.1371/journal.pone.0004811	http://dx.doi.org/10.1371/journal.pone.0004811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277207	Green Published, gold			2022-12-27	WOS:000265496100028
J	Ng, G; Tom, CGS; Park, AS; Zenad, L; Ludwig, RA				Ng, Gordon; Tom, Curtis G. S.; Park, Angela S.; Zenad, Lounis; Ludwig, Robert A.			A Novel Endo-Hydrogenase Activity Recycles Hydrogen Produced by Nitrogen Fixation	PLOS ONE			English	Article								Background: Nitrogen (N(2)) fixation also yields hydrogen (H(2)) at 1:1 stoichiometric amounts. In aerobic diazotrophic (able to grow on N(2) as sole N-source) bacteria, orthodox respiratory hupSL-encoded hydrogenase activity, associated with the cell membrane but facing the periplasm (exo-hydrogenase), has nevertheless been presumed responsible for recycling such endogenous hydrogen. Methods and Findings: As shown here, for Azorhizobium caulinodans diazotrophic cultures open to the atmosphere, exo-hydrogenase activity is of no consequence to hydrogen recycling. In a bioinformatic analysis, a novel seven-gene A. caulinodans hyq cluster encoding an integral-membrane, group-4, Ni,Fe-hydrogenase with homology to respiratory complex I (NADH : quinone dehydrogenase) was identified. By analogy, Hyq hydrogenase is also integral to the cell membrane, but its active site faces the cytoplasm (endo-hydrogenase). An A. caulinodans in-frame hyq operon deletion mutant, constructed by "crossover PCR'', showed markedly decreased growth rates in diazotrophic cultures; normal growth was restored with added ammonium-as expected of an H(2)-recycling mutant phenotype. Using A. caulinodans hyq merodiploid strains expressing beta-glucuronidase as promoter-reporter, the hyq operon proved strongly and specifically induced in diazotrophic culture; as well, hyq operon induction required the NIFA transcriptional activator. Therefore, the hyq operon is constituent of the nif regulon. Conclusions: Representative of aerobic N(2)-fixing and H(2)-recycling alpha-proteobacteria, A. caulinodans possesses two respiratory Ni,Fe-hydrogenases: HupSL exo-hydrogenase activity drives exogenous H(2) respiration, and Hyq endo-hydrogenase activity recycles endogenous H(2), specifically that produced by N(2) fixation. To benefit human civilization, H(2) has generated considerable interest as potential renewable energy source as its makings are ubiquitous and its combustion yields no greenhouse gases. As such, the reversible, group-4 Ni, Fe-hydrogenases, such as the A. caulinodans Hyq endo-hydrogenase, offer promise as biocatalytic agents for H(2) production and/or consumption.	[Ng, Gordon; Tom, Curtis G. S.; Park, Angela S.; Zenad, Lounis; Ludwig, Robert A.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Ng, G (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	rludwig@ucsc.edu			University of California Energy Institute	University of California Energy Institute(University of California System)	This work is funded by the University of California Energy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Baginsky C, 2004, FEMS MICROBIOL LETT, V237, P399, DOI 10.1016/j.femsle.2004.07.003; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; BUCKMILLER LM, 1991, J BACTERIOL, V173, P2017, DOI 10.1128/jb.173.6.2017-2025.1991; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Burris R. H., 1980, Nitrogen fixation [Proceedings of the Phytochemical Society of Europe Symposium Sussex, UK, September, 1979]., P37; COPELAND A, 2007, COMPLETE SEQUE UNPUB; DIXON ROD, 1972, ARCH MIKROBIOL, V85, P193, DOI 10.1007/BF00408844; DONALD RGK, 1986, J BACTERIOL, V165, P72, DOI 10.1128/jb.165.1.72-81.1986; DREYFUS BL, 1981, FEMS MICROBIOL LETT, V10, P313; Fox JD, 1996, J BACTERIOL, V178, P1515, DOI 10.1128/jb.178.6.1515-1524.1996; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; HYNDMAN LA, 1953, J BACTERIOL, V65, P522, DOI 10.1128/JB.65.5.522-531.1953; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOROCH AI, 1995, J BACTERIOL, V177, P7210, DOI 10.1128/jb.177.24.7210-7221.1995; Ludwig RA, 2004, RES MICROBIOL, V155, P61, DOI 10.1016/j.resmic.2003.11.001; LUDWIG RA, 1986, J BACTERIOL, V165, P304, DOI 10.1128/jb.165.1.304-307.1986; PETERSON GL, 1979, ANAL BIOCHEM, V10, P101; Phelps AS, 1941, P SOC EXP BIOL MED, V47, P473; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHUBERT KR, 1976, P NATL ACAD SCI USA, V73, P1207, DOI 10.1073/pnas.73.4.1207; Scott JD, 2004, MICROBIOL-SGM, V150, P117, DOI 10.1099/mic.0.26603-0; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH LA, 1976, NATURE, V262, P209, DOI 10.1038/262209a0; Thorneley R. N. F., 1985, MOLYBDENUM ENZYMES, P221; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; WEINSTOCK GM, 1983, P NATL ACAD SCI-BIOL, V80, P4432, DOI 10.1073/pnas.80.14.4432	33	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4695	10.1371/journal.pone.0004695	http://dx.doi.org/10.1371/journal.pone.0004695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277114	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496100003
J	Stillwell, E; Vitale, J; Zhao, QS; Beck, A; Schneider, J; Khadim, F; Elson, G; Altaf, A; Yehia, G; Dong, JH; Liu, J; Mark, W; Bhaumik, M; Grange, R; Fraidenraich, D				Stillwell, Elizabeth; Vitale, Joseph; Zhao, Qingshi; Beck, Amanda; Schneider, Joel; Khadim, Farah; Elson, Genie; Altaf, Aneela; Yehia, Ghassan; Dong, Jia-hui; Liu, Jing; Mark, Willie; Bhaumik, Mantu; Grange, Robert; Fraidenraich, Diego			Blastocyst Injection of Wild Type Embryonic Stem Cells Induces Global Corrections in Mdx Mice	PLOS ONE			English	Article								Duchenne muscular dystrophy (DMD) is an incurable neuromuscular degenerative disease, caused by a mutation in the dystrophin gene. Mdx mice recapitulate DMD features. Here we show that injection of wild-type (WT) embryonic stem cells (ESCs) into mdx blastocysts produces mice with improved pathology and function. A small fraction of WT ESCs incorporates into the mdx mouse nonuniformly to upregulate protein levels of dystrophin in the skeletal muscle. The chimeric muscle shows reduced regeneration and restores dystrobrevin, a dystrophin-related protein, in areas with high and with low dystrophin content. WT ESC injection increases the amount of fat in the chimeras to reach WT levels. ESC injection without dystrophin does not prevent the appearance of phenotypes in the skeletal muscle or in the fat. Thus, dystrophin supplied by the ESCs reverses disease in mdx mice globally in a dose-dependent manner.	[Stillwell, Elizabeth; Vitale, Joseph; Zhao, Qingshi; Beck, Amanda; Schneider, Joel; Khadim, Farah; Elson, Genie; Altaf, Aneela; Yehia, Ghassan; Fraidenraich, Diego] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Dong, Jia-hui; Liu, Jing; Mark, Willie] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY USA; [Bhaumik, Mantu] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ USA; [Grange, Robert] Virginia Polytech Inst & State Univ, Dept Human Nutr, Foods & Exercise, Blacksburg, VA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Virginia Polytechnic Institute & State University	Stillwell, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 S Orange Ave, Newark, NJ 07103 USA.	fraidedi@umdnj.edu	Zhao, Qingshi/H-9839-2013		Muscular Dystrophy Association	Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was funded by the Muscular Dystrophy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2008, J CELL SCI, V121, P48, DOI 10.1242/jcs.020701; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; Chien KR, 2004, SCIENCE, V306, P239, DOI 10.1126/science.1104769; Colussi C, 2008, GENE THER, V15, P1075, DOI 10.1038/gt.2008.95; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Fraidenraich Diego, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS14, DOI 10.1038/ncpcardio0402; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ito K, 2006, HUM MOL GENET, V15, P2266, DOI 10.1093/hmg/ddl151; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; MATSUDA R, 1983, DEV BIOL, V100, P478, DOI 10.1016/0012-1606(83)90240-3; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nawrotzki R, 1998, J CELL SCI, V111, P2595; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Personius KE, 2005, MUSCLE NERVE, V32, P656, DOI 10.1002/mus.20405; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Radley HG, 2007, INT J BIOCHEM CELL B, V39, P469, DOI 10.1016/j.biocel.2006.09.009; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Satomura S, 2001, METABOLISM, V50, P1181, DOI 10.1053/meta.2001.26701; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straino S, 2004, CIRCULATION, V110, P3341, DOI 10.1161/01.CIR.0000147776.50787.74; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961; WATKINS SC, 1989, MUSCLE NERVE, V12, P861, DOI 10.1002/mus.880121013; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wolff AV, 2006, MUSCLE NERVE, V34, P304, DOI 10.1002/mus.20588; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602; YU FX, 1994, CELL MOTIL CYTOSKEL, V27, P13, DOI 10.1002/cm.970270103; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4759	10.1371/journal.pone.0004759	http://dx.doi.org/10.1371/journal.pone.0004759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277212	Green Published, gold			2022-12-27	WOS:000265496100009
J	Worobey, CC; Fisher, NDL; Cox, D; Forman, JP; Curhan, GC				Worobey, Cynthia Cooper; Fisher, Naomi D. L.; Cox, David; Forman, John P.; Curhan, Gary C.			Genetic Polymorphisms and the Risk of Accelerated Renal Function Decline in Women	PLOS ONE			English	Article							CONVERTING-ENZYME GENE; ALDOSTERONE SYNTHASE GENE; CHRONIC KIDNEY-DISEASE; ANGIOTENSINOGEN GENE; DIABETIC-NEPHROPATHY; BLOOD-PRESSURE; PROGRESSION; ADDUCIN; ASSOCIATION; IMPACT	Background: Reduced glomerular filtration rate is an important predictor of cardiovascular disease and death. Genetic polymorphisms, particularly in genes involved in the renin-angiotensin system (RAS), may influence the rate of renal function decline. Methodology/Principal Findings: We examined the relation between specific single nucleotide polymorphisms (SNPs), including those in the RAS, apolipoprotein E and alpha-adducin, and renal function decline assessed by estimated glomerular filtration rate (eGFR) over an 11-year period in 2578 Caucasian participants of the Nurses' Health Study. Logistic regression was used to examine the associations between genotype and risk of eGFR decline of >= 25%. Results: After 11 years between creatinine measurements, the eGFR declined by >= 25% in 423 of 2578 (16%) women. The angiotensinogen (AGT) A-20C polymorphism was associated with a higher risk of renal function decline when two risk alleles were present than if one or no alleles were present (CC vs AA and AC) OR 1.83 (95% CI 1.02-3.26; p = 0.04). The angiotensin II type 1 receptor (AT(1)R) A1166C polymorphism was marginally associated with a higher risk of renal function decline when two risk alleles were present (CC vs AA, OR = 1.41; 95% CI 0.98-2.01; p = 0.06). The alpha-adducin G460W polymorphism was associated with a lower risk of renal function decline when any number of risk alleles were present (WG vs GG, OR = 0.78, 95% CI 0.61-0.99, p = 0.04; WW vs GG, OR = 0.46; 95% CI 0.20-1.07, p = 0.07). Linear regression analysis with change in eGFR as the outcome showed a larger decline of 3.5 (95% CI 0.5 to 6.4, p = 0.02) ml/min/1.73 m(2) in AGT A-20C CC homozygotes. No other polymorphisms were significantly associated with renal function decline or absolute change in eGFR over the study period. Conclusions: Genetic variants in the angiotensinogen, angiotensin II type 1 receptor and alpha-adducin genes may contribute to loss of renal function in the general female Caucasian population.	[Worobey, Cynthia Cooper] Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA; [Fisher, Naomi D. L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Div Endocrine Hypertens, Boston, MA USA; [Cox, David; Forman, John P.; Curhan, Gary C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Forman, John P.; Curhan, Gary C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Renal Div, Boston, MA USA; [Curhan, Gary C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Worobey, CC (corresponding author), Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA.	gcurhan@partners.org	Cox, David/ABA-7454-2020; Cox, David G/A-2023-2009	Cox, David G/0000-0002-2152-9259	National Institutes of Health [DK66574, CA87969, DK07791]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066574, T32DK007791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by Grants DK66574, CA87969 and DK07791 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; Amoroso A, 1998, NEPHROL DIAL TRANSPL, V13, P3184, DOI 10.1093/ndt/13.12.3184; Beeks E, 2004, HYPERTENSION, V44, P419, DOI 10.1161/01.HYP.0000141410.72537.fd; Bianchi G, 2004, HYPERTENSION, V44, P394, DOI 10.1161/01.HYP.0000141413.91223.2c; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Brand E, 1998, HYPERTENSION, V32, P198, DOI 10.1161/01.HYP.32.2.198; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Buraczynska M, 2002, NEPHRON, V92, P51, DOI 10.1159/000064455; Butkus Donald E, 2002, J Miss State Med Assoc, V43, P71; Casiglia E, 2005, J HYPERTENS, V23, P1991, DOI 10.1097/01.hjh.0000183119.92455.a7; Castellano M, 1997, J HYPERTENS, V15, P1707, DOI 10.1097/00004872-199715120-00076; Coll E, 2003, J NEPHROL, V16, P357; Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519; Doria A, 1998, HORM RES, V50, P6, DOI 10.1159/000053095; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Fisher NDL, 2002, HYPERTENSION, V39, P914, DOI 10.1161/01.HYP.0000013784.18175.51; Freedman BI, 1997, J AM SOC NEPHROL, V8, P1942; Goto S, 2002, KIDNEY INT, V62, P980, DOI 10.1046/j.1523-1755.2002.00517.x; HANKINSON SE, 1989, CLIN CHEM, V35, P2313; Hopkins PN, 1996, J HYPERTENS, V14, P199, DOI 10.1097/00004872-199602000-00008; Hsu CC, 2005, JAMA-J AM MED ASSOC, V293, P2892, DOI 10.1001/jama.293.23.2892; Hunley TE, 1996, KIDNEY INT, V49, P571, DOI 10.1038/ki.1996.81; Jeunemaitre X, 1997, AM J HUM GENET, V60, P1448, DOI 10.1086/515452; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kimura H, 1998, AM J KIDNEY DIS, V31, P666, DOI 10.1053/ajkd.1998.v31.pm9531184; Knight EL, 2003, ANN INTERN MED, V138, P460, DOI 10.7326/0003-4819-138-6-200303180-00009; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lovati E, 2001, KIDNEY INT, V60, P46, DOI 10.1046/j.1523-1755.2001.00769.x; MARRE M, 1994, DIABETES, V43, P384, DOI 10.2337/diabetes.43.3.384; Mayeux R, 2005, J CLIN INVEST, V115, P1404, DOI 10.1172/JCI25421; Miller JA, 1999, KIDNEY INT, V56, P2173, DOI 10.1046/j.1523-1755.1999.00770.x; Miller JA, 2004, CURR OPIN NEPHROL HY, V13, P101, DOI 10.1097/00041552-200401000-00014; Nakanishi K, 2004, PEDIATR NEPHROL, V19, P144, DOI 10.1007/s00467-003-1350-7; Nicod J, 2002, KIDNEY INT, V61, P1270, DOI 10.1046/j.1523-1755.2002.00275.x; Parving HH, 1996, J AM SOC NEPHROL, V7, P2509; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Quinn M, 1996, DIABETOLOGIA, V39, P940; Ribstein J, 2005, J AM SOC NEPHROL, V16, P1320, DOI 10.1681/ASN.2004100878; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rogus JJ, 1998, HYPERTENSION, V31, P627, DOI 10.1161/01.HYP.31.2.627; Schmidt S, 1996, NEPHROL DIAL TRANSPL, V11, P1755; SCHMIDT S, 1995, KIDNEY INT, V47, P1176, DOI 10.1038/ki.1995.167; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Solini A, 1999, AM J KIDNEY DIS, V34, P1002, DOI 10.1016/S0272-6386(99)70004-1; SPRAY BJ, 1995, J AM SOC NEPHROL, V5, P1806; Tonelli M, 2003, ANN INTERN MED, V138, P98, DOI 10.7326/0003-4819-138-2-200301210-00010; Tsujita Y, 2001, HYPERTENS RES, V24, P105, DOI 10.1291/hypres.24.105; Tsukada K, 2002, J HUM HYPERTENS, V16, P789, DOI 10.1038/sj.jhh.1001484; van Dijk MA, 2000, NEPHROL DIAL TRANSPL, V15, P836, DOI 10.1093/ndt/15.6.836; Wattanakit K, 2006, J AM COLL CARDIOL, V48, P1183, DOI 10.1016/j.jacc.2006.05.047; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	53	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4787	10.1371/journal.pone.0004787	http://dx.doi.org/10.1371/journal.pone.0004787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274077	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496000023
J	Latzin, P; Roth, S; Thamrin, C; Hutten, GJ; Pramana, I; Kuehni, CE; Casaulta, C; Nelle, M; Riedel, T; Frey, U				Latzin, Philipp; Roth, Stefan; Thamrin, Cindy; Hutten, Gerard J.; Pramana, Isabelle; Kuehni, Claudia E.; Casaulta, Carmen; Nelle, Matthias; Riedel, Thomas; Frey, Urs			Lung Volume, Breathing Pattern and Ventilation Inhomogeneity in Preterm and Term Infants	PLOS ONE			English	Article								Background: Morphological changes in preterm infants with bronchopulmonary dysplasia (BPD) have functional consequences on lung volume, ventilation inhomogeneity and respiratory mechanics. Although some studies have shown lower lung volumes and increased ventilation inhomogeneity in BPD infants, conflicting results exist possibly due to differences in sedation and measurement techniques. Methodology/Principal Findings: We studied 127 infants with BPD, 58 preterm infants without BPD and 239 healthy term-born infants, at a matched post-conceptional age of 44 weeks during quiet natural sleep according to ATS/ERS standards. Lung function parameters measured were functional residual capacity (FRC) and ventilation inhomogeneity by multiple breath washout as well as tidal breathing parameters. Preterm infants with BPD had only marginally lower FRC (21.4 mL/kg) than preterm infants without BPD (23.4 mL/kg) and term-born infants (22.6 mL/kg), though there was no trend with disease severity. They also showed higher respiratory rates and lower ratios of time to peak expiratory flow and expiratory time (t(PTEF)/t(E)) than healthy preterm and term controls. These changes were related to disease severity. No differences were found for ventilation inhomogeneity. Conclusions: Our results suggest that preterm infants with BPD have a high capacity to maintain functional lung volume during natural sleep. The alterations in breathing pattern with disease severity may reflect presence of adaptive mechanisms to cope with the disease process.	[Latzin, Philipp; Roth, Stefan; Thamrin, Cindy; Hutten, Gerard J.; Pramana, Isabelle; Casaulta, Carmen; Frey, Urs] Univ Bern, Inselspital, Dept Paediat, Div Resp Med, CH-3010 Bern, Switzerland; [Latzin, Philipp; Kuehni, Claudia E.] Univ Bern, ISPM, CH-3012 Bern, Switzerland; [Nelle, Matthias; Riedel, Thomas] Univ Bern, Inselspital, Dept Paediat, Div Paediat & Neonatal Intensive Care, CH-3012 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Latzin, P (corresponding author), Univ Bern, Inselspital, Dept Paediat, Div Resp Med, CH-3010 Bern, Switzerland.	philipp.latzin@insel.ch	; Latzin, Philipp/F-2206-2017	Thamrin, Cindy/0000-0003-3284-3558; Latzin, Philipp/0000-0002-5239-1571; Riedel, Thomas/0000-0002-7153-5251; Kuehni, Claudia E./0000-0001-8957-2002; Hutten, Jeroen/0000-0003-4368-6519	Swiss National Foundation [3200-B0-112099, 3200-069349]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Swiss National Foundation grant 3200-B0-112099 to U.F. and P.L. and Swiss National Foundation PROSPER grnt 3200-069349 to C.K. The funding sources had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Baldwin DN, 2006, PEDIATR PULM, V41, P391, DOI 10.1002/ppul.20400; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; BURGER EJ, 1968, J APPL PHYSIOL, V25, P139, DOI 10.1152/jappl.1968.25.2.139; Bush A, 2008, COPD, V5, P53, DOI 10.1080/15412550701815965; CLARKE JR, 1994, PEDIATR PULM, V17, P285, DOI 10.1002/ppul.1950170504; de Winter JP, 2000, AM J PERINAT, V17, P377, DOI 10.1055/s-2000-13446; DEZATEUX CA, 1994, PEDIATR PULM, V18, P299, DOI 10.1002/ppul.1950180507; Eber E, 2001, THORAX, V56, P317, DOI 10.1136/thorax.56.4.317; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Friedrich L, 2006, AM J RESP CRIT CARE, V173, P442, DOI 10.1164/rccm.200503-444OC; Friedrich L, 2007, AM J RESP CRIT CARE, V176, P1269, DOI 10.1164/rccm.200703-476OC; Gappa M, 2006, PEDIATR PULM, V41, P291, DOI 10.1002/ppul.20380; Gappa M, 2003, AM J RESP CRIT CARE, V168, P399, DOI 10.1164/ajrccm.168.3.955; Gustafsson PM, 2003, EUR RESPIR J, V21, P1033, DOI 10.1183/09031936.03.00049302; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hjalmarson O, 2005, J PEDIATR-US, V146, P86, DOI 10.1016/j.jpeds.2004.08.044; Hjalmarson O, 2002, AM J RESP CRIT CARE, V165, P83, DOI 10.1164/ajrccm.165.1.2107093; Hofhuis W, 2002, AM J RESP CRIT CARE, V166, P1539, DOI 10.1164/rccm.2202046; Hulskamp G, 2006, PEDIATR PULM, V41, P1, DOI 10.1002/ppul.20318; Hulskamp G, 2003, AM J RESP CRIT CARE, V168, P1003, DOI 10.1164/rccm.200303-460OC; HULSKAMP G, 2003, EUR RESP J S45, V22, pS382; Hutten GJ, 2008, PEDIATR PULM, V43, P882, DOI 10.1002/ppul.20874; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; KATZSALAMON M, 1995, PEDIATR PULM, V20, P101, DOI 10.1002/ppul.1950200209; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; KOSCH PC, 1984, J APPL PHYSIOL, V57, P1126, DOI 10.1152/jappl.1984.57.4.1126; Kumar R, 2008, J ALLERGY CLIN IMMUN, V121, P878, DOI 10.1016/j.jaci.2008.01.030; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Latzin P, 2006, AM J RESP CRIT CARE, V174, P1292, DOI 10.1164/rccm.200606-782OC; MORTOLA JP, 1982, J APPL PHYSIOL, V52, P1209, DOI 10.1152/jappl.1982.52.5.1209; Narang I, 2008, AM J RESP CRIT CARE, V178, P74, DOI 10.1164/rccm.200705-701OC; Pillow JJ, 2006, PEDIATR PULM, V41, P105, DOI 10.1002/ppul.20319; Poets CF, 1997, AM J RESP CRIT CARE, V155, P649, DOI 10.1164/ajrccm.155.2.9032208; PRECHTL HFR, 1974, BRAIN RES, V76, P185, DOI 10.1016/0006-8993(74)90454-5; Prisk GK, 1996, J APPL PHYSIOL, V80, P1126, DOI 10.1152/jappl.1996.80.4.1126; RIEDEL T, 2008, INTENSIVE CARE MED; Schibler A, 2002, EUR RESPIR J, V20, P912, DOI 10.1183/09031936.02.00226002; Schmalisch G, 2005, BMC Pediatr, V5, P36, DOI 10.1186/1471-2431-5-36; Stocks J, 2007, PEDIATR PULM, V42, P3, DOI 10.1002/ppul.20520; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Totapally BR, 2002, CRIT CARE, V6, P160, DOI 10.1186/cc1476; van der Walt J, 2006, PEDIATR ANESTH, V16, P1205, DOI 10.1111/j.1460-9592.2006.02073.x; Vrijlandt EJLE, 2007, J PEDIATR-US, V150, P256, DOI 10.1016/j.jpeds.2006.12.007; Vrijlandt EJLE, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-117; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC; WILLIAMS BA, 1991, J PHYSIOL-LONDON, V442, P81, DOI 10.1113/jphysiol.1991.sp018783; 1993, LANCET, V342, P193	49	78	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4635	10.1371/journal.pone.0004635	http://dx.doi.org/10.1371/journal.pone.0004635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247491	gold, Green Submitted, Green Published			2022-12-27	WOS:000265487800017
J	Wang, CM; Wu, YY; Qin, JH; Sun, HX; He, HX				Wang, Chengmin; Wu, Yanyun; Qin, Jianhua; Sun, Haoxue; He, Hongxuan			Induced Susceptibility of Host Is Associated with an Impaired Antioxidant System Following Infection with Cryptosporidium parvum in Se-Deficient Mice	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; GAMMA-INTERFERON; SELENIUM SUPPLEMENTATION; IMMUNE-RESPONSE; T-LYMPHOCYTES; C57BL/6 MICE; MOUSE MODEL; 2 STRAINS; RESISTANCE; EXPRESSION	Background: Susceptibility or resistance to infection with Cryptosporidium parvum (C. parvum) correlates with Selenium (Se) deficiency in response to infection. Both adult Se-adequate and Se-deficient mouse models of cryptosporidiosis were used to study the cell-mediated immune response during the course of C. parvum infection. Methodology/Principal Findings: Blood samples from mouse models were used for Se status. The concentration of MDA, SOD, GPx and CAT in blood has revealed that lower Se level exist in Se-deficient mice. Mesenteric lymph node (MLN) lymphocytes from both mouse models were proliferated after ex vivo re-stimulation with C. parvum sporozoite antigen. The study of the cytokine profiles from the supernatant of proliferated MLN cells revealed that Se-adequate mice produced higher levels of Th1 (IFN-gamma and IL-2) and moderate amounts of Th2 (IL-4) cytokines throughout the course of infection. Whereas, MLN cells from Se-deficient mice produced lower levels of IFN-gamma, IL-2 and IL-4 cytokines. The counts of total white cell and CD3, CD4, CD8 cell in Se-adequate were higher than that in Se-deficient mice. Significance: These results suggest that Cell immunity is affected by Se status after infection with C. parvum from kinetic changes of different white cells and cytokine. In conclusion, induced susceptibility of host is associated with an impaired antioxidant system following infection with C. parvum in C57BL/6 Selenium deficient mice.	[Wang, Chengmin; Wu, Yanyun; Sun, Haoxue; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Qin, Jianhua] Hebei Agr Univ, Dept Animal Sci & Technol, Baoding, Hebei, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Hebei Agricultural University	Wang, CM (corresponding author), Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	hehx@ioz.ac.cn			The National Key Basic Research and Development Program of China [9732007BC109103]; The National Natural Sciences Foundation of China [30671576]; World Conservation Association [ECBP/06/085]	The National Key Basic Research and Development Program of China(National Basic Research Program of China); The National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); World Conservation Association	The study was supported by grants from The National Key Basic Research and Development Program of China (9732007BC109103), The National Natural Sciences Foundation of China (30671576) and World Conservation Association (ECBP/06/085). The sponsor had no role in any aspects of this study.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguirre SA, 1998, J IMMUNOL, V161, P1891; AGUIRRE SA, 1994, INFECT IMMUN, V62, P697, DOI 10.1128/IAI.62.2.697-699.1994; ANDREA P, 2002, EXP PARASITOL, V101, P193; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Arthur JR, 1999, P NUTR SOC, V58, P507; BECK MA, 1994, J INFECT DIS, V170, P351, DOI 10.1093/infdis/170.2.351; Beck MA, 2000, AM J CLIN NUTR, V71, p1676S, DOI 10.1093/ajcn/71.6.1676S; BEDWAL RS, 1994, EXPERIENTIA, V50, P626, DOI 10.1007/BF01952862; BOYNE R, 1986, J NUTR, V116, P816, DOI 10.1093/jn/116.5.816; Briviba K, 1998, CHEM RES TOXICOL, V11, P1398, DOI 10.1021/tx980086y; Chan S, 1998, CLIN LAB MED, V18, P673; CHANDRA S, 1986, PROG FOOD NUTR SCI, V10, P1; CHEN WX, 1993, INFECT IMMUN, V61, P3548, DOI 10.1128/IAI.61.8.3548-3551.1993; CHEN WX, 1993, INFECT IMMUN, V61, P3928, DOI 10.1128/IAI.61.9.3928-3932.1993; CURRENT WL, 1983, NEW ENGL J MED, V309, P1326; Davis CD, 1998, J PARASITOL, V84, P1274, DOI 10.2307/3284689; DHUR A, 1990, COMP BIOCHEM PHYS C, V96, P271, DOI 10.1016/0742-8413(90)90007-V; DIPLOCK AT, 1987, FREE RADICAL BIO MED, V3, P199, DOI 10.1016/0891-5849(87)90006-2; ENRIQUEZ FJ, 1993, FOLIA PARASIT, V40, P307; FAYER R, 1986, MICROBIOL REV, V50, P458, DOI 10.1128/MMBR.50.4.458-483.1986; Harbige Laurence S., 1996, Nutrition and Health (Bicester), V10, P285; Hayward AR, 2000, J INFECT DIS, V182, P1001, DOI 10.1086/315802; HOLLY JR, 2005, BIOL CONTROL, V32, P419; Jensen P, 2003, REC RES DEV ENTOMOL, V4, P1; Kaushal N, 2007, J NUTR BIOCHEM, V18, P553, DOI 10.1016/j.jnutbio.2006.11.003; Kautiainen A, 2000, J NUTR BIOCHEM, V11, P425, DOI 10.1016/S0955-2863(00)00099-1; KEVIN B, 2001, J NUTR BIOCH, V12, P693; KOSSAKOWSKI S, 1980, MEDWET, V35, P108; KUHLS TL, 1994, J PARASITOL, V80, P480, DOI 10.2307/3283423; Lacroix S, 2001, INFECT IMMUN, V69, P1635, DOI 10.1128/IAI.69.3.1635-1642.2001; Lean IS, 2003, INFECT IMMUN, V71, P4580, DOI 10.1128/IAI.71.8.4580-4585.2003; LIU DY, 2006, SCI AGR SINICA, V22, P32; MCDONALD V, 1994, PARASITE IMMUNOL, V16, P315, DOI 10.1111/j.1365-3024.1994.tb00354.x; Mead JR, 1998, J PARASITOL, V84, P1045, DOI 10.2307/3284643; MELINDA BA, 2005, FREE RADICAL BIOMED, V38, P112; MILLER RA, 1990, LAB ANIM SCI, V40, P42; Miller TA, 2006, VET PARASITOL, V141, P66, DOI 10.1016/j.vetpar.2006.04.016; Moreno-Reyes R, 2001, J BONE MINER RES, V16, P1556, DOI 10.1359/jbmr.2001.16.8.1556; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ribeiro F, 1998, PARASITOLOGY, V116, P229, DOI 10.1017/S0031182097002291; ROY M, 1993, P SOC EXP BIOL MED, V202, P295, DOI 10.3181/00379727-202-43538; SEGAL R, 1987, DERMATOLOGICA, V175, P205, DOI 10.1159/000248827; SMITH AM, 1982, AM J CLIN NUTR, V35, P521, DOI 10.1093/ajcn/35.3.521; Smith LM, 2000, J PARASITOL, V86, P300, DOI 10.2307/3284773; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; SUTTLE NF, 1989, J NUTR, V119, P1055, DOI 10.1093/jn/119.7.1055; Theodos CM, 1997, INFECT IMMUN, V65, P4761, DOI 10.1128/IAI.65.11.4761-4769.1997; TZIPORI S, 1988, ADV PARASIT, V27, P63, DOI 10.1016/S0065-308X(08)60353-X; TZIPORI S, 1995, J INFECT DIS, V172, P1160, DOI 10.1093/infdis/172.4.1160; UNGAR BLP, 1991, J IMMUNOL, V147, P1014; UNGAR BLP, 1990, INFECT IMMUN, V58, P961, DOI 10.1128/IAI.58.4.961-969.1990; Urban JF, 1996, J IMMUNOL, V156, P263; VERMA S, 2008, VIROL J, V66, P1; Waters WR, 1996, INFECT IMMUN, V64, P1854, DOI 10.1128/IAI.64.5.1854-1857.1996; WHITMIRE WM, 1990, J PARASITOL, V76, P450, DOI 10.2307/3282689; WINNEFELD K, 1997, MED KLIN S3, V15, P8; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005	59	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4628	10.1371/journal.pone.0004628	http://dx.doi.org/10.1371/journal.pone.0004628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247447	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487800010
J	Colombatti, M; Grasso, S; Porzia, A; Fracasso, G; Scupoli, MT; Cingarlini, S; Poffe, O; Naim, HY; Heine, M; Tridente, G; Mainiero, F; Ramarli, D				Colombatti, Marco; Grasso, Silvia; Porzia, Alessandra; Fracasso, Giulio; Scupoli, Maria Teresa; Cingarlini, Sara; Poffe, Ornella; Naim, Hassan Y.; Heine, Martin; Tridente, Giuseppe; Mainiero, Fabrizio; Ramarli, Dunia			The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways	PLOS ONE			English	Article								The interleukin-6 (IL-6) and the chemokine CCL5 are implicated in the development and progression of several forms of tumours including that of the prostate. The expression of the prostate specific membrane antigen (PSMA) is augmented in high-grade and metastatic tumors. Observations of the clinical behaviour of prostate tumors suggest that the increased secretion of IL-6 and CCL5 and the higher expression of PSMA may be correlated. We hypothesized that PSMA could be endowed with signalling properties and that its stimulation might impact on the regulation of the gene expression of IL-6 and CCL5. We herein demonstrate that the cross-linking of cell surface PSMA with specific antibodies activates the small GTPases RAS and RAC1 and the MAPKs p38 and ERK1/2 in prostate carcinoma LNCaP cells. As downstream effects of the PSMA-fostered RAS-RAC1-MAPK pathway activation we observed a strong induction of NF-kappa B activation associated with an increased expression of IL-6 and CCL5 genes. Pharmacological blockade with specific inhibitors revealed that both p38 and ERK1/2 participate in the phenomenon, although a major role exerted by p38 was evident. Finally we demonstrate that IL-6 and CCL5 enhanced the proliferative potential of LNCaP cells synergistically and in a dose-dependent manner and that CCL5 functioned by receptor-mediated activation of the STAT5-Cyclin D1 pro-proliferative pathway. The novel functions attributable to PSMA which are described in the present report may have profound influence on the survival and proliferation of prostate tumor cells, accounting for the observation that PSMA overexpression in prostate cancer patients is related to a worse prognosis.	[Colombatti, Marco; Grasso, Silvia; Fracasso, Giulio; Cingarlini, Sara; Poffe, Ornella; Tridente, Giuseppe] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Tridente, Giuseppe; Ramarli, Dunia] Giovanni Battista Rossi Hosp, Verona, Italy; [Porzia, Alessandra; Mainiero, Fabrizio] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Expt Med, Rome, Italy; [Scupoli, Maria Teresa] Univ Verona, LURM, I-37100 Verona, Italy; [Naim, Hassan Y.; Heine, Martin] Sch Vet Med, Dept Physiol Chem, Hannover, Germany	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Verona; University of Veterinary Medicine Hannover, Foundation	Colombatti, M (corresponding author), Univ Verona, Dept Pathol, I-37100 Verona, Italy.	dunia.ramarli@univr.it	Fracasso, Giulio/O-3955-2019; SCUPOLI, Maria/AAX-9712-2021; Cingarlini, Sara/AAJ-5263-2021; Heine, Martin/C-6285-2011; cingarlini, sara/ABB-5280-2020; porzia, alessandra/AAA-7753-2020; Fracasso, Giulio/E-1271-2013	Fracasso, Giulio/0000-0003-3024-0307; SCUPOLI, Maria/0000-0002-3352-7859; Cingarlini, Sara/0000-0003-4786-4781; Fracasso, Giulio/0000-0003-3024-0307; porzia, alessandra/0000-0002-7545-3018; Mainiero, Fabrizio/0000-0002-7136-9839	Fondazione Cariverona; MIUR; ABO-Project	Fondazione Cariverona(Fondazione Cariverona); MIUR(Ministry of Education, Universities and Research (MIUR)); ABO-Project	This work was partially supported by grants from Fondazione Cariverona (Progetti Bando 2004, Progetti Bando 2007), by MIUR (PRIN 2005), and by ABO-Project (to MC).	Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Bander NH, 2005, J CLIN ONCOL, V23, P4591, DOI 10.1200/JCO.2005.05.160; Barwe SP, 2007, INT J ONCOL, V30, P899; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Carey AM, 2007, INT J CANCER, V121, P520, DOI 10.1002/ijc.22715; Chang Sam S, 2004, Rev Urol, V6 Suppl 10, pS13; Chen TS, 2000, CANCER RES, V60, P2132; Colombara M, 2005, J IMMUNOL, V175, P7021, DOI 10.4049/jimmunol.175.10.7021; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Dagvadorj A, 2008, CLIN CANCER RES, V14, P1317, DOI 10.1158/1078-0432.CCR-07-2024; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Ghosh A, 2005, CANCER RES, V65, P727; Hobisch A, 2000, J PATHOL, V191, P239, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee SO, 2003, CLIN CANCER RES, V9, P370; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Liu H, 1997, CANCER RES, V57, P3629; Mainiero F, 2003, EUR J IMMUNOL, V33, P3038, DOI 10.1002/eji.200323931; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Rajasekaran AK, 2005, AM J PHYSIOL-CELL PH, V288, pC975, DOI 10.1152/ajpcell.00506.2004; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; SIEGALL CB, 1990, CANCER RES, V50, P7786; Silver DA, 1997, CLIN CANCER RES, V3, P81; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wong M, 1998, J BIOL CHEM, V273, P309, DOI 10.1074/jbc.273.1.309; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Zerbini LF, 2003, CANCER RES, V63, P2206	34	59	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4608	10.1371/journal.pone.0004608	http://dx.doi.org/10.1371/journal.pone.0004608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242540	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487500012
J	Lee, G; Santat, LA; Chang, MS; Choi, S				Lee, Gwang; Santat, Leah A.; Chang, Mi Sook; Choi, Sangdun			RNAi Methodologies for the Functional Study of Signaling Molecules	PLOS ONE			English	Article							SMALL INTERFERING RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; CPG DNA; G-ALPHA-I2-DEFICIENT MICE; STRANDED-RNA; CYCLOOXYGENASE-2 EXPRESSION; RIG-I; ACTIVATION; KINASE	RNA interference (RNAi) was investigated with the aim of achieving gene silencing with diverse RNAi platforms that include small interfering RNA (siRNA), short hairpin RNA (shRNA) and antisense oligonucleotides (ASO). Different versions of each system were used to silence the expression of specific subunits of the heterotrimeric signal transducing G-proteins, G alpha i2 and G beta 2, in the RAW 264.7 murine macrophage cell line. The specificity of the different RNA interference (RNAi) platforms was assessed by DNA microarray analysis. Reliable RNAi methodologies against the genes of interest were then developed and applied to functional studies of signaling networks. This study demonstrates a successful knockdown of target genes and shows the potential of RNAi for use in functional studies of signaling molecules.	[Lee, Gwang; Choi, Sangdun] Ajou Univ, Coll Nat Sci, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Gwang] Ajou Univ, Coll Nat Sci, Inst Med Sci, Suwon 441749, South Korea; [Santat, Leah A.; Chang, Mi Sook] CALTECH, Mol Biol Lab, Div Biol, Alliance Cellular Signaling, Pasadena, CA 91125 USA; [Choi, Sangdun] Ajou Univ, Coll Nat Sci, Dept Biol Sci, Suwon 441749, South Korea	Ajou University; Ajou University; California Institute of Technology; Ajou University	Lee, G (corresponding author), Ajou Univ, Coll Nat Sci, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr			Korea Science and Engineering Foundation (KOSEF); Korean Government (MOST) [R01-2007-000-20533-0]; Korea Research Foundation; MOEHRD [KRF-2006-311-C00482]; Ajou University Research Fellowship	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korean Government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Korea Research Foundation(National Research Foundation of Korea); MOEHRD(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ajou University Research Fellowship	This work was supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean Government (MOST) (R01-2007-000-20533-0). This work was also partly supported by a Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2006-311-C00482) and by the Ajou University Research Fellowship of 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baritono E, 2004, J HYPERTENS, V22, P783, DOI 10.1097/00004872-200404000-00022; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bjursten M, 2005, SCAND J IMMUNOL, V61, P29, DOI 10.1111/j.0300-9475.2005.01535.x; Bjursten M, 2004, CELL IMMUNOL, V228, P77, DOI 10.1016/j.cellimm.2004.05.001; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Endesfelder S, 2005, J MOL MED, V83, P64, DOI 10.1007/s00109-004-0607-3; FAN H, 2005, AM J PHYSL CELL PHYS; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hwang JI, 2004, P NATL ACAD SCI USA, V101, P488, DOI 10.1073/pnas.0307549100; HWANG JI, 2005, P NATL ACAD SCI US; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Koller E, 2006, NUCLEIC ACIDS RES, V34, P4467, DOI 10.1093/nar/gkl589; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Overhoff M, 2005, J MOL BIOL, V348, P871, DOI 10.1016/j.jmb.2005.03.012; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; RUDOLPH U, 1995, J CLIN IMMUNOL, V15, P101; Salmon P, 2000, BLOOD, V96, P3392; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stovall SH, 2004, J BIOL CHEM, V279, P13809, DOI 10.1074/jbc.M311434200; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang Q, 1999, J BIOL CHEM, V274, P17365, DOI 10.1074/jbc.274.24.17365; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yeo SJ, 2003, J BIOL CHEM, V278, P40590, DOI 10.1074/jbc.M306280200; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711; YIN C, 2005, J MOL CELL CARDIOL; Zhang YJ, 2005, INT IMMUNOL, V17, P233, DOI 10.1093/intimm/dxh204	55	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4559	10.1371/journal.pone.0004559	http://dx.doi.org/10.1371/journal.pone.0004559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238203	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000265487400001
J	Almeida, T; Alonso, I; Martins, S; Ramos, EM; Azevedo, L; Ohno, K; Amorim, A; Saraiva-Pereira, ML; Jardim, LB; Matsuura, T; Sequeiros, J; Silveira, I				Almeida, Teresa; Alonso, Isabel; Martins, Sandra; Ramos, Eliana Marisa; Azevedo, Luisa; Ohno, Kinji; Amorim, Antonio; Saraiva-Pereira, Maria Luiza; Jardim, Laura Bannach; Matsuura, Tohru; Sequeiros, Jorge; Silveira, Isabel			Ancestral Origin of the ATTCT Repeat Expansion in Spinocerebellar Ataxia Type 10 (SCA10)	PLOS ONE			English	Article								Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurodegenerative disease characterized by cerebellar ataxia and seizures. The disease is caused by a large ATTCT repeat expansion in the ATXN10 gene. The first families reported with SCA10 were of Mexican origin, but the disease was soon after described in Brazilian families of mixed Portuguese and Amerindian ancestry. The origin of the SCA10 expansion and a possible founder effect that would account for its geographical distribution have been the source of speculation over the last years. To unravel the mutational origin and spread of the SCA10 expansion, we performed an extensive haplotype study, using closely linked STR markers and intragenic SNPs, in families from Brazil and Mexico. Our results showed (1) a shared disease haplotype for all Brazilian and one of the Mexican families, and (2) closely-related haplotypes for the additional SCA10 Mexican families; (3) little or null genetic distance in small normal alleles of different repeat sizes, from the same SNP lineage, indicating that they are being originated by a single step mechanism; and (4) a shared haplotype for pure and interrupted expanded alleles, pointing to a gene conversion model for its generation. In conclusion, we show evidence for an ancestral common origin for SCA10 in Latin America, which might have arisen in an ancestral Amerindian population and later have been spread into the mixed populations of Mexico and Brazil.	[Almeida, Teresa; Alonso, Isabel; Ramos, Eliana Marisa; Sequeiros, Jorge; Silveira, Isabel] Univ Porto, UnIGENe, IBMC, P-4100 Oporto, Portugal; [Martins, Sandra; Azevedo, Luisa; Amorim, Antonio] IPATIMUP, Oporto, Portugal; [Ohno, Kinji; Matsuura, Tohru] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet & Bioinformat, Nagoya, Aichi, Japan; [Amorim, Antonio] Univ Porto, Fac Ciencias, Oporto, Portugal; [Saraiva-Pereira, Maria Luiza; Jardim, Laura Bannach] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Sequeiros, Jorge] Univ Porto, ICBAS, Oporto, Portugal	Universidade do Porto; Nagoya University; Universidade do Porto; Universidade do Porto	Almeida, T (corresponding author), Univ Porto, UnIGENe, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	isilveir@ibmc.up.pt	Inagemp, Inct/J-9451-2013; Jardim, Laura B/B-6149-2013; Alonso, Isabel/I-4307-2013; Ohno, Kinji/H-4020-2012; Amorim, Antonio/A-7938-2008; Martins, Sandra/I-5159-2013; Ohno, Kinji/ABD-5787-2020; Saraiva-Pereira, Maria Luiza/H-6302-2013; Azevedo, Luisa/J-4051-2013; Silveira, Isabel/D-6881-2012; Martins, Sandra/AAG-2601-2020; Pereira, Maria/GZA-9681-2022	Alonso, Isabel/0000-0001-8549-6903; Ohno, Kinji/0000-0002-1529-2750; Amorim, Antonio/0000-0002-7518-6247; Martins, Sandra/0000-0002-3720-2920; Ohno, Kinji/0000-0002-1529-2750; Saraiva-Pereira, Maria Luiza/0000-0003-3905-9563; Azevedo, Luisa/0000-0002-3157-7342; Silveira, Isabel/0000-0002-2610-5260; Martins, Sandra/0000-0002-3720-2920; Sequeiros, Jorge/0000-0002-9846-1037	FCT, Portugal [POCI/SAU-MMO/56387/2004, scholarships]; FEDER [POCI/SAU-MMO/56387/2004]; CNPq (Brazilian Funding Agency); POCI 2010, VI Programa Quadro	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); CNPq (Brazilian Funding Agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); POCI 2010, VI Programa Quadro	This work was supported by a research grant POCI/SAU-MMO/56387/2004, FCT, and co-funded by FEDER. T.A., I.A. and S.M. are recipients of scholarships from FCT, Portugal. MLSP and LBJ are supported by CNPq (Brazilian Funding Agency). IPATIMUP is partially supported by POCI 2010, VI Programa Quadro (2002 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2006, NEUROLOGY, V66, P1602, DOI 10.1212/01.wnl.0000216266.30177.bb; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gatto EM, 2007, NEUROLOGY, V69, P216, DOI 10.1212/01.wnl.0000265596.72492.89; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Marrero AR, 2007, HUM HERED, V64, P160, DOI 10.1159/000102989; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2006, AM J HUM GENET, V78, P125, DOI 10.1086/498654; Matsuura T, 2002, NEUROLOGY, V58, P983, DOI 10.1212/WNL.58.6.983; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Raskin S, 2007, ARCH NEUROL-CHICAGO, V64, P591, DOI 10.1001/archneur.64.4.591; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Sambrook J., 2002, MOL CLONING LAB MANU; Seixas AI, 2005, AM J MED GENET A, V136A, P87, DOI 10.1002/ajmg.a.30761; Smith AFA, REPEATMASKER OPEN 3; Teive HAG, 2004, NEUROLOGY, V63, P1509; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	20	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4553	10.1371/journal.pone.0004553	http://dx.doi.org/10.1371/journal.pone.0004553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234597	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487200009
J	Mano, SH; Endo, TA; Oka, A; Ozawa, A; Gojobori, T; Inoko, H				Mano, Shuhei; Endo, Takaho A.; Oka, Akira; Ozawa, Akira; Gojobori, Takashi; Inoko, Hidetoshi			Detecting Linkage between a Trait and a Marker in a Random Mating Population without Pedigree Record	PLOS ONE			English	Article							PAIRWISE RELATEDNESS	Modern linkage-based approaches employing extended pedigrees are becoming powerful tools for localizing complex quantitative trait loci. For these linkage mapping methods, it is necessary to reconstruct extended pedigrees which include living individuals, using extensive pedigree records. Unfortunately, such records are not always easy to obtain and application of the linkage-based approaches has been restricted. Within a finite population under random mating, latent inbreeding rather than non-random inbreeding by consanguineous marriages is expected to occur and is attributable to coalescence in a finite population. Interestingly, it has been revealed that significant random inbreeding exists even in general human populations. Random inbreeding should be used to detect the hidden coancestry between individuals for a particular chromosomal position and it could also have application in linkage mapping methods. Here we present a novel method, named finite population based linkage mapping (FPL) method, to detect linkage between a quantitative trait and a marker via random inbreeding in a finite population without pedigree records. We show how to estimate coancestry for a chromosomal position between individuals by using multipoint Bayesian estimation. Subsequently, we describe the FPL method for detecting linkage via interval mapping method using a nonparametric test. We show that the FPL method does work via simulated data. For a random sample from a finite population, the FPL method is more powerful than a standard pedigree-based linkage mapping method with using genotypes of all parents of the sample. In addition, the FPL method was demonstrated by actual microsatellite genotype data of 750 Japanese individuals that are unrelated according to pedigree records to map a known Psoriasis susceptible locus. For samples without pedigree records, it was suggested that the FPL method require limited number of individuals, therefore would be better than other methods using thousands of individuals.	[Mano, Shuhei] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan; [Mano, Shuhei] Japan Sci & Technol Agcy, Saitama, Japan; [Endo, Takaho A.] RIKEN, Genom Sci Ctr, Kanagawa, Japan; [Oka, Akira; Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Mol Life Sci, Hiratsuka, Kanagawa 25912, Japan; [Ozawa, Akira] Tokai Univ, Sch Med, Dept Dermatol, Hiratsuka, Kanagawa 25912, Japan; [Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka, Japan; [Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka, Japan	Nagoya City University; Japan Science & Technology Agency (JST); RIKEN; Tokai University; Tokai University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Mano, SH (corresponding author), Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan.	mano@nsc.nagoya-cu.ac.jp	Endo, Takaho/B-5763-2017	Endo, Takaho/0000-0002-2801-2463	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grants-in-Aids for Scientific Research]; National Institute of Genetics	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Genetics	This work was supported by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S.M. and H.I.) and the National Institute of Genetics cooperative research program (to S.M. and T.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN G, 1965, EUGEN QUART, V12, P181, DOI 10.1080/19485565.1965.9987629; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Blangero J, 2004, CURR OPIN GENET DEV, V14, P233, DOI 10.1016/j.gde.2004.04.009; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; DENNISTON C, 1974, THEOR POPUL BIOL, V6, P58, DOI 10.1016/0040-5809(74)90031-8; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; JACQUARD A, 1972, BIOMETRICS, V28, P1101, DOI 10.2307/2528643; Lynch M, 1999, GENETICS, V152, P1753; Lynch M., 1998, GENETICS ANAL QUANTI; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, 1995, ORIGIN MODERN HUMANS; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; Wang JL, 2002, GENETICS, V160, P1203; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Wright A, 2003, TRENDS GENET, V19, P97, DOI 10.1016/S0168-9525(02)00033-1; WRIGHT S, 1951, ANN EUGENIC, V15, P323	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4956	10.1371/journal.pone.0004956	http://dx.doi.org/10.1371/journal.pone.0004956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308260	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499000007
J	Richards, KL; Zhang, B; Baggerly, KA; Colella, S; Lang, JC; Schuller, DE; Krahe, R				Richards, Kristy L.; Zhang, Baili; Baggerly, Keith A.; Colella, Stefano; Lang, James C.; Schuller, David E.; Krahe, Ralf			Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability	PLOS ONE			English	Article							DNA METHYLATION; MICROSATELLITE INSTABILITY; LINE-1 HYPOMETHYLATION; HUMAN-PAPILLOMAVIRUS; COLORECTAL-CANCER; LEVEL; ALU; CARCINOMA; BIOMARKER; ELEMENTS	Loss of genome-wide methylation is a common feature of cancer, and the degree of hypomethylation has been correlated with genomic instability. Global methylation of repetitive elements possibly arose as a defense mechanism against parasitic DNA elements, including retrotransposons and viral pathogens. Given the alterations of global methylation in both viral infection and cancer, we examined genome-wide methylation levels in head and neck squamous cell carcinoma (HNSCC), a cancer causally associated with human papilloma virus (HPV). We assayed global hypomethylation levels in 26 HNSCC samples, compared with their matched normal adjacent tissue, using Pyrosequencing-based methylation assays for LINE repeats. In addition, we examined cell lines derived from a variety of solid tumors for LINE and SINE (Alu) repeats. The degree of LINE and Alu hypomethylation varied among different cancer cell lines. There was only moderate correlation between LINE and Alu methylation levels, with the range of variation in methylation levels being greater for the LINE elements. LINE hypomethylation was more pronounced in HPV-negative than in HPV-positive tumors. Moreover, genomic instability, as measured by genome-wide loss-of-heterozygosity (LOH) single nucleotide polymorphism (SNP) analysis, was greater in HNSCC samples with more pronounced LINE hypomethylation. Global hypomethylation was variable in HNSCC. Its correlation with both HPV status and degree of LOH as a surrogate for genomic instability may reflect alternative oncogenic pathways in HPV-positive versus HPV-negative tumors.	[Richards, Kristy L.; Zhang, Baili; Colella, Stefano; Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX USA; [Baggerly, Keith A.] Univ Texas M. D. Anderson Canc Ctr, Dept Bioinformat & Comput Biol, Houston, TX USA; [Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA; [Richards, Kristy L.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX USA; [Baggerly, Keith A.; Krahe, Ralf] Univ Texas, Houston Grad Sch Biomed Sci, Grad Program Human & Mol Genet, Houston, TX USA; [Krahe, Ralf] Univ Texas, Houston Grad Sch Biomed Sci, Grad Program Genes & Dev, Houston, TX USA; [Lang, James C.; Schuller, David E.] Ohio State Univ, Comprehensive Canc Ctr, Mol Biol & Canc Genet Programs, Columbus, OH 43210 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas System; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Richards, KL (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol Oncol, Chapel Hill, NC 27599 USA.	rkrahe@mdanderson.org	Colella, Stefano/A-7040-2008	Colella, Stefano/0000-0003-3139-6055	Kleberg Foundation; State of Texas Tobacco Research Funds; Texas Tobacco Settlement Funds; University of Texas M. D. Anderson Cancer Center; DoD [W81XWH-05-2-0027]	Kleberg Foundation; State of Texas Tobacco Research Funds; Texas Tobacco Settlement Funds; University of Texas M. D. Anderson Cancer Center; DoD(United States Department of Defense)	This work was supported in part by the Kleberg Foundation, State of Texas Tobacco Research Funds, an institutional research grant from the Texas Tobacco Settlement Funds (University of Texas M. D. Anderson Cancer Center), and DoD W81XWH-05-2-0027 to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD AP, 1993, COLD SPRING HARB SYM, V58, P281, DOI 10.1101/SQB.1993.058.01.033; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; COLELLA S, 2008, HEAD NECK IN PRESS; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; PATTAMADILOK J, 2007, INT J GYNECOL CANC; Price AL, 2004, GENOME RES, V14, P2245, DOI 10.1101/gr.2693004; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; ROSL F, 1993, J GEN VIROL, V74, P791, DOI 10.1099/0022-1317-74-5-791; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	27	95	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4941	10.1371/journal.pone.0004941	http://dx.doi.org/10.1371/journal.pone.0004941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293934	Green Submitted, gold, Green Published			2022-12-27	WOS:000265496600016
J	Alsop, GB; Chen, W; Foss, M; Tseng, KF; Zhang, DH				Alsop, G. Bradley; Chen, Wei; Foss, Margit; Tseng, Kuo-Fu; Zhang, Dahong			Redistribution of Actin during Assembly and Reassembly of the Contractile Ring in Grasshopper Spermatocytes	PLOS ONE			English	Article								Cytokinesis in animal cells requires the assembly of an actomyosin contractile ring to cleave the cell. The ring is highly dynamic; it assembles and disassembles during each cell cleavage, resulting in the recurrent redistribution of actin. To investigate this process in grasshopper spermatocytes, we mechanically manipulated the spindle to induce actin redistribution into ectopic contractile rings, around reassembled lateral spindles. To enhance visualization of actin, we folded the spindle at its equator to convert the remnants of the partially assembled ring into a concentrated source of actin. Filaments from the disintegrating ring aligned along reorganizing spindle microtubules, suggesting that their incorporation into the new ring was mediated by microtubules. We tracked incorporation by speckling actin filaments with Qdots and/or labeling them with Alexa 488-phalloidin. The pattern of movement implied that actin was transported along spindle microtubules, before entering the ring. By double-labeling dividing cells, we imaged actin filaments moving along microtubules near the contractile ring. Together, our findings indicate that in one mechanism of actin redistribution, actin filaments are transported along spindle microtubule tracks in a plus-end-directed fashion. After reaching the spindle midzone, the filaments could be transported laterally to the ring. Notably, actin filaments undergo a dramatic trajectory change as they enter the ring, implying the existence of a pulling force. Two other mechanisms of actin redistribution, cortical flow and de novo assembly, are also present in grasshopper, suggesting that actin converges at the nascent contractile ring from diffuse sources within the cytoplasm and cortex, mediated by spindle microtubules.	[Alsop, G. Bradley; Chen, Wei; Foss, Margit; Tseng, Kuo-Fu; Zhang, Dahong] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Alsop, G. Bradley; Chen, Wei; Tseng, Kuo-Fu] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Zhang, Dahong] Oregon State Univ, CGRB, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Zhang, DH (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	zhangd@science.oregonstate.edu			National Science Foundation (NSF) [GK-12 Program fellowship, MCB-0090725, MCB-0424897]; American Heart Association [0510084Z]	National Science Foundation (NSF)(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by a National Science Foundation (NSF) GK-12 Program fellowship to GBA, an American Heart Association predoctoral fellowship 0510084Z to WC and NSF grants to DZ (MCB-0090725 and MCB-0424897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson R, 2008, J CELL BIOL, V181, P777, DOI 10.1083/jcb.200803096; Alsop GB, 2004, J CELL SCI, V117, P1591, DOI 10.1242/jcs.01007; Alsop GB, 2003, J CELL BIOL, V162, P383, DOI 10.1083/jcb.200301073; Arai R, 2002, J CELL SCI, V115, P887; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; CAO LG, 1990, J CELL BIOL, V111, P1905, DOI 10.1083/jcb.111.5.1905; CAO LG, 1990, J CELL BIOL, V110, P1089, DOI 10.1083/jcb.110.4.1089; Chen W, 2008, PLOS BIOL, V6, P1927, DOI 10.1371/journal.pbio.0060209; D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Foe VE, 2000, DEVELOPMENT, V127, P1767; FUKUI Y, 1991, CELL MOTIL CYTOSKEL, V18, P41, DOI 10.1002/cm.970180105; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hirata H, 2007, BBA-GEN SUBJECTS, V1770, P1115, DOI 10.1016/j.bbagen.2007.03.010; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Huang YY, 2008, J CELL BIOL, V183, P979, DOI 10.1083/jcb.200806151; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; NICKLAS RB, 1979, J CELL SCI, V35, P87; Noguchi T, 2001, J CELL SCI, V114, P401; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pollard TD, 2008, BIOCHEM SOC T, V36, P425, DOI 10.1042/BST0360425; Rappaport R., 1996, CYTOKINESIS ANIMAL C; RIS H, 1949, BIOL BULL, V96, P90, DOI 10.2307/1538001; Roberts-Galbraith RH, 2008, GENE DEV, V22, P3082, DOI 10.1101/gad.1748908; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SATTERWHITE L L, 1992, Current Opinion in Cell Biology, V4, P43, DOI 10.1016/0955-0674(92)90057-J; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wolfe BA, 2005, TRENDS CELL BIOL, V15, P10, DOI 10.1016/j.tcb.2004.11.006; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Ybo J, 2008, EXP CELL RES, V314, P3563, DOI 10.1016/j.yexcr.2008.09.014; Yonetani A, 2008, MOL BIOL CELL, V19, P2208, DOI 10.1091/mbc.E07-07-0731; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; Zhang DH, 1999, METHOD CELL BIOL, V61, P209; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4892	10.1371/journal.pone.0004892	http://dx.doi.org/10.1371/journal.pone.0004892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287500	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496400022
J	Pechhold, K; Koczwara, K; Zhu, XL; Harrison, VS; Walker, G; Lee, J; Harlan, DM				Pechhold, Klaus; Koczwara, Kerstin; Zhu, Xiaolong; Harrison, Victor S.; Walker, Greg; Lee, Janet; Harlan, David M.			Blood Glucose Levels Regulate Pancreatic beta-Cell Proliferation during Experimentally-Induced and Spontaneous Autoimmune Diabetes in Mice	PLOS ONE			English	Article							ISLET NEOGENESIS; MASS; INSULIN; REGENERATION; GROWTH; PROTEIN; MOUSE; REPLICATION; PROGENITORS; HYPERPLASIA	Background: Type 1 diabetes mellitus is caused by immune-mediated destruction of pancreatic beta-cells leading to insulin deficiency, impaired intermediary metabolism, and elevated blood glucose concentrations. While at autoimmune diabetes onset a limited number of beta-cells persist, the cells' regenerative potential and its regulation have remained largely unexplored. Using two mouse autoimmune diabetes models, this study examined the proliferation of pancreatic islet beta-cells and other endocrine and non-endocrine subsets, and the factors regulating that proliferation. Methodology and Principal Findings: We adapted multi-parameter flow cytometry techniques (including DNA-content measurements and 5'-bromo-2'-deoxyuridine [BrdU] incorporation) to study pancreatic islet single cell suspensions. These studies demonstrate that beta-cell proliferation rapidly increases at diabetes onset, and that this proliferation is closely correlated with the diabetic animals' elevated blood glucose levels. For instance, we show that when normoglycemia is restored by exogenous insulin or islet transplantation, the beta-cell proliferation rate returns towards low levels found in control animals, yet surges when hyperglycemia recurs. In contrast, other-than-beta endocrine islet cells did not exhibit the same glucose-dependent proliferative responses. Rather, disease-associated alterations of BrdU-incorporation rates of delta-ells (minor decrease), and non-endocrine islet cells (slight increase) were not affected by blood glucose levels, or were inversely related to glycemia control after diabetes onset (alpha-cells). Conclusion: We conclude that murine beta-cells' ability to proliferate in response to metabolic need (i. e. rising blood glucose concentrations) is remarkably well preserved during severe, chronic beta-cell autoimmunity. These data suggest that timely control of the destructive immune response after disease manifestation could allow spontaneous regeneration of sufficient beta-cell mass to restore normal glucose homeostasis.	[Pechhold, Klaus; Koczwara, Kerstin; Zhu, Xiaolong; Harrison, Victor S.; Walker, Greg; Lee, Janet; Harlan, David M.] NIDDK, NIH, Diabetes Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Pechhold, K (corresponding author), NIDDK, NIH, Diabetes Branch, Bethesda, MD USA.	KlausP@intra.NIDDK.NIH.gov		Harrison, Victor/0000-0003-3397-6045	Intramural Research Program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK055113, ZIADK062002, Z01DK062002, ZIADK055113] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIH, NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Bouwens L, 2006, CURR DIABETES REV, V2, P3, DOI 10.2174/157339906775473644; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; COBBOLD S, 1986, TRANSPLANTATION, V41, P634, DOI 10.1097/00007890-198605000-00016; COOPER GJS, 1991, MED HYPOTHESES, V36, P284, DOI 10.1016/0306-9877(91)90150-W; Del Zotto H, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740225; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanley NA, 2008, MOL CELL ENDOCRINOL, V288, P79, DOI 10.1016/j.mce.2008.03.001; Hardikar AA, 1999, J ENDOCRINOL, V162, P189, DOI 10.1677/joe.0.1620189; HARLAN DM, 1995, DIABETES, V44, P816, DOI 10.2337/diabetes.44.7.816; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Juan G, 2001, METHOD CELL BIOL, V63, P343; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; KRISS JP, 1962, CANCER RES, V22, P254; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Lin YQ, 2001, DIABETOLOGIA, V44, P1026, DOI 10.1007/s001250100597; Lipsett M, 2007, CELL BIOCHEM BIOPHYS, V48, P127, DOI 10.1007/s12013-007-0028-3; Lombardo F, 2002, DIABETES NUTR METAB, V15, P246; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005; Paris M, 2003, ENDOCRINOLOGY, V144, P2717, DOI 10.1210/en.2002-221112; Paris M, 2004, EXP DIABESITY RES, V5, P111, DOI 10.1080/15438600490455079; Pechhold K, 2003, J AUTOIMMUN, V20, P1, DOI 10.1016/S0896-8411(02)00105-1; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Ramiya V, 2004, PEDIATR DIABETES, V5, P45, DOI 10.1111/j.1399-543X.2004.00079.x; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHAPIRO H, 2003, PRACTICAL FLOW CYTOM, P285; SHAPIRO HM, 2003, PRACTICAL FLOW CYTOM, P448; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Stoffers DA, 2004, HORM METAB RES, V36, P811, DOI 10.1055/s-2004-826168; SWENNE I, 1982, DIABETES, V31, P754, DOI 10.2337/diab.31.9.754; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Topp BB, 2004, DIABETOLOGIA, V47, P1602, DOI 10.1007/s00125-004-1493-5; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2002, ENDOCRINOLOGY, V143, P3540, DOI 10.1210/en.2002-220089	62	28	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4827	10.1371/journal.pone.0004827	http://dx.doi.org/10.1371/journal.pone.0004827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287497	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400003
J	Johannesson, M; Stahlberg, A; Ameri, J; Sand, FW; Norrman, K; Semb, H				Johannesson, Martina; Stahlberg, Anders; Ameri, Jacqueline; Sand, Fredrik Wolfhagen; Norrman, Karin; Semb, Henrik			FGF4 and Retinoic Acid Direct Differentiation of hESCs into PDX1-Expressing Foregut Endoderm in a Time- and Concentration-Dependent Manner	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PANCREAS DEVELOPMENT; TRANSCRIPTION FACTOR; SONIC-HEDGEHOG; DEFINITIVE ENDODERM; HUMAN BLASTOCYSTS; ENDOCRINE-CELLS; SPINAL-CORD; SOX9; GENES	Background: Retinoic acid (RA) and fibroblast growth factor 4 (FGF4) signaling control endoderm patterning and pancreas induction/expansion. Based on these findings, RA and FGFs, excluding FGF4, have frequently been used in differentiation protocols to direct differentiation of hESCs into endodermal and pancreatic cell types. In vivo, these signaling pathways act in a temporal and concentration-dependent manner. However, in vitro, the underlying basis for the time of addition of growth and differentiation factors (GDFs), including RA and FGFs, as well as the concentration is lacking. Thus, in order to develop robust and reliable differentiation protocols of ESCs into mature pancreatic cell types, including insulin-producing beta cells, it will be important to mechanistically understand each specification step. This includes differentiation of mesendoderm/definitive endoderm into foregut endoderm-the origin of pancreatic endoderm. Methodology/Principal Findings: Here, we provide data on the individual and combinatorial role of RA and FGF4 in directing differentiation of ActivinA (AA)-induced hESCs into PDX1-expressing cells. FGF4's ability to affect endoderm patterning and specification in vitro has so far not been tested. By testing out the optimal concentration and timing of addition of FGF4 and RA, we present a robust differentiation protocol that on average generates 32% PDX1(+) cells. Furthermore, we show that RA is required for converting AA-induced hESCs into PDX1(+) cells, and that part of the underlying mechanism involves FGF receptor signaling. Finally, further characterization of the PDX1(+) cells suggests that they represent foregut endoderm not yet committed to pancreatic, posterior stomach, or duodenal endoderm. Conclusion/Significance: In conclusion, we show that RA and FGF4 jointly direct differentiation of PDX1(+) foregut endoderm in a robust and efficient manner. RA signaling mediated by the early induction of RAR beta through AA/Wnt3a is required for PDX1 expression. Part of RA's activity is mediated by FGF signaling.	[Johannesson, Martina; Stahlberg, Anders; Ameri, Jacqueline; Sand, Fredrik Wolfhagen; Norrman, Karin; Semb, Henrik] Lund Univ, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Stahlberg, Anders] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehab, S-41124 Gothenburg, Sweden	Lund University; University of Gothenburg	Johannesson, M (corresponding author), Lund Univ, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden.	henrik.semb@med.lu.se		Stahlberg, Anders/0000-0003-4243-0191; Ameri, Jacqueline/0000-0002-6146-3944; Semb, Henrik/0000-0002-6747-787X	Juvenile Diabetes Research Foundation (JDRF); Swedish Research Council; Swedish Diabetes Association Research Foundation; Stem Cell Center; Lund University; JDRF-Center for Beta cell Therapy in Europe; Medical Faculty of Lund University	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association Research Foundation; Stem Cell Center; Lund University; JDRF-Center for Beta cell Therapy in Europe; Medical Faculty of Lund University	The work has been supported by Juvenile Diabetes Research Foundation (JDRF), Swedish Research Council, Swedish Diabetes Association Research Foundation, Stem Cell Center, Lund University and JDRF-Center for Beta cell Therapy in Europe (supported by JDRF&EU). MJ was supported by the Medical Faculty of Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Deutsch G, 2001, DEVELOPMENT, V128, P871; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Frandsen U, 2007, BIOCHEM BIOPH RES CO, V362, P568, DOI 10.1016/j.bbrc.2007.07.200; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Grand EK, 2004, LEUKEMIA, V18, P962, DOI 10.1038/sj.leu.2403347; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hoffman L, 2002, INT J DEV BIOL, V46, P949; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Offield MF, 1996, DEVELOPMENT, V122, P983; Pedersen JK, 2005, DEV BIOL, V288, P487, DOI 10.1016/j.ydbio.2005.10.001; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Shiotsugu J, 2004, DEVELOPMENT, V131, P2653, DOI 10.1242/dev.01129; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Spokony RF, 2002, DEVELOPMENT, V129, P421; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wilding L, 2004, DIABETES-METAB RES, V20, P114, DOI 10.1002/dmrr.429; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	60	85	104	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4794	10.1371/journal.pone.0004794	http://dx.doi.org/10.1371/journal.pone.0004794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277121	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496100016
J	Kaur, H; Kaur, R; Kaur, S; Baldwin, IT; Inderjit				Kaur, Harleen; Kaur, Rajwant; Kaur, Surinder; Baldwin, Ian T.; Inderjit			Taking Ecological Function Seriously: Soil Microbial Communities Can Obviate Allelopathic Effects of Released Metabolites	PLOS ONE			English	Article							ALLELOCHEMICAL (+/-)-CATECHIN; CENTAUREA-DIFFUSA; DEGRADATION; INVASION; NUTRIENT; TYROSINE; JUGLONE; WEAPONS; GROWTH; ROOTS	Background: Allelopathy (negative, plant-plant chemical interactions) has been largely studied as an autecological process, often assuming simplistic associations between pairs of isolated species. The growth inhibition of a species in filter paper bioassay enriched with a single chemical is commonly interpreted as evidence of an allelopathic interaction, but for some of these putative examples of allelopathy, the results have not been verifiable in more natural settings with plants growing in soil. Methodology/Principal findings: On the basis of filter paper bioassay, a recent study established allelopathic effects of m-tyrosine, a component of root exudates of Festuca rubra ssp. commutata. We re-examined the allelopathic effects of m-tyrosine to understand its dynamics in soil environment. Allelopathic potential of m-tyrosine with filter paper and soil (non-sterile or sterile) bioassays was studied using Lactuca sativa, Phalaris minor and Bambusa arundinacea as assay species. Experimental application of m-tyrosine to non-sterile and sterile soil revealed the impact of soil microbial communities in determining the soil concentration of m-tyrosine and growth responses. Conclusions/Significance: Here, we show that the allelopathic effects of m-tyrosine, which could be seen in sterilized soil with particular plant species were significantly diminished when non-sterile soil was used, which points to an important role for rhizosphere-specific and bulk soil microbial activity in determining the outcome of this allelopathic interaction. Our data show that the amounts of m-tyrosine required for root growth inhibition were higher than what would normally be found in F. rubra ssp. commutata rhizosphere. We hope that our study will motivate researchers to integrate the role of soil microbial communities in bioassays in allelopathic research so that its importance in plant-plant competitive interactions can be thoroughly evaluated.	[Kaur, Harleen; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany; [Kaur, Rajwant; Inderjit] Univ Delhi, CEMDE, Delhi 110007, India; [Kaur, Surinder] Univ Delhi, SGTB Khalsa Coll, Dept Bot, Delhi 110007, India	Max Planck Society; University of Delhi; Sri Guru Tegh Bahadur Khalsa College Delhi; University of Delhi	Kaur, H (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	inderjit@cemde.du.ac.in	K, Harleen/T-2613-2019; Baldwin, Ian T/K-1809-2013	Baldwin, Ian/0000-0001-5371-2974	University of Delhi; the Department of Science & Technology, India; Max Planck Society	University of Delhi; the Department of Science & Technology, India(University of Delhi); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the University of Delhi; the Department of Science & Technology, India; and the Max Planck Society. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anaya AL, 2005, PHYTOCHEMISTRY, V66, P487, DOI 10.1016/j.phytochem.2004.12.028; Anderson J. P., 1982, SOIL RESP METHODS 2, V2, P831, DOI DOI 10.2134/agronmonogr9.2.2ed.c41; [Anonymous], 1999, SPSS BAS 10 0 WIND U; [Anonymous], 2007, ACTA ECOLOGIA SINICA; ARONSON JN, 1965, J BACTERIOL, V90, P38, DOI 10.1128/JB.90.1.38-46.1965; ARONSON JN, 1967, J BACTERIOL, V93, P1174, DOI 10.1128/JB.93.3.1174-1176.1967; Bais HP, 2002, PLANT PHYSIOL, V128, P1173, DOI 10.1104/pp.011019; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; DUKE SO, 2009, J CHEM ECOL IN PRESS; Duke SO, 2007, P NATL ACAD SCI USA, V104, P16729, DOI 10.1073/pnas.0707837104; Foy CL, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P25; Haney RL, 2008, RENEW AGR FOOD SYST, V23, P171, DOI 10.1017/S174217050800224X; Harper J. L., 1994, POPULATION BIOL PLAN; Huang PM, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P287; Inderjit, 2006, SOIL BIOL BIOCHEM, V38, P256, DOI 10.1016/j.soilbio.2005.05.004; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P255; Inderjit, 2003, CRIT REV PLANT SCI, V22, P221, DOI 10.1080/713610857; Inderjit, 2001, AGRON J, V93, P79; Inderjit, 2001, PERSPECT PLANT ECOL, V4, P3, DOI 10.1078/1433-8319-00011; INDERJIT, 2005, PLANT SOIL, V53, P97; Ito I, 1998, ANN BOT-LONDON, V82, P625, DOI 10.1006/anbo.1998.0722; Kaushik S, 2007, BIOL FERT SOILS, V43, P557, DOI 10.1007/s00374-006-0136-z; Macias FA, 2005, J AGR FOOD CHEM, V53, P554, DOI 10.1021/jf048702l; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; Norton AP, 2008, BIOL INVASIONS, V10, P79, DOI 10.1007/s10530-007-9111-3; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; Qiu Song, 2005, Wetlands Ecology and Management, V13, P43, DOI 10.1007/s11273-003-3054-y; Quintana N, 2008, PHYTOCHEMISTRY, V69, P2572, DOI 10.1016/j.phytochem.2008.07.015; RETTENMAIER H, 1983, FEMS MICROBIOL LETT, V19, P193, DOI 10.1016/0378-1097(83)90058-7; Schmidt SK, 2004, PLANT SOIL, V259, P1, DOI 10.1023/B:PLSO.0000020933.32473.7e; SCHMIDT SK, 1988, J CHEM ECOL, V14, P1561, DOI 10.1007/BF01012522; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; SMITH LC, 1964, ARCH BIOCHEM BIOPHYS, V105, P424, DOI 10.1016/0003-9861(64)90026-8; Tharayil N, 2009, NEW PHYTOL, V181, P424, DOI 10.1111/j.1469-8137.2008.02647.x; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Weir TL, 2003, J CHEM ECOL, V29, P2397, DOI 10.1023/A:1026313031091	41	132	154	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4700	10.1371/journal.pone.0004700	http://dx.doi.org/10.1371/journal.pone.0004700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277112	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496100005
J	Moll, AG; Lindenmeyer, MT; Kretzler, M; Nelson, PJ; Zimmer, R; Cohen, CD				Moll, Anton G.; Lindenmeyer, Maja T.; Kretzler, Matthias; Nelson, Peter J.; Zimmer, Ralf; Cohen, Clemens D.			Transcript-Specific Expression Profiles Derived from Sequence-Based Analysis of Standard Microarrays	PLOS ONE			English	Article								Background: Alternative mRNA processing mechanisms lead to multiple transcripts (i.e. splice isoforms) of a given gene which may have distinct biological functions. Microarrays like Affymetrix GeneChips measure mRNA expression of genes using sets of nucleotide probes. Until recently probe sets were not designed for transcript specificity. Nevertheless, the re-analysis of established microarray data using newly defined transcript-specific probe sets may provide information about expression levels of specific transcripts. Methodology/Principal Findings: In the present study alignment of probe sequences of the Affymetrix microarray HG-U133A with Ensembl transcript sequences was performed to define transcript-specific probe sets. Out of a total of 247,965 perfect match probes, 95,008 were designated "transcript-specific'', i.e. showing complete sequence alignment, no cross-hybridization, and transcript-, not only gene-specificity. These probes were grouped into 7,941 transcript- specific probe sets and 15,619 gene-specific probe sets, respectively. The former were used to differentiate 445 alternative transcripts of 215 genes. For selected transcripts, predicted by this analysis to be differentially expressed in the human kidney, confirmatory real-time RT-PCR experiments were performed. First, the expression of two specific transcripts of the genes PPM1A (PP2CA_HUMAN and P35813) and PLG (PLMN_HUMAN and Q5TEH5) in human kidneys was determined by the transcript-specific array analysis and confirmed by real-time RT-PCR. Secondly, disease-specific differential expression of single transcripts of PLG and ABCA1 (ABCA1_HUMAN and Q5VYS0_HUMAN) was computed from the available array data sets and confirmed by transcript-specific real-time RT-PCR. Conclusions: Transcript-specific analysis of microarray experiments can be employed to study gene-regulation on the transcript level using conventional microarray data. In this study, predictions based on sufficient probe set size and fold-change are confirmed by independent means.	[Moll, Anton G.; Lindenmeyer, Maja T.; Cohen, Clemens D.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Moll, Anton G.; Lindenmeyer, Maja T.; Kretzler, Matthias; Cohen, Clemens D.] Univ Zurich, Clin Nephrol, Zurich, Switzerland; [Moll, Anton G.; Lindenmeyer, Maja T.; Nelson, Peter J.; Cohen, Clemens D.] Univ Munich, Klin Biochem, Medizin Poliklin, D-80539 Munich, Germany; [Kretzler, Matthias] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany	University of Zurich; University of Zurich; University of Munich; University of Michigan System; University of Michigan; University of Munich	Moll, AG (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	clemens.cohen@access.uzh.ch	Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Hide, Winston A/V-2727-2017; Zimmer, Ralf/L-9295-2019	Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Lindenmeyer, Maja/0000-0003-4162-9107	Else Kroener-Fresenius Foundation; DFG; NIH [U54-DA021519]; NCIBI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	Else Kroener-Fresenius Foundation; DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCIBI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the Else Kroener-Fresenius Foundation to CDC and DFG funding from SFB 571 to PJN and CDC, and NIH Grant # U54-DA021519: NCIBI to MK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	*AFF, AFF HG U133A PROB FI; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burden CJ, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016004; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Cohen CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002937; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; *ENS, ENS ENS REL 42 TRANS; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Harbig J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni027; JAMES N, BIOAFFYMETRIX 0 5; Johnson ACM, 2003, AM J PATHOL, V162, P283, DOI 10.1016/S0002-9440(10)63819-9; Kahn AB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-75; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; Rambaldi D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S17; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; SCHWENDER H, SIGGENES; Sherlock G, 2005, NAT METHODS, V2, P329, DOI 10.1038/nmeth0505-329; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-194	27	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4702	10.1371/journal.pone.0004702	http://dx.doi.org/10.1371/journal.pone.0004702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277110	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496100006
J	Shapira, Y; Katz, M; Ali, M; Kaplan, M; Brazowski, E; Halpern, Z; Elinav, E				Shapira, Yami; Katz, Meirav; Ali, Muhammad; Kaplan, Michael; Brazowski, Eli; Halpern, Zamir; Elinav, Eran			Utilization of Murine Laparoscopy for Continuous In-Vivo Assessment of the Liver in Multiple Disease Models	PLOS ONE			English	Article								Background: Current strategies for follow up of murine models of liver disease are flawed by inability to continuously monitor disease progression in the tissue level, and necessitate sacrifice of animals for tissue sampling. Aims: In this study we aimed at developing a safe repetitive tool for sampling livers in vivo, by utilization of a miniaturized endoscopy system for laparoscopic liver biopsies and for injection of tumor cells into livers. Results: We report the development of a protocol for murine laparoscopy that allows repeated visualization of murine intra-abdominal organs. The system enables safe and repeated liver biopsies in mice and rats, yielding adequate tissue for histological staining and RNA extraction. In addition, injection of tumor cells into livers facilitates under-vision implantation of hepatic tumors in liver, followed by visualization of tumor growth. Conclusions: Murine laparoscopy may be employed as a novel imaging modality for continuous assessment and manipulation of chronic liver disease models.	[Shapira, Yami; Katz, Meirav; Ali, Muhammad; Kaplan, Michael; Brazowski, Eli; Halpern, Zamir; Elinav, Eran] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Shapira, Y (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel.	erane@tasmc.health.gov.il	Elinav, Eran/C-8077-2011; Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110				Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Denzer U, 2007, J CLIN GASTROENTEROL, V41, P103, DOI 10.1097/01.mcg.0000225612.86846.82; FIDLER IJ, 1994, CANCER METAST REV, V13, P209, DOI 10.1007/BF00689637; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Goetz M, 2007, ENDOSCOPY, V39, P350, DOI 10.1055/s-2007-966262; Goetz M, 2008, J HEPATOL, V48, P91, DOI 10.1016/j.jhep.2007.07.029; Helmreich-Becker I, 2003, ENDOSCOPY, V35, P55, DOI 10.1055/s-2003-36419; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; MORIKAWA K, 1988, CANCER RES, V48, P6863; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Oren R, 1996, HEPATOLOGY, V24, P419; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; RUSCIANO D, 1994, INVAS METAST, V14, P349; Schnater JM, 2006, J HEPATOL, V45, P377, DOI 10.1016/j.jhep.2006.03.018; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Weltman MD, 1996, GASTROENTEROLOGY, V111, P1645, DOI 10.1016/S0016-5085(96)70028-8	16	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4776	10.1371/journal.pone.0004776	http://dx.doi.org/10.1371/journal.pone.0004776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274092	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000015
J	Couture, JP; Daviau, A; Fradette, J; Blouin, R				Couture, Jean-Philippe; Daviau, Alex; Fradette, Julie; Blouin, Richard			The Mixed-Lineage Kinase DLK Is a Key Regulator of 3T3-L1 Adipocyte Differentiation	PLOS ONE			English	Article								Background: The mixed-lineage kinase (MLK) family member DLK has been proposed to serve as a regulator of differentiation in various cell types; however, its role in adipogenesis has not been investigated. In this study, we used the 3T3-L1 preadipocyte cell line as a model to examine the function of DLK in adipocyte differentiation. Methods and Findings: Immunoblot analyses and kinase assays performed on 3T3-L1 cells showed that the expression and activity of DLK substantially increase as differentiation occurs. Interestingly, DLK appears crucial for differentiation since its depletion by RNA interference impairs lipid accumulation as well as expression of the master regulators of adipogenesis C/EBP alpha and PPAR gamma 2 at both the mRNA and protein levels. In contrast, neither the expression nor the DNA binding activity of C/EBP beta, an activator for C/EBP alpha and PPAR gamma, is affected by DLK loss. Conclusions: Taken together, these results suggest that DLK is important for expression of mature adipocyte markers and that its action most likely takes place via regulation of C/EBP beta transcriptional activity and/or initiation of C/EBP alpha and PPAR gamma 2 gene transcription.	[Couture, Jean-Philippe; Daviau, Alex; Blouin, Richard] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Fradette, Julie] Univ Quebec, Hop St Sacrement, Ctr Hosp Affilie, Lab Organogenese Expt, Quebec City, PQ, Canada	University of Sherbrooke; Laval University; University of Quebec	Couture, JP (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	Richard.Blouin@USherbrooke.ca		Fradette, Julie/0000-0002-1851-5112	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR). CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Blouin R, 1996, DNA CELL BIOL, V15, P631, DOI 10.1089/dna.1996.15.631; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Daviau A, 2009, CELL SIGNAL, V21, P577, DOI 10.1016/j.cellsig.2008.12.009; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Feve B, 2005, BEST PRACT RES CL EN, V19, P483, DOI 10.1016/j.beem.2005.07.007; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hirai S, 1996, ONCOGENE, V12, P641; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Marques BG, 1998, AM J PHYSIOL-REG I, V275, pR1898, DOI 10.1152/ajpregu.1998.275.6.R1898; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Nadeau A, 1997, J HISTOCHEM CYTOCHEM, V45, P107, DOI 10.1177/002215549704500114; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Robitaille H, 2005, J BIOL CHEM, V280, P12732, DOI 10.1074/jbc.M411619200; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	45	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4743	10.1371/journal.pone.0004743	http://dx.doi.org/10.1371/journal.pone.0004743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270737	Green Published, Green Submitted, gold			2022-12-27	WOS:000265495900011
J	Gegg, ME; Cooper, JM; Schapira, AHV; Taanman, JW				Gegg, Matthew E.; Cooper, J. Mark; Schapira, Anthony H. V.; Taanman, Jan-Willem			Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells	PLOS ONE			English	Article							LOSS-OF-FUNCTION; PARKINSONS-DISEASE; COMPLEX-I; RESPIRATORY-CHAIN; COPY NUMBER; MUTATIONS; DEPLETION; DYSFUNCTION; MUTANTS; RELEASE	Background: Mitochondrial dysfunction has been implicated in the pathogenesis of Parkinson's disease (PD). Impairment of the mitochondrial electron transport chain (ETC) and an increased frequency in deletions of mitochondrial DNA (mtDNA), which encodes some of the subunits of the ETC, have been reported in the substantia nigra of PD brains. The identification of mutations in the PINK1 gene, which cause an autosomal recessive form of PD, has supported mitochondrial involvement in PD. The PINK1 protein is a serine/threonine kinase localized in mitochondria and the cytosol. Its precise function is unknown, but it is involved in neuroprotection against a variety of stress signalling pathways. Methodology/Principal Findings: In this report we have investigated the effect of silencing PINK1 expression in human dopaminergic SH-SY5Y cells by siRNA on mtDNA synthesis and ETC function. Loss of PINK1 expression resulted in a decrease in mtDNA levels and mtDNA synthesis. We also report a concomitant loss of mitochondrial membrane potential and decreased mitochondrial ATP synthesis, with the activity of complex IV of the ETC most affected. This mitochondrial dysfunction resulted in increased markers of oxidative stress under basal conditions and increased cell death following treatment with the free radical generator paraquat. Conclusions: This report highlights a novel function of PINK1 in mitochondrial biogenesis and a role in maintaining mitochondrial ETC activity. Dysfunction of both has been implicated in sporadic forms of PD suggesting that these may be key pathways in the development of the disease.	[Gegg, Matthew E.; Cooper, J. Mark; Schapira, Anthony H. V.; Taanman, Jan-Willem] UCL, Dept Clin Neurosci, Inst Neurol, London, England	University of London; University College London	Gegg, ME (corresponding author), UCL, Dept Clin Neurosci, Inst Neurol, London, England.	j.taanman@medsch.ucl.ac.uk	Gegg, Matthew E/B-4826-2011; Schapira, Anthony H V/A-1245-2010; Taanman, Jan W/A-5379-2011; Cooper, Jonathan/GLS-9195-2022; Cooper, J Mark/D-5826-2013	Gegg, Matthew E/0000-0001-8093-0723; Schapira, Anthony H V/0000-0002-3018-3966; Taanman, Jan W/0000-0002-5476-9785; Cooper, Jonathan/0000-0002-2358-1050; Cooper, J Mark/0000-0002-3007-3054	Parkinson's Disease Society of the United Kingdom [4071]; Bachmann-Strauss Dystonia and Parkinson Foundation, Inc; Medical Research Council [G0601943] Funding Source: researchfish; MRC [G0601943] Funding Source: UKRI	Parkinson's Disease Society of the United Kingdom; Bachmann-Strauss Dystonia and Parkinson Foundation, Inc; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Parkinson's Disease Society of the United Kingdom (4071) and the Bachmann-Strauss Dystonia and Parkinson Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bohm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2002, ANAL BIOCHEM, V304, P26, DOI 10.1006/abio.2001.5607; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; MOISOI N, 2009, CELL DEATH IN PRESS; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Seidel-Rogol BL, 2002, NUCLEIC ACIDS RES, V30, P1929, DOI 10.1093/nar/30.9.1929; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xu N, 2005, GENE, V354, P37, DOI 10.1016/j.gene.2005.03.018; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008	51	154	158	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4756	10.1371/journal.pone.0004756	http://dx.doi.org/10.1371/journal.pone.0004756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270741	Green Published, gold, Green Submitted			2022-12-27	WOS:000265495900023
J	Kobayashi, T; Kim, TS; Jacob, A; Walsh, MC; Kadono, Y; Fuentes-Panana, E; Yoshioka, T; Yoshimura, A; Yamamoto, M; Kaisho, T; Akira, S; Monroe, JG; Choi, Y				Kobayashi, Takashi; Kim, Tae Soo; Jacob, Anand; Walsh, Matthew C.; Kadono, Yuho; Fuentes-Panana, Ezequiel; Yoshioka, Tomoko; Yoshimura, Akihiko; Yamamoto, Masahiro; Kaisho, Tsuneyasu; Akira, Shizuo; Monroe, John G.; Choi, Yongwon			TRAF6 Is Required for Generation of the B-1a B Cell Compartment as well as T Cell-Dependent and -Independent Humoral Immune Responses	PLOS ONE			English	Article							CD40-DEFICIENT MICE; ACTIVATION; BAFF; MATURATION; SUBSETS; REVEALS; ANTIGEN	TNF receptor superfamily members, such as CD40 and the Toll-like receptors (TLRs), regulate many aspects of B cell differentiation and activation. TRAF6 is an intracellular signaling adaptor molecule for these receptors, but its role in B cells has not been clarified by previous genetic approaches, as the systemic deletion of the TRAF6 gene results in perinatal lethality. Here we show that B cell-specific TRAF6 deficiency results in a reduced number of mature B cells in the bone marrow and spleen. Optimal T cell-dependent (TD) antigen responses, as characterized by isotype switching and long-lived plasma cell generation, are also impaired in B cell-specific TRAF6-deficient mice. B cell-specific TRAF6-deficient mice also exhibit lower levels of serum IgM and IgG2b and defective antigen-specific IgM production in response to T cell-independent (TI) antigens. Unexpectedly, TRAF6-deficient B cell progenitors are unable to generate CD5(+) B-1 cells. These results reveal critical roles for TRAF6 in TD and TI humoral immune responses and in inductive fate decisions necessary to generate the B-1 B cell compartment.	[Kobayashi, Takashi; Yoshioka, Tomoko] Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan; [Kim, Tae Soo; Jacob, Anand; Walsh, Matthew C.; Kadono, Yuho; Fuentes-Panana, Ezequiel; Monroe, John G.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Kim, Tae Soo; Jacob, Anand; Walsh, Matthew C.; Kadono, Yuho; Fuentes-Panana, Ezequiel; Monroe, John G.; Choi, Yongwon] Univ Penn, Sch Med, Lab Med, Philadelphia, PA 19104 USA; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 108, Japan; [Yamamoto, Masahiro; Kaisho, Tsuneyasu; Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Dept Host Defense, Suita, Osaka 565, Japan; [Yamamoto, Masahiro; Kaisho, Tsuneyasu; Akira, Shizuo] Osaka Univ, Res Inst Microb Dis, Dept Host Defense, Suita, Osaka 565, Japan	Kyushu University; University of Pennsylvania; University of Pennsylvania; Keio University; Osaka University; Osaka University	Kobayashi, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan.	takashik@bioreg.kyushu-u.ac.jp; ychoi3@mail.med.upenn.edu	Fuentes-Pananá, Ezequiel/AAI-2856-2020; Kaisho, Tsuneyasu/B-4130-2012; Kadono, Yuho/AAO-2405-2020; Yoshimura, Akihiko/K-5515-2013; Akira, Shizuo/C-3134-2009	Fuentes-Panana, Ezequiel M./0000-0003-2872-0459	National Institutes of Health [RO1-AI32592, P01-AI43260]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants RO1-AI32592, P01-AI43260 (to J.G.M and Y.C.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Cervenak L, 2001, IMMUNOL LETT, V78, P89, DOI 10.1016/S0165-2478(01)00239-5; Chung JY, 2002, J CELL SCI, V115, P679; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; MCKEARN JP, 1984, J IMMUNOL, V132, P332; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Schneider P, 2003, IMMUNOL LETT, V88, P57, DOI 10.1016/S0165-2478(03)00050-6; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	35	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4736	10.1371/journal.pone.0004736	http://dx.doi.org/10.1371/journal.pone.0004736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270748	Green Published, Green Submitted, gold			2022-12-27	WOS:000265495900005
J	Cate, AD; Herron, TJ; Yund, EW; Stecker, GC; Rinne, T; Kang, XJ; Petkov, CI; Disbrow, EA; Woods, DL				Cate, Anthony D.; Herron, Timothy J.; Yund, E. William; Stecker, G. Christopher; Rinne, Teemu; Kang, Xiaojian; Petkov, Christopher I.; Disbrow, Elizabeth A.; Woods, David L.			Auditory Attention Activates Peripheral Visual Cortex	PLOS ONE			English	Article							CONGENITALLY BLIND HUMANS; EVENT-RELATED POTENTIALS; PRIMATE STRIATE CORTEX; CROSS-MODAL PLASTICITY; LATE-ONSET BLINDNESS; HUMAN BRAIN; SPATIAL ATTENTION; OCCIPITAL CORTEX; FUNCTIONAL MRI; CEREBRAL-CORTEX	Background: Recent neuroimaging studies have revealed that putatively unimodal regions of visual cortex can be activated during auditory tasks in sighted as well as in blind subjects. However, the task determinants and functional significance of auditory occipital activations (AOAs) remains unclear. Methodology/Principal Findings: We examined AOAs in an intermodal selective attention task to distinguish whether they were stimulus-bound or recruited by higher-level cognitive operations associated with auditory attention. Cortical surface mapping showed that auditory occipital activations were localized to retinotopic visual cortex subserving the far peripheral visual field. AOAs depended strictly on the sustained engagement of auditory attention and were enhanced in more difficult listening conditions. In contrast, unattended sounds produced no AOAs regardless of their intensity, spatial location, or frequency. Conclusions/Significance: Auditory attention, but not passive exposure to sounds, routinely activated peripheral regions of visual cortex when subjects attended to sound sources outside the visual field. Functional connections between auditory cortex and visual cortex subserving the peripheral visual field appear to underlie the generation of AOAs, which may reflect the priming of visual regions to process soon-to-appear objects associated with unseen sound sources.	[Cate, Anthony D.; Herron, Timothy J.; Yund, E. William; Kang, Xiaojian; Woods, David L.] Vet Adm No Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA USA; [Kang, Xiaojian; Disbrow, Elizabeth A.; Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA USA; [Disbrow, Elizabeth A.; Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA USA; [Stecker, G. Christopher] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Rinne, Teemu] Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland; [Petkov, Christopher I.] Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Disbrow, Elizabeth A.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of Helsinki; Newcastle University - UK; University of California System; University of California San Francisco	Cate, AD (corresponding author), Vet Adm No Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA USA.	acate@ebire.org	Rinne, Teemu/A-6090-2009; Cate, Anthony/R-5104-2019; Petkov, Christopher/O-5318-2015	Rinne, Teemu/0000-0002-3142-9438; Cate, Anthony/0000-0003-0135-1622; Petkov, Christopher/0000-0002-4932-7907; Herron, Timothy/0000-0002-4297-014X	DLW [DCD5814]; VA Research Service	DLW; VA Research Service(US Department of Veterans Affairs)	Supported by grant DCD5814 to DLW and the VA Research Service.	Alain C, 2005, NEUROIMAGE, V26, P592, DOI 10.1016/j.neuroimage.2005.02.006; ALHO K, 1993, ELECTROEN CLIN NEURO, V86, P418, DOI 10.1016/0013-4694(93)90137-K; Amunts K, 2007, NEUROIMAGE, V37, P1061, DOI 10.1016/j.neuroimage.2007.02.037; Arno P, 2001, NEUROIMAGE, V13, P632, DOI 10.1006/nimg.2000.0731; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2006, NEUROSCI LETT, V392, P38, DOI 10.1016/j.neulet.2005.09.015; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Carmody DP, 2006, BRAIN RES, V1116, P153, DOI 10.1016/j.brainres.2006.07.121; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Degerman A, 2007, NEUROIMAGE, V34, P1683, DOI 10.1016/j.neuroimage.2006.11.019; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Eisenberg DF, 2005, NEUROREPORT, V16, P1473; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Falchier A, 2002, J NEUROSCI, V22, P5749; Fieger A, 2006, J COGNITIVE NEUROSCI, V18, P149, DOI 10.1162/089892906775783697; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Garg A, 2007, NEUROPSYCHOLOGIA, V45, P2307, DOI 10.1016/j.neuropsychologia.2007.02.015; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hasegawa M, 2002, NEUROIMAGE, V15, P647, DOI 10.1006/nimg.2001.1001; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Just MA, 2004, NEUROIMAGE, V21, P112, DOI 10.1016/j.neuroimage.2003.08.042; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; KANG XJ, 2007, MAGN RESON IN PRESS; Kansaku K, 2006, NEUROIMAGE, V31, P649, DOI 10.1016/j.neuroimage.2005.12.023; Kawashima R, 1999, NEUROIMAGE, V10, P209, DOI 10.1006/nimg.1999.0452; Kerkhoff G, 1999, NEUROREPORT, V10, P3555, DOI 10.1097/00001756-199911260-00017; KUJALA T, 1992, ELECTROEN CLIN NEURO, V84, P469, DOI 10.1016/0168-5597(92)90034-9; Kujala T, 2005, NEUROSCI LETT, V379, P127, DOI 10.1016/j.neulet.2004.12.070; Kujala T, 1997, PSYCHOPHYSIOLOGY, V34, P213, DOI 10.1111/j.1469-8986.1997.tb02134.x; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Langers DRM, 2007, NEUROIMAGE, V35, P709, DOI 10.1016/j.neuroimage.2006.12.013; Lasota KJ, 2003, J COMPUT ASSIST TOMO, V27, P213, DOI 10.1097/00004728-200303000-00018; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lewald J, 2004, J COGNITIVE NEUROSCI, V16, P828, DOI 10.1162/089892904970834; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Liotti M, 1998, NEUROREPORT, V9, P1007, DOI 10.1097/00001756-199804200-00010; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Mayer AR, 2006, NEUROIMAGE, V30, P938, DOI 10.1016/j.neuroimage.2005.10.050; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; MUCHNIK C, 1991, SCAND AUDIOL, V20, P19, DOI 10.3109/01050399109070785; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Roder B, 1996, COGNITIVE BRAIN RES, V4, P77, DOI 10.1016/0926-6410(96)00024-9; Ross DA, 2003, MAGN RESON IMAGING, V21, P821, DOI 10.1016/S0730-725X(03)00103-6; Sabri M, 2008, NEUROIMAGE, V39, P1444, DOI 10.1016/j.neuroimage.2007.09.052; Saito DN, 2005, CEREB CORTEX, V15, P1750, DOI 10.1093/cercor/bhi052; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; SMITH RB, 1981, QUAL QUANT, V15, P279; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Stenbacka L, 2007, CLIN NEUROPHYSIOL, V118, P1303, DOI 10.1016/j.clinph.2007.01.023; Stevens AA, 2007, J NEUROSCI, V27, P10734, DOI 10.1523/JNEUROSCI.1669-07.2007; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Voss P, 2006, NEUROREPORT, V17, P383, DOI 10.1097/01.wnr.0000204983.21748.2d; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Weaver KE, 2007, J COGNITIVE NEUROSCI, V19, P315, DOI 10.1162/jocn.2007.19.2.315; Weeks R, 2000, J NEUROSCI, V20, P2664; WOODS DL, 2009, FUNCTIONAL MAP UNPUB; WOODS DL, 2008, FUNCTIONAL MAP UNPUB; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Zhang NY, 2006, EXP BRAIN RES, V172, P57, DOI 10.1007/s00221-005-0304-7; Zimmer U, 2005, NEURON, V47, P893, DOI 10.1016/j.neuron.2005.07.019; Zimmer U, 2004, EUR J NEUROSCI, V20, P3148, DOI 10.1111/j.1460-9568.2004.03766.x	102	75	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4645	10.1371/journal.pone.0004645	http://dx.doi.org/10.1371/journal.pone.0004645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247451	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800025
J	Lohmus, M; Bjorklund, M				Lohmus, Mare; Bjorklund, Mats			Leptin Affects Life History Decisions in a Passerine Bird: A Field Experiment	PLOS ONE			English	Article								Background: Organisms face trade-offs regarding their life-history strategies, such as decisions of single or multiple broods within a year. In passerines displaying facultative multiple breeding, the probability of laying a second clutch is influenced by several life-history factors. However, information about the mechanistic background of these trade-offs is largely lacking. Leptin is a protein hormone produced by white fat cells, and acts as a signal between peripheral energy depots and the central nervous system. In addition, leptin affects cells at all levels of the reproductive axis and plays a critical role in regulating the allocation of metabolic energy to reproduction. As such, it is possible that leptin levels influence the decision of whether or not to invest time and energy into a second clutch. Accordingly, we expect a treatment with exogenous leptin to result in an increased number of second broods. Methodology/Principal Findings: At a later stage during the first brood, female great tits were treated either with long-term leptin-filled cholesterol pellets (the experimental birds) or with pellets containing only cholesterol (the control birds). We found that leptin-treated females were significantly more likely to have a second brood and that the earlier females were more likely to lay a second clutch than the late females. Conclusions/Significance: As both timing of first brood and treatment with leptin were important in the decision of having multiple broods, the trade-offs involved in the breeding strategy most likely depend on multiple factors. Presumably leptin has evolved as a signal of energy supply status to regulate the release of reproductive hormones so that reproduction is coordinated with periods of sufficient nutrients. This study investigated the role of leptin as a mediator between energy resources and reproductive output, providing a fundamentally new insight into how trade-offs work on a functional basis.	[Lohmus, Mare; Bjorklund, Mats] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Lohmus, M (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	mare.lohmus@ebc.uu.se	Lõhmus, Mare/E-2442-2012	Lohmus, Mare/0000-0002-6619-9679	Swedish Research Council [Post-doc in Sweden]; Stiftelsen for Zoologisk Forskning, Uppsala	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stiftelsen for Zoologisk Forskning, Uppsala	This study was funded by a Post-doc in Sweden grant from the Swedish Research Council (VR) to ML, by research grants from VR to MB, and by Stiftelsen for Zoologisk Forskning, Uppsala to ML and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb CR, 2004, DOMEST ANIM ENDOCRIN, V26, P201, DOI 10.1016/j.domaniend.2003.10.004; Both C, 1998, J ANIM ECOL, V67, P667, DOI 10.1046/j.1365-2656.1998.00228.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brinkhof MWG, 2002, EVOLUTION, V56, P400; Budak E, 2006, FERTIL STERIL, V85, P1563, DOI 10.1016/j.fertnstert.2005.09.065; DELAET JF, 1989, IBIS, V131, P281; DRENT RH, 1980, ARDEA, V68, P225; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; Hansson B, 2000, OIKOS, V90, P575, DOI 10.1034/j.1600-0706.2000.900315.x; Henson M. C., 2003, LEPTIN REPROD; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; La Cava A, 2004, J MOL MED, V82, P4, DOI 10.1007/s00109-003-0492-1; LINDEN M, 1988, OIKOS, V51, P285, DOI 10.2307/3565309; Magi M, 2004, ECOSCIENCE, V11, P361; Perrins C.M., 1979, BRIT TITS; Roff Derek, 2002, pi; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; SMITH HG, 1987, AUK, V104, P700, DOI 10.1093/auk/104.4.700; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; SVENSSON E, 1995, ANIM BEHAV, V49, P1569, DOI 10.1016/0003-3472(95)90078-0; TINBERGEN JM, 1987, ARDEA, V75, P111; Tremblay I, 2003, ECOLOGY, V84, P3033, DOI 10.1890/02-0663; Verboven N, 2001, ARDEA, V89, P387; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Wiktander U, 2001, IBIS, V143, P72, DOI 10.1111/j.1474-919X.2001.tb04171.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2	28	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4602	10.1371/journal.pone.0004602	http://dx.doi.org/10.1371/journal.pone.0004602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242553	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487500008
J	van Leeuwen, WMA; Lehto, M; Karisola, P; Lindholm, H; Luukkonen, R; Sallinen, M; Harma, M; Porkka-Heiskanen, T; Alenius, H				van Leeuwen, Wessel M. A.; Lehto, Maili; Karisola, Piia; Lindholm, Harri; Luukkonen, Ritva; Sallinen, Mikael; Harma, Mikko; Porkka-Heiskanen, Tarja; Alenius, Harri			Sleep Restriction Increases the Risk of Developing Cardiovascular Diseases by Augmenting Proinflammatory Responses through IL-17 and CRP	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NATURAL-KILLER; INTERLEUKIN-6; DURATION; HEPATOCYTES; DEPRIVATION; CYTOKINES; MARKERS; CELLS; BETA	Background:Sleep restriction, leading to deprivation of sleep, is common in modern 24-h societies and is associated with the development of health problems including cardiovascular diseases. Our objective was to investigate the immunological effects of prolonged sleep restriction and subsequent recovery sleep, by simulating a working week and following recovery weekend in a laboratory environment. Methods and Findings:After 2 baseline nights of 8 hours time in bed (TIB), 13 healthy young men had only 4 hours TIB per night for 5 nights, followed by 2 recovery nights with 8 hours TIB. 6 control subjects had 8 hours TIB per night throughout the experiment. Heart rate, blood pressure, salivary cortisol and serum C-reactive protein (CRP) were measured after the baseline (BL), sleep restriction (SR) and recovery (REC) period. Peripheral blood mononuclear cells (PBMC) were collected at these time points, counted and stimulated with PHA. Cell proliferation was analyzed by thymidine incorporation and cytokine production by ELISA and RT-PCR. CRP was increased after SR (145% of BL; p<0.05), and continued to increase after REC (231% of BL; p<0.05). Heart rate was increased after REC (108% of BL; p<0.05). The amount of circulating NK-cells decreased (65% of BL; p<0.005) and the amount of B-cells increased (121% of BL; p<0.005) after SR, but these cell numbers recovered almost completely during REC. Proliferation of stimulated PBMC increased after SR (233% of BL; p<0.05), accompanied by increased production of IL-1 beta (137% of BL; p<0.05), IL-6 (163% of BL; p<0.05) and IL-17 (138% of BL; p<0.05) at mRNA level. After REC, IL-17 was still increased at the protein level (119% of BL; p<0.05). Conclusions:5 nights of sleep restriction increased lymphocyte activation and the production of proinflammatory cytokines including IL-1 beta IL-6 and IL-17; they remained elevated after 2 nights of recovery sleep, accompanied by increased heart rate and serum CRP, 2 important risk factors for cardiovascular diseases. Therefore, long-term sleep restriction may lead to persistent changes in the immune system and the increased production of IL-17 together with CRP may increase the risk of developing cardiovascular diseases.	[van Leeuwen, Wessel M. A.; Sallinen, Mikael; Harma, Mikko] Finnish Inst Occupat Hlth, Brain & Work Res Ctr, Helsinki, Finland; [Lehto, Maili; Karisola, Piia; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [van Leeuwen, Wessel M. A.; Porkka-Heiskanen, Tarja] Univ Helsinki, Inst Biomed, Dept Physiol, Helsinki, Finland; [Lindholm, Harri] Finnish Inst Occupat Hlth, Ctr Excellence Hlth & Work Abil, Helsinki, Finland; [Luukkonen, Ritva] Finnish Inst Occupat Hlth, Stat Serv Team, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health	van Leeuwen, WMA (corresponding author), Finnish Inst Occupat Hlth, Brain & Work Res Ctr, Helsinki, Finland.	Harri.Alenius@ttl.fi	van Leeuwen, Wessel M.A./A-5812-2019	van Leeuwen, Wessel M.A./0000-0003-0834-0811; Stenberg, Tarja/0000-0003-1843-7625; Alenius, Harri/0000-0003-0106-8923; Sallinen, Mikael/0000-0001-6507-3807; Karisola, Piia/0000-0003-0635-2704	European Union [MCRTN-CT-2004-512362]; Finnish Work Environment Fund [104073, 108203]	European Union(European Commission); Finnish Work Environment Fund	This work was supported by the European Union Framework 6 (MCRTN-CT-2004-512362) and the Finnish Work Environment Fund (104073 and 108203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; ERRIE JE, 2007, SLEEP, V30, P1659; Everson CA, 2000, AM J PHYSIOL-REG I, V278, pR905, DOI 10.1152/ajpregu.2000.278.4.R905; Foglar C, 1998, ORTHOPEDICS, V21, P687; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Gonzales XF, 2008, BRAIN BEHAV IMMUN, V22, P552, DOI 10.1016/j.bbi.2007.11.005; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Irwin M, 1996, FASEB J, V10, P643, DOI 10.1096/fasebj.10.5.8621064; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Jean-Louis G, 2000, BIOL PSYCHIAT, V47, P921, DOI 10.1016/S0006-3223(99)00169-9; Kohatsu ND, 2006, ARCH INTERN MED, V166, P1701, DOI 10.1001/archinte.166.16.1701; Kronholm E, 2008, J SLEEP RES, V17, P54, DOI 10.1111/j.1365-2869.2008.00627.x; Lehto M, 2007, CLIN EXP ALLERGY, V37, P133, DOI 10.1111/j.1365-2222.2006.02622.x; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; UAACK M, 2007, SLEEP, V30, P1145; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002	31	284	287	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4589	10.1371/journal.pone.0004589	http://dx.doi.org/10.1371/journal.pone.0004589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240794	Green Submitted, Green Published, gold			2022-12-27	WOS:000278086700007
J	Koliaraki, V; Marinou, M; Vassilakopoulos, TP; Vavourakis, E; Tsochatzis, E; Pangalis, GA; Papatheodoridis, G; Stamoulakatou, A; Swinkels, DW; Papanikolaou, G; Mamalaki, A				Koliaraki, Vasiliki; Marinou, Martha; Vassilakopoulos, Theodoros P.; Vavourakis, Eustathios; Tsochatzis, Emmanuel; Pangalis, Gerassimos A.; Papatheodoridis, George; Stamoulakatou, Alexandra; Swinkels, Dorine W.; Papanikolaou, George; Mamalaki, Avgi			A Novel Immunological Assay for Hepcidin Quantification in Human Serum	PLOS ONE			English	Article								Background: Hepcidin is a 25-aminoacid cysteine-rich iron regulating peptide. Increased hepcidin concentrations lead to iron sequestration in macrophages, contributing to the pathogenesis of anaemia of chronic disease whereas decreased hepcidin is observed in iron deficiency and primary iron overload diseases such as hereditary hemochromatosis. Hepcidin quantification in human blood or urine may provide further insights for the pathogenesis of disorders of iron homeostasis and might prove a valuable tool for clinicians for the differential diagnosis of anaemia. This study describes a specific and non-operator demanding immunoassay for hepcidin quantification in human sera. Methods and Findings: An ELISA assay was developed for measuring hepcidin serum concentration using a recombinant hepcidin25-His peptide and a polyclonal antibody against this peptide, which was able to identify native hepcidin. The ELISA assay had a detection range of 10-1500 mu g/L and a detection limit of 5.4 mu g/L. The intra-and interassay coefficients of variance ranged from 8-15% and 5-16%, respectively. Mean linearity and recovery were 101% and 107%, respectively. Mean hepcidin levels were significantly lower in 7 patients with juvenile hemochromatosis (12.8 mu g/L) and 10 patients with iron deficiency anemia (15.7 mu g/L) and higher in 7 patients with Hodgkin lymphoma (116.7 mu g/L) compared to 32 age-matched healthy controls (42.7 mu g/L). Conclusions: We describe a new simple ELISA assay for measuring hepcidin in human serum with sufficient accuracy and reproducibility.	[Koliaraki, Vasiliki; Marinou, Martha; Mamalaki, Avgi] Hellenic Pasteur Inst, Dept Biochem, Lab Mol Biol & Immunobiotechnol, Athens, Greece; [Vassilakopoulos, Theodoros P.; Pangalis, Gerassimos A.; Papanikolaou, George] Univ Athens, Sch Med, Dept Internal Med 1, Athens, Greece; [Vassilakopoulos, Theodoros P.; Pangalis, Gerassimos A.; Papanikolaou, George] Univ Athens, Sch Med, Dept Hematol, Athens, Greece; [Vavourakis, Eustathios; Stamoulakatou, Alexandra] Aghia Sophia Childrens Hosp, Hematol Lab, Athens, Greece; [Tsochatzis, Emmanuel; Papatheodoridis, George] Univ Athens, Sch Med, Hippokration Gen Hosp Athens, Dept Internal Med 2, Athens, Greece; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Clin Chem, Nijmegen, Netherlands	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Athens Medical School; National & Kapodistrian University of Athens; Radboud University Nijmegen	Koliaraki, V (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Lab Mol Biol & Immunobiotechnol, Athens, Greece.	amamalaki@pasteur.gr	Swinkels, Dorine W./H-8098-2014; Papatheodoridis, George/A-4603-2008; PAPANIKOLAOU, GEORGE/AAL-9017-2021; Tsochatzis, Emmanuel A/A-1651-2012; Koliaraki, Vasiliki/B-8618-2015; Girelli, Domenico/B-1183-2008; Koliaraki, Vasiliki/W-3083-2019	Swinkels, Dorine W./0000-0002-1040-9446; Papatheodoridis, George/0000-0002-3518-4060; PAPANIKOLAOU, GEORGE/0000-0002-6755-3633; Tsochatzis, Emmanuel A/0000-0001-5069-2461; Koliaraki, Vasiliki/0000-0003-1694-6987; Girelli, Domenico/0000-0001-9684-1899; Koliaraki, Vasiliki/0000-0003-1694-6987	Greek General Secretariat of Research and Technology [EPAN YB/13, KAN 047]	Greek General Secretariat of Research and Technology(Greek Ministry of Development-GSRT)	This work was supported by grants from the Greek General Secretariat of Research and Technology EPAN YB/13 and KAN 047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Crowther J.R., 2000, METHODS MOL BIOL, V149, pIII, DOI [10.1385/1592590497, DOI 10.1385/1592590497]; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; GAUSE A, 1992, LYMPHOKINE CYTOK RES, V11, P109; HEBERT GA, 1973, APPL MICROBIOL, V25, P26, DOI 10.1128/AEM.25.1.26-36.1973; Kemna E, 2005, BLOOD, V106, P3268, DOI 10.1182/blood-2005-05-1873; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Kobold U, 2008, CLIN CHEM, V54, P1584, DOI 10.1373/clinchem.2008.107029; Koliaraki V, 2008, BIOCHIMIE, V90, P726, DOI 10.1016/j.biochi.2008.01.012; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Kulaksiz H, 2004, GUT, V53, P735, DOI 10.1136/gut.2003.022863; Murphy AT, 2007, BLOOD, V110, P1048, DOI 10.1182/blood-2006-11-057471; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Roe MA, 2007, BRIT J NUTR, V97, P544, DOI 10.1017/S0007114507336829; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Semrin G, 2006, INFLAMM BOWEL DIS, V12, P1101, DOI 10.1097/01.mib.0000235097.86360.04; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Taes YEC, 2004, CLIN CHEM LAB MED, V42, P387, DOI 10.1515/CCLM.2004.069; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; Ward DG, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-28; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631	33	68	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4581	10.1371/journal.pone.0004581	http://dx.doi.org/10.1371/journal.pone.0004581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238200	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487400013
J	Liu, T; Dartevelle, L; Yuan, CY; Wei, HP; Wang, Y; Ferveur, JF; Guo, A				Liu, Tong; Dartevelle, Laurence; Yuan, Chunyan; Wei, Hongping; Wang, Ying; Ferveur, Jean-Francois; Guo, Aike			Reduction of Dopamine Level Enhances the Attractiveness of Male Drosophila to Other Males	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; GENETIC-CONTROL; COURTSHIP; SEROTONIN; EVOLUTION; MUTANTS	Dopamine is an important neuromodulator in animals and its roles in mammalian sexual behavior are extensively studied. Drosophila as a useful model system is widely used in many fields of biological studies. It has been reported that dopamine reduction can affect female receptivity in Drosophila and leave male-female courtship behavior unaffected. Here, we used genetic and pharmacological approaches to decrease the dopamine level in dopaminergic cells in Drosophila, and investigated the consequence of this manipulation on male homosexual courtship behavior. We find that reduction of dopamine level can induce Drosophila male-male courtship behavior, and that this behavior is mainly due to the increased male attractiveness or decreased aversiveness towards other males, but not to their enhanced propensity to court other males. Chemical signal input probably plays a crucial role in the male-male courtship induced by the courtees with reduction of dopamine. Our finding provides insight into the relationship between the dopamine reduction and male-male courtship behavior, and hints dopamine level is important for controlling Drosophila courtship behavior.	[Liu, Tong; Yuan, Chunyan; Wei, Hongping; Wang, Ying; Guo, Aike] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Liu, Tong; Wei, Hongping] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Guo, Aike] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognitive Sci, Beijing 100864, Peoples R China; [Dartevelle, Laurence; Ferveur, Jean-Francois] Univ Bourgogne, CNRS, UMRS 5548, F-21004 Dijon, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Liu, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	jean-francois.ferveur@u-bourgogne.fr; akguo@ion.ac.cn			National Science Foundation of China [30270341, 30630028, 30621004]; Multidisciplinary Research Program (Brain and Mind) of the Chinese Academy of Sciences; Major State Basic Research Program [G20000 77800, 2006CB806600, 2006CB911003]; Precedent Project of Important Intersectional Disciplines in the Knowledge Innovation Engineering Department of the Chinese Academy of Sciences [KJCX1-09-03, KSCX2-YW-R-28]; CNRS; Burgundy Regional Council	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Multidisciplinary Research Program (Brain and Mind) of the Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Program(National Basic Research Program of China); Precedent Project of Important Intersectional Disciplines in the Knowledge Innovation Engineering Department of the Chinese Academy of Sciences; CNRS(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte)	This research was supported by the National Science Foundation of China (Grant 30270341, 30630028, and 30621004) (A.G), the Multidisciplinary Research Program (Brain and Mind) of the Chinese Academy of Sciences, and the Major State Basic Research Program (G20000 77800, 2006CB806600, and 2006CB911003) (A.G), and the Precedent Project of Important Intersectional Disciplines in the Knowledge Innovation Engineering Department of the Chinese Academy of Sciences (Grant No. KJCX1-09-03, KSCX2-YW-R-28) (A.G), and by the CNRS and the Burgundy Regional Council (L.D. and JF.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Bradbury Jack W., 1998, pi; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Llopart A, 2002, NATURE, V419, P360, DOI 10.1038/419360a; Marican C, 2004, INSECT BIOCHEM MOLEC, V34, P823, DOI 10.1016/j.ibmb.2004.05.002; MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; ROBERTSON HM, 1983, EVOLUTION, V37, P1283, DOI 10.1111/j.1558-5646.1983.tb00244.x; Savarit F, 2002, J EXP BIOL, V205, P3241; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Villella A, 1997, GENETICS, V147, P1107; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; Yamamoto D, 1999, CELL MOL LIFE SCI, V56, P634, DOI 10.1007/s000180050458	26	28	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4574	10.1371/journal.pone.0004574	http://dx.doi.org/10.1371/journal.pone.0004574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238209	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487400007
J	Akan, P; Sahlen, M; Deloukas, P				Akan, Pelin; Sahlen, Martin; Deloukas, Panagiotis			A Histone Map of Human Chromosome 20q13.12	PLOS ONE			English	Article								Background: We present a systematic search for regulatory elements in a 3.5 Mb region on human chromosome 20q13.12, a region associated with a number of medical conditions such as type II diabetes and obesity. Methodology/Principal Findings: We profiled six histone modifications alongside RNA polymerase II (PolII) and CTCF in two cell lines, HeLa S3 and NTERA-2 clone D1 (NT2/D1), by chromatin immunoprecipitation using an in-house spotted DNA array, constructed with 1.8 kb overlapping plasmid clones. In both cells, more than 90% of transcription start sites (TSSs) of expressed genes showed enrichments with PolII, di-methylated lysine 4 of histone H3 (H3K4me2), tri-methylated lysine 4 of histone H3 (H3K4me3) or acetylated H3 (H3Ac), whereas mono-methylated lysine 4 of histone H3 (H3K4me1) signals did not correlate with expression. No TSSs were enriched with tri-methylated lysine 27 of histone H3 (H3K27me3) in HeLa S3, while eight TSSs (4 expressed) showed enrichments in NT2/D1. We have also located several CTCF binding sites that are potential insulator elements. Conclusions/Significance: In summary, we annotated a number of putative regulatory elements in 20q13.12 and went on to verify experimentally a subset of them using dual luciferase reporter assays. Correlating this data to sequence variation can aid identification of disease causing variants.	[Akan, Pelin; Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge, England; [Sahlen, Martin] Univ Sussex, Astron Ctr, Brighton BN1 9RH, E Sussex, England	Wellcome Trust Sanger Institute; University of Sussex	Akan, P (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	pa2@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Sahlén, Martin/N-7951-2019; Sahlen, Pelin/AAJ-1824-2021	Deloukas, Panos/0000-0001-9251-070X; Sahlén, Martin/0000-0003-0973-4804; 	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Dimova I, 2005, EUR J OBSTET GYN R B, V118, P81, DOI 10.1016/j.ejogrb.2004.06.007; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; Hani E, 1998, J CLIN INVEST, V101, P521, DOI 10.1172/JCI1403; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hunt SC, 2001, HUM GENET, V109, P279, DOI 10.1007/s004390100581; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klochkov D, 2006, MOL CELL BIOL, V26, P1589, DOI 10.1128/MCB.26.5.1589-1597.2006; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kumar S, 1999, J BIOL CHEM, V274, P17123, DOI 10.1074/jbc.274.24.17123; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; SPENCER CCA, 2006, PLOS GENETICS PREPRI; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugimoto K, 1996, J BIOL CHEM, V271, P11548, DOI 10.1074/jbc.271.19.11548; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033	54	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4479	10.1371/journal.pone.0004479	http://dx.doi.org/10.1371/journal.pone.0004479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229332	Green Submitted, Green Published, gold			2022-12-27	WOS:000265486200001
J	Jansson, L; Tobias, J; Jarefjall, C; Lebens, M; Svennerholm, AM; Teneberg, S				Jansson, Lena; Tobias, Joshua; Jarefjall, Catharina; Lebens, Michael; Svennerholm, Ann-Mari; Teneberg, Susann			Sulfatide Recognition by Colonization Factor Antigen CS6 from Enterotoxigenic Escherichia coli	PLOS ONE			English	Article								The first step in the pathogenesis of enterotoxigenic Escherichia coli (ETEC) infections is adhesion of the bacterium to the small intestinal epithelium. Adhesion of ETEC is mediated by a number of antigenically distinct colonization factors, and among these, one of the most commonly detected is the non-fimbrial adhesin coli surface antigen 6 (CS6). The potential carbohydrate recognition by CS6 was investigated by binding of recombinant CS6-expressing E. coli and purified CS6 protein to a large number of variant glycosphingolipids separated on thin-layer chromatograms. Thereby, a highly specific binding of the CS6-expressing E. coli, and the purified CS6 protein, to sulfatide (SO3-3Gal beta 1Cer) was obtained. The binding of the CS6 protein and CS6-expressing bacteria to sulfatide was inhibited by dextran sulfate, but not by dextran, heparin, galactose 4-sulfate or galactose 6-sulfate. When using recombinantly expressed and purified CssA and CssB subunits of the CS6 complex, sulfatide binding was obtained with the CssB subunit, demonstrating that the glycosphingolipid binding capacity of CS6 resides within this subunit. CS6-binding sulfatide was present in the small intestine of species susceptible to CS6-mediated infection, e. g. humans and rabbits, but lacking in species not affected by CS6 ETEC, e. g. mice. The ability of CS6-expressing ETEC to adhere to sulfatide in target small intestinal epithelium may thus contribute to virulence.	[Jansson, Lena; Jarefjall, Catharina; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Tobias, Joshua; Lebens, Michael; Svennerholm, Ann-Mari] Univ Gothenburg, Inst Biomed, Dept Med Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Jansson, L (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Medical Research Council [12628, 16X-09084]; Swedish Cancer Foundation; Magnus Bergvalls Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Foundation; Magnus Bergvalls Foundation	This study was supported by the Swedish Medical Research Council (Grant nos. 12628 (ST), and 16X-09084 (AMS)), the Swedish Cancer Foundation, and Magnus Bergvalls Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gallas N, 2007, AM J TROP MED HYG, V77, P571, DOI 10.4269/ajtmh.2007.77.571; Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; BREIMER ME, 1983, J BIOCHEM, V93, P1473, DOI 10.1093/oxfordjournals.jbchem.a134285; BRENNAN MJ, 1991, J BIOL CHEM, V266, P18827; ESKO JD, 1999, ESSENTIALS GLYCOBIOL, P429; FALK KE, 1979, FEBS LETT, V101, P273, DOI 10.1016/0014-5793(79)81024-8; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Helander A, 1997, MICROB PATHOGENESIS, V23, P335, DOI 10.1006/mpat.1997.0163; Huesca M, 1998, INFECT IMMUN, V66, P4061; Huesca M, 1996, INFECT IMMUN, V64, P2643, DOI 10.1128/IAI.64.7.2643-2648.1996; Jansson L, 2006, INFECT IMMUN, V74, P3488, DOI 10.1128/IAI.02006-05; Kamisago S, 1996, INFECT IMMUN, V64, P624, DOI 10.1128/IAI.64.2.624-628.1996; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; Khan AS, 1996, INFECT IMMUN, V64, P3688, DOI 10.1128/IAI.64.9.3688-3693.1996; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; KRIVAN HC, 1989, J BIOL CHEM, V264, P9283; LEFFLER H, 1985, J BIOL CHEM, V261, P1440; NILSSON O, 1981, FEBS LETT, V133, P197, DOI 10.1016/0014-5793(81)80504-2; OFEK I, 1994, BACTERIAL ADHESION C, P94; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Qadri F, 2007, INFECT IMMUN, V75, P2269, DOI 10.1128/IAI.01856-06; Rousset E, 1998, INFECT IMMUN, V66, P5650, DOI 10.1128/IAI.66.12.5650-5658.1998; Sack DA, 2007, VACCINE, V25, P4392, DOI 10.1016/j.vaccine.2007.03.034; SAITOH T, 1991, FEBS LETT, V282, P385, DOI 10.1016/0014-5793(91)80519-9; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; STULTS CLM, 1989, METHOD ENZYMOL, V179, P167; SVENNERHOLM AM, 1988, INFECT IMMUN, V56, P523, DOI 10.1128/IAI.56.2.523-528.1988; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067; TENEBERG S, 1990, FEBS LETT, V263, P10, DOI 10.1016/0014-5793(90)80693-D; TENEBERG S, 1994, J BIOCHEM, V116, P560, DOI 10.1093/oxfordjournals.jbchem.a124562; Tobias J, 2008, VACCINE, V26, P5373, DOI 10.1016/j.vaccine.2008.07.091; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Wolf MK, 1997, FEMS MICROBIOL LETT, V148, P35, DOI 10.1016/S0378-1097(97)00009-8; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569	36	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4487	10.1371/journal.pone.0004487	http://dx.doi.org/10.1371/journal.pone.0004487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19242561	Green Published, Green Submitted, gold			2022-12-27	WOS:000265485700012
J	Bachar, E; Ariav, Y; Ketzinel-Gilad, M; Cerasi, E; Kaiser, N; Leibowitz, G				Bachar, Etti; Ariav, Yafa; Ketzinel-Gilad, Mali; Cerasi, Erol; Kaiser, Nurit; Leibowitz, Gil			Glucose Amplifies Fatty Acid- Induced Endoplasmic Reticulum Stress in Pancreatic beta-Cells via Activation of mTORC1	PLOS ONE			English	Article								Background: Palmitate is a potent inducer of endoplasmic reticulum ( ER) stress in beta-cells. In type 2 diabetes, glucose amplifies fatty-acid toxicity for pancreatic beta-cells, leading to beta-cell dysfunction and death. Why glucose exacerbates beta-cell lipotoxicity is largely unknown. Glucose stimulates mTORC1, an important nutrient sensor involved in the regulation of cellular stress. Our study tested the hypothesis that glucose augments lipotoxicity by stimulating mTORC1 leading to increased beta-cell ER stress. Principal Findings: We found that glucose amplifies palmitate-induced ER stress by increasing IRE1 alpha protein levels and activating the JNK pathway, leading to increased beta-cell apoptosis. Moreover, glucose increased mTORC1 activity and its inhibition by rapamycin decreased beta-cell apoptosis under conditions of glucolipotoxicity. Inhibition of mTORC1 by rapamycin did not affect proinsulin and total protein synthesis in b-cells incubated at high glucose with palmitate. However, it decreased IRE1 alpha expression and signaling and inhibited JNK pathway activation. In TSC2-deficient mouse embryonic fibroblasts, in which mTORC1 is constitutively active, mTORC1 regulated the stimulation of JNK by ER stressors, but not in response to anisomycin, which activates JNK independent of ER stress. Finally, we found that JNK inhibition decreased beta-cell apoptosis under conditions of glucolipotoxicity. Conclusions/Significance: Collectively, our findings suggest that mTORC1 mediates glucose amplification of lipotoxicity, acting through activation of ER stress and JNK. Thus, mTORC1 is an important transducer of ER stress in beta-cell glucolipotoxicity. Moreover, in stressed beta-cells mTORC1 inhibition decreases IRE1 alpha protein expression and JNK activity without affecting ER protein load, suggesting that mTORC1 regulates the beta-cell stress response to glucose and fatty acids by modulating the synthesis and activity of specific proteins involved in the execution of the ER stress response. This novel paradigm may have important implications for understanding beta-cell failure in type 2 diabetes.	[Bachar, Etti; Ariav, Yafa; Ketzinel-Gilad, Mali; Cerasi, Erol; Kaiser, Nurit; Leibowitz, Gil] Hadassah Hebrew Univ, Endocrinol & Metab Serv, Dept Med, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Leibowitz, G (corresponding author), Hadassah Hebrew Univ, Endocrinol & Metab Serv, Dept Med, Med Ctr, Jerusalem, Israel.	gleib@hadassah.org.il	Bachar-Wikström, Etty/AAJ-1147-2020	Bachar-Wikstrom, Etty/0000-0002-3283-6721	Israel Science foundation	Israel Science foundation(Israel Science Foundation)	This study was supported by a grant from the Israel Science foundation to Gil Leibowitz and Nurit Kaiser. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON C, 1993, J BIOL CHEM, V268, P4276; Attali V, 2006, ENDOCRINOLOGY, V147, P5110, DOI 10.1210/en.2006-0496; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Fonseca SG, 2007, ANTIOXID REDOX SIGN, V9, P2335, DOI 10.1089/ars.2007.1790; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goh TT, 2007, AM J PHYSIOL-ENDOC M, V292, pE549, DOI 10.1152/ajpendo.00255.2006; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; KAISER N, 1991, ENDOCRINOLOGY, V129, P2067, DOI 10.1210/endo-129-4-2067; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Serizawa M, 2008, ATHEROSCLEROSIS, V199, P340, DOI 10.1016/j.atherosclerosis.2007.11.009; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Trusina A, 2008, P NATL ACAD SCI USA, V105, P20280, DOI 10.1073/pnas.0803476105; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	53	110	113	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4954	10.1371/journal.pone.0004954	http://dx.doi.org/10.1371/journal.pone.0004954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305497	Green Published, Green Submitted, gold			2022-12-27	WOS:000265498800007
J	Lovegrove, FE; Tangpukdee, N; Opoka, RO; Lafferty, EI; Rajwans, N; Hawkes, M; Krudsood, S; Looareesuwan, S; John, CC; Liles, WC; Kain, KC				Lovegrove, Fiona E.; Tangpukdee, Noppadon; Opoka, Robert O.; Lafferty, Erin I.; Rajwans, Nimerta; Hawkes, Michael; Krudsood, Srivicha; Looareesuwan, Sornchai; John, Chandy C.; Liles, W. Conrad; Kain, Kevin C.			Serum Angiopoietin-1 and-2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SEVERE FALCIPARUM-MALARIA; VON-WILLEBRAND-FACTOR; PLASMODIUM-FALCIPARUM; FACTOR-ALPHA; ENDOTHELIAL ACTIVATION; BRAIN; BARRIER; SEVERITY	Background: Limited tools exist to identify which individuals infected with Plasmodium falciparum are at risk of developing serious complications such as cerebral malaria (CM). The objective of this study was to assess serum biomarkers that differentiate between CM and non-CM, with the long-term goal of developing a clinically informative prognostic test for severe malaria. Methodology/Principal Findings: Based on the hypothesis that endothelial activation and blood-brain-barrier dysfunction contribute to CM pathogenesis, we examined the endothelial regulators, angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2), in serum samples from P. falciparum-infected patients with uncomplicated malaria (UM) or CM, from two diverse populations - Thai adults and Ugandan children. Angiopoietin levels were compared to tumour necrosis factor (TNF). In both populations, ANG-1 levels were significantly decreased and ANG-2 levels were significantly increased in CM versus UM and healthy controls (p < 0.001). TNF was significantly elevated in CM in the Thai adult population (p < 0.001), but did not discriminate well between CM and UM in African children. Receiver operating characteristic curve analysis showed that ANG-1 and the ratio of ANG-2: ANG-1 accurately discriminated CM patients from UM in both populations. Applied as a diagnostic test, ANG-1 had a sensitivity and specificity of 100% for distinguishing CM from UM in Thai adults and 70% and 75%, respectively, for Ugandan children. Across both populations the likelihood ratio of CM given a positive test (ANG-1<15 ng/mL) was 4.1 (2.7-6.5) and the likelihood ratio of CM given a negative test was 0.29 (0.20-0.42). Moreover, low ANG-1 levels at presentation predicted subsequent mortality in children with CM (p=0.027). Conclusions/Significance: ANG-1 and the ANG-2/1 ratio are promising clinically informative biomarkers for CM. Additional studies should address their utility as prognostic biomarkers and potential therapeutic targets in severe malaria.	[Lovegrove, Fiona E.; Lafferty, Erin I.; Rajwans, Nimerta; Hawkes, Michael; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Univ Hlth Network, Toronto, ON, Canada; [Tangpukdee, Noppadon; Krudsood, Srivicha; Looareesuwan, Sornchai] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Opoka, Robert O.] Makerere Univ, Dept Paediat & Child Hlth, Kampala, Uganda; [John, Chandy C.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mahidol University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto	Lovegrove, FE (corresponding author), Univ Toronto, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Univ Hlth Network, Toronto, ON, Canada.	kevin.kain@uhn.on.ca	John, Chandy/GNP-8431-2022; , Michael/AAP-3049-2020	John, Chandy/0000-0002-1634-1411; Kain, Kevin/0000-0001-6068-1272; Tangpukdee, Noppadon/0000-0002-4551-6268	CIHR [MT-13721, Canada Research Chairs]; Ontario Genomics Institute; NIH Fogarty International Center [R21 TW-006794]; The McLaughlin Centre for Molecular Medicine; FOGARTY INTERNATIONAL CENTER [R21TW006794] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); The McLaughlin Centre for Molecular Medicine; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a CIHR Team Grant in Malaria (KCK), operating grant MT-13721(KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chairs (KCK, WCL), the NIH Fogarty International Center (grant R21 TW-006794, CCJ), and The McLaughlin Centre for Molecular Medicine (KCK, WCL). The funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x; Giuliano JS, 2007, SHOCK, V28, P650, DOI 10.1097/shk.0b013e318123867b; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Idro R, 2004, ANN TROP PAEDIATR, V24, P17, DOI 10.1179/027249304225013240; Jaffar S, 1997, AM J TROP MED HYG, V57, P20, DOI 10.4269/ajtmh.1997.57.20; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; Kochar D K, 2000, J Assoc Physicians India, V48, P1222; Kochar DK, 1998, QJM-INT J MED, V91, P845, DOI 10.1093/qjmed/91.12.845; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LOOAREESUWAN S, 1995, CLIN INFECT DIS, V21, P300, DOI 10.1093/clinids/21.2.300; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marty AM, 2006, CLIN LAB MED, V26, P345, DOI 10.1016/j.cll.2006.05.001; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Orfanos SE, 2007, CRIT CARE MED, V35, P1224, DOI 10.1097/01.ccm.0000264153.90247.11; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Tripathi AK, 2007, J INFECT DIS, V195, P942, DOI 10.1086/512083; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; WARRELL DA, 1986, AM J TROP MED HYG, V35, P882, DOI 10.4269/ajtmh.1986.35.882; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	44	156	159	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4912	10.1371/journal.pone.0004912	http://dx.doi.org/10.1371/journal.pone.0004912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300530	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000265496800009
J	Passalacqua, KD; Varadarajan, A; Byrd, B; Bergman, NH				Passalacqua, Karla D.; Varadarajan, Anjana; Byrd, Benjamin; Bergman, Nicholas H.			Comparative Transcriptional Profiling of Bacillus cereus Sensu Lato Strains during Growth in CO2-Bicarbonate and Aerobic Atmospheres	PLOS ONE			English	Article								Background: Bacillus species are spore-forming bacteria that are ubiquitous in the environment and display a range of virulent and avirulent phenotypes. This range is particularly evident in the Bacillus cereus sensu lato group; where closely related strains cause anthrax, food-borne illnesses, and pneumonia, but can also be non-pathogenic. Although much of this phenotypic range can be attributed to the presence or absence of a few key virulence factors, there are other virulence-associated loci that are conserved throughout the B. cereus group, and we hypothesized that these genes may be regulated differently in pathogenic and non-pathogenic strains. Methodology/Principal Findings: Here we report transcriptional profiles of three closely related but phenotypically unique members of the Bacillus cereus group-a pneumonia-causing B. cereus strain (G9241), an attenuated strain of B. anthracis (Sterne 34F(2)), and an avirulent B. cereus strain (10987)-during exponential growth in two distinct atmospheric environments: 14% CO2/bicarbonate and ambient air. We show that the disease-causing Bacillus strains undergo more distinctive transcriptional changes between the two environments, and that the expression of plasmid-encoded virulence genes was increased exclusively in the CO2 environment. We observed a core of conserved metabolic genes that were differentially expressed in all three strains in both conditions. Additionally, the expression profiles of putative virulence genes in G9241 suggest that this strain, unlike Bacillus anthracis, may regulate gene expression with both PlcR and AtxA transcriptional regulators, each acting in a different environment. Conclusions/Significance: We have shown that homologous and even identical genes within the genomes of three closely related members of the B. cereus sensu lato group are in some instances regulated very differently, and that these differences can have important implications for virulence. This study provides insights into the evolution of the B. cereus group, and highlights the importance of looking beyond differences in gene content in comparative genomics studies.	[Passalacqua, Karla D.; Varadarajan, Anjana; Byrd, Benjamin; Bergman, Nicholas H.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bergman, Nicholas H.] Georgia Tech Res Inst, Electro Opt Syst Lab, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Passalacqua, KD (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	nickbergman@gatech.edu	Passalacqua, Karla/AAU-8156-2021	Passalacqua, Karla/0000-0002-2672-3261	DHHS [N266200400059C, N01-AI-40059]; Southeast RCE for Biodefense and Emerging Infectious Diseases [New Opportunities award]	DHHS; Southeast RCE for Biodefense and Emerging Infectious Diseases	This work was supported by DHHS contract N266200400059C/N01-AI-40059 and by a New Opportunities award from the Southeast RCE for Biodefense and Emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Bsat N, 1999, J BACTERIOL, V181, P4299, DOI 10.1128/JB.181.14.4299-4307.1999; Casey JR, 2006, BIOCHEM CELL BIOL, V84, P930, DOI 10.1139/O06-184; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Drysdale M, 2004, J BACTERIOL, V186, P307, DOI 10.1128/JB.186.2.307-315.2004; Duport C, 2006, J BACTERIOL, V188, P6640, DOI 10.1128/JB.00702-06; Ehling-Schulz M, 2006, FEMS MICROBIOL LETT, V260, P232, DOI 10.1111/j.1574-6968.2006.00320.x; ELIASSON R, 1995, BIOCHEM BIOPH RES CO, V214, P28, DOI 10.1006/bbrc.1995.2252; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 1999, J APPL MICROBIOL, V87, P279, DOI 10.1046/j.1365-2672.1999.00887.x; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoffmaster AR, 1997, INFECT IMMUN, V65, P3091, DOI 10.1128/IAI.65.8.3091-3099.1997; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaaskelainen EL, 2004, INT J FOOD MICROBIOL, V96, P75, DOI 10.1016/j.ijfoodmicro.2004.03.011; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mignot T, 2004, INT J MED MICROBIOL, V293, P619, DOI 10.1078/1438-4221-00306; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; Moat A.G., 2002, MICROBIAL PHYSL; Ngamwongsatit P, 2008, INT J FOOD MICROBIOL, V121, P352, DOI 10.1016/j.ijfoodmicro.2007.11.013; Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Ouhib O, 2006, CURR MICROBIOL, V53, P222, DOI 10.1007/s00284-006-0094-6; Passalacqua KD, 2006, FUTURE MICROBIOL, V1, P397, DOI 10.2217/17460913.1.4.397; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Pruss BM, 1999, APPL ENVIRON MICROB, V65, P5436; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; RAVEL J, 2008, J BACTERIOL; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Rivera AMG, 2000, FEMS MICROBIOL LETT, V190, P151, DOI 10.1111/j.1574-6968.2000.tb09278.x; Rowland BM, 1996, GENE, V178, P119, DOI 10.1016/0378-1119(96)00349-6; Ruzicka FJ, 2000, J BACTERIOL, V182, P469, DOI 10.1128/JB.182.2.469-476.2000; Sirard JC, 1995, RES MICROBIOL, V146, P729, DOI 10.1016/0923-2508(96)81069-2; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; STERNE M, 1957, J BACTERIOL, V74, P541, DOI 10.1128/JB.74.4.541-542.1957; Sue D, 2006, J CLIN MICROBIOL, V44, P3426, DOI 10.1128/JCM.00873-06; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Wilson AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000210; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Zwick ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002513	58	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4904	10.1371/journal.pone.0004904	http://dx.doi.org/10.1371/journal.pone.0004904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295911	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496700006
J	Bourjade, M; des Roches, AD; Hausberger, M				Bourjade, Marie; des Roches, Alice de Boyer; Hausberger, Martine			Adult-Young Ratio, a Major Factor Regulating Social Behaviour of Young: A Horse Study	PLOS ONE			English	Article							CAPTIVE GROUP; DAY-CARE; QUALITY; COMMUNICATION; CONTACT; FOALS	Background: Adults play an important role in regulating the social behaviour of young individuals. However, a few pioneer studies suggest that, more than the mere presence of adults, their proportions in social groups affect the social development of young. Here, we hypothesized that aggression rates and social cohesion were correlated to adult-young ratios. Our biological model was naturally-formed groups of Przewalski horses, Equus f. przewalskii, varying in composition. Methodology/Principal Findings: We investigated the social interactions and spatial relationships of 12 one-and two-year-old Przewalski horses belonging to five families with adult-young ratios (AYR) ranging from 0.67 to 1.33. We found striking variations of aggression rates and spatial relationships related to the adult-young ratio: the lower this ratio, the more the young were aggressive, the more young and adults segregated and the tighter the young bonded to other young. Conclusion/Significance: This is the first study demonstrating a correlation between adult-young ratios and aggression rates and social cohesion of young individuals in a naturalistic setting. The increase of aggression and the emergence of social segregation in groups with lower proportions of adults could reflect a related decrease of the influence of adults as regulators of the behaviour of young. This social regulation has both theoretical and practical implications for understanding the modalities of the influence of adults during ontogeny and for recommending optimal settings, as for instance, for schooling or animal group management.	[Bourjade, Marie; des Roches, Alice de Boyer; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine, CNRS, Rennes, France; [Bourjade, Marie] Assoc Takh Pour Cheval Przewalski, Stn Biol Tour Valat, Arles, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Bourjade, M (corresponding author), Univ Rennes 1, Lab Ethol Anim & Humaine, CNRS, Rennes, France.	marie.bourjade@gmail.com		de Boyer des Roches, Alice/0000-0002-6903-7456	MAVA foundation	MAVA foundation	The Association Takh was supported financially by the MAVA foundation but this work did not receive specific funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Bourjade M, 2008, DEV PSYCHOBIOL, V50, P408, DOI 10.1002/dev.20301; Boyd L, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P55; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Burchinal MR, 2000, CHILD DEV, V71, P339, DOI 10.1111/1467-8624.00149; Burchinal MR, 1997, CHILD DEV, V68, P935, DOI 10.1111/j.1467-8624.1997.tb01972.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cousillas H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002194; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Feh C, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P83; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Henry S, 2007, DEV PSYCHOBIOL, V49, P514, DOI 10.1002/dev.20225; Henry S, 2005, APPL ANIM BEHAV SCI, V93, P341, DOI 10.1016/j.applanim.2005.01.008; HOWES C, 1985, CHILD YOUTH CARE Q, V14, P140, DOI 10.1007/BF01113407; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; MCCARTNEY K, 1984, DEV PSYCHOL, V20, P244, DOI 10.1037/0012-1649.20.2.244; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Monfort S.L., 1994, P173; Pettit GS, 1999, CHILD DEV, V70, P768, DOI 10.1111/1467-8624.00055; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; RUBENSTEIN J, 1976, CHILD DEV, V47, P597; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; THORHALLSDOTTIR AG, 1990, APPL ANIM BEHAV SCI, V25, P25, DOI 10.1016/0168-1591(90)90066-M; Vandell DL, 1996, EARLY CHILD RES Q, V11, P269, DOI 10.1016/S0885-2006(96)90009-5; Voelkl B, 2006, ANIM BEHAV, V72, P365, DOI 10.1016/j.anbehav.2005.10.013; West MJ, 2003, ANIM BEHAV, V66, P617, DOI 10.1006/anbe.2003.2221; White DJ, 2002, ETHOLOGY, V108, P23, DOI 10.1046/j.1439-0310.2002.00755.x; White DJ, 2002, BEHAV ECOL, V13, P487, DOI 10.1093/beheco/13.4.487; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	23	23	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4888	10.1371/journal.pone.0004888	http://dx.doi.org/10.1371/journal.pone.0004888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293930	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496600008
J	Gavara, N; Chadwick, RS				Gavara, Nuria; Chadwick, Richard S.			Collagen-Based Mechanical Anisotropy of the Tectorial Membrane: Implications for Inter-Row Coupling of Outer Hair Cell Bundles	PLOS ONE			English	Article								Background: The tectorial membrane (TM) in the mammalian cochlea displays anisotropy, where mechanical or structural properties differ along varying directions. The anisotropy arises from the presence of collagen fibrils organized in fibers of,1 mm diameter that run radially across the TM. Mechanical coupling between the TM and the sensory epithelia is required for normal hearing. However, the lack of a suitable technique to measure mechanical anisotropy at the microscale level has hindered understanding of the TM's precise role. Methodology/Principal Findings: Here we report values of the three elastic moduli that characterize the anisotropic mechanical properties of the TM. Our novel technique combined Atomic Force Microscopy (AFM), modeling, and optical tracking of microspheres to determine the elastic moduli. We found that the TM's large mechanical anisotropy results in a marked transmission of deformations along the direction that maximizes sensory cell excitation, whereas in the perpendicular direction the transmission is greatly reduced. Conclusions/Significance: Computational results, based on our values of elastic moduli, suggest that the TM facilitates the directional cooperativity of sensory cells in the cochlea, and that mechanical properties of the TM are tuned to guarantee that the magnitude of sound-induced tip-link stretching remains similar along the length of the cochlea. Furthermore, we anticipate our assay to be a starting point for other studies of biological tissues that require directional functionality.	[Gavara, Nuria; Chadwick, Richard S.] Natl Inst Deafness & Other Commun Disorders, Auditory Mech Sect, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Gavara, N (corresponding author), Natl Inst Deafness & Other Commun Disorders, Auditory Mech Sect, NIH, Bethesda, MD USA.	chadwick@helix.nih.gov	Gavara, Núria/AAI-2448-2020	Gavara, Núria/0000-0002-7666-110X	NIDCD Intramural Program [Z01-DC000033-10]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000033, ZIADC000033] Funding Source: NIH RePORTER	NIDCD Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The NIDCD Intramural Program Project Z01-DC000033-10 supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2000, HEARING RES, V144, P29, DOI 10.1016/S0378-5955(00)00041-1; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Cai HX, 2004, P NATL ACAD SCI USA, V101, P6243, DOI 10.1073/pnas.0401395101; Chadwick RS, 2004, SIAM J APPL MATH, V64, P1186, DOI 10.1137/S0036139903425338; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Dierkes K, 2008, P NATL ACAD SCI USA, V105, P18669, DOI 10.1073/pnas.0805752105; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; FURNESS DN, 1990, ACTA OTO-LARYNGOL, V109, P66, DOI 10.3109/00016489009107416; Ghaffari R, 2007, P NATL ACAD SCI USA, V104, P16510, DOI 10.1073/pnas.0703665104; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Gueta R, 2008, BIOPHYS J, V94, P4570, DOI 10.1529/biophysj.107.125203; Gueta R, 2007, J STRUCT BIOL, V159, P103, DOI 10.1016/j.jsb.2007.03.002; Gueta R, 2006, P NATL ACAD SCI USA, V103, P14790, DOI 10.1073/pnas.0603429103; KROS CJ, 1996, COCHLEA, P319; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; LIM DJ, 1972, ARCHIV OTOLARYNGOL, V96, P199; Masaki K, 2006, BIOPHYS J, V91, P2356, DOI 10.1529/biophysj.105.078121; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Richter CP, 2007, BIOPHYS J, V93, P2265, DOI 10.1529/biophysj.106.094474; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; SAITO K, 1979, J ELECTRON MICROSC, V28, P36; SHAH DM, 1995, HEARING RES, V87, P187, DOI 10.1016/0378-5955(95)00089-M; Shoelson B, 2004, BIOPHYS J, V87, P2768, DOI 10.1529/biophysj.104.040774; SPENCER JM, 1984, CONTINUM THEORY MECH, P1; STEEL KP, 1983, HEARING RES, V9, P327, DOI 10.1016/0378-5955(83)90035-7; Teudt IU, 2007, J NEUROSCI METH, V162, P187, DOI 10.1016/j.jneumeth.2007.01.012; Thiers FA, 2002, JARO-J ASSOC RES OTO, V3, P269, DOI 10.1007/s101620020024; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tsuprun V, 1998, J NEUROCYTOL, V27, P517, DOI 10.1023/A:1006903926571	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4877	10.1371/journal.pone.0004877	http://dx.doi.org/10.1371/journal.pone.0004877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293929	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496600006
J	Mortaz, E; Kraneveld, AD; Smit, JJ; Kool, M; Lambrecht, BN; Kunkel, SL; Lukacs, NW; Nijkamp, FP; Folkerts, G				Mortaz, Esmaeil; Kraneveld, Aletta D.; Smit, Joost J.; Kool, Mirjam; Lambrecht, Bart N.; Kunkel, Steven L.; Lukacs, Nicholas W.; Nijkamp, Frans P.; Folkerts, Gert			Effect of Cigarette Smoke Extract on Dendritic Cells and Their Impact on T-Cell Proliferation	PLOS ONE			English	Article								Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation. Cigarette smoke has been considered a major player in the pathogenesis of COPD. The inflamed airways of COPD patients contain several inflammatory cells including neutrophils, macrophages, T lymphocytes, and dendritic cells (DCs). The relative contributions of these various inflammatory cells to airway injury and remodeling are not well documented. In particular, the potential role of DCs as mediators of inflammation in the smoker's airways and COPD patients is poorly understood. In the current study we analyzed the effects of cigarette smoke extract on mouse bone marrow derived DC and the production of chemokines and cytokines were studied. In addition, we assessed CSE-induced changes in cDC function in the mixed lymphocyte reaction (MLR) examining CD4+ and CD8+ T cell proliferation. Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS). In a mixed-leukocyte reaction assay, cigarette smoke-primed DCs potentiate CD8+ T cell proliferation via CCL3. In contrast, proliferation of CD4+ T cells is suppressed via an unknown mechanism. The cigarette smoke-induced release of CCL3 and CXCL2 by DCs may contribute to the influx of CD8+ T cells and neutrophils into the airways, respectively.	[Mortaz, Esmaeil; Kraneveld, Aletta D.; Nijkamp, Frans P.; Folkerts, Gert] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands; [Mortaz, Esmaeil] Tarbiat Modares Univ, Fac Med Sci, Dept Biochem, Tehran, Iran; [Mortaz, Esmaeil] Urmia Univ, Fac Vet Med, Dept Basic Sci, Sect Biochem, Orumiyeh, Iran; [Smit, Joost J.] Univ Utrecht, IRAS, Utrecht, Netherlands; [Kool, Mirjam; Lambrecht, Bart N.] Erasmus Univ, Med Ctr, Dept Pulmonary Med, NL-3000 DR Rotterdam, Netherlands; [Kool, Mirjam; Lambrecht, Bart N.] Univ Ghent, Dept Pulm Med, Lab Immunoreg & Mucosal Immun, Ghent, Belgium; [Kunkel, Steven L.; Lukacs, Nicholas W.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	Utrecht University; Tarbiat Modares University; Urmia University; Utrecht University; Erasmus University Rotterdam; Erasmus MC; Ghent University; University of Michigan System; University of Michigan	Mortaz, E (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands.	e.mortaz@uu.nl	Lambrecht, Bart N/K-2484-2014; Kraneveld, Aletta D/J-3351-2016; Lukacs, Nicholas W/ABH-5583-2020	Lambrecht, Bart N/0000-0003-4376-6834; Kraneveld, Aletta D/0000-0001-9819-383X; Smit, Joost/0000-0003-4612-4036; Mortaz, Esmaeil/0000-0003-0250-087X; Adcock, Ian/0000-0003-2101-8843	Dutch Top Institute Pharma [T1-103, D1.101]	Dutch Top Institute Pharma	This study was performed within the framework of Dutch Top Institute Pharma (project numbers T1-103 and D1.101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Beaudeux J. -L., 2006, ANNALES PHARMACEUTIQUES FRANCAISES, V64, P373, DOI 10.1016/S0003-4509(06)75332-9; Bell D, 1999, ADV IMMUNOL, V72, P255, DOI 10.1016/S0065-2776(08)60023-1; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; CHANG JCC, 1990, TOXICOL APPL PHARM, V102, P514, DOI 10.1016/0041-008X(90)90046-W; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Folkerts G, 2008, TRENDS PHARMACOL SCI, V29, P181, DOI 10.1016/j.tips.2008.01.005; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Karimi K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-66; Kim HY, 2007, IMMUNOL CELL BIOL, V85, P60, DOI 10.1038/sj.icb.7100001; Kinnula Vuokko L., 2005, Current Drug Targets - Inflammation and Allergy, V4, P465, DOI 10.2174/1568010054526368; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Lambrecht BN, 2002, CLIN EXP ALLERGY, V32, P805, DOI 10.1046/j.1365-2745.2002.01434.x; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Liu XD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-66; Lukacs NW, 1999, J CLIN INVEST, V104, P995, DOI 10.1172/JCI8125; Ma B, 2004, J IMMUNOL, V172, P1872, DOI 10.4049/jimmunol.172.3.1872; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Mortaz E, 2005, BIOCHEM PHARMACOL, V69, P1049, DOI 10.1016/j.bcp.2004.12.018; Nouri-Shirazi M, 2006, IMMUNOL LETT, V103, P167, DOI 10.1016/j.imlet.2005.10.024; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Palucka K, 1999, J CLIN IMMUNOL, V19, P12, DOI 10.1023/A:1020558317162; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Robbins CS, 2008, J IMMUNOL, V180, P6623, DOI 10.4049/jimmunol.180.10.6623; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Spurzem JR, 2005, SEMIN RESP CRIT CARE, V26, P142, DOI 10.1055/s-2005-869535; Stevenson CS, 2005, AM J PHYSIOL-LUNG C, V288, pL514, DOI 10.1152/ajplung.00317.2004; Taub DD, 1996, J IMMUNOL, V156, P2095; Thatcher TH, 2005, AM J PHYSIOL-LUNG C, V289, pL322, DOI 10.1152/ajplung.00039.2005; Tsoumakidou M, 2008, AM J RESP CRIT CARE, V177, P1180, DOI 10.1164/rccm.200711-1727PP; Vassallo R, 2008, MOL IMMUNOL, V45, P3321, DOI 10.1016/j.molimm.2008.04.014; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006	43	54	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4946	10.1371/journal.pone.0004946	http://dx.doi.org/10.1371/journal.pone.0004946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293939	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496600017
J	Awan, A; Bell, AJ; Satir, P				Awan, Aashir; Bell, Aaron J.; Satir, Peter			Kin5 Knockdown in Tetrahymena thermophila Using RNAi Blocks Cargo Transport of Gef1	PLOS ONE			English	Article								A critical process that builds and maintains the eukaryotic cilium is intraflagellar transport (IFT). This process utilizes members of the kinesin-2 superfamily to transport cargo into the cilium (anterograde transport) and a dynein motor for the retrograde traffic. Using a novel RNAi knockdown method, we have analyzed the function of the homodimeric IFT kinesin-2, Kin5, in Tetrahymena ciliary transport. In RNAi transformants, Kin5 was severely downregulated and disappeared from the cilia, but cilia did not resorb, although tip structure was affected. After deciliation of the knockdown cell, cilia regrew and cells swam, which suggested that Kin5 is not responsible for the trafficking of axonemal precursors to build the cilium, but could be transporting molecules that act in ciliary signal transduction, such as guanine nucleotide exchange proteins (GEFs). Gef1 is a Tetrahymena ciliary protein, and current coimmunoprecipitation and immunofluorescence studies showed that it is absent in regrowing cilia of the knockdown cells lacking ciliary Kin5. We suggest that one important cargo of Kin5 is Gef1 and knockdown of Kin5 results in cell lethality.	[Awan, Aashir; Bell, Aaron J.; Satir, Peter] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Awan, A (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	satir@aecom.yu.edu		Awan, Aashir/0000-0002-8726-2921				Awan A, 2004, CELL MOTIL CYTOSKEL, V58, P1, DOI 10.1002/cm.10170; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; CassidyHanley D, 1997, GENETICS, V146, P135; Christensen ST, 2003, CURR BIOL, V13, pR50, DOI 10.1016/S0960-9822(02)01425-2; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Dondero F, 2004, PROTIST, V155, P157, DOI 10.1078/143446104774199565; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Flannery RJ, 2006, BIOPHYS J, V91, P179, DOI 10.1529/biophysj.105.079046; GAERTIG J, 1994, P NATL ACAD SCI USA, V91, P4549, DOI 10.1073/pnas.91.10.4549; Hai B, 2000, METHOD CELL BIOL, V62, P513; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; Howard-Till RA, 2006, MOL CELL BIOL, V26, P8731, DOI 10.1128/MCB.01430-06; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Linder JU, 1999, EMBO J, V18, P4222, DOI 10.1093/emboj/18.15.4222; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nair S, 1999, FASEB J, V13, P1249, DOI 10.1096/fasebj.13.10.1249; NILSSON JR, 1989, EUR J PROTISTOL, V25, P2, DOI 10.1016/S0932-4739(89)80074-4; ORIAS E, 1975, GENETICS, V79, P187; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Piperno G, 1996, J CELL BIOL, V133, P371, DOI 10.1083/jcb.133.2.371; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; VELAND IR, 2009, J NEPHROLOG IN PRESS	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4873	10.1371/journal.pone.0004873	http://dx.doi.org/10.1371/journal.pone.0004873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290045	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496500007
J	Werner, M; Semsey, S; Sneppen, K; Krishna, S				Werner, Maria; Semsey, Szabolcs; Sneppen, Kim; Krishna, Sandeep			Dynamics of Uptake and Metabolism of Small Molecules in Cellular Response Systems	PLOS ONE			English	Article							MECHANISMS; HOMEOSTASIS; EXPRESSION	Background: Proper cellular function requires uptake of small molecules from the environment. In response to changes in extracellular conditions cells alter the import and utilization of small molecules. For a wide variety of small molecules the cellular response is regulated by a network motif that combines two feedback loops, one which regulates the transport and the other which regulates the subsequent metabolism. Results: We analyze the dynamic behavior of two widespread but logically distinct two-loop motifs. These motifs differ in the logic of the feedback loop regulating the uptake of the small molecule. Our aim is to examine the qualitative features of the dynamics of these two classes of feedback motifs. We find that the negative feedback to transport is accompanied by overshoot in the intracellular amount of small molecules, whereas a positive feedback to transport removes overshoot by boosting the final steady state level. On the other hand, the negative feedback allows for a rapid initial response, whereas the positive feedback is slower. We also illustrate how the dynamical deficiencies of one feedback motif can be mitigated by an additional loop, while maintaining the original steady-state properties. Conclusions: Our analysis emphasizes the core of the regulation found in many motifs at the interface between the metabolic network and the environment of the cell. By simplifying the regulation into uptake and the first metabolic step, we provide a basis for elaborate studies of more realistic network structures. Particularly, this theoretical analysis predicts that FeS cluster formation plays an important role in the dynamics of iron homeostasis.	[Werner, Maria] Albanova Univ Ctr, Royal Inst Technol, Dept Computat Biol, Stockholm, Sweden; [Semsey, Szabolcs] Eotvos Lorand Univ, Dept Genet, H-1364 Budapest, Hungary; [Sneppen, Kim; Krishna, Sandeep] Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, DK-1168 Copenhagen, Denmark	Royal Institute of Technology; Eotvos Lorand University; University of Copenhagen; Niels Bohr Institute	Werner, M (corresponding author), Albanova Univ Ctr, Royal Inst Technol, Dept Computat Biol, Stockholm, Sweden.	mariawer@kth.se	Semsey, Szabolcs/L-6329-2013	Sneppen, Kim/0000-0001-9820-3567; Semsey, Szabolcs/0000-0002-4522-5495; krishna, sandeep/0000-0002-0581-173X	Danish National Research Foundation; Swedish Research Council;  [OTKA PD75496]	Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); 	This work was funded by Danish National Research Foundation, the Swedish Research Council and by the grant OTKA PD75496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; ONG IM, 2006, BIOINFORMATICS, V18, pS241; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pruteanu M, 2007, J BACTERIOL, V189, P3017, DOI 10.1128/JB.01531-06; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Semsey S, 2007, MOL MICROBIOL, V65, P465, DOI 10.1111/j.1365-2958.2007.05798.x; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o	15	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4923	10.1371/journal.pone.0004923	http://dx.doi.org/10.1371/journal.pone.0004923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290058	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496500017
J	Kim, SHJ; Yu, W; Mostov, K; Matthay, MA; Hunt, CA				Kim, Sean H. J.; Yu, Wei; Mostov, Keith; Matthay, Michael A.; Hunt, C. Anthony			A Computational Approach to Understand In Vitro Alveolar Morphogenesis	PLOS ONE			English	Article								Primary human alveolar type II (AT II) epithelial cells maintained in Matrigel cultures form alveolar-like cysts (ALCs) using a cytogenesis mechanism that is different from that of other studied epithelial cell types: neither proliferation nor death is involved. During ALC formation, AT II cells engage simultaneously in fundamentally different, but not fully characterized activities. Mechanisms enabling these activities and the roles they play during different process stages are virtually unknown. Identifying, characterizing, and understanding the activities and mechanisms are essential to achieving deeper insight into this fundamental feature of morphogenesis. That deeper insight is needed to answer important questions. When and how does an AT cell choose to switch from one activity to another? Why does it choose one action rather than another? We report obtaining plausible answers using a rigorous, multi-attribute modeling and simulation approach that leveraged earlier efforts by using new, agent and object-oriented capabilities. We discovered a set of cell-level operating principles that enabled in silico cells to self-organize and generate systemic cystogenesis phenomena that are quantitatively indistinguishable from those observed in vitro. Success required that the cell components be quasi-autonomous. As simulation time advances, each in silico cell autonomously updates its environment information to reclassify its condition. It then uses the axiomatic operating principles to execute just one action for each possible condition. The quasi-autonomous actions of individual in silico cells were sufficient for developing stable cyst-like structures. The results strengthen in silico to in vitro mappings at three levels: mechanisms, behaviors, and operating principles, thereby achieving a degree of validation and enabling answering the questions posed. We suggest that the in silico operating principles presented may have a biological counterpart and that a semiquantitative mapping exists between in silico causal events and in vitro causal events.	[Kim, Sean H. J.; Hunt, C. Anthony] Univ Calif Berkeley, UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; [Yu, Wei; Mostov, Keith] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Hunt, C. Anthony] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kim, SHJ (corresponding author), Univ Calif Berkeley, UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA 94720 USA.	a.hunt@ucsf.edu		mostov, keith/0000-0002-8123-6247; Hunt, C. Anthony/0000-0001-9372-6860	CDH Research Foundation [08-0023]; International Foundation for Ethical Research [graduate student fellowship]; National Kidney Foundation [fellowship]; NIH [R01 DK074398, R01 DK067153]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, R01DK067153] Funding Source: NIH RePORTER	CDH Research Foundation; International Foundation for Ethical Research; National Kidney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the CDH Research Foundation grant 08-0023, and a graduate student fellowship from the International Foundation for Ethical Research, a fellowship from the National Kidney Foundation to WY, and NIH grants R01 DK074398 and R01 DK067153 to KM. CAH is a trustee of the CDH Research Foundation. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Christley S, 2007, PLOS COMPUT BIOL, V3, P743, DOI 10.1371/journal.pcbi.0030076.eor; Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Grant MR, 2006, PLOS COMPUT BIOL, V2, P1193, DOI 10.1371/journal.pcbi.0020129; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Hunt CA, 2008, NAT BIOTECHNOL, V26, P737, DOI 10.1038/nbt0708-737; Hunt CA, 2006, J PHARMACOKINET PHAR, V33, P737, DOI 10.1007/s10928-006-9031-3; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; KIM SH, 2007, P ISCA 20 INT C COMP; Law A. M., 2000, SIMULATION MODELING; Longo D, 2004, DEV BIOL, V271, P210, DOI 10.1016/j.ydbio.2004.03.021; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Newman SA, 2008, CURR TOP DEV BIOL, V81, P311, DOI 10.1016/S0070-2153(07)81011-8; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Peirce SM, 2004, FASEB J, V18, P731, DOI 10.1096/fj.03-0933fje; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Robertson SH, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-46; Rorth P, 2003, CELL, V112, P595, DOI 10.1016/S0092-8674(03)00156-9; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Tang J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-14; Thorne BC, 2007, BRIEF BIOINFORM, V8, P245, DOI 10.1093/bib/bbm024; Walker D, 2006, J THEOR BIOL, V242, P774, DOI 10.1016/j.jtbi.2006.04.020; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zeigler B., 2000, THEORY MODELING SIMU	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4819	10.1371/journal.pone.0004819	http://dx.doi.org/10.1371/journal.pone.0004819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283073	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496300005
J	Sunagawa, S; DeSalvo, MK; Voolstra, CR; Reyes-Bermudez, A; Medina, M				Sunagawa, Shinichi; DeSalvo, Michael K.; Voolstra, Christian R.; Reyes-Bermudez, Alejandro; Medina, Monica			Identification and Gene Expression Analysis of a Taxonomically Restricted Cysteine-Rich Protein Family in Reef-Building Corals	PLOS ONE			English	Article							ANCESTRAL COMPLEXITY; GENOME REVEALS; SEQUENCE; EVOLUTION; REPERTOIRE; COMPONENTS; SITES	The amount of genomic sequence information continues to grow at an exponential rate, while the identification and characterization of genes without known homologs remains a major challenge. For non-model organisms with limited resources for manipulative studies, high-throughput transcriptomic data combined with bioinformatics methods provide a powerful approach to obtain initial insights into the function of unknown genes. In this study, we report the identification and characterization of a novel family of putatively secreted, small, cysteine-rich proteins herein named Small Cysteine-Rich Proteins (SCRiPs). Their discovery in expressed sequence tag (EST) libraries from the coral Montastraea faveolata required the performance of an iterative search strategy based on BLAST and Hidden-Markov-Model algorithms. While a discernible homolog could neither be identified in the genome of the sea anemone Nematostella vectensis, nor in a large EST dataset from the symbiotic sea anemone Aiptasia pallida, we identified SCRiP sequences in multiple scleractinian coral species. Therefore, we postulate that this gene family is an example of lineage-specific gene expansion in reef-building corals. Previously published gene expression microarray data suggest that a sub-group of SCRiPs is highly responsive to thermal stress. Furthermore, data from microarray experiments investigating developmental gene expression in the coral Acropora millepora suggest that different SCRiPs may play distinct roles in the development of corals. The function of these proteins remains to be elucidated, but our results from in silico, transcriptomic, and phylogenetic analyses provide initial insights into the evolution of SCRiPs, a novel, taxonomically restricted gene family that may be responsible for a lineage-specific trait in scleractinian corals.	[Sunagawa, Shinichi; DeSalvo, Michael K.; Voolstra, Christian R.; Reyes-Bermudez, Alejandro; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Merced	Sunagawa, S (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	mmedina@ucmerced.edu	Sunagawa, Shinichi/Q-5950-2019; Voolstra, Christian R/H-7158-2014	Sunagawa, Shinichi/0000-0003-3065-0314; Voolstra, Christian R/0000-0003-4555-3795; Reyes-Bermudez, Alejandro/0000-0002-4588-3770	NSF [BE-GEN 0313708, IOS 0644438]; Division Of Integrative Organismal Systems [1402065] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported through NSF awards BE-GEN 0313708 and IOS 0644438 funded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lynch M, 2000, GENETICS, V154, P459; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Miller DJ, 2008, TRENDS GENET, V24, P1, DOI 10.1016/j.tig.2007.10.002; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; NAKAYAMA K, 1992, J BIOL CHEM, V267, P16335; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, EVOLUTION GENE DUPLI; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; RHOLAM M, 1995, EUR J BIOCHEM, V227, P707, DOI 10.1111/j.1432-1033.1995.tb20192.x; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Steele RE, 2005, INTEGR COMP BIOL, V45, P639, DOI 10.1093/icb/45.4.639; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Watanabe T, 2003, COMP BIOCHEM PHYS B, V136, P767, DOI 10.1016/S1096-4959(03)00177-5; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; SYMBIOSYS; AIPTASIABASE	40	54	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4865	10.1371/journal.pone.0004865	http://dx.doi.org/10.1371/journal.pone.0004865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283069	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496300009
J	Pages, JM; Lavigne, JP; Leflon-Guibout, V; Marcon, E; Bert, F; Noussair, L; Nicolas-Chanoine, MH				Pages, Jean-Marie; Lavigne, Jean-Philippe; Leflon-Guibout, Veronique; Marcon, Estelle; Bert, Frederic; Noussair, Latifa; Nicolas-Chanoine, Marie-Helene			Efflux Pump, the Masked Side of beta-Lactam Resistance in Klebsiella pneumoniae Clinical Isolates	PLOS ONE			English	Article								Background: beta-lactamase production and porin decrease are the well-recognized mechanisms of acquired beta-lactam resistance in Klebsiella pneumoniae isolates. However, such mechanisms proved to be absent in K. pneumoniae isolates that are non susceptible to cefoxitin (FOX) and succeptible to amoxicillin+clavulanic acid in our hospital. Assessing the role of efflux pumps in this b-lactam phenotype was the aim of this study. Methodology/Findings: MICs of 9 beta-lactams, including cloxacillin (CLX), and other antibiotic families were tested alone and with an efflux pump inhibitor (EPI), then with both CLX (subinhibitory concentrations) and EPI against 11 unique bacteremia K. pneumoniae isolates displaying the unusual phenotype, and 2 ATCC strains. CLX and EPI-dose dependent effects were studied on 4 representatives strains. CLX MICs significantly decreased when tested with EPI. A similar phenomenon was observed with piperacillin+tazobactam whereas MICs of the other b-lactams significantly decreased only in the presence of both EPI and CLX. Thus, FOX MICs decreased 128 fold in the K. pneumoniae isolates but also16 fold in ATCC strain. Restoration of FOX activity was CLX dose-dependent suggesting a competitive relationship between CLX and the other beta-lactams with regard to their efflux. For chloramphenicol, erythromycin and nalidixic acid whose resistance was also due to efflux, adding CLX to EPI did not increase their activity suggesting differences between the efflux process of these molecules and that of beta-lactams. Conclusion: This is the first study demonstrating that efflux mechanism plays a key role in the beta-lactam susceptibility of clinical isolates of K. pneumoniae. Such data clearly evidence that the involvement of efflux pumps in beta-lactam resistance is specially underestimated in clinical isolates.	[Pages, Jean-Marie; Lavigne, Jean-Philippe] Univ Aix Marseille 2, Fac Med & Pharm, UMR MD 1, IFR88, Marseille, France; [Leflon-Guibout, Veronique; Marcon, Estelle; Bert, Frederic; Noussair, Latifa; Nicolas-Chanoine, Marie-Helene] AP HP, Hop Beaujon, Serv Microbiol, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Univ D Diderot, CRB3, INSERM, U 773, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Pages, JM (corresponding author), Univ Aix Marseille 2, Fac Med & Pharm, UMR MD 1, IFR88, Marseille, France.	Jean-Marie.PAGES@univmed.fr	Lavigne, Jean-Philippe/E-1756-2014; PAGES, jean-marie/F-2555-2013	Lavigne, Jean-Philippe/0000-0002-9484-0304; PAGES, jean-marie/0000-0001-7092-7977	Service de Sante des Armees [2004RC16]; Universite de la Mediterranee	Service de Sante des Armees; Universite de la Mediterranee	This study was supported by the Service de Sante des Armees (contrat recherche clinique 2004RC16 and livre rouge operation 23e) and by the Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2003, ANTIMICROB AGENTS CH, V47, P1165, DOI 10.1128/AAC.47.3.1165-1168.2003; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Chevalier J, 2000, BIOCHEM BIOPH RES CO, V274, P496, DOI 10.1006/bbrc.2000.3159; Chevalier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003203; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P3621, DOI 10.1128/AAC.48.9.3621-3624.2004; Dastidar V, 2007, J BACTERIOL, V189, P5550, DOI 10.1128/JB.00471-07; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Elkins CA, 2003, DRUG RESIST UPDATE, V6, P9, DOI 10.1016/S1368-7646(03)00004-9; Elkins CA, 2007, ANTIMICROB AGENTS CH, V51, P923, DOI 10.1128/AAC.01048-06; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Gori A, 1996, J CLIN MICROBIOL, V34, P2448, DOI 10.1128/JCM.34.10.2448-2453.1996; Gruteke P, 2003, J CLIN MICROBIOL, V41, P1161, DOI 10.1128/JCM.41.3.1161-1166.2003; Haeggman S, 2004, ANTIMICROB AGENTS CH, V48, P2400, DOI 10.1128/AAC.48.7.2400-2408.2004; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Leflon-Guibout V, 2004, ANTIMICROB AGENTS CH, V48, P3736, DOI 10.1128/AAC.48.10.3736-3742.2004; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2005, J BACTERIOL, V187, P1879, DOI 10.1128/JB.187.6.1879-1883.2005; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; PAGES JM, 2009, BIOCH BIOPH IN PRESS; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Simonet V, 1996, FEMS MICROBIOL LETT, V136, P91; Su CC, 2007, FEBS LETT, V581, P4972, DOI 10.1016/j.febslet.2007.09.035; Su SC, 2008, ANTIMICROB AGENTS CH, V52, P804, DOI 10.1128/AAC.01269-07; Yan MG, 2006, J ANTIMICROB CHEMOTH, V58, P1154, DOI 10.1093/jac/dkl412	38	77	87	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4817	10.1371/journal.pone.0004817	http://dx.doi.org/10.1371/journal.pone.0004817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279676	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496200004
J	Jancke, L; Koeneke, S; Hoppe, A; Rominger, C; Hanggi, J				Jaencke, Lutz; Koeneke, Susan; Hoppe, Ariana; Rominger, Christina; Haenggi, Juergen			The Architecture of the Golfer's Brain	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER DENSITY; PREMOTOR AREAS; NON-MUSICIANS; MOTOR SKILL; NEUROPLASTICITY; ACQUISITION; CORTEX; STIMULATION; PLASTICITY	Background: Several recent studies have shown practice-dependent structural alterations in humans. Cross-sectional studies of intensive practice of specific tasks suggest associated long-term structural adaptations. Playing golf at a high level of performance is one of the most demanding sporting activities. In this study, we report the relationship between a particular level of proficiency in playing golf (indicated by golf handicap level) and specific neuroanatomical features. Principal Findings: Using voxel-based morphometry (VBM) of grey (GM) and white matter (WM) volumes and fractional anisotropy (FA) measures of the fibre tracts, we identified differences between skilled (professional golfers and golfers with an handicap from 1-14) and less-skilled golfers (golfers with an handicap from 15-36 and non-golfer). Larger GM volumes were found in skilled golfers in a fronto-parietal network including premotor and parietal areas. Skilled golfers revealed smaller WM volume and FA values in the vicinity of the corticospinal tract at the level of the internal and external capsule and in the parietal operculum. However, there was no structural difference within the skilled and less-skilled golfer group. Conclusion: There is no linear relationship between the anatomical findings and handicap level, amount of practice, and practice hours per year. There was however a strong difference between highly-practiced golfers (at least 800-3,000 hours) and those who have practised less or non-golfers without any golfing practise, thus indicating a step-wise structural and not a linear change.	[Jaencke, Lutz; Koeneke, Susan; Hoppe, Ariana; Rominger, Christina; Haenggi, Juergen] Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland; [Jaencke, Lutz] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Biol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jancke, L (corresponding author), Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland.	l.jaencke@psychologie.uzh.ch	Jäncke, Lutz/C-3792-2009; Jancke, Lutz/D-2910-2013	Jäncke, Lutz/0000-0002-8115-4890; Hanggi, Jurgen/0000-0001-8124-6018; Jancke, Lutz/0000-0003-2110-9067; Merillat, Susan/0000-0002-0566-088X	Swiss National Science Foundation (SNF)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Swiss National Science Foundation (SNF) - The SNF is the national non-profit funding organization controlled by the Swiss government. The funder did not play any role in designing, conducting and analyzing study.	Abe M, 2007, J NEUROSCI, V27, P3429, DOI 10.1523/JNEUROSCI.4273-06.2007; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Aydin K, 2007, AM J NEURORADIOL, V28, P1859, DOI 10.3174/ajnr.A0696; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; BOYKE J, 2008, J NEUROSCIENCE; BRUNTON H, 2007, DEV EXPERTISE ELITE; Cannonieri GC, 2007, NEUROREPORT, V18, P1063, DOI 10.1097/WNR.0b013e3281a030e5; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; ERICSSON KA, 1993, ORIGINS DEV HIGH ABI, V178, P222; Gaser C, 2003, J NEUROSCI, V23, P9240; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; KARNI A, 1995, NATURE, V377, P155; Kiehl KA, 2006, PSYCHIAT RES, V142, P107, DOI 10.1016/j.psychres.2005.09.013; Koeneke S, 2006, EXP BRAIN RES, V174, P199, DOI 10.1007/s00221-006-0440-8; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mars RB, 2008, CORTEX, V44, P479, DOI 10.1016/j.cortex.2008.03.002; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; SCHLAUG G, 1994, EXP BRAIN RES, V98, P523; Schmithorst VJ, 2002, NEUROSCI LETT, V321, P57, DOI 10.1016/S0304-3940(02)00054-X; Schulze K, 2002, CORTEX, V38, P805, DOI 10.1016/S0010-9452(08)70047-9; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sudhyadhom A, 2007, CURR NEUROL NEUROSCI, V7, P278, DOI 10.1007/s11910-007-0043-1; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Viviani P, 1998, EXP BRAIN RES, V120, P531, DOI 10.1007/s002210050428	38	132	135	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4785	10.1371/journal.pone.0004785	http://dx.doi.org/10.1371/journal.pone.0004785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OF	19277116	Green Published, gold			2022-12-27	WOS:000265496100013
J	Thines, M				Thines, Marco			Bridging the Gulf: Phytophthora and Downy Mildews Are Connected by Rare Grass Parasites	PLOS ONE			English	Article								Downy mildews and root and foliar rots caused by Phytophthora are among the most destructive plant pathogens and therefore have attracted considerable attention during the past two decades. Although it has been realized that a close phylogenetic relationship exists, so far sharp distinction has been made between the obligate biotrophic downy mildews and the hemibiotrophic Phytophthora. In the study presented here, it is shown that a continuum of character states from hemibiotrophic Phytophthora species to obligate biotrophic downy mildews is present. Intermediate character states between downy mildews and Phytophthora species exist in several rare parasites of grasses, which are not embedded within the major clades of the downy mildews but are placed sister to these, with unresolved affinities to both these clades and to Phytophthora. They still have retained traits hitherto thought to be exclusive for Phytophthora. A careful review of previous research is presented and it is highlighted that uniquely for downy mildews, Poakatesthia may form an intracellular mycelium, growing through several host cells. In addition, scanning electron microscopy reveals that sporangiophore growth is not determinate in Viennotia and that outgrowth from sporangiophores is very similar to Phytophthora infestans. It is concluded that the sharp morphological distinction between downy mildews and Phytophthora species (that are often placed in separate families and even different orders), is rather artificial, since all features thought to be exclusive to Phytophthora or the downy mildews are united in the rare grass-parasitizing down mildew genera Viennotia and Poakatesthia and the enigmatic genus Sclerophthora. Therefore, several paradigms regarding the distinction between Phytophthora and the downy mildews need to be reconsidered.	[Thines, Marco] Univ Hohenheim, Inst Bot, D-7000 Stuttgart, Germany	University Hohenheim	Thines, M (corresponding author), Univ Hohenheim, Inst Bot, D-7000 Stuttgart, Germany.	thines@uni-hohenheim.de	Thines, Marco/H-1685-2011		German Science Foundation; Elite Program for Post-Docs of the Landesstiftung Baden-Wurttemberg	German Science Foundation(German Research Foundation (DFG)); Elite Program for Post-Docs of the Landesstiftung Baden-Wurttemberg	This study has been funded by grants from the German Science Foundation and the Elite Program for Post-Docs of the Landesstiftung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bary De, 1863, ANN SCI NAT BOT BIOL, V20, P5; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; DICK MW, 1984, BOT J LINN SOC, V89, P171, DOI 10.1111/j.1095-8339.1984.tb01008.x; Dick MW, 2001, STRAMINIPILOUS FUNGI; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FRAYMOUTH JOAN, 1956, TRANS BRIT MYCOL SOC, V39, P79; FRY WE, 1992, ANNU REV PHYTOPATHOL, V30, P107, DOI 10.1146/annurev.py.30.090192.000543; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2003, CAN J BOT, V81, P672, DOI [10.1139/b03-066, 10.1139/B03-066]; GOKER M, 2006, GERM C BIOINF 2006 T; Greenshields DL, 2008, CURR BIOL, V18, pR128, DOI 10.1016/j.cub.2007.11.064; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kenneth RG., 1981, DOWNY MILDEWS, P367; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; NOVOTELNOVA, 1966, MUCHNISTAYA ROSA POS; Parniske M, 2000, CURR OPIN PLANT BIOL, V3, P320, DOI 10.1016/S1369-5266(00)00088-1; PAYAK MM, 1967, PHYTOPATHOLOGY, V57, P394; Qutob D, 2000, PLANT PHYSIOL, V123, P243, DOI 10.1104/pp.123.1.243; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Ristaino JB, 2002, MICROBES INFECT, V4, P1369, DOI 10.1016/S1286-4579(02)00010-2; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Ryley MJ, 2001, AUST J BOT, V49, P487, DOI 10.1071/BT00088; Saccardo PA, 1890, HEDWIGIA, V29, P154; Sasabe M, 2000, EUR J BIOCHEM, V267, P5005, DOI 10.1046/j.1432-1327.2000.01553.x; SHAW CG, 1978, MYCOLOGIA, V70, P594, DOI 10.2307/3759397; Shaw CG, 1981, DOWNY MILDEWS, P17; TANAKA I., 1940, Annals of the Phytopathological Society of Japan, V10, P127; TAVEL F, 1892, VERGLEICHENDE MORPHO; Thines M, 2008, MYCOL RES, V112, P345, DOI 10.1016/j.mycres.2007.10.010; Thines M, 2007, MYCOL RES, V111, P1377, DOI 10.1016/j.mycres.2007.09.006; Thines M, 2006, MYCOTAXON, V97, P195; Thines M, 2006, MYCOL RES, V110, P646, DOI 10.1016/j.mycres.2006.04.001; THIRUMALACHAR M. J., 1953, Bulletin of the Torrey Botanical Club, V80, P299, DOI 10.2307/2481765; TIPPETT JT, 1976, ARCH MICROBIOL, V108, P231, DOI 10.1007/BF00454847; TIWARI MM, 1969, SCIENCE, V163, P291, DOI 10.1126/science.163.3864.291; Tokura R, 1975, TROP AGRIC RES SER, V8, P57; Waterhouse GM, 1963, 92 CMI; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	41	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4790	10.1371/journal.pone.0004790	http://dx.doi.org/10.1371/journal.pone.0004790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274081	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496000026
J	Shajahan, TK; Nayak, AR; Pandit, R				Shajahan, T. K.; Nayak, Alok Ranjan; Pandit, Rahul			Spiral-Wave Turbulence and Its Control in the Presence of Inhomogeneities in Four Mathematical Models of Cardiac Tissue	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; IONIC CURRENTS; BREAKUP; OBSTACLE; CHAOS; HETEROGENEITY; ELIMINATION; TACHYCARDIA; ATTACHMENT; MOVEMENT	Regular electrical activation waves in cardiac tissue lead to the rhythmic contraction and expansion of the heart that ensures blood supply to the whole body. Irregularities in the propagation of these activation waves can result in cardiac arrhythmias, like ventricular tachycardia (VT) and ventricular fibrillation (VF), which are major causes of death in the industrialised world. Indeed there is growing consensus that spiral or scroll waves of electrical activation in cardiac tissue are associated with VT, whereas, when these waves break to yield spiral- or scroll-wave turbulence, VT develops into life-threatening VF: in the absence of medical intervention, this makes the heart incapable of pumping blood and a patient dies in roughly two-and-a-half minutes after the initiation of VF. Thus studies of spiral- and scroll-wave dynamics in cardiac tissue pose important challenges for in vivo and in vitro experimental studies and for in silico numerical studies of mathematical models for cardiac tissue. A major goal here is to develop low-amplitude defibrillation schemes for the elimination of VT and VF, especially in the presence of inhomogeneities that occur commonly in cardiac tissue. We present a detailed and systematic study of spiral- and scroll-wave turbulence and spatiotemporal chaos in four mathematical models for cardiac tissue, namely, the Panfilov, Luo-Rudy phase 1 (LRI), reduced Priebe-Beuckelmann (RPB) models, and the model of ten Tusscher, Noble, Noble, and Panfilov (TNNP). In particular, we use extensive numerical simulations to elucidate the interaction of spiral and scroll waves in these models with conduction and ionic inhomogeneities; we also examine the suppression of spiral- and scroll-wave turbulence by low-amplitude control pulses. Our central qualitative result is that, in all these models, the dynamics of such spiral waves depends very sensitively on such inhomogeneities. We also study two types of control schemes that have been suggested for the control of spiral turbulence, via low amplitude current pulses, in such mathematical models for cardiac tissue; our investigations here are designed to examine the efficacy of such control schemes in the presence of inhomogeneities. We find that a local pulsing scheme does not suppress spiral turbulence in the presence of inhomogeneities; but a scheme that uses control pulses on a spatially extended mesh is more successful in the elimination of spiral turbulence. We discuss the theoretical and experimental implications of our study that have a direct bearing on defibrillation, the control of life-threatening cardiac arrhythmias such as ventricular fibrillation.	[Shajahan, T. K.; Nayak, Alok Ranjan; Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India; [Shajahan, T. K.] IISER, CET Campus, Thiruvananthapuram, Kerala, India; [Pandit, Rahul] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Shajahan, TK (corresponding author), Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India.	rahul@physics.iisc.ernet.in	Nayak, Alok Ranjan/AAF-1119-2020; Nayak, Alok/E-2979-2016; Shajahan, T K/AAG-4094-2019	Nayak, Alok/0000-0003-0102-0778; Shajahan, TK/0000-0001-5551-1324	Department of Science and Technology, India; University Grants Commission, India; Council for Scientific and Industrial Research (CSIR), India [fellowship]; Jawaharlal Nehru Centre for Advanced Scientific Research, India [fellowship]	Department of Science and Technology, India(Department of Science & Technology (India)); University Grants Commission, India(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Jawaharlal Nehru Centre for Advanced Scientific Research, India(Department of Science & Technology (India))	This study was supported by research grants from Department of Science and Technology, India and University Grants Commission, India. While this study was being conducted TKS was supported by research fellowships from the Council for Scientific and Industrial Research (CSIR), India and the Jawaharlal Nehru Centre for Advanced Scientific Research, India; ARN was also supported by a CSIR fellowship. Computational resources were also provided by SERC (IISc).	AGLADZE K, 1994, SCIENCE, V264, P1746, DOI 10.1126/science.264.5166.1746; ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; BECK CS, 1947, JAMA-J AM MED ASSOC, V135, P985, DOI 10.1001/jama.1947.62890150005007a; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; Biktashev VN, 1998, CHAOS, V8, P48, DOI 10.1063/1.166307; Biktashev VN, 1999, J ELECTROCARDIOL, V32, P76; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Christini DJ, 2002, CHAOS, V12, P732, DOI 10.1063/1.1504061; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; DAVIDENKO JM, 1990, P NATL ACAD SCI USA, V87, P8785, DOI 10.1073/pnas.87.22.8785; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Garfinkel A, 1997, J CLIN INVEST, V99, P305, DOI 10.1172/JCI119159; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Gray RA, 1996, INT J BIFURCAT CHAOS, V6, P415, DOI 10.1142/S0218127496000163; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hwang SM, 2005, P NATL ACAD SCI USA, V102, P10363, DOI 10.1073/pnas.0501539102; Ikeda T, 1997, CIRC RES, V81, P753; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; JALIFE J, 1998, CHAOS, V8, P5764; KARMA A, 1993, PHYS REV LETT, V71, P1103, DOI 10.1103/PhysRevLett.71.1103; Kim YH, 1997, J CLIN INVEST, V100, P2486, DOI 10.1172/JCI119791; KRISNSKY VI, 1966, BIOFIZIKA, V11, P676; Lim ZY, 2006, CIRCULATION, V114, P2113, DOI 10.1161/CIRCULATIONAHA.105.598631; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Nash MP, 2006, CIRCULATION, V114, P536, DOI 10.1161/CIRCULATIONAHA.105.602870; Osipov GV, 1998, PHYS REV E, V58, P6955, DOI 10.1103/PhysRevE.58.6955; Osipov GV, 1999, PHYS REV E, V60, P54, DOI 10.1103/PhysRevE.60.54; Pandit R, 2002, PHYSICA A, V306, P211, DOI 10.1016/S0378-4371(02)00499-5; PANFILOV A, 1993, PHYS LETT A, V176, P295, DOI 10.1016/0375-9601(93)90921-L; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; POOL R, 1990, SCIENCE, V247, P1294, DOI 10.1126/science.2315697; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Pumir A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208101; Qu ZL, 2000, ANN BIOMED ENG, V28, P755, DOI 10.1114/1.1289474; Rappel WJ, 1999, PHYS REV LETT, V83, P456, DOI 10.1103/PhysRevLett.83.456; SEPULVEDA NG, 1989, BIOPHYS J, V55, P987, DOI 10.1016/S0006-3495(89)82897-8; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Shajahan TK, 2003, INT J MOD PHYS B, V17, P5645, DOI 10.1142/S0217979203023318; SHAJAHAN TK, 2007, LIFE SCI SE IN PRESS; Shajahan TK, 2008, THESIS INDIAN I SCI; SHAJAHAN TK, 2005, P INDIAN NATL SCI A, V71, P4757; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; SRIDHAR S, 2008, EUROPHYSICS IN PRESS; Starobin JM, 1996, PHYS REV E, V54, P430, DOI 10.1103/PhysRevE.54.430; TACKER WA, 1968, ELECT DEFIBRILLATION; ten Tusscher KHWJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.062902; Ten Tusscher KHWJ, 2006, PROG BIOPHYS MOL BIO, V90, P326, DOI 10.1016/j.pbiomolbio.2005.05.015; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Valderrabano M, 2000, J AM COLL CARDIOL, V36, P2000, DOI 10.1016/S0735-1097(00)00941-4; Winfree AT, 2002, J BIOSCIENCES, V27, P465, DOI 10.1007/BF02705042; Winfree AT, 1998, CHAOS, V8, P1, DOI 10.1063/1.166306; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355; Xie FG, 2001, AM J PHYSIOL-HEART C, V280, pH535, DOI 10.1152/ajpheart.2001.280.2.H535; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134; ZYKOVE VS, 1980, BIOPHYSICS-USSR, V25, P940	64	61	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4738	10.1371/journal.pone.0004738	http://dx.doi.org/10.1371/journal.pone.0004738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270753	gold, Green Published, Green Submitted			2022-12-27	WOS:000265495900007
J	Delfosse, V; Girard, E; Birck, C; Delmarcelle, M; Delarue, M; Poch, O; Schultz, P; Mayer, C				Delfosse, Vanessa; Girard, Eric; Birck, Catherine; Delmarcelle, Michael; Delarue, Marc; Poch, Olivier; Schultz, Patrick; Mayer, Claudine			Structure of the Archaeal Pab87 Peptidase Reveals a Novel Self-Compartmentalizing Protease Family	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AMINOPEPTIDASE; PYROCOCCUS; PATHWAYS; SOFTWARE; SYSTEM	Self-compartmentalizing proteases orchestrate protein turnover through an original architecture characterized by a central catalytic chamber. Here we report the first structure of an archaeal member of a new self-compartmentalizing protease family forming a cubic-shaped octamer with D4 symmetry and referred to as CubicO. We solved the structure of the Pyrococcus abyssi Pab87 protein at 2.2 angstrom resolution using the anomalous signal of the high-phasing-power lanthanide derivative Lu-HPDO3A. A 20 angstrom wide channel runs through this supramolecular assembly of 0.4 MDa, giving access to a 60 angstrom wide central chamber holding the eight active sites. Surprisingly, activity assays revealed that Pab87 degrades specifically D-amino acid containing peptides, which have never been observed in archaea. Genomic context of the Pab87 gene showed that it is surrounded by genes involved in the amino acid/peptide transport or metabolism. We propose that CubicO proteases are involved in the processing of D-peptides from environmental origins.	[Delfosse, Vanessa; Mayer, Claudine] Univ Paris 06, INSERM, LRMA, Ctr Rech Cordeliers,UMR S 872, Paris, France; [Girard, Eric] UJF, CNRS, CEA, Inst Biol Structurale, UMR5075, Grenoble, France; [Birck, Catherine; Poch, Olivier; Schultz, Patrick] IGBMC, Dept Biol Genom Structurales, Illkirch Graffenstaden, France; [Delmarcelle, Michael] Univ Liege, Inst Chim B6, Ctr Ingenier Proteines, B-4000 Liege, Belgium; [Delarue, Marc; Mayer, Claudine] Inst Pasteur, CNRS, URA 2185, Dept Biol Structurale Chim, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Delfosse, V (corresponding author), Univ Paris 06, INSERM, LRMA, Ctr Rech Cordeliers,UMR S 872, Paris, France.	mayer@pasteur.fr		Girard, Eric/0000-0002-5758-6095; schultz, patrick/0000-0002-7310-6186; Delfosse, Vanessa/0000-0002-7436-7935	French Ministry of Research and higher education	French Ministry of Research and higher education	Vanessa Delfosse was supported by a scholarship from the French Ministry of Research and higher education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett AJ, 2007, BIOL CHEM, V388, P1151, DOI 10.1515/BC.2007.151; Bishop RE, 2000, BBA-PROTEIN STRUCT M, V1482, P73, DOI 10.1016/S0167-4838(00)00138-2; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Delfosse V, 2005, ACTA CRYSTALLOGR F, V61, P1006, DOI 10.1107/S1744309105033464; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1877, DOI 10.1107/S0907444903016871; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GRACY J, 1993, PROTEIN ENG, V6, P821, DOI 10.1093/protein/6.8.821; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; Jawhari A, 2006, EMBO REP, V7, P500, DOI 10.1038/sj.embor.7400663; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kecha M, 2007, EXTREMOPHILES, V11, P65, DOI 10.1007/s00792-006-0010-9; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Rasulova FS, 1998, FEBS LETT, V432, P179, DOI 10.1016/S0014-5793(98)00859-X; Remaut H, 2001, NAT STRUCT BIOL, V8, P674, DOI 10.1038/90380; Rockel B, 2005, P NATL ACAD SCI USA, V102, P10135, DOI 10.1073/pnas.0504569102; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; Schoehn G, 2006, J BIOL CHEM, V281, P36327, DOI 10.1074/jbc.M604417200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Vandeputte-Rutten L, 2002, CURR OPIN STRUC BIOL, V12, P704, DOI 10.1016/S0959-440X(02)00393-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walz J, 1999, J STRUCT BIOL, V128, P65, DOI 10.1006/jsbi.1999.4169; Yao TT, 1999, CURR BIOL, V9, pR551, DOI 10.1016/S0960-9822(99)80352-2	46	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4712	10.1371/journal.pone.0004712	http://dx.doi.org/10.1371/journal.pone.0004712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19266066	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490600022
J	Pages, F; Peyrefitte, CN; Mve, MT; Jarjaval, F; Brisse, S; Iteman, I; Gravier, P; Nkoghe, D; Grandadam, M				Pages, Frederic; Peyrefitte, Christophe N.; Mve, Medard Toung; Jarjaval, Fanny; Brisse, Sylvain; Iteman, Isabelle; Gravier, Patrick; Nkoghe, Dieudonne; Grandadam, Marc			Aedes albopictus Mosquito: The Main Vector of the 2007 Chikungunya Outbreak in Gabon	PLOS ONE			English	Article								The primary vector at the origin of the 2007 outbreak in Libreville, Gabon is identified as Aedes albopictus, trapped around the nearby French military camp. The Chikungunya virus was isolated from mosquitoes and found to be identical to the A226V circulating human strain. This is the first field study showing the role of the recently arrived species Aedes albopictus in Chikungunya virus transmission in Central Africa, and it demonstrates this species' role in modifying the epidemiological presentation of Chikungunya in Gabon.	[Pages, Frederic; Jarjaval, Fanny] Inst Trop Med, Serv Sante Armees, Unite Entomol Med, URMITE UMR 6236, Marseille, France; [Peyrefitte, Christophe N.; Gravier, Patrick; Grandadam, Marc] Inst Med Trop Serv Sante Armees, Unite Virol Trop, Marseille, France; [Mve, Medard Toung; Nkoghe, Dieudonne] Minist Sante Publ, Libreville, Gabon; [Brisse, Sylvain; Iteman, Isabelle] Inst Pasteur, Paris, France; [Gravier, Patrick] Serv Med du 6e BIMA, Libreville, Gabon	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pages, F (corresponding author), Inst Trop Med, Serv Sante Armees, Unite Entomol Med, URMITE UMR 6236, Marseille, France.	frederic_pages@yahoo.com	Brisse, Sylvain/M-8723-2013; GRANDADAM, Marc/GNP-7470-2022	Brisse, Sylvain/0000-0002-2516-2108; 	french surgeon general	french surgeon general	This work is supported by the french surgeon general. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, S AFR I MED RES; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Coffinet T, 2007, J AM MOSQUITO CONTR, V23, P471, DOI 10.2987/5636.1; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Edwards F.W., 1941, MOSQUITOES ETHIOPIAN; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; MATHIOT CC, 1990, AM J TROP MED HYG, V42, P386, DOI 10.4269/ajtmh.1990.42.386; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; Peyrefitte CN, 2008, J MED VIROL, V80, P430, DOI 10.1002/jmv.21090; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROSS R. W., 1956, JOUR HYG, V54, P177; SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262; Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; Vazeille M, 2008, TROP MED INT HEALTH, V13, P1176, DOI 10.1111/j.1365-3156.2008.02123.x; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; YIAUMINHUANG, 2004, ZOOTAXA, V700, P1	27	90	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4691	10.1371/journal.pone.0004691	http://dx.doi.org/10.1371/journal.pone.0004691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259263	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490500010
J	Dinkla, K; Talay, SR; Morgelin, M; Graham, RMA; Rohde, M; Nitsche-Schmitz, DP; Chhatwal, GS				Dinkla, Katrin; Talay, Susanne R.; Moergelin, Matthias; Graham, Rikki M. A.; Rohde, Manfred; Nitsche-Schmitz, D. Patric; Chhatwal, Gursharan S.			Crucial Role of the CB3-Region of Collagen IV in PARF-Induced Acute Rheumatic Fever	PLOS ONE			English	Article								Acute rheumatic fever (ARF) and rheumatic heart disease are serious autoimmune sequelae to infections with Streptococcus pyogenes. Streptococcal M-proteins have been implicated in ARF pathogenesis. Their interaction with collagen type IV (CIV) is a triggering step that induces generation of collagen-specific auto-antibodies. Electron microscopy of the protein complex between M-protein type 3 (M3-protein) and CIV identified two prominent binding sites of which one is situated in the CB3-region of CIV. In a radioactive binding assay, M3-protein expressing S. pyogenes and S. gordonii bound the CB3-fragment. Detailed analysis of the interactions by surface plasmon resonance measurements and site directed mutagenesis revealed high affinity interactions with dissociation constants in the nanomolar range that depend on the recently described collagen binding motif of streptococcal M-proteins. Because of its role in the induction of disease-related collagen autoimmunity the motif is referred to as "peptide associated with rheumatic fever'' (PARF). Both, sera of mice immunized with M3-protein as well as sera from patients with ARF contained anti-CB3 auto-antibodies, indicating their contribution to ARF pathogenesis. The identification of the CB3-region as a binding partner for PARF directs the further approaches to understand the unusual autoimmune pathogenesis of PARF-dependent ARF and forms a molecular basis for a diagnostic test that detects rheumatogenic streptococci.	[Dinkla, Katrin; Talay, Susanne R.; Graham, Rikki M. A.; Rohde, Manfred; Nitsche-Schmitz, D. Patric; Chhatwal, Gursharan S.] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Braunschweig, Germany; [Moergelin, Matthias] Lund Univ, BMC B14, Dept Clin Sci, Lund, Sweden	Helmholtz Association; Helmholtz-Center for Infection Research; Lund University	Dinkla, K (corresponding author), Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Braunschweig, Germany.	gsc@helmholtz-hzi.de			European Community's Sixth Framework Program [FP6-2004-INCO-DEV-3-032390]	European Community's Sixth Framework Program	This work was supported by a grant of the European Community's Sixth Framework Program under Contract No. FP6-2004-INCO-DEV-3-032390. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Dinkla K, 2007, J BIOL CHEM, V282, P18686, DOI 10.1074/jbc.M701047200; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Oggioni MR, 1996, GENE, V169, P85, DOI 10.1016/0378-1119(95)00775-X; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; *WHO, 2004, 923923 WHO	15	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4666	10.1371/journal.pone.0004666	http://dx.doi.org/10.1371/journal.pone.0004666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252743	Green Published, gold, Green Submitted			2022-12-27	WOS:000265489900008
J	Al-Ejeh, F; Darby, JM; Tsopelas, C; Smyth, D; Manavis, J; Brown, MP				Al-Ejeh, Fares; Darby, Jocelyn M.; Tsopelas, Chris; Smyth, Douglas; Manavis, Jim; Brown, Michael P.			APOMAB (R), a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy	PLOS ONE			English	Article								Background: Antineoplastic therapy may impair the survival of malignant cells to produce cell death. Consequently, direct measurement of tumor cell death in vivo is a highly desirable component of therapy response monitoring. We have previously shown that APOMAB (R) representing the DAB4 clone of a La/SSB-specific murine monoclonal autoantibody is a malignant cell-death ligand, which accumulates preferentially in tumors in an antigen-specific and dose-dependent manner after DNA-damaging chemotherapy. Here, we aim to image tumor uptake of APOMAB (R) (DAB4) and to define its biological correlates. Methodology/Principal Findings: Brisk tumor cell apoptosis is induced in the syngeneic EL4 lymphoma model after treatment of tumor-bearing mice with DNA-damaging cyclophosphamide/etoposide chemotherapy. Tumor and normal organ accumulation of Indium 111 (In-111)-labeled La-specific DAB4 mAb as whole IgG or IgG fragments was quantified by whole-body static imaging and organ assay in tumor-bearing mice. Immunohistochemical measurements of tumor caspase-3 activation and PARP-1 cleavage, which are indicators of early and late apoptosis, respectively, were correlated with tumor accumulation of DAB4. Increased tumor accumulation of DAB4 was associated directly with both the extent of chemotherapy-induced tumor cell death and DAB4 binding per dead tumor cell. Tumor DAB4 accumulation correlated with cumulative caspase-3 activation and PARP-1 cleavage as tumor biomarkers of apoptosis and was directly related to the extended median survival time of tumor-bearing mice. Conclusions/Significance: Radiolabeled La-specific monoclonal antibody, DAB4, detected dead tumor cells after chemotherapy, rather than chemosensitive normal tissues of gut and bone marrow. DAB4 identified late apoptotic tumor cells in vivo. Hence, radiolabeled DAB4 may usefully image responses to human carcinoma therapy because DAB4 would capture the protracted cell death of carcinoma. We believe that the ability of radiolabeled DAB4 to rapidly assess the apoptotic tumor response and, consequently, to potentially predict extended survival justifies its future clinical development as a radioimmunoscintigraphic agent. This article is part I of a two-part series providing proof-of-concept for the the diagnostic and therapeutic use of a La-specific monoclonal antibody, the DAB4 clone of which is represented by the registered trademark, APOMAB (R).	[Al-Ejeh, Fares; Darby, Jocelyn M.; Brown, Michael P.] Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia; [Tsopelas, Chris; Smyth, Douglas] Royal Adelaide Hosp, Dept Nuclear Med, Adelaide, SA, Australia; [Manavis, Jim] Hanson Inst, Ctr Neurol Dis, Adelaide, SA, Australia; [Brown, Michael P.] Univ Adelaide, Royal Adelaide Hosp Canc Ctr, Dept Med Oncol, Adelaide, SA 5005, Australia; [Brown, Michael P.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia	Hanson Institute; Royal Adelaide Hospital; Hanson Institute; Royal Adelaide Hospital; University of Adelaide; University of Adelaide	Al-Ejeh, F (corresponding author), Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia.	michael.brown@health.sa.gov.au	Al-Ejeh, Fares/M-7032-2016; Brown, Michael/C-2081-2014	Al-Ejeh, Fares/0000-0002-1553-0077; Darby, Jocelyn/0000-0002-1819-6000; Brown, Michael/0000-0002-5796-1932	Oncaidia Ltd; National Health and Medical Research Council Research [ID511303]	Oncaidia Ltd; National Health and Medical Research Council Research	Oncaidia Ltd funded the salary of FA for 2007, the salary of JMD as well as equipment and research. National Health and Medical Research Council Research also supplied funding through Project Grant ID511303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5519S, DOI 10.1158/1078-0432.CCR-07-0964; Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; ALEJEH F, NUCL MED BI IN PRESS; Ayukawa K, 2000, J BIOL CHEM, V275, P34465, DOI 10.1074/jbc.M003673200; BEHR TM, 1995, CANCER RES, V55, P3825; Belhocine T, 2004, TECHNOL CANCER RES T, V3, P23, DOI 10.1177/153303460400300103; Biggiogera M, 2004, BIOL CELL, V96, P603, DOI 10.1016/j.biolcel.2004.04.013; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; CARMOFONSECA M, 1989, EXP CELL RES, V185, P73, DOI 10.1016/0014-4827(89)90038-4; Chang J, 2000, CANCER-AM CANCER SOC, V89, P2145, DOI 10.1002/1097-0142(20001201)89:11<2145::AID-CNCR1>3.0.CO;2-S; Corsten MF, 2006, CANCER RES, V66, P1255, DOI 10.1158/0008-5472.CAN-05-3000; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Davis DW, 2003, CLIN CANCER RES, V9, P955; El-Deiry WS, 2006, J CLIN ONCOL, V24, P3261, DOI 10.1200/JCO.2006.06.5623; Green AM, 2002, CANCER J, V8, P82, DOI 10.1097/00130404-200203000-00002; Gwyther SJ, 2006, EUR J NUCL MED MOL I, V33, pS11, DOI 10.1007/s00259-006-0130-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kahlem P, 2004, J CLIN INVEST, V113, P169, DOI 10.1172/JCI200420784; Kartachova M, 2007, J CLIN ONCOL, V25, P2534, DOI 10.1200/JCO.2006.10.1337; Kelloff GJ, 2005, CLIN CANCER RES, V11, P7967, DOI 10.1158/1078-0432.CCR-05-1302; Kenan DJ, 2004, NAT STRUCT MOL BIOL, V11, P303, DOI 10.1038/nsmb0404-303; Larson SM, 2006, J NUCL MED, V47, P901; Leers MPG, 2002, CELL MOL LIFE SCI, V59, P1358, DOI 10.1007/s00018-002-8513-8; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mason KA, 1999, INT J RADIAT ONCOL, V44, P1125, DOI 10.1016/S0360-3016(99)00134-0; Neufing PJ, 2005, ARTHRITIS RHEUM-US, V52, P3934, DOI 10.1002/art.21486; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Shankar LK, 2006, J NUCL MED, V47, P1059; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Thiede B, 2004, MASS SPECTROM REV, V23, P333, DOI 10.1002/mas.10079; Tran HB, 2002, ARTHRITIS RHEUM, V46, P202, DOI 10.1002/1529-0131(200201)46:1<202::AID-ART10062>3.0.CO;2-Y; Van den Abbeele AD, 2002, EUR J CANCER, V38, pS60, DOI 10.1016/S0959-8049(02)80604-9; Vand de Wiele C, 2003, J CLIN ONCOL, V21, P3483, DOI 10.1200/JCO.2003.12.096; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weber WA, 2008, NAT CLIN PRACT ONCOL, V5, P44, DOI 10.1038/ncponc0982; Weber WA, 2006, J CLIN ONCOL, V24, P3282, DOI 10.1200/JCO.2006.06.6068; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; White RJ, 2004, EUR J CANCER, V40, P21, DOI 10.1016/j.ejca.2003.09.027; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wood W, 2000, DEVELOPMENT, V127, P5245; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241	48	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4558	10.1371/journal.pone.0004558	http://dx.doi.org/10.1371/journal.pone.0004558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247492	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487800001
J	Iida, S; Miyagi, A; Aoki, S; Ito, M; Kadono, Y; Kosuge, K				Iida, Satoko; Miyagi, Atsuko; Aoki, Seishiro; Ito, Motomi; Kadono, Yasuro; Kosuge, Keiko			Molecular Adaptation of rbcL in the Heterophyllous Aquatic Plant Potamogeton	PLOS ONE			English	Article								Background: Heterophyllous aquatic plants show marked phenotypic plasticity. They adapt to environmental changes by producing different leaf types: submerged, floating and terrestrial leaves. By contrast, homophyllous plants produce only submerged leaves and grow entirely underwater. Heterophylly and submerged homophylly evolved under selective pressure modifying the species-specific optima for photosynthesis, but little is known about the evolutionary outcome of habit. Recent evolutionary analyses suggested that rbcL, a chloroplast gene that encodes a catalytic subunit of RuBisCO, evolves under positive selection in most land plant lineages. To examine the adaptive evolutionary process linked to heterophylly or homophylly, we analyzed positive selection in the rbcL sequences of ecologically diverse aquatic plants, Japanese Potamogeton. Principal Findings: Phylogenetic and maximum likelihood analyses of codon substitution models indicated that Potamogeton rbcL has evolved under positive Darwinian selection. The positive selection has operated specifically in heterophyllous lineages but not in homophyllous ones in the branch-site models. This suggests that the selective pressure on this chloroplast gene was higher for heterophyllous lineages than for homophyllous lineages. The replacement of 12 amino acids occurred at structurally important sites in the quaternary structure of RbcL, two of which (residue 225 and 281) were identified as potentially under positive selection. Conclusions/Significance: Our analysis did not show an exact relationship between the amino acid replacements and heterophylly or homophylly but revealed that lineage-specific positive selection acted on the Potamogeton rbcL. The contrasting ecological conditions between heterophyllous and homophyllous plants have imposed different selective pressures on the photosynthetic system. The increased amino acid replacement in RbcL may reflect the continuous fine-tuning of RuBisCO under varying ecological conditions.	[Iida, Satoko; Kosuge, Keiko] Kobe Univ, Res Ctr Environm Genom, Kobe, Hyogo, Japan; [Miyagi, Atsuko; Kadono, Yasuro] Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo, Japan; [Aoki, Seishiro; Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan	Kobe University; Kobe University; University of Tokyo	Iida, S (corresponding author), Kobe Univ, Res Ctr Inland Seas, Awaji, Hyogo, Japan.	iida@kobe-u.ac.jp	Miyagi, Atsuko/N-8621-2015	Miyagi, Atsuko/0000-0003-4314-6555; Iida, Satoko/0000-0002-2693-6996				ALBERT VA, 1994, ANN MO BOT GARD, V81, P534, DOI 10.2307/2399902; Amano M, 2008, BUNRUI, V8, P129; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arber A., 1920, WATER PLANTS STUDY A; Christin PA, 2008, MOL BIOL EVOL, V25, P2361, DOI 10.1093/molbev/msn178; Cook C.D.K., 1990, AQUATIC PLANT BOOK; COOK SA, 1968, EVOLUTION, V22, P496, DOI 10.1111/j.1558-5646.1968.tb03988.x; FROSTCHRISTENSEN H, 1995, AQUAT BOT, V51, P121, DOI 10.1016/0304-3770(95)00455-9; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOLADAY AS, 1980, PLANT PHYSIOL, V65, P331, DOI 10.1104/pp.65.2.331; Hutchinson G.E., 1975, TREATISE LIMNOLOGY, VIII; Iida S, 2004, AQUAT BOT, V80, P115, DOI 10.1016/j.aquabot.2004.08.005; Iida S, 2007, J PLANT RES, V120, P473, DOI 10.1007/s10265-007-0087-y; IKUSIMA I, 1972, SEITAIGAKUKOUZA 7 SU, V1; KADONO Y, 1982, BOT MAG TOKYO, V95, P63, DOI 10.1007/BF02493411; KADONO Y, 1984, Japanese Journal of Ecology, V34, P161; Kaplan Z, 2003, PLANT SYST EVOL, V239, P95, DOI 10.1007/s00606-002-0252-7; Kaplan Z, 2002, FOLIA GEOBOT, V37, P141, DOI 10.1007/BF02804229; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; Kellogg EA, 1997, AM J BOT, V84, P413, DOI 10.2307/2446015; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Larcher W., 1994, OKOPHYSIOLOGIE PFLAN; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; LES DH, 1983, RHODORA, V85, P301; Li GF, 2002, BIOCHEM BIOPH RES CO, V290, P1128, DOI 10.1006/bbrc.2001.6322; Lindqvist C, 2006, CLADISTICS, V22, P568, DOI 10.1111/j.1096-0031.2006.00124.x; Maberly SC, 2002, FUNCT PLANT BIOL, V29, P393, DOI 10.1071/PP01187; Magnin NC, 1997, PLANT PHYSIOL, V115, P1681, DOI 10.1104/pp.115.4.1681; Miller SR, 2003, MOL ECOL, V12, P1237, DOI 10.1046/j.1365-294X.2003.01831.x; Moreno J, 1999, J BIOL CHEM, V274, P26789, DOI 10.1074/jbc.274.38.26789; Nozaki H, 2002, J MOL EVOL, V55, P414, DOI 10.1007/s00239-002-2338-9; Parry MAJ, 2002, ANN BOT-LONDON, V89, P833, DOI 10.1093/aob/mcf103; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P169, DOI 10.1016/S0022-0981(00)00196-9; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; WIEGLEB G, 1988, Feddes Repertorium, V99, P249; WIEGLEB G, 1989, NORD J BOT, V9, P167, DOI 10.1111/j.1756-1051.1989.tb02112.x; Wolfe AD, 1997, PLANT MOL BIOL, V33, P965, DOI 10.1023/A:1005739223993; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; WOOTEN JW, 1970, J ECOL, V58, P233, DOI 10.2307/2258178; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	52	44	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4633	10.1371/journal.pone.0004633	http://dx.doi.org/10.1371/journal.pone.0004633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247501	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487800015
J	Bibby, TS; Zhang, YA; Chen, M				Bibby, Thomas S.; Zhang, Yinan; Chen, Min			Biogeography of Photosynthetic Light-Harvesting Genes in Marine Phytoplankton	PLOS ONE			English	Article							CHLOROPHYLL-PROTEIN COMPLEX; PROCHLOROCOCCUS ECOTYPES; ANTENNA RING; IRON LIMITATION; PHOTOSYSTEM-I; PACIFIC-OCEAN; EVOLUTION; GENOME; SYNECHOCOCCUS; DIVERSITY	Background: Photosynthetic light-harvesting proteins are the mechanism by which energy enters the marine ecosystem. The dominant prokaryotic photoautotrophs are the cyanobacterial genera Prochlorococcus and Synechococcus that are defined by two distinct light-harvesting systems, chlorophyll-bound protein complexes or phycobilin-bound protein complexes, respectively. Here, we use the Global Ocean Sampling (GOS) Project as a unique and powerful tool to analyze the environmental diversity of photosynthetic light-harvesting genes in relation to available metadata including geographical location and physical and chemical environmental parameters. Methods: All light-harvesting gene fragments and their metadata were obtained from the GOS database, aligned using ClustaIX and classified phylogenetically. Each sequence has a name indicative of its geographic location; subsequent biogeographical analysis was performed by correlating light-harvesting gene budgets for each GOS station with surface chlorophyll concentration. Conclusion/Significance: Using the GOS data, we have mapped the biogeography of light-harvesting genes in marine cyanobacteria on ocean-basin scales and show that an environmental gradient exists in which chlorophyll concentration is correlated to diversity of light-harvesting systems. Three functionally distinct types of light-harvesting genes are defined: (1) the phycobilisome (PBS) genes of Synechococcus; (2) the pcb genes of Prochlorococcus; and (3) the iron-stress-induced (isiA) genes present in some marine Synechococcus. At low chlorophyll concentrations, where nutrients are limited, the Pcb-type light-harvesting system shows greater genetic diversity; whereas at high chlorophyll concentrations, where nutrients are abundant, the PBS-type light-harvesting system shows higher genetic diversity. We interpret this as an environmental selection of specific photosynthetic strategy. Importantly, the unique light-harvesting system isiA is found in the iron-limited, high-nutrient low-chlorophyll region of the equatorial Pacific. This observation demonstrates the ecological importance of isiA genes in enabling marine Synechococcus to acclimate to iron limitation and suggests that the presence of this gene can be a natural biomarker for iron limitation in oceanic environments.	[Bibby, Thomas S.] Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton, Hants, England; [Bibby, Thomas S.; Zhang, Yinan; Chen, Min] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	NERC National Oceanography Centre; University of Sydney	Bibby, TS (corresponding author), Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton, Hants, England.	minchen@bio.usyd.edu.au	Bibby, Thomas/C-9159-2014	Bibby, Thomas/0000-0003-1743-473X; Chen, Min/0000-0001-8070-3248	Australian Research Council (ARC) [DP0878174, DP0665169]; University of Sydney, Australia; Natural Environment Research Council [NE/E009670/1] Funding Source: researchfish; NERC [NE/E009670/1] Funding Source: UKRI	Australian Research Council (ARC)(Australian Research Council); University of Sydney, Australia(University of Sydney); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Australian Research Council (ARC)(DP0878174) and (DP0665169) to Dr Chen. University of Sydney, Australia for providing an International Visiting Research Fellowship to Dr Bibby. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Bibby TS, 2001, NATURE, V413, P590, DOI 10.1038/35098153; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; CAMPBELL L, 1993, DEEP-SEA RES PT I, V40, P2043, DOI 10.1016/0967-0637(93)90044-4; Chen M, 2005, PHOTOSYNTH RES, V86, P165, DOI 10.1007/s11120-005-1330-9; Chen M, 2008, PHOTOSYNTH RES, V95, P147, DOI 10.1007/s11120-007-9255-0; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Everroad RC, 2006, J PHYCOL, V42, P1300, DOI 10.1111/j.1529-8817.2006.00282.x; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; GEIDER RJ, 1996, LIMNOLOGY OCEANOGRAP, V43, P679; Geiss U, 2001, APPL ENVIRON MICROB, V67, P5247; GOERICKE R, 1993, DEEP-SEA RES PT I, V40, P2283, DOI 10.1016/0967-0637(93)90104-B; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hess WR, 2001, PHOTOSYNTH RES, V70, P53, DOI 10.1023/A:1013835924610; HESSWR, 1996, P NATL ACAD SCI USA, V93, P11126; Heywood JL, 2006, DEEP-SEA RES PT II, V53, P1530, DOI 10.1016/j.dsr2.2006.05.005; Hopkinson BM, 2008, LIMNOL OCEANOGR, V53, P1303, DOI 10.4319/lo.2008.53.4.1303; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutchins DA, 1998, LIMNOL OCEANOGR, V43, P1037, DOI 10.4319/lo.1998.43.6.1037; Jensen PR, 2008, ANTON LEEUW INT J G, V94, P51, DOI 10.1007/s10482-008-9239-x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Partensky F, 2003, ADV PHOTO RESPIRAT, V14, P29; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Ting CS, 2001, MICROBIOL-SGM, V147, P3171, DOI 10.1099/00221287-147-11-3171; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang RR, 2008, SMART STRUCT SYST, V4, P1; Zhang YN, 2007, J MOL EVOL, V64, P321, DOI 10.1007/s00239-006-0058-2; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	53	37	37	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4601	10.1371/journal.pone.0004601	http://dx.doi.org/10.1371/journal.pone.0004601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240807	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000278086700016
J	Kovas, Y; Giampietro, V; Viding, E; Ng, V; Brammer, M; Barker, GJ; Happe, FGE; Plomin, R				Kovas, Yulia; Giampietro, Vincent; Viding, Essi; Ng, Virginia; Brammer, Michael; Barker, Gareth J.; Happe, Francesca G. E.; Plomin, Robert			Brain Correlates of Non-Symbolic Numerosity Estimation in Low and High Mathematical Ability Children	PLOS ONE			English	Article							INTRAPARIETAL SULCUS; NUMBER; MAGNITUDE; REPRESENTATIONS; DYSCALCULIA; ACTIVATION; ORIGINS; CORTEX; ADULTS; SIZE	Previous studies have implicated several brain areas as subserving numerical approximation. Most studies have examined brain correlates of adult numerical approximation and have not considered individual differences in mathematical ability. The present study examined non-symbolic numerical approximation in two groups of 10-year-olds: Children with low and high mathematical ability. The aims of this study were to investigate the brain mechanisms associated with approximate numerosity in children and to assess whether individual differences in mathematical ability are associated with differential brain correlates during the approximation task. The results suggest that, similarly to adults, multiple and distributed brain areas are involved in approximation in children. Despite equal behavioral performance, there were differences in the brain activation patterns between low and high mathematical ability groups during the approximation task. This suggests that individual differences in mathematical ability are reflected in differential brain response during approximation.	Kings Coll London, Inst Psychiat, London WC2R 2LS, England; UCL, Div Psychol & Language Sci, London WC1E 6BT, England; Univ London, Dept Psychol, London WC1E 7HU, England	University of London; King's College London; University of London; University College London; University of London	Kovas, Y (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	y.kovas@iop.kcl.ac.uk	Barker, Gareth J/C-9616-2009; Kovas, Yulia/L-7116-2019; Plomin, Robert/B-8911-2008; Brammer, Michael J/B-7128-2012; Giampietro, Vincent P/D-1279-2011	Barker, Gareth J/0000-0002-5214-7421; Kovas, Yulia/0000-0001-9633-6374; Brammer, Michael J/0000-0001-9800-2052; Giampietro, Vincent P/0000-0002-9381-8201; Viding, Essi/0000-0001-8468-8874; Plomin, Robert/0000-0002-0756-3629; Happe, Francesca/0000-0001-9226-4000	U.K. Medical Research Council [G9424799, G050079]; US National Institute of Child Health and Human Development; Office of Special Education and Rehabilitative Services [HD 46167]; Medical Research Council [G9817803B, G0500079, G19/2] Funding Source: researchfish; MRC [G19/2, G0500079] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046167] Funding Source: NIH RePORTER	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Special Education and Rehabilitative Services; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	TEDS has been funded since 1995 by a programme grant from the U.K. Medical Research Council (G9424799, now G050079). Our work on mathematics is supported in part by the US National Institute of Child Health and Human Development and the Office of Special Education and Rehabilitative Services (HD 46167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; BRAMMER M, 2007, XBAM V3 4 METHOD; BRAMMER M, 2005, XBAM V3 4 MANUAL; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Kovas Y, 2007, J LEARN DISABIL-US, V40, P554, DOI 10.1177/00222194070400060601; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Kucian K, 2005, PSYCHOL SCI, V47, P112; Kucian Karin, 2006, Behav Brain Funct, V2, P31; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Price GR, 2007, CURR BIOL, V17, pR1042, DOI 10.1016/j.cub.2007.10.013; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005	22	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4587	10.1371/journal.pone.0004587	http://dx.doi.org/10.1371/journal.pone.0004587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KW	19238205	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265487400016
J	Ruas, LP; Bernardes, ES; Fermino, ML; de Oliveira, LL; Hsu, DK; Liu, FT; Chammas, R; Roque-Barreira, MC				Ruas, Luciana Pereira; Bernardes, Emerson Soares; Fermino, Marise Lopes; de Oliveira, Leandro Licursi; Hsu, Daniel K.; Liu, Fu-Tong; Chammas, Roger; Roque-Barreira, Maria-Cristina			Lack of Galectin-3 Drives Response to Paracoccidioides brasiliensis toward a Th2-Biased Immunity	PLOS ONE			English	Article								There is recent evidence that galectin-3 participates in immunity to infections, mostly by tuning cytokine production. We studied the balance of Th1/Th2 responses to P. brasiliensis experimental infection in the absence of galectin-3. The intermediate resistance to the fungal infection presented by C57BL/6 mice, associated with the development of a mixed type of immunity, was replaced with susceptibility to infection and a Th2-polarized immune response, in galectin-3-deficient (gal3(-/-)) mice. Such a response was associated with defective inflammatory and delayed type hypersensitivity (DTH) reactions, high IL-4 and GATA-3 expression and low nitric oxide production in the organs of infected animals. Gal3(-/-) macrophages exhibited higher TLR2 transcript levels and IL-10 production compared to wild-type macrophages after stimulation with P. brasiliensis antigens. We hypothesize that, during an in vivo P. brasiliensis infection, galectin-3 exerts its tuning role on immunity by interfering with the generation of regulatory macrophages, thus hindering the consequent Th2-polarized type of response.	[Ruas, Luciana Pereira; Bernardes, Emerson Soares; Fermino, Marise Lopes; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, Brazil; [de Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA USA; [Chammas, Roger] Univ Sao Paulo, Fac Med, Lab Oncol Expt, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Vicosa; University of California System; University of California Davis; Universidade de Sao Paulo	Ruas, LP (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, Brazil.	mcrbarre@fmrp.usp.br	Roque-Barreira, Maria-Cristina/A-4552-2008; Ruas, Luciana/A-4259-2013; Chammas, Roger/A-8004-2011; Bernardes, Emerson Soares/D-3711-2017; de Oliveira, Leandro Licursi/D-3616-2009; Liu, FU-TONG/A-5749-2019	Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Ruas, Luciana/0000-0002-1028-7872; Chammas, Roger/0000-0003-0342-8726; Bernardes, Emerson Soares/0000-0002-0029-7313; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Liu, FU-TONG/0000-0002-3354-1001	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [scholarship]; Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq). L.P.R. is a PhD student with a scholarship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda C, 2004, INFECT IMMUN, V72, P3932, DOI 10.1128/IAI.72.7.3932-3940.2004; Bernardes ES, 2006, AM J PATHOL, V168, P1910, DOI 10.2353/ajpath.2006.050636; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Burger E, 1996, AM J TROP MED HYG, V55, P235, DOI 10.4269/ajtmh.1996.55.235; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P585; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; de Brito T, 1994, Rev Inst Med Trop Sao Paulo, V36, P185, DOI 10.1590/S0036-46651994000200016; Fava Netto C, 1969, REV INST MED TROP SP, V11, P177; FAZIOLI RD, 1994, MYCOPATHOLOGIA, V126, P137, DOI 10.1007/BF01103767; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Ferreira KS, 2007, J INFECT DIS, V196, P1108, DOI 10.1086/521369; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; HO MK, 1982, J IMMUNOL, V128, P1221; HOSTETLER JS, 1993, CLIN EXP IMMUNOL, V94, P11, DOI 10.1111/j.1365-2249.1993.tb05969.x; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; KASHINO SS, 1995, MYCOPATHOLOGIA, V130, P131, DOI 10.1007/BF01103095; Kashino SS, 2000, J INTERF CYTOK RES, V20, P89, DOI 10.1089/107999000312766; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; MAGEE DM, 1995, INFECT IMMUN, V63, P3514, DOI 10.1128/IAI.63.9.3514-3519.1995; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; MIYAJI M, 1983, MYCOPATHOLOGIA, V82, P129, DOI 10.1007/BF00439218; MOSCARDIBACCHI M, 1994, J MED MICROBIOL, V40, P159, DOI 10.1099/00222615-40-3-159; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Pina A, 2004, INFECT IMMUN, V72, P2369, DOI 10.1128/IAI.72.4.2369-2378.2004; ROMANI L, 1992, J EXP MED, V176, P19, DOI 10.1084/jem.176.1.19; San-Blas G, 2005, J CLIN MICROBIOL, V43, P4255, DOI 10.1128/JCM.43.8.4255-4257.2005; SINGERVERMES LM, 1993, CLIN EXP IMMUNOL, V94, P75, DOI 10.1111/j.1365-2249.1993.tb05980.x; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	39	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4519	10.1371/journal.pone.0004519	http://dx.doi.org/10.1371/journal.pone.0004519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229338	gold, Green Published, Green Submitted			2022-12-27	WOS:000265486200006
J	Sellin, CI; Jegou, JF; Renneson, J; Druelle, J; Wild, TF; Marie, JC; Horvat, B				Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka			Interplay between Virus-Specific Effector Response and Foxp3(+) Regulatory T Cells in Measles Virus Immunopathogenesis	PLOS ONE			English	Article								Measles is a highly contagious childhood disease associated with an immunological paradox: although a strong virus-specific immune response results in virus clearance and the establishment of a life-long immunity, measles infection is followed by an acute and profound immunosuppression leading to an increased susceptibility to secondary infections and high infant mortality. In certain cases, measles is followed by fatal neurological complications. To elucidate measles immunopathology, we have analyzed the immune response to measles virus in mice transgenic for the measles virus receptor, human CD150. These animals are highly susceptible to intranasal infection with wild-type measles strains. Similarly to what has been observed in children with measles, infection of suckling transgenic mice leads to a robust activation of both T and B lymphocytes, generation of virus-specific cytotoxic T cells and antibody responses. Interestingly, Foxp3(+)CD25(+)CD4(+) regulatory T cells are highly enriched following infection, both in the periphery and in the brain, where the virus intensively replicates. Although specific anti-viral responses develop in spite of increased frequency of regulatory T cells, the capability of T lymphocytes to respond to virus-unrelated antigens was strongly suppressed. Infected adult CD150 transgenic mice crossed in an interferon receptor type I-deficient background develop generalized immunosuppression with an increased frequency of CD4(+)CD25(+)Foxp3(+) T cells and strong reduction of the hypersensitivity response. These results show that measles virus affects regulatory T-cell homeostasis and suggest that an interplay between virus-specific effector responses and regulatory T cells plays an important role in measles immunopathogenesis. A better understanding of the balance between measles-induced effector and regulatory T cells, both in the periphery and in the brain, may be of critical importance in the design of novel approaches for the prevention and treatment of measles pathology.	[Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] INSERM, U758, F-69008 Lyon, France; [Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] Ecole Normale Superieure Lyon, Lyon, France; [Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] IFR128 BioSci Lyon Gerland Lyon Sud, Lyon, France; [Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] Univ Lyon 1, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sellin, CI (corresponding author), INSERM, U758, F-69008 Lyon, France.	branka.horvat@inserm.fr	Marie, Julien/I-5084-2016; Horvat, Branka/M-3504-2014	Horvat, Branka/0000-0003-0578-7765; Marie, Julien/0000-0001-6713-7923; Jegou, Jean-Francois/0000-0002-9703-5976	INSERM; Fondation pour la Recherche Medicale (FRM); MRT; ARSEP	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); MRT; ARSEP	This work was supported by institutional grant from INSERM and by Fondation pour la Recherche Medicale (FRM). Coauthors were supported by FRM (CIS, JR), MRT (JD) and ARSEP (JFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2007, CIRCULATION, V116, P1707, DOI 10.1161/CIRCULATIONAHA.107.699470; ARNEBORN P, 1983, CLIN EXP IMMUNOL, V51, P165; ARNEBORN P, 1983, INFECT IMMUN, V39, P29, DOI 10.1128/IAI.39.1.29-37.1983; Atabani SF, 2001, J INFECT DIS, V184, P1, DOI 10.1086/321009; Avota E, 2001, NAT MED, V7, P725, DOI 10.1038/89106; BEAUVERGER P, 1993, J VIROL METHODS, V44, P199, DOI 10.1016/0166-0934(93)90055-V; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Beloeil L, 2003, J IMMUNOL, V171, P2995, DOI 10.4049/jimmunol.171.6.2995; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Coquerelle C, 2008, IMMUNOL LETT, V119, P12, DOI 10.1016/j.imlet.2008.05.005; Druelle J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-22; Evlashev A, 2001, J GEN VIROL, V82, P2125, DOI 10.1099/0022-1317-82-9-2125; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; GALAMA JMD, 1980, CELL IMMUNOL, V50, P405, DOI 10.1016/0008-8749(80)90294-4; GIRAUDON P, 1985, VIROLOGY, V144, P46, DOI 10.1016/0042-6822(85)90303-4; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; GRIFFIN DE, 1989, NEW ENGL J MED, V320, P1667, DOI 10.1056/NEJM198906223202506; GRIFFIN DE, 1986, CLIN IMMUNOL IMMUNOP, V40, P305, DOI 10.1016/0090-1229(86)90035-8; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; GRIFFIN DE, 1993, J INFECT DIS, V168, P275, DOI 10.1093/infdis/168.2.275; GRIFFIN DE, 1994, J INFECT DIS, V170, pS24, DOI 10.1093/infdis/170.Supplement_1.S24; Grosjean I, 1997, J EXP MED, V186, P801, DOI 10.1084/jem.186.6.801; Hahm B, 2004, VIROLOGY, V323, P292, DOI 10.1016/j.virol.2004.03.011; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Kerdiles YM, 2006, VIRAL IMMUNOL, V19, P324, DOI 10.1089/vim.2006.19.324; Kerdiles YM, 2006, REV MED VIROL, V16, P49, DOI 10.1002/rmv.486; Li Mei-Zhong, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P211; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Marie JC, 2001, IMMUNITY, V14, P69, DOI 10.1016/S1074-7613(01)00090-5; Marie JC, 2004, J VIROL, V78, P11952, DOI 10.1128/JVI.78.21.11952-11961.2004; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Moss WJ, 2002, J INFECT DIS, V186, P879, DOI 10.1086/344230; Okada H, 2000, ARCH VIROL, V145, P905, DOI 10.1007/s007050050683; Oldstone MBA, 2005, J EXP MED, V202, P1185, DOI 10.1084/jem.20051376; Patterson CE, 2003, J IMMUNOL, V171, P3102, DOI 10.4049/jimmunol.171.6.3102; Sato H, 2008, COMP IMMUNOL MICROB, V31, P25, DOI 10.1016/j.cimid.2007.03.003; Schlender J, 1996, P NATL ACAD SCI USA, V93, P13194, DOI 10.1073/pnas.93.23.13194; Schneider-Schaulies S, 2006, J GEN VIROL, V87, P1423, DOI 10.1099/vir.0.81713-0; Schnorr JJ, 1997, P NATL ACAD SCI USA, V94, P5326, DOI 10.1073/pnas.94.10.5326; Sellin CI, 2009, CURR TOP MICROBIOL, V330, P111; Sellin CI, 2006, J VIROL, V80, P6420, DOI 10.1128/JVI.00209-06; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Yu XL, 2008, J IMMUNOL, V181, P7356, DOI 10.4049/jimmunol.181.10.7356	48	28	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4948	10.1371/journal.pone.0004948	http://dx.doi.org/10.1371/journal.pone.0004948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319188	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499200007
J	Viaud, S; Terme, M; Flament, C; Taieb, J; Andre, F; Novault, S; Escudier, B; Robert, C; Caillat-Zucman, S; Tursz, T; Zitvogel, L; Chaput, N				Viaud, Sophie; Terme, Magali; Flament, Caroline; Taieb, Julien; Andre, Fabrice; Novault, Sophie; Escudier, Bernard; Robert, Caroline; Caillat-Zucman, Sophie; Tursz, Thomas; Zitvogel, Laurence; Chaput, Nathalie			Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15R alpha	PLOS ONE			English	Article							PEPTIDE-BASED VACCINE; REGULATORY T-CELLS; METASTATIC MELANOMA; CANCER REGRESSION; NK CELLS; IN-VIVO; CUTTING EDGE; RECEPTOR; TUMORS; RESPONSES	Dendritic cell (DC) derived-exosomes (Dex) are nanomeric vesicles harboring functional MHC/peptide complexes promoting T cell-dependent tumor rejection. In the first Phase I trial using peptide-pulsed Dex, the observation of clinical regressions in the absence of T cell responses prompted the search for alternate effector mechanisms. Mouse studies unraveled the bioactivity of Dex on NK cells. Indeed, Dex promoted an IL-15R alpha-and NKG2D-dependent NK cell proliferation and activation respectively, resulting in anti-metastatic effects mediated by NK1.1(+) cells. In humans, Dex express functional IL-15R alpha which allow proliferation and IFN gamma secretion by NK cells. In contrast to immature DC, human Dex harbor NKG2D ligands on their surface leading to a direct engagement of NKG2D and NK cell activation ex vivo. In our phase I clinical trial, we highlight the capacity of Dex based-vaccines to restore the number and NKG2D-dependent function of NK cells in 7/14 patients. Altogether, these data provide a mechanistic explanation on how Dex may stimulate non MHC restricted-anti-tumor effectors and induce tumor regression in vivo.	[Viaud, Sophie; Terme, Magali; Flament, Caroline; Taieb, Julien; Andre, Fabrice; Novault, Sophie; Zitvogel, Laurence; Chaput, Nathalie] Inst Natl Sante & Rech Med, Unite 805, Villejuif, France; [Viaud, Sophie; Terme, Magali; Flament, Caroline; Taieb, Julien; Andre, Fabrice; Novault, Sophie; Tursz, Thomas; Zitvogel, Laurence; Chaput, Nathalie] Inst Gustave Roussy, Villejuif, France; [Flament, Caroline; Zitvogel, Laurence; Chaput, Nathalie] Inst Gustave Roussy, Ctr Clin Investigat Biotherap, CICBT507, Villejuif, France; [Taieb, Julien] APHP, Hop Europeen Georges Pompidou, Dept Hepatogastroenterol, Paris, France; [Escudier, Bernard] Inst Gustave Roussy, Dept Immunother, Villejuif, France; [Robert, Caroline] Inst Gustave Roussy, Dept Dermatol, Villejuif, France; [Caillat-Zucman, Sophie] Hop St Vincent De Paul, Inst Natl Sante Rech Med, Unite 561, Paris, France; [Zitvogel, Laurence] Univ Paris Sud XI, Fac Med, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Viaud, S (corresponding author), Inst Natl Sante & Rech Med, Unite 805, Villejuif, France.	nathalie.chaput@igr.fr	TERME, Magali/GZK-9661-2022; Robert, Caroline/G-6157-2018; ANDRE, Fabrice/AAL-2683-2020	TERME, Magali/0000-0003-0857-7237; Robert, Caroline/0000-0002-9493-0238; ANDRE, Fabrice/0000-0001-5795-8357; Caillat-Zucman, Sophie/0000-0002-4535-3550; ZITVOGEL, laurence/0000-0003-1596-0998	AP-HP; ARC Institut Gustave Roussy; Young Investigator Award; ASCO 2002; EC Cell factory program project; ALLOSTEM European; Ligue labellisee contre le cancer; Canceropcle Ile de France;  [QLRT-2001-00093]	AP-HP; ARC Institut Gustave Roussy; Young Investigator Award; ASCO 2002; EC Cell factory program project; ALLOSTEM European; Ligue labellisee contre le cancer; Canceropcle Ile de France; 	QLRT-2001-00093, AP-HP, ARC Institut Gustave Roussy, the Young Investigator Award, ASCO 2002, the EC Cell factory program project, ALLOSTEM European grant, the Ligue labellisee contre le cancer and Canceropcle Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boon T, 2003, NEW ENGL J MED, V348, P252, DOI 10.1056/NEJMe020165; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Chaput N, 2004, J IMMUNOL, V172, P2137, DOI 10.4049/jimmunol.172.4.2137; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Chiong B, 2004, J IMMUNOTHER, V27, P368, DOI 10.1097/00002371-200409000-00005; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Coulie PG, 2001, P NATL ACAD SCI USA, V98, P10290, DOI 10.1073/pnas.161260098; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; Jager E, 2000, INT J CANCER, V86, P538; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kruit WHJ, 2005, INT J CANCER, V117, P596, DOI 10.1002/ijc.21264; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Osada T, 2006, CANCER IMMUNOL IMMUN, V55, P1122, DOI 10.1007/s00262-005-0089-3; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Palucka AK, 2003, J IMMUNOTHER, V26, P432, DOI 10.1097/00002371-200309000-00006; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Pilla L, 2006, CANCER IMMUNOL IMMUN, V55, P958, DOI 10.1007/s00262-005-0084-8; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6; Rosenberg SA, 2008, NEW ENGL J MED, V359, P1072, DOI 10.1056/NEJMc081511; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schuler-Thurner B, 2002, J EXP MED, V195, P1279, DOI 10.1084/jem.20012100; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Segura E, 2005, BLOOD CELL MOL DIS, V35, P89, DOI 10.1016/j.bcmd.2005.05.003; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Sprent J, 2005, BLOOD CELL MOL DIS, V35, P17, DOI 10.1016/j.bcmd.2005.04.004; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Taieb J, 2006, J IMMUNOL, V176, P2722, DOI 10.4049/jimmunol.176.5.2722; Terme M, 2004, J IMMUNOL, V172, P5957, DOI 10.4049/jimmunol.172.10.5957; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Theoret MR, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3032; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Viaud S, 2008, HORM METAB RES, V40, P82, DOI 10.1055/s-2007-1022548; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Watzl C, 2003, MICROBES INFECT, V5, P31, DOI 10.1016/S1286-4579(02)00057-6; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	79	296	309	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4942	10.1371/journal.pone.0004942	http://dx.doi.org/10.1371/journal.pone.0004942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319200	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499200006
J	Resendis-Antonio, O				Resendis-Antonio, Osbaldo			Filling Kinetic Gaps: Dynamic Modeling of Metabolism Where Detailed Kinetic Information Is Lacking	PLOS ONE			English	Article							ESCHERICHIA-COLI; HIGH-THROUGHPUT; ROBUSTNESS; SIMULATION; RECONSTRUCTION; METABOLOMICS; CELLS	Background: Integrative analysis between dynamical modeling of metabolic networks and data obtained from high throughput technology represents a worthy effort toward a holistic understanding of the link among phenotype and dynamical response. Even though the theoretical foundation for modeling metabolic network has been extensively treated elsewhere, the lack of kinetic information has limited the analysis in most of the cases. To overcome this constraint, we present and illustrate a new statistical approach that has two purposes: integrate high throughput data and survey the general dynamical mechanisms emerging for a slightly perturbed metabolic network. Methodology/Principal Findings: This paper presents a statistic framework capable to study how and how fast the metabolites participating in a perturbed metabolic network reach a steady-state. Instead of requiring accurate kinetic information, this approach uses high throughput metabolome technology to define a feasible kinetic library, which constitutes the base for identifying, statistical and dynamical properties during the relaxation. For the sake of illustration we have applied this approach to the human Red blood cell metabolism (hRBC) and its capacity to predict temporal phenomena was evaluated. Remarkable, the main dynamical properties obtained from a detailed kinetic model in hRBC were recovered by our statistical approach. Furthermore, robust properties in time scale and metabolite organization were identify and one concluded that they are a consequence of the combined performance of redundancies and variability in metabolite participation. Conclusions/Significance: In this work we present an approach that integrates high throughput metabolome data to define the dynamic behavior of a slightly perturbed metabolic network where kinetic information is lacking. Having information of metabolite concentrations at steady-state, this method has significant relevance due its potential scope to analyze others genome scale metabolic reconstructions. Thus, I expect this approach will significantly contribute to explore the relationship between dynamic and physiology in other metabolic reconstructions, particularly those whose kinetic information is practically nulls. For instances, I envisage that this approach can be useful in genomic medicine or pharmacogenomics, where the estimation of time scales and the identification of metabolite organization may be crucial to characterize and identify (dis)functional stages.	UNAM, Ctr Genom Sci, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Resendis-Antonio, O (corresponding author), UNAM, Ctr Genom Sci, Cuernavaca, Morelos, Mexico.	resendis@ccg.unam.mx	RESENDIS, OSBALDO/ADE-5280-2022	RESENDIS, OSBALDO/0000-0001-5220-541X	National Institute of Health [GM68837]; PAPITT-UNAM [IN203809]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068837] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PAPITT-UNAM(Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institute of Health Grant GM68837 and PAPITT-UNAM grant IN203809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AC, 2006, PLOS MED, V3, P956, DOI 10.1371/journal.pmed.0030209; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Bailey JE, 2001, NAT BIOTECHNOL, V19, P503, DOI 10.1038/89204; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Famili I, 2005, BIOPHYS J, V88, P1616, DOI 10.1529/biophysj.104.050385; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; Hardy BJ, 2008, NAT REV GENET, V9, pS23, DOI 10.1038/nrg2444; Heinrich R., 1996, REGULATION CELLULAR; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jamshidi N, 2001, BIOINFORMATICS, V17, P286, DOI 10.1093/bioinformatics/17.3.286; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Jamshidi N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000177; Jollife I. T., 2002, PRINCIPAL COMPONENT; Kauffman KJ, 2002, BIOPHYS J, V83, P646, DOI 10.1016/S0006-3495(02)75198-9; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Kinoshita A, 2007, J BIOL CHEM, V282, P10731, DOI 10.1074/jbc.M610717200; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Nakayama Y, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-18; Ni TC, 1996, J BIOL CHEM, V271, P7927, DOI 10.1074/jbc.271.14.7927; Palsson BO, 2004, CURR OPIN BIOTECH, V15, P50, DOI 10.1016/j.copbio.2004.01.006; PALSSON BO, 1987, CHEM ENG SCI, V42, P447, DOI 10.1016/0009-2509(87)80007-6; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; PRIGOGINE ISA, 1980, ADV CHEM PHYS, V43; REICH JG, 1981, ENERGY METABOLISM CE; Resendis-Antonio O, 2007, PLOS COMPUT BIOL, V3, P1887, DOI 10.1371/journal.pcbi.0030192; Rojas I, 2007, BMC SYST BIOL, DOI [DOI 10.1186/1752-0509-1-51-56, 10.1186/1752-0509-1-S1-S6, DOI 10.1186/1752-0509-1-S1-S6]; Rojas Isabel, 2007, In Silico Biology, V7, pS37; Santillan M, 2008, BIOPHYS J, V94, P2065, DOI 10.1529/biophysj.107.118026; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4967	10.1371/journal.pone.0004967	http://dx.doi.org/10.1371/journal.pone.0004967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305506	Green Published, gold, Green Submitted			2022-12-27	WOS:000265498800015
J	Cotter, LE; Chevrier, J; El-Nachef, WN; Radhakrishna, R; Rahangdale, L; Weiser, SD; Iacopino, V				Cotter, L. Emily; Chevrier, Jonathan; El-Nachef, Wael Noor; Radhakrishna, Rohan; Rahangdale, Lisa; Weiser, Sheri D.; Iacopino, Vincent			Health and Human Rights Education in US Schools of Medicine and Public Health: Current Status and Future Challenges	PLOS ONE			English	Article							CHI-SQUARED TESTS; GLOBAL HEALTH; PHYSICIANS; CONFLICTS; TABLES; CALL	Background: Despite increasing recognition of the importance of human rights in the protection and promotion of health, formal human rights education has been lacking in schools of medicine and public health. Our objectives were: 1) to determine the nature and extent of health and human rights (HHR) education among schools of medicine (SOMs) and public health (SPHs); 2) to identify perceived barriers to implementing HHR curricula; 3) to learn about deans' interests and attitudes toward HHR education, and; 4) to identify factors associated with offering HHR education. Methods and Principal Findings: We conducted a cross-sectional survey among deans of all accredited allopathic SOMs and SPHs in the United States and Puerto Rico. Seventy-one percent of U. S. SOMs and SPHs responded. Thirty-seven percent of respondents indicated that their schools offered some form of HHR education. Main barriers to offering HHR education included competition for time, lack of qualified instructors and lack of funding. Among schools not offering HHR education, 35% of deans were interested in offering HHR education. Seventy-six percent of all deans believed that it was very important or important to offer HHR education. Multiple regression analysis revealed that deans' attitudes were the most important factor associated with offering any HHR education. Conclusion: Findings indicate that though a majority of deans of SOMs and SPHs believe that knowledge about human rights is important in health practice and support the inclusion of HHR studies in their schools, HHR education is lacking at most of their institutions. These results and the growing recognition of the critical interdependence between health and human rights indicate a need for SOMs and SPHs to work towards formal inclusion of HHR studies in their curricula, and that HHR competency requirements be considered to overcome barriers to its inclusion.	[Cotter, L. Emily; Chevrier, Jonathan; Radhakrishna, Rohan; Iacopino, Vincent] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Cotter, L. Emily] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA; [El-Nachef, Wael Noor] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA; [Radhakrishna, Rohan] Univ Calif San Francisco, Div Hlth & Med Sci, Joint Med Program, San Francisco, CA 94143 USA; [Radhakrishna, Rohan] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rahangdale, Lisa] Stanford Univ, Med Ctr, Dept Obstet & Gynecol, Palo Alto, CA USA; [Weiser, Sheri D.] Univ Calif San Francisco, San Francisco Gen Hosp, Positive Hlth Program, San Francisco, CA 94143 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Iacopino, Vincent] Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA; [Iacopino, Vincent] Univ Minnesota, Sch Med, Dept Internal Med, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; George Washington University; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Stanford University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities	Cotter, LE (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	viacopino@aol.com						AHMED KA, 2003, ENV PROTECTION PUBLI; *AM PUBL HLTH ASS, 2005, PRINC PUBL HLTH HUM; American Medical Association, DECL PROF RESP MED S; Benatar SR, 2005, PERSPECT BIOL MED, V48, P344, DOI 10.1353/pbm.2005.0067; Benatar SR, 1998, AM J PUBLIC HEALTH, V88, P295, DOI 10.2105/AJPH.88.2.295; Beyrer C, 2007, LANCET, V370, P619, DOI 10.1016/S0140-6736(07)61301-4; Braveman P, 2003, B WORLD HEALTH ORGAN, V81, P539; Brenner, 1996, Health Hum Rights, V2, P129, DOI 10.2307/4065239; *BRIT MED ASS, 2001, MED PROF HUM RIGHTS; *CESCR, 2000, GEN COMM 14 ART 12 I; *COMM BUR REF EUR, 1994, GUID PROD CERT BCR R, P1; *CTR STUD HUM RIGH, 1994, UN DECL HUM RIGHTS 2; EASLEY CE, PERSPECTIVES HLTH HU; Farmer P, 1999, AM J PUBLIC HEALTH, V89, P1486, DOI 10.2105/AJPH.89.10.1486; FORROW L, 1997, WAR PUBLIC HLTH, P336; FOX D, COMMUNICATION; GEIGER HJ, 1993, JAMA-J AM MED ASSOC, V270, P616; Gruskin S, 1998, JAMA-J AM MED ASSOC, V280, P462; GRUSKIN S, 2000, HLTH HUMAN RIGHTS, P1; *HARV SCH PUBL HLT, PROGR INT HLTH; Iacopino V, 1996, JAMA-J AM MED ASSOC, V276, P396, DOI 10.1001/jama.276.5.396; Iacopino V, 1999, JAMA-J AM MED ASSOC, V282, P479, DOI 10.1001/jama.282.5.479; Iacopino V., 2002, HLTH HUMAN RIGHTS ED, P21; IACOPINO V, 1995, MED HLTH CARE 21 CEN, P376; Iacopino Vincent, 1999, WAR CRIMES KOSOVO PO; KIM JY, 2000, DYING GROWTH GLOBAL, P177; KNOX R, 1997, VT BASED MINE FOES A; Kuszler PC, 2007, ASIAN J WTO INT HEAL, V2, P99; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; MPINGA EK, 2006, REV MED SUISSE, V2, P1544; *OFF UN HIGH COMM, INT CONV EC SOC CULT; Panosian C, 2006, NEW ENGL J MED, V354, P1771, DOI 10.1056/NEJMp068035; PROCTOR RN, 1995, NAZI DOCTORS NUREMBE; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; RUBENSTEIN L, 2007, HUMAN RIGHTS IMPERAT; SILOVE D, 1990, SOC SCI MED, V30, P417, DOI 10.1016/0277-9536(90)90344-R; Sonis J, 1996, JAMA-J AM MED ASSOC, V276, P1676, DOI 10.1001/jama.276.20.1676; *UN GEN ASS, 2001, ARESS262 UN GEN ASS; UNESCO, 2005, UN DECL BIOETH HUM R; United Nations Development Programme (UNDP), 2007, HUMAN DEV REPORT 200; Wilks M, 2005, LANCET, V366, P429, DOI 10.1016/S0140-6736(05)67035-3; World Health Organization, 2003, WHO FRAM CONV TOB CO; *WORLD MED ASS, 1999, WORLD MED ASS RES IN; Yamin A E, 1997, J Am Med Womens Assoc (1972), V52, P169; 1998, JAMA, V280, P469	46	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4916	10.1371/journal.pone.0004916	http://dx.doi.org/10.1371/journal.pone.0004916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293936	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496600012
J	Srivastava, B; Blazejewska, P; Hessmann, M; Bruder, D; Geffers, R; Mauel, S; Gruber, AD; Schughart, K				Srivastava, Barkha; Blazejewska, Paulina; Hessmann, Manuela; Bruder, Dunja; Geffers, Robert; Mauel, Susanne; Gruber, Achim D.; Schughart, Klaus			Host Genetic Background Strongly Influences the Response to Influenza A Virus Infections	PLOS ONE			English	Article								The genetic make-up of the host has a major influence on its response to combat pathogens. For influenza A virus, several single gene mutations have been described which contribute to survival, the immune response and clearance of the pathogen by the host organism. Here, we have studied the influence of the genetic background to influenza A H1N1 (PR8) and H7N7 (SC35M) viruses. The seven inbred laboratory strains of mice analyzed exhibited different weight loss kinetics and survival rates after infection with PR8. Two strains in particular, DBA/2J and A/J, showed very high susceptibility to viral infections compared to all other strains. The LD50 to the influenza virus PR8 in DBA/2J mice was more than 1000-fold lower than in C57BL/6J mice. High susceptibility in DBA/2J mice was also observed after infection with influenza strain SC35M. In addition, infected DBA/2J mice showed a higher viral load in their lungs, elevated expression of cytokines and chemokines, and a more severe and extended lung pathology compared to infected C57BL/6J mice. These findings indicate a major contribution of the genetic background of the host to influenza A virus infections. The overall response in highly susceptible DBA/2J mice resembled the pathology described for infections with the highly virulent influenza H1N1-1918 and newly emerged H5N1 viruses.	[Srivastava, Barkha; Blazejewska, Paulina; Hessmann, Manuela; Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany; [Srivastava, Barkha; Blazejewska, Paulina; Hessmann, Manuela; Schughart, Klaus] Univ Vet Med Hannover, Braunschweig, Germany; [Bruder, Dunja] Helmholtz Ctr Infect Res, Res Grp Immunoregulat, Braunschweig, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany; [Mauel, Susanne; Gruber, Achim D.] Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, D-1000 Berlin, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Free University of Berlin	Srivastava, B (corresponding author), Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany.	kls@helmholtz-hzi.de	Gruber, Achim D./ABA-4514-2021	Schughart, Klaus/0000-0002-6824-7523	Helmholtz-Association (Program Infection and Immunity); FluResearchNet [01KI07137]; German Ministry of Education and Research; Georg-Christoph-Lichtenberg Foundation [PhD fellowship]	Helmholtz-Association (Program Infection and Immunity)(Helmholtz Association); FluResearchNet; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Georg-Christoph-Lichtenberg Foundation	This work was supported by intra-mural grants from the Helmholtz-Association (Program Infection and Immunity) and a research grant FluResearchNet (No. 01KI07137) from the German Ministry of Education and Research to KS. PB has obtained a PhD fellowship from the Georg-Christoph-Lichtenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Buer J, 2003, NAT REV GENET, V4, P195, DOI 10.1038/nrg1019; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Ding M, 2008, GENES BRAIN BEHAV, V7, P173, DOI 10.1111/j.1601-183X.2007.00335.x; DROEBNER K, 2008, J VIROL; Fadell SA, 2008, EUR J IMMUNOL, V38, P3376, DOI 10.1002/eji.200838628; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gottfredsson M, 2008, P NATL ACAD SCI USA, V105, P1303, DOI 10.1073/pnas.0707659105; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; HALLER O, 1976, INFECT IMMUN, V13, P844, DOI 10.1128/IAI.13.3.844-854.1976; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hollingsworth JW, 2007, IMMUNOGENETICS, V59, P713, DOI 10.1007/s00251-007-0242-6; JANEWAY GA, 2001, IMMUNOBIOLOGY; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lengeling A, 2001, MAMM GENOME, V12, P261, DOI 10.1007/s003350040001; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Marquis JF, 2008, CURR TOP MICROBIOL, V321, P27; Marquis JF, 2008, INFECT IMMUN, V76, P78, DOI 10.1128/IAI.00369-07; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Medina E, 2001, J INFECT DIS, V184, P846, DOI 10.1086/323292; Mitsos LM, 2000, GENES IMMUN, V1, P467, DOI 10.1038/sj.gene.6363712; Mitsos LM, 2003, P NATL ACAD SCI USA, V100, P6610, DOI 10.1073/pnas.1031727100; Murphy PM, 2000, PHARMACOL REV, V52, P145; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Rajagopal S, 2007, SEMIN RESP CRIT CARE, V28, P159, DOI 10.1055/s-2007-976488; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; STAMBAS J, 2008, PHARM THER; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Vanlaere I, 2008, CYTOKINE, V42, P62, DOI 10.1016/j.cyto.2008.01.013; Vidal SM, 2008, ANNU REV IMMUNOL, V26, P81, DOI 10.1146/annurev.immunol.26.021607.090304; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	59	143	148	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4857	10.1371/journal.pone.0004857	http://dx.doi.org/10.1371/journal.pone.0004857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293935	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496600005
J	Konig, P; Krain, B; Krasteva, G; Kummer, W				Koenig, Peter; Krain, Benjamin; Krasteva, Gabriela; Kummer, Wolfgang			Serotonin Increases Cilia-Driven Particle Transport via an Acetylcholine-Independent Pathway in the Mouse Trachea	PLOS ONE			English	Article								Background: Mucociliary clearance in the airways is driven by the coordinated beating of ciliated cells. Classical neuromediators such as noradrenalin and acetylcholine increase ciliary beat frequency and thus cilia-driven transport. Despite the fact that the neuromediator serotonin is ciliostimulatory in invertebrates and has been implied in releasing acetylcholine from the airway epithelium, its role in regulating cilia function in vertebrate airways is not established. Methodology/Principal Findings: We examined the effects of serotonin on ciliary beat frequency and cilia-driven particle transport in the acutely excised submerged mouse trachea and determined the sources of serotonin in this tissue by immunohistochemistry. Serotonin (100 mu M) increased cilary beat frequency (8.9+/-1.2 Hz to 17.0+/-2.7 Hz) and particle transport speed (38.9+/-4.6 mu m/s to 83.4+/-8.3 mu m/s) to an extent that was comparable to a supramaximal dose of ATP. The increase in particle transport speed was totally prevented by methysergide (100 mu M). Blockade of muscarinic receptors by atropine (1 mu M) did not reduce the effect of serotonin, although it was effective in preventing the increase in particle transport speed mediated by muscarine (100 mu M). Immunohistochemistry demonstrated serotonin in mast cells pointing towards mast cells and platelets as possible endogenous sources of serotonin. Conclusions/Significance: These results indicate that serotonin is a likely endogenous mediator that can increase cilia-driven transport independent from acetylcholine during activation of mast cells and platelets.	[Koenig, Peter] Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany; [Krain, Benjamin; Krasteva, Gabriela; Kummer, Wolfgang] Univ Giessen, Univ Giessen Lung Ctr, Inst Anat & Zellbiol, D-35390 Giessen, Germany	University of Lubeck; Justus Liebig University Giessen	Konig, P (corresponding author), Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany.	koenig@anat.uni-luebeck.de	Krasteva-Christ, Gabriela/K-7253-2015; Krasteva-Christ, Gabriela/CAI-9036-2022; König, Peter/AAK-2021-2020	Krasteva-Christ, Gabriela/0000-0002-0113-521X; Krasteva-Christ, Gabriela/0000-0002-0113-521X; Kummer, Wolfgang/0000-0002-3946-0683	Medizinische Fakultat der Universitat zu Lubeck [A31-2007, E21-2008]; Fachbereich Medizin der Justus-Liebig-Universitat Giessen; DFG, Excellence Cluster Cardiopulmonary System	Medizinische Fakultat der Universitat zu Lubeck; Fachbereich Medizin der Justus-Liebig-Universitat Giessen; DFG, Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG))	This work was supported by grants to PK from the Medizinische Fakultat der Universitat zu Lubeck (A31-2007; E21-2008), to GK from the Fachbereich Medizin der Justus-Liebig-Universitat Giessen, and by the DFG, Excellence Cluster Cardiopulmonary System (GK, WK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; ASKENASE PW, 1995, INT ARCH ALLERGY IMM, V107, P145, DOI 10.1159/000236958; Bai Y, 2007, AM J RESP CELL MOL, V36, P122, DOI 10.1165/rcmb.2006-0036OC; Christopher KJ, 1996, J EXP BIOL, V199, P1105; DOELLER JE, 1993, J EXP ZOOL, V265, P1, DOI 10.1002/jez.1402650102; Fernandez-Gonzalez A, 2009, AM J RESP CELL MOL, V40, P305, DOI 10.1165/rcmb.2008-0102OC; FORSSMANN WG, 1977, ANAT RECORD, V188, P307, DOI 10.1002/ar.1091880304; GOLDBERG JI, 1994, J NEUROBIOL, V25, P1545, DOI 10.1002/neu.480251207; GOSSELIN RE, 1961, J CELL COMPAR PHYSL, V58, P17, DOI 10.1002/jcp.1030580104; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Ikawati Z, 2000, EUR J PHARMACOL, V402, P297, DOI 10.1016/S0014-2999(00)00482-9; JOHNSON DE, 1989, AM REV RESPIR DIS, V140, P1807, DOI 10.1164/ajrccm/140.6.1807; KIMURA ET, 1959, ARCHIV OTOLARYNGOL, V69, P674; KLEIN MK, 2009, EUR RESP J IN PRESS; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KRUEGER AP, 1960, J GEN PHYSIOL, V43, P533, DOI 10.1085/jgp.43.3.533; Kummer W, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-65; Kushnir-Sukhov NM, 2007, J ALLERGY CLIN IMMUN, V119, P498, DOI 10.1016/j.jaci.2006.09.003; Lima C, 2007, CLIN EXP ALLERGY, V37, P723, DOI 10.1111/j.1365-2222.2007.02700.x; MacLean MR, 2000, BRIT J PHARMACOL, V131, P161, DOI 10.1038/sj.bjp.0703570; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Moffatt JD, 2004, BRIT J PHARMACOL, V141, P1159, DOI 10.1038/sj.bjp.0705720; Nagase T, 1996, J APPL PHYSIOL, V80, P583, DOI 10.1152/jappl.1996.80.2.583; Nam BD, 2006, PHYSIOL RES, V55, P397, DOI 10.33549/physiolres.930553; Nguyen T, 2001, J PHYSIOL-LONDON, V531, P131, DOI 10.1111/j.1469-7793.2001.0131j.x; Olivenstein R, 1997, PULM PHARMACOL THER, V10, P223, DOI 10.1006/pupt.1997.0095; Pitchford SC, 2006, CLIN EXP ALLERGY, V36, P399, DOI 10.1111/j.1365-2222.2006.02462.x; Ricciardolo FLM, 2000, AM J RESP CELL MOL, V22, P97, DOI 10.1165/ajrcmb.22.1.3706; Salathe M, 1997, AM J PHYSIOL-LUNG C, V272, pL301, DOI 10.1152/ajplung.1997.272.2.L301; TSUCHIYA M, 1959, FED PROC, V18, P453; Wada Y, 1997, J EXP BIOL, V200, P9; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; WASSERMAN SI, 1980, ENVIRON HEALTH PERSP, V35, P153, DOI 10.2307/3428985	33	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4938	10.1371/journal.pone.0004938	http://dx.doi.org/10.1371/journal.pone.0004938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290057	Green Submitted, gold, Green Published			2022-12-27	WOS:000265496500021
J	Bren, GD; Trushin, SA; Whitman, J; Shepard, B; Badley, AD				Bren, Gary D.; Trushin, Sergey A.; Whitman, Joe; Shepard, Brett; Badley, Andrew D.			HIV gp120 Induces, NF-kappa B Dependent, HIV Replication that Requires Procaspase 8	PLOS ONE			English	Article								Background: HIV envelope glycoprotein gp120 causes cellular activation resulting in anergy, apoptosis, proinflammatory cytokine production, and through an unknown mechanism, enhanced HIV replication. Methodology/Principal Findings: We describe that the signals which promote apoptosis are also responsible for the enhanced HIV replication. Specifically, we demonstrate that the caspase 8 cleavage fragment Caspase8p43, activates p50/p65 Nuclear Factor kappa B (NF-kappa B), in a manner which is inhibited by dominant negative IkB alpha. This caspase 8 dependent NF-kappa B activation occurs following stimulation with gp120, TNF, or CD3/CD28 crosslinking, but these treatments do not activate NFkB in cells deficient in caspase 8. The Casp8p43 cleavage fragment also transactivates the HIV LTR through NF-kappa B, and the absence of caspase 8 following HIV infection greatly inhibits HIV replication. Conclusion/Significance: Gp120 induced caspase 8 dependent NF-kappa B activation is a novel pathway of HIV replication which increases understanding of the biology of T-cell death, as well as having implications for understanding treatment and prevention of HIV infection.	[Bren, Gary D.; Trushin, Sergey A.; Whitman, Joe; Shepard, Brett; Badley, Andrew D.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Trushin, Sergey A.; Badley, Andrew D.] Mayo Clin, Program Translat Immunovirol & Biodefense, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Badley, AD (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	badley, andrew d/O-9022-2014	Badley, Andrew/0000-0001-7796-7680	NIH [R01 AI62261, R01 AI40384]; Burroughs Wellcome Award [1005160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261, R01AI040384] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: Dr. Andrew Badley is supported by the following grants: NIH R01 AI62261, R01 AI40384 and a Burroughs Wellcome Award ID #1005160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich Alicia, 2007, Open Virol J, V1, P39, DOI 10.2174/1874357900701010039; Asin S, 1999, J VIROL, V73, P3893, DOI 10.1128/JVI.73.5.3893-3903.1999; BADLEY AD, 2006, CELL DEATH HIV INFEC; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Bren GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002112; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cicala C, 2006, VIROLOGY, V345, P105, DOI 10.1016/j.virol.2005.09.052; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Lee S, 2002, MOL CELLS, V14, P348; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; MCELHINNY JA, 1995, J VIROL, V69, P1500, DOI 10.1128/JVI.69.3.1500-1509.1995; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Oakley JD, 2003, IUBMB LIFE, V55, P415, DOI 10.1080/1521654031000146768; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Roggero R, 2001, J VIROL, V75, P7637, DOI 10.1128/JVI.75.16.7637-7650.2001; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Takasawa R, 2005, APOPTOSIS, V10, P1121, DOI 10.1007/s10495-005-0901-8; Trushin SA, 2007, J IMMUNOL, V178, P4846, DOI 10.4049/jimmunol.178.8.4846; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4875	10.1371/journal.pone.0004875	http://dx.doi.org/10.1371/journal.pone.0004875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287489	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400016
J	Xing, LJ; Li, J; Xu, YY; Xu, ZH; Chong, K				Xing, Lijing; Li, Juan; Xu, Yunyuan; Xu, Zhihong; Chong, Kang			Phosphorylation Modification of Wheat Lectin VER2 Is Associated with Vernalization-Induced O-GlcNAc Signaling and Intracellular Motility	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINE; JACALIN-RELATED LECTINS; ARABIDOPSIS-THALIANA; NUCLEAR MIGRATION; NUCLEOCYTOPLASMIC PROTEINS; PREVACUOLAR COMPARTMENT; MOLECULAR-BASIS; BINDING LECTIN; ROOT HAIRS; POST-GOLGI	Background: O-linked b-N-acetylglucosamine (O-GlcNAc) modification of proteins mediates stress response and cellular motility in animal cells. The plant lectin concanavalin A can increase nuclear O-GlcNAc levels and decrease cytoplasmic O-GlcNAc levels in T lymphocytes. However, the functions of O-GlcNAc signaling in plants, as well as the relation between plant lectins and O-GlcNAc in response to environmental stimuli are largely undefined. Methodology/Principal Findings: We describe a jacalin-like lectin VER2 in wheat that shows N-acetylglucosamine and galactose specificity. Immunocytochemical localization showed VER2 expression induced predominantly at potential nuclear structures in shoot tips and young leaves and weakly in cytoplasm in response to vernalization. In contrast, under devernalization (continuous stimulation with a higher temperature after vernalization), VER2 signals appeared predominantly in cytoplasm. 2-D electrophoresis, together with western blot analysis, showed phosphorylation modification of VER2 under vernalization. Immunoblot assay with O-GlcNAc-specific antibody revealed that vernalization increased O-GlcNAc modification of proteins at the global level. An O-GlcNAc-modified protein co-immunoprecipitated with VER2 in vernalized wheat plants but not in devernalized materials. The dynamic of VER2 was observed in transgenic Arabidopsis overexpressing the VER2-GFP fusion protein. Overexpressed VER2 accelerated nuclear migration. Immunogold labeling and indirect immunofluoresence colocalization assay indicated that VER2-GFP was targeted to the secretory pathway. Conclusions/Significance: O-GlcNAc signaling is involved in the vernalization response in wheat, and phosphorylation is necessary for the lectin VER2 involving O-GlcNAc signaling during vernalization. Our findings open the way to studies of O-GlcNAc protein modification in response to environmental signals in plants.	[Xing, Lijing; Li, Juan; Xu, Yunyuan; Chong, Kang] Chinese Acad Sci, Inst Bot, Res Ctr Mol Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China; [Xu, Zhihong; Chong, Kang] Natl Ctr Plant Gene Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences	Chong, K (corresponding author), Chinese Acad Sci, Inst Bot, Res Ctr Mol Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China.	chongk@ibcas.ac.cn			National Natural Science Foundation of China NSFC [30470167]; National Science Foundation for Distinguished Young Scholars of China [30525026]; Major State Basic Research Program of the People's Republic of China [2007CB108700]	National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Major State Basic Research Program of the People's Republic of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (NSFC 30470167); the National Science Foundation for Distinguished Young Scholars of China (30525026); and the Major State Basic Research Program of the People's Republic of China (2007CB108700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmed SU, 2000, J CELL BIOL, V149, P1335, DOI 10.1083/jcb.149.7.1335; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BEDNAREK SY, 1990, PLANT CELL, V2, P1145, DOI 10.1105/tpc.2.12.1145; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Chen Y, 2002, FASEB J, V16, P905, DOI 10.1096/fj.01-0598fje; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Foresti O, 2006, PLANT CELL, V18, P2275, DOI 10.1105/tpc.105.040279; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Grunwald I, 2007, PLANTA, V226, P225, DOI 10.1007/s00425-006-0467-x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hartweck LM, 2006, J EXP BOT, V57, P865, DOI 10.1093/jxb/erj071; Hartweck LM, 2002, GENETICS, V161, P1279; HOLWERDA BC, 1992, PLANT CELL, V4, P307, DOI 10.1105/tpc.4.3.307; Holzinger A, 2002, CELL BIOL INT, V26, P689, DOI 10.1006/cbir.2002.0920; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Jiang JF, 2006, TOXICON, V47, P133, DOI 10.1016/j.toxicon.2005.10.010; KAMINSKYJ SGW, 1989, J CELL SCI, V94, P663; Kennard JL, 1997, CELL MOTIL CYTOSKEL, V36, P55; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; Kim SY, 2005, PLANT CELL, V17, P3301, DOI 10.1105/tpc.105.034645; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Kneass ZT, 2004, J BIOL CHEM, V279, P45759, DOI 10.1074/jbc.M407911200; Lannoo N, 2006, FEBS LETT, V580, P6329, DOI 10.1016/j.febslet.2006.10.044; Lefebvre T, 2001, BIOCHEM J, V360, P179, DOI 10.1042/0264-6021:3600179; Li YB, 2002, PLANT CELL PHYSIOL, V43, P726, DOI 10.1093/pcp/pcf085; Liu TY, 2002, J CELL SCI, V115, P1907; MADRID JF, 1994, HISTOCHEMISTRY, V101, P195, DOI 10.1007/BF00269544; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; OAKLEY BR, 1980, CELL, V19, P255, DOI 10.1016/0092-8674(80)90407-9; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; Peumans WJ, 2000, FEBS LETT, V477, P186, DOI 10.1016/S0014-5793(00)01801-9; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; RUHLAND W, 1965, HDB PFLANZENPHYSIOLO, P1479; Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Van Bruaene N, 2003, J MICROSC-OXFORD, V211, P167, DOI 10.1046/j.1365-2818.2003.01217.x; Van Damme EJM, 1999, EUR J BIOCHEM, V259, P135, DOI 10.1046/j.1432-1327.1999.00013.x; Van Damme EJM, 2004, TRENDS PLANT SCI, V9, P484, DOI 10.1016/j.tplants.2004.08.003; Van Damme EJM, 2003, GLYCOCONJUGATE J, V20, P449, DOI 10.1023/B:GLYC.0000038291.67527.a5; Van Damme EJM, 2002, PLANT PHYSIOL, V130, P757, DOI 10.1104/pp.005892; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Xing LJ, 2004, PROG BIOCHEM BIOPHYS, V31, P150; Yong WD, 2003, PLANTA, V217, P261, DOI 10.1007/s00425-003-0994-7; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang WL, 2000, PLANTA, V210, P970, DOI 10.1007/s004250050705	69	37	44	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4854	10.1371/journal.pone.0004854	http://dx.doi.org/10.1371/journal.pone.0004854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287503	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400011
J	Agrillo, C; Dadda, M; Serena, G; Bisazza, A				Agrillo, Christian; Dadda, Marco; Serena, Giovanna; Bisazza, Angelo			Use of Number by Fish	PLOS ONE			English	Article							NUMERICAL COMPETENCE; MACACA-MULATTA; NUMEROSITY DISCRIMINATION; QUANTITY DISCRIMINATION; INFANTS DISCRIMINATION; FEMALE MOSQUITOFISH; CONTINUOUS EXTENT; PAN-TROGLODYTES; CONTOUR LENGTH; CEBUS-APELLA	Background: Research on human infants, mammals, birds and fish has demonstrated that rudimentary numerical abilities pre-date the evolution of human language. Yet there is controversy as to whether animals represent numbers mentally or rather base their judgments on non-numerical perceptual variables that co-vary with numerosity. To date, mental representation of number has been convincingly documented only for a few mammals. Methodology/Principal Findings: Here we used a training procedure to investigate whether mosquitofish could learn to discriminate between two and three objects even when denied access to non-numerical information. In the first experiment, fish were trained to discriminate between two sets of geometric figures. These varied in shape, size, brightness and distance, but no control for non-numerical variables was made. Subjects were then re-tested while controlling for one non-numerical variable at a time. Total luminance of the stimuli and the sum of perimeter of figures appeared irrelevant, but performance dropped to chance level when stimuli were matched for the cumulative surface area or for the overall space occupied by the arrays, indicating that these latter cues had been spontaneously used by the fish during the learning process. In a second experiment, where the task consisted of discriminating 2 vs 3 elements with all non-numerical variables simultaneously controlled for, all subjects proved able to learn the discrimination, and interestingly they did not make more errors than the fish in Experiment 1 that could access non-numerical information in order to accomplish the task. Conclusions/Significance: Mosquitofish can learn to discriminate small quantities, even when non-numerical indicators of quantity are unavailable, hence providing the first evidence that fish, like primates, can use numbers. As in humans and non-human primates, genuine counting appears to be a 'last resort' strategy in fish, when no other perceptual mechanism may suggest the quantity of the elements. However, our data suggest that, at least in fish, the priority of perceptual over numerical information is not related to a greater cognitive load imposed by direct numerical computation.	[Agrillo, Christian; Dadda, Marco; Serena, Giovanna; Bisazza, Angelo] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Agrillo, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	christian.agrillo@unipd.it	Dadda, Marco/D-2417-2014; DADDA, Marco/ABI-7266-2020	DADDA, Marco/0000-0001-7944-4058; Bisazza, Angelo/0000-0003-0209-7638; Agrillo, Christian/0000-0002-7391-8934	Progetti di Ricerca di Ateneo [CPDA087853/08]	Progetti di Ricerca di Ateneo	This study was funded by "Progetti di Ricerca di Ateneo", No. CPDA087853/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2007, ETHOL ECOL EVOL, V19, P145, DOI 10.1080/08927014.2007.9522574; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2008, ETHOLOGY, V114, P479, DOI 10.1111/j.1439-0310.2008.01493.x; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beran MJ, 2008, J EXP PSYCHOL ANIM B, V34, P63, DOI 10.1037/0097-7403.34.1.63; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Binoy VV, 2004, CURR SCI INDIA, V86, P207; Brannon E. M., 2005, HDB MATH COGNITION; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Breukelaar JWC, 1998, J EXP PSYCHOL ANIM B, V24, P84, DOI 10.1037/0097-7403.24.1.84; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Cordes S, 2008, CHILD DEV, V79, P476, DOI 10.1111/j.1467-8624.2007.01137.x; DAVIS H, 1982, PSYCHOL BULL, V92, P547, DOI 10.1037/0033-2909.92.3.547; DURGIN FH, 1995, J EXP PSYCHOL HUMAN, V21, P149, DOI 10.1037/0096-1523.21.1.149; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; IRIESUGIMOTO N, 2009, ANIMAL COGNITION, V21, P193; Jordan KE, 2006, ANIM COGN, V9, P159, DOI 10.1007/s10071-006-0017-8; Judge PG, 2005, J EXP PSYCHOL-ANIM B, V31, P79, DOI 10.1037/0097-7403.31.1.79; Kamil A. C., 1987, FORAGING BEHAV; Kilian A, 2003, LEARN BEHAV, V31, P133; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; MCARTHUR RH, 1966, AM NAT, V100, P603; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Roberts WA, 2000, PSYCHOL SCI, V11, P218, DOI 10.1111/1467-9280.00244; Rugani R, 2007, J EXP PSYCHOL ANIM B, V33, P21, DOI 10.1037/0097-7403.33.1.21; RUMBAUGH DM, 1987, J EXP PSYCHOL ANIM B, V13, P107, DOI 10.1037/0097-7403.13.2.107; Seron X, 2001, MIND LANG, V16, P76, DOI 10.1111/1468-0017.00158; Sovrano VA, 2002, COGNITION, V85, pB51, DOI 10.1016/S0010-0277(02)00110-5; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Tomonaga M, 2008, ANIM COGN, V11, P43, DOI 10.1007/s10071-007-0089-0; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; VOS PG, 1988, PSYCHOL RES-PSYCH FO, V50, P148, DOI 10.1007/BF00310175; West RE, 2002, ANIM COGN, V5, P183, DOI 10.1007/s10071-002-0140-0; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	48	107	108	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4786	10.1371/journal.pone.0004786	http://dx.doi.org/10.1371/journal.pone.0004786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OE	19274079	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496000022
J	Aivaliotis, M; Macek, B; Gnad, F; Reichelt, P; Mann, M; Oesterhelt, D				Aivaliotis, Michalis; Macek, Boris; Gnad, Florian; Reichelt, Peter; Mann, Matthias; Oesterhelt, Dieter			Ser/Thr/Tyr Protein Phosphorylation in the Archaeon Halobacterium salinarum-A Representative of the Third Domain of Life	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; PHOSPHOPROTEOME ANALYSIS; SULFOLOBUS-SOLFATARICUS; SIGNAL-TRANSDUCTION; SITE DATABASE; IN-VIVO; KINASE; IDENTIFICATION; PHOSPHATASES; EVOLUTION	In the quest for the origin and evolution of protein phosphorylation, the major regulatory post-translational modification in eukaryotes, the members of archaea, the "third domain of life", play a protagonistic role. A plethora of studies have demonstrated that archaeal proteins are subject to post-translational modification by covalent phosphorylation, but little is known concerning the identities of the proteins affected, the impact on their functionality, the physiological roles of archaeal protein phosphorylation/dephosphorylation, and the protein kinases/phosphatases involved. These limited studies led to the initial hypothesis that archaea, similarly to other prokaryotes, use mainly histidine/aspartate phosphorylation, in their two-component systems representing a paradigm of prokaryotic signal transduction, while eukaryotes mostly use Ser/Thr/Tyr phosphorylation for creating highly sophisticated regulatory networks. In antithesis to the above hypothesis, several studies showed that Ser/Thr/Tyr phosphorylation is also common in the bacterial cell, and here we present the first genome-wide phosphoproteomic analysis of the model organism of archaea, Halobacterium salinarum, proving the existence/conservation of Ser/Thr/Tyr phosphorylation in the "third domain" of life, allowing a better understanding of the origin and evolution of the so-called "Nature's premier" mechanism for regulating the functional properties of proteins.	[Aivaliotis, Michalis; Reichelt, Peter; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, Martinsried, Germany; [Macek, Boris; Gnad, Florian; Mann, Matthias] Max Planck Inst Biochem, Dept Proteom & Sign Transduct, Martinsried, Germany	Max Planck Society; Max Planck Society	Aivaliotis, M (corresponding author), Acad Athens, Biomed Res Ctr, Ctr Basic Res 2, Athens, Greece.	michalis@biochem.mpg.de	Macek, Boris/N-1442-2015; Aivaliotis, Michalis/D-4841-2011; Mann, Matthias/A-3454-2013	Macek, Boris/0000-0002-1206-2458; Aivaliotis, Michalis/0000-0003-1173-7705; Mann, Matthias/0000-0003-1292-4799	German Federal Ministry for Education and Research BMBF [0316865B]; European Union Interaction Proteome; Alexander von Humboldt Foundation; Max Planck Society	German Federal Ministry for Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); European Union Interaction Proteome(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the German Federal Ministry for Education and Research BMBF (grant 0316865B) (QuantPro) and the European Union Interaction Proteome (6th Framework Program). M.A. thanks Alexander von Humboldt Foundation and Max Planck Society for the financial support.	Aivaliotis M, 2007, J PROTEOME RES, V6, P2195, DOI 10.1021/pr0700347; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BONET ML, 1992, INT J BIOCHEM, V24, P839; CHANG CL, 1994, NATURE, V370, P335, DOI 10.1038/370335a0; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Daas PJH, 1996, J BIOL CHEM, V271, P22339, DOI 10.1074/jbc.271.37.22339; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Grabowski B, 2001, J BACTERIOL, V183, P5459, DOI 10.1128/JB.183.18.5459-5464.2001; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Jedrzejas MJ, 2000, EMBO J, V19, P1419, DOI 10.1093/emboj/19.7.1419; Jeon SJ, 2002, BIOCHEM BIOPH RES CO, V295, P508, DOI 10.1016/S0006-291X(02)00705-2; Johnston M, 1996, CURR BIOL, V6, P500, DOI 10.1016/S0960-9822(02)00526-2; Kennelly PJ, 2003, BIOCHEM J, V370, P373, DOI 10.1042/BJ20021547; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Koch MK, 2005, MOL MICROBIOL, V55, P1681, DOI 10.1111/j.1365-2958.2005.04516.x; Koonin EV, 2000, J MOL MICROB BIOTECH, V2, P509; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; LEFFERS H, 1989, J MOL BIOL, V206, P1, DOI 10.1016/0022-2836(89)90519-6; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Liu HT, 1999, BIOCHEM BIOPH RES CO, V254, P203, DOI 10.1006/bbrc.1998.9893; Lower BH, 2003, J BACTERIOL, V185, P3436, DOI 10.1128/JB.185.11.3436-3445.2003; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mijakovic I, 2005, J MOL MICROB BIOTECH, V9, P189, DOI 10.1159/000089647; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; OESTERHELT D, 1983, ANN INST PASTEUR MIC, VB134, P137, DOI 10.1016/S0769-2609(83)80101-X; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Osorio G, 1996, MICROBIOL-SGM, V142, P1531, DOI 10.1099/13500872-142-6-1531; OXENRIDER KA, 1993, BIOCHEM BIOPH RES CO, V194, P1330, DOI 10.1006/bbrc.1993.1970; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ray WK, 2005, J BACTERIOL, V187, P4270, DOI 10.1128/JB.187.12.4270-4275.2005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; RUDOLPH J, 1995, EMBO J, V14, P4249, DOI 10.1002/j.1460-2075.1995.tb00099.x; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Serganov A, 2002, J MOL BIOL, V320, P963, DOI 10.1016/S0022-2836(02)00553-3; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SKORKO R, 1989, J BACTERIOL, V171, P5162, DOI 10.1128/jb.171.9.5162-5164.1989; SKORKO R, 1984, EUR J BIOCHEM, V145, P617, DOI 10.1111/j.1432-1033.1984.tb08601.x; Smith SC, 1997, J BACTERIOL, V179, P2418, DOI 10.1128/jb.179.7.2418-2420.1997; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Solow B, 1998, PROTEIN SCI, V7, P105, DOI 10.1002/pro.5560070111; SOUFI B, 2008, PROTEOMICS IN PRESS; SPUDICH JL, 1980, J BIOL CHEM, V255, P5501; STREIF S, 2009, REV SCI INS IN PRESS; Tahara M, 2004, J BIOCHEM, V135, P479, DOI 10.1093/jb/mvh055; Tebbe A, 2005, PROTEOMICS, V5, P168, DOI 10.1002/pmic.200400910; Wurgler-Murphy SM, 2004, PROTEOMICS, V4, P1562, DOI 10.1002/pmic.200300711; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248	69	67	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4777	10.1371/journal.pone.0004777	http://dx.doi.org/10.1371/journal.pone.0004777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274099	Green Published, gold			2022-12-27	WOS:000265496000016
J	Kijas, JW; Townley, D; Dalrymple, BP; Heaton, MP; Maddox, JF; McGrath, A; Wilson, P; Ingersoll, RG; McCulloch, R; McWilliam, S; Tang, D; McEwan, J; Cockett, N; Oddy, VH; Nicholas, FW; Raadsma, H				Kijas, James W.; Townley, David; Dalrymple, Brian P.; Heaton, Michael P.; Maddox, Jillian F.; McGrath, Annette; Wilson, Peter; Ingersoll, Roxann G.; McCulloch, Russell; McWilliam, Sean; Tang, Dave; McEwan, John; Cockett, Noelle; Oddy, V. Hutton; Nicholas, Frank W.; Raadsma, Herman		International Sheep Genomics Conso	A Genome Wide Survey of SNP Variation Reveals the Genetic Structure of Sheep Breeds	PLOS ONE			English	Article							POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; DOMESTIC SHEEP; DIVERSITY; SEQUENCE; SELECTION; ASSOCIATION; HAPLOTYPES; DISCOVERY; LINEAGES	The genetic structure of sheep reflects their domestication and subsequent formation into discrete breeds. Understanding genetic structure is essential for achieving genetic improvement through genome-wide association studies, genomic selection and the dissection of quantitative traits. After identifying the first genome-wide set of SNP for sheep, we report on levels of genetic variability both within and between a diverse sample of ovine populations. Then, using cluster analysis and the partitioning of genetic variation, we demonstrate sheep are characterised by weak phylogeographic structure, overlapping genetic similarity and generally low differentiation which is consistent with their short evolutionary history. The degree of population substructure was, however, sufficient to cluster individuals based on geographic origin and known breed history. Specifically, African and Asian populations clustered separately from breeds of European origin sampled from Australia, New Zealand, Europe and North America. Furthermore, we demonstrate the presence of stratification within some, but not all, ovine breeds. The results emphasize that careful documentation of genetic structure will be an essential prerequisite when mapping the genetic basis of complex traits. Furthermore, the identification of a subset of SNP able to assign individuals into broad groupings demonstrates even a small panel of markers may be suitable for applications such as traceability.	[Kijas, James W.; Townley, David; Dalrymple, Brian P.; McCulloch, Russell; McWilliam, Sean; Tang, Dave] CSIRO Livestock Ind, Brisbane, Qld, Australia; [Heaton, Michael P.] USDA, ARS, Meat Anim Res Ctr, Clay Ctr, NE USA; [Maddox, Jillian F.] Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia; [McGrath, Annette; Wilson, Peter] Australian Genome Res Ctr, Brisbane, Qld, Australia; [Ingersoll, Roxann G.] Johns Hopkins Univ, Inst Genet Med, Baltimore, MD 21218 USA; [McEwan, John] Invermay Agr Ctr, AgResearch, Mosgie, New Zealand; [Cockett, Noelle] Utah State Univ, Coll Agr, ADVS Dept, Logan, UT 84322 USA; [Oddy, V. Hutton] Univ New England, Sch Meat Sci, Armidale, NSW, Australia; [Nicholas, Frank W.; Raadsma, Herman] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Agriculture (USDA); University of Melbourne; Johns Hopkins University; Utah System of Higher Education; Utah State University; University of New England; University of Sydney	Kijas, JW (corresponding author), CSIRO Livestock Ind, Brisbane, Qld, Australia.	James.Kijas@csiro.au	Tang, Dave/G-9670-2014; Nicholas, Frank William/AAE-5566-2022; Kijas, James W/A-4656-2011; McGrath, Annette/T-7991-2018; Simianer, Henner/A-6574-2015; Dalrymple, Brian P/F-8721-2010; Nicholas, Frank/AGY-8318-2022; McWilliam, Sean M/H-8978-2013; McEwan, John/A-1143-2008; AJMONE MARSAN, Paolo/M-2466-2018; Coltman, David/A-4453-2012; Hunt, Peter/H-3545-2013	Tang, Dave/0000-0002-4790-9014; Nicholas, Frank William/0000-0002-9178-3965; Kijas, James W/0000-0002-1417-8278; McGrath, Annette/0000-0002-1765-7039; Simianer, Henner/0000-0002-7551-3797; Dalrymple, Brian P/0000-0003-3891-5233; Nicholas, Frank/0000-0002-9178-3965; McWilliam, Sean M/0000-0002-3148-0428; McEwan, John/0000-0003-4801-6207; , Roxann/0000-0002-4266-613X; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Coltman, David/0000-0002-1268-2307; Hunt, Peter/0000-0001-5679-2404; Hanotte, Olivier/0000-0002-2877-4767; Heaton, Michael/0000-0003-1386-1208	Australian Government [International Science Linkage grant]; sheepGENOMICS; Meat and Livestock Australia; Australian Wool Innovation; National Key Technology R&D Program [2007BAD52B05]; USDA Agricultural Research Service; Alliance for Animal Genome Research; USDA/CSREES	Australian Government(Australian GovernmentCGIAR); sheepGENOMICS; Meat and Livestock Australia(Meat and Livestock Australia); Australian Wool Innovation(Australian Wool Innovation); National Key Technology R&D Program(National Key Technology R&D Program); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Alliance for Animal Genome Research; USDA/CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	The work was supported by an Australian Government International Science Linkage grant, sheepGENOMICS, a joint initiative of Meat and Livestock Australia and Australian Wool Innovation, the National Key Technology R&D Program during the 11th "Five-Year" Plan in China (2007BAD52B05), the USDA Agricultural Research Service and the Alliance for Animal Genome Research. Funding for the BAC end sequencing was provided by USDA/CSREES. The funders had no role in study design, data collection or analysis. sheepGENOMICS approved the contents of the manuscript prior to publication.	Alvarez I, 2004, J ANIM SCI, V82, P2246; [Anonymous], AUSTR MERINO; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gizaw S, 2007, ANIM GENET, V38, P621, DOI 10.1111/j.1365-2052.2007.01659.x; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; Hayes BJ, 2008, ANIM GENET, V39, P105, DOI 10.1111/j.1365-2052.2007.01683.x; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Khatkar MS, 2006, GENETICS, V174, P79, DOI 10.1534/genetics.106.060418; Legge T., 1996, ORIGINS SPREAD AGR P, P238; Lewis PO, 2001, GENETIC DATA ANAL GD; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; McRae AF, 2005, GENETICS, V171, P251, DOI 10.1534/genetics.105.040972; Meadows JRS, 2006, ANIM GENET, V37, P444, DOI 10.1111/j.1365-2052.2006.01496.x; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Meadows JRS, 2004, ANIM GENET, V35, P379, DOI 10.1111/j.1365-2052.2004.01180.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Mukesh M, 2006, J ANIM BREED GENET, V123, P258, DOI 10.1111/j.1439-0388.2006.00599.x; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Oliphant A., 2002, BIOTECHNIQUES, V32, pS56, DOI DOI 10.2144/JUN0207; Panitz F, 2007, BIOINFORMATICS, V23, pI387, DOI 10.1093/bioinformatics/btm192; Parsonson Ian M, 1998, AUSTR ARK HIST DOMES; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Piper L, 1997, GENETICS SHEEP; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quignon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001324; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Scherf D.B., 2000, WORLD WATCH LIST DOM; Tapio I, 2005, HEREDITY, V94, P448, DOI 10.1038/sj.hdy.6800640; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	59	225	239	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2009	4	3							e4668	10.1371/journal.pone.0004668	http://dx.doi.org/10.1371/journal.pone.0004668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LX	19270757	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490100001
J	Basso, A; Martinez, L; Manso, F				Basso, Alicia; Martinez, Laura; Manso, Fanny			The Significance of Genetic Polymorphisms within and between Founder Populations of Ceratitis capitata (Wied.) from Argentina	PLOS ONE			English	Article							STERILE INSECT TECHNIQUE; FRUIT-FLY DIPTERA; TRANSPOSABLE ELEMENTS; AUTOCIDAL CONTROL; TEPHRITIDAE; EVOLUTION; BEHAVIOR; FLOW	Background: The Mediterranean fruit fly Ceratitis Capitata (DIPTERA: Tephritidae) is a major agricultural pest in Argentina. One main cause for the success of non-contaminant control programs based on genetic strategies is compatibility between natural and laboratory germplasms. A comprehensive characterization of the fruit fly based on genetic studies and compatibility analysis was undertaken on two founder populations from the provinces of Buenos Aires and Mendoza, used in pioneering sterile male technique control programmes in our country. The locations are 1,000 km apart from each other. Methodology/Principal Findings: We compared the genetic composition of both populations based on cytological, physiological and morphological characterization. Compatibility studies were performed in order to determine the presence of isolation barriers. Results indicate that the Buenos Aires germplasm described previously is partially different from that of the Mendoza population. Both laboratory colonies are a reservoir of mutational and cytological polymorphisms. Some sexual chromosome variants such as the XL and the YL resulting from attachment of a B-chromosome to the X-chromosome or Y-chromosome behave as a lethal sex-linked factor. Our results also show incompatibility between both germplasms and pre-zygotic isolation barriers between them. Our evidence is consistent with the fact that polymorphisms are responsible for the lack of compatibility. Conclusions: The genetic control mechanism should be directly produced in the germplasm of the target population in order to favour mating conditions. This is an additional requirement for the biological as well as economic success of control programs based on genetic strategies such as the sterile insect technique. The analysis of representative samples also revealed natural auto-control mechanisms which could be used in modifying pest population dynamics.	[Basso, Alicia] Univ Buenos Aires, Fac Agron, Catedra Genet, Buenos Aires, DF, Argentina; [Basso, Alicia; Martinez, Laura; Manso, Fanny] CNIA Inst Nacl Tecnol Agropecuar, Inst Genet Ewald A Favret, Lab Insectos, Castelar, Argentina	University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Basso, A (corresponding author), Univ Buenos Aires, Fac Agron, Catedra Genet, Buenos Aires, DF, Argentina.	abasso@agro.uba.ar			Instituto Nacional de Tecnologia Agropecuaria [320101, 81048]	Instituto Nacional de Tecnologia Agropecuaria	This work was supported by the Instituto Nacional de Tecnologia Agropecuaria (INTA- 320101, and INTA-81048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUFFI L, 1995, HEREDITY, V74, P425, DOI 10.1038/hdy.1995.60; BASSO A, 1995, REV BRAS GENET, V18, P165; Basso A., 1995, Cytobios, V83, P237; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Brookfield JFY, 2004, CURR BIOL, V14, pR344, DOI 10.1016/j.cub.2004.04.021; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Cayol JP, 1999, J ECON ENTOMOL, V92, P140, DOI 10.1093/jee/92.1.140; Cayol JP, 2002, FLA ENTOMOL, V85, P51, DOI 10.1653/0015-4040(2002)085[0051:SCIMDT]2.0.CO;2; CLADERA JL, 1981, EXPERIENTIA, V37, P342, DOI 10.1007/BF01959852; CLADERA JL, 1981, MENDELIANA, V5, P33; Crow James F., 1992, P132; Crow James F., 1993, Oxford Surveys in Evolutionary Biology, V9, P3; DELPRAT A, 1999, THESIS U BUENOS AIRE; Dyer KA, 2007, P NATL ACAD SCI USA, V104, P1587, DOI 10.1073/pnas.0605578104; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Ford EB, 1971, ECOLOGICAL GENETICS; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gasparich GE, 1997, ANN ENTOMOL SOC AM, V90, P790, DOI 10.1093/aesa/90.6.790; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Gomulski LM, 2004, INSECT BIOCHEM MOLEC, V34, P139, DOI 10.1016/j.ibmb.2003.06.015; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Hall DW, 2004, EVOLUTION, V58, P925; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Kourti A, 2004, J ECON ENTOMOL, V97, P1186, DOI 10.1603/0022-0493(2004)097[1186:POVWAB]2.0.CO;2; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Lerner I. M., 1958, GENETIC BASIS SELECT; Lewontin RC, 1974, GENETIC BASIS EVOLUT; LIFSCHITZ E, 1989, FRUIT FLIES THEIR B, V3, P3; LIFSCHITZ E, 1980, CONS M GEN SEX MECH, P2; LIFSCHITZ E, 1983, REP RES COORD M DEV; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; MANSO F, 1979, B GENETICO I FITOTEC, V10, P31; Manso F. C, 1992, CIENC INVEST, V44, P225; MANSO FC, 1986, 2 P INT S FRUIT FLIE, P159; MARSHALL E, 1981, SCIENCE, V213, P417, DOI 10.1126/science.213.4506.417; MARTINEZ L, 1988, P 19 ARG GEN M SOC A; McInnis DO, 1996, ANN ENTOMOL SOC AM, V89, P739, DOI 10.1093/aesa/89.5.739; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Pizarro JM, 1997, ANN ENTOMOL SOC AM, V90, P220, DOI 10.1093/aesa/90.2.220; Reyes A, 2004, J APPL ENTOMOL, V128, P358, DOI 10.1111/j.1439-0418.2004.00858; RICHARDSON RH, 1982, SCIENCE, V215, P361, DOI 10.1126/science.7199204; Robinson AS, 2002, GENETICA, V116, P5, DOI 10.1023/A:1020951407069; Robinson AS, 2002, FLA ENTOMOL, V85, P171, DOI 10.1653/0015-4040(2002)085[0171:RFOMSB]2.0.CO;2; Sokal R.R., 2012, BIOMETRY; Strickberger M. W., 2000, EVOLUTION; Swanson C.P., 1957, CYTOLOGY CYTOGENETIC; TERAN H R, 1977, Revista Agronomica del Noroeste Argentino, V14, P17; Torti C, 2005, GENETICA, V123, P313, DOI 10.1007/s10038-004-7126-5; Torti C, 2000, CHROMOSOMA, V108, P523, DOI 10.1007/s004120050404; WEDEKIND L, 2007, SCI SEX SUPERFLIES F, P1; Zar JH, 1999, BIOSTATISTICAL ANAL	52	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4665	10.1371/journal.pone.0004665	http://dx.doi.org/10.1371/journal.pone.0004665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252742	Green Published, gold, Green Submitted			2022-12-27	WOS:000265489900007
J	Gesase, S; Gosling, RD; Hashim, R; Ord, R; Naidoo, I; Madebe, R; Mosha, JF; Joho, A; Mandia, V; Mrema, H; Mapunda, E; Savael, Z; Mosha, FW; Greenwood, B; Roper, C; Chandramohan, D				Gesase, Samwel; Gosling, Roly D.; Hashim, Ramadhan; Ord, Rosalynn; Naidoo, Inbarani; Madebe, Rashid; Mosha, Jacklin F.; Joho, Angel; Mandia, Victor; Mrema, Hedwiga; Mapunda, Ephraim; Savael, Zacharia; Mosha, Frank W.; Greenwood, Brian; Roper, Cally; Chandramohan, Daniel			High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581	PLOS ONE			English	Article								Background: Sulphadoxine-pyrimethamine (SP) a widely used treatment for uncomplicated malaria and recommended for intermittent preventive treatment of malaria in pregnancy, is being investigated for intermittent preventive treatment of malaria in infants (IPTi). High levels of drug resistance to SP have been reported from north-eastern Tanzania associated with mutations in parasite genes. This study compared the in vivo efficacy of SP in symptomatic 6-59 month children with uncomplicated malaria and in asymptomatic 2-10 month old infants. Methodology and Principal Findings: An open label single arm (SP) standard 28 day in vivo WHO antimalarial efficacy protocol was used in 6 to 59 months old symptomatic children and a modified protocol used in 2 to 10 months old asymptomatic infants. Enrolment was stopped early (87 in the symptomatic and 25 in the asymptomatic studies) due to the high failure rate. Molecular markers were examined for recrudescence, re-infection and markers of drug resistance and a review of literature of studies looking for the 581G dhps mutation was carried out. In symptomatic children PCR-corrected early treatment failure was 38.8% (95% CI 26.8-50.8) and total failures by day 28 were 82.2% (95% CI 72.5-92.0). There was no significant difference in treatment failures between asymptomatic and symptomatic children. 96% of samples carried parasites with mutations at codons 51, 59 and 108 in the dhfr gene and 63% carried a double mutation at codons 437 and 540. 55% carried a third mutation with the addition of a mutation at codon 581 in the dhps gene. This triple: triple haplotype maybe associated with earlier treatment failure. Conclusion: In northern Tanzania SP is a failed drug for treatment and its utility for prophylaxis is doubtful. The study found a new combination of parasite mutations that maybe associated with increased and earlier failure.	[Gesase, Samwel; Hashim, Ramadhan; Madebe, Rashid; Joho, Angel; Mandia, Victor; Mrema, Hedwiga; Mapunda, Ephraim; Savael, Zacharia] Tanga Ctr, Natl Inst Med Res, Tanga, Tanzania; [Gosling, Roly D.; Ord, Rosalynn; Naidoo, Inbarani; Greenwood, Brian; Roper, Cally; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Naidoo, Inbarani] MRC, Malaria Res Lead Programme, Durban, South Africa; [Mosha, Jacklin F.; Joho, Angel; Mosha, Frank W.] Kilimanjaro Christian Med Coll, Moshi, Tanzania	National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	Gesase, S (corresponding author), Tanga Ctr, Natl Inst Med Res, Tanga, Tanzania.	Roly.Gosling@gmail.com	Roper, Cally/K-2989-2013	Roper, Cally/0000-0002-6545-309X; Naidoo, Inbarani/0000-0001-7590-0618; Mosha, Jacklin/0000-0001-7940-8903	Bill and Melinda Gates Foundation [38773]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation through a grant awarded to the IPTi Consortiums Drug Resistance Working Group. Grant number:38773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Elbasit IE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-108; Alker AP, 2005, ANTIMICROB AGENTS CH, V49, P3919, DOI 10.1128/AAC.49.9.3919-3921.2005; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Borrmann S, 2008, ANTIMICROB AGENTS CH, V52, P1799, DOI 10.1128/AAC.00755-07; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; Chandler CIR, 2006, TROP MED INT HEALTH, V11, P1178, DOI 10.1111/j.1365-3156.2006.01672.x; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Djimde AA, 2003, AM J TROP MED HYG, V69, P558, DOI 10.4269/ajtmh.2003.69.558; Gebru-Woldearegai T, 2005, AM J TROP MED HYG, V73, P1131, DOI 10.4269/ajtmh.2005.73.1131; *GLAXOSMITHKLINE, 2008, UPD GSKS MAL TREATM; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Hamel MJ, 2008, T ROY SOC TROP MED H, V102, P338, DOI 10.1016/j.trstmh.2008.01.018; Hyde JE, 2008, T ROY SOC TROP MED H, V102, P301, DOI 10.1016/j.trstmh.2008.01.003; Jelinek T, 1999, AM J TROP MED HYG, V61, P463, DOI 10.4269/ajtmh.1999.61.463; Jelinek T, 1999, TROP MED INT HEALTH, V4, P476, DOI 10.1046/j.1365-3156.1999.00428.x; Jelinek T, 1998, TROP MED INT HEALTH, V3, P605, DOI 10.1046/j.1365-3156.1998.00280.x; Krudsood S, 2005, T ROY SOC TROP MED H, V99, P142, DOI 10.1016/j.trstmh.2004.07.001; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Lynch C, 2008, J INFECT DIS, V197, P1598, DOI 10.1086/587845; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Mbugi EV, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-94; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2006, J INFECT DIS, V194, P189, DOI 10.1086/504687; Ministry of Health, 2000, NAT GUID MAL DIAGN T; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Mugittu K, 2004, AM J TROP MED HYG, V71, P696, DOI 10.4269/ajtmh.2004.71.696; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Omar SA, 2001, T ROY SOC TROP MED H, V95, P315, DOI 10.1016/S0035-9203(01)90250-0; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; Schonfeld M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-2; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Staedke SG, 2004, TROP MED INT HEALTH, V9, P624, DOI 10.1111/j.1365-3156.2004.01239.x; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Tagbor HK, 2007, EXPERT OPIN DRUG SAF, V6, P631, DOI 10.1517/14740338.6.6.631; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Trigg JK, 1997, ACTA TROP, V63, P185, DOI 10.1016/S0001-706X(96)00617-1; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153, DOI 10.4269/ajtmh.2007.77.153; Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X; Warsame M, 1999, T ROY SOC TROP MED H, V93, P312, DOI 10.1016/S0035-9203(99)90034-2; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; Wilairatana P, 1997, ANN TROP MED PARASIT, V91, P125, DOI 10.1080/00034989761454	46	112	113	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4569	10.1371/journal.pone.0004569	http://dx.doi.org/10.1371/journal.pone.0004569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238219	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000265487400004
J	Engelmann, JB; Capra, CM; Noussair, C; Berns, GS				Engelmann, Jan B.; Capra, C. Monica; Noussair, Charles; Berns, Gregory S.			Expert Financial Advice Neurobiologically "Offloads'' Financial Decision-Making under Risk	PLOS ONE			English	Article							PROBABILITY WEIGHTING FUNCTION; POSTERIOR CINGULATE CORTEX; TEMPORO-PARIETAL JUNCTION; NEURAL BASIS; DOPAMINE NEURONS; PROSPECT-THEORY; UTILITY-THEORY; REWARD; MIND; UNCERTAINTY	Background: Financial advice from experts is commonly sought during times of uncertainty. While the field of neuroeconomics has made considerable progress in understanding the neurobiological basis of risky decision-making, the neural mechanisms through which external information, such as advice, is integrated during decision-making are poorly understood. In the current experiment, we investigated the neurobiological basis of the influence of expert advice on financial decisions under risk. Methodology/Principal Findings: While undergoing fMRI scanning, participants made a series of financial choices between a certain payment and a lottery. Choices were made in two conditions: 1) advice from a financial expert about which choice to make was displayed (MES condition); and 2) no advice was displayed (NOM condition). Behavioral results showed a significant effect of expert advice. Specifically, probability weighting functions changed in the direction of the expert's advice. This was paralleled by neural activation patterns. Brain activations showing significant correlations with valuation (parametric modulation by value of lottery/sure win) were obtained in the absence of the expert's advice (NOM) in intraparietal sulcus, posterior cingulate cortex, cuneus, precuneus, inferior frontal gyrus and middle temporal gyrus. Notably, no significant correlations with value were obtained in the presence of advice (MES). These findings were corroborated by region of interest analyses. Neural equivalents of probability weighting functions showed significant flattening in the MES compared to the NOM condition in regions associated with probability weighting, including anterior cingulate cortex, dorsolateral PFC, thalamus, medial occipital gyrus and anterior insula. Finally, during the MES condition, significant activations in temporoparietal junction and medial PFC were obtained. Conclusions/Significance: These results support the hypothesis that one effect of expert advice is to "offload'' the calculation of value of decision options from the individual's brain.	[Engelmann, Jan B.; Berns, Gregory S.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Capra, C. Monica; Berns, Gregory S.] Emory Univ, Dept Econ, Atlanta, GA 30322 USA; [Noussair, Charles] Tilburg Univ, Dept Econ, Tilburg, Netherlands; [Berns, Gregory S.] Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA	Emory University; Emory University; Tilburg University; Emory University	Engelmann, JB (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gberns@emory.edu	Engelmann, Jan B./H-8429-2014; Capra, C. Monica/H-6686-2017	Engelmann, Jan B./0000-0001-6493-8792; 	NIDA [R01 DA016434, R01 DA20116, T32 DA15040]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020116, T32DA015040, R01DA016434] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by grants from NIDA (R01 DA016434 and R01 DA20116 to G.S.B. and T32 DA15040 to J.B.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui M, 2000, MANAGE SCI, V46, P1497, DOI 10.1287/mnsc.46.11.1497.12080; Berns GS, 2008, NEUROIMAGE, V39, P2047, DOI 10.1016/j.neuroimage.2007.10.028; Berns GS, 2005, BIOL PSYCHIAT, V58, P245, DOI 10.1016/j.biopsych.2005.04.012; Birn RM, 2002, NEUROIMAGE, V15, P252, DOI 10.1006/nimg.2001.0964; Bonaccio S, 2006, ORGAN BEHAV HUM DEC, V101, P127, DOI 10.1016/j.obhdp.2006.07.001; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CAMERER CF, 1994, J RISK UNCERTAINTY, V8, P167, DOI 10.1007/BF01065371; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; CHO Y, 1994, J EXP PSYCHOL HUMAN, V20, P931, DOI 10.1037/0096-1523.20.5.931; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Fehr-Duda H, 2006, THEOR DECIS, V60, P283, DOI 10.1007/s11238-005-4590-0; Ferstl EC, 2002, NEUROIMAGE, V17, P1599, DOI 10.1006/nimg.2002.1247; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; Gonzalez R, 1999, COGNITIVE PSYCHOL, V38, P129, DOI 10.1006/cogp.1998.0710; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Huettel SA, 2006, COGN AFFECT BEHAV NE, V6, P141, DOI 10.3758/CABN.6.2.141; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kuhberger A, 1999, ORGAN BEHAV HUM DEC, V78, P204, DOI 10.1006/obhd.1999.2830; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Luce RD, 2000, UTILITY GAINS LOSSES; Matsumoto M, 2008, PROG BRAIN RES, V171, P399, DOI 10.1016/S0079-6123(08)00658-4; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573; Quiggin John., 1993, GEN EXPECTED UTILITY, V1st ed.; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Small DM, 2001, BRAIN, V124, P1566, DOI 10.1093/brain/124.8.1566; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; WOODRUFF RS, 1952, J AM STAT ASSOC, V47, P635, DOI 10.2307/2280781; Wu G, 1996, MANAGE SCI, V42, P1676, DOI 10.1287/mnsc.42.12.1676; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; Zink CF, 2003, J NEUROSCI, V23, P8092	74	60	60	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4957	10.1371/journal.pone.0004957	http://dx.doi.org/10.1371/journal.pone.0004957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PI	19308261	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499000008
J	Merabishvili, M; Pirnay, JP; Verbeken, G; Chanishvili, N; Tediashvili, M; Lashkhi, N; Glonti, T; Krylov, V; Mast, J; Van Parys, L; Lavigne, R; Volckaert, G; Mattheus, W; Verween, G; De Corte, P; Rose, T; Jennes, S; Zizi, M; De Vos, D; Vaneechoutte, M				Merabishvili, Maya; Pirnay, Jean-Paul; Verbeken, Gilbert; Chanishvili, Nina; Tediashvili, Marina; Lashkhi, Nino; Glonti, Thea; Krylov, Victor; Mast, Jan; Van Parys, Luc; Lavigne, Rob; Volckaert, Guido; Mattheus, Wesley; Verween, Gunther; De Corte, Peter; Rose, Thomas; Jennes, Serge; Zizi, Martin; De Vos, Daniel; Vaneechoutte, Mario			Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials	PLOS ONE			English	Article							ESCHERICHIA-COLI DIARRHEA; PSEUDOMONAS-AERUGINOSA; GENOMIC ANALYSIS; PHI-KMV; PHAGE; THERAPY; MICE; INFECTIONS; EFFICACY; CALVES	We describe the small-scale, laboratory-based, production and quality control of a cocktail, consisting of exclusively lytic bacteriophages, designed for the treatment of Pseudomonas aeruginosa and Staphylococcus aureus infections in burn wound patients. Based on succesive selection rounds three bacteriophages were retained from an initial pool of 82 P. aeruginosa and 8 S. aureus bacteriophages, specific for prevalent P. aeruginosa and S. aureus strains in the Burn Centre of the Queen Astrid Military Hospital in Brussels, Belgium. This cocktail, consisting of P. aeruginosa phages 14/1 (Myoviridae) and PNM (Podoviridae) and S. aureus phage ISP (Myoviridae) was produced and purified of endotoxin. Quality control included Stability (shelf life), determination of pyrogenicity, sterility and cytotoxicity, confirmation of the absence of temperate bacteriophages and transmission electron microscopy-based confirmation of the presence of the expected virion morphologic particles as well as of their specific interaction with the target bacteria. Bacteriophage genome and proteome analysis confirmed the lytic nature of the bacteriophages, the absence of toxin-coding genes and showed that the selected phages 14/1, PNM and ISP are close relatives of respectively F8, phi KMV and phage G1. The bacteriophage cocktail is currently being evaluated in a pilot clinical study cleared by a leading Medical Ethical Committee.	[Merabishvili, Maya; Chanishvili, Nina; Tediashvili, Marina; Lashkhi, Nino; Glonti, Thea] EIBMV, Tbilisi, Georgia; [Merabishvili, Maya; Pirnay, Jean-Paul; Verbeken, Gilbert; Verween, Gunther; De Corte, Peter; Rose, Thomas; Jennes, Serge; De Vos, Daniel] Queen Astrid Mil Hosp, Burn Ctr, LabMCT, Brussels, Belgium; [Krylov, Victor] SIGSIM, Lab Bacteriophage Genet, Moscow, Russia; [Mast, Jan] VAR, Unit Electron Microscopy, Brussels, Belgium; [Van Parys, Luc; Zizi, Martin] Queen Astrid Mil Hosp, Sect Hlth Div WellBeing, Brussels, Belgium; [Lavigne, Rob; Volckaert, Guido; Mattheus, Wesley] Katholieke Univ Leuven, LoGT, Louvain, Belgium; [Zizi, Martin] Free Univ Brussels, Dept Physiol, B-1050 Brussels, Belgium; [Merabishvili, Maya; Vaneechoutte, Mario] Ghent Univ Hosp, LBR, Ghent, Belgium	Queen Astrid Military Hospital; Queen Astrid Military Hospital; KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital	Merabishvili, M (corresponding author), EIBMV, Tbilisi, Georgia.	jean-paul.pirnay@mil.be	Chanishvili, Nina/CAG-5114-2022; Vaneechoutte, Mario/A-6189-2009; Merabishvili, Maia/GLU-4387-2022	Chanishvili, Nina/0000-0002-7859-3032; Vaneechoutte, Mario/0000-0002-4586-203X; Merabishvili, Maia/0000-0002-2566-0772; Pirnay, Jean-Paul/0000-0002-6863-5219; Tediashvili, Marina/0000-0003-4035-4746; Mast, Jan/0000-0002-4879-3367; Lavigne, Rob/0000-0001-7377-1314	Belgian Ministry of Defence; K.U.Leuven [OT/05/47, WB15]; Royal High Institute for Defence (RHID)	Belgian Ministry of Defence; K.U.Leuven(KU Leuven); Royal High Institute for Defence (RHID)	MM, JPP, GiV, LVP, GuV, PDC, TR, SJ, MZ and DDV were financially supported by the Belgian Ministry of Defence. This work was partially supported by the research council of the K.U.Leuven (OT/05/47) and grant WB15 of the Royal High Institute for Defence (RHID). Selection and initial characterisation of the phages was financed by INTAS project 6610. Laboratories 1, 2, 3 and 6 are part of the research community PhageBiotics, supported by the FWO Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MH., 1959, BACTERIOPHAGES, P450, DOI 10.5962/bhl.title.6966; Altoparlak U, 2004, BURNS, V30, P660, DOI 10.1016/j.burns.2004.03.005; BABALOVA E G, 1968, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, V45, P143; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Boratynski J, 2004, CELL MOL BIOL LETT, V9, P253; Bruessow Harald, 2007, P159; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Calendar R., 2006, BACTERIOPHAGES; Capparelli R, 2006, CLIN MICROBIOL INFEC, V12, P248, DOI 10.1111/j.1469-0691.2005.01340.x; Carlson K, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P437; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chanishvili N, 2001, J CHEM TECHNOL BIOT, V76, P689, DOI 10.1002/jctb.438; Chibani-Chennoufi S, 2004, ANTIMICROB AGENTS CH, V48, P2558, DOI 10.1128/AAC.48.7.2558-2569.2004; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; Gill JJ, 2006, ANTIMICROB AGENTS CH, V50, P2912, DOI 10.1128/AAC.01630-05; Gorski A, 2007, BACTERIOPHAGE GENETI, P126; Imberechts H, 1996, MICROB PATHOGENESIS, V21, P183, DOI 10.1006/mpat.1996.0053; KERBY GP, 1949, J IMMUNOL, V63, P93; Krylova OV, 2001, RUSS J ORG CHEM+, V37, P887, DOI 10.1023/A:1012482103171; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Lavigne R, 2003, VIROLOGY, V312, P49, DOI 10.1016/S0042-6822(03)00123-5; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Mcvay CS, 2007, ANTIMICROB AGENTS CH, V51, P1934, DOI 10.1128/AAC.01028-06; Merabishvili M, 2007, RES MICROBIOL, V158, P572, DOI 10.1016/j.resmic.2007.06.002; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Miller Robert V., 1998, P218; O'Flaherty S, 2004, J BACTERIOL, V186, P2862, DOI 10.1128/JB.186.9.2862-2871.2004; PEREZCAPPELANO R, 1976, BURNS, V3, P42; Pirnay JP, 2003, J CLIN MICROBIOL, V41, P1192, DOI 10.1128/JCM.41.3.1192-1202.2003; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; SOOTHILL JS, 1992, J MED MICROBIOL, V37, P258, DOI 10.1099/00222615-37-4-258; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Verbeken G, 2007, FUTURE MICROBIOL, V2, P485, DOI 10.2217/17460913.2.5.485; Villarreal Luis P., 2005, P1; Watanabe R, 2007, ANTIMICROB AGENTS CH, V51, P446, DOI 10.1128/AAC.00635-06; Wills QF, 2005, ANTIMICROB AGENTS CH, V49, P1220, DOI 10.1128/AAC.49.3.1220-1221.2005	40	315	336	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4944	10.1371/journal.pone.0004944	http://dx.doi.org/10.1371/journal.pone.0004944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300511	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496800012
J	Day, CJ; Tiralongo, J; Hartnell, RD; Logue, CA; Wilson, JC; von Itzstein, M; Korolik, V				Day, Christopher J.; Tiralongo, Joe; Hartnell, Regan D.; Logue, Carie-Anne; Wilson, Jennifer C.; von Itzstein, Mark; Korolik, Victoria			Differential Carbohydrate Recognition by Campylobacter jejuni Strain 11168: Influences of Temperature and Growth Conditions	PLOS ONE			English	Article								The pathogenic clinical strain NCTC11168 was the first Campylobacter jejuni strain to be sequenced and has been a widely used laboratory model for studying C. jejuni pathogenesis. However, continuous passaging of C. jejuni NCTC11168 has been shown to dramatically affect its colonisation potential. Glycan array analysis was performed on C. jejuni NCTC11168 using the frequently passaged, non-colonising, genome sequenced (11168-GS) and the infrequently passaged, original, virulent (11168-O) isolates grown or maintained under various conditions. Glycan structures recognised and bound by C. jejuni included terminal mannose, N-acetylneuraminic acid, galactose and fucose. Significantly, it was found that only when challenged with normal oxygen at room temperature did 11168-O consistently bind to sialic acid or terminal mannose structures, while 11168-GS bound these structures regardless of growth/maintenance conditions. Further, binding of uncapped galactose and fucosylated structures was significantly reduced when C. jejuni was maintained at 25 degrees C under atmospheric oxygen conditions. These binding differences identified through glycan array analysis were confirmed by the ability of specific lectins to competitively inhibit the adherence of C. jejuni to a Caco-2 intestinal cell line. Our data suggests that the binding of mannose and/or N-acetylneuraminic acid may provide the initial interactions important for colonisation following environmental exposure.	[Day, Christopher J.; Tiralongo, Joe; Hartnell, Regan D.; Logue, Carie-Anne; Wilson, Jennifer C.; von Itzstein, Mark; Korolik, Victoria] Griffith Univ, Inst Glyc, Nathan, Qld 4111, Australia	Griffith University	Day, CJ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Nathan, Qld 4111, Australia.	j.tiralongo@griffith.edu.au; v.korolik@griffith.edu.au	von Itzstein, Mark/E-4823-2010; Wilson, Jennifer/H-5297-2013	Day, Christopher/0000-0001-7953-4408; Tiralongo, Joe/0000-0002-3529-6310; Korolik, Victoria/0000-0002-5535-4151	Queensland State Government [Smart State Research Fellowship]; Rural Industries Research and Development Corporation; Griffith University; Australian Research Council [Australian Postdoctoral Fellowship, Federation Fellowship]	Queensland State Government; Rural Industries Research and Development Corporation; Griffith University(Griffith University); Australian Research Council(Australian Research Council)	This work was supported by a Queensland State Government Smart State Research Fellowship (CJD) in conjunction with the Rural Industries Research and Development Corporation and Griffith University. JT and MvI were supported by the Australian Research Council through the awarding of an Australian Postdoctoral Fellowship and a Federation Fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano J, 2001, ARCH BIOCHEM BIOPHYS, V395, P191, DOI 10.1006/abbi.2001.2572; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bradner JE, 2006, NAT PROTOC, V1, P2344, DOI 10.1038/nprot.2006.282; Cheng JS, 2008, GLYCOBIOLOGY, V18, P686, DOI 10.1093/glycob/cwn047; Cioci G, 2003, FEBS LETT, V555, P297, DOI 10.1016/S0014-5793(03)01249-3; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; Demetter P, 2008, J PATHOL, V215, P1, DOI 10.1002/path.2334; Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gaynor EC, 2001, MOL MICROBIOL, V39, P1546, DOI 10.1046/j.1365-2958.2001.02341.x; Gilboa-Garber N, 1999, FEMS IMMUNOL MED MIC, V25, P365, DOI 10.1111/j.1574-695X.1999.tb01361.x; Gouyer V, 2001, J CELL SCI, V114, P1455; Grover V, 2001, ARCH BIOCHEM BIOPHYS, V390, P109, DOI 10.1006/abbi.2001.2355; Grover V, 2007, CURR MICROBIOL, V54, P175, DOI 10.1007/s00284-005-0366-6; GUCCIONE E, 2008, MOL MICROBIOL; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hazeleger WC, 1998, APPL ENVIRON MICROB, V64, P3917; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560, DOI 10.1128/IAI.56.6.1560-1566.1988; Hyland RM, 2008, CELL MICROBIOL, V10, P177, DOI 10.1111/j.1462-5822.2007.01028.x; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Isshiki S, 2003, J BIOL CHEM, V278, P36611, DOI 10.1074/jbc.M302681200; Kakiuchi Y, 2002, CANCER RES, V62, P1567; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Linden SK, 2007, HELICOBACTER, V12, P341, DOI 10.1111/j.1523-5378.2007.00509.x; Logan RPH, 1998, J IMMUNOL METHODS, V213, P19, DOI 10.1016/S0022-1759(98)00018-0; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Malagolini N, 2007, GLYCOBIOLOGY, V17, P688, DOI 10.1093/glycob/cwm040; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Morrow AL, 2004, ADV EXP MED BIOL, V554, P443; Morrow AL, 2005, J NUTR, V135, P1304, DOI 10.1093/jn/135.5.1304; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parry S, 2006, GLYCOBIOLOGY, V16, P623, DOI 10.1093/glycob/cwj110; Rhim AD, 2001, GLYCOCONJUGATE J, V18, P649, DOI 10.1023/A:1020815205022; Rhim AD, 2000, GLYCOCONJUGATE J, V17, P385, DOI 10.1023/A:1007156014384; Ringoir DD, 2003, VET MICROBIOL, V92, P225, DOI 10.1016/S0378-1135(02)00378-4; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; RUSSELL RG, 1994, INFECT IMMUN, V62, P3773, DOI 10.1128/IAI.62.9.3773-3779.1994; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Sharon N, 1996, ADV EXP MED BIOL, V408, P1; Siebert HC, 2003, BIOCHEMISTRY-US, V42, P14762, DOI 10.1021/bi035477c; SKIRROW MB, 1991, INT J FOOD MICROBIOL, V12, P9, DOI 10.1016/0168-1605(91)90044-P; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Sung MA, 2001, J BIOMOL NMR, V19, P197, DOI 10.1023/A:1008330323188; Sung MA, 2001, EMBO REP, V2, P621, DOI 10.1093/embo-reports/kve133; Thomas CJ, 2002, J AM CHEM SOC, V124, P12926, DOI 10.1021/ja0208916; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VETTER D, 1995, BIOCONJUGATE CHEM, V6, P316, DOI 10.1021/bc00033a013; Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049; Wu AM, 2006, BIOCHIMIE, V88, P1479, DOI 10.1016/j.biochi.2006.05.004	59	78	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4927	10.1371/journal.pone.0004927	http://dx.doi.org/10.1371/journal.pone.0004927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290056	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496500020
J	Schillace, RV; Miller, CL; Pisenti, N; Grotzke, JE; Swarbrick, GM; Lewinsohn, DM; Carr, DW				Schillace, Robynn V.; Miller, Casey L.; Pisenti, Neal; Grotzke, Jeff E.; Swarbrick, Gwendolyn M.; Lewinsohn, David M.; Carr, Daniel W.			A-Kinase Anchoring in Dendritic Cells Is Required for Antigen Presentation	PLOS ONE			English	Article								Background: Dendritic cells (DC) are the most potent antigen presenting cells (APC) of the immune system. Prostaglandin E-2, cyclic AMP, and protein kinase A (PKA) have all been shown to regulate DC maturation and activity. In other cells, the ability of these molecules to convey their signals has been shown to be dependent on A-kinase anchoring proteins (AKAPs). Here we present evidence for the existence and functional importance of AKAPs in human DC. Methodology/Principal Findings: Using immunofluorescence and/or western analyses we identify AKAP79, AKAP149, AKAP95, AKAP LBC and Ezrin. We also demonstrate by western analysis that expression of AKAP79, AKAP149 and RII are upregulated with DC differentiation and maturation. We establish the functional importance of PKA anchoring in multiple aspects of DC biology using the anchoring inhibitor peptides Ht31 and AKAP-IS. Incubation of protein or peptide antigen loaded DC with Ht31 or AKAP-IS results in a 30-50% decrease in antigen presentation as measured by IFN-gamma production from antigen specific CD4(+) T cells. Incubation of LPS treated DC with Ht31 results in 80% inhibition of TNF-alpha and IL-10 production. Ht31 slightly decreases the expression of CD18 and CD11a and CD11b, slightly increases the basal expression of CD83, dramatically decreases the LPS stimulated expression of CD40, CD80 and CD83, and significantly increases the expression of the chemokine receptor CCR7. Conclusions: These experiments represent the first evidence for the functional importance of PKA anchoring in multiple aspects of DC biology.	[Schillace, Robynn V.; Miller, Casey L.; Pisenti, Neal; Lewinsohn, David M.; Carr, Daniel W.] Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97201 USA; [Schillace, Robynn V.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Grotzke, Jeff E.] Oregon Hlth & Sci Univ, Dept Microbiol & Mol Immunol, Portland, OR 97201 USA; [Swarbrick, Gwendolyn M.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulmonary Med, Portland, OR 97201 USA; [Carr, Daniel W.] Oregon Hlth & Sci Univ, Dept Endocrinol, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Schillace, RV (corresponding author), Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97201 USA.	carrd@ohsu.edu	Lewinsohn, David/I-4936-2013	Lewinsohn, David/0000-0001-9906-9494	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development Service	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development Service(US Department of Veterans Affairs)	This research was supported by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development Service (DWC). VA Merit Review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1992, J BIOL CHEM, V267, P13376; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dodge KL, 1999, ENDOCRINOLOGY, V140, P5165, DOI 10.1210/en.140.11.5165; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Eun SY, 2006, J IMMUNOL, V177, P4271, DOI 10.4049/jimmunol.177.7.4271; Furusawa M, 2002, J BIOL CHEM, V277, P50885, DOI 10.1074/jbc.M206387200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; GONZALEZ AM, 2008, J BIOL CHEM; Grunig G, 2005, PHARMACOL THERAPEUT, V106, P75, DOI 10.1016/j.pharmthera.2004.11.004; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Harizi H, 2001, CELL IMMUNOL, V209, P19, DOI 10.1006/cimm.2001.1785; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Jones SL, 2005, J LEUKOCYTE BIOL, V78, P248, DOI 10.1189/jlb.0804459; Jones SL, 2002, J LEUKOCYTE BIOL, V71, P1042; Kambayashi T, 2001, J LEUKOCYTE BIOL, V70, P903; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; LIM CJ, 2008, MOL BIOL CELL; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; MCCONNELL BK, 2008, J BIOL CHEM; Meja KK, 2004, J PHARMACOL EXP THER, V309, P833, DOI 10.1124/jpet.103.060020; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Rodriguez-Fernandez Jose Luis, 2005, Curr Opin Investig Drugs, V6, P1103; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schillace RV, 2006, CRIT REV IMMUNOL, V26, P113, DOI 10.1615/CritRevImmunol.v26.i2.20; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Smith CW, 2008, J ALLERGY CLIN IMMUN, V121, pS375, DOI 10.1016/j.jaci.2007.07.030; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Uchiya K, 2004, INFECT IMMUN, V72, P1964, DOI 10.1128/IAI.72.4.1964-1973.2004; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Williams RO, 2002, J IMMUNOL, V168, P5392, DOI 10.4049/jimmunol.168.11.5392; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447	50	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4807	10.1371/journal.pone.0004807	http://dx.doi.org/10.1371/journal.pone.0004807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277197	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496100024
J	Bianco-Miotto, T; Hussey, DJ; Day, TK; O'Keefe, DS; Dobrovic, A				Bianco-Miotto, Tina; Hussey, Damian J.; Day, Tanya K.; O'Keefe, Denise S.; Dobrovic, Alexander			DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients	PLOS ONE			English	Article							BLOOD-GROUP-A; RELIABLE PCR METHOD; GROUP ANTIGEN-A; RED-CELL; RAPID METHOD; H-ANTIGENS; DOVAM-S; BLADDER; GENE; CLONING	Background: Loss of A, B and H antigens from the red blood cells of patients with myeloid malignancies is a frequent occurrence. Previously, we have reported alterations in ABH antigens on the red blood cells of 55% of patients with myeloid malignancies. Methodology/Principal Findings: To determine the underlying molecular mechanisms of this loss, we assessed ABO allelic expression in 21 patients with ABH antigen loss previously identified by flow cytometric analysis as well as an additional 7 patients detected with ABH antigen changes by serology. When assessing ABO mRNA allelic expression, 6/12 (50%) patients with ABH antigen loss detected by flow cytometry and 5/7 (71%) of the patients with ABH antigen loss detected by serology had a corresponding ABO mRNA allelic loss of expression. We examined the ABO locus for copy number and DNA methylation alterations in 21 patients, 11 with loss of expression of one or both ABO alleles, and 10 patients with no detectable allelic loss of ABO mRNA expression. No loss of heterozygosity (LOH) at the ABO locus was observed in these patients. However in 8/11 (73%) patients with loss of ABO allelic expression, the ABO promoter was methylated compared with 2/10 (20%) of patients with no ABO allelic expression loss (P = 0.03). Conclusions/Significance: We have found that loss of ABH antigens in patients with hematological malignancies is associated with a corresponding loss of ABO allelic expression in a significant proportion of patients. Loss of ABO allelic expression was strongly associated with DNA methylation of the ABO promoter.	[Bianco-Miotto, Tina; Hussey, Damian J.; Day, Tanya K.; Dobrovic, Alexander] Dept Haematol Oncol, Woodville, SA, Australia; [Bianco-Miotto, Tina; Hussey, Damian J.; Day, Tanya K.; Dobrovic, Alexander] Univ Adelaide, Queen Elizabeth Hosp, Woodville, SA, Australia; [Bianco-Miotto, Tina] Univ Adelaide, Hanson Inst, Dame Roma Mitchell Canc Res Lab, Adelaide, SA 5005, Australia; [Hussey, Damian J.] Flinders Univ S Australia, Flinders Med Ctr, Dept Surg, Bedford Pk, SA 5001, Australia; [O'Keefe, Denise S.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA; [Dobrovic, Alexander] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Dobrovic, Alexander] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	University of Adelaide; Hanson Institute; University of Adelaide; Flinders Medical Centre; Flinders University South Australia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peter Maccallum Cancer Center; University of Melbourne	Bianco-Miotto, T (corresponding author), Dept Haematol Oncol, Woodville, SA, Australia.	tina.bianco-miotto@imvs.sa.gov.au	Day, Tanya/J-2187-2012; Bianco-Miotto, Tina/C-4808-2008; O'Keefe, Denise/A-6273-2010	Bianco-Miotto, Tina/0000-0002-8431-5338; Hussey, Damian/0000-0002-6121-6740; Dobrovic, Alexander/0000-0003-3414-112X	National Health and Medical Research Council Peter Doherty Fellowship	National Health and Medical Research Council Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	TBM is supported by a National Health and Medical Research Council Peter Doherty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco T, 2001, BLOOD, V97, P3633, DOI 10.1182/blood.V97.11.3633; Bianco T, 1999, HUM MUTAT, V14, P289, DOI 10.1002/(SICI)1098-1004(199910)14:4<289::AID-HUMU3>3.0.CO;2-A; Buzin CH, 2000, BIOTECHNIQUES, V28, P746, DOI 10.2144/00284rr04; Chihara Y, 2005, LAB INVEST, V85, P895, DOI 10.1038/labinvest.3700268; DABELSTEEN E, 1988, Proceedings of the Finnish Dental Society, V84, P19; DABELSTEEN E, 1988, CANCER RES, V48, P181; DANIELS G, 1995, HUMAN BLOOD GROUPS; Dobrovic A, 2002, METHODS, V27, P134, DOI 10.1016/S1046-2023(02)00065-8; Dobrovic A, 2005, MOL DIAGNOSTICS CLIN, P149; Eaton MC, 1997, BIOTECHNIQUES, V22, P100, DOI 10.2144/97221st01; EVDOKIOU A, 1993, GENOMICS, V18, P731, DOI 10.1016/S0888-7543(05)80388-X; FIALKOW PJ, 1981, BLOOD, V57, P1068; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Hata Y, 2002, VOX SANG, V82, P39, DOI 10.1046/j.0042-9007.2001.00134.x; HIROHASHI S, 1984, J NATL CANCER I, V72, P1299; Ichikawa D, 1998, INT J CANCER, V76, P284, DOI 10.1002/(SICI)1097-0215(19980413)76:2<284::AID-IJC17>3.0.CO;2-C; KAHN A, 1971, LANCET, V2, P933; KEINANEN M, 1988, NEW ENGL J MED, V318, P1153, DOI 10.1056/NEJM198805053181803; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Kominato Y, 1999, J BIOL CHEM, V274, P37240, DOI 10.1074/jbc.274.52.37240; Kuemmel A, 2007, TUMOR BIOL, V28, P340, DOI 10.1159/000124298; LANGE PH, 1978, J UROLOGY, V119, P52, DOI 10.1016/S0022-5347(17)57379-6; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LEE JCI, 1992, J FORENSIC SCI, V37, P1269; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; LIMAS C, 1979, CANCER, V44, P2099, DOI 10.1002/1097-0142(197912)44:6<2099::AID-CNCR2820440621>3.0.CO;2-I; Liu Q, 1999, BIOTECHNIQUES, V26, P932, DOI 10.2144/99265rr03; MARSDEN KA, 1992, CANCER GENET CYTOGEN, V64, P80, DOI 10.1016/0165-4608(92)90328-6; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moldvay J, 2000, CLIN CANCER RES, V6, P1125; Nakagoe T, 1998, CANCER DETECT PREV, V22, P499, DOI 10.1046/j.1525-1500.1998.00045.x; OKeefe DS, 1996, BLOOD, V87, P3061, DOI 10.1182/blood.V87.7.3061b.bloodjournal8773061b; OKEEFE DS, 1993, HUM MUTAT, V2, P67, DOI 10.1002/humu.1380020112; OKeefe DS, 1996, HUM MUTAT, V8, P358, DOI 10.1002/(SICI)1098-1004(1996)8:4<358::AID-HUMU9>3.0.CO;2-3; Orlow I, 1998, INT J CANCER, V75, P819, DOI 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y; ORNTOFT TF, 1989, J HISTOCHEM CYTOCHEM, V37, P1153, DOI 10.1177/37.7.2732458; PERLMAN EJ, 1990, AM J SURG PATHOL, V14, P810, DOI 10.1097/00000478-199009000-00002; Race RR., 1975, BLOOD GROUPS MAN; SALMON C, 1968, REV FR ETUD CLIN BIO, V13, P296; SALMON C, 1984, REV FR TRANSFUS IMMU, V27, P625, DOI 10.1016/S0338-4535(84)80084-7; SCHOENTAG R, 1987, CANCER RES, V47, P1695; SUCIU S, 1993, CANCER GENET CYTOGEN, V70, P1, DOI 10.1016/0165-4608(93)90122-3; VAN LOGHEM J J Jr, 1957, Vox Sang, V2, P16; Welshinger M, 1996, GYNECOL ONCOL, V62, P106, DOI 10.1006/gyno.1996.0198; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Worm J, 2001, CLIN CHEM, V47, P1183; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Xu Hua, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P240; YAMAMOTO F, 1990, TRANSFUSION, V30, P671, DOI 10.1046/j.1537-2995.1990.30891020320.x; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; Yamamoto F, 2004, Immunohematology, V20, P3; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yamamoto F, 2001, TRANSFUSION MED, V11, P281, DOI 10.1046/j.1365-3148.2001.00316.x	55	39	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4788	10.1371/journal.pone.0004788	http://dx.doi.org/10.1371/journal.pone.0004788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274076	Green Published, Green Accepted, gold			2022-12-27	WOS:000265496000024
J	Akundi, RS; Rivkees, SA				Akundi, Ravi Shankar; Rivkees, Scott A.			Hypoxia Alters Cell Cycle Regulatory Protein Expression and Induces Premature Maturation of Oligodendrocyte Precursor Cells	PLOS ONE			English	Article								Background: Periventricular white matter injury (PWMI) is a common form of brain injury sustained by preterm infants. A major factor that predisposes to PWMI is hypoxia. Because oligodendrocytes (OLs) are responsible for myelination of axons, abnormal OL development or function may affect brain myelination. At present our understanding of the influences of hypoxia on OL development is limited. To examine isolated effects of hypoxia on OLs, we examined the influences of hypoxia on OL development in vitro. Methodology/Findings: Cultures of oligodendrocyte precursor cells (OPCs) were prepared from mixed glial cultures and were 99% pure. OPCs were maintained at 21% O-2 or hypoxia (1% or 4% O-2) for up to 7 days. We observed that 1% O2 lead to an increase in the proportion of myelin basic protein (MBP)-positive OLs after 1 week in culture, and a decrease in the proportion of platelet-derived growth factor receptor a (PDGFRa)-positive cells suggesting premature OL maturation. Increased expression of the cell cycle regulatory proteins p27(Kip1) and phospho-cdc2, which play a role in OL differentiation, was seen as well. Conclusions: These results show that hypoxia interferes with the normal process of OL differentiation by inducing premature OPC maturation.	[Akundi, Ravi Shankar; Rivkees, Scott A.] Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Sect Dev Biol & Endocrinol, New Haven, CT 06520 USA	Yale University	Akundi, RS (corresponding author), Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Sect Dev Biol & Endocrinol, New Haven, CT 06520 USA.	scott.rivkees@yale.edu	Messier, Claude/A-2322-2008; Akundi, Ravi Shankar/J-2673-2019	Messier, Claude/0000-0002-4791-1763; Akundi, Ravi Shankar/0000-0003-3782-5965	American Heart Association; March of Dimes; National Institutes of Health [NS051191]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051191] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by awards from the American Heart Association (RSA), March of Dimes (SAR), and the National Institutes of Health (NS051191, SAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Back SA, 2001, AM HEART MONOGR S, P131; Back SA, 1997, MENT RETARD DEV D R, V3, P96, DOI 10.1002/(SICI)1098-2779(1997)3:1<96::AID-MRDD12>3.0.CO;2-M; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Bansal R, 2005, J NEUROSCI RES, V80, P360, DOI 10.1002/jnr.20454; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; CRAIG A, 2003, EXP NEUROL, P181; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; FAULSTICH H, 1988, J MUSCLE RES CELL M, V9, P370, DOI 10.1007/BF01774064; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; GARD AL, 1993, NEUROPROTOCOLS, V2, P209; GOEBEL HH, 1987, ACTA HISTOCHEM, P81; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Li S, 1999, J CLIN INVEST, V103, P1141, DOI 10.1172/JCI5367; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; NIGG EA, 1992, CIBA F SYMP, V170, P72; NIGG EA, 1992, CIBA F SYMP, V170, P84; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Raff M, 2001, NOVART FDN SYMP, V237, P100, DOI 10.1002/0470846666.ch9; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Resnik ER, 2007, P NATL ACAD SCI USA, V104, P18789, DOI 10.1073/pnas.0706019104; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Stark George R, 2004, Methods Mol Biol, V280, P51; WARRINGTON AE, 1992, DEV NEUROSCI-BASEL, V14, P93, DOI 10.1159/000111652; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104; YAN H, 2005, NEUROREPORT IN PRESS; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323	39	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4739	10.1371/journal.pone.0004739	http://dx.doi.org/10.1371/journal.pone.0004739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270736	gold, Green Published, Green Submitted			2022-12-27	WOS:000265495900008
J	Alles, MC; Gardiner-Garden, M; Nott, DJ; Wang, YX; Foekens, JA; Sutherland, RL; Musgrove, EA; Ormandy, CJ				Alles, M. Chehani; Gardiner-Garden, Margaret; Nott, David J.; Wang, Yixin; Foekens, John A.; Sutherland, Robert L.; Musgrove, Elizabeth A.; Ormandy, Christopher J.			Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the "Basal" Breast Cancer Subgroup	PLOS ONE			English	Article							ESTROGEN-RECEPTOR STATUS; C-MYC; EXPRESSION SIGNATURE; RESPONSIVE GENES; IN-VIVO; IDENTIFICATION; CARCINOMAS; DISCOVERY; SUBTYPES; PATTERNS	Background: Breast cancers lacking the estrogen receptor ( ER) can be distinguished from other breast cancers on the basis of poor prognosis, high grade, distinctive histopathology and unique molecular signatures. These features further distinguish estrogen receptor negative (ER2) tumor subtypes, but targeted therapy is currently limited to tumors over-expressing the ErbB2 receptor. Methodology/Principal Findings: To uncover the pathways against which future therapies could be developed we undertook a meta-analysis of gene expression from five large microarray datasets relative to ER status. A measure of association with ER status was calculated for every Affymetrix HG-U133A probe set and the pathways that distinguished ER2 tumors were defined by testing for enrichment of biologically defined gene sets using Gene Set Enrichment Analysis (GSEA). As expected, the expression of the direct transcriptional targets of the ER was muted in ER2 tumors, but the expression of genes indirectly regulated by estrogen was enhanced. We also observed enrichment of independent MYC- and E2F-driven transcriptional programs. We used a cell model of estrogen and MYC action to define the interaction between estrogen and MYC transcriptional activity in breast cancer. We found that the basal subgroup of ER2 breast cancer showed a strong MYC transcriptional response that reproduced the indirect estrogen response seen in estrogen receptor positive (ER+) breast cancer cells. Conclusions/Significance: Increased transcriptional activity of MYC is a characteristic of basal breast cancers where it mimics a large part of an estrogen response in the absence of the ER, suggesting a mechanism by which these cancers achieve estrogen-independence and providing a potential therapeutic target for this poor prognosis sub group of breast cancer.	[Alles, M. Chehani; Gardiner-Garden, Margaret; Sutherland, Robert L.; Musgrove, Elizabeth A.; Ormandy, Christopher J.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Nott, David J.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Wang, Yixin] Veridex LLC, Johnson & Johnson CO, Raritan, NJ USA; [Foekens, John A.] Erasmus MC, Canc Genom Ctr, Rotterdam, Netherlands; [Foekens, John A.] Erasmus MC, Dept Med Oncol, Josephine Nefkens Inst, Rotterdam, Netherlands	Garvan Institute of Medical Research; National University of Singapore; Johnson & Johnson; Johnson & Johnson USA; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Alles, MC (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	c.ormandy@garvan.org.au	Sutherland, Robert L/A-8378-2008; Ormandy, Chris/G-4165-2014	Ormandy, Christopher/0000-0002-2504-7919; Nott, David/0000-0002-5416-0005	Cancer Institute NSW [Fellow]; National Health and Medical Research Council of Australia (NH&MRC) [Senior Principal Research Fellow, Senior Research Fellow]; Petre Foundation; RT Hall Trust; Australian Postgraduate Award; Cancer Institute NSW Infrastructure; Australian Research Council; Veridex; Johnson & Johnson; Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Cancer Institute NSW; National Health and Medical Research Council of Australia (NH&MRC)(National Health and Medical Research Council (NHMRC) of Australia); Petre Foundation; RT Hall Trust; Australian Postgraduate Award(Australian Government); Cancer Institute NSW Infrastructure; Australian Research Council(Australian Research Council); Veridex; Johnson & Johnson(Johnson & JohnsonJohnson & Johnson USA); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Work in these laboratories is supported by grants from the Cancer Institute NSW, National Health and Medical Research Council of Australia (NH&MRC), the Petre Foundation and the RT Hall Trust. MCA is the recipient of an Australian Postgraduate Award. MGG is supported by a Cancer Institute NSW Infrastructure grant. DJN was supported by an Australian Research Council grant for the duration of this work. YW is funded internally by Veridex, Johnson & Johnson. JAF is funded by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. RLS is a Senior Principal Research Fellow of the NH&MRC. EAM is a Cancer Institute NSW Fellow. CJO is a Senior Research Fellow of the NH&MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Adem C, 2004, GENE CHROMOSOME CANC, V41, P1, DOI 10.1002/gcc.20057; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Blancato J, 2004, BRIT J CANCER, V90, P1612, DOI 10.1038/sj.bjc.6601703; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; Cunliffe HE, 2003, CANCER RES, V63, P7158; Cuny M, 2000, CANCER RES, V60, P1077; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efstratiadis A, 2007, CELL CYCLE, V6, P418, DOI 10.4161/cc.6.4.3838; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Fulford LG, 2006, HISTOPATHOLOGY, V49, P22, DOI 10.1111/j.1365-2559.2006.02453.x; Gruvberger S, 2001, CANCER RES, V61, P5979; Jones C, 2004, CLIN CANCER RES, V10, P5988, DOI 10.1158/1078-0432.CCR-03-0731; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; LUSA L, 2006, GENEMETA METAANALYSI; McNeil CM, 2006, J STEROID BIOCHEM, V102, P147, DOI 10.1016/j.jsbmb.2006.09.028; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Naidu R, 2002, INT J MOL MED, V9, P189; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rodriguez-Pinilla SM, 2007, J CLIN PATHOL, V60, P1017, DOI 10.1136/jcp.2006.043869; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Schneider J, 2006, INT J CANCER, V119, P2974, DOI 10.1002/ijc.22234; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	53	74	75	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4710	10.1371/journal.pone.0004710	http://dx.doi.org/10.1371/journal.pone.0004710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270750	Green Submitted, Green Published, gold			2022-12-27	WOS:000265495900003
J	Milner, ARC; Harris, JD; Lockley, MG; Kirkland, JI; Matthews, NA				Milner, Andrew R. C.; Harris, Jerald D.; Lockley, Martin G.; Kirkland, James I.; Matthews, Neffra A.			Bird-Like Anatomy, Posture, and Behavior Revealed by an Early Jurassic Theropod Dinosaur Resting Trace	PLOS ONE			English	Article							TROODONTID DINOSAUR; MOENAVE FORMATION; FORELIMB; SANDSTONE; ARIZONA; CHINA; UTAH; AGE	Background: Fossil tracks made by non-avian theropod dinosaurs commonly reflect the habitual bipedal stance retained in living birds. Only rarely-captured behaviors, such as crouching, might create impressions made by the hands. Such tracks provide valuable information concerning the often poorly understood functional morphology of the early theropod forelimb. Methodology/Principal Findings: Here we describe a well-preserved theropod trackway in a Lower Jurassic (similar to 198 million-year-old) lacustrine beach sandstone in the Whitmore Point Member of the Moenave Formation in southwestern Utah. The trackway consists of prints of typical morphology, intermittent tail drags and, unusually, traces made by the animal resting on the substrate in a posture very similar to modern birds. The resting trace includes symmetrical pes impressions and well-defined impressions made by both hands, the tail, and the ischial callosity. Conclusions/Significance: The manus impressions corroborate that early theropods, like later birds, held their palms facing medially, in contrast to manus prints previously attributed to theropods that have forward-pointing digits. Both the symmetrical resting posture and the medially-facing palms therefore evolved by the Early Jurassic, much earlier in the theropod lineage than previously recognized, and may characterize all theropods.	[Milner, Andrew R. C.] St George Dinosaur Discovery Site Johnson Farm, St George, UT USA; [Harris, Jerald D.] Dixie State Coll, St George, UT USA; [Lockley, Martin G.] Univ Colorado Denver, Dinosaur Tracks Museum, Denver, CO USA; [Kirkland, James I.] Utah Geol Survey, Salt Lake City, UT USA; [Matthews, Neffra A.] USDOI Bureau Land Management, Natl Operat Ctr, Denver, CO USA	Utah System of Higher Education; Dixie State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Milner, ARC (corresponding author), St George Dinosaur Discovery Site Johnson Farm, St George, UT USA.	amilner@sgcity.org						[Anonymous], 1964, ESTUDIOS ICNOLOGICOS; Baird D., 1980, P219; Baird D., 1957, Bulletin of the Museum of Comparative Zoology, V117, P449; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; BOCK WILHELM, 1952, JOUR PALEONTOL, V26, P395; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P157; Branson E.B., 1932, GEOLOGICAL SOC AM B, V43, P383; BULKLEY S, 1996, MUS N ARIZ B, V60, P167; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Chatterjee S, 2004, LIFE O PAST, P251; Clark James M., 1999, American Museum Novitates, V3265, P1; CLEMMENSEN LB, 1989, GEOL SOC AM BULL, V101, P759, DOI 10.1130/0016-7606(1989)101<0759:EMDITL>2.3.CO;2; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Demathieu Georges R.S., 1993, Zubia Monografico, V5, P229; Ellenberger P., 1972, PALAEOVERTEBRATA, P1; ELLENBERGER P, 1974, CONTRIBUTION CLASSIF, V1, P1; Farlow JO, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P248; FRASER NC, 1996, TRIASSIC VIRGINIA JE, V7, P1; GIERLINSKI G, 1991, PALAEOGEOGR PALAEOCL, V85, P137, DOI 10.1016/0031-0182(91)90030-U; GIERLINSKI G, 1996, GEOL Q, V40, P119; Gierlinski Gerard, 2004, Ichnos, V11, P195, DOI 10.1080/10420940490444861; Gierlinski Gerard, 2002, Geological Quarterly, V46, P467; Gierlinski Gerard, 1994, Przeglad Geologiczny, V42, P280; HAMBLIN AH, 2006, N M MUS NAT HIST SCI, V37, P276; Harris JD, 1996, CRETACEOUS RES, V17, P381, DOI 10.1006/cres.1996.0024; Haubold H., 1984, SAURIERFAHRTEN; HAUBOLD H, 1986, BEGINNING AGE DINOSA, P189; Haubold Hartmut, 2000, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V22, P59; HITCHCOCK E, 1856, AM J SCI, V21, P96; Hitchcock E., 1858, ICHNOLOGY NEW ENGLAN; HITCHCOCK EH, 1845, P 6 ANN M ASS AM GEO, V6, P23; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P21; Irby Grace V., 1996, Museum of Northern Arizona Bulletin, V60, P147; Kirkland, 2006, NEW MEXICO MUSEUM NA, V37, P510; Kirkland, 2007, UTAH GEOLOGICAL SURV, V39, P1; Kirkland J.I., 2006, NEW MEXICO MUSEUM NA, V37, P289; KIRKLAND JI, 2002, UTAH SURVEY NOTES, V34, P4; KIRKLAND JI, 2002, UTAH SURVEY NOTES, V34, P12; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Lingham-Soliar Theagarten, 2000, Ichnos, V7, P135; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley Martin, 2003, Ichnos, V10, P169, DOI 10.1080/10420940390256249; Lockley Martin, 2000, Gaia (Lisboa), V15, P279; Lockley Martin G., 1996, Museum of Northern Arizona Bulletin, V60, P113; LOCKLEY MG, 2005, TRACKING DINOSAUR OR, P12; LOCKLEY MG, 2006, NEW MEXICO MUSEUM NA, V37, P269; LUCAS S.G., 2006, NEW MEXICO MUSEUM NA, V37, P421; Lucas SG, 2001, NEUES JAHRB GEOL P-M, P435; LUCAS SG, 1994, WYOMING GEOLOGICAL A, V44, P105; LUCAS SG, 1993, MUSEUM NO ARIZONA B, V59, P27; LUCAS SG, 1997, SW PALEONTOLOGICAL S, V1, P49; LUCAS SG, 2006, NEW MEXICO MUSEUM NA, V37, P128; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V29, P84; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V29, P95; LULL RS, 1953, B CONNECTICUT STATE, V81, P1; Lull RS., 1904, MEMOIRS BOSTON SOC N, V5, P461; Martin A, 2005, J VERTEBR PALEONTOL, V25, p89A; MARZOLF JE, 1991, GEOLOGY, V19, P320, DOI 10.1130/0091-7613(1991)019<0320:LJUJFT>2.3.CO;2; MARZOLF JE, 1996, MUS N ARIZ B, V60, P441; MATTHEWS NA, 2006, NEW MEXICO MUSEUM NA, V34, P119; McCrea Richard T., 2002, Journal of Vertebrate Paleontology, V22, p86A; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; Milan J, 2006, PALAEONTOLOGY, V49, P405, DOI 10.1111/j.1475-4983.2006.00543.x; Milan J, 2008, ACTA PALAEONTOL POL, V53, P197, DOI 10.4202/app.2008.0203; Milner A. R. C., 2006, NEW MEXICO MUS NAT H, V37, P315; Milner A.R.C., 2006, NEW MEXICO MUS NAT H, V37, P329; MILNER ARC, 2005, GEOL SOC AM ABSTR, V37, P5; Molina-Garza RS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001909; Molnar R.E., 1985, P209; MORALES M, 1993, NEW MEXICO MUSEUM NA, V3, P357; Morales Michael, 1996, Museum of Northern Arizona Bulletin, V60, P143; Naish Darren, 2000, Archaeopteryx, V18, P35; Olsen P.E., 1986, P61; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586, DOI 10.1080/02724634.1998.10011086; Piubelli D, 2005, BOLL SOC GEOL ITAL, V124, P259; RAIKOW RJ, 1968, WILSON BULL, V80, P312; RAINFORTH E., 1997, VERTEBRATE ICH UNPUB; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Romer A, 1956, OSTEOLOGY REPTILES; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; SAFRAN J, 2004, GEOL SOC AM ABSTR, V36, P96; Schudack M.E., 2006, TRIASSIC JURASSIC TE, V37, P427; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; SERENO PC, 2006, HIST BIOL, V19, P145; SERENO PC, 1998, DIN S APR 17 19 1998; Smith JB, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P273; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; SULLIVAN RM, 1994, GEOL, V25, P2; THULBORN RA, 1984, ALCHERINGA, V8, P243, DOI 10.1080/03115518408618947; Thulborn RA., 1990, DINOSAUR TRACKS; Tidwell WD, 2006, NEW MEXICO MUSEUM NA, V37, P414; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; VAZQUEZ RJ, 1994, ZOOMORPHOLOGY, V114, P59, DOI 10.1007/BF00574915; Weems R.E., 1992, P 26 FORUM GEOLOGY I, V119, P113; Weems RE, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P293; Weems RE, 2006, NEW MEXICO MUSEUM NA, V37, P369; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Welles S.P., 1971, Plateau, V44, P27; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu Xing, 2003, Vertebrata Palasiatica, V41, P195; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; [No title captured]	104	56	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4591	10.1371/journal.pone.0004591	http://dx.doi.org/10.1371/journal.pone.0004591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259260	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490500002
J	Valverde, O; Celerier, E; Baranyi, M; Vanderhaeghen, P; Maldonado, R; Sperlagh, B; Vassart, G; Ledent, C				Valverde, Olga; Celerier, Evelyne; Baranyi, Maria; Vanderhaeghen, Pierre; Maldonado, Rafael; Sperlagh, Beata; Vassart, Gilbert; Ledent, Catherine			GPR3 Receptor, a Novel Actor in the Emotional-Like Responses	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; TAIL SUSPENSION TEST; MICE DEFICIENT; MOLECULAR-CLONING; INVERSE AGONIST; MEIOTIC ARREST; MUTANT MICE; ANXIETY; DEPRESSION; HABENULA	GPR3 is an orphan G protein-coupled receptor endowed with constitutive Gs signaling activity, which is expressed broadly in the central nervous system, with maximal expression in the habenula. We investigated the consequences of its genetic deletion in several behavioral paradigms and on neurotransmission. Compared to wild-type, hippocampal neurons from Gpr3(-/-) mice displayed lower basal intracellular cAMP levels, consistent with the strong constitutive activity of GPR3 in transiently transfected cells. Behavioral analyses revealed that Gpr3(-/-) mice exhibited a high level of avoidance of novel and unfamiliar environment, associated with increased stress reactivity in behavioral despair paradigms and aggressive behavior in the resident-intruder test. On the contrary, no deficit was found in the learning ability to avoid an aversive event in active avoidance task. The reduced ability of Gpr3(-/-) mice to cope with stress was unrelated to dysfunction of the hypothalamic-pituitary-adrenal axis, with Gpr3(-/-) mice showing normal corticosterone production under basal or stressful conditions. In contrast, dramatic alterations of monoamine contents were found in hippocampus, hypothalamus and frontal cortex of Gpr3(-/-) mice. Our results establish a link between tonic stimulation of the cAMP signaling pathway by GPR3 and control of neurotransmission by monoamines throughout the forebrain. GPR3 qualifies as a new player in the modulation of behavioral responses to stress and constitutes a novel promising pharmacological target for treatment of emotional disorders.	[Valverde, Olga] Univ Pompeu Fabra, Grp Recerca Neurobiol Comportament, Dept Ciencies Expt & Salut, Barcelona, Spain; [Celerier, Evelyne; Maldonado, Rafael] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Neurofarmacol, Barcelona, Spain; [Baranyi, Maria; Sperlagh, Beata] Hungarian Acad Sci, Inst Expt Med, H-1051 Budapest, Hungary; [Vanderhaeghen, Pierre; Vassart, Gilbert; Ledent, Catherine] Free Univ Brussels, IRIBHM, Campus Erasme, B-1050 Brussels, Belgium	Pompeu Fabra University; Pompeu Fabra University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Valverde, O (corresponding author), Univ Pompeu Fabra, Grp Recerca Neurobiol Comportament, Dept Ciencies Expt & Salut, Barcelona, Spain.	cledent@ulb.ac.be	Valverde, Olga/D-8654-2012; Maldonado, Rafael/F-5657-2014	Valverde, Olga/0000-0003-2264-7852; Maldonado, Rafael/0000-0002-4359-8773; Vanderhaeghen, Pierre/0000-0001-7899-5720	Interuniversity Attraction Poles Programme (P6-14) - Belgian State - Belgian Science Policy; Fondation Medicale Reine Elisabeth; Walloon Region (Programme d'Excellence "CIBLES"); Fonds National de la Recherche Scientifique; Spanish Ministry of Science and Technology [SAF2007/60249]; Spanish Ministery of Health [RD06/0001/1001]; Hungarian Research and Development Fund [OTKA 061758]	Interuniversity Attraction Poles Programme (P6-14) - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Fondation Medicale Reine Elisabeth; Walloon Region (Programme d'Excellence "CIBLES"); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministery of Health; Hungarian Research and Development Fund	This work was supported by the Interuniversity Attraction Poles Programme (P6-14) - Belgian State - Belgian Science Policy, the Fondation Medicale Reine Elisabeth, the Walloon Region (Programme d'Excellence "CIBLES"), the Fonds National de la Recherche Scientifique, the Spanish Ministry of Science and Technology (SAF2007/60249), the Spanish Ministery of Health (PNSD and RD06/0001/1001) and the Hungarian Research and Development Fund (OTKA 061758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; BAGDY G, 1995, EUR J PHARMACOL, V275, P301, DOI 10.1016/0014-2999(95)00051-L; Baranyi M, 2006, J CHROMATOGR A, V1120, P13, DOI 10.1016/j.chroma.2006.03.018; Bjork JM, 1999, PSYCHOPHARMACOLOGY, V142, P24, DOI 10.1007/s002130050858; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHAMBERLAIN B, 1987, PHARMACOL BIOCHEM BE, V28, P503, DOI 10.1016/0091-3057(87)90513-2; Cherry JA, 1999, J COMP NEUROL, V407, P287; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DENG J, 2008, J BIOL CHEM, V193, P265; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Ferraro G, 1997, J NEURAL TRANSM, V104, P615, DOI 10.1007/BF01291880; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Hen R, 1996, NEURON, V16, P17, DOI 10.1016/S0896-6273(00)80019-7; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Joost P, 2002, GENOME BIOL, V3; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Leurs R, 1998, TRENDS BIOCHEM SCI, V23, P418, DOI 10.1016/S0968-0004(98)01287-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malberg JE, 2005, TRENDS PHARMACOL SCI, V26, P631, DOI 10.1016/j.tips.2005.10.005; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; PUCILOWSKI O, 1983, BEHAV BRAIN RES, V9, P33, DOI 10.1016/0166-4328(83)90012-8; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Salas R, 2003, J NEUROSCI, V23, P6255; SANSONE M, 1975, ARCH INT PHARMACOD T, V218, P125; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; VACCARI S, 2008, DEV BIOL; Valverde O, 2004, NEUROPSYCHOPHARMACOL, V29, P1122, DOI 10.1038/sj.npp.1300416; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Wilson MA, 2004, PHARMACOL BIOCHEM BE, V78, P445, DOI 10.1016/j.pbb.2004.04.017; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587	53	50	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4704	10.1371/journal.pone.0004704	http://dx.doi.org/10.1371/journal.pone.0004704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259266	Green Published, gold			2022-12-27	WOS:000265490500015
J	Kang, SM; Yoo, DG; Lipatov, AS; Song, JM; Davis, CT; Quan, FS; Chen, LM; Donis, RO; Compans, RW				Kang, Sang-Moo; Yoo, Dae-Goon; Lipatov, Aleksandr S.; Song, Jae-Min; Davis, C. Todd; Quan, Fu-Shi; Chen, Li-Mei; Donis, Ruben O.; Compans, Richard W.			Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles	PLOS ONE			English	Article							MEMORY B-CELLS; A VIRUS; PANDEMIC INFLUENZA; LETHAL INFLUENZA; T-CELL; MF59-ADJUVANTED INFLUENZA; VACCINE; HEMAGGLUTININ; IMMUNIZATION; CHALLENGE	Background: Recurrent outbreaks of highly pathogenic H5N1 avian influenza virus pose a threat of eventually causing a pandemic. Early vaccination of the population would be the single most effective measure for the control of an emerging influenza pandemic. Methodology/Principal Findings: Influenza virus-like particles (VLPs) produced in insect cell-culture substrates do not depend on the availability of fertile eggs for vaccine manufacturing. We produced VLPs containing influenza A/Viet Nam1203/04 (H5N1) hemagglutinin, neuraminidase, and matrix proteins, and investigated their preclinical immunogenicity and protective efficacy. Mice immunized intranasally with H5N1 VLPs developed high levels of H5N1 specific antibodies and were 100% protected against a high dose of homologous H5N1 virus infection at 30 weeks after immunization. Protection is likely to be correlated with humoral and cellular immunologic memory at systemic and mucosal sites as evidenced by rapid anamnestic responses to re-stimulation with viral antigen in vivo and in vitro. Conclusions/Significance: These results provide support for clinical evaluation of H5N1 VLP vaccination as a public health intervention to mitigate a possible pandemic of H5N1 influenza.	[Kang, Sang-Moo; Yoo, Dae-Goon; Song, Jae-Min; Quan, Fu-Shi; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Kang, Sang-Moo; Yoo, Dae-Goon; Song, Jae-Min; Quan, Fu-Shi; Compans, Richard W.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Lipatov, Aleksandr S.; Davis, C. Todd; Chen, Li-Mei; Donis, Ruben O.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA	Emory University; Emory University; Centers for Disease Control & Prevention - USA	Kang, SM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	skang2@emory.edu; compans@microbio.emory.edu	Quan, Fu-Shi/V-1826-2019; Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X	NIH/NIAID [AI0680003]; Korea Ginseng Society	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Korea Ginseng Society	This work was supported by NIH/NIAID grant AI0680003 (R.W.C.) and partially by funds from Korea Ginseng Society (S.K.). The funders did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The findings and conclusions of this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC). Proprietary or brand names used are necessary to report factually on available data. However, the CDC neither guarantees nor warrants the standard of the product, and the use of names by the CDC implies no approval of the product to the exclusion of others that may also be suitable.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], FIELDS VIROLOGY; ARORA DJS, 1985, ANAL BIOCHEM, V144, P189, DOI 10.1016/0003-2697(85)90103-4; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; BLOCK SL, 2008, SHEDDING IMMUNOGENIC; Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Chen JJ, 2005, VACCINE, V23, P4322, DOI 10.1016/j.vaccine.2005.03.035; Chen Z, 1999, VACCINE, V17, P653, DOI 10.1016/S0264-410X(98)00247-3; Cintra Otávio A. L., 2006, J. Pediatr. (Rio J.), V82, ps83, DOI [10.1590/S0021-75572006000400010, 10.2223/JPED.1494]; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Demicheli V, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001269.PUB2, 10.1002/14651858.CD001269]; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; DESHEVA J, 2006, VACCINE; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Galarza JM, 2005, VIRAL IMMUNOL, V18, P244, DOI 10.1089/vim.2005.18.244; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; LU X, 2006, VACCINE; Luke CJ, 2006, EMERG INFECT DIS, V12, P66, DOI 10.3201/eid1201.051147; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Pushko P, 2007, VACCINE, V25, P4283, DOI 10.1016/j.vaccine.2007.02.059; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Ruat C, 2008, J VIROL, V82, P2565, DOI 10.1128/JVI.01928-07; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Slifka MK, 1996, J VIROL, V70, P2902, DOI 10.1128/JVI.70.5.2902-2910.1996; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; SUGUITAN AL, 2006, PLOS MED, V360, pN1; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Trollfors B, 2006, ACTA PAEDIATR, V95, P774, DOI 10.1080/08035250600729126; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1988, VIROLOGY, V164, P230, DOI 10.1016/0042-6822(88)90640-X; Wu HY, 1997, SCAND J IMMUNOL, V46, P506, DOI 10.1046/j.1365-3083.1997.d01-159.x; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008	54	88	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4667	10.1371/journal.pone.0004667	http://dx.doi.org/10.1371/journal.pone.0004667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252744	Green Published, Green Submitted, gold			2022-12-27	WOS:000265489900009
J	Reich, J; Snee, MJ; Macdonald, PM				Reich, John; Snee, Mark J.; Macdonald, Paul M.			miRNA-Dependent Translational Repression in the Drosophila Ovary	PLOS ONE			English	Article							OSKAR MESSENGER-RNA; SELFISH GENETIC ELEMENTS; BINDING-PROTEIN; LOCALIZATION; MICRORNA; AUBERGINE; INITIATION; DECAY; ASSOCIATION; MECHANISM	Background: The Drosophila ovary is a tissue rich in post-transcriptional regulation of gene expression. Many of the regulatory factors are proteins identified via genetic screens. The more recent discovery of microRNAs, which in other animals and tissues appear to regulate translation of a large fraction of all mRNAs, raised the possibility that they too might act during oogenesis. However, there has been no direct demonstration of microRNA-dependent translational repression in the ovary. Methodology/Principal Findings: Here, quantitative analyses of transcript and protein levels of transgenes with or without synthetic miR-312 binding sites show that the binding sites do confer translational repression. This effect is dependent on the ability of the cells to produce microRNAs. By comparison with microRNA-dependent translational repression in other cell types, the regulated mRNAs and the protein factors that mediate repression were expected to be enriched in sponge bodies, subcellular structures with extensive similarities to the P bodies found in other cells. However, no such enrichment was observed. Conclusions/Significance: Our results reveal the variety of post-transcriptional regulatory mechanisms that operate in the Drosophila ovary, and have implications for the mechanisms of miRNA-dependent translational control used in the ovary.	[Reich, John; Snee, Mark J.; Macdonald, Paul M.] Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Reich, J (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	pmacdonald@mail.utexas.edu		Snee, Mark/0000-0003-4018-816X	NIH [GM54409, 1-FY08-445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant GM54409 and in part by Research Grant No. 1-FY08-445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burgler C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-88; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cox DN, 2000, DEVELOPMENT, V127, P503; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Lin MD, 2006, DEV CELL, V10, P601, DOI 10.1016/j.devcel.2006.02.021; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Snee M, 2008, RNA BIOL, V5, P49, DOI 10.4161/rna.5.1.5735; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; SNEE MJ, 2009, DEV DYNAMIC IN PRESS; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477	65	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4669	10.1371/journal.pone.0004669	http://dx.doi.org/10.1371/journal.pone.0004669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252745	gold, Green Published, Green Submitted			2022-12-27	WOS:000265489900010
J	Duellman, SJ; Burgess, RR				Duellman, Sarah J.; Burgess, Richard R.			Antigen-Binding Properties of Monoclonal Antibodies Reactive with EBNA1 and Use in Immunoaffinity Chromatography	PLOS ONE			English	Article								Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) was overexpressed and purified from Escherichia coli. Mouse monoclonal antibodies (mAbs) were prepared that react with EBNA1. Eleven high affinity mAbs were recovered. Nine mAbs are isotype IgG (all subisotype IgG(1)) and two mAbs are isotype IgM. All mAbs react strongly with EBNA1 in an ELISA assay while only one mAb (designated 1EB6) fails to react in a Western blot assay. The epitopes for these mAbs were mapped to seven different regions, providing good coverage of the entire EBNA1 protein. The mAbs had differing affinity for an EBNA1/DNA complex with four mAbs able to supershift the complex completely. All mAbs can immunoprecipitate EBNA1 from E. coli overexpressing EBNA1. A modified ELISA assay, termed ELISA-elution assay, was used to screen for mAbs that release EBNA1 in the presence of a low molecular weight polyhydroxylated compound (polyol) and a nonchaotropic salt. MAbs with this property, termed polyol-responsive (PR)-mAbs, allow gentle elution of labile proteins and protein complexes. Four mAbs are polyol-responsive with two showing usefulness in gentle immunoaffinity chromatography. Purification with these PR-mAbs may be useful in purifying EBNA1 complexes and elucidating EBNA1-associated proteins. This panel of anti-EBNA1 mAbs will advance the study of EBV by providing new tools to detect and purify EBNA1.	[Duellman, Sarah J.; Burgess, Richard R.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Duellman, SJ (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	burgess@oncology.wisc.edu						Aiyar A, 1998, J BIOL CHEM, V273, P33073, DOI 10.1074/jbc.273.49.33073; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Duellman SJ, 2006, PROTEIN EXPRES PURIF, V47, P434, DOI 10.1016/j.pep.2005.11.023; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; GAHN TA, 1995, J VIROL, V69, P2633, DOI 10.1128/JVI.69.4.2633-2636.1995; GRASSER FA, 1994, BLOOD, V84, P3792, DOI 10.1182/blood.V84.11.3792.bloodjournal84113792; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; Kennedy G, 2003, MOL CELL BIOL, V23, P6901, DOI 10.1128/MCB.23.19.6901-6908.2003; Lee MA, 1999, J VIROL, V73, P2974, DOI 10.1128/JVI.73.4.2974-2982.1999; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Lynch NA, 1996, APPL ENVIRON MICROB, V62, P2133, DOI 10.1128/AEM.62.6.2133-2137.1996; MACKEY D, 1995, J VIROL, V69, P6199, DOI 10.1128/JVI.69.10.6199-6208.1995; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shire K, 2006, J VIROL, V80, P5261, DOI 10.1128/JVI.02682-05; SU W, 1991, P NATL ACAD SCI USA, V88, P10870, DOI 10.1073/pnas.88.23.10870; SUGDEN B, 1989, J VIROL, V63, P2644, DOI 10.1128/JVI.63.6.2644-2649.1989; Thompson N.E., 2001, CURRENT PROTOCOLS MO; Thompson NE, 1996, METHOD ENZYMOL, V274, P513; THOMPSON NE, 1992, BIOCHEMISTRY-US, V31, P7003, DOI 10.1021/bi00145a019; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	25	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4614	10.1371/journal.pone.0004614	http://dx.doi.org/10.1371/journal.pone.0004614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242546	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487500016
J	Capellini, I; McNamara, P; Preston, BT; Nunn, CL; Barton, RA				Capellini, Isabella; McNamara, Patrick; Preston, Brian T.; Nunn, Charles L.; Barton, Robert A.			Does Sleep Play a Role in Memory Consolidation? A Comparative Test	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; BRAIN; EVOLUTION	Sleep is a pervasive characteristic of mammalian species, yet its purpose remains obscure. It is often proposed that 'sleep is for the brain', a view that is supported by experimental studies showing that sleep improves cognitive processes such as memory consolidation. Some comparative studies have also reported that mammalian sleep durations are higher among more encephalized species. However, no study has assessed the relationship between sleep and the brain structures that are implicated in specific cognitive processes across species. The hippocampus, neocortex and amygdala are important for memory consolidation and learning and are also in a highly actived state during sleep. We therefore investigated the evolutionary relationship between mammalian sleep and the size of these brain structures using phylogenetic comparative methods. We found that evolutionary increases in the size of the amygdala are associated with corresponding increases in NREM sleep durations. These results are consistent with the hypothesis that NREM sleep is functionally linked with specializations of the amygdala, including perhaps memory processing.	[Capellini, Isabella; Barton, Robert A.] Univ Durham, Dept Anthropol, Durham, England; [McNamara, Patrick] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McNamara, Patrick] Boston VA Healthcare Syst, Boston, MA USA; [Preston, Brian T.; Nunn, Charles L.] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Nunn, Charles L.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Nunn, Charles L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Durham University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Max Planck Society; University of California System; University of California Berkeley	Capellini, I (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	Isabella.Capellini@durham.ac.uk	Capellini, Isabella/H-4813-2013	Capellini, Isabella/0000-0001-8065-2436	NIMH [1R01MH070415-01A1]; Max Planck Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070415] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH grant number 1R01MH070415-01A1 to PM, RB and CN and the Max Planck Society (CN, BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; ALLISON T, 1976, SCIENCE, V194, P732, DOI 10.1126/science.982039; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Barton RA, 2003, P ROY SOC B-BIOL SCI, V270, P539, DOI 10.1098/rspb.2002.2276; BARTON RA, 1998, P ROY SOC LOND B BIO, V268, P1933; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BININDAEMONDS ORP, 2006, NATURE, V156, P274; BOBERLY AA, 2005, PRINCIPLES PRACTICE, P105; Bonnet MH., 2005, SLEEP DEPRIVATION BA, P103; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; ELGAR MA, 1988, ANIM BEHAV, V36, P1407, DOI 10.1016/S0003-3472(88)80211-2; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Harvey P.H., 1991, COMP METHOD EVOLUTIO; ISAACSON RI, 2008, ENCY NEUROSCIENCE; KREBS JR, 1990, PHILOS T ROY SOC B, V329, P153, DOI 10.1098/rstb.1990.0160; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; McNamara Patrick, 2008, Open Sleep J, V1, P11; Mukhametov L. M., 1984, EXPT BRAIN RES S, P227, DOI [10.1007/978-3-[ 642-69554-4_17spinal, DOI 10.1007/978-3-642-69554-E]; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pare D, 2003, ANN NY ACAD SCI, V985, P78; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Preston BT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-7; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Roth TC, 2008, P ROY SOC LOND B BIO, V276, P401; SEJUOKSKI TJ, 2000, BRAIN RES S, V886, P208; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; SQUIRE LR, NEUROPSYCHOLOGY MEMO; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; YOU SS, 2007, CURR BIOL, V17, pR877; Zepelin H, 2005, PRINCIPLES PRACTICE, P91, DOI [10.1016/B0-72-160797-7/50015-X, DOI 10.1016/B0-72-160797-7/50015-X]; Zepelin Harold, 1989, PRINCIPLES PRACTICE, P30	47	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4609	10.1371/journal.pone.0004609	http://dx.doi.org/10.1371/journal.pone.0004609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240803	Green Published, Green Accepted, gold			2022-12-27	WOS:000278086700019
J	Gandhi, J; Zhang, JL; Xie, Y; Soh, J; Shigematsu, H; Zhang, W; Yamamoto, H; Peyton, M; Girard, L; Lockwood, WW; Lam, WL; Varella-Garcia, M; Minna, JD; Gazdar, AF				Gandhi, Jeet; Zhang, Jianling; Xie, Yang; Soh, Junichi; Shigematsu, Hisayuki; Zhang, Wei; Yamamoto, Hiromasa; Peyton, Michael; Girard, Luc; Lockwood, William W.; Lam, Wan L.; Varella-Garcia, Marileila; Minna, John D.; Gazdar, Adi F.			Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines	PLOS ONE			English	Article								Background: Deregulation of EGFR signaling is common in non-small cell lung cancers (NSCLC) and this finding led to the development of tyrosine kinase inhibitors (TKIs) that are highly effective in a subset of NSCLC. Mutations of EGFR (mEGFR) and copy number gains (CNGs) of EGFR (gEGFR) and HER2 (gHER2) have been reported to predict for TKI response. Mutations in KRAS (mKRAS) are associated with primary resistance to TKIs. Methodology/Principal Findings: We investigated the relationship between mutations, CNGs and response to TKIs in a large panel of NSCLC cell lines. Genes studied were EGFR, HER2, HER3 HER4, KRAS, BRAF and PIK3CA. Mutations were detected by sequencing, while CNGs were determined by quantitative PCR (qPCR), fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH). IC50 values for the TKIs gefitinib (Iressa) and erlotinib (Tarceva) were determined by MTS assay. For any of the seven genes tested, mutations (39/77, 50.6%), copy number gains (50/77, 64.9%) or either (65/77, 84.4%) were frequent in NSCLC lines. Mutations of EGFR (13%) and KRAS (24.7%) were frequent, while they were less frequent for the other genes. The three techniques for determining CNG were well correlated, and qPCR data were used for further analyses. CNGs were relatively frequent for EGFR and KRAS in adenocarcinomas. While mutations were largely mutually exclusive, CNGs were not. EGFR and KRAS mutant lines frequently demonstrated mutant allele specific imbalance i.e. the mutant form was usually in great excess compared to the wild type form. On a molar basis, sensitivity to gefitinib and erlotinib were highly correlated. Multivariate analyses led to the following results: 1. mEGFR and gEGFR and gHER2 were independent factors related to gefitinib sensitivity, in descending order of importance. 2. mKRAS was associated with increased in vitro resistance to gefitinib. Conclusions/Significance: Our in vitro studies confirm and extend clinical observations and demonstrate the relative importance of both EGFR mutations and CNGs and HER2 CNGs in the sensitivity to TKIs.	[Gandhi, Jeet; Zhang, Jianling; Soh, Junichi; Shigematsu, Hisayuki; Zhang, Wei; Yamamoto, Hiromasa; Peyton, Michael; Girard, Luc; Minna, John D.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA; [Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX USA; [Lockwood, William W.; Lam, Wan L.] British Columbia Canc Res Ctr, Dept Canc Genet & Dev Biol, Vancouver, BC, Canada; [Varella-Garcia, Marileila] Univ Colorado Canc Ctr, Dept Internal Med, Aurora, CO USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; British Columbia Cancer Agency; University of Colorado System; University of Colorado Anschutz Medical Campus	Gandhi, J (corresponding author), Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	adi.gazdar@utsouthwestern.edu	Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; Peyton, Michael/A-8728-2008; Lockwood, William W/A-2879-2009	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; 	Specialized Program of Research Excellence in Lung Cancer [P50CA70907]; Early Detection Research Network, National Cancer Institute, Bethesda, Maryland [U01CA084971]; NATIONAL CANCER INSTITUTE [U01CA084971, P50CA070907] Funding Source: NIH RePORTER	Specialized Program of Research Excellence in Lung Cancer; Early Detection Research Network, National Cancer Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was recieved from the Specialized Program of Research Excellence in Lung Cancer (P50CA70907) and Early Detection Research Network, National Cancer Institute, Bethesda, Maryland (U01CA084971). Funds from both grants were utilized for salary support and for performance of assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieche I, 1999, CLIN CHEM, V45, P1148; Cappuzzo F, 2005, BRIT J CANCER, V93, P1334, DOI 10.1038/sj.bjc.6602865; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; EVERIT B, 1994, STAT METHODS MED INV; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Galanis E, 1997, CANCER-AM CANCER SOC, V79, P1729, DOI 10.1002/(SICI)1097-0142(19970501)79:9<1729::AID-CNCR14>3.0.CO;2-#; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; GAZDAR AF, 2008, CANCER PREV RES, V1, P6; Gondek LP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001225; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jong K, 2004, BIOINFORMATICS, V20, P3636, DOI 10.1093/bioinformatics/bth355; Jung SH, 2001, STAT MED, V20, P1971, DOI 10.1002/sim.846.abs; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lockwood WW, 2007, INT J CANCER, V120, P436, DOI 10.1002/ijc.22335; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Lyng H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r86; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Mellinghoff IK, 2007, CLIN CANCER RES, V13, P378, DOI 10.1158/1078-0432.CCR-06-1992; Naoki K, 2002, CANCER RES, V62, P7001; NETTER J, 1996, APPL LINEAR STAT MOD; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nomura M, 2007, PLOS MED, V4, P715, DOI 10.1371/journal.pmed.0040125; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; PAWSON T, 1994, BIOCHEM SOC T, V22, P455, DOI 10.1042/bst0220455; Phelps RM, 1996, J CELL BIOCHEM, P32; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rosenberg C, 1997, CYTOMETRY, V29, P113, DOI 10.1002/(SICI)1097-0320(19971001)29:2<113::AID-CYTO3>3.0.CO;2-E; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2007, J THORAC ONCOL, V2, pS68, DOI 10.1097/01.JTO.0000269737.05962.a0; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soh J, 2008, J THORAC ONCOL, V3, P340, DOI 10.1097/JTO.0b013e318168d20a; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; TANG X, 2008, CANCER PREV RES, V1, P9; Tyybakinoja A, 2008, HAEMATOLOGICA, V93, P631, DOI 10.3324/haematol.12232; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Varella-Garcia M, 2003, ONCOLOGIST, V8, P45, DOI 10.1634/theoncologist.8-1-45; YAMAMOTO H, 2008, CANC RES, V68; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211; Zhang J, 2008, CANCER PREV RES, V1, P201, DOI 10.1158/1940-6207.CAPR-08-0014; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	54	160	164	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4576	10.1371/journal.pone.0004576	http://dx.doi.org/10.1371/journal.pone.0004576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238210	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487400009
J	Mei, J; Li, Z; Gui, JF				Mei, Jie; Li, Zhi; Gui, Jian-Fang			Cooperation of Mtmr8 with PI3K Regulates Actin Filament Modeling and Muscle Development in Zebrafish	PLOS ONE			English	Article							PROTEIN-KINASE-A; SONIC-HEDGEHOG; TYROSINE PHOSPHATASES; MYOTUBULAR MYOPATHY; MUSCULAR-DYSTROPHY; CELL MIGRATION; GRAM DOMAIN; GENE; DISEASE; FAMILY	Background: It has been shown that mutations in at least four myotubularin family genes (MTM1, MTMR1, 2 and 13) are causative for human neuromuscular disorders. However, the pathway and regulative mechanism remain unknown. Methodology/Principal Findings: Here, we reported a new role for Mtmr8 in neuromuscular development of zebrafish. Firstly, we cloned and characterized zebrafish Mtmr8, and revealed the expression pattern predominantly in the eye field and somites during early somitogenesis. Using morpholino knockdown, then, we observed that loss-of-function of Mtmr8 led to defects in somitogenesis. Subsequently, the possible underlying mechanism and signal pathway were examined. We first checked the Akt phosphorylation, and observed an increase of Akt phosphorylation in the morphant embryos. Furthermore, we studied the PH/G domain function within Mtmr8. Although the PH/G domain deletion by itself did not result in embryonic defect, addition of PI3K inhibitor LY294002 did give a defective phenotype in the PH/G deletion morphants, indicating that the PH/G domain was essential for Mtmr8's function. Moreover, we investigated the cooperation of Mtmr8 with PI3K in actin filament modeling and muscle development, and found that both Mtmr8-MO1 and Mtmr8-MO2+LY294002 led to the disorganization of the actin cytoskeleton. In addition, we revealed a possible participation of Mtmr8 in the Hedgehog pathway, and cell transplantation experiments showed that Mtmr8 worked in a non-cell autonomous manner in actin modeling. Conclusion/Significance: The above data indicate that a conserved functional cooperation of Mtmr8 with PI3K regulates actin filament modeling and muscle development in zebrafish, and reveal a possible participation of Mtmr8 in the Hedgehog pathway. Therefore, this work provides a new clue to study the physiological function of MTM family members.	[Mei, Jie; Li, Zhi; Gui, Jian-Fang] Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Mei, J (corresponding author), Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn	Mei, Jie/C-5261-2012		National Major Basic Research Program [6462004CB117401]; Innovation Project of Chinese Academy of Sciences [KSCX2-YW-N-020]; Innovation Project of IHB, CAS [075A01-1-301]	National Major Basic Research Program(National Basic Research Program of China); Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Innovation Project of IHB, CAS(Chinese Academy of Sciences)	This work was supported by the National Major Basic Research Program (grant No. 6462004CB117401), the Innovation Project of Chinese Academy of Sciences (grant No.KSCX2-YW-N-020), and the Innovation Project of IHB, CAS (grant No. 075A01-1-301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Buj-Bello A, 2002, HUM MOL GENET, V11, P2297, DOI 10.1093/hmg/11.19.2297; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Carricaburu V, 2003, P NATL ACAD SCI USA, V100, P9867, DOI 10.1073/pnas.1734038100; Chodniewicz D, 2003, BLOOD, V101, P1181, DOI 10.1182/blood-2002-05-1435; Chojnowski A, 2007, NEUROBIOL DIS, V26, P323, DOI 10.1016/j.nbd.2006.12.018; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Croushore JA, 2005, DEV DYNAM, V234, P911, DOI 10.1002/dvdy.20576; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Guyon JR, 2007, BBA-MOL BASIS DIS, V1772, P205, DOI 10.1016/j.bbadis.2006.07.003; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Hunter T, 1998, NAT GENET, V18, P303; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lorenzo O, 2005, J CELL SCI, V118, P2005, DOI 10.1242/jcs.02325; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; Mei J, 2008, MOL CELL ENDOCRINOL, V289, P67, DOI 10.1016/j.mce.2008.02.016; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004; Wang W, 2005, BIOCHEM BIOPH RES CO, V330, P1127, DOI 10.1016/j.bbrc.2005.03.082; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whittard JD, 2001, J CELL SCI, V114, P3265; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07	63	23	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4979	10.1371/journal.pone.0004979	http://dx.doi.org/10.1371/journal.pone.0004979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325702	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499400003
J	Bortolotti, GR; Mougeot, F; Martinez-Padilla, J; Webster, LMI; Piertney, SB				Bortolotti, Gary R.; Mougeot, Francois; Martinez-Padilla, Jesus; Webster, Lucy M. I.; Piertney, Stuart B.			Physiological Stress Mediates the Honesty of Social Signals	PLOS ONE			English	Article							IMMUNOCOMPETENCE HANDICAP HYPOTHESIS; AUTUMN TERRITORIAL BEHAVIOR; LAGOPUS-LAGOPUS-SCOTICUS; RED GROUSE; TRICHOSTRONGYLUS-TENUIS; PLUMAGE COLORATION; IMMUNE FUNCTION; ZEBRA FINCHES; TESTOSTERONE; CORTICOSTERONE	Background: Extravagant ornaments used as social signals evolved to advertise their bearers' quality. The Immunocompetence Handicap Hypothesis proposes that testosterone-dependent ornaments reliably signal health and parasite resistance; however, empirical studies have shown mixed support. Alternatively, immune function and parasite resistance may be indirectly or directly related to glucocorticoid stress hormones. We propose that an understanding of the interplay between the individual and its environment, particularly how they cope with stressors, is crucial for understanding the honesty of social signals. Methodology/Principal Findings: We analyzed corticosterone deposited in growing feathers as an integrated measure of hypothalamic-pituitary-adrenal activity in a wild territorial bird, the red grouse Lagopus lagopus scoticus. We manipulated two key, interrelated components, parasites and testosterone, which influence both ornamentation and fitness. Birds were initially purged of parasites, and later challenged with parasites or not, while at the same time being given testosterone or control implants, using a factorial experimental design. At the treatment level, testosterone enhanced ornamentation, while parasites reduced it, but only in males not implanted with testosterone. Among individuals, the degree to which both parasites and testosterone had an effect was strongly dependent on the amount of corticosterone in the feather grown during the experiment. The more stressors birds had experienced (i.e., higher corticosterone), the more parasites developed, and the less testosterone enhanced ornamentation. Conclusions/Significance: With this unique focus on the individual, and a novel, integrative, measure of response to stressors, we show that ornamentation is ultimately a product of the cumulative physiological response to environmental challenges. These findings lead toward a more realistic concept of honesty in signaling as well as a broader discussion of the concept of stress.	[Bortolotti, Gary R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Mougeot, Francois] CSIC, Estac Experiment Zonas Aridas, Almeria, Spain; [Mougeot, Francois] IREC, CSIC, UCLM, JCCM, Ciudad Real, Spain; [Martinez-Padilla, Jesus; Webster, Lucy M. I.; Piertney, Stuart B.] Univ Aberdeen, Sch Biol Sci, Aberdeen AB9 1FX, Scotland	University of Saskatchewan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Aberdeen	Bortolotti, GR (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	gary.bortolotti@usask.ca	Mougeot, Francois/B-1894-2009; Mougeot, Francois/Y-9569-2019; Martinez-Padilla, Jesus/C-6446-2008; Piertney, Stuart/I-3144-2012	Mougeot, Francois/0000-0002-5819-6275; Mougeot, Francois/0000-0002-5819-6275; Martinez-Padilla, Jesus/0000-0003-2956-5163; Piertney, Stuart/0000-0001-6654-0569	NERC [NE/D000602/1, Advanced Fellowship, Discovery Grant]; Stuart and Mary Houston Professorship in Ornithology; Natural Environment Research Council [NE/D000602/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Stuart and Mary Houston Professorship in Ornithology; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	NERC Advanced Fellowship to FM; NERC grant (NE/D000602/1) to SP and LW; NSERC Discovery Grant to GRB; Stuart and Mary Houston Professorship in Ornithology to GRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; BORTOLOTTI GR, 2009, J EXPT BIOL IN PRESS; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; DELAHAY RJ, 1995, PARASITOLOGY, V110, P473, DOI 10.1017/S0031182000064817; Evans MR, 2000, BEHAV ECOL SOCIOBIOL, V47, P156, DOI 10.1007/s002650050006; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hudson PJ, 1986, RED GROUSE BIOL MANA; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Maney DL, 2008, ETHOLOGY, V114, P369, DOI 10.1111/j.1439-0310.2008.01476.x; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McNamara JM, 2005, BEHAV ECOL, V16, P1008, DOI 10.1093/beheco/ari087; MOSS R, 1979, AGGRESSIVE BEHAV, V5, P59, DOI 10.1002/1098-2337(1979)5:1<59::AID-AB2480050108>3.0.CO;2-S; MOSS R, 1985, AGGRESSIVE BEHAV, V11, P253, DOI 10.1002/1098-2337(1985)11:3<253::AID-AB2480110308>3.0.CO;2-Z; Mougeot F, 2006, BEHAV ECOL, V17, P117, DOI 10.1093/beheco/arj005; Mougeot F, 2005, AM NAT, V166, P158, DOI 10.1086/431256; Mougeot F, 2005, OECOLOGIA, V144, P289, DOI 10.1007/s00442-005-0080-x; Mougeot F, 2005, HORM BEHAV, V47, P576, DOI 10.1016/j.yhbeh.2004.11.021; Mougeot F, 2004, J AVIAN BIOL, V35, P425, DOI 10.1111/j.0908-8857.2004.03256.x; Mougeot F, 2003, J ANIM ECOL, V72, P1073, DOI 10.1046/j.1365-2656.2003.00781.x; Owen-Ashley NT, 2004, AM NAT, V164, P490, DOI 10.1086/423714; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Perez-Rodriguez L, 2006, ANIM BEHAV, V72, P97, DOI 10.1016/j.anbehav.2005.09.021; Redpath SM, 2006, ANIM BEHAV, V71, P1297, DOI 10.1016/j.anbehav.2005.08.012; Roberts ML, 2007, J EXP BIOL, V210, P4368, DOI 10.1242/jeb.007104; Roberts ML, 2007, ANIM BEHAV, V74, P921, DOI 10.1016/j.anbehav.2006.12.021; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Rubenstein DR, 2007, P ROY SOC B-BIOL SCI, V274, P967, DOI 10.1098/rspb.2006.0051; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seivwright LJ, 2005, P ROY SOC B-BIOL SCI, V272, P2299, DOI 10.1098/rspb.2005.3233; SEIVWRIGHT LJ, 2004, PATTERN TRICHOSTRONG; SHAW JL, 1988, RES VET SCI, V45, P256, DOI 10.1016/S0034-5288(18)30943-3; SHAW JL, 1989, PARASITOLOGY, V99, P259, DOI 10.1017/S0031182000058716; Washburn BE, 2007, CONDOR, V109, P181, DOI 10.1650/0010-5422(2007)109[181:UACAEI]2.0.CO;2; WATSON A, 1985, OECOLOGIA, V67, P493, DOI 10.1007/BF00790019; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Zahavi A., 1997, HANDICAP PRINCIPLE	44	79	80	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4983	10.1371/journal.pone.0004983	http://dx.doi.org/10.1371/journal.pone.0004983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PK	19319197	Green Published, gold			2022-12-27	WOS:000265499200014
J	Craig, M; Slauch, JM				Craig, Maureen; Slauch, James M.			Phagocytic Superoxide Specifically Damages an Extracytoplasmic Target to Inhibit or Kill Salmonella	PLOS ONE			English	Article								Background: The phagocytic oxidative burst is a primary effector of innate immunity that protects against bacterial infection. However, the mechanism by which reactive oxygen species (ROS) kill or inhibit bacteria is not known. It is often assumed that DNA is a primary target of oxidative damage, consistent with known effects of endogenously produced ROS in the bacterial cytoplasm. But most studies fail to distinguish between effects of host derived ROS versus damage caused by endogenous bacterial sources. We took advantage of both the ability of Salmonella enterica serovar Typhimurium to survive in macrophages and the genetic tractability of the system to test the hypothesis that phagocytic superoxide damages cytoplasmic targets including DNA. Methodology/Principal Findings: SodCI is a periplasmic Cu-Zn superoxide dismutase ( SOD) that contributes to the survival of Salmonella Typhimurium in macrophages. Through competitive virulence assays, we asked if sodCI has a genetic interaction with various cytoplasmic systems. We found that SodCI acts independently of cytoplasmic SODs, SodA and SodB. In addition, SodCI acts independently of the base excision repair system and RuvAB, involved in DNA repair. Although sodCI did show genetic interaction with recA, this was apparently independent of recombination and is presumably due to the pleiotropic effects of a recA mutation. Conclusions/Significance: Taken together, these results suggest that bacterial inhibition by phagocytic superoxide is primarily the result of damage to an extracytoplasmic target.	[Craig, Maureen; Slauch, James M.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Slauch, James M.] Univ Illinois, Coll Med, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Slauch, JM (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	slauch@illinois.edu			Public Health Service [AI63230]; NIH [GM007283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063230] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI63230 to JMS. MC was partially supported by NIH training grant GM007283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola S, 2008, J BIOL CHEM, V283, P13688, DOI 10.1074/jbc.M710499200; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001; BIELSKI BHJ, 1977, J PHYS CHEM-US, V81, P1048, DOI 10.1021/j100526a005; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Bunny K, 2002, J BACTERIOL, V184, P6235, DOI 10.1128/JB.184.22.6235-6249.2002; Cano DA, 2002, J BACTERIOL, V184, P592, DOI 10.1128/JB.184.2.592-595.2002; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CAYROL C, 1995, P NATL ACAD SCI USA, V92, P11806, DOI 10.1073/pnas.92.25.11806; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DEMPLE B, 1983, J BACTERIOL, V153, P1079, DOI 10.1128/JB.153.2.1079-1082.1983; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Fang FC, 1997, INFECT IMMUN, V65, P5371, DOI 10.1128/IAI.65.12.5371-5375.1997; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; Farrant JL, 1997, MOL MICROBIOL, V25, P785, DOI 10.1046/j.1365-2958.1997.5151877.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Ho TD, 2001, J BACTERIOL, V183, P611, DOI 10.1128/JB.183.2.611-620.2001; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; Krishnakumar R, 2004, J BACTERIOL, V186, P5230, DOI 10.1128/JB.186.16.5230-5238.2004; Krishnakumar R, 2007, J BACTERIOL, V189, P4343, DOI 10.1128/JB.00010-07; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; LESCA C, 1991, BIOCHIMIE, V73, P407, DOI 10.1016/0300-9084(91)90107-C; Linehan SA, 2003, IMMUNOL LETT, V85, P183, DOI 10.1016/S0165-2478(02)00227-4; Maloy SR., 1996, GENETIC ANAL PATHOGE; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; PETIT C, 1993, J BACTERIOL, V175, P642, DOI 10.1128/JB.175.3.642-646.1993; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Reeves EP, 2003, J MED MICROBIOL, V52, P643, DOI 10.1099/jmm.0.05181-0; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Sansone A, 2002, MICROBIOL-SGM, V148, P719, DOI 10.1099/00221287-148-3-719; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Suvarnapunya AE, 2003, MOL MICROBIOL, V48, P549, DOI 10.1046/j.1365-2958.2003.03460.x; Suvarnapunya AE, 2005, MICROBIOL-SGM, V151, P557, DOI 10.1099/mic.0.27555-0; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; TSOLIS RM, 1995, INFECT IMMUN, V63, P1739, DOI 10.1128/IAI.63.5.1739-1744.1995; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Uzzau S, 2002, MOL MICROBIOL, V46, P147, DOI 10.1046/j.1365-2958.2002.03145.x; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; WANG TCV, 1991, BIOCHEM BIOPH RES CO, V180, P774, DOI 10.1016/S0006-291X(05)81132-5; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	68	63	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4975	10.1371/journal.pone.0004975	http://dx.doi.org/10.1371/journal.pone.0004975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305502	gold, Green Published, Green Submitted			2022-12-27	WOS:000265498800017
J	Guillon, N; Tirode, F; Boeva, V; Zynovyev, A; Barillot, E; Delattre, O				Guillon, Noelle; Tirode, Franck; Boeva, Valentina; Zynovyev, Andrei; Barillot, Emmanuel; Delattre, Olivier			The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							EWINGS-SARCOMA TRANSLOCATION; DNA-BINDING; TARGET GENE; EWS GENE; FUSION; GENOME; EWS/FLI; IDENTIFICATION; ONCOPROTEINS; ENRICHMENT	The fusion between EWS and ETS family members is a key oncogenic event in Ewing tumors and important EWS-FLI1 target genes have been identified. However, until now, the search for EWS-FLI1 targets has been limited to promoter regions and no genome-wide comprehensive analysis of in vivo EWS-FLI1 binding sites has been undertaken. Using a ChIP-Seq approach to investigate EWS-FLI1-bound DNA sequences in two Ewing cell lines, we show that this chimeric transcription factor preferentially binds two types of sequences including consensus ETS motifs and microsatellite sequences. Most bound sites are found outside promoter regions. Microsatellites containing more than 9 GGAA repeats are very significantly enriched in EWS-FLI1 immunoprecipitates. Moreover, in reporter gene experiments, the transcription activation is highly dependent upon the number of repeats that are included in the construct. Importantly, in vivo EWS-FLI1-bound microsatellites are significantly associated with EWS-FLI1-driven gene activation. Put together, these results point out the likely contribution of microsatellite elements to long-distance transcription regulation and to oncogenesis.	[Guillon, Noelle; Tirode, Franck; Boeva, Valentina; Zynovyev, Andrei; Barillot, Emmanuel; Delattre, Olivier] Inst Curie, Paris, France; [Guillon, Noelle; Tirode, Franck; Boeva, Valentina; Delattre, Olivier] INSERM, U830, Paris, France; [Boeva, Valentina; Zynovyev, Andrei; Barillot, Emmanuel] INSERM, U900, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Delattre, O (corresponding author), Inst Curie, Paris, France.	olivier.delattre@curie.fr	TIRODE, Franck/HHS-7070-2022; Boeva, Valentina/C-2855-2017; Zinovyev, Andrei/B-4715-2010; Tirode, Franck/B-4586-2009	Boeva, Valentina/0000-0002-4382-7185; Zinovyev, Andrei/0000-0002-9517-7284; BARILLOT, Emmanuel/0000-0003-2724-2002; Tirode, Franck/0000-0003-4731-7817; delattre, olivier/0000-0002-8730-2276	Institut National de la Sante et de la Recherche Medicale; Institut Curie; Ligue Nationale contre le Cancer; Agence Nationale de la Recherche	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Institut Curie, the Ligue Nationale contre le Cancer (Equipe labellise and CIT program) and the Agence Nationale de la Recherche (SITCON project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Caramel J, 2008, CANCER RES, V68, P6154, DOI 10.1158/0008-5472.CAN-08-0115; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2003, CANCER RES, V63, P4268; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fukuma M, 2003, ONCOGENE, V22, P1, DOI 10.1038/sj.onc.1206055; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; GARCIAARAGONCIL.E, 2008, ONCOGENE; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; JEON IS, 1995, ONCOGENE, V10, P1229; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; KIKUCHI R, 2006, ONCOGENE; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Li X, 2005, INT J CANCER, V116, P385, DOI 10.1002/ijc.21010; MagnaghiJaulin L, 1996, NUCLEIC ACIDS RES, V24, P1052, DOI 10.1093/nar/24.6.1052; MAO XH, 1994, J BIOL CHEM, V269, P18216; May WA, 1997, CURR TOP MICROBIOL, V220, P143; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Potikyan G, 2007, CANCER RES, V67, P6675, DOI 10.1158/0008-5472.CAN-06-4140; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; RAYGALLET D, 1995, ONCOGENE, V11, P303; SHORE P, 1995, NUCLEIC ACIDS RES, V23, P4698, DOI 10.1093/nar/23.22.4698; Siligan C, 2005, ONCOGENE, V24, P2512, DOI 10.1038/sj.onc.1208455; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Urano F, 1996, BIOCHEM BIOPH RES CO, V219, P608, DOI 10.1006/bbrc.1996.0281; Valbuena Alberto, 2008, PLoS One, V3, pe1642, DOI 10.1371/journal.pone.0001642; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wai DH, 2002, INT J ONCOL, V20, P441; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104	52	114	118	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4932	10.1371/journal.pone.0004932	http://dx.doi.org/10.1371/journal.pone.0004932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305498	Green Published, gold, Green Submitted			2022-12-27	WOS:000265498800004
J	Lickwar, CR; Rao, B; Shabalin, AA; Nobel, AB; Strahl, BD; Lieb, JD				Lickwar, Colin R.; Rao, Bhargavi; Shabalin, Andrey A.; Nobel, Andrew B.; Strahl, Brian D.; Lieb, Jason D.			The Set2/Rpd3S Pathway Suppresses Cryptic Transcription without Regard to Gene Length or Transcription Frequency	PLOS ONE			English	Article								In cells lacking the histone methyltransferase Set2, initiation of RNA polymerase II transcription occurs inappropriately within the protein-coding regions of genes, rather than being restricted to the proximal promoter. It was previously reported that this "cryptic'' transcription occurs preferentially in long genes, and in genes that are infrequently transcribed. Here, we mapped the transcripts produced in an S. cerevisiae strain lacking Set2, and applied rigorous statistical methods to identify sites of cryptic transcription at high resolution. We find that suppression of cryptic transcription occurs independent of gene length or transcriptional frequency. Our conclusions differ with those reported previously because we obtained a higher-resolution dataset, we accounted for the fact that gene length and transcriptional frequency are not independent variables, and we accounted for several ascertainment biases that make cryptic transcription easier to detect in long, infrequently transcribed genes. These new results and conclusions have implications for many commonly used genomic analysis approaches, and for the evolution of high-fidelity RNA polymerase II transcriptional initiation in eukaryotes.	[Lickwar, Colin R.; Rao, Bhargavi; Strahl, Brian D.; Lieb, Jason D.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Shabalin, Andrey A.; Nobel, Andrew B.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA; [Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Lickwar, Colin R.; Rao, Bhargavi; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Dept Biol, Chapel Hill, NC 27515 USA; [Lickwar, Colin R.; Rao, Bhargavi; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehensive Canc Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lickwar, CR (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	jlieb@bio.unc.edu	Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Shabalin, Andrey/0000-0003-0309-6821	NIH [GM072518, GM68088]; Pew Scholar in the Biomedical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518, R01GM068088] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in the Biomedical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH grants GM072518 (JDL) and GM68088 (BDS). BDS is a Pew Scholar in the Biomedical Sciences. The funding agencies played no active role in the study design or publication of this work.	Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; ANDREWS DWK, 1993, ECONOMETRICA, V61, P821, DOI 10.2307/2951764; Bai JS, 1998, ECONOMETRICA, V66, P47, DOI 10.2307/2998540; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; CEDAR H, 1973, J MOL BIOL, V77, P237, DOI 10.1016/0022-2836(73)90334-3; CHEUNG V, 2008, GENOME PLOS BIOL, V6, pE277; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huarte M, 2007, J BIOL CHEM, V282, P21662, DOI 10.1074/jbc.M703897200; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lieb JD, 2005, CELL, V123, P1187, DOI 10.1016/j.cell.2005.12.010; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	32	46	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4886	10.1371/journal.pone.0004886	http://dx.doi.org/10.1371/journal.pone.0004886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295910	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496700003
J	Kuipers, SD; Tiron, A; Soule, J; Messaoudi, E; Trentani, A; Bramham, CR				Kuipers, Sjoukje D.; Tiron, Adrian; Soule, Jonathan; Messaoudi, Elhoucine; Trentani, Andrea; Bramham, Clive R.			Selective Survival and Maturation of Adult-Born Dentate Granule Cells Expressing the Immediate Early Gene Arc/Arg3.1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CYTOSKELETON-ASSOCIATED PROTEIN; ENHANCED SYNAPTIC PLASTICITY; NEWLY GENERATED NEURONS; RAT HIPPOCAMPUS; NEUROGENESIS; GYRUS; CONSOLIDATION; PML; ARC	Progenitor cells in the adult dentate gyrus provide a constant supply of neuronal precursors, yet only a small fraction of these cells survive and develop into mature dentate granule cells (DGCs). A major challenge of current research is thus to understand the stringent selection process that governs the maturation and functional integration of adult-born DGCs. In mature DGCs, high-frequency stimulation (HFS) of the perforant path input elicits robust expression of the immediate early gene Arc/Arg3.1, trafficking of its mRNA to dendrites, and local synthesis of the protein necessary for consolidation of long-term potentiation (LTP). Given the synaptic commitment inherent in LTP consolidation, we considered that HFS-evoked expression of Arc could be used to timemap the functional integration of newborn DGCs. Dividing cells were birthmarked by BrdU-labeling at 1, 7, 14, 21, or 28 days prior to induction of LTP and expression of Arc was examined by confocal microscopy. Contrary to expectation, LTP did not induce Arc expression in newborn cells at any age, suggesting they might be refractory to synaptically-evoked Arc expression for at least one month. Importantly, however, spontaneous expression of Arc was detected in BrdU-labeled cells and strongly associated with the survival and maturation of NeuN-positive DGCs. Moreover, Arc expression at the earliest ages (1 and 7 days), clearly precedes the formation of glutamatergic synapses on new neurons. These results suggest an unexpected early role for Arc in adult-born DGCs, distinct from its functions in LTP, LTD, and homeostatic synaptic plasticity.	[Kuipers, Sjoukje D.; Tiron, Adrian; Soule, Jonathan; Messaoudi, Elhoucine; Trentani, Andrea; Bramham, Clive R.] Univ Bergen, Dept Biomed, Bergen, Norway; [Kuipers, Sjoukje D.; Tiron, Adrian; Soule, Jonathan; Messaoudi, Elhoucine; Trentani, Andrea; Bramham, Clive R.] Univ Bergen, Bergen Mental Hlth Res Ctr, Bergen, Norway	University of Bergen; University of Bergen	Kuipers, SD (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	clive.bramham@biomed.uib.no	Tiron, Adrian/AAQ-4002-2020; Trentani, Andrea/AAF-7273-2021; Bramham, Clive/Q-1854-2018	Tiron, Adrian/0000-0002-7006-5884; Trentani, Andrea/0000-0003-3304-2066; Bramham, Clive/0000-0001-5958-7115	Norwegian Research Council (NFR); Netherlands Organisation for Scientific Research (NWO)	Norwegian Research Council (NFR)(Research Council of Norway); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by research grants from the the Norwegian Research Council (NFR) and the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bloomer WAC, 2007, BRAIN RES, V1153, P20, DOI 10.1016/j.brainres.2007.03.079; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Bramham CR, 2007, PROG BRAIN RES, V163, P453, DOI 10.1016/S0079-6123(07)63025-8; BRAMHAM CR, 2008, CURR OPIN NEUROBIOL; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuipers SD, 2006, NEUROPHARMACOLOGY, V50, P428, DOI 10.1016/j.neuropharm.2005.10.006; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Matsuzaki M, 2007, NEUROSCI RES, V57, P1, DOI 10.1016/j.neures.2006.09.017; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; RAJEEVKUMAR R, 2007, NUCL TRANSLOCATION S; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; ROSS HH, 2008, STEM CELLS; Sanchez-Pulido L, 2007, TRENDS BIOCHEM SCI, V32, P400, DOI 10.1016/j.tibs.2007.08.001; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	62	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4885	10.1371/journal.pone.0004885	http://dx.doi.org/10.1371/journal.pone.0004885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290048	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496500008
J	Popp, A; Jaenisch, N; Witte, OW; Frahm, C				Popp, Anke; Jaenisch, Nadine; Witte, Otto W.; Frahm, Christiane			Identification of Ischemic Regions in a Rat Model of Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HEAT-SHOCK-PROTEIN; HSP70 MESSENGER-RNA; MICROTUBULE-ASSOCIATED PROTEIN-2; ARTERY OCCLUSION; DIFFERENTIAL EXPRESSION; C-FOS; INDUCTION; BRAIN; CHLORIDE	Background: Investigations following stroke first of all require information about the spatio-temporal dimension of the ischemic core as well as of perilesional and remote affected tissue. Here we systematically evaluated regions differently impaired by focal ischemia. Methodology/Principal Findings: Wistar rats underwent a transient 30 or 120 min suture-occlusion of the middle cerebral artery (MCAO) followed by various reperfusion times (2 h, 1 d, 7 d, 30 d) or a permanent MCAO (1 d survival). Brains were characterized by TTC, thionine, and immunohistochemistry using MAP2, HSP72, and HSP27. TTC staining reliably identifies the infarct core at 1 d of reperfusion after 30 min MCAO and at all investigated times following 120 min and permanent MCAO. Nissl histology denotes the infarct core from 2 h up to 30 d after transient as well as permanent MCAO. Absent and attenuated MAP2 staining clearly identifies the infarct core and perilesional affected regions at all investigated times, respectively. HSP72 denotes perilesional areas in a limited post-ischemic time (1 d). HSP27 detects perilesional and remote impaired tissue from post-ischemic day 1 on. Furthermore a simultaneous expression of HSP72 and HSP27 in perilesional neurons was revealed. Conclusions/Significance: TTC and Nissl staining can be applied to designate the infarct core. MAP2, HSP72, and HSP27 are excellent markers not only to identify perilesional and remote areas but also to discriminate affected neuronal and glial populations. Moreover markers vary in their confinement to different reperfusion times. The extent and consistency of infarcts increase with prolonged occlusion of the MCA. Therefore interindividual infarct dimension should be precisely assessed by the combined use of different markers as described in this study.	[Popp, Anke; Jaenisch, Nadine; Witte, Otto W.; Frahm, Christiane] Univ Jena, Dept Neurol, Jena, Germany	Friedrich Schiller University of Jena	Popp, A (corresponding author), Univ Jena, Dept Neurol, Jena, Germany.	christiane.frahm@med.uni-jena.de	Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	BMBF [01GZ0306, 0311578]; Kompetenznetzwerk Schlaganfall, BMBF [01GI9905]	BMBF(Federal Ministry of Education & Research (BMBF)); Kompetenznetzwerk Schlaganfall, BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the BMBF (nos. 01GZ0306 and 0311578) and the Kompetenznetzwerk Schlaganfall, BMBF (no. 01GI9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspey BS, 2000, NEUROPATH APPL NEURO, V26, P232, DOI 10.1046/j.1365-2990.2000.00221.x; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; COLE DJ, 1990, ACTA NEUROPATHOL, V80, P152, DOI 10.1007/BF00308918; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dittmar MS, 2006, J NEUROSCI METH, V156, P50, DOI 10.1016/j.jneumeth.2006.02.003; FEENEY C, 2005, NEUROGLIA, P421; Haupt C, 2007, NEUROSCIENCE, V144, P562, DOI 10.1016/j.neuroscience.2006.09.054; Haupt C, 2007, MOL CELL NEUROSCI, V35, P89, DOI 10.1016/j.mcn.2007.02.005; He Z, 1999, STROKE, V30, P2743, DOI 10.1161/01.STR.30.12.2743; Imura T, 1999, J NEUROSCI, V19, P9768; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kanemitsu H, 2002, J CEREBR BLOOD F MET, V22, P1196, DOI 10.1097/01.wcb.0000037992.07114.95; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Keyvani K, 2002, J CEREBR BLOOD F MET, V22, P153, DOI 10.1097/00004647-200202000-00003; KINOUCHI H, 1993, J CEREBR BLOOD F MET, V13, P105, DOI 10.1038/jcbfm.1993.13; KINOUCHI H, 1994, J CEREBR BLOOD F MET, V14, P808, DOI 10.1038/jcbfm.1994.101; KINOUCHI H, 1993, BRAIN RES, V619, P334, DOI 10.1016/0006-8993(93)91630-B; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Klettner A, 2004, DRUG NEWS PERSPECT, V17, P299, DOI 10.1358/dnp.2004.17.5.829033; Koizumi J., 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kokubo Y, 2003, NEUROSURGERY, V53, P186, DOI 10.1227/01.NEU.0000069023.01440.D6; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; Lafuente JV, 2007, NEUROSCI RES, V57, P354, DOI 10.1016/j.neures.2006.11.005; LI Y, 1993, J NEUROL SCI, V120, P187, DOI 10.1016/0022-510X(93)90272-Z; LI Y, 1992, STROKE, V23, P1292, DOI 10.1161/01.STR.23.9.1292; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mathews KS, 2000, J NEUROSCI METH, V102, P43, DOI 10.1016/S0165-0270(00)00277-6; MERKSZ M, 1978, ACTA MORPHOL HUNG, V26, P139; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Nishino K, 2004, J CEREBR BLOOD F MET, V24, P167, DOI 10.1097/01.WCB.0000100853.67976.8B; Noto T, 2007, BIOL PHARM BULL, V30, P313, DOI 10.1248/bpb.30.313; Oechmichen M, 2006, J FORENSIC SCI, V51, P880, DOI 10.1111/j.1556-4029.2006.00174.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Plumier JCL, 1997, J CEREBR BLOOD F MET, V17, P781; Plumier JCL, 1997, MOL BRAIN RES, V45, P239, DOI 10.1016/S0169-328X(96)00255-0; Plumier JCL, 1997, J COMP NEUROL, V384, P409; RIEKE GK, 1987, AM J ANAT, V178, P45, DOI 10.1002/aja.1001780106; SCHROETER M, 1995, EXP BRAIN RES, V106, P1; SHARP FR, 1991, J CEREBR BLOOD F MET, V11, P621, DOI 10.1038/jcbfm.1991.113; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; States BA, 1996, J CEREBR BLOOD F MET, V16, P1165, DOI 10.1097/00004647-199611000-00011; STOLL G, 2008, J CEREB BLOOD FLOW M; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Wang W, 2008, J CLIN NEUROSCI, V15, P278, DOI 10.1016/j.jocn.2007.02.004; Weinstein PR, 2004, STROKE, V35, P2666, DOI 10.1161/01.STR.0000144052.10644.ed; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Zhan XH, 2008, BRAIN RES, V1234, P183, DOI 10.1016/j.brainres.2008.07.094	59	166	172	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4764	10.1371/journal.pone.0004764	http://dx.doi.org/10.1371/journal.pone.0004764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274095	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000005
J	Ronn, T; Poulsen, P; Tuomi, T; Isomaa, B; Groop, L; Vaag, A; Ling, C				Ronn, Tina; Poulsen, Pernille; Tuomi, Tiinamaija; Isomaa, Bo; Groop, Leif; Vaag, Allan; Ling, Charlotte			Genetic Variation in ATP5O Is Associated with Skeletal Muscle ATP50 mRNA Expression and Glucose Uptake in Young Twins	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN ACTION; DNA METHYLATION; VISUALIZATION; DYSFUNCTION; METABOLISM; SECRETION; ZYGOSITY; POWER; LOCI	Background: Impaired oxidative capacity of skeletal muscle mitochondria contribute to insulin resistance and type 2 diabetes (T2D). Furthermore, mRNA expression of genes involved in oxidative phosphorylation, including ATP5O, is reduced in skeletal muscle from T2D patients. Our aims were to investigate mechanisms regulating ATP5O expression in skeletal muscle and association with glucose metabolism, and the relationship between ATP5O single nucleotide polymorphisms (SNPs) and risk of T2D. Methodology/Principal Findings: ATP5O mRNA expression was analyzed in skeletal muscle from young (n = 86) and elderly (n = 68) non-diabetic twins before and after a hyperinsulinemic euglycemic clamp. 11 SNPs from the ATP5O locus were genotyped in the twins and a T2D case-control cohort (n = 1466). DNA methylation of the ATP5O promoter was analyzed in twins (n = 22) using bisulfite sequencing. The mRNA level of ATP5O in skeletal muscle was reduced in elderly compared with young twins, both during basal and insulin-stimulated conditions (p < 0.0005). The degree of DNA methylation around the transcription start of ATP5O was < 1% in both young and elderly twins and not associated with mRNA expression (p = 0.32). The mRNA level of ATP5O in skeletal muscle was positively related to insulin-stimulated glucose uptake (regression coefficient = 6.6; p = 0.02). Furthermore, two SNPs were associated with both ATP5O mRNA expression (rs12482697: T/T versus T/G; p = 0.02 and rs11088262: A/A versus A/G; p = 0.004) and glucose uptake (rs11088262: A/A versus A/G; p = 0.002 and rs12482697: T/T versus T/G; p = 0.005) in the young twins. However, we could not detect any genetic association with T2D. Conclusions/Significance: Genetic variation and age are associated with skeletal muscle ATP5O mRNA expression and glucose disposal rate, suggesting that combinations of genetic and non-genetic factors may cause the reduced expression of ATP5O in T2D muscle. These findings propose a role for ATP5O, in cooperation with other OXPHOS genes, in the regulation of in vivo glucose metabolism.	[Ronn, Tina; Groop, Leif; Vaag, Allan; Ling, Charlotte] Lund Univ, CRC Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Res Unit, Malmo, Sweden; [Poulsen, Pernille; Vaag, Allan] Steno Diabetes Ctr, Gentofte, Denmark; [Tuomi, Tiinamaija; Isomaa, Bo; Groop, Leif] Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland; [Tuomi, Tiinamaija] Univ Helsinki, Cent Hosp, Dept Med, FIN-00014 Helsinki, Finland; [Tuomi, Tiinamaija; Isomaa, Bo] Folkhalsan Res Ctr, Genet Inst, Helsinki, Finland; [Isomaa, Bo] Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland	Lund University; Steno Diabetes Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center	Ronn, T (corresponding author), Lund Univ, CRC Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Res Unit, Malmo, Sweden.	tina.ronn@med.lu.se	Ling, Charlotte/Q-2432-2015	Ling, Charlotte/0000-0003-0587-7154; Tuomi, Tiinamaija/0000-0002-8306-6202; Ronn, Tina/0000-0001-7622-800X; Vaag, Allan Arthur/0000-0002-3690-2191	Danish Medical Research Council; Danish Diabetes Association; Region Skane; Malmo University Hospital; Knut and Alice Wallenberg Foundation; Swegene; Diabetes Programme at Lund University; Novo Nordisk; Swedish Research Council [522-2006-6480];  [B31 5631/2006]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Diabetes Association; Region Skane; Malmo University Hospital; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swegene; Diabetes Programme at Lund University; Novo Nordisk(Novo Nordisk); Swedish Research Council(Swedish Research CouncilEuropean Commission); 	This study was supported by grants from the Danish Medical Research Council, Danish Diabetes Association, Region Skane, Malmo University Hospital, Knut and Alice Wallenberg Foundation, Swegene, the Diabetes Programme at Lund University, Novo Nordisk, Crafoord, Hedlund, Bergvall, Wiberg, Pahlsson, Hains, Lundberg, Exgenesis and Linne grant (B31 5631/2006) and grant 522-2006-6480 from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devenish RJ, 2000, J BIOENERG BIOMEMBR, V32, P507, DOI 10.1023/A:1005621125812; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Frayling TM, 2007, DIABETOLOGIA, V50, P2229, DOI 10.1007/s00125-007-0825-7; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Huang X, 1999, DIABETES, V48, P1508, DOI 10.2337/diabetes.48.8.1508; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neale MC, 1992, NATO ASI SER, P35; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Poulsen P, 2002, DIABETOLOGIA, V45, P1649, DOI 10.1007/s00125-002-0983-6; Poulsen P, 2006, DIABETES, V55, P1819, DOI 10.2337/db05-1462; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ronn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Storgaard H, 2006, J CLIN ENDOCR METAB, V91, P702, DOI 10.1210/jc.2005-1172; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; VAAG A, 1995, DIABETOLOGIA, V38, P326, DOI 10.1007/s001250050289; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	33	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4793	10.1371/journal.pone.0004793	http://dx.doi.org/10.1371/journal.pone.0004793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274082	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000027
J	Aldinger, KA; Sokoloff, G; Rosenberg, DM; Palmer, AA; Millen, KJ				Aldinger, Kimberly A.; Sokoloff, Greta; Rosenberg, David M.; Palmer, Abraham A.; Millen, Kathleen J.			Genetic Variation and Population Substructure in Outbred CD-1 Mice: Implications for Genome-Wide Association Studies	PLOS ONE			English	Article								Outbred laboratory mouse populations are widely used in biomedical research. Since little is known about the degree of genetic variation present in these populations, they are not widely used for genetic studies. Commercially available outbred CD-1 mice are drawn from an extremely large breeding population that has accumulated many recombination events, which is desirable for genome-wide association studies. We therefore examined the degree of genome-wide variation within CD-1 mice to investigate their suitability for genetic studies. The CD-1 mouse genome displays patterns of linkage disequilibrium and heterogeneity similar to wild-caught mice. Population substructure and phenotypic differences were observed among CD-1 mice obtained from different breeding facilities. Differences in genetic variation among CD-1 mice from distinct facilities were similar to genetic differences detected between closely related human populations, consistent with a founder effect. This first large-scale genetic analysis of the outbred CD-1 mouse strain provides important considerations for the design and analysis of genetic studies in CD-1 mice.	[Aldinger, Kimberly A.; Rosenberg, David M.; Palmer, Abraham A.; Millen, Kathleen J.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Sokoloff, Greta; Palmer, Abraham A.; Millen, Kathleen J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Millen, Kathleen J.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Aldinger, KA (corresponding author), Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA.	kmillen@genetics.bsd.uchicago.edu	Palmer, Abraham/L-2158-2014; Aldinger, Kimberly/ABB-1561-2020	Palmer, Abraham/0000-0003-3634-0747; Aldinger, Kimberly/0000-0002-5406-8911; Millen, Kathleen/0000-0001-9978-675X; Rosenberg, David/0000-0003-4914-3195; Sokoloff, Greta/0000-0003-3651-1980	National Institutes of Health [HD053703, DA021336, MH70933, MH79103, DA024845]; Autism Speaks [Pre-doctoral Fellowship]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH070933, R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336, R21DA024845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health (HD053703 to KJM and DA021336, MH70933, MH79103 and DA024845 to AAP). KAA was supported by an Autism Speaks Pre-doctoral Fellowship (to KAA and KJM). Funding agencies had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Brown JA, 2000, AM J PHYSIOL-REG I, V278, pR320, DOI 10.1152/ajpregu.2000.278.2.R320; CHESLER EJ, 2008, COLLABORATIVE CROSS; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; CUI SL, 1993, LAB ANIM, V27, P116, DOI 10.1258/002367793780810397; Falush D, 2003, GENETICS, V164, P1567; Festing MFW, 1999, NEUROBIOL AGING, V20, P237; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P1321, DOI 10.1038/sj.npp.1301254; Graber JH, 2006, J EXP ZOOL PART A, V305A, P683, DOI 10.1002/jez.a.322; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; HAYAKAWA J, 1980, LAB ANIM-UK, V14, P233, DOI 10.1258/002367780780937625; Iraqi FA, 2008, MAMM GENOME, V19, P379, DOI 10.1007/s00335-008-9113-1; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Kuc KA, 2006, GENES BRAIN BEHAV, V5, P355, DOI 10.1111/j.1601-183X.2005.00168.x; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Lehoczky JA, 2006, MAMM GENOME, V17, P903, DOI 10.1007/s00335-006-0041-7; Lewis SR, 2007, PHYSIOL BEHAV, V90, P82, DOI 10.1016/j.physbeh.2006.08.028; Lewis SR, 2006, PHYSIOL BEHAV, V88, P516, DOI 10.1016/j.physbeh.2006.05.003; Lewis SR, 2006, PHYSIOL BEHAV, V87, P595, DOI 10.1016/j.physbeh.2005.12.002; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Manenti G, 2003, CARCINOGENESIS, V24, P1143, DOI 10.1093/carcin/bgg065; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McKerchar TL, 2005, J EXP ANAL BEHAV, V84, P339, DOI 10.1901/jeab.2005.95-04; Miller RA, 1999, NEUROBIOL AGING, V20, P217; Morahan G, 2008, MAMM GENOME, V19, P390, DOI 10.1007/s00335-008-9134-9; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; MORAN JL, 2006, ASHG ANN M NEW ORL L; Novembre J, 2008, NATURE, V456, P274, DOI 10.1038/nature07566; Peirce JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001977; Petkov PM, 2007, PLOS BIOL, V5, P984, DOI 10.1371/journal.pbio.0050127; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wahlsten D, 2003, GENES BRAIN BEHAV, V2, P71, DOI 10.1034/j.1601-183X.2003.00012.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	49	92	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4729	10.1371/journal.pone.0004729	http://dx.doi.org/10.1371/journal.pone.0004729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266100	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490800010
J	Elwyn, G; O'Connor, AM; Bennett, C; Newcombe, RG; Politi, M; Durand, MA; Drake, E; Joseph-Williams, N; Khangura, S; Saarimaki, A; Sivell, S; Stiel, M; Bernstein, SJ; Col, N; Coulter, A; Eden, K; Harter, M; Rovner, MH; Moumjid, N; Stacey, D; Thomson, R; Whelan, T; van der Weijden, T; Edwards, A				Elwyn, Glyn; O'Connor, Annette M.; Bennett, Carol; Newcombe, Robert G.; Politi, Mary; Durand, Marie-Anne; Drake, Elizabeth; Joseph-Williams, Natalie; Khangura, Sara; Saarimaki, Anton; Sivell, Stephanie; Stiel, Mareike; Bernstein, Steven J.; Col, Nananda; Coulter, Angela; Eden, Karen; Haerter, Martin; Rovner, Margaret Holmes; Moumjid, Nora; Stacey, Dawn; Thomson, Richard; Whelan, Tim; van der Weijden, Trudy; Edwards, Adrian			Assessing the Quality of Decision Support Technologies Using the International Patient Decision Aid Standards instrument (IPDASi)	PLOS ONE			English	Article								Objectives: To describe the development, validation and inter-rater reliability of an instrument to measure the quality of patient decision support technologies (decision aids). Design: Scale development study, involving construct, item and scale development, validation and reliability testing. Setting: There has been increasing use of decision support technologies-adjuncts to the discussions clinicians have with patients about difficult decisions. A global interest in developing these interventions exists among both for-profit and not-for-profit organisations. It is therefore essential to have internationally accepted standards to assess the quality of their development, process, content, potential bias and method of field testing and evaluation. Methods: Scale development study, involving construct, item and scale development, validation and reliability testing. Participants: Twenty-five researcher-members of the International Patient Decision Aid Standards Collaboration worked together to develop the instrument (IPDASi). In the fourth Stage (reliability study), eight raters assessed thirty randomly selected decision support technologies. Results: IPDASi measures quality in 10 dimensions, using 47 items, and provides an overall quality score (scaled from 0 to 100) for each intervention. Overall IPDASi scores ranged from 33 to 82 across the decision support technologies sampled (n = 30), enabling discrimination. The inter-rater intraclass correlation for the overall quality score was 0.80. Correlations of dimension scores with the overall score were all positive (0.31 to 0.68). Cronbach's alpha values for the 8 raters ranged from 0.72 to 0.93. Cronbach's alphas based on the dimension means ranged from 0.50 to 0.81, indicating that the dimensions, although well correlated, measure different aspects of decision support technology quality. A short version (19 items) was also developed that had very similar mean scores to IPDASi and high correlation between short score and overall score 0.87 (CI 0.79 to 0.92). Conclusions: This work demonstrates that IPDASi has the ability to assess the quality of decision support technologies. The existing IPDASi provides an assessment of the quality of a DST's components and will be used as a tool to provide formative advice to DSTs developers and summative assessments for those who want to compare their tools against an existing benchmark.	[Elwyn, Glyn; Newcombe, Robert G.; Durand, Marie-Anne; Joseph-Williams, Natalie; Sivell, Stephanie; Stiel, Mareike; Edwards, Adrian] Cardiff Univ, Dept Publ Hlth & Primary Care, Sch Med, Cardiff, S Glam, Wales; [Elwyn, Glyn; Newcombe, Robert G.; Durand, Marie-Anne; Joseph-Williams, Natalie; Sivell, Stephanie; Stiel, Mareike; Edwards, Adrian] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [O'Connor, Annette M.; Bennett, Carol; Drake, Elizabeth; Khangura, Sara; Saarimaki, Anton] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON K1N 6N5, Canada; [Stacey, Dawn] Univ Ottawa, Sch Nurs, Ottawa, ON K1N 6N5, Canada; [Politi, Mary] Brown Univ, W Alpert Med Sch, Ctr Behav & Prevent Med, Providence, RI 02912 USA; [Bernstein, Steven J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Col, Nananda] Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME USA; [Coulter, Angela] Kings Mead House, Picker Inst Europe, Oxford, England; [Eden, Karen] Oregon Hlth & Sci Univ, John M Eisenberg Clin Decisions & Communicat Sci C, Dept Med Informat & Clin Epidemiol, Portland, OR USA; [Haerter, Martin] Univ Med Ctr Hamburg Eppendorf, Inst & Policlin Med Psychol, Hamburg, Germany; [Rovner, Margaret Holmes] Michigan State Univ, Coll Human Med, Ctr Ethics, E Lansing, MI 48824 USA; [Moumjid, Nora] Univ Lyon, Ctr Leon Berard, Lyon, France; [Thomson, Richard] Univ Newcastle, Sch Med, Inst Hlth & Society, Framlington Place, Newcastle Upon Tyne, Tyne & Wear, England; [Whelan, Tim] McMaster Univ, Juravinski Canc Ctr, Dept Oncol, Hamilton, ON L8S 4L8, Canada; [van der Weijden, Trudy] Maastricht Univ, CAPHRI, Dept Gen Practice, Maastricht, Netherlands	Cardiff University; Cardiff University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Brown University; University of Michigan System; University of Michigan; Maine Medical Center; Oregon Health & Science University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Michigan State University; Michigan State University College of Human Medicine; UNICANCER; Centre Leon Berard; Newcastle University - UK; McMaster University; Maastricht University; Maastricht University Medical Centre (MUMC)	Elwyn, G (corresponding author), Cardiff Univ, Dept Publ Hlth & Primary Care, Sch Med, Cardiff, S Glam, Wales.	elwyng@cardiff.ac.uk	Coulter, Angela/N-6998-2019; /H-9741-2016; Stiel, Mareike/A-1628-2010; Sivell, Stephanie/AAC-2256-2022; Sivell, Stephanie/B-3175-2011; Col, Nananda/AAE-3445-2019; Durand, Marie-Anne/Z-1747-2018; Elwyn, G./L-4292-2015; Khangura, Sara/AAD-7987-2021; Evans, Diane/F-9258-2017; Whelan, Timothy/D-3185-2017; Elwyn, Glyn/B-4798-2009	Coulter, Angela/0000-0002-6308-8375; /0000-0003-0253-1860; Sivell, Stephanie/0000-0003-0253-1860; Sivell, Stephanie/0000-0003-0253-1860; Whelan, Timothy/0000-0001-9844-2023; Harter, Martin/0000-0001-7443-9890; Col, Nananda/0000-0001-7106-662X; Khangura, Sara/0000-0003-0094-6771; Durand, Marie-Anne/0000-0002-1127-9348; Elwyn, Glyn/0000-0002-0917-6286; Bennett, Carol/0000-0002-3033-9860; Bernstein, Steven/0000-0003-3359-7168; Politi, Mary/0000-0001-9103-6495	Canadian Institutes of Health Research; Cardiff University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cardiff University	Canadian Institutes of Health Research Group grant; Cardiff University internal funding. No other external funding.	Banta D, 2003, HEALTH POLICY, V63, P121, DOI 10.1016/S0168-8510(02)00059-3; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Charles C, 2005, HEALTH EXPECT, V8, P114, DOI 10.1111/j.1369-7625.2005.00325.x; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Coulter A., 2006, ASSESSING QUALITY IN; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; DURAND MA, 2008, PATIENT ED COUN 0130; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Evans R, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e21; GODLEE F, BMJ-BRIT MED J, V334, DOI DOI 10.1136/BMJ.39252.523519.477; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Holmes-Rovner M, 2007, MED DECIS MAKING, V27, P599, DOI 10.1177/0272989x07307272; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; O'Connor AM, 2008, BMJ-BRIT MED J, V336, P228, DOI 10.1136/bmj.39435.643275.BE; O'Connor AM, 2007, MED DECIS MAKING, V27, P554, DOI 10.1177/0272989x07307319; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; O'Connor Annette M, 2004, Health Aff (Millwood), VSuppl Variation, pVAR63; OCONNOR AM, 2004, COCHRANE REV; STREINER N, 1995, HLTH MEASUREMENT SCA; Williams L, 2008, J EVAL CLIN PRACT, V14, P70, DOI 10.1111/j.1365-2753.2007.00798.x; YAFFEE RA, 1998, ENHANCEMENT RELIABIL	22	301	307	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4705	10.1371/journal.pone.0004705	http://dx.doi.org/10.1371/journal.pone.0004705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259269	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000265490500016
J	Graubert, TA; Payton, MA; Shao, J; Walgren, RA; Monahan, RS; Frater, JL; Walshauser, MA; Martin, MG; Kasai, Y; Walter, MJ				Graubert, Timothy A.; Payton, Michelle A.; Shao, Jin; Walgren, Richard A.; Monahan, Ryan S.; Frater, John L.; Walshauser, Mark A.; Martin, Mike G.; Kasai, Yumi; Walter, Matthew J.			Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; IN-SITU HYBRIDIZATION; CANDIDATE; INVOLVEMENT	Deletions spanning chromosome 5q31.2 are among the most common recurring cytogenetic abnormalities detectable in myelodysplastic syndromes (MDS). Prior genomic studies have suggested that haploinsufficiency of multiple 5q31.2 genes may contribute to MDS pathogenesis. However, this hypothesis has never been formally tested. Therefore, we designed this study to systematically and comprehensively evaluate all 28 chromosome 5q31.2 genes and directly test whether haploinsufficiency of a single 5q31.2 gene may result from a heterozygous nucleotide mutation or microdeletion. We selected paired tumor (bone marrow) and germline (skin) DNA samples from 46 de novo MDS patients (37 without a cytogenetic 5q31.2 deletion) and performed total exonic gene resequencing (479 amplicons) and array comparative genomic hybridization (CGH). We found no somatic nucleotide changes in the 46 MDS samples, and no cytogenetically silent 5q31.2 deletions in 20/20 samples analyzed by array CGH. Twelve novel single nucleotide polymorphisms were discovered. The mRNA levels of 7 genes in the commonly deleted interval were reduced by 50% in CD34+ cells from del(5q) MDS samples, and no gene showed complete loss of expression. Taken together, these data show that small deletions and/or point mutations in individual 5q31.2 genes are not common events in MDS, and implicate haploinsufficiency of multiple genes as the relevant genetic consequence of this common deletion.	[Graubert, Timothy A.; Payton, Michelle A.; Shao, Jin; Walgren, Richard A.; Monahan, Ryan S.; Walshauser, Mark A.; Martin, Mike G.; Walter, Matthew J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Graubert, Timothy A.; Walter, Matthew J.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Frater, John L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kasai, Yumi] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA; [Kasai, Yumi] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai	Graubert, TA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	mjwalter@dom.wustl.edu	Walter, Matthew J/S-7758-2018	Graubert, Timothy/0000-0002-7710-1171	National Institutes of Health [HL082973, T32-HL07088]; Center for Genome Sciences. Washington University School of Medicine; Aplastic Anemia & MDS International Foundation, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088, R01HL082973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Genome Sciences. Washington University School of Medicine; Aplastic Anemia & MDS International Foundation, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL082973 (TAG, MJW), T32-HL07088 (RAW), the Center for Genome Sciences. Washington University School of Medicine (TAG, MJW), and the Aplastic Anemia & MDS International Foundation, Inc. (MJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2002, CANCER GENET CYTOGEN, V136, P101, DOI 10.1016/S0165-4608(02)00515-0; Bigoni R, 2001, HAEMATOLOGICA, V86, P375; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Dubourg C, 2002, CANCER GENET CYTOGEN, V134, P33, DOI 10.1016/S0165-4608(01)00605-7; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; GRAVEN SE, 2005, BLOOD, V103, P3528; Horrigan SK, 2000, BLOOD, V95, P2372, DOI 10.1182/blood.V95.7.2372.007k20_2372_2377; Hu ZB, 2001, ONCOGENE, V20, P6946, DOI 10.1038/sj.onc.1204850; JAJN RJ, 2000, GENE CHROMOSOME CANC, V29, P276; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; LEBEAU MM, 1993, P NATL ACAD SCI USA, V90, P5484, DOI 10.1073/pnas.90.12.5484; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; OLNEY BJ, 2007, LEUKEMIA RES, V31, P127; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; TOTNASSON MH, 2008, BLOOD, V11, P1797; Xie H, 2000, LEUKEMIA, V14, P2128, DOI 10.1038/sj.leu.2401935; ZHAO N, 1997, P NATL ACAD SCI USA, V91, P6918	24	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4583	10.1371/journal.pone.0004583	http://dx.doi.org/10.1371/journal.pone.0004583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240791	Green Submitted, Green Published, gold			2022-12-27	WOS:000278086700005
J	Ande, SR; Moulik, S; Mishra, S				Ande, Sudharsana R.; Moulik, Saby; Mishra, Suresh			Interaction between O-GlcNAc Modification and Tyrosine Phosphorylation of Prohibitin: Implication for a Novel Binary Switch	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; LIPID RAFTS; INSULIN; TRANSFERASE; PROTEINS; DOMAIN; ROLES; CELLS	Prohibitin (PHB or PHB1) is an evolutionarily conserved, multifunctional protein which is present in various cellular compartments including the plasma membrane. However, mechanisms involved in various functions of PHB are not fully explored yet. Here we report for the first time that PHB interacts with O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase, OGT) and is O-GlcNAc modified; and also undergoes tyrosine phosphorylation in response to insulin. Tyrosine 114 (Tyr114) and tyrosine 259 (Tyr259) in PHB are in the close proximity of potential O-GlcNAc sites serine 121 (Ser121) and threonine 258 (Thr258) respectively. Substitution of Tyr114 and Tyr259 residues in PHB with phenylalanine by site-directed mutagenesis results in reduced tyrosine phosphorylation as well as reduced O-GlcNAc modification of PHB. Surprisingly, this also resulted in enhanced tyrosine phosphorylation and activity of OGT. This is attributed to the presence of similar tyrosine motifs in PHB and OGT. Substitution of Ser121 and Thr258 with alanine and isoleucine respectively resulted in attenuation of O-GlcNAc modification and increased tyrosine phosphorylation of PHB suggesting an association between these two dynamic modifications. Sequence analysis of O-GlcNAc modified proteins having known O-GlcNAc modification site(s) or known tyrosine phosphorylation site(s) revealed a strong potential association between these two posttranslational modifications in various proteins. We speculate that O-GlcNAc modification and tyrosine phosphorylation of PHB play an important role in tyrosine kinase signaling pathways including insulin, growth factors and immune receptors signaling. In addition, we propose that O-GlcNAc modification and tyrosine phosphorylation is a novel previously unidentified binary switch which may provide new mechanistic insights into cell signaling pathways and is open for direct experimental examination.	[Ande, Sudharsana R.; Mishra, Suresh] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Moulik, Saby; Mishra, Suresh] Univ Manitoba, Dept Physiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba	Ande, SR (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	Mishra@cc.umanitoba.ca	Moulik, Sabyasachi/AAV-4234-2020; Mishra, Suresh/W-1633-2019; Ande, Sudharsana Rao/AAU-6950-2021	Ande, Sudharsana Rao/0000-0001-8194-2902; Mishra, Suresh/0000-0002-0364-1538; Moulik, Sabyasachi/0000-0003-2225-2615	Manitoba Health Research Council (MHRC) [Postdoctoral Fellowship]; Winnipeg Health Sciences Centre Foundation	Manitoba Health Research Council (MHRC); Winnipeg Health Sciences Centre Foundation	This work was supported by funds from Manitoba Health Research Council (MHRC) and Winnipeg Health Sciences Centre Foundation to SM. SRA is a recipient of MHRC Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Han EKH, 2008, ANTICANCER RES, V28, P957; Ikonen E., 2005, SCI STKE, V268, ppe3; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Mishra S, 2006, J BIOL CHEM, V281, P5532, DOI 10.1074/jbc.M506864200; MISHRA S, 2007, END M; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; SLAWSON C, 2008, MOL BIOL CELL   0723, V23; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	27	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4586	10.1371/journal.pone.0004586	http://dx.doi.org/10.1371/journal.pone.0004586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238206	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487400015
J	Kam, Y; Quaranta, V				Kam, Yoonseok; Quaranta, Vito			Cadherin-Bound beta-Catenin Feeds into the Wnt Pathway upon Adherens Junctions Dissociation: Evidence for an Intersection between beta-Catenin Pools	PLOS ONE			English	Article								beta-catenin is an essential component of two cellular systems: cadherin-based adherens junctions (AJ) and the Wnt signaling pathway. A functional or physical connection between these beta-catenin pools has been suggested in previous studies, but not conclusively demonstrated to date. To further examine this intersection, we treated A431 cell colonies with lysophosphatidic acid (LPA), which forces rapid and synchronized dissociation of AJ. A combination of immunostaining, time-lapse microscopy using photoactivatable-GFP-tagged beta-catenin, and image analyses indicate that the cadherin-bound pool of beta-catenin, internalized together with E-cadherin, accumulates at the perinuclear endocytic recycling compartment (ERC) upon AJ dissociation, and can be translocated into the cell nucleus upon Wnt pathway activation. These results suggest that the ERC may be a site of residence for beta-catenin destined to enter the nucleus, and that dissociation of AJ may influence beta-catenin levels in the ERC, effectively affecting beta-catenin substrate levels available downstream for the Wnt pathway. This intersection provides a mechanism for integrating cell-cell adhesion with Wnt signaling and could be critical in developmental and cancer processes that rely on beta-catenin-dependent gene expression.	[Kam, Yoonseok; Quaranta, Vito] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University	Kam, Y (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	vito.quaranta@vanderbilt.edu	Quaranta, Vito/G-6512-2016	Quaranta, Vito/0000-0001-7491-8672; Kam, Yoonseok/0000-0003-4712-9058	NIH [RO1 GM067221]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding received from NIH RO1 GM067221 awarded to Vito Quaranta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 2000, EXP CELL RES, V261, P75, DOI 10.1006/excr.2000.5045; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gavard J, 2005, BIOL CELL, V97, P921; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; HUOT J, 1972, EXPERIENTIA, V28, P456, DOI 10.1007/BF02008338; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jourquin J, 2006, J CELL PHYSIOL, V206, P337, DOI 10.1002/jcp.20470; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Kappes A, 2007, SURGERY, V141, P161, DOI 10.1016/j.surg.2006.12.005; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9; Nathke I, 2004, J CELL SCI, V117, P4873, DOI 10.1242/jcs.01313; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; THIERY JP, 2002, NATURE, V2, P444; TOMOOKA Y, 1983, J CELL PHYSIOL, V117, P290, DOI 10.1002/jcp.1041170303; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	60	115	119	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4580	10.1371/journal.pone.0004580	http://dx.doi.org/10.1371/journal.pone.0004580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238201	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487400012
J	Griffin, HR; Hall, DH; Topf, A; Eden, J; Stuart, AG; Parsons, J; Peart, I; Deanfield, JE; O'Sullivan, J; Babu-Narayan, SV; Gatzoulis, MA; Bu'Lock, FA; Bhattacharya, S; Bentham, J; Farrall, M; Riveron, JG; Brook, JD; Burn, J; Cordell, HJ; Goodship, JA; Keavney, B				Griffin, Helen R.; Hall, Darroch H.; Topf, Ana; Eden, James; Stuart, A. Graham; Parsons, Jonathan; Peart, Ian; Deanfield, John E.; O'Sullivan, John; Babu-Narayan, Sonya V.; Gatzoulis, Michael A.; Bu'Lock, Frances A.; Bhattacharya, Shoumo; Bentham, Jamie; Farrall, Martin; Riveron, Javier Granados; Brook, J. David; Burn, John; Cordell, Heather J.; Goodship, Judith A.; Keavney, Bernard			Genetic Variation in VEGF Does Not Contribute Significantly to the Risk of Congenital Cardiovascular Malformation	PLOS ONE			English	Article								Several previous studies have investigated the role of common promoter variants in the vascular endothelial growth factor (VEGF) gene in causing congenital cardiovascular malformation (CVM). However, results have been discrepant between studies and no study to date has comprehensively characterised variation throughout the gene. We genotyped 771 CVM cases, of whom 595 had the outflow tract malformation Tetralogy of Fallot (TOF), and carried out TDT and case-control analyses using haplotype-tagging SNPs in VEGF. We carried out a meta-analysis of previous case-control or family-based studies that had typed VEGF promoter SNPs, which included an additional 570 CVM cases. To identify rare variants potentially causative of CVM, we carried out mutation screening in all VEGF exons and splice sites in 93 TOF cases. There was no significant effect of any VEGF haplotype-tagging SNP on the risk of CVM in our analyses of 771 probands. When the results of this and all previous studies were combined, there was no significant effect of the VEGF promoter SNPs rs699947 (OR 1.05 [95% CI 0.95-1.17]); rs1570360 (OR 1.17 [95% CI 0.99-1.26]); and rs2010963 (OR 1.04 [95% CI 0.93-1.16]) on the risk of CVM in 1341 cases. Mutation screening of 93 TOF cases revealed no VEGF coding sequence variants and no changes at splice consensus sequences. Genetic variation in VEGF appears to play a small role, if any, in outflow tract CVM susceptibility.	[Griffin, Helen R.; Hall, Darroch H.; Topf, Ana; Eden, James; Burn, John; Cordell, Heather J.; Goodship, Judith A.; Keavney, Bernard] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Stuart, A. Graham] Bristol Royal Hosp Children, Congenital Heart Ctr, Bristol, Avon, England; [Parsons, Jonathan] Leeds Gen Infirmary, Paediat Cardiol Unit, Leeds, W Yorkshire, England; [Peart, Ian] Alder Hey Royal Childrens Hosp, Dept Paediat Cardiol, Liverpool, Merseyside, England; [Deanfield, John E.] Great Ormond St Hosp Sick Children, Cardiothorac Unit, London, England; [O'Sullivan, John] Freeman Rd Hosp, Cardiothorac Ctr, Congenital Heart Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Babu-Narayan, Sonya V.; Gatzoulis, Michael A.] Imperial Coll, Royal Brompton Hosp, London, England; [Babu-Narayan, Sonya V.; Gatzoulis, Michael A.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Bu'Lock, Frances A.] Glenfield Hosp, Congenital & Paediat Cardiol Serv, Leicester, Leics, England; [Bhattacharya, Shoumo; Bentham, Jamie; Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; [Riveron, Javier Granados; Brook, J. David] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England	Newcastle University - UK; Bristol Royal Hospital For Children; Leeds General Infirmary; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle Freeman Hospital; Newcastle University - UK; Imperial College London; Royal Brompton Hospital; Imperial College London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Oxford; Wellcome Centre for Human Genetics; University of Nottingham	Griffin, HR (corresponding author), Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.	b.d.keavney@ncl.ac.uk	Granados-Riverón, Javier T/F-9768-2010; Bhattacharya, Shoumo/F-4127-2010	Bhattacharya, Shoumo/0000-0002-5571-0478; Burn, John/0000-0002-9823-2322; Granados-Riveron, Javier T./0000-0002-0368-225X; Keavney, Bernard/0000-0001-9573-0812; Stuart, Alan Graham/0000-0003-2789-2216; Deanfield, John/0000-0001-8806-6052; Brook, John David/0000-0002-5946-6740; Griffin, Helen R/0000-0002-5288-3322; Cordell, Heather/0000-0002-1879-5572; Granados-Riveron, Javier Tadeo/0000-0001-5485-654X	British Heart Foundation; Wellcome Trust; Medical Research Council; Heart Research UK; European Community's Sixth Framework Programme [LSHM-CT-2005-018630]; Federated Foundation; British Heart Foundation [RG/08/012/25941, RG/07/010/23676, PG/07/045/22690] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heart Research UK; European Community's Sixth Framework Programme(European Commission); Federated Foundation; British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (www.bhf.org.uk), the Wellcome Trust(www.wellcome.ac.uk), Medical Research Council (www.mrc.ac.uk), Heart Research UK (www.heartresearch.org.uk), the European Community's Sixth Framework Programme contract (HeartRepair) LSHM-CT-2005-018630, and the Federated Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dor Y, 2003, ANAT REC PART A, V271A, P202, DOI 10.1002/ar.a.10026; Dor Y, 2001, DEVELOPMENT, V128, P1531; Drake CJ, 2006, DEV DYNAM, V235, P10, DOI 10.1002/dvdy.20539; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; Feucht M, 1997, AM J PATHOL, V151, P1407; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lambrechts D, 2005, J MED GENET, V42, P519, DOI 10.1136/jmg.2004.026443; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Sugishita Y, 2004, DEV BIOL, V273, P285, DOI 10.1016/j.ydbio.2004.05.036; van den Akker NMS, 2007, CIRC RES, V100, P842, DOI 10.1161/01.RES.0000261656.04773.39; Vannay A, 2006, AM HEART J, V151, P878, DOI 10.1016/j.ahj.2005.10.012; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Xie J, 2007, EUR J HUM GENET, V15, P1246, DOI 10.1038/sj.ejhg.5201890	23	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4978	10.1371/journal.pone.0004978	http://dx.doi.org/10.1371/journal.pone.0004978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308252	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499000010
J	Bretteville, A; Ando, K; Ghestem, A; Loyens, A; Begard, S; Beauvillain, JC; Sergeant, N; Hamdane, M; Buee, L				Bretteville, Alexis; Ando, Kunie; Ghestem, Antoine; Loyens, Anne; Begard, Severine; Beauvillain, Jean-Claude; Sergeant, Nicolas; Hamdane, Malika; Buee, Luc			Two-Dimensional Electrophoresis of Tau Mutants Reveals Specific Phosphorylation Pattern Likely Linked to Early Tau Conformational Changes	PLOS ONE			English	Article								The role of Tau phosphorylation in neurofibrillary degeneration linked to Alzheimer's disease remains to be established. While transgenic mice based on FTDP-17 Tau mutations recapitulate hallmarks of neurofibrillary degeneration, cell models could be helpful for exploratory studies on molecular mechanisms underlying Tau pathology. Here, "human neuronal cell lines'' overexpressing Wild Type or mutated Tau were established. Two-dimensional electrophoresis highlights that mutated Tau displayed a specific phosphorylation pattern, which occurs in parallel to the formation of Tau clusters as visualized by electron microscopy. In fact, this pattern is also displayed before Tau pathology onset in a well established mouse model relevant to Tau aggregation in Alzheimer's disease. This study suggests first that pathological Tau mutations may change the distribution of phosphate groups. Secondly, it is possible that this molecular event could be one of the first Tau modifications in the neurofibrillary degenerative process, as this phenomenon appears prior to Tau pathology in an in vivo model and is linked to early steps of Tau nucleation in Tau mutants cell lines. Such cell lines consist in suitable and evolving models to investigate additional factors involved in molecular pathways leading to whole Tau aggregation.	[Bretteville, Alexis; Ando, Kunie; Ghestem, Antoine; Loyens, Anne; Begard, Severine; Beauvillain, Jean-Claude; Sergeant, Nicolas; Hamdane, Malika; Buee, Luc] INSERM, U837, F-59045 Lille, France; [Bretteville, Alexis; Ando, Kunie; Ghestem, Antoine; Loyens, Anne; Begard, Severine; Beauvillain, Jean-Claude; Sergeant, Nicolas; Hamdane, Malika; Buee, Luc] Univ Lille 2, Fac Med, Jean Pierre Aubert Res Ctr, Inst Med Predict Rech Therapeut, F-59800 Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bretteville, A (corresponding author), INSERM, U837, F-59045 Lille, France.	luc.buee@inserm.fr	BUEE, Luc/B-3126-2010; Sergeant, Nicolas/O-5467-2017	BUEE, Luc/0000-0002-6261-4230; Sergeant, Nicolas/0000-0003-1448-124X; Ando, Kunie/0000-0003-3822-175X; Hamdane, Malika/0000-0001-7971-8696	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante Et de la Recherche Medicale (Inserm); University of Lille 2; European Community [LSHM-CT-2003-503330, LSHM-CT-2007-037950, 200611]; Federation pour la Recherche sur le Cerveau (FRC); Gis Longevite; F.E.D.E.R; Lille County Hospital (CHRU-Lille)/Region Nord/Pas-de-Calais; French Foreign Affairs Ministry	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante Et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Lille 2; European Community(European Commission); Federation pour la Recherche sur le Cerveau (FRC); Gis Longevite; F.E.D.E.R(European Commission); Lille County Hospital (CHRU-Lille)/Region Nord/Pas-de-Calais(Region Hauts-de-France); French Foreign Affairs Ministry	These studies were supported by Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante Et de la Recherche Medicale (Inserm), University of Lille 2, the European Community (APOPIS LSHM-CT-2003-503330, and cNEUPRO LSHM-CT-2007-037950 and MEMOSAD FP7 grant agreement 200611), Federation pour la Recherche sur le Cerveau (FRC), the Gis Longevite and the F.E.D.E.R.. A. Bretteville and K. Ando are recipients of a scholarship from Lille County Hospital (CHRU-Lille)/Region Nord/Pas-de-Calais and French Foreign Affairs Ministry respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BILLINGS PC, 1979, NUCLEIC ACIDS RES, V6, P2151, DOI 10.1093/nar/6.6.2151; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; Delobel P, 2003, ANN NY ACAD SCI, V1010, P623, DOI 10.1196/annals.1299.115; Delobel P, 2002, J BIOL CHEM, V277, P9199, DOI 10.1074/jbc.M107716200; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Gotz J, 2006, MED J AUSTRALIA, V185, P381, DOI 10.5694/j.1326-5377.2006.tb00615.x; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Hamdane M, 2006, MOL CELL NEUROSCI, V32, P155, DOI 10.1016/j.mcn.2006.03.006; Hanger DP, 2002, FEBS LETT, V531, P538, DOI 10.1016/S0014-5793(02)03611-6; Iliev AI, 2006, J BIOL CHEM, V281, P37195, DOI 10.1074/jbc.M604863200; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Ko LW, 2005, BBA-MOL BASIS DIS, V1739, P125, DOI 10.1016/j.bbadis.2004.09.004; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LINDWALL G, 1984, J BIOL CHEM, V259, P2241; Mailliot C, 2000, J CEREBR BLOOD F MET, V20, P543, DOI 10.1097/00004647-200003000-00013; Perez M, 2002, EUR J BIOCHEM, V269, P1484, DOI 10.1046/j.1432-1033.2002.02794.x; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200	25	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4843	10.1371/journal.pone.0004843	http://dx.doi.org/10.1371/journal.pone.0004843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290042	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496500003
J	Tsuji, T; Miyoshi, T; Higashida, C; Narumiya, S; Watanabe, N				Tsuji, Takahiro; Miyoshi, Takushi; Higashida, Chiharu; Narumiya, Shuh; Watanabe, Naoki			An Order of Magnitude Faster AIP1-Associated Actin Disruption than Nucleation by the Arp2/3 Complex in Lamellipodia	PLOS ONE			English	Article								The mechanism of lamellipod actin turnover is still under debate. To clarify the intracellular behavior of the recently-identified actin disruption mechanism, we examined kinetics of AIP1 using fluorescent single-molecule speckle microscopy. AIP1 is thought to cap cofilin-generated actin barbed ends. Here we demonstrate a reduction in actin-associated AIP1 in lamellipodia of cells overexpressing LIM-kinase. Moreover, actin-associated AIP1 was rapidly abolished by jasplakinolide, which concurrently blocked the F-actin-cofilin interaction. Jasplakinolide also slowed dissociation of AIP1, which is analogous to the effect of this drug on capping protein. These findings provide in vivo evidence of the association of AIP1 with barbed ends generated by cofilin-catalyzed filament disruption. Single-molecule observation found distribution of F-actin-associated AIP1 throughout lamellipodia, and revealed even faster dissociation of AIP1 than capping protein. The estimated overall AIP1-associated actin disruption rate, 1.8 mu M/s, was one order of magnitude faster than Arp2/3 complex-catalyzed actin nucleation in lamellipodia. This rate does not suffice the filament severing rate predicted in our previous high frequency filament severing-annealing hypothesis. Our data together with recent biochemical studies imply barbed end-preferred frequent filament disruption. Frequent generation of AIP1-associated barbed ends and subsequent release of AIP1 may be the mechanism that facilitates previously observed ubiquitous actin polymerization throughout lamellipodia.	[Tsuji, Takahiro; Miyoshi, Takushi; Higashida, Chiharu; Narumiya, Shuh; Watanabe, Naoki] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan	Kyoto University	Tsuji, T (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan.	naoki-w@mfour.med.kyoto-u.ac.jp	TSUJI, Takahiro/AAP-7549-2020	Tsuji, Takahiro/0000-0002-5706-8300	Ministry of Education, Culture, Sport, Science and Technology of Japan [19390075]; Uehara Memorial Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work is supported in part by a Grant-in-Aid for Scientific Research (19390075) from the Ministry of Education, Culture, Sport, Science and Technology of Japan and by Special Project Research Grant (Systems biology) from Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Aizawa H, 1999, GENES CELLS, V4, P311, DOI 10.1046/j.1365-2443.1999.00262.x; Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Carlsson AE, 2004, BIOPHYS J, V86, P1074, DOI 10.1016/S0006-3495(04)74182-X; CASEY P, 1994, PROG PALLIAT CARE, V2, P1; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Clark MG, 2007, GENETICS, V176, P1527, DOI 10.1534/genetics.107.072066; Dawes AT, 2006, J THEOR BIOL, V242, P265, DOI 10.1016/j.jtbi.2006.02.017; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Higashida C, 2008, J CELL SCI, V121, P3403, DOI 10.1242/jcs.030940; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Iida K, 1999, GENES CELLS, V4, P21, DOI 10.1046/j.1365-2443.1999.00235.x; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Liu HX, 2008, NEUROSCI LETT, V448, P67, DOI 10.1016/j.neulet.2008.09.084; Maciver SK, 1998, CURR OPIN CELL BIOL, V10, P140, DOI 10.1016/S0955-0674(98)80097-5; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mohri K, 2003, J CELL SCI, V116, P4107, DOI 10.1242/jcs.00717; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; Okada K, 1999, J CELL SCI, V112, P1553; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Ono S, 2001, J CELL BIOL, V152, P1313, DOI 10.1083/jcb.152.6.1313; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tardy Y, 1995, BIOPHYS J, V69, P1674, DOI 10.1016/S0006-3495(95)80085-8; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; TILNEY LG, 1992, J CELL BIOL, V118, P71, DOI 10.1083/jcb.118.1.71; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	55	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4921	10.1371/journal.pone.0004921	http://dx.doi.org/10.1371/journal.pone.0004921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290054	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496500015
J	Matsumoto, K; Isagawa, T; Nishimura, T; Ogaeri, T; Eto, K; Miyazaki, S; Miyazaki, J; Aburatani, H; Nakauchi, H; Ema, H				Matsumoto, Kenji; Isagawa, Takayuki; Nishimura, Toshinobu; Ogaeri, Takunori; Eto, Koji; Miyazaki, Satsuki; Miyazaki, Jun-ichi; Aburatani, Hiroyuki; Nakauchi, Hiromitsu; Ema, Hideo			Stepwise Development of Hematopoietic Stem Cells from Embryonic Stem Cells	PLOS ONE			English	Article							YOLK-SAC; DEFINITIVE HEMATOPOIESIS; COMMON PRECURSOR; CD34 EXPRESSION; IN-VITRO; LIVER; FETAL; DIFFERENTIATION; HEMANGIOBLAST; PURIFICATION	The cellular ontogeny of hematopoietic stem cells (HSCs) remains poorly understood because their isolation from and their identification in early developing small embryos are difficult. We attempted to dissect early developmental stages of HSCs using an in vitro mouse embryonic stem cell (ESC) differentiation system combined with inducible HOXB4 expression. Here we report the identification of pre-HSCs and an embryonic type of HSCs (embryonic HSCs) as intermediate cells between ESCs and HSCs. Both pre-HSCs and embryonic HSCs were isolated by their c-Kit+ CD41+ CD45 2 phenotype. Pre-HSCs did not engraft in irradiated adult mice. After co-culture with OP9 stromal cells and conditional expression of HOXB4, pre-HSCs gave rise to embryonic HSCs capable of engraftment and long-term reconstitution in irradiated adult mice. Blast colony assays revealed that most hemangioblast activity was detected apart from the pre-HSC population, implying the early divergence of pre-HSCs from hemangioblasts. Gene expression profiling suggests that a particular set of transcripts closely associated with adult HSCs is involved in the transition of pre-HSC to embryonic HSCs. We propose an HSC developmental model in which pre-HSCs and embryonic HSCs sequentially give rise to adult types of HSCs in a stepwise manner.	[Matsumoto, Kenji; Nishimura, Toshinobu; Ogaeri, Takunori; Eto, Koji; Nakauchi, Hiromitsu; Ema, Hideo] Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan; [Isagawa, Takayuki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Advanced Sci & Technol, Genome Sci Div, Tokyo, Japan; [Miyazaki, Satsuki; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 565, Japan	University of Tokyo; University of Tokyo; Osaka University	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan.	nakauchi@ims.u-tokyo.ac.jp; hema@ims.u-tokyo.ac.jp	Nishimura, Toshinobu/AAZ-7675-2021; Miyazaki, Jun-ichi/N-1976-2015	Nishimura, Toshinobu/0000-0002-5425-1708; Miyazaki, Jun-ichi/0000-0003-2475-589X; Miyazaki, Satsuki/0000-0003-1781-1590	Ministry of Education, Culture, Sport, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21390321] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sport, Science, and Technology, Japan. These grants have no financial interests, and played no role in study and preparation of the manuscript.	Abkowitz JL, 2007, BLOOD, V109, P5186, DOI 10.1182/blood-2006-08-044503; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Choi K, 1998, DEVELOPMENT, V125, P725; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fujimoto T, 2001, GENES CELLS, V6, P1113, DOI 10.1046/j.1365-2443.2001.00490.x; Furuta C, 2006, DEVELOPMENT, V133, P2771, DOI 10.1242/dev.02440; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lacaud G, 2001, ANN NY ACAD SCI, V938, P96; LACAUD G, 2001, ANN NY ACAD SCI, V938, P108; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; Matsuoka S, 2001, BLOOD, V97, P419, DOI 10.1182/blood.V97.2.419; McKinney-Freeman SL, 2008, BLOOD, V111, P4944, DOI 10.1182/blood-2007-11-124644; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Miyazaki S, 2005, BIOCHEM BIOPH RES CO, V338, P1083, DOI 10.1016/j.bbrc.2005.10.054; Mizuguchi H, 2002, J GENE MED, V4, P240, DOI 10.1002/jgm.261; MOORE MAS, 2004, HDB STEM CELLS, P159; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nobuhisa I, 2007, EXP CELL RES, V313, P965, DOI 10.1016/j.yexcr.2006.12.024; OKADA S, 1991, BLOOD, V78, P1706; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; SMITH RA, 1982, DEV COMP IMMUNOL, V6, P359, DOI 10.1016/S0145-305X(82)80019-0; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	47	35	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4820	10.1371/journal.pone.0004820	http://dx.doi.org/10.1371/journal.pone.0004820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287487	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496400002
J	Opresko, PL; Sowd, G; Wang, H				Opresko, Patricia L.; Sowd, Gregory; Wang, Hong			The Werner Syndrome Helicase/Exonuclease Processes Mobile D-Loops through Branch Migration and Degradation	PLOS ONE			English	Article							SYNDROME PROTEIN WRN; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; RECQ HELICASES; SUBSTRATE-SPECIFICITY; MAMMALIAN TELOMERES; HOLLIDAY JUNCTIONS; DNA; MECHANISM; BLM	RecQ DNA helicases are critical for preserving genome integrity. Of the five RecQ family members identified in humans, only the Werner syndrome protein (WRN) possesses exonuclease activity. Loss of WRN causes the progeroid disorder Werner syndrome which is marked by cancer predisposition. Cellular evidence indicates that WRN disrupts potentially deleterious intermediates in homologous recombination (HR) that arise in genomic and telomeric regions during DNA replication and repair. Precisely how the WRN biochemical activities process these structures is unknown, especially since the DNA unwinding activity is poorly processive. We generated biologically relevant mobile D-loops which mimic the initial DNA strand invasion step in HR to investigate whether WRN biochemical activities can disrupt this joint molecule. We show that WRN helicase alone can promote branch migration through an 84 base pair duplex region to completely displace the invading strand from the D-loop. However, substrate processing is altered in the presence of the WRN exonuclease activity which degrades the invading strand both prior to and after release from the D-loop. Furthermore, telomeric D-loops are more refractory to disruption by WRN, which has implications for tighter regulation of D-loop processing at telomeres. Finally, we show that WRN can recognize and initiate branch migration from both the 59 and 39 ends of the invading strand in the D-loops. These findings led us to propose a novel model for WRN D-loop disruption. Our biochemical results offer an explanation for the cellular studies that indicate both WRN activities function in processing HR intermediates.	[Opresko, Patricia L.; Sowd, Gregory] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Wang, Hong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wang, Hong] Univ Pittsburgh, Canc Inst, Hillman Canc Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Opresko, PL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	plo4@pitt.edu	Wang, Hong/F-3164-2014	Wang, Hong/0000-0003-0165-3559; Opresko, Patricia/0000-0002-6470-2189	NIH [ES0515052]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015052, R00ES016758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH grant ES0515052 (P.L.O.) and the Ellison Medical Foundation (P.L.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Choi JM, 2007, J BIOL CHEM, V282, P9941, DOI 10.1074/jbc.M609657200; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Driscoll HC, 2003, J BIOL CHEM, V278, P41126, DOI 10.1074/jbc.M304798200; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hile SE, 2000, CANCER RES, V60, P1698; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-6; Machwe A, 2002, J BIOL CHEM, V277, P4492, DOI 10.1074/jbc.M108880200; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Ozsoy AZ, 2003, NUCLEIC ACIDS RES, V31, P1554, DOI 10.1093/nar/gkg243; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Tarsounas M, 2005, CELL CYCLE, V4, P672, DOI 10.4161/cc.4.5.1689; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	62	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4825	10.1371/journal.pone.0004825	http://dx.doi.org/10.1371/journal.pone.0004825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283071	Green Published, gold, Green Accepted			2022-12-27	WOS:000265496300007
J	Si, H; Banga, RS; Kapitsinou, P; Ramaiah, M; Lawrence, J; Kambhampati, G; Gruenwald, A; Bottinger, E; Glicklich, D; Tellis, V; Greenstein, S; Thomas, DB; Pullman, J; Fazzari, M; Susztak, K				Si, Han; Banga, Ramandeep S.; Kapitsinou, Pinelopi; Ramaiah, Manjunath; Lawrence, Janis; Kambhampati, Ganesh; Gruenwald, Antje; Bottinger, Erwin; Glicklich, Daniel; Tellis, Vivian; Greenstein, Stuart; Thomas, David B.; Pullman, James; Fazzari, Melissa; Susztak, Katalin			Human and Murine Kidneys Show Gender- and Species-Specific Gene Expression Differences in Response to Injury	PLOS ONE			English	Article							ESTROGEN; INACTIVATION; DISEASE; BRAIN; GLOMERULOSCLEROSIS; PROGRESSION; TISSUE	The incidence of End Stage Renal Disease (ESRD) is approximately 50% higher in men than women. In order to understand the molecular basis of this gender disparity, we examined sex specific gene expression patterns in control and diseased, human and murine kidney samples. Using the Affymetrix platform we performed comprehensive gene expression analysis on 42 microdissected human kidney samples (glomeruli and tubules). We identified 67 genes with gender biased expression in healthy human kidneys and 24 transcripts in diseased male and female human kidneys. Similar analysis performed in mice using male and female control and doxorubicin induced nephrotic syndrome kidneys identified significantly larger number of differentially expressed transcripts. The majority of genes showing gender biased expression either in diseased human and murine kidneys were different from those differentially expressed in healthy kidneys. Only 9 sexually dimorphic transcripts were common to healthy human and murine kidneys and five showed differential regulation in both human and murine diseased kidneys. In humans, sex biased genes showed statistical enrichment only to sex chromosomes while in mice they were enriched to sex chromosomes and various autosomes. Thus we present a comprehensive analysis of gender biased genes in the kidney. We show that sexually dimorphic genes in the kidney show species specific regulation. Our results also indicate that male and female kidneys respond differently to injury. These studies could provide the basis for the development of new treatment strategies for men and women with kidney disease.			Si, H (corresponding author), Albert Einstein Coll Med, Dep Med Nephrol, Bronx, NY 10467 USA.	ksusztak@aecom.yu.edu	Susztak, Katalin/ABE-7474-2021	Susztak, Katalin/0000-0002-1005-3726; Fazzari, Melissa/0000-0002-5674-3589	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087635, R01DK073960, R01DK060043, R01DK076077] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK087635-01, R01 DK087635, R01 DK073960, R01 DK076077, R01 DK076077-02, R01 DK060043] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Arnold AP, 2004, TRENDS ENDOCRIN MET, V15, P6, DOI 10.1016/j.tem.2003.11.001; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; BAYLIS C, 1994, J CLIN INVEST, V94, P1823, DOI 10.1172/JCI117531; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cohen CD, 2002, NEPHRON, V92, P522, DOI 10.1159/000064099; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Cowley BD, 1997, AM J KIDNEY DIS, V29, P265, DOI 10.1016/S0272-6386(97)90039-1; De Boer E, 1999, J AM SOC NEPHROL, V10, P2359; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Elliot SJ, 2007, KIDNEY INT, V72, P464, DOI 10.1038/sj.ki.5002328; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Isensee J, 2007, GENDER MED, V4, pS75, DOI 10.1016/S1550-8579(07)80049-0; Joles JA, 1998, KIDNEY INT, V53, P862, DOI 10.1111/j.1523-1755.1998.00825.x; LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Schoolwerth Anton C, 2006, Prev Chronic Dis, V3, pA57; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tan JC, 2008, TRANSPLANTATION, V86, P75, DOI 10.1097/TP.0b013e31817352b9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; *US REN DAT SYST, USRDS 2007 ANN REP A; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	34	53	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4802	10.1371/journal.pone.0004802	http://dx.doi.org/10.1371/journal.pone.0004802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277126	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496100021
J	Sanz, MA; Castello, A; Ventoso, I; Berlanga, JJ; Carrasco, L				Angel Sanz, Miguel; Castello, Alfredo; Ventoso, Ivan; Jose Berlanga, Juan; Carrasco, Luis			Dual Mechanism for the Translation of Subgenomic mRNA from Sindbis Virus in Infected and Uninfected Cells	PLOS ONE			English	Article								Infection of BHK cells by Sindbis virus (SV) gives rise to a profound inhibition of cellular protein synthesis, whereas translation of viral subgenomic mRNA that encodes viral structural proteins, continues for hours. To gain further knowledge on the mechanism by which this subgenomic mRNA is translated, the requirements for some initiation factors (eIFs) and for the presence of the initiator AUG were examined both in infected and in uninfected cells. To this end, BHK cells were transfected with different SV replicons or with in vitro made SV subgenomic mRNAs after inactivation of some eIFs. Specifically, eIF4G was cleaved by expression of the poliovirus 2A protease (2A(pro)) and the alpha subunit of eIF2 was inactivated by phosphorylation induced by arsenite treatment. Moreover, cellular location of these and other translation components was analyzed in BHK infected cells by confocal microscopy. Cleavage of eIF4G by poliovirus 2A(pro) does not hamper translation of subgenomic mRNA in SV infected cells, but bisection of this factor blocks subgenomic mRNA translation in uninfected cells or in cell-free systems. SV infection induces phosphorylation of eIF2 alpha, a process that is increased by arsenite treatment. Under these conditions, translation of subgenomic mRNA occurs to almost the same extent as controls in the infected cells but is drastically inhibited in uninfected cells. Notably, the correct initiation site on the subgenomic mRNA is still partially recognized when the initiation codon AUG is modified to other codons only in infected cells. Finally, immunolocalization of different eIFs reveals that eIF2 alpha and eIF4G are excluded from the foci, where viral RNA replication occurs, while eIF3, eEF2 and ribosomes concentrate in these regions. These findings support the notion that canonical initiation takes place when the subgenomic mRNA is translated out of the infection context, while initiation can occur without some eIFs and even at non-AUG codons in infected cells.	[Angel Sanz, Miguel; Castello, Alfredo; Ventoso, Ivan; Jose Berlanga, Juan; Carrasco, Luis] Univ Autonoma Madrid, Ctr Biol Mol, Severo Ochoa CSIC UAM, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz, MA (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, Severo Ochoa CSIC UAM, E-28049 Madrid, Spain.	lcarrasco@cbm.uam.es	Castello, Alfredo/U-6317-2018; Carrasco, Luis/E-2435-2012; Palomares, Alfredo Castello/K-8062-2019; Carrasco, Luis/H-3001-2017; sanz-gomez, miguel/Y-6244-2019; Berlanga, Juan José/N-1718-2015; Ventoso, Iván/N-4018-2014; Sanz, Miguel A/H-1914-2015	Castello, Alfredo/0000-0002-1499-4662; Palomares, Alfredo Castello/0000-0002-1499-4662; Carrasco, Luis/0000-0003-3833-8835; sanz-gomez, miguel/0000-0002-5761-9010; Berlanga, Juan José/0000-0002-2408-6561; Ventoso, Iván/0000-0001-7887-3520; Sanz, Miguel A/0000-0001-6573-883X	DGICYT [BFU 2006-02182]	DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	DGICYT Grant (BFU 2006-02182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Annamalai P, 2008, J VIROL, V82, P1484, DOI 10.1128/JVI.01540-07; BELSHAM GJ, 2008, DIVERGENT PICORNAVIR; Bonderoff JM, 2008, CURR TOP MICROBIOL, V323, P123; Burgui I, 2007, J VIROL, V81, P12427, DOI 10.1128/JVI.01105-07; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Feduchi E, 1995, EUR J BIOCHEM, V234, P849, DOI 10.1111/j.1432-1033.1995.849_a.x; FROLOV I, 1994, J VIROL, V68, P1721, DOI 10.1128/JVI.68.3.1721-1727.1994; Frolov I, 1996, J VIROL, V70, P1182, DOI 10.1128/JVI.70.2.1182-1190.1996; FROLOV I, 1994, J VIROL, V68, P8111, DOI 10.1128/JVI.68.12.8111-8117.1994; Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006; FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075; Gorchakov R, 2004, J VIROL, V78, P8455, DOI 10.1128/JVI.78.16.8455-8467.2004; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Li ML, 2007, J VIROL, V81, P4371, DOI 10.1128/JVI.02672-06; LILJESTROM P, 1991, J VIROL, V65, P4107; LUKAVSKY PJ, 2008, VIRUS RES; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Mizumoto H, 2006, J VIROL, V80, P3781, DOI 10.1128/JVI.80.8.3781-3791.2006; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; Novoa I, 1997, BIOCHEMISTRY-US, V36, P7802, DOI 10.1021/bi9631172; OU JH, 1982, P NATL ACAD SCI-BIOL, V79, P5235, DOI 10.1073/pnas.79.17.5235; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pfingsten JS, 2008, RNA, V14, P1255, DOI 10.1261/rna.987808; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Sanz MA, 2003, J BIOL CHEM, V278, P2051, DOI 10.1074/jbc.M206611200; Sanz MA, 2001, J VIROL, V75, P7778, DOI 10.1128/JVI.75.16.7778-7784.2001; Sanz MA, 2007, J VIROL, V81, P7061, DOI 10.1128/JVI.02529-06; Savinova O, 1997, METHODS, V11, P419, DOI 10.1006/meth.1996.0438; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; Whitlow ZW, 2006, J VIROL, V80, P11733, DOI 10.1128/JVI.00971-06; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Xi QR, 2004, GENE DEV, V18, P1997, DOI 10.1101/gad.1212504	52	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4772	10.1371/journal.pone.0004772	http://dx.doi.org/10.1371/journal.pone.0004772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274090	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000265496000012
J	Doube, M; Conroy, AW; Christiansen, P; Hutchinson, JR; Shefelbine, S				Doube, Michael; Conroy, Alexis Wiktorowicz; Christiansen, Per; Hutchinson, John R.; Shefelbine, Sandra			Three-Dimensional Geometric Analysis of Felid Limb Bone Allometry	PLOS ONE			English	Article								Background: Studies of bone allometry typically use simple measurements taken in a small number of locations per bone; often the midshaft diameter or joint surface area is compared to body mass or bone length. However, bones must fulfil multiple roles simultaneously with minimum cost to the animal while meeting the structural requirements imposed by behaviour and locomotion, and not exceeding its capacity for adaptation and repair. We use entire bone volumes from the forelimbs and hindlimbs of Felidae (cats) to investigate regional complexities in bone allometry. Method/Principal Findings: Computed tomographic (CT) images (16435 slices in 116 stacks) were made of 9 limb bones from each of 13 individuals of 9 feline species ranging in size from domestic cat (Felis catus) to tiger (Panthera tigris). Eleven geometric parameters were calculated for every CT slice and scaling exponents calculated at 5% increments along the entire length of each bone. Three-dimensional moments of inertia were calculated for each bone volume, and spherical radii were measured in the glenoid cavity, humeral head and femoral head. Allometry of the midshaft, moments of inertia and joint radii were determined. Allometry was highly variable and related to local bone function, with joint surfaces and muscle attachment sites generally showing stronger positive allometry than the midshaft. Conclusions/Significance: Examining whole bones revealed that bone allometry is strongly affected by regional variations in bone function, presumably through mechanical effects on bone modelling. Bone's phenotypic plasticity may be an advantage during rapid evolutionary divergence by allowing exploitation of the full size range that a morphotype can occupy. Felids show bone allometry rather than postural change across their size range, unlike similar-sized animals.	[Doube, Michael; Shefelbine, Sandra] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Conroy, Alexis Wiktorowicz; Hutchinson, John R.] Univ London Royal Vet Coll, Structure & Motion Lab, Hatfield, Herts, England; [Christiansen, Per] Universitetsparken, Zool Museum, Copenhagen, Denmark	Imperial College London; University of London; University of London Royal Veterinary College	Doube, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	m.doube@imperial.ac.uk	Hutchinson, John/AAH-1593-2020; Doube, Michael/L-6769-2016	Doube, Michael/0000-0002-8021-8127; Hutchinson, John/0000-0002-6767-7038	Biotechnology and Biological Sciences Research Council, UK; BBSRC [BB/F000863/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000863/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1979, J ZOOL, V189, P305; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1983, J ZOOL, V201, P67, DOI 10.1111/j.1469-7998.1983.tb04261.x; BIEWENER AA, 1988, J ZOOL, V214, P547, DOI 10.1111/j.1469-7998.1988.tb03759.x; Boyde A, 2003, J ANAT, V203, P173, DOI 10.1046/j.1469-7580.2003.00213.x; Brianza SZM, 2007, BONE, V40, P1635, DOI 10.1016/j.bone.2007.02.013; Bulstrode C, 1986, LANCET, V327, P29, DOI DOI 10.1016/S0140-6736(86)91905-7; Carpenter RD, 2008, BIOMECH MODEL MECHAN, V7, P227, DOI 10.1007/s10237-007-0087-9; CARTER DR, 1981, ACTA ORTHOP SCAND, V52, P481, DOI 10.3109/17453678108992136; Castleman K. R., 1996, DIGITAL IMAGE PROCES; Christiansen P, 1999, J MORPHOL, V239, P167, DOI 10.1002/(SICI)1097-4687(199902)239:2<167::AID-JMOR5>3.3.CO;2-#; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; DAVIS DD, 1962, EVOLUTION, V16, P505, DOI 10.2307/2406182; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; ECONOMOS AC, 1983, J THEOR BIOL, V103, P167, DOI 10.1016/0022-5193(83)90206-0; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Firth EC, 2005, NEW ZEAL VET J, V53, P101, DOI 10.1080/00480169.2005.36487; Franklyn M, 2008, AM J SPORT MED, V36, P1179, DOI 10.1177/0363546508314408; Garcia GJM, 2006, PHYS LIFE REV, V3, P188, DOI 10.1016/j.plrev.2006.07.002; Gautier E, 2000, INJURY, V31, P37, DOI 10.1016/S0020-1383(00)80030-3; GODFREY L, 1991, J ZOOL, V223, P603, DOI 10.1111/j.1469-7998.1991.tb04391.x; GOODSHIP AE, 1979, J BONE JOINT SURG AM, V61, P539, DOI 10.2106/00004623-197961040-00008; HARTMAN W, 1984, AM J VET RES, V45, P880; ILIZAROV GA, 1990, CLIN ORTHOP RELAT R, P8; Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x; LANYON LE, 1980, J ZOOL, V192, P457; Lascelles BDX, 2007, VET REC, V160, P512, DOI 10.1136/vr.160.15.512; Main RP, 2007, J ANAT, V210, P272, DOI 10.1111/j.1469-7580.2007.00696.x; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; MCMAHON TA, 1975, J APPL PHYSIOL, V39, P619, DOI 10.1152/jappl.1975.39.4.619; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; Mow V.C., 2005, BASIC ORTHOPAEDIC BI; Nowak RM, 1983, WALKERS MAMMALS WORL, VII; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; Preparata F.P., 1985, COMPUTATIONAL GEOMET; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Reilly GC, 1999, J EXP BIOL, V202, P543; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Rho JY, 2001, J EXP BIOL, V204, P1775; Riggs CM, 1999, EQUINE VET J, V31, P130, DOI 10.1111/j.2042-3306.1999.tb03806.x; RIGGS CM, 1993, ANAT EMBRYOL, V187, P231; Roberts-Harry D, 2004, BRIT DENT J, V196, P391, DOI 10.1038/sj.bdj.4811129; RODRIGUEZ JI, 1992, TERATOLOGY, V45, P213, DOI 10.1002/tera.1420450215; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruohola JPS, 2006, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000194668.70225.24; SELKER F, 1989, J BIOMECH, V22, P1175, DOI 10.1016/0021-9290(89)90219-4; Takano Y, 1999, J ORTHOP RES, V17, P59, DOI 10.1002/jor.1100170110; TAKEBE K, 1984, ROLE FIBULA WEIGHT B, P289; Ventura J, 2005, J WILDLIFE DIS, V41, P728, DOI 10.7589/0090-3558-41.4.728; Wang Q, 1996, CLIN ORTHOP RELAT R, P261; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Warton D. I., 2007, SMATR STANDARDISED M; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WOBESER G, 1992, J WILDLIFE DIS, V28, P268, DOI 10.7589/0090-3558-28.2.268; Yang Y, 2008, THESIS IMPERIAL COLL	61	49	49	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4742	10.1371/journal.pone.0004742	http://dx.doi.org/10.1371/journal.pone.0004742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270749	gold, Green Published			2022-12-27	WOS:000265495900010
J	Knorr, E; Schmidtberg, H; Vilcinskas, A; Altincicek, B				Knorr, Eileen; Schmidtberg, Henrike; Vilcinskas, Andreas; Altincicek, Boran			MMPs Regulate both Development and Immunity in the Tribolium Model Insect	PLOS ONE			English	Article								Background: Matrix metalloproteinases (MMPs) are evolutionarily conserved and multifunctional effector molecules in development and homeostasis. In spite of previous, intensive investigation in vitro and in cell culture, their pleiotrophic functions in vivo are still not well understood. Methodology/Principal Findings: We show that the genetically amenable beetle Tribolium castaneum represents a feasible model organism to explore MMP functions in vivo. We silenced expression of three insect-type Tribolium MMP paralogs and their physiological inhibitors, TIMP and RECK, by dsRNA-mediated genetic interference (RNAi). Knock-down of MMP-1 arrested development during pupal morphogenesis giving phenotypes with altered antennae, compound eyes, wings, legs, and head. Parental RNAi-mediated knock-down of MMP-1 or MMP-2 resulted in larvae with non-lethal tracheal defects and with abnormal intestines, respectively, implicating additional roles of MMPs during beetle embryogenesis. This is different to findings from the fruit fly Drosophila melanogaster, in which MMPs have a negligible role in embryogenesis. Confirming pleiotrophic roles of MMPs our results also revealed that MMPs are required for proper insect innate immunity because systemic knock-down of Tribolium MMP-1 resulted in significantly higher susceptibility to the entomopathogenic fungus Beauveria bassiana. Moreover, mRNA levels of MMP-1, TIMP, and RECK, and also MMP enzymatic activity were significantly elevated in immune-competent hemocytes upon stimulation. To confirm collagenolytic activity of Tribolium MMP-1 we produced and purified recombinant enzyme and determined a similar collagen IV degrading activity as observed for the most related human MMP, MMP-19. Conclusions/Significance: This is the first study, to our knowledge, investigating the in vivo role of virtually all insect MMP paralogs along with their inhibitors TIMP and RECK in both insect development and immunity. Our results from the Tribolium model insect indicate that MMPs regulate tracheal and gut development during beetle embryogenesis, pupal morphogenesis, and innate immune defense reactions thereby revealing the evolutionarily conserved roles of MMPs.	[Knorr, Eileen; Schmidtberg, Henrike; Vilcinskas, Andreas; Altincicek, Boran] Univ Giessen, Inst Phytopathol & Appl Zool, Interdisciplinary Res Ctr, Giessen, Germany	Justus Liebig University Giessen	Knorr, E (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, Interdisciplinary Res Ctr, Giessen, Germany.	Boran.Altincicek@agrar.uni-giessen.de	Altincicek, Boran/C-1191-2009	Altincicek, Boran/0000-0003-2019-452X	Deutsche Forschungsgemeinschaft (Bonn, Germany) [AL 902/2-1]	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG))	This project was supported by a grant (AL 902/2-1) to B. A. from the Deutsche Forschungsgemeinschaft (Bonn, Germany). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-6; Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P400, DOI 10.1016/j.dci.2007.08.001; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Altincicek B, 2007, INFECT IMMUN, V75, P175, DOI 10.1128/IAI.01385-06; Altincicek B, 2006, DEV COMP IMMUNOL, V30, P1108, DOI 10.1016/j.dci.2006.03.002; Beck IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002343; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fu XY, 2008, SEMIN CELL DEV BIOL, V19, P2, DOI 10.1016/j.semcdb.2007.06.005; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hillegass JM, 2007, TOXICOL SCI, V100, P168, DOI 10.1093/toxsci/kfm192; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Leontovich AA, 2000, DEVELOPMENT, V127, P907; Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200; Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Madri J A, 2000, Dev Immunol, V7, P103, DOI 10.1155/2000/79045; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Montagnani C, 2007, DEV COMP IMMUNOL, V31, P1, DOI 10.1016/j.dci.2006.04.002; Munoz P, 2003, J PARASITOL, V89, P941, DOI 10.1645/GE-3126; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, BIOINFORMATICS METHO; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Sadowski T, 2003, J INVEST DERMATOL, V121, P989, DOI 10.1046/j.1523-1747.2003.12526.x; Schroder R, 2008, DEV GENES EVOL, V218, P119, DOI 10.1007/s00427-008-0214-3; Sokoloff A, 1974, BIOL TRIBOLIUM SPECI; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wedde M, 2007, BIOL CHEM, V388, P119, DOI 10.1515/BC.2007.013; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WHITTEN JM, 1957, J CELL SCI, V41, P123; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhang JS, 2003, DEV GENES EVOL, V213, P456, DOI 10.1007/s00427-003-0346-4	62	64	68	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4751	10.1371/journal.pone.0004751	http://dx.doi.org/10.1371/journal.pone.0004751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270735	Green Published, gold, Green Submitted			2022-12-27	WOS:000265495900018
J	Ong, PC; Golding, SJ; Pearce, MC; Irving, JA; Grigoryev, SA; Pike, D; Langendorf, CG; Bashtannyk-Puhalovich, TA; Bottomley, SP; Whisstock, JC; Pike, RN; McGowan, S				Ong, Poh Chee; Golding, Sarah J.; Pearce, Mary C.; Irving, James A.; Grigoryev, Sergei A.; Pike, Debbie; Langendorf, Christopher G.; Bashtannyk-Puhalovich, Tanya A.; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.; McGowan, Sheena			Conformational Change in the Chromatin Remodelling Protein MENT	PLOS ONE			English	Article								Chromatin condensation to heterochromatin is a mechanism essential for widespread suppression of gene transcription, and the means by which a chromatin-associated protein, MENT, induces a terminally differentiated state in cells. MENT, a protease inhibitor of the serpin superfamily, is able to undergo conformational change in order to effect enzyme inhibition. Here, we sought to investigate whether conformational change in MENT is 'fine-tuned' in the presence of a bound ligand in an analogous manner to other serpins, such as antithrombin where such movements are reflected by a change in intrinsic tryptophan fluorescence. Using this technique, MENT was found to undergo structural shifts in the presence of DNA packaged into nucleosomes, but not naked DNA. The contribution of the four Trp residues of MENT to the fluorescence change was mapped using deconvolution analysis of variants containing single Trp to Phe mutations. The analysis indicated that the overall emission spectra is dominated by a helix-H tryptophan, but this residue did not dominate the conformational change in the presence of chromatin, suggesting that other Trp residues contained in the A-sheet and RCL regions contribute to the conformational change. Mutagenesis revealed that the conformational change requires the presence of the DNA-binding 'M-loop' and D-helix of MENT, but is independent of the protease specificity determining 'reactive centre loop'. The D-helix mutant of MENT, which is unable to condense chromatin, does not undergo a conformational change, despite being able to bind chromatin, indicating that the conformational change may contribute to chromatin condensation by the serpin.	[Ong, Poh Chee; Golding, Sarah J.; Pearce, Mary C.; Irving, James A.; Pike, Debbie; Langendorf, Christopher G.; Bashtannyk-Puhalovich, Tanya A.; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.; McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Hershey, PA USA	Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ong, PC (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	rob.pike@med.monash.edu.au; sheena.mcgowan@med.monash.edu.au	Irving, James A/I-8467-2015; Irving, James/P-3860-2019; McGowan, Sheena/C-4797-2014	Irving, James/0000-0003-3204-6356; McGowan, Sheena/0000-0001-6863-1106; Pike, Robert/0000-0002-2083-0269; Golding, Sarah/0000-0002-6578-4390; Whisstock, James/0000-0003-4200-5611; Langendorf, Christopher/0000-0002-9049-5283	National Health and Medical Research Council (NHMRC) of Australia [Senior Research Fellow, CJ Martin Postdoctoral Research Fellow]; Australian Research Council (ARC) [Federation Fellow]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	We thank the National Health and Medical Research Council (NHMRC) of Australia and the Australian Research Council (ARC) for generous support. JCW is a ARC Federation Fellow. SPB is a NHMRC Senior Research Fellow. JAI is a NHMRC CJ Martin Postdoctoral Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Dafforn TR, 2004, METHODS, V32, P150, DOI 10.1016/S1046-2023(03)00206-8; GRIGORYEV SA, 1992, EXP CELL RES, V198, P268, DOI 10.1016/0014-4827(92)90379-M; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; HASSELBACHER CA, 1995, BIOPHYS J, V69, P20, DOI 10.1016/S0006-3495(95)79891-5; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Langdown J, 2004, J BIOL CHEM, V279, P47288, DOI 10.1074/jbc.M408961200; LOCKE BC, 1992, BIOCHEMISTRY-US, V31, P2376, DOI 10.1021/bi00123a024; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mazumder A, 2007, BIOPHYS J, V93, P2209, DOI 10.1529/biophysj.106.102202; McGowan S, 2006, EMBO J, V25, P3144, DOI 10.1038/sj.emboj.7601201; Meagher JL, 1998, J BIOL CHEM, V273, P23283, DOI 10.1074/jbc.273.36.23283; Montel F, 2007, BIOPHYS J, V93, P566, DOI 10.1529/biophysj.107.105569; OLSON ST, 1992, THROMBIN STRUCTURE F, P159; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4727	10.1371/journal.pone.0004727	http://dx.doi.org/10.1371/journal.pone.0004727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266095	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490800008
J	Bellgard, MI; Wanchanthuek, P; La, T; Ryan, K; Moolhuijzen, P; Albertyn, Z; Shaban, B; Motro, Y; Dunn, DS; Schibeci, D; Hunter, A; Barrero, R; Phillips, ND; Hampson, DJ				Bellgard, Matthew I.; Wanchanthuek, Phatthanaphong; La, Tom; Ryan, Karon; Moolhuijzen, Paula; Albertyn, Zayed; Shaban, Babak; Motro, Yair; Dunn, David S.; Schibeci, David; Hunter, Adam; Barrero, Roberto; Phillips, Nyree D.; Hampson, David J.			Genome Sequence of the Pathogenic Intestinal Spirochete Brachyspira hyodysenteriae Reveals Adaptations to Its Lifestyle in the Porcine Large Intestine	PLOS ONE			English	Article								Brachyspira hyodysenteriae is an anaerobic intestinal spirochete that colonizes the large intestine of pigs and causes swine dysentery, a disease of significant economic importance. The genome sequence of B. hyodysenteriae strain WA1 was determined, making it the first representative of the genus Brachyspira to be sequenced, and the seventeenth spirochete genome to be reported. The genome consisted of a circular 3,000,694 base pair (bp) chromosome, and a 35,940 bp circular plasmid that has not previously been described. The spirochete had 2,122 protein-coding sequences. Of the predicted proteins, more had similarities to proteins of the enteric Escherichia coli and Clostridium species than they did to proteins of other spirochetes. Many of these genes were associated with transport and metabolism, and they may have been gradually acquired through horizontal gene transfer in the environment of the large intestine. A reconstruction of central metabolic pathways identified a complete set of coding sequences for glycolysis, gluconeogenesis, a non-oxidative pentose phosphate pathway, nucleotide metabolism, lipooligosaccharide biosynthesis, and a respiratory electron transport chain. A notable finding was the presence on the plasmid of the genes involved in rhamnose biosynthesis. Potential virulence genes included those for 15 proteases and six hemolysins. Other adaptations to an enteric lifestyle included the presence of large numbers of genes associated with chemotaxis and motility. B. hyodysenteriae has diverged from other spirochetes in the process of accommodating to its habitat in the porcine large intestine.	[Bellgard, Matthew I.; Wanchanthuek, Phatthanaphong; Ryan, Karon; Moolhuijzen, Paula; Albertyn, Zayed; Shaban, Babak; Motro, Yair; Dunn, David S.; Schibeci, David; Hunter, Adam; Barrero, Roberto] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia; [Wanchanthuek, Phatthanaphong] Mahasarakham Univ, Fac Informat, Maha Sarakham, Thailand; [La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Biomed Sci, Anim Res Inst, Murdoch, WA 6150, Australia	Murdoch University; Mahasarakham University; Murdoch University	Bellgard, MI (corresponding author), Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia.	d.hampson@murdoch.edu.au	Hampson, David/AAE-3666-2019; Hampson, David J/A-9464-2008	Hampson, David J/0000-0002-7729-0427; Barrero, Roberto/0000-0002-7735-665X; Bellgard, Matthew/0000-0002-6303-9469	Australian Research Council; Novartis Animal Vaccines [LP0348441]; Western Australian State Government	Australian Research Council(Australian Research Council); Novartis Animal Vaccines; Western Australian State Government	This study was supported by the Australian Research Council and Novartis Animal Vaccines through Linkage grant number LP0348441 for Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery, and by the Western Australian State Government in establishment of the WA Centre of Excellence for Comparative Genomics and support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Born TL, 1999, CURR OPIN CHEM BIOL, V3, P607, DOI 10.1016/S1367-5931(99)00016-2; Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375; Bulach DM, 2000, INFECT IMMUN, V68, P3793, DOI 10.1128/IAI.68.7.3793-3798.2000; Chen YJ, 2003, MAMM GENOME, V14, P859, DOI 10.1007/s00335-003-2296-6; Cho NH, 2005, ANN NY ACAD SCI, V1063, P100, DOI 10.1196/annals.1355.016; Datta HJ, 1999, P NATL ACAD SCI USA, V96, P73, DOI 10.1073/pnas.96.1.73; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Farn J, 2004, INFECT IMMUN, V72, P7357, DOI 10.1128/IAI.72.12.7357-7359.2004; Fondi M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S12; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; Goonesekere NCW, 2008, PROTEINS, V71, P910, DOI 10.1002/prot.21775; HALTER MR, 1988, INFECT IMMUN, V56, P3152, DOI 10.1128/IAI.56.12.3152-3156.1988; HAMPSON DJ, 2006, DIS SWINE, P785; HENNEBERRY RC, 1970, CAN J MICROBIOL, V16, P41, DOI 10.1139/m70-007; Hsu T, 2001, INFECT IMMUN, V69, P706, DOI 10.1128/IAI.69.2.706-711.2001; HUNTER A, 2005, AUSTR WORKSH GRID CO; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Kada S, 2004, FEMS MICROBIOL LETT, V236, P13, DOI 10.1016/j.femsle.2004.05.028; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KENNEDY MJ, 1988, J GEN MICROBIOL, V134, P1565; KUNKLE RA, 1986, J CLIN MICROBIOL, V24, P669, DOI 10.1128/JCM.24.4.669-671.1986; KUO SC, 1989, J BACTERIOL, V171, P6279, DOI 10.1128/jb.171.11.6279-6287.1989; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lux R, 2000, J MOL MICROB BIOTECH, V2, P355; MAGASANIK B, 1982, ANNU REV GENET, V16, P135, DOI 10.1146/annurev.ge.16.120182.001031; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; MENESTRINA G, 1994, TOXICOLOGY, V87, P249, DOI 10.1016/0300-483X(94)90254-2; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MILNER JA, 1994, INFECT IMMUN, V62, P4095, DOI 10.1128/IAI.62.9.4095-4099.1994; MOTRO Y, 2009, VET MICROBI IN PRESS; Mulder Nicola, 2007, V396, P59; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Paster BJ, 2000, J MOL MICROB BIOTECH, V2, P341; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Rashid N, 2004, J BACTERIOL, V186, P4185, DOI 10.1128/JB.186.13.4185-4191.2004; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rosey EL, 1996, INFECT IMMUN, V64, P4154, DOI 10.1128/IAI.64.10.4154-4162.1996; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; STANTON TB, 1987, INFECT IMMUN, V55, P304, DOI 10.1128/IAI.55.2.304-308.1987; STANTON TB, 1989, APPL ENVIRON MICROB, V55, P2365, DOI 10.1128/AEM.55.9.2365-2371.1989; Stanton TB, 2001, APPL ENVIRON MICROB, V67, P2037, DOI 10.1128/AEM.67.5.2037-2043.2001; Stanton TB, 1999, APPL ENVIRON MICROB, V65, P5028; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TERHUURNE AAHM, 1995, VET MICROBIOL, V46, P347, DOI 10.1016/0378-1135(95)00049-G; TERHUURNE AAHM, 1994, MICROB PATHOGENESIS, V16, P269, DOI 10.1006/mpat.1994.1028; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wilson K, 1990, CURRENT PROTOCOLS MO, P241; XIANG SH, 1993, J BACTERIOL, V175, P4877, DOI 10.1128/JB.175.15.4877-4884.1993; ZUERNER RL, 1994, J BACTERIOL, V176, P1087, DOI 10.1128/JB.176.4.1087-1092.1994	63	78	192	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4641	10.1371/journal.pone.0004641	http://dx.doi.org/10.1371/journal.pone.0004641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262690	Green Published, gold			2022-12-27	WOS:000265490600002
J	Kloting, N; Berthold, S; Kovacs, P; Schon, MR; Fasshauer, M; Ruschke, K; Stumvoll, M; Bluher, M				Kloeting, Nora; Berthold, Susan; Kovacs, Peter; Schoen, Michael R.; Fasshauer, Mathias; Ruschke, Karen; Stumvoll, Michael; Blueher, Matthias			MicroRNA Expression in Human Omental and Subcutaneous Adipose Tissue	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FAT; IDENTIFICATION; PROFILES	MicroRNAs (miRNAs) are small non-coding RNAs, that play important regulatory roles in a variety of biological processes, including development, differentiation, apoptosis, and metabolism. In mammals, miRNAs have been shown to modulate adipocyte differentiation. Therefore, we performed a global miRNA gene expression assay in different fat depots of overweight and obese individuals to investigate whether miRNA expression in human adipose tissue is fat-depot specific and associated with parameters of obesity and glucose metabolism. Paired samples of abdominal subcutaneous (SC) and intraabdominal omental adipose tissue were obtained from fifteen individuals with either normal glucose tolerance (NGT, n = 9) or newly diagnosed type 2 diabetes (T2D, n = 6). Expression of 155 miRNAs was carried out using the TaqMan (R) MicroRNA Assays Human Panel Early Access Kit (Applied Biosystems, Darmstadt, Germany). We identified expression of 106 (68%) miRNAs in human omental and SC adipose tissue. There was no miRNA exclusively expressed in either fat depot, suggesting common developmental origin of both fat depots. Sixteen miRNAs (4 in NGT, 12 in T2D group) showed a significant fat depot specific expression pattern. We identified significant correlations between the expression of miRNA-17-5p, -132, -99a, -134, 181a, -145, -197 and both adipose tissue morphology and key metabolic parameters, including visceral fat area, HbA(1c), fasting plasma glucose, and circulating leptin, adiponectin, interleukin-6. In conclusion, microRNA expression differences may contribute to intrinsic differences between omental and subcutaneous adipose tissue. In addition, human adipose tissue miRNA expression correlates with adipocyte phenotype, parameters of obesity and glucose metabolism.	[Kloeting, Nora; Berthold, Susan; Fasshauer, Mathias; Ruschke, Karen; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, IZKF, Junior Res Grp N06, Leipzig, Germany; [Schoen, Michael R.] Clin Visceral Surg, Stadtisches Klin Karlsruhe, Karlsruhe, Germany	Leipzig University; Leipzig University; Municipal Hospital Karlsruhe	Kloting, N (corresponding author), Univ Leipzig, Dept Med, Leipzig, Germany.	bluma@medizin.uni-leipzig.de	Ruschke, Karen/E-6320-2014; Stumvoll, Michael/ABE-1121-2021	Ruschke, Karen/0000-0001-5285-9675; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Schon, Michael/0000-0002-0698-4130	Deutsche Forschungsgemeinschaft (DFG) [BL 833/1-1]; Interdisciplinary Center of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig	This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) the Clinical Research group "Atherobesity" KFO 152 (project BL 833/1-1) (MB), the Interdisciplinary Center of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig (Project B24 to MB and Project N06 to PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Gavin JR, 2000, DIABETES CARE, V23, pS4; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001713; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	26	237	248	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4699	10.1371/journal.pone.0004699	http://dx.doi.org/10.1371/journal.pone.0004699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259271	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490500014
J	Babu, CK; Suwansrinon, K; Bren, GD; Badley, AD; Rizza, SA				Babu, Challagundla K.; Suwansrinon, Kanitta; Bren, Gary D.; Badley, Andrew D.; Rizza, Stacey A.			HIV Induces TRAIL Sensitivity in Hepatocytes	PLOS ONE			English	Article								Background: HIV infected patients have an increased susceptibility to liver disease due to Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), alcoholic, and non-alcoholic steatohepatitis. Clinically, this results in limited options for antiretroviral therapy and accelerated rates of liver disease, causing liver disease to be the second leading cause of death for HIV infected patients. The mechanisms causing this propensity for liver dysfunction during HIV remains unknown. Methodology/Principal Findings: We demonstrate that HIV and/or the HIV glycoprotein gp120 ligation of CXCR4 on hepatocytes selectively up-regulates TRAIL R2 expression and confers an acquired sensitivity to TRAIL mediated apoptosis which is mediated by JNK II, but not p38 nor G-proteins. Conclusions/Significance: These findings suggest that HIV infection renders hepatocytes more susceptible to liver injury during disease states associated with enhanced TRAIL production such as HBV, HCV, or steatohepatitis.	[Babu, Challagundla K.; Suwansrinon, Kanitta; Bren, Gary D.; Badley, Andrew D.; Rizza, Stacey A.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Badley, Andrew D.; Rizza, Stacey A.] Mayo Clin, Program Translat Immunovirol & Biodefense, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Babu, CK (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	rizza.stacey@mayo.edu	Challagundla, Kishore B./H-8189-2019; badley, andrew d/O-9022-2014; Serei, Virian D/B-4616-2015	Challagundla, Kishore B./0000-0001-8654-7717; Badley, Andrew/0000-0001-7796-7680	National Institutes of Health [R01 AI62261, R01 AI40384, R21DK 77575-1]; Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research [1005160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040384, R01AI062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Andrew Badley is supported by grants from the National Institutes of Health (R01 AI62261 and R01 AI40384), and the Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research (ID#1005160). Dr. Stacey Rizza is supported by a grant from the National Institute of Health (R21DK 77575-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt C, 1998, P NATL ACAD SCI USA, V95, P12556, DOI 10.1073/pnas.95.21.12556; Bongiovanni M, 2007, CURR HIV RES, V5, P490, DOI 10.2174/157016207781662407; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; de Ledinghen V, 2008, J VIRAL HEPATITIS, V15, P427, DOI 10.1111/j.1365-2893.2007.00962.x; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gores GJ, 2001, HEPATOLOGY, V34, P3, DOI 10.1053/jhep.2001.25173; Hao CH, 2004, CANCER RES, V64, P8502, DOI 10.1158/0008-5472.CAN-04-2599; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Higuchi H, 2003, J BIOL CHEM, V278, P454, DOI 10.1074/jbc.M209387200; HOUSSET C, 1990, HUM PATHOL, V21, P404, DOI 10.1016/0046-8177(90)90202-G; Janssen HLA, 2003, J HEPATOL, V39, P414, DOI 10.1016/S0168-8278(03)00265-4; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kim N, 2007, J VIROL, V81, P7584, DOI 10.1128/JVI.02616-06; LEFKOWITCH JH, 1994, DIGEST DIS, V12, P321, DOI 10.1159/000171468; Liu YG, 2007, BIOCHEM BIOPH RES CO, V352, P329, DOI 10.1016/j.bbrc.2006.11.024; Lum JJ, 2005, AIDS, V19, P1125, DOI 10.1097/01.aids.0000176212.16205.23; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Ohtsuka T, 2003, ONCOGENE, V22, P2034, DOI 10.1038/sj.onc.1206290; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Trushin SA, 2007, J IMMUNOL, V178, P4846, DOI 10.4049/jimmunol.178.8.4846; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; Vlahakis SR, 2001, J CLIN INVEST, V107, P207, DOI 10.1172/JCI11109; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yang Y, 2007, INTERVIROLOGY, V50, P323, DOI 10.1159/000106463; Yi YJ, 2004, J NEUROVIROL, V10, P91, DOI 10.1080/13550280490268313	42	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4623	10.1371/journal.pone.0004623	http://dx.doi.org/10.1371/journal.pone.0004623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247452	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487800006
J	Dall, SRX; Wright, J				Dall, Sasha R. X.; Wright, Jonathan			Rich Pickings Near Large Communal Roosts Favor 'Gang' Foraging by Juvenile Common Ravens, Corvus corax	PLOS ONE			English	Article							INFORMATION-CENTER HYPOTHESIS; BLACK VULTURES; RECRUITMENT; FOOD	Ravens (Corvus corax) feed primarily on rich but ephemeral carcasses of large animals, which are usually defended by territorial pairs of adults. Non-breeding juveniles forage socially and aggregate in communal winter roosts, and these appear to function as 'information centers' regarding the location of the rare food bonanzas: individuals search independently of one another and pool their effort by recruiting each other at roosts. However, at a large raven roost in Newborough on Anglesey, North Wales, some juveniles have been observed recently to forage in 'gangs' and to roost separately from other birds. Here we adapt a general model of juvenile common raven foraging behavior where, in addition to the typical co-operative foraging strategy, such gang foraging behavior could be evolutionarily stable near winter raven roosts. We refocus the model on the conditions under which this newly documented, yet theoretically anticipated, gang-based foraging has been observed. In the process, we show formally how the trade off between search efficiency and social opportunity can account for the existence of the alternative social foraging tactics that have been observed in this species. This work serves to highlight a number of fruitful avenues for future research, both from a theoretical and empirical perspective.	[Dall, Sasha R. X.; Wright, Jonathan] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Dall, SRX (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England.	sashadall@iname.com; jonathan.wright@bio.ntnu.no	Dall, Sasha/B-2642-2010	Dall, Sasha/0000-0001-9873-6507	Natural Environment Research Council (U.K.) [AF11/03, NER/A/S/2002/00898]; Natural Environment Research Council [NER/A/S/2002/00898] Funding Source: researchfish	Natural Environment Research Council (U.K.)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was undertaken as an unfunded side project while SRXD was supported by grants to I. L. Boyd and T. H. Clutton-Brock (AF11/03) and R. A. Johnstone (NER/A/S/2002/00898) by the Natural Environment Research Council (U.K.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, RAVEN NATURAL HIST B; BARTA Z, 1992, BEHAV ECOL, V3, P318, DOI 10.1093/beheco/3.4.318; Buckley NJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P267, DOI 10.1007/s002650050388; Dall SRX, 2002, BEHAV ECOL, V13, P42, DOI 10.1093/beheco/13.1.42; GIBBONS MM, 1999, BEHAV ECOL, V10, P377; GIRALDEAN LA, 2000, SOCIAL FORAGING THEO; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; HEINRICH B, 1994, CONDOR, V96, P545, DOI 10.2307/1369334; HEINRICH B, 1994, AUK, V111, P764; HEINRICH B, 1993, AUK, V110, P247; HEINRICH B, 1988, CONDOR, V90, P950, DOI 10.2307/1368859; Heinrich B., 1989, RAVENS WINTER; Houston AI, 1999, MODELS ADAPTIVE BEHA; HURRELL HG, 1956, BR BIRDS, V19, P28; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; MARZLUFF JM, 1991, ANIM BEHAV, V42, P755, DOI 10.1016/S0003-3472(05)80121-6; Maynard Smith J., 1982, pi; Mesterton-Gibbons M, 1998, P ROY SOC B-BIOL SCI, V265, P1237, DOI 10.1098/rspb.1998.0425; RABENOLD PP, 1987, ANIM BEHAV, V35, P1775, DOI 10.1016/S0003-3472(87)80070-2; RABENOLD PP, 1986, AUK, V103, P32, DOI 10.1093/auk/103.1.32; RABENOLD PP, 1983, VULTURE BIOL MANAGEM, P303; Richner H, 1996, BEHAV ECOL, V7, P115, DOI 10.1093/beheco/7.1.115; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wolfram S., 1991, MATH SYSTEM DOING MA; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x	27	29	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4530	10.1371/journal.pone.0004530	http://dx.doi.org/10.1371/journal.pone.0004530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240813	Green Published, gold, Green Submitted			2022-12-27	WOS:000278086700002
J	Gomez, GA; Veldman, MB; Zhao, Y; Burgess, S; Lin, S				Gomez, Gustavo A.; Veldman, Matthew B.; Zhao, Yan; Burgess, Shawn; Lin, Shuo			Discovery and Characterization of Novel Vascular and Hematopoietic Genes Downstream of Etsrp in Zebrafish	PLOS ONE			English	Article							MICROARRAY ANALYSIS; EMBRYONIC BLOOD; EXPRESSION; RECEPTOR; PROTEIN; FAMILY; IDENTIFICATION; CLOCHE; DIFFERENTIATION; PRECURSOR	The transcription factor Etsrp is required for vasculogenesis and primitive myelopoiesis in zebrafish. When ectopically expressed, etsrp is sufficient to induce the expression of many vascular and myeloid genes in zebrafish. The mammalian homolog of etsrp, ER71/Etv2, is also essential for vascular and hematopoietic development. To identify genes downstream of etsrp, gain-of-function experiments were performed for etsrp in zebrafish embryos followed by transcription profile analysis by microarray. Subsequent in vivo expression studies resulted in the identification of fourteen genes with blood and/or vascular expression, six of these being completely novel. Regulation of these genes by etsrp was confirmed by ectopic induction in etsrp overexpressing embryos and decreased expression in etsrp deficient embryos. Additional functional analysis of two newly discovered genes, hapln1b and sh3gl3, demonstrates their importance in embryonic vascular development. The results described here identify a group of genes downstream of etsrp likely to be critical for vascular and/or myeloid development.	[Gomez, Gustavo A.; Veldman, Matthew B.; Zhao, Yan; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Burgess, Shawn] Natl Human Genome Res Inst, NIH, Genome Technol Branch, Bethesda, MD USA	University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Gomez, GA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	shuolin@ucla.edu		Burgess, Shawn/0000-0003-1147-0596; Gomez, Gustavo/0000-0001-9294-4276	HIN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000183, Z01HG000183] Funding Source: NIH RePORTER	HIN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	HIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Choi K, 1998, DEVELOPMENT, V125, P725; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Coolen M, 2005, DEV GENES EVOL, V215, P327, DOI 10.1007/s00427-005-0476-y; Dieterlen-Lievre F, 2004, MECH DEVELOP, V121, P1117, DOI 10.1016/j.mod.2004.06.008; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liao W, 1997, DEVELOPMENT, V124, P381; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Manzanares M, 1997, NATURE, V387, P191, DOI 10.1038/387191a0; Martins-Green M, 2000, INT J BIOCHEM CELL B, V32, P351, DOI 10.1016/S1357-2725(99)00118-1; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Miller RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002176; Moens CB, 1998, DEVELOPMENT, V125, P381; Narumiya H, 2007, BIOCHEM BIOPH RES CO, V357, P896, DOI 10.1016/j.bbrc.2007.04.030; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Palis J, 1999, DEVELOPMENT, V126, P5073; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Schvarzstein M, 1999, MECH DEVELOP, V80, P223, DOI 10.1016/S0925-4773(98)00220-2; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; So CW, 2000, BIOCHEM J, V348, P447, DOI 10.1042/0264-6021:3480447; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; St Croix B, 2000, SCIENCE, V289, P1197; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Toyama R, 1998, MECH DEVELOP, V71, P197, DOI 10.1016/S0925-4773(97)00202-5; Vogel BE, 2001, DEVELOPMENT, V128, P883; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Xu XH, 2007, J HISTOCHEM CYTOCHEM, V55, P119, DOI 10.1369/jhc.6A6975.2006; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yang SY, 2002, ARTERIOSCL THROM VAS, V22, P1797, DOI 10.1161/01.ATV.0000038995.31179.24; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	66	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4994	10.1371/journal.pone.0004994	http://dx.doi.org/10.1371/journal.pone.0004994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308258	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499000011
J	Qi, XP; Bao, FS; Xie, ZX				Qi, Xiaopeng; Bao, Forrest Sheng; Xie, Zhixin			Small RNA Deep Sequencing Reveals Role for Arabidopsis thaliana RNA-Dependent RNA Polymerases in Viral siRNA Biogenesis	PLOS ONE			English	Article								RNA silencing functions as an important antiviral defense mechanism in a broad range of eukaryotes. In plants, biogenesis of several classes of endogenous small interfering RNAs (siRNAs) requires RNA-dependent RNA Polymerase (RDR) activities. Members of the RDR family proteins, including RDR1 and RDR6, have also been implicated in antiviral defense, although a direct role for RDRs in viral siRNA biogenesis has yet to be demonstrated. Using a crucifer-infecting strain of Tobacco Mosaic Virus (TMV-Cg) and Arabidopsis thaliana as a model system, we analyzed the viral small RNA profile in wild-type plants as well as rdr mutants by applying small RNA deep sequencing technology. Over 100,000 TMV-Cg-specific small RNA reads, mostly of 21- (78.4%) and 22-nucleotide (12.9%) in size and originating predominately (79.9%) from the genomic sense RNA strand, were captured at an early infection stage, yielding the first high-resolution small RNA map for a plant virus. The TMV-Cg genome harbored multiple, highly reproducible small RNA-generating hot spots that corresponded to regions with no apparent local hairpin-forming capacity. Significantly, both the rdr1 and rdr6 mutants exhibited globally reduced levels of viral small RNA production as well as reduced strand bias in viral small RNA population, revealing an important role for these host RDRs in viral siRNA biogenesis. In addition, an informatics analysis showed that a large set of host genes could be potentially targeted by TMV-Cg-derived siRNAs for posttranscriptional silencing. Two of such predicted host targets, which encode a cleavage and polyadenylation specificity factor (CPSF30) and an unknown protein similar to translocon-associated protein alpha (TRAP alpha), respectively, yielded a positive result in cleavage validation by 5'RACE assays. Our data raised the interesting possibility for viral siRNA-mediated virus-host interactions that may contribute to viral pathogenicity and host specificity.	[Qi, Xiaopeng; Xie, Zhixin] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Bao, Forrest Sheng] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Qi, XP (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	zhixin.xie@ttu.edu	Bao, Forrest/C-6464-2011	Xie, Zhixin/0000-0002-6191-5170	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2006-35319-17438]	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service grant 2006-35319-17438 (to Z.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Buck KW, 1999, PHILOS T R SOC B, V354, P613, DOI 10.1098/rstb.1999.0413; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding XS, 2004, MOL PLANT MICROBE IN, V17, P583, DOI 10.1094/MPMI.2004.17.6.583; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; ISHIKAWA M, 1991, MOL GEN GENET, V230, P33, DOI 10.1007/BF00290647; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kurihara Y, 2007, J GEN VIROL, V88, P2347, DOI 10.1099/vir.0.82994-0; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	198	210	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4971	10.1371/journal.pone.0004971	http://dx.doi.org/10.1371/journal.pone.0004971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308254	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499000009
J	Nakamura, F; Heikkinen, O; Pentikainen, OT; Osborn, TM; Kasza, KE; Weitz, DA; Kupiainen, O; Permi, P; Kilpelainen, I; Ylanne, J; Hartwig, JH; Stossel, TP				Nakamura, Fumihiko; Heikkinen, Outi; Pentikaeinen, Olli T.; Osborn, Teresia M.; Kasza, Karen E.; Weitz, David A.; Kupiainen, Olga; Permi, Perttu; Kilpelaeinen, Ilkka; Ylaenne, Jari; Hartwig, John H.; Stossel, Thomas P.			Molecular Basis of Filamin A-FilGAP Interaction and Its Impairment in Congenital Disorders Associated with Filamin A Mutations	PLOS ONE			English	Article								Background: Mutations in filamin A (FLNa), an essential cytoskeletal protein with multiple binding partners, cause developmental anomalies in humans. Methodology/Principal Findings: We determined the structure of the 23(rd) Ig repeat of FLNa (IgFLNa23) that interacts with FilGAP, a Rac-specific GTPase-activating protein and regulator of cell polarity and movement, and the effect of the three disease-related mutations on this interaction. A combination of NMR structural analysis and in silico modeling revealed the structural interface details between the C and D beta-strands of the IgFLNa23 and the C-terminal 32 residues of FilGAP. Mutagenesis of the predicted key interface residues confirmed the binding constraints between the two proteins. Specific loss-of-function FLNa constructs were generated and used to analyze the importance of the FLNa-FilGAP interaction in vivo. Point mutagenesis revealed that disruption of the FLNa-FilGAP interface perturbs cell spreading. FilGAP does not bind FLNa homologs FLNb or FLNc establishing the importance of this interaction to the human FLNa mutations. Tight complex formation requires dimerization of both partners and the correct alignment of the binding surfaces, which is promoted by a flexible hinge domain between repeats 23 and 24 of FLNa. FLNa mutations associated with human developmental anomalies disrupt the binding interaction and weaken the elasticity of FLNa/F-actin network under high mechanical stress. Conclusions/Significance: Mutational analysis informed by structure can generate reagents for probing specific cellular interactions of FLNa. Disease-related FLNa mutations have demonstrable effects on FLNa function.	[Nakamura, Fumihiko; Osborn, Teresia M.; Hartwig, John H.; Stossel, Thomas P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Translat Med Div, Boston, MA 02115 USA; [Heikkinen, Outi; Kupiainen, Olga; Kilpelaeinen, Ilkka] Univ Helsinki, Dept Chem, Lab Organ Chem, FIN-00014 Helsinki, Finland; [Pentikaeinen, Olli T.; Ylaenne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, SF-40351 Jyvaskyla, Finland; [Kasza, Karen E.; Weitz, David A.] Harvard Univ, Dept Phys, SEAS, Cambridge, MA USA; [Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FIN-00014 Helsinki, Finland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Helsinki; University of Jyvaskyla; Harvard University; University of Helsinki	Nakamura, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Translat Med Div, Boston, MA 02115 USA.	fnakamura@rics.bwh.harvard.edu	Nakamura, Fumihiko/N-5476-2016; Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Ylanne, Jari/0000-0003-4627-021X; Kasza, Karen/0000-0002-0888-3579; Nakamura, Fumihiko/0000-0002-6872-4246	National Institutes of Health [HL-19429, HL-56252]; HUSEC Seed Fund for Interdisciplinary Science; National Science Foundation's Graduate Research Fellowship Program; Academy of Finland [114713, 122170]; Finnish IT Center for Science [jyy2516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056252, R01HL019429, R37HL019429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HUSEC Seed Fund for Interdisciplinary Science; National Science Foundation's Graduate Research Fellowship Program(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); Finnish IT Center for Science(Finnish IT center for science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health Grants HL-19429 (TPS) and HL-56252 (JHH), the HUSEC Seed Fund for Interdisciplinary Science (DAW and TPS), the National Science Foundation's Graduate Research Fellowship Program (KEK), Academy of Finland (114713, JY, 122170, PP), and the Finnish IT Center for Science (computational grant for project jyy2516, OTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASE DA, 2004, AMBER, V8; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Goddard T., 2008, SPARKY, V3; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; MORRIS RJ, 1995, MONOCLONAL ANTIBODIE, P34; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Permi P, 2004, PROG NUCL MAG RES SP, V44, P97, DOI 10.1016/j.pnmrs.2003.12.001; Permi P, 2002, J BIOMOL NMR, V23, P201, DOI 10.1023/A:1019819514298; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Robertson SP, 2006, AM J MED GENET A, V140A, P1726, DOI 10.1002/ajmg.a.31322; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; TAKALA H, 2008, BLOOD; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	44	51	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4928	10.1371/journal.pone.0004928	http://dx.doi.org/10.1371/journal.pone.0004928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293932	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496600014
J	Rollins, B; Martin, MV; Sequeira, PA; Moon, EA; Morgan, LZ; Watson, SJ; Schatzberg, A; Akil, H; Myers, RM; Jones, EG; Wallace, DC; Bunney, WE; Vawter, MP				Rollins, Brandi; Martin, Maureen V.; Sequeira, P. Adolfo; Moon, Emily A.; Morgan, Ling Z.; Watson, Stanley J.; Schatzberg, Alan; Akil, Huda; Myers, Richard M.; Jones, Edward G.; Wallace, Douglas C.; Bunney, William E.; Vawter, Marquis P.			Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MTDNA POINT MUTATIONS; SUBUNIT GENE NDUFV2; DNA DELETION LEVELS; COMPLEX-I; PARENTAL TRANSMISSION; RAPID IDENTIFICATION; MATERNAL INHERITANCE; GLUCOSE-METABOLISM; BAYESIAN-INFERENCE	Backgroud: Mitochondria provide most of the energy for brain cells by the process of oxidative phosphorylation. Mitochondrial abnormalities and deficiencies in oxidative phosphorylation have been reported in individuals with schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD) in transcriptomic, proteomic, and metabolomic studies. Several mutations in mitochondrial DNA (mtDNA) sequence have been reported in SZ and BD patients. Methodology/Principal Findings: Dorsolateral prefrontal cortex (DLPFC) from a cohort of 77 SZ, BD, and MDD subjects and age-matched controls (C) was studied for mtDNA sequence variations and heteroplasmy levels using Affymetrix mtDNA resequencing arrays. Heteroplasmy levels by microarray were compared to levels obtained with SNaPshot and allele specific real-time PCR. This study examined the association between brain pH and mtDNA alleles. The microarray resequencing of mtDNA was 100% concordant with conventional sequencing results for 103 mtDNA variants. The rate of synonymous base pair substitutions in the coding regions of the mtDNA genome was 22% higher (p = 0.0017) in DLPFC of individuals with SZ compared to controls. The association of brain pH and super haplogroup (U, K, UK) was significant (p = 0.004) and independent of postmortem interval time. Conclusions: Focusing on haplogroup and individual susceptibility factors in psychiatric disorders by considering mtDNA variants may lead to innovative treatments to improve mitochondrial health and brain function.	[Rollins, Brandi; Martin, Maureen V.; Sequeira, P. Adolfo; Moon, Emily A.; Morgan, Ling Z.; Bunney, William E.; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Schatzberg, Alan] Stanford Univ, Dept Psychiat, Palo Alto, CA USA; [Myers, Richard M.] Hudson Alpha Inst Biotechnol, Huntsville, AL USA; [Jones, Edward G.] Univ Calif Davis, Neurosci Ctr, Davis, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of Michigan System; University of Michigan; Stanford University; University of California System; University of California Davis; University of California System; University of California Irvine	Rollins, B (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	mvawter@uci.edu	Sequeira, Adolfo/K-7278-2015	Sequeira, Adolfo/0000-0003-3040-1190	NIMH Conte Center [P50 MH60398, MH54844, MH42251]; Pritzker Family Philanthropic Fund; William Lion Penzner Foundation; Della Martin Foundation; W.M. Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054844, P50MH060398] Funding Source: NIH RePORTER	NIMH Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pritzker Family Philanthropic Fund; William Lion Penzner Foundation; Della Martin Foundation; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Family Philanthropic Fund, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA). The authors are members of a Conte Center supported by the NIMH and members of the Pritzker Neuropsychiatric Disorders Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Balijepalli S, 1999, NEUROPHARMACOLOGY, V38, P567, DOI 10.1016/S0028-3908(98)00215-9; Bamne MN, 2008, SCHIZOPHRENIA BULL, V34, P458, DOI 10.1093/schbul/sbm100; Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177; Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318; BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Buchsbaum MS, 1998, SCHIZOPHRENIA BULL, V24, P343, DOI 10.1093/oxfordjournals.schbul.a033331; Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009; Cavelier L, 2000, HUM GENET, V107, P45, DOI 10.1007/s004390050009; CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234; Coon KD, 2006, MITOCHONDRION, V6, P194, DOI 10.1016/j.mito.2006.07.002; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; DEICKEN RF, 1995, AM J PSYCHIAT, V152, P915; DeLisi LE, 2000, BIOL PSYCHIAT, V48, P706, DOI 10.1016/S0006-3223(00)00939-2; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Fan HX, 2006, J MOL DIAGN, V8, P277, DOI 10.2353/jmoldx.2006.050066; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1; Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Gardner A, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-7; Gardner A, 2008, PSYCHOTHER PSYCHOSOM, V77, P127, DOI 10.1159/000112891; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; Gibson GE, 2008, ANN NY ACAD SCI, V1147, pXI, DOI 10.1196/annals.1427.039; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOLDSTEIN JM, 1992, SCHIZOPHR RES, V7, P135, DOI 10.1016/0920-9964(92)90043-5; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; Grigoroiu-Serbanescu M, 1998, AM J MED GENET, V81, P397, DOI 10.1002/(SICI)1096-8628(19980907)81:5<397::AID-AJMG8>3.0.CO;2-Q; Grigoroiu-Serbanescu M, 2001, AM J MED GENET, V105, P765, DOI 10.1002/ajmg.10047; Hamakawa H, 1999, PSYCHOL MED, V29, P639, DOI 10.1017/S0033291799008442; HARRISON PJ, 1991, MOL BRAIN RES, V9, P161, DOI 10.1016/0169-328X(91)90143-L; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112; Jakupciak JP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-95; Jakupciak JP, 2005, J MOL DIAGN, V7, P258, DOI 10.1016/S1525-1578(10)60553-3; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Johnston NL, 1997, J NEUROSCI METH, V77, P83, DOI 10.1016/S0165-0270(97)00115-5; Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213; Kato T, 1996, J AFFECT DISORDERS, V37, P67, DOI 10.1016/0165-0327(95)00050-X; Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7; Kato T, 1998, J AFFECT DISORDERS, V50, P135, DOI 10.1016/S0165-0327(97)00102-X; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926; Kato T, 2008, CELL CALCIUM, V44, P92, DOI 10.1016/j.ceca.2007.11.005; Kato T, 2007, CAN J PSYCHIAT, V52, P763; Kato T, 2006, DRUG NEWS PERSPECT, V19, P597, DOI 10.1358/dnp.2006.19.10.1068006; Kazuno AA, 2005, PSYCHIAT CLIN NEUROS, V59, P497, DOI 10.1111/j.1440-1819.2005.01404.x; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kegeles LS, 1998, BIOL PSYCHIAT, V44, P382, DOI 10.1016/S0006-3223(97)00425-3; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kornberg JR, 2000, J AFFECT DISORDERS, V59, P183, DOI 10.1016/S0165-0327(99)00151-2; Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891; Lin JP, 1997, GENET EPIDEMIOL, V14, P665, DOI 10.1002/(SICI)1098-2272(1997)14:6<665::AID-GEPI19>3.0.CO;2-O; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; Lindholm E, 1997, EUR J HUM GENET, V5, P406, DOI 10.1159/000484799; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Maragh S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-7; Marchbanks RM, 2003, SCHIZOPHR RES, V65, P33, DOI 10.1016/S0920-9964(03)00011-2; Martorell L, 2006, EUR J HUM GENET, V14, P520, DOI 10.1038/sj.ejhg.5201606; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041; Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015; Munakata K, 2007, MUTAT RES-FUND MOL M, V617, P119, DOI 10.1016/j.mrfmmm.2007.01.006; NEI M, 1986, MOL BIOL EVOL, V3, P418; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753; SHIMIZU A, 1987, JPN J PSYCHIAT NEUR, V41, P65; SHOFFNER JM, 1995, METABOLIC MOL BASIS, V1, P1535; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Strakowski SM, 2000, BIPOLAR DISORD, V2, P148, DOI 10.1034/j.1399-5618.2000.020302.x; Strand H, 2008, CLIN CHIM ACTA, V390, P126, DOI 10.1016/j.cca.2008.01.010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Volz HP, 1997, BIOL PSYCHIAT, V41, P644, DOI 10.1016/S0006-3223(96)00062-5; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Washizuka S, 2006, AM J MED GENET B, V141B, P301, DOI 10.1002/ajmg.b.30285; Washizuka S, 2005, BIPOLAR DISORD, V7, P146, DOI 10.1111/j.1399-5618.2005.00184.x; Washizuka S, 2003, INT J NEUROPSYCHOPH, V6, P421, DOI 10.1017/S1461145703003778; Washizuka S, 2003, AM J MED GENET B, V120B, P72, DOI 10.1002/ajmg.b.20041; WESTER P, 1985, NEUROCHEM PATHOL, V3, P169, DOI 10.1007/BF02834269; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; WOLYNIEC PS, 1992, J PSYCHIAT RES, V26, P17, DOI 10.1016/0022-3956(92)90012-D; Yildiz-Yesiloglu A, 2006, PROG NEURO-PSYCHOPH, V30, P969, DOI 10.1016/j.pnpbp.2006.03.012; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008	109	160	165	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4913	10.1371/journal.pone.0004913	http://dx.doi.org/10.1371/journal.pone.0004913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290059	Green Published, gold			2022-12-27	WOS:000265496500012
J	Aicher, A; Heeschen, C; Feil, S; Hofmann, F; Mendelsohn, ME; Feil, R; Dimmeler, S				Aicher, Alexandra; Heeschen, Christopher; Feil, Susanne; Hofmann, Franz; Mendelsohn, Michael E.; Feil, Robert; Dimmeler, Stefanie			cGMP-Dependent Protein Kinase I Is Crucial for Angiogenesis and Postnatal Vasculogenesis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE SYNTHASE; MARROW MONONUCLEAR-CELLS; STIMULATES ANGIOGENESIS; INDUCED MOBILIZATION; NO; NEOVASCULARIZATION; ACTIVATION; CAPACITY; PATHWAY	Background: Endothelium-derived nitric oxide plays an important role for the bone marrow microenvironment. Since several important effects of nitric oxide are mediated by cGMP-dependent pathways, we investigated the role of the cGMP downstream effector cGMP-dependent protein kinase I (cGKI) on postnatal neovascularization. Methodology/Principal Findings: In a disc neovascularization model, cGKI(-/-) mice showed an impaired neovascularization as compared to their wild-type (WT) littermates. Infusion of WT, but not cGKI(-/-) bone marrow progenitors rescued the impaired ingrowth of new vessels in cGKI-deficient mice. Bone marrow progenitors from cGKI(-/-) mice showed reduced proliferation and survival rates. In addition, we used cGKI alpha leucine zipper mutant (LZM) mice as model for cGKI deficiency. LZM mice harbor a mutation in the cGKIa leucine zipper that prevents interaction with downstream signaling molecules. Consistently, LZM mice exhibited reduced numbers of vasculogenic progenitors and impaired neovascularization following hindlimb ischemia compared to WT mice. Conclusions/Significance: Our findings demonstrate that the cGMP-cGKI pathway is critical for postnatal neovascularization and establish a new role for cGKI in vasculogenesis, which is mediated by bone marrow-derived progenitors.	[Aicher, Alexandra; Heeschen, Christopher; Dimmeler, Stefanie] Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Feil, Susanne; Feil, Robert] Univ Tubingen, Interfakult Inst Biochem, D-72074 Tubingen, Germany; [Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, D-8000 Munich, Germany; [Mendelsohn, Michael E.] Tufts Univ, Sch Med, Mol Cardiol Res Inst, Medford, MA 02155 USA	Goethe University Frankfurt; Eberhard Karls University of Tubingen; Technical University of Munich; Tufts University	Aicher, A (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.	aicher_a@yahoo.com; dimmeler@em.uni-frankfurt.de	Aicher, Alexandra/GZK-8031-2022; Feil, Robert/B-8918-2014; Feil, Susanne/AAF-7032-2019; Guba, Markus/M-4309-2019	Feil, Robert/0000-0002-7335-4841; Dimmeler, Stefanie/0000-0002-1045-2436; Aicher, Alexandra/0000-0002-8920-9577; Heeschen, Christopher/0000-0002-1158-8554	SFB [553 B6]	SFB(Austrian Science Fund (FWF))	This work was supported by SFB 553 B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Chan SL, 2003, MOL HUM REPROD, V9, P775, DOI 10.1093/molehr/gag094; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; DRAIJER R, 1995, CIRC RES, V77, P897, DOI 10.1161/01.RES.77.5.897; FAJARDO LF, 1988, LAB INVEST, V58, P718; Feil R, 2005, TRENDS MOL MED, V11, P71, DOI 10.1016/j.molmed.2004.12.001; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hornig B, 1998, CIRCULATION, V97, P363; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Massberg S, 1999, J EXP MED, V189, P1255, DOI 10.1084/jem.189.8.1255; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; OSHITA AK, 1977, BLOOD, V49, P585; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Santhanam AVR, 2008, PEPTIDES, V29, P1451, DOI 10.1016/j.peptides.2008.03.016; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Senthilkumar A, 2007, ARTERIOSCL THROM VAS, V27, P1947, DOI 10.1161/ATVBAHA.107.147421; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Springer ML, 2000, MOL THER, V1, P82, DOI 10.1006/mthe.1999.0006; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4879	10.1371/journal.pone.0004879	http://dx.doi.org/10.1371/journal.pone.0004879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287493	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496400019
J	Rambert, J; Mamani-Matsuda, M; Moynet, D; Dubus, P; Desplat, V; Kauss, T; Dehais, J; Schaeverbeke, T; Ezzedine, K; Malvy, D; Vincendeau, P; Mossalayi, MD				Rambert, Jerome; Mamani-Matsuda, Maria; Moynet, Daniel; Dubus, Pierre; Desplat, Vanessa; Kauss, Tina; Dehais, Joel; Schaeverbeke, Thierry; Ezzedine, Khaled; Malvy, Denis; Vincendeau, Philippe; Mossalayi, M. Djavad			Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis	PLOS ONE			English	Article								Background: CD23 is a differentiation/activation antigen expressed by a variety of hematopoietic and epithelial cells. It can also be detected in soluble forms in biological fluids. Initially known as the low-affinity receptor for immunoglobulin E (Fc epsilon RII), CD23 displays various other physiologic ligands such as CD21, CD11b/c, CD47-vitronectin, and mannose-containing proteins. CD23 mediates numerous immune responses by enhancing IgE-specific antigen presentation, regulating IgE synthesis, influencing cell differentiation and growth of both B- and T-cells. CD23-crosslinking promotes the secretion of pro-inflammatory mediators from human monocytes/macrophages, eosinophils and epithelial cells. Increased CD23 expression is found in patients during allergic reactions and rheumatoid arthritis while its physiopathologic role in these diseases remains to be clarified. Methodology/Principal Findings: We previously generated heptapeptidic countrestructures of human CD23. Based on in vitro studies on healthy and arthritic patients' cells, we showed that CD23-specific peptide addition to human macrophages greatly diminished the transcription of genes encoding inflammatory cytokines. This was also confirmed by significant reduction of mediator levels in cell supernatants. We also show that CD23 peptide decreased IgE-mediated activation of both human and rat CD23(+) macrophages. In vivo studies in rat model of arthritis showed that CD23-blocking peptide ameliorates clinical scores and prevent bone destruction in a dose dependent manner. Ex-vivo analysis of rat macrophages further confirmed the inhibitory effect of peptides on their activation. Taken together our results support the role of CD23 activation and subsequent inflammatory response in arthritis. Conclusion: CD23-blocking peptide (p30A) prevents the activation of monocytes/macrophages without cell toxicity. Thus, targeting CD23 by antagonistic peptide decreases inflammatory markers and may have clinical value in the treatment of human arthritis and allergic reactions involving CD23.	[Rambert, Jerome; Mamani-Matsuda, Maria; Moynet, Daniel; Desplat, Vanessa; Kauss, Tina; Ezzedine, Khaled; Malvy, Denis; Vincendeau, Philippe; Mossalayi, M. Djavad] Univ Bordeaux 2, UFR Sci Pharmaceut, Lab Immunol & Parasitol, Grp Therapeut Inflammat & Infect, F-33076 Bordeaux, France; [Dubus, Pierre] Univ Bordeaux 2, EA 2406, F-33076 Bordeaux, France; [Dehais, Joel; Schaeverbeke, Thierry] Univ Pellegrin, Ctr Hosp, Serv Rhumatol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Rambert, J (corresponding author), Univ Bordeaux 2, UFR Sci Pharmaceut, Lab Immunol & Parasitol, Grp Therapeut Inflammat & Infect, F-33076 Bordeaux, France.	djavad.mossalayi@u-bordeaux2.fr	Ezzedine, Khaled/A-3072-2009; MALVY, Denis/T-7930-2019; Ezzedine, Khaled/F-2716-2017; Kauss, Tina/ABC-4020-2020	Ezzedine, Khaled/0000-0002-5468-4589; Kauss, Tina/0000-0002-0541-6684; Dubus, Pierre/0000-0003-1803-4711	Association pour la recherche sur la polyarthrite [pre-doctoral fellowship]; Bordeaux 2 University	Association pour la recherche sur la polyarthrite; Bordeaux 2 University	J.R. was supported by a pre-doctoral fellowship of the Association pour la recherche sur la polyarthrite. This work was supported by the intramural program of the Bordeaux 2 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1995, J IMMUNOL, V154, P6475; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Aubry JP, 1997, J IMMUNOL, V159, P614; Becherel PA, 1997, J IMMUNOL, V159, P5761; Becherel PA, 1997, MOL MED, V3, P686, DOI 10.1007/BF03401707; BECHEREL PA, 1994, J CLIN INVEST, V93, P2275, DOI 10.1172/JCI117227; BECKER H, 1991, CLIN EXP IMMUNOL, V85, P61; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; DUGAS B, 1995, IMMUNOL TODAY, V16, P574, DOI 10.1016/0167-5699(95)80080-8; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hermann P, 1999, J CELL BIOL, V144, P767, DOI 10.1083/jcb.144.4.767; KAISERLIAN D, 1993, IMMUNOLOGY, V80, P90; Karagiannis SN, 2007, J IMMUNOL, V179, P2832, DOI 10.4049/jimmunol.179.5.2832; Kleinau S, 1999, J IMMUNOL, V162, P4266; KOGA T, 1973, J IMMUNOL, V111, P599; KOLB JP, 1994, J BIOL CHEM, V269, P9811; LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7; Loza E, 1999, RHEUMATOLOGY, V38, P325, DOI 10.1093/rheumatology/38.4.325; LUDIN C, 1987, EMBO J, V6, P109, DOI 10.1002/j.1460-2075.1987.tb04726.x; Massa M, 1998, CLIN EXP RHEUMATOL, V16, P611; Montagnac G, 2005, J IMMUNOL, V174, P5562, DOI 10.4049/jimmunol.174.9.5562; Mossalayi M D, 1997, Int Rev Immunol, V16, P129, DOI 10.3109/08830189709045706; MOSSALAYI MD, 1992, EMBO J, V11, P4323, DOI 10.1002/j.1460-2075.1992.tb05531.x; OUAAZ F, 1994, BLOOD, V84, P3095; Pathan NI, 2008, BLOOD, V111, P1594, DOI 10.1182/blood-2007-03-082024; PLATERZYBERK C, 1995, NAT MED, V1, P781, DOI 10.1038/nm0895-781; Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932; Riffo-Vasquez Y, 2000, CLIN EXP ALLERGY, V30, P728; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; So EY, 2002, FEBS LETT, V518, P53, DOI 10.1016/S0014-5793(02)02635-2; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; Sukumar S, 2006, J IMMUNOL, V176, P4811, DOI 10.4049/jimmunol.176.8.4811; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; YOKOTA A, 1992, P NATL ACAD SCI USA, V89, P5030, DOI 10.1073/pnas.89.11.5030	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4834	10.1371/journal.pone.0004834	http://dx.doi.org/10.1371/journal.pone.0004834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279679	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496200011
J	Ogutu, BR; Apollo, OJ; McKinney, D; Okoth, W; Siangla, J; Dubovsky, F; Tucker, K; Waitumbi, JN; Diggs, C; Wittes, J; Malkin, E; Leach, A; Soisson, LA; Milman, JB; Otieno, L; Holland, CA; Polhemus, M; Remich, SA; Ockenhouse, CF; Cohen, J; Ballou, WR; Martin, SK; Angov, E; Stewart, VA; Lyon, JA; Heppner, DG; Withers, MR				Ogutu, Bernhards R.; Apollo, Odika J.; McKinney, Denise; Okoth, Willis; Siangla, Joram; Dubovsky, Filip; Tucker, Kathryn; Waitumbi, John N.; Diggs, Carter; Wittes, Janet; Malkin, Elissa; Leach, Amanda; Soisson, Lorraine A.; Milman, Jessica B.; Otieno, Lucas; Holland, Carolyn A.; Polhemus, Mark; Remich, Shon A.; Ockenhouse, Christian F.; Cohen, Joe; Ballou, W. Ripley; Martin, Samuel K.; Angov, Evelina; Stewart, V. Ann; Lyon, Jeffrey A.; Heppner, D. Gray, Jr.; Withers, Mark R.		MSP-1 Malaria Vaccine Working Grp	Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL FRAGMENT; FALCIPARUM-MALARIA; CLINICAL IMMUNITY; FINE SPECIFICITY; SERUM ANTIBODIES; AOTUS MONKEYS; INFECTION; DISEASE; CHALLENGE	Objective: The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P. falciparum. Formulated with AS02 (a proprietary Adjuvant System), it constitutes the FMP1/AS02 candidate malaria vaccine. We evaluated this vaccine's safety, immunogenicity, and efficacy in African children. Methods: A randomised, double-blind, Phase IIb, comparator-controlled trial. The trial was conducted in 13 field stations of one mile radii within Kombewa Division, Nyanza Province, Western Kenya, an area of holoendemic transmission of P. falciparum. We enrolled 400 children aged 12-47 months in general good health. Children were randomised in a 1: 1 fashion to receive either FMP1/AS02 (50 mu g) or Rabipur (R) rabies vaccine. Vaccinations were administered on a 0, 1, and 2 month schedule. The primary study endpoint was time to first clinical episode of P. falciparum malaria (temperature >= 37.5 degrees C with asexual parasitaemia of >= 50,000 parasites/mu L of blood) occurring between 14 days and six months after a third dose. Case detection was both active and passive. Safety and immunogenicity were evaluated for eight months after first immunisations; vaccine efficacy (VE) was measured over a six-month period following third vaccinations. Results: 374 of 400 children received all three doses and completed six months of follow-up. FMP1/AS02 had a good safety profile and was well-tolerated but more reactogenic than the comparator. Geometric mean anti-MSP-1(42) antibody concentrations increased from 1.3 mu g/mL to 27.3 mu g/mL in the FMP1/AS02 recipients, but were unchanged in controls. 97 children in the FMP1/AS02 group and 98 controls had a primary endpoint episode. Overall VE was 5.1% (95% CI: 226% to +28%; p-value = 0.7). Conclusions: FMP1/AS02 is not a promising candidate for further development as a monovalent malaria vaccine. Future MSP-142 vaccine development should focus on other formulations and antigen constructs. Trial Registration: Clinicaltrials. gov NCT00223990	[Ogutu, Bernhards R.; Apollo, Odika J.; McKinney, Denise; Okoth, Willis; Siangla, Joram; Waitumbi, John N.; Otieno, Lucas; Polhemus, Mark; Remich, Shon A.; Martin, Samuel K.; Withers, Mark R.] USA, Med Res Unit Kenya, Nairobi, Kenya; [Ogutu, Bernhards R.; Apollo, Odika J.; McKinney, Denise; Okoth, Willis; Siangla, Joram; Waitumbi, John N.; Malkin, Elissa; Otieno, Lucas; Polhemus, Mark; Remich, Shon A.; Martin, Samuel K.; Withers, Mark R.] Kenya Govt Med Res Ctr, Ctr Clin Res, Nairobi, Kenya; [Dubovsky, Filip; Milman, Jessica B.] PATH Malaria Vaccine Initiative, Bethesda, MD USA; [Tucker, Kathryn; Wittes, Janet] Stat Collaborative Inc, Washington, DC USA; [Diggs, Carter; Soisson, Lorraine A.] US Agcy Int Dev, Malaria Vaccine Dev Program, Washington, DC USA; [Leach, Amanda; Cohen, Joe; Ballou, W. Ripley; Heppner, D. Gray, Jr.] GlaxoSmithKline Biol sa, Rixensart, Belgium; [Holland, Carolyn A.; Ockenhouse, Christian F.; Angov, Evelina; Stewart, V. Ann; Lyon, Jeffrey A.] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA	Kenya Medical Research Institute; United States Agency for International Development (USAID); GlaxoSmithKline; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Ogutu, BR (corresponding author), USA, Med Res Unit Kenya, Nairobi, Kenya.	bogutu@wrp-ksm.org	Holland, Carolyn/B-7880-2011; Leach, Amanda/AAS-1120-2020	Leach, Amanda/0000-0002-7114-9967	PATH Malaria Vaccine Initiative (MVI); Malaria Vaccine Development Program (MVDP) of the US Agency for International Development (USAID); US Army Medical Research and Materiel Command (USAMRMC)	PATH Malaria Vaccine Initiative (MVI); Malaria Vaccine Development Program (MVDP) of the US Agency for International Development (USAID)(United States Agency for International Development (USAID)); US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The PATH Malaria Vaccine Initiative (MVI), the Malaria Vaccine Development Program (MVDP) of the US Agency for International Development (USAID), and the US Army Medical Research and Materiel Command (USAMRMC) provided funding. The three funding agencies were involved in all aspects of study design, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all study data and had final responsibility for the decision to submit for publication. The study sponsor was the Office of the Surgeon General, US Army.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALYAMAN F, 1995, T ROY SOC TROP MED H, V89, P555, DOI 10.1016/0035-9203(95)90106-X; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Ballou WR, 2004, AM J TROP MED HYG, V71, P239; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Blackman MJ, 1996, EXP PARASITOL, V83, P229, DOI 10.1006/expr.1996.0069; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Chang SP, 1996, INFECT IMMUN, V64, P253, DOI 10.1128/IAI.64.1.253-261.1996; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; DIGGS CL, 1993, PARASITOL TODAY, V9, P300, DOI 10.1016/0169-4758(93)90130-8; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Shi YP, 1996, INFECT IMMUN, V64, P2716, DOI 10.1128/IAI.64.7.2716-2723.1996; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; STOUTE JA, 2005, VACCINE IN PRESS; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032; Yoon IK, 2005, AM J TROP MED HYG, V72, P714, DOI 10.4269/ajtmh.2005.72.714	32	215	219	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4708	10.1371/journal.pone.0004708	http://dx.doi.org/10.1371/journal.pone.0004708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262754	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490600019
J	Helmy, M; Gohda, J; Inoue, J; Tomita, M; Tsuchiya, M; Selvarajoo, K				Helmy, Mohamed; Gohda, Jin; Inoue, Jun-ichiro; Tomita, Masaru; Tsuchiya, Masa; Selvarajoo, Kumar			Predicting Novel Features of Toll-Like Receptor 3 Signaling in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR RECEPTOR; REGULATORY FACTOR-3; ACTIVATION; TOLL-LIKE-RECEPTOR-4; INTERFERON; EXPRESSION; TRADD; TLR; RECOGNITION	The Toll-like receptor (TLR) 3 plays a critical role in mammalian innate immune response against viral attacks by recognizing double-stranded RNA (dsRNA) or its synthetic analog polyinosinic-polycytidylic acid (poly (I: C)). This leads to the activation of MAP kinases and NF-kappa B which results in the induction of type I interferons and proinflammatory cytokines to combat the viral infection. To understand the complex interplay of the various intracellular signaling molecules in the regulation of NF kappa B and MAP kinases, we developed a computational TLR3 model based upon perturbation-response approach. We curated literature and databases to determine the TLR3 signaling topology specifically for murine macrophages. For initial model creation, we used wildtype temporal activation profiles of MAP kinases and NF-kappa B and, for model testing, used TRAF6 KO and TRADD KO data. From dynamic simulations we predict i) the existence of missing intermediary steps between extracellular poly (I: C) stimulation and intracellular TLR3 binding, and ii) the presence of a novel pathway which is essential for JNK and p38, but not NF-kappa B, activation. Our work shows activation dynamics of signaling molecules can be used in conjunction with perturbation-response models to decipher novel signaling features of complicated immune pathways.	[Helmy, Mohamed; Tomita, Masaru; Tsuchiya, Masa; Selvarajoo, Kumar] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Helmy, Mohamed] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Gohda, Jin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo, Japan	Keio University; Keio University; University of Tokyo	Helmy, M (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; kumar@ttck.keio.ac.jp		Selvarajoo, Kumar/0000-0002-0314-9666; Helmy, Mohamed/0000-0002-9561-7956	JST CREST; the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Egyptian bureau of culture, sciences and education in Japan; Tsuruoka City, Yamagata prefecture	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Egyptian bureau of culture, sciences and education in Japan; Tsuruoka City, Yamagata prefecture	This study is funded by JST CREST, from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Egyptian bureau of culture, sciences and education in Japan (M. Helmy) and by the Tsuruoka City, Yamagata prefecture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bach JF, 2005, NAT MED, V11, P120, DOI 10.1038/nm0205-120; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hulejova H, 2007, CYTOKINE, V38, P151, DOI 10.1016/j.cyto.2007.06.001; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pindado J, 2007, J IMMUNOL, V179, P4821, DOI 10.4049/jimmunol.179.7.4821; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Selvarajoo K, 2006, FEBS LETT, V580, P1457, DOI 10.1016/j.febslet.2006.01.046; SELVARAJOO K, 2007, INTRO SYSTEMS BIOL, P449; SELVARAJOO K, 2008, J BIOINFORM IN PRESS; SELVARAJOO K, 2006, E CELL SYSTEM BASIC; SELVARAJOO K, 2008, 10 INT C MOL SYST BI, P110; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Vance W, 2002, P NATL ACAD SCI USA, V99, P5816, DOI 10.1073/pnas.022049699; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	45	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4661	10.1371/journal.pone.0004661	http://dx.doi.org/10.1371/journal.pone.0004661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252739	gold, Green Submitted, Green Published			2022-12-27	WOS:000265489900004
J	Sakkas, GK; Mulligan, K; DaSilva, M; Doyle, JW; Khatami, H; Schleich, T; Kent-Braun, JA; Schambelan, M				Sakkas, Giorgos K.; Mulligan, Kathleen; DaSilva, Makani; Doyle, Julie W.; Khatami, Hootan; Schleich, Thomas; Kent-Braun, Jane A.; Schambelan, Morris			Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study	PLOS ONE			English	Article								Background: Progressive resistance exercise training (PRT) improves physical functioning in patients with HIV infection. Creatine supplementation can augment the benefits derived from training in athletes and improve muscle function in patients with muscle wasting. The objective of this study was to determine whether creatine supplementation augments the effects of PRT on muscle strength, energetics, and body composition in HIV-infected patients. Methodology/Principal Findings: This is a randomized, double blind, placebo-controlled, clinical research center-based, outpatient study in San Francisco. 40 HIV-positive men (20 creatine, 20 placebo) enrolled in a 14-week study. Subjects were randomly assigned to receive creatine monohydrate or placebo for 14 weeks. Treatment began with a loading dose of 20 g/day or an equivalent number of placebo capsules for 5 days, followed by maintenance dosing of 4.8 g/day or placebo. Beginning at week 2 and continuing to week 14, all subjects underwent thrice-weekly supervised resistance exercise while continuing on the assigned study medication (with repeated 6-week cycles of loading and maintenance). The main outcome measurements included muscle strength (one repetition maximum), energetics (P-31 magnetic resonance spectroscopy), composition and size (magnetic resonance imaging), as well as total body composition (dual-energy X-ray absorptiometry). Thirty-three subjects completed the study (17 creatine, 16 placebo). Strength increased in all 8 muscle groups studied following PRT, but this increase was not augmented by creatine supplementation (average increase 44 vs. 42%, difference 2%, 95% CI 29.5% to 13.9%) in creatine and placebo, respectively). There were no differences between groups in changes in muscle energetics. Thigh muscle cross-sectional area increased following resistance exercise, with no additive effect of creatine. Lean body mass (LBM) increased to a significantly greater extent with creatine. Conclusions/Significance: Resistance exercise improved muscle size, strength and function in HIV-infected men. While creatine supplementation produced a greater increase in LBM, it did not augment the robust increase in strength derived from PRT.	[Sakkas, Giorgos K.; Mulligan, Kathleen; Schambelan, Morris] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Sakkas, Giorgos K.; Mulligan, Kathleen; DaSilva, Makani; Khatami, Hootan; Schambelan, Morris] San Francisco Gen Hosp, Div Endocrinol, San Francisco, CA USA; [Sakkas, Giorgos K.] Univ Thessaly, Dept Med, Thessaly, Greece; [Doyle, Julie W.] No Calif Inst Res & Ed, San Francisco, CA USA; [Schleich, Thomas] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Kent-Braun, Jane A.] Univ Massachusetts, Dept Exercise Sci, Amherst, MA 01003 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of Thessaly; Northern California Institute for Research & Education; University of California System; University of California Santa Cruz; University of Massachusetts System; University of Massachusetts Amherst	Sakkas, GK (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	morrie@sfghgcrc.ucsf.edu	Sakkas, Giorgos K./AAJ-4745-2021	Sakkas, Giorgos K./0000-0002-2462-995X	National Center for Complementary and Alternative Medicine of the National Institutes of Health [AT00491, DK45833, DK54615, RR-00083]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000491] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045833, R01DK054615] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was performed under a grant from the National Center for Complementary and Alternative Medicine of the National Institutes of Health (AT00491, DK45833, DK54615, RR-00083). Creatine monohydrate and placebo were donated by Jarrow Universal Herbs, Inc., but they provided neither funds for this study nor any input on data analysis.	BALSOM PD, 1994, SPORTS MED, V18, P268, DOI 10.2165/00007256-199418040-00005; Culpepper RM, 1998, SOUTHERN MED J, V91, P890, DOI 10.1097/00007611-199809000-00032; Derave W, 2004, J APPL PHYSIOL, V97, P852, DOI 10.1152/japplphysiol.00206.2004; Dolan SE, 2006, ARCH INTERN MED, V166, P1225, DOI 10.1001/archinte.166.11.1225; EARNEST CP, 1995, ACTA PHYSIOL SCAND, V153, P207, DOI 10.1111/j.1748-1716.1995.tb09854.x; Gilliam JD, 2000, MED SCI SPORT EXER, V32, P993; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; Green AL, 1996, AM J PHYSIOL-ENDOC M, V271, pE821, DOI 10.1152/ajpendo.1996.271.5.E821; GREENHAFF PL, 1994, AM J PHYSIOL, V266, pE725, DOI 10.1152/ajpendo.1994.266.5.E725; Grinspoon S, 2000, ANN INTERN MED, V133, P348, DOI 10.7326/0003-4819-133-5-200009050-00010; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd; Hubal MJ, 2005, MED SCI SPORT EXER, V37, P964, DOI 10.1249/01.mss.0000170469.90461.5f; Izquierdo M, 2002, MED SCI SPORT EXER, V34, P332, DOI 10.1097/00005768-200202000-00023; Karatzaferi C, 1999, EUR J APPL PHYSIOL O, V80, P508, DOI 10.1007/s004210050626; Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072; Kent-Braun JA, 2002, J APPL PHYSIOL, V93, P1813, DOI 10.1152/japplphysiol.00091.2002; Kilduff LP, 2002, MED SCI SPORT EXER, V34, P1176, DOI 10.1097/00005768-200207000-00019; Kinugasa R, 2004, EUR J APPL PHYSIOL, V91, P230, DOI 10.1007/s00421-003-0970-8; Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1; Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x; Kreider RB, 1998, MED SCI SPORT EXER, V30, P73, DOI 10.1097/00005768-199801000-00011; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Lox CL, 1996, INT J BEHAV MED, V3, P55, DOI 10.1207/s15327558ijbm0301_5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; Mujika I, 1997, INT J SPORTS MED, V18, P491, DOI 10.1055/s-2007-972670; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Nissen SL, 2003, J APPL PHYSIOL, V94, P651, DOI 10.1152/japplphysiol.00755.2002; Nolte LA, 2001, DIABETES, V50, P1397, DOI 10.2337/diabetes.50.6.1397; Rawson ES, 2002, ACTA PHYSIOL SCAND, V174, P57, DOI 10.1046/j.1365-201x.2002.00924.x; RIGSBY LW, 1992, MED SCI SPORT EXER, V24, P6; Robinson FP, 2007, BIOL RES NURS, V8, P177, DOI 10.1177/1099800406295520; Roubenoff R, 2001, MED SCI SPORT EXER, V33, P1811, DOI 10.1097/00005768-200111000-00003; Shevitz AH, 2005, JAIDS-J ACQ IMM DEF, V38, P399, DOI 10.1097/01.qai.0000152647.89008.2b; SINNWELL TM, 1995, J CLIN INVEST, V96, P126, DOI 10.1172/JCI118012; SMITH DA, 1992, ANN PHARMACOTHER, V26, P653, DOI 10.1177/106002809202600510; SMITH DA, 1992, ANN PHARMACOTHER, V26, P520, DOI 10.1177/106002809202600414; Smith SA, 1999, J APPL PHYSIOL, V87, P116, DOI 10.1152/jappl.1999.87.1.116; Snow RJ, 1998, J APPL PHYSIOL, V84, P1667, DOI 10.1152/jappl.1998.84.5.1667; Syrotuik DG, 2004, J STRENGTH COND RES, V18, P610; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; Tarnopolsky M, 2004, MUSCLE NERVE, V29, P51, DOI 10.1002/mus.10527; Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D; Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C; Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991; Volek JS, 2004, EUR J APPL PHYSIOL, V91, P628, DOI 10.1007/s00421-003-1031-z; Volek JS, 1997, J AM DIET ASSOC, V97, P765, DOI 10.1016/S0002-8223(97)00189-2; Walter MC, 2002, J NEUROL, V249, P1717, DOI 10.1007/s00415-002-0923-x; Walter MC, 2000, NEUROLOGY, V54, P1848, DOI 10.1212/WNL.54.9.1848; Winett RA, 2000, JAMA-J AM MED ASSOC, V284, P175, DOI 10.1001/jama.284.2.175; Yarasheski KE, 2001, J APPL PHYSIOL, V90, P133, DOI 10.1152/jappl.2001.90.1.133; Zange J, 2002, ANN NEUROL, V52, P126, DOI 10.1002/ana.10197	54	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4605	10.1371/journal.pone.0004605	http://dx.doi.org/10.1371/journal.pone.0004605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242554	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487500010
J	Marguet, C; Lubrano, M; Gueudin, M; Le Roux, P; Deschildre, A; Forget, C; Couderc, L; Siret, D; Donnou, MD; Bubenheim, M; Vabret, A; Freymuth, F				Marguet, Christophe; Lubrano, Marc; Gueudin, Marie; Le Roux, Pascal; Deschildre, Antoine; Forget, Chantal; Couderc, Laure; Siret, Daniel; Donnou, Marie-Dominique; Bubenheim, Michael; Vabret, Astrid; Freymuth, Francois			In Very Young Infants Severity of Acute Bronchiolitis Depends On Carried Viruses	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; INFECTION; CHILDREN; IMPACT; PCR; ASSOCIATION; DISEASE; SINGLE	Background: RI amplification reaction has revealed that various single viruses or viral co-infections caused acute bronchiolitis in infants, and RV appeared to have a growing involvement in early respiratory diseases. Because remaining controversial, the objective was to determine prospectively the respective role of RSV, RV, hMPV and co-infections on the severity of acute bronchiolitis in very young infants. Methods and Principal Findings: 209 infants (median age: 2.4 months) were enrolled in a prospective study of infants <1 year old, hospitalized for a first episode of bronchiolitis during the winter epidemic season and with no high risk for severe disease. The severity was assessed by recording SaO(2)% at admission, a daily clinical score (scale 0-18), the duration of oxygen supplementation and the length of hospitalization. Viruses were identified in 94.7% by RT amplification reaction: RSV only (45.8%), RV only (7.2%), hMPV only (3.8%), dual RSV/RV (14.3%), and other virus only (2%) or coinfections (9%). RV compared respectively with RSV and dual RSV/RV infection caused a significant less severe disease with a lower clinical score (5[3.2-6] vs. 6[4-8], p=0.01 and 5.5[5-7], p=0.04), a shorter time in oxygen supplementation (0[0-1] days vs. 2[0-3] days, p=0.02 and 2[0-3] days, p=0.03) and a shorter hospital stay (3[3-4.7] days vs.6 [5-8] days, p=0.001 and 5[4-6] days, p=0.04). Conversely, RSV infants had also longer duration of hospitalization in comparison with RSV/RV (p=0.01) and hMPV (p=0.04). The multivariate analyses showed that the type of virus carried was independently associated with the duration of hospitalization. Conclusion: This study underlined the role of RV in early respiratory diseases, as frequently carried by young infants with a first acute bronchiolitis. RSV caused the more severe disease and conversely RV the lesser severity. No additional effect of dual RSV/RV infection was observed on the severity.	[Marguet, Christophe; Lubrano, Marc; Couderc, Laure] Rouen Univ Hosp Charles Nicolle, Dept Pediat, Resp Dis Allergy & CF Unit, Rouen, France; [Gueudin, Marie] Rouen Univ Hosp Charles Nicolle, Dept Virol, Rouen, France; [Le Roux, Pascal] Reg Hosp Flaubert, Dept Pediat, Resp Dis Allergy & CF Unit, Le Havre, France; [Deschildre, Antoine] Lille Univ Hosp Jeanne de Flandres, Dept Pediat, Resp Dis Allergy & CF Unit, Lille, France; [Forget, Chantal] Reg Hosp, Dept Pediat, Resp Dis & Allergy Unit, Elbeuf, France; [Siret, Daniel] Reg Hosp Moulin du Pre, Dept Pediat, Resp Dis Allergy & CF Unit, St Nazaire, France; [Donnou, Marie-Dominique] Brest Univ Hosp, Pediat Lung Funct Tests & Resp Dis Unit, Brest, France; [Bubenheim, Michael] Rouen Univ Hosp Charles Nicolle, Dept Biostat, Rouen, France; [Vabret, Astrid; Freymuth, Francois] Caen Univ Hosp Clemenceau, Lab Human & Mol Virol, Caen, France	CHU de Rouen; CHU de Rouen; Universite de Lille - ISITE; CHU Lille; CHU Brest; CHU de Rouen; CHU de Caen NORMANDIE; Universite de Caen Normandie	Marguet, C (corresponding author), Rouen Univ Hosp Charles Nicolle, Dept Pediat, Resp Dis Allergy & CF Unit, Rouen, France.	christophe.marguet@chu-rouen.fr		VABRET, Astrid/0000-0002-8940-7645	French National Clinical Research Program [2000/020/HP]	French National Clinical Research Program	This work has been funded by the French National Clinical Research Program n. 2000/020/HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Causse M, 2007, J CLIN MICROBIOL, V45, P3811, DOI 10.1128/JCM.00345-07; Eugene-Ruellan G, 1998, J CLIN MICROBIOL, V36, P796, DOI 10.1128/JCM.36.3.796-801.1998; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; HELMINEN M, 2008, PEDIAT PULMONOL, V13, P394; Jacques J, 2006, J CLIN VIROL, V35, P463, DOI 10.1016/j.jcv.2005.11.009; Korppi M, 2004, PEDIATR INFECT DIS J, V23, P995, DOI 10.1097/01.inf.0000143642.72480.53; Korppi M, 2007, J ALLERGY CLIN IMMUN, V119, P1561, DOI 10.1016/j.jaci.2007.02.008; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Legg JP, 2005, PEDIATR INFECT DIS J, V24, P611, DOI 10.1097/01.inf.0000168747.94999.aa; Manoha C, 2007, J CLIN VIROL, V38, P221, DOI 10.1016/j.jcv.2006.12.005; Mansbach JM, 2008, PEDIATRICS, V121, P680, DOI 10.1542/peds.2007-1418; Marguet C, 2008, PEDIAT ALLERG IMM-UK, V19, P157, DOI 10.1111/j.1399-3038.2007.00600.x; MAUSBACH JM, 2008, ACAD EMERG MED, V15, P111; McNamara PS, 2007, PEDIATR PULM, V42, P740, DOI 10.1002/ppul.20649; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Ordas J, 2006, J CLIN MICROBIOL, V44, P2739, DOI 10.1128/JCM.00164-06; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Parkin PC, 1996, J CLIN EPIDEMIOL, V49, P821, DOI 10.1016/0895-4356(96)00027-3; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4; Xepapadaki P, 2004, J CLIN VIROL, V30, P267, DOI 10.1016/j.jcv.2003.12.012	30	116	121	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4596	10.1371/journal.pone.0004596	http://dx.doi.org/10.1371/journal.pone.0004596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240806	Green Published, Green Submitted, gold			2022-12-27	WOS:000278086700011
J	Ruckenstuhl, C; Buttner, S; Carmona-Gutierrez, D; Eisenberg, T; Kroemer, G; Sigrist, SJ; Frohlich, KU; Madeo, F				Ruckenstuhl, Christoph; Buettner, Sabrina; Carmona-Gutierrez, Didac; Eisenberg, Tobias; Kroemer, Guido; Sigrist, Stephan J.; Froehlich, Kai-Uwe; Madeo, Frank			The Warburg Effect Suppresses Oxidative Stress Induced Apoptosis in a Yeast Model for Cancer	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; CYTOCHROME-C; MITOCHONDRIA; METABOLISM; GROWTH; PROLIFERATION; RELEASE; OXYGEN; TUMORS	Background: Otto Warburg observed that cancer cells are often characterized by intense glycolysis in the presence of oxygen and a concomitant decrease in mitochondrial respiration. Research has mainly focused on a possible connection between increased glycolysis and tumor development whereas decreased respiration has largely been left unattended. Therefore, a causal relation between decreased respiration and tumorigenesis has not been demonstrated. Methodology/Principal Findings: For this purpose, colonies of Saccharomyces cerevisiae, which is suitable for manipulation of mitochondrial respiration and shows mitochondria-mediated cell death, were used as a model. Repression of respiration as well as ROS-scavenging via glutathione inhibited apoptosis and conferred a survival advantage during seeding and early development of this fast proliferating solid cell population. In contrast, enhancement of respiration triggered cell death. Conclusion/Significance: Thus, the Warburg effect might directly contribute to the initiation of cancer formation - not only by enhanced glycolysis - but also via decreased respiration in the presence of oxygen, which suppresses apoptosis.	[Ruckenstuhl, Christoph; Buettner, Sabrina; Carmona-Gutierrez, Didac; Eisenberg, Tobias; Froehlich, Kai-Uwe; Madeo, Frank] Graz Univ, Inst Mol Biosci, Graz, Austria; [Kroemer, Guido] INSERM, U848, Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Kroemer, Guido] Univ Paris 11, Villejuif, France; [Sigrist, Stephan J.] FU Berlin, Inst Biol, Berlin, Germany; [Sigrist, Stephan J.] Charite, NeuroCure Cluster Excellence, Berlin, Germany	University of Graz; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ruckenstuhl, C (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	frank.madeo@uni-graz.at	Kroemer, Guido/AAY-9859-2020; Eisenberg, Tobias/AAV-7806-2021; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Madeo, Frank/0000-0002-5070-1329; Buttner, Sabrina/0000-0002-2786-8542; Ruckenstuhl, Christoph/0000-0002-4338-4679; Eisenberg, Tobias/0000-0003-3559-1130	FWF-FSP [593]; EU STREP [511983]	FWF-FSP(Austrian Science Fund (FWF)); EU STREP(European Commission)	This work was supported by grant FWF-FSP 593 to F. M. and grant EU STREP 511983 (TransDeath) to K-U.F.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denko NC, 2008, NAT REV CANC; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; HANSSMANN P, 1976, MOL GEN GENET, V148, P205; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Meunier JR, 1999, YEAST, V15, P1159, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1159::AID-YEA441>3.0.CO;2-D; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; VAUGHU AE, 2008, NAT CELL BIOL, V10, P1177; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138	34	89	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4592	10.1371/journal.pone.0004592	http://dx.doi.org/10.1371/journal.pone.0004592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240798	Green Published, gold, Green Submitted			2022-12-27	WOS:000278086700009
J	Magdaleno, A; Ahn, IY; Paes, LS; Silber, AM				Magdaleno, Anahi; Ahn, Il-Young; Paes, Lisvane Silva; Silber, Ariel M.			Actions of a Proline Analogue, L-Thiazolidine-4-Carboxylic Acid (T4C), on Trypanosoma cruzi	PLOS ONE			English	Article								It is well established that L-proline has several roles in the biology of trypanosomatids. In Trypanosoma cruzi, the etiological agent of Chagas' disease, this amino acid is involved in energy metabolism, differentiation processes and resistance to osmotic stress. In this study, we analyzed the effects of interfering with L-proline metabolism on the viability and on other aspects of the T. cruzi life cycle using the proline analogue L- thiazolidine-4-carboxylic acid (T4C). The growth of epimastigotes was evaluated using different concentrations of T4C in standard culture conditions and at high temperature or acidic pH. We also evaluated possible interactions of this analogue with stress conditions such as those produced by nutrient starvation and oxidative stress. T4C showed a dose-response effect on epimastigote growth (IC50 = 0.89+/-0.02 mM at 28 degrees C), and the inhibitory effect of this analogue was synergistic (p<0.05) with temperature (0.54+/-0.01 mM at 37 degrees C). T4C significantly diminished parasite survival (p<0.05) in combination with nutrient starvation and oxidative stress conditions. Pre-incubation of the parasites with L-proline resulted in a protective effect against oxidative stress, but this was not seen in the presence of the drug. Finally, the trypomastigote bursting from infected mammalian cells was evaluated and found to be inhibited by up to 56% when cells were treated with non-toxic concentrations of T4C (between 1 and 10 mM). All these data together suggest that T4C could be an interesting therapeutic drug if combined with others that affect, for example, oxidative stress. The data also support the participation of proline metabolism in the resistance to oxidative stress.	[Magdaleno, Anahi; Ahn, Il-Young; Paes, Lisvane Silva; Silber, Ariel M.] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil	Universidade de Sao Paulo	Magdaleno, A (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil.	asilber@usp.br	Vieira, Lisvane Paes/AAI-6761-2020; 4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Silber, Ariel/O-6951-2015	Vieira, Lisvane Paes/0000-0001-8589-5939; Silber, Ariel/0000-0003-4528-4732	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/57596-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473906/2008-2]; Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant #08/57596-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant # 473906/2008-2) and Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-de-Faria M, 1999, EXP PARASITOL, V92, P263, DOI 10.1006/expr.1999.4423; Alves MJM, 2007, IUBMB LIFE, V59, P274, DOI 10.1080/15216540701200084; Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; ASIN S, 1995, J PARASITOL, V81, P1, DOI 10.2307/3283997; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BOHLER S, 1989, INFUSIONSTHERAPIE, V16, P82; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; Chen CB, 2006, APPL ENVIRON MICROB, V72, P4001, DOI 10.1128/AEM.02428-05; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1; Deutch CE, 2004, FEMS MICROBIOL LETT, V238, P383, DOI 10.1016/j.femsle.2004.08.001; ELTHON TE, 1984, PLANT PHYSIOL, V74, P213, DOI 10.1104/pp.74.2.213; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Finzi JK, 2004, MOL BIOCHEM PARASIT, V133, P37, DOI 10.1016/j.molbiopara.2003.08.011; Kollien AH, 1998, AM J TROP MED HYG, V59, P166, DOI 10.4269/ajtmh.1998.59.166; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Landfear SM, 2008, ADV EXP MED BIOL, V625, P22; Miranda MR, 2006, EXP PARASITOL, V114, P341, DOI 10.1016/j.exppara.2006.04.004; Molinari BL, 2003, ANAL QUANT CYTOL, V25, P254; Monaghan PJ, 2007, FEBS J, V274, P2070, DOI 10.1111/j.1742-4658.2007.05750.x; Nomura M, 2003, J BIOCHEM, V133, P67, DOI 10.1093/jb/mvg003; Pereira CA, 1999, J EUKARYOT MICROBIOL, V46, P566, DOI 10.1111/j.1550-7408.1999.tb05132.x; Pereira CA, 2003, FEBS LETT, V554, P201, DOI 10.1016/S0014-5793(03)01171-2; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Ratner S, 1937, J AM CHEM SOC, V59, P200, DOI 10.1021/ja01280a050; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Silber AM, 2006, INT J PARASITOL, V36, P157, DOI 10.1016/j.ijpara.2005.10.006; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; SYLVESTER D, 1976, COMP BIOCHEM PHYS B, V55, P443, DOI 10.1016/0305-0491(76)90318-7; Tempone Andre Gustavo, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P222; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; UNGER L, 1966, J BACTERIOL, V91, P1564, DOI 10.1128/JB.91.4.1564-1569.1966; UNGER L, 1966, J BACTERIOL, V91, P1556, DOI 10.1128/JB.91.4.1556-1563.1966; Urbina JA, 2002, CURR PHARM DESIGN, V8, P287, DOI 10.2174/1381612023396177; *WHO, 2002, WHO TECH REP SER, V905, P64; ZILBERSTEIN D, 1993, ADV PARASIT, V32, P261, DOI 10.1016/S0065-308X(08)60209-2	49	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4534	10.1371/journal.pone.0004534	http://dx.doi.org/10.1371/journal.pone.0004534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229347	gold, Green Published			2022-12-27	WOS:000265486200011
J	Lefevre-Colau, MM; Fayad, F; Rannou, F; Fermanian, J; Coriat, F; Mace, Y; Revel, M; Poiraudeau, S				Lefevre-Colau, Marie-Martine; Fayad, Fouad; Rannou, Francois; Fermanian, Jacques; Coriat, Fernand; Mace, Yann; Revel, Michel; Poiraudeau, Serge			Frequency and Interrelations of Risk Factors for Chronic Low Back Pain in a Primary Care Setting	PLOS ONE			English	Article								Introduction: Many risk factors have been identified for chronic low back pain (cLBP), but only one study evaluated their interrelations. We aimed to investigate the frequency of cLBP risk factors and their interrelations in patients consulting their general practitioners (GPs) for cLBP. Methods: A cross-sectional, descriptive, national survey was performed. 3000 GPs randomly selected were asked to include at least one patient consulting for cLBP. Demographic, clinical characteristics and the presence of cLBP risk factors were recorded. The frequency of each cLBP risk factor was calculated and multiple correspondence analysis (MCA) was performed to study their interrelations. Results: A total of 2068 GPs (68.9%) included at least 1 patient, for 4522 questionnaires analyzed. In the whole sample of patients, the 2 risk factors most commonly observed were history of recurrent LBP (72.1%) and initial limitation of activities of daily living (66.4%). For working patients, common professional risk factors were beliefs, that LBP was due to maintaining a specific posture at work (79.0%) and frequent heavy lifting at work (65.5%). On MCA, we identified 3 risk-factor dimensions (axes) for working and nonworking patients. The main dimension for working patients involved professional risk factors and among these factors, patients' job satisfaction and job recognition largely contribute to this dimension. Discussion: Our results shed in light for the first time the interrelation and the respective contribution of several previously identified cLBP risk factors. They suggest that risk factors representing a "work-related'' dimension are the most important cLBP risk factors in the working population.			Lefevre-Colau, MM (corresponding author), Paris Descartes Univ, Corentin Celton Hosp, AP HP, Dept Phys Med & Rehabil, Issy Les Moulineaux, France.	marie-martine.lefevre-colau@ccl.aphp.fr		Poiraudeau, Serge/0000-0002-1988-9124; lefevre-colau, marie-martine/0000-0002-7493-1225				Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Atlas SJ, 2003, MUSCLE NERVE, V27, P265, DOI 10.1002/mus.10311; Atlas SJ, 2000, J BONE JOINT SURG AM, V82A, P4, DOI 10.2106/00004623-200001000-00002; Bildt C, 2000, INT J BEHAV MED, V7, P372, DOI 10.1207/S15327558IJBM0704_07; Cedraschi C, 2005, BEST PRACT RES CL RH, V19, P577, DOI 10.1016/j.berh.2005.03.002; Clauw DJ, 1999, SPINE, V24, P2035, DOI 10.1097/00007632-199910010-00013; Ekman M, 2005, SPINE, V30, P1777, DOI 10.1097/01.brs.0000171911.99348.90; Fayad F., 2004, Annales de Readaptation et de Medecine Physique, V47, P179, DOI 10.1016/j.annrmp.2004.01.005; Fishbain DA, 1997, CLIN J PAIN, V13, P197, DOI 10.1097/00002508-199709000-00004; Fransen M, 2002, SPINE, V27, P92, DOI 10.1097/00007632-200201010-00022; Fritz JM, 2001, PAIN, V94, P7, DOI 10.1016/S0304-3959(01)00333-5; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Gatchel RJ, 1995, SPINE, V20, P2702, DOI 10.1097/00007632-199512150-00011; George SZ, 2003, SPINE, V28, P2551, DOI 10.1097/01.BRS.0000096677.84605.A2; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Henrotin Y., 2006, REV RHUM, V73, ps33; Hoogendoorn WE, 2002, OCCUP ENVIRON MED, V59, P323, DOI 10.1136/oem.59.5.323; Linton SJ, 2000, SPINE, V25, P2825, DOI 10.1097/00007632-200011010-00017; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Macfarlane GJ, 1999, PAIN, V80, P113, DOI 10.1016/S0304-3959(98)00209-7; Muller CF, 1999, SPINE, V24, P1562, DOI 10.1097/00007632-199908010-00010; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; POLATIN PB, 1993, SPINE, V18, P66, DOI 10.1097/00007632-199301000-00011; *SBU, 2000, 145 SBU; Schiottz-Christensen B, 1999, FAM PRACT, V16, P223, DOI 10.1093/fampra/16.3.223; Seferlis T, 2000, J SPINAL DISORD, V13, P470, DOI 10.1097/00002517-200012000-00002; Swinkels-Meewisse IEJ, 2006, CLIN J PAIN, V22, P45, DOI 10.1097/01.ajp.0000148626.84874.93; Tabachnick BG., USING MULTIVARIATE S; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; Valat JP, 2000, JOINT BONE SPINE, V67, P456; van der Weide WE, 1999, SCAND J WORK ENV HEA, V25, P50, DOI 10.5271/sjweh.383; vandenHoogen H, 1997, SPINE, V22, P1515, DOI 10.1097/00007632-199707010-00019; VOLINN E, 1991, SPINE, V16, P542, DOI 10.1097/00007632-199105000-00010; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; Williams RA, 1998, ARCH PHYS MED REHAB, V79, P366, DOI 10.1016/S0003-9993(98)90135-6; 1987, SPINE S, V12, P1	38	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4874	10.1371/journal.pone.0004874	http://dx.doi.org/10.1371/journal.pone.0004874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287499	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400015
J	Valin, A; Barnay-Verdier, S; Robert, T; Ripoche, H; Brellier, F; Chevallier-Lagente, O; Avril, MF; Magnaldo, T				Valin, Alexandre; Barnay-Verdier, Stephanie; Robert, Thomas; Ripoche, Hugues; Brellier, Florence; Chevallier-Lagente, Odile; Avril, Marie-Francoise; Magnaldo, Thierry			PTCH1(+/-) Dermal Fibroblasts Isolated from Healthy Skin of Gorlin Syndrome Patients Exhibit Features of Carcinoma Associated Fibroblasts	PLOS ONE			English	Article								Gorlin's or nevoid basal cell carcinoma syndrome (NBCCS) causes predisposition to basal cell carcinoma (BCC), the commonest cancer in adult human. Mutations in the tumor suppressor gene PTCH1 are responsible for this autosomal dominant syndrome. In NBCCS patients, as in the general population, ultraviolet exposure is a major risk factor for BCC development. However these patients also develop BCCs in sun-protected areas of the skin, suggesting the existence of other mechanisms for BCC predisposition in NBCCS patients. As increasing evidence supports the idea that the stroma influences carcinoma development, we hypothesized that NBCCS fibroblasts could facilitate BCC occurence of the patients. WT (n = 3) and NBCCS fibroblasts bearing either nonsense (n = 3) or missense (n = 3) PTCH1 mutations were cultured in dermal equivalents made of a collagen matrix and their transcriptomes were compared by whole genome microarray analyses. Strikingly, NBCCS fibroblasts over-expressed mRNAs encoding pro-tumoral factors such as Matrix Metalloproteinases 1 and 3 and tenascin C. They also over-expressed mRNA of pro-proliferative diffusible factors such as fibroblast growth factor 7 and the stromal cell-derived factor 1 alpha, known for its expression in carcinoma associated fibroblasts. These data indicate that the PTCH1(+/-) genotype of healthy NBCCS fibroblasts results in phenotypic traits highly reminiscent of those of BCC associated fibroblasts, a clue to the yet mysterious proneness to non photo-exposed BCCs in NBCCS patients.	[Valin, Alexandre; Ripoche, Hugues; Chevallier-Lagente, Odile; Magnaldo, Thierry] Univ Paris 11, Inst Gustave Roussy, CNRS, FRE2939, Villejuif, France; [Barnay-Verdier, Stephanie] Univ Paris 05, Ctr Rech Cordeliers, INSERM, UMRS872, F-75270 Paris, France; [Robert, Thomas] Univ Paris Sud, Inst Gustave Roussy, CNRS, Unite Genom Fonct, Villejuif, France; [Brellier, Florence] Friedrich Miescher Inst, Basel, Switzerland; [Avril, Marie-Francoise] Univ Paris 05, APHP, Serv Dermatol, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Friedrich Miescher Institute for Biomedical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite	Magnaldo, T (corresponding author), Univ Paris 11, Inst Gustave Roussy, CNRS, FRE2939, Villejuif, France.	tmagnaldo@unice.fr		Thierry, Magnaldo/0000-0001-9174-8599; Ripoche, Hugues/0000-0003-0433-1125; Barnay-Verdier, Stephanie/0000-0002-4615-3059; Brellier, Florence/0000-0002-0143-472X	Universite Paris Diderot-Paris 7 [PhD fellowship]; IGR [post-doctoral]; CNRS; Association pour la Recherche sur le Cancer [9500]; Fondation de l'Avenir; Societe Francaise de Dermatologie; Association Francaise contre les Myopathies	Universite Paris Diderot-Paris 7; IGR; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation de l'Avenir; Societe Francaise de Dermatologie; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	AV is recipient of a PhD fellowship from the Universite Paris Diderot-Paris 7. SB was recipient of post-doctoral grant from the IGR. TR is recipient of a grant from the CNRS. This work was performed in the frame of fund for the taxe d'apprentissage from the Institut Gustave Roussy. This work was supported by the CNRS, the Association pour la Recherche sur le Cancer (# 9500), the Fondation de l'Avenir, the Societe Francaise de Dermatologie, the Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Basler K, 2000, EMBO J, V19, P1169, DOI 10.1093/emboj/19.6.1169; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Brellier F, 2008, ONCOGENE, V27, P6601, DOI 10.1038/onc.2008.260; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Chin CWS, 2003, J PATHOL, V200, P308, DOI 10.1002/path.1363; Chu CY, 2007, ONCOGENE, V26, P2491, DOI 10.1038/sj.onc.1210040; COOPER M, 1977, CANCER RES, V37, P2544; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Danaee H, 2006, J INVEST DERMATOL, V126, P1152, DOI 10.1038/sj.jid.5700209; DARMIENTO J, 1995, MOL CELL BIOL, V15, P5732; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Fischer H, 2001, CARCINOGENESIS, V22, P875, DOI 10.1093/carcin/22.6.875; FRECHET M, 2008, ONCOGENE; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Green J, 1998, BRIT J DERMATOL, V139, P911; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Heitzer E, 2007, J INVEST DERMATOL, V127, P2872, DOI 10.1038/sj.jid.5700923; Howell BG, 2005, J DERMATOL SCI, V39, P39, DOI 10.1016/j.jdermsci.2005.02.004; IMAI K, 1994, FEBS LETT, V352, P216, DOI 10.1016/0014-5793(94)00960-0; Ito Y, 2003, CANCER RES, V63, P6651; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; MAJMUDAR G, 1994, MOL CARCINOGEN, V11, P29, DOI 10.1002/mc.2940110106; MAJMUDAR G, 1994, MOL CARCINOGEN, V9, P17, DOI 10.1002/mc.2940090105; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Monhian N, 2005, ARCH FACIAL PLAST S, V7, P238, DOI 10.1001/archfaci.7.4.238; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; Nishiura R, 2005, GYNECOL ENDOCRINOL, V21, P111, DOI 10.1080/09513590500168399; O'Driscoll L, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-74; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Robinson JK, 2003, ARCH DERMATOL, V139, P643, DOI 10.1001/archderm.139.5.643; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rubin AI, 2005, NEW ENGL J MED, V353, P2262, DOI 10.1056/NEJMra044151; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Slavik MA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-9; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; STAMP GWH, 1989, J PATHOL, V159, P225, DOI 10.1002/path.1711590309; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Unden AB, 1996, CANCER RES, V56, P4562; Unden AB, 1997, CANCER RES, V57, P2336; VANSCOTT EJ, 1961, J INVEST DERMATOL, V36, P109, DOI 10.1038/jid.1961.21; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wong CSM, 2003, BMJ-BRIT MED J, V327, P794, DOI 10.1136/bmj.327.7418.794; Yamazaki F, 2001, BRIT J DERMATOL, V145, P771, DOI 10.1046/j.1365-2133.2001.04468.x; Zedan W, 2001, J PATHOL, V194, P473, DOI 10.1002/path.940	70	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4818	10.1371/journal.pone.0004818	http://dx.doi.org/10.1371/journal.pone.0004818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287498	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496400001
J	Ahmed, BA; Bukhari, IA; Jeffus, BC; Harney, JT; Thyparambil, S; Ziu, E; Fraer, M; Rusch, NJ; Zimniak, P; Lupashin, V; Tang, D; Kilic, F				Ahmed, Billow A.; Bukhari, Irfan A.; Jeffus, Brandon C.; Harney, Justin T.; Thyparambil, Sheeno; Ziu, Endrit; Fraer, Mony; Rusch, Nancy J.; Zimniak, Piotr; Lupashin, Vladimir; Tang, Dale; Kilic, Fusun			The Cellular Distribution of Serotonin Transporter Is Impeded on Serotonin-Altered Vimentin Network	PLOS ONE			English	Article								Background: The C-terminus of the serotonin transporter (SERT) contains binding domains for different proteins and is critical for its functional expression. In endogenous and heterologous expression systems, our proteomic and biochemical analysis demonstrated that an intermediate filament, vimentin, binds to the C-terminus of SERT. It has been reported that 5HT-stimulation of cells leads to disassembly and spatial reorientation of vimentin filaments. Methodology/Principal Findings: We tested the impact of 5HT-stimulation on vimentin-SERT association and found that 5HT-stimulation accelerates the translocation of SERT from the plasma membrane via enhancing the level of association between phosphovimentin and SERT. Furthermore a progressive truncation of the C-terminus of SERT was performed to map the vimentin-SERT association domain. Deletion of up to 20, but not 14 amino acids arrested the transporters at intracellular locations. Although, truncation of the last 14 amino acids, did not alter 5HT uptake rates of transporter but abolished its association with vimentin. To understand the involvement of 5HT in phosphovimentin-SERT association from the plasma membrane, we further investigated the six amino acids between Delta 14 and Delta 20, i.e., the SITPET sequence of SERT. While the triple mutation on the possible kinase action sites, S(611), T(613), and T(616) arrested the transporter at intracellular locations, replacing the residues with aspartic acid one at a time altered neither the 5HT uptake rates nor the vimentin association of these mutants. However, replacing the three target sites with alanine, either simultaneously or one at a time, had no significant effect on 5HT uptake rates or the vimentin association with transporter. Conclusions/Significance: Based on our findings, we propose that phosphate modification of the SITPET sequence differentially, one at a time exposes the vimentin binding domain on the C-terminus of SERT. Conversely, following 5HT stimulation, the association between vimentin-SERT is enhanced which changes the cellular distribution of SERT on an altered vimentin network.	[Ahmed, Billow A.; Bukhari, Irfan A.; Jeffus, Brandon C.; Harney, Justin T.; Thyparambil, Sheeno; Ziu, Endrit; Kilic, Fusun] Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Fraer, Mony] Univ Arkansas Med Sci, Coll Med, Dept Internal Med, Little Rock, AR 72205 USA; [Rusch, Nancy J.; Zimniak, Piotr] Univ Arkansas Med Sci, Coll Med, Dept Pharmacol, Little Rock, AR 72205 USA; [Lupashin, Vladimir] Univ Arkansas Med Sci, Coll Med, Dept Physiol, Little Rock, AR 72205 USA; [Tang, Dale] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Albany Medical College	Ahmed, BA (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	kilicfusun@uams.edu	Bukhari, Syed/B-2885-2017; Lupashin, Vladimir/E-3013-2013; Lupashin, Vladimir/AAB-4312-2020; T, Dale/AAE-9643-2020	Bukhari, Syed/0000-0003-0203-0003; Lupashin, Vladimir/0000-0002-2350-1962; Lupashin, Vladimir/0000-0002-2350-1962; T, Dale/0000-0002-7339-9249	National Science foundation [MCB-0234822, MCB-0645163]; National Institute of Child Health and Human Development [HD053477]; American Heart Association [0660032Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053477] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083144] Funding Source: NIH RePORTER	National Science foundation(National Science Foundation (NSF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support provided by the National Science foundation (MCB-0234822; MCB-0645163 to V.L.) and the National Institute of Child Health and Human Development (HD053477 to FK) and American Heart Association (0660032Z to FK). The sponsors had no role in the design and conduct of the study.	Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200; ANDERSON GM, 1992, BIOCHIM BIOPHYS ACTA, V1137, P331, DOI 10.1016/0167-4889(92)90154-4; Bauman AL, 2000, J NEUROSCI, V20, P7571; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Blakely RD, 1998, BIOL PSYCHIAT, V44, P169, DOI 10.1016/S0006-3223(98)00124-3; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Carneiro AMD, 2006, J BIOL CHEM, V281, P24769, DOI 10.1074/jbc.M603877200; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Distelmaier F, 2004, J NEUROCHEM, V91, P537, DOI 10.1111/j.1471-4159.2004.02729.x; Gadda G, 1997, J BIOL CHEM, V272, P5563, DOI 10.1074/jbc.272.9.5563; Harlow E., 1988, ANITBODIES LAB MANUA; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; Jayanthi LD, 2005, MOL PHARMACOL, V67, P2077, DOI 10.1124/mol.104.009555; Jess U, 2002, BIOCHEM BIOPH RES CO, V294, P272, DOI 10.1016/S0006-291X(02)00460-6; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Mochizuki H, 2005, NEUROCHEM INT, V46, P93, DOI 10.1016/j.neuint.2004.08.008; MUSZBEK L, 1987, EUR J CELL BIOL, V43, P501; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; QIAN Y, 1995, J NEUROSCI, V15, P1261; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Reith MEA., 1997, NEUROTRANSMITTER TRA, P29, DOI 10.1007/978-1-59259-470-2_2; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; TABLIN F, 1987, CELL MOTIL CYTOSKEL, V8, P61, DOI 10.1002/cm.970080109; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462	34	21	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4730	10.1371/journal.pone.0004730	http://dx.doi.org/10.1371/journal.pone.0004730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270731	gold, Green Published, Green Submitted			2022-12-27	WOS:000265495900004
J	Albrecht-Buehler, G				Albrecht-Buehler, Guenter			Outline of a Genome Navigation System Based on the Properties of GA-Sequences and Their Flanks	PLOS ONE			English	Article							ALU; TRANSCRIPTION; BINDING; DNA	Introducing a new method to visualize large stretches of genomic DNA (see Appendix S1) the article reports that most GA-sequences [1] shared chains of tetra-GA-motifs and contained upstream poly(A)-segments. Although not integral parts of them, Alu-elements were found immediately upstream of all human and chimpanzee GA-sequences with an upstream poly(A)-segment. The article hypothesizes that genome navigation uses these properties of GA-sequences in the following way. (1) Poly(A) binding proteins interact with the upstream poly(A)-segments and arrange adjacent GA-sequences side-byside ('GA-ribbon'), while folding the intervening DNA sequences between them into loops ('associated DNA-loops'). (2) Genome navigation uses the GA-ribbon as a search path for specific target genes that is up to 730-fold shorter than the full-length chromosome. (3) As to the specificity of the search, each molecule of a target protein is assumed to catalyze the formation of specific oligomers from a set of transcription factors that recognize tetra-GA-motifs. Their specific combinations of tetra-GA motifs are assumed to be present in the particular GA-sequence whose associated loop contains the gene for the target protein. As long as the target protein is abundant in the cell it produces sufficient numbers of such oligomers which bind to their specific GA-sequences and, thereby, inhibit locally the transcription of the target protein in the associated loop. However, if the amount of target protein drops below a certain threshold, the resultant reduction of specific oligomers leaves the corresponding GA-sequence 'denuded'. In response, the associated DNA-loop releases its nucleosomes and allows transcription of the target protein to proceed. (4) The Alu-transcripts may help control the general background of protein synthesis proportional to the number of transcriptionally active associated loops, especially in stressed cells. (5) The model offers a new mechanism of co-regulation of protein synthesis based on the shared segments of different GA-sequences.	[Albrecht-Buehler, Guenter] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Albrecht-Buehler, G (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	g-buehler@northwestern.edu						Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Albrecht-Buehler G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003818; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; CHU WM, 1995, NUCLEIC ACIDS RES, V23, P1750, DOI 10.1093/nar/23.10.1750; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Kim C, 2001, GENE, V276, P127, DOI 10.1016/S0378-1119(01)00639-4; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; MARKHAM R, 1963, VIROLOGY, V20, P88, DOI 10.1016/0042-6822(63)90143-0; Melnikova L, 2004, P NATL ACAD SCI USA, V101, P14806, DOI 10.1073/pnas.0403959101; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4701	10.1371/journal.pone.0004701	http://dx.doi.org/10.1371/journal.pone.0004701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270754	Green Submitted, Green Published, gold			2022-12-27	WOS:000265495900002
J	Bennett, DE; Camacho, RJ; Otelea, D; Kuritzkes, DR; Fleury, H; Kiuchi, M; Heneine, W; Kantor, R; Jordan, MR; Schapiro, JM; Vandamme, AM; Sandstrom, P; Boucher, CAB; van de Vijver, D; Rhee, SY; Liu, TF; Pillay, D; Shafer, RW				Bennett, Diane E.; Camacho, Ricardo J.; Otelea, Dan; Kuritzkes, Daniel R.; Fleury, Herve; Kiuchi, Mark; Heneine, Walid; Kantor, Rami; Jordan, Michael R.; Schapiro, Jonathan M.; Vandamme, Anne-Mieke; Sandstrom, Paul; Boucher, Charles A. B.; van de Vijver, David; Rhee, Soo-Yon; Liu, Tommy F.; Pillay, Deenan; Shafer, Robert W.			Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update	PLOS ONE			English	Article								Programs that monitor local, national, and regional levels of transmitted HIV-1 drug resistance inform treatment guidelines and provide feedback on the success of HIV-1 treatment and prevention programs. To accurately compare transmitted drug resistance rates across geographic regions and times, the World Health Organization has recommended the adoption of a consensus genotypic definition of transmitted HIV-1 drug resistance. In January 2007, we outlined criteria for developing a list of mutations for drug-resistance surveillance and compiled a list of 80 RT and protease mutations meeting these criteria (surveillance drug resistance mutations; SDRMs). Since January 2007, several new drugs have been approved and several new drug-resistance mutations have been identified. In this paper, we follow the same procedures described previously to develop an updated list of SDRMs that are likely to be useful for ongoing and future studies of transmitted drug resistance. The updated SDRM list has 93 mutations including 34 NRTI-resistance mutations at 15 RT positions, 19 NNRTI-resistance mutations at 10 RT positions, and 40 PI-resistance mutations at 18 protease positions.	[Bennett, Diane E.] WHO, CH-1211 Geneva, Switzerland; [Camacho, Ricardo J.] Ctr Hosp Lisboa Ocident, Mol Biol Lab, Lisbon, Portugal; [Otelea, Dan] Inst Infect Dis, Bucharest, Romania; [Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Fleury, Herve] Univ Bordeaux, Lab Virol, EA 2968, Bordeaux, France; [Kiuchi, Mark; Schapiro, Jonathan M.; Rhee, Soo-Yon; Liu, Tommy F.; Shafer, Robert W.] Stanford Univ, Div Infect Dis, Stanford, CA 94305 USA; [Heneine, Walid] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kantor, Rami] Brown Univ, Div Infect Dis, Providence, RI 02912 USA; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA USA; [Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Sandstrom, Paul] Publ Hlth Agcy Canada, Ctr Infect Dis Prevent & Control, Ottawa, ON, Canada; [Boucher, Charles A. B.; van de Vijver, David] Erasmus MC, Univ Med Ctr Rotterdam, Dept Virol, Rotterdam, Netherlands; [Boucher, Charles A. B.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3508 TC Utrecht, Netherlands; [Pillay, Deenan] UCL, Ctr Virol, Div Infect & Immun, London, England; [Pillay, Deenan] UCL, Ctr Infect, Hlth Protect Agcy, London, England	World Health Organization; Centro Hospitalar de Lisboa Ocidental, EPE; National Institute for Infectious Diseases "Matei Bals"; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UDICE-French Research Universities; Universite de Bordeaux; Stanford University; Centers for Disease Control & Prevention - USA; Brown University; Tufts University; KU Leuven; Public Health Agency of Canada; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; University of London; University College London; Health Protection Agency; University of London; University College London	Bennett, DE (corresponding author), WHO, CH-1211 Geneva, Switzerland.	rshafer@stanford.edu	Camacho, Ricardo J/I-7629-2012; Rhee, Soo-Yon/L-4597-2013; Otelea, Dan/AAV-6467-2021; Vandamme, Anne-Mieke/I-4127-2012	Camacho, Ricardo J/0000-0002-9129-3237; Vandamme, Anne-Mieke/0000-0002-6594-2766; Otelea, Dan/0000-0002-0821-6346; Rhee, Soo-Yon/0000-0002-1231-6542; van de Vijver, David/0000-0001-5877-8526	NIAID [AI06858]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SY Rhee, TF Liu, M Kiuchi, and RW Shafer were supported by a grant from the NIAID (AI06858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz WE, 2008, ANTIVIR THER, V13, P89; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; BENNETT DE, 2007, ANTIVIR THER S; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Carr JK, 2005, JAIDS-J ACQ IMM DEF, V39, P570; de Meyer S, 2008, AIDS RES HUM RETROV, V24, P379, DOI 10.1089/aid.2007.0173; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Green H, 2008, JAIDS-J ACQ IMM DEF, V49, P196, DOI 10.1097/QAI.0b013e318185725f; Kamoto K, 2008, ANTIVIR THER, V13, P83; KORBER BTM, 2007, HIV MOL IMMUNOLOGY 2; Maphalala G, 2008, ANTIVIR THER, V13, P95; MARGOT NA, 2006, ANTIMICROB AGENTS CH; Mueller SM, 2007, J VIROL, V81, P2887, DOI 10.1128/JVI.01547-06; Myers RE, 2005, BIOINFORMATICS, V21, P3535, DOI 10.1093/bioinformatics/bti569; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Nguyen HT, 2008, ANTIVIR THER, V13, P115; Pillay D, 2004, ANTIVIR THER, V9, P695; Pillay V, 2008, ANTIVIR THER, V13, P101; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Ross LL, 2006, AIDS, V20, P787, DOI 10.1097/01.aids.0000216387.60481.0e; Shafer RW, 2008, ANTIVIR THER, V13, P59; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Sirivichoyaku S, 2008, ANTIVIR THER, V13, P109; Somi GR, 2008, ANTIVIR THER, V13, P77; *TIB, 2008, INT PACK INS; Vingerhoets J, 2007, ANTIVIR THER, V12, pS34; Vingerhoets J, 2005, J VIROL, V79, P12773, DOI 10.1128/JVI.79.20.12773-12782.2005; VINGERHOETS J, 2004, 11 C RETR OPP INF SA	28	742	783	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4724	10.1371/journal.pone.0004724	http://dx.doi.org/10.1371/journal.pone.0004724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266092	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490800005
J	Chatterjee, C; Sarkar, RR				Chatterjee, Chandrajit; Sarkar, Ram Rup			Multi-Step Polynomial Regression Method to Model and Forecast Malaria Incidence	PLOS ONE			English	Article							INFECTIOUS-DISEASES; FALCIPARUM-MALARIA; RISK; EPIDEMICS; PATTERNS; DIPTERA; SPREAD	Malaria is one of the most severe problems faced by the world even today. Understanding the causative factors such as age, sex, social factors, environmental variability etc. as well as underlying transmission dynamics of the disease is important for epidemiological research on malaria and its eradication. Thus, development of suitable modeling approach and methodology, based on the available data on the incidence of the disease and other related factors is of utmost importance. In this study, we developed a simple non-linear regression methodology in modeling and forecasting malaria incidence in Chennai city, India, and predicted future disease incidence with high confidence level. We considered three types of data to develop the regression methodology: a longer time series data of Slide Positivity Rates (SPR) of malaria; a smaller time series data (deaths due to Plasmodium vivax) of one year; and spatial data (zonal distribution of P. vivax deaths) for the city along with the climatic factors, population and previous incidence of the disease. We performed variable selection by simple correlation study, identification of the initial relationship between variables through non-linear curve fitting and used multistep methods for induction of variables in the non-linear regression analysis along with applied Gauss-Markov models, and ANOVA for testing the prediction, validity and constructing the confidence intervals. The results execute the applicability of our method for different types of data, the autoregressive nature of forecasting, and show high prediction power for both SPR and P. vivax deaths, where the one-lag SPR values plays an influential role and proves useful for better prediction. Different climatic factors are identified as playing crucial role on shaping the disease curve. Further, disease incidence at zonal level and the effect of causative factors on different zonal clusters indicate the pattern of malaria prevalence in the city. The study also demonstrates that with excellent models of climatic forecasts readily available, using this method one can predict the disease incidence at long forecasting horizons, with high degree of efficiency and based on such technique a useful early warning system can be developed region wise or nation wise for disease prevention and control activities.	[Chatterjee, Chandrajit; Sarkar, Ram Rup] Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chatterjee, C (corresponding author), Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India.	ramrup@ccmb.res.in		SARKAR, RAM RUP/0000-0001-7115-163X	Department of Science and Technology (DST), Govt. of India [SR/FTP/MS-06/2005]	Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India))	R.R. Sarkar is thankful to the Department of Science and Technology (DST), Govt. of India, for financial support under the project grant SR/FTP/MS-06/2005.	Abeku TA, 2002, TROP MED INT HEALTH, V7, P851, DOI 10.1046/j.1365-3156.2002.00924.x; AGUR Z, 1993, P NATL ACAD SCI USA, V90, P11698, DOI 10.1073/pnas.90.24.11698; ANDERSON R M, 1991; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Anderson T. W., 1958, INTRO MULTIVARIATE S; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-76; Cancre N, 2000, AM J EPIDEMIOL, V152, P760, DOI 10.1093/aje/152.8.760; Chattopadhyay J, 2004, ECOL MODEL, V177, P179, DOI 10.1016/j.ecolmodel.2004.03.001; Cliff A D, 1983, Ecol Dis, V2, P377; Dash AP, 2008, J BIOSCIENCES, V33, P583, DOI 10.1007/s12038-008-0076-x; FIELD A, 2004, FACTOR ANAL USING SP; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HETHCOTE HW, 1981, SIAM J APPL MATH, V40, P1, DOI 10.1137/0140001; Himeidan Y. E., 2007, Eastern Mediterranean Health Journal, V13, P17; KALLEN A, 1985, J THEOR BIOL, V116, P377, DOI 10.1016/S0022-5193(85)80276-9; KHANUM S, 2007, REGIONAL HLTH FORUM, V11, P33; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; KSHIRSAGAR AM, 1972, MULTIVARIATE ANAL, V2; Kuhn KG, 2002, J MED ENTOMOL, V39, P621, DOI 10.1603/0022-2585-39.4.621; Kumar AR, 2008, CURR SCI INDIA, V94, P1012; LAYNE SP, 2007, EPIDEMIOLOGY EPI, V220; Lindblade KA, 2000, J MED ENTOMOL, V37, P664, DOI 10.1603/0022-2585-37.5.664; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; MORITA T, 1994, ESTIMATION CLIMATE C; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546; RURU Y, 2003, PHILIPPINE STAT, V52, P27; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; *WHO, WORLD HLTH ORG WHO G; WICKWIRE K, 1977, THEOR POPUL BIOL, V11, P182, DOI 10.1016/0040-5809(77)90025-9; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; [No title captured]	40	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4726	10.1371/journal.pone.0004726	http://dx.doi.org/10.1371/journal.pone.0004726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266093	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490800007
J	Sellick, MJ; Kyser, TK; Wunder, MB; Chipley, D; Norris, DR				Sellick, Megan J.; Kyser, T. Kurt; Wunder, Michael B.; Chipley, Don; Norris, D. Ryan			Geographic Variation of Strontium and Hydrogen Isotopes in Avian Tissue: Implications for Tracking Migration and Dispersal	PLOS ONE			English	Article							STABLE-ISOTOPES; WINTERING GROUNDS; BREEDING ORIGINS; NORTH-AMERICA; RATIOS; FEATHERS; TRACERS; BIRDS; PRECIPITATION; ASSIGNMENT	Background: Isotopes can provide unique solutions to fundamental problems related to the ecology and evolution of migration and dispersal because prior movements of individuals can theoretically be tracked from tissues collected from a single capture. However, there is still remarkably little information available about how and why isotopes vary in wild animal tissues, especially over large spatial scales. Methodology/Principal Findings: Here, we describe variation in both stable-hydrogen (delta D-F) and strontium (Sr-87/Sr-86(F)) isotopic compositions in the feathers of a migratory songbird, the Tree Swallow ( Tachycineta bicolor), across 18 sampling sites in North America and then examine potential mechanisms driving this variation. We found that dDF was correlated with latitude of the sampling site, whereas Sr-87/Sr-86(F) was correlated with longitude. delta D-F was related to delta D of meteoric waters where molting occurred and Sr-87/Sr-86(F) was influenced primarily by the geology in the area where feathers were grown. Using simulation models, we then assessed the utility of combining both markers to estimate the origin of individuals. Using 13 geographic regions, we found that the number of individuals correctly assigned to their site of origin increased from less than 40% using either delta D or Sr-87/Sr-86 alone to 74% using both isotopes. Conclusions/Significance: Our results suggest that these isotopes have the potential to provide predictable and complementary markers for estimating long-distance animal movements. Combining isotopes influenced by different global-scale processes may allow researchers to link the population dynamics of animals across large geographic ranges.	[Sellick, Megan J.; Norris, D. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Kyser, T. Kurt; Chipley, Don] Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada; [Wunder, Michael B.] Univ Colorado, Dept Biol, Denver, CO USA	University of Guelph; Queens University - Canada; University of Colorado System; University of Colorado Denver	Sellick, MJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	rnorris@uoguelph.ca	Norris, Ryan/F-4720-2011	Norris, Ryan/0000-0003-4874-1425; Kyser, Kurt/0000-0001-9667-4103	Natural Sciences and Engineering Research Council; Canadian Foundation for Innovation; Ontario Innovation Trust; University of Guelph; Queen's University; Ontario Graduate Scholarship; American Ornithologist' Union; Society of Canadian Ornithologists; Ellis Bird Farm	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; University of Guelph; Queen's University; Ontario Graduate Scholarship(Ontario Graduate Scholarship); American Ornithologist' Union; Society of Canadian Ornithologists; Ellis Bird Farm	Funding for this research was provided by the Natural Sciences and Engineering Research Council (DRN, TKK, MJS), Canadian Foundation for Innovation (TKK, DRN), Ontario Innovation Trust (TKK), University of Guelph (DRN) and Queen's University (TKK), Ontario Graduate Scholarship (MJS), American Ornithologist' Union (MJS), Society of Canadian Ornithologists (MJS), and the Ellis Bird Farm (MJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG G, 1995, WATER AIR SOIL POLL, V79, P309, DOI 10.1007/BF01100444; Bairlein F, 2001, ARDEA, V89, P7; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; BREWER D, 2000, CANADIAN ATLAS BIRD; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Colbert J, 2001, DISPERSAL; CRESSIE N, 1990, MATH GEOL, V22, P241; DANSGAARD W, 1964, TELLUS, V16, P436; ESTEP MF, 1981, SCIENCE, V214, P1374; Faure G., 1972, STRONTIUM ISOTOPE GE; Font L, 2007, J ANAL ATOM SPECTROM, V22, P513, DOI 10.1039/b616328a; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, 2004, CONDOR, V106, P732, DOI 10.1650/7631; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2001, AUK, V118, P16, DOI 10.1642/0004-8038(2001)118[0016:LBAWGO]2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoppe KA, 1999, GEOLOGY, V27, P439, DOI 10.1130/0091-7613(1999)027<0439:TMAMRO>2.3.CO;2; Hoppe KA, 2007, QUATERNARY RES, V68, P347, DOI 10.1016/j.yqres.2007.08.001; HUSSELL DJT, 1983, WILSON BULL, V95, P470; Kelly JF, 2008, ECOL APPL, V18, P568, DOI 10.1890/07-0027.1; Kelly JF, 2005, ECOL APPL, V15, P1487, DOI 10.1890/04-1704; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Lott CA, 2006, AUK, V123, P822, DOI 10.1642/0004-8038(2006)123[822:AGATET]2.0.CO;2; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; Meehan TD, 2001, CONDOR, V103, P11, DOI 10.1650/0010-5422(2001)103[0011:UHIGTE]2.0.CO;2; MIZUTANI H, 1990, AUK, V107, P400, DOI 10.2307/4087626; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Pyle P, 1997, IDENTIFICATION GUIDE; ROBERTSON RJ, 1992, TREE SWALLOW, P1, DOI DOI 10.2173/BNA.11; Rocque DA, 2006, J ORNITHOL, V147, P395, DOI 10.1007/s10336-006-0068-2; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Sauer J. R., 2005, N AM BREEDING BIRD S; Vann J, 2003, AUSTRALAS I MIN MET, V2003, P215; VOGEL JC, 1990, NATURE, V346, P747, DOI 10.1038/346747a0; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunder MB, 2005, OECOLOGIA, V144, P607, DOI 10.1007/s00442-005-0071-y; Wunder MB, 2008, TERR ECOL SER, V2, P107, DOI 10.1016/S1936-7961(07)00005-X; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1	49	52	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4735	10.1371/journal.pone.0004735	http://dx.doi.org/10.1371/journal.pone.0004735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266102	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490800015
J	Williams, R; Lim, JE; Harr, B; Wang, C; Walters, R; Distler, MG; Teschke, M; Wu, CL; Wiltshire, T; Su, AI; Sokoloff, G; Tarantino, LM; Borevitz, JO; Palmer, AA				Williams, Richard; Lim, Jackie E.; Harr, Bettina; Wang, Claudia; Walters, Ryan; Distler, Margaret G.; Teschke, Meike; Wu, Chunlei; Wiltshire, Tim; Su, Andrew I.; Sokoloff, Greta; Tarantino, Lisa M.; Borevitz, Justin O.; Palmer, Abraham A.			A Common and Unstable Copy Number Variant Is Associated with Differences in Glo1 Expression and Anxiety-Like Behavior	PLOS ONE			English	Article							GLYOXALASE-I; CANDIDATE GENES; TRAIT ANXIETY; MOUSE MODEL; MICE; POLYMORPHISM; DISORDER; AUTISM; IDENTIFICATION; NUCLEOTIDE	Glyoxalase 1 (Glo1) has been implicated in anxiety-like behavior in mice and in multiple psychiatric diseases in humans. We used mouse Affymetrix exon arrays to detect copy number variants (CNV) among inbred mouse strains and thereby identified a similar to 475 kb tandem duplication on chromosome 17 that includes Glo1 ( 30,174,390 - 30,651,226 Mb; mouse genome build 36). We developed a PCR-based strategy and used it to detect this duplication in 23 of 71 inbred strains tested, and in various outbred and wild-caught mice. Presence of the duplication is associated with a cis-acting expression QTL for Glo1 (LOD > 30) in BXD recombinant inbred strains. However, evidence for an eQTL for Glo1 was not obtained when we analyzed single SNPs or 3-SNP haplotypes in a panel of 27 inbred strains. We conclude that association analysis in the inbred strain panel failed to detect an eQTL because the duplication was present on multiple highly divergent haplotypes. Furthermore, we suggest that non-allelic homologous recombination has led to multiple reversions to the non-duplicated state among inbred strains. We show associations between multiple duplication-containing haplotypes, Glo1 expression and anxiety-like behavior in both inbred strain panels and outbred CD-1 mice. Our findings provide a molecular basis for differential expression of Glo1 and further implicate Glo1 in anxiety-like behavior. More broadly, these results identify problems with commonly employed tests for association in inbred strains when CNVs are present. Finally, these data provide an example of biologically significant phenotypic variability in model organisms that can be attributed to CNVs.	[Williams, Richard] Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA; [Lim, Jackie E.; Wang, Claudia; Walters, Ryan; Distler, Margaret G.; Sokoloff, Greta; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Harr, Bettina; Teschke, Meike] Max Planck Inst Evolut Biol, Dept Evolut Genet, Plon, Germany; [Wu, Chunlei; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Wiltshire, Tim] Univ N Carolina, Sch Pharm, Department of Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Tarantino, Lisa M.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA; [Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL USA	University of Chicago; University of Chicago; Max Planck Society; Novartis; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Chicago; University of Chicago	Williams, R (corresponding author), Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA.	aap@uchicago.edu	Palmer, Abraham/L-2158-2014; Borevitz, Justin/B-5423-2012	Palmer, Abraham/0000-0003-3634-0747; Borevitz, Justin/0000-0001-8408-3699; Su, Andrew I./0000-0002-9859-4104; Sokoloff, Greta/0000-0003-3651-1980; Wing, Claudia/0000-0002-8243-5598	 [MH070933];  [MH79103];  [MH020065]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079103, K01MH070933] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	These studies were funded by MH070933, MH79103 and MH020065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DW, 1978, ORIGINS INBRED MICE, P197; Bogue MA, 2007, NUCLEIC ACIDS RES, V35, pD643, DOI 10.1093/nar/gkl1049; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bouayed J, 2007, EUR J PHARMACOL, V564, P146, DOI 10.1016/j.ejphar.2007.02.055; Cook MN, 2001, BEHAV NEUROSCI, V115, P468, DOI 10.1037/0735-7044.115.2.468; COOPER GM, 2007, NAT GENET; CUTLER G, 2007, GENOME RES; Ditzen C, 2006, MOL CELL PROTEOMICS, V5, P1914, DOI 10.1074/mcp.M600088-MCP200; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fujimoto M, 2008, NEUROSCI LETT, V438, P196, DOI 10.1016/j.neulet.2008.04.024; Gingrich JA, 2005, NAT MED, V11, P1281, DOI 10.1038/nm1205-1281; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Junaid MA, 2004, AM J MED GENET A, V131A, P11, DOI 10.1002/ajmg.a.30349; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Liu XQ, 2003, BRAIN RES BULL, V60, P223, DOI 10.1016/S0361-9230(03)00033-9; MCCARROLL SA, 2007, NAT GENET; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; MEO T, 1977, SCIENCE, V198, P311, DOI 10.1126/science.910130; Politi P, 2006, NEUROSCI LETT, V396, P163, DOI 10.1016/j.neulet.2005.11.028; Rehnstrom K, 2008, AM J MED GENET B, V147B, P124, DOI 10.1002/ajmg.b.30582; Rottscheidt R, 2007, GENETICS, V177, P1553, DOI 10.1534/genetics.107.076190; Sacco R, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-11; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Thornalley PJ, 2006, TRENDS MOL MED, V12, P195, DOI 10.1016/j.molmed.2006.03.004; WAHLSTEN D, 2006, COVER STABILITY INBR, P16364; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Wu YY, 2008, PROG NEURO-PSYCHOPH, V32, P1740, DOI 10.1016/j.pnpbp.2008.07.019	38	69	71	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4649	10.1371/journal.pone.0004649	http://dx.doi.org/10.1371/journal.pone.0004649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266052	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490800001
J	Ahn, B; Lee, JW; Jung, H; Beck, G; Bohr, VA				Ahn, Byungchan; Lee, Jae Wan; Jung, Hana; Beck, Gad; Bohr, Vilhelm A.			Mechanism of Werner DNA Helicase: POT1 and RPA Stimulates WRN to Unwind beyond Gaps in the Translocating Strand	PLOS ONE			English	Article							SYNDROME PROTEIN; EXCISION-REPAIR; MUTATIONS; BASE; MODULATION; COMPLEX	WRN belongs to the RecQ family of DNA helicases and it plays a role in recombination, replication, telomere maintenance and long-patch base excision repair. Here, we demonstrate that WRN efficiently unwinds DNA substrates containing a 1-nucleotide gap in the translocating DNA strand, but when the gap size is increased to 3-nucleotides unwinding activity significantly declines. In contrast, E. coli UvrD (3'-> 5' helicase), which recognizes nicks in DNA to initiate unwinding, does not unwind past a 1-nucleotide gap. This unique ability of WRN to bypass gaps supports its involvement in DNA replication and LP-BER where such gaps can be produced by glycosylases and the apurinic/apyrimidinic endonuclease 1 (APE1). Furthermore, we tested telomere repeat binding factor 2 (TRF2), both variants 1 and 2 of protector of telomeres 1 (POT1v1 and POT1v2) and RPA on telomeric DNA substrates containing much bigger gaps than 3-nucleotides in order to determine whether unwinding could be facilitated through WRN-protein interaction. Interestingly, POT1v1 and RPA are capable of stimulating WRN helicase on gapped DNA and 5'-overhang substrates, respectively.	[Ahn, Byungchan; Jung, Hana; Beck, Gad] Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea; [Lee, Jae Wan; Bohr, Vilhelm A.] NIA, NIH, Biomed Res Ctr, Lab Mol Gerontol, Baltimore, MD USA	University of Ulsan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ahn, B (corresponding author), Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea.	bohrv@grc.nia.nih.gov	Bohr, Vilhelm/AAP-5931-2020		Intramural Research Program of the National Institute of Health, National Institute on Aging; Korean Government (MOEHRD) [KRF-2008-521-C00211]; Basic Research Promotion Fund [KRF-2008-412-J00303]; NATIONAL INSTITUTE ON AGING [ZIAAG000721, Z01AG000721] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Basic Research Promotion Fund(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute of Health, National Institute on Aging (to V.A.B). This work was supported by the Brain Korea 21 Project in 2008 from KRF, a Korea Research Foundation Grant of the Korean Government (MOEHRD) (KRF-2008-521-C00211), and the Basic Research Promotion Fund (KRF-2008-412-J00303) (to B.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn B, 2004, J BIOL CHEM, V279, P53465, DOI 10.1074/jbc.M409624200; Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Choudhary S, 2006, J BIOL CHEM, V281, P6000, DOI 10.1074/jbc.M510122200; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Goto M, 2000, CLIN EXP RHEUMATOL, V18, P760; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Harrigan JA, 2003, J BIOL CHEM, V278, P22686, DOI 10.1074/jbc.M213103200; HOEIJMAKERS JHJ, 1990, CANCER CELL-MON REV, V2, P311; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lee JW, 2005, J BIOL CHEM, V280, P39627, DOI 10.1074/jbc.M506112200; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Moser MJ, 1999, HUM MUTAT, V13, P271, DOI 10.1002/(SICI)1098-1004(1999)13:4<271::AID-HUMU2>3.0.CO;2-Q; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Oshima J, 1996, HUM MOL GENET, V5, P1909, DOI 10.1093/hmg/5.12.1909; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; VAN OM, 2006, CURR BIOL; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wong D, 2003, J BIOL CHEM, V278, P36242, DOI 10.1074/jbc.M306065200; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yu CE, 1997, AM J HUM GENET, V60, P330	42	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4673	10.1371/journal.pone.0004673	http://dx.doi.org/10.1371/journal.pone.0004673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262689	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490600006
J	van Zweden, JS; Heinze, J; Boomsma, JJ; d'Ettorre, P				van Zweden, Jelle S.; Heinze, Juergen; Boomsma, Jacobus J.; d'Ettorre, Patrizia			Ant Queen Egg-Marking Signals: Matching Deceptive Laboratory Simplicity with Natural Complexity	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; CUTICULAR HYDROCARBONS; NESTMATE RECOGNITION; DUFOURS GLAND; WORKER; FERTILITY; BEHAVIOR; REPRODUCTIVES; CONFLICT; ORIGIN	Background: Experiments under controlled laboratory conditions can produce decisive evidence for testing biological hypotheses, provided they are representative of the more complex natural conditions. However, whether this requirement is fulfilled is seldom tested explicitly. Here we provide a lab/field comparison to investigate the identity of an egg-marking signal of ant queens. Our study was based on ant workers resolving conflict over male production by destroying each other's eggs, but leaving queen eggs unharmed. For this, the workers need a proximate cue to discriminate between the two egg types. Earlier correlative evidence indicated that, in the ant Pachycondyla inversa, the hydrocarbon 3,11-dimethylheptacosane ( 3,11-diMeC(27)) is more abundant on the surface of queen-laid eggs. Methodology: We first tested the hypothesis that 3,11-diMeC(27) functions as a queen egg-marking pheromone using laboratory-maintained colonies. We treated worker-laid eggs with synthetic 3,11-diMeC(27) and found that they were significantly more accepted than sham-treated worker-laid eggs. However, we repeated the experiment with freshly collected field colonies and observed no effect of treating worker-laid eggs with 3,11-diMeC(27), showing that this compound by itself is not the natural queen egg-marking pheromone. We subsequently investigated the overall differences of entire chemical profiles of eggs, and found that queen-laid eggs in field colonies are more distinct from worker-laid eggs than in lab colonies, have more variation in profiles, and have an excess of longer-chain hydrocarbons. Conclusions: Our results suggest that queen egg-marking signals are significantly affected by transfer to the laboratory, and that this change is possibly connected to reduced queen fertility as predicted by honest signaling theory. This change is reflected in the worker egg policing response under field and laboratory conditions.	[van Zweden, Jelle S.; Boomsma, Jacobus J.; d'Ettorre, Patrizia] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [van Zweden, Jelle S.; Heinze, Juergen; d'Ettorre, Patrizia] Univ Regensburg, D-8400 Regensburg, Germany	University of Copenhagen; University of Regensburg	van Zweden, JS (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	jvzweden@bio.ku.dk	Boomsma, Jacobus J/M-2785-2014; van Zweden, Jelle S./AAD-7858-2020	Boomsma, Jacobus J/0000-0002-3598-1609; van Zweden, Jelle S./0000-0001-5283-5470	EU Marie Curie Excellence Grant [CODICES-EXT-CT-2004-014202]; Faculty of Science, University of Copenhagen [Freia]; Deutsche Forschungsgemeinschaft [DE 893/1-2]; Danish National Research Foundation	EU Marie Curie Excellence Grant; Faculty of Science, University of Copenhagen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish National Research Foundation(Danmarks Grundforskningsfond)	The work was supported by the EU Marie Curie Excellence Grant CODICES-EXT-CT-2004-014202 granted to Patrizia d'Ettorre, a "Freia grant" from the Faculty of Science, University of Copenhagen, assigned to PdE, the Deutsche Forschungsgemeinschaft Grant DE 893/1-2, also to Patrizia d'Ettorre, and the Danish National Research Foundation to Jacobus J. Boomsma. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravo ISJ, 1998, ENTOMOL EXP APPL, V87, P67, DOI 10.1023/A:1003211931514; Christensen JH, 2007, J CHROMATOGR A, V1169, P1, DOI 10.1016/j.chroma.2007.08.077; Christensen JH, 2004, ENVIRON SCI TECHNOL, V38, P2912, DOI 10.1021/es035261y; CROSLAND MWJ, 1989, ANIM BEHAV, V37, P912, DOI 10.1016/0003-3472(89)90135-8; Cuvillier-Hot V, 2004, ANIM BEHAV, V68, P1209, DOI 10.1016/j.anbehav.2003.11.026; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; D'Ettorre P, 2006, NATURWISSENSCHAFTEN, V93, P136, DOI 10.1007/s00114-005-0075-9; D'Ettorre P, 2004, P ROY SOC B-BIOL SCI, V271, P1427, DOI 10.1098/rspb.2004.2742; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; de Biseau JC, 2004, J INSECT PHYSIOL, V50, P585, DOI 10.1016/j.jinsphys.2004.04.005; dEttorre P., 2008, SOCIOBIOLOGY COMMUNI, P81, DOI [10.1093/acprof:oso/9780199216840.003.0005, DOI 10.1093/ACPROF:OSO/9780199216840.003.0005, DOI 10.1093/ACPR0F:0S0/9780199216840.003.0005]; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; ENDLER A, 2006, BEHAV ECOL SOCIOBIOL, P1; GAMBOA GJ, 1986, ANIM BEHAV, V34, P685, DOI 10.1016/S0003-3472(86)80053-7; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; Hannonen M, 2002, ANIM BEHAV, V64, P477, DOI 10.1006/anbe.2002.4001; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; HELANTERA H, 2009, BEHAV ECOLOGY SOCIOB; HOLLDOBLER B, 1995, P NATL ACAD SCI USA, V92, P19, DOI 10.1073/pnas.92.1.19; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hurst JL, 2005, P ROY SOC B-BIOL SCI, V272, P715, DOI 10.1098/rspb.2004.3004; KALMUS H, 1952, PROC R SOC SER B-BIO, V140, P50, DOI 10.1098/rspb.1952.0043; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Liebig J, 1999, P ROY SOC B-BIOL SCI, V266, P1865, DOI 10.1098/rspb.1999.0858; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Lommelen E, 2006, J CHEM ECOL, V32, P2023, DOI 10.1007/s10886-006-9126-8; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Martin SJ, 2004, PHYSIOL ENTOMOL, V29, P395, DOI 10.1111/j.0307-6962.2004.00404.x; Martin SJ, 2002, NATURWISSENSCHAFTEN, V89, P528, DOI 10.1007/s00114-002-0367-2; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Martin Stephen J., 2005, Journal of Negative Results Ecology & Evolutionary Biology, V2, P1; Meza-Hernandez JS, 2006, J ECON ENTOMOL, V99, P1979, DOI 10.1603/0022-0493-99.6.1979; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; OBIN MS, 1988, ANIM BEHAV, V36, P1361, DOI 10.1016/S0003-3472(88)80205-7; Postma E, 2007, J EVOLUTION BIOL, V20, P1823, DOI 10.1111/j.1420-9101.2007.01379.x; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Smith AA, 2008, J CHEM ECOL, V34, P1275, DOI 10.1007/s10886-008-9529-9; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; van Zweden JS, 2007, P ROY SOC B-BIOL SCI, V274, P1421, DOI 10.1098/rspb.2007.0113; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zhou L, 2007, FIELD CROP RES, V100, P294, DOI 10.1016/j.fcr.2006.08.003	49	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4718	10.1371/journal.pone.0004718	http://dx.doi.org/10.1371/journal.pone.0004718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262683	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490600028
J	Gregory, RD; Willis, SG; Jiguet, F; Vorisek, P; Klvanova, A; van Strien, A; Huntley, B; Collingham, YC; Couvet, D; Green, RE				Gregory, Richard D.; Willis, Stephen G.; Jiguet, Frederic; Vorisek, Petr; Klvanova, Alena; van Strien, Arco; Huntley, Brian; Collingham, Yvonne C.; Couvet, Denis; Green, Rhys E.			An Indicator of the Impact of Climatic Change on European Bird Populations	PLOS ONE			English	Article								Rapid climatic change poses a threat to global biodiversity. There is extensive evidence that recent climatic change has affected animal and plant populations, but no indicators exist that summarise impacts over many species and large areas. We use data on long-term population trends of European birds to develop such an indicator. We find a significant relationship between interspecific variation in population trend and the change in potential range extent between the late 20(th) and late 21(st) centuries, forecasted by climatic envelope models. Our indicator measures divergence in population trend between bird species predicted by climatic envelope models to be favourably affected by climatic change and those adversely affected. The indicator shows a rapid increase in the past twenty years, coinciding with a period of rapid warming.	[Gregory, Richard D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Willis, Stephen G.; Huntley, Brian; Collingham, Yvonne C.] Univ Durham, Sch Biol & Biomed Sci, Inst Ecosyst Sci, Durham DH1 3HP, England; [Jiguet, Frederic; Couvet, Denis] CRBPO, MNHN, CNRS, UPMC, Museum Natl Hist Nat, Paris, France; [Vorisek, Petr; Klvanova, Alena] Czech Soc Ornithol, Prague, Czech Republic; [van Strien, Arco] Stat Netherlands, Voorburg, Netherlands; [Green, Rhys E.] Royal Soc Protect Birds, Sandy, Beds, England; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 1TN, England	Royal Society for Protection of Birds; Durham University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Royal Society for Protection of Birds; University of Cambridge	Gregory, RD (corresponding author), Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England.	richard.gregory@rspb.org.uk	Willis, Stephen G/F-8503-2015; van Strien, Arco/AAG-1843-2020; Vorisek, Petr/E-3336-2012	Willis, Stephen G/0000-0002-8656-5808; couvet, denis/0000-0001-8692-9694; Gregory, Richard/0000-0002-7419-5053; Klvanova, Alena/0000-0002-6061-0930	European Commission; RSPB; NERC	European Commission(European CommissionEuropean Commission Joint Research Centre); RSPB; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The European Commission and RSPB support the Pan-European Common Bird Monitoring Scheme. RSPB and NERC supported the initial climate envelope modelling work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; [Anonymous], 2007, 11 EEA; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Blumstein DT, 2008, BIOL LETTERS, V4, P146, DOI 10.1098/rsbl.2007.0606; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; *CRU, 2003, CRU GLOB AV TEMP CHA; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; IPCC, 2007, CLIM CHANG 2007 PHYS; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Pannekoek J., 2001, 0102 CBS VOORB; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Zimmer C, 2007, SCIENCE, V317, P892, DOI 10.1126/science.317.5840.892; FURTHER MAT METHODS	28	193	219	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4678	10.1371/journal.pone.0004678	http://dx.doi.org/10.1371/journal.pone.0004678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259270	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265490500006
J	Harbaugh, DT; Wagner, WL; Percy, DM; James, HF; Fleischer, RC				Harbaugh, Danica T.; Wagner, Warren L.; Percy, Diana M.; James, Helen F.; Fleischer, Robert C.			Genetic Structure of the Polymorphic Metrosideros (Myrtaceae) Complex in the Hawaiian Islands Using Nuclear Microsatellite Data	PLOS ONE			English	Article							POPULATION-STRUCTURE; SIZE HOMOPLASY; TREE; DIVERSITY; LOCI; DIFFERENTIATION; DISPERSAL; GRADIENT; ORIGIN; FLOW	Background: Five species of Metrosideros (Myrtaceae) are recognized in the Hawaiian Islands, including the widespread M. polymorpha, and are characterized by a multitude of distinctive, yet overlapping, habit, ecological, and morphological forms. It remains unclear, despite several previous studies, whether the morphological variation within Hawaiian Metrosideros is due to hybridization, genetic polymorphism, phenotypic plasticity, or some combination of these processes. The Hawaiian Metrosideros complex has become a model system to study ecology and evolution; however this is the first study to use microsatellite data for addressing inter-island patterns of variation from across the Hawaiian Islands. Methodology/Principal Findings: Ten nuclear microsatellite loci were genotyped from 143 individuals of Metrosideros. We took advantage of the bi-parental inheritance and rapid mutation rate of these data to examine the validity of the current taxonomy and to investigate whether Metrosideros plants from the same island are more genetically similar than plants that are morphologically similar. The Bayesian algorithm of the program STRUCTURE was used to define genetic groups within Hawaiian Metrosideros and the closely related taxon M. collina from the Marquesas and Austral Islands. Several standard and nested AMOVAs were conducted to test whether the genetic diversity is structured geographically or taxonomically. Conclusions/Significance: The results suggest that Hawaiian Metrosideros have dynamic gene flow, with genetic and morphological diversity structured not simply by geography or taxonomy, but as a result of parallel evolution on islands following rampant island-island dispersal, in addition to ancient chloroplast capture. Results also suggest that the current taxonomy requires major revisions in order to reflect the genetic structure revealed in the microsatellite data.	[Harbaugh, Danica T.; Wagner, Warren L.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Percy, Diana M.] Univ British Columbia, Ctr Plant Res, Vancouver, BC V5Z 1M9, Canada; [Percy, Diana M.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [James, Helen F.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC USA; [Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Washington, DC USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of British Columbia; University of British Columbia; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Harbaugh, DT (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	harbaughd@si.edu		James, Helen/0000-0002-2495-6133	Center for Conservation and Evolutionary Genetics at the Smithsonian Institution; National Tropical Botanical Garden	Center for Conservation and Evolutionary Genetics at the Smithsonian Institution; National Tropical Botanical Garden	Laboratory expenses for this study were covered by the Center for Conservation and Evolutionary Genetics at the Smithsonian Institution, and by the National Tropical Botanical Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 2000, MOL BIOL EVOL, V17, P1926, DOI 10.1093/oxfordjournals.molbev.a026294; ARADHYA KM, 1993, GENET RES, V61, P159, DOI 10.1017/S0016672300031335; ARADHYA KM, 1991, HEREDITY, V67, P129, DOI 10.1038/hdy.1991.72; BAZZAZ EA, 1996, PLANTS CHANGING ENV; Bottin L, 2005, MOL ECOL, V14, P1979, DOI 10.1111/j.1365-294X.2005.02576.x; Bradshaw HD, 1998, GENETICS, V149, P367; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; Corn C. A., 1972, CHALLENGING BIOL PRO, P422; CORN CA, 1973, AM J BOT, V60, P991, DOI 10.2307/2441513; Crawford NG, 2008, MOL ECOL RESOUR, V8, P308, DOI 10.1111/j.1471-8286.2007.01937.x; Dawson J., 1999, MANUAL FLOWERING PLA, P964; Doyle JJ, 1998, MOL BIOL EVOL, V15, P215, DOI 10.1093/oxfordjournals.molbev.a025916; DRAKE DR, 1992, AM J BOT, V79, P1224, DOI 10.2307/2445048; Dutech C, 2004, HEREDITY, V92, P69, DOI 10.1038/sj.hdy.6800384; England PR, 2002, MOL ECOL, V11, P967, DOI 10.1046/j.1365-294X.2002.01500.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Funk V. A., 1995, P379; Gardner RC, 2004, BIOL J LINN SOC, V83, P399, DOI 10.1111/j.1095-8312.2004.00398.x; GEESKE J, 1994, BIOTROPICA, V26, P17, DOI 10.2307/2389106; Harr B, 1998, CURR BIOL, V8, P1183, DOI 10.1016/S0960-9822(07)00490-3; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; James SA, 2004, NEW ZEAL J BOT, V42, P263, DOI 10.1080/0028825X.2004.9512903; Jarvi SI, 2004, MOL ECOL, V13, P2157, DOI 10.1111/j.1365-294X.2004.02228.x; Kikuchi S, 2002, HEREDITY, V88, P313, DOI 10.1038/sj.hdy.6800047; Koskinen MT, 2002, HEREDITY, V88, P391, DOI 10.1038/sj.hdy.6800072; Lhuillier E, 2006, MOL ECOL NOTES, V6, P653, DOI 10.1111/j.1471-8286.2006.01279.x; Orti G, 1997, P NATL ACAD SCI USA, V94, P10745, DOI 10.1073/pnas.94.20.10745; Percy DM, 2008, P ROY SOC B-BIOL SCI, V275, P1479, DOI 10.1098/rspb.2008.0191; PORTER JR, 1973, 27 U HAW; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Schweitzer JA, 1999, J TORREY BOT SOC, V126, P15, DOI 10.2307/2997251; STEMMERMANN L, 1983, PAC SCI, V37, P361; Tarr Cheryl L., 1995, P147; Treseder KK, 2001, OECOLOGIA, V126, P266, DOI 10.1007/s004420000523; WILLIAMS DG, 1995, ECOLOGY, V76, P1569, DOI 10.2307/1938158; WITTER MS, 1988, EVOLUTION, V42, P1278, DOI 10.1111/j.1558-5646.1988.tb04187.x; Wright SD, 2001, J BIOGEOGR, V28, P769, DOI 10.1046/j.1365-2699.2001.00605.x; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	45	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4698	10.1371/journal.pone.0004698	http://dx.doi.org/10.1371/journal.pone.0004698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259272	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490500013
J	Blagoev, KB				Blagoev, Krastan B.			Cell Proliferation in the Presence of Telomerase	PLOS ONE			English	Article							LENGTH HOMEOSTASIS; CANCER-CELLS; RECOMBINATION; MAINTENANCE; SENESCENCE; ALT; ACCUMULATION; CHROMOSOMES; DEFICIENT; PATHWAY	Background: Telomerase, which is active early in development and later in stem and germline cells, is also active in the majority of human cancers. One of the known functions of telomerase is to extend the ends of linear chromosomes, countering their gradual shortening at each cell division due to the end replication problem and postreplication processing. Telomerase concentration levels vary between different cell types as well as between different tumors. In addition variable telomerase concentrations will exist in different cells in the same tumor when telomerase inhibitors are used, because of limitations of drug delivery in tissue. Telomerase extends short telomeres more frequently than long telomeres and the relation between the extension frequency and the telomere length is nonlinear. Methodolgy/Principal Findings: Here, the biological data of the nonlinear telomerase-telomere dynamics is incorporated in a mathematical theory to relate the proliferative potential of a cell to the telomerase concentration in that cell. The main result of the paper is that the proliferative capacity of a cell grows exponentially with the telomerase concentration. Conclusions/Significance: The theory presented here suggests that long term telomerase inhibition in every cancer progenitor or cancer stem cell is needed for successful telomere targeted cancer treatment. This theory also can be used to plan and asses the results of clinical trials targeting telomerase.	[Blagoev, Krastan B.] Natl Sci Fdn, Arlington, VA 22230 USA	National Science Foundation (NSF)	Blagoev, KB (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	kblagoev@nsf.gov			National Science Foundation of the United States of America	National Science Foundation of the United States of America(National Science Foundation (NSF))	This work was funded by the National Science Foundation of the United States of America.	Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Blagoev KB, 2008, DNA REPAIR, V7, P199, DOI 10.1016/j.dnarep.2007.09.012; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Datar RH, 1999, GYNECOL ONCOL, V74, P338, DOI 10.1006/gyno.1999.5506; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Fordyce CA, 2006, BREAST CANCER RES TR, V99, P193, DOI 10.1007/s10549-006-9204-1; Gertler R, 2008, CANCER-AM CANCER SOC, V112, P2173, DOI 10.1002/cncr.23419; Goldman FD, 2008, BLOOD, V111, P4523, DOI 10.1182/blood-2007-10-120204; Greider CW, 2006, COLD SPRING HARB SYM, V71, P225, DOI 10.1101/sqb.2006.71.063; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gryaznov SM, 2007, NUCLEOS NUCLEOT NUCL, V26, P1577, DOI 10.1080/15257770701547271; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hemann MT, 2000, COLD SPRING HARB SYM, V65, P275, DOI 10.1101/sqb.2000.65.275; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ju Z, 2006, GENOME DYN, V1, P84, DOI 10.1159/000092502; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Neumann AA, 2002, NAT REV CANCER, V2, P879, DOI 10.1038/nrc929; Ogino H, 1998, BIOCHEM BIOPH RES CO, V248, P223, DOI 10.1006/bbrc.1998.8875; Oh BK, 2008, LAB INVEST, V88, P144, DOI 10.1038/labinvest.3700710; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Quinones-Hinojosa A, 2005, J NEURO-ONCOL, V74, P19, DOI 10.1007/s11060-004-5758-0; Roth CW, 1997, MOL CELL BIOL, V17, P5176, DOI 10.1128/MCB.17.9.5176; SHAMMAS MA, 2008, LEUKEMIA; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005; Yeager TR, 1999, CANCER RES, V59, P4175; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	51	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4622	10.1371/journal.pone.0004622	http://dx.doi.org/10.1371/journal.pone.0004622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247450	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800005
J	Guilmoto, CZ; Hoang, X; Van, TN				Guilmoto, Christophe Z.; Hoang, Xuyen; Van, Toan Ngo			Recent Increase in Sex Ratio at Birth in Viet Nam	PLOS ONE			English	Article							INDIA	Introduction: Since the 1980s, sex ratio at birth (male births per 100 female births) has increased in many Asian countries as a result of selective abortions, but to date there has been no such evidence for Viet Nam. Our aim in this paper is to ascertain the situation with respect to sex ratio at birth in Viet Nam over the past five years. Materials and Methods: Original data were obtained from sample population surveys in Viet Nam recording annual birth rates since 2000 of about 450,000 women, as well as from two successive birth surveys conducted for the first time in 2007 (1.1 million births). The annual population surveys include specific information on birth history and mothers' characteristics to be used for the analysis of trends and differentials in sex ratio at birth. Results and Discussion: Birth history statistics indicate that the SRB in Viet Nam has recorded a steady growth since 2001. Starting from a level probably close to the biological standard of 105, the SRB reached 108 in 2005 and 112 in 2006, a value significantly above the normal level. An independent confirmation of these results comes from the surveys of births in health facilities which yielded a SRB of 110 in 2006-07. High SRB is linked to various factors such as access to modern health care, number of prenatal visits, level of higher education and employment status, young age, province of residence and prenatal sex determination. These results suggest that prenatal sex determination followed by selective abortion has recently become more common in Viet Nam. This recent trend is a consequence of various factors such as preference for sons, declining fertility, easy access to abortion, economic development as well as the increased availability of ultrasonography facilities.	[Guilmoto, Christophe Z.] CEPED Univ Paris Descartes Ined IRD, Paris, France; [Hoang, Xuyen] Gen Stat Office, Hanoi, Vietnam; [Van, Toan Ngo] Hanoi Med Univ, Hanoi, Vietnam	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Hanoi Medical University	Guilmoto, CZ (corresponding author), CEPED Univ Paris Descartes Ined IRD, Paris, France.	guilmoto@ird.fr			United National Population Fund Country Office; CEPED	United National Population Fund Country Office; CEPED	The General Statistics Office, Hanoi has conducted the surveys and the United National Population Fund Country Office has supported the primary analysis of results. Additional support from CEPED is gratefully acknowledged. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Attane Isabelle, 2007, WATERING NEIGHBOURS; Belanger D, 2002, STUD FAMILY PLANN, V33, P321, DOI 10.1111/j.1728-4465.2002.00321.x; BELANGER D, 2003, POPULATION, V2, P231; BHAT PNM, 2002, ECON POLIT WEEKLY, V51, P5105; BHAT PNM, 2002, ECON POLIT WEEKLY, V52, P5244; BOOTH BE, 1994, BRIT MED J, V309, P1259, DOI 10.1136/bmj.309.6964.1259; Ding QJ, 2006, BMJ-BRIT MED J, V333, P371, DOI 10.1136/bmj.38775.672662.80; DOUGLAS A, 2008, PNAS, V15, P5681; Dubuc S, 2007, POPUL DEV REV, V33, P383, DOI 10.1111/j.1728-4457.2007.00173.x; Gallo MF, 2007, SOC SCI MED, V64, P1812, DOI 10.1016/j.socscimed.2007.02.005; Gammeltoft T, 2007, REPROD HEALTH MATTER, V15, P163, DOI 10.1016/S0968-8080(06)29280-2; Gammeltoft T, 2007, SOC SCI MED, V64, P2248, DOI 10.1016/j.socscimed.2007.02.015; *GEN STAT OFF, 2008, 2007 POP CHANG FAM P; GOODKIND D, 1994, STUD FAMILY PLANN, V25, P342, DOI 10.2307/2137878; GOODKIND D, 2008, ANN M POP ASS AM NEW; *GSO UNICEF, 2007, MULT IND CLUST SURV; GUBRY P, 2000, POPULATION DEV VIET; GUILMOTO CZ, 2007, ANN M POP ASS AM MAR; Haughton J, 1995, STUD FAMILY PLANN, V26, P325, DOI 10.2307/2138098; Heinimann A., 2004, SOCIOECONOMIC ATLAS; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; *I SOC DEV STUD, 2007, NEW COMM SENS FAM PL; LE LC, 2006, ASIA PACIFIC POP J, V2, P45; MENCHINI L, 2007, 200701 UNICEF INN RE; *MIN HLTH, 2006, VIET NAM HLTH REP 20; *MIN HLTH, HLTH STAT YB MIN HLT; *NAT COMM POP FAM, 1999, DEM HLTH SURV 1997; PARK CB, 1995, POPUL DEV REV, V21, P59, DOI 10.2307/2137413; Sahni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002224; SCORNET C, 2001, POPULATION, V2, P101; *UNFPA, 2007, POP GROWTH VIET NAM; *VIET COMM POP FAM, 2003, VIET DEM HLTH SURV 2; VO AD, 2005, INT C FEM DEF AS TRE; Waller L.A., 2004, APPL SPATIAL STAT PU; 2007, VIET NAM NEWS   1226	36	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4624	10.1371/journal.pone.0004624	http://dx.doi.org/10.1371/journal.pone.0004624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247453	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487800007
J	Miyagawa, Y; Okita, H; Itagaki, M; Toyoda, M; Katagiri, YU; Fujimoto, J; Hata, J; Umezawa, A; Kiyokawa, N				Miyagawa, Yoshitaka; Okita, Hajime; Itagaki, Mitsuko; Toyoda, Masashi; Katagiri, Yohko U.; Fujimoto, Junichiro; Hata, Jun-ichi; Umezawa, Akihiro; Kiyokawa, Nobutaka			EWS/ETS Regulates the Expression of the Dickkopf Family in Ewing Family Tumor Cells	PLOS ONE			English	Article								Background: The Dickkopf (DKK) family comprises a set of proteins that function as regulators of Wnt/beta-catenin signaling and has a crucial role in development. Recent studies have revealed the involvement of this family in tumorigenesis, however their role in tumorigenesis is still remained unclear. Methodology/Principal Findings: We found increased expression of DKK2 but decreased expression of DKK1 in Ewing family tumor (EFT) cells. We showed that EFT-specific EWS/ETS fusion proteins enhance the DKK2 promoter activity, but not DKK1 promoter activity, via ets binding sites (EBSs) in the 5' upstream region. EWS/ETS-mediated transactivation of the promoter was suppressed by the deletion and mutation of EBSs located upstream of the DKK2 gene. Interestingly, the inducible expression of EWS/ETS resulted in the strong induction of DKK2 expression and inhibition of DKK1 expression in human primary mesenchymal progenitor cells that are thought to be a candidate of cell origin of EFT. In addition, using an EFT cell line SK-ES1 cells, we also demonstrated that the expression of DKK1 and DKK2 is mutually exclusive, and the ectopic expression of DKK1, but not DKK2, resulted in the suppression of tumor growth in immuno-deficient mice. Conclusions/Significance: Our results suggested that DKK2 could not functionally substitute for DKK1 tumor-suppressive effect in EFT. Given the mutually exclusive expression of DKK1 and DKK2, EWS/ETS regulates the transcription of the DKK family, and the EWS/ETS-mediated DKK2 up-regulation could affect the tumorigenicity of EFT in an indirect manner.	[Miyagawa, Yoshitaka; Okita, Hajime; Itagaki, Mitsuko; Katagiri, Yohko U.; Hata, Jun-ichi; Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Dev Biol, Setagaya Ku, Tokyo, Japan; [Fujimoto, Junichiro] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Toyoda, Masashi; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reproduct Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Miyagawa, Y (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Dev Biol, Setagaya Ku, Tokyo, Japan.	okita@nch.go.jp		Miyagawa, Yoshitaka/0000-0003-2629-7503	Health and Labour Sciences [H19-010, H18-005, H19-003]; Ministry of Health, Labour and Welfare of Japan, JSPS [KAKENHI 18790263]; CREST, JST; Japan Health Sciences Foundation for Research on Publicly Essential Drugs and Medical Devices; Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology; Foundation for Promotion of Cancer Research (Japan) [Research Resident Fellowship]	Health and Labour Sciences; Ministry of Health, Labour and Welfare of Japan, JSPS; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Health Sciences Foundation for Research on Publicly Essential Drugs and Medical Devices; Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research (Japan)	This work was supported in part by Health and Labour Sciences Research Grants (the 3rd term comprehensive 10-year-strategy for cancer control H19-010, Research on Children and Families H18-005 and H19-003, Research on Human Genome Tailor made and Research on Publicly Essential Drugs and Medical Devices H18-005) and Grant for Child Health and Development from the Ministry of Health, Labour and Welfare of Japan, JSPS. KAKENHI 18790263. This work was also supported by CREST, JST, a grant from the Japan Health Sciences Foundation for Research on Publicly Essential Drugs and Medical Devices and the Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology, based on the screening and counseling by the Atomic Energy Commission. Y. Miyagawa is an Awardee of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-Year-Strategy for Cancer Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Fuchs B, 2004, CLIN CANCER RES, V10, P1344, DOI 10.1158/1078-0432.CCR-03-0038; Fujii Y, 1989, Hum Cell, V2, P190; GILBERT F, 1982, CANCER GENET CYTOGEN, V7, P33, DOI 10.1016/0165-4608(82)90105-4; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gregory CA, 2005, J BIOL CHEM, V280, P2309, DOI 10.1074/jbc.M406275200; Grotewold L, 1999, MECH DEVELOP, V89, P151, DOI 10.1016/S0925-4773(99)00194-X; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; HARA S, 1989, BRIT J CANCER, V60, P875, DOI 10.1038/bjc.1989.383; Hata J, 1989, Hum Cell, V2, P382; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Horwitz EM, 2004, TRENDS BIOTECHNOL, V22, P386, DOI 10.1016/j.tibtech.2004.05.006; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Im YH, 2000, CANCER RES, V60, P1536; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Khoury JD, 2005, ADV ANAT PATHOL, V12, P212, DOI 10.1097/01.pap.0000175114.55541.52; Kiyokawa N, 1997, J BIOL CHEM, V272, P18656, DOI 10.1074/jbc.272.30.18656; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lee JN, 2008, HANN BEITR NACHRICHT, V1, P109, DOI 10.1109/ICUWB.2008.4653296; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li X, 2005, INT J CANCER, V116, P385, DOI 10.1002/ijc.21010; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; MIKHEEV AM, 2007, CANC RES TREAT; Mikheev AM, 2007, BIOCHEM BIOPH RES CO, V352, P675, DOI 10.1016/j.bbrc.2006.11.079; Miyagawa Y, 2005, INSECT MOL BIOL, V14, P245, DOI 10.1111/j.1365-2583.2005.00553.x; MIYAGAWA Y, 2008, MOL CELL BIOL; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; NISHI Y, 1992, MAMM GENOME, V2, P11; Polakis P, 2000, GENE DEV, V14, P1837; Reguart Noemi, 2005, Future Oncol, V1, P787, DOI 10.2217/14796694.1.6.787; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Takahashi A, 2003, CANCER RES, V63, P8338; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Yamashita Jun, 2007, Journal of Insect Biotechnology and Sericology, V76, P137; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	58	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4634	10.1371/journal.pone.0004634	http://dx.doi.org/10.1371/journal.pone.0004634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247449	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800016
J	Daprati, E; Iosa, M; Haggard, P				Daprati, Elena; Iosa, Marco; Haggard, Patrick			A Dance to the Music of Time: Aesthetically-Relevant Changes in Body Posture in Performing Art	PLOS ONE			English	Article							BALLET DANCERS; HIP; PREFERENCE; MOTION; RANGE	In performing arts, body postures are both means for expressing an artist's intentions, and also artistic objects, appealing to the audience. The postures of classical ballet obey the body's biomechanical limits, but also follow strict rules established by tradition. This combination offers a perfect milieu for assessing scientifically how the execution of this particular artistic activity has changed over time, and evaluating what factors may induce such changes. We quantified angles between body segments in archive material showing dancers from a leading company over a 60-year period. The data showed that body positions supposedly fixed by codified choreography were in fact implemented by very different elevation angles, according to the year of ballet production. Progressive changes lead to increasingly vertical positions of the dancer's body over the period studied. Experimental data showed that these change reflected aesthetic choices of naive modern observers. Even when reduced to stick figures and unrecognisable shapes, the more vertical postures drawn from later productions were systematically preferred to less vertical postures from earlier productions. This gradual change within a conservative art form provides scientific evidence that aesthetic change may arise from continuous interaction between artistic tradition, individual artists' creativity, and a wider environmental context. This context may include social aesthetic pressure from audiences.	[Daprati, Elena] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Daprati, Elena] IRCCS Fdn Santa Lucia, Dipartimento Fisiol Neuromotor, Rome, Italy; [Iosa, Marco] Ist Univ Sci Motor, Dipartimento Sci Movimento Umano Sport, Rome, Italy; [Haggard, Patrick] UCL, Inst Cognitive Neurosci, London WC1E 6BT, England	University of Rome Tor Vergata; IRCCS Santa Lucia; University of London; University College London	Daprati, E (corresponding author), Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy.	p.haggard@ucl.ac.uk	Iosa, Marco/B-9531-2012; Haggard, Patrick/A-5081-2010; Iosa, Marco/AAC-1693-2022; daprati, elena/AAA-2224-2019	Iosa, Marco/0000-0003-2434-3887; Haggard, Patrick/0000-0001-7798-793X	Leverhulme Trust; BBSRC ISIS	Leverhulme Trust(Leverhulme Trust); BBSRC ISIS(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by a Leverhulme Trust project grant, and a BBSRC ISIS grant awarded to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor W., 1970, AESTHETISCHE THEORIE; Gallego MAA, 2007, REV DERECHO COMUNITA, V11, P203; Austin TR, 1951, J APPL PSYCHOL, V35, P430, DOI 10.1037/h0058574; Bandura Albert, 1977, SOCIAL LEARNING THEO; Birkhoff GD, 1933, AESTHETIC MEASURE; BOSELIE F, 1992, EMPIR STUD ARTS, V10, P1, DOI DOI 10.2190/QB14-NK7B-ARYT-W5QT; Calvo-Merino B, 2008, CONSCIOUS COGN, V17, P911, DOI 10.1016/j.concog.2007.11.003; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chomsky Noam, 1988, LANGUAGE PROBLEMS KN; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Cohn J., 1894, PHILOS STUD, V10, P562; Cutting J., 2006, NEW DIRECTIONS AESTH, P33, DOI [10.4324/9781315224084-4, DOI 10.4324/9781315224084-4]; Dawkins Richard, 1976, SELFISH GENE; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; EYSENCK HJ, 1968, J GEN PSYCHOL, V79, P3, DOI 10.1080/00221309.1968.9710447; Fechner G.T., 1876, VORSCHULE STHETIK; FECHNER GT, 1897, VORSCHULE ASTHETIK; Funch BjarneS., 1997, PSYCHOL ART APPRECIA; Gombrich Ernst., 1972, STORY ART, V13; Gupta A, 2004, BRIT J SPORT MED, V38, P778, DOI 10.1136/bjsm.2003.010827; Khan K, 1997, CLIN J SPORT MED, V7, P174, DOI 10.1097/00042752-199707000-00004; KUSHNER S, 1990, AM J SPORT MED, V18, P286, DOI 10.1177/036354659001800312; LABAN R, 1928, KINETOGRAPHIE; Noverre J.G, 2009, LETT DANSE BALLETS, V2; RAMACHANDRAN VS, 1999, J CONSCIOUSNESS STUD, V6; Schama S., 2006, POWER ART; Stepanov Vladimir Ivanovich, 1892, ALPHABET MOUVEMENTS; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P2	29	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e5023	10.1371/journal.pone.0005023	http://dx.doi.org/10.1371/journal.pone.0005023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PM	19325705	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499400008
J	Santos, LO; Marinho, FA; Altoe, EF; Vitorio, BS; Alves, CR; Britto, C; Motta, MCM; Branquinha, MH; Santos, ALS; d'Avila-Levy, CM				Santos, Livia O.; Marinho, Fernanda A.; Altoe, Ellen F.; Vitorio, Bianca S.; Alves, Carlos R.; Britto, Constanca; Motta, Maria Cristina M.; Branquinha, Marta H.; Santos, Andre L. S.; d'Avila-Levy, Claudia M.			HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTILEISHMANIAL ACTIVITY; VISCERAL LEISHMANIASIS; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; CYSTEINE PEPTIDASES; AUTOPHAGY; REPLICATION; EXPRESSION; VIRULENCE	Background: Leishmania is the etiologic agent of leishmanisais, a protozoan disease whose pathogenic events are not well understood. Current therapy is suboptimal due to toxicity of the available therapeutic agents and the emergence of drug resistance. Compounding these problems is the increase in the number of cases of Leishmania-HIV coinfection, due to the overlap between the AIDS epidemic and leishmaniasis. Methodology/Principal Findings: In the present report, we have investigated the effect of HIV aspartyl peptidase inhibitors (PIs) on the Leishmania amazonensis proliferation, ultrastructure, interaction with macrophage cells and expression of classical peptidases which are directly involved in the Leishmania pathogenesis. All the HIV PIs impaired parasite growth in a dose-dependent fashion, especially nelfinavir and lopinavir. HIV PIs treatment caused profound changes in the leishmania ultrastructure as shown by transmission electron microscopy, including cytoplasm shrinking, increase in the number of lipid inclusions and some cells presenting the nucleus closely wrapped by endoplasmic reticulum resembling an autophagic process, as well as chromatin condensation which is suggestive of apoptotic death. The hydrolysis of HIV peptidase substrate by L. amazonensis extract was inhibited by pepstatin and HIV PIs, suggesting that an aspartyl peptidase may be the intracellular target of the inhibitors. The treatment with HIV PIs of either the promastigote forms preceding the interaction with macrophage cells or the amastigote forms inside macrophages drastically reduced the association indexes. Despite all these beneficial effects, the HIV PIs induced an increase in the expression of cysteine peptidase b (cpb) and the metallopeptidase gp63, two well-known virulence factors expressed by Leishmania spp. Conclusions/Significance: In the face of leishmaniasis/HIV overlap, it is critical to further comprehend the sophisticated interplays among Leishmania, HIV and macrophages. In addition, there are many unresolved questions related to the management of Leishmania-HIV-coinfected patients. For instance, the efficacy of therapy aimed at controlling each pathogen in coinfected individuals remains largely undefined. The results presented herein add new in vitro insight into the wide spectrum efficacy of HIV PIs and suggest that additional studies about the synergistic effects of classical antileishmanial compounds and HIV PIs in macrophages coinfected with Leishmania and HIV-1 should be performed.	[Santos, Livia O.; Altoe, Ellen F.; Vitorio, Bianca S.; Alves, Carlos R.; Britto, Constanca; d'Avila-Levy, Claudia M.] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Marinho, Fernanda A.; Branquinha, Marta H.; Santos, Andre L. S.] Univ Fed Rio de Janeiro UFRJ, CCS, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Geral, BR-21941 Rio De Janeiro, Brazil; [Motta, Maria Cristina M.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude CCS, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Santos, LO (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil.	davila.levy@ioc.fiocruz.br	Alves, Carlos Roberto/AAA-2071-2020; Santos, André/Z-5853-2019; Motta, Maria Cristina M/I-3140-2014; Branquinha, Marta/AAA-3084-2019; Santos, Livia/H-1027-2013; d'Avila-Levy, Claudia M/O-7192-2014; Britto, Constanca/L-7658-2016	Alves, Carlos Roberto/0000-0001-8703-426X; Santos, André/0000-0003-0821-8592; d'Avila-Levy, Claudia M/0000-0001-8042-4695; Britto, Constanca/0000-0003-0788-7030; Motta, Maria Cristina/0000-0002-0947-4830	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FIOCRUZ (Fundacao Oswaldo Cruz)	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ (Fundacao Oswaldo Cruz)	This study was supported by the Brazilian agencies: MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), FUJB (Fundacao Universitaria Jose Bonifacio), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and FIOCRUZ (Fundacao Oswaldo Cruz). A.L.S.S, C.M.D., C.R.A., C.B., M.C.M.M., M.H.B. are CNPq research fellows.	Alexander J, 1999, J CELL SCI, V112, P2993; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alves CR, 2005, EXP PARASITOL, V109, P38, DOI 10.1016/j.exppara.2004.10.005; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Andrews L, 2000, INFECT DIS CLIN N AM, V14, P901, DOI 10.1016/S0891-5520(05)70139-2; Barat C, 2007, J INFECT DIS, V195, P236, DOI 10.1086/510398; Barreto-de-Souza V, 2008, MICROBES INFECT, V10, P642, DOI 10.1016/j.micinf.2008.02.014; Bektic J, 2001, FEMS IMMUNOL MED MIC, V31, P65, DOI 10.1111/j.1574-695X.2001.tb01588.x; Blasi E, 2004, FEMS IMMUNOL MED MIC, V42, P187, DOI 10.1016/j.femsim.2004.05.001; Chang KP, 1999, CLIN DERMATOL, V17, P269, DOI 10.1016/S0738-081X(99)00055-3; Cruz I, 2006, INDIAN J MED RES, V123, P357; Cupolillo E, 2001, MED MICROBIOL IMMUN, V190, P57, DOI 10.1007/s004300100080; d'Avila-Levy CM, 2006, INT J ANTIMICROB AG, V28, P138, DOI 10.1016/j.ijantimicag.2006.03.021; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Dutta A, 2005, PARASITOL INT, V54, P119, DOI 10.1016/j.parint.2005.01.001; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Garg R, 2008, J INFECT DIS, V197, P1701, DOI 10.1086/588146; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gradoni L, 1996, AIDS, V10, P785, DOI 10.1097/00002030-199606001-00014; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lopez-Velez R, 1998, AM J TROP MED HYG, V58, P436, DOI 10.4269/ajtmh.1998.58.436; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Marques Nuno, 2007, Acta Med Port, V20, P291; Mastroianni CM, 1999, AIDS, V13, P883, DOI 10.1097/00002030-199905280-00003; Mezzaroma I, 1999, AIDS, V13, P1187, DOI 10.1097/00002030-199907090-00006; Monari C, 2005, J INFECT DIS, V191, P307, DOI 10.1086/426828; Mottram JC, 2004, CURR OPIN MICROBIOL, V7, P375, DOI 10.1016/j.mib.2004.06.010; Palmeira VF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003382; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Pereira FM, 2009, PARASITOLOGY, V136, P45, DOI 10.1017/S0031182008005209; Pernerstorfer-Schoen H, 2001, AIDS, V15, P725, DOI 10.1097/00002030-200104130-00008; Pintado V, 2001, MEDICINE, V80, P54, DOI 10.1097/00005792-200101000-00006; Powderly WG, 1998, JAMA-J AM MED ASSOC, V280, P72, DOI 10.1001/jama.280.1.72; Pozio E, 2005, TRENDS PARASITOL, V21, P58, DOI 10.1016/j.pt.2004.11.003; Rabello A, 2003, Ann Trop Med Parasitol, V97 Suppl 1, P17; Robertson CD, 1999, MOL BIOCHEM PARASIT, V103, P49, DOI 10.1016/S0166-6851(99)00110-3; RUCHEL R, 1990, ZBL BAKT-INT J MED M, V273, P391; Saag MS, 1998, CURR CLIN TOPICS INF, V18, P154; Pereira BAS, 2008, VET PARASITOL, V158, P239, DOI 10.1016/j.vetpar.2008.09.015; Savoia D, 2005, INT J ANTIMICROB AG, V26, P92, DOI 10.1016/j.ijantimicag.2005.04.003; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Soares RMD, 2003, EXP PARASITOL, V104, P104, DOI 10.1016/S0014-4894(03)00135-8; Tiuman TS, 2005, ANTIMICROB AGENTS CH, V49, P176, DOI 10.1128/AAC.49.11.176-182.2005; Trudel N, 2008, J INFECT DIS, V198, P1292, DOI 10.1086/592280; Valdivieso E, 2007, EXP PARASITOL, V116, P77, DOI 10.1016/j.exppara.2006.10.006; Vermelrio A.B., 2007, CURR ENZYME INHIB, V3, P19; *WHO, 2007, 5 CONS M LEISHM HIV, P1; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zhao CQ, 2006, J GEN VIROL, V87, P1295, DOI 10.1099/vir.0.81647-0; Zhao CQ, 2004, CLIN IMMUNOL, V113, P81, DOI 10.1016/j.clim.2004.06.003	55	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4918	10.1371/journal.pone.0004918	http://dx.doi.org/10.1371/journal.pone.0004918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325703	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499400002
J	Shiryaev, SA; Savinov, AY; Cieplak, P; Ratnikov, BI; Motamedchaboki, K; Smith, JW; Strongin, AY				Shiryaev, Sergey A.; Savinov, Alexei Y.; Cieplak, Piotr; Ratnikov, Boris I.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.			Matrix Metalloproteinase Proteolysis of the Myelin Basic Protein Isoforms Is a Source of Immunogenic Peptides in Autoimmune Multiple Sclerosis	PLOS ONE			English	Article								Background: Matrix metalloproteinases (MMPs) play a significant role in the fragmentation of myelin basic protein (MBP) and demyelination leading to autoimmune multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). The classic MBP isoforms are predominantly expressed in the oligodendrocytes of the CNS. The splice variants of the single MBP gene (Golli-MBP BG21 and J37) are widely expressed in the neurons and also in the immune cells. The relative contribution of the individual MMPs to the MBP cleavage is not known. Methodology/Principal Findings: To elucidate which MMP plays the primary role in cleaving MBP, we determined the efficiency of MMP-2, MMP-8, MMP-9, MMP-10, MMP-12, MT1-MMP, MT2-MMP, MT3-MMP, MT4-MMP, MT5-MMP and MT6-MMP in the cleavage of the MBP, BG21 and J37 isoforms in the in vitro cleavage reactions followed by mass-spectroscopy analysis of the cleavage fragments. As a result, we identified the MMP cleavage sites and the sequence of the resulting fragments. We determined that MBP, BG21 and J37 are highly sensitive to redundant MMP proteolysis. MT6-MMP (initially called leukolysin), however, was superior over all of the other MMPs in cleaving the MBP isoforms. Using the mixed lymphocyte culture assay, we demonstrated that MT6-MMP proteolysis of the MBP isoforms readily generated, with a near quantitative yield, the immunogenic N-terminal 1-15 MBP peptide. This peptide selectively stimulated the proliferation of the PGPR7.5 T cell clone isolated from mice with EAE and specific for the 1-15 MBP fragment presented in the MHC H-2(U) context. Conclusions/Significance: In sum, our biochemical observations led us to hypothesize that MT6-MMP, which is activated by furin and associated with the lipid rafts, plays an important role in MS pathology and that MT6-MMP is a novel and promising drug target in MS especially when compared with other individual MMPs.	[Shiryaev, Sergey A.; Savinov, Alexei Y.; Cieplak, Piotr; Ratnikov, Boris I.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.] Burnham Inst Med Res, Inflammatory & Infect Dis Ctr, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Burnham Inst Med Res, Inflammatory & Infect Dis Ctr, La Jolla, CA USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Messier, Claude/A-2322-2008	Strongin, Alex/0000-0003-3765-3016; Messier, Claude/0000-0002-4791-1763	NIH [CA83017, CA77470, RR020843]; Susan G. Komen Breast Cancer Foundation [BCTR0601231]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470, R01CA108959] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work reported here was supported by NIH Grants CA83017, CA77470 and the Susan G. Komen Breast Cancer Foundation Grant BCTR0601231 (to AYStr), and NIH Grant RR020843 (to JWS and AYStr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Bar-Or A, 2007, ARCH NEUROL-CHICAGO, V64, P1407, DOI 10.1001/archneur.64.10.nct70002; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; DaSliva AG, 2008, J NEUROIMMUNOL, V199, P24, DOI 10.1016/j.jneuroim.2008.04.034; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Feng JM, 2004, J NEUROIMMUNOL, V152, P57, DOI 10.1016/j.jneuroim.2004.03.021; Filipovic R, 2002, J NEUROIMMUNOL, V127, P1, DOI 10.1016/S0165-5728(02)00070-X; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Givogri MI, 2000, J NEUROSCI RES, V59, P153, DOI 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.3.CO;2-6; Hellings N, 2001, J NEUROSCI RES, V63, P290, DOI 10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Jacobs EC, 2005, J NEUROSCI, V25, P7004, DOI 10.1523/JNEUROSCI.0288-05.2005; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Katsara M, 2008, J MED CHEM, V51, P3971, DOI 10.1021/jm8000554; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Landry CF, 1998, J NEUROSCI, V18, P7315; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; PitchekianHalabi H, 1996, J NEUROIMMUNOL, V68, P121, DOI 10.1016/0165-5728(96)00084-7; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2001, J CLIN IMMUNOL, V21, P93, DOI 10.1023/A:1011020225433; STEINMAN L, 1995, MOL MED TODAY, V1, P79, DOI 10.1016/S1357-4310(95)92366-7; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Toft-Hansen H, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-24; Tosic M, 2002, GLIA, V37, P219, DOI 10.1002/glia.10028; Tranquill LR, 1996, J NEUROSCI RES, V45, P820, DOI 10.1002/(SICI)1097-4547(19960915)45:6<820::AID-JNR19>3.0.CO;2-Z; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tselios T, 2002, J MED CHEM, V45, P275, DOI 10.1021/jm0102147; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; Velasco G, 2000, CANCER RES, V60, P877; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; Voskuhl RR, 1996, J NEUROIMMUNOL, V70, P103, DOI 10.1016/S0165-5728(96)00054-9; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Werner SR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-83; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	49	69	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4952	10.1371/journal.pone.0004952	http://dx.doi.org/10.1371/journal.pone.0004952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300513	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496800013
J	Garcia-Lavandeira, M; Quereda, V; Flores, I; Saez, C; Diaz-Rodriguez, E; Japon, MA; Ryan, AK; Blasco, MA; Dieguez, C; Malumbres, M; Alvarez, CV				Garcia-Lavandeira, Montse; Quereda, Victor; Flores, Ignacio; Saez, Carmen; Diaz-Rodriguez, Esther; Japon, Miguel A.; Ryan, Aymee K.; Blasco, Maria A.; Dieguez, Carlos; Malumbres, Marcos; Alvarez, Clara V.			A GRFa2/Prop1/Stem (GPS) Cell Niche in the Pituitary	PLOS ONE			English	Article								Background: The adult endocrine pituitary is known to host several hormone-producing cells regulating major physiological processes during life. Some candidates to progenitor/stem cells have been proposed. However, not much is known about pituitary cell renewal throughout life and its homeostatic regulation during specific physiological changes, such as puberty or pregnancy, or in pathological conditions such as tumor development. Principal Findings: We have identified in rodents and humans a niche of non-endocrine cells characterized by the expression of GFRa2, a Ret co-receptor for Neurturin. These cells also express b-Catenin and E-cadherin in an oriented manner suggesting a planar polarity organization for the niche. In addition, cells in the niche uniquely express the pituitary-specific transcription factor Prop1, as well as known progenitor/stem markers such as Sox2, Sox9 and Oct4. Half of these GPS (GFRa2/Prop1/Stem) cells express S-100 whereas surrounding elongated cells in contact with GPS cells express Vimentin. GFRa2+-cells form non-endocrine spheroids in culture. These spheroids can be differentiated to hormone-producing cells or neurons outlining the neuroectoderm potential of these progenitors. In vivo, GPSs cells display slow proliferation after birth, retain BrdU label and show long telomeres in its nuclei, indicating progenitor/stem cell properties in vivo. Significance: Our results suggest the presence in the adult pituitary of a specific niche of cells characterized by the expression of GFRa2, the pituitary-specific protein Prop1 and stem cell markers. These GPS cells are able to produce different hormone-producing and neuron-like cells and they may therefore contribute to postnatal pituitary homeostasis. Indeed, the relative abundance of GPS numbers is altered in Cdk4-deficient mice, a model of hypopituitarism induced by the lack of this cyclin-dependent kinase. Thus, GPS cells may display functional relevance in the physiological expansion of the pituitary gland throughout life as well as protection from pituitary disease.	[Garcia-Lavandeira, Montse; Diaz-Rodriguez, Esther; Dieguez, Carlos; Alvarez, Clara V.] Univ Santiago de Compostela, Sch Med, Dept Physiol, Santiago De Compostela, Spain; [Quereda, Victor; Malumbres, Marcos] CNIO, Cell Div, Madrid, Spain; [Quereda, Victor; Flores, Ignacio; Malumbres, Marcos] CNIO, Canc Grp, Madrid, Spain; [Blasco, Maria A.] CNIO, Telomeres & Telomerase Grp, Madrid, Spain; [Saez, Carmen; Japon, Miguel A.] Hosp Univ Virgen Rocio, Dept Pathol, Seville, Spain; [Ryan, Aymee K.] McGill Univ, Dept Human Geneti, Montreal, PQ H3A 2T5, Canada; [Dieguez, Carlos] CIBER Obesity & Nutr ISCIII, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Virgen del Rocio University Hospital; McGill University	Garcia-Lavandeira, M (corresponding author), Univ Santiago de Compostela, Sch Med, Dept Physiol, Santiago De Compostela, Spain.	malumbres@cnio.es; clara.alvarez@usc.es	Malumbres, Marcos/E-8834-2011; Sáez, Carmen/B-9468-2015; Quereda, Victor/J-8120-2019; IBIS, TUMORIGENESIS/P-3506-2015; Flores, Ignacio/E-8304-2016; Holt, Janet E/B-2415-2013; Blasco, Maria A./M-1694-2014; Lavandeira, Montserrat García/R-4708-2019; Japón, Miguel A/L-2555-2017; Alvarez, Clara V/AAN-4173-2020	Malumbres, Marcos/0000-0002-0829-6315; Sáez, Carmen/0000-0002-8600-0508; Quereda, Victor/0000-0002-9966-9104; Flores, Ignacio/0000-0001-8789-6396; Blasco, Maria A./0000-0002-4211-233X; Lavandeira, Montserrat García/0000-0001-9208-2418; Japón, Miguel A/0000-0002-5980-5044; Alvarez, Clara V/0000-0003-1500-4058; dieguez, carlos/0000-0002-0919-4337	Spanish Ministry of Education and Science [fellowship]; Foundation of the Asociacion Espanola contra el Cancer; Foundation Mutua Madrilena Automovilista; Xunta de Galicia [PGIDIT05BTF20803PR]; Ministry of Education and Science [SAF2004-03131, BFU2007-60571, SAF2006-05186]; OncoCycle programme from the Comunidad de Madrid [S-BIO-0283-2006]; Consolider-Ingenio, MICINN [CSD2007-00017]	Spanish Ministry of Education and Science(Spanish Government); Foundation of the Asociacion Espanola contra el Cancer; Foundation Mutua Madrilena Automovilista; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OncoCycle programme from the Comunidad de Madrid; Consolider-Ingenio, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	V.Q. was supported by a fellowship from the Spanish Ministry of Education and Science. This work was funded by grants from the Foundation of the Asociacion Espanola contra el Cancer (AECC; to M.M.), Foundation Mutua Madrilena Automovilista (to M.M.), Xunta de Galicia PGIDIT05BTF20803PR (to C.V.A. and C.D.) and the Ministry of Education and Science (MICINN; SAF2004-03131 and BFU2007-60571 to C.V.A. and SAF2006-05186, to M.M.). The Cell Division and Cancer Group of the CNIO is supported by the OncoCycle programme from the Comunidad de Madrid (S-BIO-0283-2006) and the Consolider-Ingenio (CSD2007-00017) program from the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P5256, DOI 10.1210/jc.2004-0661; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Cushman LJ, 2001, HUM MOL GENET, V10, P1141, DOI 10.1093/hmg/10.11.1141; DESAI B, 1995, EUR J ENDOCRINOL, V133, P25, DOI 10.1530/eje.0.1330025; DODD J, 1984, NATURE, V311, P469, DOI 10.1038/311469a0; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Fofanova O, 1998, J CLIN ENDOCR METAB, V83, P2601; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Garcia A, 2001, MOL ENDOCRINOL, V15, P1484, DOI 10.1210/me.15.9.1484; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Hagstrom SA, 2005, AM J MED GENET A, V138A, P95, DOI 10.1002/ajmg.a.30803; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horvath E, 2002, ULTRASTRUCT PATHOL, V26, P219, DOI 10.1080/01913120290104476; ISLAM O, 2007, RATHKE CLEFTT CYSTS; Itakura E, 2007, ENDOCRINOLOGY, V148, P1518, DOI 10.1210/en.2006-1390; Japon MA, 2002, J CLIN ENDOCR METAB, V87, P1879, DOI 10.1210/jc.87.4.1879; Johnson MD, 2007, J HISTOCHEM CYTOCHEM, V55, P1265, DOI 10.1369/jhc.7A7311.2007; KASPER M, 1988, CELL TISSUE RES, V253, P419; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kovacs K, 1998, J NEUROSURG, V88, P1111, DOI 10.3171/jns.1998.88.6.1111; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Lepore DA, 2005, EXP CELL RES, V308, P166, DOI 10.1016/j.yexcr.2005.04.023; Lepore DA, 2006, STEM CELLS, V24, P2382, DOI 10.1634/stemcells.2006-0085; Li HY, 2007, STEM CELLS, V25, P2053, DOI 10.1634/stemcells.2007-0080; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MARIN F, 1989, ANAT EMBRYOL, V179, P491, DOI 10.1007/BF00319592; MARIN F, 1989, ARCH HISTOL CYTOL, V52, P241, DOI 10.1679/aohc.52.241; Martin J, 2003, ONCOGENE, V22, P5261, DOI 10.1038/sj.onc.1206506; Matsuno A, 1996, ACTA NEUROCHIR, V138, P1002, DOI 10.1007/BF01411291; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; NAKAJIMA T, 1980, BRAIN RES, V191, P523, DOI 10.1016/0006-8993(80)91300-1; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SHANKLIN WM, 1951, ACTA ANAT, V11, P361; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Suh H, 2002, DEVELOPMENT, V129, P329; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; U HS, 2002, MOL ENDOCRINOL, V16, P2645, DOI 10.1210/me.2002-0094; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Urbano AG, 2000, ENDOCRINOLOGY, V141, P1893, DOI 10.1210/en.141.5.1893; Vallette-Kasic S, 2001, J CLIN ENDOCR METAB, V86, P4529, DOI 10.1210/jc.86.9.4529; Vankelecom H, 2007, NEUROENDOCRINOLOGY, V85, P110, DOI 10.1159/000100278; Vankelecom H, 2007, SEMIN CELL DEV BIOL, V18, P559, DOI 10.1016/j.semcdb.2007.04.006; Vesper AH, 2006, ENDOCRINOLOGY, V147, P1654, DOI 10.1210/en.2005-1080; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Ward RD, 2006, MOL ENDOCRINOL, V20, P1378, DOI 10.1210/me.2005-0409; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Widenfalk J, 2000, CELL TISSUE RES, V299, P409, DOI 10.1007/s004410050039; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Xie T, 2007, DEVELOPMENT, V134, P2001, DOI 10.1242/dev.002022; YOSHIMURA F, 1977, ENDOCRINOL JAPON, V24, P301; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	81	130	132	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4815	10.1371/journal.pone.0004815	http://dx.doi.org/10.1371/journal.pone.0004815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283075	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496300004
J	Junno, JA; Niskanen, M; Nieminen, MT; Maijanen, H; Niinimaki, J; Bloigu, R; Tuukkanen, J				Junno, Juho-Antti; Niskanen, Markku; Nieminen, Miika T.; Maijanen, Heli; Niinimaki, Jaakko; Bloigu, Risto; Tuukkanen, Juha			Temporal Trends in Vertebral Size and Shape from Medieval to Modern-Day	PLOS ONE			English	Article							BONE-MINERAL DENSITY; QUANTITATIVE COMPUTED-TOMOGRAPHY; BODY-MASS PREDICTION; GENDER-DIFFERENCES; LUMBAR SPINE; COMPRESSIVE STRENGTH; OSTEOPOROSIS; MEN; FRAGILITY; FRACTURES	Human lumbar vertebrae support the weight of the upper body. Loads lifted and carried by the upper extremities cause significant loading stress to the vertebral bodies. It is well established that trauma-induced vertebral fractures are common especially among elderly people. The aim of this study was to investigate the morphological factors that could have affected the prevalence of trauma-related vertebral fractures from medieval times to the present day. To determine if morphological differences existed in the size and shape of the vertebral body between medieval times and the present day, the vertebral body size and shape was measured from the 4th lumbar vertebra using magnetic resonance imaging (MRI) and standard osteometric calipers. The modern samples consisted of modern Finns and the medieval samples were from archaeological collections in Sweden and Britain. The results show that the shape and size of the 4th lumbar vertebra has changed significantly from medieval times in a way that markedly affects the biomechanical characteristics of the lumbar vertebral column. These changes may have influenced the incidence of trauma-induced spinal fractures in modern populations.	[Junno, Juho-Antti; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland; [Junno, Juho-Antti; Niskanen, Markku; Maijanen, Heli; Niinimaki, Jaakko] Univ Oulu, Dept Arts & Anthropol, Oulu, Finland; [Nieminen, Miika T.] Univ Oulu Hosp, Dept Diagnost Radiol, Oulu, Finland; [Bloigu, Risto] Univ Oulu, Med Informat Grp, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Junno, JA (corresponding author), Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland.	juho-antti.junno@oulu.fi	Nieminen, Miika/G-7798-2012; Tuukkanen, Juha/R-3728-2018; Niinimäki, Jaakko/O-2186-2014	Nieminen, Miika/0000-0002-2300-2848; Tuukkanen, Juha/0000-0002-1723-6461; Niinimaki, Jaakko/0000-0002-5591-3726; Maijanen, Heli/0000-0001-8720-9680	University of Oulu	University of Oulu	This study was supported by University of Oulu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ARCUS, 1996, REP HUM REM BLACKG; Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; BIGGEMANN M, 1988, SKELETAL RADIOL, V17, P264, DOI 10.1007/BF00401809; Black DM, 1999, J BONE MINER RES, V14, P90, DOI 10.1359/jbmr.1999.14.1.90; Brickley M, 2002, INT J OSTEOARCHAEOL, V12, P364, DOI 10.1002/oa.635; DAHLSTROM S, 1981, THESIS I DENT DEPT; Duan YB, 2001, J BONE MINER RES, V16, P2267, DOI 10.1359/jbmr.2001.16.12.2267; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; Ebbesen EN, 1999, BONE, V25, P713, DOI 10.1016/S8756-3282(99)00216-1; Gejvall N.-G., 1960, WESTERHUS MEDIEVAL P; GILLIAM T, 2008, MED SCI SPORTS EXERC, V13, P65; GILSANZ V, 1994, RADIOLOGY, V190, P678, DOI 10.1148/radiology.190.3.8115610; GILSANZ V, 1994, RADIOLOGY, V190, P673, DOI 10.1148/radiology.190.3.8115609; KAJANOJA, 1971, ANN ACAD SCIENTIARUM, V146, P1; Kenny A, 2000, Clin Cornerstone, V2, P45, DOI 10.1016/S1098-3597(00)90005-X; Lanier RR, 1939, AM J PHYS ANTHROPOL, V25, P341, DOI 10.1002/ajpa.1330250330; LUNDBERG H, 1926, RACIAL CHARACTERS SW; MAYS S, 1996, INT J OSTEOARCHAEOL, V6, P144, DOI 10.1002/(SICI)1099-1212(199603)6:2<144::AID-OA261>3.0.CO;2-G; Mays SA, 1999, J CLIN DENSITOM, V2, P71, DOI 10.1385/JCD:2:1:71; McHenry H.M., 1988, P133; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; Melton LJ, 1997, J BONE MINER RES, V12, P1769, DOI 10.1359/jbmr.1997.12.11.1769; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; MOSEKILDE L, 1989, BONE, V10, P425, DOI 10.1016/8756-3282(89)90074-4; Niskanen M, 2002, MANKIND QUART, V43, P121; NISKANEN M, 2004, MUINAISTUTKIJA, P26; ODVINA CV, 1988, METABOLISM, V37, P221, DOI 10.1016/0026-0495(88)90099-6; PEEL NFA, 1994, J BONE MINER RES, V9, P317; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Raxter MH, 2006, AM J PHYS ANTHROPOL, V130, P374, DOI 10.1002/ajpa.20361; Ruff C, 2005, J HUM EVOL, V48, P381, DOI 10.1016/j.jhevol.2004.11.009; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Ruff CB, 2000, AM J PHYS ANTHROPOL, V113, P507, DOI 10.1002/1096-8644(200012)113:4<507::AID-AJPA5>3.0.CO;2-F; Ruff C, 2008, J HUM EVOL, V54, P383, DOI 10.1016/j.jhevol.2007.09.001; Ruff CB, 2006, AM SCI, V94, P508, DOI 10.1511/2006.62.1007; Ruyssen-Witrand A, 2007, OSTEOPOROSIS INT, V18, P1271, DOI 10.1007/s00198-007-0356-6; Seeman E, 1999, BONE, V25, P143, DOI 10.1016/S8756-3282(99)00117-9; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Sievanen H, 2007, J BONE MINER RES, V22, P537, DOI 10.1359/JBMR.070102; TAYLOR JR, 1990, PARAPLEGIA, V28, P119, DOI 10.1038/sc.1990.14; Thomsen JS, 2002, BONE, V30, P502, DOI 10.1016/S8756-3282(01)00702-5; Vega E, 1998, CALCIFIED TISSUE INT, V62, P465, DOI 10.1007/s002239900462; Videman T, 2007, J BONE MINER RES, V22, P1455, DOI 10.1359/JBMR.070606	43	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4836	10.1371/journal.pone.0004836	http://dx.doi.org/10.1371/journal.pone.0004836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OG	19279681	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496200013
J	Martinez-Mekler, G; Martinez, RA; del Rio, MB; Mansilla, R; Miramontes, P; Cocho, G				Martinez-Mekler, Gustavo; Alvarez Martinez, Roberto; Beltran del Rio, Manuel; Mansilla, Ricardo; Miramontes, Pedro; Cocho, Germinal			Universality of Rank-Ordering Distributions in the Arts and Sciences	PLOS ONE			English	Article								Searching for generic behaviors has been one of the driving forces leading to a deep understanding and classification of diverse phenomena. Usually a starting point is the development of a phenomenology based on observations. Such is the case for power law distributions encountered in a wealth of situations coming from physics, geophysics, biology, lexicography as well as social and financial networks. This finding is however restricted to a range of values outside of which finite size corrections are often invoked. Here we uncover a universal behavior of the way in which elements of a system are distributed according to their rank with respect to a given property, valid for the full range of values, regardless of whether or not a power law has previously been suggested. We propose a two parameter functional form for these rank-ordered distributions that gives excellent fits to an impressive amount of very diverse phenomena, coming from the arts, social and natural sciences. It is a discrete version of a generalized beta distribution, given by f(r) = A(N+1-r)(b)/r(a), where r is the rank, N its maximum value, A the normalization constant and (a, b) two fitting exponents. Prompted by our genetic sequence observations we present a growth probabilistic model incorporating mutation-duplication features that generates data complying with this distribution. The competition between permanence and change appears to be a relevant, though not necessary feature. Additionally, our observations mainly of social phenomena suggest that a multifactorial quality resulting from the convergence of several heterogeneous underlying processes is an important feature. We also explore the significance of the distribution parameters and their classifying potential. The ubiquity of our findings suggests that there must be a fundamental underlying explanation, most probably of a statistical nature, such as an appropriate central limit theorem formulation.	[Martinez-Mekler, Gustavo] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Martinez-Mekler, Gustavo; Alvarez Martinez, Roberto; Cocho, Germinal] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Cuernavaca 62191, Morelos, Mexico; [Alvarez Martinez, Roberto; Beltran del Rio, Manuel; Cocho, Germinal] Univ Nacl Autonoma Mexico, Inst Fis, Cuernavaca 62191, Morelos, Mexico; [Mansilla, Ricardo] Univ Nacl Autonoma Mexico, Ctr Investigac Interdisciplin Ciencias Humanidades, Cuernavaca 62191, Morelos, Mexico; [Miramontes, Pedro] Univ Nacl Autonoma Mexico, Fac Ciencias, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Mekler, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico.	mekler@fis.unam.mx	Mansilla, Ricardo/HIR-3991-2022	Mansilla, Ricardo/0000-0002-1248-0959; Martinez-Mekler, Gustavo/0000-0002-1192-9769	CONACyT [47836-F, DGAPA-UNAM-IN115908, DGAPA-UNAM-IN112407-3, scholarship]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Support from CONACyT 47836-F, DGAPA-UNAM-IN115908 and DGAPA-UNAM-IN112407-3 grants are acknowledged. R. Alvarez thanks CONACyT for a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; AMARAL LAN, PNAS, V97, P11149; [Anonymous], ACAD RANKING WORLD U; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Bury K., 1999, STAT DISTRIBUTIONS E; CANCHO FFI, 2001, QUANTITATIVE LINGUIS, V8, P165; CZIROK A, 1995, CORRELATIONS BINARY; del Rio MB, 2008, PHYSICA A, V387, P5552, DOI 10.1016/j.physa.2008.05.031; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Frisch U., 1995, TURBULENCE LEGACY AN; Hong HS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258701; Kadanoff L. P., 2000, STAT PHYS STATICS DY; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; LI WT, 1991, PHYS REV A, V43, P5240, DOI 10.1103/PhysRevA.43.5240; Mansilla R, 2007, J INFORMETR, V1, P155, DOI 10.1016/j.joi.2007.01.001; MCDONALD JB, 1984, ECONOMETRICA, V52, P647, DOI 10.2307/1913469; *MEX NAT I STAT, 2003, GEOGR INF; MONTROLL EW, 1983, J STAT PHYS, V32, P209, DOI 10.1007/BF01012708; Naumis GG, 2008, PHYSICA A, V387, P84, DOI 10.1016/j.physa.2007.08.002; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Popescu I., 2003, GLOTTOMETRICS, V6, P83; QUAN HL, 2000, P 17 INT C COMPUTERL; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sornette D, 2003, PHYS REP, V378, P1, DOI 10.1016/S0370-1573(02)00634-8; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; CONCISE OXFORD DICT; 2001, MAJOR FIGURES 2000 P	31	96	97	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4791	10.1371/journal.pone.0004791	http://dx.doi.org/10.1371/journal.pone.0004791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277122	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496100014
J	Egesten, A; Olin, AI; Linge, HM; Yadav, M; Morgelin, M; Karlsson, A; Collin, M				Egesten, Arne; Olin, Anders I.; Linge, Helena M.; Yadav, Manisha; Morgelin, Matthias; Karlsson, Anna; Collin, Mattias			SpeB of Streptococcus pyogenes Differentially Modulates Antibacterial and Receptor Activating Properties of Human Chemokines	PLOS ONE			English	Article								Background: CXC chemokines are induced by inflammatory stimuli in epithelial cells and some, like MIG/CXCL9, IP-10/CXCL10 and I-TAC/CXCL11, are antibacterial for Streptococcus pyogenes. Methodology/Principal Findings: SpeB from S. pyogenes degrades a wide range of chemokines (i.e. IP10/CXCL10, I-TAC/CXCL11, PF4/CXCL4, GRO alpha/CXCL1, GRO beta/CXCL2, GRO gamma/CXCL3, ENA78/CXCL5, GCP-2/CXCL6, NAP-2/CXCL7, SDF-1/CXCL12, BCA-1/CXCL13, BRAK/CXCL14, SRPSOX/CXCL16, MIP-3 alpha/CCL20, Lymphotactin/XCL1, and Fractalkine/CX3CL1), has no activity on IL-8/CXCL8 and RANTES/CCL5, partly degrades SRPSOX/CXCL16 and MIP-3 alpha/CCL20, and releases a 6 kDa CXCL9 fragment. CXCL10 and CXCL11 loose receptor activating and antibacterial activities, while the CXCL9 fragment does not activate the receptor CXCR3 but retains its antibacterial activity. Conclusions/Significance: SpeB destroys most of the signaling and antibacterial properties of chemokines expressed by an inflamed epithelium. The exception is CXCL9 that preserves its antibacterial activity after hydrolysis, emphasizing its role as a major antimicrobial on inflamed epithelium.	[Egesten, Arne; Linge, Helena M.] Lund Univ, Div Resp Med, Dept Clin Sci Lund, Lund, Sweden; [Olin, Anders I.; Yadav, Manisha; Morgelin, Matthias; Collin, Mattias] Lund Univ, Dept Clin Sci Lund, Div Infect Med, S-22100 Lund, Sweden; [Karlsson, Anna] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Lund University; Lund University; University of Gothenburg	Egesten, A (corresponding author), Lund Univ, Div Resp Med, Dept Clin Sci Lund, Lund, Sweden.	Mattias.Collin@med.lu.se	Collin, Mattias/C-6398-2009; Karlsson, Anna/A-4130-2012	Collin, Mattias/0000-0002-6166-7410; Karlsson, Anna/0000-0001-6796-1154; Linge, Helena/0000-0002-8919-0300	Swedish Research Council [2005-4791, 2007-2880, Assistant Professorship]; Swedish Heart and Lung Foundation; Foundations of Crafoord; Foundations of Jeansson; Foundations of Zoega; Foundations of Kock; Foundations of Bergh; Foundations of Bergvall; Foundations of Hedberg; Foundations of Osterlund; Foundations of Groschinsky; Swedish Society of Medicine; Royal Physiografic Society; Medical Faculty at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Foundations of Crafoord; Foundations of Jeansson; Foundations of Zoega; Foundations of Kock; Foundations of Bergh; Foundations of Bergvall; Foundations of Hedberg; Foundations of Osterlund; Foundations of Groschinsky; Swedish Society of Medicine; Royal Physiografic Society(Royal Society of London); Medical Faculty at Lund University	This work was supported by grants from the Swedish Research Council (projects 2005-4791 and 2007-2880), the Swedish Heart and Lung Foundation, the Foundations of Crafoord, Jeansson, Zoega, Kock, Bergh, Bergvall, Hedberg, Osterlund, Groschinsky, the Swedish Society of Medicine, the Royal Physiografic Society, and the Medical Faculty at Lund University. M.C. is the recipient of an Assistant Professorship from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Ashbaugh CD, 2001, INFECT IMMUN, V69, P6683, DOI 10.1128/IAI.69.11.6683-6686.2001; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Collin M, 2008, J REPROD IMMUNOL, V79, P37, DOI 10.1016/j.jri.2008.08.003; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Eliasson M, 2007, MICROB PATHOGENESIS, V43, P224, DOI 10.1016/j.micpath.2007.06.007; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; GERLACH D, 1983, ZBL BAKT-INT J MED M, V255, P221, DOI 10.1016/S0174-3031(83)80161-9; Granfeldt D, 2002, J LEUKOCYTE BIOL, V71, P611; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Linge HM, 2008, J INTERF CYTOK RES, V28, P190, DOI 10.1089/jir.2007.0100; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Lukomski S, 1999, INFECT IMMUN, V67, P1779; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Malkowski MG, 1997, J MOL BIOL, V266, P367, DOI 10.1006/jmbi.1996.0796; Matsuka YV, 1999, INFECT IMMUN, V67, P4326, DOI 10.1128/IAI.67.9.4326-4333.1999; Nyberg P, 2004, J BIOL CHEM, V279, P52820, DOI 10.1074/jbc.C400485200; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Sauty A, 1999, J IMMUNOL, V162, P3549; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schmidtchen A, 2001, MOL MICROBIOL, V39, P708, DOI 10.1046/j.1365-2958.2001.02251.x; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Stone, 1998, EFFICIENT LIB PARALL; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; SUMBY P, 2008, INFECT IMMUN, V105, P1698; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; TALKINGTON DF, 1993, INFECT IMMUN, V61, P3369, DOI 10.1128/IAI.61.8.3369-3374.1993; TANG YQ, INFECT IMMUN, V7, P6524; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Vinh DC, 2005, LANCET INFECT DIS, V5, P501, DOI 10.1016/S1473-3099(05)70191-2; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; WOLF BB, 1994, J BIOL CHEM, V269, P30682; Xanthou G, 2003, EUR J IMMUNOL, V33, P2927, DOI 10.1002/eji.200324235; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yount NY, 2007, BBA-BIOMEMBRANES, V1768, P598, DOI 10.1016/j.bbamem.2006.11.011; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	65	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4769	10.1371/journal.pone.0004769	http://dx.doi.org/10.1371/journal.pone.0004769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274094	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496000009
J	Farina, AK; Bong, YS; Feltes, CM; Byers, SW				Farina, Anne K.; Bong, Yong-Sik; Feltes, Carolyn M.; Byers, Stephen W.			Post-Transcriptional Regulation of Cadherin-11 Expression by GSK-3 and beta-Catenin in Prostate and Breast Cancer Cells	PLOS ONE			English	Article								Background: The cell-cell adhesion molecule cadherin-11 is important in embryogenesis and bone morphogenesis, invasion of cancer cells, lymphangiogenesis, homing of cancer cells to bone, and rheumatoid arthritis. However, very little is known about the regulation of cadherin-11 expression. Methodology/Principal Findings: Here we show that cell density and GSK-3 beta regulate cadherin-11 levels in cancer cells. Inactivation of GSK3 beta with lithium chloride or the GSK3 inhibitor BIO and GSK3b knockdown with siRNA repressed cadherin-11 mRNA and protein levels. RNA Polymerase II chromatin immunoprecipitation experiments showed that inhibition of GSK3 does not affect cadherin-11 gene transcription. Although the cadherin-11 3'UTR contains putative microRNA target sites and is regulated by Dicer, its stability is not regulated by GSK3 inhibition or density. Our data show that GSK3b regulates cadherin-11 expression in two ways: first a beta-catenin-independent regulation of cadherin-11 steady state mRNA levels, and second a beta-catenin-dependent effect on cadherin-11 3'UTR stability and protein translation. Conclusions: Cadherin-11 mRNA and protein levels are regulated by the activity of GSK3b and a significant degree of this regulation is exerted by the GSK3 target, beta-catenin, at the level of the cadherin-11 3'UTR	[Farina, Anne K.; Bong, Yong-Sik; Feltes, Carolyn M.; Byers, Stephen W.] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Farina, Anne K.; Bong, Yong-Sik; Feltes, Carolyn M.; Byers, Stephen W.] Georgetown Univ, Sch Med, Dept Oncol & Biochem Mol & Cellular Biol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Farina, AK (corresponding author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	byerss@georgetown.edu			DOD Idea Award [DAMD17-01-1-0245]; DOD Prostate Cancer Research Predoctoral Traineeship Award [W81XWH-05-1-0559]	DOD Idea Award; DOD Prostate Cancer Research Predoctoral Traineeship Award	DOD Idea Award DAMD17-01-1-0245 (SWB), DOD Prostate Cancer Research Predoctoral Traineeship Award W81XWH-05-1-0559 (AKF).	Barker N, 2000, ADV CANCER RES, V77, P1; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Chen GTC, 1999, MOL REPROD DEV, V52, P158, DOI 10.1002/(SICI)1098-2795(199902)52:2<158::AID-MRD6>3.0.CO;2-3; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Getsios S, 1998, J REPROD FERTIL, V114, P357; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Hadeball B, 1998, MECH DEVELOP, V72, P101, DOI 10.1016/S0925-4773(98)00022-7; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Ji Y, 2008, ONCOGENE, V27, P755, DOI 10.1038/sj.onc.1210667; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee HK, 2007, CANCER RES, V67, P9315, DOI 10.1158/0008-5472.CAN-07-1128; Lee HK, 2006, CANCER RES, V66, P10560, DOI 10.1158/0008-5472.CAN-06-2526; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McMenamin ME, 1999, CANCER RES, V59, P4291; Ohigashi T, 2005, PROSTATE, V62, P61, DOI 10.1002/pros.20117; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Orlandini M, 2003, J BIOL CHEM, V278, P44650, DOI 10.1074/jbc.M304255200; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pishvaian MJ, 1999, CANCER RES, V59, P947; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tomita K, 2000, CANCER RES, V60, P3650; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; Whittle BJR, 2006, BRIT J PHARMACOL, V147, P575, DOI 10.1038/sj.bjp.0706509; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	43	24	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4797	10.1371/journal.pone.0004797	http://dx.doi.org/10.1371/journal.pone.0004797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274078	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496000030
J	Lehmann, M; Noack, D; Wood, M; Perego, M; Knaus, UG				Lehmann, Mandy; Noack, Deborah; Wood, Malcolm; Perego, Marta; Knaus, Ulla G.			Lung Epithelial Injury by B-Anthracis Lethal Toxin Is Caused by MKK-Dependent Loss of Cytoskeletal Integrity	PLOS ONE			English	Article							KERATINOCYTE-GROWTH-FACTOR; SIGNALING PATHWAYS; PATHOGENESIS; PROTEINS; BARRIER; CDC42; MODULATION; CORTACTIN; DYNAMICS; KINASES	Bacillus anthracis lethal toxin (LT) is a key virulence factor of anthrax and contributes significantly to the in vivo pathology. The enzymatically active component is a Zn2+-dependent metalloprotease that cleaves most isoforms of mitogen-activated protein kinase kinases (MKKs). Using ex vivo differentiated human lung epithelium we report that LT destroys lung epithelial barrier function and wound healing responses by immobilizing the actin and microtubule network. Long-term exposure to the toxin generated a unique cellular phenotype characterized by increased actin filament assembly, microtubule stabilization, and changes in junction complexes and focal adhesions. LT-exposed cells displayed randomly oriented, highly dynamic protrusions, polarization defects and impaired cell migration. Reconstitution of MAPK pathways revealed that this LT-induced phenotype was primarily dependent on the coordinated loss of MKK1 and MKK2 signaling. Thus, MKKs control fundamental aspects of cytoskeletal dynamics and cell motility. Even though LT disabled repair mechanisms, agents such as keratinocyte growth factor or dexamethasone improved epithelial barrier integrity by reducing cell death. These results suggest that co-administration of anti-cytotoxic drugs may be of benefit when treating inhalational anthrax.	[Lehmann, Mandy; Noack, Deborah; Knaus, Ulla G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wood, Malcolm] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA USA; [Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Lehmann, M (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	uknaus@scripps.edu			CDC [CI000095]; NIH/NIAID [AI024838, AI077042, AI055860]; NIH/NIGMS [GM019416, GM055594]; Stein Beneficial Trust; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077042, R01AI024838, R01AI055860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019416, R01GM019416, R01GM055594] Funding Source: NIH RePORTER	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stein Beneficial Trust; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CDC grant CI000095 (U.G.K. and M. P.), NIH/NIAID grants AI024838 and AI077042 (U.G.K.), AI055860 (M.P.) and NIH/NIGMS grants GM019416 and GM055594 (M.P.). Oligonucleotide synthesis and DNA sequencing were supported in part by the Stein Beneficial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Agrawal A, 2004, CELL MOL LIFE SCI, V61, P2859, DOI 10.1007/s00018-004-4251-4; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Desai LP, 2004, AM J PHYSIOL-LUNG C, V287, pL1134, DOI 10.1152/ajplung.00022.2004; Duesbery NS, 1999, J APPL MICROBIOL, V87, P289, DOI 10.1046/j.1365-2672.1999.00892.x; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Frazier AA, 2006, J THORAC IMAG, V21, P252, DOI 10.1097/01.rti.0000213570.71161.84; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gomperts BN, 2007, AM J RESP CELL MOL, V37, P48, DOI 10.1165/rcmb.2006-0384OC; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; Harwood A, 2003, NAT CELL BIOL, V5, P275, DOI 10.1038/ncb0403-275; Hong J, 2007, J BIOL CHEM, V282, P19781, DOI 10.1074/jbc.M700128200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Knaus Ulla G., 2007, V412, P59, DOI 10.1007/978-1-59745-467-4_5; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Peixoto EBMI, 2006, CELL BIOL INT, V30, P101, DOI 10.1016/j.cellbi.2005.08.004; Pentecost Mickey, 2006, PLoS Pathogens, V2, P29; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Russell BH, 2008, CELL MICROBIOL, V10, P945, DOI 10.1111/j.1462-5822.2007.01098.x; Sapra R, 2006, MICROB PATHOGENESIS, V41, P157, DOI 10.1016/j.micpath.2006.07.002; Shafazand S, 1999, CHEST, V116, P1369, DOI 10.1378/chest.116.5.1369; STOFEGA M, 2006, TRIPHOSPHATASE ACTIV, P269; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Ware LB, 2004, INT J RADIAT ONCOL, V60, P1345, DOI 10.1016/j.ijrobp.2004.09.015; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783	42	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4755	10.1371/journal.pone.0004755	http://dx.doi.org/10.1371/journal.pone.0004755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270742	Green Submitted, gold, Green Published			2022-12-27	WOS:000265495900022
J	Yuan, A; Farber, EL; Rapoport, AL; Tejada, D; Deniskin, R; Akhmedov, NB; Farber, DB				Yuan, Alex; Farber, Erica L.; Rapoport, Ana Lia; Tejada, Desiree; Deniskin, Roman; Akhmedov, Novrouz B.; Farber, Debora B.			Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles	PLOS ONE			English	Article							MEMBRANE MICROPARTICLES; MESSENGER-RNA; EXPRESSION; SURFACE; IDENTIFICATION; DEFECT; TIME	Microvesicles are plasma membrane-derived vesicles released into the extracellular environment by a variety of cell types. Originally characterized from platelets, microvesicles are a normal constituent of human plasma, where they play an important role in maintaining hematostasis. Microvesicles have been shown to transfer proteins and RNA from cell to cell and they are also believed to play a role in intercellular communication. We characterized the RNA and protein content of embryonic stem cell microvesicles and show that they can be engineered to carry exogenously expressed mRNA and protein such as green fluorescent protein (GFP). We demonstrate that these engineered microvesicles dock and fuse with other embryonic stem cells, transferring their GFP. Additionally, we show that embryonic stem cells microvesicles contain abundant microRNA and that they can transfer a subset of microRNAs to mouse embryonic fibroblasts in vitro. Since microRNAs are short (21-24 nt), naturally occurring RNAs that regulate protein translation, our findings open up the intriguing possibility that stem cells can alter the expression of genes in neighboring cells by transferring microRNAs contained in microvesicles. Embryonic stem cell microvesicles may be useful therapeutic tools for transferring mRNA, microRNAs, protein, and siRNA to cells and may be important mediators of signaling within stem cell niches.	[Yuan, Alex; Farber, Erica L.; Rapoport, Ana Lia; Tejada, Desiree; Deniskin, Roman; Akhmedov, Novrouz B.; Farber, Debora B.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yuan, A (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	farber@jsei.ucla.edu		Yuan, Alex/0000-0003-0191-8035; Farber, Debora/0000-0002-3207-697X	NIH [EY018739]; The Vision of Children; Hope for Vision; NATIONAL EYE INSTITUTE [R21EY018739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Vision of Children; Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from NIH (EY018739), The Vision of Children, and Hope for Vision. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahams VM, 2003, CANCER RES, V63, P5573; Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Fritzsching B, 2002, J IMMUNOL, V169, P5531, DOI 10.4049/jimmunol.169.10.5531; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Manly BFJ, 1997, RANDOMIZATION BOOTST; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Quesenberry PJ, 2008, STEM CELL REV, V4, P137, DOI 10.1007/s12015-008-9036-y; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Sloand EM, 1998, BLOOD, V92, P4439, DOI 10.1182/blood.V92.11.4439.423k24_4439_4445; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tahinci E, 2004, CURR OPIN GENET DEV, V14, P361, DOI 10.1016/j.gde.2004.06.013; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437	36	329	360	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4722	10.1371/journal.pone.0004722	http://dx.doi.org/10.1371/journal.pone.0004722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266099	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490800004
J	White, GE; Erickson, HP				White, Glenn E.; Erickson, Harold P.			The Coiled Coils of Cohesin Are Conserved in Animals, but Not In Yeast	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; SACCHAROMYCES-SENSU-STRICTO; GENE-EXPRESSION; SMC PROTEINS; DIVERGENCE TIMES; NIPPED-B; DROSOPHILA; COMPLEX; CTCF	Background: The SMC proteins are involved in DNA repair, chromosome condensation, and sister chromatid cohesion throughout Eukaryota. Long, anti-parallel coiled coils are a prominent feature of SMC proteins, and are thought to serve as spacer rods to provide an elongated structure and to separate domains. We reported recently that the coiled coils of mammalian condensin (SMC2/4) showed moderate sequence divergence (approximate to 10-15%) consistent with their functioning as spacer rods. The coiled coils of mammalian cohesins (SMC1/3), however, were very highly constrained, with amino acid sequence divergence typically <0.5%. These coiled coils are among the most highly conserved mammalian proteins, suggesting that they make extensive contacts over their entire surface. Methodology/Principal Findings: Here, we broaden our initial analysis of condensin and cohesin to include additional vertebrate and invertebrate organisms and multiple species of yeast. We found that the coiled coils of SMC1/3 are highly constrained in Drosophila and other insects, and more generally across all animal species. However, in yeast they are no more constrained than the coils of SMC2/4 and Ndc80/Nuf2p, suggesting that they are serving primarily as spacer rods. Conclusions/Significance: SMC1/3 functions for sister chromatid cohesion in all species. Since its coiled coils apparently serve only as spacer rods in yeast, it is likely that this is sufficient for sister chromatid cohesion in all species. This suggests an additional function in animals that constrains the sequence of the coiled coils. Several recent studies have demonstrated that cohesin has a role in gene expression in post-mitotic neurons of Drosophila, and other animal cells. Some variants of human Cornelia de Lange Syndrome involve mutations in human SMC1/3. We suggest that the role of cohesin in gene expression may involve intimate contact of the coiled coils of SMC1/3, and impose the constraint on sequence divergence.	[White, Glenn E.] Longwood Univ, Dept Biol & Environm Sci, Farmville, VA USA; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27706 USA	Longwood University; Duke University	White, GE (corresponding author), Longwood Univ, Dept Biol & Environm Sci, Farmville, VA USA.	h.erickson@cellbio.duke.edu			NIH [CA47056]; NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH grant CA47056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley M, 2002, GENOME RES, V12, P1201, DOI 10.1101/gr107302; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Gause M, 2008, CHROMOSOMA, V117, P51, DOI 10.1007/s00412-007-0125-5; Ghiselli G, 2000, J BIOL CHEM, V275, P20235, DOI 10.1074/jbc.C000213200; Ghiselli G, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-34; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Guacci V, 2007, GENES CELLS, V12, P693, DOI 10.1111/j.1365-2443.2007.01093.x; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Jones S, 2001, GENOME BIOL, V2; Kawahara Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-9; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lin J J, 1997, Int Rev Cytol, V170, P1, DOI 10.1016/S0074-7696(08)61619-8; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McNairn AJ, 2008, TRENDS GENET, V24, P382, DOI 10.1016/j.tig.2008.06.002; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Rainieri S, 2003, J BIOSCI BIOENG, V96, P1; Revenkova E, 2005, REPRODUCTION, V130, P783, DOI 10.1530/rep.1.00864; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; REVENKOVA E, 2008, HUM MOL GENET; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Surcel A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002453; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Thomas JAI, 2008, CELL MOTIL CYTOSKEL, V65, P979, DOI 10.1002/cm.20320; Valdeolmillos AM, 2007, PLOS GENET, V3, P204, DOI 10.1371/journal.pgen.0030028; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; White GE, 2006, J STRUCT BIOL, V154, P111, DOI 10.1016/j.jsb.2006.01.001; Wong RW, 2008, P NATL ACAD SCI USA, V105, P15441, DOI 10.1073/pnas.0807660105; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	63	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4674	10.1371/journal.pone.0004674	http://dx.doi.org/10.1371/journal.pone.0004674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262687	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490600007
J	Zhang, Y; Zhou, X; Ge, X; Jiang, JH; Li, MW; Jia, SH; Yang, XN; Kan, YC; Miao, XX; Zhao, GP; Li, F; Huang, YP				Zhang, Yong; Zhou, Xue; Ge, Xie; Jiang, Jianhao; Li, Muwang; Jia, Shihai; Yang, Xiaonan; Kan, Yunchao; Miao, Xuexia; Zhao, Guoping; Li, Fei; Huang, Yongping			Insect-Specific microRNA Involved in the Development of the Silkworm Bombyx mori	PLOS ONE			English	Article								MicroRNAs (miRNAs) are endogenous non-coding genes that participate in post-transcription regulation by either degrading mRNA or blocking its translation. It is considered to be very important in regulating insect development and metamorphosis. We conducted a large-scale screening for miRNA genes in the silkworm Bombyx mori using sequence-by-synthesis (SBS) deep sequencing of mixed RNAs from egg, larval, pupal, and adult stages. Of 2,227,930 SBS tags, 1,144,485 ranged from 17 to 25 nt, corresponding to 256,604 unique tags. Among these non-redundant tags, 95,184 were matched to the silkworm genome. We identified 3,750 miRNA candidate genes using a computational pipeline combining RNAfold and TripletSVM algorithms. We confirmed 354 miRNA genes using miRNA microarrays and then performed expression profile analysis on these miRNAs for all developmental stages. While 106 miRNAs were expressed in all stages, 248 miRNAs were egg-and pupa-specific, suggesting that insect miRNAs play a significant role in embryogenesis and metamorphosis. We selected eight miRNAs for quantitative RT-PCR analysis; six of these were consistent with our microarray results. In addition, we searched for orthologous miRNA genes in mammals, a nematode, and other insects and found that most silkworm miRNAs are conserved in insects, whereas only a small number of silkworm miRNAs has orthologs in mammals and the nematode. These results suggest that there are many miRNAs unique to insects.	[Zhang, Yong; Ge, Xie; Jiang, Jianhao; Jia, Shihai; Yang, Xiaonan; Miao, Xuexia; Zhao, Guoping; Huang, Yongping] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Zhou, Xue; Li, Fei] Nanjing Agr Univ, Nanjing, Peoples R China; [Li, Muwang] Chinese Acad Agr Sci, Sericult Res Inst, Zhenjiang, Peoples R China; [Kan, Yunchao] Nan Yang Normal Univ, Nanyang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences	Zhang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	lifei@njau.edu.cn; yphuang@sibs.ac.cn	Zhang, Yong/G-9808-2011; Li, Fei/B-3687-2012; ZHANG, YONG/H-1671-2012	Li, Fei/0000-0002-8410-5250; Jia, Shihai/0000-0003-1144-4291; Zhao, Guo-Ping/0000-0002-7621-6620	National High-Tech R&D Program [2006AA10A119]; National Basic Research Program of China [2005CB121000]; Natural Science Foundation of Jiangsu Province [BK2007524]; National Science Foundation of China [30870337, 30174417]	National High-Tech R&D Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High-Tech R&D Program (2006AA10A119), the National Basic Research Program of China (2005CB121000), the Natural Science Foundation of Jiangsu Province (BK2007524), and grants from National Science Foundation of China (30870337, 30174417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; CAO J, 2008, INSECT BIOCH MOL BIO; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Willis Judith H., 1995, P1; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-93; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhang Y, 2007, GENOMICS, V90, P372, DOI 10.1016/j.ygeno.2007.05.005; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	36	86	102	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4677	10.1371/journal.pone.0004677	http://dx.doi.org/10.1371/journal.pone.0004677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262741	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490600009
J	Biocca, S; Falconi, M; Filesi, I; Baldini, F; Vecchione, L; Mango, R; Romeo, F; Federici, G; Desideri, A; Novelli, G				Biocca, Silvia; Falconi, Mattia; Filesi, Ilaria; Baldini, Francesco; Vecchione, Lucia; Mango, Ruggiero; Romeo, Francesco; Federici, Giorgio; Desideri, Alessandro; Novelli, Giuseppe			Functional Analysis and Molecular Dynamics Simulation of LOX-1 K167N Polymorphism Reveal Alteration of Receptor Activity	PLOS ONE			English	Article								The human lectin-like oxidized low density lipoprotein receptor 1 LOX-1, encoded by the ORL1 gene, is the major scavenger receptor for oxidized low density lipoprotein in endothelial cells. Here we report on the functional effects of a coding SNP, c.501G>C, which produces a single amino acid change (K>N at codon 167). Our study was aimed at elucidating whether the c.501G>C polymorphism changes the binding affinity of LOX-1 receptor altering its function. The presence of p.K167N mutation reduces ox-LDL binding and uptake. Ox-LDL activated extracellular signal-regulated kinases 1 and 2 (ERK 1/2) is inhibited. Furthermore, ox-LDL induced biosynthesis of LOX-1 receptors is dependent on the p.K167N variation. In human macrophages, derived from c.501G>C heterozygous individuals, the ox-LDL induced LOX-1 46 kDa band is markedly lower than in induced macrophages derived from c.501G>C controls. Investigation of p.K167N mutation through molecular dynamics simulation and electrostatic analysis suggests that the ox-LDL binding may be attributed to the coupling between the electrostatic potential distribution and the asymmetric flexibility of the basic spine residues. The N/N-LOX-1 mutant has either interrupted electrostatic potential and asymmetric fluctuations of the basic spine arginines.	[Biocca, Silvia; Filesi, Ilaria; Baldini, Francesco] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Falconi, Mattia; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Biocca, Silvia; Falconi, Mattia; Desideri, Alessandro; Novelli, Giuseppe] Univ Roma Tor Vergata, Ctr Biostat & Bioinformat, Rome, Italy; [Vecchione, Lucia; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Rome, Italy; [Vecchione, Lucia; Novelli, Giuseppe] Univ Roma Tor Vergata, Sch Med, Ctr Excellence Genom Risk Assessment Multifactor, Rome, Italy; [Mango, Ruggiero; Romeo, Francesco; Federici, Giorgio] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Mango, Ruggiero] IRCCS Humanitas, Milan, Italy; [Romeo, Francesco; Novelli, Giuseppe] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR USA; [Romeo, Francesco; Novelli, Giuseppe] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Biocca, S (corresponding author), Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy.	biocca@med.uniroma2.it	Novelli, Giuseppe/A-5195-2013; Baldini, Francesco/I-3996-2019; Novelli, Giuseppe/GQB-3329-2022; Biocca, Silvia/AAH-7310-2021; Novelli, Giuseppe/T-8822-2019	Novelli, Giuseppe/0000-0002-7781-602X; Baldini, Francesco/0000-0002-5904-4070; Novelli, Giuseppe/0000-0002-7781-602X; Biocca, Silvia/0000-0001-5838-4674; desideri, alessandro/0000-0003-1541-4217; FALCONI, MATTIA/0000-0002-3990-4758	Italian Ministry of Health, Italian Ministry of University; R.E.D.D. s.r.l.	Italian Ministry of Health, Italian Ministry of University; R.E.D.D. s.r.l.	This work was supported by grants of the Italian Ministry of Health, Italian Ministry of University and Research through R.E.D.D. s.r.l., a spin-off of the Tor Vergata University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biocca S, 2008, J MOL CELL CARDIOL, V44, P561, DOI 10.1016/j.yjmcc.2007.11.017; Cardinale A, 2005, J BIOL CHEM, V280, P685, DOI 10.1074/jbc.M407360200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen MY, 2001, BIOCHEM BIOPH RES CO, V282, P153, DOI 10.1006/bbrc.2001.4516; Chen Q, 2003, CIRCULATION, V107, P3146, DOI 10.1161/01.CIR.0000074207.85796.36; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Hou XW, 2008, CLIN CHIM ACTA, V388, P200, DOI 10.1016/j.cca.2007.11.016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataoka H, 2001, ARTERIOSCL THROM VAS, V21, P955, DOI 10.1161/01.ATV.21.6.955; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Knowles JW, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-23; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Li DY, 2000, CIRCULATION, V102, P1970, DOI 10.1161/01.CIR.102.16.1970; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Mango R, 2005, CIRC RES, V97, P152, DOI 10.1161/01.RES.0000174563.62625.8e; Mango R, 2003, J MED GENET, V40, P933, DOI 10.1136/jmg.40.12.933; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Ohmori R, 2004, CLIN CARDIOL, V27, P641, DOI 10.1002/clc.4960271112; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sattler W, 1992, ISOLATION HUMAN VLDL; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Tanigawa H, 2006, HYPERTENSION, V48, P294, DOI 10.1161/01.HYP.0000229825.98545.5e; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Tatsuguchi M, 2003, BIOCHEM BIOPH RES CO, V303, P247, DOI 10.1016/S0006-291X(03)00326-7; Vohra RS, 2006, TRENDS CARDIOVAS MED, V16, P60, DOI 10.1016/j.tcm.2005.12.001; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; YUAN XM, 1995, ARTERIOSCL THROM VAS, V15, P1345, DOI 10.1161/01.ATV.15.9.1345; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	42	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4648	10.1371/journal.pone.0004648	http://dx.doi.org/10.1371/journal.pone.0004648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247493	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000265487800028
J	Cheng, G; Tse, J; Jain, RK; Munn, LL				Cheng, Gang; Tse, Janet; Jain, Rakesh K.; Munn, Lance L.			Micro-Environmental Mechanical Stress Controls Tumor Spheroid Size and Morphology by Suppressing Proliferation and Inducing Apoptosis in Cancer Cells	PLOS ONE			English	Article								Background: Compressive mechanical stress produced during growth in a confining matrix limits the size of tumor spheroids, but little is known about the dynamics of stress accumulation, how the stress affects cancer cell phenotype, or the molecular pathways involved. Methodology/Principal Findings: We co-embedded single cancer cells with fluorescent micro-beads in agarose gels and, using confocal microscopy, recorded the 3D distribution of micro-beads surrounding growing spheroids. The change in micro-bead density was then converted to strain in the gel, from which we estimated the spatial distribution of compressive stress around the spheroids. We found a strong correlation between the peri-spheroid solid stress distribution and spheroid shape, a result of the suppression of cell proliferation and induction of apoptotic cell death in regions of high mechanical stress. By compressing spheroids consisting of cancer cells overexpressing anti-apoptotic genes, we demonstrate that mechanical stress-induced apoptosis occurs via the mitochondrial pathway. Conclusions/Significance: Our results provide detailed, quantitative insight into the role of micro-environmental mechanical stress in tumor spheroid growth dynamics, and suggest how tumors grow in confined locations where the level of solid stress becomes high. An important implication is that apoptosis via the mitochondrial pathway, induced by compressive stress, may be involved in tumor dormancy, in which tumor growth is held in check by a balance of apoptosis and proliferation.	[Cheng, Gang; Tse, Janet; Jain, Rakesh K.; Munn, Lance L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Cheng, Gang; Tse, Janet; Jain, Rakesh K.; Munn, Lance L.] Harvard Univ, Sch Med, Boston, MA USA; [Tse, Janet] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Cheng, G (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA.	lance@steele.mgh.harvard.edu	Munn, Lance L/L-3950-2016; Jain, Rakesh K/I-1384-2017	Munn, Lance L/0000-0003-0698-7232; Jain, Rakesh K/0000-0001-7571-3548	NIH [P01CA80124, R01CA085140, R01CA126642]; NATIONAL CANCER INSTITUTE [P01CA080124, R01CA085140, R01CA126642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants P01CA80124, R01CA085140 and R01CA126642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; de Freitas PS, 2006, J BIOMED MATER RES B, V78B, P347, DOI 10.1002/jbm.b.30494; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; EAVES G, 1973, J PATHOL, V109, P233, DOI 10.1002/path.1711090308; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GARTNER MFRM, 1992, BRIT J CANCER, V65, P487, DOI 10.1038/bjc.1992.101; Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Haykal J, 2008, RADIOTHER ONCOL, V86, P412, DOI 10.1016/j.radonc.2007.10.013; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Martin M, 2003, J NATL CANCER I, V95, P704, DOI 10.1093/jnci/95.10.704; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Retsky M, 2004, J THEOR BIOL, V229, P289, DOI 10.1016/j.jtbi.2004.04.008; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; VAAGE J, 1992, INT J CANCER, V51, P325, DOI 10.1002/ijc.2910510225; YOUNG JS, 1959, J PATHOL BACTERIOL, V77, P321, DOI 10.1002/path.1700770203; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	27	293	297	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4632	10.1371/journal.pone.0004632	http://dx.doi.org/10.1371/journal.pone.0004632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247489	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487800014
J	Nekhoroshkova, E; Albert, S; Becker, M; Rapp, UR				Nekhoroshkova, Elena; Albert, Stefan; Becker, Matthias; Rapp, Ulf R.			A-RAF Kinase Functions in ARF6 Regulated Endocytic Membrane Traffic	PLOS ONE			English	Article								Background: RAF kinases direct ERK MAPK signaling to distinct subcellular compartments in response to growth factor stimulation. Methodology/Principal Findings: Of the three mammalian isoforms A-RAF is special in that one of its two lipid binding domains mediates a unique pattern of membrane localization. Specific membrane binding is retained by an N-terminal fragment (AR149) that corresponds to a naturally occurring splice variant termed DA-RAF2. AR149 colocalizes with ARF6 on tubular endosomes and has a dominant negative effect on endocytic trafficking. Moreover actin polymerization of yeast and mammalian cells is abolished. AR149/DA-RAF2 does not affect the internalization step of endocytosis, but trafficking to the recycling compartment. Conclusions/Significance: A-RAF induced ERK activation is required for this step by activating ARF6, as A-RAF depletion or inhibition of the A-RAF controlled MEK-ERK cascade blocks recycling. These data led to a new model for A-RAF function in endocytic trafficking.	[Nekhoroshkova, Elena; Albert, Stefan; Becker, Matthias; Rapp, Ulf R.] Univ Wurzburg, Inst MSZ, Wurzburg, Germany	University of Wurzburg	Nekhoroshkova, E (corresponding author), Univ Wurzburg, Inst MSZ, Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de			DFG [RA-642/11-2, GRK1141/1, SFB 581, SFB 487]	DFG(German Research Foundation (DFG))	EN was supported by DFG grant RA-642/11-2, Deutsch-Franzosiches Graduierten kolleg GRK1141/1, SFB 581 Project B5 and SFB 487 Project C3. MB was supported by SFB 487 of the DFG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Guthrie C, 1991, GUIDE YEAST GENETICS; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Improta-Brears T, 1999, MOL CELL BIOCHEM, V198, P171, DOI 10.1023/A:1006981411691; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; JANSEN HW, 1984, NATURE, V307, P281, DOI 10.1038/307281a0; Johnson LM, 2005, BIOCHEMISTRY-US, V44, P3432, DOI 10.1021/bi0487692; Lambert AA, 2007, FEMS YEAST RES, V7, P782, DOI 10.1111/j.1567-1364.2007.00239.x; Lee JE, 1996, ONCOGENE, V12, P1669; Li M, 2006, CANCER RES, V66, P1583, DOI 10.1158/0008-5472.CAN-05-2424; Luckett JCA, 2000, CELL GROWTH DIFFER, V11, P163; MARK GE, 1984, SCIENCE, V224, P285, DOI 10.1126/science.6324342; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Matsuya S, 2005, J NEUROCHEM, V93, P674, DOI 10.1111/j.1471-4159.2005.03072.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Rapp UR, 2003, ADV ENZYME REGUL, V43, P183, DOI 10.1016/S0065-2571(03)00002-5; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662; Smaczynska-de Rooij II, 2008, TRAFFIC, V9, P559, DOI 10.1111/j.1600-0854.2008.00708.x; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; van Drogen F, 2001, BIOL CELL, V93, P63, DOI 10.1016/S0248-4900(01)01123-6; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4647	10.1371/journal.pone.0004647	http://dx.doi.org/10.1371/journal.pone.0004647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247477	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487800027
J	Modinos, G; Ormel, J; Aleman, A				Modinos, Gemma; Ormel, Johan; Aleman, Andre			Activation of Anterior Insula during Self-Reflection	PLOS ONE			English	Article							PREFRONTAL ACTIVITY; CONSCIOUS EMOTION; SOCIAL COGNITION; NEURAL ACTIVITY; DEFAULT MODE; JUDGMENTS; BRAIN; REPRESENTATION; AWARENESS; FEELINGS	Background: Functional neuroimaging studies have suggested activation of midline frontoparietal brain regions to be at the core of self-related processes. However, although some studies reported involvement of the insula, little attention has been paid to this region as forming part of the "self''-network. Methodology/Principal Findings: Using functional magnetic resonance imaging (fMRI), we aimed at replicating and extending previous studies by scanning subjects whilst reflecting upon their own personal qualities as compared to those of an acquaintance. A third condition with statements about general knowledge was used to control for attention, semantic processing and decision making processes. The results showed a significant effect of task in brain activity, consistent with previous findings, by which both person conditions recruited a common set of medial prefrontal and posterior regions, yet significant differences between self and other were found in the medial prefrontal cortex (MPFC) and the anterior cingulate cortex (ACC). Notably, significant neural activation in the left anterior insula was observed as uniquely associated with self-reflection. Conclusions/Significance: The results provide further evidence for the specific recruitment of anterior MPFC and ACC regions for self-related processing, and highlight a role for the insula in self-reflection. As the insula is closely connected with ascending internal body signals, this may indicate that the accumulation of changes in affective states that might be implied in self-processing may contribute to our sense of self.	[Modinos, Gemma; Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Ormel, Johan] Univ Groningen, Univ Med Ctr Groningen, ICPE, Dept Psychiat, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen	Modinos, G (corresponding author), Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.	g.modinos@med.umcg.nl	Modinos, Gemma/AAD-6448-2022; Aleman, Andre/E-1341-2012; ormel, johan/AAC-5584-2019; Ormel, Johan/C-6094-2013	Modinos, Gemma/0000-0002-7870-066X; ormel, johan/0000-0002-5463-037X; 	European Science Foundation EURYI [044035001]	European Science Foundation EURYI(European Science Foundation (ESF))	This work was supported by European Science Foundation EURYI grant (NWO number: 044035001) awarded to AA. The funding source had no further role in the study and preparation of the manuscript.	Aleman A, 2005, TRENDS COGN SCI, V9, P553, DOI 10.1016/j.tics.2005.10.002; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beer JS, 2007, TRENDS COGN SCI, V11, P187, DOI 10.1016/j.tics.2007.02.004; Cannon TD, 1998, ORIGINS AND DEVELOPMENT OF SCHIZOPHRENIA, P67, DOI 10.1037/10305-003; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A, 2003, NATURE, V423, P227, DOI 10.1038/423227a; DAVID AS, 1990, BRIT J PSYCHIAT, V156, P798, DOI 10.1192/bjp.156.6.798; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fink GR, 1996, J NEUROSCI, V16, P4275; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Flashman Laura A, 2002, Curr Psychiatry Rep, V4, P346, DOI 10.1007/s11920-002-0082-x; Fossati P, 2004, NEUROIMAGE, V22, P1596, DOI 10.1016/j.neuroimage.2004.03.034; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gray MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000546; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Heinzel A, 2006, SOC NEUROSCI, V1, P41, DOI 10.1080/17470910600663137; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; Lindner M, 2008, NEUROIMAGE, V40, P963, DOI 10.1016/j.neuroimage.2007.12.022; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2009, HUM BRAIN MAPP, V30, P369, DOI 10.1002/hbm.20510; Oatley K., 1996, UNDERSTANDING EMOTIO; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7	62	123	124	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4618	10.1371/journal.pone.0004618	http://dx.doi.org/10.1371/journal.pone.0004618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KX	19242539	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487500019
J	Agnew, DJ; Pearce, J; Pramod, G; Peatman, T; Watson, R; Beddington, JR; Pitcher, TJ				Agnew, David J.; Pearce, John; Pramod, Ganapathiraju; Peatman, Tom; Watson, Reg; Beddington, John R.; Pitcher, Tony J.			Estimating the Worldwide Extent of Illegal Fishing	PLOS ONE			English	Article							MARINE ECOSYSTEMS; CATCH; FISHERIES	Illegal and unreported fishing contributes to overexploitation of fish stocks and is a hindrance to the recovery of fish populations and ecosystems. This study is the first to undertake a world-wide analysis of illegal and unreported fishing. Reviewing the situation in 54 countries and on the high seas, we estimate that lower and upper estimates of the total value of current illegal and unreported fishing losses worldwide are between $10 bn and $23.5 bn annually, representing between 11 and 26 million tonnes. Our data are of sufficient resolution to detect regional differences in the level and trend of illegal fishing over the last 20 years, and we can report a significant correlation between governance and the level of illegal fishing. Developing countries are most at risk from illegal fishing, with total estimated catches in West Africa being 40% higher than reported catches. Such levels of exploitation severely hamper the sustainable management of marine ecosystems. Although there have been some successes in reducing the level of illegal fishing in some areas, these developments are relatively recent and follow growing international focus on the problem. This paper provides the baseline against which successful action to curb illegal fishing can be judged.	[Agnew, David J.; Beddington, John R.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Pearce, John; Peatman, Tom] MRAG Ltd, London, England; [Pramod, Ganapathiraju; Watson, Reg; Pitcher, Tony J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Beddington, John R.] United Kingdom Govt Off Sci, London, England	Imperial College London; University of British Columbia	Agnew, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England.	d.agnew@imperial.ac.uk	Pramod, Ganapathiraju/AAI-5018-2020; Watson, Reg A/F-4850-2012	Watson, Reg A/0000-0001-7201-8865; Ganapathiraju, Pramod/0000-0001-8126-3432	UK Department for Environment, Food and Rural Affairs; UK Department for International Development; Pew Charitable Trusts	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); UK Department for International Development; Pew Charitable Trusts	This work was supported by the UK Department for Environment, Food and Rural Affairs and the UK Department for International Development. The Sea Around Us project is supported by the Pew Charitable Trusts. The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Agnew DJ, 2000, MAR POLICY, V24, P361, DOI 10.1016/S0308-597X(00)00012-9; Agnew DJ, 2005, CCAMLR SCI, V12, P119; Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Ainsworth CH, 2005, FISH RES, V75, P40, DOI 10.1016/j.fishres.2005.05.003; ANGANUZZI A, 2001, FISH PIRACY COMBATIN, P147; [Anonymous], 1995, COD COND RESP FISH; [Anonymous], RES PUBLIC POLICY SE; [Anonymous], BACKGROUND PAPER 200; Bailey M, 2008, MAR POLICY, V32, P483, DOI 10.1016/j.marpol.2007.09.010; Barnes CT, 2004, FISH PIRACY COMBATIN; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Benavente-Villena A.B., 2004, TURBULENT SEAS STATU; Bernal PA, 1999, OCEAN COAST MANAGE, V42, P119, DOI 10.1016/S0964-5691(98)00049-0; Birkun A, 2002, CETACEANS MEDITERRAN; BRACK D, 2006, ILLEGAL LOGGING; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Bray K., 2000, AUSIUU20006 FAO; BUDDYR M, 2002, FISHERIES CTR RES RE, V93, P191; Butcher John., 2004, CLOSING FRONTIER HIS; Butcher John G., 2002, INT J MARITIME HIST, V14, P85; *CEDEPESCA, 2003, 9 CEDEPESCA; CHIMANOVICH M, 2001, ZONA MARITIME; CLARKE S, 2008, ILLEGAL FISHING EXCL; *COMM EUR COMM, 2007, EST COMM SYST PREV D; *DAFF, 2005, EFF EXP CONTR ILL HA; ESMARK M, 2004, 42004 WWF; Falaye A. E., 2008, ILLEGAL UNREPORTED U; *FAO, 2006, REP FAO CECAF WORK G; FAO, 2006, STAT WORLD FISH AQ; FAO, 1997, FAO TECHN GUID RESP; *FAO, 2007, COMM 2005 YB FISH ST, V101; FLEWWELING P, 2006, 188 FAO, P168; FLEWWELLING P, 2001, C6 FAO; Gianni Matthew, 2005, CHANGING NATURE HIGH; GUENETTE S, 2001, FISHERIES CTR RES 3, V9, P206; HARIRI KI, STATUS LIVING MARINE; *HIGH SEAS TASK FO, 2006, CLOS ART STOPP ILL F; HOMELAND G, 2004, RUSSIAN FISHERY MANA; ICCAT, 2008, REP STAND COMM RES S; JOSEPH I, 1999, CASE STUDIES MANAGEM, P339; KALENTCHENKO M, 2005, ANAL ILLEGAL FISHER; KALIKOSKI D, 2008, ASSESSING ILLEGAL UN; Kelleher K., 2002, PLANNING COST EFFECT; Kraay Aart, 2007, 4280 WORLD BANK POLI; KUO CL, 2001, AQUACULTURE FISHERIE, P211; LONG R, 2002, INT J MARINE COASTAL, V17, P235; Marine Resources Assessment Group Ltd (MRAG), 2005, IUU FISH HIGH SEAS I; MATISHOV G, 2004, BARENTS SEAS GIWA RE; Melnychuk M., 2001, FISHERIES CTR RES RE, P221; Mendo J., 1987, PERUVIAN ANCHOVETA I, P109; Montes HML, 2008, FRONT ECOL ENVIRON, V6, P75, DOI 10.1890/070056; MORATO T, 2002, FISHERIES CTR RES RE, V9, P214; MORATO T, 2004, FISHERIES CTR RES RE, V125; Morgan G., 2006, FAO FISH TECH PAP, V488, P337; MRAG, 2005, REV IMP ILL UNR UNR; *MRAG CAPFISH, 2008, STUD AN STAT ICU FIS, V2; Nurhakim S., 2008, STUDY ILLEGAL UNREPO; Nurhakim S., 2008, STUDY ILLEGAL UNREPO, P41; Palma M. A., 2008, CASE STUDY IMPACTS I; PATTERSON KR, 1993, FISH RES, V18, P199, DOI 10.1016/0165-7836(93)90153-X; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PE M, 2004, NATL REPORT MYAMMAR; PEARSE MI, 1979, NMES FOREIGN FISH LE; Pitcher T., 2008, EVALUATION PROGR IMP; PITCHER TJ, 2008, SAFE CONDUCT; PITCHER TJ, 2006, FISHERIES CTR RES RE, V14; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; PRAMOD G, 2008, FISH CTR RES REPORTS, V16, P247; RAJAN PT, 2003, FIELD GUID MARINE FO; Restrepo V., 2004, FISH PIRACY COMBATIN, P155; *SCI COMM CONS ANT, 2007, REP 26 M SCI COMM; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; TAGHAVI SA, 1999, GCPINT643XOR FAO; Tesfamichael D, 2007, AFR J MAR SCI, V29, P55, DOI 10.2989/AJMS.2007.29.1.5.70; Tudela S, 2005, BIOL CONSERV, V121, P65, DOI 10.1016/j.biocon.2004.04.010; TUDELA S, 2001, GFCM STUDIES REV, V74; VAISMAN A, 2001, TRAWLING MIST IND FI; VARKEY DA, 2008, ASSESSING ILLEGAL UN, P120; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; WATSON R, 2004, NATURE, V44, P534; WEIDNER DM, 1993, WORLD FISHING FLEETS, V4; WILLONGHBY N, 1997, REG WORKSH PREC APPR; *WWF, 2008, ILL FISH ARCT WAT; *WWF, 2007, MIDT REV EC COMM FIS; ZULETA A, 2004, 700 FAO; [No title captured]	86	549	560	4	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4570	10.1371/journal.pone.0004570	http://dx.doi.org/10.1371/journal.pone.0004570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240812	Green Published, gold			2022-12-27	WOS:000278086700003
J	Kim, JY; Kajino-Sakamoto, R; Omori, E; Jobin, C; Ninomiya-Tsuji, J				Kim, Jae-Young; Kajino-Sakamoto, Rie; Omori, Emily; Jobin, Christian; Ninomiya-Tsuji, Jun			Intestinal Epithelial-Derived TAK1 Signaling Is Essential for Cytoprotection against Chemical-Induced Colitis	PLOS ONE			English	Article								Background: We have previously reported that intestinal epithelium-specific TAK1 deleted mice exhibit severe inflammation and mortality at postnatal day 1 due to TNF-induced epithelial cell death. Although deletion of TNF receptor 1 (TNFR1) can largely rescue those neonatal phenotypes, mice harboring double deletion of TNF receptor 1 (TNFR1) and intestinal epithelium-specific deletion of TAK1 (TNFR1KO/TAK1(IE)KO) still occasionally show increased inflammation. This indicates that TAK1 is important for TNF-independent regulation of intestinal integrity. Methodology/Principal Findings: In this study, we investigated the TNF-independent role of TAK1 in the intestinal epithelium. Because the inflammatory conditions were sporadically developed in the double mutant TNFR1KO/TAK1(IE)KO mice, we hypothesize that epithelial TAK1 signaling is important for preventing stress-induced barrier dysfunction. To test this hypothesis, the TNFR1KO/TAK1(IE)KO mice were subjected to acute colitis by administration of dextran sulfate sodium (DSS). We found that loss of TAK1 significantly augments DSS-induced experimental colitis. DSS induced weight loss, intestinal damages and inflammatory markers in TNFR1KO/TAK1(IE)KO mice at higher levels compared to the TNFR1KO control mice. Apoptosis was strongly induced and epithelial cell proliferation was decreased in the TAK1-deficient intestinal epithelium upon DSS exposure. These suggest that epithelial-derived TAK1 signaling is important for cytoprotection and repair against injury. Finally, we showed that TAK1 is essential for interleukin 1- and bacterial components-induced expression of cytoprotective factors such as interleukin 6 and cycloxygenase 2. Conclusions: Homeostatic cytokines and microbes-induced intestinal epithelial TAK1 signaling regulates cytoprotective factors and cell proliferation, which is pivotal for protecting the intestinal epithelium against injury.	[Kim, Jae-Young; Kajino-Sakamoto, Rie; Omori, Emily; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Jobin, Christian] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Jobin, Christian] Univ N Carolina, Ctr Gastrointest Biol & Dis, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kim, JY (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu		Kim, Jae-Young/0000-0001-6700-1372; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	Crohn's and Colitis Foundation of America; National Institutes of Health [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812, R01GM084406] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Crohn's and Colitis Foundation of America and from National Institutes of Health (GM068812) to J. N-T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; HALL PA, 1994, J CELL SCI, V107, P3569; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Inan MS, 2000, AM J PHYSIOL-GASTR L, V279, pG1282, DOI 10.1152/ajpgi.2000.279.6.G1282; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Karrasch T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000596; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Menard S, 2008, J EXP MED, V205, P183, DOI 10.1084/jem.20071022; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Seitz CS, 2000, CANCER RES, V60, P4085; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810	38	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4561	10.1371/journal.pone.0004561	http://dx.doi.org/10.1371/journal.pone.0004561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234607	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487200015
J	Kim, HM; Hwang, DH; Lee, JE; Kim, SU; Kim, BG				Kim, Hyuk Min; Hwang, Dong Hoon; Lee, Jong Eun; Kim, Seung U.; Kim, Byung G.			Ex Vivo VEGF Delivery by Neural Stem Cells Enhances Proliferation of Glial Progenitors, Angiogenesis, and Tissue Sparing after Spinal Cord Injury	PLOS ONE			English	Article								The present study was undertaken to examine multifaceted therapeutic effects of vascular endothelial growth factor (VEGF) in a rat spinal cord injury (SCI) model, focusing on its capability to stimulate proliferation of endogenous glial progenitor cells. Neural stem cells (NSCs) can be genetically modified to efficiently transfer therapeutic genes to diseased CNS. We adopted an ex vivo approach using immortalized human NSC line (F3 cells) to achieve stable and robust expression of VEGF in the injured spinal cord. Transplantation of NSCs retrovirally transduced to overexpress VEGF (F3. VEGF cells) at 7 days after contusive SCI markedly elevated the amount of VEGF in the injured spinal cord tissue compared to injection of PBS or F3 cells without VEGF. Concomitantly, phosphorylation of VEGF receptor flk-1 increased in F3. VEGF group. Stereological counting of BrdU+ cells revealed that transplantation of F3. VEGF significantly enhanced cellular proliferation at 2 weeks after SCI. The number of proliferating NG2+ glial progenitor cells (NG2+/BrdU+) was also increased by F3. VEGF. Furthermore, transplantation of F3. VEGF increased the number of early proliferating cells that differentiated into mature oligodendrocytes, but not astrocytes, at 6 weeks after SCI. F3. VEGF treatment also increased the density of blood vessels in the injured spinal cord and enhanced tissue sparing. These anatomical results were accompanied by improved BBB locomotor scores. The multifaceted effects of VEGF on endogenous gliogenesis, angiogenesis, and tissue sparing could be utilized to improve functional outcomes following SCI.	[Kim, Hyuk Min; Hwang, Dong Hoon; Kim, Byung G.] Ajou Univ, Sch Med, Inst Med Sci, Brain Dis Res Ctr, Suwon 441749, South Korea; [Kim, Byung G.] Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea; [Lee, Jong Eun] Yonsei Univ, Coll Med, Dept Anat, Seoul 120749, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V5Z 1M9, Canada; [Kim, Seung U.] Chung Ang Univ, Sch Med, Med Res Inst, Seoul, South Korea	Ajou University; Ajou University; Yonsei University; Yonsei University Health System; University of British Columbia; Chung Ang University; Chung Ang University Hospital	Kim, HM (corresponding author), Ajou Univ, Sch Med, Inst Med Sci, Brain Dis Res Ctr, Suwon 441749, South Korea.	kimbg@ajou.ac.kr	Kim, Byung Gon/L-6884-2019	Kim, Byung Gon/0000-0003-2233-9569; Lee, Jong Eun/0000-0001-6203-7413	Korean Government [KRF-2007-E00200, R01-2007-000-20617-0]	Korean Government(Korean Government)	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MEST, KRF-2007-E00200) and by the Korean Science and Engineering Foundation (KOSEF) grant funded by the Korea government(MEST) (R01-2007-000-20617-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Bhat RV, 1996, GLIA, V17, P169; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; BREAKEFIELD X, 1999, CNS REGENERATION BAS, P251; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Davis LE, 2006, LANCET NEUROL, V5, P7, DOI 10.1016/S1474-4422(05)70259-3; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gundersen G, 1998, ANIM BEHAV, V56, P1355, DOI 10.1006/anbe.1998.0911; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jandial R, 2008, MOL THER, V16, P450, DOI 10.1038/sj.mt.6300402; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Mani N, 2005, EXP NEUROL, V192, P394, DOI 10.1016/j.expneurol.2004.12.022; Martinez-Serrano A, 1998, P NATL ACAD SCI USA, V95, P1858, DOI 10.1073/pnas.95.4.1858; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; WAXMAN SG, 1992, J NEUROTRAUM, V9, pS105; Weiss S, 1996, J NEUROSCI, V16, P7599; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176	44	93	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4987	10.1371/journal.pone.0004987	http://dx.doi.org/10.1371/journal.pone.0004987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319198	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499200016
J	Remais, J; Chen, L; Seto, E				Remais, Justin; Chen, Lin; Seto, Edmund			Leveraging Rural Energy Investment for Parasitic Disease Control: Schistosome Ova Inactivation and Energy Co-Benefits of Anaerobic Digesters in Rural China	PLOS ONE			English	Article							BIOMASS FUELS; AIR-POLLUTION; TRANSMISSION; HEALTH; JAPONICUM; PATHOGENS; SICHUAN; AREAS; MODEL	Background: Cooking and heating remain the most energy intensive activities among the world's poor, and thus improved access to clean energies for these tasks has been highlighted as a key requirement of attaining the major objectives of the UN Millennium Development Goals. A move towards clean energy technologies such as biogas systems (which produce methane from human and animal waste) has the potential to provide immediate benefits for the control of neglected tropical diseases. Here, an assessment of the parasitic disease and energy benefits of biogas systems in Sichuan Province, China, is presented, highlighting how the public health sector can leverage the proliferation of rural energy projects for infectious disease control. Methodology/Findings: First, the effectiveness of biogas systems at inactivating and removing ova of the human parasite Schistosoma japonicum is experimentally evaluated. Second, the impact of biogas infrastructure on energy use and environmental quality as reported by surveyed village populations is assessed, as is the community acceptance of the technology. No viable eggs were recovered in the effluent collected weekly from biogas systems for two months following seeding with infected stool. Less than 1% of ova were recovered viable from a series of nylon bags seeded with ova, a 2-log removal attributable to biochemical inactivation. More than 90% of Ascaris lumbricoides ova (used as a proxy for S. japonicum ova) counted at the influent of two biogas systems were removed in the systems when adjusted for system residence time, an approximate 1-log removal attributable to sedimentation. Combined, these inactivation/removal processes underscore the promise of biogas infrastructure for reducing parasite contamination resulting from nightsoil use. When interviewed an average of 4 years after construction, villagers attributed large changes in fuel usage to the installation of biogas systems. Household coal usage decreased by 68%, wood by 74%, and crop waste by 6%. With reported energy savings valued at roughly 600 CNY per year, 2-3 years were required to recoup the capital costs of biogas systems. In villages without subsidies, no new biogas systems were implemented. Conclusions: Sustainable strategies that integrate rural energy needs and sanitation offer tremendous promise for long-term control of parasitic diseases, while simultaneously reducing energy costs and improving quality of life. Government policies can enhance the financial viability of such strategies by introducing fiscal incentives for joint sanitation/sustainable energy projects, along with their associated public outreach and education programs.	[Remais, Justin] Emory Univ, Rollins Sch Publ Hlth, Dept Environm & Occupat Hlth, Atlanta, GA 30322 USA; [Chen, Lin] Sichuan Provinc Ctr Dis Control & Prevent, Inst Parasit Dis, Sichuan, Peoples R China; [Seto, Edmund] Univ Calif Berkeley, Sch Publ Hlth, Ctr Occupat & Environm Hlth, Berkeley, CA 94720 USA	Emory University; Rollins School Public Health; University of California System; University of California Berkeley	Remais, J (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm & Occupat Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Remais, Justin/V-3207-2019	Remais, Justin/0000-0002-0223-4615	National Institute for Allergy and Infectious Disease [R01 AI-050612]; NIH/NSF Ecology of Infectious Disease Program [0622743]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050612] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NSF Ecology of Infectious Disease Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institute for Allergy and Infectious Disease (grant R01 AI-050612) and the NIH/NSF Ecology of Infectious Disease Program (grant 0622743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOTT M, 1984, BIOGAS BIOFERTILIZER, pR11; *ARTI, 2006, COMM IMPR BIOM FUELS; Borges ESM, 2005, WATER SCI TECHNOL, V52, P227, DOI 10.2166/wst.2005.0698; CAI J, 2007, RENEWABLE S IN PRESS; CHEN B H, 1990, World Health Statistics Quarterly, V43, P127; *CHIN MIN HLTH, 2000, HDB SCHIST CONTR; DONG R, 2006, ASSESSMENT IMPROVEME; Fenwick A, 2006, SCIENCE, V313, P1077, DOI 10.1126/science.1127184; *FOOD AGR ORG UN, 1986, BIOG 2 BUILD BETT BI; *FOOD AGR ORG UN, 1984, BIOG WHAT IT IS IT I; GUNNERSON CG, 1986, ANAEROBIC DIGESTION, pR15; Haines A., 2007, LANCET; *HDIP, 2005, PAK EN YB; House D., 1981, BIOGAS HDB; HU R, 2005, IND BIOTECHNOLOGY, P222; Ilyas S. Z., 2006, AM EURASIAN J SCI RE, V1, P42; Islam AKMS, 2006, RENEW ENERG, V31, P677, DOI 10.1016/j.renene.2005.08.004; JINGFEI WXL, 2005, RENEW SUST ENERG REV, V9, P229; KISHORE VVN, 1987, FIXED DOME BIOGAS PL, pR7; LI J, 2006, ANAEROBIC DIGESTION; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Liang S, 2005, TROP MED INT HEALTH, V10, P263, DOI 10.1111/j.1365-3156.2005.01386.x; Liang S, 2007, P NATL ACAD SCI USA, V104, P7110, DOI 10.1073/pnas.0701878104; LICHTMAN R, 1987, WORLD DEV, V15, P347, DOI 10.1016/0305-750X(87)90018-0; MARCHAIM U, 1992, BIOGAS PROCESSES SUS, pR7; MCGARRY MG, 1978, COMPOST FERTILIZER B; NAKAGAWA CH, 1981, CHINESE BIOGAS DIGES; National Development and Reform Commission, 2007, MED LONG TERM DEV PL; Ni JQ, 1996, ENERG CONVERS MANAGE, V37, P1525, DOI 10.1016/0196-8904(95)00354-1; Plachy P, 1996, VET MED-CZECH, V41, P255; Qi XS, 2005, ECOL ENG, V24, P177, DOI 10.1016/j.ecoleng.2004.11.001; RAVINDRANATH NH, 1997, ENERGY POLICY, V25; SANTERRE MT, 1982, WORLD DEV, V10, P239, DOI 10.1016/0305-750X(82)90013-4; SASSE L, 1984, BIOGAS PLANTS DESIGN; Schonning C, 2007, J WATER HEALTH, V5, P117, DOI 10.2166/wh.2006.049; Shrestha IL, 2005, INT J OCCUP ENV HEAL, V11, P150, DOI 10.1179/oeh.2005.11.2.150; Shuval H.I., 1986, WASTEWATER IRRIGATIO; SINGH L, 1995, B ENVIRON CONTAM TOX, V54, P472, DOI 10.1007/BF00195123; SMIL V, 2004, CHINAS PAST CHINAS F, pR15; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; Smith SR, 2005, WASTE MANAGE, V25, P417, DOI 10.1016/j.wasman.2005.02.010; Spear RC, 2004, AM J TROP MED HYG, V70, P48, DOI 10.4269/ajtmh.2004.70.48; Spear RC, 2002, ENVIRON HEALTH PERSP, V110, P907, DOI 10.1289/ehp.02110907; SRINIVASAN S, 2007, RENEWABLE S IN PRESS; SUBRAMANIAN SK, 1977, BIOGAS SYSTEMS ASIA, pR10; Svensson K, 2004, J AGR SCI-CAMBRIDGE, V142, P461, DOI 10.1017/S0021859604004514; *UN EC SOC COMM AS, 1980, GUID BIOG DEV; *UN EC SOC COMM AS, 1984, UPD GUIDB BIOG DEV, pR11; *UNAPCAEM, 2007, REC DEV BIOG TECHN P; *UNESCAP, 2007, REC DEV BIOG TECHN P; Van Buren A., 1979, CHINESE BIOGAS MANUA; VANBUREN EA, 1981, BIOGAS FERTILIZER SY; Wang XH, 2007, RENEW SUST ENERG REV, V11, P1018, DOI 10.1016/j.rser.2005.08.001; WANG Y, 2002, CHINA BIOGAS, V20, P46; *WHO, 1983, CELL FAEC THICK EX T; YAO Y, 1992, BIOGAS TECHNOLOGY CH; ZENG B, 2000, CHINA BIOGAS, V18, P31; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhang PD, 2007, RENEW SUST ENERG REV, V11, P1903, DOI 10.1016/j.rser.2005.11.009; 1977, CHIN MED J ENGL, V3, P361	60	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4856	10.1371/journal.pone.0004856	http://dx.doi.org/10.1371/journal.pone.0004856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293926	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496600004
J	Ferreira, VM; Gomes, TS; Reis, LA; Ferreira, AT; Razvickas, CV; Schor, N; Boim, MA				Ferreira, Vanessa M.; Gomes, Thiago S.; Reis, Luciana A.; Ferreira, Alice T.; Razvickas, Clara V.; Schor, Nestor; Boim, Mirian A.			Receptor-Induced Dilatation in the Systemic and Intrarenal Adaptation to Pregnancy in Rats	PLOS ONE			English	Article								Normal pregnancy is associated with systemic and intrarenal vasodilatation resulting in an increased glomerular filtration rate. This adaptive response occurs in spite of elevated circulating levels of angiotensin II (Ang II). In the present study, we evaluated the potential mechanisms responsible for this adaptation. The reactivity of the mesangial cells (MCs) cultured from 14-day-pregnant rats to Ang II was measured through changes in the intracellular calcium concentration ([Cai]). The expression levels of inducible nitric oxide synthase (iNOS), the Ang II-induced vasodilatation receptor AT2, and the relaxin (LGR7) receptor were evaluated in cultured MCs and in the aorta, renal artery and kidney cortex by real time-PCR. The intrarenal distribution of LGR7 was further analyzed by immunohistochemistry. The MCs displayed a relative insensitivity to Ang II, which was paralleled by an impressive increase in the expression level of iNOS, AT2 and LGR7. These results suggest that the MCs also adapt to the pregnancy, thereby contributing to the maintenance of the glomerular surface area even in the presence of high levels of Ang II. The mRNA expression levels of AT2 and LGR7 also increased in the aorta, renal artery and kidney of the pregnant animals, whereas the expression of the AT1 did not significantly change. This further suggests a role of these vasodilatation-induced receptors in the systemic and intrarenal adaptation during pregnancy. LGR7 was localized in the glomeruli and on the apical membrane of the tubular cells, with stronger labeling in the kidneys of pregnant rats. These results suggest a role of iNOS, AT2, and LGR7 in the systemic vasodilatation and intrarenal adaptation to pregnancy and also suggest a pivotal role for relaxin in the tubular function during gestation.	[Ferreira, Vanessa M.; Gomes, Thiago S.; Reis, Luciana A.; Razvickas, Clara V.; Schor, Nestor; Boim, Mirian A.] Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil; [Gomes, Thiago S.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil; [Ferreira, Alice T.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Boim, MA (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil.	mirian@nefro.epm.br	Batista, Marcelo/K-4305-2013; Boim, Mirian A/L-6574-2013; Schor, Nestor/K-4364-2013		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES); Fundacao Oswaldo Ramos (FOR); Fundo de Auxilio aos Docentes e Alunos (FADA)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Ramos (FOR); Fundo de Auxilio aos Docentes e Alunos (FADA)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Fundacao Oswaldo Ramos (FOR), and Fundo de Auxilio aos Docentes e Alunos (FADA) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Baylis C, 1996, KIDNEY INT, V49, P1727, DOI 10.1038/ki.1996.256; BAYLIS C, 1987, AM J KIDNEY DIS, V9, P260, DOI 10.1016/S0272-6386(87)80119-1; BAYLIS C, 1980, J PHYSIOL-LONDON, V305, P405, DOI 10.1113/jphysiol.1980.sp013372; BAYLIS C, 1992, CLIN EXP HYPERTENS B, V11, P1117; Bobadilla RA, 2003, CAN J PHYSIOL PHARM, V81, P1, DOI 10.1139/Y02-168; Bogzil AH, 2005, AM J PHYSIOL-REG I, V288, pR322, DOI 10.1152/ajpregu.00509.2004; BOIM MA, 1994, BRAZ J MED BIOL RES, V27, P1431; Burrell JH, 1997, EUR J PHARMACOL, V330, P257, DOI 10.1016/S0014-2999(97)00167-2; Carey RM, 2005, CURR OPIN NEPHROL HY, V14, P67, DOI 10.1097/00041552-200501000-00011; Conrad KP, 1999, AM J PHYSIOL-RENAL, V276, pF767, DOI 10.1152/ajprenal.1999.276.5.F767; Conrad KP, 2005, ANN NY ACAD SCI, V1041, P147, DOI 10.1196/annals.1282.022; Conrad KP, 2004, J SOC GYNECOL INVEST, V11, P438, DOI 10.1016/j.jsgi.2004.05.002; CONRAD KP, 1991, J CLIN INVEST, V87, P1700, DOI 10.1172/JCI115187; Cox BE, 1996, AM J PHYSIOL-HEART C, V271, pH212, DOI 10.1152/ajpheart.1996.271.1.H212; Danielson LA, 1999, J CLIN INVEST, V103, P525, DOI 10.1172/JCI5630; DANIELSON LA, 1995, J CLIN INVEST, V96, P482, DOI 10.1172/JCI118059; Danielson LA, 2000, AM J PHYSIOL-REG I, V279, pR1298, DOI 10.1152/ajpregu.2000.279.4.R1298; Debrah DO, 2006, ENDOCRINOLOGY, V147, P5126, DOI 10.1210/en.2006-0567; GREENSPON SA, 1950, ARCH PATHOL, V49, P291; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hadad SJ, 1997, KIDNEY INT, V51, P87, DOI 10.1038/ki.1997.11; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; MACKANJEE HR, 1991, AM J OBSTET GYNECOL, V165, P1641, DOI 10.1016/0002-9378(91)90008-F; Nistri Silvia, 2003, Reprod Biol Endocrinol, V1, P5, DOI 10.1186/1477-7827-1-5; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Novak J, 2002, AM J PHYSIOL-REG I, V283, pR349, DOI 10.1152/ajpregu.00635.2001; Novak J, 2006, FASEB J, V20, P2352, DOI 10.1096/fj.06-6263com; RAIJ L, 1995, KIDNEY INT, V48, P20, DOI 10.1038/ki.1995.262; Schauser KH, 1998, BIOL REPROD, V59, P684, DOI 10.1095/biolreprod59.3.684; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; SCHRIER RW, 1987, AM J KIDNEY DIS, V9, P284, DOI 10.1016/S0272-6386(87)80123-3; SHANMUGAM S, 1995, AM J PHYSIOL-RENAL, V268, pF922, DOI 10.1152/ajprenal.1995.268.5.F922; Shanmugam S, 1996, CELL BIOL INT, V20, P169, DOI 10.1006/cbir.1996.0021; SHERWOOD OD, 1994, RELAXIN, P861; SHULTZ PJ, 1994, KIDNEY INT, V46, P683, DOI 10.1038/ki.1994.321; Siragy HM, 1996, J CLIN INVEST, V97, P1978, DOI 10.1172/JCI118630; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; Smith MC, 2006, J AM SOC NEPHROL, V17, P3192, DOI 10.1681/ASN.2005090950; WILSON M, 1980, AM J MED, V68, P97, DOI 10.1016/0002-9343(80)90178-3	41	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4845	10.1371/journal.pone.0004845	http://dx.doi.org/10.1371/journal.pone.0004845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287481	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400007
J	Mushlin, RA; Gallagher, S; Kershenbaum, A; Rebbeck, TR				Mushlin, Richard A.; Gallagher, Stephen; Kershenbaum, Aaron; Rebbeck, Timothy R.			Clique-Finding for Heterogeneity and Multidimensionality in Biomarker Epidemiology Research: The CHAMBER Algorithm	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; ESTROGEN METABOLISM GENOTYPES; GENE; REGRESSION; STATISTICS; DISCOVERY	Background: Commonly-occurring disease etiology may involve complex combinations of genes and exposures resulting in etiologic heterogeneity. We present a computational algorithm that employs clique-finding for heterogeneity and multidimensionality in biomedical and epidemiological research (the "CHAMBER'' algorithm). Methodology/Principal Findings: This algorithm uses graph-building to (1) identify genetic variants that influence disease risk and (2) predict individuals at risk for disease based on inherited genotype. We use a set-covering algorithm to identify optimal cliques and a Boolean function that identifies etiologically heterogeneous groups of individuals. We evaluated this approach using simulated case-control genotype-disease associations involving two-and four-gene patterns. The CHAMBER algorithm correctly identified these simulated etiologies. We also used two population-based case-control studies of breast and endometrial cancer in African American and Caucasian women considering data on genotypes involved in steroid hormone metabolism. We identified novel patterns in both cancer sites that involved genes that sulfate or glucuronidate estrogens or catecholestrogens. These associations were consistent with the hypothesized biological functions of these genes. We also identified cliques representing the joint effect of multiple candidate genes in all groups, suggesting the existence of biologically plausible combinations of hormone metabolism genes in both breast and endometrial cancer in both races. Conclusions: The CHAMBER algorithm may have utility in exploring the multifactorial etiology and etiologic heterogeneity in complex disease.	[Gallagher, Stephen; Rebbeck, Timothy R.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Gallagher, Stephen; Rebbeck, Timothy R.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Mushlin, Richard A.] PsychoGenics Inc, Tarrytown, NY USA; [Kershenbaum, Aaron] IBM Corp, TJ Watson Res Ctr, Yorktown Hts, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; International Business Machines (IBM)	Rebbeck, TR (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	rebbeck@mail.med.upenn.edu	Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900	Commonwealth of Pennsylvania and Public Health Service [P01-CA77596]; NATIONAL CANCER INSTITUTE [P01CA077596] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania and Public Health Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the Commonwealth of Pennsylvania and Public Health Service grant P01-CA77596. The study sponsors had no say in study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit it for publication. The authors have no financial, personal, or professional interests that could be construed to have influenced the paper. The WISE Study group includes: Andrea Troxel, Mona Baumgarten, Jesse Berlin, Michelle Berlin, Greta Bunin, Rebecca Blanchard, Lewis Chodosh, Ekaterina Shatalova, Stephen Rubin, Angela M. DeMichele, Sandra Norman, Rita Schinnar, Brian Strom.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2017, CLASSIFICATION REGRE; Brinza D, 2006, BIOINFORMATICS, V22, P371, DOI 10.1093/bioinformatics/bti785; Chen JB, 2007, GENET EPIDEMIOL, V31, P238, DOI 10.1002/gepi.20205; Conti DV, 2003, HUM HERED, V56, P83, DOI 10.1159/000073736; CORTESSIS V, 2004, TOXICOKINETIC GENETI, P127; ERLENKOTTER D, 1978, OPER RES, V26, P992, DOI 10.1287/opre.26.6.992; Foulkes AS, 2005, STAT MED, V24, P775, DOI 10.1002/sim.1965; FRIEDMAN JH, 1974, IEEE T COMPUT, VC 23, P881, DOI 10.1109/T-C.1974.224051; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Hoh J, 2000, P NATL ACAD SCI USA, V97, P9615, DOI 10.1073/pnas.170179197; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; KIRA K, 1992, MACHINE LEARNING /, P249; KONONENKO I, P EUR C MACH LEARN N, P171; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lepre J, 2004, BIOINFORMATICS, V20, P1033, DOI 10.1093/bioinformatics/bth035; LIEHR JG, 1990, MUTAT RES, V238, P269, DOI 10.1016/0165-1110(90)90018-7; Michie D., 1994, MACHINE LEARNING NEU; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; MUSHLIN R, 2007, IBM SYSTEMS IN PRESS; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; PAVLOV Y, 1997, PROBABILITY METHODS, V1; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rebbeck TR, 2007, CANCER EPIDEM BIOMAR, V16, P1318, DOI 10.1158/1055-9965.EPI-07-0084; Rebbeck TR, 2007, CANCER EPIDEM BIOMAR, V16, P444, DOI 10.1158/1055-9965.EPI-06-0800; Rebbeck TR, 2006, J NATL CANCER I, V98, P1311, DOI 10.1093/jnci/djj360; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Shannon WD, 2001, GENET EPIDEMIOL, V20, P293, DOI 10.1002/gepi.1; Strom BL, 2006, AM J EPIDEMIOL, V164, P775, DOI 10.1093/aje/kwj316; Tahri-Daizadeh N, 2004, ANN HUM GENET, V68, P405, DOI 10.1046/j.1529-8817.2004.00107.x; Tahri-Daizadeh N, 2003, GENOME RES, V13, P1952, DOI 10.1101/gr.1254203; THOMAS H, 2001, INTRO ALGORITHMS, P643; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Vapnik V, 2000, NEURAL COMPUT, V12, P2013, DOI 10.1162/089976600300015042; Witten I.H., 2005, DATA MINING PRACTICA	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4862	10.1371/journal.pone.0004862	http://dx.doi.org/10.1371/journal.pone.0004862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287484	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496400012
J	Spring, S; Lunsdorf, H; Fuchs, BM; Tindall, BJ				Spring, Stefan; Luensdorf, Heinrich; Fuchs, Bernhard M.; Tindall, Brian J.			The Photosynthetic Apparatus and Its Regulation in the Aerobic Gammaproteobacterium Congregibacter litoralis gen. nov., sp nov.	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES 2.4.1; ANOXYGENIC PHOTOTROPHIC BACTERIA; ELECTRON-TRANSPORT; RHODOSPIRILLUM-RUBRUM; CHROMATIUM-VINOSUM; ROSEOBACTER CLADE; TERMINAL OXIDASE; LIGHT-INTENSITY; SURFACE WATERS; CYTOCHROME-C	Background: There is accumulating evidence that in some marine environments aerobic bacteriochlorophyll a-producing bacteria represent a significant part of the microbial population. The interaction of photosynthesis and carbon metabolism in these interesting bacteria is still largely unknown and requires further investigation in order to estimate their contribution to the marine carbon cycle. Methodology/Principal Findings: Here, we analyzed the structure, composition and regulation of the photosynthetic apparatus in the obligately aerobic marine gammaproteobacterium KT71(T). Photoheterotrophically grown cells were characterized by a poorly developed lamellar intracytoplasmic membrane system, a type 1 light-harvesting antenna complex and a photosynthetic reaction center associated with a tetraheme cytochrome c. The only photosynthetic pigments produced were bacteriochlorophyll a and spirilloxanthin. Under semiaerobic conditions KT71(T) cells expressing a photosynthetic apparatus showed a light-dependent increase of growth yield in the range of 1.3-2.5 fold. The expression level of the photosynthetic apparatus depended largely on the utilized substrate, the intermediary carbon metabolism and oxygen tension. In addition, pigment synthesis was strongly influenced by light, with blue light exerting the most significant effect, implicating that proteins containing a BLUF domain may be involved in regulation of the photosynthetic apparatus. Several phenotypic traits in KT71(T) could be identified that correlated with the assumed redox state of growing cells and thus could be used to monitor the cellular redox state under various incubation conditions. Conclusions/Significance: In a hypothetical model that explains the regulation of the photosynthetic apparatus in strain KT71(T) we propose that the expression of photosynthesis genes depends on the cellular redox state and is maximal under conditions that allow a balanced membrane redox state. So far, bacteria capable of an obligately aerobic, photosynthetic metabolism constitute a unique phenotype within the class Gammaproteobacteria, so that it is justified to propose a new genus and species, Congregibacter litoralis gen. nov, sp. nov., represented by the type strain KT71(T) (= DSM 17192(T) = NBRC 104960(T)).	[Spring, Stefan; Tindall, Brian J.] Deutsch Sammlung Mikroorganismen & Zellkulturen, D-3300 Braunschweig, Germany; [Luensdorf, Heinrich] Helmholtz Zent Infektionsforsch, Braunschweig, Germany; [Fuchs, Bernhard M.] Max Planck Inst Marine Mikrobiol, Bremen, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Max Planck Society	Spring, S (corresponding author), Deutsch Sammlung Mikroorganismen & Zellkulturen, D-3300 Braunschweig, Germany.	ssp@dsmz.de	Spring, Stefan/N-6933-2013	Spring, Stefan/0000-0001-6247-0938; Fuchs, Bernhard/0000-0001-9828-1290	Leibniz Association; Helmholtz Society; Max Planck Society	Leibniz Association; Helmholtz Society(Helmholtz Association); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Research of SS and BJT is supported by the Leibniz Association (WGL), HL is supported by the Helmholtz Society (HGF) and BMF by the Max Planck Society (MPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalidis I, 1999, PHOTOSYNTH RES, V62, P31, DOI 10.1023/A:1006384113191; Allgaier M, 2003, APPL ENVIRON MICROB, V69, P5051, DOI 10.1128/AEM.69.9.5051-5059.2003; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; BAUER C, 1993, TRENDS GENET, V9, P56, DOI 10.1016/0168-9525(93)90188-N; Beatty JT, 2002, PHOTOSYNTH RES, V73, P109, DOI 10.1023/A:1020493518379; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Brostedt E, 1997, FEMS MICROBIOL LETT, V150, P263, DOI 10.1111/j.1574-6968.1997.tb10379.x; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Candela M, 2001, ARCH MICROBIOL, V175, P168, DOI 10.1007/s002030100251; Cho JC, 2007, ENVIRON MICROBIOL, V9, P1456, DOI 10.1111/j.1462-2920.2007.01264.x; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Cho SH, 2004, MICROBIOL-SGM, V150, P697, DOI 10.1099/mic.0.26777-0; CLAYTON RK, 1955, ARCH MIKROBIOL, V22, P180, DOI 10.1007/BF00409304; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; COREMANS JMCC, 1985, BIOCHIM BIOPHYS ACTA, V807, P134, DOI 10.1016/0005-2728(85)90116-1; Cousin S, 2008, INT MICROBIOL, V11, P91, DOI 10.2436/20.1501.01.48; Csotonyi JT, 2008, EXTREMOPHILES, V12, P529, DOI 10.1007/s00792-008-0156-8; DREWS G, 1985, MICROBIOL REV, V49, P59, DOI 10.1128/MMBR.49.1.59-70.1985; Dubbs JM, 2004, FEMS MICROBIOL REV, V28, P353, DOI 10.1016/j.femsre.2004.01.002; Eiler A, 2006, APPL ENVIRON MICROB, V72, P7431, DOI 10.1128/AEM.01559-06; Eilers H, 2001, APPL ENVIRON MICROB, V67, P5134, DOI 10.1128/AEM.67.11.5134-5142.2001; Elsen S, 2005, MOL MICROBIOL, V57, P17, DOI 10.1111/j.1365-2958.2005.04655.x; Fuchs BM, 2007, P NATL ACAD SCI USA, V104, P2891, DOI 10.1073/pnas.0608046104; FUJIWARA T, 1992, J BIOCHEM, V112, P290, DOI 10.1093/oxfordjournals.jbchem.a123893; Gerhardt P., 1994, METHODS GEN MOL BACT; Giraud E, 2004, J BIOL CHEM, V279, P15076, DOI 10.1074/jbc.M312113200; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Graeber I, 2008, INT J SYST EVOL MICR, V58, P585, DOI 10.1099/ijs.0.65438-0; Grammel H, 2003, APPL ENVIRON MICROB, V69, P6577, DOI 10.1128/AEM.69.11.6577-6586.2003; Grammel H, 2008, J BACTERIOL, V190, P4912, DOI 10.1128/JB.00423-08; Happ HN, 2005, MOL MICROBIOL, V58, P903, DOI 10.1111/j.1365-2958.2005.04882.x; HARASHIMA K, 1987, PLANT CELL PHYSIOL, V28, P365; Hill BC, 1996, BIOCHEMISTRY-US, V35, P6136, DOI 10.1021/bi952486f; HOCHKOEPPLER A, 1995, FEBS LETT, V375, P197, DOI 10.1016/0014-5793(95)01188-K; HOCHKOEPPLER A, 1995, BBA-BIOENERGETICS, V1229, P73, DOI 10.1016/0005-2728(94)00189-C; HOLT SC, 1965, J BACTERIOL, V89, P1421, DOI 10.1128/JB.89.5.1421-1429.1965; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jaubert M, 2004, J BIOL CHEM, V279, P44407, DOI 10.1074/jbc.M408039200; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; JURTSHUK P, 1976, APPL ENVIRON MICROB, V31, P668, DOI 10.1128/AEM.31.5.668-679.1976; Kaksonen AH, 2006, INT J SYST EVOL MICR, V56, P2603, DOI 10.1099/ijs.0.64439-0; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; KELLY DP, 1968, ARCH MIKROBIOL, V61, P59, DOI 10.1007/BF00704292; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Koblizek M, 2005, FEMS MICROBIOL ECOL, V51, P353, DOI 10.1016/j.femsec.2004.09.016; Kolber Z, 2007, OCEANOGRAPHY, V20, P79, DOI 10.5670/oceanog.2007.51; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620, DOI 10.1128/AEM.62.10.3620-3631.1996; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; LOTSPEICH WD, 1952, BIOCHEM J, V51, P20, DOI 10.1042/bj0510020; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lunsdorf H, 2001, METHODS ENZYMOL, V336, P317; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; MEYER TE, 1994, METHOD ENZYMOL, V243, P435; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Oh JI, 2000, EMBO J, V19, P4237, DOI 10.1093/emboj/19.16.4237; Pernthaler A, 2005, APPL ENVIRON MICROB, V71, P4638, DOI 10.1128/AEM.71.8.4638-4644.2005; PETERS RA, 1953, NATURE, V171, P1111, DOI 10.1038/1711111a0; PETTIGREW GW, 1988, BIOCHEM J, V252, P427, DOI 10.1042/bj2520427; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rathgeber C, 2004, PHOTOSYNTH RES, V81, P113, DOI 10.1023/B:PRES.0000035036.49977.bc; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; SCHWERZMANN RU, 1989, PLANT CELL PHYSIOL, V30, P497, DOI 10.1093/oxfordjournals.pcp.a077768; Smith L, 1978, Methods Enzymol, V53, P202; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stouthamer A. H., 1979, INT REV BIOCHEM, V21, P1; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; TAUSCHEL HD, 1967, ARCH MIKROBIOL, V59, P381, DOI 10.1007/BF00412163; TINDALL BJ, 1990, FEMS MICROBIOL LETT, V66, P199; Urios L, 2008, INT J SYST EVOL MICR, V58, P1233, DOI 10.1099/ijs.0.65470-0; Van Driessche G, 2003, J MOL EVOL, V57, P181, DOI 10.1007/s00239-003-2465-y; VANDERREST M, 1974, J BIOL CHEM, V249, P6446; VANGEMERDEN H, 1980, ARCH MICROBIOL, V125, P115, DOI 10.1007/BF00403207; Yeliseev AA, 1996, J BACTERIOL, V178, P5877, DOI 10.1128/jb.178.20.5877-5883.1996; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; [No title captured]	90	65	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4866	10.1371/journal.pone.0004866	http://dx.doi.org/10.1371/journal.pone.0004866			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287491	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496400014
J	Pontoppidan, MB; Himaman, W; Hywel-Jones, NL; Boomsma, JJ; Hughes, DP				Pontoppidan, Maj-Britt; Himaman, Winanda; Hywel-Jones, Nigel L.; Boomsma, Jacobus J.; Hughes, David P.			Graveyards on the Move: The Spatio-Temporal Distribution of Dead Ophiocordyceps-Infected Ants	PLOS ONE			English	Article								Parasites are likely to play an important role in structuring host populations. Many adaptively manipulate host behaviour, so that the extended phenotypes of these parasites and their distributions in space and time are potentially important ecological variables. The fungus Ophiocordyceps unilateralis, which is pan-tropical in distribution, causes infected worker ants to leave their nest and die under leaves in the understory of tropical rainforests. Working in a forest dynamic plot in Southern Thailand we mapped the occurrence of these dead ants by examining every leaf in 1,360 m 2 of primary rainforest. We established that high density aggregations exist (up to 26 dead ants/m(2)), which we coined graveyards. We further established that graveyards are patchily distributed in a landscape with no or very few O. unilateralis-killed ants. At some, but not all, spatial scales of analysis the density of dead ants correlated with temperature, humidity and vegetation cover. Remarkably, having found 2243 dead ants inside graveyards we only found 2 live ants of the principal host, ant Camponotus leonardi, suggesting that foraging host ants actively avoid graveyards. We discovered that the principal host ant builds nests in high canopy and its trails only occasionally descend to the forest floor where infection occurs. We advance the hypothesis that rare descents may be a function of limited canopy access to tree crowns and that resource profitability of such trees is potentially traded off against the risk of losing workers due to infection when forest floor trails are the only access routes. Our work underscores the need for an integrative approach that recognises multiple facets of parasitism, such as their extended phenotypes.	[Pontoppidan, Maj-Britt] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark; [Himaman, Winanda] Natl Park Wildlife & Plant Conserv Dt, Forest Entomol & Microbiol Grp, Bangkok, Thailand; [Hywel-Jones, Nigel L.] Natl Ctr Genet Engn & Biotechnol, Mycol Lab, Pathum Thani, Thailand; [Boomsma, Jacobus J.; Hughes, David P.] Univ Copenhagen, Ctr Social Evolut, Dept Biol, DK-1168 Copenhagen, Denmark; [Hughes, David P.] Harvard Univ, Dept Organism & Evolut Biol, Museum Comparative Zool Labs, Cambridge, MA 02138 USA; [Hughes, David P.] Univ Exeter, Sch Biosci, Exeter EX4 4QJ, Devon, England	University of Copenhagen; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Copenhagen; Harvard University; University of Exeter	Pontoppidan, MB (corresponding author), Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark.	mbp@bio.ku.dk; dhughes@oeb.harvard.edu	Boomsma, Jacobus J/M-2785-2014	Boomsma, Jacobus J/0000-0002-3598-1609	Oticon; Novozymes/WWF; Marie Curie Individual Intra-European Fellowships [MEIF-CT-2006-041613]	Oticon; Novozymes/WWF; Marie Curie Individual Intra-European Fellowships	M.B.P. was supported by a grant from Oticon and a Novozymes/WWF Biodiversity Grant to D.P.H who is also supported by a Marie Curie Individual Intra-European Fellowships in the Framework Program 6 (MEIF-CT-2006-041613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthurs S, 2001, J INVERTEBR PATHOL, V78, P59, DOI 10.1006/jipa.2001.5050; Arthurs S, 2001, BIOCONTROL SCI TECHN, V11, P411, DOI 10.1080/09583150120055826; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Dawkins R., 1982, pi; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Evans H.C., 1989, P205; Evans H. C., 2003, Clavicipitalean Fungi: evolutionary biology, chemistry, biocontrol and cultural impacts, P517; EVANS HC, 1982, T BRIT MYCOL SOC, V79, P431, DOI 10.1016/S0007-1536(82)80037-5; EVANS HC, 1982, ECOL ENTOMOL, V7, P47, DOI 10.1111/j.1365-2311.1982.tb00643.x; EVANS HC, 1984, T BRIT MYCOL SOC, V82, P127, DOI 10.1016/S0007-1536(84)80219-3; Fargues J, 1998, BIOCONTROL SCI TECHN, V8, P323, DOI 10.1080/09583159830135; HYWELJONES NL, 2001, RES REPORTS 2001 BIO, P34; Luz C, 1997, MYCOPATHOLOGIA, V138, P117, DOI 10.1023/A:1006803812504; MAEYAMA T, 1994, SOCIOBIOLOGY, V24, P115; Miura O, 2006, P ROY SOC B-BIOL SCI, V273, P1323, DOI 10.1098/rspb.2005.3451; Moore J., 2002, PARASITES BEHAV ANIM; MULLER CB, 1994, ANIM BEHAV, V48, P961, DOI 10.1006/anbe.1994.1321; Perry JN, 2002, ECOSCIENCE, V9, P133, DOI 10.1080/11956860.2002.11682699; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Perry JN, 1998, ECOLOGY, V79, P1008, DOI 10.1890/0012-9658(1998)079[1008:MOSPFC]2.0.CO;2; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Sanders NJ, 2007, BIOTROPICA, V39, P422, DOI 10.1111/j.1744-7429.2007.00263.x; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 1998, P ROY SOC B-BIOL SCI, V265, P1091, DOI 10.1098/rspb.1998.0403; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; Zar JH, 1999, BIOSTATISTICAL ANAL	32	64	68	1	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4835	10.1371/journal.pone.0004835	http://dx.doi.org/10.1371/journal.pone.0004835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279680	Green Published, gold			2022-12-27	WOS:000265496200012
J	Roybon, L; Hjalt, T; Stott, S; Guillemot, F; Li, JY; Brundin, P				Roybon, Laurent; Hjalt, Tord; Stott, Simon; Guillemot, Francois; Li, Jia-Yi; Brundin, Patrik			Neurogenin2 Directs Granule Neuroblast Production and Amplification while NeuroD1 Specifies Neuronal Fate during Hippocampal Neurogenesis	PLOS ONE			English	Article								The specification and differentiation of dentate gyrus granule neurons in the hippocampus require temporally and spatially coordinated actions of both intrinsic and extrinsic molecules. The basic helix-loop-helix transcription factor Neurogenin2 (Ngn2) and NeuroD1 are key regulators in these processes. Based on existing classification, we analyzed the molecular events occurring during hippocampal neurogenesis, primarily focusing on juvenile animals. We found that Ngn2 is transiently expressed by late type-2a amplifying progenitors. The Ngn2 progenies mature into hippocampal granule neurons. Interestingly, the loss of Ngn2 at early stages of development leads to a robust reduction in neurogenesis, but does not disturb granule neuron maturation per se. We found that the role of Ngn2 is to maintain progenitors in an undifferentiated state, allowing them to amplify prior to their maturation into granule neurons upon NeuroD1 induction. When we overexpressed Ngn2 and NeuroD1 in vivo, we found NeuroD1 to exhibit a more pronounced neuron-inductive effect, leading to granule neuron commitment, than that displayed by Ngn2. Finally, we observed that all markers expressed during the transcriptional control of hippocampal neurogenesis in rodents are also present in the human hippocampus. Taken together, we demonstrate a critical role of for Ngn2 and NeuroD1 in controlling neuronal commitment and hippocampal granule neuroblast formation, both during embryonic development and in post-natal hippocampal granule neurogenesis.	[Roybon, Laurent; Hjalt, Tord; Li, Jia-Yi; Brundin, Patrik] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden; [Stott, Simon] MRC, Natl Inst Med Res, Div Dev Neurobiol, London, England; [Guillemot, Francois] MRC, Natl Inst Med Res, Div Mol Neurobiol, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Roybon, L (corresponding author), Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden.	laurent.roybon@med.lu.se	Guillemot, Francois/AAV-1482-2021	Stott, Simon/0000-0002-5741-4664; Li, Jia-Yi/0000-0002-7770-7376	Swedish Research Council; Hjarnfonden [fellowship]; Swedish Parkinson Foundation; Syskonen Svenssons Foundation; Konung den V:s och Drottning Victorias Stiftelse; PROMEMORIA; European grant [LHSB-CT-2006-037328];  [LSHM-CT-2005-512012]; Medical Research Council [MC_U117570528] Funding Source: researchfish; MRC [MC_U117570528] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Hjarnfonden; Swedish Parkinson Foundation; Syskonen Svenssons Foundation; Konung den V:s och Drottning Victorias Stiftelse; PROMEMORIA; European grant; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by the Swedish Research Council, Hjarnfonden, the Swedish Parkinson Foundation, the Syskonen Svenssons Foundation and the Konung den V:s och Drottning Victorias Stiftelse and PROMEMORIA (From cell-cell recognition to memory formation; new strategies for the treatment of dysfunctional plasticity, learning and memory LSHM-CT-2005-512012). L.R. was supported by a European grant (LHSB-CT-2006-037328; STEMS) and currently supported by a Hjarnfonden fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Cau E, 2002, DEVELOPMENT, V129, P1871; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Falk A, 2002, EXP CELL RES, V279, P34, DOI 10.1006/excr.2002.5569; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GALICHET C, 2008, DEVELOPMENT; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee SMK, 2000, DEVELOPMENT, V127, P457; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Namba T, 2005, EUR J NEUROSCI, V22, P1928, DOI 10.1111/j.1460-9568.2005.04396.x; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Ozen I, 2007, EUR J NEUROSCI, V25, P2591, DOI 10.1111/j.1460-9568.2007.05541.x; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Rogelius N, 2008, MOL CELL NEUROSCI, V38, P453, DOI 10.1016/j.mcn.2008.04.008; Roybon L, 2008, J NEUROSCI, V28, P3644, DOI 10.1523/JNEUROSCI.0311-08.2008; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tonchev AB, 2006, NEUROSCIENCE, V139, P1355, DOI 10.1016/j.neuroscience.2006.01.053; Yamashima T, 2007, REV NEUROSCIENCE, V18, P67; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	49	110	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4779	10.1371/journal.pone.0004779	http://dx.doi.org/10.1371/journal.pone.0004779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274100	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000018
J	Maor, E; Ivorra, A; Rubinsky, B				Maor, Elad; Ivorra, Antoni; Rubinsky, Boris			Non Thermal Irreversible Electroporation: Novel Technology for Vascular Smooth Muscle Cells Ablation	PLOS ONE			English	Article							RADIATION-THERAPY; TISSUE ABLATION; ELUTING STENT; ENDOTHELIALIZATION; IMPEDANCE; OCCLUSION	Background: Non thermal Irreversible electroporation (NTIRE) is a new tissue ablation method that induces selective damage only to the cell membrane while sparing all other tissue components. Our group has recently showed that NTIRE attenuated neointimal formation in rodent model. The goal of this study was to determine optimal values of NTIRE for vascular smooth muscle cell (VSMC) ablation. Methods and Results: 33 Sprague-Dawley rats were used to compare NTIRE protocols. Each animal had NTIRE applied to its left common carotid artery using a custom-made electrodes. The right carotid artery was used as control. Electric pulses of 100 microseconds were used. Eight IRE protocols were compared: 1-4) 10 pulses at a frequency of 10 Hz with electric fields of 3500, 1750, 875 and 437.5 V/cm and 5-8) 45 and 90 pulses at a frequency of 1 Hz with electric fields of 1750 and 875 V/cm. Animals were euthanized after one week. Histological analysis included VSMC counting and morphometry of 152 sections. Selective slides were stained with elastic Van Gieson and Masson trichrome to evaluate extra-cellular structures. The most efficient protocols were 10 pulses of 3500 V/cm at a frequency of 10 Hz and 90 pulses of 1750 V/cm at a frequency of 1 Hz, with ablation efficiency of 89 +/- 16% and 94 +/- 9% respectively. Extra-cellular structures were not damaged and the endothelial layer recovered completely. Conclusions: NTIRE is a promising, efficient and simple novel technology for VMSC ablation. It enables ablation within seconds without causing damage to extra-cellular structures, thus preserving the arterial scaffold and enabling endothelial regeneration. This study provides scientific information for future anti-restenosis experiments utilizing NTIRE.	[Maor, Elad; Rubinsky, Boris] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Ivorra, Antoni; Rubinsky, Boris] Univ Calif Berkeley, Dept Mechan Engn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91905 Jerusalem, Israel	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Maor, E (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	eladmaor@gmail.com	Rubinsky, Boris/B-4439-2010; Maor, Elad/J-9157-2015; Ivorra, Antoni/A-3155-2008	Rubinsky, Boris/0000-0002-2794-1543; Maor, Elad/0000-0002-5087-0464; Ivorra, Antoni/0000-0001-7718-8767	U.S. National Institutes of Health (NIH) [R01 RR018961]; Israel Science Foundation [403/06]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018961] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the U.S. National Institutes of Health (NIH) under Grant NIH R01 RR018961 and by the Israel Science Foundation (grant no 403/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; AUBART FC, 2008, MOL THER; Belov S. V., 1978, Biomedical Engineering, V12, P209, DOI 10.1007/BF00562049; Bennett MR, 2003, HEART, V89, P218, DOI 10.1136/heart.89.2.218; Cheneau E, 2003, CIRCULATION, V107, P2153, DOI 10.1161/01.CIR.0000062648.39025.09; Costa MA, 1999, CIRCULATION, V100, P789, DOI 10.1161/01.CIR.100.8.789; DAVALOS R, 2007, Patent No. 20070043345; Davalos RV, 2003, BIOELECTROCHEMISTRY, V61, P99, DOI 10.1016/j.bioelechem.2003.07.001; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Esser AT, 2007, TECHNOL CANCER RES T, V6, P261, DOI 10.1177/153303460700600402; Fava M, 2004, J VASC INTERV RADIOL, V15, P1239, DOI 10.1097/01.RVI.0000136291.07304.EA; Ivorra A, 2007, IFMBE PROC, V17, P130; Jackson VM, 2002, BRIT J PHARMACOL, V137, P488, DOI 10.1038/sj.bjp.0704863; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Lee RC, 2005, ANN NY ACAD SCI, V1066, P85, DOI 10.1196/annals.1363.007; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; LIAO TJ, 1994, TOHOKU J EXP MED, V173, P303, DOI 10.1620/tjem.173.303; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MAOR E, 2007, TECHNOL CANCER RES T, V6, P255; Maor E, 2008, IEEE T BIO-MED ENG, V55, P2268, DOI 10.1109/TBME.2008.923909; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Shiffman CA, 2003, PHYSIOL MEAS, V24, P213, DOI 10.1088/0967-3334/24/1/316; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Taylor GW, 2000, CIRCULATION, V101, P1736; Valic B, 2003, EUR BIOPHYS J BIOPHY, V32, P519, DOI 10.1007/s00249-003-0296-9; Waksman R, 2000, J AM COLL CARDIOL, V36, P65, DOI 10.1016/S0735-1097(00)00681-1; Waksman R, 2006, HEART, V92, P1138, DOI 10.1136/hrt.2005.073486; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002	36	98	130	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4757	10.1371/journal.pone.0004757	http://dx.doi.org/10.1371/journal.pone.0004757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270746	Green Published, gold			2022-12-27	WOS:000265495900024
J	Almendro, V; Ametller, E; Garcia-Recio, S; Collazo, O; Casas, I; Auge, JM; Maurel, J; Gascon, P				Almendro, Vanessa; Ametller, Elisabet; Garcia-Recio, Susana; Collazo, Olga; Casas, Ignasi; Auge, Josep M.; Maurel, Joan; Gascon, Pedro			The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin	PLOS ONE			English	Article								Background: The efficacy of oxaliplatin in cancer chemotherapy is limited by the development of drug resistance. MMP7 has been related to the loss of tumor cell response to cytotoxic agents although the exact mechanism is not fully understood. Moreover, MMP7 is an independent prognosis factor for survival in patients with colorectal cancer. The aim of the present study was to analyze the role of MMP7 and its cross-talk with the Fas/FasL system during the acquisition of oxaliplatin resistance in colon cancer cells. Principal Findings: For this purpose we have developed three different oxaliplatin-resistant cell lines (RHT29, RHCT116 p53(+/+), RHCT116 p53(-/-)) from the parental HT29, HCT116 p53(+/+) and HCT116 p53(-/-) colon cancer cells. MMP7 basal expression was higher in the resistant compared to the parental cell lines. MMP7 was also upregulated by oxaliplatin in both HT29 (p53 mutant) and RHCT116 p53(-/-) but not in the RHCT116 p53(+/+). Inhibition of MMP by 1,10-phenantroline monohydrate or siRNA of MMP7 restores cell sensitivity to oxaliplatin-induced apoptosis in both HT29 and RHCT116 p53(-/-) but not in the RHCT116 p53(+/+). Some of these effects are caused by alterations in Fas receptor. Fas is upregulated by oxaliplatin in colon cancer cells, however the RHT29 cells treated with oxaliplatin showed a 3.8-fold lower Fas expression at the cell surface than the HT29 cells. Decrease of Fas at the plasma membrane seems to be caused by MMP7 since its inhibition restores Fas levels. Moreover, functional analysis of Fas demonstrates that this receptor was less potent in inducing apoptosis in RHT29 cells and that its activation induces MAPK signaling in resistant cells. Conclusions: Taking together, these results suggest that MMP7 is related to the acquisition of oxaliplatin-resistance and that its inhibition restores drug sensitivity by increasing Fas receptor. Furthermore, Fas undergoes a change in its functionality in oxaliplatin-resistant cells inducing survival pathways instead of apoptotic signals.	[Almendro, Vanessa; Ametller, Elisabet; Garcia-Recio, Susana; Collazo, Olga; Casas, Ignasi; Maurel, Joan; Gascon, Pedro] Univ Barcelona, Fac Med, ICMHO,Hosp Clin, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Barcelona 7, Spain; [Auge, Josep M.] Univ Barcelona, Fac Med, Dept Biochem, ICMHO,Hosp Clin, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Barcelona 7, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Almendro, V (corresponding author), Univ Barcelona, Fac Med, ICMHO,Hosp Clin, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Barcelona 7, Spain.	almendro@clinic.ub.es	Gascon, Pere/F-7905-2015; Auge, Josep Maria/AAA-2963-2019	Auge, Josep Maria/0000-0001-6383-7308; Ametller, elisabet/0000-0001-9947-7033; Collazo Otero, Olga Maria/0000-0002-1775-3194	Fundacion Cellex; Asociacion Espanola Contra el Cancer (AECC)	Fundacion Cellex; Asociacion Espanola Contra el Cancer (AECC)	This work has been partially financed by grants from Fundacion Cellex, and by a grant from the Asociacion Espanola Contra el Cancer (AECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chen CC, 2007, BRIT J CANCER, V97, P334, DOI 10.1038/sj.bjc.6603866; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P317, DOI 10.1016/S1040-8428(01)00219-0; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferrer B, 2005, PATHOBIOLOGY, V72, P225, DOI 10.1159/000089416; Fingleton B, 2001, NEOPLASIA, V3, P459, DOI 10.1038/sj.neo.7900190; Giambernardi TA, 1998, MATRIX BIOL, V16, P483, DOI 10.1016/S0945-053X(98)90019-1; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Ii M, 2006, EXP BIOL MED, V231, P20; KALTSCHMIDT C, 1995, BIOL CHEM H-S, V376, P9; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kurokawa S, 2005, GUT, V54, P1751, DOI 10.1136/gut.2005.071035; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Liu KB, 2003, J IMMUNOL, V171, P4164, DOI 10.4049/jimmunol.171.8.4164; Maurel J, 2007, INT J CANCER, V121, P1066, DOI 10.1002/ijc.22799; Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783; Mitsiades N, 2001, CANCER RES, V61, P577; Mizutani Y, 2001, CANCER, V92, P287, DOI 10.1002/1097-0142(20010715)92:2<287::AID-CNCR1321>3.0.CO;2-4; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nonomura N, 2000, UROLOGY, V55, P151, DOI 10.1016/S0090-4295(99)00379-9; Osorio LM, 2001, EUR J HAEMATOL, V66, P342, DOI 10.1034/j.1600-0609.2001.066005342.x; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Petak I, 2000, CLIN CANCER RES, V6, P4432; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Rudolph-Owen LA, 1998, CANCER RES, V58, P5500; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Vargo-Gogola T, 2002, CANCER RES, V62, P5559; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; WITTY JP, 1994, CANCER RES, V54, P4805; Yamamoto H, 1999, CANCER RES, V59, P3313; Yamamoto H, 2001, J CLIN ONCOL, V19, P1118, DOI 10.1200/JCO.2001.19.4.1118; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038	35	55	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4728	10.1371/journal.pone.0004728	http://dx.doi.org/10.1371/journal.pone.0004728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266094	Green Submitted, gold, Green Published			2022-12-27	WOS:000265490800009
J	Lim, RH; Kobzik, L				Lim, Robert H.; Kobzik, Lester			Transplacental Passage of Interleukins 4 and 13?	PLOS ONE			English	Article								The mechanisms by which prenatal events affect development of adult disease are incompletely characterized. Based on findings in a murine model of maternal transmission of asthma risk, we sought to test the role of the pro-asthmatic cytokines interleukin IL-4 and -13. To assess transplacental passage of functional cytokines, we assayed phosphorylation of STAT-6, a marker of IL-4 and -13 signaling via heterodimeric receptor complexes which require an IL-4 receptor alpha subunit. IL-4 receptor alpha-/- females were mated to wild-type males, and pregnant females were injected with supraphysiologic doses of IL-4 or 13. One hour after injection, the receptor heterozygotic embryos were harvested and tissue nuclear proteins extracts assayed for phosphorylation of STAT-6 by Western blot. While direct injection of embryos produced a robust positive control, no phosphorylation was seen after maternal injection with either IL-4 or -13, indicating that neither crossed the placenta in detectable amounts. The data demonstrate a useful approach to assay for transplacental passage of functional maternal molecules, and indicate that molecules other than IL-4 and IL-13 may mediate transplacental effects in maternal transmission of asthma risk.	[Lim, Robert H.; Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lim, Robert H.] Childrens Hosp Boston, Div Resp Dis, Boston, MA USA; [Kobzik, Lester] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Lim, RH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	rlim@hsph.harvard.edu; lkobzik@hsph.harvard.edu			 [F32 HL086196-010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL086196] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by an F32 grant (F32 HL086196-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; de Rooij SR, 2006, PSYCHONEUROENDOCRINO, V31, P1257, DOI 10.1016/j.psyneuen.2006.09.007; Devereux G, 2001, CLIN EXP ALLERGY, V31, P1686, DOI 10.1046/j.1365-2222.2001.01215.x; Fasler-Kan E, 1998, EUR J BIOCHEM, V254, P514, DOI 10.1046/j.1432-1327.1998.2540514.x; Franzek EJ, 2008, ADDICTION, V103, P433, DOI 10.1111/j.1360-0443.2007.02084.x; Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Herz U, 2000, EUR J IMMUNOL, V30, P714, DOI 10.1002/1521-4141(200002)30:2<714::AID-IMMU714>3.0.CO;2-P; Herz U, 2000, AM J RESP CRIT CARE, V162, pS62, DOI 10.1164/ajrccm.162.supplement_2.ras-1; HIROTA JA, 2008, CLIN EXP ALLERGY; Hoshino A, 2004, INT IMMUNOL, V16, P1497, DOI 10.1093/intimm/dxh151; Hubeau C, 2006, AM J PATHOL, V168, P1931, DOI 10.2353/ajpath.2006.051231; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Ostojic S, 2003, AM J REPROD IMMUNOL, V49, P101, DOI 10.1034/j.1600-0897.2003.01150.x; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Patel BKR, 1996, J BIOL CHEM, V271, P22175, DOI 10.1074/jbc.271.36.22175; Qin JZ, 2001, BLOOD, V98, P2778, DOI 10.1182/blood.V98.9.2778; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Rees J, 2005, BRIT MED J, V331, P443, DOI 10.1136/bmj.331.7514.443; Reisenberger K, 1996, OBSTET GYNECOL, V87, P613, DOI 10.1016/0029-7844(95)00473-4; Roth P, 1998, BLOOD, V91, P3773, DOI 10.1182/blood.V91.10.3773.3773_3773_3783; Smith JT, 2003, ENDOCRINOLOGY, V144, P3024, DOI 10.1210/en.2003-0145; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; WAYSBORT A, 1993, ANTIMICROB AGENTS CH, V37, P1232, DOI 10.1128/AAC.37.6.1232; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Zaretsky MV, 2004, OBSTET GYNECOL, V103, P546, DOI 10.1097/01.AOG.0000114980.40445.83; Zourbas S, 2001, CLIN EXP IMMUNOL, V126, P519, DOI 10.1046/j.1365-2249.2001.01607.x	33	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4660	10.1371/journal.pone.0004660	http://dx.doi.org/10.1371/journal.pone.0004660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252738	Green Submitted, Green Published, gold			2022-12-27	WOS:000265489900003
J	Gogishvili, T; Langenhorst, D; Luhder, F; Elias, F; Elflein, K; Dennehy, KM; Gold, R; Hunig, T				Gogishvili, Tea; Langenhorst, Daniela; Luehder, Fred; Elias, Fernando; Elflein, Karin; Dennehy, Kevin M.; Gold, Ralf; Huenig, Thomas			Rapid Regulatory T-Cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice	PLOS ONE			English	Article								Superagonistic CD28-specific monoclonal antibodies (CD28SA) are highly effective activators of regulatory T-cells (Treg cells) in rats, but a first-in-man trial of the human CD28SA TGN1412 resulted in an unexpected cytokine release syndrome. Using a novel mouse anti-mouse CD28SA, we re-investigate the relationship between Treg activation and systemic cytokine release. Treg activation by CD28SA was highly efficient but depended on paracrine IL-2 from CD28SA-stimulated conventional T-cells. Systemic cytokine levels were innocuous, but depletion of Treg cells prior to CD28SA stimulation led to systemic release of proinflammatory cytokines, indicating that in rodents, Treg cells effectively suppress the inflammatory response. Since the human volunteers of the TGN1412 study were not protected by this mechanism, we also tested whether corticosteroid prophylaxis would be compatible with CD28SA induced Treg activation. We show that neither the expansion nor the functional activation of Treg cells is affected by high-dose dexamethasone sufficient to control systemic cytokine release. Our findings warn that preclinical testing of activating biologicals in rodents may miss cytokine release syndromes due to the rapid and efficacious response of the rodent Treg compartment, and suggest that polyclonal Treg activation is feasible in the presence of antiphlogistic corticosteroid prophylaxis.	[Gogishvili, Tea; Langenhorst, Daniela; Elias, Fernando; Elflein, Karin; Dennehy, Kevin M.; Huenig, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Luehder, Fred] Univ Gottingen, Inst Multiple Sclerosis Res, D-3400 Gottingen, Germany; [Luehder, Fred] Gemeinnutzige Hertie Stiftung, Gottingen, Germany; [Dennehy, Kevin M.] Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72074 Tubingen, Germany; [Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany	University of Wurzburg; University of Gottingen; Eberhard Karls University of Tubingen; Ruhr University Bochum	Gogishvili, T (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	huenig@vim.uni-wuerzburg.de			Deutsche Forschungsgemeinschaft [SFBs479, 581, TR52]; Graduate School of Life Sciences; Hertie foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of Life Sciences; Hertie foundation	Supported by Deutsche Forschungsgemeinschaft through SFBs479, 581, TR52, and the Graduate School of Life Sciences, and by the Hertie foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Adorini L, 2004, SEMIN IMMUNOL, V16, P127, DOI 10.1016/j.smim.2003.12.008; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; Chatenoud L, 1991, Curr Top Microbiol Immunol, V174, P121; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.200635873; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Duff G., 2006, FINAL REPORT 2006, P1; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Guilliams M, 2008, J INFECT DIS, V198, P781, DOI 10.1086/590439; Hanke T, 2006, LANCET, V368, P1569, DOI 10.1016/S0140-6736(06)69651-7; HEBART H, 1995, BONE MARROW TRANSPL, V15, P891; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hunig T, 2007, ADV IMMUNOL, V95, P111, DOI 10.1016/S0065-2776(07)95004-X; Kitazawa Y, 2008, J HEART LUNG TRANSPL, V27, P362, DOI 10.1016/j.healun.2008.01.004; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Muller N, 2008, J CLIN INVEST, V118, P1405, DOI 10.1172/JCI32698; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Schraven B, 2008, IMMUNITY, V28, P591, DOI 10.1016/j.immuni.2008.04.003; Seifert Georg, 2006, Haematologica, V91, pECR23; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tischner D, 2006, BRAIN, V129, P2635, DOI 10.1093/brain/awl213; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T	42	64	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4643	10.1371/journal.pone.0004643	http://dx.doi.org/10.1371/journal.pone.0004643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247496	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487800023
J	Graham, DB; Zinselmeyer, BH; Mascarenhas, F; Delgado, R; Miller, MJ; Swat, W				Graham, Daniel B.; Zinselmeyer, Bernd H.; Mascarenhas, Francesca; Delgado, Ryan; Miller, Mark J.; Swat, Wojciech			ITAM Signaling by Vav Family Rho Guanine Nucleotide Exchange Factors Regulates Interstitial Transit Rates of Neutrophils In Vivo	PLOS ONE			English	Article								Background: In response to infection, neutrophils are quickly recruited from the blood into inflamed tissues. The interstitial migration of neutrophils is crucial for the efficient capture and control of rapidly proliferating microbes before microbial growth can overwhelm the host's defenses. However, the molecular mechanisms that regulate interstitial migration are incompletely understood. Methodology/Principal Findings: Here, we use two-photon microscopy (2PM) to study discrete steps of neutrophil responses during subcutaneous infection with bacteria. Our study demonstrates that signals emanating from ITAM-containing receptors mediated by Vav family Rho GEFs control the velocity, but not the directionality, of neutrophil migration towards sites of bacterial infection. Conclusions/Significance: Here we show that during neutrophil migration towards sites of bacterial infection, signals emanating from ITAM-containing receptors specifically control interstitial neutrophil velocity.	[Graham, Daniel B.; Zinselmeyer, Bernd H.; Mascarenhas, Francesca; Delgado, Ryan; Miller, Mark J.; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Graham, DB (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	miller@wustl.edu; swat@wustl.edu	Zinselmeyer, Bernd/X-4802-2018	Zinselmeyer, Bernd/0000-0003-4172-6767; Miller, Mark/0000-0001-5676-389X	NIH [AI06107703, AI06302402, T32 CA009547]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI06107703 and AI06302402 to W.S., and T32 CA009547 to D.B.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2007, IMMUNOL REV, V218, P29, DOI 10.1111/j.1600-065X.2007.00531.x; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; Bezman N, 2007, IMMUNOL REV, V218, P9, DOI 10.1111/j.1600-065X.2007.00541.x; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Faust N, 2000, BLOOD, V96, P719; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zinselmeyer BH, 2008, INFLAMM RES, V57, P93, DOI 10.1007/s00011-007-7195-y; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	26	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4652	10.1371/journal.pone.0004652	http://dx.doi.org/10.1371/journal.pone.0004652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247495	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800031
J	Pistis, G; Piras, I; Pirastu, N; Persico, I; Sassu, A; Picciau, A; Prodi, D; Fraumene, C; Mocci, E; Manias, MT; Atzeni, R; Cosso, M; Pirastu, M; Angius, A				Pistis, Giorgio; Piras, Ignazio; Pirastu, Nicola; Persico, Ivana; Sassu, Alessandro; Picciau, Andrea; Prodi, Dionigio; Fraumene, Cristina; Mocci, Evelina; Manias, Maria Teresa; Atzeni, Rossano; Cosso, Massimiliano; Pirastu, Mario; Angius, Andrea			High Differentiation among Eight Villages in a Secluded Area of Sardinia Revealed by Genome-Wide High Density SNPs Analysis	PLOS ONE			English	Article							LINKAGE-DISEQUILIBRIUM; POPULATION-STRUCTURE; SUBSTRUCTURE; PATTERNS; HAPLOTYPES; FREQUENCY; INFERENCE; HISTORY; DISEASE; ISOLATE	To better design association studies for complex traits in isolated populations it's important to understand how history and isolation moulded the genetic features of different communities. Population isolates should not "a priori" be considered homogeneous, even if the communities are not distant and part of a small region. We studied a particular area of Sardinia called Ogliastra, characterized by the presence of several distinct villages that display different history, immigration events and population size. Cultural and geographic isolation characterized the history of these communities. We determined LD parameters in 8 villages and defined population structure through high density SNPs (about 360 K) on 360 unrelated people (45 selected samples from each village). These isolates showed differences in LD values and LD map length. Five of these villages show high LD values probably due to their reduced population size and extreme isolation. High genetic differentiation among villages was detected. Moreover population structure analysis revealed a high correlation between genetic and geographic distances. Our study indicates that history, geography and biodemography have influenced the genetic features of Ogliastra communities producing differences in LD and population structure. All these data demonstrate that we can consider each village an isolate with specific characteristics. We suggest that, in order to optimize the study design of complex traits, a thorough characterization of genetic features is useful to identify the presence of sub-populations and stratification within genetic isolates.	[Pistis, Giorgio; Persico, Ivana; Pirastu, Mario; Angius, Andrea] CNR, Ist Genet Popolaz, Sassari, Italy; [Piras, Ignazio; Pirastu, Nicola; Sassu, Alessandro; Picciau, Andrea; Prodi, Dionigio; Fraumene, Cristina; Mocci, Evelina; Manias, Maria Teresa; Atzeni, Rossano; Cosso, Massimiliano; Pirastu, Mario; Angius, Andrea] Shardna Life Sci, Cagliari, Italy	Consiglio Nazionale delle Ricerche (CNR)	Pistis, G (corresponding author), CNR, Ist Genet Popolaz, Sassari, Italy.	angius@igm.ss.cnr.it	Pirastu, Nicola/G-4358-2011; Angius, Andrea/P-9549-2015; Angius, Andrea/B-8966-2015; Persico, Ivana/AAX-7255-2020; Pirastu, Nicola/AHB-6226-2022	Angius, Andrea/0000-0003-2596-6461; Persico, Ivana/0000-0001-9946-1509; Angius, Andrea/0000-0001-9372-1162; Piras, Ignazio/0000-0003-4024-3368; Pirastu, Nicola/0000-0002-5363-3886; Atzeni, Rossano/0000-0003-0020-0013	Italian Ministry of Education, University and Research (MIUR) [5571/DSPAR/2002]; FIRB [718/Ric/2005]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants from the Italian Ministry of Education, University and Research (MIUR) n: 5571/DSPAR/2002 and (FIRB) D.M. n.718/Ric/2005.	Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Angius A, 2008, HUM HERED, V65, P9, DOI 10.1159/000106058; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Babron MC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S18; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Belkhir K., 2003, GENETIX LOGICIEL WIN; Benzecri Jean-Paul, 1973, ANAL DONNEES, V2; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; CLAYTON D, 2001, HDB STAT GENETICS, P519; COCCO F, 1987, DATI RELATIVI STORIA, V3; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Escofier B., 1990, ANAL FACTORIELLES SI; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; FALUSH D, 2007, MOL ECOL NOTES; Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fraumene C, 2003, HUM GENET, V114, P1, DOI 10.1007/s00439-003-1008-3; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Ghiani ME, 2002, COLLEGIUM ANTROPOL, V26, P387; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Greenacre Michael, 1984, THEORY APPL CORRES A; Guinand B, 1996, BIOL J LINN SOC, V58, P173, DOI 10.1111/j.1095-8312.1996.tb01430.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; HILL WG, 1994, AM J HUM GENET, V54, P705; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jousilahti P, 1998, ANN MED, V30, P481, DOI 10.3109/07853899809002490; KIMURA M, 1964, GENETICS, V49, P725; Lampis R, 2000, TISSUE ANTIGENS, V56, P515, DOI 10.1034/j.1399-0039.2000.560605.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Latini V, 2003, HUM BIOL, V75, P855, DOI 10.1353/hub.2004.0008; Lee N, 2001, AM J HUM GENET, V68, P397, DOI 10.1086/318197; LEWONTIN RC, 1964, GENETICS, V49, P49; LONG JC, 1986, GENETICS, V112, P629; Loudianos G, 1999, J MED GENET, V36, P833; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; MANTEL N, 1967, CANCER RES, V27, P209; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marroni F, 2006, ANN HUM GENET, V70, P812, DOI 10.1111/j.1469-1809.2006.00274.x; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morelli L, 2000, HUM BIOL, V72, P585; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Pritchard JK, 2000, GENETICS, V155, P945; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; RELETHFORD JH, 1994, ANN HUM BIOL, V21, P13, DOI 10.1080/03014469400003042; REYNOLDS J, 1983, GENETICS, V105, P767; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; SHE JX, 1987, BIOL J LINN SOC, V32, P357, DOI 10.1111/j.1095-8312.1987.tb00437.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SMOUSE PE, 1988, 2ND P INT C QUANT GE, P32; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003862; TUOMILEHTO J, 1992, EUR HEART J, V13, P577, DOI 10.1093/oxfordjournals.eurheartj.a060219; Vitart V, 2006, EUR J HUM GENET, V14, P478, DOI 10.1038/sj.ejhg.5201589; VONA G, 1997, INT J ANTHR, V12, P71, DOI DOI 10.1007/BF02447890; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Wright S., 1978, EVOLUTION GENETIC PO; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	82	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4654	10.1371/journal.pone.0004654	http://dx.doi.org/10.1371/journal.pone.0004654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247500	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487800033
J	Premi, S; Srivastava, J; Chandy, SP; Ali, S				Premi, Sanjay; Srivastava, Jyoti; Chandy, Sebastian Padinjarel; Ali, Sher			Unique Signatures of Natural Background Radiation on Human Y Chromosomes from Kerala, India	PLOS ONE			English	Article							COPY NUMBER POLYMORPHISM; IONIZING-RADIATION; DAZ GENES; REGION; DELETIONS; COPIES; SRY; MICRODELETIONS; RECOMBINATION; DNA	Background: The most frequently observed major consequences of ionizing radiation are chromosomal lesions and cancers, although the entire genome may be affected. Owing to its haploid status and absence of recombination, the human Y chromosome is an ideal candidate to be assessed for possible genetic alterations induced by ionizing radiation. We studied the human Y chromosome in 390 males from the South Indian state of Kerala, where the level of natural background radiation (NBR) is ten-fold higher than the worldwide average, and that from 790 unexposed males as control. Results: We observed random microdeletions in the Azoospermia factor (AZF) a, b and c regions in >90%, and tandem duplication and copy number polymorphism (CNP) of 11 different Y-linked genes in about 80% of males exposed to NBR. The autosomal homologues of Y-linked CDY genes largely remained unaffected. Multiple polymorphic copies of the Y-linked genes showing single Y-specific signals suggested their tandem duplication. Some exposed males showed unilocus duplication of DAZ genes resulting in six copies. Notably, in the AZFa region, approximately 25% of exposed males showed deletion of the DBY gene, whereas flanking genes USP9Y and UTY remained unaffected. All these alterations were detected in blood samples but not in the germline (sperm) samples. Conclusions: Exposure to high levels of NBR correlated with several interstitial polymorphisms of the human Y chromosome. CNPs and enhanced transcription of the SRY gene after duplication are envisaged to compensate for the loss of Y chromosome in some cells. The aforesaid changes, confined to peripheral blood lymphocytes, suggest a possible innate mechanism protecting the germline DNA from the NBR. Genome analysis of a larger population focusing on greater numbers of genes may provide new insights into the mechanisms and risks of the resultant genetic damages. The present work demonstrates unique signatures of NBR on human Y chromosomes from Kerala, India.	[Premi, Sanjay; Srivastava, Jyoti; Chandy, Sebastian Padinjarel; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Premi, S (corresponding author), Natl Inst Immunol, Mol Genet Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	alisher@nii.res.in	SRIVASTAVA, JYOTI/J-6065-2014; Premi, Sanjay/ABB-1423-2020; Srivastava, Jyoti/AAD-7610-2022; Premi, Sanjay/J-4351-2014	SRIVASTAVA, JYOTI/0000-0002-5727-741X; Premi, Sanjay/0000-0002-5492-5469; 	Alexander Von Humboldt Foundation, Bonn, Germany; DBT [BT/PR2225/Med/13/077/2000]; DST [SP/SO/DO3/99]; Department of Biotechnology, Govt. of India to National Institute of Immunology, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi [Senior Research Fellowship]	Alexander Von Humboldt Foundation, Bonn, Germany(Alexander von Humboldt Foundation); DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); Department of Biotechnology, Govt. of India to National Institute of Immunology, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	We thank Alexander Von Humboldt Foundation, Bonn, Germany for Equipment donation. This work was supported by DBT grant no. BT/PR2225/Med/13/077/2000 and DST grant no. SP/SO/DO3/99) to SA and a core grant from the Department of Biotechnology, Govt. of India to National Institute of Immunology, New Delhi. SP is thankful to the Council of Scientific and Industrial Research (CSIR), New Delhi for the Senior Research Fellowship. This work has been seen and approved by all the authors and they do not have any conflict of personal communication or financial interests.	Buckley PG, 2005, TRENDS GENET, V21, P315, DOI 10.1016/j.tig.2005.04.007; Bullejos M, 1999, CYTOGENET CELL GENET, V86, P46, DOI 10.1159/000015428; Cheriyan VD, 1999, RADIAT RES, V152, pS154, DOI 10.2307/3580136; Dubrova YE, 2002, AM J HUM GENET, V71, P801, DOI 10.1086/342729; Dubrova YE, 2002, SCIENCE, V295, P1037, DOI 10.1126/science.1068102; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499; FRIEDBERG EC, 1995, DNA REP MUTAGEN; Hande MP, 2003, AM J HUM GENET, V72, P1162, DOI 10.1086/375041; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; HOOF V, 2005, GENETICS, V171, P1455; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jaikrishan G, 1999, RADIAT RES, V152, pS149, DOI 10.2307/3580135; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; KUZIN A M, 1983, Radiobiologiya, V23, P192; Loucas BD, 2004, CYTOGENET GENOME RES, V104, P206, DOI 10.1159/000077490; Lundrigan BL, 1997, J MOL EVOL, V45, P60, DOI 10.1007/PL00006202; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Murthy SK, 2005, ARCH PATHOL LAB MED, V129, P39; Nadeau JH, 2006, NATURE, V439, P798, DOI 10.1038/439798a; Nakajima M, 1996, ENVIRON HEALTH PERSP, V104, P1336, DOI 10.2307/3432971; ONEILL P, 1993, ADV RADIAT BIOL, V17, P53; Ottolenghi C, 2000, GENOMICS, V64, P170, DOI 10.1006/geno.2000.6121; Premi S, 2006, MOL HUM REPROD, V12, P113, DOI 10.1093/molehr/gal012; Premi S, 2007, HUM GENET, V121, P337, DOI 10.1007/s00439-006-0318-7; Prise KM, 2001, RADIAT RES, V156, P572, DOI 10.1667/0033-7587(2001)156[0572:AROSOI]2.0.CO;2; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Sankaranarayanan K, 1999, MUTAT RES-FUND MOL M, V429, P45, DOI 10.1016/S0027-5107(99)00100-1; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; SUNDARAM K, 1977, NATURE, V267, P728, DOI 10.1038/267728b0; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; *UNSCEAR UN SCI CO, 1993, 1993 REP GEN ASS WIT; XIONGLEI H, 2005, CURR BIOL, V15, P1016	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4541	10.1371/journal.pone.0004541	http://dx.doi.org/10.1371/journal.pone.0004541			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242544	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487500002
J	Morlan, J; Baker, J; Sinicropi, D				Morlan, John; Baker, Joffre; Sinicropi, Dominick			Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; COLORECTAL-CANCER; RAS MUTATIONS; BLOCKER-PCR; DNA; KRAS; AMPLIFICATION; CHEMOTHERAPY	Background: Molecular tests for diagnosis of disease, particularly cancer, are gaining increased acceptance by physicians and their patients for disease prognosis and selection of treatment options. Gene expression profiles and genetic mutations are key parameters used for the molecular characterization of tumors. A variety of methods exist for mutation analysis but the development of assays with high selectivity tends to require a process of trial and error, and few are compatible with real-time PCR. We sought to develop a real-time PCR-based mutation assay methodology that successfully addresses these issues. Methodology/Principal Findings:The method we describe is based on the widely used TaqMan (R) real-time PCR technology, and combines Allele-Specific PCR with a Blocking reagent (ASB-PCR) to suppress amplification of the wildype allele. ASB-PCR can be used for detection of germ line or somatic mutations in either DNA or RNA extracted from any type of tissue, including formalin-fixed paraffin-embedded tumor specimens. A set of reagent design rules was developed enabling sensitive and selective detection of single point substitutions, insertions, or deletions against a background of wild-type allele in thousand-fold or greater excess. Conclusions/Significance: ASB-PCR is a simple and robust method for assaying single nucleotide mutations and polymorphisms within the widely used TaqMan (R) protocol for real time RT-PCR. The ASB-PCR design rules consistently produce highly selective mutation assays while obviating the need for redesign and optimization of the assay reagents. The method is compatible with formalin-fixed tissue and simultaneous analysis of gene expression by RT-PCR on the same plate. No proprietary reagents other than those for TaqMan chemistry are required, so the method can be performed in any research laboratory with real-time PCR capability.	[Morlan, John; Baker, Joffre; Sinicropi, Dominick] Genom Hlth Inc, Redwood City, CA USA	Genomic Health	Morlan, J (corresponding author), Genom Hlth Inc, Redwood City, CA USA.	dsinicropi@genomichealth.com			Genomic Health, Inc.	Genomic Health, Inc.	Genomic Health, Inc. provided funding for this work. The funders had no role in study design, data collection and analysis, or preparation of the manuscript but approved the decision to publish.	Akbari M, 2005, J MOL DIAGN, V7, P36, DOI 10.1016/S1525-1578(10)60006-2; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Amicarelli G, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm809; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; AUSUBEL FM, 1992, SHORT PROTOCOLS MOL, P8; Baker JB, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3512; Breen G, 2000, BIOTECHNIQUES, V28, P464, DOI 10.2144/00283st03; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; GRONIN M, 2001, AM J PATHOL, V164, P35; Hodgson DR, 2001, CLIN CHEM, V47, P774; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li BH, 2004, GENOMICS, V83, P311, DOI 10.1016/j.ygeno.2003.08.005; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Liu Q, 2004, HUM MUTAT, V23, P426, DOI 10.1002/humu.20036; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2006, NEW ENGL J MED, V354, P526; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; OROU A, 1995, HUM MUTAT, V6, P163, DOI 10.1002/humu.1380060209; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parsons BL, 2005, METH MOL B, V291, P235; Prix L, 2002, CLIN CHEM, V48, P428; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; SATNOWITZ WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; SEYAMA T, 1992, NUCLEIC ACIDS RES, V20, P2493, DOI 10.1093/nar/20.10.2493; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Taback B, 2004, INT J CANCER, V111, P409, DOI 10.1002/ijc.20268; Ugozzoli LA, 2004, ANAL BIOCHEM, V324, P143, DOI 10.1016/j.ab.2003.09.003; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	44	73	91	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4584	10.1371/journal.pone.0004584	http://dx.doi.org/10.1371/journal.pone.0004584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240792	Green Submitted, Green Published, gold			2022-12-27	WOS:000278086700006
J	Lehmann, T; Hume, JCC; Licht, M; Burns, CS; Wollenberg, K; Simard, F; Ribeiro, JMC				Lehmann, Tovi; Hume, Jen C. C.; Licht, Monica; Burns, Christopher S.; Wollenberg, Kurt; Simard, Fred; Ribeiro, Jose M. C.			Molecular Evolution of Immune Genes in the Malaria Mosquito Anopheles gambiae	PLOS ONE			English	Article								Background: As pathogens that circumvent the host immune response are favoured by selection, so are host alleles that reduce parasite load. Such evolutionary processes leave their signature on the genes involved. Deciphering modes of selection operating on immune genes might reveal the nature of host-pathogen interactions and factors that govern susceptibility in host populations. Such understanding would have important public health implications. Methodology/Findings: We analyzed polymorphisms in four mosquito immune genes (SP14D1, GNBP, defensin, and gambicin) to decipher selection effects, presumably mediated by pathogens. Using samples of Anopheles arabiensis, An. quadriannulatus and four An. gambiae populations, as well as published sequences from other Culicidae, we contrasted patterns of polymorphisms between different functional units of the same gene within and between populations. Our results revealed selection signatures operating on different time scales. At the most recent time scale, within-population diversity revealed purifying selection. Between populations and between species variation revealed reduced differentiation (GNBP and gambicin) at coding vs. noncoding-regions, consistent with balancing selection. McDonald-Kreitman tests between An. quadriannulatus and both sibling species revealed higher fixation rate of synonymous than nonsynonymous substitutions (GNBP) in accordance with frequency dependent balancing selection. At the longest time scale (>100 my), PAML analysis using distant Culicid taxa revealed positive selection at one codon in gambicin. Patterns of genetic variation were independent of exposure to human pathogens. Significance and Conclusions: Purifying selection is the most common form of selection operating on immune genes as it was detected on a contemporary time scale on all genes. Selection for "hypervariability" was not detected, but negative balancing selection, detected at a recent evolutionary time scale between sibling species may be rather common. Detection of positive selection at the deepest evolutionary time scale suggests that it occurs infrequently, possibly in association with speciation events. Our results provided no evidence to support the hypothesis that selection was mediated by pathogens that are transmitted to humans.	[Lehmann, Tovi; Licht, Monica; Burns, Christopher S.] Ctr Dis Control & Prevent, Entomol Branch, Div Parasit Dis, Chamblee, GA USA; [Lehmann, Tovi; Licht, Monica; Burns, Christopher S.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Lehmann, Tovi; Hume, Jen C. C.; Burns, Christopher S.; Ribeiro, Jose M. C.] NIAID, NIH, Lab Malaria & Vector Res, Rockville, MD USA; [Wollenberg, Kurt] NIAID, NIH, Office Cyber Infrastructure & Computat Biol, Bioinformat & Computat Biosci Branch, Bethesda, MD USA; [Simard, Fred] Org lutte Contre grandes Endemies Afrique Cent, LabInst Rech Dev, RU 016, Yaounde, Cameroon	Centers for Disease Control & Prevention - USA; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lehmann, T (corresponding author), Ctr Dis Control & Prevent, Entomol Branch, Div Parasit Dis, Chamblee, GA USA.	TLehmann@niaid.nih.gov	Frederic, SIMARD/AFV-5001-2022; SIMARD, Frederic/J-9489-2016	Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Ribeiro, Jose/0000-0002-9107-0818; Lehmann, Tovi/0000-0002-8142-3915; Wollenberg, Kurt/0000-0002-4973-9370	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); Entomology Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention; Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001062, Z01AI000810, ZIAAI001062, Z01AI000629, ZIAAI000629] Funding Source: NIH RePORTER	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); Entomology Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Entomology Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention, and by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barillas-Mury C, 2000, INSECT BIOCHEM MOLEC, V30, P429, DOI 10.1016/S0965-1748(00)00018-7; BEIER JC, 1990, J MED ENTOMOL, V27, P570, DOI 10.1093/jmedent/27.4.570; Besansky NJ, 1997, GENETICS, V147, P1817; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Chun J, 2000, INSECT MOL BIOL, V9, P39, DOI 10.1111/j.1365-2583.2000.00157.x; Clark AG, 1997, GENETICS, V147, P713; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; COLLINS FH, 1988, J MED ENTOMOL, V25, P116, DOI 10.1093/jmedent/25.2.116; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRITZ RS, 1992, PLANT RESISTANCE HER; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; GITHEKO AK, 1994, ACTA TROP, V58, P307, DOI 10.1016/0001-706X(94)90024-8; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1992, GENETICS, V132, P583; HUFF CG, 1965, EXP PARASITOL, V16, P107, DOI 10.1016/0014-4894(65)90036-6; HUFF CG, 1951, J INFECT DIS, V88, P17, DOI 10.1093/infdis/88.1.17; HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Jiggins FM, 2003, J MOL EVOL, V57, P598, DOI 10.1007/s00239-003-2506-6; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2003, MOL BIOL EVOL, V20, P914, DOI 10.1093/molbev/msg109; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lenhart Audrey, 2007, Filaria J, V6, P14, DOI 10.1186/1475-2883-6-14; Levine MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000442; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; MBOGO CNM, 1993, AM J TROP MED HYG, V49, P245, DOI 10.4269/ajtmh.1993.49.245; MCDONALD GH, 1994, NONNEUTRAL EVOLUTION, P88; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mukoko DAN, 2004, ANN TROP MED PARASIT, V98, P801, DOI 10.1179/000349804X3225; Obbard DJ, 2007, MOL ECOL, V16, P3497, DOI 10.1111/j.1365-294X.2007.03395.x; Paterson S, 1998, J HERED, V89, P289, DOI 10.1093/jhered/89.4.289; Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; *SAS I, 1990, SAS LANG REF VERS 6; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Schlenke TA, 2003, GENETICS, V164, P1471; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Shahabuddin M, 1998, EXP PARASITOL, V89, P103, DOI 10.1006/expr.1998.4212; Simard F, 2007, INFECT GENET EVOL, V7, P285, DOI 10.1016/j.meegid.2006.11.004; Slotman MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000793; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; Wright S, 1978, VARIABILITY NATURAL; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	73	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4549	10.1371/journal.pone.0004549	http://dx.doi.org/10.1371/journal.pone.0004549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234606	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487200005
J	Roy, SW				Roy, Scott William			Probing Evolutionary Repeatability: Neutral and Double Changes and the Predictability of Evolutionary Adaptation	PLOS ONE			English	Article								Background: The question of how organisms adapt is among the most fundamental in evolutionary biology. Two recent studies investigated the evolution of Escherichia coli in response to challenge with the antibiotic cefotaxime. Studying five mutations in the beta-lactamase gene that together confer significant antibiotic resistance, the authors showed a complex fitness landscape that greatly constrained the identity and order of intermediates leading from the initial wildtype genotype to the final resistant genotype. Out of 18 billion possible orders of single mutations leading from non-resistant to fully-resistant form, they found that only 27 (1.5x10(-7)%) pathways were characterized by consistently increasing resistance, thus only a tiny fraction of possible paths are accessible by positive selection. I further explore these data in several ways. Principal Findings: Allowing neutral changes (those that do not affect resistance) increases the number of accessible pathways considerably, from 27 to 629. Allowing multiple simultaneous mutations also greatly increases the number of accessible pathways. Allowing a single case of double mutation to occur along a pathway increases the number of pathways from 27 to 259, and allowing arbitrarily many pairs of simultaneous changes increases the number of possible pathways by more than 100 fold, to 4800. I introduce the metric 'repeatability,' the probability that two random trials will proceed via the exact same pathway. In general, I find that while the total number of accessible pathways is dramatically affected by allowing neutral or double mutations, the overall evolutionary repeatability is generally much less affected. Conclusions: These results probe the conceivable pathways available to evolution. Even when many of the assumptions of the analysis of Weinreich et al. (2006) are relaxed, I find that evolution to more highly cefotaxime resistant beta-lactamase proteins is still highly repeatable.	[Roy, Scott William] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Roy, SW (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	royscott@ncbi.nlm.nih.gov			National Institutes of Health Intramural Research Program	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health Intramural Research Program	DePristo MA, 2007, MOL BIOL EVOL, V24, P1608, DOI 10.1093/molbev/msm118; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; KIMURA M, 1962, GENETICS, V47, P713; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; STEMMER WP, 1994, NATURE, V4, P389; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1175; Wilke CO, 2001, B MATH BIOL, V63, P715, DOI 10.1006/bulm.2001.0244	9	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4500	10.1371/journal.pone.0004500	http://dx.doi.org/10.1371/journal.pone.0004500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234610	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487200002
J	Sole, X; Bonifaci, N; Lopez-Bigas, N; Berenguer, A; Hernandez, P; Reina, O; Maxwell, CA; Aguilar, H; Urruticoechea, A; de Sanjose, S; Comellas, F; Capella, G; Moreno, V; Pujana, MA				Sole, Xavier; Bonifaci, Nuria; Lopez-Bigas, Nuria; Berenguer, Antoni; Hernandez, Pilar; Reina, Oscar; Maxwell, Christopher A.; Aguilar, Helena; Urruticoechea, Ander; de Sanjose, Silvia; Comellas, Francesc; Capella, Gabriel; Moreno, Victor; Pujana, Miguel Angel			Biological Convergence of Cancer Signatures	PLOS ONE			English	Article								Gene expression profiling has identified cancer prognostic and predictive signatures with superior performance to conventional histopathological or clinical parameters. Consequently, signatures are being incorporated into clinical practice and will soon influence everyday decisions in oncology. However, the slight overlap in the gene identity between signatures for the same cancer type or condition raises questions about their biological and clinical implications. To clarify these issues, better understanding of the molecular properties and possible interactions underlying apparently dissimilar signatures is needed. Here, we evaluated whether the signatures of 24 independent studies are related at the genome, transcriptome or proteome levels. Significant associations were consistently observed across these molecular layers, which suggest the existence of a common cancer cell phenotype. Convergence on cell proliferation and death supports the pivotal involvement of these processes in prognosis, metastasis and treatment response. In addition, functional and molecular associations were identified with the immune response in different cancer types and conditions that complement the contribution of cell proliferation and death. Examination of additional, independent, cancer datasets corroborated our observations. This study proposes a comprehensive strategy for interpreting cancer signatures that reveals common design principles and systems-level properties.	[Sole, Xavier; Bonifaci, Nuria; Berenguer, Antoni; Moreno, Victor; Pujana, Miguel Angel] IDIBELL, Catalan Inst Oncol, Bioinformat & Biostat Unit, Barcelona, Spain; [Bonifaci, Nuria; Hernandez, Pilar; Maxwell, Christopher A.; Aguilar, Helena; Urruticoechea, Ander; Capella, Gabriel; Pujana, Miguel Angel] IDIBELL, Hosp, Catalan Inst Oncol, Translat Res Lab, Barcelona, Spain; [Lopez-Bigas, Nuria] UPF, Res Unit Biomed Informat IMIM, Barcelona, Spain; [Reina, Oscar; de Sanjose, Silvia] IDIBELL, Hosp, Catalan Inst Oncol, CIBERESP, Epidemiol Res Canc Program, Unit Infect & Canc, Barcelona, Spain; [Comellas, Francesc] Tech Univ Catalonia, Dept Applied Math 4, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universitat Politecnica de Catalunya	Sole, X (corresponding author), IDIBELL, Catalan Inst Oncol, Bioinformat & Biostat Unit, Barcelona, Spain.	mapujana@ico.scs.es	Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011; Maxwell, Christopher A/B-3044-2011; Capella, Gabriel/I-1879-2015; bonifaci, nuria/B-8104-2019; Moreno, Victor/A-1697-2010; Solé, Xavier/AAF-3015-2019; Pujana, Miquel Angel/N-3127-2014; de Sanjosé Llongueras, Silvia/H-6339-2014; Comellas, Francesc/I-4868-2014	Lopez-Bigas, Nuria/0000-0003-4925-8988; Maxwell, Christopher A/0000-0002-0713-7136; Capella, Gabriel/0000-0002-4669-7320; bonifaci, nuria/0000-0002-8193-6825; Moreno, Victor/0000-0002-2818-5487; Solé, Xavier/0000-0002-2197-3325; Pujana, Miquel Angel/0000-0003-3222-4044; Comellas, Francesc/0000-0003-4523-0240; Reina Garcia, Oscar/0000-0002-1031-2732; Urruticoechea, Ander/0000-0003-0359-3641; Maxwell, Christopher/0000-0002-0860-4031; Berenguer-LLergo, Antoni/0000-0002-3742-8161	The la Caixa Foundation [BM 05/254]; Spanish Ministry of Health [FIS 05/1006, 06/0545, RCESP C03/09, RTICCC C03/10, postdoctoral fellowship]; AGAUR agency of the Catalan Government [Beatriu de Pinos fellowship]; Spanish Ministry of Education and Science [Ramon y Cajal Researcher]	The la Caixa Foundation; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AGAUR agency of the Catalan Government(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Spanish Ministry of Education and Science(Spanish Government)	The la Caixa Foundation grant BM 05/254 (MAP) and the Spanish Ministry of Health grants FIS 05/1006 (VM) and 06/0545 (MAP), RCESP C03/09 and RTICCC C03/10 (VM and GC). CAM is supported by a Beatriu de Pinos fellowship from the AGAUR agency of the Catalan Government, HA is supported by a postdoctoral fellowship of the Spanish Ministry of Health and MAP is a Ramon y Cajal Researcher with the Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Ambs Stefan, 2008, Cancer Res, V68, P4031, DOI 10.1158/0008-5472.CAN-08-0521; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; GREIG KT, 2008, SEMIN IMMUNOL; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-185; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ishikawa H, 2007, J MOL ENDOCRINOL, V39, P333, DOI 10.1677/JME-06-0069; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jin VX, 2006, GENOME RES, V16, P1585, DOI 10.1101/gr.5520206; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Michiels S, 2007, BRIT J CANCER, V96, P1155, DOI 10.1038/sj.bjc.6603673; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morris SR, 2007, CURR OPIN ONCOL, V19, P547, DOI 10.1097/CCO.0b013e3282f0ada3; Nuyten DSA, 2008, SEMIN RADIAT ONCOL, V18, P105, DOI 10.1016/j.semradonc.2007.10.007; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pliskova M, 2005, TOXICOL SCI, V83, P246, DOI 10.1093/toxsci/kfi040; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Roepman P, 2006, CANCER RES, V66, P2361, DOI 10.1158/0008-5472.CAN-05-3960; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; Shen RL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-28; Sherlock G, 2005, NAT METHODS, V2, P329, DOI 10.1038/nmeth0505-329; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Tsuchihashi Z, 2005, NEW ENGL J MED, V353, P208, DOI 10.1056/NEJM200507143530218; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vuaroqueaux V, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1681; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Wennmalm K, 2007, NEW ENGL J MED, V356, P1887; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182; Zhang Z, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-331	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4544	10.1371/journal.pone.0004544	http://dx.doi.org/10.1371/journal.pone.0004544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229342	gold, Green Published, Green Submitted			2022-12-27	WOS:000265486200015
J	Fox, BA; Sheppard, PO; O'Hara, PJ				Fox, Brian A.; Sheppard, Paul O.; O'Hara, Patrick J.			The Role of Genomic Data in the Discovery, Annotation and Evolutionary Interpretation of the Interferon-Lambda Family	PLOS ONE			English	Article							IFN-LAMBDA; GENE; RECEPTOR; IDENTIFICATION; CONSERVATION; ZEBRAFISH; CYTOKINES; SYSTEM; NUMBER; IL-29	Background: Type-I interferons, type-II interferons, and the IL-10 family are helical cytokines with similar three-dimensional folds. However, their homologous relationship is difficult to detect on the basis of sequence alone. We have previously described the discovery of the human type-III interferons (IFN lambda-1, -2, -3 or IL-29, IL-28A, IL-28B), which required a combination of manual and computational techniques applied to predicted protein sequences. Principal Findings: Here we describe how the use of gene structure analysis and comparative genomics enabled a more extensive understanding of these genes early in the discovery process. More recently, additional mammalian genome sequences have shown that there are between one and potentially nine copies of interferon lambda genes in each genome, and that several species have single exon versions of the interferon lambda gene. Significance: The variable number of single exon type-I interferons in mammals, along with recently identified genes in zebrafish homologous to interferons allows a story of interferon evolution to be proposed. This model suggests that the gene duplications and single exon retrotransposons of mammalian type-III interferons are positively selected for within a genome. These characteristics are also shared with the fish interferons and could be responsible for the generation of the IL10 family and also the single exon type-I interferons.	[Fox, Brian A.; Sheppard, Paul O.; O'Hara, Patrick J.] Zymogenet Inc, Bioinformat Dept, Seattle, WA 98105 USA	Zymogenet Inc.	Fox, BA (corresponding author), Zymogenet Inc, Bioinformat Dept, Seattle, WA 98105 USA.	bfox@novonordisk.com		Fox, Brian/0000-0001-6620-3853	ZymoGenetics	ZymoGenetics	This study was funded by ZymoGenetics. As an employer, the funder(s) had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript	Altmann SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Brosius J, 1995, VIRUS GENES, V11, P163, DOI 10.1007/BF01728656; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Conklin D, 2005, BIOINFORMATICS, V21, P1776, DOI 10.1093/bioinformatics/bti283; Conklin D, 2004, J COMPUT BIOL, V11, P1189, DOI 10.1089/cmb.2004.11.1189; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Jordan WJ, 2007, GENES IMMUN, V8, P13, DOI 10.1038/sj.gene.6364348; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002; Krivan W, 2005, LECT NOTES COMPUT SC, V3318, P22; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Long S, 2004, DEV COMP IMMUNOL, V28, P97, DOI 10.1016/S0145-305X(03)00122-8; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Robertsen B, 2003, J INTERF CYTOK RES, V23, P601, DOI 10.1089/107999003322485107; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; SHEPPARD PO, 2002, Patent No. 0202627; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Vogel JH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-230; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Woelk CH, 2007, GENE, V397, P38, DOI 10.1016/j.gene.2007.03.018; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859	37	59	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4933	10.1371/journal.pone.0004933	http://dx.doi.org/10.1371/journal.pone.0004933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300512	Green Submitted, gold, Green Published			2022-12-27	WOS:000265496800011
J	Brunoni, AR; Lopes, M; Kaptchuk, TJ; Fregni, F				Brunoni, Andre Russowsky; Lopes, Mariana; Kaptchuk, Ted J.; Fregni, Felipe			Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; RANDOMIZED CONTROLLED-TRIAL; SHAM-CONTROLLED TRIAL; ADD-ON RTMS; DOUBLE-BLIND; ANTIDEPRESSANT EFFICACY; PREFRONTAL CORTEX; FOLLOW-UP; RESISTANT DEPRESSION; HIGH-FREQUENCY	Background: Although meta-analyses have shown that placebo responses are large in Major Depressive Disorder (MDD) trials; the placebo response of devices such as repetitive transcranial magnetic stimulation (rTMS) has not been systematically assessed. We proposed to assess placebo responses in two categories of MDD trials: pharmacological (antidepressant drugs) and non-pharmacological (device-rTMS) trials. Methodology/Principal Findings: We performed a systematic review and meta-analysis of the literature from April 2002 to April 2008, searching MEDLINE, Cochrane, Scielo and CRISP electronic databases and reference lists from retrieved studies and conference abstracts. We used the keywords placebo and depression and escitalopram for pharmacological studies; and transcranial magnetic stimulation and depression and sham for non-pharmacological studies. All randomized, double-blinded, placebo-controlled, parallel articles on major depressive disorder were included. Forty-one studies met our inclusion criteria-29 in the rTMS arm and 12 in the escitalopram arm. We extracted the mean and standard values of depression scores in the placebo group of each study. Then, we calculated the pooled effect size for escitalopram and rTMS arm separately, using Cohen's d as the measure of effect size. We found that placebo response are large for both escitalopram (Cohen's d-random-effects model-1.48; 95% C.I. 1.26 to 1.6) and rTMS studies (0.82; 95% C.I. 0.63 to 1). Exploratory analyses show that sham response is associated with refractoriness and with the use of rTMS as an add-on therapy, but not with age, gender and sham method utilized. Conclusions/Significance: We confirmed that placebo response in MDD is large regardless of the intervention and is associated with depression refractoriness and treatment combination (add-on rTMS studies). The magnitude of the placebo response seems to be related with study population and study design rather than the intervention itself.	[Brunoni, Andre Russowsky; Lopes, Mariana; Fregni, Felipe] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Brunoni, Andre Russowsky] Univ Sao Paulo, Dept Psychiat, BR-05508 Sao Paulo, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Dept Psychiat, Inst Psychiat, BR-05508 Sao Paulo, Brazil; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Osher Res Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade de Sao Paulo; Universidade de Sao Paulo; Harvard University; Harvard Medical School	Brunoni, AR (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA.	ffregni@bidmc.harvard.edu	Brunoni, Andre R./H-8394-2012	Brunoni, Andre R./0000-0002-6310-3571; Fregni, Felipe/0000-0001-9359-8643	National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER; NCCIH NIH HHS [K24 AT004095] Funding Source: Medline	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		ALEXOPOULOS G, 2004, PLACEBOCONTROLLED TR; Altshuler LL, 2003, BIOL PSYCHIAT, V53, P691, DOI 10.1016/S0006-3223(03)00087-8; Anderson IM, 2007, BRIT J PSYCHIAT, V190, P533, DOI 10.1192/bjp.bp.106.028019; Avery DH, 2006, BIOL PSYCHIAT, V59, P187, DOI 10.1016/j.biopsych.2005.07.003; Baethge C, 2003, ACTA PSYCHIAT SCAND, V107, P260, DOI 10.1034/j.1600-0447.2003.02057.x; Bortolomasi M, 2007, PSYCHIAT RES, V150, P181, DOI 10.1016/j.psychres.2006.04.010; Bose A, 2008, AM J GERIAT PSYCHIAT, V16, P14, DOI 10.1097/JGP.0b013e3181591c09; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutros NN, 2002, PSYCHIAT RES, V113, P245, DOI 10.1016/S0165-1781(02)00267-6; Bretlau LG, 2008, PHARMACOPSYCHIATRY, V41, P41, DOI 10.1055/s-2007-993210; Burke WJ, 2002, J CLIN PSYCHIAT, V63, P331, DOI 10.4088/JCP.v63n0410; Clayton AH, 2006, J CLIN PSYCHIAT, V67, P736, DOI 10.4088/JCP.v67n0507; Couturier JL, 2005, J PSYCHIATR NEUROSCI, V30, P83; de Craen AJM, 2000, J NEUROL, V247, P183, DOI 10.1007/s004150050560; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fergusson D, 2004, BRIT MED J, V328, P432, DOI 10.1136/bmj.37952.631667.EE; Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002; Fitzgerald PB, 2006, AM J PSYCHIAT, V163, P88, DOI 10.1176/appi.ajp.163.1.88; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Fregni F, 2006, INT J NEUROPSYCHOPH, V9, P641, DOI 10.1017/S1461145705006280; Garcia-Toro M, 2006, PSYCHIAT RES-NEUROIM, V146, P53, DOI 10.1016/j.pscychresns.2004.08.005; Gross M, 2007, ACTA PSYCHIAT SCAND, V116, P165, DOI 10.1111/j.1600-0447.2007.01049.x; Hausmann A, 2004, J NEUROL NEUROSUR PS, V75, P320; Hermann LL, 2006, J CLIN PSYCHIAT, V67, P1870, DOI 10.4088/JCP.v67n1206; Herwig U, 2007, BRIT J PSYCHIAT, V191, P441, DOI 10.1192/bjp.bp.106.034371; Herwig U, 2003, J PSYCHIATR RES, V37, P267, DOI 10.1016/S0022-3956(03)00042-6; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Holtzheimer PE, 2004, DEPRESS ANXIETY, V19, P24, DOI 10.1002/da.10147; Hoppner J, 2003, EUR ARCH PSY CLIN N, V253, P103, DOI 10.1007/s00406-003-0416-7; Hrobjartsson A, 2002, J CLIN EPIDEMIOL, V55, P430, DOI 10.1016/S0895-4356(01)00496-6; Januel D, 2006, PROG NEURO-PSYCHOPH, V30, P126, DOI 10.1016/j.pnpbp.2005.08.016; Jorge RE, 2004, BIOL PSYCHIAT, V55, P398, DOI 10.1016/j.biopsych.2003.08.017; Jorge RE, 2008, ARCH GEN PSYCHIAT, V65, P268, DOI 10.1001/archgenpsychiatry.2007.45; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kasper S, 2005, AM J GERIAT PSYCHIAT, V13, P884, DOI 10.1176/appi.ajgp.13.10.884; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Koerselman F, 2004, J CLIN PSYCHIAT, V65, P1323, DOI 10.4088/JCP.v65n1005; Lam RW, 2008, CAN J PSYCHIAT, V53, P621, DOI 10.1177/070674370805300909; Lepola UM, 2003, INT CLIN PSYCHOPHARM, V18, P211, DOI 10.1097/00004850-200307000-00003; LISANBY SH, 2008, NEUROPSYCHOPHARMACOL; Loo CK, 2000, BIOL PSYCHIAT, V47, P325, DOI 10.1016/S0006-3223(99)00285-1; Loo CK, 2003, PSYCHOL MED, V33, P33, DOI 10.1017/S0033291702006839; Loo CK, 2007, PSYCHOL MED, V37, P341, DOI 10.1017/S0033291706009597; Martin JLR, 2003, BRIT J PSYCHIAT, V182, P480, DOI 10.1192/bjp.182.6.480; Mitchell PB, 2006, AUST NZ J PSYCHIAT, V40, P406, DOI 10.1111/j.1440-1614.2006.01816.x; Mogg A, 2008, PSYCHOL MED, V38, P323, DOI 10.1017/S0033291707001663; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Mosimann UP, 2004, PSYCHIAT RES, V126, P123, DOI 10.1016/j.psychres.2003.10.006; Nierenberg AA, 2007, CURR MED RES OPIN, V23, P401, DOI 10.1185/030079906X167453; NINAN P, 2003, ESCITALOPRAM IS EFFE; O'Reardon JP, 2007, DEPRESS ANXIETY, V24, P537, DOI 10.1002/da.20261; Papakostas GI, 2007, J CLIN PSYCHIAT, V68, P826, DOI 10.4088/JCP.v68n0602; Posternak MA, 2007, BRIT J PSYCHIAT, V190, P287, DOI 10.1192/bjp.bp.106.028555; Poulet E, 2004, EUR PSYCHIAT, V19, P382, DOI 10.1016/j.eurpsy.2004.06.021; Rapaport MH, 2004, J CLIN PSYCHIAT, V65, P44; Rossini D, 2005, J CLIN PSYCHIAT, V66, P1569, DOI 10.4088/JCP.v66n1212; Rossini D, 2005, PSYCHIAT RES, V137, P1, DOI 10.1016/j.psychres.2005.06.008; Rumi DO, 2005, BIOL PSYCHIAT, V57, P162, DOI 10.1016/j.biopsych.2004.10.029; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Schulz DL, 2008, 2008 FLEXIBLE ELECTRONICS & DISPLAYS CONFERENCE AND EXHIBITION, P5; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schwartz NA, 2000, ACAD EMERG MED, V7, P857, DOI 10.1111/j.1553-2712.2000.tb02061.x; Stein DJ, 2006, J CLIN PSYCHIAT, V67, P1741, DOI 10.4088/JCP.v67n1111; Stern WM, 2007, J NEUROPSYCH CLIN N, V19, P179, DOI 10.1176/appi.neuropsych.19.2.179; Stolk P, 2003, ANN PHARMACOTHER, V37, P1891, DOI 10.1345/aph.1D172; Su TP, 2005, J CLIN PSYCHIAT, V66, P930, DOI 10.4088/JCP.v66n0718; TRIVEDI MH, 1994, NEUROPSYCHOPHARMACOL, V11, P33, DOI 10.1038/npp.1994.63; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Wade A, 2002, INT CLIN PSYCHOPHARM, V17, P95, DOI 10.1097/00004850-200205000-00001; Wagner KD, 2006, J AM ACAD CHILD PSY, V45, P280, DOI 10.1097/01.chi.0000192250.38400.9e; Walach H, 2001, J ALTERN COMPLEM MED, V7, P213, DOI 10.1089/107555301300328070; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Woods SW, 2005, ARCH GEN PSYCHIAT, V62, P961, DOI 10.1001/archpsyc.62.9.961	74	133	133	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4824	10.1371/journal.pone.0004824	http://dx.doi.org/10.1371/journal.pone.0004824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293925	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496600001
J	Bansal, K; Kapoor, N; Narayana, Y; Puzo, G; Gilleron, M; Balaji, KN				Bansal, Kushagra; Kapoor, Nisha; Narayana, Yeddula; Puzo, Germain; Gilleron, Martine; Balaji, Kithiganahalli Narayanaswamy			PIM2 Induced COX-2 and MMP-9 Expression in Macrophages Requires PI3K and Notch1 Signaling	PLOS ONE			English	Article								Activation of inflammatory immune responses during granuloma formation by the host upon infection of mycobacteria is one of the crucial steps that is often associated with tissue remodeling and breakdown of the extracellular matrix. In these complex processes, cyclooxygenase-2 (COX-2) plays a major role in chronic inflammation and matrix metalloproteinase-9 (MMP-9) significantly in tissue remodeling. In this study, we investigated the molecular mechanisms underlying Phosphatidyl-myo-inositol dimannosides (PIM2), an integral component of the mycobacterial envelope, triggered COX-2 and MMP-9 expression in macrophages. PIM2 triggers the activation of Phosphoinositide-3 Kinase (PI3K) and Notch1 signaling leading to COX-2 and MMP-9 expression in a Toll-like receptor 2 (TLR2)-MyD88 dependent manner. Notch1 signaling perturbations data demonstrate the involvement of the cross-talk with members of PI3K and Mitogen activated protein kinase pathway. Enforced expression of the cleaved Notch1 in macrophages induces the expression of COX-2 and MMP-9. PIM2 triggered significant p65 nuclear factor-kappa B (NF-kappa B) nuclear translocation that was dependent on activation of PI3K or Notch1 signaling. Furthermore, COX-2 and MMP-9 expression requires Notch1 mediated recruitment of Suppressor of Hairless (CSL) and NF-kappa B to respective promoters. Inhibition of PIM2 induced COX-2 resulted in marked reduction in MMP-9 expression clearly implicating the role of COX-2 dependent signaling events in driving the MMP-9 expression. Taken together, these data implicate PI3K and Notch1 signaling as obligatory early proximal signaling events during PIM2 induced COX-2 and MMP-9 expression in macrophages.	[Bansal, Kushagra; Kapoor, Nisha; Narayana, Yeddula; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Puzo, Germain; Gilleron, Martine] Univ Paul Sabatier, Toulouse, France; [Puzo, Germain; Gilleron, Martine] CNRS, Inst Pharmacol Biol Struct, Dept Mol Mechanisms Mycobact Infect, Toulouse, France	Indian Institute of Science (IISC) - Bangalore; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bansal, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	Yeddula, Narayana/H-4893-2011	GILLERON, Martine/0000-0002-2581-3302	Department of Biotechnology (DBT); Department of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR) [fellowship]; Indian Institute of Science, Bangalore, India [fellowship]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Science, Bangalore, India	This study was funded by the Department of Biotechnology (DBT), Department of Science and Technology (DST), Council for Scientific and Industrial Research (CSIR). Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) is acknowledged. KB and NK acknowledges fellowship from Indian Institute of Science, Bangalore, India. YN is supported by a fellowship from CSIR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Basu S, 2007, CELL MICROBIOL, V9, P2804, DOI 10.1111/j.1462-5822.2007.00997.x; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; Dixon DA, 2004, CURR PHARM DESIGN, V10, P635, DOI 10.2174/1381612043453171; Fitzgerald K, 2000, ONCOGENE, V19, P4191, DOI 10.1038/sj.onc.1203766; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Hoppe HC, 1997, INFECT IMMUN, V65, P3896, DOI 10.1128/IAI.65.9.3896-3905.1997; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; Lee KY, 2004, J NEUROL SCI, V220, P73, DOI 10.1016/j.jns.2004.02.008; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Masuya M, 2002, INT J HEMATOL, V75, P269, DOI 10.1007/BF02982040; Matsuura E, 2000, J NEUROL SCI, V173, P45, DOI 10.1016/S0022-510X(99)00303-2; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Okamoto T, 2004, BIOL CHEM, V385, P997, DOI 10.1515/BC.2004.130; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pathak SK, 2004, J BIOL CHEM, V279, P55127, DOI 10.1074/jbc.M409885200; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Price NM, 2003, J IMMUNOL, V171, P5579, DOI 10.4049/jimmunol.171.10.5579; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rojas RE, 2006, J IMMUNOL, V177, P2959, DOI 10.4049/jimmunol.177.5.2959; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; Shibata Y, 2006, J LEUKOCYTE BIOL, V80, P590, DOI 10.1189/jlb.1205737; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Vas V, 2004, J LEUKOCYTE BIOL, V75, P714, DOI 10.1189/jlb.1003462; Wang ZW, 2006, INT J CANCER, V118, P1930, DOI 10.1002/ijc.21589; WHO, 2007, WHOHTMTB2007376; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	52	48	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4911	10.1371/journal.pone.0004911	http://dx.doi.org/10.1371/journal.pone.0004911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290049	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000265496500011
J	Franciosa, G; Maugliani, A; Scalfaro, C; Aureli, P				Franciosa, Giovanna; Maugliani, Antonella; Scalfaro, Concetta; Aureli, Paolo			Evidence that Plasmid-Borne Botulinum Neurotoxin Type B Genes Are Widespread among Clostridium botulinum Serotype B Strains	PLOS ONE			English	Article								Background: Plasmids that encode certain subtypes of the botulinum neurotoxin type B have recently been detected in some Clostridium botulinum strains. The objective of the present study was to investigate the frequency with which plasmid carriage of the botulinum neurotoxin type B gene (bont/B) occurs in strains of C. botulinum type B, Ab, and A(B), and whether plasmid carriage is bont/B subtype-related. Methodology/Principal Findings: PCR-Restriction fragment length polymorphism was employed to identify subtypes of the bont/B gene. Pulsed-field gel electrophoresis and Southern blot hybridization with specific probes were performed to analyze the genomic location of the bont/B subtype genes. All five known bont/B subtype genes were detected among the strains; the most frequently detected subtype genes were bont/B1 and /B2. Surprisingly, the bont/B subtype gene was shown to be plasmid-borne in >50% of the total strains. The same bont/B subtype gene was associated with the chromosome in some strains, whereas it was associated with a plasmid in others. All five known bont/B subtype genes were in some cases found to reside on plasmids, though with varying frequency (e. g., most of the bont/B1 subtype genes were located on plasmids, whereas all but one of the bont/B2 subtypes were chromosomally-located). Three bivalent isolates carried both bont/A and /B genes on the same plasmid. The plasmids carrying the bont gene were five different sizes, ranging from similar to 55 kb to similar to 245 kb. Conclusions/Significance: The unexpected finding of the widespread distribution of plasmids harboring the bont/B gene among C. botulinum serotype B strains provides a chance to examine their contribution to the dissemination of the bont genes among heterogeneous clostridia, with potential implications on issues related to pathogenesis and food safety.	[Franciosa, Giovanna; Maugliani, Antonella; Scalfaro, Concetta; Aureli, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Unit Microorganisms & Food Technol, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Franciosa, G (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Unit Microorganisms & Food Technol, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanna.franciosa@iss.it	FRANCIOSA, GIOVANNA/C-7040-2015; MAUGLIANI, ANTONELLA/C-3920-2015; SCALFARO, CONCETTA/C-7041-2015	FRANCIOSA, GIOVANNA/0000-0003-1520-4826; MAUGLIANI, ANTONELLA/0000-0002-2745-1472; SCALFARO, CONCETTA/0000-0001-8626-7563	Italy-USA Agreement [28C4]	Italy-USA Agreement	This study was supported by the Italy-USA Agreement: Preparedness against attacks with biological agents (no. 28C4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bruggemann H, 2005, CURR OPIN MICROBIOL, V8, P601, DOI 10.1016/j.mib.2005.08.006; CAMPBELL K, 1993, BIOCHIM BIOPHYS ACTA, V1216, P487, DOI 10.1016/0167-4781(93)90020-E; Centers for Disease Control and Prevention, 1998, HDB EP CLIN LAB WORK; EKLUND MW, 1972, NATURE-NEW BIOL, V235, P16, DOI 10.1038/newbio235016a0; EKLUND MW, 1988, APPL ENVIRON MICROB, V54, P1405, DOI 10.1128/AEM.54.6.1405-1408.1988; FINN CW, 1984, SCIENCE, V224, P881, DOI 10.1126/science.6326263; Franciosa G, 2004, APPL ENVIRON MICROB, V70, P7192, DOI 10.1128/AEM.70.12.7192-7199.2004; FRANCIOSA G, 1994, J CLIN MICROBIOL, V32, P1911, DOI 10.1128/JCM.32.8.1911-1917.1994; Franciosa G, 2006, FEMS MICROBIOL LETT, V261, P88, DOI 10.1111/j.1574-6968.2006.00331.x; GIMENEZ DF, 1995, INT J FOOD MICROBIOL, V27, P1, DOI 10.1016/0168-1605(94)00144-U; HATHEWAY CL, 1981, J CLIN MICROBIOL, V14, P607, DOI 10.1128/JCM.14.6.607-611.1981; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; INOUE K, 1970, JPN J MICROBIOL, V14, P87, DOI 10.1111/j.1348-0421.1970.tb00495.x; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P951, DOI 10.1016/j.fct.2008.02.006; Kirma N, 2004, FEMS MICROBIOL LETT, V231, P159, DOI 10.1016/S0378-1097(03)00911-X; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; Raphael BH, 2008, APPL ENVIRON MICROB, V74, P4390, DOI 10.1128/AEM.00260-08; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; SIMSKE JS, 1989, NUCLEIC ACIDS RES, V17, P4359, DOI 10.1093/nar/17.11.4359; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; TERRE H, 1999, EUROSURVEILLANCE, V4, P2; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000; Yamakawa K, 1997, J CLIN MICROBIOL, V35, P2163, DOI 10.1128/JCM.35.8.2163-2164.1997; ZHOU YT, 1995, INFECT IMMUN, V63, P2087, DOI 10.1128/IAI.63.5.2087-2091.1995	32	58	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4829	10.1371/journal.pone.0004829	http://dx.doi.org/10.1371/journal.pone.0004829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287483	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496400004
J	Alberts, JB				Alberts, Jonathan B.			Biophysically Realistic Filament Bending Dynamics in Agent-Based Biological Simulation	PLOS ONE			English	Article							SEGREGATION; SPINDLE; MOTORS	An appealing tool for study of the complex biological behaviors that can emerge from networks of simple molecular interactions is an agent-based, computational simulation that explicitly tracks small-scale local interactions - following thousands to millions of states through time. For many critical cell processes (e. g. cytokinetic furrow specification, nuclear centration, cytokinesis), the flexible nature of cytoskeletal filaments is likely to be critical. Any computer model that hopes to explain the complex emergent behaviors in these processes therefore needs to encode filament flexibility in a realistic manner. Here I present a numerically convenient and biophysically realistic method for modeling cytoskeletal filament flexibility in silico. Each cytoskeletal filament is represented by a series of rigid segments linked end-to-end in series with a variable attachment point for the translational elastic element. This connection scheme allows an empirically tuning, for a wide range of segment sizes, viscosities, and time-steps, that endows any filament species with the experimentally observed (or theoretically expected) static force deflection, relaxation time-constant, and thermal writhing motions. I additionally employ a unique pair of elastic elements-one representing the axial and the other the bending rigidity-that formulate the restoring force in terms of single time-step constraint resolution. This method is highly local -adjacent rigid segments of a filament only interact with one another through constraint forces-and is thus well-suited to simulations in which arbitrary additional forces (e. g. those representing interactions of a filament with other bodies or cross-links / entanglements between filaments) may be present. Implementation in code is straightforward; Java source code is available at www.celldynamics.org.	[Alberts, Jonathan B.] Univ Washington, Dept Biol, Ctr Cell Dynam, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Alberts, JB (corresponding author), Univ Washington, Dept Biol, Ctr Cell Dynam, Seattle, WA 98195 USA.	jalberts@u.washington.edu			National Institutes of Health [NIGMS 5P50 GM 666050-02]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded under National Institutes of Health grant NIGMS 5P50 GM 666050-02. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS B, 2007, MOL BIOL CELL, P965; Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Carlsson AE, 2001, BIOPHYS J, V81, P1907, DOI 10.1016/S0006-3495(01)75842-0; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Howard J., 2001, MECH MOTOR PROTEINS; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Nedelec F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/427; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Schaus TE, 2008, BIOPHYS J, V95, P1393, DOI 10.1529/biophysj.107.125005; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758	15	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4748	10.1371/journal.pone.0004748	http://dx.doi.org/10.1371/journal.pone.0004748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283085	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496300001
J	Kenefic, LJ; Pearson, T; Okinaka, RT; Schupp, JM; Wagner, DM; Ravel, J; Hoffmaster, AR; Trim, CP; Chung, WK; Beaudry, JA; Foster, JT; Mead, JI; Keim, P				Kenefic, Leo J.; Pearson, Talima; Okinaka, Richard T.; Schupp, James M.; Wagner, David M.; Ravel, Jacques; Hoffmaster, Alex R.; Trim, Carla P.; Chung, Wai-Kwan; Beaudry, Jodi A.; Foster, Jeffrey T.; Mead, James I.; Keim, Paul			Pre-Columbian Origins for North American Anthrax	PLOS ONE			English	Article								Disease introduction into the New World during colonial expansion is well documented and had a major impact on indigenous populations; however, few diseases have been associated with early human migrations into North America. During the late Pleistocene epoch, Asia and North America were joined by the Beringian Steppe ecosystem which allowed animals and humans to freely cross what would become a water barrier in the Holocene. Anthrax has clearly been shown to be dispersed by human commerce and trade in animal products contaminated with Bacillus anthracis spores. Humans appear to have brought B. anthracis to this area from Asia and then moved it further south as an ice-free corridor opened in central Canada similar to 13,000 ybp. In this study, we have defined the evolutionary history of Western North American (WNA) anthrax using 2,850 single nucleotide polymorphisms (SNPs) and 285 geographically diverse B. anthracis isolates. Phylogeography of the major WNA B. anthracis clone reveals ancestral populations in northern Canada with progressively derived populations to the south; the most recent ancestor of this clonal lineage is in Eurasia. Our phylogeographic patterns are consistent with B. anthracis arriving with humans via the Bering Land Bridge. This northern-origin hypothesis is highly consistent with our phylogeographic patterns and rates of SNP accumulation observed in current day B. anthracis isolates. Continent-wide dispersal of WNA B. anthracis likely required movement by later European colonizers, but the continent's first inhabitants may have seeded the initial North American populations.	[Kenefic, Leo J.; Pearson, Talima; Okinaka, Richard T.; Schupp, James M.; Wagner, David M.; Trim, Carla P.; Chung, Wai-Kwan; Beaudry, Jodi A.; Foster, Jeffrey T.; Mead, James I.; Keim, Paul] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD USA; [Hoffmaster, Alex R.] Ctr Dis Control & Prevent, Bacterial Zoonoses Branch, Atlanta, GA USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA	Northern Arizona University; University System of Maryland; University of Maryland Baltimore; Centers for Disease Control & Prevention - USA; Translational Genomics Research Institute	Kenefic, LJ (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu	Pearson, Talima/O-7840-2019; Ravel, Jacques/D-2530-2009; Keim, Paul S/A-2269-2010; Wagner, David M/A-5125-2010	Pearson, Talima/0000-0003-3696-041X; Wagner, David/0000-0003-2684-6007; Ravel, Jacques/0000-0002-0851-2233; Foster, Jeffrey/0000-0001-8235-8564	NIH NIGMS [1R01GM060795]; DHS [NBCH2070001]; NIH NIAID [N01-AI15447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060795] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DHS(United States Department of Homeland Security (DHS)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NIGMS (1R01GM060795), DHS (NBCH2070001) and NIH NIAID (N01-AI15447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; BRACHMAN PS, 1970, ANN NY ACAD SCI, V174, P577, DOI 10.1111/j.1749-6632.1970.tb45583.x; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; Dragon DC, 2005, APPL ENVIRON MICROB, V71, P1610, DOI 10.1128/AEM.71.3.1610-1615.2005; Dragon DC, 2001, ARCTIC, V54, P32; Eskey CR., 1940, PUB HLTH B, V254, P1; GREEN DM, 1958, LANCET, V2, P153; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; HANSON ROBERT P., 1959, JOUR AMER VET MED ASSOC, V135, P463; Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x; KENEFIC L, 2008, EMERG INFEC IN PRESS; KLEMM DORIS M., 1959, JOUR AMER VET MED ASSOC, V135, P458; LINK V B, 1955, Public Health Monogr, V26, P1; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; *MMWR, 2006, MMWR-MORBID MORTAL W, V55, P280; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Pavesi A, 2004, J MOL EVOL, V58, P304, DOI 10.1007/s00239-003-2552-0; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Plotkin SA, 2002, AM J MED, V112, P4, DOI 10.1016/S0002-9343(01)01050-6; PLOTKIN SA, 2002, AM J MED, V112, P12; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Swofford D., 2003, PHYLOGENETIC ANAL US; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06	27	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4813	10.1371/journal.pone.0004813	http://dx.doi.org/10.1371/journal.pone.0004813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283072	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496300003
J	Ansong, C; Yoon, H; Porwollik, S; Mottaz-Brewer, H; Petritis, BO; Jaitly, N; Adkins, JN; McClelland, M; Heffron, F; Smith, RD				Ansong, Charles; Yoon, Hyunjin; Porwollik, Steffen; Mottaz-Brewer, Heather; Petritis, Brianne O.; Jaitly, Navdeep; Adkins, Joshua N.; McClelland, Michael; Heffron, Fred; Smith, Richard D.			Global Systems-Level Analysis of Hfq and SmpB Deletion Mutants in Salmonella: Implications for Virulence and Global Protein Translation	PLOS ONE			English	Article								Using sample-matched transcriptomics and proteomics measurements it is now possible to begin to understand the impact of post-transcriptional regulatory programs in Enterobacteria. In bacteria post-transcriptional regulation is mediated by relatively few identified RNA-binding protein factors including CsrA, Hfq and SmpB. A mutation in any one of these three genes, csrA, hfq, and smpB, in Salmonella is attenuated for mouse virulence and unable to survive in macrophages. CsrA has a clearly defined specificity based on binding to a specific mRNA sequence to inhibit translation. However, the proteins regulated by Hfq and SmpB are not as clearly defined. Previous work identified proteins regulated by hfq using purification of the RNA-protein complex with direct sequencing of the bound RNAs and found binding to a surprisingly large number of transcripts. In this report we have used global proteomics to directly identify proteins regulated by Hfq or SmpB by comparing protein abundance in the parent and isogenic hfq or smpB mutant. From these same samples we also prepared RNA for microarray analysis to determine if alteration of protein expression was mediated post-transcriptionally. Samples were analyzed from bacteria grown under four different conditions; two laboratory conditions and two that are thought to mimic the intracellular environment. We show that mutants of hfq and smpB directly or indirectly modulate at least 20% and 4% of all possible Salmonella proteins, respectively, with limited correlation between transcription and protein expression. These proteins represent a broad spectrum of Salmonella proteins required for many biological processes including host cell invasion, motility, central metabolism, LPS biosynthesis, two-component regulatory systems, and fatty acid metabolism. Our results represent one of the first global analyses of post-transcriptional regulons in any organism and suggest that regulation at the translational level is widespread and plays an important role in virulence regulation and environmental adaptation for Salmonella.	[Ansong, Charles; Petritis, Brianne O.; Jaitly, Navdeep; Adkins, Joshua N.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Yoon, Hyunjin; Heffron, Fred] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR USA; [Mottaz-Brewer, Heather] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Porwollik, Steffen; McClelland, Michael] Sidney Kimmel Canc Ctr, San Diego, CA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Oregon Health & Science University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Smith, RD (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	rds@pnl.gov	McClelland, Michael/A-8583-2011; Smith, Richard D/J-3664-2012; Adkins, Joshua/B-9881-2013	Smith, Richard D/0000-0002-2381-2349; Adkins, Joshua/0000-0003-0399-0700; McClelland, Michael/0000-0003-1788-9347	National Institute of Allergy and Infectious Diseases NIH/DHHS [Y1-AI-4894-01]; National Center for Research Resources [RR18522]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Portions of this research were supported by the National Institute of Allergy and Infectious Diseases NIH/DHHS through interagency agreement Y1-AI-4894-01, and the National Center for Research Resources (RR18522). Portions of the work were performed in the Environmental Molecular Science Laboratory, a U.S. Department of Energy (DOE) national scientific user facility at Pacific Northwest National Laboratory (PNNL) in Richland, WA, using capabilities established by the DOE Office of Biological and Environmental Research. Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JN, 2006, MOL CELL PROTEOMICS, V5, P1450, DOI 10.1074/mcp.M600139-MCP200; Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Coombes BK, 2005, J MOL BIOL, V348, P817, DOI 10.1016/j.jmb.2005.03.024; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; Farrant JL, 1997, MOL MICROBIOL, V25, P785, DOI 10.1046/j.1365-2958.1997.5151877.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; GarciadelPortillo F, 1997, INFECT IMMUN, V65, P24, DOI 10.1128/IAI.65.1.24-34.1997; Geddes K, 2005, INFECT IMMUN, V73, P6260, DOI 10.1128/IAI.73.10.6260-6271.2005; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; JAITLY N, 2008, P 55 ASMS C MASS SPE; Jaitly N, 2006, ANAL CHEM, V78, P7397, DOI 10.1021/ac052197p; JOHNSON K, 1991, MOL MICROBIOL, V5, P401, DOI 10.1111/j.1365-2958.1991.tb02122.x; Julio SM, 2000, J BACTERIOL, V182, P1558, DOI 10.1128/JB.182.6.1558-1563.2000; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kelly RT, 2007, ANAL CHEM, V79, P4192, DOI 10.1021/ac062417e; Kiebel GR, 2006, PROTEOMICS, V6, P1783, DOI 10.1002/pmic.200500500; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nielsen JS, 2007, RNA, V13, P2213, DOI 10.1261/rna.689007; Nogueira T, 2000, CURR OPIN MICROBIOL, V3, P154, DOI 10.1016/S1369-5274(00)00068-0; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Page JS, 2006, J AM SOC MASS SPECTR, V17, P586, DOI 10.1016/j.jasms.2005.12.013; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Petritis K, 2006, ANAL CHEM, V78, P5026, DOI 10.1021/ac060143p; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Porwollik S, 2003, NUCLEIC ACIDS RES, V31, P1869, DOI 10.1093/nar/gkg298; Ranquet C, 2007, J BACTERIOL, V189, P4872, DOI 10.1128/JB.01838-06; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Rosu V, 2006, J BACTERIOL, V188, P4497, DOI 10.1128/JB.01552-05; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Sydenham M, 2000, INFECT IMMUN, V68, P1109, DOI 10.1128/IAI.68.3.1109-1115.2000; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P179, DOI 10.1093/nar/30.1.179; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	64	101	103	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4809	10.1371/journal.pone.0004809	http://dx.doi.org/10.1371/journal.pone.0004809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277208	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496100026
J	Coble, MD; Loreille, OM; Wadhams, MJ; Edson, SM; Maynard, K; Meyer, CE; Niederstatter, H; Berger, C; Berger, B; Falsetti, AB; Gill, P; Parson, W; Finelli, LN				Coble, Michael D.; Loreille, Odile M.; Wadhams, Mark J.; Edson, Suni M.; Maynard, Kerry; Meyer, Carna E.; Niederstaetter, Harald; Berger, Cordula; Berger, Burkhard; Falsetti, Anthony B.; Gill, Peter; Parson, Walther; Finelli, Louis N.			Mystery Solved: The Identification of the Two Missing Romanov Children Using DNA Analysis	PLOS ONE			English	Article								One of the greatest mysteries for most of the twentieth century was the fate of the Romanov family, the last Russian monarchy. Following the abdication of Tsar Nicholas II, he and his wife, Alexandra, and their five children were eventually exiled to the city of Yekaterinburg. The family, along with four loyal members of their staff, was held captive by members of the Ural Soviet. According to historical reports, in the early morning hours of July 17, 1918 the entire family along with four loyal members of their staff was executed by a firing squad. After a failed attempt to dispose of the remains in an abandoned mine shaft, the bodies were transported to an open field only a few kilometers from the mine shaft. Nine members of the group were buried in one mass grave while two of the children were buried in a separate grave. With the official discovery of the larger mass grave in 1991, and subsequent DNA testing to confirm the identities of the Tsar, the Tsarina, and three of their daughters - doubt persisted that these remains were in fact those of the Romanov family. In the summer of 2007, a group of amateur archeologists discovered a collection of remains from the second grave approximately 70 meters from the larger grave. We report forensic DNA testing on the remains discovered in 2007 using mitochondrial DNA (mtDNA), autosomal STR, and Y- STR testing. Combined with additional DNA testing of material from the 1991 grave, we have virtually irrefutable evidence that the two individuals recovered from the 2007 grave are the two missing children of the Romanov family: the Tsarevich Alexei and one of his sisters.	[Coble, Michael D.; Loreille, Odile M.; Wadhams, Mark J.; Edson, Suni M.; Maynard, Kerry; Meyer, Carna E.; Finelli, Louis N.] Armed Forces Inst Pathol, Armed Forces DNA Identificat Lab, Rockville, MD USA; [Niederstaetter, Harald; Berger, Cordula; Berger, Burkhard; Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria; [Falsetti, Anthony B.] Univ Florida, Gainesville, FL 32611 USA; [Gill, Peter] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G1 1XQ, Lanark, Scotland; [Gill, Peter] Univ Oslo, Inst Forens Med, N-0316 Oslo, Norway	United States Department of Defense; Medical University of Innsbruck; State University System of Florida; University of Florida; University of Strathclyde; University of Oslo	Coble, MD (corresponding author), Armed Forces Inst Pathol, Armed Forces DNA Identificat Lab, Rockville, MD USA.	mike.coble@us.army.mil	Parson, Walther/AAD-6845-2020; Gill, Peter/C-3056-2009; Coble, Michael D/E-7540-2010	Edson, Suni/0000-0003-0211-9251; Loreille, Odile/0000-0001-7437-7298; Coble, Michael/0000-0003-3687-0342; Parson, Walther/0000-0002-5692-2392	U.S. Armed Forces DNA Identification Laboratory; Innsbruck Medical University, Innsbruck, Austria	U.S. Armed Forces DNA Identification Laboratory; Innsbruck Medical University, Innsbruck, Austria	This study was funded by the U.S. Armed Forces DNA Identification Laboratory and the Innsbruck Medical University, Innsbruck, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bar W., 1997, FORENSIC SCI INT, V87, P179, DOI DOI 10.1007/S004140050061; BERGER C, MINIMIDIMITO ADAPTIN; Butler JM, 2003, J FORENSIC SCI, V48, P1054; Edson S. M., 2004, FORENSIC SCI REV, V16, P64; Eichmann C, 2008, INT J LEGAL MED, V122, P385, DOI 10.1007/s00414-008-0227-5; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gill P, 2000, FORENSIC SCI INT, V112, P17, DOI 10.1016/S0379-0738(00)00158-4; Gill P, 2004, SCIENCE, V306, P408; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Grubwieser P, 2006, INT J LEGAL MED, V120, P115, DOI 10.1007/s00414-005-0013-6; Hofreiter M, 2004, SCIENCE, V306, P407; Irwin JA, 2007, J FORENSIC SCI, V52, P1322, DOI 10.1111/j.1556-4029.2007.00561.x; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; KIMPTON C, 1994, INT J LEGAL MED, V106, P302, DOI 10.1007/BF01224776; Knight A, 2004, SCIENCE, V306, P409; Knight A, 2004, ANN HUM BIOL, V31, P129, DOI 10.1080/03014460310001652257; Loreille OM, 2007, FORENSIC SCI INT-GEN, V1, P191, DOI 10.1016/j.fsigen.2007.02.006; LOREILLE OM, J FORENSIC IN PRESS; Massie R.K., 1995, ROMANOVS FINAL CHAPT; Melton T., 2004, FORENSIC SCI REV, V16, P2; Niederstatter H, 2007, FORENSIC SCI INT-GEN, V1, P29, DOI 10.1016/j.fsigen.2006.10.007; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Radzinsky E, 1993, LAST TSAR LIFE DEATH; RAPPAPORT H, EKATERINBURG; STONEKING M, 1995, NAT GENET, V9, P9, DOI 10.1038/ng0195-9; TRYNOVA E, FORENSIC DNA P UNPUB; Walker JA, 2005, ANAL BIOCHEM, V337, P89, DOI 10.1016/j.ab.2004.09.036; Zhivotovsky LA, 1999, ANN HUM BIOL, V26, P569, DOI 10.1080/030144699282480	30	87	90	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4838	10.1371/journal.pone.0004838	http://dx.doi.org/10.1371/journal.pone.0004838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277206	Green Published, gold			2022-12-27	WOS:000265496100030
J	Cheon, DJ; Wang, Y; Deng, JM; Lu, Z; Xiao, L; Chen, CM; Bast, RC; Behringer, RR				Cheon, Dong-Joo; Wang, Ying; Deng, Jian Min; Lu, Zhen; Xiao, Lianchun; Chen, Chun-Ming; Bast, Robert C., Jr.; Behringer, Richard R.			CA125/MUC16 Is Dispensable for Mouse Development and Reproduction	PLOS ONE			English	Article								Cancer antigen 125 (CA125) is a blood biomarker that is routinely used to monitor the progression of human epithelial ovarian cancer (EOC) and is encoded by MUC16, a member of the mucin gene family. The biological function of CA125/MUC16 and its potential role in EOC are poorly understood. Here we report the targeted disruption of the of the Muc16 gene in the mouse. To generate Muc16 knockout mice, 6.0 kb was deleted that included the majority of exon 3 and a portion of intron 3 and replaced with a lacZ reporter cassette. Loss of Muc16 protein expression suggests that Muc16 homozygous mutant mice are null mutants. Muc16 homozygous mutant mice are viable, fertile, and develop normally. Histological analysis shows that Muc16 homozygous mutant tissues are normal. By the age of 1 year, Muc16 homozygous mutant mice appear normal. Downregulation of transcripts from another mucin gene (Muc1) was detected in the Muc16 homozygous mutant uterus. Lack of any prominent abnormal phenotype in these Muc16 knockout mice suggests that CA125/MUC16 is not required for normal development or reproduction. These knockout mice provide a unique platform for future studies to identify the role of CA125/MUC16 in organ homeostasis and ovarian cancer.	[Cheon, Dong-Joo; Chen, Chun-Ming; Behringer, Richard R.] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; [Cheon, Dong-Joo; Wang, Ying; Deng, Jian Min; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX USA; [Lu, Zhen; Bast, Robert C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Xiao, Lianchun] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Cheon, DJ (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA.	rrb@mdanderson.org	Lu, Zhen/E-5221-2015; Bast, Robert C/E-6585-2011	Bast, Robert C/0000-0003-4621-8462; Lu, Zhen/0000-0002-9596-0148; Chen, Chun-Ming/0000-0001-8873-7602	United States Department of the Army [DAMD 17-03-1-0449]; Ben F. Love Endowment; Bettyann Asche-Murray Ovarian Cancer Fellowship; Schissler Foundation Fellowship in Genetics of Human Disease; NIH Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	United States Department of the Army; Ben F. Love Endowment; Bettyann Asche-Murray Ovarian Cancer Fellowship; Schissler Foundation Fellowship in Genetics of Human Disease; NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a United States Department of the Army grant DAMD 17-03-1-0449 to R.R.B. and R.C.B, Jr., the Ben F. Love Endowment to R.R.B.. D.-J. Cheon was supported by a Bettyann Asche-Murray Ovarian Cancer Fellowship and a Schissler Foundation Fellowship in Genetics of Human Disease. DNA sequencing and veterinary resources were supported by the NIH Cancer Center Support (Core) Grant, CA16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Belisle JA, 2007, IMMUNOLOGY, V122, P418, DOI 10.1111/j.1365-2567.2007.02660.x; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; BRAGA VMM, 1993, J CELL SCI, V105, P397; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; Gaetje R, 2002, Clin Exp Obstet Gynecol, V29, P34; Gaetje R, 1999, J SOC GYNECOL INVEST, V6, P278, DOI 10.1016/S1071-5576(99)00027-1; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; HARDARDOTTIR H, 1990, AM J OBSTET GYNECOL, V163, P1925, DOI 10.1016/0002-9378(90)90775-3; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jager K, 2007, HISTOCHEM CELL BIOL, V127, P433, DOI 10.1007/s00418-006-0246-6; KABAWAT SE, 1983, INT J GYNECOL PATHOL, V2, P275, DOI 10.1097/00004347-198303000-00005; Kitamura K, 1999, DEVELOPMENT, V126, P5749; McDonnel AC, 2003, REPRODUCTION, V126, P615, DOI 10.1530/reprod/126.5.615; Nagy A., 2003, MANIPULATING MOUSE E; NOUWEN EJ, 1986, CANCER RES, V46, P866; NOUWEN EJ, 1987, AM J PATHOL, V126, P230; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Patankar MS, 2005, GYNECOL ONCOL, V99, P704, DOI 10.1016/j.ygyno.2005.07.030; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang Y, 2008, DIFFERENTIATION, V76, P1081, DOI 10.1111/j.1432-0436.2008.00295.x; Yin BWT, 2002, INT J CANCER, V98, P737, DOI 10.1002/ijc.10250; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	29	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4675	10.1371/journal.pone.0004675	http://dx.doi.org/10.1371/journal.pone.0004675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262696	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490600008
J	Diguet, E; Petit, F; Escartin, C; Cambon, K; Bizat, N; Dufour, N; Hantraye, P; Deglon, N; Brouillet, E				Diguet, Elsa; Petit, Fanny; Escartin, Carole; Cambon, Karine; Bizat, Nicolas; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole; Brouillet, Emmanuel			Normal Aging Modulates the Neurotoxicity of Mutant Huntingtin	PLOS ONE			English	Article								Aging likely plays a role in neurodegenerative disorders. In Huntington's disease (HD), a disorder caused by an abnormal expansion of a polyglutamine tract in the protein huntingtin (Htt), the role of aging is unclear. For a given tract length, the probability of disease onset increases with age. There are mainly two hypotheses that could explain adult onset in HD: Either mutant Htt progressively produces cumulative defects over time or "normal'' aging renders neurons more vulnerable to mutant Htt toxicity. In the present study, we directly explored whether aging affected the toxicity of mutant Htt in vivo. We studied the impact of aging on the effects produced by overexpression of an N-terminal fragment of mutant Htt, of wild-type Htt or of a beta-Galactosidase (beta-Gal) reporter gene in the rat striatum. Stereotaxic injections of lentiviral vectors were performed simultaneously in young (3 week) and old (15 month) rats. Histological evaluation at different time points after infection demonstrated that the expression of mutant Htt led to pathological changes that were more severe in old rats, including an increase in the number of small Htt-containing aggregates in the neuropil, a greater loss of DARPP-32 immunoreactivity and striatal neurons as assessed by unbiased stereological counts. The present results support the hypothesis that "normal'' aging is involved in HD pathogenesis, and suggest that age-related cellular defects might constitute potential therapeutic targets for HD.	[Diguet, Elsa; Petit, Fanny; Escartin, Carole; Cambon, Karine; Bizat, Nicolas; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole; Brouillet, Emmanuel] CEA, I2BM, MIRCen, Orsay, France; [Diguet, Elsa; Petit, Fanny; Escartin, Carole; Cambon, Karine; Bizat, Nicolas; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole; Brouillet, Emmanuel] CNRS, CEA, Unite Rech Associee, Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Diguet, E (corresponding author), CEA, I2BM, MIRCen, Orsay, France.	emmanuel.brouillet@cea.fr	Escartin, Carole/A-1952-2010; Brouillet, Emmanuel/B-4784-2014; Deglon, Nicole/A-2265-2012	Escartin, Carole/0000-0003-3613-4118; Brouillet, Emmanuel/0000-0001-6322-7403; Deglon, Nicole/0000-0003-4475-9476; Cambon, Karine/0000-0001-9263-4366	GIS (Groupement d'Interet Scientifique) "Longevite"	GIS (Groupement d'Interet Scientifique) "Longevite"	This study was partially supported by a government grant entitled GIS (Groupement d'Interet Scientifique) "Longevite". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango M, 2006, J NEUROSCI, V26, P4649, DOI 10.1523/JNEUROSCI.5409-05.2006; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Asanuma M, 1996, MOL BRAIN RES, V41, P210, DOI 10.1016/0169-328X(96)00098-8; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bizat N, 2003, J NEUROSCI, V23, P5020; Bogdanov MB, 1998, J NEUROCHEM, V71, P2642; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; de Almeida LP, 2002, J NEUROSCI, V22, P3473; de Almeida LP, 2001, NEUROBIOL DIS, V8, P433, DOI 10.1006/nbdi.2001.0388; Deglon N, 2002, CURR TOP MICROBIOL, V261, P191; Deglon N, 2005, J GENE MED, V7, P530, DOI 10.1002/jgm.707; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Madeira MD, 1997, J NEUROSCI, V17, P1302; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Palfi S, 2007, MOL THER, V15, P1444, DOI 10.1038/sj.mt.6300185; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Regulier E, 2002, HUM GENE THER, V13, P1981, DOI 10.1089/10430340260355383; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	65	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4637	10.1371/journal.pone.0004637	http://dx.doi.org/10.1371/journal.pone.0004637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247483	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800019
J	Franchini, DM; Benoukraf, T; Jaeger, S; Ferrier, P; Payet-Bornet, D				Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique			Initiation of V(D)J Recombination by D beta-Associated Recombination Signal Sequences: A Critical Control Point in TCR beta Gene Assembly	PLOS ONE			English	Article							CODING END SEQUENCE; V-BETA; REARRANGEMENT; RAG2; RESTRICTION; MECHANISM; LYSINE-4; PROTEINS; ENHANCER; COMPLEX	T cell receptor (TCR) beta gene assembly by V(D)J recombination proceeds via successive D beta-to-J beta and V beta-to-DJ beta rearrangements. This two-step process is enforced by a constraint, termed beyond (B) 12/23, which prohibits direct V beta-to-J beta rearrangements. However the B12/23 restriction does not explain the order of TCR beta assembly for which the regulation remains an unresolved issue. The initiation of V(D) J recombination consists of the introduction of single-strand DNA nicks at recombination signal sequences (RSSs) containing a 12 base-pairs spacer. An RSS containing a 23 base-pairs spacer is then captured to form a 12/23 RSSs synapse leading to coupled DNA cleavage. Herein, we probed RSS nicks at the TCR beta locus and found that nicks were only detectable at D beta-associated RSSs. This pattern implies that D beta 12RSS and, unexpectedly, D beta 23RSS initiate V(D) J recombination and capture their respective V beta or J beta RSS partner. Using both in vitro and in vivo assays, we further demonstrate that the D beta 23RSS impedes cleavage at the adjacent D beta 1 12RSS and consequently V beta-to-D beta 1 rearrangement first requires the D beta 1 23RSS excision. Altogether, our results provide the molecular explanation to the B12/23 constraint and also uncover a 'D beta 1 23RSS-mediated' restriction operating beyond chromatin accessibility, which directs D beta 1 ordered rearrangements.	[Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique] Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France; [Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique] CNRS, UMR6102, Marseille, France; [Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique] Inserm, U631, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Franchini, DM (corresponding author), Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France.	payet@ciml.univ-mrs.fr	Benoukraf, Touati/K-9978-2019; BORNET, Dominique PAYET/O-8367-2016; Franchini, Don Marc/A-5203-2015	Benoukraf, Touati/0000-0002-4789-8028; BORNET, Dominique PAYET/0000-0003-3196-3814; Franchini, Don Marc/0000-0002-2562-5643	Inserm; CNRS; Fondation Princesse Grace de Monaco; Association pour la Recherche sur le Cancer [ARC 3275XA0331F]; Agence Nationale de la Recherche [ANR-06-BYOS-0006]; Commission of the European Communities [MRTN-CT-2006-035733]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Princesse Grace de Monaco; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Commission of the European Communities(European Commission)	This work was supported by institutional grants from Inserm and the CNRS, and by specific grants from the 'Fondation Princesse Grace de Monaco', the 'Association pour la Recherche sur le Cancer' (ARC 3275XA0331F), the 'Agence Nationale de la Recherche' (ANR-06-BYOS-0006) and the Commission of the European Communities (MRTN-CT-2006-035733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Drejer-Teel AH, 2007, MOL CELL BIOL, V27, P6288, DOI 10.1128/MCB.00835-07; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; EZEKIEL UR, 1995, IMMUNITY, V2, P381, DOI 10.1016/1074-7613(95)90146-9; Feeney AJ, 2004, IMMUNOL REV, V200, P44, DOI 10.1111/j.0105-2896.2004.00163.x; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hughes MM, 2003, J IMMUNOL, V171, P6604, DOI 10.4049/jimmunol.171.12.6604; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jackson AM, 2006, IMMUNOL REV, V209, P129, DOI 10.1111/j.0105-2896.2006.00342.x; Jackson AM, 2005, J IMMUNOL, V175, P5186, DOI 10.4049/jimmunol.175.8.5186; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Jung D, 2003, IMMUNITY, V18, P65, DOI 10.1016/S1074-7613(02)00507-1; Lee AI, 2003, PLOS BIOL, V1, P56, DOI 10.1371/journal.pbio.0000001; LEU TMJ, 1995, MOL CELL BIOL, V15, P5657; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Livak F, 2000, J EXP MED, V192, P1191, DOI 10.1084/jem.192.8.1191; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Nagawa F, 2004, J BIOL CHEM, V279, P38360, DOI 10.1074/jbc.M405485200; Olaru A, 2004, MOL IMMUNOL, V40, P1189, DOI 10.1016/j.molimm.2003.11.019; Olaru A, 2003, J IMMUNOL, V171, P3605, DOI 10.4049/jimmunol.171.7.3605; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; Sleckman BP, 2000, P NATL ACAD SCI USA, V97, P7975, DOI 10.1073/pnas.130190597; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Tillman RE, 2004, IMMUNOL REV, V200, P36, DOI 10.1111/j.0105-2896.2004.00156.x; Tillman RE, 2003, J IMMUNOL, V170, P5, DOI 10.4049/jimmunol.170.1.5; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; Wang XM, 2008, NAT IMMUNOL, V9, P794, DOI 10.1038/ni.1614; Wilson A, 2001, J IMMUNOL, V166, P51, DOI 10.4049/jimmunol.166.1.51; Wu C, 2003, IMMUNITY, V18, P75, DOI 10.1016/S1074-7613(02)00515-0; Yu KF, 1999, MOL CELL BIOL, V19, P8094	46	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4575	10.1371/journal.pone.0004575	http://dx.doi.org/10.1371/journal.pone.0004575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238214	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487400008
J	Halaban, R; Krauthammer, M; Cheng, MPE; Kovacs, D; Sznol, M; Ariyan, S; Narayan, D; Bacchiocchi, A; Molinaro, A; Kluger, Y; Deng, M; Tran, N; Zhang, WG; Picardo, M; Enghild, JJ				Halaban, Ruth; Krauthammer, Michael; Cheng, Mattia Pelizzola Elaine; Kovacs, Daniela; Sznol, Mario; Ariyan, Stephan; Narayan, Deepak; Bacchiocchi, Antonella; Molinaro, Annette; Kluger, Yuval; Deng, Min; Tran, Nam; Zhang, Wengeng; Picardo, Mauro; Enghild, Jan J.			Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications	PLOS ONE			English	Article							BETA-CATENIN; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; HDAC INHIBITORS; EXPRESSION; 5-AZA-2'-DEOXYCYTIDINE; METHYLATION; CANCER; GENES; DEMETHYLATION	Decitabine, an epigenetic modifier that reactivates genes otherwise suppressed by DNA promoter methylation, is effective for some, but not all cancer patients, especially those with solid tumors. It is commonly recognized that to overcome resistance and improve outcome, treatment should be guided by tumor biology, which includes genotype, epigenotype, and gene expression profile. We therefore took an integrative approach to better understand melanoma cell response to clinically relevant dose of decitabine and identify complementary targets for combined therapy. We employed eight different melanoma cell strains, determined their growth, apoptotic and DNA damage responses to increasing doses of decitabine, and chose a low, clinically relevant drug dose to perform whole-genome differential gene expression, bioinformatic analysis, and protein validation studies. The data ruled out the DNA damage response, demonstrated the involvement of p21(Cip1) in a p53-independent manner, identified the TGF beta pathway genes CLU and TGFBI as markers of sensitivity to decitabine and revealed an effect on histone modification as part of decitabine-induced gene expression. Mutation analysis and knockdown by siRNA implicated activated beta-catenin/MITF, but not BRAF, NRAS or PTEN mutations as a source for resistance. The importance of protein stability predicted from the results was validated by the synergistic effect of Bortezomib, a proteasome inhibitor, in enhancing the growth arrest of decitabine in otherwise resistant melanoma cells. Our integrative analysis show that improved therapy can be achieved by comprehensive analysis of cancer cells, identified biomarkers for patient's selection and monitoring response, as well as targets for improved combination therapy.	[Halaban, Ruth; Bacchiocchi, Antonella; Deng, Min; Zhang, Wengeng] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Krauthammer, Michael; Tran, Nam] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Cheng, Mattia Pelizzola Elaine; Molinaro, Annette] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Sznol, Mario] Yale Univ, Sch Med, Dept Comprehensive Canc Ctr, Sect Med Oncol, New Haven, CT 06520 USA; [Ariyan, Stephan; Narayan, Deepak] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; [Kluger, Yuval] NYU, Sch Med, Dept Cell Biol, New York, NY USA; [Kovacs, Daniela; Picardo, Mauro] San Gallicano Dermatol Inst, Rome, Italy; [Enghild, Jan J.] Univ Aarhus, DK-8000 Aarhus, Denmark	Yale University; Yale University; Yale University; Yale University; Yale University; New York University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Aarhus University	Halaban, R (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	ruth.halaban@yale.edu	kovacs, daniela/H-4418-2014; Picardo, Mauro/A-6978-2011	kovacs, daniela/0000-0003-1873-0549; Picardo, Mauro/0000-0003-4899-6639; Zhang, Wengeng/0000-0002-1000-4692; Pelizzola, Mattia/0000-0001-6672-9636; Enghild, Jan Johannes/0000-0001-9292-9172; Krauthammer, Michael/0000-0002-4808-1845; Sznol, Mario/0000-0002-4359-8749	National Cancer Institute [1 P50 CA121974, K22CA123146-2]; Yale Skin Diseases Research Core Center; National Library of Medicine [K22LM009255]; Progetto Italia-USA [530/F-A1]; NATIONAL CANCER INSTITUTE [P50CA121974, K22CA123146] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM009255] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yale Skin Diseases Research Core Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Progetto Italia-USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Yale Spore in Skin Cancer grant from the National Cancer Institute number 1 P50 CA121974 (Halaban, PI), and the Yale Skin Diseases Research Core Center (Tigelaar, PI). M.K. was supported by the National Library of Medicine grant K22LM009255, A.M.M. by the National Cancer Institute grant K22CA123146-2 and DK by the Progetto Italia-USA Grant 530/F-A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Borden EC, 2007, CYTOKINE GROWTH F R, V18, P491, DOI 10.1016/j.cytogfr.2007.06.022; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chai GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002445; Cheng E, 2006, J INVEST DERMATOL, V126, P2257, DOI 10.1038/sj.jid.5700386; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; CHUN T, 2008, CARCINOGENESIS, V4, P4; Curtin JA, 2006, J INVEST DERMATOL, V126, P1660, DOI 10.1038/sj.jid.5700311; Dahl C, 2007, APMIS, V115, P1161, DOI 10.1111/j.1600-0463.2007.apm_855.xml.x; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Giles FJ, 2008, SEMIN ONCOL, V35, pS1, DOI 10.1053/j.seminoncol.2007.12.002; Gimsing P, 2008, EUR J HAEMATOL, V81, P170, DOI 10.1111/j.1600-0609.2008.01102.x; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Gollob JA, 2006, CLIN CANCER RES, V12, P4619, DOI 10.1158/1078-0432.CCR-06-0883; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032; Herranz Michel, 2007, Methods Mol Biol, V361, P25; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Jabbour E, 2008, CANCER-AM CANCER SOC, V112, P2341, DOI 10.1002/cncr.23463; John T, 2008, CLIN CANCER RES, V14, P5173, DOI 10.1158/1078-0432.CCR-07-4170; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Liu HS, 2008, RARE METALS, V27, P545, DOI 10.1016/S1001-0521(08)60179-5; Luong T, 2007, P 2 BIOCREATIVE CHAL, P145; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Reu FJ, 2006, J CLIN ONCOL, V24, P3771, DOI 10.1200/JCO.2005.03.4074; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Schmelz K, 2005, INT J CANCER, V114, P683, DOI 10.1002/ijc.20797; Scott SA, 2006, LEUKEMIA RES, V30, P69, DOI 10.1016/j.leukres.2005.05.010; Shang DH, 2008, UROLOGY, V71, P1220, DOI 10.1016/j.urology.2007.11.029; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Steele NL, 2008, CLIN CANCER RES, V14, P804, DOI 10.1158/1078-0432.CCR-07-1786; Tamm I, 2005, ANN HEMATOL, V84, P47, DOI 10.1007/s00277-005-0013-0; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	56	53	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4563	10.1371/journal.pone.0004563	http://dx.doi.org/10.1371/journal.pone.0004563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234609	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487200017
J	Yang, ZS; Tang, HD; Huang, H; Deng, HY				Yang, Zhangsheng; Tang, Haidong; Huang, Hai; Deng, Hongyu			RTA Promoter Demethylation and Histone Acetylation Regulation of Murine Gammaherpesvirus 68 Reactivation	PLOS ONE			English	Article								Gammaherpesviruses have a common biological characteristic, latency and lytic replication. The balance between these two phases in murine gammaherpesvirus 68 (MHV-68) is controlled by the replication and transcription activator (RTA) gene. In this report, we investigated the effect of DNA demethylation and histone acetylation on MHV-68 replication. We showed that distinctivemethylation patterns were associated with MHV-68 at the RTA promoter during latency or lytic replication. Treatment of MHV-68 latently-infected S11E cells with a DNA methyltransferases (DNMTs) inhibitor 5-azacytidine (5-AzaC), only weakly reactivated MHV-68, despite resulted in demethylation of the viral RTA promoter. In contrast, treatment with a histone deacetylase (HDAC) inhibitor trichostatin A (TSA) strongly reactivated MHV-68 from latency, and this was associated with significant change in histone H3 and H4 acetylation levels at the RTA promoter. We further showed that HDAC3 was recruited to the RTA promoter and inhibited RTA transcription during viral latency. However, TSA treatment caused rapid removal of HDAC3 and also induced passive demethylation at the RTA promoter. In vivo, we found that the RTA promoter was hypomethylated during lytic infection in the lung and that methylation level increased with virus latent infection in the spleen. Collectively, our data showed that histone acetylation, but not DNA demethylation, is sufficient for effective reactivation of MHV-68 from latency in S11E cells.	[Yang, Zhangsheng; Tang, Haidong; Huang, Hai; Deng, Hongyu] Chinese Acad Sci, Ctr Infect & Immun, Beijing, Peoples R China; [Yang, Zhangsheng; Tang, Haidong; Huang, Hai; Deng, Hongyu] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Yang, Zhangsheng; Tang, Haidong; Huang, Hai] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Deng, Hongyu] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Los Angeles	Yang, ZS (corresponding author), Chinese Acad Sci, Ctr Infect & Immun, Beijing, Peoples R China.	rrain6@yahoo.com	Yang, Zhangsheng/N-4080-2013; Huang, Hai/CZY-9855-2022; Tang, Haidong/P-1729-2019; Tang, Haidong/G-1800-2011	Yang, Zhangsheng/0000-0003-2208-8632; Huang, Hai/0000-0003-2331-6238; Tang, Haidong/0000-0002-1512-2655; 	National Science Foundation [30570075]; NIH [DE15612]; International Fogarty Program on AIDS Malignancies; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE015612] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Fogarty Program on AIDS Malignancies; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Science Foundation grant 30570075, NIH grant DE15612 and International Fogarty Program on AIDS Malignancies.	Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; BENSASSON SA, 1981, INT J CANCER, V28, P131, DOI 10.1002/ijc.2910280204; Blackman MA, 2002, J EXP MED, V195, pF29, DOI 10.1084/jem.20020243; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chen J, 2001, P NATL ACAD SCI USA, V98, P4119, DOI 10.1073/pnas.051004198; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Esteller M, 2005, CURR OPIN ONCOL, V17, P55, DOI 10.1097/01.cco.0000147383.04709.10; Fenic I, 2004, J ANDROL, V25, P811; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Fog CK, 2007, APMIS, V115, P1060, DOI 10.1111/j.1600-0463.2007.apm_776.xml.x; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; Gibbons RJ, 2005, HUM MOL GENET, V14, pR85, DOI 10.1093/hmg/ddi106; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lu F, 2003, J VIROL, V77, P11425, DOI 10.1128/JVI.77.21.11425-11435.2003; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Moore SM, 2001, ANTIMICROB AGENTS CH, V45, P2082, DOI 10.1128/AAC.45.7.2082-2091.2001; Moser JM, 2005, J VIROL, V79, P9480, DOI 10.1128/JVI.79.15.9480-9491.2005; Moser JM, 2005, J VIROL, V79, P5227, DOI 10.1128/JVI.79.8.5227-5231.2005; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Seo JS, 2008, ONCOL REP, V19, P93; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Singal R, 1999, BLOOD, V93, P4059, DOI 10.1182/blood.V93.12.4059; Speck SH, 1999, CURR OPIN MICROBIOL, V2, P403; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; Takami Y, 2000, J BIOL CHEM, V275, P16191, DOI 10.1074/jbc.M908066199; Tao Q, 2003, CLIN IMMUNOL, V109, P53, DOI 10.1016/S1521-6616(03)00198-0; Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Virgin HW, 1999, CURR OPIN IMMUNOL, V11, P371, DOI 10.1016/S0952-7915(99)80063-6; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	68	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4556	10.1371/journal.pone.0004556	http://dx.doi.org/10.1371/journal.pone.0004556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234612	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487200012
J	Cardoso, CMP; Groth-Pedersen, L; Hoyer-Hansen, M; Kirkegaard, T; Corcelle, E; Andersen, JS; Jaattela, M; Nylandsted, J				Cardoso, Carla M. P.; Groth-Pedersen, Line; Hoyer-Hansen, Maria; Kirkegaard, Thomas; Corcelle, Elizabeth; Andersen, Jens S.; Jaattela, Marja; Nylandsted, Jesper			Depletion of Kinesin 5B Affects Lysosomal Distribution and Stability and Induces Peri-Nuclear Accumulation of Autophagosomes in Cancer Cells	PLOS ONE			English	Article								Background: Enhanced lysosomal trafficking is associated with metastatic cancer. In an attempt to discover cancer relevant lysosomal motor proteins, we compared the lysosomal proteomes from parental MCF-7 breast cancer cells with those from highly invasive MCF-7 cells that express an active form of the ErbB2 (Delta N-ErbB2). Methodology/Principal Findings: Mass spectrometry analysis identified kinesin heavy chain protein KIF5B as the only microtubule motor associated with the lysosomes in MCF-7 cells, and ectopic Delta N-ErbB2 enhanced its lysosomal association. KIF5B associated with lysosomes also in HeLa cervix carcinoma cells as analyzed by subcellular fractionation. The depletion of KIF5B triggered peripheral aggregations of lysosomes followed by lysosomal destabilization, and cell death in HeLa cells. Lysosomal exocytosis in response to plasma membrane damage as well as fluid phase endocytosis functioned, however, normally in these cells. Both HeLa and MCF-7 cells appeared to express similar levels of the KIF5B isoform but the death phenotype was weaker in KIF5B-depleted MCF-7 cells. Surprisingly, KIF5B depletion inhibited the rapamycin-induced accumulation of autophagosomes in MCF-7 cells. In KIF5B-depleted cells the autophagosomes formed and accumulated in the close proximity to the Golgi apparatus, whereas in the control cells they appeared uniformly distributed in the cytoplasm. Conclusions/Significance: Our data identify KIF5B as a cancer relevant lysosomal motor protein with additional functions in autophagosome formation.	[Cardoso, Carla M. P.; Corcelle, Elizabeth] Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Groth-Pedersen, Line; Hoyer-Hansen, Maria; Kirkegaard, Thomas; Corcelle, Elizabeth; Jaattela, Marja; Nylandsted, Jesper] Danish Canc Soc, Inst Canc Biol, Apoptosis Dept & Ctr Genotox Stress Res, Copenhagen, Denmark; [Corcelle, Elizabeth; Andersen, Jens S.] Univ So Denmark, CEBI, Odense, Denmark	Universidade de Coimbra; Danish Cancer Society; University of Southern Denmark	Cardoso, CMP (corresponding author), Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	mj@cancer.dk; jnl@cancer.dk	Nylandsted, Jesper/ABE-7192-2021; Corcelle-Termeau, Elisabeth/ABA-9247-2020; Jäättelä, Marja/AAT-7932-2021; Andersen, Jens S/L-2100-2015	Jäättelä, Marja/0000-0001-5950-7111; Andersen, Jens S/0000-0002-6091-140X; Cardoso, Carla/0000-0002-0985-7487; Nylandsted, Jesper/0000-0001-6474-5093; Corcelle-Termeau, Elisabeth/0000-0002-3706-3756	Portuguese Foundation for Science and Technology [SFRH/BPD/14448/2003]; Danish Cancer Society; Danish National Research Foundation; Danish Medical Research Council; Meyer Foundation; M.L. JArgensen and Gunnar Hansens Foundation; Novo Foundation; Vilhelm Pedersen Foundation; Danish Cancer Research Foundation; European Commission FP7 APO-SYS consortium	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Meyer Foundation; M.L. JArgensen and Gunnar Hansens Foundation; Novo Foundation; Vilhelm Pedersen Foundation; Danish Cancer Research Foundation; European Commission FP7 APO-SYS consortium	CMP Cardoso was a recipient of a grant from the Portuguese Foundation for Science and Technology (SFRH/BPD/14448/2003). This work was supported by grants from the Danish Cancer Society (MJ), the Danish National Research Foundation (MJ), the Danish Medical Research Council (JN and MJ), the Meyer Foundation (MJ), the M.L. JArgensen and Gunnar Hansens Foundation (MJ), the Novo Foundation (MJ and MHH), the Vilhelm Pedersen Foundation (JN and MJ), the Danish Cancer Research Foundation (MJ) and the European Commission FP7 APO-SYS consortium (MJ and JSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Egeblad M, 2001, INT J CANCER, V94, P185, DOI 10.1002/ijc.1459; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fehrenbacher N, 2004, CANCER RES, V64, P5301, DOI 10.1158/0008-5472.CAN-04-1427; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kasprzak AA, 2002, ACTA BIOCHIM POL, V49, P813; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Ostenfeld MS, 2008, AUTOPHAGY, V4, P487, DOI 10.4161/auto.5774; Potter H., 2001, CURR PROTOC IMMUNOL; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Ross, 1998, Oncologist, V3, P237; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2	27	77	80	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4424	10.1371/journal.pone.0004424	http://dx.doi.org/10.1371/journal.pone.0004424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19242560	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484000013
J	Rao, S; Kong, WP; Wei, CJ; Yang, ZY; Nason, M; Styles, D; DeTolla, LJ; Sorrell, EM; Song, HC; Wan, HQ; Ramirez-Nieto, GC; Perez, D; Nabel, GJ				Rao, Srinivas; Kong, Wing-Pui; Wei, Chih-Jen; Yang, Zhi-Yong; Nason, Martha; Styles, Darrel; DeTolla, Louis J.; Sorrell, Erin M.; Song, Haichen; Wan, Hongquan; Ramirez-Nieto, Gloria C.; Perez, Daniel; Nabel, Gary J.			Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice	PLOS ONE			English	Article								Background: Sustained outbreaks of highly pathogenic avian influenza (HPAI) H5N1 in avian species increase the risk of reassortment and adaptation to humans. The ability to contain its spread in chickens would reduce this threat and help maintain the capacity for egg-based vaccine production. While vaccines offer the potential to control avian disease, a major concern of current vaccines is their potency and inability to protect against evolving avian influenza viruses. Methodology/Principal Findings: The ability of DNA vaccines encoding hemagglutinin (HA) proteins from different HPAI H5N1 serotypes was evaluated for its ability to elicit neutralizing antibodies and to protect against homologous and heterologous HPAI H5N1 strain challenge in mice and chickens after DNA immunization by needle and syringe or with a pressure injection device. These vaccines elicited antibodies that neutralized multiple strains of HPAI H5N1 when given in combinations containing up to 10 HAs. The response was dose-dependent, and breadth was determined by the choice of the influenza virus HA in the vaccine. Monovalent and trivalent HA vaccines were tested first in mice and conferred protection against lethal H5N1 A/Vietnam/1203/2004 challenge 68 weeks after vaccination. In chickens, protection was observed against heterologous strains of HPAI H5N1 after vaccination with a trivalent H5 serotype DNA vaccine with doses as low as 5 mg DNA given twice either by intramuscular needle injection or with a needle-free device. Conclusions/Significance: DNA vaccines offer a generic approach to influenza virus immunization applicable to multiple animal species. In addition, the ability to substitute plasmids encoding different strains enables rapid adaptation of the vaccine to newly evolving field isolates.	[Rao, Srinivas; Kong, Wing-Pui; Wei, Chih-Jen; Yang, Zhi-Yong; Nason, Martha; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Styles, Darrel] United States Dept Agr, Anim & Plant Hlth Inspect Serv, Riverdale, MD USA; [Sorrell, Erin M.; Song, Haichen; Wan, Hongquan; Ramirez-Nieto, Gloria C.; Perez, Daniel] Univ Maryland, Coll Vet Med, College Pk, MD USA; [DeTolla, Louis J.] Univ Maryland Baltimore, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Rao, S (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA.	gnabel@nih.gov	Perez, Daniel R./D-5044-2016; Ramirez-Nieto, Gloria C/N-2600-2018; Wei, Chih/GVT-5734-2022	Perez, Daniel R./0000-0002-6569-5689; Ramirez-Nieto, Gloria C/0000-0002-8313-1609; Wan, Hongquan/0000-0002-6374-0343	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND G, EFFICACY AGROJET MIT; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Barry MA, 1997, VACCINE, V15, P788, DOI 10.1016/S0264-410X(96)00265-4; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Enserink M, 2004, SCIENCE, V306, P2016, DOI 10.1126/science.306.5704.2016; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Fomsgaard A, 1999, IMMUNOL LETT, V65, P127, DOI 10.1016/S0165-2478(98)00135-7; Gares SL, 2006, CLIN VACCINE IMMUNOL, V13, P958, DOI 10.1128/CVI.00080-06; Grim KC, 2004, J ZOO WILDLIFE MED, V35, P154, DOI 10.1638/03-060; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Higginson Ray, 2005, Br J Nurs, V14, P632; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Jiang Y, 2007, ANTIVIR RES, V75, P234, DOI 10.1016/j.antiviral.2007.03.009; Kapczynski DR, 2003, AVIAN DIS, V47, P1376, DOI 10.1637/7033; Kodihalli S, 1997, J VIROL, V71, P3391, DOI 10.1128/JVI.71.5.3391-3396.1997; Kodihalli S, 2000, VACCINE, V18, P2592, DOI 10.1016/S0264-410X(99)00485-5; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Kumar M, 2007, AVIAN DIS, V51, P481, DOI 10.1637/7605-041706R1.1; Kutzler MA, 2004, JAVMA-J AM VET MED A, V225, P414, DOI 10.2460/javma.2004.225.414; Lee CW, 2006, CLIN VACCINE IMMUNOL, V13, P395, DOI 10.1128/CVI.13.3.395-402.2006; Li SQ, 1999, J INFECT DIS, V179, P1132, DOI 10.1086/314713; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; McCluskie MJ, 1999, MOL MED, V5, P287, DOI 10.1007/BF03402065; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Oshop GL, 2002, VET IMMUNOL IMMUNOP, V89, P1, DOI 10.1016/S0165-2427(02)00189-7; Rao SS, 2006, VACCINE, V24, P367, DOI 10.1016/j.vaccine.2005.07.072; Raviprakash Kanakatte, 2006, V127, P83; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robinson H L, 1997, Semin Immunol, V9, P271, DOI 10.1006/smim.1997.0083; Roh HJ, 2006, J VET SCI, V7, P361, DOI 10.4142/jvs.2006.7.4.361; Ruiz LM, 2007, VET PARASITOL, V144, P138, DOI 10.1016/j.vetpar.2006.09.033; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Skinner MA, 2003, INFECT IMMUN, V71, P4901, DOI 10.1128/IAI.71.9.4901-4907.2003; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Sorrell EM, 2007, CYTOGENET GENOME RES, V117, P394, DOI 10.1159/000103203; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Subbarao K, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030040; Swayne DE, 2006, ANN NY ACAD SCI, V1081, P174, DOI 10.1196/annals.1373.021; Taubenberger JK, 2007, JAMA-J AM MED ASSOC, V297, P2025, DOI 10.1001/jama.297.18.2025; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Verminnen K, 2005, VACCINE, V23, P4509, DOI 10.1016/j.vaccine.2005.04.014; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463	55	42	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2432	10.1371/journal.pone.0002432	http://dx.doi.org/10.1371/journal.pone.0002432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	19293944	gold, Green Published			2022-12-27	WOS:000263280700017
J	Lam, JBB; Chow, KHM; Xu, AM; Lam, KSL; Liu, J; Wong, NS; Moon, RT; Shepherd, PR; Cooper, GJS; Wang, Y				Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Lam, Karen S. L.; Liu, Jing; Wong, Nai-Sum; Moon, Randall T.; Shepherd, Peter R.; Cooper, Garth J. S.; Wang, Yu			Adiponectin Haploinsufficiency Promotes Mammary Tumor Development in MMTV-PyVT Mice by Modulation of Phosphatase and Tensin Homolog Activities	PLOS ONE			English	Article								Background: Adiponectin is an adipokine possessing beneficial effects on obesity-related medical complications. A negative association of adiponectin levels with breast cancer development has been demonstrated. However, the precise role of adiponectin deficiency in mammary carcinogenesis remains elusive. Methodology/Principal Findings: In the present study, MMTV-polyomavirus middle T antigen (MMTV-PyVT) transgenic mice with reduced adiponectin expressions were established and the stromal effects of adiponectin haploinsufficiency on mammary tumor development evaluated. In mice from both FVB/N and C57BL/6J backgrounds, insufficient adiponectin production promoted mammary tumor onset and development. A distinctive basal-like subtype of tumors, with a more aggressive phenotype, was derived from adiponectin haplodeficient MMTV-PyVT mice. Comparing with those from control MMTV-PyVT mice, the isolated mammary tumor cells showed enhanced tumor progression in re-implanted nude mice, accelerated proliferation in primary cultures, and hyperactivated phosphatidylinositol-3-kinase (PI3K)/Akt/beta-catenin signaling, which at least partly attributed to the decreased phosphatase and tensin homolog (PTEN) activities. Further analysis revealed that PTEN was inactivated by a redox-regulated mechanism. Increased association of PTEN-thioredoxin complexes was detected in tumors derived from mice with reduced adiponectin levels. The activities of thioredoxin (Trx1) and thioredoxin reductase (TrxR1) were significantly elevated, whereas treatment with either curcumin, an irreversible inhibitor of TrxR1, or adiponectin largely attenuated their activities and resulted in the re-activation of PTEN in these tumor cells. Moreover, adiponectin could inhibit TrxR1 promoter-mediated transcription and restore the mRNA expressions of TrxR1. Conclusion: Adiponectin haploinsufficiency facilitated mammary tumorigenesis by down-regulation of PTEN activity and activation of PI3K/Akt signalling pathway through a mechanism involving Trx1/TrxR1 redox regulations.	[Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Liu, Jing; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Lam, Karen S. L.; Liu, Jing] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Lam, Karen S. L.; Liu, Jing; Wang, Yu] Univ Hong Kong, Res Ctr Heart, Brain, Hormone, & Healthy Aging, Hong Kong, Peoples R China; [Wong, Nai-Sum] Univ Hong Kong, Dept Biochem, Hong Kong, Peoples R China; [Wang, Yu] Univ Hong Kong, Inst Mol Technol Drug Discovery & Synthesis, Open Lab Chem Biol, Hong Kong, Peoples R China; [Moon, Randall T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Lam, Janice B. B.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Shepherd, Peter R.; Cooper, Garth J. S.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Auckland; University of Auckland	Lam, JBB (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	yuwanghk@hku.hk	Moon, Randall/M-5605-2019; Cooper, Garth JS/I-3201-2015; Moon, Randall T/B-1743-2014; Xu, Aimin/D-3291-2013	Moon, Randall/0000-0002-9352-1408; Cooper, Garth JS/0000-0001-5241-3163; Moon, Randall T/0000-0002-9352-1408; Xu, Aimin/0000-0002-0668-033X; Chow, Hei-Man/0000-0003-1203-2096; wang, yu/0000-0001-8697-2940	University of Hong Kong [Seeding Funds for Basic Research]; Hong Kong Research Grant Council [HKU 777908M, HKU 779707M]; University Grants Committee, HKSAR [AoE/P-10-01]; US National Institutes of Health [HL-51586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	University of Hong Kong(University of Hong Kong); Hong Kong Research Grant Council(Hong Kong Research Grants Council); University Grants Committee, HKSAR; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the grants from Seeding Funds for Basic Research of the University of Hong Kong (Y. Wang), Hong Kong Research Grant Council grants HKU 777908M (Y. Wang) and HKU 779707M (A. Xu), and the Area of Excellent Scheme (AoE/P-10-01) established under the University Grants Committee, HKSAR. Adiponectin knockout mice were kindly provided by Dr. Lawrence Chan at Baylor College of Medicine, who generated these mice with the support of the US National Institutes of Health grant HL-51586. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi JD, 2007, HORM METAB RES, V39, P9, DOI 10.1055/s-2007-956518; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Baillargeon J, 2006, INT J ONCOL, V28, P737; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Berstein L M, 2005, Adv Gerontol, V16, P51; Bloomfield KL, 2003, GENE, V319, P107, DOI 10.1016/S0378-1119(03)00799-6; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chen DC, 2006, CANCER LETT, V237, P109, DOI 10.1016/j.canlet.2005.05.047; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; JARDE T, 2008, P NUTR SOC, V67, pE184; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Kang JH, 2007, J KOREAN MED SCI, V22, P117, DOI 10.3346/jkms.2007.22.1.117; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; LIU J, 2008, CARCINOGENESIS, V28, P163; Livasy CA, 2007, HUM PATHOL, V38, P197, DOI 10.1016/j.humpath.2006.08.017; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; McTiernan A, 2005, ONCOLOGY-NY, V19, P871; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; NAKAYAMA S, 2007, BREAST CANC RES TREA; Pfeiler GH, 2008, ONCOL REP, V19, P787; Pischon T, 2008, P NUTR SOC, V67, P128, DOI 10.1017/S0029665108006976; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tamura T, 2002, METHOD ENZYMOL, V347, P297; Tian YF, 2007, ENDOCR-RELAT CANCER, V14, P669, DOI 10.1677/ERC-06-0089; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Tureckova J, 2006, INT J MOL MED, V17, P69; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Varticovski L, 2007, CLIN CANCER RES, V13, P2168, DOI 10.1158/1078-0432.CCR-06-0918; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wang Y, 2007, CELL RES, V17, P280, DOI 10.1038/cr.2007.14; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Zhao H, 2005, CANCER RES, V65, P6864, DOI 10.1158/0008-5472.CAN-05-0181; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444	57	65	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4968	10.1371/journal.pone.0004968	http://dx.doi.org/10.1371/journal.pone.0004968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319191	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499200010
J	Saleh, N; Moutereau, S; Durr, A; Krystkowiak, P; Azulay, JP; Tranchant, C; Broussolle, E; Morin, F; Bachoud-Levi, AC; Maison, P				Saleh, Nadine; Moutereau, Stephane; Durr, Alexandra; Krystkowiak, Pierre; Azulay, Jean-Philippe; Tranchant, Christine; Broussolle, Emmanuel; Morin, Francoise; Bachoud-Levi, Anne-Catherine; Maison, Patrick			Neuroendocrine Disturbances in Huntington's Disease	PLOS ONE			English	Article								Background: Huntington's disease (HD) is a severe inherited neurodegenerative disorder characterized, in addition to neurological impairment, by weight loss suggesting endocrine disturbances. The aims of this study were to look for neuroendocrine disturbances in patients with Huntington's disease (HD) and to determine the relationship with weight loss seen in HD Methods and Finding: We compared plasma levels of hormones from the five pituitary axes in 219 patients with genetically documented HD and in 71 sex-and age-matched controls. Relationships between hormone levels and disease severity, including weight-loss severity, were evaluated. Growth hormone (GH) and standard deviation score of insulin-like growth factor 1 (SDS IGF-1) were significantly higher in patients than in controls (0.25 (0.01-5.89) vs. 0.15 (0.005-4.89) ng/ml, p = 0.013 and 0.16 +/- 1.02 vs. 0.06 +/- 0.91, p = 0.039; respectively). Cortisol was higher (p = 0.002) in patients (399.14 +/- 160.5 nmol/L vs. 279.8 +/- 130.1 nmol/L), whereas no differences were found for other hormone axes. In patients, elevations in GH and IGF-1 and decreases in thyroid-stimulating hormone, free triiodothyronine and testosterone (in men) were associated with severity of impairments (Independence scale, Functional score, Total Functional Capacity, Total Motor score, Behavioral score). Only GH was independently associated with body mass index (beta = 20.26, p = 0.001). Conclusion: Our data suggest that the thyrotropic and in men gonadotropic axes are altered in HD according to the severity of the disease. The somatotropic axis is overactive even in patients with early disease, and could be related to the weight loss seen in HD patients.	[Saleh, Nadine; Durr, Alexandra; Bachoud-Levi, Anne-Catherine] Grp Henri Mondor Albert Chenevier Pitie Salpetrie, AP HP, Ctr Reference Malad Huntington, Paris, France; [Saleh, Nadine; Maison, Patrick] Grp Henri Mondor Albert Chenevier Pitie Salpetrie, AP HP, Serv Pharmacol Clin, Paris, France; [Saleh, Nadine; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Univ Paris 12, Fac Med, F-94010 Creteil, France; [Saleh, Nadine; Bachoud-Levi, Anne-Catherine; Maison, Patrick] INSERM, Unite U955, Equipe 1, Creteil, France; [Moutereau, Stephane] Grp Henri Mondor Albert Chenevier, AP HP, Serv Biochim, Paris, France; [Durr, Alexandra] Pitie Salpetriere, Dept Genet Cytogenet & Embryol, INSERM, U289, Paris, France; [Krystkowiak, Pierre] CHU Amiens, Neurol Dept, Amiens, France; [Azulay, Jean-Philippe] La Timone Hosp, CNRS, APM, Marseille, France; [Tranchant, Christine] Hop Univ, Neurol Dept, Strasbourg, France; [Broussolle, Emmanuel] Pierre Wertheimer Neurol Hosp, Neurol Dept, Lyon, France; [Morin, Francoise] EFS Ile France, Bobigny, France; [Bachoud-Levi, Anne-Catherine] Ecole Normale Superieure, Dept Etudes Cognitives, Paris, France; [Maison, Patrick] Grp Henri Mondor Albert Chenevier, AP HP, Unite Rech Clin, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; CHU Lyon; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Saleh, N (corresponding author), Grp Henri Mondor Albert Chenevier Pitie Salpetrie, AP HP, Ctr Reference Malad Huntington, Paris, France.	bachoud@gmail.com	Broussolle, Emmanuel/H-1592-2017; Bachoud-Lévi, Anne-Catherine/GYU-8680-2022	Broussolle, Emmanuel/0000-0002-0410-9519; Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; tranchant, christine/0000-0002-2895-1292	Institut National de la Sante et de la Recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS)- Institut des Maladies Rares.	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS)- Institut des Maladies Rares.	This work was supported by cooperative contracts between the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Association Francaise contre les Myopathies (AFM), as well as by the Association Huntington France (AHF) and the Groupement d'Interet Scientifique (GIS)- Institut des Maladies Rares. The funder had no role in the study design, data collection and analysis,the decision to publish or preparation of the manuscript.	Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; BRANDT J, 1991, P241; BRUYN GW, 1973, LANCET, V1, P1382; Busiguina S, 2000, NEUROBIOL DIS, V7, P657, DOI 10.1006/nbdi.2000.0311; CAINE E, 1978, LIFE SCI, V22, P911, DOI 10.1016/0024-3205(78)90616-1; CARACENI T, 1977, J CLIN ENDOCR METAB, V44, P870, DOI 10.1210/jcem-44-5-870; CHALMERS RJ, 1978, J NEUROL NEUROSUR PS, V41, P135, DOI 10.1136/jnnp.41.2.135; de Aguilar JLG, 2003, NEUROENDOCRINOLOGY, V78, P244, DOI 10.1159/000074445; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Dore S, 2000, Pharm Acta Helv, V74, P273, DOI 10.1016/S0031-6865(99)00037-0; FEDOROFF JP, 1994, J NEUROPSYCH CLIN N, V6, P147; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; HAYDEN MR, 1977, LANCET, V2, P423; HEUSER IJE, 1991, BIOL PSYCHIAT, V30, P943, DOI 10.1016/0006-3223(91)90007-9; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; KREMER HPH, 1991, NEUROSCI LETT, V132, P101, DOI 10.1016/0304-3940(91)90443-W; KREMER HPH, 1990, J NEUROPATH EXP NEUR, V49, P371, DOI 10.1097/00005072-199007000-00002; LAVIN PJM, 1981, J NEUROL NEUROSUR PS, V44, P414, DOI 10.1136/jnnp.44.5.414; LEBLHUBER F, 1995, J NEUROL SCI, V132, P76, DOI 10.1016/0022-510X(95)00114-H; LEOPOLD NA, 1975, J CLIN ENDOCR METAB, V41, P160, DOI 10.1210/jcem-41-1-160; LEVY CL, 1979, LIFE SCI, V24, P743, DOI 10.1016/0024-3205(79)90357-6; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; MULLER EE, 1977, LANCET, V2, P764; Nagel BHP, 1997, EUR J PEDIATR, V156, P758, DOI 10.1007/s004310050707; Oge A, 2005, ENDOCR J, V52, P213, DOI 10.1507/endocrj.52.213; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; PHILLIPSON OT, 1976, CLIN SCI MOL MED, V50, P551, DOI 10.1042/cs0500551; PODOLSKY S, 1974, J CLIN ENDOCR METAB, V39, P36, DOI 10.1210/jcem-39-1-36; POLLERI A, 1980, LIFE SCI, V26, P1609, DOI 10.1016/0024-3205(80)90364-1; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; SHOULSON I, 1981, NEUROLOGY, V31, P1333, DOI 10.1212/WNL.31.10.1333; Van den Berghe G, 2003, ENDOCRIN METAB CLIN, V32, P385, DOI 10.1016/S0889-8529(03)00005-7; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Yilmaz N, 2007, MED PRIN PRACT, V16, P137, DOI 10.1159/000098367	43	88	91	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4962	10.1371/journal.pone.0004962	http://dx.doi.org/10.1371/journal.pone.0004962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319184	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499200009
J	Stegemann, S; Dahlberg, S; Kroger, A; Gereke, M; Bruder, D; Henriques-Normark, B; Gunzer, M				Stegemann, Sabine; Dahlberg, Sofia; Kroeger, Andrea; Gereke, Marcus; Bruder, Dunja; Henriques-Normark, Birgitta; Gunzer, Matthias			Increased Susceptibility for Superinfection with Streptococcus pneumoniae during Influenza Virus Infection Is Not Caused by TLR7-Mediated Lymphopenia	PLOS ONE			English	Article								Influenza A virus (IAV) causes respiratory tract infections leading to recurring epidemics with high rates of morbidity and mortality. In the past century IAV induced several world-wide pandemics, the most aggressive occurring in 1918 with a death toll of 20-50 million cases. However, infection with IAV alone is rarely fatal. Instead, death associated with IAV is usually mediated by superinfection with bacteria, mainly Streptococcus pneumoniae. The reasons for this increased susceptibility to bacterial superinfection have not been fully elucidated. We previously demonstrated that triggering of TLR7 causes immune incompetence in mice by induction of lymphopenia. IAV is recognized by TLR7 and infections can lead to lymphopenia. Since lymphocytes are critical to protect from S. pneumoniae it has long been speculated that IAV-induced lymphopenia might mediate increased susceptibility to superinfection. Here we show that sub-lethal pre-infections of mice with IAV-PR8/A/34 strongly increased their mortality in non-lethal SP infections, surprisingly despite the absence of detectable lymphopenia. In contrast to SP-infection alone co-infected animals were unable to control the exponential growth of SP. However, lymphopenia forced by TLR7-triggering or antibody-mediated neutropenia did not increase SP-susceptibility or compromise the ability to control SP growth. Thus, the immune-incompetence caused by transient lympho or leukopenia is not sufficient to inhibit potent antibacterial responses of the host and mechanisms distinct from leukodepletion must account for increased bacterial superinfection during viral defence.	[Stegemann, Sabine; Gunzer, Matthias] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Stegemann, Sabine; Gereke, Marcus; Bruder, Dunja] Helmholtz Ctr Infect Res, Res Grp Immuneregulat, Braunschweig, Germany; [Dahlberg, Sofia; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Dahlberg, Sofia; Henriques-Normark, Birgitta] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Kroeger, Andrea] Helmholtz Ctr Infect Res, Dept Gene Regulat & Different, Braunschweig, Germany	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Helmholtz Association; Helmholtz-Center for Infection Research	Stegemann, S (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.	Matthias.gunzer@med.ovgu.de	Stegemann-Koniszewski, Sabine/AAS-1926-2020; Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055	German Research Foundation (DFG) [SFB 587]; Deutsche Forschungsgemeinschaft; Torsten och Ragnar Soederbergs Foundation; Swedish Research Council	German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Torsten och Ragnar Soederbergs Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the International Research Training Group 1273 funded by the German Research Foundation (DFG) and by grants from the Deutsche Forschungsgemeinschaft to M. Gunzer. and B.H-N, the Torsten och Ragnar Soederbergs Foundation and the Swedish Research Council to B.H-N and the DFG (SFB 587) to D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan I, 2000, J INFECTION, V40, P256, DOI 10.1053/jinf.2000.0653; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Denny P, 2003, MAMM GENOME, V14, P448, DOI 10.1007/S00335-002-2261-9; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Garcia-Sastre A, 2006, J INFECT DIS, V194, pS127, DOI 10.1086/507546; Gauthier JF, 2007, INFECT IMMUN, V75, P5361, DOI 10.1128/IAI.02008-06; Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; HEIL F, 2004, SCIENCE; HESTDAL K, 1991, J IMMUNOL, V147, P22; Kadioglu A, 2004, INFECT IMMUN, V72, P2689, DOI 10.1128/IAI.72.5.2689-2697.2004; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KAMPHUIS E, 2006, BLOOD; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Marks M, 2007, INFECT IMMUN, V75, P1586, DOI 10.1128/IAI.01579-06; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; NAVARINI AA, 2006, P NATL ACAD SCI US; Paterson GK, 2006, MICROBIOL-SGM, V152, P285, DOI 10.1099/mic.0.28551-0; Preston JA, 2004, EUR RESPIR J, V23, P224, DOI 10.1183/09031936.03.00081403; REED LJ, 1938, AM J HYG, V27; Reis e Sousa A, 2006, SCIENCE; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Speshock JL, 2007, INFECT IMMUN, V75, P3102, DOI 10.1128/IAI.01943-06; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392	45	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4840	10.1371/journal.pone.0004840	http://dx.doi.org/10.1371/journal.pone.0004840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290047	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496500001
J	Gemenetzidis, E; Bose, A; Riaz, AM; Chaplin, T; Young, BD; Ali, M; Sugden, D; Thurlow, JK; Cheong, SC; Teo, SH; Wan, H; Waseem, A; Parkinson, EK; Fortune, F; Teh, MT				Gemenetzidis, Emilios; Bose, Amrita; Riaz, Adeel M.; Chaplin, Tracy; Young, Bryan D.; Ali, Muhammad; Sugden, David; Thurlow, Johanna K.; Cheong, Sok-Ching; Teo, Soo-Hwang; Wan, Hong; Waseem, Ahmad; Parkinson, Eric K.; Fortune, Farida; Teh, Muy-Teck			FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation	PLOS ONE			English	Article							GENETIC PROGRESSION MODEL; ORAL SUBMUCOUS FIBROSIS; TRANSCRIPTION FACTOR; PLK1-DEPENDENT PHOSPHORYLATION; CLINICAL-IMPLICATIONS; FIELD CANCERIZATION; MESENCHYMAL CELLS; EPITHELIAL-CELLS; FAMILY-MEMBER; NECK-CANCER	Background: Cancer associated with smoking and drinking remains a serious health problem worldwide. The survival of patients is very poor due to the lack of effective early biomarkers. FOXM1 overexpression is linked to the majority of human cancers but its mechanism remains unclear in head and neck squamous cell carcinoma (HNSCC). Methodology/Principal Findings: FOXM1 mRNA and protein expressions were investigated in four independent cohorts (total 75 patients) consisting of normal, premalignant and HNSCC tissues and cells using quantitative PCR (qPCR), expression microarray, immunohistochemistry and immunocytochemistry. Effect of putative oral carcinogens on FOXM1 transcriptional activity was dose-dependently assayed and confirmed using a FOXM1-specific luciferase reporter system, qPCR, immunoblotting and short-hairpin RNA interference. Genome-wide single nucleotide polymorphism (SNP) array was used to 'trace' the genomic instability signature pattern in 8 clonal lines of FOXM1-induced malignant human oral keratinocytes. Furthermore, acute FOXM1 upregulation in primary oral keratinocytes directly induced genomic instability. We have shown for the first time that overexpression of FOXM1 precedes HNSCC malignancy. Screening putative carcinogens in human oral keratinocytes surprisingly showed that nicotine, which is not perceived to be a human carcinogen, directly induced FOXM1 mRNA, protein stabilisation and transcriptional activity at concentrations relevant to tobacco chewers. Importantly, nicotine also augmented FOXM1-induced transformation of human oral keratinocytes. A centrosomal protein CEP55 and a DNA helicase/putative stem cell marker HELLS, both located within a consensus loci (10q23), were found to be novel targets of FOXM1 and their expression correlated tightly with HNSCC progression. Conclusions/Significance: This study cautions the potential co-carcinogenic effect of nicotine in tobacco replacement therapies. We hypothesise that aberrant upregulation of FOXM1 may be inducing genomic instability through a program of malignant transformation involving the activation of CEP55 and HELLS which may facilitate aberrant mitosis and epigenetic modifications. Our finding that FOXM1 is upregulated early during oral cancer progression renders FOXM1 an attractive diagnostic biomarker for early cancer detection and its candidate mechanistic targets, CEP55 and HELLS, as indicators of malignant conversion and progression.	[Gemenetzidis, Emilios; Bose, Amrita; Riaz, Adeel M.; Ali, Muhammad; Wan, Hong; Waseem, Ahmad; Parkinson, Eric K.; Fortune, Farida; Teh, Muy-Teck] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England; [Chaplin, Tracy; Young, Bryan D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Canc Res UK Med Oncol Lab, London, England; [Sugden, David] Kings Coll London, Sch Biomed & Hlth Sci, Div Reproduct & Endocrinol, London WC2R 2LS, England; [Thurlow, Johanna K.] Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Cheong, Sok-Ching; Teo, Soo-Hwang] Canc Res Initiatives Fdn CARIF, Subang Jaya Med Ctr, Outpatient Ctr 2 fl, Selangor, Malaysia	University of London; Queen Mary University London; Cancer Research UK; University of London; Queen Mary University London; University of London; King's College London; Beatson Institute	Teh, MT (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	m.t.teh@qmul.ac.uk	Teh, Muy-Teck/B-9284-2016; Teo, Soo-hwang/H-2353-2014	Teh, Muy-Teck/0000-0002-7725-8355; 	MRC [PhD studentship]; Institute of Dentistry; Barts and the London School of Medicine and Dentistry; Queen Mary University of London	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Dentistry; Barts and the London School of Medicine and Dentistry; Queen Mary University of London	This work was co-funded by MRC PhD studentship (E.G.) and the Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary University of London. The sponsors had no role in the study design, data collection and analysis, interpretation of the results, the preparation of the manuscript, or the decision to submit the manuscript for publication.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Banerjee AG, 2007, MOL CELL BIOCHEM, V305, P113, DOI 10.1007/s11010-007-9534-2; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Bock FG, 1980, BANBURY REPORT SAFE, P129; Braakhuis BJM, 2004, J ORAL PATHOL MED, V33, P317; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Califano J, 1996, CANCER RES, V56, P2488; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Deng H, 1997, NAT BIOTECHNOL, V15, P1388, DOI 10.1038/nbt1297-1388; EDINGTON KG, 1995, MOL CARCINOGEN, V13, P254, DOI 10.1002/mc.2940130408; Einbond LS, 2007, ANTICANCER RES, V27, P697; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gasparotto D, 1999, INT J CANCER, V84, P432, DOI 10.1002/(SICI)1097-0215(19990820)84:4<432::AID-IJC18>3.0.CO;2-#; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Hamid S, 2007, INT J MOL MED, V19, P453; Homsy W, 1997, J CLIN PHARMACOL, V37, P728, DOI 10.1002/j.1552-4604.1997.tb04360.x; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Hunter KD, 2006, CANCER RES, V66, P7405, DOI 10.1158/0008-5472.CAN-06-0186; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Katoh M, 2004, INT J ONCOL, V25, P1495; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; KULKARNI PS, 1995, CARCINOGENESIS, V16, P2515, DOI 10.1093/carcin/16.10.2515; Lalli A, 2008, J ORAL PATHOL MED, V37, P211, DOI 10.1111/j.1600-0714.2007.00609.x; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2000, CANCER RES, V60, P3612; Lee HJ, 2005, J ORAL PATHOL MED, V34, P436, DOI 10.1111/j.1600-0714.2005.00342.x; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Muller A, 2007, BIOINFORMATICS, V23, P496, DOI 10.1093/bioinformatics/btl608; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ransom DT, 1996, HEAD NECK-J SCI SPEC, V18, P248; REISS M, 1985, J NATL CANCER I, V74, P1015; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; RHEINWALD JG, 1981, CANCER RES, V41, P1657; ROSOWSKY A, 1987, CANCER RES, V47, P5913; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Silvia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-200; Singh B, 2001, CANCER RES, V61, P4506; Staab CA, 2004, ATLA-ALTERN LAB ANIM, V32, P401, DOI 10.1177/026119290403200412; Takebayashi S, 2004, GENE CHROMOSOME CANC, V41, P145, DOI 10.1002/gcc.20066; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Teh MT, 2008, J ORAL PATHOL MED, V37, P430, DOI 10.1111/j.1600-0714.2008.00643.x; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Teh MT, 2002, CANCER RES, V62, P4773; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker DM, 2003, PATHOLOGY, V35, P376, DOI 10.1080/00310290310001602558; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yano M, 2004, INT J CANCER, V112, P8, DOI 10.1002/ijc.20407; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	68	143	150	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4849	10.1371/journal.pone.0004849	http://dx.doi.org/10.1371/journal.pone.0004849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287496	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400010
J	Gaskell, EA; Smith, JE; Pinney, JW; Westhead, DR; McConkey, GA				Gaskell, Elizabeth A.; Smith, Judith E.; Pinney, John W.; Westhead, Dave R.; McConkey, Glenn A.			A Unique Dual Activity Amino Acid Hydroxylase in Toxoplasma gondii	PLOS ONE			English	Article								The genome of the protozoan parasite Toxoplasma gondii was found to contain two genes encoding tyrosine hydroxylase; that produces L-DOPA. The encoded enzymes metabolize phenylalanine as well as tyrosine with substrate preference for tyrosine. Thus the enzymes catabolize phenylalanine to tyrosine and tyrosine to L-DOPA. The catalytic domain descriptive of this class of enzymes is conserved with the parasite enzyme and exhibits similar kinetic properties to metazoan tyrosine hydroxylases, but contains a unique N-terminal extension with a signal sequence motif. One of the genes, TgAaaH1, is constitutively expressed while the other gene, TgAaaH2, is induced during formation of the bradyzoites of the cyst stages of the life cycle. This is the first description of an aromatic amino acid hydroxylase in an apicomplexan parasite. Extensive searching of apicomplexan genome sequences revealed an ortholog in Neospora caninum but not in Eimeria, Cryptosporidium, Theileria, or Plasmodium. Possible role(s) of these bi-functional enzymes during host infection are discussed.			Gaskell, EA (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	A.McConkey@Leeds.ac.uk	McConkey, Glenn A./I-4062-2019	Westhead, David/0000-0002-0519-3820; McConkey, Glenn/0000-0001-6529-794X; Smith, Judith/0000-0002-2206-3534	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Appleford PJ, 1997, ACTA TROP, V65, P97, DOI 10.1016/S0001-706X(97)00656-6; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Bohne W, 1998, MOL BIOCHEM PARASIT, V92, P291, DOI 10.1016/S0166-6851(97)00236-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; DARDE ML, 1990, PARASITOL RES, V76, P367, DOI 10.1007/BF00928194; Daubner SC, 1997, BIOCHEMISTRY-US, V36, P11574, DOI 10.1021/bi9711137; Daubner SC, 2000, BIOCHEMISTRY-US, V39, P9652, DOI 10.1021/bi000493k; DAUBNER SC, 1993, PROTEIN SCI, V2, P1452, DOI 10.1002/pro.5560020909; Daubner SC, 1997, ARCH BIOCHEM BIOPHYS, V348, P295, DOI 10.1006/abbi.1997.0435; DICKSON PW, 1994, J BIOL CHEM, V269, P20369; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FITZPATRICK PF, 1989, BIOCHEM BIOPH RES CO, V161, P211, DOI 10.1016/0006-291X(89)91582-9; FITZPATRICK PF, 1991, BIOCHEMISTRY-US, V30, P3658, DOI 10.1021/bi00229a010; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; HAUER CR, 1993, J BIOL CHEM, V268, P4828; Hyland C, 2006, NUCLEIC ACIDS RES, V34, pW725, DOI 10.1093/nar/gkl196; KUHN DM, 1983, BIOCHEM BIOPH RES CO, V117, P894, DOI 10.1016/0006-291X(83)91680-7; Laliberte J, 2008, CELL MOL LIFE SCI, V65, P1900, DOI 10.1007/s00018-008-7556-x; LAMBERTON PH, 2008, PARASITOLOGY, P1; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Odaert H, 1996, PARASITOL RES, V82, P28, DOI 10.1007/BF03035408; OdbergFerragut C, 1996, MOL BIOCHEM PARASIT, V82, P237, DOI 10.1016/0166-6851(96)02740-5; Pattison DI, 2002, TOXICOLOGY, V177, P23, DOI 10.1016/S0300-483X(02)00193-2; PEMBER SO, 1989, BIOCHEMISTRY-US, V28, P2124, DOI 10.1021/bi00431a024; Pinney JW, 2007, TRENDS PARASITOL, V23, P548, DOI 10.1016/j.pt.2007.08.013; Pinney JW, 2005, NUCLEIC ACIDS RES, V33, P1399, DOI 10.1093/nar/gki285; RAMSEY AJ, 1995, PROTEIN SCI, V4, P2082; RIBEIRO P, 1993, J MOL NEUROSCI, V4, P125, DOI 10.1007/BF02782125; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; Sura GR, 2004, J NEUROCHEM, V90, P970, DOI 10.1111/j.1471-4159.2004.02566.x; SUZUKI Y, 1989, J INFECT DIS, V159, P790, DOI 10.1093/infdis/159.4.790; WALKER SJ, 1994, BBA-PROTEIN STRUCT M, V1206, P113, DOI 10.1016/0167-4838(94)90079-5; WANG YH, 1991, P NATL ACAD SCI USA, V88, P8779, DOI 10.1073/pnas.88.19.8779; Yahiaoui B, 1999, MOL BIOCHEM PARASIT, V99, P223, DOI 10.1016/S0166-6851(99)00019-5; YANG SM, 1995, MOL BIOCHEM PARASIT, V73, P291, DOI 10.1016/0166-6851(95)00124-J	43	199	205	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4801	10.1371/journal.pone.0004801	http://dx.doi.org/10.1371/journal.pone.0004801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277211	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496100020
J	Abdelkarim, M; Guenin, E; Sainte-Catherine, O; Vintonenko, N; Peyri, N; Perret, GY; Crepin, M; Khatib, AM; Lecouvey, M; Di Benedetto, M				Abdelkarim, Mohamed; Guenin, Erwann; Sainte-Catherine, Odile; Vintonenko, Nadejda; Peyri, Nicole; Perret, Gerard Yves; Crepin, Michel; Khatib, Abdel-Majid; Lecouvey, Marc; Di Benedetto, Melanie			New Symmetrically Esterified m-Bromobenzyl Non-Aminobisphosphonates Inhibited Breast Cancer Growth and Metastases	PLOS ONE			English	Article							IN-VITRO; BISPHOSPHONATES; BONE; PROLIFERATION; OSTEONECROSIS; JAW	Background: Although there was growing evidence in the potential use of Bisphosphonates (BPs) in cancer therapy, their strong osseous affinities that contrast their poor soft tissue uptake limited their use. Here, we developed a new strategy to overcome BPs hydrophilicity by masking the phosphonic acid through organic protecting groups and introducing hydrophobic functions in the side chain. Methodology/Principal Findings: We synthesized non-nitrogen BPs (non N-BPs) containing bromobenzyl group (BP7033Br) in their side chain that were symmetrically esterified with hydrophobic 4-methoxphenyl (BP7033BrALK) and assessed their effects on breast cancer estrogen-responsive cells (T47D, MCF-7) as well as on non responsive ones (SKBR3, MDA-MB-231 and its highly metastatic derived D3H2LN subclone). BP7033Br ALK was more efficient in inhibiting tumor cell proliferation, migration and survival when compared to BP7033Br. Although both compounds inhibited tumor growth without side effects, only BP7033Br ALK abrogated tumor angiogenesis and D3H2LN cells-induced metastases formation. Conclusion/Significance: Taken together these data suggest the potential therapeutic use of this new class of esterified Bisphosphonates (BPs) in the treatment of tumor progression and metastasis without toxic adverse effects.	[Abdelkarim, Mohamed; Guenin, Erwann; Sainte-Catherine, Odile; Vintonenko, Nadejda; Perret, Gerard Yves; Lecouvey, Marc; Di Benedetto, Melanie] Univ Paris 13, CNRS FRE CSPBAT, Lab Chim Struct Biomol, Lab Pharmacol,UFR SMBH, Bobigny, France; [Abdelkarim, Mohamed; Vintonenko, Nadejda; Peyri, Nicole; Crepin, Michel] INSERM 553, Endothelium Angiogenese Lab Hemostase, Paris, France; [Khatib, Abdel-Majid; Di Benedetto, Melanie] INSERM, UP7 UMRS 940, Equipe Avenir, IGM, Paris, France	Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Abdelkarim, M (corresponding author), Univ Paris 13, CNRS FRE CSPBAT, Lab Chim Struct Biomol, Lab Pharmacol,UFR SMBH, Bobigny, France.	dibenedetto22@yahoo.fr	abdelkarim, mohamed/AAK-5563-2020; KHATIB, Abdel-Majid/A-9948-2015; Di Benedetto, Melanie MD/C-1512-2018; PERRET, gerard/A-7379-2008	abdelkarim, mohamed/0000-0002-0984-6083; KHATIB, Abdel-Majid/0000-0001-6957-0384; Di Benedetto, Melanie MD/0000-0003-1119-3752; PERRET, gerard/0000-0003-0645-3337; Guenin, Erwann/0000-0002-7125-9074	Association Martine Midy; Institut National de Recherche sur le Cancer (INCA); Ligue regionale contre le cancer-comite Ile de France	Association Martine Midy; Institut National de Recherche sur le Cancer (INCA)(Institut National du Cancer (INCA) France); Ligue regionale contre le cancer-comite Ile de France	This work was supported by grants from the Association Martine Midy and by the Institut National de Recherche sur le Cancer (INCA) and the Ligue regionale contre le cancer-comite Ile de France. We particularly acknowledge Dr. Olivier Rixe and Tatiana Theys for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2001, CLIN CANCER RES, V7, P1246; Caraglia M, 2006, ENDOCR-RELAT CANCER, V13, P7, DOI 10.1677/erc.1.01094; Clezardin P, 2005, CANCER RES, V65, P4971, DOI 10.1158/0008-5472.CAN-05-0264; Clezardin P, 2003, CURR MED CHEM, V10, P173, DOI 10.2174/0929867033368529; Diel IJ, 2007, CRIT REV ONCOL HEMAT, V64, P198, DOI 10.1016/j.critrevonc.2007.07.005; Ezra A, 2000, ADV DRUG DELIVER REV, V42, P175, DOI 10.1016/S0169-409X(00)00061-2; Fromigue O, 2000, J BONE MINER RES, V15, P2211, DOI 10.1359/jbmr.2000.15.11.2211; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Guenin E, 2005, ANTICANCER RES, V25, P1139; Hamma-Kourbali Y, 2003, BIOCHEM BIOPH RES CO, V310, P816, DOI 10.1016/j.bbrc.2003.09.083; HIGARA T, 2001, CANCER RES, V61, P4418; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Journe F, 2004, BRIT J CANCER, V91, P1703, DOI 10.1038/sj.bjc.6602181; Kavanagh KL, 2006, J BIOL CHEM, V281, P22004, DOI 10.1074/jbc.M602603200; Lecouvey M, 2001, TETRAHEDRON LETT, V42, P8475, DOI 10.1016/S0040-4039(01)01844-5; Ledoux D, 2006, ANTI-CANCER DRUG, V17, P479, DOI 10.1097/01.cad.0000198909.52701.0f; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Mao JH, 2006, J AM CHEM SOC, V128, P14485, DOI 10.1021/ja061737c; Migianu E, 2005, NUCLEOS NUCLEOT NUCL, V24, P121, DOI 10.1081/NCN-200051890; Monkkonen H, 2008, ANTI-CANCER DRUG, V19, P391, DOI 10.1097/CAD.0b013e3282f632bf; Monteil M, 2005, TETRAHEDRON, V61, P7528, DOI 10.1016/j.tet.2005.05.053; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; SASAKI A, 1995, CANCER RES, V55, P3551; Sebbah-Louriki M, 2002, ANTICANCER RES, V22, P3925; Senaratne SG, 2000, BRIT J CANCER, V82, P1459, DOI 10.1054/bjoc.1999.1131; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007; Tetko IV, 2008, J INORG BIOCHEM, V102, P1424, DOI 10.1016/j.jinorgbio.2007.12.029; Van den Wyngaert T, 2006, ANN ONCOL, V17, P1197, DOI 10.1093/annonc/mdl294; Wakchoure S, 2006, CLIN CANCER RES, V12, P2862, DOI 10.1158/1078-0432.CCR-05-2766; Wang WG, 2002, CANCER RES, V62, P6278; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4685	10.1371/journal.pone.0004685	http://dx.doi.org/10.1371/journal.pone.0004685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262688	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490600013
J	Coron, E; Flamant, M; Aubert, P; Wedel, T; Pedron, T; Letessier, E; Galmiche, JP; Sansonetti, PJ; Neunlist, M				Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Wedel, Thilo; Pedron, Thierry; Letessier, Eric; Galmiche, Jean P.; Sansonetti, Philippe J.; Neunlist, Michel			Characterisation of Early Mucosal and Neuronal Lesions Following Shigella flexneri Infection in Human Colon	PLOS ONE			English	Article								Background: Shigella, an enteroinvasive bacteria induces a major inflammatory response responsible for acute rectocolitis in humans. However, early effect of Shigella flexneri (S. flexneri) infection upon the human mucosa and its microenvironement, in particular the enteric nervous system, remains currently unknown. Therefore, in this study, we sought to characterize ex vivo the early events of shigellosis in a model of human colonic explants. In particular, we aimed at identifying factors produced by S. flexneri and responsible for the lesions of the barrier. We also aimed at determining the putative lesions of the enteric nervous system induced by S. flexneri. Methodology/Principal Findings: We first showed that, following 3 h of infection, the invasive but not the non-invasive strain of S. flexneri induced significant desquamation of the intestinal epithelial barrier and a reduction of epithelial height. These changes were significantly reduced following infection with SepA deficient S. flexneri strains. Secondly, S. flexneri induced rapid neuronal morphological alterations suggestive of cell death in enteric submucosal neurones. These alterations were associated with a significant increase in the proportion of vasoactive intestinal peptide (VIP) immunoreactive (IR) neurons but not in total VIP levels. The NMDA receptor antagonist MK-801 blocked neuronal morphological changes induced by S. flexneri, but not the increase in the proportion of VIP-IR. Conclusions/Significance: This human explant model can be used to gain better insight into the early pathogenic events following S. flexneri infection and the mechanisms involved.	[Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Galmiche, Jean P.; Neunlist, Michel] INSERM, U913, Nantes, France; [Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Letessier, Eric; Galmiche, Jean P.; Neunlist, Michel] Univ Nantes, Fac Med, F-44035 Nantes, France; [Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Letessier, Eric; Galmiche, Jean P.; Neunlist, Michel] CHU Nantes, Inst Maladies Appareil Digest, Hotel Dieu, Nantes, France; [Wedel, Thilo] Univ Kiel, Inst Anat, D-24098 Kiel, Germany; [Pedron, Thierry; Sansonetti, Philippe J.] Inst Pasteur, Unite INSERM 786, Unite Pathogen Microbienne Mol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; University of Kiel; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Coron, E (corresponding author), INSERM, U913, Nantes, France.	michel.neunlist@univ-nantes.fr	Neunlist, Michel/K-2388-2015; Aubert, Philippe/K-2352-2015; Wedel, Thilo/B-1247-2010; Coron, Emmanuel/K-2415-2015	Aubert, Philippe/0000-0001-7471-7694; Wedel, Thilo/0000-0002-8146-2711; Aubert, Philippe/0000-0002-3126-6202				Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Benjelloun-Touimi Z, 1998, MICROBIOL-SGM, V144, P1815, DOI 10.1099/00221287-144-7-1815; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; Cattaruzza F, 2006, AM J PATHOL, V169, P177, DOI 10.2353/ajpath.2006.051098; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; De Giorgio R, 2004, GASTROENTEROLOGY, V126, P1872, DOI 10.1053/j.gastro.2004.02.024; Jarry A, 2006, BRIT J PHARMACOL, V147, P64, DOI 10.1038/sj.bjp.0706449; Ji S, 2005, J GASTROEN HEPATOL, V20, P381, DOI 10.1111/j.1440-1746.2005.03574.x; Kirchgessner AL, 1997, J NEUROSCI, V17, P8804; Neunlist M, 2008, J INTERN MED, V263, P577, DOI 10.1111/j.1365-2796.2008.01963.x; Niyogi SK, 2005, J MICROBIOL, V43, P133; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; Schemann M, 2004, NEUROGASTROENT MOTIL, V16, P55, DOI 10.1111/j.1743-3150.2004.00476.x; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Tixier E, 2005, CELL MICROBIOL, V7, P1798, DOI 10.1111/j.1462-5822.2005.00596.x; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vergnolle N, 2006, J CLIN INVEST, V116, P2056, DOI 10.1172/JCI21689R1; Wang LH, 2004, GUT, V53, P1390, DOI 10.1136/gut.2003.021154corr1; Zhang Z, 2001, INFECT IMMUN, V69, P3240, DOI 10.1128/IAI.69.5.3240-3247.2001	24	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4713	10.1371/journal.pone.0004713	http://dx.doi.org/10.1371/journal.pone.0004713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19274103	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490600023
J	He, M; Gitschier, J; Zerjal, T; de Knijff, P; Tyler-Smith, C; Xue, YL				He, Miao; Gitschier, Jane; Zerjal, Tatiana; de Knijff, Peter; Tyler-Smith, Chris; Xue, Yali			Geographical Affinities of the HapMap Samples	PLOS ONE			English	Article							CELL-LINE PANEL; HUMAN GENOME; POPULATION-STRUCTURE; HAPLOTYPE MAP; Y-CHROMOSOME; COPY NUMBER; DIVERSITY; POLYMORPHISM; ASSOCIATION; SELECTION	Background: The HapMap samples were collected for medical-genetic studies, but are also widely used in population-genetic and evolutionary investigations. Yet the ascertainment of the samples differs from most population-genetic studies which collect individuals who live in the same local region as their ancestors. What effects could this non-standard ascertainment have on the interpretation of HapMap results? Methodology/Principal Findings: We compared the HapMap samples with more conventionally-ascertained samples used in population-and forensic-genetic studies, including the HGDP-CEPH panel, making use of published genome-wide autosomal SNP data and Y-STR haplotypes, as well as producing new Y-STR data. We found that the HapMap samples were representative of their broad geographical regions of ancestry according to all tests applied. The YRI and JPT were indistinguishable from independent samples of Yoruba and Japanese in all ways investigated. However, both the CHB and the CEU were distinguishable from all other HGDP-CEPH populations with autosomal markers, and both showed Y-STR similarities to unusually large numbers of populations, perhaps reflecting their admixed origins. Conclusions/Significance: The CHB and JPT are readily distinguished from one another with both autosomal and Y-chromosomal markers, and results obtained after combining them into a single sample should be interpreted with caution. The CEU are better described as being of Western European ancestry than of Northern European ancestry as often reported. Both the CHB and CEU show subtle but detectable signs of admixture. Thus the YRI and JPT samples are well-suited to standard population-genetic studies, but the CHB and CEU less so.	[He, Miao; Gitschier, Jane; Zerjal, Tatiana; Tyler-Smith, Chris; Xue, Yali] Wellcome Trust Sanger Inst, Hinxton, England; [Gitschier, Jane] Univ Calif San Francisco, Dept Med & Pediat, San Francisco, CA 94143 USA; [Zerjal, Tatiana] Stn Genet Vegetale, Ferme Moulon, Gif Sur Yvette, France; [de Knijff, Peter] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Human Genet, NL-2300 RA Leiden, Netherlands	Wellcome Trust Sanger Institute; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	He, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	ylx@sanger.ac.uk	zerjal, tatiana/AAO-9473-2020; de Knijff, Peter/Y-2519-2018	de Knijff, Peter/0000-0002-0899-771X	The Wellcome Trust; Howard Hughes Medical Institute; Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO)	The Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Wellcome Trust (MH, CT-S, YX), the Howard Hughes Medical Institute (JG) and a grant from the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO) within the framework of the Forensic Genomics Consortium Netherlands (PdK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Crawford MH, 2007, ANTHROPOLOGICAL GENETICS: THEORY, METHODS AND APPLICATIONS, P1; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McCarthy MI, 2008, HUM MOL GENET, V17, pR100, DOI 10.1093/hmg/ddn298; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Mulero JJ, 2006, J FORENSIC SCI, V51, P64, DOI 10.1111/j.1556-4029.2005.00016.x; Powell GT, 2007, FORENSIC SCI INT-GEN, V1, P115, DOI 10.1016/j.fsigen.2007.01.015; Pritchard JK, 2000, GENETICS, V155, P945; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Willner AE, 2007, NAT PHOTONICS, V1, P87, DOI 10.1038/nphoton.2006.88; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	31	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4684	10.1371/journal.pone.0004684	http://dx.doi.org/10.1371/journal.pone.0004684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259268	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490500007
J	Wagai, J; Senga, J; Fegan, G; English, M				Wagai, John; Senga, John; Fegan, Greg; English, Mike			Examining Agreement between Clinicians when Assessing Sick Children	PLOS ONE			English	Article								Background: Case management guidelines use a limited set of clinical features to guide assessment and treatment for common childhood diseases in poor countries. Using video records of clinical signs we assessed agreement among experts and assessed whether Kenyan health workers could identify signs defined by expert consensus. Methodology: 104 videos representing 11 clinical sign categories were presented to experts using a web questionnaire. Proportionate agreement and agreement beyond chance were calculated using kappa and the AC1 statistic. 31 videos were selected and presented to local health workers, 20 for which experts had demonstrated clear agreement and 11 for which experts could not demonstrate agreement. Principal Findings: Experts reached very high level of chance adjusted agreement for some videos while for a few videos no agreement beyond chance was found. Where experts agreed Kenyan hospital staff of all cadres recognised signs with high mean sensitivity and specificity (sensitivity: 0.897-0.975, specificity: 0.813-0.894); years of experience, gender and hospital had no influence on mean sensitivity or specificity. Local health workers did not agree on videos where experts had low or no agreement. Results of different agreement statistics for multiple observers, the AC1 and Fleiss' kappa, differ across the range of proportionate agreement. Conclusion: Videos provide a useful means to test agreement amongst geographically diverse groups of health workers. Kenyan health workers are in agreement with experts where clinical signs are clear-cut supporting the potential value of assessment and management guidelines. However, clinical signs are not always clear-cut. Video recordings offer one means to help standardise interpretation of clinical signs.	[Wagai, John; Senga, John; English, Mike] KEMRI, Child & Newborn Hlth Grp, Ctr Geog Med, Wellcome Trust Programme, Nairobi, Kenya; [Fegan, Greg] KEMRI, Ctr Geograph Med Res Coast, Kilifi, Kenya; [Fegan, Greg] London Sch Hygiene & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London, England; [English, Mike] Univ Oxford, Dept Paediat, Oxford OX1 2JD, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Wagai, J (corresponding author), KEMRI, Child & Newborn Hlth Grp, Ctr Geog Med, Wellcome Trust Programme, Nairobi, Kenya.	jwagai@nairobi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018	Fegan, Greg W/0000-0002-2663-2765; English, Michael/0000-0002-7427-0826	Wellcome Trust Senior Fellowship [076827]	Wellcome Trust Senior Fellowship(Wellcome Trust)	Funds from a Wellcome Trust Senior Fellowship awarded to Dr. Mike English (#076827) made this work possible. The funders had no role in the design, conduct, analyses or writing of this study nor in the decision to submit for publication.	Basnet Sudha, 2006, Indian Journal of Pediatrics, V73, P777, DOI 10.1007/BF02790384; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Casebeer L, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-37; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; ENGLISH M, 1995, ARCH DIS CHILD, V72, P334, DOI 10.1136/adc.72.4.334; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Goswami V, 2006, INDIAN PEDIATR, V43, P1042; Gupta R, 2000, Indian Pediatr, V37, P383; Gwet KL., 2001, HDB INTERRATER RELIA; Handschu R, 2003, STROKE, V34, P2842, DOI 10.1161/01.STR.0000102043.70312.E9; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Kernaghan D, 2006, QUAL SAF HEALTH CARE, V15, P359, DOI 10.1136/qshc.2006.018572; LANDIS JR, 1977, BIOMETRICS, V33, P174; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Usen S, 1999, BMJ-BRIT MED J, V318, P86, DOI 10.1136/bmj.318.7176.86; Zucker JR, 1997, B WORLD HEALTH ORGAN, V75, P97	17	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4626	10.1371/journal.pone.0004626	http://dx.doi.org/10.1371/journal.pone.0004626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247448	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000265487800008
J	Wang, L; Di, LJ; Lv, X; Zheng, W; Xue, Z; Guo, ZC; Liu, DP; Liang, CC				Wang, Li; Di, Li-Jun; Lv, Xiang; Zheng, Wei; Xue, Zheng; Guo, Zhi-Chen; Liu, De-Pei; Liang, Chi-Chuan			Inter-MAR Association Contributes to Transcriptionally Active Looping Events in Human beta-globin Gene Cluster	PLOS ONE			English	Article								Matrix attachment regions (MARs) are important in chromatin organization and gene regulation. Although it is known that there are a number of MAR elements in the beta-globin gene cluster, it is unclear that how these MAR elements are involved in regulating beta-globin genes expression. Here, we report the identification of a new MAR element at the LCR(locus control region) of human beta-globin gene cluster and the detection of the inter-MAR association within the beta-globin gene cluster. Also, we demonstrate that SATB1, a protein factor that has been implicated in the formation of network like higher order chromatin structures at some gene loci, takes part in beta-globin specific inter-MAR association through binding the specific MARs. Knocking down of SATB1 obviously reduces the binding of SATB1 to the MARs and diminishes the frequency of the inter-MAR association. As a result, the ACH establishment and the alpha-like globin genes and beta-like globin genes expressions are affected either. In summary, our results suggest that SATB1 is a regulatory factor of hemoglobin genes, especially the early differentiation genes at least through affecting the higher order chromatin structure.	[Wang, Li; Di, Li-Jun; Lv, Xiang; Zheng, Wei; Xue, Zheng; Guo, Zhi-Chen; Liu, De-Pei; Liang, Chi-Chuan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100037, Peoples R China; [Wang, Li; Di, Li-Jun; Lv, Xiang; Zheng, Wei; Xue, Zheng; Guo, Zhi-Chen; Liu, De-Pei; Liang, Chi-Chuan] PUMC, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100037, Peoples R China.	liudp@pumc.edu.cn	Di, Li-jun/B-3352-2011	Liu, De-Pei/0000-0002-2636-4297	National Natural Science Foundation of China [30721063, U0632005]; "973" program of China [2005CB522402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (grant No. 30721063 and U0632005) and "973" program of China (grant No. 2005CB522402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkuhn M, 2008, BBA-MOL CELL RES, V1783, P2161, DOI 10.1016/j.bbamcr.2008.07.011; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Boulikas T, 1995, INT REV CYTOL, V162A, P279; BOULIKAS T, 1993, J CELL BIOCHEM, V52, P23, DOI 10.1002/jcb.240520105; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Case SS, 1999, DNA CELL BIOL, V18, P805, DOI 10.1089/104454999314809; CHOU RH, 1990, CANCER RES, V50, P3199; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; DEAN A, 1981, SCIENCE, V212, P459, DOI 10.1126/science.6163216; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Di LJ, 2008, J CELL BIOCHEM, V105, P301, DOI 10.1002/jcb.21826; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; GAZIT B, 1982, SCIENCE, V217, P648, DOI 10.1126/science.6283640; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; JACKSON CE, 1995, J BIOL CHEM, V270, P28448; JARMAN AP, 1988, EMBO J, V7, P3337, DOI 10.1002/j.1460-2075.1988.tb03205.x; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; LI QL, 1994, MOL CELL BIOL, V14, P6087, DOI 10.1128/MCB.14.9.6087; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Ma C, 2007, ONCOGENE, V26, P2649, DOI 10.1038/sj.onc.1210069; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Ostermeier GC, 2003, NUCLEIC ACIDS RES, V31, P3257, DOI 10.1093/nar/gkg424; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; ROWLEY PT, 1984, LEUKEMIA RES, V8, P45, DOI 10.1016/0145-2126(84)90030-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Smith RD, 2000, NUCLEIC ACIDS RES, V28, P4998, DOI 10.1093/nar/28.24.4998; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Weber M, 2003, MOL CELL BIOL, V23, P8953, DOI 10.1128/MCB.23.24.8953-8959.2003; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Yan Z J, 1998, Cell Res, V8, P209; Zhou GL, 2006, MOL CELL BIOL, V26, P5096, DOI 10.1128/MCB.02454-05	59	27	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4629	10.1371/journal.pone.0004629	http://dx.doi.org/10.1371/journal.pone.0004629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247486	Green Published, gold			2022-12-27	WOS:000265487800011
J	Altaba, CR				Altaba, Cristian R.			Universal Artifacts Affect the Branching of Phylogenetic Trees, Not Universal Scaling Laws	PLOS ONE			English	Article							DNA-SEQUENCE DATA; MOLECULAR PHYLOGENY; DIVERSIFICATION RATES; EVOLUTIONARY HISTORY; MAXIMUM-LIKELIHOOD; STOCHASTIC-MODELS; EXTINCTION RATES; CYTOCHROME-B; SPECIATION; GASTROPODA	Background: The superficial resemblance of phylogenetic trees to other branching structures allows searching for macroevolutionary patterns. However, such trees are just statistical inferences of particular historical events. Recent meta-analyses report finding regularities in the branching pattern of phylogenetic trees. But is this supported by evidence, or are such regularities just methodological artifacts? If so, is there any signal in a phylogeny? Methodology: In order to evaluate the impact of polytomies and imbalance on tree shape, the distribution of all binary and polytomic trees of up to 7 taxa was assessed in tree-shape space. The relationship between the proportion of outgroups and the amount of imbalance introduced with them was assessed applying four different tree-building methods to 100 combinations from a set of 10 ingroup and 9 outgroup species, and performing covariance analyses. The relevance of this analysis was explored taking 61 published phylogenies, based on nucleic acid sequences and involving various taxa, taxonomic levels, and tree-building methods. Principal Findings: All methods of phylogenetic inference are quite sensitive to the artifacts introduced by outgroups. However, published phylogenies appear to be subject to a rather effective, albeit rather intuitive control against such artifacts. The data and methods used to build phylogenetic trees are varied, so any meta-analysis is subject to pitfalls due to their uneven intrinsic merits, which translate into artifacts in tree shape. The binary branching pattern is an imposition of methods, and seldom reflects true relationships in intraspecific analyses, yielding artifactual polytomies in short trees. Above the species level, the departure of real trees from simplistic random models is caused at least by two natural factors uneven speciation and extinction rates; and artifacts such as choice of taxa included in the analysis, and imbalance introduced by outgroups and basal paraphyletic taxa. This artifactual imbalance accounts for tree shape convergence of large trees. Significance: There is no evidence for any universal scaling in the tree of life. Instead, there is a need for improved methods of tree analysis that can be used to discriminate the noise due to outgroups from the phylogenetic signal within the taxon of interest, and to evaluate realistic models of evolution, correcting the retrospective perspective and explicitly recognizing extinction as a driving force. Artifacts are pervasive, and can only be overcome through understanding the structure and biological meaning of phylogenetic trees. Catalan Abstract in Translation S1.	[Altaba, Cristian R.] Univ Balearic Isl, Lab Human Systemat, Balearic Isl, Spain	Universitat de les Illes Balears	Altaba, CR (corresponding author), Univ Balearic Isl, Lab Human Systemat, Balearic Isl, Spain.	cristianr.altaba@uib.es						Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Ahyong ST, 2004, RAFFLES B ZOOL, V52, P673; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Alonso MR, 2006, BIOL J LINN SOC, V89, P169, DOI 10.1111/j.1095-8312.2006.00670.x; Altaba CR, 1997, CONTRIB ZOOL, V66, P257; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Barriel V, 1998, CLADISTICS, V14, P193, DOI 10.1111/j.1096-0031.1998.tb00332.x; Billera LJ, 2001, ADV APPL MATH, V27, P733, DOI 10.1006/aama.2001.0759; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Bokma F, 2003, EVOLUTION, V57, P2469; BOKMA F, 2008, EVOLUTION IN PRESS; Bokma F, 2006, J THEOR BIOL, V243, P449, DOI 10.1016/j.jtbi.2006.06.023; Bonett RM, 2004, MOL ECOL, V13, P1189, DOI 10.1111/j.1365-294X.2004.02130.x; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Brambilla M, 2008, MOL PHYLOGENET EVOL, V48, P461, DOI 10.1016/j.ympev.2008.05.013; Bretagnolle V, 1998, AUK, V115, P188, DOI 10.2307/4089123; Cela-Conde CJ, 2002, S AFR J SCI, V98, P229; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Cicero C, 2001, MOL PHYLOGENET EVOL, V20, P27, DOI 10.1006/mpev.2001.0944; Coddington JA, 1996, CLADISTICS, V12, P139, DOI 10.1111/j.1096-0031.1996.tb00198.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dietzen C, 2008, J ORNITHOL, V149, P1, DOI 10.1007/s10336-007-0192-7; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dubey S, 2008, MOL PHYLOGENET EVOL, V47, P877, DOI 10.1016/j.ympev.2007.12.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 2004, INFERRING PHYLOGENIE; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; FORD DJ, 2005, ARXIVMATH0511246V1; Francois O, 2007, MATH BIOSCI, V209, P108, DOI 10.1016/j.mbs.2007.01.005; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Geiger Daniel L., 2005, Molluscan Research, V25, P47; Giribet G, 2002, CLADISTICS, V18, P5, DOI 10.1006/clad.2001.0185; GOLOBOFF P, 2000, TNT TREE ANAL USING; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOULD S J, 1977, Paleobiology, V3, P23; Guan F, 2008, MOL PHYLOGENET EVOL, V48, P702, DOI 10.1016/j.ympev.2008.04.021; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; HARVEY PH, 1994, BIOESSAYS, V16, P767, DOI 10.1002/bies.950161012; Heard SB, 1996, EVOLUTION, V50, P2141, DOI 10.1111/j.1558-5646.1996.tb03604.x; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Heard SB, 1996, SYST BIOL, V45, P115, DOI 10.2307/2413517; Herrada EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002757; HEY J, 1992, EVOLUTION, V46, P627, DOI [10.2307/2409633, 10.1111/j.1558-5646.1992.tb02071.x]; Hidalgo O, 2006, ANN BOT-LONDON, V97, P705, DOI 10.1093/aob/mcl029; HOELZER GA, 1994, TRENDS ECOL EVOL, V9, P104, DOI 10.1016/0169-5347(94)90207-0; Holmes S, 2003, THEOR POPUL BIOL, V63, P17, DOI 10.1016/S0040-5809(02)00005-9; Huelsenbeck JP, 1996, EVOLUTION, V50, P1418, DOI 10.1111/j.1558-5646.1996.tb03915.x; Huff SW, 2004, J MOLLUS STUD, V70, P379, DOI 10.1093/mollus/70.4.379; Hyman IT, 2007, MOL PHYLOGENET EVOL, V45, P792, DOI 10.1016/j.ympev.2007.08.018; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P250, DOI 10.1006/mpev.1999.0615; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Manos PS, 2007, SYST BIOL, V56, P412, DOI 10.1080/10635150701408523; Marjanovic D, 2007, SYST BIOL, V56, P369, DOI 10.1080/10635150701397635; Matsen FA, 2006, SYST BIOL, V55, P652, DOI 10.1080/10635150600889617; Mooers A.O., 2007, RECONSTRUCTING EVOLU, P149; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; MOOERS AO, 1995, EVOLUTION, V49, P379, DOI [10.2307/2410349, 10.1111/j.1558-5646.1995.tb02251.x]; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Murtagh F, 2007, ST CLASS DAT ANAL, P263, DOI 10.1007/978-3-540-70981-7_30; Murtagh F, 2006, AIP CONF PROC, V826, P151, DOI 10.1063/1.2193119; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Page RDM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-158; Paradis E, 2003, P ROY SOC B-BIOL SCI, V270, P2499, DOI 10.1098/rspb.2003.2513; Paxinos EE, 2002, P NATL ACAD SCI USA, V99, P1399, DOI 10.1073/pnas.032166399; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Piaggio AJ, 2001, MOL PHYLOGENET EVOL, V20, P335, DOI 10.1006/mpev.2001.0975; Plucinski M, 2008, J THEOR BIOL, V251, P82, DOI 10.1016/j.jtbi.2007.10.042; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Puslednik L, 2008, MOL PHYLOGENET EVOL, V48, P1178, DOI 10.1016/j.ympev.2008.05.006; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; RAMMAL R, 1986, REV MOD PHYS, V58, P765, DOI 10.1103/RevModPhys.58.765; Redding DW, 2008, J THEOR BIOL, V251, P606, DOI 10.1016/j.jtbi.2007.12.006; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; ROBERTS MD, 2008, ARXIVCS9810012V4; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salisbury BA, 1999, SYST BIOL, V48, P153, DOI 10.1080/106351599260508; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; Sanderson MJ, 1996, TRENDS ECOL EVOL, V11, P15, DOI 10.1016/0169-5347(96)81059-7; Sasaki T, 2006, SYST BIOL, V55, P912, DOI 10.1080/10635150601058014; Simon C, 2005, SYST BIOL, V54, P1, DOI 10.1080/10635150590930463; Sousa A, 2008, MOL PHYLOGENET EVOL, V48, P563, DOI 10.1016/j.ympev.2008.04.030; SRIDHAR S, 2007, THESIS CARNEGIE MELL; Stam E, 2002, EVOLUTION, V56, P1292; Steel M, 2000, SYST BIOL, V49, P363, DOI 10.1093/sysbio/49.2.363; Steel M, 2005, TRENDS GENET, V21, P307, DOI 10.1016/j.tig.2005.04.001; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Sumner JG, 2008, J THEOR BIOL, V253, P601, DOI 10.1016/j.jtbi.2008.04.001; Sundberg P, 2001, MOL PHYLOGENET EVOL, V20, P327, DOI 10.1006/mpev.2001.0982; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Tuffley C, 1997, B MATH BIOL, V59, P581, DOI 10.1016/S0092-8240(97)00001-3; Vela E, 2008, GEODIVERSITAS, V30, P233; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Vogt L, 2008, CLADISTICS, V24, P62, DOI 10.1111/j.1096-0031.2007.00169.x; Wallace RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001697; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842; Westerman Michael, 1999, Journal of Mammalian Evolution, V6, P271, DOI 10.1023/A:1020565724799; Wethington AR, 2007, J MOLLUS STUD, V73, P241, DOI 10.1093/mollus/eym021; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilke T, 2000, AM J TROP MED HYG, V62, P453, DOI 10.4269/ajtmh.2000.62.453; Zeng LY, 2005, CAN J ZOOL, V83, P24, DOI 10.1139/z05-010; Zhou Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-206	124	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4611	10.1371/journal.pone.0004611	http://dx.doi.org/10.1371/journal.pone.0004611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242549	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487500013
J	Stavrum, R; Myneedu, VP; Arora, VK; Ahmed, N; Grewal, HMS				Stavrum, Ruth; Myneedu, Vithal Prasad; Arora, Virendra K.; Ahmed, Niyaz; Grewal, Harleen M. S.			In-Depth Molecular Characterization of Mycobacterium tuberculosis from New Delhi - Predominance of Drug Resistant Isolates of the 'Modern' (TbD1(-)) Type	PLOS ONE			English	Article							PYRAZINAMIDE RESISTANCE; PULMONARY TUBERCULOSIS; RIFAMPICIN-RESISTANCE; PNCA MUTATIONS; COMPLEX; GENE; EPIDEMIOLOGY; IDENTIFICATION; STRAINS; RECOMMENDATIONS	Background: India has the highest estimated burden of tuberculosis in the world, accounting for 21% of all tuberculosis cases world-wide. However, due to lack of systematic analysis using multiple markers the available information on the genomic diversity of Mycobacterium tuberculosis in India is limited. Methodology/Principal Findings: Thus, 65 M. tuberculosis isolates from New Delhi, India were analyzed by spoligotyping, MIRU-VNTR, large deletion PCR typing and single nucleotide polymorphism analysis (SNP). The Central Asian (CAS) 1_DELHI sub-lineage was the most prevalent sub-lineage comprising 46.2% (n = 30) of all isolates, with shared-type (ST) 26 being the most dominant genotype comprising 24.6% (n = 16) of all isolates. Other sub-lineages observed were: East-African Indian (EAI)-5 (9.2%, n = 6), EAI6_BGD1 (6.2%, n = 4), EAI3_IND, CAS and T1 with 6.2% each (n = 4 each), Beijing (4.6%, n = 3), CAS2 (3.1%, n = 2), and X1 and X2 with 1 isolate each. Genotyping results from five isolates (7.7%) did not match any existing spoligopatterns, and one isolate, ST124, belonged to an undefined lineage. Twenty-six percent of the isolates belonged to the TbD1+ PGG1 genogroup. SNP analysis of the pncA gene revealed a CAS-lineage specific silent mutation, S65S, which was observed for all CAS-lineage isolates (except two ST26 isolates) and in 1 orphan. Mutations in the pncA gene, conferring resistance to pyrazinamide, were observed in 15.4% of all isolates. Collectively, mutations in the rpoB gene, the katG gene and in both rpoB and katG genes, conferring resistance to rifampicin and isoniazid, respectively, were more frequent in CAS1_DELHI isolates compared to non-CAS_DELHI isolates (OR: 3.1, CI95% [1.11, 8.70], P = 0.045). The increased frequency of drug-resistance could not be linked to the patients' history of previous anti-tuberculosis treatment (OR: 1.156, CI95% [0.40, 3.36], P = 0.79). Fifty-six percent of all new tuberculosis patients had mutations in either the katG gene or the rpoB gene, or in both katG and rpoB genes. Conclusion: CAS1_DELHI isolates circulating in New Delhi, India have a high frequency of mutations in the rpoB and katG genes. A silent mutation (S65S) in the pncA gene can be used as a putative genetic marker for CAS-lineage isolates.	[Stavrum, Ruth; Grewal, Harleen M. S.] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Stavrum, Ruth; Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol & Immunol, Bergen, Norway; [Myneedu, Vithal Prasad; Arora, Virendra K.] Lala Ram Sarup Inst TB & Resp Dis, New Delhi, India; [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India	University of Bergen; University of Bergen; Haukeland University Hospital; University of Hyderabad	Stavrum, R (corresponding author), Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway.	Harleen.Grewal@Gades.uib.no	Ahmed, Niyaz/D-2589-2010; Grewal, Harleen/ABC-5831-2020	Ahmed, Niyaz/0000-0001-6425-7583; 	Department of Biotechnology of the Indian Government; Research Council of Norway; University of Bergen; Western Norway Regional Health Authority	Department of Biotechnology of the Indian Government; Research Council of Norway(Research Council of Norway); University of Bergen; Western Norway Regional Health Authority	Department of Biotechnology of the Indian Government is acknowledged for providing core support to Niyaz Ahmed and the Research Council of Norway, University of Bergen and Western Norway Regional Health Authority for financial support.	Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; AHMED N, 2008, INFECT GENE IN PRESS, DOI DOI 10.1016/J.MEEGID.2008.1010.1001; Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P31, DOI 10.1186/1476-0711-5-31; Almeida D, 2005, CLIN INFECT DIS, V40, P881, DOI 10.1086/427940; Bhanu NV, 2002, TUBERCULOSIS, V82, P105, DOI 10.1054/tube.2002.0332; Braden CR, 2002, EMERG INFECT DIS, V8, P1210; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; DEBEENHOUWER H, 1995, TUBERCLE LUNG DIS, V76, P425, DOI 10.1016/0962-8479(95)90009-8; Dooley S. W. Jr., 1994, P171; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hasan Z, 2006, J CLIN MICROBIOL, V44, P1763, DOI 10.1128/JCM.44.5.1763-1768.2006; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; Mphahlele M, 2008, J CLIN MICROBIOL, V46, P3459, DOI 10.1128/JCM.00973-08; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Rahim Z, 2007, J CLIN MICROBIOL, V45, P3791, DOI 10.1128/JCM.01247-07; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P2802, DOI 10.1128/JCM.00352-07; Sharma P, 2008, INFECT GENET EVOL, V8, P621, DOI 10.1016/j.meegid.2008.05.002; Siddiqi N, 2001, INFECT GENET EVOL, V1, P109, DOI 10.1016/S1567-1348(01)00014-4; Silva MSN, 2003, J CLIN MICROBIOL, V41, P4471, DOI 10.1128/JCM.41.9.4471-4474.2003; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Somoskovi A, 2007, J CLIN MICROBIOL, V45, P595, DOI 10.1128/JCM.01454-06; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P636, DOI 10.1128/AAC.41.3.636; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suresh N, 2006, INFECT GENET EVOL, V6, P474, DOI 10.1016/j.meegid.2006.03.001; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TSUKAMURA M, 1972, Tubercle, V53, P111, DOI 10.1016/0041-3879(72)90027-X; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Victor T. C., 1999, Tubercle and Lung Disease, V79, P343, DOI 10.1054/tuld.1999.0222; WHO, 2008, 2008 WHO; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	47	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4540	10.1371/journal.pone.0004540	http://dx.doi.org/10.1371/journal.pone.0004540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234602	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487200003
J	Yoon, J; Deisboeck, TS				Yoon, Jeongah; Deisboeck, Thomas S.			Investigating Differential Dynamics of the MAPK Signaling Cascade Using a Multi-Parametric Global Sensitivity Analysis	PLOS ONE			English	Article								Cell growth critically depends on signalling pathways whose regulation is the focus of intense research. Without utilizing a priori knowledge of the relative importance of pathway components, we have applied in silico computational methods to the EGF-induced MAPK cascade. Specifically, we systematically perturbed the entire parameter space, including initial conditions, using a Monte Carlo approach, and investigate which protein components or kinetic reaction steps contribute to the differentiation of ERK responses. The model, based on previous work by Brightman and Fell (2000), is composed of 28 reactions, 27 protein molecules, and 48 parameters from both mass action and Michaelis-Menten kinetics. Our multiparametric systems analysis confirms that Raf inactivation is one of the key steps regulating ERK responses to be either transient or sustained. Furthermore, the results of amplitude-differential ERK phosphorylations within the transient case are mainly attributed to the balance between activation and inactivation of Ras while duration-differential ERK responses for the sustained case are, in addition to Ras, markedly affected by dephospho-/phosphorylation of both MEK and ERK. Our sub-module perturbations showed that MEK and ERK's contribution to this differential ERK activation originates from fluctuations in intermediate pathway module components such as Ras and Raf, implicating a cooperative regulatory mode among the key components. The initial protein concentrations of corresponding reactions such as Ras, GAP, and Raf also influence the distinct signalling outputs of ERK activation. We then compare these results with those obtained from a single-parametric perturbation approach using an overall state sensitivity (OSS) analysis. The OSS findings indicate a more pronounced role of ERK's inhibitory feedback effect on catalysing the dissociation of the SOS complex. Both approaches reveal the presence of multiple specific reactions involved in the distinct dynamics of ERK responses and the cell fate decisions they trigger. This work adds a mechanistic insight of the contribution of key pathway components, thus may support the identification of biomarkers for pharmaceutical drug discovery processes.	[Yoon, Jeongah; Deisboeck, Thomas S.] Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging, Harvard MIT HST, Complex Biosyst Modeling Lab, Charlestown, MA USA	Harvard University; Massachusetts General Hospital	Yoon, J (corresponding author), Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging, Harvard MIT HST, Complex Biosyst Modeling Lab, Charlestown, MA USA.	deisboec@helix.mgh.harvard.edu			NIH [CA 113004]; Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging and the Department of Radiology at Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [U56CA113004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging and the Department of Radiology at Massachusetts General Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by NIH grant CA 113004 and by the Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging and the Department of Radiology at Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; BRIGHTMAN FA, 2001, COMPUTER SIMULATION; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho KH, 2003, SIMUL-T SOC MOD SIM, V79, P726, DOI 10.1177/0037549703040943; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Markevich NI, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100108; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Smolen P, 2008, AM J PHYSIOL-CELL PH, V294, pC503, DOI 10.1152/ajpcell.00447.2007; Snoep JL, 2005, CURR OPIN BIOTECH, V16, P336, DOI 10.1016/j.copbio.2005.05.003; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Tombes RM, 1998, BIOCHEM J, V330, P1451; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Yaka R, 1998, J CELL BIOCHEM, V70, P425, DOI 10.1002/(SICI)1097-4644(19980901)70:3<425::AID-JCB15>3.0.CO;2-J; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034	37	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4560	10.1371/journal.pone.0004560	http://dx.doi.org/10.1371/journal.pone.0004560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234599	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487200014
J	Jubelin, G; Chavez, CV; Taieb, F; Banfield, MJ; Samba-Louaka, A; Nobe, R; Nougayrede, JP; Zumbihl, R; Givaudan, A; Escoubas, JM; Oswald, E				Jubelin, Gregory; Chavez, Carolina Varela; Taieb, Frederic; Banfield, Mark J.; Samba-Louaka, Ascel; Nobe, Rika; Nougayrede, Jean-Philippe; Zumbihl, Robert; Givaudan, Alain; Escoubas, Jean-Michel; Oswald, Eric			Cycle Inhibiting Factors (CIFs) Are a Growing Family of Functional Cyclomodulins Present in Invertebrate and Mammal Bacterial Pathogens	PLOS ONE			English	Article							HOST-CELL-CYCLE; III SECRETION SYSTEM; PHOTORHABDUS-ASYMBIOTICA; YERSINIA EFFECTOR; PROTEIN; SYMBIOSIS; YOPJ; LUMINESCENS; RECOGNITION; ACTIVATION	The cycle inhibiting factor (Cif) produced by enteropathogenic and enterohemorrhagic Escherichia coli was the first cyclomodulin to be identified that is injected into host cells via the type III secretion machinery. Cif provokes cytopathic effects characterized by G(1) and G(2) cell cycle arrests, accumulation of the cyclin-dependent kinase inhibitors (CKIs) p21(waf1/cip1) and p27(kip1) and formation of actin stress fibres. The X-ray crystal structure of Cif revealed it to be a divergent member of a superfamily of enzymes including cysteine proteases and acetyltransferases that share a conserved catalytic triad. Here we report the discovery and characterization of four Cif homologs encoded by different pathogenic or symbiotic bacteria isolated from vertebrates or invertebrates. Cif homologs from the enterobacteria Yersinia pseudotuberculosis, Photorhabdus luminescens, Photorhabdus asymbiotica and the beta-proteobacterium Burkholderia pseudomallei all induce cytopathic effects identical to those observed with Cif from pathogenic E. coli. Although these Cif homologs are remarkably divergent in primary sequence, the catalytic triad is strictly conserved and was shown to be crucial for cell cycle arrest, cytoskeleton reorganization and CKIs accumulation. These results reveal that Cif proteins form a growing family of cyclomodulins in bacteria that interact with very distinct hosts including insects, nematodes and humans.	[Jubelin, Gregory; Taieb, Frederic; Samba-Louaka, Ascel; Nobe, Rika; Nougayrede, Jean-Philippe; Oswald, Eric] INRA, UMR1225, F-31931 Toulouse, France; [Jubelin, Gregory; Taieb, Frederic; Samba-Louaka, Ascel; Nobe, Rika; Nougayrede, Jean-Philippe; Oswald, Eric] Univ Toulouse, ENVT, UMR 1225, F-31042 Toulouse, France; [Chavez, Carolina Varela; Zumbihl, Robert; Givaudan, Alain; Escoubas, Jean-Michel] INRA, Lab EMIP, UMR 1133, Montpellier, France; [Chavez, Carolina Varela; Zumbihl, Robert; Givaudan, Alain; Escoubas, Jean-Michel] Univ Montpellier 2, Lab EMIP, UMR 1133, F-34095 Montpellier, France; [Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE; Universite de Montpellier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Jubelin, G (corresponding author), INRA, UMR1225, F-31931 Toulouse, France.	e.oswald@envt.fr	Banfield, Mark/C-7453-2013; ESCOUBAS, Jean-Michel/G-4027-2010; Nougayrede, Jean-Philippe/I-6362-2019; Samba-Louaka, Ascel/H-7073-2016	Banfield, Mark/0000-0001-8921-3835; ESCOUBAS, Jean-Michel/0000-0002-6138-1148; Nougayrede, Jean-Philippe/0000-0002-6802-1890; Oswald, Eric/0000-0002-3017-0081; JUBELIN, Gregory/0000-0002-9902-0663; taieb, frederic/0000-0001-9612-2069; Samba-Louaka, Ascel/0000-0003-4417-6254	Agence Nationale de la Recherche [ANR-05-MIIM-009]; Biotechnology and Biological Sciences (UK) [BB/F0087321]; Royal Society (UK) [University Research Fellowship]; INRA and Languedoc-Rousillon region; BBSRC [BB/F008732/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008732/1] Funding Source: researchfish	Agence Nationale de la Recherche(French National Research Agency (ANR)); Biotechnology and Biological Sciences (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society (UK)(Royal Society of London); INRA and Languedoc-Rousillon region; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant ANR-05-MIIM-009 from the Agence Nationale de la Recherche and Grant BB/F0087321 from the Biotechnology and Biological Sciences (UK, to MJB). MJB is supported by the Royal Society (UK) through the award of a University Research Fellowship. CVC is supported by a grant from INRA and Languedoc-Rousillon region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2004, INT J SYST EVOL MICR, V54, P1301, DOI 10.1099/ijs.0.03005-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Carnoy C, 2002, J BACTERIOL, V184, P4489, DOI 10.1128/JB.184.16.4489-4499.2002; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Gerrard JG, 2006, EMERG INFECT DIS, V12, P1562, DOI 10.3201/eid1210.060464; Hsu Y, 2008, J MOL BIOL, V384, P465, DOI 10.1016/j.jmb.2008.09.051; Hurst MRH, 2007, FEMS MICROBIOL LETT, V270, P42, DOI 10.1111/j.1574-6968.2007.00645.x; Hurst MRH, 2004, J BACTERIOL, V186, P5116, DOI 10.1128/jb.186.15.5116-5128.2004; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; KAMBARA K, 2008, MOL MICROBIOL, DOI DOI 10.1111/J.1365-2958.2008.06507; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Loukiadis E, 2008, J BACTERIOL, V190, P275, DOI 10.1128/JB.00844-07; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Marches O, 2000, INFECT IMMUN, V68, P2171, DOI 10.1128/IAI.68.4.2171-2182.2000; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Naktin J, 1999, CLIN LAB MED, V19, P523; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Nougayrede JP, 2001, INFECT IMMUN, V69, P6785, DOI 10.1128/IAI.69.11.6785-6795.2001; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Schesser K, 2000, MICROB PATHOGENESIS, V28, P59, DOI 10.1006/mpat.1999.0324; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	47	47	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4855	10.1371/journal.pone.0004855	http://dx.doi.org/10.1371/journal.pone.0004855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308257	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499000002
J	Cebrian, J; Shurin, JB; Borer, ET; Cardinale, BJ; Ngai, JT; Smith, MD; Fagan, WF				Cebrian, Just; Shurin, Jonathan B.; Borer, Elizabeth T.; Cardinale, Bradley J.; Ngai, Jacqueline T.; Smith, Melinda D.; Fagan, William F.			Producer Nutritional Quality Controls Ecosystem Trophic Structure	PLOS ONE			English	Article								Trophic structure, or the distribution of biomass among producers and consumers, determines key ecosystem values, such as the abundance of infectious, harvestable or conservation target species, and the storage and cycling of carbon and nutrients. There has been much debate on what controls ecosystem trophic structure, yet the answer is still elusive. Here we show that the nutritional quality of primary producers controls the trophic structure of ecosystems. By increasing the efficiency of trophic transfer, higher producer nutritional quality results in steeper ecosystem trophic structure, and those changes are more pronounced in terrestrial than in aquatic ecosystems probably due to the more stringent nutritional limitation of terrestrial herbivores. These results explain why ecosystems composed of highly nutritional primary producers feature high consumer productivity, fast energy recycling, and reduced carbon accumulation. Anthropogenic changes in producer nutritional quality, via changes in trophic structure, may alter the values and functions of ecosystems, and those alterations may be more important in terrestrial ecosystems.	[Cebrian, Just] Univ S Alabama, Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Cebrian, Just] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL USA; [Shurin, Jonathan B.; Ngai, Jacqueline T.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Borer, Elizabeth T.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Cardinale, Bradley J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA USA; [Smith, Melinda D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Dauphin Island Sea Lab; University of South Alabama; University of South Alabama; University of British Columbia; Oregon State University; University of California System; University of California Santa Barbara; Yale University; University System of Maryland; University of Maryland College Park	Cebrian, J (corresponding author), Univ S Alabama, Dauphin Isl Sea Lab, Dauphin Isl, AL USA.	jcebrian@disl.org	Cardinale, Bradley J/I-7076-2013; Smith, Melinda D/J-8987-2014	Borer, Elizabeth/0000-0003-2259-5853	National Science Foundation; University of California; University of California at Santa Barbara	National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); University of California at Santa Barbara	This work was supported by funding provided by the National Science Foundation, the University of California, and the University of California at Santa Barbara to the NCEAS working group "Trophic Comparison Across Ecosystems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Cebrian J, 2004, ECOL MONOGR, V74, P237, DOI 10.1890/03-4019; CEBRIAN J, 1995, SCIENCE, V268, P1606, DOI 10.1126/science.268.5217.1606; Cebrian J, 2004, ECOL LETT, V7, P232, DOI 10.1111/j.1461-0248.2004.00574.x; CEBRIAN J, 1994, FUNCT ECOL, V8, P518, DOI 10.2307/2390077; DELGIORGIO PA, 1995, AM NAT, V146, P135, DOI 10.1086/285790; Duffy JE, 2006, MAR ECOL PROG SER, V311, P179, DOI 10.3354/meps311179; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; ELSER JJ, 1994, NATURE, V370, P211, DOI 10.1038/370211a0; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 2001, ECOLOGY, V82, P898, DOI 10.1890/0012-9658(2001)082[0898:NLRFQF]2.0.CO;2; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Marba N, 2007, P NATL ACAD SCI USA, V104, P15777, DOI 10.1073/pnas.0703476104; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; ODUM HT, 1957, ECOL MONOGR, V27, P55, DOI 10.2307/1948571; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Zar, 2011, BIOSTAT ANAL	29	106	108	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4929	10.1371/journal.pone.0004929	http://dx.doi.org/10.1371/journal.pone.0004929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300514	Green Published, gold			2022-12-27	WOS:000265496800010
J	Delgado-Eckert, E				Delgado-Eckert, Edgar			Reverse Engineering Time Discrete Finite Dynamical Systems: A Feasible Undertaking?	PLOS ONE			English	Article							NETWORKS	With the advent of high-throughput profiling methods, interest in reverse engineering the structure and dynamics of biochemical networks is high. Recently an algorithm for reverse engineering of biochemical networks was developed by Laubenbacher and Stigler. It is a top-down approach using time discrete dynamical systems. One of its key steps includes the choice of a term order, a technicality imposed by the use of Grobner-bases calculations. The aim of this paper is to identify minimal requirements on data sets to be used with this algorithm and to characterize optimal data sets. We found minimal requirements on a data set based on how many terms the functions to be reverse engineered display. Furthermore, we identified optimal data sets, which we characterized using a geometric property called "general position''. Moreover, we developed a constructive method to generate optimal data sets, provided a codimensional condition is fulfilled. In addition, we present a generalization of their algorithm that does not depend on the choice of a term order. For this method we derived a formula for the probability of finding the correct model, provided the data set used is optimal. We analyzed the asymptotic behavior of the probability formula for a growing number of variables n (i.e. interacting chemicals). Unfortunately, this formula converges to zero as fast as r(q(n)), where q is an element of N and 0<r<1. Therefore, even if an optimal data set is used and the restrictions in using term orders are overcome, the reverse engineering problem remains unfeasible, unless prodigious amounts of data are available. Such large data sets are experimentally impossible to generate with today's technologies.	[Delgado-Eckert, Edgar] Tech Univ Munich, Ctr Math Sci, D-8046 Garching, Germany; [Delgado-Eckert, Edgar] Tufts Univ, Dept Pathol, Boston, MA USA	Technical University of Munich; Tufts University	Delgado-Eckert, E (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	edgar.delgado-eckert@mytum.de	Delgado-Eckert, Edgar/AEV-0018-2022	Delgado-Eckert, Edgar/0000-0001-6415-4971	Public Health Research [RO1 AI062989]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062989] Funding Source: NIH RePORTER	Public Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Research Grant RO1 AI062989 to Dr. David Thorley-Lawson at Tufts University, Boston, MA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2006, J THEOR BIOL, V238, P317, DOI 10.1016/j.jtbi.2005.05.010; BERNARD M, 2005, P 2005 INT S SYMB AL; CABOARA M, 1997, P ISSAC 97 MAUI HAW, P404; Cox D., 1997, UNDERGRADUATE TEXTS, DOI 10.1007/978-3-662-41154-4; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dimitrova ES, 2007, ISSAC 2007: PROCEEDINGS OF THE 2007 INTERNATIONAL SYMPOSIUM ON SYMBOLIC AND ALGEBRAIC COMPUTATION, P122; DIMITROVA ES, 2005, DISCRETIZATION TIME; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Gentle J. E., 2007, MATRIX ALGEBRA; Golan J.S., 2004, LINEAR ALGEBRA BEGIN; Jarrah AS, 2007, ADV APPL MATH, V39, P477, DOI 10.1016/j.aam.2006.08.004; Just W, 2006, J COMPUT BIOL, V13, P1435, DOI 10.1089/cmb.2006.13.1435; Kauffman S.A., 1993, ORIGINS ORDER; Kehrein A, 2005, ALGORITHM COMP MATH, V14, P169; Kehrein A, 2005, J PURE APPL ALGEBRA, V196, P251, DOI 10.1016/j.jpaa.2004.08.028; Krupa B, 2002, J THEOR BIOL, V219, P257, DOI 10.1006/jtbi.2002.3119; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Ljung L., 1999, SYSTEM IDENTIFICATIO; LORENZO R, 1998, GROBNER BASES APPL, P179; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; MEYBERG K, 1975, MATH GRUNDLAGEN MATH; Moller H.M., 1982, CONSTRUCTION MULTIVA, P24; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4939	10.1371/journal.pone.0004939	http://dx.doi.org/10.1371/journal.pone.0004939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295916	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000265496700011
J	Reinke, S; Karhausen, T; Doehner, W; Taylor, W; Hottenrott, K; Duda, GN; Reinke, P; Volk, HD; Anker, SD				Reinke, Simon; Karhausen, Tim; Doehner, Wolfram; Taylor, William; Hottenrott, Kuno; Duda, Georg N.; Reinke, Petra; Volk, Hans-Dieter; Anker, Stefan D.			The Influence of Recovery and Training Phases on Body Composition, Peripheral Vascular Function and Immune System of Professional Soccer Players	PLOS ONE			English	Article								Professional soccer players have a lengthy playing season, throughout which high levels of physical stress are maintained. The following recuperation period, before starting the next pre-season training phase, is generally considered short but sufficient to allow a decrease in these stress levels and therefore a reduction in the propensity for injury or musculoskeletal tissue damage. We hypothesised that these physical extremes influence the body composition, blood flow, and endothelial/immune function, but that the recuperation may be insufficient to allow a reduction of tissue stress damage. Ten professional football players were examined at the end of the playing season, at the end of the season intermission, and after the next pre-season endurance training. Peripheral blood flow and body composition were assessed using venous occlusion plethysmography and DEXA scanning respectively. In addition, selected inflammatory and immune parameters were analysed from blood samples. Following the recuperation period a significant decrease of lean body mass from 74.4 +/- 4.2 kg to 72.2 +/- 3.9 kg was observed, but an increase of fat mass from 10.3 +/- 5.6 kg to 11.1 +/- 5.4 kg, almost completely reversed the changes seen in the pre-season training phase. Remarkably, both resting and post-ischemic blood flow (7.3 +/- 3.4 and 26.0 +/- 6.3 ml/100 ml/min) respectively, were strongly reduced during the playing and training stress phases, but both parameters increased to normal levels (9.0 +/- 2.7 and 33.9 +/- 7.6 ml/100 ml/min) during the season intermission. Recovery was also characterized by rising levels of serum creatinine, granulocytes count, total IL-8, serum nitrate, ferritin, and bilirubin. These data suggest a compensated hypo-perfusion of muscle during the playing season, followed by an intramuscular ischemia/reperfusion syndrome during the recovery phase that is associated with muscle protein turnover and inflammatory endothelial reaction, as demonstrated by iNOS and HO-1 activation, as well as IL-8 release. The data provided from this study suggest that the immune system is not able to function fully during periods of high physical stress. The implications of this study are that recuperation should be carefully monitored in athletes who undergo intensive training over extended periods, but that these parameters may also prove useful for determining an individual's risk of tissue stress and possibly their susceptibility to progressive tissue damage or injury.	[Reinke, Simon; Karhausen, Tim; Doehner, Wolfram; Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, CVK, D-13353 Berlin, Germany; [Reinke, Simon; Taylor, William; Duda, Georg N.; Reinke, Petra; Volk, Hans-Dieter] Charite, BCRT, D-13353 Berlin, Germany; [Reinke, Simon; Taylor, William; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Reinke, Simon; Taylor, William; Hottenrott, Kuno; Duda, Georg N.] Charite, Ctr Musculoskelet Surg, D-13353 Berlin, Germany; Univ Halle Wittenberg, Dept Sportwissenschaft, D-4010 Halle, Germany; [Reinke, Petra] Charite, Dept Nephrol & Internal Intensive Care, CVK, D-13353 Berlin, Germany; [Volk, Hans-Dieter] Charite, Inst Med Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Reinke, S (corresponding author), Charite, Dept Cardiol, Div Appl Cachexia Res, CVK, D-13353 Berlin, Germany.	simon.reinke@charite.de	volk, hans-dieter/AAV-8053-2021; Taylor, William R./F-8692-2010; Duda, Georg N/H-2085-2016	volk, hans-dieter/0000-0002-7743-6668; Taylor, William R./0000-0003-4060-4098; Duda, Georg N/0000-0001-7605-3908; Reinke, Petra/0000-0003-0771-4375; Doehner, Wolfram/0000-0001-7598-708X; Reinke, Simon/0000-0002-3451-9383	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung) [0313911]	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung - 0313911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADTKE G, 1999, LEHRBUCH SPORTMEDIZI; BERNDT G, 2004, ANTIOXIDATIVE WIRKUN; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Boutcher YN, 2005, EUR J APPL PHYSIOL, V95, P83, DOI 10.1007/s00421-005-1377-5; CHEN HI, 2007, CHIN J PHYSL, V50, P149; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Doehner W, 2001, AM HEART J, V141, P792, DOI 10.1067/mhj.2001.114367; Drexler H, 1999, J MOL CELL CARDIOL, V31, P51, DOI 10.1006/jmcc.1998.0843; Duda GN, 2008, EXERC SPORT SCI REV, V36, P64, DOI 10.1097/JES.0b013e318168eb88; FROBOSE I, 1990, Z ORTHOP GRENZGEB, V128, P218, DOI 10.1055/s-2008-1039503; Hale T, 2008, J SPORT SCI, V26, P365, DOI 10.1080/02640410701701016; HARRE D, 1982, TRAININGSLEHRE; Hollmann W, 2001, SPORTS MED, V31, P315, DOI 10.2165/00007256-200131050-00002; HOLLMANN W, 1990, SPORTMEDIZIN ARBEITS; Ispirlidis I, 2008, CLIN J SPORT MED, V18, P423, DOI 10.1097/JSM.0b013e3181818e0b; Jugdutt Bodh I, 2002, Heart Fail Rev, V7, P391, DOI 10.1023/A:1020718619155; Kreckel V, 2004, SPORTVERLETZ SPORTSC, V18, P142, DOI 10.1055/s-2004-813149; Kroidl RF, 2007, KURSBUCH SPIROERGOME; Liesen H, 1997, SPORT IMMUNSYSTEM; Lind E, 2005, PREV MED, V40, P407, DOI 10.1016/j.ypmed.2004.07.006; LOTZERICH H, 1995, HOCHLEISTUNGSSPORT I; Malm C, 1999, J APPL PHYSIOL, V86, P461, DOI 10.1152/jappl.1999.86.2.461; NEUMANN G, 1997, SPORT MED; Niess AM, 1999, FREE RADICAL BIO MED, V26, P184, DOI 10.1016/S0891-5849(98)00192-0; Poveda JJ, 1997, EUR J CLIN INVEST, V27, P967, DOI 10.1046/j.1365-2362.1997.2220763.x; Qi WN, 2004, J APPL PHYSIOL, V97, P1323, DOI 10.1152/japplphysiol.00380.2004; SCHELLONG SM, 1998, PATHOPHYSIOLOGY KLIN, V27, P207; Scott A, 2004, BRIT J SPORT MED, V38, P372, DOI 10.1136/bjsm.2004.011312; Steinacker JM, 1998, MED SCI SPORT EXER, V30, P1158, DOI 10.1097/00005768-199807000-00022; Thomas L., 2005, LABOR DIAGNOSE; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wassermann K, 2005, PRINCIPLES EXERCISE, V4th; Wienecke E, 1998, PATIENT BUNDESLIGA	34	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4910	10.1371/journal.pone.0004910	http://dx.doi.org/10.1371/journal.pone.0004910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293937	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496600010
J	Chiel, E; Zchori-Fein, E; Inbar, M; Gottlieb, Y; Adachi-Hagimori, T; Kelly, SE; Asplen, MK; Hunter, MS				Chiel, Elad; Zchori-Fein, Einat; Inbar, Moshe; Gottlieb, Yuval; Adachi-Hagimori, Tetsuya; Kelly, Suzanne E.; Asplen, Mark K.; Hunter, Martha S.			Almost There: Transmission Routes of Bacterial Symbionts between Trophic Levels	PLOS ONE			English	Article							BEMISIA-TABACI HOMOPTERA; HORIZONTAL TRANSFER; WOLBACHIA; ENDOSYMBIONTS; RICKETTSIA; HYMENOPTERA; EVOLUTION; APHIDS; TRANSFECTION; RESISTANCE	Many intracellular microbial symbionts of arthropods are strictly vertically transmitted and manipulate their host's reproduction in ways that enhance their own transmission. Rare horizontal transmission events are nonetheless necessary for symbiont spread to novel host lineages. Horizontal transmission has been mostly inferred from phylogenetic studies but the mechanisms of spread are still largely a mystery. Here, we investigated transmission of two distantly related bacterial symbionts - Rickettsia and Hamiltonella - from their host, the sweet potato whitefly, Bemisia tabaci, to three species of whitefly parasitoids: Eretmocerus emiratus, Eretmocerus eremicus and Encarsia pergandiella. We also examined the potential for vertical transmission of these whitefly symbionts between parasitoid generations. Using florescence in situ hybridization (FISH) and transmission electron microscopy we found that Rickettsia invades Eretmocerus larvae during development in a Rickettsia-infected host, persists in adults and in females, reaches the ovaries. However, Rickettsia does not appear to penetrate the oocytes, but instead is localized in the follicular epithelial cells only. Consequently, Rickettsia is not vertically transmitted in Eretmocerus wasps, a result supported by diagnostic polymerase chain reaction (PCR). In contrast, Rickettsia proved to be merely transient in the digestive tract of Encarsia and was excreted with the meconia before wasp pupation. Adults of all three parasitoid species frequently acquired Rickettsia via contact with infected whiteflies, most likely by feeding on the host hemolymph (host feeding), but the rate of infection declined sharply within a few days of wasps being removed from infected whiteflies. In contrast with Rickettsia, Hamiltonella did not establish in any of the parasitoids tested, and none of the parasitoids acquired Hamiltonella by host feeding. This study demonstrates potential routes and barriers to horizontal transmission of symbionts across trophic levels. The possible mechanisms that lead to the differences in transmission of species of symbionts among species of hosts are discussed.	[Chiel, Elad; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Chiel, Elad; Zchori-Fein, Einat] ARO, Newe Yaar Res Ctr, Dept Entomol, Ramat Yishai, Israel; [Chiel, Elad; Adachi-Hagimori, Tetsuya; Kelly, Suzanne E.; Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Gottlieb, Yuval] ARO, Volcani Ctr, Dept Entomol, Bet Dagan, Israel; [Adachi-Hagimori, Tetsuya] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima 730, Japan; [Asplen, Mark K.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of Haifa; University of Arizona; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hiroshima University; University of Minnesota System; University of Minnesota Twin Cities	Chiel, E (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	chiel@email.arizona.edu	Gottlieb, Yuval/H-6461-2013; Hunter, Martha/AAF-5288-2020; Hunter, Martha/B-7307-2012	Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; Inbar, Moshe/0000-0002-4707-9508; Chiel, Elad/0000-0002-7146-3219	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel [2004416]; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2006-35302-17165]; The United-States - Israel Binational Agricultural Research and Development fund (BARD) [GS-1-2007]; Agricultural Research Organization, Bet Dagan, Israel [503/08]	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); The United-States - Israel Binational Agricultural Research and Development fund (BARD)(US-Israel Binational Science Foundation); Agricultural Research Organization, Bet Dagan, Israel	This research was supported by the following sources: grant No 2004416 from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel to EZ-F and MSH; The National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant No 2006-35302-17165 to MSH and EZ-F and The United-States - Israel Binational Agricultural Research and Development fund (BARD), Graduate Student Fellow award No GS-1-2007 to EC. Contribution No 503/08 from the Agricultural Research Organization, Bet Dagan, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplen MK, 2006, J MORPHOL, V267, P1066, DOI 10.1002/jmor.10459; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BRAIG HR, 1994, NATURE, V367, P453, DOI 10.1038/367453a0; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; CHIEL E, 2009, ANN ENTOMOL IN PRESS; Enigl M, 2005, EXP APPL ACAROL, V36, P249, DOI 10.1007/s10493-005-6075-9; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fujii Y, 2001, P ROY SOC B-BIOL SCI, V268, P855, DOI 10.1098/rspb.2001.1593; GERLING D, 1990, ARCH INSECT BIOCHEM, V13, P247, DOI 10.1002/arch.940130311; Gerling D, 2001, CROP PROT, V20, P779, DOI 10.1016/S0261-2194(01)00111-9; GERLING D, 1966, CAN ENTOMOL, V98, P707, DOI 10.4039/Ent98707-7; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Grenier S, 1998, P ROY SOC B-BIOL SCI, V265, P1441, DOI 10.1098/rspb.1998.0455; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Heraty J, 2007, CATALOG ENCARSIA WOR; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Jaenike J, 2007, BIOL LETTERS, V3, P23, DOI 10.1098/rsbl.2006.0577; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; van Meer MMM, 1999, INSECT MOL BIOL, V8, P399, DOI 10.1046/j.1365-2583.1999.83129.x; Varaldi J, 2005, PARASITOLOGY, V131, P161, DOI 10.1017/S0031182005007602; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Viljakainen L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-55; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; WERREN JH, 1986, SCIENCE, V231, P990, DOI 10.1126/science.3945814; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zolnerowich G, 2008, J INSECT SCI, V8, P54	49	93	100	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4767	10.1371/journal.pone.0004767	http://dx.doi.org/10.1371/journal.pone.0004767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274091	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000007
J	Westerterp, KR; Plasqui, G				Westerterp, Klaas R.; Plasqui, Guy			Physically Active Lifestyle Does Not Decrease the Risk of Fattening	PLOS ONE			English	Article								Background: Increasing age is associated with declining physical activity and a gain in fat mass. The objective was to observe the consequence of the age-associated reduction in physical activity for the maintenance of energy balance as reflected in the fat store of the body. Methodology/Principal Findings: Young adults were observed over an average time interval of more than 10 years. Physical activity was measured over two-week periods with doubly labeled water and doubly labeled water validated triaxial accelerometers, and body fat gain was measured with isotope dilution. There was a significant association between the change in physical activity and the change in body fat, where a high initial activity level was predictive for a higher fat gain. Conclusion/Significance: The change from a physically active to a more sedentary routine does not induce an equivalent reduction of energy intake and requires cognitive restriction to maintain energy balance.	[Westerterp, Klaas R.; Plasqui, Guy] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands	Maastricht University	Westerterp, KR (corresponding author), Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.	K.Westerterp@HB.Unimaas.NL						Plasqui G, 2005, OBES RES, V13, P1363, DOI 10.1038/oby.2005.165; Speakman J.R., 1997, DOUBLY LABELLED WATE; Stubbs RJ, 2004, AM J CLIN NUTR, V79, P62; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Westerterp KR, 2004, CURR OPIN CLIN NUTR, V7, P607, DOI 10.1097/00075197-200411000-00004; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475	6	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4745	10.1371/journal.pone.0004745	http://dx.doi.org/10.1371/journal.pone.0004745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270740	Green Published, gold			2022-12-27	WOS:000265495900013
J	Byrne, LJ; Cole, DJ; Cox, BS; Ridout, MS; Morgan, BJT; Tuite, MF				Byrne, Lee J.; Cole, Diana J.; Cox, Brian S.; Ridout, Martin S.; Morgan, Byron J. T.; Tuite, Mick F.			The Number and Transmission of [PSI+] Prion Seeds (Propagons) in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							GUANIDINE-HYDROCHLORIDE; HSP104; AGGREGATION; ELIMINATION; PROPAGATION; GENERATION; URE3; APPROXIMATIONS; CHAPERONES; DIVISION	Background: Yeast (Saccharomyces cerevisiae) prions are efficiently propagated and the on-going generation and transmission of prion seeds (propagons) to daughter cells during cell division ensures a high degree of mitotic stability. The reversible inhibition of the molecular chaperone Hsp104p by guanidine hydrochloride (GdnHCl) results in cell division-dependent elimination of yeast prions due to a block in propagon generation and the subsequent dilution out of propagons by cell division. Principal Findings: Analysing the kinetics of the GdnHCl-induced elimination of the yeast [PSI+] prion has allowed us to develop novel statistical models that aid our understanding of prion propagation in yeast cells. Here we describe the application of a new stochastic model that allows us to estimate more accurately the mean number of propagons in a [PSI+] cell. To achieve this accuracy we also experimentally determine key cell reproduction parameters and show that the presence of the [PSI+] prion has no impact on these key processes. Additionally, we experimentally determine the proportion of propagons transmitted to a daughter cell and show this reflects the relative cell volume of mother and daughter cells at cell division. Conclusions: While propagon generation is an ATP-driven process, the partition of propagons to daughter cells occurs by passive transfer via the distribution of cytoplasm. Furthermore, our new estimates of n(0), the number of propagons per cell (500-1000), are some five times higher than our previous estimates and this has important implications for our understanding of the inheritance of the [PSI+] and the spontaneous formation of prion-free cells.	[Byrne, Lee J.; Cox, Brian S.; Tuite, Mick F.] Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury, Kent, England; [Cole, Diana J.; Ridout, Martin S.; Morgan, Byron J. T.] Univ Kent, Inst Math Stat & Actuar Sci, Canterbury CT2 7NZ, Kent, England	University of Kent; University of Kent	Byrne, LJ (corresponding author), Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury, Kent, England.	M.F.Tuite@kent.ac.uk	Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X; Ridout, Martin/0000-0001-7233-2985; Cole, Diana/0000-0002-8109-4832	EPSRC; BBSRC; Biotechnology and Biological Sciences Research Council [E18382] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a project grant jointly funded by the EPSRC and the BBSRC. Neither of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailleul PA, 1999, GENETICS, V153, P81; Bailleul-Winslett PA, 2000, GENE EXPRESSION, V9, P145; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cole DJ, 2007, BIOMETRICS, V63, P1023, DOI 10.1111/j.1541-0420.2007.00780.x; Cole DJ, 2004, MATH MED BIOL, V21, P369, DOI 10.1093/imammb/21.4.369; Cox B, 2003, GENETICS, V165, P23; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; COX BS, 1980, GENETICS, V95, P589; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Fernandez-Bellot E, 2002, EMBO REP, V3, P76, DOI 10.1093/embo-reports/kvf011; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Morgan BJT, 2003, BIOMETRICS, V59, P562, DOI 10.1111/1541-0420.00066; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Ridout MS, 2006, BIOMETRICS, V62, P1216, DOI 10.1111/j.1541-0420.2006.00564.x; Ripaud L, 2004, J BIOL CHEM, V279, P50962, DOI 10.1074/jbc.M408792200; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; Tuite MF, 2006, METHODS, V39, P9, DOI 10.1016/j.ymeth.2006.04.001; Tuite MF, 2007, METHOD MICROBIOL, V36, P491, DOI 10.1016/S0580-9517(06)36020-5	39	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4670	10.1371/journal.pone.0004670	http://dx.doi.org/10.1371/journal.pone.0004670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262693	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490600003
J	Lecube, A; Sampol, G; Lloberes, P; Romero, O; Mesa, J; Hernandez, C; Simo, R				Lecube, Albert; Sampol, Gabriel; Lloberes, Patricia; Romero, Odile; Mesa, Jordi; Hernandez, Cristina; Simo, Rafael			Diabetes Is an Independent Risk Factor for Severe Nocturnal Hypoxemia in Obese Patients. A Case-Control Study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; DAYTIME SLEEPINESS	Background: Type 2 diabetes mellitus (T2DM) and obesity have become two of the main threats to public health in the Western world. In addition, obesity is the most important determinant of the sleep apnea-hypopnea syndrome (SAHS), a condition that adversely affects glucose metabolism. However, it is unknown whether patients with diabetes have more severe SAHS than non-diabetic subjects. The aim of this cross-sectional case-control study was to evaluate whether obese patients with T2DM are more prone to severe SAHS than obese non-diabetic subjects. Methodology/Principal Findings: Thirty obese T2DM and 60 non-diabetic women closely matched by age, body mass index, waist circumference, and smoking status were recruited from the outpatient Obesity Unit of a university hospital. The exclusion criteria included chronic respiratory disease, smoking habit, neuromuscular and cerebrovascular disease, alcohol abuse, use of sedatives, and pregnancy. Examinations included a non-attended respiratory polygraphy, pulmonary function testing, and an awake arterial gasometry. Oxygen saturation measures included the percentage of time spent at saturations below 90% (CT90). A high prevalence of SAHS was found in both groups (T2DM: 80%, nondiabetic: 78.3%). No differences in the number of sleep apnea-hypopnea events between diabetic and non-diabetic patients were observed. However, in diabetic patients, a significantly increase in the CT90 was detected (20.2 +/- 30.2% vs. 6.8 +/- 13,5%; p = 0.027). In addition, residual volume (RV) was significantly higher in T2DM (percentage of predicted: 79.7 +/- 18.1 vs. 100.1 +/- 22.8; p<0.001). Multiple linear regression analyses showed that T2DM but not RV was independently associated with CT90. Conclusions/Significance: T2DM adversely affects breathing during sleep, becoming an independent risk factor for severe nocturnal hypoxemia in obese patients. Given that SAHS is a risk factor of cardiovascular disease, the screening for SAHS in T2DM patients seems mandatory.	[Lecube, Albert; Mesa, Jordi; Hernandez, Cristina; Simo, Rafael] Hosp Univ Vall Hebron, Inst Recerca, CIBER Diabet & Enfermedades Metab Asociadas, Diabet & Metab Res Unit,ISCIII, Barcelona, Spain; [Sampol, Gabriel; Lloberes, Patricia] Hosp Univ Vall Hebron, Inst Recerca, CIBER Enfermedades Resp, Pneumol Serv, Sleep Unit,ISCIII, Barcelona, Spain; [Romero, Odile] Hosp Univ Vall Hebron, Neurophysiol Serv, Sleep Unit, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron	Lecube, A (corresponding author), Hosp Univ Vall Hebron, Inst Recerca, CIBER Diabet & Enfermedades Metab Asociadas, Diabet & Metab Res Unit,ISCIII, Barcelona, Spain.	alecube@vhebron.net	Romero, Odile/N-8109-2015; Lloberes Canadell, Patricia/F-9707-2014; Lecube, Albert/H-3813-2019	Romero, Odile/0000-0002-0147-596X; Lloberes Canadell, Patricia/0000-0002-1595-8225; Lecube, Albert/0000-0001-9684-0183; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721	Instituto de Salud Carlos III [PI060476]; CIBER de Diabetes y Enfermedades Metababolicas Asociadas (CIBERDEM); CIBER de Enfermedades Respiratorias (CIBERES)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBER de Diabetes y Enfermedades Metababolicas Asociadas (CIBERDEM); CIBER de Enfermedades Respiratorias (CIBERES)	This study was supported by a grant from the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria, PI060476). CIBER de Diabetes y Enfermedades Metababolicas Asociadas (CIBERDEM) and CIBER de Enfermedades Respiratorias (CIBERES) are an initiative of the Instituto Carlos III. Funder had no role in the research.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Bottini P, 2003, EUR RESPIR J, V22, P654, DOI 10.1183/09031936.03.00070402; BRADLEY TD, 1985, J APPL PHYSIOL, V59, P1364, DOI 10.1152/jappl.1985.59.5.1364; Campo A, 2007, EUR RESPIR J, V30, P223, DOI 10.1183/09031936.00115006; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; Guazzi M, 2002, DIABETES CARE, V25, P1802, DOI 10.2337/diacare.25.10.1802; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; HEIN MS, 1994, P SOC EXP BIOL MED, V207, P213; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Lloberes P, 2001, EUR RESPIR J, V18, P530, DOI 10.1183/09031936.01.00072401; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Peltier AC, 2007, SLEEP MED, V8, P149, DOI 10.1016/j.sleep.2006.06.010; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; QUANJER PH, 1996, EUR RESPIR J, V16, P41; Ramadan W, 2007, OBESITY, V15, P1409, DOI 10.1038/oby.2007.169; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P517, DOI 10.1210/jc.86.2.517; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Williams A, 2007, SLEEP BREATH, V11, P69, DOI 10.1007/s11325-007-0106-1; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005	25	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4692	10.1371/journal.pone.0004692	http://dx.doi.org/10.1371/journal.pone.0004692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262746	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490600016
J	Tursun, B; Cochella, L; Carrera, I; Hobert, O				Tursun, Baris; Cochella, Luisa; Carrera, Ines; Hobert, Oliver			A Toolkit and Robust Pipeline for the Generation of Fosmid-Based Reporter Genes in C. elegans	PLOS ONE			English	Article								Engineering fluorescent proteins into large genomic clones, contained within BACs or fosmid vectors, is a tool to visualize and study spatiotemporal gene expression patterns in transgenic animals. Because these reporters cover large genomic regions, they most likely capture all cis-regulatory information and can therefore be expected to recapitulate all aspects of endogenous gene expression. Inserting tags at the target gene locus contained within genomic clones by homologous recombination ("recombineering'') represents the most straightforward method to generate these reporters. In this methodology paper, we describe a simple and robust pipeline for recombineering of fosmids, which we apply to generate reporter constructs in the nematode C. elegans, whose genome is almost entirely covered in an available fosmid library. We have generated a toolkit that allows for insertion of fluorescent proteins (GFP, YFP, CFP, VENUS, mCherry) and affinity tags at specific target sites within fosmid clones in a virtually seamless manner. Our new pipeline is less complex and, in our hands, works more robustly than previously described recombineering strategies to generate reporter fusions for C. elegans expression studies. Furthermore, our toolkit provides a novel recombineering cassette which inserts a SL2-spliced intercistronic region between the gene of interest and the fluorescent protein, thus creating a reporter controlled by all 59 and 39 cis-acting regulatory elements of the examined gene without the direct translational fusion between the two. With this configuration, the onset of expression and tissue specificity of secreted, sub-cellular compartmentalized or short-lived gene products can be easily detected. We describe other applications of fosmid recombineering as well. The simplicity, speed and robustness of the recombineering pipeline described here should prompt the routine use of this strategy for expression studies in C. elegans.	[Tursun, Baris; Cochella, Luisa; Carrera, Ines; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Tursun, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	bt2189@columbia.edu; mlc2155@columbia.edu; or38@columbia.edu	Cochella, Luisa/AHD-8261-2022; Cochella, Luisa/B-6536-2016	Cochella, Luisa/0000-0003-4018-7722; Cochella, Luisa/0000-0003-4018-7722; Hobert, Oliver/0000-0002-7634-2854; Carrera, Ines/0000-0003-0903-4672; Tursun, Baris/0000-0001-7293-8629	Francis Goelet Postdoctoral Fellowship; Helen Hay Whitney Foundation [Postdoctoral Fellowship]; HHMI	Francis Goelet Postdoctoral Fellowship; Helen Hay Whitney Foundation; HHMI(Howard Hughes Medical Institute)	BT is funded by a Francis Goelet Postdoctoral Fellowship, LC by a Helen Hay Whitney Foundation Postdoctoral Fellowship and OH by the HHMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BOULIN T, 2006, REPORTER GENE FUSION, P1, DOI [10.1895/wormbook.1.106.1, DOI 10.1895/WORMBOOK.1.106.1]; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Huang T, 2001, MOL CELL BIOL, V21, P1111, DOI 10.1128/MCB.21.4.1111-1120.2001; Johnston RJ, 2005, DEVELOPMENT, V132, P5451, DOI 10.1242/dev.02163; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nonet ML, 1998, J NEUROSCI, V18, P70; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Praitis V, 2001, GENETICS, V157, P1217; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Seibler J, 1997, BIOCHEMISTRY-US, V36, P1740, DOI 10.1021/bi962443e; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	30	126	127	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4625	10.1371/journal.pone.0004625	http://dx.doi.org/10.1371/journal.pone.0004625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259264	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490500004
J	Fujiwara, T				Fujiwara, Takeo			Is Altruistic Behavior Associated with Major Depression Onset?	PLOS ONE			English	Article							UNITED-STATES; MENTAL-HEALTH; PREVALENCE; SYMPTOMS; OTHERS; ADULTS; GUILT	Background: Previous cross-sectional study showed altruistic behaviors were harmful on major depression (MD). It is needed to investigate the impact of altruistic behaviors by its contents on the development of MD prospectively. Methodology/Principal Findings: The National Survey of Midlife Development in the United States (MIDUS) in 1995-1996 and the MIDUS Psychological Experience Follow-Up study in 1998 were analyzed (weighted N = 563). Financial support of 10 or more dollars per month had a significant impact on the development of MD in comparison to no financial support (OR: 2.64, 95% CI: 1.05-6.62). Unpaid assistance and providing emotional support were not significantly associated with the development of MD in later life. Conclusions/Significances: Those who provide financial contribution to individuals other than family members can be at risk of developing MD.	[Fujiwara, Takeo] Natl Inst Publ Hlth, Dept Hlth Promot & Res, Sect Behav Sci, Wako, Saitama 3510197, Japan	National Institute of Public Health - Japan	Fujiwara, T (corresponding author), Natl Inst Publ Hlth, Dept Hlth Promot & Res, Sect Behav Sci, Wako, Saitama 3510197, Japan.	tfujiwara@niph.go.jp						Aalto-Setala T, 2002, PSYCHOL MED, V32, P1309, DOI 10.1017/S0033291702005810; Alexander R. D., 1987, BIOL MORAL SYSTEM; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; BRIM OG, 2000, ICPSR B, V20, P1; Brim OG, 2003, NATL SURVEY MIDLIFE; Brown SL, 2003, PSYCHOL SCI, V14, P320, DOI 10.1111/1467-9280.14461; BURTON L, 1992, GENERATIONS, V17, P51; CARLSMITH JM, 1968, J PERS SOC PSYCHOL, V11, P232; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Exline JJ, 2000, J CLIN PSYCHOL, V56, P1481, DOI 10.1002/1097-4679(200012)56:12<1481::AID-1>3.0.CO;2-A; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; FUJIWARA T, 2008, CLIN MED PSYCHIAT, V0001; Fujiwara T, 2008, J AFFECT DISORDERS, V107, P29, DOI 10.1016/j.jad.2007.08.016; Fujiwara T, 2007, J AFFECT DISORDERS, V101, P219, DOI 10.1016/j.jad.2006.11.024; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; HANLEY A, 1992, J ECON PSYCHOL, V13, P5, DOI 10.1016/0167-4870(92)90049-D; Keeton CP, 2008, J FAM PSYCHOL, V22, P212, DOI 10.1037/0893-3200.22.2.212; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Martin Y, 2006, AGING MENT HEALTH, V10, P101, DOI 10.1080/13607860500311953; Monroe K. R., 1996, HEART ALTRUISM PERCE; Schwartz C, 2003, PSYCHOSOM MED, V65, P778, DOI 10.1097/01.PSY.0000079378.39062.D4; Schwartz CE, 1999, SOC SCI MED, V48, P1563, DOI 10.1016/S0277-9536(99)00049-0; Taylor J, 2001, J HEALTH SOC BEHAV, V42, P310, DOI 10.2307/3090217; Vaillant GE, 2000, AM PSYCHOL, V55, P89, DOI 10.1037/0003-066X.55.1.89; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; WETHINGTON E, 2005, ICPSR02911V1	27	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4557	10.1371/journal.pone.0004557	http://dx.doi.org/10.1371/journal.pone.0004557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KU	19234611	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487200013
J	Bjorklund, M; Ranta, E; Kaitala, V; Bach, LA; Lundberg, P; Stenseth, NC				Bjorklund, Mats; Ranta, Esa; Kaitala, Veijo; Bach, Lars A.; Lundberg, Per; Stenseth, Nils Chr.			Quantitative Trait Evolution and Environmental Change	PLOS ONE			English	Article							POPULATION PERSISTENCE; EXTINCTION; SELECTION; GROWTH; COLOR; MODEL; RISK	Background: Given the recent changes in climate, there is an urgent need to understand the evolutionary ability of populations to respond to these changes. Methodology/Principal Findings: We performed individual-based simulations with different shapes of the fitness curve, different heritabilities, different levels of density compensation, and different autocorrelation of environmental noise imposed on an environmental trend to study the ability of a population to adapt to changing conditions. The main finding is that when there is a positive autocorrelation of environmental noise, the outcome of the evolutionary process is much more unpredictable compared to when the noise has no autocorrelation. In addition, we found that strong selection resulted in a higher load, and more extinctions, and that this was most pronounced when heritability was low. The level of density-compensation was important in determining the variance in load when there was strong selection, and when genetic variance was lower when the level of density-compensation was low. Conclusions: The strong effect of the details of the environmental fluctuations makes predictions concerning the evolutionary future of populations very hard to make. In addition, to be able to make good predictions we need information on heritability, fitness functions and levels of density compensation. The results strongly suggest that patterns of environmental noise must be incorporated in future models of environmental change, such as global warming.	Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [Ranta, Esa; Kaitala, Veijo] Univ Helsinki, Dept Biol & Environm Sci, Integrative Ecol Unit, FIN-00014 Helsinki, Finland; [Bach, Lars A.; Lundberg, Per] Lund Univ, Dept Theoret Ecol, Lund, Sweden; [Stenseth, Nils Chr.] Univ Oslo, CEES, Dept Biol, N-0316 Oslo, Norway	Uppsala University; University of Helsinki; Lund University; University of Oslo	Bjorklund, M (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	Mats.Bjorklund@ebc.uu.se	Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399; Bach, Lars A./0000-0001-8610-7834; Bjorklund, Mats/0000-0001-5436-6989; Lundberg, Per/0000-0002-9609-726X	EcoClim; NorFa; Swedish Research Council	EcoClim; NorFa; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was for this study was provided by EcoClim, NorFa and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Boulding EG, 2001, HEREDITY, V86, P313, DOI 10.1046/j.1365-2540.2001.00829.x; Bulmer MG, 1980, MATH THEORY QUANTITA; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Denny MW, 2000, CHANCE BIOL; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Houghton J. T., 2001, CLIMATE CHANGE 2001; JONZEN N, 2002, P ROY SOC LOND B BIO, V269, P331; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Kaitala V, 1997, P ROY SOC B-BIOL SCI, V264, P943, DOI 10.1098/rspb.1997.0130; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; KIRKPATRICK M, 1989, J MATH BIOL, V27, P429, DOI 10.1007/BF00290638; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Ranta Esa, 2006, P1; Ripa J, 1996, P ROY SOC B-BIOL SCI, V263, P1751, DOI 10.1098/rspb.1996.0256; Roff Derek, 2002, pi; Saether BE, 2002, POPULATION VIABILITY ANALYSIS, P191; Schwager M, 2006, AM NAT, V167, P879, DOI 10.1086/503609; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Zhang XS, 2005, EVOLUTION, V59, P1237	27	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4521	10.1371/journal.pone.0004521	http://dx.doi.org/10.1371/journal.pone.0004521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229330	Green Published, Green Submitted, gold			2022-12-27	WOS:000265486200008
J	Pepper, DJ; Rebe, K; Morroni, C; Wilkinson, RJ; Meintjes, G				Pepper, Dominique J.; Rebe, Kevin; Morroni, Chelsea; Wilkinson, Robert J.; Meintjes, Graeme			Clinical Deterioration during Antitubercular Treatment at a District Hospital in South Africa: The Importance of Drug Resistance and AIDS Defining Illnesses	PLOS ONE			English	Article								Background: Clinical deterioration on drug therapy for tuberculosis is a common cause of hospital admission in Africa. Potential causes for clinical deterioration in settings of high HIV-1 prevalence include drug resistant Mycobacterium tuberculosis (M. tb), co-morbid illnesses, poor adherence to therapy, tuberculosis associated-immune reconstitution inflammatory syndrome (TB-IRIS) and subtherapeutic antitubercular drug levels. It is important to derive a rapid diagnostic work-up to determine the cause of clinical deterioration as well as specific management to prevent further clinical deterioration and death. We undertook this study among tuberculosis (TB) patients referred to an adult district level hospital situated in a high HIV-1 prevalence setting to determine the frequency, reasons and outcome for such clinical deterioration. Method: A prospective observational study conducted during the first quarter of 2007. We defined clinical deterioration as clinical worsening or failure to stabilise after 14 or more days of antitubercular treatment, resulting in hospital referral. We collected data on tuberculosis diagnosis and treatment, HIV-1 status and antiretroviral treatment, and investigated reasons for clinical deterioration as well as outcome. Results: During this period, 352 TB patients met inclusion criteria; 296 were admitted to hospital accounting for 17% of total medical admissions (n = 1755). Eighty three percent of TB patients (291/352) were known to be HIV-1 co-infected with a median CD4 count of 89cells/mm(3) (IQR 38-157). Mortality among TB patients admitted to hospital was 16% (n = 48). The median duration of hospital admission was 9.5 days (IQR 4-18), longer than routine in this setting (4 days). Among patients in whom HIV-1 status was known (n = 324), 72% of TB patients (n = 232) had an additional illness to tuberculosis; new AIDS defining illnesses (n = 80) were the most frequent additional illnesses (n = 208) in HIV-1 co-infected patients (n = 291). Rifampin-resistant M. tb (n = 41), TB-IRIS (n = 51) and drug resistant bacterial infections (n = 12) were found in 12%, 14% and 3.4% of the 352 cases, respectively. Interpretation: In our setting, new AIDS defining illnesses, drug resistant M. tb and other drug resistant bacteria are important reasons for clinical deterioration in HIV-1 co-infected patients receiving antitubercular treatment. HIV-1 co-infected patients may be at increased risk of acquiring nosocomial drug resistant pathogens because profound immune suppression results in co-morbid illnesses that require prolonged inpatient admissions. Routine infection control is essential and needs to be strengthened in our setting.	[Pepper, Dominique J.; Rebe, Kevin; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Pepper, Dominique J.; Rebe, Kevin; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Infect Dis Unit, Manenberg, South Africa; [Morroni, Chelsea] Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Wilkinson, Robert J.] Imperial Coll London, Wellcome Trust Ctr Res Clin Trop Med, Div Med, London, England; [Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Cape Town, South Africa; [Wilkinson, Robert J.] Natl Inst Med Res, London, England	University of Cape Town; University of Cape Town; Imperial College London; University of Cape Town; MRC National Institute for Medical Research	Pepper, DJ (corresponding author), Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa.	dominiquepepper@gmail.com		Morroni, Chelsea/0000-0002-2026-6039; Wilkinson, Robert/0000-0002-2753-1800; Meintjes, Graeme/0000-0003-1196-4414	United States Agency for International Development (USAID); PEPFAR; Wellcome Trust [072070, 081667]; Medical Research Council (UK); MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117588499] Funding Source: researchfish	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); PEPFAR; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Perinatal HIV Research Unit from the United States Agency for International Development (USAID) and PEPFAR supports Dominique Pepper. The Wellcome Trust (072070) and the Medical Research Council (UK) support Robert Wilkinson. The Wellcome Trust (081667) supports Graeme Meintjes. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. None of the funders had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; nor preparation, review, or approval of the manuscript. This research paper is made possible by funding through the Perinatal HIV-1 Research Unit affiliated with the United States Agency for International Development (USAID) and PEPFAR.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; BARNARD M, 2008, AM J RESP CRIT CARE; Borges Aercio Sebastiao, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P217; Bousquet J., 2007, GLOBAL SURVEILLANCE, P146; Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Brudney Karen, 1992, Journal of Public Health Policy, V13, P435, DOI 10.2307/3342533; Burch VC, 2006, SAMJ S AFR MED J, V96, P796; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Dhasmana DJ, 2008, DRUGS, V68, P191, DOI 10.2165/00003495-200868020-00004; Eza D, 2006, PATHOL RES PRACT, V202, P767, DOI 10.1016/j.prp.2006.07.005; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2001, J INFECT DIS, V184, P1127, DOI 10.1086/323649; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; MARTINSON N, 2007, 14 C RETR OPP INF; Matta F, 2008, AM J MED SCI, V336, P402, DOI 10.1097/MAJ.0b013e31816dd2fd; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Pepper DJ, 2007, DRUG DISCOV TODAY, V12, P980, DOI 10.1016/j.drudis.2007.08.001; RAO SN, 2000, AM COLL CHEST PHYS, P734; *SATBGUIDELINES, 2004, S AFR NAT TUB CONTR; SHELBURNE SA, 2006, BR SOC ANTIMICROB CH, P167; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; *TB HIVPOLICY, 2004, TB HIV POL TASK GROU; Toossi T, 2001, J ACQ IMMUN DEF SYND, V28, P1, DOI 10.1097/00042560-200109010-00001; WEYER K, 2007, B WHO, V85; WHITE NW, 1989, LANCET, V2, P434; *WHO, 2005, KEY TB TB HIV FACTS; *WHO, 2008, AIDS STAT S AFR 2007; *WHO, 2008, TB INC S AFR 2006; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; World Health Organization, 2007, GLOB MDR TB XDR TB R	38	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4520	10.1371/journal.pone.0004520	http://dx.doi.org/10.1371/journal.pone.0004520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229341	Green Published, Green Submitted, gold			2022-12-27	WOS:000265486200007
J	Heffelfinger, JD; Voetsch, AC; Nakamura, GV; Sullivan, PS; McNaghten, AD; Huang, L				Heffelfinger, James D.; Voetsch, Andrew C.; Nakamura, Glenn V.; Sullivan, Patrick S.; McNaghten, A. D.; Huang, Laurence			Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; CARINII PNEUMONIA; UNITED-STATES; DRUG-USE; ADHERENCE; PATIENT; EPIDEMIOLOGY; BIAS; AIDS	Background: Despite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis. Methodology/Principal Findings: We used 2000-2004 data from the Supplement to HIV/AIDS Surveillance (SHAS) project, a cross-sectional interview project of HIV-infected persons >= 18 years conducted in 18 states. We limited the analysis to persons who denied having prior PCP, reported having a current prescription to prevent PCP, and answered the question "In the past 30 days, how often were you able to take the PCP medication(s) exactly the way your doctor told you to take them?'' We used multivariable logistic regression to describe factors associated with nonadherence. Of 1,666 subjects prescribed PCP prophylaxis, 305 (18.3%) were nonadherent. Persons were more likely to be nonadherent if they reported using marijuana (adjusted odds ratio [aOR] = 1.6, 95% confidence interval [CI] = 1.1-2.4), non-injection drugs other than marijuana (aOR = 1.5, 95% CI = 1.0-2.1), or injection drugs (aOR = 2.3, 95% CI = 1.3-4.1) in the past year; their mental health was "not good'' for >= 1 day during the past month (aOR = 1.6, 95% CI = 1.2-2.2); their most recent CD4 count was,200 cells/mu L (aOR = 1.6, 95% CI = 1.1-2.2); or taking ART usually (aOR = 9.6, 95% CI = 6.7-13.7) or sometimes/rarely/never (aOR = 18.4, 95% CI = 11.1-30.4), compared with always, as prescribed. Conclusion/Significance: Providers should inquire about and promote strategies to improve adherence to PCP prophylaxis, particularly among persons who use illicit drugs, have mental health issues, and who are not compliant with ART to reduce the occurrence of PCP.	[Heffelfinger, James D.; Voetsch, Andrew C.; Nakamura, Glenn V.; McNaghten, A. D.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Huang, Laurence] Univ Calif San Francisco, HIV AIDS Div, San Francisco, CA 94143 USA; [Huang, Laurence] Univ Calif San Francisco, Div Pulmonary & Critical Care Med, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Heffelfinger, JD (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	izh7@cdc.gov	Voetsch, Andrew/CAF-1978-2022; Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021	Huang, Laurence/0000-0003-3888-2195; Voetsch, Andrew/0000-0002-0783-1312; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institutes of Health (NIH) [K24 087713]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LH was partly funded by the National Institutes of Health (NIH) K24 087713. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Buehler JW, 1996, PUBLIC HEALTH REP, V111, P133; Carrieri MP, 2006, JAIDS-J ACQ IMM DEF, V41, P477, DOI 10.1097/01.qai.0000186364.27587.0e; *CDC, 1990, HIV AIDS SURV REP 19; *CDC, 1993, HIV AIDS SURV REP 19; Eldred LJ, 1998, J ACQ IMMUN DEF SYND, V18, P117, DOI 10.1097/00042560-199806010-00003; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466; HAYNES RB, 1980, HYPERTENSION, V2, P757, DOI 10.1161/01.HYP.2.6.757; Holmes WC, 2002, J GEN INTERN MED, V17, P677, DOI 10.1046/j.1525-1497.2002.00746.x; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kaplan JE, 1999, J ACQ IMMUN DEF SYND, V21, P228, DOI 10.1097/00126334-199907010-00008; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Lafeuillade A, 2001, INT J STD AIDS, V12, P18, DOI 10.1258/0956462011924290; Lundberg BE, 2000, AIDS, V14, P2559, DOI 10.1097/00002030-200011100-00019; Maisto SA, 2003, AM J ADDICTION, V12, pS12, DOI 10.1111/j.1521-0391.2003.tb00493.x; Martini M, 2004, EUR J EPIDEMIOL, V19, P585, DOI 10.1023/B:EJEP.0000032353.03967.ef; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Murri R, 2004, J GEN INTERN MED, V19, P1104, DOI 10.1111/j.1525-1497.2004.30248.x; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; SAMET JH, 1992, AM J MED, V92, P495, DOI 10.1016/0002-9343(92)90746-X; Starace F, 2002, JAIDS, V31, pS136, DOI 10.1097/00126334-200212153-00010; Sullivan PS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000552; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Teshale EH, 2007, CLIN INFECT DIS, V44, P879, DOI 10.1086/511862; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e5002	10.1371/journal.pone.0005002	http://dx.doi.org/10.1371/journal.pone.0005002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319199	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499200019
J	Warraich, HJ; Javed, F; Faraz-Ul-Haq, M; Khawaja, FB; Saleem, S				Warraich, Haider Javed; Javed, Faisal; Faraz-ul-Haq, Mohammed; Khawaja, Fariha Batool; Saleem, Sarah			Prevalence of Obesity in School-Going Children of Karachi	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PAKISTANI POPULATION; HEALTH-STATUS; OVERWEIGHT; UNDERNUTRITION; INTERVENTIONS; ASSOCIATION; TRANSITION; WEIGHT; INDIA	Background: Obesity is an emerging problem in Pakistan. The authors sought to determine prevalence of obesity and malnutrition in school-going children, from grades 6(th) to 8(th) of different schools of Karachi and assess associations that affect the weight of the children. Methodology/Principal Findings: A cross sectional study design with children studying in grades 6(th) to 8(th) grade, in different schools of Karachi. We visited 10 schools of which 4 consented; two subsidized government schools and two private schools. A questionnaire was developed in consultation with a qualified nutritionist. Height and weight were measured on calibrated scales. A modified BMI criterion for Asian populations was used. Data was collected from 284 students. Of our sample, 52% were found to be underweight whereas 34% of all the children were normal. Of the population, 6% was obese and 8% overweight. Of all obese children, 70% belonged to the higher socio-economic status (SES) group, while of the underweight children, 63.3% were in the lower SES. Amongst obese children in our study, 65% ate meat every day, compared to 33% of normal kids. Conclusion: Obesity and undernutrition co-exist in Pakistani school-children. Our study shows that socio-economic factors are important since obesity and overweight increase with SES. Higher SES groups should be targeted for overweight while underweight is a problem of lower SES. Meat intake and lack of physical activity are some of the other factors that have been highlighted in our study.	[Warraich, Haider Javed; Javed, Faisal; Faraz-ul-Haq, Mohammed; Khawaja, Fariha Batool] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Warraich, HJ (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	haider_warrraich@hotmail.com						Aeberli I, 2007, SWISS MED WKLY, V137, P424; Ahmad K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-51; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Bharmal F Y, 2000, J Pak Med Assoc, V50, P159; Bogdanska A, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P213; Boon CS, 2005, CRIT REV FOOD SCI, V45, P511, DOI 10.1080/10408690590957160; Carvalhal MM, 2007, EUR J PUBLIC HEALTH, V17, P42, DOI 10.1093/eurpub/ckl093; Chhatwal J, 2004, ASIA PAC J CLIN NUTR, V13, P231; Dennis Barbara, 2006, J Pak Med Assoc, V56, P267; Dowda M, 2001, ARCH PEDIAT ADOL MED, V155, P711, DOI 10.1001/archpedi.155.6.711; DURKIN MS, 1994, SOC SCI MED, V38, P1289, DOI 10.1016/0277-9536(94)90192-9; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; JAFAR T, 2007, ARCH DIS CHILD; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Khor Geok Lin, 2003, Nepal Med Coll J, V5, P113; Menghetti E, 2004, Minerva Pediatr, V56, P311; Misra A, 2006, DIABETES RES CLIN PR, V71, P101, DOI 10.1016/j.diabres.2005.06.006; Nagel G, 2008, CLIN CHEM, V54, P317, DOI 10.1373/clinchem.2007.094821; Nanan D, 2001, AM J PUBLIC HEALTH, V91, P1545, DOI 10.2105/AJPH.91.10.1545; Pappas G, 2001, AM J PUBLIC HEALTH, V91, P93, DOI 10.2105/AJPH.91.1.93; Planinsec J, 2004, COLLEGIUM ANTROPOL, V28, P747; Ramachandran A, 2002, DIABETES RES CLIN PR, V57, P185, DOI 10.1016/S0168-8227(02)00056-6; Ritchie LD, 2006, J AM DIET ASSOC, V106, P925, DOI 10.1016/j.jada.2006.03.001; Shah SM, 2003, PEDIATR INT, V45, P49, DOI 10.1046/j.1442-200X.2003.01652.x; Sidhu S, 2005, COLLEGIUM ANTROPOL, V29, P53; Singh RB, 2007, ACTA CARDIOL, V62, P119, DOI 10.2143/AC.62.2.2020231; Verma M, 1994, Indian Pediatr, V31, P1065; Walker L, 2001, Pediatr Rev, V22, P250; *WHO GSOD PHYS ACT, 2008, OB OV	29	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4816	10.1371/journal.pone.0004816	http://dx.doi.org/10.1371/journal.pone.0004816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PI	19308262	Green Published, gold			2022-12-27	WOS:000265499000001
J	Allen, JM; Light, JE; Perotti, MA; Braig, HR; Reed, DL				Allen, Julie M.; Light, Jessica E.; Perotti, M. Alejandra; Braig, Henk R.; Reed, David L.			Mutational Meltdown in Primary Endosymbionts: Selection Limits Muller's Ratchet	PLOS ONE			English	Article							BACTERIAL ENDOSYMBIONTS; EVOLUTIONARY RELATIONSHIPS; ACCELERATED EVOLUTION; SYMBIOSIS; GENOME; LICE; PHYLOGENETICS; COSPECIATION; TOPOLOGIES; INSIGHTS	Background: Primary bacterial endosymbionts of insects (p-endosymbionts) are thought to be undergoing the process of Muller's ratchet where they accrue slightly deleterious mutations due to genetic drift in small populations with negligible recombination rates. If this process were to go unchecked over time, theory predicts mutational meltdown and eventual extinction. Although genome degradation is common among p-endosymbionts, we do not observe widespread p-endosymbiont extinction, suggesting that Muller's ratchet may be slowed or even stopped over time. For example, selection may act to slow the effects of Muller's ratchet by removing slightly deleterious mutations before they go to fixation thereby causing a decrease in nucleotide substitutions rates in older p-endosymbiont lineages. Methodology/Principal Findings: To determine whether selection is slowing the effects of Muller's ratchet, we determined the age of the Candidatus Riesia/sucking louse assemblage and analyzed the nucleotide substitution rates of several p-endosymbiont lineages that differ in the length of time that they have been associated with their insect hosts. We find that Riesia is the youngest p-endosymbiont known to date, and has been associated with its louse hosts for only 13-25 My. Further, it is the fastest evolving p-endosymbiont with substitution rates of 19-34% per 50 My. When comparing Riesia to other insect p-endosymbionts, we find that nucleotide substitution rates decrease dramatically as the age of endosymbiosis increases. Conclusions/Significance: A decrease in nucleotide substitution rates over time suggests that selection may be limiting the effects of Muller's ratchet by removing individuals with the highest mutational loads and decreasing the rate at which new mutations become fixed. This countering effect of selection could slow the overall rate of endosymbiont extinction.	[Allen, Julie M.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Light, Jessica E.; Reed, David L.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL USA; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Plant Sci Lab, Reading RG6 2AH, Berks, England; [Braig, Henk R.] Univ Wales Coll Cardiff, Sch Biol Sci, Cardiff CF1 3NS, S Glam, Wales	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Reading; Cardiff University	Allen, JM (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	juliema@ufl.edu	Braig, Henk/I-5477-2013	Braig, Henk/0000-0001-9592-1141	University of Florida [Research Opportunity SEED Fund]; National Science Foundation [DEB 0445712, DEB 0555024, DEB 0717165]; American Philosophical Society; Leverhulme Trust; NERC	University of Florida(University of Florida); National Science Foundation(National Science Foundation (NSF)); American Philosophical Society; Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants to DLR from the University of Florida Research Opportunity SEED Fund and the National Science Foundation (DEB 0445712, DEB 0555024, and DEB 0717165), and from grants to JMA from the American Philosophical Society. MAP and HRB were supported by the Leverhulme Trust and NERC. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aksoy S., 1995, Insect Molecular Biology, V4, P15, DOI 10.1111/j.1365-2583.1995.tb00003.x; Allen JM, 2007, APPL ENVIRON MICROB, V73, P1659, DOI 10.1128/AEM.01877-06; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; BANDI C, 1995, P ROY SOC B-BIOL SCI, V259, P293, DOI 10.1098/rspb.1995.0043; Bergstrom CT, 1998, GENETICS, V149, P2135; BRAIG HR, 2009, INSECT SYMBIOSIS, V3, P221; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; BUTCHER D, 1995, GENETICS, V141, P431; Canback B, 2004, MOL BIOL EVOL, V21, P1110, DOI 10.1093/molbev/msh122; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Corsaro D, 1999, CRIT REV MICROBIOL, V25, P39, DOI 10.1080/10408419991299167; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Dedeine F, 2003, CONT T ENT, P267; Degnan PH, 2004, SYST BIOL, V53, P95, DOI 10.1080/10635150490264842; Delmotte F, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-56; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; FELSENSTEIN J, 1974, GENETICS, V78, P737; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Hurst LD, 1996, NATURE, V381, P650, DOI 10.1038/381650a0; Hypsa V, 2007, MICROB ECOL, V54, P242, DOI 10.1007/s00248-006-9194-x; Ihlen PG, 2002, BIOL J LINN SOC, V77, P535, DOI 10.1046/j.1095-8312.2002.00127.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; KONDRASHOV AS, 1994, GENETICS, V136, P1469; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lutzoni F, 1997, P NATL ACAD SCI USA, V94, P11422, DOI 10.1073/pnas.94.21.11422; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI 10.1111/j.1558-5646.1990.tb05244.x; Maddison WP., 2000, MACCLADE ANAL PHYLOG; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; O'Fallon B, 2008, EVOLUTION, V62, P361, DOI 10.1111/j.1558-5646.2007.00289.x; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Perotti MA, 2007, FASEB J, V21, P1058, DOI 10.1096/fj.06-6808com; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; PEROTTI MA, 2009, INSECT SYMBIOSIS, V3, P205; Poinar GO., 1992, LIFE AMBER; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reed DL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-7; Reed DL, 2002, MICROB ECOL, V44, P78, DOI 10.1007/s00248-002-0009-4; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; WALLACE B, 1987, J HERED, V78, P134, DOI 10.1093/oxfordjournals.jhered.a110345; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	69	32	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4969	10.1371/journal.pone.0004969	http://dx.doi.org/10.1371/journal.pone.0004969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305500	Green Published, Green Submitted, gold			2022-12-27	WOS:000265498800016
J	Chen, LG; Sanderson, RD				Chen, Ligong; Sanderson, Ralph D.			Heparanase Regulates Levels of Syndecan-1 in the Nucleus	PLOS ONE			English	Article								Syndecan-1 is a transmembrane heparan sulfate-bearing proteoglycan known to regulate multiple biological functions at the cell surface and within the extracellular matrix. Its functional activity can be modulated by heparanase, an enzyme that cleaves heparan sulfate chains and whose expression has been associated with an aggressive phenotype in many cancers. In addition to remodeling syndecan-1 by cleaving its heparan sulfate chains, heparanase influences syndecan-1 location by upregulating expression of enzymes that accelerate its shedding from the cell surface. In the present study we discovered that heparanase also alters the level of nuclear syndecan-1. Upon upregulation of heparanase expression or following addition of recombinant heparanase to myeloma cells, the nuclear localization of syndecan-1 drops dramatically as revealed by confocal microscopy, western blotting and quantification by ELISA. This effect requires enzymatically active heparanase because cells expressing high levels of mutated, enzymatically inactive heparanase, failed to diminish syndecan-1 levels in the nucleus. Although heparan sulfate function within the nucleus is not well understood, there is emerging evidence that it may act to repress transcriptional activity. The resulting changes in gene expression facilitated by the loss of nuclear syndecan-1 could explain how heparanase enhances expression of MMP-9, VEGF, tissue factor and perhaps other effectors that condition the tumor microenvironment to promote an aggressive cancer phenotype.	[Chen, Ligong; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Univ Alabama, Ctr Metabol Bone Dis, Birmingham, AL USA; [Sanderson, Ralph D.] Univ Alabama, Comprehensive Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	sanderson@uab.edu			NIH [CA135075, CA103054, CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA103054, R01CA135075] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by NIH grants CA135075, CA103054 (to RDS) and by CA013148 (cancer center core support grant to the UAB Comprehensive Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borset M, 2000, BLOOD, V96, P2528; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Costes V, 1999, HUM PATHOL, V30, P1405, DOI 10.1016/S0046-8177(99)90160-0; Dobra K, 2003, ANTICANCER RES, V23, P2435; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; Joshi R, 2008, J CLIN PATHOL, V61, P213, DOI 10.1136/jcp.2007.049130; Kovalszky I, 1998, MOL CELL BIOCHEM, V183, P11, DOI 10.1023/A:1006898920637; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liang Y, 1997, J CELL BIOL, V139, P851, DOI 10.1083/jcb.139.4.851; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; MALI M, 1990, J BIOL CHEM, V265, P6884; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; NADIR Y, 2006, J THROMB HAEMOST; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Richardson TP, 2001, J CELL SCI, V114, P1613; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; Schubert SY, 2004, LAB INVEST, V84, P535, DOI 10.1038/labinvest.3700084; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	35	86	87	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4947	10.1371/journal.pone.0004947	http://dx.doi.org/10.1371/journal.pone.0004947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305494	Green Submitted, gold, Green Published			2022-12-27	WOS:000265498800005
J	Batiz, LF; De Blas, GA; Michaut, MA; Ramirez, AR; Rodriguez, F; Ratto, MH; Oliver, C; Tomes, CN; Rodriguez, EM; Mayorga, LS				Federico Batiz, Luis; De Blas, Gerardo A.; Michaut, Marcela A.; Ramirez, Alfredo R.; Rodriguez, Facundo; Ratto, Marcelo H.; Oliver, Cristian; Tomes, Claudia N.; Rodriguez, Esteban M.; Mayorga, Luis S.			Sperm from Hyh Mice Carrying a Point Mutation in alpha SNAP Have a Defect in Acrosome Reaction	PLOS ONE			English	Article								Hydrocephalus with hop gait (hyh) is a recessive inheritable disease that arose spontaneously in a mouse strain. A missense mutation in the Napa gene that results in the substitution of a methionine for isoleucine at position 105 (M105I) of alpha SNAP has been detected in these animals. alpha SNAP is a ubiquitous protein that plays a key role in membrane fusion and exocytosis. In this study, we found that male hyh mice with a mild phenotype produced morphologically normal and motile sperm, but had a strongly reduced fertility. When stimulated with progesterone or A23187 (a calcium ionophore), sperm from these animals had a defective acrosome reaction. It has been reported that the M105I mutation affects the expression but not the function of the protein. Consistent with an hypomorphic phenotype, the testes and epididymides of hyh mice had low amounts of the mutated protein. In contrast, sperm had aSNAP levels indistinguishable from those found in wild type cells, suggesting that the mutated protein is not fully functional for acrosomal exocytosis. Corroborating this possibility, addition of recombinant wild type aSNAP rescued exocytosis in streptolysin O-permeabilized sperm, while the mutant protein was ineffective. Moreover, addition of recombinant aSNAP. M105I inhibited acrosomal exocytosis in permeabilized human and wild type mouse sperm. We conclude that the M105I mutation affects the expression and also the function of aSNAP, and that a fully functional aSNAP is necessary for acrosomal exocytosis, a key event in fertilization.	[Federico Batiz, Luis; Oliver, Cristian; Rodriguez, Esteban M.] Univ Austral Chile, Facultad de Medicina, Inst Anat Histol Patol, Valdivia, Chile; [De Blas, Gerardo A.; Michaut, Marcela A.; Rodriguez, Facundo; Tomes, Claudia N.; Mayorga, Luis S.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol Embriol IHEM CONICET, Lab Biol Celular Mol, Mendoza, Argentina; [Ramirez, Alfredo R.; Ratto, Marcelo H.] Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Unidad Reprod, Valdivia, Chile	Universidad Austral de Chile; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Universidad Austral de Chile	Mayorga, LS (corresponding author), Univ Austral Chile, Facultad de Medicina, Inst Anat Histol Patol, Valdivia, Chile.	lmayorga@fcm.uncu.edu.ar	Ratto, Marcelo/AAV-8250-2020; Ramirez, Alfredo/AAF-8536-2020; Michaut, Marcela Alejandra/D-3725-2015	Michaut, Marcela Alejandra/0000-0002-0528-6605; Mayorga, Luis S/0000-0002-5995-0671; Batiz, Luis Federico/0000-0002-3043-8797; Ratto, Marcelo Hector/0000-0002-6072-7469; Ramirez, Alfredo/0000-0003-4782-4261	Fondecyt [1070241]; ANPCyT; CONICET (Argentina) [fellowship]; Fundacion Florencio Fiorini (Argentina); Institut Pasteur-Montevideo (Uruguay); International Brain Research Organization (IBRO, France); CONICYT (Chile) [fellowship]; Escuela de Graduados, Facultad de Ciencias, UACh; Programa de Integracion, Universidad Nacional de Cuyo, Argentina;  [DID-UACh D-2005-12]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ANPCyT(ANPCyT); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Florencio Fiorini (Argentina); Institut Pasteur-Montevideo (Uruguay); International Brain Research Organization (IBRO, France); CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Escuela de Graduados, Facultad de Ciencias, UACh; Programa de Integracion, Universidad Nacional de Cuyo, Argentina; 	This work was supported by grants Fondecyt 1070241 to EMR, ANPCyT and CONICET (Argentina) to LSM, DID-UACh D-2005-12 to LFB, and Fundacion Florencio Fiorini (Argentina), Institut Pasteur-Montevideo (Uruguay), and International Brain Research Organization (IBRO, France) to GADB. The work of GADB and FR was supported by CONICET fellowships (Argentina). LFB was supported by a CONICYT fellowship (Chile) and by Escuela de Graduados, Facultad de Ciencias, UACh. MAM received support from Programa de Integracion, Universidad Nacional de Cuyo, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Batiz LF, 2006, NEUROBIOL DIS, V23, P152, DOI 10.1016/j.nbd.2006.02.009; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Diaz A, 1996, ANDROLOGIA, V28, P21; Gissen P, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050294; Green M. C., 1991, HDB GENETICALLY STAN; Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kitamura K, 2003, J BIOL CHEM, V278, P44417, DOI 10.1074/jbc.M304306200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; QUINN P, 1985, FERTIL STERIL, V44, P493; Ramalho-Santos J, 2001, EXP CELL RES, V267, P45, DOI 10.1006/excr.2000.5119; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; TOMES C, 2006, MOL MECH EXOCYTOSIS, P117; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Whitten WK, 1971, ADV BIOSCI, V6, P129, DOI DOI 10.1016/B978-0-08-017571-3.50013-9; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; Yanagimachi R., 1994, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zhao LM, 2008, REPRODUCTION, V136, P323, DOI 10.1530/REP-07-0569; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	33	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4963	10.1371/journal.pone.0004963	http://dx.doi.org/10.1371/journal.pone.0004963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305511	Green Submitted, Green Published, gold			2022-12-27	WOS:000265498800011
J	Hamza, MS; Pott, S; Vega, VB; Thomsen, JS; Kandhadayar, GS; Ng, PWP; Chiu, KP; Pettersson, S; Wei, CL; Ruan, YJ; Liu, ET				Hamza, Mohamed Sabry; Pott, Sebastian; Vega, Vinsensius B.; Thomsen, Jane S.; Kandhadayar, Gopalan Srinivasan; Ng, Patrick Wei Pern; Chiu, Kuo Ping; Pettersson, Sven; Wei, Chia Lin; Ruan, Yijun; Liu, Edison T.			De-Novo Identification of PPAR gamma/RXR Binding Sites and Direct Targets during Adipogenesis	PLOS ONE			English	Article								Background: The pathophysiology of obesity and type 2 diabetes mellitus is associated with abnormalities in endocrine signaling in adipose tissue and one of the key signaling affectors operative in these disorders is the nuclear hormone transcription factor peroxisome proliferator-activated receptor-gamma (PPAR gamma). PPAR gamma has pleiotropic functions affecting a wide range of fundamental biological processes including the regulation of genes that modulate insulin sensitivity, adipocyte differentiation, inflammation and atherosclerosis. To date, only a limited number of direct targets for PPAR gamma have been identified through research using the well established pre-adipogenic cell line, 3T3-L1. In order to obtain a genome-wide view of PPAR gamma binding sites, we applied the pair end-tagging technology (ChIP-PET) to map PPAR gamma binding sites in 3T3-L1 preadipocyte cells. Methodology/Principal Findings: Coupling gene expression profile analysis with ChIP-PET, we identified in a genome-wide manner over 7700 DNA binding sites of the transcription factor PPAR gamma and its heterodimeric partner RXR during the course of adipocyte differentiation. Our validation studies prove that the identified sites are bona fide binding sites for both PPAR gamma and RXR and that they are functionally capable of driving PPAR gamma specific transcription. Our results strongly indicate that PPAR gamma is the predominant heterodimerization partner for RXR during late stages of adipocyte differentiation. Additionally, we find that PPAR gamma/RXR association is enriched within the proximity of the 59 region of the transcription start site and this association is significantly associated with transcriptional up-regulation of genes involved in fatty acid and lipid metabolism confirming the role of PPAR gamma as the master transcriptional regulator of adipogenesis. Evolutionary conservation analysis of these binding sites is greater when adjacent to up-regulated genes than down-regulated genes, suggesting the primordial function of PPAR gamma/RXR is in the induction of genes. Our functional validations resulted in identifying novel PPAR gamma direct targets that have not been previously reported to promote adipogenic differentiation. Conclusions/Significance: We have identified in a genome-wide manner the binding sites of PPAR gamma and RXR during the course of adipogenic differentiation in 3T3L1 cells, and provide an important resource for the study of PPAR gamma function in the context of adipocyte differentiation.	[Hamza, Mohamed Sabry; Pott, Sebastian; Vega, Vinsensius B.; Thomsen, Jane S.; Kandhadayar, Gopalan Srinivasan; Ng, Patrick Wei Pern; Chiu, Kuo Ping; Pettersson, Sven; Wei, Chia Lin; Ruan, Yijun; Liu, Edison T.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Pott, Sebastian; Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-10401 Stockholm, Sweden	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet	Vega, VB (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	liue@gis.a-star.edu.sg	Liu, Edison/C-4141-2008; Hamza, Sabry/B-8184-2011; Chiu, Kuo-Ping/AAG-8855-2020; Pettersson, Sven/F-9511-2015	Chiu, Kuo-Ping/0000-0001-9144-0674; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502	Singapore Agency for Science, Technology and Research (A*STAR); Karolinska Institutet	Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Karolinska Institutet(Karolinska Institutet)	This study was supported by the Singapore Agency for Science, Technology and Research (A*STAR). SP was funded by grants from Karolinska Institutet through Sven Pettersson and by an A*STAR-KI exchange scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2002, CURR OPIN CLIN NUTR, V5, P385, DOI 10.1097/00075197-200207000-00006; Balakumar P, 2007, PHARMACOLOGY, V80, P1, DOI 10.1159/000102594; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Chaldakov GN, 2003, CURR PHARM DESIGN, V9, P1023, DOI 10.2174/1381612033455152; DANESCH U, 1992, J BIOL CHEM, V267, P7185; Dominiczak MH, 2003, CLIN CHEM LAB MED, V41, P1266, DOI 10.1515/CCLM.2003.194; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P314, DOI 10.1055/s-2007-976539; FITZPATRICK DR, 1995, GENOMICS, V27, P457, DOI 10.1006/geno.1995.1077; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Gimeno RE, 2005, CURR OPIN PHARMACOL, V5, P122, DOI 10.1016/j.coph.2005.01.006; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; KELLER P, 2008, J BIOL CHEM; Ko JA, 2006, J CELL SCI, V119, P5106, DOI 10.1242/jcs.03290; Krishnan A, 2007, CURR MOL MED, V7, P532, DOI 10.2174/156652407781695765; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; Okuno M, 2001, BIOCHEM J, V353, P193, DOI 10.1042/0264-6021:3530193; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Panigrahy D, 2005, CANCER BIOL THER, V4, P687, DOI 10.4161/cbt.4.7.2014; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Popivanova BK, 2007, CANCER SCI, V98, P321, DOI 10.1111/j.1349-7006.2007.00390.x; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Takano H, 2004, CURR PHARM DESIGN, V10, P2779, DOI 10.2174/1381612043383719; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VEGA VB, 2008, INT C COMP SCI 2008; Walczak R, 2002, J LIPID RES, V43, P177; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200; 1997, J BIOL CHEM, V272, P20108	51	90	94	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4907	10.1371/journal.pone.0004907	http://dx.doi.org/10.1371/journal.pone.0004907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300518	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496800008
J	Sugiura, H; Dickinson, MH				Sugiura, Hiroki; Dickinson, Michael H.			The Generation of Forces and Moments during Visual-Evoked Steering Maneuvers in Flying Drosophila	PLOS ONE			English	Article							LEADING-EDGE VORTEX; INSECT FLIGHT; MELANOGASTER; DYNAMICS; MOTION; WINGS; AERODYNAMICS; ROTATION; BEHAVIOR; THRUST	Sideslip force, longitudinal force, rolling moment, and pitching moment generated by tethered fruit flies, Drosophila melanogaster, were measured during optomotor reactions within an electronic flight simulator. Forces and torques were acquired by optically measuring the angular deflections of the beam to which the flies were tethered using a laser and a photodiode. Our results indicate that fruit flies actively generate both sideslip and roll in response to a lateral focus of expansion (FOE). The polarity of this behavior was such that the animal's aerodynamic response would carry it away from the expanding pattern, suggesting that it constitutes an avoidance reflex or centering response. Sideslip forces and rolling moments were sinusoidal functions of FOE position, whereas longitudinal force was proportional to the absolute value of the sine of FOE position. Pitching moments remained nearly constant irrespective of stimulus position or strength, with a direction indicating a tonic nose-down pitch under tethered conditions. These experiments expand our understanding of the degrees of freedom that a fruit fly can actually control in flight.	[Sugiura, Hiroki] Japan Aerosp Explorat Agcy, Tokyo, Japan; [Dickinson, Michael H.] CALTECH, Pasadena, CA 91125 USA	Japan Aerospace Exploration Agency (JAXA); California Institute of Technology	Sugiura, H (corresponding author), Japan Aerosp Explorat Agcy, Tokyo, Japan.	sugiura.hiroki@jaxa.jp	Sikandar, Usama/F-6586-2016					Balint CN, 2004, J EXP BIOL, V207, P3813, DOI 10.1242/jeb.01229; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; BLONDEAU J, 1981, J EXP BIOL, V92, P155; BLONDEAU J, 1982, J COMP PHYSIOL, V145, P321, DOI 10.1007/BF00619336; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; DAVID CT, 1985, NATURE, V313, P48, DOI 10.1038/313048a0; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 1996, J EXP BIOL, V199, P2085; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; DICKSON WB, 2006, 200634 AIAA; Duistermars BJ, 2007, J EXP BIOL, V210, P3218, DOI 10.1242/jeb.007807; FONTAINE E, 2009, J EXP BIOL IN PRESS; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Franceschini N, 2007, CURR BIOL, V17, P329, DOI 10.1016/j.cub.2006.12.032; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; GOTZ KG, 1987, J EXP BIOL, V128, P35; GOTZ KG, 1984, BIOL CYBERN, V51, P135, DOI 10.1007/BF00357927; HEISENBERG M, 1988, J COMP PHYSIOL A, V163, P373, DOI 10.1007/BF00604013; Hollick FSJ, 1941, PHILOS T ROY SOC B, V230, P357; HUMBERT J, 2005, 20056280 AIAA; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lehmann FO, 2007, J EXP BIOL, V210, P1362, DOI 10.1242/jeb.02746; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; Ramamurti R, 2002, J EXP BIOL, V205, P1507; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; RISTROPH L, 2008, J EXP BIOL IN PRESS; Schenato L, 2001, IEEE INT CONF ROBOT, P1641, DOI 10.1109/ROBOT.2001.932846; Shimoyama I., 1993, IEEE Control Systems Magazine, V13, P37, DOI 10.1109/37.184791; Srinivasan MV, 1999, VISION RES, V39, P2749, DOI 10.1016/S0042-6989(99)00002-4; STEVENS BL, 2003, AIRCRAFT CONTROL SIM, P73; Sun Y, 2005, J MICROELECTROMECH S, V14, P4, DOI 10.1109/JMEMS.2004.839028; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Tanikawa T, 2001, IEEE INT CONF ROBOT, P610, DOI 10.1109/ROBOT.2001.932617; Taylor GK, 2005, J ROY SOC INTERFACE, V2, P197, DOI 10.1098/rsif.2005.0036; Taylor GK, 2001, BIOL REV, V76, P449, DOI 10.1017/S1464793101005759; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; ZANKER JM, 1990, PHILOS T ROY SOC B, V327, P19, DOI 10.1098/rstb.1990.0041	39	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4883	10.1371/journal.pone.0004883	http://dx.doi.org/10.1371/journal.pone.0004883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300507	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000265496800004
J	Iwami, S; Suzuki, T; Takeuchi, Y				Iwami, Shingo; Suzuki, Takafumi; Takeuchi, Yasuhiro			Paradox of Vaccination: Is Vaccination Really Effective against Avian Flu Epidemics?	PLOS ONE			English	Article							H5N1 INFLUENZA VARIANT; DRUG-RESISTANCE; H7N7 EPIDEMIC; VIRUS; EMERGENCE; NETHERLANDS; INFECTION; POULTRY; SPREAD; STRAIN	Background: Although vaccination can be a useful tool for control of avian influenza epidemics, it might engender emergence of a vaccine-resistant strain. Field and experimental studies show that some avian influenza strains acquire resistance ability against vaccination. We investigated, in the context of the emergence of a vaccine-resistant strain, whether a vaccination program can prevent the spread of infectious disease. We also investigated how losses from immunization by vaccination imposed by the resistant strain affect the spread of the disease. Methods and Findings: We designed and analyzed a deterministic compartment model illustrating transmission of vaccine-sensitive and vaccine-resistant strains during a vaccination program. We investigated how the loss of protection effectiveness impacts the program. Results show that a vaccination to prevent the spread of disease can instead spread the disease when the resistant strain is less virulent than the sensitive strain. If the loss is high, the program does not prevent the spread of the resistant strain despite a large prevalence rate of the program. The epidemic's final size can be larger than that before the vaccination program. We propose how to use poor vaccines, which have a large loss, to maximize program effects and describe various program risks, which can be estimated using available epidemiological data. Conclusions: We presented clear and simple concepts to elucidate vaccination program guidelines to avoid negative program effects. Using our theory, monitoring the virulence of the resistant strain and investigating the loss caused by the resistant strain better development of vaccination strategies is possible.	[Iwami, Shingo; Takeuchi, Yasuhiro] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan; [Suzuki, Takafumi] Shizuoka Univ, Grad Sch Engn, Shizuoka, Japan	Shizuoka University; Shizuoka University	Iwami, S (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.	takeuchi@sys.eng.shizuoka.ac.jp			Japan Society for the Promotion of Science for Young Scientists [Research Fellowships]	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; ANDERSON R M, 1991; Capua A, 2004, VACCINE, V22, P4137, DOI 10.1016/j.vaccine.2004.04.017; Capua I, 2007, REV SCI TECH OIE, V26, P217, DOI 10.20506/rst.26.1.1741; Capua I, 2004, EUR J CLIN MICROBIOL, V23, P1, DOI 10.1007/s10096-003-1059-3; Capua I, 2006, EMERG INFECT DIS, V12, P1319, DOI 10.3201/eid1209.060430; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Elbers ARW, 2005, AVIAN PATHOL, V34, P181, DOI 10.1080/03079450500096497; Elbers ARW, 2004, AVIAN DIS, V48, P691, DOI 10.1637/7149; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Guan Y, 2007, POULTRY SCI, V86, P437, DOI 10.1093/ps/86.3.437; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; IWAMI S, GEOGRAPHICA IN PRESS; Iwami S, 2008, J THEOR BIOL, V252, P732, DOI 10.1016/j.jtbi.2008.02.020; Iwami S, 2007, MATH BIOSCI, V207, P1, DOI 10.1016/j.mbs.2006.08.001; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Leung FC, 2007, POULTRY SCI, V86, P435, DOI 10.1093/ps/86.3.435; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Marangon S, 2008, ZOONOSES PUBLIC HLTH, V55, P65, DOI 10.1111/j.1863-2378.2007.01086.x; McCaw JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002362; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Pasquato A, 2008, J MOL NEUROSCI, V35, P339, DOI 10.1007/s12031-008-9052-z; Peyre M, 2009, EPIDEMIOL INFECT, V137, P1, DOI 10.1017/S0950268808001039; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Savill NJ, 2006, NATURE, V442, P757, DOI 10.1038/442757a; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; Swayne DE, 1999, AVIAN PATHOL, V28, P245, DOI 10.1080/03079459994731; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; van den Berg T, 2008, COMP IMMUNOL MICROB, V31, P121, DOI 10.1016/j.cimid.2007.07.004; WEBSTER RG, 1985, J VIROL, V55, P173, DOI 10.1128/JVI.55.1.173-176.1985	37	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4915	10.1371/journal.pone.0004915	http://dx.doi.org/10.1371/journal.pone.0004915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19295921	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496600011
J	Santhanam, AN; Bindewald, E; Rajasekhar, VK; Larsson, O; Sonenberg, N; Colburn, NH; Shapiro, BA				Santhanam, Arti N.; Bindewald, Eckart; Rajasekhar, Vinagolu K.; Larsson, Ola; Sonenberg, Nahum; Colburn, Nancy H.; Shapiro, Bruce A.			Role of 3 ' UTRs in the Translation of mRNAs Regulated by Oncogenic eIF4E-A Computational Inference	PLOS ONE			English	Article							SECONDARY STRUCTURE; INITIATION; EXPRESSION; MICRORNAS; CELLS; RECRUITMENT; ACTIVATION; PREDICTION; MIRBASE; PROTEIN	Eukaryotic cap-dependent mRNA translation is mediated by the initiation factor eIF4E, which binds mRNAs and stimulates efficient translation initiation. eIF4E is often overexpressed in human cancers. To elucidate the molecular signature of eIF4E target mRNAs, we analyzed sequence and structural properties of two independently derived polyribosome recruited mRNA datasets. These datasets originate from studies of mRNAs that are actively being translated in response to cells overexpressing eIF4E or cells with an activated oncogenic AKT: eIF4E signaling pathway, respectively. Comparison of eIF4E target mRNAs to mRNAs insensitive to eIF4E-regulation has revealed surprising features in mRNA secondary structure, length and microRNA-binding properties. Fold-changes (the relative change in recruitment of an mRNA to actively translating polyribosomal complexes in response to eIF4E overexpression or AKT upregulation) are positively correlated with mRNA G+C content and negatively correlated with total and 3'UTR length of the mRNAs. A machine learning approach for predicting the fold change was created. Interesting tendencies of secondary structure stability are found near the start codon and at the beginning of the 3'UTR region. Highly upregulated mRNAs show negative selection (site avoidance) for binding sites of several microRNAs. These results are consistent with the emerging model of regulation of mRNA translation through a dynamic balance between translation initiation at the 5'UTR and microRNA binding at the 3'UTR.	[Santhanam, Arti N.] NCI, Gene Regulat Sect, Lab Canc Prevent, Frederick, MD 21701 USA; [Bindewald, Eckart; Colburn, Nancy H.] NCI, SAIC Frederick Inc, Basic Res Program, Frederick, MD USA; [Rajasekhar, Vinagolu K.] Memorial Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY USA; [Larsson, Ola; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Larsson, Ola; Sonenberg, Nahum] McGill Univ, McGill Canc Ctr, Montreal, PQ H3A 2T5, Canada; [Shapiro, Bruce A.] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Memorial Sloan Kettering Cancer Center; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Santhanam, AN (corresponding author), NCI, Gene Regulat Sect, Lab Canc Prevent, Frederick, MD 21701 USA.	bshapiro@ncifcrf.gov	Larsson, Ola/F-8151-2013	Larsson, Ola/0000-0003-1412-1308; Vinagolu, Rajasekhar/0000-0002-7364-2675	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010026, ZIABC008382] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Bindewald E, 2006, RNA, V12, P342, DOI 10.1261/rna.2164906; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; FILIPOWICZ W, 2008, NAT REV GENET; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HARVEY M, 1995, INTUITIVE BIOSTATIST; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Hon LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r166; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; KUMAR MS, 2008, P NATL ACAD SCI US; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Polunovsky Vitaly A, 2006, RNA Biol, V3, P10; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shantz LM, 1996, CANCER RES, V56, P3265; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; WU Z, 2003, MODEL BASED BACKGROU; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Zimmer SG, 2000, ANTICANCER RES, V20, P1343	47	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4868	10.1371/journal.pone.0004868	http://dx.doi.org/10.1371/journal.pone.0004868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290046	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496500005
J	Hoerndli, FJ; Walser, M; Hoier, EF; de Quervain, D; Papassotiropoulos, A; Hajnal, A				Hoerndli, Frederic J.; Walser, Michael; Hoier, Erika Froehli; de Quervain, Dominique; Papassotiropoulos, Andreas; Hajnal, Alex			A Conserved Function of C. elegans CASY-1 Calsyntenin in Associative Learning	PLOS ONE			English	Article								Background: Whole-genome association studies in humans have enabled the unbiased discovery of new genes associated with human memory performance. However, such studies do not allow for a functional or causal testing of newly identified candidate genes. Since polymorphisms in Calsyntenin 2 (CLSTN2) showed a significant association with episodic memory performance in humans, we tested the C. elegans CLSTN2 ortholog CASY-1 for possible functions in the associative behavior of C. elegans. Methodology/Principal Findings: Using three different associative learning paradigms and functional rescue experiments, we show that CASY-1 plays an important role during associative learning in C. elegans. Furthermore, neuronal expression of human CLSTN2 in C. elegans rescues the learning defects of casy-1 mutants. Finally, genetic interaction studies and neuron-specific expression experiments suggest that CASY-1 may regulate AMPA-like GLR-1 glutamate receptor signaling. Conclusion/Significance: Our experiments demonstrate a remarkable conservation of the molecular function of Calsyntenins between nematodes and humans and point at a role of C. elegans casy-1 in regulating a glutamate receptor signaling pathway.			Hajnal, A (corresponding author), Univ Zurich, Inst Zool, Zurich, Switzerland.	ahajnal@zool.uzh.ch		Hajnal, Alex/0000-0002-4098-3721; Walser, Michael/0000-0003-3506-4621; Hoerndli, Frederic/0000-0001-6838-0386; Papassotiropoulos, Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464				Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Bernhard N, 2000, LEARN MEMORY, V7, P199, DOI 10.1101/lm.7.4.199; BRENNER S, 1974, GENETICS, V77, P71; Cassata G, 2000, GENESIS, V27, P141, DOI 10.1002/1526-968X(200008)27:4<141::AID-GENE20>3.0.CO;2-K; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Colbert HA, 1997, J NEUROSCI, V17, P8259; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; JACOBSEN LK, 2008, BIOL PSYCHIAT; KANDEL ER, 1983, COLD SPRING HARB SYM, V48, P821, DOI 10.1101/SQB.1983.048.01.085; Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; Morrison GE, 2001, BEHAV NEUROSCI, V115, P640, DOI 10.1037//0735-7044.115.3.640; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rose JK, 2003, J NEUROSCI, V23, P9595; Saeki S, 2001, J EXP BIOL, V204, P1757; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SPEAR NE, 1985, ANN NY ACAD SCI, V443, P42, DOI 10.1111/j.1749-6632.1985.tb27062.x; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	29	28	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4880	10.1371/journal.pone.0004880	http://dx.doi.org/10.1371/journal.pone.0004880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287492	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496400020
J	He, CJ; Zhou, F; Zuo, ZX; Cheng, HH; Zhou, RJ				He, Chunjiang; Zhou, Fang; Zuo, Zhixiang; Cheng, Hanhua; Zhou, Rongjia			A Global View of Cancer-Specific Transcript Variants by Subtractive Transcriptome-Wide Analysis	PLOS ONE			English	Article							IDENTIFICATION; DATABASE; MUTATIONS; DISCOVERY; ASAP	Background: Alternative pre-mRNA splicing (AS) plays a central role in generating complex proteomes and influences development and disease. However, the regulation and etiology of AS in human tumorigenesis is not well understood. Methodology/Principal Findings: A Basic Local Alignment Search Tool database was constructed for the expressed sequence tags (ESTs) from all available databases of human cancer and normal tissues. An insertion or deletion in the alignment of EST/EST was used to identify alternatively spliced transcripts. Alignment of the ESTs with the genomic sequence was further used to confirm AS. Alternatively spliced transcripts in each tissue were then subtractively cross-screened to obtain tissue-specific variants. We systematically identified and characterized cancer/tissue-specific and alternatively spliced variants in the human genome based on a global view. We identified 15,093 cancer-specific variants of 9,989 genes from 27 types of human cancers and 14,376 normal tissue-specific variants of 7,240 genes from 35 normal tissues, which cover the main types of human tumors and normal tissues. Approximately 70% of these transcripts are novel. These data were integrated into a database HCSAS (http://202.114.72.39/database/human.html, pass: 68756253). Moreover, we observed that the cancer-specific AS of both oncogenes and tumor suppressor genes are associated with specific cancer types. Cancer shows a preference in the selection of alternative splice-sites and utilization of alternative splicing types. Conclusions/Significance: These features of human cancer, together with the discovery of huge numbers of novel splice forms for cancer-associated genes, suggest an important and global role of cancer-specific AS during human tumorigenesis. We advise the use of cancer-specific alternative splicing as a potential source of new diagnostic, prognostic, predictive, and therapeutic tools for human cancer. The global view of cancer-specific AS is not only useful for exploring the complexity of the cancer transcriptome but also widens the eyeshot of clinical research.	[He, Chunjiang; Zhou, Fang; Zuo, Zhixiang; Cheng, Hanhua; Zhou, Rongjia] Wuhan Univ, Dept Genet, Wuhan 430072, Peoples R China	Wuhan University	He, CJ (corresponding author), Wuhan Univ, Dept Genet, Wuhan 430072, Peoples R China.	hhcheng@whu.edu.cn; rjzhou@whu.edu.cn	Zhou, Rongjia/G-4660-2013; Zhou, Rongjia/N-9739-2019; Zuo, Zhixiang/M-4441-2016; He, Chunjiang/N-4316-2016	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009; Zuo, Zhixiang/0000-0002-2492-2689; He, Chunjiang/0000-0002-4868-331X	National Natural Science Foundation of China; National Key Basic Research project [2006CB102103, 2004CB117401]; Program for New Century Excellent Talents in University; 111 project [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 111 project(Ministry of Education, China - 111 Project)	The work was supported by the National Natural Science Foundation of China, the National Key Basic Research project (2006CB102103, 2004CB117401), the Program for New Century Excellent Talents in University, and the 111 project #B06018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gupta S, 2004, BIOINFORMATICS, V20, P2579, DOI 10.1093/bioinformatics/bth288; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; Hui LJ, 2004, ONCOGENE, V23, P3013, DOI 10.1038/sj.onc.1207362; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Ladd AN, 2002, GENOME BIOL, V3; Lee C, 2003, NUCLEIC ACIDS RES, V31, P101, DOI 10.1093/nar/gkg029; Li CX, 2006, CANCER RES, V66, P1990, DOI 10.1158/0008-5472.CAN-05-2593; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Roy M, 2005, NUCLEIC ACIDS RES, V33, P5026, DOI 10.1093/nar/gki792; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZN, 2003, CANCER RES, V63, P655; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang CL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-202; Zheng CL, 2005, RNA, V11, P1767, DOI 10.1261/rna.2650905	36	65	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4732	10.1371/journal.pone.0004732	http://dx.doi.org/10.1371/journal.pone.0004732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266097	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490800012
J	Maradeo, ME; Skibbens, RV				Maradeo, Marie E.; Skibbens, Robert V.			The Elg1-RFC Clamp-Loading Complex Performs a Role in Sister Chromatid Cohesion	PLOS ONE			English	Article								It is widely accepted that of the four Replication Factor C (RFC) complexes (defined by the associations of either Rfc1p, Ctf18p, Elg1p or Rad24p with Rfc2p-Rfc5p), only Ctf18-RFC functions in sister chromatid cohesion. This model is based on findings that CTF18 deletion is lethal in combination with mutations in either CTF7(ECO1) or MCD1 sister chromatid cohesion genes and that ctf18 mutant cells exhibit cohesion defects. Here, we report that Elg1-RFC not only participates in cohesion but performs a function that is distinct from that of Ctf18-RFC. The results show that deletion of ELG1 rescues both ctf7(eco1) mutant cell temperature sensitivity and cohesion defects. Moreover, over-expression of ELG1 enhances ctf7(eco1) mutant cell phenotypes. These findings suggest that the balance of Ctf7p(Eco1p) activity depends on both Ctf18-RFC and Elg1-RFC. We also report that ELG1 deletion produces cohesion defects and intensifies the conditional phenotype of mcd1 mutant cells, further supporting a role for Elg1-RFC in cohesion. Attesting to the specificity of these interactions, deletion of RAD24 neither suppressed nor exacerbated cohesion defects in either ctf7(eco1) or mcd1 mutant cells. While parallel analyses failed to uncover a similar role in cohesion for Rad24-RFC, it is well known that Rad24-RFC, Elg1-RFC and Ctf18-RFC play key roles in DNA damage responses. We tested and found that Ctf7p(Eco1p) plays a significant role in Rad24-RFC-based DNA response pathways. In combination, these findings challenge current views and document new and distinct roles for RFC complexes in cohesion and for Ctf7p(Eco1p) in DNA repair.	[Maradeo, Marie E.; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Maradeo, ME (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institutes of General Medicine [1R15GM083269]; Susan G. Komen for the Cure Foundation [BCTR0707708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083269] Funding Source: NIH RePORTER	National Institutes of General Medicine; Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RVS is supported by awards from the National Institutes of General Medicine (1R15GM083269) and by the Susan G. Komen for the Cure Foundation (BCTR0707708). Any opinions, findings, and conclusions or recommendations expressed in this study are those of the authors and do not necessarily reflect the views of the National Institutes of General Medicine nor of the Susan G. Komen Foundation. The authors are also indebted to BD for the gift of a FACSCantoII cytometer to Lehigh University.	Antoniacci LM, 2006, CURR BIOL, V16, P902, DOI 10.1016/j.cub.2006.03.060; Antoniacci LM, 2004, J BIOL CHEM, V279, P49542, DOI 10.1074/jbc.M404324200; Banerjee S, 2004, EUKARYOT CELL, V3, P1557, DOI 10.1128/EC.3.6.1557-1566.2004; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; BENAROYA S, 2003, EMBO J, V22, P4304; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Brands A, 2008, GENETICS, V180, P7, DOI 10.1534/genetics.108.092288; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kim J, 2005, NUCLEIC ACIDS RES, V33, P4078, DOI 10.1093/nar/gki728; Kondo T, 1999, MOL CELL BIOL, V19, P1136; KOUPRINA N, 1994, GENETICS, V138, P1067; Krause SA, 2001, MOL CELL BIOL, V21, P5156, DOI 10.1128/MCB.21.15.5156-5168.2001; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Naiki T, 2001, MOL CELL BIOL, V21, P5838, DOI 10.1128/MCB.21.17.5838-5845.2001; O'Donnell M, 2001, CURR BIOL, V11, pR935, DOI 10.1016/S0960-9822(01)00559-0; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 2007, J CELL SCI, V120, P2471, DOI 10.1242/jcs.011999; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 2004, EXP CELL RES, V296, P80, DOI 10.1016/j.yexcr.2004.03.005; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Watts FZ, 2006, DNA REPAIR, V5, P399, DOI 10.1016/j.dnarep.2005.11.002; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200	47	50	50	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4707	10.1371/journal.pone.0004707	http://dx.doi.org/10.1371/journal.pone.0004707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262753	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490600018
J	Yin, J; Li, L; Shaw, N; Li, Y; Song, JK; Zhang, WP; Xia, CF; Zhang, RG; Joachimiak, A; Zhang, HC; Wang, LX; Liu, ZJ; Wang, P				Yin, Jie; Li, Lei; Shaw, Neil; Li, Yang; Song, Jing Katherine; Zhang, Wenpeng; Xia, Chengfeng; Zhang, Rongguang; Joachimiak, Andrzej; Zhang, Hou-Cheng; Wang, Lai-Xi; Liu, Zhi-Jie; Wang, Peng			Structural Basis and Catalytic Mechanism for the Dual Functional Endo-beta-N-Acetylglucosaminidase A	PLOS ONE			English	Article							TRANSGLYCOSYLATION ACTIVITY; ENHANCED TRANSGLYCOSYLATION; OLIGOSACCHARIDE SYNTHESIS; COMPLEX OLIGOSACCHARIDES; CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEINS; GLYCOPEPTIDES; PURIFICATION; GLYCOSYNTHASES; REFINEMENT	Endo-beta-N-acetylglucosaminidases (ENGases) are dual specificity enzymes with an ability to catalyze hydrolysis and transglycosylation reactions. Recently, these enzymes have become the focus of intense research because of their potential for synthesis of glycopeptides. We have determined the 3D structures of an ENGase from Arthrobacter protophormiae (Endo-A) in 3 forms, one in native form, one in complex with Man(3)GlcNAc-thiazoline and another in complex with GlcNAc-Asn. The carbohydrate moiety sits above the TIM-barrel in a cleft region surrounded by aromatic residues. The conserved essential catalytic residues - E173, N171 and Y205 are within hydrogen bonding distance of the substrate. W216 and W244 regulate access to the active site during transglycosylation by serving as "gate-keepers''. Interestingly, Y299F mutation resulted in a 3 fold increase in the transglycosylation activity. The structure provides insights into the catalytic mechanism of GH85 family of glycoside hydrolases at molecular level and could assist rational engineering of ENGases.	[Yin, Jie; Shaw, Neil; Li, Yang; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Yin, Jie; Li, Yang] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Li, Lei; Zhang, Hou-Cheng; Wang, Peng] Shandong Univ, Natl Glycoengn Res Ctr, Shandong, Peoples R China; [Li, Lei; Zhang, Hou-Cheng; Wang, Peng] Shandong Univ, Sch Life Sci, State Key Lab Microb Technol, Shandong, Peoples R China; [Li, Lei; Song, Jing Katherine; Zhang, Wenpeng; Xia, Chengfeng; Wang, Peng] Ohio State Univ, Dept Biochem & Chem, Columbus, OH 43210 USA; [Zhang, Rongguang; Joachimiak, Andrzej] Structural Biol Ctr, Argonne Natl Lab, Argonne, IL USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wang, Peng] Nankai Univ, Coll Pharm, Tianjin, Peoples R China; [Wang, Peng] Nankai Univ, State Key Lab Elemento Organ Chem, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong University; Shandong University; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nankai University; Nankai University	Yin, J (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	zjliu@ibp.ac.cn; pwang@sdu.edu.cn	Liu, Zhi-Jie/A-3946-2012; Li, Yang/G-3685-2011; WANG, Peng/GSN-5263-2022; Wang, Lai-Xi/E-8755-2019; Yin, Jie/J-8932-2016; Ying, Chieh/E-4296-2016; Li, Yang/M-1246-2013; Wang, Lai-Xi/E-8790-2019; wang, xl/Y-8251-2019	Liu, Zhi-Jie/0000-0001-7279-2893; Wang, Lai-Xi/0000-0003-4293-5819; Shaw, Neil/0000-0003-2722-9967	National Natural Science Foundation of China [20872068, 30721003, 30870483, 30700123]; Ministry of Health [2008ZX10404]; Ministry of Science and Technology of China [2006AA02A316, 2006CB910901, 2006CB910903, 2007CB914803, 2007CB914403]; CAS [KSCX2-YW-R-127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health; Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAS(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (Grants: 20872068, 30721003, 30870483 and 30700123), the Ministry of Health (Grant 2008ZX10404), the Ministry of Science and Technology of China (Grants 2006AA02A316, 2006CB910901, 2006CB910903, 2007CB914803 and 2007CB914403), CAS Research Grant (KSCX2-YW-R-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BOURGERIE S, 1994, J BACTERIOL, V176, P6170, DOI 10.1128/jb.176.20.6170-6174.1994; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN JQ, 1995, J BIOL CHEM, V270, P17723, DOI 10.1074/jbc.270.30.17723; Fujita K, 2004, BIOSCI BIOTECH BIOCH, V68, P1059, DOI 10.1271/bbb.68.1059; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Hauser S, 2005, BIOCHEM BIOPH RES CO, V328, P580, DOI 10.1016/j.bbrc.2005.01.012; He Y, 2007, ACTA CRYSTALLOGR D, V63, P793, DOI 10.1107/S0907444907023451; ITO K, 1993, J BIOL CHEM, V268, P16074; KADOWAKI S, 1988, AGR BIOL CHEM TOKYO, V52, P2387; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Kimura Y, 2002, BBA-GEN SUBJECTS, V1570, P38, DOI 10.1016/S0304-4165(02)00149-6; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2008, BIOORGAN MED CHEM, V16, P4670, DOI 10.1016/j.bmc.2008.02.032; LI SC, 1981, BIOCHIM BIOPHYS ACTA, V660, P278, DOI 10.1016/0005-2744(81)90171-6; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai H, 2008, J AM CHEM SOC, V130, P13790, DOI 10.1021/ja805044x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Shaw N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-46; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 1998, J BIOL CHEM, V273, P10083, DOI 10.1074/jbc.273.17.10083; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2006, CURR OPIN DRUG DISC, V9, P194; Wang LX, 2004, ACS SYM SER, V873, P73; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72	38	52	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4658	10.1371/journal.pone.0004658	http://dx.doi.org/10.1371/journal.pone.0004658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252736	Green Published, Green Submitted, gold			2022-12-27	WOS:000265489900001
J	Vij, N; Mazur, S; Zeitlin, PL				Vij, Neeraj; Mazur, Steven; Zeitlin, Pamela L.			CFTR Is a Negative Regulator of NF kappa B Mediated Innate Immune Response	PLOS ONE			English	Article								Background: Dysfunctional CFTR in the airways is associated with elevated levels of NF kappa B mediated IL-8 signaling leading to neutrophil chemotaxis and chronic lung inflammation in cystic fibrosis. The mechanism(s) by which CFTR mediates inflammatory signaling is under debate. Methodology/Principal Findings: We tested the hypothesis that wt-CFTR down-regulates NF kappa B mediated IL-8 secretion. We transiently co-expressed wt-CFTR and IL-8 or NF kappa B promoters driving luciferase expression in HEK293 cells. Wt-CFTR expression in HEK293 cells suppresses both basal and IL1 beta induced IL-8, and NF kappa B promoter activities as compared to the control cells transfected with empty vector (p<0.05). We also confirmed these results using CFBE41o- cells and observed that cells stably transduced with wt-CFTR secrete significantly lower amounts of IL-8 chemokine as compared to non-transfected control cells. To test the hypothesis that CFTR must be localized to cell surface lipid rafts in polarized airway epithelial cells in order to mediate the inflammatory response, we treated CFBE41o- cells that had been stably transduced with wt-CFTR with methyl-beta-cyclodextrin (CD). At baseline, CD significantly (p<0.05) induced IL-8 and NF kappa B reporter activities as compared to control cells suggesting a negative regulation of NF kappa B mediated IL-8 signaling by CFTR in cholesterol-rich lipid rafts. Untreated cells exposed to the CFTR channel blocker CFTR-172 inhibitor developed a similar increase in IL-8 and NF kappa B reporter activities suggesting that not only must CFTR be present on the cell surface but it must be functional. We verified these results in vivo by comparing survival, body weight and pro-inflammatory cytokine response to P. aeruginosa LPS in CFTR knock out (CFKO) mice as compared to wild type controls. There was a significant (p<0.05) decrease in survival and body weight, an elevation in IL-1 beta in whole lung extract (p<0.01), as well as a significant increase in phosphorylated I kappa B, an inducer of NF kappa B mediated signaling in the CFKO mice. Conclusions/Significance: Our data suggest that CFTR is a negative regulator of NF kappa B mediated innate immune response and its localization to lipid rafts is involved in control of inflammation.	[Vij, Neeraj; Mazur, Steven; Zeitlin, Pamela L.] Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Vij, N (corresponding author), Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD USA.	nvij1@jhmi.edu			Cystic Fibrosis Foundation [R025-CR07, VIJ07IO]; NIH [R01 HL59410]; CTSA [UL RR 025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R025-CR07 and VIJ07IO grants from the Cystic Fibrosis Foundation to NV, and in part by NIH grants R01 HL59410 and CTSA UL RR 025005 to PZ and NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DS, 1995, BRIT MED J, V310, P1571, DOI 10.1136/bmj.310.6994.1571; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Blackwell TS, 2001, AM J PHYSIOL-LUNG C, V281, pL69, DOI 10.1152/ajplung.2001.281.1.L69; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; Hentchel-Franks K, 2004, AM J RESP CELL MOL, V31, P140, DOI 10.1165/rcmb.2004-0012OC; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; MASSION PP, 1994, J CLIN INVEST, V93, P26, DOI 10.1172/JCI116954; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Reiniger N, 2007, INFECT IMMUN, V75, P1598, DOI 10.1128/IAI.01980-06; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rubin BK, 2003, CHEST, V123, P1792, DOI 10.1378/chest.123.6.1792; Rubin BK, 2007, AM J PHYSIOL-LUNG C, V292, pL381, DOI 10.1152/ajplung.00375.2006; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Srivastava M, 2004, P NATL ACAD SCI USA, V101, P7693, DOI 10.1073/pnas.0402030101; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Vij N, 2008, AM J RESP CELL MOL, V38, P176, DOI 10.1165/rcmb.2007-0197OC; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zaman MM, 2004, CLIN DIAGN LAB IMMUN, V11, P819, DOI 10.1128/CDLI.11.5.819-824.2004	43	127	131	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4664	10.1371/journal.pone.0004664	http://dx.doi.org/10.1371/journal.pone.0004664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247502	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800037
J	Tibber, MS; Anderson, EJ; Melmoth, DR; Rees, G; Morgan, MJ				Tibber, Marc S.; Anderson, Elaine J.; Melmoth, Dean R.; Rees, Geraint; Morgan, Michael J.			Common Cortical Loci Are Activated during Visuospatial Interpolation and Orientation Discrimination Judgements	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; HUMAN EXTRASTRIATE CORTEX; HUMAN VISUAL-SYSTEM; OBJECT IDENTIFICATION; HUMAN BRAIN; SURFACE-ORIENTATION; PARIETAL CORTEX; NEGATIVE BOLD; ANATOMICAL LANDMARK; RECEPTIVE-FIELDS	There is a wealth of literature on the role of short-range interactions between low-level orientation-tuned filters in the perception of discontinuous contours. However, little is known about how spatial information is integrated across more distant regions of the visual field in the absence of explicit local orientation cues, a process referred to here as visuospatial interpolation (VSI). To examine the neural correlates of VSI high field functional magnetic resonance imaging was used to study brain activity while observers either judged the alignment of three Gabor patches by a process of interpolation or discriminated the local orientation of the individual patches. Relative to a fixation baseline the two tasks activated a largely over-lapping network of regions within the occipito-temporal, occipito-parietal and frontal cortices. Activated clusters specific to the orientation task (orientation. interpolation) included the caudal intraparietal sulcus, an area whose role in orientation encoding per se has been hotly disputed. Surprisingly, there were few task-specific activations associated with visuospatial interpolation (VSI. orientation) suggesting that largely common cortical loci were activated by the two experimental tasks. These data are consistent with previous studies that suggest higher level grouping processes-putatively involved in VSI-are automatically engaged when the spatial properties of a stimulus (e. g. size, orientation or relative position) are used to make a judgement.	[Tibber, Marc S.; Melmoth, Dean R.; Morgan, Michael J.] City Univ London, Dept Optometry & Visual Sci, London, England; [Anderson, Elaine J.; Rees, Geraint; Morgan, Michael J.] UCL, Inst Cognitive Neurosci, London WC1E 6BT, England; [Anderson, Elaine J.; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London WC1E 6BT, England	City University London; University of London; University College London; University of London; University College London	Tibber, MS (corresponding author), City Univ London, Dept Optometry & Visual Sci, London, England.	mtibber@yahoo.com	Rees, Geraint/C-1493-2008	Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [079766]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant no. 079766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2005, NEUROPSYCHOLOGIA, V43, P2101, DOI 10.1016/j.neuropsychologia.2005.03.015; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; Aso T, 2007, NEUROSCI LETT, V415, P225, DOI 10.1016/j.neulet.2007.01.051; BOUCART M, 1995, J EXP PSYCHOL HUMAN, V21, P584, DOI 10.1037/0096-1523.21.3.584; Boucart M, 1997, PERCEPTION, V26, P1197, DOI 10.1068/p261197; BOUCART M, 1994, J EXP PSYCHOL HUMAN, V20, P61, DOI 10.1037/0096-1523.20.1.61; BOUCART M, 1992, J EXP PSYCHOL HUMAN, V18, P785, DOI 10.1037/0096-1523.18.3.785; Boucart M, 2000, NEUROREPORT, V11, P2379, DOI 10.1097/00001756-200008030-00009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURBECK CA, 1987, VISION RES, V27, P417, DOI 10.1016/0042-6989(87)90090-3; CANT JS, 2004, J VISION, V4, P510; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Dupont P, 1998, EUR J NEUROSCI, V10, P3689, DOI 10.1046/j.1460-9568.1998.00376.x; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Faillenot I, 2001, EUR J NEUROSCI, V13, P585, DOI 10.1046/j.1460-9568.2001.01399.x; Faillenot I, 1999, NEUROIMAGE, V10, P114, DOI 10.1006/nimg.1999.0449; FIELD D, 2001, VISUAL NEUROSCIENCES, P1069; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Harris IM, 2008, J COGNITIVE NEUROSCI, V20, P916, DOI 10.1162/jocn.2008.20513; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; HESS RF, 1994, VISION RES, V34, P625, DOI 10.1016/0042-6989(94)90018-3; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Humphreys GW, 1997, J EXP PSYCHOL HUMAN, V23, P136; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; KELLMAN PJ, 2001, FRAGMENTS OBJECTS SE, P181; Kitada R, 2006, J NEUROSCI, V26, P7491, DOI 10.1523/JNEUROSCI.0822-06.2006; KOOI FL, 1991, VISION RES, V31, P1627, DOI 10.1016/0042-6989(91)90139-V; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; KOURTZI Z, 2005, FITTING MIND WORLD; Laurienti PJ, 2004, J COGNITIVE NEUROSCI, V16, P1481, DOI 10.1162/0898929042568596; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Levi DM, 1996, VISION RES, V36, P573, DOI 10.1016/0042-6989(95)00128-X; Marr D., 1982, VISION COMPUTATIONAL; Mendola JD, 1999, J NEUROSCI, V19, P8560; Morgan M. J., 1990, SPATIAL VISION; MORGAN MJ, 1990, J OPT SOC AM A, V7, P297, DOI 10.1364/JOSAA.7.000297; MORGAN MJ, 1987, VISION RES, V27, P107, DOI 10.1016/0042-6989(87)90147-7; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Orban GA, 1997, EUR J NEUROSCI, V9, P246, DOI 10.1111/j.1460-9568.1997.tb01395.x; Ostwald D, 2008, J NEUROPHYSIOL, V99, P2456, DOI 10.1152/jn.01307.2007; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pins D, 2004, NEUROPSYCHOLOGIA, V42, P1247, DOI 10.1016/j.neuropsychologia.2004.01.005; PINS D, 2001, J VISION, V1; Pourtois G, 2001, NEUROREPORT, V12, P2369, DOI 10.1097/00001756-200108080-00017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rice NJ, 2007, NEUROIMAGE, V36, pT87, DOI 10.1016/j.neuroimage.2007.03.032; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Talairach J., 1988, COPLANAR STEREOTAXIC; TOET A, 1988, VISION RES, V28, P133, DOI 10.1016/S0042-6989(88)80013-0; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Valyear KF, 2006, NEUROPSYCHOLOGIA, V44, P218, DOI 10.1016/j.neuropsychologia.2005.05.004; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; Wade AR, 2002, NEURON, V36, P993, DOI 10.1016/S0896-6273(02)01138-8; WATT RJ, 1984, VISION RES, V24, P1377, DOI 10.1016/0042-6989(84)90193-7; WAUGH SJ, 1995, J OPT SOC AM A, V12, P2305, DOI 10.1364/JOSAA.12.002305; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]	85	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4585	10.1371/journal.pone.0004585	http://dx.doi.org/10.1371/journal.pone.0004585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KW	19238207	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000265487400014
J	Kourtis, N; Tavernarakis, N				Kourtis, Nikos; Tavernarakis, Nektarios			Cell-Specific Monitoring of Protein Synthesis In Vivo	PLOS ONE			English	Article								Analysis of general and specific protein synthesis provides important information, relevant to cellular physiology and function. However, existing methodologies, involving metabolic labelling by incorporation of radioactive amino acids into nascent polypeptides, cannot be applied to monitor protein synthesis in specific cells or tissues, in live specimens. We have developed a novel approach for monitoring protein synthesis in specific cells or tissues, in vivo. Fluorescent reporter proteins such as GFP are expressed in specific cells and tissues of interest or throughout animals using appropriate promoters. Protein synthesis rates are assessed by following fluorescence recovery after partial photobleaching of the fluorophore at targeted sites. We evaluate the method by examining protein synthesis rates in diverse cell types of live, wild type or mRNA translation-defective Caenorhabditis elegans animals. Because it is non-invasive, our approach allows monitoring of protein synthesis in single cells or tissues with intrinsically different protein synthesis rates. Furthermore, it can be readily implemented in other organisms or cell culture systems.	[Kourtis, Nikos; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH)	Kourtis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466	EMBO; Empeirikeion Foundation; EU 6th Framework Programme	EMBO(European Molecular Biology Organization (EMBO)); Empeirikeion Foundation; EU 6th Framework Programme(European Commission)	This work is supported by grants from EMBO, the Empeirikeion Foundation and the EU 6th Framework Programme. N.K. is a recipient of the Manasaki scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Barstead Robert J., 2006, V351, P51; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; BRENNER S, 1974, GENETICS, V77, P71; Epstein H F, 1995, CAENORHABDITIS ELEGA; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fostel JL, 2003, BIOCHEM BIOPH RES CO, V312, P173, DOI 10.1016/j.bbrc.2003.09.248; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2000, GENETICS, V154, P1597; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gribbon P, 1998, BIOPHYS J, V75, P1032, DOI 10.1016/S0006-3495(98)77592-7; HOPE IA, 1999, C ELEGANS PRACTICAL, pR21; Hoppe PE, 2000, GENETICS, V156, P631; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; JACOBSON K, 1991, SCANNING MICROSCOPY, V5, P357; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; MARTIN R, 1998, PROTEIN SYNTHESIS  M, pR14; Mello C, 1995, METHOD CELL BIOL, V48, P451; Melov, 2007, WORMBOOK, P1, DOI DOI 10.I895/W0RMB00K.I.127.2; OKKEMA PG, 1993, GENETICS, V135, P385; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; RENNIE MJ, 1994, AM J PHYSIOL, V266, pE298, DOI 10.1152/ajpendo.1994.266.3.E298; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; STRANGE K, 2006, C ELEGANS METHODS AP, pR12; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Thatcher JD, 1999, DEVELOPMENT, V126, P97; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	34	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4547	10.1371/journal.pone.0004547	http://dx.doi.org/10.1371/journal.pone.0004547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234598	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487200004
J	Kim, Y; McBride, J; Kimlin, L; Pae, EK; Deshpande, A; Wong, DT				Kim, Yong; McBride, Jim; Kimlin, Lauren; Pae, Eung-Kwon; Deshpande, Amit; Wong, David T.			Targeted Inactivation of p12(Cdk2ap1), CDK2 Associating Protein 1, Leads to Early Embryonic Lethality	PLOS ONE			English	Article								Targeted disruption of murine Cdk2ap1, an inhibitor of CDK2 function and hence G1/S transition, results in the embryonic lethality with a high penetration rate. Detailed timed pregnancy analysis of embryos showed that the lethality occurred between embryonic day 3.5 pc and 5.5 pc, a period of implantation and early development of implanted embryos. Two homozygous knockout mice that survived to term showed identical craniofacial defect, including a short snout and a round forehead. Examination of craniofacial morphology by measuring Snout Length (SL) vs. Face Width (FW) showed that the Cdk2ap1(+/-) mice were born with a reduced SL/FW ratio compared to the Cdk2ap1(+/+) and the reduction was more pronounced in Cdk2ap1(-/-) mice. A transgenic rescue of the lethality was attempted by crossing Cdk2ap1(+/-) animals with K14-Cdk2ap1 transgenic mice. Resulting Cdk2ap1(+/-:K14-Cdk2ap1) transgenic mice showed an improved incidence of full term animals (16.7% from 0.5%) on a Cdk2ap1(-/-) background. Transgenic expression of Cdk2ap1 in Cdk2ap1(-/-:K14-Cdk2ap1) animals restored SL/FW ratio to the level of Cdk2ap1(+/-:K14-Cdk2ap1) mice, but not to that of the Cdk2ap1(+/+:K14-Cdk2ap1) mice. Teratoma formation analysis using mESCs showed an abrogated in vivo pluripotency of Cdk2ap1(-/-) mESCs towards a restricted mesoderm lineage specification. This study demonstrates that Cdk2ap1 plays an essential role in the early stage of embryogenesis and has a potential role during craniofacial morphogenesis.	[Kim, Yong; McBride, Jim; Kimlin, Lauren; Deshpande, Amit; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Kim, Yong; Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehensive Canc Ctr, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Div Head & Neck Surg Otolaryngol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Henry Samueli Sch Engn, Los Angeles, CA 90024 USA; [Pae, Eung-Kwon] Univ Calif Los Angeles, Sch Dentist, Sect Orthodont, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kim, Y (corresponding author), Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Div Oral Biol & Med, Los Angeles, CA 90024 USA.	thadyk@ucla.edu; dtww@ucla.edu			PHS [R01 DE 14857, T32 DE 007296-08]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014857, T32DE007296] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by PHS Grants R01 DE 14857 [D.T.W.] and T32 DE 007296-08 [Y.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Bair SR, 2004, MOL CELL BIOL, V24, P5383, DOI 10.1128/MCB.24.12.5383-5390.2004; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; CONWAY AE, 2008, STEM CELLS; Cwikla SJ, 2000, J ORAL MAXIL SURG, V58, P406, DOI 10.1016/S0278-2391(00)90924-8; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Dudas M, 2005, CURR TOP DEV BIOL, V66, P65, DOI 10.1016/S0070-2153(05)66003-6; Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x; Figueiredo ML, 2006, MOL REPROD DEV, V73, P987, DOI 10.1002/mrd.20458; Figueiredo ML, 2005, CLIN CANCER RES, V11, P3939, DOI 10.1158/1078-0432.CCR-04-2085; Gallicano GI, 2001, FRONT BIOSCI-LANDMRK, V6, pD1089, DOI 10.2741/Gallican; Greene RM, 2005, HUM EXP TOXICOL, V24, P1, DOI 10.1191/0960327105ht492oa; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hay ED, 1995, ACTA ANAT, V154, P8; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kim Y, 2005, ONCOGENE, V24, P407, DOI 10.1038/sj.onc.1208222; Kim Y, 2001, INT J ORAL BIOL  DEC, V2001, P87; Kohno Y, 2002, ORAL ONCOL, V38, P274, DOI 10.1016/S1368-8375(01)00055-0; LeCouter JE, 1998, DEVELOPMENT, V125, P4669; Lee S, 2003, MOL REPROD DEV, V64, P405, DOI 10.1002/mrd.10232; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; Mizuno S, 1998, J CLIN INVEST, V101, P1827, DOI 10.1172/JCI1709; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peng H, 2006, NEOPLASIA, V8, P1028, DOI 10.1593/neo.06580; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shintani S, 2001, CLIN CANCER RES, V7, P2776; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Strothmann K, 2004, CELL TISSUE RES, V315, P249, DOI 10.1007/s00441-003-0834-x; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	45	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4518	10.1371/journal.pone.0004518	http://dx.doi.org/10.1371/journal.pone.0004518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229340	gold, Green Published, Green Submitted			2022-12-27	WOS:000265486200005
J	Nasser, NJ; Kaplan, M; Nevo, E; Aviram, M				Nasser, Nicola J.; Kaplan, Marielle; Nevo, Eviatar; Aviram, Michael			Lipid Profile and Serum Characteristics of the Blind Subterranean Mole Rat, Spalax	PLOS ONE			English	Article								Background: Spalax (blind subterranean mole rat), is a mammal adapted to live in fluctuating oxygen levels, and can survive severe hypoxia and hypercapnia. The adaptive evolution of Spalax to underground life resulted in structural and molecular-genetic differences comparing to above-ground mammals. These differences include higher myocardial maximal oxygen consumption, increased lung diffusion capacity, increased blood vessels density, and unique expression patterns of cancer and angiogenesis related genes such as heparanase, vascular endothelial growth factor, and P53. Methodology/Principal Findings: Here we elucidate the main characteristics of Spalax lipid profile, as well as its main antioxidant and serum parameters. Compared to human, Spalax possesses lower total-cholesterol, low density lipoproteins (LDL) and triglycerides levels, and higher levels of high density lipoproteins (HDL). Apolipoprotein A-I and apolipoprotein B-100 were significantly lower in Spalax compared to human. Paraoxonase (PON) 1 arylesterase activity, was higher in Spalax compared to both human and mouse serum levels. Analysis of serum chemistry of Spalax revealed special features in this mammal. Conclusions/Significance: Spalax possesses a unique lipid profile with high HDL and low LDL lipoproteins. The antioxidant serum content in the mole rat is higher than that of human and mouse. Serum C reactive protein (CRP) levels are significantly lower in Spalax compared to that of human or mouse, reflecting low levels of inflammation. These differences between Spalax, human and mouse are due to several factors including the intensive activity life-style that Spalax pursue underground, dietary components, and evolutionary genetic adaptations. Unfolding the genetic basis of these differences will probably result in unique treatments for a variety of human diseases such as dyslipedemias, inflammation and cancer.	Shaare Zedek Med Ctr, Dept Oncol, Jerusalem, Israel; [Kaplan, Marielle] Rambam Med Ctr, Clin Biochem Lab, Haifa, Israel; [Nevo, Eviatar] Univ Haifa, Int Grad Ctr Evolut, Inst Evolut, IL-31999 Haifa, Israel; [Aviram, Michael] Rambam Med Ctr, Rappaport Family Inst Res Med Sci, Technion Fac Med, Lipid Res Lab, Haifa, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Haifa; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Nasser, NJ (corresponding author), Shaare Zedek Med Ctr, Dept Oncol, Jerusalem, Israel.	nicola.nasser@gmail.com			Ancell Teicher Research Foundation for Molecular Genetics and Evolution	Ancell Teicher Research Foundation for Molecular Genetics and Evolution	This research was supported by the Ancell Teicher Research Foundation for Molecular Genetics and Evolution (to E.N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; ARIELI R, 1990, PROG CLIN BIOL RES, V335, P251; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Aviram M, 2001, METHOD ENZYMOL, V335, P244; Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje; Avivi A, 2005, CELL CYCLE, V4, P368, DOI 10.4161/cc.4.3.1534; Avivi A, 2004, J BIOL RHYTHM, V19, P22, DOI 10.1177/0748730403260622; Avivi A, 1999, FEBS LETT, V452, P133, DOI 10.1016/S0014-5793(99)00584-0; BROWN WV, 1990, ANN NY ACAD SCI, V598, P376, DOI 10.1111/j.1749-6632.1990.tb42308.x; Caballero B, 2006, J COMP PHYSIOL A, V192, P753, DOI 10.1007/s00359-006-0111-z; EDOUTE Y, 1988, J COMP PHYSIOL B, V158, P575, DOI 10.1007/BF00692566; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; Mason MJ, 2002, J COMP PSYCHOL, V116, P158, DOI 10.1037//0735-7036.116.2.158; Mitchell TW, 2007, EXP GERONTOL, V42, P1053, DOI 10.1016/j.exger.2007.09.004; Nasser NJ, 2008, CELL MOL LIFE SCI, V65, P1706, DOI 10.1007/s00018-008-7584-6; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Nauck M, 2002, CLIN CHEM, V48, P236; Nevo, 1999, MOSAIC EVOLUTION SUB; NEVO E., 2001, ADAPTIVE RAD BLIND S; Shams I, 2005, COMP BIOCHEM PHYS A, V142, P376, DOI 10.1016/j.cbpa.2005.09.003; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; WEIBEL ER, 1993, RESP PHYSIOL, V93, P125, DOI 10.1016/0034-5687(93)90001-Q; Werner SJ, 2005, PHYSIOL BEHAV, V85, P340, DOI 10.1016/j.physbeh.2005.04.024; Widmer HR, 1997, P NATL ACAD SCI USA, V94, P2062, DOI 10.1073/pnas.94.5.2062; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4528	10.1371/journal.pone.0004528	http://dx.doi.org/10.1371/journal.pone.0004528			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229331	Green Submitted, gold, Green Published			2022-12-27	WOS:000265486200010
J	Fukuda, S; Nakanishi, Y; Chikayama, E; Ohno, H; Hino, T; Kikuchi, J				Fukuda, Shinji; Nakanishi, Yumiko; Chikayama, Eisuke; Ohno, Hiroshi; Hino, Tsuneo; Kikuchi, Jun			Evaluation and Characterization of Bacterial Metabolic Dynamics with a Novel Profiling Technique, Real-Time Metabolotyping	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; UNSATURATED FATTY-ACIDS; MAGNETIC-RESONANCE-SPECTROSCOPY; BUTYRIVIBRIO-FIBRISOLVENS; ESCHERICHIA-COLI; IN-VIVO; ARABIDOPSIS-THALIANA; BUTYRATE PRODUCTION; LACTOBACILLUS SPP.; SYSTEMS BIOLOGY	Background: Environmental processes in ecosystems are dynamically altered by several metabolic responses in microorganisms, including intracellular sensing and pumping, battle for survival, and supply of or competition for nutrients. Notably, intestinal bacteria maintain homeostatic balance in mammals via multiple dynamic biochemical reactions to produce several metabolites from undigested food, and those metabolites exert various effects on mammalian cells in a time-dependent manner. We have established a method for the analysis of bacterial metabolic dynamics in real time and used it in combination with statistical NMR procedures. Methodology/Principal Findings: We developed a novel method called real-time metabolotyping (RT-MT), which performs sequential H-1-NMR profiling and two-dimensional (2D) H-1, C-13-HSQC (heteronuclear single quantum coherence) profiling during bacterial growth in an NMR tube. The profiles were evaluated with such statistical methods as Z-score analysis, principal components analysis, and time series of statistical TOtal Correlation SpectroScopY (TOCSY). In addition, using 2D H-1, C-13-HSQC with the stable isotope labeling technique, we observed the metabolic kinetics of specific biochemical reactions based on time-dependent 2D kinetic profiles. Using these methods, we clarified the pathway for linolenic acid hydrogenation by a gastrointestinal bacterium, Butyrivibrio fibrisolvens. We identified trans11, cis13 conjugated linoleic acid as the intermediate of linolenic acid hydrogenation by B. fibrisolvens, based on the results of C-13-labeling RT-MT experiments. In addition, we showed that the biohydrogenation of polyunsaturated fatty acids serves as a defense mechanism against their toxic effects. Conclusions: RT-MT is useful for the characterization of beneficial bacterium that shows potential for use as probiotic by producing bioactive compounds.	[Hino, Tsuneo] Meiji Univ, Dept Life Sci, Tama Ku, Kawasaki, Kanagawa, Japan; [Fukuda, Shinji; Ohno, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Fukuda, Shinji; Nakanishi, Yumiko; Ohno, Hiroshi; Kikuchi, Jun] Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa, Japan; [Nakanishi, Yumiko; Chikayama, Eisuke; Kikuchi, Jun] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan	Meiji University; RIKEN; Yokohama City University; RIKEN; Nagoya University	Hino, T (corresponding author), Meiji Univ, Dept Life Sci, Tama Ku, Kawasaki, Kanagawa, Japan.	hino@isc.meiji.ac.jp; kikuchi@psc.riken.jp	Kikuchi, Jun/O-4725-2019; Kikuchi, Jun/M-5512-2015	Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X; Fukuda, Shinji/0000-0001-5161-9880	RIKEN; CREST; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN; CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from RIKEN President's Special Research Grant (J.K.), CREST, the Japan Science and Technology Agency (J.K.), and the Ministry of Education, Culture, Sports, Science and Technology of Japan (J. K. and T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Asanuma N, 2005, CURR MICROBIOL, V51, P91, DOI 10.1007/s00284-005-4477-x; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barbosa TM, 2005, APPL ENVIRON MICROB, V71, P968, DOI 10.1128/AEM.71.2.968-978.2005; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Brecker L, 1999, MICROBIOL-SGM, V145, P3389, DOI 10.1099/00221287-145-12-3389; Chalova VI, 2008, J ENVIRON SCI HEAL B, V43, P193, DOI 10.1080/03601230701795262; Chikayama E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003805; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; DAWSON RMC, 1969, BIOCHEM J, V115, P351, DOI 10.1042/bj1150351; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Diez-Gonzalez F, 1999, ARCH MICROBIOL, V171, P324, DOI 10.1007/s002030050717; EAKIN RT, 1972, FEBS LETT, V28, P259, DOI 10.1016/0014-5793(72)80726-9; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fukuda S, 2007, J APPL MICROBIOL, V103, P365, DOI 10.1111/j.1365-2672.2006.03247.x; Fukuda S, 2006, J APPL MICROBIOL, V100, P787, DOI 10.1111/j.1365-2672.2006.02864.x; Fukuda S, 2006, J DAIRY SCI, V89, P1043, DOI 10.3168/jds.S0022-0302(06)72171-3; Fukuda S, 2005, J GEN APPL MICROBIOL, V51, P105, DOI 10.2323/jgam.51.105; Fukuda S, 2002, J VET MED SCI, V64, P987, DOI 10.1292/jvms.64.987; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GRIVET JP, 1989, REPROD NUTR DEV, V29, P83, DOI 10.1051/rnd:19890106; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Igarashi M, 2000, CANCER LETT, V148, P173, DOI 10.1016/S0304-3835(99)00332-8; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; KEPLER CR, 1970, J BIOL CHEM, V245, P3612; KEPLER CR, 1971, J BIOL CHEM, V246, P2765; KEPLER CR, 1967, J BIOL CHEM, V242, P5686; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Koba K, 2002, LIPIDS, V37, P343, DOI 10.1007/s11745-002-0901-7; Kraft J, 2003, LIPIDS, V38, P657, DOI 10.1007/s11745-003-1111-z; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ladero V, 2007, APPL ENVIRON MICROB, V73, P1864, DOI 10.1128/AEM.02304-06; Lecuit M, 2007, J BIOL CHEM, V282, P15065, DOI 10.1074/jbc.M610926200; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li W, 2006, ANALYST, V131, P777, DOI 10.1039/b605110c; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Maher AD, 2007, ANAL CHEM, V79, P5204, DOI 10.1021/ac070212f; Majors PD, 2008, J MAGN RESON, V192, P159, DOI 10.1016/j.jmr.2008.02.014; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; OGINO T, 1982, P NATL ACAD SCI-BIOL, V79, P5828, DOI 10.1073/pnas.79.19.5828; Ohkawara S, 2005, J NUTR, V135, P2878, DOI 10.1093/jn/135.12.2878; Pariza MW, 2004, AM J CLIN NUTR, V79, p1132S, DOI 10.1093/ajcn/79.6.1132S; Pizarro F, 2007, YEAST, V24, P977, DOI 10.1002/yea.1545; Portais JC, 1997, FEBS LETT, V412, P485, DOI 10.1016/S0014-5793(97)00832-6; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sekiyama Y, 2007, PHYTOCHEMISTRY, V68, P2320, DOI 10.1016/j.phytochem.2007.04.011; Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w; SHANE BS, 1969, J GEN MICROBIOL, V55, P445, DOI 10.1099/00221287-55-3-445; SHULMAN RG, 1979, SCIENCE, V205, P160, DOI 10.1126/science.36664; Suzuki R, 2001, LIPIDS, V36, P477, DOI 10.1007/s11745-001-0746-0; Tang AL, 2007, J FOOD SCI, V72, pM431, DOI 10.1111/j.1750-3841.2007.00520.x; Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; Teusink B, 2006, NAT REV MICROBIOL, V4, P46, DOI 10.1038/nrmicro1319; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Tiziani S, 2008, ANAL CHIM ACTA, V610, P80, DOI 10.1016/j.aca.2008.01.030; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Villas-Boas SG, 2007, OMICS, V11, P305, DOI 10.1089/omi.2007.0005; Vinderola G, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-19; Wahl A, 2004, BIOTECHNOL PROGR, V20, P706, DOI 10.1021/bp0342755; Walker WA, 2008, CLIN INFECT DIS, V46, pS87, DOI 10.1086/523335; Watzl B, 2005, BRIT J NUTR, V93, pS49, DOI 10.1079/BJN20041357; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336	88	51	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4893	10.1371/journal.pone.0004893	http://dx.doi.org/10.1371/journal.pone.0004893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287504	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400023
J	Stork, W; Diezel, C; Halitschke, R; Galis, I; Baldwin, IT				Stork, William; Diezel, Celia; Halitschke, Rayko; Galis, Ivan; Baldwin, Ian T.			An Ecological Analysis of the Herbivory-Elicited JA Burst and Its Metabolism: Plant Memory Processes and Predictions of the Moving Target Model	PLOS ONE			English	Article								Background: Rapid herbivore-induced jasmonic acid (JA) accumulation is known to mediate many induced defense responses in vascular plants, but little is known about how JA bursts are metabolized and modified in response to repeated elicitations, are propagated throughout elicited leaves, or how they directly influence herbivores. Methodology/Principal Findings: We found the JA burst in a native population of Nicotiana attenuata to be highly robust despite environmental variation and we examined the JA bursts produced by repeated elicitations with Manduca sexta oral secretions (OS) at whole- and within-leaf spatial scales. Surprisingly, a 2(nd) OS-elicitation suppressed an expected JA burst at both spatial scales, but subsequent elicitations caused more rapid JA accumulation in elicited tissue. The baseline of induced JA/JA-Ile increased with number of elicitations in discrete intervals. Large veins constrained the spatial spread of JA bursts, leading to heterogeneity within elicited leaves. 1(st)-instar M. sexta larvae were repelled by elicitations and changed feeding sites. JA conjugated with isoleucine (JA-Ile) translates elicitations into defense production (e. g., TPIs), but conjugation efficiency varied among sectors and depended on NaWRKY3/6 transcription factors. Elicited TPI activity correlated strongly with the heterogeneity of JA/JA-Ile accumulations after a single elicitation, but not repeated elicitations. Conclusions/Significance: Ecologically informed scaling of leaf elicitation reveals the contribution of repeated herbivory events to the formation of plant memory of herbivory and the causes and importance of heterogeneity in induced defense responses. Leaf vasculature, in addition to transmitting long-distance damage cues, creates heterogeneity in JA bursts within attacked leaves that may be difficult for an attacking herbivore to predict. Such unpredictability is a central tenet of the Moving Target Model of defense, which posits that variability in itself is defensive.	[Stork, William; Diezel, Celia; Halitschke, Rayko; Galis, Ivan; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Stork, W (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Beutenberg Campus, Jena, Germany.	baldwin@ice.mpg.de	Galis, Ivan/F-5734-2011; Halitschke, Rayko/AAY-2365-2020; Baldwin, Ian T/K-1809-2013	Halitschke, Rayko/0000-0002-1109-8782; Baldwin, Ian/0000-0001-5371-2974; Galis, Ivan/0000-0001-9840-8845	Max Planck Society; Deutscher Akademischer Austauschdienst	Max Planck Society(Max Planck Society); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	Funding provided by the Max Planck Society and the Deutscher Akademischer Austauschdienst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER FR, 1994, AM NAT, V144, P813, DOI 10.1086/285708; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; BALDWIN IT, 1994, J CHEM ECOL, V20, P2373, DOI 10.1007/BF02033208; Beckers GJ, 2007, CURR OPIN PLANT BIOL, V10, P425, DOI 10.1016/j.pbi.2007.06.002; Bernays EA, 2000, J INSECT PHYSIOL, V46, P825, DOI 10.1016/S0022-1910(99)00172-9; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Conconi A, 1996, NATURE, V383, P826, DOI 10.1038/383826a0; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; GALIS I, 2008, PLANT CELL IN PRESS; GFELLER A, 2006, SCI STKE, pCM1; Giri AP, 2006, PLANT PHYSIOL, V142, P1621, DOI 10.1104/pp.106.088781; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Guranowski A, 2007, FEBS LETT, V581, P815, DOI 10.1016/j.febslet.2007.01.049; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; JONGSMA MA, 1993, ANAL BIOCHEM, V212, P79, DOI 10.1006/abio.1993.1294; JONGSMA MA, 1994, PLANTA, V195, P29, DOI 10.1007/BF00206288; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, PLANT J, V38, P639, DOI 10.1111/j.1365-313X.2004.02076.x; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; OHNMEISS TE, 1994, ECOLOGY, V75, P995, DOI 10.2307/1939423; Orians CM, 2000, J CHEM ECOL, V26, P471, DOI 10.1023/A:1005469724427; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; PENACORTES H, 1995, P NATL ACAD SCI USA, V92, P4106, DOI 10.1073/pnas.92.10.4106; Preston CA, 1999, ECOLOGY, V80, P481, DOI 10.1890/0012-9658(1999)080[0481:PANSRG]2.0.CO;2; Rakwal R, 2000, ELECTROPHORESIS, V21, P2492, DOI 10.1002/1522-2683(20000701)21:12<2492::AID-ELPS2492>3.3.CO;2-U; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schittko U, 2000, PLANTA, V210, P343, DOI 10.1007/PL00008143; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; SEMBDNER G, 1993, ANNU REV PLANT PHYS, V44, P569, DOI 10.1146/annurev.pp.44.060193.003033; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shroff R, 2008, P NATL ACAD SCI USA, V105, P6196, DOI 10.1073/pnas.0711730105; SKIBBE M, 2008, PLANT CELL IN PRESS; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; van Bentem SD, 2007, TRENDS PLANT SCI, V12, P404, DOI 10.1016/j.tplants.2007.08.007; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Van Dam NM, 2001, ECOL ENTOMOL, V26, P578, DOI 10.1046/j.1365-2311.2001.00366.x; von Dahl CC, 2004, PHYSIOL PLANTARUM, V120, P474, DOI 10.1111/j.0031-9317.2004.00269.x; Wang L, 2007, PLANTA, V226, P159, DOI 10.1007/s00425-007-0477-3; Winz RA, 2001, PLANT PHYSIOL, V125, P2189, DOI 10.1104/pp.125.4.2189; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2006, PLANTA, V224, P750, DOI 10.1007/s00425-006-0256-6; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x	65	47	49	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4697	10.1371/journal.pone.0004697	http://dx.doi.org/10.1371/journal.pone.0004697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277115	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496100004
J	Debily, MA; El Marhomy, S; Boulanger, V; Eveno, E; Mariage-Samson, R; Camarca, A; Auffray, C; Piatier-Tonneau, D; Imbeaud, S				Debily, Marie-Anne; El Marhomy, Sandrine; Boulanger, Virginie; Eveno, Eric; Mariage-Samson, Regine; Camarca, Alessandra; Auffray, Charles; Piatier-Tonneau, Dominique; Imbeaud, Sandrine			A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer	PLOS ONE			English	Article							DISEASE FLUID PROTEIN-15; PROLACTIN-INDUCIBLE PROTEIN; HUMAN SEMINAL PLASMA; GENE-EXPRESSION; GROWTH-FACTOR; CD4-BINDING GLYCOPROTEIN; CELL-PROLIFERATION; SIGNAL TRANSDUCER; MICROARRAY DATA; IN-VITRO	Background: The PIP (prolactin-inducible protein) gene has been shown to be expressed in breast cancers, with contradictory results concerning its implication. As both the physiological role and the molecular pathways in which PIP is involved are poorly understood, we conducted combined gene expression profiling and network analysis studies on selected breast cancer cell lines presenting distinct PIP expression levels and hormonal receptor status, to explore the functional and regulatory network of PIP co-modulated genes. Principal Findings: Microarray analysis allowed identification of genes co-modulated with PIP independently of modulations resulting from hormonal treatment or cell line heterogeneity. Relevant clusters of genes that can discriminate between [PIP+] and [PIP-] cells were identified. Functional and regulatory network analyses based on a knowledge database revealed a master network of PIP co-modulated genes, including many interconnecting oncogenes and tumor suppressor genes, half of which were detected as differentially expressed through high-precision measurements. The network identified appears associated with an inhibition of proliferation coupled with an increase of apoptosis and an enhancement of cell adhesion in breast cancer cell lines, and contains many genes with a STAT5 regulatory motif in their promoters. Conclusions: Our global exploratory approach identified biological pathways modulated along with PIP expression, providing further support for its good prognostic value of disease-free survival in breast cancer. Moreover, our data pointed to the importance of a regulatory subnetwork associated with PIP expression in which STAT5 appears as a potential transcriptional regulator.	[Debily, Marie-Anne; El Marhomy, Sandrine; Boulanger, Virginie; Eveno, Eric; Mariage-Samson, Regine; Auffray, Charles; Piatier-Tonneau, Dominique; Imbeaud, Sandrine] CNRS, Array S IMAGE Genexpress Funct Genom & Syst Biol, LGN UMR 7091, Villejuif, France; [Debily, Marie-Anne] CEA, DSV, IRCM, LEFG, Lab Genomes Funct Explorat, Evry, France; [Debily, Marie-Anne] Univ Evry Val Essonne, Evry, France; [Camarca, Alessandra] CNR, Inst Food Sci, Avellino, Italy; [Imbeaud, Sandrine] CNRS, Ctr Genet Mol, UPR 2167, GODMAP, Gif Sur Yvette, France; [Imbeaud, Sandrine] Univ Paris 11, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Debily, MA (corresponding author), CNRS, Array S IMAGE Genexpress Funct Genom & Syst Biol, LGN UMR 7091, Villejuif, France.	marie-anne.debily@cea.fr	Debily, Marie-Anne/X-7697-2018; Imbeaud, Sandrine/P-8780-2017	Debily, Marie-Anne/0000-0002-8509-6165; Imbeaud, Sandrine/0000-0001-8439-6732; Eveno, Eric/0000-0002-7282-280X	Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer (ARC)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and by grants from Association pour la Recherche sur le Cancer (ARC) to D.P.T.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbaria R, 1997, ONCOL RES, V9, P111; AKASOFU M, 1993, ACTA PATHOL JAPON, V43, P736; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; AUTIERO M, 1991, EXP CELL RES, V197, P268, DOI 10.1016/0014-4827(91)90432-T; Autiero M, 1997, IMMUNOGENETICS, V46, P345; AUTIERO M, 1995, EUR J IMMUNOL, V25, P1461, DOI 10.1002/eji.1830250550; Autiero M, 2002, INT J CANCER, V99, P370, DOI 10.1002/ijc.10368; Autiero M, 1999, DNA CELL BIOL, V18, P481, DOI 10.1089/104454999315204; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Basmaciogullari S, 2000, BIOCHEMISTRY-US, V39, P5332, DOI 10.1021/bi992398l; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson M, 2006, CURR MOL MED, V6, P695, DOI 10.2174/156652406778195044; Bertucci F, 2002, HUM MOL GENET, V11, P863, DOI 10.1093/hmg/11.8.863; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brenner AJ, 1997, PROG CLIN BIOL RES, V396, P63; Brizzi MF, 2004, FASEB J, V18, P1249, DOI 10.1096/fj.03-1053fje; Campbell I, 2000, CANCER GENE THER, V7, P1270, DOI 10.1038/sj.cgt.7700226; Caputo E, 2000, J BIOL CHEM, V275, P7935, DOI 10.1074/jbc.275.11.7935; Carsol JL, 2002, MOL ENDOCRINOL, V16, P1696, DOI 10.1210/me.16.7.1696; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cho DI, 2003, LIFE SCI, V73, P2991, DOI 10.1016/S0024-3205(03)00707-0; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Ciullo M, 2002, HUM MOL GENET, V11, P2887, DOI 10.1093/hmg/11.23.2887; Clark JW, 1999, BRIT J CANCER, V81, P1002, DOI 10.1038/sj.bjc.6690799; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Cull VS, 2003, BLOOD, V101, P2727, DOI 10.1182/blood-2002-05-1521; Duan JM, 2004, INT J ONCOL, V24, P1597; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiel MI, 1996, ACTA CYTOL, V40, P637; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P1221, DOI 10.14670/HH-22.1221; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; Gaubin M, 1999, J IMMUNOL, V162, P2631; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; GUTZMAN JH, 2007, ONCOGENE; HAAGENSEN JDE, 1986, DIS BREAST, P474; Harbeck N, 1999, BRIT J CANCER, V80, P419, DOI 10.1038/sj.bjc.6690373; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Humphreys RC, 1999, CELL GROWTH DIFFER, V10, P685; Hwa V, 2004, J BIOL CHEM, V279, P2728, DOI 10.1074/jbc.M310495200; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; JIN XM, 1995, CANCER RES, V55, P3250; JOENSUU H, 1993, AM J PATHOL, V143, P867; Kim HJ, 2006, YONSEI MED J, V47, P333, DOI 10.3349/ymj.2006.47.3.333; Kim K, 1998, INT J CANCER, V79, P324, DOI 10.1002/(SICI)1097-0215(19980821)79:4<324::AID-IJC4>3.3.CO;2-N; Kloth MT, 2002, J BIOL CHEM, V277, P8693, DOI 10.1074/jbc.M111884200; Kudoh M, 2002, CANCER RES, V62, P1904; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Li Tianhong, 2003, Clin Breast Cancer, V3, P405, DOI 10.3816/CBC.2003.n.005; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loos S, 1999, INT J MOL MED, V4, P135; Lyzak JS, 1997, HUM PATHOL, V28, P772, DOI 10.1016/S0046-8177(97)90148-9; Maniatis T., 1982, MOL CLONING; MCPHERSON K, 1994, BRIT MED J, V309, P1003, DOI 10.1136/bmj.309.6960.1003; Meyer AN, 2004, J BIOL CHEM, V279, P28450, DOI 10.1074/jbc.M403335200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mogi S, 2005, ANTICANCER RES, V25, P751; MONTEAGUDO C, 1991, HUM PATHOL, V22, P368, DOI 10.1016/0046-8177(91)90084-3; Moritani S, 2008, HUM PATHOL, V39, P666, DOI 10.1016/j.humpath.2007.09.009; MURPHY LC, 1987, CANCER RES, V47, P4160; Mylona E, 2007, HISTOPATHOLOGY, V50, P338, DOI 10.1111/j.1365-2559.2007.02615.x; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Nagy N, 2002, GUT, V50, P392, DOI 10.1136/gut.50.3.392; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Niedergethmann M, 2000, INT J PANCREATOL, V28, P31, DOI 10.1385/IJGC:28:1:31; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Perry A, 1997, HUM PATHOL, V28, P938, DOI 10.1016/S0046-8177(97)90009-5; Qin WX, 2003, BIOCHEM BIOPH RES CO, V308, P379, DOI 10.1016/S0006-291X(03)01387-1; RHEE K, 1995, CANCER RES, V55, P4188; Rhodes DR, 2002, BIOINFORMATICS, V18, P205, DOI 10.1093/bioinformatics/18.1.205; RIEGEL AT, 1994, BREAST CANCER RES TR, V31, P309; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; SIMARD J, 1989, MOL ENDOCRINOL, V3, P694, DOI 10.1210/mend-3-4-694; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Tajeddine N, 2005, CANCER RES, V65, P7348, DOI 10.1158/0008-5472.CAN-04-4011; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDEWALLE B, 1987, J CANCER RES CLIN, V113, P550, DOI 10.1007/BF00390864; Wang CH, 2006, J CELL PHYSIOL, V208, P246, DOI 10.1002/jcp.20660; WELLS CA, 1995, J CLIN PATHOL, V48, P737, DOI 10.1136/jcp.48.8.737; WICK MR, 1989, HUM PATHOL, V20, P281, DOI 10.1016/0046-8177(89)90137-8; Yang XH, 2001, CANCER RES, V61, P5284; Yasuda M, 2001, INT IMMUNOL, V13, P1309, DOI 10.1093/intimm/13.10.1309; Zagorianakou P, 2006, VIRCHOWS ARCH, V448, P525, DOI 10.1007/s00428-005-0095-z	107	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4696	10.1371/journal.pone.0004696	http://dx.doi.org/10.1371/journal.pone.0004696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262752	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490600017
J	Tremblay, Y; Robinson, PW; Costa, DP				Tremblay, Yann; Robinson, Patrick W.; Costa, Daniel P.			A Parsimonious Approach to Modeling Animal Movement Data	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; STATE-SPACE MODEL; SATELLITE TELEMETRY; FORAGING ECOLOGY; TRACKING; GEOLOCATION; ALGORITHM; ACCURACY; HABITAT; SYSTEM	Animal tracking is a growing field in ecology and previous work has shown that simple speed filtering of tracking data is not sufficient and that improvement of tracking location estimates are possible. To date, this has required methods that are complicated and often time-consuming (state-space models), resulting in limited application of this technique and the potential for analysis errors due to poor understanding of the fundamental framework behind the approach. We describe and test an alternative and intuitive approach consisting of bootstrapping random walks biased by forward particles. The model uses recorded data accuracy estimates, and can assimilate other sources of data such as sea-surface temperature, bathymetry and/or physical boundaries. We tested our model using ARGOS and geolocation tracks of elephant seals that also carried GPS tags in addition to PTTs, enabling true validation. Among pinnipeds, elephant seals are extreme divers that spend little time at the surface, which considerably impact the quality of both ARGOS and light-based geolocation tracks. Despite such low overall quality tracks, our model provided location estimates within 4.0, 5.5 and 12.0 km of true location 50% of the time, and within 9, 10.5 and 20.0 km 90% of the time, for above, equal or below average elephant seal ARGOS track qualities, respectively. With geolocation data, 50% of errors were less than 104.8 km (<0.94 degrees), and 90% were less than 199.8 km (<1.80 degrees). Larger errors were due to lack of sea-surface temperature gradients. In addition we show that our model is flexible enough to solve the obstacle avoidance problem by assimilating high resolution coastline data. This reduced the number of invalid on-land location by almost an order of magnitude. The method is intuitive, flexible and efficient, promising extensive utilization in future research.	[Tremblay, Yann] CRH UMR 212, Inst Rech Dev, Sete, France; [Tremblay, Yann; Robinson, Patrick W.; Costa, Daniel P.] Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95064 USA	Institut de Recherche pour le Developpement (IRD); University of California System; University of California Santa Cruz	Tremblay, Y (corresponding author), CRH UMR 212, Inst Rech Dev, Sete, France.	yann.tremblay@ird.fr	Costa, Daniel/E-2616-2013	Costa, Daniel/0000-0002-0233-5782; Tremblay, Yann/0000-0002-4653-9269	Packard, Moore and Sloan foundations; Office of Naval Research and the Office of Polar Programs, NSF	Packard, Moore and Sloan foundations; Office of Naval Research and the Office of Polar Programs, NSF	This effort was funded by the Packard, Moore and Sloan foundations and from the Office of Naval Research and the Office of Polar Programs, NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSONSPRECHER R, 1994, BIOMETRICS, V50, P406, DOI 10.2307/2533384; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Beck CA, 2002, MAR MAMMAL SCI, V18, P940, DOI 10.1111/j.1748-7692.2002.tb01083.x; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Georges JY, 1997, IBIS, V139, P403, DOI 10.1111/j.1474-919X.1997.tb04644.x; Hill Roger D., 1994, P227; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen Ian D., 2003, Ecological Society of America Annual Meeting Abstracts, V88, P173; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nicholls D. G., 2007, Notornis, V54, P137; Nicholls D. G., 2007, Notornis, V54, P121; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Powell BS, 2008, OCEAN MODEL, V23, P130, DOI 10.1016/j.ocemod.2008.04.008; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Royer F, 2005, OIKOS, V109, P473, DOI 10.1111/j.0030-1299.2005.13777.x; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Turchin Peter, 1998; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104	38	53	55	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4711	10.1371/journal.pone.0004711	http://dx.doi.org/10.1371/journal.pone.0004711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262755	Green Submitted, gold, Green Published			2022-12-27	WOS:000265490600021
J	Busan, P; Barbera, C; Semenic, M; Monti, F; Pizzolato, G; Pelamatti, G; Battaglini, PP				Busan, Pierpaolo; Barbera, Claudia; Semenic, Mauro; Monti, Fabrizio; Pizzolato, Gilberto; Pelamatti, Giovanna; Battaglini, Piero Paolo			Effect of Transcranial Magnetic Stimulation (TMS) on Parietal and Premotor Cortex during Planning of Reaching Movements	PLOS ONE			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; MACAQUE MONKEY; AREA V6A; CORTICAL MECHANISMS; DORSAL PREMOTOR; EYE; SYSTEM; BRAIN; SELECTION; PATHWAYS	Background: Cerebral activation during planning of reaching movements occurs both in the superior parietal lobule (SPL) and premotor cortex (PM), and their activation seems to take place in parallel. Methodology: The activation of the SPL and PM has been investigated using transcranial magnetic stimulation (TMS) during planning of reaching movements under visual guidance. Principal Findings: A facilitory effect was found when TMS was delivered on the parietal cortex at about half of the time from sight of the target to hand movement, independently of target location in space. Furthermore, at the same stimulation time, a similar facilitory effect was found in PM, which is probably related to movement preparation. Conclusions: This data contributes to the understanding of cortical dynamics in the parieto-frontal network, and suggests that it is possible to interfere with the planning of reaching movements at different cortical points within a particular time window. Since similar effects may be produced at similar times on both the SPL and PM, parallel processing of visuomotor information is likely to take place in these regions.	[Busan, Pierpaolo; Battaglini, Piero Paolo] Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy; [Barbera, Claudia; Pelamatti, Giovanna] Univ Trieste, Dept Psychol, I-34127 Trieste, Italy; [Semenic, Mauro; Monti, Fabrizio; Pizzolato, Gilberto] Univ Trieste, Dept Clin & Expt Med & Clin & Expt Neurosci, I-34127 Trieste, Italy	University of Trieste; University of Trieste; University of Trieste	Busan, P (corresponding author), Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy.	busan@dfp.units.it		Battaglini, Piero Paolo/0000-0003-4697-8648	Ministero dell'Universita, Italy	Ministero dell'Universita, Italy	This work was supported by grants from the Ministero dell'Universita, Italy.	Anand S, 2002, BRAIN COGNITION, V50, P366, DOI 10.1016/S0278-2626(02)00512-2; Battaglia-Mayer A, 2007, CEREB CORTEX, V17, P1350, DOI 10.1093/cercor/bhl046; Buneo CA, 2008, EXP BRAIN RES, V188, P77, DOI 10.1007/s00221-008-1340-x; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Favilla M, 1996, NEUROPSYCHOLOGIA, V34, P609, DOI 10.1016/0028-3932(95)00135-2; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Himmelbach M, 2006, NEUROPSYCHOLOGIA, V44, P2749, DOI 10.1016/j.neuropsychologia.2006.04.030; Johnson SH, 2003, PROG BRAIN RES, V142, P127; Kalaska JF, 1998, NOVART FDN SYMP, V218, P176; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Mars RB, 2007, CEREB CORTEX, V17, P2972, DOI 10.1093/cercor/bhm022; Matelli M, 2001, NEUROIMAGE, V14, pS27, DOI 10.1006/nimg.2001.0835; Mayer AB, 1998, EXP BRAIN RES, V123, P172, DOI 10.1007/s002210050559; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Mottaghy FM, 2006, BEHAV NEUROL, V17, P177, DOI 10.1155/2006/768413; Naranjo JR, 2007, NEUROIMAGE, V34, P1673, DOI 10.1016/j.neuroimage.2006.07.049; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Ryan S, 2006, EXP BRAIN RES, V173, P389, DOI 10.1007/s00221-006-0379-9; Sawaki L, 1999, EXP BRAIN RES, V127, P402, DOI 10.1007/s002210050808; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Silvanto J, 2008, NEUROIMAGE, V39, P549, DOI 10.1016/j.neuroimage.2007.09.008; Silvanto J, 2008, J NEUROPHYSIOL, V99, P2725, DOI 10.1152/jn.01392.2007; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Tanne J, 1995, NEUROREPORT, V7, P267, DOI 10.1097/00001756-199512000-00064; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; Walsh V, 2003, BRADFORD BOOKS, P1	46	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4621	10.1371/journal.pone.0004621	http://dx.doi.org/10.1371/journal.pone.0004621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247490	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800004
J	Cockerham, RE; Puche, AC; Munger, SD				Cockerham, Renee E.; Puche, Adam C.; Munger, Steven D.			Heterogeneous Sensory Innervation and Extensive Intrabulbar Connections of Olfactory Necklace Glomeruli	PLOS ONE			English	Article								The mammalian nose employs several olfactory subsystems to recognize and transduce diverse chemosensory stimuli. These subsystems differ in their anatomical position within the nasal cavity, their targets in the olfactory forebrain, and the transduction mechanisms they employ. Here we report that they can also differ in the strategies they use for stimulus coding. Necklace glomeruli are the sole main olfactory bulb (MOB) targets of an olfactory sensory neuron (OSN) subpopulation distinguished by its expression of the receptor guanylyl cyclase GC-D and the phosphodiesterase PDE2, and by its chemosensitivity to the natriuretic peptides uroguanylin and guanylin and the gas CO2. In stark contrast to the homogeneous sensory innervation of canonical MOB glomeruli from OSNs expressing the same odorant receptor (OR), we find that each necklace glomerulus of the mouse receives heterogeneous innervation from at least two distinct sensory neuron populations: one expressing GC-D and PDE2, the other expressing olfactory marker protein. In the main olfactory system it is thought that odor identity is encoded by a combinatorial strategy and represented in the MOB by a pattern of glomerular activation. This combinatorial coding scheme requires functionally homogeneous sensory inputs to individual glomeruli by OSNs expressing the same OR and displaying uniform stimulus selectivity; thus, activity in each glomerulus reflects the stimulation of a single OSN type. The heterogeneous sensory innervation of individual necklace glomeruli by multiple, functionally distinct, OSN subtypes precludes a similar combinatorial coding strategy in this olfactory subsystem.	[Cockerham, Renee E.; Puche, Adam C.; Munger, Steven D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Cockerham, RE (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	smung001@umaryland.edu			NIH/NIDCD [DC005633]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005633] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by a grant from the NIH/NIDCD (DC005633 to SDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Baker H, 1999, J NEUROSCI, V19, P9313; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; CHERRY JA, 1995, J NEUROBIOL, V28, P102, DOI 10.1002/neu.480280109; Duda T, 2008, BIOCHEM BIOPH RES CO, V367, P440, DOI 10.1016/j.bbrc.2007.12.153; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fleischer J, 2006, HISTOCHEM CELL BIOL, V125, P337, DOI 10.1007/s00418-005-0077-x; FLEISCHER J, 2008, HISTOCHEM CELL BIOL; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Koos DS, 2005, NEUROREPORT, V16, P1929, DOI 10.1097/01.wnr.0000186597.72081.10; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Ma MH, 2007, CRIT REV BIOCHEM MOL, V42, P463, DOI 10.1080/10409230701693359; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mamasuew K, 2008, EUR J NEUROSCI, V28, P1775, DOI 10.1111/j.1460-9568.2008.06465.x; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Munger SD, 2008, ANN REV PHYSL; MUNGER SD, 2008, ANN REV PHY IN PRESS, V71; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Ring G, 1997, J COMP NEUROL, V388, P415; Roppolo D, 2006, EUR J NEUROSCI, V23, P2887, DOI 10.1111/j.1460-9568.2006.04818.x; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; SHINODA K, 1993, BRAIN RES, V618, P160, DOI 10.1016/0006-8993(93)90440-X; SHINODA K, 1989, J COMP NEUROL, V284, P362, DOI 10.1002/cne.902840304; Shipley MY, 2004, RAT NERVOUS SYSTEM; Storan MJ, 2006, J COMP NEUROL, V494, P834, DOI 10.1002/cne.20858; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Walz A, 2007, DEVELOPMENT, V134, P4063, DOI 10.1242/dev.008722; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4657	10.1371/journal.pone.0004657	http://dx.doi.org/10.1371/journal.pone.0004657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247478	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800036
J	Dong, HY; Yauk, CL; Rowan-Carroll, A; You, SH; Zoeller, RT; Lambert, L; Wade, MG				Dong, Hongyan; Yauk, Carole L.; Rowan-Carroll, Andrea; You, Seo-Hee; Zoeller, R. Thomas; Lambert, Lain; Wade, Michael G.			Identification of Thyroid Hormone Receptor Binding Sites and Target Genes Using ChIP-on-Chip in Developing Mouse Cerebellum	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; BASIC-PROTEIN GENE; RAT-BRAIN; CONGENITAL HYPOTHYROIDISM; RESPONSE ELEMENT; NEONATAL-HYPOTHYROIDISM; DIFFERENTIAL REGULATION; UNITED-STATES; WHITE-MATTER; 1ST INTRON	Thyroid hormone (TH) is critical to normal brain development, but the mechanisms operating in this process are poorly understood. We used chromatin immunoprecipitation to enrich regions of DNA bound to thyroid receptor beta (TR beta) of mouse cerebellum sampled on post natal day 15. Enriched target was hybridized to promoter microarrays (ChIP-on-chip) spanning -8 kb to +2 kb of the transcription start site (TSS) of 5000 genes. We identified 91 genes with TR binding sites. Roughly half of the sites were located in introns, while 30% were located within 1 kb upstream (5') of the TSS. Of these genes, 83 with known function included genes involved in apoptosis, neurodevelopment, metabolism and signal transduction. Two genes, MBP and CD44, are known to contain TREs, providing validation of the system. This is the first report of TR binding for 81 of these genes. ChIP-on-chip results were confirmed for 10 of the 13 binding fragments using ChIP-PCR. The expression of 4 novel TH target genes was found to be correlated with TH levels in hyper/hypothyroid animals providing further support for TR binding. A TR beta binding site upstream of the coding region of myelin associated glycoprotein was demonstrated to be TH-responsive using a luciferase expression system. Motif searches did not identify any classic binding elements, indicating that not all TR binding sites conform to variations of the classic form. These findings provide mechanistic insight into impaired neurodevelopment resulting from TH deficiency and a rich bioinformatics resource for developing a better understanding of TR binding.	[Dong, Hongyan; Wade, Michael G.] Hlth Canada, EHSRB, Hazard Identificat Div, Ottawa, ON K1A 0L2, Canada; [Yauk, Carole L.; Rowan-Carroll, Andrea] Hlth Canada, EHSRB, Mechanist Study Div, Ottawa, ON K1A 0L2, Canada; [You, Seo-Hee; Zoeller, R. Thomas] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA; [Lambert, Lain] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Health Canada; Health Canada; University of Massachusetts System; University of Massachusetts Amherst; Carleton University	Dong, HY (corresponding author), Hlth Canada, EHSRB, Hazard Identificat Div, Ottawa, ON K1A 0L2, Canada.	hongyan_dong@hc-sc.gc.ca		Wade, Michael/0000-0002-7331-3839; Yauk, Carole/0000-0002-6725-3454; Yauk, Carole/0000-0003-4919-876X	Health Canada Genomics RD	Health Canada Genomics RD	This work was founded by the Health Canada Genomics R&D fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011; ALM J, 1984, BRIT MED J, V289, P1171, DOI 10.1136/bmj.289.6453.1171; Anderson GW, 2008, CEREBELLUM, V7, P60, DOI 10.1007/s12311-008-0021-4; Auso E, 2004, ENDOCRINOLOGY, V145, P4037, DOI 10.1210/en.2004-0274; Bansal R, 2005, DEV BRAIN RES, V156, P13, DOI 10.1016/j.devbrainres.2005.01.007; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; BOEHM T, 1991, ONCOGENE, V6, P695; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x; Delange F, 1997, HORM RES, V48, P51, DOI 10.1159/000185485; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Dong HY, 2005, BIOCHEM BIOPH RES CO, V330, P1182, DOI 10.1016/j.bbrc.2005.03.099; Dowling ALS, 2000, J NEUROSCI, V20, P2255; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; GRIMA B, 1992, J NEUROCHEM, V59, P2318; Haas MJ, 2004, NEUROSCI LETT, V365, P14, DOI 10.1016/j.neulet.2004.04.028; Harris KB, 2007, MOL GENET METAB, V91, P268, DOI 10.1016/j.ymgme.2007.03.012; Helledie T, 2002, J BIOL CHEM, V277, P26821, DOI 10.1074/jbc.M111295200; Hinks GL, 1997, J NEUROSCI, V17, P5549; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Ibarrola N, 1997, BRAIN RES, V752, P285, DOI 10.1016/S0006-8993(96)01480-1; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; JACOBSEN BB, 1981, ARCH DIS CHILD, V56, P134, DOI 10.1136/adc.56.2.134; Kakizawa S, 2000, J NEUROSCI, V20, P4954; KLEIN RZ, 1996, THYROID FUNDAMENTAL, P984; Klein RZ., 1980, NEONATAL THYROID SCR, P51; KOENIG JI, 1989, TOXICOL PATHOL, V17, P256, DOI 10.1177/019262338901700204; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; MUNOZ A, 1991, MOL ENDOCRINOL, V5, P273, DOI 10.1210/mend-5-2-273; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; NICHOLSON JL, 1972, SCIENCE, V176, P530, DOI 10.1126/science.176.4034.530; Paez PM, 2007, J NEUROSCI, V27, P12690, DOI 10.1523/JNEUROSCI.2381-07.2007; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; RAMI A, 1990, DEV NEUROSCI-BASEL, V12, P398, DOI 10.1159/000111867; RODRIGUEZPENA A, 1993, J CLIN INVEST, V91, P812, DOI 10.1172/JCI116301; Ruike Y, 2007, J HUM GENET, V52, P172, DOI 10.1007/s10038-006-0099-9; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Segall MA, 1996, ALCOHOL, V13, P559, DOI 10.1016/S0741-8329(96)00068-7; Sharlin DS, 2008, ENDOCRINOLOGY, V149, P2527, DOI 10.1210/en.2007-1431; Sharlin DS, 2006, ENDOCRINOLOGY, V147, P846, DOI 10.1210/en.2005-0778; Steketee K, 2004, J MOL ENDOCRINOL, V33, P477, DOI 10.1677/jme.1.01478; Thompson CC, 1996, J NEUROSCI, V16, P7832; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Xiao Qianxun, 1998, Frontiers in Bioscience, V3, pA52; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; YEN PM, 2005, THYROID FUNDAMENTAL, P135; Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107; Zoeller RT, 2004, J NEUROENDOCRINOL, V16, P809, DOI 10.1111/j.1365-2826.2004.01243.x	63	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4610	10.1371/journal.pone.0004610	http://dx.doi.org/10.1371/journal.pone.0004610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240802	Green Published, gold			2022-12-27	WOS:000278086700020
J	Koschwanez, JH; Carlson, RH; Meldrum, DR				Koschwanez, John H.; Carlson, Robert H.; Meldrum, Deirdre R.			Thin PDMS Films Using Long Spin Times or Tert-Butyl Alcohol as a Solvent	PLOS ONE			English	Article								Thin polydimethylsiloxane (PDMS) films are frequently used in "lab on a chip'' devices as flexible membranes. The common solvent used to dilute the PDMS for thin films is hexane, but hexane can swell the underlying PDMS substrate. A better solvent would be one that dissolves uncured PDMS but doesn't swell the underlying substrate. Here, we present protocols and spin curves for two alternatives to hexane dilution: longer spin times and dilution in tert-butyl alcohol. The thickness of the PDMS membranes under different spin speeds, spin times, and PDMS concentrations was measured using an optical profilometer. The use of tert-butyl alcohol to spin thin PDMS films does not swell the underlying PDMS substrate, and we have used these films to construct multilayer PDMS devices.	[Koschwanez, John H.; Carlson, Robert H.; Meldrum, Deirdre R.] Univ Washington, Dept Electrical Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Koschwanez, JH (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jkoschwanez@cgr.harvard.edu	MLSC, Colletion/B-3912-2013		NIH NHGRI;  [1 R01 HG01497]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001497] Funding Source: NIH RePORTER	NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	NIH NHGRI Grant No. 1 R01 HG01497. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSON R, 2007, LOW POWER LOW COST T; EMSLIE AG, 1958, J APPL PHYS, V29, P858, DOI 10.1063/1.1723300; Harmon ME, 2003, POLYMER, V44, P4547, DOI 10.1016/S0032-3861(03)00463-4; Hosokawa K, 2000, J MICROMECH MICROENG, V10, P415, DOI 10.1088/0960-1317/10/3/317; Koschwanez JH, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2722400; LAWRENCE CJ, 1988, PHYS FLUIDS, V31, P2786, DOI 10.1063/1.866986; Norrman K, 2005, ANN RP CH C, V101, P174, DOI 10.1039/b408857n; Paunovic M., 2006, ECS SERIES TEXTS MON; REDON C, 1994, MACROMOLECULES, V27, P468, DOI 10.1021/ma00080a021; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Werber A, 2005, APPL OPTICS, V44, P3238, DOI 10.1364/AO.44.003238; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153	12	104	105	14	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4572	10.1371/journal.pone.0004572	http://dx.doi.org/10.1371/journal.pone.0004572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238212	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487400006
J	Bonkowski, MS; Dominici, FP; Arum, O; Rocha, JS; Al Regaiey, KA; Westbrook, R; Spong, A; Panici, J; Masternak, MM; Kopchick, JJ; Bartke, A				Bonkowski, Michael S.; Dominici, Fernando P.; Arum, Oge; Rocha, Juliana S.; Al Regaiey, Khalid A.; Westbrook, Reyhan; Spong, Adam; Panici, Jacob; Masternak, Michal M.; Kopchick, John J.; Bartke, Andrzej			Disruption of Growth Hormone Receptor Prevents Calorie Restriction from Improving Insulin Action and Longevity	PLOS ONE			English	Article							LIFE-SPAN; TARGETED DISRUPTION; DIETARY RESTRICTION; GENE; MICE; EXPRESSION; RESISTANCE; MOUSE; YEAST	Most mutations that delay aging and prolong lifespan in the mouse are related to somatotropic and/or insulin signaling. Calorie restriction (CR) is the only intervention that reliably increases mouse longevity. There is considerable phenotypic overlap between long-lived mutant mice and normal mice on chronic CR. Therefore, we investigated the interactive effects of CR and targeted disruption or knock out of the growth hormone receptor (GHRKO) in mice on longevity and the insulin signaling cascade. Every other day feeding corresponds to a mild (i.e. 15%) CR which increased median lifespan in normal mice but not in GHRKO mice corroborating our previous findings on the effects of moderate (30%) CR on the longevity of these animals. To determine why insulin sensitivity improves in normal but not GHRKO mice in response to 30% CR, we conducted insulin stimulation experiments after one year of CR. In normal mice, CR increased the insulin stimulated activation of the insulin signaling cascade (IR/IRS/PI3K/AKT) in liver and muscle. Livers of GHRKO mice responded to insulin by increased activation of the early steps of insulin signaling, which was dissipated by altered PI3K subunit abundance which putatively inhibited AKT activation. In the muscle of GHRKO mice, there was elevated downstream activation of the insulin signaling cascade (IRS/PI3K/AKT) in the absence of elevated IR activation. Further, we found a major reduction of inhibitory Ser phosphorylation of IRS-1 seen exclusively in GHRKO muscle which may underpin their elevated insulin sensitivity. Chronic CR failed to further modify the alterations in insulin signaling in GHRKO mice as compared to normal mice, likely explaining or contributing to the absence of CR effects on insulin sensitivity and longevity in these long-lived mice.	[Bonkowski, Michael S.; Arum, Oge; Rocha, Juliana S.; Al Regaiey, Khalid A.; Westbrook, Reyhan; Spong, Adam; Panici, Jacob; Masternak, Michal M.; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Internal Med Geriatr Res, Springfield, IL USA; [Bonkowski, Michael S.; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Pharmacol & Physiol, Springfield, IL USA; [Dominici, Fernando P.] Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, RA-1053 Buenos Aires, DF, Argentina; [Rocha, Juliana S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Al Regaiey, Khalid A.] King Saud Univ, Coll Med, Dept Physiol, Riyadh, Saudi Arabia; [Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Dept Biomed Sci, Athens, OH 45701 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Buenos Aires; Universidade Federal de Minas Gerais; King Saud University; University System of Ohio; Ohio University	Bonkowski, MS (corresponding author), So Illinois Univ, Sch Med, Dept Internal Med Geriatr Res, Springfield, IL USA.	abartke@siumed.edu	Bartke, Andzej/D-6640-2017; Al-Regaiey, Khalid/AAG-4217-2019	Bartke, Andzej/0000-0002-2569-557X; Al-Regaiey, Khalid/0000-0001-9770-5637; Bonkowski, Michael/0000-0003-3416-4612; Dominici, Fernando Pablo/0000-0002-4351-0057	NIA [AG 19899, u19 AG023122]; Ellison Medical Foundation; SIU Geriatrics Medicine Initiative; Ohio's Eminent Scholars Program;  [AG19899-05]; NATIONAL INSTITUTE ON AGING [U19AG023122, R01AG019899] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); SIU Geriatrics Medicine Initiative; Ohio's Eminent Scholars Program; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by NIA, AG 19899 and u19 AG023122, by the Ellison Medical Foundation, and by the SIU Geriatrics Medicine Initiative. JJK is supported in part by the state of Ohio's Eminent Scholars Program that includes a gift from Milton and Lawrence Goll and by AG19899-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adochio R, 2009, ENDOCRINOLOGY, V150, P1165, DOI 10.1210/en.2008-0437; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Al-Regaiey KA, 2007, J GERONTOL A-BIOL, V62, P18, DOI 10.1093/gerona/62.1.18; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bartke A, 2008, HORM-INT J ENDOCRINO, V7, P17, DOI 10.14310/horm.2002.1111033; Bartke Andrzej, 2007, V35, P69; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; Dominici FP, 2000, J ENDOCRINOL, V166, P579, DOI 10.1677/joe.0.1660579; Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Ishizuka T, 2004, ENDOCR RES, V30, P287, DOI 10.1081/ERC-120039580; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KAHN CR, 2002, MOL CELL BIOL, V22, P965; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Robertson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE491, DOI 10.1152/ajpendo.00378.2005; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; STROBL JS, 1994, PHARMACOL REV, V46, P1; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Vance ML, 1999, NEW ENGL J MED, V341, P1206, DOI 10.1056/NEJM199910143411607; WEINDRUCH R, 2007, METABOLIC SHIFTS IND, V21; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	34	102	103	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4567	10.1371/journal.pone.0004567	http://dx.doi.org/10.1371/journal.pone.0004567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234595	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487200018
J	Carbone, L; Mootnick, AR; Nadler, T; Moisson, P; Ryder, O; Roos, C; de Jong, PJ				Carbone, Lucia; Mootnick, Alan R.; Nadler, Tilo; Moisson, Pierre; Ryder, Oliver; Roos, Christian; de Jong, Pieter J.			A Chromosomal Inversion Unique to the Northern White-Cheeked Gibbon	PLOS ONE			English	Article							EVOLUTION; NOMASCUS; PHYLOGENY; TAXONOMY; CONCOLOR; GENOME; GENE	The gibbon family belongs to the superfamily Hominoidea and includes 15 species divided into four genera. Each genus possesses a distinct karyotype with chromosome numbers varying from 38 to 52. This diversity is the result of numerous chromosomal changes that have accumulated during the evolution of the gibbon lineage, a quite unique feature in comparison with other hominoids and most of the other primates. Some gibbon species and subspecies rank among the most endangered primates in the world. Breeding programs can be extremely challenging and hybridization plays an important role within the factors responsible for the decline of captive gibbons. With less than 500 individuals left in the wild, the northern white-cheeked gibbon (Nomascus leucogenys leucogenys, NLE) is the most endangered primate in a successful captive breeding program. We present here the analysis of an inversion that we show being specific for the northern white-cheeked gibbon and can be used as one of the criteria to distinguish this subspecies from other gibbon taxa. The availability of the sequence spanning for one of the breakpoints of the inversion allows detecting it by a simple PCR test also on low quality DNA. Our results demonstrate the important role of genomics in providing tools for conservation efforts.	[Carbone, Lucia; de Jong, Pieter J.] Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; [Mootnick, Alan R.] Gibbon Conservat Ctr GCC, Santa Clara, CA USA; [Nadler, Tilo] Endangered Primate Rescue Ctr, Cuc Phuong Natl Pk, Nho Quan, Ninh Binh, Vietnam; [Moisson, Pierre] Parc Zool Botan, Mulhouse, France; [Ryder, Oliver] Zool Soc San Diego, San Diego, CA USA; [Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Zoological Society of San Diego; Deutsches Primatenzentrum (DPZ)	Carbone, L (corresponding author), Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA.	lcarbone@chori.org						Carbone L, 2006, PLOS GENET, V2, P2162, DOI 10.1371/journal.pgen.0020223; COUTURIER J, 1991, FOLIA PRIMATOL, V56, P95, DOI 10.1159/000156533; DUTRILLAUX B, 1975, CYTOGENET CELL GENET, V15, P81, DOI 10.1159/000130504; ELLIOT DG, 1913, REVIEW PRIMATES, V3, P262; Geissmann T, 2002, EVOL ANTHROPOL, V11, P28, DOI 10.1002/evan.10047; Groves C.P., 2001, PRIMATE TAXONOMY; Hall LM, 1998, MOL PHYLOGENET EVOL, V10, P281, DOI 10.1006/mpev.1998.0539; Hirai H, 2007, HUM GENET, V122, P477, DOI 10.1007/s00439-007-0425-0; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Konrad R, 2006, INT J PRIMATOL, V27, P713, DOI 10.1007/s10764-006-9042-3; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MARGULIS S, 2008, N AM REGIONAL STUDBO; Misceo D, 2008, GENOME RES, V18, P1530, DOI 10.1101/gr.078295.108; MOISSON P, 2007, EUROPEAN STUDBOOK CR; Monda K, 2007, AM J PRIMATOL, V69, P1285, DOI 10.1002/ajp.20439; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; Mootnick Alan R., 2006, Primate Conservation, V21, P103, DOI 10.1896/0898-6207.21.1.103; MOOTNICK AR, 2007, PRIMATE CONSERVATION, V22, P16; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; Nakayama K, 2006, GENOME RES, V16, P485, DOI 10.1101/gr.4763906; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; PROUTY LA, 1983, CYTOGENET CELL GENET, V35, P141, DOI 10.1159/000131856; Roberto R, 2007, GENOME RES, V17, P249, DOI 10.1101/gr.6052507; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; STANYON R, 1983, J HUM EVOL, V12, P305, DOI 10.1016/S0047-2484(83)80152-3; VANTUINEN P, 1989, CYTOGENET CELL GENET, V51, P1094	29	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4999	10.1371/journal.pone.0004999	http://dx.doi.org/10.1371/journal.pone.0004999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319194	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499200018
J	Clarke, RA; Zhao, ZM; Guo, AY; Roper, K; Teng, L; Fang, ZM; Samaratunga, H; Lavin, MF; Gardiner, RA				Clarke, Raymond A.; Zhao, Zhongming; Guo, An-Yuan; Roper, Kathrein; Teng, Linda; Fang, Zhi-Ming; Samaratunga, Hema; Lavin, Martin F.; Gardiner, Robert A.			New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression	PLOS ONE			English	Article							NONCODING RNAS; EXPRESSION; PREDISPOSITION; MUTATIONS; PROTEINS; FAMILIES; LINKAGE; BNIP2; SRY	Background: The prostate cancer antigen 3 (PCA3/DD3) gene is a highly specific biomarker upregulated in prostate cancer (PCa). In order to understand the importance of PCA3 in PCa we investigated the organization and evolution of the PCA3 gene locus. Methods/Principal Findings: We have employed cDNA synthesis, RTPCR and DNA sequencing to identify 4 new transcription start sites, 4 polyadenylation sites and 2 new differentially spliced exons in an extended form of PCA3. Primers designed from these novel PCA3 exons greatly improve RT-PCR based discrimination between PCa, PCa metastases and BPH specimens. Comparative genomic analyses demonstrated that PCA3 has only recently evolved in an anti-sense orientation within a second gene, BMCC1/PRUNE2. BMCC1 has been shown previously to interact with RhoA and RhoC, determinants of cellular transformation and metastasis, respectively. Using RT-PCR we demonstrated that the longer BMCC1-1 isoform - like PCA3 - is upregulated in PCa tissues and metastases and in PCa cell lines. Furthermore PCA3 and BMCC1-1 levels are responsive to dihydrotestosterone treatment. Conclusions/Significance: Upregulation of two new PCA3 isoforms in PCa tissues improves discrimination between PCa and BPH. The functional relevance of this specificity is now of particular interest given PCA3's overlapping association with a second gene BMCC1, a regulator of Rho signalling. Upregulation of PCA3 and BMCC1 in PCa has potential for improved diagnosis.	[Clarke, Raymond A.; Fang, Zhi-Ming] Univ New S Wales, St George Hosp Clin Sch Med, Canc Care Ctr, Prostate Canc Inst, Kogarah, NSW, Australia; [Clarke, Raymond A.; Teng, Linda; Lavin, Martin F.] Queensland Inst Med Res, Div Canc & Cell Biol, Brisbane, Qld, Australia; [Zhao, Zhongming; Guo, An-Yuan] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Zhao, Zhongming; Guo, An-Yuan] Virginia Commonwealth Univ, Ctr Study Biol Complexity, Richmond, VA USA; [Roper, Kathrein] Stanford Univ, Hopkins Marine Stn, Stanford, CA 94305 USA; [Samaratunga, Hema] Sullivan & Nicolaides Pathol, Brisbane, Qld, Australia; [Lavin, Martin F.; Gardiner, Robert A.] Univ Queensland, Ctr Clin Res, St Lucia, Qld 4067, Australia	St George Hospital; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; Virginia Commonwealth University; Virginia Commonwealth University; Stanford University; University of Queensland	Clarke, RA (corresponding author), Univ New S Wales, St George Hosp Clin Sch Med, Canc Care Ctr, Prostate Canc Inst, Kogarah, NSW, Australia.	martin.lavin@qimr.edu.au; f.gardiner@uq.edu.au	Lavin, Martin F/F-5961-2014; Samaratunga, Hemamali M L/D-1559-2013; Gardiner, Robert/G-2096-2010; Guo, An-Yuan/K-3656-2012	Lavin, Martin F/0000-0002-5940-4769; Samaratunga, Hemamali M L/0000-0001-5796-1791; Clarke, Raymond/0000-0002-7196-9623	Australian National Health and Medical Research Council; Cancer Council of Queensland; NIH [LM009598]; National Library of Medicine; Thomas F. and Kate Miller Jeffress Memorial Trust Fund; American Cancer Society [IRG-73-001-31]; NATIONAL LIBRARY OF MEDICINE [R03LM009598] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Thomas F. and Kate Miller Jeffress Memorial Trust Fund; American Cancer Society(American Cancer Society); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding is provided by Australian National Health and Medical Research Council and the Cancer Council of Queensland. Zhongming Zhao is supported by a NIH grant (LM009598) from the National Library of Medicine, the Thomas F. and Kate Miller Jeffress Memorial Trust Fund, and Institutional Research Grant IRG-73-001-31 from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarotto E, 2008, INT J CANCER, V122, P969, DOI 10.1002/ijc.23343; Bratt O, 2007, BJU INT, V99, P743, DOI 10.1111/j.1464-410X.2006.06666.x; Brossner C, 2000, BJU INT, V85, P705, DOI 10.1046/j.1464-410x.2000.00558.x; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Chu JX, 2002, BBA-MOL BASIS DIS, V1587, P183, DOI 10.1016/S0925-4439(02)00081-9; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Datta MW, 2007, ADV ANAT PATHOL, V14, P408, DOI 10.1097/PAP.0b013e318155709a; Engers R, 2007, WORLD J UROL, V25, P595, DOI 10.1007/s00345-007-0209-0; Frith MC, 2007, GENE, V403, P188, DOI 10.1016/j.gene.2007.08.012; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Langeberg WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4101, DOI 10.2741/2374; LAZAR MA, 1990, J BIOL CHEM, V265, P12859; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Machida T, 2006, ONCOGENE, V25, P1931, DOI 10.1038/sj.onc.1209225; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanna CR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-169; Schalken JA, 2003, UROLOGY, V62, P34, DOI 10.1016/S0090-4295(03)00759-3; SCHRODER FH, 2003, PROSTATE CANC; Shand RL, 2006, CURR OPIN UROL, V16, P123, DOI 10.1097/01.mou.0000193384.39351.64; Soh UJK, 2008, J CELL SCI, V121, P1739, DOI 10.1242/jcs.021774; Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Thompson HH, 2005, IEEE SECUR PRIV, V3, P66, DOI 10.1109/MSP.2005.3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson M, 2008, PROSTATE, V68, P1248, DOI 10.1002/pros.20792; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan X, 2001, J BIOL CHEM, V276, P46647, DOI 10.1074/jbc.M108404200; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	42	65	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4995	10.1371/journal.pone.0004995	http://dx.doi.org/10.1371/journal.pone.0004995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319183	Green Published, gold			2022-12-27	WOS:000265499200017
J	Garzia, L; Andolfo, I; Cusanelli, E; Marino, N; Petrosino, G; De Martino, D; Esposito, V; Galeone, A; Navas, L; Esposito, S; Gargiulo, S; Fattet, S; Donofrio, V; Cinalli, G; Brunetti, A; Del Vecchio, L; Northcott, PA; Delattre, O; Taylor, MD; Iolascon, A; Zollo, M				Garzia, Livia; Andolfo, Immacolata; Cusanelli, Emilio; Marino, Natascia; Petrosino, Giuseppe; De Martino, Daniela; Esposito, Veronica; Galeone, Aldo; Navas, Luigi; Esposito, Silvia; Gargiulo, Sara; Fattet, Sarah; Donofrio, Vittoria; Cinalli, Giuseppe; Brunetti, Arturo; Del Vecchio, Luigi; Northcott, Paul A.; Delattre, Olivier; Taylor, Michael D.; Iolascon, Achille; Zollo, Massimo			MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma	PLOS ONE			English	Article								Background: Through negative regulation of gene expression, microRNAs (miRNAs) can function in cancers as oncosuppressors, and they can show altered expression in various tumor types. Here we have investigated medulloblastoma tumors (MBs), which arise from an early impairment of developmental processes in the cerebellum, where Notch signaling is involved in many cell-fate-determining stages. MBs occur bimodally, with the peak incidence seen between 3-4 years and 8-9 years of age, although it can also occur in adults. Notch regulates a subset of the MB cells that have stem-cell-like properties and can promote tumor growth. On the basis of this evidence, we hypothesized that miRNAs targeting the Notch pathway can regulated these phenomena, and can be used in anti-cancer therapies. Methodology/Principal Findings: In a screening of MB cell lines, the miRNA miR-199b-5p was seen to be a regulator of the Notch pathway through its targeting of the transcription factor HES1. Down-regulation of HES1 expression by miR-199b-5p negatively regulates the proliferation rate and anchorage-independent growth of MB cells. MiR-199b-5p over-expression blocks expression of several cancer stem-cell genes, impairs the engrafting potential of MB cells in the cerebellum of athymic/nude mice, and of particular interest, decreases the MB stem-cell-like (CD133+) subpopulation of cells. In our analysis of 61 patients with MB, the expression of miR-199b-5p in the non-metastatic cases was significantly higher than in the metastatic cases (P = 0.001). Correlation with survival for these patients with high levels of miR-199b expression showed a positive trend to better overall survival than for the low-expressing patients. These data showing the down-regulation of miR-199b-5p in metastatic MBs suggest a potential silencing mechanism through epigenetic or genetic alterations. Upon induction of de-methylation using 5-aza-deoxycytidine, lower miR-199b-5p expression was seen in a panel of MB cell lines, supported an epigenetic mechanism of regulation. Furthermore, two cell lines (Med8a and UW228) showed significant upregulation of miR-199b-5p upon treatment. Infection with MB cells in an induced xenograft model in the mouse cerebellum and the use of an adenovirus carrying miR-199b-5p indicate a clinical benefit through this negative influence of miR-199b-5p on tumor growth and on the subset of MB stem-cell-like cells, providing further proof of concept. Conclusions/Significance: Despite advances in our understanding of the pathogenesis of MB, one-third of these patients remain incurable and current treatments can significantly damage long-term survivors. Here we show that miR-199b-5p expression correlates with metastasis spread, identifying a new molecular marker for a poor-risk class in patients with MB. We further show that in a xenograft model, MB tumor burden can be reduced, indicating the use of miR-199b-5p as an adjuvant therapy after surgery, in combination with radiation and chemotherapy, for the improvement of anti-cancer MB therapies and patient quality of life. To date, this is the first report that expression of a miRNA can deplete the tumor stem cells, indicating an interesting therapeutic approach for the targeting of these cells in brain tumors.	[Garzia, Livia; Andolfo, Immacolata; Cusanelli, Emilio; Marino, Natascia; Petrosino, Giuseppe; De Martino, Daniela; Esposito, Silvia; Brunetti, Arturo; Del Vecchio, Luigi; Iolascon, Achille; Zollo, Massimo] Ctr Ingn Genet & Biotecnol Avanzate, CEINGE, Naples, Italy; [Esposito, Veronica; Galeone, Aldo] Univ Naples Federico 2, Dip Chim Sostanze Nat, Naples, Italy; [Navas, Luigi] Univ Naples Federico 2, Dip Sci Clin Vet, Sez Clin Chirurg, Naples, Italy; [Gargiulo, Sara] Univ Naples Federico 2, Diagnost Imaging Dept, Naples, Italy; [Gargiulo, Sara] IBB CNR, Naples, Italy; [Fattet, Sarah; Delattre, Olivier] Inst Curie, Unite Genet Biol Canc, Paris, France; [Donofrio, Vittoria] Anat Patol Ospedale Pausilipon AORN Santobono Paus, Naples, Italy; [Cinalli, Giuseppe] Santobono Pausilipon Childrens Hosp, Naples, Italy; [Brunetti, Arturo] Univ Naples Federico 2, Inst Biostructures & Bioimages, Dept Biomorphol & Funct Sci, Natl Res Council, Naples, Italy; [Del Vecchio, Luigi; Iolascon, Achille; Zollo, Massimo] Univ Naples Federico 2, Dip Biochim Biotecnol Med, DBBM, Naples, Italy; [Northcott, Paul A.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada; [Zollo, Massimo] Univ Naples Federico 2, Fac Sci Biotecnol, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Naples Federico II	Garzia, L (corresponding author), Ctr Ingn Genet & Biotecnol Avanzate, CEINGE, Naples, Italy.	zollo@ceinge.unina.it	Zollo, Massimo/K-5857-2016; Andolfo, Immacolata/Q-4012-2019; Andolfo, Immacolata/K-7381-2016; Iolascon, Achille/A-4461-2014; cinalli, giuseppe/AAC-3889-2022; Galeone, Aldo/H-7248-2019; Navas, Luigi/ABI-6516-2020; Marino, Natascia/AAM-5941-2021; NAVAS, Luigi/AAT-2506-2021; Northcott, Paul A/N-4022-2018; Brunetti, Arturo/AAE-5261-2019; Cusanelli, Emilio/G-6092-2015	Zollo, Massimo/0000-0002-0970-7243; Andolfo, Immacolata/0000-0003-0493-812X; Andolfo, Immacolata/0000-0003-0493-812X; cinalli, giuseppe/0000-0002-7797-8483; Galeone, Aldo/0000-0001-8805-6348; Marino, Natascia/0000-0001-6771-8963; NAVAS, Luigi/0000-0002-1851-5016; Northcott, Paul A/0000-0002-1220-5252; Brunetti, Arturo/0000-0001-7057-3494; Cusanelli, Emilio/0000-0002-7683-8542; Petrosino, Giuseppe/0000-0002-2835-4308; Esposito, Veronica/0000-0002-1724-7128; Gargiulo, Sara/0000-0003-1894-1047; delattre, olivier/0000-0002-8730-2276; iolascon, achille/0000-0002-9558-0356; Taylor, Michael/0000-0001-7009-3466	FP6-E.E.T pipeline [LSH-CT-2006-037260]; FP7-Tumic [HEALTH-F2-2008-201662]; Associazione contro la lotta al Neuroblastoma Italiana Progetto Pensiero; AIRC [2007]; Progetto AIRC Tumori Pediatrici; Associazione Open Neuroblastoma; Scuola Europea di Medicina Molecolare (SEMM-CEINGE) [Fellowship]; AIRC-FIRC [Fellowship]	FP6-E.E.T pipeline; FP7-Tumic; Associazione contro la lotta al Neuroblastoma Italiana Progetto Pensiero; AIRC(Fondazione AIRC per la ricerca sul cancro); Progetto AIRC Tumori Pediatrici(Fondazione AIRC per la ricerca sul cancro); Associazione Open Neuroblastoma; Scuola Europea di Medicina Molecolare (SEMM-CEINGE); AIRC-FIRC(Fondazione AIRC per la ricerca sul cancro)	This study was supported by FP6-E.E.T pipeline LSH-CT-2006-037260 (MZ), FP7-Tumic HEALTH-F2-2008-201662 (MZ), Associazione contro la lotta al Neuroblastoma Italiana Progetto Pensiero (AI,MZ), AIRC grant 2007 (MZ), Progetto AIRC Tumori Pediatrici 2008 (MZ). Associazione Open Neuroblastoma (AI), a Scuola Europea di Medicina Molecolare (SEMM-CEINGE) Fellowship (EC), and AIRC-FIRC Fellowships (LG, NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Buhren J, 2000, J NEUROPATH EXP NEUR, V59, P229; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; EBERHART C, 2007, NEUROSURG CLIN N AM, V18, pR8; Eberhart CG, 2007, NEUROSURG CLIN N AM, V18, P59, DOI 10.1016/j.nec.2006.10.005; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gilbertson RJ, 2003, NAT GENET, V35, P197, DOI 10.1038/ng1103-197; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grill J, 2005, LANCET ONCOL, V6, P573, DOI 10.1016/S1470-2045(05)70252-7; Grill J, 2006, LANCET ONCOL, V7, P787, DOI 10.1016/S1470-2045(06)70872-5; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Huntly BJP, 2005, NATURE, V435, P1169, DOI 10.1038/4351169a; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; KATSETOS CD, 1995, CLIN NEUROPATHOL, V14, P72; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kombogiorgas D, 2007, CHILD NERV SYST, V23, P399, DOI 10.1007/s00381-006-0258-5; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li XN, 2004, CLIN CANCER RES, V10, P1150, DOI 10.1158/1078-0432.CCR-0747-3; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; MacDonald TJ, 2008, J CHILD NEUROL, V23, P1195, DOI 10.1177/0883073808321769; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PATRICE SJ, 1995, PEDIATR NEUROSURG, V22, P197, DOI 10.1159/000120901; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Sandberg AA, 2002, AM J MED GENET, V115, P173, DOI 10.1002/ajmg.10693; Schabet M, 1997, MED PEDIATR ONCOL, V29, P92, DOI 10.1002/(SICI)1096-911X(199708)29:2<92::AID-MPO5>3.0.CO;2-M; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang SY, 2005, J NEUROSURG, V102, P417, DOI 10.3171/ped.2005.102.4.0417; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	56	209	224	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4998	10.1371/journal.pone.0004998	http://dx.doi.org/10.1371/journal.pone.0004998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308264	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499000012
J	Piuri, M; Jacobs, WR; Hatfull, GF				Piuri, Mariana; Jacobs, William R., Jr.; Hatfull, Graham F.			Fluoromycobacteriophages for Rapid, Specific, and Sensitive Antibiotic Susceptibility Testing of Mycobacterium tuberculosis	PLOS ONE			English	Article							LUCIFERASE REPORTER PHAGES; DRUG-RESISTANT TUBERCULOSIS; RIFAMPICIN RESISTANCE; MULTIDRUG-RESISTANT; FLOW-CYTOMETRY; ASSAY; IDENTIFICATION; FLUORESCENCE; DIAGNOSIS; SAFE	Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis is of paramount importance as multiple- and extensively-drug resistant strains of M. tuberculosis emerge and spread. We describe here a virus-based assay in which fluoromycobacteriophages are used to deliver a GFP or ZsYellow fluorescent marker gene to M. tuberculosis, which can then be monitored by fluorescent detection approaches including fluorescent microscopy and flow cytometry. Pre-clinical evaluations show that addition of either Rifampicin or Streptomycin at the time of phage addition obliterates fluorescence in susceptible cells but not in isogenic resistant bacteria enabling drug sensitivity determination in less than 24 hours. Detection requires no substrate addition, fewer than 100 cells can be identified, and resistant bacteria can be detected within mixed populations. Fluorescence withstands fixation by paraformaldehyde providing enhanced biosafety for testing MDR-TB and XDR-TB infections.	[Piuri, Mariana; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Bronx, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Piuri, M (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu		Piuri, Mariana/0000-0001-9058-8247; Jacobs, William/0000-0003-3321-3080	National Institutes of Health [AI-51519, AI21670]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by NIH grant AI21670 to WRJ. This work was funded in part by HHMI's international research programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2004, INT J TUBERC LUNG D, V8, P1114; Albert H, 2001, INT J TUBERC LUNG D, V5, P906; Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Banaiee N, 2003, J MED MICROBIOL, V52, P557, DOI 10.1099/jmm.0.05149-0; Banaiee N, 2001, J CLIN MICROBIOL, V39, P3883, DOI 10.1128/JCM.39.11.3883-3888.2001; Banaiee N, 2008, TUBERCULOSIS, V88, P64, DOI 10.1016/j.tube.2007.08.006; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; BENNEDSEN J, 1966, SCAND J RESPIR DIS, V47, P114; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Carriere C, 1997, J CLIN MICROBIOL, V35, P3232; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Eltringham IJ, 1999, J CLIN MICROBIOL, V37, P3528, DOI 10.1128/JCM.37.11.3528-3532.1999; Ford M. E., 1998, Tubercle and Lung Disease, V79, P63, DOI 10.1054/tuld.1998.0007; Fuhrmann S, 2008, CYTOM PART A, V73A, P1100, DOI 10.1002/cyto.a.20614; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hanscheid T, 2008, T ROY SOC TROP MED H, V102, P520, DOI 10.1016/j.trstmh.2008.02.020; Hazbon MH, 2003, J CLIN MICROBIOL, V41, P4865, DOI 10.1128/JCM.41.10.4865-4869.2003; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Hoek KGP, 2008, J CLIN MICROBIOL, V46, P1369, DOI 10.1128/JCM.02343-07; Jacobs W R Jr, 1989, Acta Leprol, V7 Suppl 1, P203; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; Kalantri S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-59; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kirk SM, 1998, J CLIN MICROBIOL, V36, P1568, DOI 10.1128/JCM.36.6.1568-1573.1998; Kumar V, 2008, TUBERCULOSIS, V88, P616, DOI 10.1016/j.tube.2008.02.007; Lawn SD, 2006, BRIT MED J, V333, P559, DOI 10.1136/bmj.38971.587222.AB; Luby-Phelps K, 2003, J HISTOCHEM CYTOCHEM, V51, P271, DOI 10.1177/002215540305100301; Moore AV, 1999, J CLIN MICROBIOL, V37, P479, DOI 10.1128/JCM.37.3.479-483.1999; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; OJHA AK, 2008, MOL MICROBIOL; Pai M, 2005, J INFECTION, V51, P175, DOI 10.1016/j.jinf.2005.05.017; Pearson RE, 1996, GENE, V183, P129, DOI 10.1016/S0378-1119(96)00530-6; Pina-Vaz C, 2005, J MED MICROBIOL, V54, P77, DOI 10.1099/jmm.0.45627-0; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Riska PF, 1997, J CLIN MICROBIOL, V35, P3225, DOI 10.1128/JCM.35.12.3225-3231.1997; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; SARKIS GJ, 1995, MOL MICROBIOL, V15, P1055, DOI 10.1111/j.1365-2958.1995.tb02281.x; Schwebach JR, 2001, J CLIN MICROBIOL, V39, P769, DOI 10.1128/JCM.39.2.769-771.2001; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; Watterson SA, 2000, J CLIN PATHOL, V53, P727, DOI 10.1136/jcp.53.10.727; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; Wilson SM, 1997, NAT MED, V3, P465, DOI 10.1038/nm0497-465; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10	48	75	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4870	10.1371/journal.pone.0004870	http://dx.doi.org/10.1371/journal.pone.0004870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300517	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265496800003
J	St-Onge, M; Dumas, A; Michaud, A; Laflamme, C; Dussault, AA; Pouliot, M				St-Onge, Mireille; Dumas, Aline; Michaud, Annick; Laflamme, Cynthia; Dussault, Andree-Anne; Pouliot, Marc			Impact of Anti-Inflammatory Agents on the Gene Expression Profile of Stimulated Human Neutrophils: Unraveling Endogenous Resolution Pathways	PLOS ONE			English	Article							ACTIVATED HUMAN NEUTROPHILS; ARACHIDONIC-ACID RELEASE; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; LEUKOTRIENE BIOSYNTHESIS; ADENOSINE RECEPTOR; CYCLIC-AMP; ENDOTHELIAL-CELLS; DOWN-REGULATION; ENZYME-RELEASE	Adenosine, prostaglandin E-2, or increased intracellular cyclic AMP concentration each elicit potent anti-inflammatory events in human neutrophils by inhibiting functions such as phagocytosis, superoxide production, adhesion and cytokine release. However, the endogenous molecular pathways mediating these actions are poorly understood. In the present study, we examined their impact on the gene expression profile of stimulated neutrophils. Purified blood neutrophils from healthy donors were stimulated with a cocktail of inflammatory agonists in the presence of at least one of the following anti-inflammatory agents: adenosine A(2A) receptor agonist CGS 21680, prostaglandin E-2, cyclic-AMP-elevating compounds forskolin and RO 20-1724. Total RNA was analyzed using gene chips and real-time PCR. Genes encoding transcription factors, enzymes and regulatory proteins, as well as secreted cytokines/chemokines showed differential expression. We identified 15 genes for which the anti-inflammatory agents altered mRNA levels. The agents affected the expression profile in remarkably similar fashion, suggesting a central mechanism limiting cell activation. We have identified a set of genes that may be part of important resolution pathways that interfere with cell activation. Identification of these pathways will improve understanding of the capacity of tissues to terminate inflammatory responses and contribute to the development of therapeutic strategies based on endogenous resolution.	[St-Onge, Mireille; Dumas, Aline; Michaud, Annick; Laflamme, Cynthia; Dussault, Andree-Anne; Pouliot, Marc] Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, CHUQ, Quebec City, PQ G1K 7P4, Canada; [St-Onge, Mireille; Dumas, Aline; Michaud, Annick; Laflamme, Cynthia; Dussault, Andree-Anne; Pouliot, Marc] Univ Laval, Fac Med, Dept Anat Physiol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	St-Onge, M (corresponding author), Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, CHUQ, Quebec City, PQ G1K 7P4, Canada.	Marc.Pouliot@crchul.ulaval.ca	Pouliot, Marc/G-4103-2016; Poubelle, Patrice E/G-6537-2013	Pouliot, Marc/0000-0002-2466-5424; Dumas, Aline/0000-0001-5718-7206	Canadian Institutes of Health Research [MOP-64315, NSM-72200]; Fonds de la Recherche en Sante du Quebec (FRSQ) [Senior Investigator Scholarship, studentship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work is supported by grants from the Canadian Institutes of Health Research (CIHR, to MP; grants no. MOP-64315 & NSM-72200). MP is the recipient of a Senior Investigator Scholarship from the Fonds de la Recherche en Sante du Quebec (FRSQ) and MSO is the recipient of a studentship award from the FRSQ. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Boraschi D, 2006, VITAM HORM, V74, P229, DOI 10.1016/S0083-6729(06)74009-2; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Cadieux JS, 2005, J CELL SCI, V118, P1437, DOI 10.1242/jcs.01737; Calvisi DF, 2008, CANCER RES, V68, P4192, DOI 10.1158/0008-5472.CAN-07-6157; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Conte FD, 2008, J LEUKOCYTE BIOL, V84, P652, DOI 10.1189/jlb.1207827; Cristalli G, 2008, CURR PHARM DESIGN, V14, P1525, DOI 10.2174/138161208784480081; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; de Boer Willem I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P205; Denecke B, 1999, J BIOL CHEM, V274, P26860, DOI 10.1074/jbc.274.38.26860; DIANZANI C, 1994, EUR J PHARMACOL, V263, P223, DOI 10.1016/0014-2999(94)90547-9; Dunlay SM, 2008, CIRCULATION, V118, P625, DOI 10.1161/CIRCULATIONAHA.107.759191; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; EDWARDS SW, 1994, BIOCH PHYSL NEUTROPH, P1; FANTONE JC, 1981, PROSTAG LEUKOTR ESS, V7, P195, DOI 10.1016/0161-4630(81)90062-8; FANTONE JC, 1983, J IMMUNOL, V130, P1495; FARRE AL, 1993, CIRCULATION, V88, P1166, DOI 10.1161/01.CIR.88.3.1166; FELSCH A, 1995, J IMMUNOL, V155, P333; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; Flamand N, 2000, AM J RESP CRIT CARE, V161, pS88, DOI 10.1164/ajrccm.161.supplement_1.ltta-18; Gaga M, 2008, ALLERGY, V63, P703, DOI 10.1111/j.1398-9995.2007.01578.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gawlik Radoslaw, 2007, Otolaryngol Pol, V61, P567, DOI 10.1016/S0030-6657(07)70486-9; GIRARD D, 2007, PHENOTYPIC FUNCTIONA; Golovko O, 2005, J STEROID BIOCHEM, V94, P197, DOI 10.1016/j.jsbmb.2005.01.019; Gon Y, 2004, AM J RESP CELL MOL, V31, P330, DOI 10.1165/rcmb.2003-0438OC; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HASKO BNC, 2007, ADENOSINE RECEPTORS; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hisaoka M, 2004, CANCER GENET CYTOGEN, V152, P101, DOI 10.1016/j.cancergencyto.2003.11.011; Kassuya CAL, 2008, PEPTIDES, V29, P1329, DOI 10.1016/j.peptides.2008.03.008; Kinsel JF, 2003, ANN RHEUM DIS, V62, P22; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Krump E, 1999, ADV EXP MED BIOL, V447, P107; Krump E, 1996, BRIT J PHARMACOL, V117, P1639, DOI 10.1111/j.1476-5381.1996.tb15334.x; Krump E, 1997, J EXP MED, V186, P1401, DOI 10.1084/jem.186.8.1401; Kugelmeier P, 2008, J PANCREAS, V9, P133; Kunter U, 2005, KIDNEY INT, V68, P1520, DOI 10.1111/j.1523-1755.2005.00564.x; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; LEHMEYER JE, 1978, CLIN IMMUNOL IMMUNOP, V9, P482, DOI 10.1016/0090-1229(78)90144-7; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; LYNCH JP, 1985, AM J MED, V78, P691, DOI 10.1016/0002-9343(85)90416-4; MARONE G, 1980, J IMMUNOL, V125, P2277; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; MCCOLL SR, 1990, J IMMUNOL, V145, P3047; MCDONALD PP, 1993, J LIPID MEDIATOR, V6, P59; Miao TZ, 2008, MOL CELL NEUROSCI, V37, P367, DOI 10.1016/j.mcn.2007.10.010; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; OFLAHERTY JT, 1979, PROSTAGLANDINS, V17, P201, DOI 10.1016/0090-6980(79)90039-X; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Pharoah DS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1913; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Pouliot M, 1998, FASEB J, V12, P1109, DOI 10.1096/fasebj.12.12.1109; Pouliot M, 2006, ADENOSINE RECEPTORS, P89; RIVKIN I, 1975, J IMMUNOL, V115, P1126; Sawyer D W, 1989, Rev Infect Dis, V11 Suppl 7, pS1532; Thibault N, 2000, BLOOD, V95, P519, DOI 10.1182/blood.V95.2.519; van Gassen KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/j.1528-1167.2007.01470.x; Visser SS, 2000, BIOCHEM PHARMACOL, V60, P993, DOI 10.1016/S0006-2952(00)00414-7; Welsh P, 2008, STROKE, V39, P2226, DOI 10.1161/STROKEAHA.107.504498; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Williams CS, 1996, AM J PHYSIOL-GASTR L, V270, pG393; Wu XW, 2003, SHOCK, V19, P314, DOI 10.1097/00024382-200304000-00004; Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang SY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-150; Zhao ZQ, 1996, AM J PHYSIOL-HEART C, V271, pH1456, DOI 10.1152/ajpheart.1996.271.4.H1456; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550	78	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4902	10.1371/journal.pone.0004902	http://dx.doi.org/10.1371/journal.pone.0004902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295914	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496700005
J	Rigola, D; van Oeveren, J; Janssen, A; Bonne, A; Schneiders, H; van der Poel, HJA; van Orsouw, NJ; Hogers, RCJ; de Both, MTJ; van Eijk, MJT				Rigola, Diana; van Oeveren, Jan; Janssen, Antoine; Bonne, Anita; Schneiders, Harrie; van der Poel, Hein J. A.; van Orsouw, Nathalie J.; Hogers, Rene C. J.; de Both, Michiel T. J.; van Eijk, Michiel J. T.			High-Throughput Detection of Induced Mutations and Natural Variation Using KeyPoint (TM) Technology	PLOS ONE			English	Article								Reverse genetics approaches rely on the detection of sequence alterations in target genes to identify allelic variants among mutant or natural populations. Current (pre-) screening methods such as TILLING and EcoTILLING are based on the detection of single base mismatches in heteroduplexes using endonucleases such as CEL 1. However, there are drawbacks in the use of endonucleases due to their relatively poor cleavage efficiency and exonuclease activity. Moreover, prescreening methods do not reveal information about the nature of sequence changes and their possible impact on gene function. We present KeyPoint (TM) technology, a high-throughput mutation/polymorphism discovery technique based on massive parallel sequencing of target genes amplified from mutant or natural populations. KeyPoint combines multidimensional pooling of large numbers of individual DNA samples and the use of sample identification tags ("sample barcoding'') with next-generation sequencing technology. We show the power of KeyPoint by identifying two mutants in the tomato elF4E gene based on screening more than 3000 M2 families in a single GS FLX sequencing run, and discovery of six haplotypes of tomato elF4E gene by re-sequencing three amplicons in a subset of 92 tomato lines from the EU-SOL core collection. We propose KeyPoint technology as a broadly applicable amplicon sequencing approach to screen mutant populations or germplasm collections for identification of (novel) allelic variation in a high-throughput fashion.	[Rigola, Diana; van Oeveren, Jan; Janssen, Antoine; Bonne, Anita; Schneiders, Harrie; van der Poel, Hein J. A.; van Orsouw, Nathalie J.; Hogers, Rene C. J.; de Both, Michiel T. J.; van Eijk, Michiel J. T.] Keygene NV, Wageningen, Netherlands	Keygene N.V.	Rigola, D (corresponding author), Keygene NV, Wageningen, Netherlands.	diana.rigola@keygene.com	赵, 鹏/B-8401-2009		Keygene N.V.	Keygene N.V.(Keygene N.V.)	Keygene N.V. funded the research and had role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Den Dunnen JT, 1999, HUM MUTAT, V14, P95, DOI 10.1002/(SICI)1098-1004(1999)14:2<95::AID-HUMU1>3.0.CO;2-G; Gilchrist EJ, 2005, CURR OPIN PLANT BIOL, V8, P211, DOI 10.1016/j.pbi.2005.01.004; Gilchrist EJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-262; Greene EA, 2003, GENETICS, V164, P731; Hestekin CN, 2006, ELECTROPHORESIS, V27, P3805, DOI 10.1002/elps.200600421; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jenkins GJS, 2004, MUTAGENESIS, V19, P3, DOI 10.1093/mutage/geg037; Li J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm403; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; STUART CN, 1993, BIOTECHNIQUES, V14, P748; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Taylor GR, 1999, ELECTROPHORESIS, V20, P1125, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1125::AID-ELPS1125>3.0.CO;2-O; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	27	75	87	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4761	10.1371/journal.pone.0004761	http://dx.doi.org/10.1371/journal.pone.0004761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283079	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496300002
J	Igual, JM; Tavecchia, G; Jenouvrier, S; Forero, MG; Oro, D				Manuel Igual, Jose; Tavecchia, Giacomo; Jenouvrier, Stephanie; Forero, Manuela G.; Oro, Daniel			Buying Years to Extinction: Is Compensatory Mitigation for Marine Bycatch a Sufficient Conservation Measure for Long-Lived Seabirds?	PLOS ONE			English	Article								Along the lines of the 'polluter pays principle', it has recently been proposed that the local long-line fishing industry should fund eradication of terrestrial predators at seabird breeding colonies, as a compensatory measure for the bycatch caused by the fishing activity. The measure is economically sound, but a quantitative and reliable test of its biological efficacy has never been conducted. Here, we investigated the demographic consequences of predator eradication for Cory's shearwater Calonectris diomedea, breeding in the Mediterranean, using a population model that integrates demographic rates estimated from individual life-history information with experimental measures of predation and habitat structure. We found that similar values of population growth rate can be obtained by different combinations of habitat characteristics, predator abundance and adult mortality, which explains the persistence of shearwater colonies in islands with introduced predators. Even so, given the empirically obtained values of survival, all combinations of predator abundance and habitat characteristics projected a decline in shearwater numbers. Perturbation analyses indicated that the value and the sensitivity of shearwater population growth rates were affected by all covariates considered and their interactions. A decrease in rat abundance delivered only a small increase in the population growth rate, whereas a change in adult survival (a parameter independent of rat abundance) had the strongest impact on population dynamics. When adult survival is low, rat eradication would allow us to "buy'' years before extinction but does not reverse the process. Rat eradication can therefore be seen as an emergency measure if threats on adult survival are eliminated in the medium-term period. For species with low fecundity and long life expectancy, our results suggest that rat control campaigns are not a sufficient, self-standing measure to compensate the biological toll of long-line fisheries.	[Manuel Igual, Jose; Tavecchia, Giacomo; Oro, Daniel] Imedea CSIC UIB, Esporles, Spain; [Forero, Manuela G.] CSIC Estac Biol Donana, Dept Biol Conservat, Seville, Spain; [Jenouvrier, Stephanie] Woods Hole Oceanograph Inst, Woods Hole, MA USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Woods Hole Oceanographic Institution	Igual, JM (corresponding author), Imedea CSIC UIB, Esporles, Spain.	g.tavecchia@uib.es	Oro, Daniel/H-4208-2012; Tavecchia, Giacomo/N-3961-2014; Igual, Jose/N-3975-2014	Oro, Daniel/0000-0003-4782-3007; Tavecchia, Giacomo/0000-0001-5435-2691; Igual, Jose/0000-0002-8369-3150; jenouvrier, stephanie/0000-0003-3324-2383	Consejo Superior de Investigaciones Cientificas (CSIC, Spain) [Ramon y Cajal fellowship]; Spanish Minister of Science and Tecnology (MCyT) [REN2002-00450/GLO, BOS2003-01960]; Organismo Autonomo de Parques Nacionales (OAPN)	Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Spanish Minister of Science and Tecnology (MCyT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Organismo Autonomo de Parques Nacionales (OAPN)	M.G.F. and G.T. were supported by a Ramon y Cajal fellowship from the Consejo Superior de Investigaciones Cientificas (CSIC, Spain). Financial support was provided by the projects REN2002-00450/GLO and BOS2003-01960 of the Spanish Minister of Science and Tecnology (MCyT), and the Organismo Autonomo de Parques Nacionales (OAPN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GB, 2005, BIOL CONSERV, V126, P306, DOI 10.1016/j.biocon.2005.06.001; BAXTER PWJ, 2008, CONSERVATIO IN PRESS, DOI DOI 10.1111/J.1523-1739.2007.00850.X; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; BELLVER JA, 2003, YACIMIENTO NEOLITICO; BROSTROM G, 2003, GEN LINEAR MODELS RA; CALDERON S, 1894, ANALES SOC ESPANOLA, V23, P903; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; Choquet R, 2005, U CARE2 2 USERS MANU; Cooper J, 2003, SCI MAR, V67, P57, DOI 10.3989/scimar.2003.67s257; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Cuthbert R, 2001, BIOL CONSERV, V100, P163, DOI 10.1016/S0006-3207(00)00234-2; De Leon A, 2006, BIRD STUDY, V53, P64, DOI 10.1080/00063650609461417; Doak D, 2007, FRONT ECOL ENVIRON, V5, P350, DOI 10.1890/1540-9295(2007)5[350:CMFMBW]2.0.CO;2; FAO, 2005, 753 FAO; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; HOOKER S, 1995, NEW ZEAL J ZOOL, V22, P291, DOI 10.1080/03014223.1995.9518044; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Hunter CM, 2005, J ANIM ECOL, V74, P589, DOI 10.1111/j.1365-2656.2005.00929.x; Igual JM, 2007, BIOL CONSERV, V137, P189, DOI 10.1016/j.biocon.2007.02.003; Igual JM, 2006, ANIM CONSERV, V9, P59, DOI 10.1111/j.1469-1795.2005.00005.x; Jenouvrier S, 2009, GLOBAL CHANGE BIOL, V15, P268, DOI 10.1111/j.1365-2486.2008.01715.x; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Jones IL, 2002, OECOLOGIA, V133, P38, DOI 10.1007/s00442-002-0991-8; LANDE R, 1988, OECOLOGIA, V75, P601, DOI 10.1007/BF00776426; Lande R., 2003, OXFORD SERIES ECOLOG; Le Corre M, 2008, NATURE, V451, P134, DOI 10.1038/451134a; Lebreton JD, 2005, AUST NZ J STAT, V47, P49, DOI 10.1111/j.1467-842X.2005.00371.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; *MATHWORKS INC, 2000, MATLAB; MOORS PJ, 1984, INT COUNCIL BIRD PRE, V2, P667; Mougin J.-L., 1987, Oiseau et la Revue Francaise d'Ornithologie, V57, P201; Mougin J.-L., 2002, Avocetta, V26, P7; *OECD, 1995, OECDGD95124; Oro D, 2003, SCI MAR, V67, P13, DOI 10.3989/scimar.2003.67s213; Pascal Michel, 2008, Endangered Species Research, V4, P267, DOI 10.3354/esr00080; Priddel D, 2007, FRONT ECOL ENVIRON, V5, P407, DOI 10.1890/i1540-9295-5-8-407.1; Quillfeldt P, 2008, POLAR BIOL, V31, P333, DOI 10.1007/s00300-007-0363-2; Ruffino L, 2009, BIOL INVASIONS, V11, P1631, DOI 10.1007/s10530-008-9394-z; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; WARHAM J, 1990, PETRELS THEIR ECOLOG; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2; Williams B. K., 2002, ANAL MANAGEMENT ANIM	49	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4826	10.1371/journal.pone.0004826	http://dx.doi.org/10.1371/journal.pone.0004826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279685	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496200007
J	McCormick, JB; Boyce, AM; Cho, MK				McCormick, Jennifer B.; Boyce, Angie M.; Cho, Mildred K.			Biomedical Scientists' Perceptions of Ethical and Social Implications: Is There a Role for Research Ethics Consultation?	PLOS ONE			English	Article								Background: Research ethics consultation programs are being established with a goal of addressing the ethical, societal, and policy considerations associated with biomedical research. A number of these programs are modelled after clinical ethics consultation services that began to be institutionalized in the 1980s. Our objective was to determine biomedical science researchers' perceived need for and utility of research ethics consultation, through examination of their perceptions of whether they and their institutions faced ethical, social or policy issues (outside those mandated by regulation) and examination of willingness to seek advice in addressing these issues. We conducted telephone interviews and focus groups in 2006 with researchers from Stanford University and a mailed survey in December 2006 to 7 research universities in the U. S. Findings: A total of 16 researchers were interviewed (75% response rate), 29 participated in focus groups, and 856 responded to the survey (50% response rate). Approximately half of researchers surveyed (51%) reported that they would find a research ethics consultation service at their institution moderately, very or extremely useful, while over a third (36%) reported that such a service would be useful to them personally. Respondents conducting human subjects research were more likely to find such a service very to extremely useful to them personally than respondents not conducting human subjects research (20% vs 10%; chi(2) p<.001). Conclusion: Our findings indicate that biomedical researchers do encounter and anticipate encountering ethical and societal questions and concerns and a substantial proportion, especially clinical researchers, would likely use a consultation service if they were aware of it. These findings provide data to inform the development of such consultation programs in general.	[McCormick, Jennifer B.; Boyce, Angie M.; Cho, Mildred K.] Stanford Univ, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA; [Cho, Mildred K.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [McCormick, Jennifer B.] Mayo Clin, Coll Med, Dept Med, Rochester, MN USA; [Boyce, Angie M.] Cornell Univ, Dept Sci & Technol Studies, Ithaca, NY 14853 USA	Stanford University; Stanford University; Mayo Clinic; Cornell University	McCormick, JB (corresponding author), Stanford Univ, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	micho@stanford.edu			NHGRI [Center of Excellence in ELSI Research award]; DOE; NIH [P50 HG003389]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Our work was funded by a Center of Excellence in ELSI Research award from NHGRI and DOE (Grant #NIH P50 HG003389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckwith J, 2005, NAT BIOTECHNOL, V23, P1479, DOI 10.1038/nbt1205-1479; Brown S, 1998, SCI ENG ETHICS, V4, P487; Cho MK, 2008, AM J BIOETHICS, V8, P4, DOI [10.1080/15265160802109322, 10.1080/15265160802132951]; Cho Mildred K, 2008, IRB, V30, P1; Conefrey T, 1997, DISCOURSE SOC, V8, P313, DOI 10.1177/0957926597008003003; de Melo-Martin I, 2007, ACAD MED, V82, P900, DOI 10.1097/ACM.0b013e318132f0ee; De Vries R, 2006, J EMPIR RES HUM RES, V1, P43, DOI 10.1525/jer.2006.1.1.43; Dubochet J, 2003, EMBO REP, V4, P330, DOI 10.1038/sj.embor.embor810; Jasanoff S, 2003, MINERVA, V41, P223, DOI 10.1023/A:1025557512320; Kempner J, 2005, SCIENCE, V307, P854, DOI 10.1126/science.1107576; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; NEAL HA, 2008, SPUTNIK SCI POLICY 2, pCH20; Nicholas B, 1999, SCI ENG ETHICS, V5, P515, DOI 10.1007/s11948-999-0052-3; Pilcher H, 2006, NATURE, V440, P1104, DOI 10.1038/4401104a; Pinch T, 1990, EUROPEAN J ED, V25, P295; Rotblat J., 1999, SCI HUMANITY 21 CENT; Sankar P, 2006, GENET MED, V8, P33, DOI 10.1097/01.gim.0000195894.67756.8b; Strauss A., 1990, BASICS QUALITATIVE R	18	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4659	10.1371/journal.pone.0004659	http://dx.doi.org/10.1371/journal.pone.0004659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252737	Green Published, gold, Green Submitted			2022-12-27	WOS:000265489900002
J	Schwindt, TT; Motta, FL; Barnabe, GF; Massant, CG; Guimaraes, AD; Calcagnotto, ME; Conceicao, FS; Pesquero, JB; Rehen, S; Mello, LE				Schwindt, Telma Tiemi; Motta, Fabiana Louise; Barnabe, Gabriela Filoso; Massant, Cristina Goncalves; Guimaraes, Alessander de Oliveira; Calcagnotto, Maria Elisa; Conceicao, Fabio Silva; Pesquero, Joao Bosco; Rehen, Stevens; Mello, Luiz E.			Short-Term Withdrawal of Mitogens Prior to Plating Increases Neuronal Differentiation of Human Neural Precursor Cells	PLOS ONE			English	Article								Background: Human neural precursor cells (hNPC) are candidates for neural transplantation in a wide range of neurological disorders. Recently, much work has been done to determine how the environment for NPC culture in vitro may alter their plasticity. Epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF-2) are used to expand NPC; however, it is not clear if continuous exposure to mitogens may abrogate their subsequent differentiation. Here we evaluated if short-term removal of FGF-2 and EGF prior to plating may improve hNPC differentiation into neurons. Principal Findings: We demonstrate that culture of neurospheres in suspension for 2 weeks without EGF-FGF-2 significantly increases neuronal differentiation and neurite extension when compared to cells cultured using standard protocols. In this condition, neurons were preferentially located in the core of the neurospheres instead of the shell. Moreover, after plating, neurons presented radial rather than randomly oriented and longer processes than controls, comprised mostly by neurons with short processes. These changes were followed by alterations in the expression of genes related to cell survival. Conclusions: These results show that EGF and FGF-2 removal affects NPC fate and plasticity. Taking into account that a three dimensional structure is essential for NPC differentiation, here we evaluated, for the first time, the effects of growth factors removal in whole neurospheres rather than in plated cell culture.	[Schwindt, Telma Tiemi; Motta, Fabiana Louise; Barnabe, Gabriela Filoso; Massant, Cristina Goncalves; Calcagnotto, Maria Elisa; Mello, Luiz E.] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Guimaraes, Alessander de Oliveira; Pesquero, Joao Bosco] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Conceicao, Fabio Silva; Rehen, Stevens] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Schwindt, TT (corresponding author), Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil.	lemello@unifesp.br	CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; Mello, Luiz E/B-4177-2009; calcagnotto, maria elisa/B-1645-2013; Pesquero, Joao/C-1470-2012; Barnabe, Gabriela/E-9033-2013; Rehen, Stevens/J-5874-2012	CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Mello, Luiz E/0000-0002-6969-1108; calcagnotto, maria elisa/0000-0001-8196-0596; Pesquero, Joao/0000-0002-4507-632X; Barnabe, Gabriela/0000-0001-8790-4480; Rehen, Stevens/0000-0003-4216-9501; Motta, Fabiana/0000-0003-2230-995X	FAPESP (Brazil) [fellow]; CNPq [fellow]; Institutos do Milenio de Bioengenharia Tecidual	FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institutos do Milenio de Bioengenharia Tecidual	TT Schwindt, GF Barnabe and ME Calcagnotto are FAPESP (Brazil) fellows; AO Guimaraes is CNPq fellow; Supported by grants from Institutos do Milenio de Bioengenharia Tecidual and CNPq (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Ciccolini F, 1998, J NEUROSCI, V18, P7869; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Einstein O, 2006, GLIA, V53, P449, DOI 10.1002/glia.20305; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Jacobson M., 1991, DEV NEUROBIOLOGY; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kuhn HG, 1999, BIOESSAYS, V21, P625, DOI 10.1002/(SICI)1521-1878(199908)21:8<625::AID-BIES1>3.0.CO;2-6; Kuhn HG, 1996, J NEUROSCI, V16, P2027; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; PAHLMAN S, 1991, P NATL ACAD SCI USA, V88, P9994, DOI 10.1073/pnas.88.22.9994; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; SMITS A, 1993, EUR J NEUROSCI, V5, P986, DOI 10.1111/j.1460-9568.1993.tb00950.x; Svendsen C N, 2000, Prog Brain Res, V127, P13; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; Vaccarino FM, 2001, NEUROPSYCHOPHARMACOL, V25, P805, DOI 10.1016/S0893-133X(01)00349-9; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012	26	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4642	10.1371/journal.pone.0004642	http://dx.doi.org/10.1371/journal.pone.0004642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247499	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487800022
J	Al-Zeer, MA; Al-Younes, HM; Braun, PR; Zerrahn, J; Meyer, TF				Al-Zeer, Munir A.; Al-Younes, Hesham M.; Braun, Peter R.; Zerrahn, Jens; Meyer, Thomas F.			IFN-gamma-Inducible Irga6 Mediates Host Resistance against Chlamydia trachomatis via Autophagy	PLOS ONE			English	Article								Chlamydial infection of the host cell induces Gamma interferon (IFN gamma), a central immunoprotector for humans and mice. The primary defense against Chlamydia infection in the mouse involves the IFN gamma-inducible family of IRG proteins; however, the precise mechanisms mediating the pathogen's elimination are unknown. In this study, we identify Irga6 as an important resistance factor against C. trachomatis, but not C. muridarum, infection in IFN gamma-stimulated mouse embryonic fibroblasts (MEFs). We show that Irga6, Irgd, Irgm2 and Irgm3 accumulate at bacterial inclusions in MEFs upon stimulation with IFN gamma, whereas Irgb6 colocalized in the presence or absence of the cytokine. This accumulation triggers a rerouting of bacterial inclusions to autophagosomes that subsequently fuse to lysosomes for elimination. Autophagy-deficient Atg5-/- MEFs and lysosomal acidification impaired cells surrender to infection. Irgm2, Irgm3 and Irgd still localize to inclusions in IFN gamma-induced Atg5-/- cells, but Irga6 localization is disrupted indicating its pivotal role in pathogen resistance. Irga6-deficient (Irga6-/-) MEFs, in which chlamydial growth is enhanced, do not respond to IFN gamma even though Irgb6, Irgd, Irgm2 and Irgm3 still localize to inclusions. Taken together, we identify Irga6 as a necessary factor in conferring host resistance by remodelling a classically nonfusogenic intracellular pathogen to stimulate fusion with autophagosomes, thereby rerouting the intruder to the lysosomal compartment for destruction.	[Al-Zeer, Munir A.; Braun, Peter R.; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Zerrahn, Jens] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Al-Younes, Hesham M.] Univ Jordan, Fac Sci, Dept Biol Sci, Amman, Jordan	Max Planck Society; Max Planck Society; University of Jordan	Al-Zeer, MA (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.	tfm@mpiib-berlin.mpg.de	Al-Younes, Hesham M./C-2808-2015; Meyer, Thomas F. F/J-2485-2013	Al-Younes, Hesham M./0000-0002-8210-9514; Meyer, Thomas F. F/0000-0002-6120-8679	Fonds der Chemischen Industrie; German Academic Exchange Service (DAAD) [doctoral fellowship]; Deutsche Forschungsgemeinschaft (DFG)	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part through the Fonds der Chemischen Industrie to T.F.M., by a doctoral fellowship grant of the German Academic Exchange Service (DAAD) to M.A.Z. and a visiting scientist grant of the Deutsche Forschungsgemeinschaft (DFG) to H.A.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Igietseme JU, 1998, MICROBIOL IMMUNOL, V42, P617, DOI 10.1111/j.1348-0421.1998.tb02332.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Perry LL, 1999, J IMMUNOL, V162, P3541; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; WYRICK PB, 1978, INFECT IMMUN, V19, P1054, DOI 10.1128/IAI.19.3.1054-1060.1978; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	48	92	100	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4588	10.1371/journal.pone.0004588	http://dx.doi.org/10.1371/journal.pone.0004588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242543	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487500005
J	Goodin, DS				Goodin, Douglas S.			The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; VITAMIN-D; TWIN CONCORDANCE; ANTIBODY-TITERS; INFECTIOUS-MONONUCLEOSIS; RECURRENCE RISKS; NUCLEAR ANTIGEN; GENETIC-BASIS; PREVALENCE; EXPOSURE	Background: MS pathogenesis seems to involve both genetic susceptibility and environmental risk factors. Three sequential factors are implicated in the environmental risk. The first acts near birth, the second acts during childhood, and the third acts long thereafter. Two candidate factors (vitamin D deficiency and Epstein-Barr viral infection) seem well suited to the first two environmental events. Methodology/Principal Findings: A mathematical Model for MS pathogenesis is developed, incorporating these environmental and genetic factors into a causal scheme that can explain some of the recent changes in MS-epidemiology (e. g., increasing disease prevalence, a changing sex-ratio, and regional variations in monozygotic twin concordance rates). Conclusions/Significance: This Model suggests that genetic susceptibility is overwhelmingly the most important determinant of MS pathogenesis. Indeed, over 99% of individuals seem genetically incapable of developing MS, regardless of what environmental exposures they experience. Nevertheless, the contribution of specific genes to MS-susceptibility seems only modest. Thus, despite HLA DRB1*1501 being the most consistently identified genetic marker of MS-susceptibility (being present in over 50% of northern MS patient populations), only about 1% of individuals with this allele are even genetically susceptible to getting MS. Moreover, because genetic susceptibility seems so similar throughout North America and Europe, environmental differences principally determine the regional variations in disease characteristics. Additionally, despite 75% of MS-patients being women, men are 60% more likely to be genetically-susceptible than women. Also, men develop MS at lower levels of environmental exposure than women. Nevertheless, women are more responsive to the recent changes in environmental-exposure (whatever these have been). This explains both the changing sex-ratio and the increasing disease prevalence (which has increased by a minimum of 32% in Canada over the past 35 years). As noted, environmental risk seems to result from three sequential components of environmental exposure. The potential importance of this Model for MS pathogenesis is that, if correct, a therapeutic strategy, designed to interrupt one or more of these sequential factors, has the potential to markedly reduce or eliminate disease prevalence in the future.	[Goodin, Douglas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu						ADAMS C, 1989, COLOUR ATLAS MULTIPL; ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; ALTER M, 1978, NEUROLOGY, V28, P1089, DOI 10.1212/WNL.28.11.1089; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bager P, 2006, AM J EPIDEMIOL, V163, P1112, DOI 10.1093/aje/kwj148; Barnett MH, 2003, J NEUROL SCI, V213, P1, DOI 10.1016/S0022-510X(03)00122-9; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Cantorna MT, 2000, P SOC EXP BIOL MED, V223, P230, DOI 10.1046/j.1525-1373.2000.22333.x; Celius EG, 2001, EUR J NEUROL, V8, P463, DOI 10.1046/j.1468-1331.2001.00269.x; Chaudhuri A, 2005, MED HYPOTHESES, V64, P608, DOI 10.1016/j.mehy.2004.06.022; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2006, MCALPINES MULTIPLE S, V4th; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Ebers G, 2008, ANN NEUROL, V64, pS66; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Emmons KM, 1999, J NATL CANCER I, V91, P1269, DOI 10.1093/jnci/91.15.1269; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Farrell PJ, 2007, J CLIN INVEST, V117, P2756, DOI 10.1172/JCI33563; Fisher L, 1993, BIOSTATISTICS METHOD; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Gillie O, 2006, BRIT J DERMATOL, V154, P1052, DOI 10.1111/j.1365-2133.2006.07261.x; Goldacre MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1032, DOI 10.1136/jech.2003.018366; GOODIN D, 2008, MULTIPLE SCLEROSI S1, V14; GOODIN DS, ESTABLISHING L UNPUB; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Gronlie SA, 2000, J NEUROL, V247, P129, DOI 10.1007/PL00007793; Haahr S, 2004, ACTA NEUROL SCAND, V109, P270, DOI 10.1046/j.1600-0404.2003.00221.x; Hansen T, 2005, MULT SCLER J, V11, P504, DOI 10.1191/1352458505ms1220oa; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Herrera BM, 2007, NEUROLOGY, V69, P1208, DOI 10.1212/01.wnl.0000268486.40851.d6; Holick MF, 1998, OSTEOPOROSIS INT, V8, pS24, DOI 10.1007/PL00022729; Islam T, 2006, ANN NEUROL, V60, P56, DOI 10.1002/ana.20871; Jablonski NG, 2002, SCI AM, V287, P74, DOI 10.1038/scientificamerican1002-74; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; KAHANA E, 1994, J NEUROL, V241, P341, DOI 10.1007/BF00868444; Kantarci OH, 2006, NEUROLOGY, V67, P305, DOI 10.1212/01.wnl.0000225070.13682.11; Kimball SM, 2007, AM J CLIN NUTR, V86, P645, DOI 10.1093/ajcn/86.3.645; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; Koch-Henriksen N, 1999, MULT SCLER, V5, P293, DOI 10.1191/135245899678846258; KOCHHENRIKSEN N, 1995, ACTA NEUROL SCAND, V91, P55, DOI 10.1111/j.1600-0404.1995.tb05858.x; Kuusisto H, 2008, EUR J NEUROL, V15, P1106, DOI 10.1111/j.1468-1331.2008.02262.x; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; McGuigan C, 2005, J NEUROL, V252, P1245, DOI 10.1007/s00415-005-0850-8; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Munch M, 1998, ACTA NEUROL SCAND, V97, P171; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; MURRY TJ, 2000, MULTIPLE SCLEROSIS D; Myhr KM, 1998, J NEUROL NEUROSUR PS, V64, P539, DOI 10.1136/jnnp.64.4.539; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nielsen NM, 2005, AM J EPIDEMIOL, V162, P774, DOI 10.1093/aje/kwi280; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; Ranzato F, 2003, MULT SCLER J, V9, P387, DOI 10.1191/1352458503ms920oa; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sadovnick AD, 2007, NEUROLOGY, V69, P60, DOI 10.1212/01.wnl.0000265053.22905.64; Sadovnick AD, 2005, LANCET NEUROL, V4, P611, DOI 10.1016/S1474-4422(05)70170-8; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sarasoja T, 2004, ACTA NEUROL SCAND, V110, P331, DOI 10.1111/j.1600-0404.2004.00326.x; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; SHIRODARIA PV, 1987, ARCH NEUROL-CHICAGO, V44, P1237, DOI 10.1001/archneur.1987.00520240019006; SINCLAIR H, 1977, BRIT MED J, V2, P1217, DOI 10.1136/bmj.2.6096.1217; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Suarez F, 1998, J CLIN ENDOCR METAB, V83, P3563, DOI 10.1210/jcem.83.10.5199; SUMAYA CV, 1980, ARCH NEUROL-CHICAGO, V37, P94, DOI 10.1001/archneur.1980.00500510052009; SUMAYA CV, 1985, ANN NEUROL, V17, P371, DOI 10.1002/ana.410170412; Sundstrom P, 2003, J NEUROL NEUROSUR PS, V74, P29, DOI 10.1136/jnnp.74.1.29; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; VAUGHAN JH, 1995, SPRINGER SEMIN IMMUN, V17, P203; Wagner HJ, 2000, VIRAL IMMUNOL, V13, P497, DOI 10.1089/vim.2000.13.497; Wechsler IS, 1922, ARCH NEURO PSYCHIATR, V8, P59, DOI 10.1001/archneurpsyc.1922.02190130062009; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Witte JS, 1999, GENET EPIDEMIOL, V16, P290, DOI 10.1002/(SICI)1098-2272(1999)16:3<290::AID-GEPI5>3.0.CO;2-8	102	105	106	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4565	10.1371/journal.pone.0004565	http://dx.doi.org/10.1371/journal.pone.0004565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242548	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487500003
J	Du, F; Qian, ZM; Zhu, L; Wu, XM; Yung, WH; Tsim, TY; Ke, Y				Du, Fang; Qian, Zhong-ming; Zhu, Li; Wu, Xiao Mei; Yung, Wing-ho; Tsim, Ting-yuk; Ke, Ya			L-DOPA Neurotoxicity Is Mediated by Up-Regulation of DMT1-IRE Expression	PLOS ONE			English	Article							DIVALENT METAL TRANSPORTER-1; INDUCED DYSKINESIA; TRANSFERRIN-FREE; REACTIVE OXYGEN; PLASMA-MEMBRANE; IRON UPTAKE; NEURONS; ASTROCYTES; ISOFORMS; BRAIN	Background: The mechanisms underlying neurotoxicity caused by L-DOPA are not yet completely known. Based on recent findings, we speculated that the increased expression of divalent metal transporter 1 without iron-response element (DMT1-IRE) induced by L-DOPA might play a critical role in the development of L-DOPA neurotoxicity. To test this hypothesis, we investigated the effects of astrocyte-conditioned medium (ACM) and siRNA DMT-IRE on L-DOPA neurotoxicity in cortical neurons. Methods and Findings: We demonstrated that neurons treated with L-DOPA have a significant dose-dependent decrease in neuronal viability (MTT Assay) and increase in iron content (using a graphite furnace atomic absorption spectrophotometer), DMT1-IRE expression (Western blot analysis) and ferrous iron (55Fe(II)) uptake. Neurons incubated in ACM with or without L-DOPA had no significant differences in their morphology, Hoechst-33342 staining or viability. Also, ACM significantly inhibited the effects of L-DOPA on neuronal iron content as well as DMT1-IRE expression. In addition, we demonstrated that infection of neurons with siRNA DMT-IRE led to a significant decrease in DMT1-IRE expression as well as L-DOPA neurotoxicity. Conclusion:The up-regulation of DMT1-IRE and the increase in DMT1-IRE-mediated iron influx play a key role in L-DOPA neurotoxicity in cortical neurons.	[Du, Fang; Wu, Xiao Mei; Yung, Wing-ho; Tsim, Ting-yuk; Ke, Ya] Chinese Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Qian, Zhong-ming; Zhu, Li] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Qian, Zhong-ming; Zhu, Li] Nantong Univ, Dept Neurobiol, Nantong, Peoples R China; [Qian, Zhong-ming; Zhu, Li] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China	Chinese University of Hong Kong; Hong Kong Polytechnic University; Nantong University; Nantong University	Du, F (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	bczmqian@polyu.edu.hk; yake@cuhk.edu.hk	Yung, Ho/R-6161-2018; Ke, Ya/B-3115-2010; Qian, Zhong Ming/E-8884-2016	Yung, Ho/0000-0002-5542-8173; Ke, Ya/0000-0001-8166-6653; 	HKRGC [CUHK466907-KY]; Chinese University of Hong Kong [4450226-KY, 4450273-KY]; RGC-NSFC; Hong Kong Polytechnic University [GU-384, G-YG11]; NKLCMMP; SZ-HK Innovation Circle	HKRGC(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); RGC-NSFC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Hong Kong Polytechnic University(Hong Kong Polytechnic University); NKLCMMP; SZ-HK Innovation Circle	The studies were supported by the Competitive Earmarked Grants of HKRGC (CUHK466907-KY), Direct Grant of Chinese University of Hong Kong (A/C: 4450226-KY and 4450273-KY), RGC-NSFC Grant (KY), research grants from The Hong Kong Polytechnic University (Niche Area-I-BBBL, GU-384 and G-YG11) and NKLCMMP (Shenzhen), and SZ-HK Innovation Circle Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare that we have no financial interests.	Boll MC, 1999, NEUROSCI LETT, V265, P155, DOI 10.1016/S0304-3940(99)00221-9; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Cenci MA, 2007, TRENDS NEUROSCI, V30, P236, DOI 10.1016/j.tins.2007.03.005; Chang YZ, 2006, MOL PHARMACOL, V69, P968, DOI 10.1124/mol.105.017756; Chang YZ, 2005, J CELL PHYSIOL, V204, P623, DOI 10.1002/jcp.20321; DEXTER DT, 1990, J NEUROCHEM, V55, P16, DOI 10.1111/j.1471-4159.1990.tb08814.x; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Fabbrini G, 2007, MOVEMENT DISORD, V22, P1379, DOI 10.1002/mds.21475; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; FOLEY P, 2008, J NEUROL TRANSM S, V60, P1; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Ho KP, 2003, MOL CELL BIOCHEM, V247, P219, DOI 10.1023/A:1024142004575; Jankovic J, 2007, CNS DRUGS, V21, P677, DOI 10.2165/00023210-200721080-00005; Ke Y, 2005, NEUROBIOL AGING, V26, P739, DOI 10.1016/j.neurobiolaging.2004.06.002; LeWitt PA, 2004, NEUROLOGY, V62, pS9, DOI 10.1212/WNL.62.1_suppl_1.S9; Li Z, 2008, J CELL BIOCHEM, V103, P564, DOI 10.1002/jcb.21427; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Mena MA, 1996, NEUROREPORT, V7, P441, DOI 10.1097/00001756-199601310-00016; Olanow W, 2006, NAT CLIN PRACT NEURO, V2, P382, DOI 10.1038/ncpneuro0222; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Qian ZM, 1999, EXP BRAIN RES, V129, P473, DOI 10.1007/s002210050916; Qian ZM, 2000, CELL MOL BIOL, V46, P541; QIAN ZM, 1992, BIOCHIM BIOPHYS ACTA, V1135, P35, DOI 10.1016/0167-4889(92)90163-6; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Wei H, 2008, INT J BIOCHEM CELL B, V40, P651, DOI 10.1016/j.biocel.2007.10.013; Zesiewicz TA, 2007, CURR NEUROL NEUROSCI, V7, P302, DOI 10.1007/s11910-007-0046-y; Zhu L, 2008, J CELL MOL MED, V12, P569, DOI 10.1111/j.1582-4934.2007.00145.x	32	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4593	10.1371/journal.pone.0004593	http://dx.doi.org/10.1371/journal.pone.0004593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240805	Green Published, gold			2022-12-27	WOS:000278086700010
J	Seberg, O; Petersen, G				Seberg, Ole; Petersen, Gitte			How Many Loci Does it Take to DNA Barcode a Crocus?	PLOS ONE			English	Article							LAND PLANTS; PLASTID GENOME; IDENTIFICATION; IDENTIFY; PROGRESS; GENUS; RBCL	Background: DNA barcoding promises to revolutionize the way taxonomists work, facilitating species identification by using small, standardized portions of the genome as substitutes for morphology. The concept has gained considerable momentum in many animal groups, but the higher plant world has been largely recalcitrant to the effort. In plants, efforts are concentrated on various regions of the plastid genome, but no agreement exists as to what kinds of regions are ideal, though most researchers agree that more than one region is necessary. One reason for this discrepancy is differences in the tests that are used to evaluate the performance of the proposed regions. Most tests have been made in a floristic setting, where the genetic distance and therefore the level of variation of the regions between taxa is large, or in a limited set of congeneric species. Methodology and Principal Findings:Here we present the first in-depth coverage of a large taxonomic group, all 86 known species (except two doubtful ones) of crocus. Even six average-sized barcode regions do not identify all crocus species. This is currently an unrealistic burden in a barcode context. Whereas most proposed regions work well in a floristic context, the majority will as is the case in crocus undoubtedly be less efficient in a taxonomic setting. However, a reasonable but less than perfect level of identification may be reached even in a taxonomic context. Conclusions/Significance: The time is ripe for selecting barcode regions in plants, and for prudent examination of their utility. Thus, there is no reason for the plant community to hold back the barcoding effort by continued search for the Holy Grail. We must acknowledge that an emerging system will be far from perfect, fraught with problems and work best in a floristic setting.	[Seberg, Ole; Petersen, Gitte] Nat Hist Museum Denmark, Lab Mol Systemat, Copenhagen, Denmark		Seberg, O (corresponding author), Nat Hist Museum Denmark, Lab Mol Systemat, Copenhagen, Denmark.	oles@snm.ku.dk	Seberg, Ole/A-5111-2013; Petersen, Gitte/H-1903-2011; 赵, 鹏/B-8401-2009	Seberg, Ole/0000-0001-9675-4090; Petersen, Gitte/0000-0002-2325-0059; 	Danish Natural Sciences Research Council [272-06-0436]; Sloan Foundation; Gordon and Betty Moore Foundation	Danish Natural Sciences Research Council(Danish Natural Science Research Council); Sloan Foundation(Alfred P. Sloan Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was supported by the Danish Natural Sciences Research Council (272-06-0436), the Sloan Foundation, and Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAXTER MI, 2001, PHILO T R SOC LOND B, V359, P669; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GOLOBOFF PA, 1999, NONA NO NAMEA VERSIO; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Helfenbein KG, 2005, MOL PHYLOGENET EVOL, V35, P271, DOI 10.1016/j.ympev.2005.01.003; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Kane NC, 2008, MOL ECOL, V17, P5175, DOI 10.1111/j.1365-294X.2008.03972.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kress WJ, 2005, AM J BOT, V92, P167, DOI 10.3732/ajb.92.1.167; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; MADDISON WP, 2000, MACCLADE VERSION 1 0; Mathew B., 1982, CROCUS; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; NIXON KC, 2002, WINGLADA VERSION 1 0; OLUSTEAD RG, 1994, SYST BIOL, V43, P467; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Petersen G, 2008, TAXON, V57, P487, DOI 10.2307/25066017; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Rubinoff Daniel, 2006, Trends Ecol Evol, V21, P1, DOI 10.1016/j.tree.2005.10.019; Sang T, 1997, MOL BIOL EVOL, V14, P994, DOI 10.1093/oxfordjournals.molbev.a025716; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; SWOFFORD DL, 2001, PAUT PHYLOGENETIC AN; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tate JA, 2003, SYST BOT, V28, P723; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280	39	116	140	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4598	10.1371/journal.pone.0004598	http://dx.doi.org/10.1371/journal.pone.0004598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240801	Green Published, gold, Green Submitted			2022-12-27	WOS:000278086700012
J	Fargallo, JA; Martinez-Padilla, J; Vinuela, J; Blanco, G; Torre, I; Vergara, P; De Neve, L				Fargallo, Juan A.; Martinez-Padilla, Jesus; Vinuela, Javier; Blanco, Guillermo; Torre, Ignasi; Vergara, Pablo; De Neve, Liesbeth			Kestrel-Prey Dynamic in a Mediterranean Region: The Effect of Generalist Predation and Climatic Factors	PLOS ONE			English	Article							SMALL-RODENT DYNAMICS; POPULATION-CYCLES; SMALL MAMMALS; DENSITY-DEPENDENCE; FUNCTIONAL-RESPONSES; SEMIARID CHILE; LACERTA-LEPIDA; VOLE; SPECIALIST; ABUNDANCE	Background: Most hypotheses on population limitation of small mammals and their predators come from studies carried out in northern latitudes, mainly in boreal ecosystems. In such regions, many predators specialize on voles and predator-prey systems are simpler compared to southern ecosystems where predator communities are made up mostly of generalists and predator-prey systems are more complex. Determining food limitation in generalist predators is difficult due to their capacity to switch to alternative prey when the basic prey becomes scarce. Methodology: We monitored the population density of a generalist raptor, the Eurasian kestrel Falco tinnunculus over 15 years in a mountainous Mediterranean area. In addition, we have recorded over 11 years the inter-annual variation in the abundance of two main prey species of kestrels, the common vole Microtus arvalis and the eyed lizard Lacerta lepida and a third species scarcely represented in kestrel diet, the great white-toothed shrew Crocidura russula. We estimated the per capita growth rate (PCGR) to analyse population dynamics of kestrel and predator species. Principal Findings: Multimodel inference determined that the PCGR of kestrels was better explained by a model containing the population density of only one prey species (the common vole) than a model using a combination of the densities of the three prey species. The PCGR of voles was explained by kestrel abundance in combination with annual rainfall and mean annual temperature. In the case of shrews, growth rate was also affected by kestrel abundance and temperature. Finally, we did not find any correlation between kestrel and lizard abundances. Significance: Our study showed for the first time vertebrate predator-prey relationships at southern latitudes and determined that only one prey species has the capacity to modulate population dynamics of generalist predators and reveals the importance of climatic factors in the dynamics of micromammal species and lizards in the Mediterranean region.	[Fargallo, Juan A.; Blanco, Guillermo; Vergara, Pablo] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolutiva, E-28006 Madrid, Spain; [Martinez-Padilla, Jesus] Univ Aberdeen, ACES, Aberdeen, Scotland; [Martinez-Padilla, Jesus] Macaulay Inst, Sch Biol Sci, Aberdeen, Scotland; [Vinuela, Javier] UCLM, CSIC, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Torre, Ignasi] Museu Granollers Ciencias Nat, Barcelona, Spain; [De Neve, Liesbeth] Univ Granada, Fac Ciencias, Dept Biol Anim & Ecol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Aberdeen; James Hutton Institute; University of Aberdeen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Granada	Fargallo, JA (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolutiva, E-28006 Madrid, Spain.	fargallo@mncn.csic.es	Blanco, Guillermo/L-3170-2014; De Neve, Liesbeth/F-7896-2011; Martinez-Padilla, Jesus/C-6446-2008; Fargallo, Juan A/I-5585-2015; Vergara, Pablo/G-1860-2010	Blanco, Guillermo/0000-0001-5742-4929; De Neve, Liesbeth/0000-0003-0041-9824; Martinez-Padilla, Jesus/0000-0003-2956-5163; Fargallo, Juan A/0000-0003-4090-9000; Vinuela, Javier/0000-0002-8916-0398	Spanish Ministerio de Educacion Ciencia [CGL2004-04479/BOS, CGL2007-61395/BOS]	Spanish Ministerio de Educacion Ciencia(German Research Foundation (DFG))	The Spanish Ministerio de Educacion Ciencia (Projects: CGL2004-04479/BOS and CGL2007-61395/BOS) financed the study over the last four years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio JM, 2000, ORNIS FENNICA, V77, P169; Berryman A., 1999, PRINCIPLES POPULATIO; Berryman AA, 2001, BASIC APPL ECOL, V2, P311, DOI 10.1078/1439-1791-00069; BERRYMAN AA, 1995, ECOLOGY, V76, P336, DOI 10.2307/1941193; BERRYMAN AA, 1992, ECOLOGY, V73, P694, DOI 10.2307/1940776; Berryman A, 2006, AM NAT, V168, P784, DOI 10.1086/508670; Burnham K. P., 1998, MODEL SELECTION INFE; Costantini D, 2005, BEHAVIOUR, V142, P1403, DOI 10.1163/156853905774539409; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Diaz JA, 2006, J ZOOL, V268, P295, DOI 10.1111/j.1469-7998.2005.00031.x; DIAZ M, 1992, ECOGRAPHY, V15, P77, DOI 10.1111/j.1600-0587.1992.tb00011.x; Dickman CR, 1999, OECOLOGIA, V119, P357, DOI 10.1007/s004420050796; Eccard JA, 2000, J ARID ENVIRON, V46, P103, DOI 10.1006/jare.2000.0659; ERLINGE S, 1983, OIKOS, V40, P36, DOI 10.2307/3544197; Fargallo JA, 2001, BIRD STUDY, V48, P236, DOI 10.1080/00063650109461223; FARGALLO JA, 1999, EFECTO CERNICALO VUL; FUENTES ER, 1985, J ARID ENVIRON, V8, P67, DOI 10.1016/S0140-1963(18)31338-7; Graham IM, 2002, J ANIM ECOL, V71, P946, DOI 10.1046/j.1365-2656.2002.00657.x; GUTIERREZ JR, 1993, ACTA OECOL, V14, P271; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Jedrzejewski W, 1996, J ANIM ECOL, V65, P105, DOI 10.2307/5704; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; KACPERSKA A, 1999, COLD ADAPTED ORGANIS, P79; Klemola T, 2002, OIKOS, V99, P83, DOI 10.1034/j.1600-0706.2002.990109.x; KORPIMAKI E, 1991, ECOLOGY, V72, P814, DOI 10.2307/1940584; Korpimaki E, 2005, J ANIM ECOL, V74, P1150, DOI 10.1111/j.1365-2656.2005.01015.x; Korpimaki E, 2004, BIOSCIENCE, V54, P1071, DOI 10.1641/0006-3568(2004)054[1071:TPOPCA]2.0.CO;2; KORPIMAKI E, 1985, Ornis Fennica, V62, P130; Korpimaki E, 2003, TRENDS ECOL EVOL, V18, P494, DOI 10.1016/S0169-5347(03)00159-9; KORPIMAKI E, 1991, OIKOS, V62, P195, DOI 10.2307/3545265; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Krebs C. J., 1974, ADV ECOL RES, V8, P268; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; Lima M, 2001, J ANIM ECOL, V70, P761, DOI 10.1046/j.0021-8790.2001.00536.x; Lima M, 2006, CLIM RES, V30, P125, DOI 10.3354/cr030125; Lima M, 2002, ECOL LETT, V5, P273, DOI 10.1046/j.1461-0248.2002.00312.x; Lima M, 2006, OIKOS, V112, P555, DOI 10.1111/j.0030-1299.2006.14439.x; MACKINROGALSKA R, 1990, OIKOS, V59, P343, DOI 10.2307/3545144; MESERVE PL, 1995, J MAMMAL, V76, P580, DOI 10.2307/1382367; Meserve PL, 2001, OIKOS, V94, P548, DOI 10.1034/j.1600-0706.2001.940316.x; Morris DW, 1996, ECOLOGY, V77, P2352, DOI 10.2307/2265737; Munster-Swendsen M, 2005, OIKOS, V108, P495, DOI 10.1111/j.0030-1299.2005.13747.x; Newton Ian, 2003, P5; NORRDAHL K, 1995, BIOL REV, V70, P621, DOI 10.1111/j.1469-185X.1995.tb01654.x; ORIANS GH, 1962, AM NAT, V96, P257, DOI 10.1086/282233; Pianka ER, 1983, EVOLUTIONARY ECOLOGY; Rathke D, 2005, ECOL ENG, V24, P149, DOI 10.1016/j.ecoleng.2004.12.013; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; RIVASMARTINEZ S, 1987, VEGETACION ESPANA, P419; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Royama T., 1992, ANAL POPULATION ECOL; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Salvador A, 2004, HERPETOL J, V14, P47; Slade NA, 2000, J MAMMAL, V81, P1035, DOI 10.1644/1545-1542(2000)081<1035:AETOUC>2.0.CO;2; Steffen JE, 2006, AM MIDL NAT, V156, P201, DOI 10.1674/0003-0031(2006)156[201:AOTLLL]2.0.CO;2; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; Stenseth NC, 2003, P NATL ACAD SCI USA, V100, P11478, DOI 10.1073/pnas.1935306100; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1423, DOI 10.1098/rspb.1996.0208; Tkadlec E, 2001, P ROY SOC B-BIOL SCI, V268, P1547, DOI 10.1098/rspb.2001.1694; Torre I, 2004, ACTA OECOL, V25, P137, DOI 10.1016/j.actao.2003.10.007; TORRE I, 2004, THESIS U BARCELONA B, P177; Torre I, 2007, BASIC APPL ECOL, V8, P565, DOI 10.1016/j.baae.2006.09.016; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; VALKAMA J, 2005, BIOL REV, V79, P1; VEIGA JP, 1986, MAMMALIA, V50, P114	70	46	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4311	10.1371/journal.pone.0004311	http://dx.doi.org/10.1371/journal.pone.0004311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234618	Green Published, gold			2022-12-27	WOS:000265487200001
J	He, M; Wang, Y; Li, W				He, Min; Wang, Yi; Li, Wei			PPI Finder: A Mining Tool for Human Protein-Protein Interactions	PLOS ONE			English	Article								Background: The exponential increase of published biomedical literature prompts the use of text mining tools to manage the information overload automatically. One of the most common applications is to mine protein-protein interactions (PPIs) from PubMed abstracts. Currently, most tools in mining PPIs from literature are using co-occurrence-based approaches or rule-based approaches. Hybrid methods (frame-based approaches) by combining these two methods may have better performance in predicting PPIs. However, the predicted PPIs from these methods are rarely evaluated by known PPI databases and co-occurred terms in Gene Ontology (GO) database. Methodology/Principal Findings: We here developed a web-based tool, PPI Finder, to mine human PPIs from PubMed abstracts based on their co-occurrences and interaction words, followed by evidences in human PPI databases and shared terms in GO database. Only 28% of the co-occurred pairs in PubMed abstracts appeared in any of the commonly used human PPI databases (HPRD, BioGRID and BIND). On the other hand, of the known PPIs in HPRD, 69% showed co-occurrences in the literature, and 65% shared GO terms. Conclusions: PPI Finder provides a useful tool for biologists to uncover potential novel PPIs. It is freely accessible at http://liweilab.genetics.ac.cn/tm/.	[He, Min; Wang, Yi; Li, Wei] Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [He, Min] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, M (corresponding author), Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China.	wli@genetics.ac.cn			Hi-Tech Research and Development Program of China [2006AA02Z322]; National Natural Science Foundation of China [30525007, 30730049]; National Basic Research Program of China [2006CB504100, 2006CB500700, 2007CB947200]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by Hi-Tech Research and Development Program of China (No. 2006AA02Z322), National Natural Science Foundation of China (30525007; 30730049), and National Basic Research Program of China (2006CB504100; 2006CB500700; 2007CB947200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2006, TRENDS BIOTECHNOL, V24, P571, DOI 10.1016/j.tibtech.2006.10.002; Blaschke C, 2001, COMP FUNCT GENOM, V2, P310, DOI 10.1002/cfg.102; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; *GENIA, GENIA TAGG; Hao Y, 2005, BIOINFORMATICS, V21, P3294, DOI 10.1093/bioinformatics/bti493; Kim S, 2008, NUCLEIC ACIDS RES, V36, pW411, DOI 10.1093/nar/gkn281; Krallinger M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-224; Li W, 2006, HUM MUTAT, V27, P402, DOI 10.1002/humu.20309; *NCBI, NCBI ENTR GEN; *NCBI, NCBI E UT; Shatkay H, 2003, J COMPUT BIOL, V10, P821, DOI 10.1089/106652703322756104; Temkin JM, 2003, BIOINFORMATICS, V19, P2046, DOI 10.1093/bioinformatics/btg279; Zhou D, 2008, J BIOMED INFORM, V41, P393, DOI 10.1016/j.jbi.2007.11.008	13	57	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4554	10.1371/journal.pone.0004554	http://dx.doi.org/10.1371/journal.pone.0004554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234603	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487200010
J	Lagirand-Cantaloube, J; Cornille, K; Csibi, A; Batonnet-Pichon, S; Leibovitch, MP; Leibovitch, SA				Lagirand-Cantaloube, Julie; Cornille, Karen; Csibi, Alfredo; Batonnet-Pichon, Sabrina; Leibovitch, Marie Pierre; Leibovitch, Serge A.			Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo	PLOS ONE			English	Article								Ubiquitin ligase Atrogin1/Muscle Atrophy F-box ( MAFbx) up-regulation is required for skeletal muscle atrophy but substrates and function during the atrophic process are poorly known. The transcription factor MyoD controls myogenic stem cell function and differentiation, and seems necessary to maintain the differentiated phenotype of adult fast skeletal muscle fibres. We previously showed that MAFbx mediates MyoD proteolysis in vitro. Here we present evidence that MAFbx targets MyoD for degradation in several models of skeletal muscle atrophy. In cultured myotubes undergoing atrophy, MAFbx expression increases, leading to a cytoplasmic-nuclear shuttling of MAFbx and a selective suppression of MyoD. Conversely, transfection of myotubes with sh-RNA-mediated MAFbx gene silencing (shRNAi) inhibited MyoD proteolysis linked to atrophy. Furthermore, overexpression of a mutant MyoDK133R lacking MAFbx-mediated ubiquitination prevents atrophy of mouse primary myotubes and skeletal muscle fibres in vivo. Regarding the complex role of MyoD in adult skeletal muscle plasticity and homeostasis, its rapid suppression by MAFbx seems to be a major event leading to skeletal muscle wasting. Our results point out MyoD as the second MAFbx skeletal muscle target by which powerful therapies could be developed.	[Lagirand-Cantaloube, Julie; Cornille, Karen; Csibi, Alfredo; Leibovitch, Marie Pierre; Leibovitch, Serge A.] INRA, Lab Genom Fonctionnelle Myogenese, UM II, UMR866, Montpellier, France; [Batonnet-Pichon, Sabrina] EA 300, Paris, France	INRAE; Universite de Montpellier	Lagirand-Cantaloube, J (corresponding author), CNRS, IFR122, UMR5237, Montpellier, France.	leibovs@supagro.inra.fr			Association Francaise contre les Myopathies (AFM) [graduate fellowship]; INRA [graduate fellowship]; Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de la Recherche et de la Technologie (MRT) [graduate fellowship]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); INRA; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de la Recherche et de la Technologie (MRT)	This work was supported by grants from the Association Francaise contre les Myopathies (AFM), the department PHASE from INRA and the Institut National de la Sante et de la Recherche Medicale (INSERM). J. Lagirand-Cantaloube held a graduate fellowship from the Ministere de la Recherche et de la Technologie (MRT) and an AFM fellowship. Mr. A. Csibi holds a graduate AFM and INRA fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Allen DL, 2001, J BIOL CHEM, V276, P43524, DOI 10.1074/jbc.M108017200; Batonnet S, 2004, J BIOL CHEM, V279, P5413, DOI 10.1074/jbc.M310315200; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; Ishido M, 2004, ACTA PHYSIOL SCAND, V180, P281, DOI 10.1046/j.0001-6772.2003.01238.x; Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; LIU CC, 2001, CURR RHEUMATOL REP, V4, P325; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sirri V, 2003, ONCOGENE, V22, P5658, DOI 10.1038/sj.onc.1206690; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tintignac LAJ, 2004, MOL CELL BIOL, V24, P1809, DOI 10.1128/MCB.24.4.1809-1821.2004; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	35	148	158	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4973	10.1371/journal.pone.0004973	http://dx.doi.org/10.1371/journal.pone.0004973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319192	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499200011
J	Chen, JJ; Tsai, CH; Cai, X; Horhota, AT; McLaughlin, LW; Szostak, JW				Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Horhota, Allen T.; McLaughlin, Larry W.; Szostak, Jack W.			Enzymatic Primer-Extension with Glycerol-Nucleoside Triphosphates on DNA Templates	PLOS ONE			English	Article								Background: Glycerol nucleic acid (GNA) has an acyclic phosphoglycerol backbone repeat-unit, but forms stable duplexes based on Watson-Crick base-pairing. Because of its structural simplicity, GNA is of particular interest with respect to the possibility of evolving functional polymers by in vitro selection. Template-dependent GNA synthesis is essential to any GNA-based selection system. Principal Findings: In this study, we investigated the ability of various DNA polymerases to use glycerol-nucleoside triphosphates (gNTPs) as substrates for GNA synthesis on DNA templates. Therminator DNA polymerase catalyzes quantitative primer-extension by the incorporation of two glyceronucleotides, with much less efficient extension up to five glyceronucleotides. Steady-state kinetic experiments suggested that GNA synthesis by Therminator was affected by both decreased catalytic rates and weakened substrate binding, especially for pyrimidines. In an attempt to improve pyrimidine incorporation by providing additional stacking interactions, we synthesized two new gNTP analogs with 5-propynyl substituted pyrimidine nucleobases. This led to more efficient incorporation of gC, but not gT. Conclusions: We suggest that directed evolution of Therminator might lead to mutants with improved substrate binding and catalytic efficiency.	[Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Szostak, Jack W.] Massachusetts Gen Hosp, Ctr Comput & Integrative Biol, Boston, MA 02114 USA; [Horhota, Allen T.; McLaughlin, Larry W.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02167 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston College	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu			Harvard Origins of Life Initiative [fellowship]; NSF [CHE 0434507, MCB 0451488]; Howard Hughes Medical Institute	Harvard Origins of Life Initiative; NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	JJC was supported by a fellowship from the Harvard Origins of Life Initiative. This work was supported by NSF grants CHE 0434507 to JWS and MCB 0451488 to LWM. JWS is an Investigator of the Howard Hughes Medical Institute and CHT is a Research Associate of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner SA, 2004, ACCOUNTS CHEM RES, V37, P784, DOI 10.1021/ar040004z; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Chaput JC, 2003, J AM CHEM SOC, V125, P9274, DOI 10.1021/ja035917n; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; FROEHLER BC, 1992, TETRAHEDRON LETT, V33, P5307, DOI 10.1016/S0040-4039(00)79079-4; FROEHLER BC, 1983, NUCLEIC ACIDS RES, V11, P8031, DOI 10.1093/nar/11.22.8031; He JL, 2002, NUCLEIC ACIDS RES, V30, P5485, DOI 10.1093/nar/gkf689; Heuberger BD, 2008, J AM CHEM SOC, V130, P412, DOI 10.1021/ja0770680; HOBBS FW, 1989, J ORG CHEM, V54, P3420, DOI 10.1021/jo00275a030; Horhota A, 2005, J AM CHEM SOC, V127, P7427, DOI 10.1021/ja0428255; Horhota AT, 2006, ORG LETT, V8, P5345, DOI 10.1021/ol062232u; Kempeneers V, 2005, NUCLEIC ACIDS RES, V33, P3828, DOI 10.1093/nar/gki695; Kuwahara M, 2008, NUCLEIC ACIDS RES, V36, P4257, DOI 10.1093/nar/gkn404; Kuwahara M, 2006, NUCLEIC ACIDS RES, V34, P5383, DOI 10.1093/nar/gkl637; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; ROBINS MJ, 1983, J ORG CHEM, V48, P1854, DOI 10.1021/jo00159a012; Sakthivel K, 1998, ANGEW CHEM INT EDIT, V37, P2872, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2872::AID-ANIE2872>3.0.CO;2-5; Sawai H, 2001, CHEM COMMUN, P2604, DOI 10.1039/b107838k; Schlegel MK, 2008, J AM CHEM SOC, V130, P8158, DOI 10.1021/ja802788g; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Seela F, 2007, ORG BIOMOL CHEM, V5, P1858, DOI 10.1039/b704583b; Tsai CH, 2007, P NATL ACAD SCI USA, V104, P14598, DOI 10.1073/pnas.0704211104; Wang JX, 2005, NUCLEOS NUCLEOT NUCL, V24, P947, DOI 10.1081/NCN-200059307; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Yang YW, 2007, J MOL EVOL, V65, P289, DOI 10.1007/s00239-007-9017-9; Zhang LL, 2005, J AM CHEM SOC, V127, P4174, DOI 10.1021/ja042564z; Zhang LL, 2005, J AM CHEM SOC, V127, P74, DOI 10.1021/ja043904j; Zhang Y, 2005, IEEE T WIREL COMMUN, V4, P653, DOI 10.1109/TWC.2004.842947	28	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4949	10.1371/journal.pone.0004949	http://dx.doi.org/10.1371/journal.pone.0004949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305495	gold, Green Published, Green Submitted			2022-12-27	WOS:000265498800006
J	Li, S; Rao, LL; Ren, XP; Bai, XW; Zheng, R; Li, JZ; Wang, ZJ; Liu, H				Li, Shu; Rao, Li-Lin; Ren, Xiao-Peng; Bai, Xin-Wen; Zheng, Rui; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan			Psychological Typhoon Eye in the 2008 Wenchuan Earthquake	PLOS ONE			English	Article							PERCEPTION; RISK	Background: On May 12, 2008, an earthquake measuring 8.0 on the Richter scale jolted Wenchuan, China, leading to 69,227 deaths and 374,643 injured, with 17,923 listed as missing as of Sept. 25, 2008, and shook the whole nation. We assessed the devastating effects on people's post-earthquake concern about safety and health. Methodology/Principal Findings: From June 4 to July 15, 2008, we surveyed a convenience sample of 2,262 adults on their post-earthquake concern about safety and health. Residents in non-devastated areas (Fujian and Hunan Provinces, and Beijing) and devastated areas (Sichuan and Gansu Provinces) responded to a questionnaire of 5 questions regarding safety measures, epidemic disease, medical workers, psychological workers, and medication. The ANOVAs showed a significant effect of residential devastation level on the estimated number of safety measures needed, the estimated probability of the outbreak of an epidemic, and the estimated number of medical and psychological workers needed (Ps<0.001). The post-earthquake concern decreased significantly as the level of residential devastation increased. Because of the similarity with the meteorological phenomenon of the eye of a typhoon, we dubbed these findings a "Psychological Typhoon Eye'': the closer to the center of the devastated areas, the less the concern about safety and health a resident felt. Conclusions/Significance: Contrary to common perception and ripple effect that the impact of an unfortunate event decays gradually as ripples spread outward from a center, a "Psychological Typhoon Eye'' effect was observed where the post-earthquake concern was at its lowest level in the extremely devastated areas. The resultant findings may have implications for Chinese governmental strategies for putting "psychological comfort'' into effect.	[Li, Shu; Rao, Li-Lin; Ren, Xiao-Peng; Bai, Xin-Wen; Zheng, Rui; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Ren, XP (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	renxp@psych.ac.cn; baixw@psych.ac.cn; zhengrui@psych.ac.cn	Xinwen, Bai/A-3827-2014	Xinwen, Bai/0000-0002-4750-4164	Hundred Talents Program of Chinese Academy of Sciences [KSCX2-YW-R-130]; Knowledge Innovation Project of the Chinese Academy of Sciences [KKCX1-YW-05]; National Natural Science Foundation of China [70671099]	Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the "Hundred Talents Program" of Chinese Academy of Sciences, the Knowledge Innovation Project of the Chinese Academy of Sciences (No. KSCX2-YW-R-130; KKCX1-YW-05) and the National Natural Science Foundation of China (No. 70671099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DEATH TOLL CHIN MAY; [Anonymous], 2007, 17 NAT C COMM PART C; Chen WK, 2001, ANN EMERG MED, V38, P556, DOI 10.1067/mem.2001.119054; *CHIN MED ASS, 2008, MESS PRES CHIN MED A; Festinger L., 1957, THEORY COGNITIVE DIS, V2; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G., 1991, EUROPEAN REV SOCIAL, V2, P83, DOI [https://doi.org/10.1080/14792779143000033, DOI 10.1080/14792779143000033, 10.1080/14792779143000033]; Guedeney C., 1973, ANGOISSE ATOMIQUE CE; HENDERSON AS, 1972, LANCET, V1, P1111; KUAI YH, 2008, SO PEOPLE WEEKL 0601, P56; [梁哲 LIANG Zhe], 2008, [自然灾害学报, Journal of Natural Disasters], V17, P25; MADERTHANER R, 1978, J APPL PSYCHOL, V63, P380, DOI 10.1037/0021-9010.63.3.380; MAGNIER M, 2008, LOS ANGELES TIM 0517, pA1; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; *TREE HUGG, 2008, AFT CHIN EARTHQ GRAS; Wilson H.V., 1904, MEMOIRS MUSEUM COMP, V30, P139; *XINH NEWS AG, 2008, HU URG WWELF I CONTR; *XINH NEWS AG, 2008, CHIN SAYS BLOOD EN M; Zhang K, 2007, JPN PSYCHOL RES, V49, P172, DOI 10.1111/j.1468-5884.2007.00344.x	20	43	51	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4964	10.1371/journal.pone.0004964	http://dx.doi.org/10.1371/journal.pone.0004964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PG	19305501	gold, Green Submitted, Green Published			2022-12-27	WOS:000265498800012
J	Wetzels, CTAH; Hoefnagel, JGM; Bakkers, JMJE; Dijkman, HBPM; Blokx, WAM; Melchers, WJG				Wetzels, Charlotte T. A. H.; Hoefnagel, Jolanda G. M.; Bakkers, Judith M. J. E.; Dijkman, Henry B. P. M.; Blokx, Willeke A. M.; Melchers, Willem J. G.			Ultrastructural Proof of Polyomavirus in Merkel Cell Carcinoma Tumour Cells and Its Absence in Small Cell Carcinoma of the Lung	PLOS ONE			English	Article								Background: A new virus called the Merkel Cell Polyomavirus (MCPyV) has recently been found in Merkel Cell Carcinoma (MCC). MCC is a rare aggressive small cell neuroendocrine carcinoma primarily derived from the skin, morphologically indistinguishable from small cell lung carcinoma (SCLC). So far the actual presence of the virus in MCC tumour cells on a morphological level has not been demonstrated, and the presence of MCPyV in other small cell neuroendocrine carcinomas has not been studied yet. Methodology/Principal Findings: We investigated MCC tissue samples from five patients and SCLCs from ten patients for the presence of MCPyV-DNA by PCR and sequencing. Electron microscopy was used to search ultrastructurally for morphological presence of the virus in MCPyV-DNA positive samples. MCPyV was detected in two out of five primary MCCs. In one MCC patient MCPyV-DNA was detected in the primary tumour as well as in the metastasis, strongly suggesting integration of MCPyV in the cellular DNA of the tumour in this patient. In the primary MCC of another patient viral particles in tumour cell nuclei and cytoplasm were identified by electron microscopy, indicating active viral replication in the tumour cells. In none of the SCLCs MCPyV-DNA was detected. Conclusions/Significance: Our results strongly suggest that MCPyV is an oncogenic polyomavirus in humans, and is potentially causally related to the development of MCC but not to the morphological similar SCLC.	[Wetzels, Charlotte T. A. H.; Dijkman, Henry B. P. M.; Blokx, Willeke A. M.] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Hoefnagel, Jolanda G. M.; Bakkers, Judith M. J. E.; Melchers, Willem J. G.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Wetzels, CTAH (corresponding author), Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	C.Wetzels@pathol.umcn.nl	Blokx, W.A.M./L-4205-2015; Melchers, Willem/C-8819-2015	Blokx, Willeke/0000-0002-4647-8830; Melchers, Willem/0000-0002-5446-2230				BECKER JC, 2008, J INVEST DE IN PRESS; Bialasiewicza S, 2007, J CLIN VIROL, V40, P9, DOI 10.1016/j.jcv.2007.07.015; CLAAS ECJ, 1989, AM J PATHOL, V135, P703; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; GARNESKI KM, 2008, J INVEST DERMATOL; GRECO FA, 1979, NEW ENGL J MED, V301, P355, DOI 10.1056/NEJM197908163010704; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; HAYAT MA, 1989, PRINCIPLES TECHNIQUE, P38; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Hoevenaars BM, 2008, INT J CANCER, V123, P2767, DOI 10.1002/ijc.23857; HOGAN TF, 1980, ANN INTERN MED, V92, P373, DOI 10.7326/0003-4819-92-3-373; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Krasagakis K, 2003, INT J DERMATOL, V42, P669, DOI 10.1046/j.1365-4362.2003.01912.x; Lewis KG, 2006, ARCH DERMATOL, V142, P693, DOI 10.1001/archderm.142.6.693; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Penn I, 1999, TRANSPLANTATION, V68, P1717, DOI 10.1097/00007890-199912150-00015; Poulin DL, 2006, J CLIN ONCOL, V24, P4356, DOI 10.1200/JCO.2005.03.7101; Poulsen M, 2004, LANCET ONCOL, V5, P593, DOI 10.1016/S1470-2045(04)01593-1; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; van der Heijden HFM, 2005, SOUTH MED J, V98, P345, DOI 10.1097/01.SMJ.0000145724.40477.50; van Hamont D, 2008, CARCINOGENESIS, V29, P840, DOI 10.1093/carcin/bgm287; Van Harmont D, 2008, REV MED VIROL, V18, P117, DOI 10.1002/rmv.561; zur Hausen H, 2008, INT J CANCER, V123, P247, DOI 10.1002/ijc.23620	25	52	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4958	10.1371/journal.pone.0004958	http://dx.doi.org/10.1371/journal.pone.0004958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305499	Green Published, Green Submitted, gold			2022-12-27	WOS:000265498800009
J	Wilson, A; Bonevski, B; Jones, A; Henry, D				Wilson, Amanda; Bonevski, Billie; Jones, Alison; Henry, David			Media Reporting of Health Interventions: Signs of Improvement, but Major Problems Persist	PLOS ONE			English	Article							HORMONE-THERAPY; SCIENTIFIC MEETINGS; NEWSPAPER COVERAGE; NEWS MEDIA; AUSTRALIA; IMPACT; INFORMATION; JOURNALISM; STORIES; SCIENCE	Background: Studies have persistently shown deficiencies in medical reporting by the mainstream media. We have been monitoring the accuracy and comprehensiveness of medical news reporting in Australia since mid 2004. This analysis of more than 1200 stories in the Australian media compares different types of media outlets and examines reporting trends over time. Methods and Findings: Between March 2004 and June 2008 1230 news stories were rated on a national medical news monitoring web site, Media Doctor Australia. These covered a variety of health interventions ranging from drugs, diagnostic tests and surgery to dietary and complementary therapies. Each story was independently assessed by two reviewers using ten criteria. Scores were expressed as percentages of total assessable items deemed satisfactory according to a coding guide. Analysis of variance was used to compare mean scores and Fishers exact test to compare proportions. Trends over time were analysed using un-weighted linear regression analysis. Broadsheet newspapers had the highest average satisfactory scores: 58% (95% CI 56-60%), compared with tabloid newspapers and online news outlets, 48% (95% CI 44-52) and 48% (95% CI 46-50) respectively. The lowest scores were assigned to stories broadcast by human interest/current affairs television programmes (average score 33% (95% CI 28-38)). While there was a non-significant increase in average scores for all outlets, a significant improvement was seen in the online news media: a rise of 5.1% (95% CI 1.32, 8.97; P 0.009). Statistically significant improvements were seen in coverage of the potential harms of interventions, the availability of treatment or diagnostic options, and accurate quantification of benefits. Conclusion: Although the overall quality of medical reporting in the general media remains poor, this study showed modest improvements in some areas. However, the most striking finding was the continuing very poor coverage of health news by commercial current affairs television programs.	[Wilson, Amanda; Jones, Alison] Univ Newcastle, Sch Med & Publ Hlth, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia; [Bonevski, Billie] Univ Newcastle, Sch Med & Publ Hlth, CHeRP, Newcastle, NSW 2308, Australia; [Henry, David] Sunnybrook Hlth Sci Ctr, Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Newcastle; University of Newcastle; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Wilson, A (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia.	amanda.j.wilson@studentmail.newcastle.edu.au	Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020; Bonevski, Billie/G-7298-2013	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242; Bonevski, Billie/0000-0001-8505-622X; Wilson, Amanda/0000-0001-5681-9611	Hunter Medical Research Institute; University of Newcastle	Hunter Medical Research Institute; University of Newcastle	Media Doctor Australia has received funding over the past two years from the Hunter Medical Research Institute and the University of Newcastle. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce T., 2006, JOURNALISM STUD, V7, P879; Brunt ME, 2003, J GEN INTERN MED, V18, P84, DOI 10.1046/j.1525-1497.2003.20502.x; Cassells A, 2008, OPEN MED, V2, pe20; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Cooper CP, 2002, SOC SCI MED, V54, P1887, DOI 10.1016/S0277-9536(01)00160-5; Corrigan PW, 2005, PSYCHIAT SERV, V56, P551, DOI 10.1176/appi.ps.56.5.551; Dolan G, 2004, INT J CONSUM STUD, V28, P147, DOI DOI 10.1111/J.1470-6431.2003.00363.X; Durrant R, 2003, TOB CONTROL, V12, P75; Geller G, 2003, SOC SCI MED, V56, P2211, DOI 10.1016/S0277-9536(02)00237-X; Haas JS, 2007, J GEN INTERN MED, V22, P68, DOI 10.1007/s11606-007-0122-7; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; Hodgetts D, 2008, HEALTH-LONDON, V12, P43, DOI 10.1177/1363459307083697; JACKSON L, 2005, MEDIAWATCH DEJA VU K; Larsson Anna, 2003, Health Expect, V6, P323, DOI 10.1046/j.1369-7625.2003.00228.x; LI M, 2007, HLTH ED RES; MACHILL M, 2006, JOURNALISM STUDIES, V7; MacKenzie R, 2007, MED J AUSTRALIA, V187, P507, DOI 10.5694/j.1326-5377.2007.tb01391.x; Majumdar SR, 2004, JAMA-J AM MED ASSOC, V292, P1983, DOI 10.1001/jama.292.16.1983; Miranda GF, 2004, PHARMACOL RES, V50, P267, DOI 10.1016/j.phrs.2003.12.021; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Niederkrotenthaler T, 2007, AUST NZ J PSYCHIAT, V41, P419, DOI 10.1080/00048670701266680; Ooi ES, 2003, MED J AUSTRALIA, V179, P639, DOI 10.5694/j.1326-5377.2003.tb05728.x; *OZT, 2008, E02002559 OZT; Passalacqua R, 2004, CANCER, V100, P1077, DOI 10.1002/cncr.20050; Pirkis JE, 2006, SOC SCI MED, V62, P2874, DOI 10.1016/j.socscimed.2005.11.033; *REV COMM MICR CAN, 2005, REV US MICR THER TRE; ROY E, 2008, FAIRFAX STANDING GRO; Schwartz LM, 2002, JAMA-J AM MED ASSOC, V287, P2859, DOI 10.1001/jama.287.21.2859; Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Smith BJ, 2006, AM J PREV MED, V31, P492, DOI 10.1016/j.amepre.2006.08.001; Smith DE, 2005, MED J AUSTRALIA, V183, P190, DOI 10.5694/j.1326-5377.2005.tb06992.x; Voss M., 2003, NIEMAN REPORTS, V57, P46; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Woloshin S, 2006, MED J AUSTRALIA, V184, P576, DOI 10.5694/j.1326-5377.2006.tb00384.x	35	62	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4831	10.1371/journal.pone.0004831	http://dx.doi.org/10.1371/journal.pone.0004831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293924	Green Published, gold			2022-12-27	WOS:000265496600002
J	Scotcher, MC; McGarvey, JA; Johnson, EA; Stanker, LH				Scotcher, Miles C.; McGarvey, Jeffery A.; Johnson, Eric A.; Stanker, Larry H.			Epitope Characterization and Variable Region Sequence of F1-40, a High-Affinity Monoclonal Antibody to Botulinum Neurotoxin Type A (Hall Strain)	PLOS ONE			English	Article								Background: Botulism, an often fatal neuroparalytic disease, is caused by botulinum neurotoxins (BoNT) which consist of a family of seven serotypes (A-H) produced by the anaerobic bacterium Clostridium botulinum. BoNT, considered the most potent biological toxin known, is a 150 kDa protein consisting of a 100 kDa heavy-chain (Hc) and a 50 kDa light-chain (Lc). F1-40 is a mouse-derived, IgG1 monoclonal antibody that binds the light chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection. We report the fine epitope mapping of F1-40 and the deduced amino acid sequence of the variable regions of the heavy and light chains of the antibody. Methods and Findings: To characterize the binding epitope of F1-40, three complementary experimental approaches were selected. Firstly, recombinant peptide fragments of BoNT/A light-chain were used in Western blots to identify the epitope domains. Secondly, a peptide phage-display library was used to identify the specific amino acid sequences. Thirdly, the three-dimensional structure of BoNT/A was examined in silico, and the amino acid sequences determined from the phage-display studies were mapped onto the three-dimensional structure in order to visualize the epitope. F1-40 was found to bind a peptide fragment of BoNT/A, designated L1-3, which spans from T125 to L200. The motif QPDRS was identified by phage-display, and was mapped to a region within L1-3. When the three amino acids Q138, P139 and D140 were all mutated to glycine, binding of F1-40 to the recombinant BoNT/A light chain peptide was abolished. Q-138, P-139 and D-140 form a loop on the external surface of BoNT/A, exposed to solvent and accessible to F1-40 binding. Conclusions: The epitope of F1-40 was localized to a single exposed loop (beta 4, beta 5) on the Lc of BoNT. Furthermore amino acids Q138, P139 and D140 forming the tip of the loop appear critical for binding.	[Scotcher, Miles C.; McGarvey, Jeffery A.; Stanker, Larry H.] ARS, USDA, Western Reg Res Ctr, Albany, CA USA; [Johnson, Eric A.] Univ Wisconsin, Food Res Inst, Dept Bacteriol, Madison, WI 53706 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Scotcher, MC (corresponding author), ARS, USDA, Western Reg Res Ctr, Albany, CA USA.	lstanker@pw.usda.gov			United States Department of Agriculture, Agricultural Research Service, CRIS [5325-42000-043-00D]	United States Department of Agriculture, Agricultural Research Service, CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the United States Department of Agriculture, Agricultural Research Service, CRIS project 5325-42000-043-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Arndt JW, 2005, BIOCHEMISTRY-US, V44, P9574, DOI 10.1021/bi0505924; ARNON SS, 2001, JAMA-J AM MED ASSOC, V85, P1059; Brin MF, 1997, MUSCLE NERVE, pS146; CHENG L, 2008, 45 INT BOT RES COORD, pA8; Dolimbek BZ, 2008, MOL IMMUNOL, V45, P910, DOI 10.1016/j.molimm.2007.08.007; GIBB G, 2007, CASTLEBERRYS FOODS M; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Ginsberg M. M., 2007, Morbidity and Mortality Weekly Report, V56, P767; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hengen PN, 1996, TRENDS BIOCHEM SCI, V21, P400, DOI 10.1016/S0968-0004(96)30035-2; Hill HR, 1996, MOL MICROBIOL, V20, P685, DOI 10.1111/j.1365-2958.1996.tb02508.x; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; LAMANNA C, 1959, SCIENCE, V130, P763, DOI 10.1126/science.130.3378.763; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Li Y, 2008, VACCINE, V26, P1263, DOI 10.1016/j.vaccine.2007.11.055; Li Y, 2007, J IMMUNOL METHODS, V325, P1, DOI 10.1016/j.jim.2007.05.005; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Manoutcharian K., 2001, Current Pharmaceutical Biotechnology, V2, P217; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; MORRISON S, 2002, CURRENT PROTOCOLS IM; Mullaney BP, 2001, INFECT IMMUN, V69, P6511, DOI 10.1128/IAI.69.10.6511-6514.2001; Niwa K, 2007, FEMS IMMUNOL MED MIC, V49, P346, DOI 10.1111/j.1574-695X.2006.00205.x; RECINOS A, 1995, GENE, V158, P311, DOI 10.1016/0378-1119(95)00097-P; RECINOS A, 1994, GENE, V149, P385, DOI 10.1016/0378-1119(94)90185-6; REYNOLDS G, 2007, CASTLEBERRYS RECALL; Sharma SK, 2005, J FOOD PROTECT, V68, P1256, DOI 10.4315/0362-028X-68.6.1256; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; WOOD DL, 1984, P NATL ACAD SCI-BIOL, V81, P4756, DOI 10.1073/pnas.81.15.4756; Wu HC, 2001, APPL ENVIRON MICROB, V67, P3201, DOI 10.1128/AEM.67.7.3201-3207.2001; Zilinskas RA, 1997, JAMA-J AM MED ASSOC, V278, P418, DOI 10.1001/jama.278.5.418	42	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4924	10.1371/journal.pone.0004924	http://dx.doi.org/10.1371/journal.pone.0004924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290051	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496500018
J	Wang, JB; Fang, SG; Xiao, H; Chen, B; Tam, JP; Liu, DX				Wang, Jibin; Fang, Shouguo; Xiao, Han; Chen, Bo; Tam, James P.; Liu, Ding Xiang			Interaction of the Coronavirus Infectious Bronchitis Virus Membrane Protein with beta-Actin and Its Implication in Virion Assembly and Budding	PLOS ONE			English	Article								Coronavirus M protein is an essential component of virion and plays pivotal roles in virion assembly, budding and maturation. The M protein is integrated into the viral envelope with three transmembrane domains flanked by a short amino-terminal ectodomain and a large carboxy-terminal endodomain. In this study, we showed co-purification of the M protein from coronavirus infectious bronchitis virus (IBV) with actin. To understand the cellular factors that may be involved in virion assembly, budding and maturation processes, IBV M was used as the bait in a yeast two-hybrid screen, resulting in the identification of beta-actin as a potentially interacting partner. This interaction was subsequently confirmed by coimmunoprecipitation and immunofluorescence microscopy in mammalian cells, and mutation of amino acids A159 and K160 on the M protein abolished the interaction. Introduction of the A159-K160 mutation into an infectious IBV clone system blocks the infectivity of the clone, although viral RNA replication and subgenomic mRNA transcription were actively detected. Disruption of actin filaments with cell-permeable agent cytochalasin D at early stages of the infection cycle led to the detection of viral protein synthesis in infected cells but not release of virus particles to the cultured media. However, the same treatment at late stages of the infection cycle did not affect the release of virus particles to the media, suggesting that disruption of the actin filaments might block virion assembly and budding, but not release of the virus particles. This study reveals an essential function of actin in the replication cycle of coronavirus.			Liu, DX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	dxliu@imcb.a-star.edu.sg	Liu, Ding Xiang/A-2226-2011; Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X				ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; EHRNST A, 1975, CELL, V5, P351, DOI 10.1016/0092-8674(75)90053-7; EHRNST A, 1976, EXP CELL BIOL, V44, P198; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020; FLEISSNER E, 1973, J VIROL, V11, P250, DOI 10.1128/JVI.11.2.250-262.1973; Gardet A, 2006, J VIROL, V80, P3947, DOI 10.1128/JVI.80.8.3947-3956.2006; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; Gissen P, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050294; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; GRAZI E, 1989, BIOCHEM INT, V19, P1345; Griffiths G, 1992, Semin Cell Biol, V3, P367, DOI 10.1016/1043-4682(92)90022-N; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; KRIJNSELOCKER J, 1992, J BIOL CHEM, V267, P14094; Lai MMC, 1998, VIROLOGY, V244, P1, DOI 10.1006/viro.1998.9098; LAMB RA, 1976, VIROLOGY, V69, P116, DOI 10.1016/0042-6822(76)90199-9; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; LIU DX, 1991, VIROLOGY, V185, P911, DOI 10.1016/0042-6822(91)90572-S; Liu DX, 1997, J VIROL, V71, P1814, DOI 10.1128/JVI.71.3.1814-1820.1997; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Narayanan K, 2003, J VIROL, V77, P2922, DOI 10.1128/JVI.77.5.2922-2927.2003; Nguyen VP, 1997, J VIROL, V71, P9278, DOI 10.1128/JVI.71.12.9278-9284.1997; Ogino T, 2003, BIOCHEM BIOPH RES CO, V311, P283, DOI 10.1016/j.bbrc.2003.09.205; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; OREILLY G, 1993, FEBS LETT, V321, P69, DOI 10.1016/0014-5793(93)80623-3; ORVELL C, 1978, J GEN VIROL, V41, P527, DOI 10.1099/0022-1317-41-3-527; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Rottier PJM, 1995, CORONAVIRIDAE, P115; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; STERN DF, 1982, J VIROL, V42, P208, DOI 10.1128/JVI.42.1.208-219.1982; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Surjit M, 2004, BIOCHEM J, V383, P13, DOI 10.1042/BJ20040984; TYRRELL DLJ, 1978, J GEN VIROL, V39, P219, DOI 10.1099/0022-1317-39-2-219; VANDEKERCKHOVE J, 1992, Current Opinion in Cell Biology, V4, P36, DOI 10.1016/0955-0674(92)90056-I; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Zhou B, 2008, J VIROL, V82, P6962, DOI 10.1128/JVI.00133-08	42	38	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4908	10.1371/journal.pone.0004908	http://dx.doi.org/10.1371/journal.pone.0004908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287488	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400024
J	Hamada, H; Tashima, Y; Kisaka, Y; Iwamoto, K; Hanai, T; Eguchi, Y; Okamoto, M				Hamada, Hiroyuki; Tashima, Yoshihiko; Kisaka, Yu; Iwamoto, Kazunari; Hanai, Taizo; Eguchi, Yukihiro; Okamoto, Masahiro			Sophisticated Framework between Cell Cycle Arrest and Apoptosis Induction Based on p53 Dynamics	PLOS ONE			English	Article							MOLECULAR INTERACTION MAP; P53-MDM2 FEEDBACK LOOP; DNA-REPAIR; G1/S PHASE; RADIATION; DATABASE	The tumor suppressor, p53, regulates several gene expressions that are related to the DNA repair protein, cell cycle arrest and apoptosis induction, which activates the implementation of both cell cycle arrest and induction of apoptosis. However, it is not clear how p53 specifically regulates the implementation of these functions. By applying several well-known kinetic mathematical models, we constructed a novel model that described the influence that DNA damage has on the implementation of both the G2/M phase cell cycle arrest and the intrinsic apoptosis induction via its activation of the p53 synthesis process. The model, which consisted of 32 dependent variables and 115 kinetic parameters, was used to examine interference by DNA damage in the implementation of both G2/M phase cell cycle arrest and intrinsic apoptosis induction. A low DNA damage promoted slightly the synthesis of p53, which showed a sigmoidal behavior with time. In contrast, in the case of a high DNA damage, the p53 showed an oscillation behavior with time. Regardless of the DNA damage level, there were delays in the G2/M progression. The intrinsic apoptosis was only induced in situations where grave DNA damage produced an oscillation of p53. In addition, to wreck the equilibrium between Bcl-2 and Bax the induction of apoptosis required an extreme activation of p53 produced by the oscillation dynamics, and was only implemented after the release of the G2/M phase arrest. When the p53 oscillation is observed, there is possibility that the cell implements the apoptosis induction. Moreover, in contrast to the cell cycle arrest system, the apoptosis induction system is responsible for safeguarding the system that suppresses malignant transformations. The results of these experiments will be useful in the future for elucidating of the dominant factors that determine the cell fate such as normal cell cycles, cell cycle arrest and apoptosis.	[Hamada, Hiroyuki; Tashima, Yoshihiko; Kisaka, Yu; Iwamoto, Kazunari; Hanai, Taizo; Okamoto, Masahiro] Kyushu Univ, Lab Bioinformat, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Eguchi, Yukihiro] Kyushu Univ, Bio Architecture Ctr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Hamada, H (corresponding author), Kyushu Univ, Lab Bioinformat, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	okahon@brs.kyushu-u.ac.jp		Iwamoto, Kazunari/0000-0001-9794-9420				Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Iwamoto K, 2008, BIOSYSTEMS, V94, P109, DOI 10.1016/j.biosystems.2008.05.016; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li G, 1998, BRIT J DERMATOL, V139, P3; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; NOVAK B, 1993, J CELL SCI, V106, P1153; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Sekiguchi Tatsuya, 2006, Journal of Bioinformatics and Computational Biology, V4, P621, DOI 10.1142/S0219720006002132; Sun Y, 2005, INVEST OPHTH VIS SCI, V46, P1561, DOI 10.1167/iovs.04-1362; TASHIMA Y, 2006, P INT FED MED BIOL E, V14, P195; Tashima Y, 2008, J BIOSCI BIOENG, V106, P368, DOI 10.1263/jbb.106.368; Theron T, 1998, CELL PROLIFERAT, V31, P49, DOI 10.1046/j.1365-2184.1998.00107.x; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Voit E. O., 2000, COMPUTATIONAL ANAL B; YOSHIMURA J, 2003, CHEM BIO INFO J, V3, P114; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705	29	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4795	10.1371/journal.pone.0004795	http://dx.doi.org/10.1371/journal.pone.0004795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274075	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496000028
J	Singer, MS; Mace, KC; Bernays, EA				Singer, Michael S.; Mace, Kevi C.; Bernays, Elizabeth A.			Self-Medication as Adaptive Plasticity: Increased Ingestion of Plant Toxins by Parasitized Caterpillars	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; PHENOTYPIC PLASTICITY; NEST MATERIAL; DIET CHOICE; GENERALIST; RESISTANCE; BEHAVIOR; CONSEQUENCES; PARASITOIDS; CHIMPANZEES	Self-medication is a specific therapeutic behavioral change in response to disease or parasitism. The empirical literature on self-medication has so far focused entirely on identifying cases of self-medication in which particular behaviors are linked to therapeutic outcomes. In this study, we frame self-medication in the broader realm of adaptive plasticity, which provides several testable predictions for verifying self-medication and advancing its conceptual significance. First, self-medication behavior should improve the fitness of animals infected by parasites or pathogens. Second, self-medication behavior in the absence of infection should decrease fitness. Third, infection should induce self-medication behavior. The few rigorous studies of self-medication in non-human animals have not used this theoretical framework and thus have not tested fitness costs of self-medication in the absence of disease or parasitism. Here we use manipulative experiments to test these predictions with the foraging behavior of woolly bear caterpillars (Grammia incorrupta; Lepidoptera: Arctiidae) in response to their lethal endoparasites (tachinid flies). Our experiments show that the ingestion of plant toxins called pyrrolizidine alkaloids improves the survival of parasitized caterpillars by conferring resistance against tachinid flies. Consistent with theoretical prediction, excessive ingestion of these toxins reduces the survival of unparasitized caterpillars. Parasitized caterpillars are more likely than unparasitized caterpillars to specifically ingest large amounts of pyrrolizidine alkaloids. This case challenges the conventional view that self-medication behavior is restricted to animals with advanced cognitive abilities, such as primates, and empowers the science of self-medication by placing it in the domain of adaptive plasticity theory.	[Singer, Michael S.; Mace, Kevi C.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Bernays, Elizabeth A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Wesleyan University; University of Arizona	Singer, MS (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.	msinger@wesleyan.edu			NSF [IOS 0744676]; Wesleyan University; Division Of Integrative Organismal Systems [0744676] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Wesleyan University; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grant IOS 0744676 and Wesleyan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; BERENBAUM MR, 1992, EVOLUTION, V46, P1373, DOI 10.1111/j.1558-5646.1992.tb01130.x; Bernays EA, 2005, NATURE, V436, P476, DOI 10.1038/436476a; Bernays EA, 2002, PHYSIOL ENTOMOL, V27, P312, DOI 10.1046/j.1365-3032.2002.00304.x; BOPPRE M, 1984, J CHEM ECOL, V10, P1151, DOI 10.1007/BF00987520; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Christe P, 2003, ECOL LETT, V6, P19, DOI 10.1046/j.1461-0248.2003.00395.x; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; Dyer LA, 2003, J CHEM ECOL, V29, P2499, DOI 10.1023/A:1026310001958; EISNER T. E, 2003, LOVE INSECTS, V448; Engel C, 2002, WILD HLTH; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Godfray HCJ, 1994, PARASITOIDS BEHAV EV, P488; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P1083, DOI 10.1016/j.ibmb.2005.05.011; Hartmann T, 2004, J CHEM ECOL, V30, P229, DOI 10.1023/B:JOEC.0000017975.16399.c3; HAWKINS BA, 1994, PATTERN PROCESS HOST, P200; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Huffman MA, 2001, BIOSCIENCE, V51, P651, DOI 10.1641/0006-3568(2001)051[0651:SMBITA]2.0.CO;2; Huffman MA, 1997, YEARB PHYS ANTHROPOL, V40, P171; Huffman MA, 2001, INT J PRIMATOL, V22, P329, DOI 10.1023/A:1010734310002; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; Hutchings MR, 2006, MAMMAL REV, V36, P1, DOI 10.1111/j.1365-2907.2006.00080.x; Hutchings MR, 2003, P NUTR SOC, V62, P361, DOI 10.1079/PNS2003243; Janzen D.H., 1978, P73; Karban R, 1997, ECOLOGY, V78, P603, DOI 10.1890/0012-9658(1997)078[0603:TPAHPC]2.0.CO;2; Krishnamani R, 2000, ANIM BEHAV, V59, P899, DOI 10.1006/anbe.1999.1376; Lampert EC, 2008, J CHEM ECOL, V34, P783, DOI 10.1007/s10886-008-9481-8; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lozano GA, 1998, ADV STUD BEHAV, V27, P291; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mooney KA, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P43; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; RODRIGUEZ E, 1993, RECENT ADV PHYTOCHEM, V27, P89; SAS Institute, 2007, JMP VERS 7 0; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Singer MS, 2003, OIKOS, V100, P554, DOI 10.1034/j.1600-0706.2003.11720.x; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; SMILANICH AM, 2008, THESIS TULANE U; Stireman JO, 2002, ECOL ENTOMOL, V27, P588, DOI 10.1046/j.1365-2311.2002.00450.x; Villalba JJ, 2006, ANIM BEHAV, V71, P1131, DOI 10.1016/j.anbehav.2005.09.012; WRANGHAM R W, 1983, Primates, V24, P276, DOI 10.1007/BF02381090; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404; YAMAMOTO RT, 1969, J ECON ENTOMOL, V62, P1427, DOI 10.1093/jee/62.6.1427	51	183	185	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4796	10.1371/journal.pone.0004796	http://dx.doi.org/10.1371/journal.pone.0004796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274098	gold, Green Published			2022-12-27	WOS:000265496000029
J	Kennedy, EJ; Yang, J; Pillus, L; Taylor, SS; Ghosh, G				Kennedy, Eileen J.; Yang, Jie; Pillus, Lorraine; Taylor, Susan S.; Ghosh, Gourisankar			Identifying Critical Non-Catalytic Residues that Modulate Protein Kinase A Activity	PLOS ONE			English	Article								Background: Distal interactions between discrete elements of an enzyme are critical for communication and ultimately for regulation. However, identifying the components of such interactions has remained elusive due to the delicate nature of these contacts. Protein kinases are a prime example of an enzyme with multiple regulatory sites that are spatially separate, yet communicate extensively for tight regulation of activity. Kinase misregulation has been directly linked to a variety of cancers, underscoring the necessity for understanding intramolecular kinase regulation. Methodology/Principal Findings: A genetic screen was developed to identify suppressor mutations that restored catalytic activity in vivo from two kinase-dead Protein Kinase A mutants in S. cerevisiae. The residues defined by the suppressors provide new insights into kinase regulation. Many of the acquired mutations were distal to the nucleotide binding pocket, highlighting the relationship of spatially dispersed residues in regulation. Conclusions/Significance: The suppressor residues provide new insights into kinase regulation, including allosteric effects on catalytic elements and altered protein-protein interactions. The suppressor mutations identified in this study also share overlap with mutations identified from an identical screen in the yeast PKA homolog Tpk2, demonstrating functional conservation for some residues. Some mutations were independently isolated several times at the same sites. These sites are in agreement with sites previously identified from multiple cancer data sets as areas where acquired somatic mutations led to cancer progression and drug resistance. This method provides a valuable tool for identifying residues involved in kinase activity and for studying kinase misregulation in disease states.	[Kennedy, Eileen J.; Yang, Jie; Taylor, Susan S.; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Pillus, Lorraine] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [Pillus, Lorraine] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Kennedy, EJ (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	gghosh@ucsd.edu		Kennedy, Eileen/0000-0001-5610-1677	National Science Foundation [9978892]; National Institutes of Health [GM07240, GM071862, GM19301]; American Heart Association Predoctoral Fellowship [0315003Y]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862, R01GM019301, T32GM007240, R37GM019301] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Minority Access to Science, Engineering and Mathematics Predoctoral Fellowship (National Science Foundation, 9978892), Cellular and Molecular Genetics Training Grant (National Institutes of Health, GM07240), and American Heart Association Predoctoral Fellowship (0315003Y) for E.J.K.; funding from the National Institutes of Health for the labs of L.P., G.G.(GM071862) and S.S.T.(GM19301); and funding from the Howard Hughes Medical Institute for S.S.T. The funders had no role in research design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Amberg DC., 2005, METHODS YEAST GENETI; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HEYNINCK K, 2005, NOVEL LINK LCK BAK E; Hirai H, 2005, CURR TOP MED CHEM, V5, P167, DOI 10.2174/1568026053507688; Kennedy EJ, 2008, J BIOL CHEM, V283, P1084, DOI 10.1074/jbc.M704028200; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Lengyel E, 2007, CURR MOL MED, V7, P77, DOI 10.2174/156652407779940486; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1995, GENE, V155, P51, DOI 10.1016/0378-1119(94)00915-F; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; YANG J, 2009, J BIOL CHEM; ZOLLER MJ, 1991, GENE, V99, P171, DOI 10.1016/0378-1119(91)90124-T	22	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4746	10.1371/journal.pone.0004746	http://dx.doi.org/10.1371/journal.pone.0004746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270744	Green Published, gold, Green Submitted			2022-12-27	WOS:000265495900014
J	Young, KA; Snoeks, J; Seehausen, O				Young, Kyle A.; Snoeks, Jos; Seehausen, Ole			Morphological Diversity and the Roles of Contingency, Chance and Determinism in African Cichlid Radiations	PLOS ONE			English	Article								Background: Deterministic evolution, phylogenetic contingency and evolutionary chance each can influence patterns of morphological diversification during adaptive radiation. In comparative studies of replicate radiations, convergence in a common morphospace implicates determinism, whereas non-convergence suggests the importance of contingency or chance. Methodology/Principal Findings: The endemic cichlid fish assemblages of the three African great lakes have evolved similar sets of ecomorphs but show evidence of non-convergence when compared in a common morphospace, suggesting the importance of contingency and/or chance. We then analyzed the morphological diversity of each assemblage independently and compared their axes of diversification in the unconstrained global morphospace. We find that despite differences in phylogenetic composition, invasion history, and ecological setting, the three assemblages are diversifying along parallel axes through morphospace and have nearly identical variance-covariance structures among morphological elements. Conclusions/Significance: By demonstrating that replicate adaptive radiations are diverging along parallel axes, we have shown that non-convergence in the common morphospace is associated with convergence in the global morphospace. Applying these complimentary analyses to future comparative studies will improve our understanding of the relationship between morphological convergence and non-convergence, and the roles of contingency, chance and determinism in driving morphological diversification.	[Young, Kyle A.; Seehausen, Ole] Univ Bern, Dept Aquat Ecol & Evolut, Inst Ecol & Evolut, Bern, Switzerland; [Young, Kyle A.; Seehausen, Ole] Ctr Ecol Evolut & Biogeochem, EAWAG, Kastanienbaum, Switzerland; [Snoeks, Jos] Royal Museum Cent Africa, Dept Zool, Tervuren, Belgium; [Snoeks, Jos] Univ Leuven, Dept Biol, Louvain, Belgium	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Royal Museum for Central Africa; KU Leuven	Young, KA (corresponding author), Univ Bern, Dept Aquat Ecol & Evolut, Inst Ecol & Evolut, Bern, Switzerland.	kyle_a_young@hotmail.com	Seehausen, Ole/C-8272-2011	Seehausen, Ole/0000-0001-6598-1434	NERC (U.K.) award [NER/B/S/2003/00206]; Swiss National Science Foundation; DEFRA (U.K.) Darwin Initiative [162-15-020]	NERC (U.K.) award(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DEFRA (U.K.) Darwin Initiative(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by NERC (U.K.) award NER/B/S/2003/00206 to OS, KAY and JS. OS was supported by a grant from the Swiss National Science Foundation. KAY received additional support from DEFRA (U.K.) Darwin Initiative grant # 162-15-020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Case T., 1986, COMMUNITY ECOL, P98; CAVALCANTI MJ, 2002, MANTEL VERSION 1 15; Chakrabarty P, 2005, COPEIA, P359, DOI 10.1643/CG-04-089R2; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; Fryer G, 1972, CICHLID FISHES GREAT; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gould S. J., 1989, WONDERFUL LIFE BURGE; Greenwood P.H., 1975, B BRIT NAT HIST MUS, V6, P1; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; KOCHER TD, 1993, MOL PHYLOGENET EVOL, V2, P158, DOI 10.1006/mpev.1993.1016; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; LIEM KF, 1970, SYST ZOOL, P425; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; MacLean RC, 2003, P ROY SOC B-BIOL SCI, V270, P1645, DOI 10.1098/rspb.2003.2408; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Price T, 2000, AM NAT, V156, P354, DOI 10.1086/303397; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Rohlf F. J., 2004, TPSDIG VERSION 1 40; ROHLF FJ, 2005, RELATIVE WARPS VERSI; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; SHEETS HD, 2001, SPACEANGLE6B; Steppan SJ, 1997, EVOLUTION, V51, P587, DOI 10.1111/j.1558-5646.1997.tb02445.x; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Travisano M, 2000, AM NAT, V156, pS35, DOI 10.1086/303414; Tyerman J, 2005, P ROY SOC B-BIOL SCI, V272, P1393, DOI 10.1098/rspb.2005.3068; Webster AJ, 2002, P ROY SOC B-BIOL SCI, V269, P143, DOI 10.1098/rspb.2001.1873; Williams EE., 1972, EVOL BIOL, V6, P47, DOI [DOI 10.1007/978-1-4684-9063-3_3, 10. 1007/978-1-4684-9063-3]; WITTE F, 1992, NETH J ZOOL, V42, P214; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	37	49	49	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4740	10.1371/journal.pone.0004740	http://dx.doi.org/10.1371/journal.pone.0004740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270732	gold, Green Published			2022-12-27	WOS:000265495900009
J	Zampieri, M; Passananti, C; Calabrese, R; Perilli, M; Corbi, N; De Cave, F; Guastafierro, T; Bacalini, MG; Reale, A; Amicosante, G; Calabrese, L; Zlatanova, J; Caiafa, P				Zampieri, Michele; Passananti, Claudio; Calabrese, Roberta; Perilli, Mariagrazia; Corbi, Nicoletta; De Cave, Fabiana; Guastafierro, Tiziana; Bacalini, Maria Giulia; Reale, Anna; Amicosante, Gianfranco; Calabrese, Lilia; Zlatanova, Jordanka; Caiafa, Paola			Parp1 Localizes within the Dnmt1 Promoter and Protects Its Unmethylated State by Its Enzymatic Activity	PLOS ONE			English	Article								Background: Aberrant hypermethylation of CpG islands in housekeeping gene promoters and widespread genome hypomethylation are typical events occurring in cancer cells. The molecular mechanisms behind these cancer-related changes in DNA methylation patterns are not well understood. Two questions are particularly important: (i) how are CpG islands protected from methylation in normal cells, and how is this protection compromised in cancer cells, and (ii) how does the genome-wide demethylation in cancer cells occur. The latter question is especially intriguing since so far no DNA demethylase enzyme has been found. Methodology/Principal Findings: Our data show that the absence of ADP-ribose polymers (PARs), caused by ectopic overexpression of poly(ADP-ribose) glycohydrolase (PARG) in L929 mouse fibroblast cells leads to aberrant methylation of the CpG island in the promoter of the Dnmt1 gene, which in turn shuts down its transcription. The transcriptional silencing of Dnmt1 may be responsible for the widespread passive hypomethylation of genomic DNA which we detect on the example of pericentromeric repeat sequences. Chromatin immunoprecipitation results show that in normal cells the Dnmt1 promoter is occupied by poly(ADP-ribosyl)ated Parp1, suggesting that PARylated Parp1 plays a role in protecting the promoter from methylation. Conclusions/Significance: In conclusion, the genome methylation pattern following PARG over-expression mirrors the pattern characteristic of cancer cells, supporting our idea that the right balance between Parp/Parg activities maintains the DNA methylation patterns in normal cells. The finding that in normal cells Parp1 and ADP-ribose polymers localize on the Dnmt1 promoter raises the possibility that PARylated Parp1 marks those sequences in the genome that must remain unmethylated and protects them from methylation, thus playing a role in the epigenetic regulation of gene expression.	[Zampieri, Michele; Calabrese, Roberta; De Cave, Fabiana; Guastafierro, Tiziana; Bacalini, Maria Giulia; Reale, Anna; Caiafa, Paola] Univ Roma La Sapienza, Fac Med 2, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Calabrese, Lilia] Univ Roma La Sapienza, Dept Biochem Sci, Rome, Italy; [Zampieri, Michele; Guastafierro, Tiziana; Reale, Anna; Caiafa, Paola] Pasteur Inst, Fdn Cenci Bolognetti, Rome, Italy; [Passananti, Claudio; Perilli, Mariagrazia; Corbi, Nicoletta] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Amicosante, Gianfranco] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy; [Zlatanova, Jordanka] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of L'Aquila; University of Wyoming	Zampieri, M (corresponding author), Univ Roma La Sapienza, Fac Med 2, Dept Cellular Biotechnol & Hematol, Rome, Italy.	caiafa@bce.uniroma1.it	Passananti, Claudio/K-9593-2016; Corbi, Nicoletta/AAW-8835-2020; Zampieri, Michele/F-7099-2013; guastafeierro, tiziana/J-8006-2016; Zampieri, Michele/AGF-5460-2022; Zlatanova, Jordanka/B-3273-2009; Bacalini, Maria Giulia/K-4931-2016; Corbi, Nicoletta/K-2313-2014; Reale, Anna/J-5933-2016	Zampieri, Michele/0000-0002-6799-2492; guastafeierro, tiziana/0000-0001-9433-2759; Zampieri, Michele/0000-0002-6799-2492; Bacalini, Maria Giulia/0000-0003-1618-2673; Reale, Anna/0000-0001-8988-2342; amicosante, gianfranco/0000-0002-6813-2101; CORBI, NICOLETTA/0000-0002-4505-1632; PASSANANTI, CLAUDIO/0000-0002-9288-5736	Ministero della Salute; Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy; AIRC [fellowship]; NSF [0504239]	Ministero della Salute(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); NSF(National Science Foundation (NSF))	This work was partially financed by Ministero della Salute (PC) and by Ministero dell'Istruzione, dell'Universita e della Ricerca (PC, LC, MP), Italy; MZ was supported by AIRC fellowship; JZ was supported in part by NSF grant 0504239. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Branco MR, 2008, GENE DEV, V22, P1567, DOI 10.1101/gad.1690508; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; CAIAFA P, 2008, FASEB J; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; De Capoa A, 1999, FASEB J, V13, P89; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; Klenova E, 2005, CELL CYCLE, V4, P96, DOI 10.4161/cc.4.1.1398; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Li YM, 2006, MOL CELL ENDOCRINOL, V257-8, P35, DOI 10.1016/j.mce.2006.06.008; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szyf M, 2008, CURR ONCOL, V15, P72; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zardo G, 1999, FASEB J, V13, P1518, DOI 10.1096/fasebj.13.12.1518; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zardo G, 1997, BIOCHEMISTRY-US, V36, P7937, DOI 10.1021/bi970241s; ZLATANOVA J, 2009, CELL MOL LIFE SCI	49	71	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4717	10.1371/journal.pone.0004717	http://dx.doi.org/10.1371/journal.pone.0004717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262751	gold, Green Submitted, Green Published			2022-12-27	WOS:000265490600027
J	Wopereis, S; Rubingh, CM; van Erk, MJ; Verheij, ER; van Vliet, T; Cnubben, NHP; Smilde, AK; van der Greef, J; van Ommen, B; Hendriks, HFJ				Wopereis, Suzan; Rubingh, Carina M.; van Erk, Marjan J.; Verheij, Elwin R.; van Vliet, Trinette; Cnubben, Nicole H. P.; Smilde, Age K.; van der Greef, Jan; van Ommen, Ben; Hendriks, Henk F. J.			Metabolic Profiling of the Response to an Oral Glucose Tolerance Test Detects Subtle Metabolic Changes	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; URIC-ACID; GENOMIC BIOMARKERS; PROTEIN ADDUCTS; DICLOFENAC; GLUTATHIONE; IDENTIFICATION; INFLAMMATION; OBESITY; VALIDATION	Background: The prevalence of overweight is increasing globally and has become a serious health problem. Low-grade chronic inflammation in overweight subjects is thought to play an important role in disease development. Novel tools to understand these processes are needed. Metabolic profiling is one such tool that can provide novel insights into the impact of treatments on metabolism. Methodology: To study the metabolic changes induced by a mild anti-inflammatory drug intervention, plasma metabolic profiling was applied in overweight human volunteers with elevated levels of the inflammatory plasma marker C-reactive protein. Liquid and gas chromatography mass spectrometric methods were used to detect high and low abundant plasma metabolites both in fasted conditions and during an oral glucose tolerance test. This is based on the concept that the resilience of the system can be assessed after perturbing a homeostatic situation. Conclusions: Metabolic changes were subtle and were only detected using metabolic profiling in combination with an oral glucose tolerance test. The repeated measurements during the oral glucose tolerance test increased statistical power, but the metabolic perturbation also revealed metabolites that respond differentially to the oral glucose tolerance test. Specifically, multiple metabolic intermediates of the glutathione synthesis pathway showed time-dependent suppression in response to the glucose challenge test. The fact that this is an insulin sensitive pathway suggests that inflammatory modulation may alter insulin signaling in overweight men.	[Wopereis, Suzan; Rubingh, Carina M.; van Erk, Marjan J.; Verheij, Elwin R.; van Vliet, Trinette; Cnubben, Nicole H. P.; Smilde, Age K.; van der Greef, Jan; van Ommen, Ben; Hendriks, Henk F. J.] TNO, Dept Qual Life, NL-3700 AJ Zeist, Netherlands; [Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands	Netherlands Organization Applied Science Research; University of Amsterdam	Wopereis, S (corresponding author), TNO, Dept Qual Life, NL-3700 AJ Zeist, Netherlands.	suzan.wopereis@tno.nl	Hendriks, Henk/AAU-5987-2021	Smilde, Age/0000-0002-3052-4644	TNO	TNO	The research was completely funded by TNO. No additional funding or support was received for the work presented.	Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Boelsterli UA, 2003, TOXICOL APPL PHARM, V192, P307, DOI 10.1016/S0041-008X(03)00368-5; Bonassi S, 2001, MUTAT RES-FUND MOL M, V480, P349, DOI 10.1016/S0027-5107(01)00194-4; Bro R, 1996, J CHEMOMETR, V10, P47, DOI 10.1002/(SICI)1099-128X(199601)10:1<47::AID-CEM400>3.0.CO;2-C; Choi JS, 2005, J PHARM PHARMACOL, V57, P1185, DOI 10.1211/jpp.57.9.0013; Clish CB, 2004, OMICS, V8, P3, DOI 10.1089/153623104773547453; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dillon WilliamR., 1984, MULTIVARIATE ANAL ME; Fogarty AW, 2008, AM J CLIN NUTR, V87, P30, DOI 10.1093/ajcn/87.1.30; Ginsburg GS, 2006, EXPERT REV MOL DIAGN, V6, P179, DOI 10.1586/14737159.6.2.179; Gonzalez-Ortiz M, 2005, METAB SYNDR RELAT D, V3, P95, DOI 10.1089/met.2005.3.95; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HARSHMAN RA, 1994, COMPUT STAT DATA AN, V18, P39, DOI 10.1016/0167-9473(94)90132-5; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; He Yudong D., 2006, Cancer Biomarkers, V2, P103; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Joliffe I. T., 1986, PRINCIPAL COMPONENT; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Khuseyinova N, 2006, CURR OPIN CRIT CARE, V12, P412, DOI 10.1097/01.ccx.0000244119.16377.75; Kiers HAL, 2001, PSYCHOL METHODS, V6, P84, DOI 10.1037/1082-989X.6.1.84; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Mano Y, 2005, BIOPHARM DRUG DISPOS, V26, P35, DOI 10.1002/bdd.430; Martens H., 1992, MULTIVARIATE CALIBRA; Massart D. L., 1997, HDB CHEMOMETRICS QUA, Vfirst; Masubuchi Y, 2002, DRUG METAB DISPOS, V30, P1143, DOI 10.1124/dmd.30.10.1143; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Naylor S, 2008, CURR OPIN BIOTECH, V19, P100, DOI 10.1016/j.copbio.2008.02.009; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Rajaram V, 2004, AM J CARDIOL, V93, p32C, DOI 10.1016/j.amjcard.2004.02.004; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Smilde AK, 1997, J CHEMOMETR, V11, P367, DOI 10.1002/(SICI)1099-128X(199709/10)11:5<367::AID-CEM481>3.0.CO;2-I; SMILDE AK, 2004, MULTIWAY ANAL APPL C, P221; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Uchaipichat V, 2004, DRUG METAB DISPOS, V32, P413, DOI 10.1124/dmd.32.4.413; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; van der Greef J, 2004, ADV MASS SPECTROM, V16, P145; Vandeginste B.G.M., 1998, DATA HANDLING SCI TE, V20, P57, DOI [10.1016/S0922-3487(98)80040-3, DOI 10.1016/S0922-3487(98)80040-3]; Verhoeckx KCM, 2004, INT IMMUNOPHARMACOL, V4, P1499, DOI 10.1016/j.intimp.2004.07.008; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wade LT, 1997, CHEM RES TOXICOL, V10, P546, DOI 10.1021/tx960153t; Wang SJ, 2006, PHARMACOGENOMICS J, V6, P82, DOI 10.1038/sj.tpj.6500363; Ware JA, 1998, CHEM RES TOXICOL, V11, P164, DOI 10.1021/tx970182j; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12; Yu YM, 2002, AM J PHYSIOL-ENDOC M, V282, pE247, DOI 10.1152/ajpendo.00206.2001	51	94	95	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4525	10.1371/journal.pone.0004525	http://dx.doi.org/10.1371/journal.pone.0004525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242536	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487500001
J	Damarla, M; Hasan, E; Boueiz, A; Le, A; Pae, HH; Montouchet, C; Kolb, T; Simms, T; Myers, A; Kayyali, US; Gaestel, M; Peng, XQ; Reddy, SP; Damico, R; Hassoun, PM				Damarla, Mahendra; Hasan, Emile; Boueiz, Adel; Le, Anne; Pae, Hyun Hae; Montouchet, Calypso; Kolb, Todd; Simms, Tiffany; Myers, Allen; Kayyali, Usamah S.; Gaestel, Matthias; Peng, Xinqi; Reddy, Sekhar P.; Damico, Rachel; Hassoun, Paul M.			Mitogen Activated Protein Kinase Activated Protein Kinase 2 Regulates Actin Polymerization and Vascular Leak in Ventilator Associated Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SPHINGOSINE 1-PHOSPHATE; XANTHINE OXIDOREDUCTASE; MECHANICAL VENTILATION; DEPENDENT REGULATION; ENDOTHELIAL-CELLS; MAP-KINASES; STRESS; PHOSPHORYLATION; SUSCEPTIBILITY	Mechanical ventilation, a fundamental therapy for acute lung injury, worsens pulmonary vascular permeability by exacting mechanical stress on various components of the respiratory system causing ventilator associated lung injury. We postulated that MK2 activation via p38 MAP kinase induced HSP25 phosphorylation, in response to mechanical stress, leading to actin stress fiber formation and endothelial barrier dysfunction. We sought to determine the role of p38 MAP kinase and its downstream effector MK2 on HSP25 phosphorylation and actin stress fiber formation in ventilator associated lung injury. Wild type and MK2(-/-) mice received mechanical ventilation with high (20 ml/kg) or low (7 ml/kg) tidal volumes up to 4 hrs, after which lungs were harvested for immunohistochemistry, immunoblotting and lung permeability assays. High tidal volume mechanical ventilation resulted in significant phosphorylation of p38 MAP kinase, MK2, HSP25, actin polymerization, and an increase in pulmonary vascular permeability in wild type mice as compared to spontaneous breathing or low tidal volume mechanical ventilation. However, pretreatment of wild type mice with specific p38 MAP kinase or MK2 inhibitors abrogated HSP25 phosphorylation and actin polymerization, and protected against increased lung permeability. Finally, MK2(-/-) mice were unable to phosphorylate HSP25 or increase actin polymerization from baseline, and were resistant to increases in lung permeability in response to HV(T) MV. Our results suggest that p38 MAP kinase and its downstream effector MK2 mediate lung permeability in ventilator associated lung injury by regulating HSP25 phosphorylation and actin cytoskeletal remodeling.	[Damarla, Mahendra; Hasan, Emile; Boueiz, Adel; Le, Anne; Pae, Hyun Hae; Montouchet, Calypso; Kolb, Todd; Simms, Tiffany; Myers, Allen; Peng, Xinqi; Damico, Rachel; Hassoun, Paul M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kayyali, Usamah S.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Gaestel, Matthias] Hannover Med Sch, Dept Biochem, D-3000 Hannover, Germany; [Reddy, Sekhar P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Johns Hopkins University; Tufts University; Hannover Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Damarla, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	phassoun@jhmi.edu	Kolb, Todd/ABD-8204-2020; Boueiz, Adel El/AAV-5966-2021; Gaestel, Matthias/A-6560-2013	Boueiz, Adel El/0000-0003-1638-8575; Gaestel, Matthias/0000-0002-4944-4652; Le, Anne/0000-0002-2958-8149	NIH [HL049441, HL090297, P50 HL073994]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049441, R29HL049441, P50HL073994, F32HL090297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH (HL049441, HL090297, and P50 HL073994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; BOGATCHEVA NV, 2006, AM J PHYSIOL-LUNG C; BOGATCHEVA NV, 2009, MICROVASC RES; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; BRYAN J, 2004, J CELL BIOCHEM, V92, P1075; CHAUDHURI S, 2008, AM J RESP CELL MOL B; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Fan E, 2005, JAMA-J AM MED ASSOC, V294, P2889, DOI 10.1001/jama.294.22.2889; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GALEN B, 1998, J CELLULAR PHYSL, V177, P575; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Grishko V, 2001, AM J PHYSIOL-LUNG C, V280, pL1300, DOI 10.1152/ajplung.2001.280.6.L1300; Guay J, 1997, J CELL SCI, V110, P357; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; LE A, 2008, J APPL PHYSIOL, P90689; Le A, 2008, J APPL PHYSIOL, V105, P1282, DOI 10.1152/japplphysiol.90689.2008; MacIntyre NR, 2005, CHEST, V128, p561S, DOI 10.1378/chest.128.5_suppl_2.561S; Moxley MA, 2000, AM J PHYSIOL-LUNG C, V279, pL985, DOI 10.1152/ajplung.2000.279.5.L985; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Parker JC, 2002, AM J PHYSIOL-LUNG C, V283, pL1203, DOI 10.1152/ajplung.00488.2001; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SCHMIDT EP, 2008, AM J PHYSL LUNG CELL; Verin AD, 2001, AM J PHYSIOL-LUNG C, V281, pL565, DOI 10.1152/ajplung.2001.281.3.L565; Vertii A, 2006, J BIOL CHEM, V281, P26966, DOI 10.1074/jbc.M602134200; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; YAN J, 2008, J PHARMACOL EXP THER; 2000, N ENGL J MED, V342, P1301	40	47	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4600	10.1371/journal.pone.0004600	http://dx.doi.org/10.1371/journal.pone.0004600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240800	gold, Green Submitted, Green Published			2022-12-27	WOS:000278086700014
J	Zelano, C; Montag, J; Khan, R; Sobel, N				Zelano, Christina; Montag, Jessica; Khan, Rehan; Sobel, Noam			A Specialized Odor Memory Buffer in Primary Olfactory Cortex	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; RECOGNITION MEMORY; SOMATOSENSORY CORTEX; ENTORHINAL CORTEX; PREFRONTAL CORTEX; PIRIFORM CORTEX; TERM-MEMORY; INFORMATION; BRAIN; FMRI	Background: The neural substrates of olfactory working memory are unknown. We addressed the questions of whether olfactory working memory involves a verbal representation of the odor, or a sensory image of the odor, or both, and the location of the neural substrates of these processes. Methodology/Principal Findings: We used functional magnetic resonance imaging to measure activity in the brains of subjects who were remembering either nameable or unnameable odorants. We found a double dissociation whereby remembering nameable odorants was reflected in sustained activity in prefrontal language areas, and remembering unnameable odorants was reflected in sustained activity in primary olfactory cortex. Conclusions/Significance: These findings suggest a novel dedicated mechanism in primary olfactory cortex, where odor information is maintained in temporary storage to subserve ongoing tasks.	[Zelano, Christina; Khan, Rehan; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Montag, Jessica] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Weizmann Institute of Science; University of Wisconsin System; University of Wisconsin Madison	Zelano, C (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	czelano@gmail.com	Khan, Rehan/AAR-4803-2020	Khan, Rehan/0000-0001-8724-5788; Sobel, Noam/0000-0002-3232-9391	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	This work was funded by a grant from the Israeli Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2007, PSYCHOLOGIA, V50, P76, DOI 10.2117/psysoc.2007.76; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D, 1986, WORKING MEMORY; Bensafi M, 2007, J NEUROPHYSIOL, V98, P3254, DOI 10.1152/jn.00349.2007; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cerf-Ducastel B, 2006, NEUROIMAGE, V31, P386, DOI 10.1016/j.neuroimage.2005.11.009; Dade LA, 2001, NEUROIMAGE, V14, P650, DOI 10.1006/nimg.2001.0868; DEWIJK RA, 1995, ODOR IDENTIFICATION; Djordjevic J, 2005, NEUROIMAGE, V24, P791, DOI 10.1016/j.neuroimage.2004.09.035; ENGEN T, 1973, J EXP PSYCHOL, V100, P221, DOI 10.1037/h0035492; Feredoes E, 2007, J NEUROSCI, V27, P11003, DOI 10.1523/JNEUROSCI.1573-07.2007; Fiez JA, 1996, J NEUROSCI, V16, P808; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Harris JA, 2002, J NEUROSCI, V22, P8720; Jehl C, 1997, PERCEPT PSYCHOPHYS, V59, P100, DOI 10.3758/BF03206852; Johnson BN, 2007, J NEUROSCI METH, V160, P231, DOI 10.1016/j.jneumeth.2006.09.008; Jonides J, 1998, J NEUROSCI, V18, P5026; Larsson M, 1997, MEMORY, V5, P361; MAI J, 1997, ATLAS HUMAN BRAIN AC; Miles C, 2005, MEM COGNITION, V33, P1303, DOI 10.3758/BF03193230; Miller GA, 1960, PLANS STRUCTURE BEHA; MURPHY C, 1991, AM J PSYCHOL, V104, P161, DOI 10.2307/1423153; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Parr WV, 2002, CHEM SENSES, V27, P747, DOI 10.1093/chemse/27.8.747; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PORTER J, 2005, NEURON; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Rama P, 2001, COGN AFFECT BEHAV NE, V1, P161, DOI 10.3758/CABN.1.2.161; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Savic I, 2000, CHEM SENSES, V25, P517, DOI 10.1093/chemse/25.5.517; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; White TL, 1998, ANN NY ACAD SCI, V855, P635, DOI 10.1111/j.1749-6632.1998.tb10636.x; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Yeshurun Y, 2008, BEHAV NEUROSCI, V122, P1031, DOI 10.1037/a0012806; Yonelinas AP, 2007, HIPPOCAMPUS, V17, P1134, DOI 10.1002/hipo.20341; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P10533, DOI 10.1073/pnas.93.19.10533	46	52	53	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4965	10.1371/journal.pone.0004965	http://dx.doi.org/10.1371/journal.pone.0004965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PG	19305509	gold, Green Submitted, Green Published			2022-12-27	WOS:000265498800013
J	Pendergast, JS; Nakamura, W; Friday, RC; Hatanaka, F; Takumi, T; Yamazaki, S				Pendergast, Julie S.; Nakamura, Wataru; Friday, Rio C.; Hatanaka, Fumiyuki; Takumi, Toru; Yamazaki, Shin			Robust Food Anticipatory Activity in BMAL1-Deficient Mice	PLOS ONE			English	Article							ENTRAINED CIRCADIAN-RHYTHMS; FEEDING SCHEDULES; CLOCK; RATS; BEHAVIOR; COMPONENTS; NPAS2; MPER2; MOP3	Food availability is a potent environmental cue that directs circadian locomotor activity in rodents. Even though nocturnal rodents prefer to forage at night, daytime food anticipatory activity (FAA) is observed prior to short meals presented at a scheduled time of day. Under this restricted feeding regimen, rodents exhibit two distinct bouts of activity, a nocturnal activity rhythm that is entrained to the light-dark cycle and controlled by the master clock in the suprachiasmatic nuclei (SCN) and a daytime bout of activity that is phase-locked to mealtime. FAA also occurs during food deprivation, suggesting that a food-entrainable oscillator (FEO) keeps time in the absence of scheduled feeding. Previous studies have demonstrated that the FEO is anatomically distinct from the SCN and that FAA is observed in mice lacking some circadian genes essential for timekeeping in the SCN. In the current study, we optimized the conditions for examining FAA during restricted feeding and food deprivation in mice lacking functional BMAL1, which is critical for circadian rhythm generation in the SCN. We found that BMAL1-deficient mice displayed FAA during restricted feeding in 12hr light: 12hr dark (12L: 12D) and 18L:6D lighting cycles, but distinct activity during food deprivation was observed only in 18L: 6D. While BMAL1-deficient mice also exhibited robust FAA during restricted feeding in constant darkness, mice were hyperactive during food deprivation so it was not clear that FAA consistently occurred at the time of previously scheduled food availability. Taken together, our findings suggest that optimization of experimental conditions such as photoperiod may be necessary to visualize FAA in genetically modified mice. Furthermore, the expression of FAA may be possible without a circadian oscillator that depends on BMAL1.	[Pendergast, Julie S.; Friday, Rio C.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Nakamura, Wataru; Hatanaka, Fumiyuki; Takumi, Toru] Osaka Biosci Inst, Suita, Osaka, Japan	Vanderbilt University	Pendergast, JS (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	shin.yamazaki@vanderbilt.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Yamazaki, Shin/0000-0002-6691-1531	National Institutes of Health [NS051278]; Japan Ministry of Education; Japan Society for the Promotion of Science [Fellowship]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a National Institutes of Health grant (NS051278 to S.Y.), Research Grants from the Japan Ministry of Education (to T.T.), and a Japan Society for the Promotion of Science Fellowship (to W.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; BOLLES RC, 1962, J COMP PHYSIOL PSYCH, V55, P760, DOI 10.1037/h0046716; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HONMA KI, 1983, PHYSIOL BEHAV, V30, P905, DOI 10.1016/0031-9384(83)90256-1; Iijima M, 2005, NEUROSCI RES, V52, P166, DOI 10.1016/j.neures.2005.03.003; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mistlberger RE, 2008, SCIENCE, V322, DOI 10.1126/science.1161284; Mistlberger RE, 2001, BRAIN RES, V919, P283, DOI 10.1016/S0006-8993(01)03042-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MOOREEDE MC, 1982, CLOCKS TIME US PHYSL, pR12; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Richter CP, 1927, Q REV BIOL, V2, P307, DOI 10.1086/394279; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STEPHAN FK, 1992, PHYSIOL BEHAV, V52, P985, DOI 10.1016/0031-9384(92)90381-B; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	41	84	87	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4860	10.1371/journal.pone.0004860	http://dx.doi.org/10.1371/journal.pone.0004860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300505	Green Submitted, gold, Green Published			2022-12-27	WOS:000265496800001
J	Mahdi, RN; Rouchka, EC				Mahdi, Rami N.; Rouchka, Eric C.			RBF-TSS: Identification of Transcription Start Site in Human Using Radial Basis Functions Network and Oligonucleotide Positional Frequencies	PLOS ONE			English	Article								Accurate identification of promoter regions and transcription start sites (TSS) in genomic DNA allows for a more complete understanding of the structure of genes and gene regulation within a given genome. Many recently published methods have achieved high identification accuracy of TSS. However, models providing more accurate modeling of promoters and TSS are needed. A novel identification method for identifying transcription start sites that improves the accuracy of TSS recognition for recently published methods is proposed. This method incorporates a metric feature based on oligonucleotide positional frequencies, taking into account the nature of promoters. A radial basis function neural network for identifying transcription start sites (RBF-TSS) is proposed and employed as a classification algorithm. Using non-overlapping chunks (windows) of size 50 and 500 on the human genome, the proposed method achieves an area under the Receiver Operator Characteristic curve (auROC) of 94.75% and 95.08% respectively, providing increased performance over existing TSS prediction methods.			Rouchka, EC (corresponding author), Univ Louisville, Dept Comp Sci & Comp Engn, Louisville, KY 40292 USA.	eric.rouchka@louisville.edu			NCRR NIH HHS [P20 RR016481, P20 RR16481] Funding Source: Medline; NIEHS NIH HHS [P30 ES014443] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Bajic VB, 2003, GENOME RES, V13, P1923, DOI 10.1101/gr.869803; BAJIC VB, 2004, IN SILICO BIOL, V4, P109; Broomhead D. S., 1988, Complex Systems, V2, P321; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Goni JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r263; Igel C, 2003, NEUROCOMPUTING, V50, P105, DOI 10.1016/S0925-2312(01)00700-7; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kel-Margoulis OV, 2002, NUCLEIC ACIDS RES, V30, P332, DOI 10.1093/nar/30.1.332; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KONDRAKHIN YV, 1995, COMPUT APPL BIOSCI, V11, P477; Krogh A., 1995, ADV NEURAL INFORM PR, V4, P950; MAHDI RN, 2008, P 7 INT C MACH LEARN, P203; Narang V, 2005, ARTIF INTELL MED, V35, P107, DOI 10.1016/j.artmed.2005.02.005; Ohler U, 2000, GENOME RES, V10, P539, DOI 10.1101/gr.10.4.539; ORR MJL, 2008, INTRO RADIAL BASIS F; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Schwenker F, 2001, NEURAL NETWORKS, V14, P439, DOI 10.1016/S0893-6080(01)00027-2; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Werner T, 1999, MAMM GENOME, V10, P168, DOI 10.1007/s003359900963; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4878	10.1371/journal.pone.0004878	http://dx.doi.org/10.1371/journal.pone.0004878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287502	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496400018
J	Noels, H; Somers, R; Liu, HX; Ye, HT; Du, MQ; De Wolf-Peeters, C; Marynen, P; Baens, M				Noels, Heidi; Somers, Riet; Liu, Hongxiang; Ye, Hongtao; Du, Ming-Qing; De Wolf-Peeters, Christiane; Marynen, Peter; Baens, Mathijs			Auto-Ubiquitination-Induced Degradation of MALT1-API2 Prevents BCL10 Destabilization in t(11;18)(q21;q21)-Positive MALT Lymphoma	PLOS ONE			English	Article								Background: The translocation t(11;18)(q21;q21) is the most frequent chromosomal aberration associated with MALT lymphoma and results in constitutive NF-kappa B activity via the expression of an API2-MALT1 fusion protein. The properties of the reciprocal MALT1-API2 were never investigated as it was reported to be rarely transcribed. Principal Findings: Our data indicate the presence of MALT1-API2 transcripts in the majority of t(11;18)(q21;q21)-positive MALT lymphomas. Based on the breakpoints in the MALT1 and API2 gene, the MALT1-API2 protein contains the death domain and one or both immunoglobulin-like domains of MALT1 (similar to 90% of cases) - mediating the possible interaction with BCL10 - fused to the RING domain of API2. Here we show that this RING domain enables MALT1-API2 to function as an E3 ubiquitin ligase for BCL10, inducing its ubiquitination and proteasomal degradation in vitro. Expression of MALT1-API2 transcripts in t( 11; 18)( q21; q21)- positive MALT lymphomas was however not associated with a reduction of BCL10 protein levels. Conclusion: As we observed MALT1-API2 to be an efficient target of its own E3 ubiquitin ligase activity, our data suggest that this inherent instability of MALT1-API2 prevents its accumulation and renders a potential effect on MALT lymphoma development via destabilization of BCL10 unlikely.	[Noels, Heidi; Somers, Riet; Marynen, Peter; Baens, Mathijs] VIB, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium; [Noels, Heidi; Somers, Riet; Marynen, Peter; Baens, Mathijs] Univ Leuven, Ctr Human Genet Mol Genet, Human Genome Lab, Louvain, Belgium; [Liu, Hongxiang; Ye, Hongtao; Du, Ming-Qing; De Wolf-Peeters, Christiane] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 1TN, England; [De Wolf-Peeters, Christiane] Univ Leuven, Dept Morphol & Mol Pathol, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Cambridge; KU Leuven	Noels, H (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany.	Thijs.Baens@med.kuleuven.be	Noels, Heidi/AAQ-2622-2020	Du, Ming-Qing/0000-0002-1017-5045	Interuniversity Attraction Poles [IAP5/25]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G050704]; Catholic University Leuven; Leukemia Research Fund, United Kingdom	Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Catholic University Leuven(KU Leuven); Leukemia Research Fund, United Kingdom	Supported by the Interuniversity Attraction Poles (IAP5/25), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G050704) and Catholic University Leuven (Concerted Action Grant to P.M.); and by the Leukemia Research Fund, United Kingdom (to M.Q.D.). H.N. is aspirant with the FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Baens M, 2000, GENE CHROMOSOME CANC, V29, P281, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1036>3.0.CO;2-I; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Ho L, 2005, BLOOD, V105, P2891, DOI 10.1182/blood-2004-06-2297; Hosokawa Y, 2005, BIOCHEM BIOPH RES CO, V334, P51, DOI 10.1016/j.bbrc.2005.06.058; Hosokawa Y, 2004, CANCER RES, V64, P3452, DOI 10.1158/0008-5472.CAN-03-3677; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Kalla J, 2000, LEUKEMIA, V14, P1967, DOI 10.1038/sj.leu.2401918; Lee JS, 2004, PROTEOMICS, V4, P3376, DOI 10.1002/pmic.200401000; Liu HX, 2001, BLOOD, V98, P1182, DOI 10.1182/blood.V98.4.1182; Liu HX, 2004, BRIT J HAEMATOL, V125, P318, DOI 10.1111/j.1365-2141.2004.04909.x; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Maes B, 2002, BLOOD, V99, P1398, DOI 10.1182/blood.V99.4.1398; Motegi M, 2000, AM J PATHOL, V156, P807, DOI 10.1016/S0002-9440(10)64948-6; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Remstein ED, 2006, AM J SURG PATHOL, V30, P1546, DOI 10.1097/01.pas.0000213275.60962.2a; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Stoffel A, 2004, P NATL ACAD SCI USA, V101, P9079, DOI 10.1073/pnas.0402415101; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yui D, 2001, ONCOGENE, V20, P4317, DOI 10.1038/sj.onc.1204576; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4822	10.1371/journal.pone.0004822	http://dx.doi.org/10.1371/journal.pone.0004822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279678	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496200006
J	Oyer, JA; Chu, A; Brar, S; Turker, MS				Oyer, Jon A.; Chu, Adrian; Brar, Sukhmani; Turker, Mitchell S.			Aberrant Epigenetic Silencing Is Triggered by a Transient Reduction in Gene Expression	PLOS ONE			English	Article								Background: Aberrant epigenetic silencing plays a major role in cancer formation by inactivating tumor suppressor genes. While the endpoints of aberrant silencing are known, i.e., promoter region DNA methylation and altered histone modifications, the triggers of silencing are not known. We used the tet-off system to test the hypothesis that a transient reduction in gene expression will sensitize a promoter to undergo epigenetic silencing. Methodology/Principal Findings: The tet responsive promoter (PTRE) was used to drive expression of the selectable human HPRT cDNA in independent transfectants of an Hprt deficient mouse cell line. In this system, high basal HPRT expression is greatly reduced when doxycycline (Dox) is added to the culture medium. Exposure of the PTRE-HPRT transfectants to Dox induced HPRT deficient clones in a time dependent manner. A molecular analysis demonstrated promoter region DNA methylation, loss of histone modifications associated with expression (i.e., H3 lysine 9 and 14 acetylation and lysine 4 methylation), and acquisition of the repressive histone modification H3 lysine 9 methylation. These changes, which are consistent with aberrant epigenetic silencing, were not present in the Dox-treated cultures, with the exception of reduced H3 lysine 14 acetylation. Silenced alleles readily reactivated spontaneously or after treatment of cells with inhibitors of histone deacetylation and/or DNA methylation, but re-silencing of reactivated alleles did not require a new round of Dox exposure. Inhibition of histone deacetylation inhibited both the induction of silencing and re-silencing, whereas inhibition of DNA methylation had no such effect. Conclusions/Significance: This study demonstrates that a transient reduction in gene expression triggers a pathway for aberrant silencing in mammalian cells and identifies histone deacetylation as a critical early step in this process. DNA methylation, in contrast, is a secondary step in the silencing pathway under study. A model to explain these observations is offered.	[Oyer, Jon A.; Turker, Mitchell S.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Chu, Adrian; Brar, Sukhmani; Turker, Mitchell S.] Oregon Hlth & Sci Univ, CROET, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Oyer, JA (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	turkerm@ohsu.edu		Oyer, Jon/0000-0002-5479-3400	NIH [ES015191]; DOD Concept Award [W81XWH-06-1-0579]; Medical Research Foundation; Oregon Award; CROET summer student fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015191] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Concept Award; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oregon Award; CROET summer student fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant ES015191 (MST), a DOD Concept Award W81XWH-06-1-0579 (MST), a Medical Research Foundation or Oregon Award (MST) and a CROET summer student fellowship (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Banelli B, 2000, ONCOGENE, V19, P4553, DOI 10.1038/sj.onc.1203807; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; EGGER G, 2007, CANC RES; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fahrner JA, 2002, CANCER RES, V62, P7213; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Hoffman AR, 2006, CELL MOL NEUROBIOL, V26, P425, DOI 10.1007/s10571-006-9057-5; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; LEE S, 2008, ONCOGENE; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Markus J, 2007, CANCER RES, V67, P992, DOI 10.1158/0008-5472.CAN-06-2964; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Mund C, 2006, EPIGENETICS-US, V1, P7; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sawan C, 2008, MUTAT RES-FUND MOL M, V642, P1, DOI 10.1016/j.mrfmmm.2008.03.002; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Shin-Darlak CY, 2005, DNA REPAIR, V4, P51, DOI 10.1016/j.dnarep.2004.08.006; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; TURKER MS, 1991, SOMAT CELL MOLEC GEN, V17, P151, DOI 10.1007/BF01232972; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yates PA, 1999, J BIOL CHEM, V274, P36357, DOI 10.1074/jbc.274.51.36357; Yates PA, 2003, MOL CELL BIOL, V23, P4461, DOI 10.1128/MCB.23.13.4461-4470.2003	43	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4832	10.1371/journal.pone.0004832	http://dx.doi.org/10.1371/journal.pone.0004832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279688	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496200009
J	Schmitt, A; Schuchhardt, J; Brockmann, GA				Schmitt, Armin; Schuchhardt, Johannes; Brockmann, Gudrun A.			The Action of Key Factors in Protein Evolution at High Temporal Resolution	PLOS ONE			English	Article								Background: Protein evolution is particularly shaped by the conservation of the amino acids' physico-chemical properties and the structure of the genetic code. While conservation is the result of negative selection against proteins with reduced functionality, the codon sequences determine the stochastic aspect of amino acid exchanges. Thus far, it is known that the genetic code is the dominant factor if little time has elapsed since the divergence of one gene into two, but physicochemical forces gain importance at greater evolutionary distances. Further details, however, on how the influence of these factors varies with time are unknown to date. Methodology/Principal Findings: Here, we derive each 10,000 divergence specific substitution matrices for orthologues and paralogues from the Pfam collection of multiple protein alignments and quantify the action of three physico-chemical forces and of the structure of the genetic code at high resolution using correlation analysis. For closely related proteins, the codon sequence similarity is the most influential factor controlling protein evolution, but its influence decreases rapidly as divergence grows. From a protein sequence divergence of about 20 percent on the maintenance of the hydrophobic character of an amino acid is the most influential factor. All factors lose importance from about 40 percent divergence on. This suggests that the original protein structure often does no longer represent a constraint to the protein sequence. The proteins then become free to adopt new functions. We furthermore show that the constraints exerted by both physicochemical forces and by the genetic code are quite comparable for orthologues and paralogues, however somewhat weaker for paralogues than for orthologues in weakly or moderately diverged proteins. Conclusion/Significance: Our analysis substantiates earlier findings that protein evolution is mainly governed by the structure of the genetic code in the early phase after divergence and by the conservation of physico-chemical properties at the later phase. We determine the level of sequence divergence from which on the conservation of the hydrophobic character is gaining importance over the genetic code to be 20 percent. The evolution of orthologues and paralogues is shaped by evolutionary forces in quite comparable ways.	[Schmitt, Armin; Brockmann, Gudrun A.] Humboldt Univ, Inst Anim Sci, Berlin, Germany; [Schuchhardt, Johannes] MicroDiscovery GmbH, Berlin, Germany; [Brockmann, Gudrun A.] Humboldt Univ, Interdisciplin Ctr Variabil & Adapt, D-1086 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Schmitt, A (corresponding author), Humboldt Univ, Inst Anim Sci, Berlin, Germany.	armin.schmitt@agrar.hu-berlin.de		Schmitt, Armin/0000-0002-4910-9467	German Ministry of Education and Research [20301716, 20301717]; European Union [FP6 LSHG-CT-2006-037457]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by grants from the German Ministry of Education and Research (GenoTrack 20301716, NGFNplus 20301717) and the European Union (FP6 LSHG-CT-2006-037457, SysProt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1993, J MOL EVOL, V36, P290, DOI 10.1007/BF00160485; Ardell DH, 2002, PHILOS T R SOC B, V357, P1625, DOI 10.1098/rstb.2002.1071; Ardell DH, 2001, J MOL EVOL, V53, P269, DOI 10.1007/s002390010217; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HAIG D, 1991, J MOL EVOL, V33, P412, DOI 10.1007/BF02103132; Henikoff S, 1999, BIOINFORMATICS, V15, P471, DOI 10.1093/bioinformatics/15.6.471; JUKES TH, 1979, NATURE, V281, P605, DOI 10.1038/281605a0; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Patthy Laszlo, 1999, PROTEIN EVOLUTION; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmitt AO, 2007, J THEOR BIOL, V249, P376, DOI 10.1016/j.jtbi.2007.08.001; SWANSON R, 1984, B MATH BIOL, V46, P187, DOI 10.1007/BF02460068; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; ZUCKERKANDL E, 1975, J MOL EVOL, V7, P1, DOI 10.1007/BF01732178; ZUCKERKANDL E, 1965, EVOLVING GENES PROTE, V263, P97	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4821	10.1371/journal.pone.0004821	http://dx.doi.org/10.1371/journal.pone.0004821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279682	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496200005
J	Ansari, A; Talat, N; Jamil, B; Hasan, Z; Razzaki, T; Dawood, G; Hussain, R				Ansari, Ambreen; Talat, Najeeha; Jamil, Bushra; Hasan, Zahra; Razzaki, Tashmeem; Dawood, Ghaffar; Hussain, Rabia			Cytokine Gene Polymorphisms across Tuberculosis Clinical Spectrum in Pakistani Patients	PLOS ONE			English	Article								Background: Pakistan ranks 7(th) globally in terms of tuberculosis (TB) disease burden (incidence 181/100000 pop./yr; prevalence of 329/pop./yr). Reports from different populations show variable associations of TB susceptibility and severity with cytokine gene polymorphisms. Tuberculosis clinical severity is multi-factorial and cytokines play a pivotal role in the modulation of disease severity. We have recently reported that the ratio of two key cytokines (IFN gamma and IL10) show significant correlation with the severity spectrum of tuberculosis. The objective of the current study was to analyze the frequency of cytokine gene polymorphisms linked to high and low responder phenotypes (IFN gamma + 874 T-hi -> A(lo) and IL10-1082 G(lo)-> A(hi)) in tuberculosis patients. Methods and Findings: Study groups were stratified according to disease site as well as disease severity: Pulmonary N = 111 (Minimal, PMN = 19; Moderate, PMD = 63; Advance, PAD = 29); Extra-pulmonary N = 67 (Disseminated DTB = 20, Localized LTB = 47) and compared with healthy controls (TBNA = 188). Genotype analyses were carried out using amplification refractory mutation system-PCR (ARMS-PCR) and stimulated whole blood (WB) culture assay was used for assessing cytokine profiles. Our results suggest that the IFN gamma + 874 TT genotype and T allele was overrepresented in PMN (p = 0.01) and PMD (p = 0.02). IFN gamma + 874 TT in combination with IL10 GG(lo) genotypes showed the highest association (chi(2) = 6.66, OR = 6.06, 95% CI = 1.31-28.07, p = 0.01). IFN gamma AA(lo) on the other hand in combination with IL10 GG(lo) increased the risk of PAD (OR = 5.26; p = 0.005) and DTB (OR = 3.59; p = 0.045). Conclusion: These findings are consistent with the role of IL10 in reducing collateral tissue damage and the protective role of IFN gamma in limiting disease in the lung.	[Ansari, Ambreen; Talat, Najeeha; Hasan, Zahra; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Jamil, Bushra] Aga Khan Univ, Dept Pathol & Microbiol & Med, Karachi, Pakistan; [Razzaki, Tashmeem] Sindh Inst Urol & Transplant, Karachi, Pakistan; [Dawood, Ghaffar] Masoomeen Gen Hosp, Karachi, Pakistan	Aga Khan University; Aga Khan University	Ansari, A (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hasan, Zahra/AAF-2191-2020; Hasan, Zahra/F-5111-2015; Hussain, Rabia/E-9982-2015	Hasan, Zahra/0000-0001-7580-372X; 	Higher Education Commission of Pakistan [20-796/ R]; Government of Pakistan [D/07];  [PCST/NCB-AC3/2003]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Government of Pakistan; 	This work was funded by The Grant No PCST/NCB-AC3/2003 and by the Higher Education Commission of Pakistan Grant No 20-796/ R and D/07 Government of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, EPIDEMIOL INFECT, V135, P27, DOI 10.1017/S0950268806006364; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; ATES O, 2007, J CLIN IMMUNOL, P1; Bagheri M, 2006, TRANSFUSION MED, V16, P192, DOI 10.1111/j.1365-3148.2006.00666.x; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; DHINGRA VK, 2004, INDIAN J COMM MED, V29, P1; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Etokebe GE, 2006, SCAND J IMMUNOL, V63, P136, DOI 10.1111/j.1365-3083.2005.01716.x; Ferraz JC, 2006, BRAZ J MED BIOL RES, V39, P1387, DOI 10.1590/S0100-879X2006001100002; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Henao MI, 2006, TUBERCULOSIS, V86, P11, DOI 10.1016/j.tube.2005.03.001; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Lemos Antonio Carlos, 2004, Braz J Infect Dis, V8, P424, DOI 10.1590/S1413-86702004000600006; Lio D, 2002, EUR J IMMUNOGENET, V29, P371, DOI 10.1046/j.1365-2370.2002.00327.x; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Mehdi SQ, 2002, BIODIVERSITY: BIOMOLECULAR ASPECTS OF BIODIVERSITY AND INNOVATIVE UTILIZATION, P35; Moran A, 2007, INT J TUBERC LUNG D, V11, P113; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Oh JH, 2007, RESPIROLOGY, V12, P594, DOI 10.1111/j.1440-1843.2007.01108.x; Oral HB, 2006, CYTOKINE, V35, P143, DOI 10.1016/j.cyto.2006.07.015; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Perrey C, 1998, TRANSPL IMMUNOL, V6, P193, DOI 10.1016/S0966-3274(98)80045-2; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Sallakci N, 2007, TUBERCULOSIS, V87, P225, DOI 10.1016/j.tube.2006.10.002; Scola L, 2003, MECH AGEING DEV, V124, P569, DOI 10.1016/S0047-6374(03)00038-1; Shin JE, 2005, REQUIR ENG, V10, P132, DOI 10.1007/s00766-004-0207-3; Takiff HE, 2007, TUBERCULOSIS 2007 BA, P207; Tso HW, 2005, GENES IMMUN, V6, P358, DOI 10.1038/sj.gene.6364189; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Vidyarani M, 2006, INDIAN J MED RES, V124, P403	41	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4778	10.1371/journal.pone.0004778	http://dx.doi.org/10.1371/journal.pone.0004778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274101	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496000017
J	Little, DY; Chen, L				Little, Daniel Y.; Chen, Lu			Identification of Coevolving Residues and Coevolution Potentials Emphasizing Structure, Bond Formation and Catalytic Coordination in Protein Evolution	PLOS ONE			English	Article							MUTUAL INFORMATION; CORRELATED MUTATIONS; CRYSTAL-STRUCTURE; PREDICTION; CONSERVATION; NETWORKS; CONTACTS; SYSTEM; SITES; FOLD	The structure and function of a protein is dependent on coordinated interactions between its residues. The selective pressures associated with a mutation at one site should therefore depend on the amino acid identity of interacting sites. Mutual information has previously been applied to multiple sequence alignments as a means of detecting coevolutionary interactions. Here, we introduce a refinement of the mutual information method that: 1) removes a significant, non-coevolutionary bias and 2) accounts for heteroscedasticity. Using a large, non-overlapping database of protein alignments, we demonstrate that predicted coevolving residue-pairs tend to lie in close physical proximity. We introduce coevolution potentials as a novel measure of the propensity for the 20 amino acids to pair amongst predicted coevolutionary interactions. Ionic, hydrogen, and disulfide bond-forming pairs exhibited the highest potentials. Finally, we demonstrate that pairs of catalytic residues have a significantly increased likelihood to be identified as coevolving. These correlations to distinct protein features verify the accuracy of our algorithm and are consistent with a model of coevolution in which selective pressures towards preserving residue interactions act to shape the mutational landscape of a protein by restricting the set of admissible neutral mutations.	[Little, Daniel Y.; Chen, Lu] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chen, Lu] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Little, DY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	luchen@berkeley.edu			Mabel and Arnold Beckman Foundation; David and Lucile Packard Foundation; W. M. Keck Foundation; NIH [RO1 MH069792]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069792] Funding Source: NIH RePORTER	Mabel and Arnold Beckman Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported Mabel and Arnold Beckman Foundation, the David and Lucile Packard Foundation, the W. M. Keck Foundation, and N.I.H. (L.C. RO1 MH069792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2004, J MOL BIOL, V336, P903, DOI 10.1016/j.jmb.2003.12.072; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Buss KA, 2001, J BACTERIOL, V183, P680, DOI 10.1128/JB.183.2.680-686.2001; Crisma M, 2006, BIOPOLYMERS, V84, P3, DOI 10.1002/bip.20357; DUNN SD, 2007, BIOINFORMATICS; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; FINN RD, 2007, NUCL ACIDS RES; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Giraud BG, 1998, PHYS REV E, V58, P6312, DOI 10.1103/PhysRevE.58.6312; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gouveia-Oliveira R, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-12; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Miyazawa S, 1999, PROTEINS, V34, P49; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2008, METHODS MOL BIOL, V484, P523, DOI 10.1007/978-1-59745-398-1_31; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Shackelford G, 2007, PROTEINS, V69, P159, DOI 10.1002/prot.21791; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Smith AK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S5; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Travers SAA, 2007, MOL BIOL EVOL, V24, P1032, DOI 10.1093/molbev/msm022; Wang ZO, 2007, J MOL EVOL, V65, P485, DOI 10.1007/s00239-007-9018-8; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	40	32	32	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4762	10.1371/journal.pone.0004762	http://dx.doi.org/10.1371/journal.pone.0004762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274093	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000003
J	Nowak, LG; Barone, P				Nowak, Lionel G.; Barone, Pascal			Contrast Adaptation Contributes to Contrast-Invariance of Orientation Tuning of Primate V1 Cells	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; CAT STRIATE CORTEX; SPATIAL-FREQUENCY DISCRIMINATION; MARMOSETS CALLITHRIX-JACCHUS; DIRECTION-SELECTIVE ADAPTATION; ACTIVATED POTASSIUM CHANNEL; SACCADIC EYE-MOVEMENTS; CORTICAL-NEURONS; RESPONSE PROPERTIES	Background: Studies in rodents and carnivores have shown that orientation tuning width of single neurons does not change when stimulus contrast is modified. However, in these studies, stimuli were presented for a relatively long duration (e. g., 4 seconds), making it possible that contrast adaptation contributed to contrast-invariance of orientation tuning. Our first purpose was to determine, in marmoset area V1, whether orientation tuning is still contrast-invariant with the stimulation duration is comparable to that of a visual fixation. Methodology/Principal Findings: We performed extracellular recordings and examined orientation tuning of single-units using static sine-wave gratings that were flashed for 200 msec. Sixteen orientations and three contrast levels, representing low, medium and high values in the range of effective contrasts for each neuron, were randomly intermixed. Contrast adaptation being a slow phenomenon, cells did not have enough time to adapt to each contrast individually. With this stimulation protocol, we found that the tuning width obtained at intermediate contrast was reduced to 89% (median), and that at low contrast to 76%, of that obtained at high contrast. Therefore, when probed with briefly flashed stimuli, orientation tuning is not contrast-invariant in marmoset V1. Our second purpose was to determine whether contrast adaptation contributes to contrast-invariance of orientation tuning. Stationary gratings were presented, as previously, for 200 msec with randomly varying orientations, but the contrast was kept constant within stimulation blocks lasting>20 sec, allowing for adaptation to the single contrast in use. In these conditions, tuning widths obtained at low contrast were still significantly less than at high contrast (median 85%). However, tuning widths obtained with medium and high contrast stimuli no longer differed significantly. Conclusions/Significance: Orientation tuning does not appear to be contrast-invariant when briefly flashed stimuli vary in both contrast and orientation, but contrast adaptation partially restores contrast-invariance of orientation tuning.	[Nowak, Lionel G.; Barone, Pascal] Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Nowak, LG (corresponding author), Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, F-31062 Toulouse, France.	Lionel.Nowak@cerco.ups-tlse.fr	Barone, Pascal/A-4008-2009; Nowak, Lionel/D-4120-2011; BARONE, Pascal/AHE-2323-2022	BARONE, Pascal/0000-0003-0125-7468	CNRS; Ministere delegue a la Recherche et aux nouvelles Technologies [NIC 0085]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere delegue a la Recherche et aux nouvelles Technologies	This work was supported by the CNRS, by the Ministere delegue a la Recherche et aux nouvelles Technologies (Action Concerte Incitative "Neurosciences Integratives et Computationnelles", NIC 0085) (L.G.N.) and by the CNRS ATIP program (P.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Ahmed B, 1997, CEREB CORTEX, V7, P559, DOI 10.1093/cercor/7.6.559; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; ALLISON JD, 1993, VISUAL NEUROSCI, V10, P1129, DOI 10.1017/S0952523800010233; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Banitt Y, 2007, J NEUROSCI, V27, P10230, DOI 10.1523/JNEUROSCI.1640-07.2007; BARLOW HB, 1976, VISION RES, V16, P1043, DOI 10.1016/0042-6989(76)90241-8; Beaudot WHA, 2006, VISION RES, V46, P26, DOI 10.1016/j.visres.2005.10.016; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; BJORKLUND RA, 1981, PERCEPTION, V10, P511, DOI 10.1068/p100511; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; BLAKEMORE C, 1973, VISION RES, V13, P1915, DOI 10.1016/0042-6989(73)90063-1; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Bourne JA, 2003, BRAIN RES PROTOC, V11, P168, DOI 10.1016/S1385-299X(03)00044-8; BOWNE SF, 1990, VISION RES, V30, P449, DOI 10.1016/0042-6989(90)90086-Z; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bressloff PC, 2003, PHILOS T R SOC B, V358, P1643, DOI 10.1098/rstb.2002.1109; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Buzas P, 2006, J COMP NEUROL, V499, P861, DOI 10.1002/cne.21134; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; Contreras D, 2003, J NEUROSCI, V23, P6936; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; Delorme A, 2003, J COMPUT NEUROSCI, V15, P357, DOI 10.1023/A:1027420012134; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Descalzo VF, 2005, J NEUROPHYSIOL, V93, P1111, DOI 10.1152/jn.00658.2004; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Fritsches KA, 1996, J COMP NEUROL, V372, P264; FUCHS AF, 1967, J PHYSIOL-LONDON, V191, P609, DOI 10.1113/jphysiol.1967.sp008271; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGESON M A, 1985, Spatial Vision, V1, P103, DOI 10.1163/156856885X00125; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; GILINSKY AS, 1968, J OPT SOC AM, V58, P13, DOI 10.1364/JOSA.58.000013; GOFFART L, 2008, NEW ENCY NEUROSCIENC; GREENLEE MW, 1988, VISION RES, V28, P791, DOI 10.1016/0042-6989(88)90026-0; Guo K, 2006, EXP BRAIN RES, V171, P91, DOI 10.1007/s00221-005-0248-y; HAMMETT ST, 1994, VISION RES, V34, P31, DOI 10.1016/0042-6989(94)90254-2; HAMMOND P, 1989, VISION RES, V29, P1671, DOI 10.1016/0042-6989(89)90149-1; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HARTVEIT E, 1992, VISUAL NEUROSCI, V9, P515, DOI 10.1017/S0952523800011317; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Itti L, 2000, J OPT SOC AM A, V17, P1899, DOI 10.1364/JOSAA.17.001899; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; LAZAREVA N A, 1983, Neirofiziologiya, V15, P347; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; LI CY, 1984, PFLUG ARCH EUR J PHY, V401, P304; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lui LL, 2006, CEREB CORTEX, V16, P162, DOI 10.1093/cercor/bhi094; MAATTANEN LM, 1991, EXP BRAIN RES, V87, P205; Mace MJM, 2005, EUR J NEUROSCI, V21, P2007, DOI 10.1111/j.1460-9568.2005.04029.x; MADDESS T, 1988, BIOL CYBERN, V59, P229, DOI 10.1007/BF00332911; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MAFFEI L, 1973, VISION RES, V13, P1255, DOI 10.1016/0042-6989(73)90201-0; MALPELI JG, 1981, J NEUROPHYSIOL, V46, P1102, DOI 10.1152/jn.1981.46.5.1102; Mareschal I, 2004, VISION RES, V44, P57, DOI 10.1016/j.visres.2003.07.009; MARLIN SG, 1988, J NEUROPHYSIOL, V59, P1314, DOI 10.1152/jn.1988.59.4.1314; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McIlhagga WH, 1996, VISION RES, V36, P1265, DOI 10.1016/0042-6989(95)00196-4; McLean J, 1996, VISUAL NEUROSCI, V13, P1069, DOI 10.1017/S0952523800007720; McLoughlin N, 2006, NEUROIMAGE, V31, P76, DOI 10.1016/j.neuroimage.2005.12.054; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Nasanen RE, 1997, INVEST OPHTH VIS SCI, V38, P260; NEALEY TA, 1994, J NEUROSCI, V14, P2069; NELSON SB, 1991, J NEUROSCI, V11, P344; Nowak LG, 2005, J NEUROSCI, V25, P1866, DOI 10.1523/JNEUROSCI.3897-04.2005; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PANTLE A, 1968, SCIENCE, V162, P1146, DOI 10.1126/science.162.3858.1146-a; Peterson MR, 2006, J NEUROPHYSIOL, V95, P2705, DOI 10.1152/jn.00885.2005; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Reisbeck TE, 1998, VISION RES, V38, P1105, DOI 10.1016/S0042-6989(97)00240-X; Ringach DL, 2002, J NEUROSCI, V22, P5639; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; Roe AW, 2005, ANAT REC PART A, V287A, P1213, DOI 10.1002/ar.a.20248; Rosa MGP, 1997, J COMP NEUROL, V387, P547, DOI 10.1002/(SICI)1096-9861(19971103)387:4<547::AID-CNE6>3.0.CO;2-2; Sally SL, 2007, EXP BRAIN RES, V183, P351, DOI 10.1007/s00221-007-1048-3; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2002, J NEUROPHYSIOL, V88, P1363, DOI 10.1152/jn.2002.88.3.1363; Schiessl I, 2003, NEUROIMAGE, V20, P1857, DOI 10.1016/j.neuroimage.2003.07.023; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SEKULER RW, 1965, AM J PSYCHOL, V78, P686, DOI 10.2307/1420939; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; Sengpiel F, 1996, VISUAL NEUROSCI, V13, P145, DOI 10.1017/S0952523800007197; SHAPLEY R, 1981, NATURE, V292, P543, DOI 10.1038/292543a0; SHAPLEY RM, 2002, 7206 SOC NEUR; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P264, DOI 10.1152/jn.1984.52.2.264; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; SUR M, 1982, J NEUROPHYSIOL, V47, P869, DOI 10.1152/jn.1982.47.5.869; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Teich AF, 2006, J NEUROPHYSIOL, V96, P404, DOI 10.1152/jn.00015.2005; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Troyer TW, 2002, J NEUROPHYSIOL, V87, P2741, DOI 10.1152/jn.2002.87.6.2741; Troyer TW, 1998, J NEUROSCI, V18, P5908; Ursino M, 2004, VISION RES, V44, P1641, DOI 10.1016/j.visres.2004.02.005; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Varela JA, 1999, J NEUROSCI, V19, P4293; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Webb BS, 2002, VISUAL NEUROSCI, V19, P583, DOI 10.1017/S0952523802195046; Webster MA, 1997, J OPT SOC AM A, V14, P2355, DOI 10.1364/JOSAA.14.002355; WEBSTER MA, 1990, J OPT SOC AM A, V7, P1034, DOI 10.1364/JOSAA.7.001034; Westheimer G, 1999, VISION RES, V39, P1631, DOI 10.1016/S0042-6989(98)00200-4; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; Yeh TY, 1995, J NEUROSCI, V15, P7892; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	160	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4781	10.1371/journal.pone.0004781	http://dx.doi.org/10.1371/journal.pone.0004781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OE	19274097	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496000019
J	Grosso, A; Douglas, I; Hingorani, A; MacAllister, R; Smeeth, L				Grosso, Anthony; Douglas, Ian; Hingorani, Aroon; MacAllister, Raymond; Smeeth, Liam			Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis	PLOS ONE			English	Article								Background: A recent trial unexpectedly reported that atrial fibrillation, when defined as serious, occurred more often in participants randomized to an annual infusion of the relatively new parenteral bisphosphonate, zoledronic acid, than among those given placebo, but had limited power. Two subsequent population-based case-control studies of patients receiving a more established oral bisphosphonate, alendronic acid, reported conflicting results, possibly due to uncontrolled confounding factors. Methodology/Principal Findings: We used the United Kingdom General Practice Research Database to assess the risk of atrial fibrillation and flutter in women exposed to the oral bisphosphonates, alendronic acid and risedronate sodium. The self-controlled case-series method was used to minimise the potential for confounding. The age-adjusted incidence rate ratio for atrial fibrillation or flutter in individuals during their exposure to these oral bisphosphonates (n = 2195) was 1.07 (95% CI 0.94 - 1.21). The age-adjusted incidence rate ratio for alendronic acid (n = 1489) and risedronate sodium (n = 649) exposed individuals were 1.09 (95% CI 0.93 - 1.26) and 0.99 (95% CI 0.78 - 1.26) respectively. In post-hoc analyses, an increased risk of incident atrial fibrillation or flutter was detected for patients during their first few months of alendronic acid therapy. Conclusions/Significance: We found no robust evidence of an overall long-term increased risk of atrial fibrillation or flutter associated with continued exposure to the oral bisphosphonates, alendronic acid and risedronate sodium. A possible signal for an increase in risk during the first few months of therapy with alendronic acid needs to be re-assessed in additional studies.	[Grosso, Anthony] Univ Coll London Hosp NHS Fdn Trust, Dept Pharm, London, England; [Grosso, Anthony; Hingorani, Aroon; MacAllister, Raymond] UCL, Ctr Clin Pharmacol, Div Med, London, England; [Douglas, Ian; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Hingorani, Aroon] UCL, Div Populat Hlth, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Grosso, A (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Dept Pharm, London, England.	anthony.grosso@uclh.nhs.uk	; Smeeth, Liam/X-5862-2018	Hingorani, Aroon/0000-0001-8365-0081; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust [Senior Research Fellowship in Clinical Science]; British Heart Foundation [Senior Research Fellowship in Clinical Science]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	Liam Smeeth is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. Aroon Hingorani is a British Heart Foundation Senior Research Fellow.	Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Donahue JG, 2002, ARCH INTERN MED, V162, P936, DOI 10.1001/archinte.162.8.936; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Grosso A, 2008, BRIT J CLIN PHARMACO, V66, P689, DOI 10.1111/j.1365-2125.2008.03273.x; Heckbert SR, 2008, ARCH INTERN MED, V168, P826, DOI 10.1001/archinte.168.8.826; Hubbard R, 2005, THORAX, V60, P848, DOI 10.1136/thx.2005.041798; Karam R, 2007, NEW ENGL J MED, V357, P712; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Majumdar SR, 2008, BRIT MED J, V336, P784, DOI 10.1136/bmj.39513.481065.80; Mant J, 2007, BMJ-BRIT MED J, V335, P380, DOI 10.1136/bmj.39227.551713.AE; *MHRA, 2008, MHRA DRUG SAF UPD JU, V1; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; Sorensen HT, 2008, BMJ-BRIT MED J, V336, P813, DOI 10.1136/bmj.39507.551644.BE; Whitaker H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1069; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	19	50	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4720	10.1371/journal.pone.0004720	http://dx.doi.org/10.1371/journal.pone.0004720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266096	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000265490800002
J	Striegl, H; Roske, Y; Kummel, D; Heinemann, U				Striegl, Harald; Roske, Yvette; Kuemmel, Daniel; Heinemann, Udo			Unusual Armadillo Fold in the Human General Vesicular Transport Factor p115	PLOS ONE			English	Article							PROTEIN; REPLACEMENT; COMPLEX	The golgin family gives identity and structure to the Golgi apparatus and is part of a complex protein network at the Golgi membrane. The golgin p115 is targeted by the GTPase Rab1a, contains a large globular head region and a long region of coiled-coil which forms an extended rod-like structure. p115 serves as vesicle tethering factor and plays an important role at different steps of vesicular transport. Here we present the 2.2 angstrom-resolution X-ray structure of the globular head region of p115. The structure exhibits an armadillo fold that is decorated by elongated loops and carries a C-terminal non-canonical repeat. This terminal repeat folds into the armadillo superhelical groove and allows homodimeric association with important implications for p115 mediated multiple protein interactions and tethering.	[Striegl, Harald; Roske, Yvette; Kuemmel, Daniel; Heinemann, Udo] Max Delbruck Ctr Mol Med, Berlin, Germany; [Heinemann, Udo] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin	Striegl, H (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	heinemann@mdc-berlin.de	Heinemann, Udo/S-3379-2016; Heinemann, Udo/AAH-4766-2019	Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850	Deutsche Forschungsgemeinschaft [SFB 740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through SFB 740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Heinemann U, 2003, ACCOUNTS CHEM RES, V36, P157, DOI 10.1021/ar010129t; Hofmann KP, 2006, TRENDS BIOCHEM SCI, V31, P497, DOI 10.1016/j.tibs.2006.07.006; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Satoh A, 2008, TRAFFIC, V9, P1522, DOI 10.1111/j.1600-0854.2008.00783.x; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yamakawa H, 1996, J STRUCT BIOL, V116, P356, DOI 10.1006/jsbi.1996.0053	30	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4656	10.1371/journal.pone.0004656	http://dx.doi.org/10.1371/journal.pone.0004656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247479	Green Published, gold			2022-12-27	WOS:000265487800035
J	Adio, S; Jaud, J; Ebbing, B; Rief, M; Woehlke, G				Adio, Sarah; Jaud, Johann; Ebbing, Bettina; Rief, Matthias; Woehlke, Guenther			Dissection of Kinesin's Processivity	PLOS ONE			English	Article								The protein family of kinesins contains processive motor proteins that move stepwise along microtubules. This mechanism requires the precise coupling of the catalytic steps in the two heads, and their precise mechanical coordination. Here we show that these functionalities can be uncoupled in chimera of processive and non-processive kinesins. A chimera with the motor domain of Kinesin-1 and the dimerization domain of a non-processive Kinesin-3 motor behaves qualitatively as conventional kinesin and moves processively in TIRF and bead motility assays, suggesting that spatial proximity of two Kinein-1 motor domains is sufficient for processive behavior. In the reverse chimera, the non-processive motor domains are unable to step along microtubules, despite the presence of the Kinesin-1 neck coiled coil. Still, ATP-binding to one head of these chimera induces ADP-release from the partner head, a characteristic feature of alternating site catalysis. These results show that processive movement of kinesin dimers requires elements in the motor head that respond to ADP-release and induce stepping, in addition to a proper spacing of the motor heads via the neck coiled coil.	[Adio, Sarah; Jaud, Johann; Ebbing, Bettina; Rief, Matthias; Woehlke, Guenther] Tech Univ Munich, Phys Dept E22, D-8046 Garching, Germany; [Rief, Matthias] Munich Ctr Integrated Protein Sci, Munich, Germany	Technical University of Munich	Adio, S (corresponding author), Tech Univ Munich, Phys Dept E22, D-8046 Garching, Germany.	guenther.woehlke@lrz.uni-muenchen.de	Lechner, Bettina/A-2448-2013	Adio, Sarah/0000-0002-6555-0850; Woehlke, Gunther/0000-0001-8462-9962	Deutsche Forschungsgemeinschaft DFG [SFB 614, SPP 1068, WO 614/4-1]; Fridrich-Baur-Foundation	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Fridrich-Baur-Foundation	The work presented was supported by public research funding by the Deutsche Forschungsgemeinschaft DFG (SFB 614, SPP 1068, and WO 614/4-1), and the Fridrich-Baur-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bathe F, 2005, MOL BIOL CELL, V16, P3529, DOI 10.1091/mbc.E04-11-0957; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 1999, NAT CELL BIOL, V1, pE163, DOI 10.1038/14113; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; Jaud J, 2006, BIOPHYS J, V91, P1407, DOI 10.1529/biophysj.105.076265; Kallipolitou A, 2001, EMBO J, V20, P6226, DOI 10.1093/emboj/20.22.6226; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Lakamper S, 2003, BIOPHYS J, V84, P1833, DOI 10.1016/S0006-3495(03)74991-1; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; MARX A, 2008, BIOCHEMISTRY; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Schafer F, 2003, EMBO J, V22, P450, DOI 10.1093/emboj/cdg036; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4612	10.1371/journal.pone.0004612	http://dx.doi.org/10.1371/journal.pone.0004612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242550	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487500014
J	Liu, WQ; Feng, Y; Wang, Y; Zou, QH; Chen, F; Guo, JT; Peng, YH; Jin, Y; Li, YG; Hu, SN; Johnston, RN; Liu, GR; Liu, SL				Liu, Wei-Qiao; Feng, Ye; Wang, Yan; Zou, Qing-Hua; Chen, Fang; Guo, Ji-Tao; Peng, Yi-Hong; Jin, Yan; Li, Yong-Guo; Hu, Song-Nian; Johnston, Randal N.; Liu, Gui-Rong; Liu, Shu-Lin			Salmonella paratyphi C: Genetic Divergence from Salmonella choleraesuis and Pathogenic Convergence with Salmonella typhi	PLOS ONE			English	Article							GENOMIC CLEAVAGE MAP; ENTERICA SEROTYPE CHOLERAESUIS; VIRULENCE PLASMID; TYPHIMURIUM; SEQUENCE; SEROVARS; STRAINS; ENTERITIDIS; CHROMOSOME; RECOMBINATION	Background: Although over 1400 Salmonella serovars cause usually self-limited gastroenteritis in humans, a few, e. g., Salmonella typhi and S. paratyphi C, cause typhoid, a potentially fatal systemic infection. It is not known whether the typhoid agents have evolved from a common ancestor (by divergent processes) or acquired similar pathogenic traits independently (by convergent processes). Comparison of different typhoid agents with non-typhoidal Salmonella lineages will provide excellent models for studies on how similar pathogens might have evolved. Methodologies/Principal Findings: We sequenced a strain of S. paratyphi C, RKS4594, and compared it with previously sequenced Salmonella strains. RKS4594 contains a chromosome of 4,833,080 bp and a plasmid of 55,414 bp. We predicted 4,640 intact coding sequences (4,578 in the chromosome and 62 in the plasmid) and 152 pseudogenes (149 in the chromosome and 3 in the plasmid). RKS4594 shares as many as 4346 of the 4,640 genes with a strain of S. choleraesuis, which is primarily a swine pathogen, but only 4008 genes with another human-adapted typhoid agent, S. typhi. Comparison of 3691 genes shared by all six sequenced Salmonella strains placed S. paratyphi C and S. choleraesuis together at one end, and S. typhi at the opposite end, of the phylogenetic tree, demonstrating separate ancestries of the human-adapted typhoid agents. S. paratyphi C seemed to have suffered enormous selection pressures during its adaptation to man as suggested by the differential nucleotide substitutions and different sets of pseudogenes, between S. paratyphi C and S. choleraesuis. Conclusions: S. paratyphi C does not share a common ancestor with other human-adapted typhoid agents, supporting the convergent evolution model of the typhoid agents. S. paratyphi C has diverged from a common ancestor with S. choleraesuis by accumulating genomic novelty during adaptation to man.	[Liu, Wei-Qiao; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China; [Liu, Wei-Qiao; Wang, Yan; Jin, Yan; Liu, Gui-Rong; Liu, Shu-Lin] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Feng, Ye; Hu, Song-Nian] Zhejiang Univ, JD Watson Inst Genome Sci, Hangzhou, Peoples R China; [Feng, Ye; Hu, Song-Nian] Chinese Acad Sci, Beijing Inst Genom, Beijing 100864, Peoples R China; [Zou, Qing-Hua; Chen, Fang; Guo, Ji-Tao; Peng, Yi-Hong; Liu, Gui-Rong; Liu, Shu-Lin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing, Peoples R China; [Li, Yong-Guo; Liu, Shu-Lin] Harbin Med Univ, Hosp 1, Dept Infect Dis, Harbin, Peoples R China; [Johnston, Randal N.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada	Harbin Medical University; University of Calgary; Zhejiang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Peking University; Harbin Medical University; University of Calgary	Liu, WQ (corresponding author), Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China.	grliu@ucalgary.ca; slliu@ucalgary.ca	Guo, Jitao/AAP-4971-2020; Johnston, Randal/B-9247-2009; Hu, Songnian/C-6509-2013	Guo, Jitao/0000-0002-0927-4249; Hu, Songnian/0000-0003-3966-3111; RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	Canadian Institutes of Health Research; Harbin Medical University; National Natural Science Foundation of China [NSFC30370774, NSFC30870098]; Peking University Health Science Center; Specialized Research Fund for the Doctoral Program of Higher Education [20030001029]; Natural Sciences and Engineering Research Council of Canada [Discovery Grant]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Harbin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University Health Science Center(Peking University); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Canadian Institutes of Health Research grant to RNJ; and a grant of Harbin Medical University, National Natural Science Foundation of China grants (NSFC30370774, NSFC30870098), a 985 Project grant of Peking University Health Science Center, a Specialized Research Fund for the Doctoral Program of Higher Education (No. 20030001029), and a Discovery Grant from Natural Sciences and Engineering Research Council of Canada to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Alokam S, 2002, J BACTERIOL, V184, P6190, DOI 10.1128/JB.184.22.6190-6197.2002; Baumler AJ, 1997, ADV EXP MED BIOL, V412, P149; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Chiu CH, 2006, PEDIATRICS, V117, pE1193, DOI 10.1542/peds.2005-2251; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Chu CS, 1999, INFECT IMMUN, V67, P2611, DOI 10.1128/IAI.67.5.2611-2614.1999; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; JACOBS MR, 1978, S AFR MED J, V54, P434; Jean Shio-Shin, 2006, Journal of Microbiology Immunology and Infection, V39, P358; Kariuki S, 1999, J CLIN MICROBIOL, V37, P2058, DOI 10.1128/JCM.37.6.2058-2060.1999; LAURENT E, 1979, NOUV PRESSE MED, V8, P1100; Ledeboer NA, 2006, INFECT IMMUN, V74, P3156, DOI 10.1128/IAI.01428-05; LEMINOR L, 1985, ANN INST PASTEUR MIC, V136B, P225, DOI 10.1016/S0769-2609(85)80047-8; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1995, J BACTERIOL, V177, P3355, DOI 10.1128/jb.177.11.3355-3357.1995; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; LIU SL, 1993, MOL MICROBIOL, V10, P655, DOI 10.1111/j.1365-2958.1993.tb00937.x; LIU SL, 1995, J BACTERIOL, V177, P5099, DOI 10.1128/jb.177.17.5099-5107.1995; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; POPOFF M.Y., 2005, BERGEYS MANUAL SYSTE, V2, P764; RodriguezPena JM, 1997, MICROBIOL-UK, V143, P1405, DOI 10.1099/00221287-143-4-1405; ROOF MB, 1992, VET MICROBIOL, V30, P355, DOI 10.1016/0378-1135(92)90022-L; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; SELANDER RK, 1990, INFECT IMMUN, V58, P2262, DOI 10.1128/IAI.58.7.2262-2275.1990; Soravia-Dunand VA, 1999, CLIN INFECT DIS, V29, P862, DOI 10.1086/520450; Straw BE, 2006, DIS SWINE; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Tam CKP, 2004, INFECT IMMUN, V72, P22, DOI 10.1128/IAI.72.1.22-28.2004; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Uzzau S, 1999, EPIDEMIOL INFECT, V123, P37, DOI 10.1017/S0950268899002654; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005	45	78	682	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4510	10.1371/journal.pone.0004510	http://dx.doi.org/10.1371/journal.pone.0004510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229335	gold, Green Published, Green Submitted			2022-12-27	WOS:000265486200003
J	Medina-Martinez, O; Amaya-Manzanares, F; Liu, CM; Mendoza, M; Shah, R; Zhang, L; Behringer, RR; Mahon, KA; Jamrich, M				Medina-Martinez, Olga; Amaya-Manzanares, Felipe; Liu, Chaomei; Mendoza, Marisela; Shah, Rina; Zhang, Li; Behringer, Richard R.; Mahon, Kathleen A.; Jamrich, Milan			Cell-Autonomous Requirement for Rx Function in the Mammalian Retina and Posterior Pituitary	PLOS ONE			English	Article								Rx is a paired-like homeobox gene that is required for vertebrate eye formation. Mice lacking Rx function do not develop eyes or the posterior pituitary. To determine whether Rx is required cell autonomously in these tissues, we generated embryonic chimeras consisting of wild type and Rx2/2 cells. We found that in the eye, Rx-deficient cells cannot participate in the formation of the neuroretina, retina pigment epithelium and the distal part of the optic stalk. In addition, in the ventral forebrain, Rx function is required cell autonomously for the formation of the posterior pituitary. Interestingly, Rx-/- and wild type cells segregate before the morphogenesis of these two tissues begins. Our observations suggest that Rx function is not only required for the morphogenesis of the retina and posterior pituitary, but also prior to morphogenesis, for the sorting out of cells to form distinct fields of retinal/pituitary cells.	[Medina-Martinez, Olga; Liu, Chaomei; Jamrich, Milan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Amaya-Manzanares, Felipe; Mendoza, Marisela; Shah, Rina; Zhang, Li; Mahon, Kathleen A.; Jamrich, Milan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Behringer, Richard R.] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Medina-Martinez, O (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jamrich@bcm.tmc.edu			NIH/NEI [EY12505, EY12163, T32 EY07102]; Retina Research Foundation; NATIONAL EYE INSTITUTE [T32EY007102, R01EY012505, R01EY012163] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retina Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was sponsored by NIH/NEI grants EY12505 and EY12163 to M.J., NIH/NEI training grant T32 EY07102 to O.M. and by the Retina Research Foundation to M.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreazzoli M, 2003, DEVELOPMENT, V130, P5143, DOI 10.1242/dev.00665; Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9; Brownell I, 2000, GENESIS, V27, P81, DOI 10.1002/1526-968X(200006)27:2<81::AID-GENE50>3.0.CO;2-N; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Ericson J, 1998, DEVELOPMENT, V125, P1005; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; GARDNER RL, 1968, NATURE, V220, P596, DOI 10.1038/220596a0; Gardner RL, 2000, METH MOL B, V135, P397; GARDNER RL, 1975, S SOC DEV BIOL, V33, P207; Hermesz E, 1996, DEVELOPMENT, V122, P41; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Kennedy BN, 2004, DEV BIOL, V270, P336, DOI 10.1016/j.ydbio.2004.02.026; Kondoh H, 2000, MECH DEVELOP, V96, P165, DOI 10.1016/S0925-4773(00)00387-7; Li X, 2002, SCIENCE, V297, P1180; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; Loosli F, 2001, DEVELOPMENT, V128, P4035; Lopez-Rios J, 1999, MECH DEVELOP, V83, P155, DOI 10.1016/S0925-4773(99)00017-9; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; NAGY A, 2000, MANIPULATING MOUSE E; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ohuchi H, 1999, MECH DEVELOP, V85, P193, DOI 10.1016/S0925-4773(99)00094-5; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rojas-Munoz A, 2005, DEV BIOL, V288, P348, DOI 10.1016/j.ydbio.2005.08.046; Rosenfeld MG, 2000, RECENT PROG HORM RES, V55, P1; Schwind JL, 1928, AM J ANAT, V41, P295, DOI 10.1002/aja.1000410206; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Stigloher C, 2006, DEVELOPMENT, V133, P2925, DOI 10.1242/dev.02450; Swindell EC, 2008, DEV BIOL, V322, P56, DOI 10.1016/j.ydbio.2008.07.009; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Takuma N, 1998, DEVELOPMENT, V125, P4835; Terada K, 2006, DEV BIOL, V291, P398, DOI 10.1016/j.ydbio.2005.12.029; Toy J, 1999, MECH DEVELOP, V83, P183, DOI 10.1016/S0925-4773(99)00049-0; Toy J, 1998, P NATL ACAD SCI USA, V95, P10643, DOI 10.1073/pnas.95.18.10643; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Tucker P, 2001, GENESIS, V31, P43, DOI 10.1002/gene.10003; Volokh KY, 2006, INT J DEV BIOL, V50, P359, DOI 10.1387/ijdb.052039kv; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Winkler S, 2000, DEVELOPMENT, V127, P1911; Zhang L, 2000, GENESIS, V28, P135, DOI 10.1002/1526-968X(200011/12)28:3/4<135::AID-GENE70>3.0.CO;2-P; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	47	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4513	10.1371/journal.pone.0004513	http://dx.doi.org/10.1371/journal.pone.0004513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229337	Green Submitted, Green Published, gold			2022-12-27	WOS:000265486200004
J	Tsuchiya, M; Piras, V; Choi, SD; Akira, S; Tomita, M; Giuliani, A; Selvarajoo, K				Tsuchiya, Masa; Piras, Vincent; Choi, Sangdun; Akira, Shizuo; Tomita, Masaru; Giuliani, Alessandro; Selvarajoo, Kumar			Emergent Genome-Wide Control in Wildtype and Genetically Mutated Lipopolysaccarides-Stimulated Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; GENE-EXPRESSION; SELF-ORGANIZATION; LINKING INNATE; NETWORK; BIOLOGY; CELL; NORMALIZATION; LEVEL; MYD88	Large-scale gene expression studies have mainly focused on highly expressed and 'discriminatory' genes to decipher key regulatory processes. Biological responses are consequence of the concerted action of gene regulatory network, thus, limiting our attention to genes having the most significant variations is insufficient for a thorough understanding of emergent whole genome response. Here we comprehensively analyzed the temporal oligonucleotide microarray data of lipopolysaccharide (LPS) stimulated macrophages in 4 genotypes; wildtype, Myeloid Differentiation factor 88 (MyD88) knockout (KO), TIR-domain-containing adapter-inducing interferon-beta (TRIF) KO and MyD88/TRIF double KO (DKO). Pearson correlations computed on the whole genome expression between different genotypes are extremely high (> 0.98), indicating a strong co-regulation of the entire expression network. Further correlation analyses reveal genome-wide response is biphasic, i) acute-stochastic mode consisting of small number of sharply induced immune-related genes and ii) collective mode consisting of majority of weakly induced genes of diverse cellular processes which collectively adjust their expression level. Notably, temporal correlations of a small number of randomly selected genes from collective mode show scalability. Furthermore, in collective mode, the transition from large scatter in expression distributions for single ORFs to smooth linear lines emerges as an organizing principle when grouping of 50 ORFs and above. With this emergent behavior, the role of MyD88, TRIF and novel MyD88, TRIF-independent processes for gene induction can be linearly superposed to decipher quantitative whole genome differential control of transcriptional and mRNA decay machineries. Our work demonstrates genome-wide co-regulated responses subsequent to specific innate immune stimulus which have been largely neglected.	[Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Sch Media & Govern, Syst Biol Program, Tokyo 108, Japan; [Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Akira, Shizuo] Osaka Univ, Res Inst Microb Dis, Dept Host Defense, Suita, Osaka 565, Japan; [Giuliani, Alessandro] Ist Superiore Sanita, Dept Environm & Hlth, Rome, Italy	Keio University; Keio University; Ajou University; Osaka University; Istituto Superiore di Sanita (ISS)	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; kumar@ttck.keio.ac.jp	Piras, Vincent/K-3203-2012; Giuliani, Alessandro/K-7589-2016; Akira, Shizuo/C-3134-2009; Giuliani, Alessandro/AAF-1740-2020	Piras, Vincent/0000-0002-3427-0995; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Selvarajoo, Kumar/0000-0002-0314-9666	Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Yamagata Prefecture and Tsuruoka City, Japan; Korean Government (MOEHRD) [KRF-2006-311-C00482]	Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamagata Prefecture and Tsuruoka City, Japan; Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Research fund by Yamagata Prefecture and Tsuruoka City, Japan. This work was also partly supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2006-311-C00482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Farkas I, 2003, PHYSICA A, V318, P601, DOI 10.1016/S0378-4371(02)01731-4; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Klevecz RR, 2008, FEBS J, V275, P2372, DOI 10.1111/j.1742-4658.2008.06399.x; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kurakin A, 2005, DEV GENES EVOL, V215, P46, DOI 10.1007/s00427-004-0448-7; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Pries R, 2008, CRIT REV IMMUNOL, V28, P201, DOI 10.1615/CritRevImmunol.v28.i3.20; SELVARAJOO K, 2008, E CELL SYST IN PRESS; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	40	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4905	10.1371/journal.pone.0004905	http://dx.doi.org/10.1371/journal.pone.0004905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300509	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496800006
J	Wu, G; Huang, H; Abreu, JG; He, X				Wu, Geng; Huang, He; Abreu, Jose Garcia; He, Xi			Inhibition of GSK3 Phosphorylation of beta-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6	PLOS ONE			English	Article							F-BOX PROTEIN; RECEPTOR-RELATED PROTEIN-5; SYNTHASE KINASE 3-BETA; SIGNALING PATHWAY; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; AXIS FORMATION; XENOPUS; COMPLEX; DEGRADATION	The Wnt/beta-catenin signaling pathway plays essential roles in cell proliferation and differentiation, and deregulated beta-catenin protein levels lead to many types of human cancers. On activation by Wnt, the Wnt co-receptor LDL receptor related protein 6 (LRP6) is phosphorylated at multiple conserved intracellular PPPSPXS motifs by glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1), resulting in recruitment of the scaffolding protein Axin to LRP6. As a result, beta-catenin phosphorylation by GSK3 is inhibited and beta-catenin protein is stabilized. However, how LRP6 phosphorylation and the ensuing LRP6-Axin interaction lead to the inhibition of beta-catenin phosphorylation by GSK3 is not fully understood. In this study, we reconstituted Axin-dependent beta-catenin phosphorylation by GSK3 and CK1 in vitro using recombinant proteins, and found that the phosphorylated PPPSPXS peptides directly inhibit beta-catenin phosphorylation by GSK3 in a sequence and phosphorylation-dependent manner. This inhibitory effect of phosphorylated PPPSPXS motifs is direct and specific for GSK3 phosphorylation of beta-catenin at Ser33/Ser37/Thr41 but not for CK1 phosphorylation of beta-catenin at Ser45, and is independent of Axin function. We also show that a phosphorylated PPPSPXS peptide is able to activate Wnt/beta-catenin signaling and to induce axis duplication in Xenopus embryos, presumably by inhibition of GSK3 in vivo. Based on these observations, we propose a working model that Axin recruitment to the phosphorylated LRP6 places GSK3 in the vicinity of multiple phosphorylated PPPSPXS motifs, which directly inhibit GSK3 phosphorylation of beta-catenin. This model provides a possible mechanism to account, in part, for inhibition of beta-catenin phosphorylation by Wnt-activated LRP6.	[Wu, Geng; Huang, He; Abreu, Jose Garcia; He, Xi] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Abreu, Jose Garcia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil	Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade Federal do Rio de Janeiro	Wu, G (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	geng.wu@sjtu.edu.cn; xi.he@childrens.harvard.edu	Neurociencia, Inct/I-1011-2013; Abreu, Jose G/G-6159-2010; Abreu, Jose G/ABB-1199-2021	Abreu, Jose G/0000-0002-9875-7786; Abreu, Jose G/0000-0002-1363-1755	Leukemia and Lymphoma Society [Special Fellowship]; NIH [RO1-GM74241]; CIHR (Canadian Institute of Health Research) [postdoctoral fellowship]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Brazilian Scholarship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR (Canadian Institute of Health Research)(Canadian Institutes of Health Research (CIHR)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Leukemia and Lymphoma Society Special Fellowship to G. W, and by NIH RO1-GM74241 to X. H, who is a Leukemia and Lymphoma Society Scholar. HH is supported by a postdoctoral fellowship from CIHR (Canadian Institute of Health Research). JGA is a visiting professor and in part supported by a Brazilian Scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Wu G, 2006, BIOCHEMISTRY-US, V45, P5319, DOI 10.1021/bi0601149; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu G, 2004, MOL CELL, V13, P451, DOI 10.1016/S1097-2765(04)00090-5; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	55	148	157	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4926	10.1371/journal.pone.0004926	http://dx.doi.org/10.1371/journal.pone.0004926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293931	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496600013
J	Bargielowski, I; Koella, JC				Bargielowski, Irka; Koella, Jacob C.			A Possible Mechanism for the Suppression of Plasmodium berghei Development in the Mosquito Anopheles gambiae by the Microsporidian Vavraia culicis	PLOS ONE			English	Article								Background: Microsporidian parasites of mosquitoes offer a possible way of controlling malaria, as they impede the development of Plasmodium parasites within the mosquito. The mechanism involved in this interference process is unknown. Methodology: We evaluated the possibility that larval infection by a microsporidian primes the immune system of adult mosquitoes in a way that enables a more effective anti-Plasmodium response. To do so, we infected 2-day old larvae of the mosquito Anopheles gambiae with one of 4 isolates of the microsporidian Vavraia culicis and reared one group as an uninfected control. Within each treatment, we fed half the adult females on a mix of P. berghei ookinetes and blood and inoculated the other half with a negatively charged CM-25 Sephadex bead to evaluate the mosquitoes' melanisation response. Conclusions: The microsporidian-infected mosquitoes were less likely to harbour oocysts (58.5% vs. 81.8%), harboured fewer oocysts (8.9 oocysts vs. 20.7 oocysts) if the malaria parasite did develop and melanised the Sephadex bead to a greater degree (73% vs. 35%) than the controls. While the isolates differed in the number of oocysts and in the melanisation response, the stimulation of the immune response was not correlated with either measure of malaria development. Nevertheless, the consistent difference between microsporidian-infected and -uninfected mosquitoes - more effective melanisation and less successful infection by malaria - suggests that microsporidians impede the development of malaria by priming the mosquito's immune system.	[Bargielowski, Irka; Koella, Jacob C.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biol, London, England	Imperial College London	Bargielowski, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biol, London, England.	irka.bargielowski06@imperial.ac.uk			Imperial College London; Natural Environment Research Council [NE/F011288/1] Funding Source: researchfish; NERC [NE/F011288/1] Funding Source: UKRI	Imperial College London(General Electric); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Imperial College London partially supported IB during her MSc, as well as providing additional funding to JCK for this research. IB thanks Imperial College London for partial support during her MSc thesis, and JCK thanks Imperial College London for the financial support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Biron DG, 2005, INT J PARASITOL, V35, P1385, DOI 10.1016/j.ijpara.2005.05.015; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; FOX RM, 1959, J PARASITOL, V45, P21, DOI 10.2307/3274782; GAJANANA A, 1979, INDIAN J MED RES, V70, P417; Gorman MJ, 1997, AM J TROP MED HYG, V56, P446, DOI 10.4269/ajtmh.1997.56.446; HAQ N, 1981, J INVERTEBR PATHOL, V37, P236, DOI 10.1016/0022-2011(81)90081-1; HULLS RH, 1971, T ROY SOC TROP MED H, V65, P421, DOI 10.1016/0035-9203(71)90120-9; Koella JC, 1997, OIKOS, V78, P311, DOI 10.2307/3546298; Lambrechts L, 2004, EVOLUTION, V58, P2377, DOI 10.1111/j.0014-3820.2004.tb01611.x; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; MARGOS G, 1992, PARASITOL RES, V78, P168, DOI 10.1007/BF00931661; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; PASKEWITZ S, 1994, DEV COMP IMMUNOL, V18, P369, DOI 10.1016/0145-305X(94)90002-7; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x; Rivero A, 2007, PARASITOLOGY, V134, P1355, DOI 10.1017/S0031182007002703; SCHENKER W, 1992, PARASITOL RES, V78, P56, DOI 10.1007/BF00936182; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; UNDEEN AH, 1975, J INVERTEBR PATHOL, V25, P19, DOI 10.1016/0022-2011(75)90281-5; WARD RA, 1972, P HELM SOC WASH, V39, P434; WEISER J, 1980, DATA SHEET BIOL CONT, P1	27	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4676	10.1371/journal.pone.0004676	http://dx.doi.org/10.1371/journal.pone.0004676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277119	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496100001
J	Dheda, K; Smit, RNV; Sechi, LA; Badri, M; Meldau, R; Symons, G; Khalfey, H; Carr, I; Maredza, A; Dawson, R; Wainright, H; Whitelaw, A; Bateman, ED; Zumla, A				Dheda, Keertan; Smit, Richard N. Van-Zyl; Sechi, Leonardo A.; Badri, Motasim; Meldau, Richard; Symons, Gregory; Khalfey, Hoosein; Carr, Igshaan; Maredza, Alice; Dawson, Rodney; Wainright, Helen; Whitelaw, Andrew; Bateman, Eric D.; Zumla, Alimuddin			Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting	PLOS ONE			English	Article								Background: Current tools for the diagnosis of tuberculosis pleural effusions are sub-optimal. Data about the value of new diagnostic technologies are limited, particularly, in high burden settings. Preliminary case control studies have identified IFN-gamma-inducible-10kDa protein (IP-10) as a promising diagnostic marker; however, its diagnostic utility in a day-to-day clinical setting is unclear. Detection of LAM antigen has not previously been evaluated in pleural fluid. Methods: We investigated the comparative diagnostic utility of established (adenosine deaminase [ADA]), more recent (standardized nucleic-acid-amplification-test [NAAT]) and newer technologies (a standardized LAM mycobacterial antigen-detection assay and IP-10 levels) for the evaluation of pleural effusions in 78 consecutively recruited South African tuberculosis suspects. All consenting participants underwent pleural biopsy unless contra-indicated or refused. The reference standard comprised culture positivity for M. tuberculosis or histology suggestive of tuberculosis. Principal Findings: Of 74 evaluable subjects 48, 7 and 19 had definite, probable and non-TB, respectively. IP-10 levels were significantly higher in TB vs non-TB participants (p<0.0001). The respective outcomes [sensitivity, specificity, PPV, NPV %] for the different diagnostic modalities were: ADA at the 30 IU/L cut-point [96; 69; 90; 85], NAAT [6; 93; 67; 28], IP-10 at the 28,170 pg/ml ROC-derived cut-point [80; 82; 91; 64], and IP-10 at the 4035 pg/ml cut-point [100; 53; 83; 100]. Thus IP-10, using the ROC-derived cut-point, missed similar to 20% of TB cases and mis-diagnosed similar to 20% of non-TB cases. By contrast, when a lower cut-point was used a negative test excluded TB. The NAAT had a poor sensitivity but high specificity. LAM antigen-detection was not diagnostically useful. Conclusion: Although IP-10, like ADA, has sub-optimal specificity, it may be a clinically useful rule-out test for tuberculous pleural effusions. Larger multi-centric studies are now required to confirm our findings.	[Dheda, Keertan; Smit, Richard N. Van-Zyl; Badri, Motasim; Meldau, Richard; Symons, Gregory; Khalfey, Hoosein; Carr, Igshaan; Maredza, Alice; Dawson, Rodney; Wainright, Helen; Bateman, Eric D.] Univ Cape Town, Lung Inst, CTBRI, Lung Infect & Immunity Unit, Cape Town, South Africa; [Dheda, Keertan; Smit, Richard N. Van-Zyl; Badri, Motasim; Meldau, Richard; Symons, Gregory; Khalfey, Hoosein; Carr, Igshaan; Maredza, Alice; Dawson, Rodney; Wainright, Helen; Bateman, Eric D.] Univ Cape Town, Dept Med, Div Pulmonol, Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Dheda, Keertan; Zumla, Alimuddin] Univ Coll Med Sch, Centre for Infect Dis & Int Hlth, London, England; [Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Whitelaw, Andrew] Natl Hlth Lab Serv, Cape Town, South Africa; [Whitelaw, Andrew] Univ Cape Town, Dept Clin Lab Sci, Div Med Microbiol, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; University of Sassari; University of Cape Town	Dheda, K (corresponding author), Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Sechi, Leonardo Antonio/Y-3109-2018; ZUMLA, Alimuddin/ABA-8208-2020; Badri, Motasim/E-1141-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; van Zyl-Smit, Richard/0000-0002-4115-5362; sechi, leonardo antonio/0000-0003-0566-2049; Whitelaw, Andrew/0000-0001-9070-5247; Badri, Motasim/0000-0002-5268-6492	South African National Research Foundation (SARChI); South African Medical Research Council; UCL-UCT Collaboration Initiative	South African National Research Foundation (SARChI)(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL-UCT Collaboration Initiative	This work was supported by the South African National Research Foundation (SARChI), the South African Medical Research Council and the UCL-UCT Collaboration Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Dheda K, 2007, TUBERCULOSIS, V87, P237, DOI 10.1016/j.tube.2006.11.001; Fierro MT, 2006, DERMATOLOGY, V213, P284, DOI 10.1159/000096191; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Greco S, 2003, INT J TUBERC LUNG D, V7, P777; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Lande R, 2003, J IMMUNOL, V170, P1174, DOI 10.4049/jimmunol.170.3.1174; Mazzanti B, 2008, J NEUROIMMUNOL, V199, P142, DOI 10.1016/j.jneuroim.2008.05.006; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Nakayama S, 2005, RESP MED, V99, P1145, DOI 10.1016/j.rmed.2005.02.021; Neves DD, 2007, BRAZ J INFECT DIS, V11, P83, DOI 10.1590/S1413-86702007000100019; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P509, DOI 10.1586/14737159.6.4.509; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Porcel Jose Manuel, 2003, Med Sci Monit, V9, pCR175; RUHWALD M, 2008, EUR RESP J; Sharma SK, 2005, J CLIN LAB ANAL, V19, P40, DOI 10.1002/jcla.20054; Torvinen M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-80; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; Yang CS, 2008, RESP MED, V102, P280, DOI 10.1016/j.rmed.2007.08.016; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; YEW WW, 1991, CHEST, V100, P1261, DOI 10.1378/chest.100.5.1261	24	66	67	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4689	10.1371/journal.pone.0004689	http://dx.doi.org/10.1371/journal.pone.0004689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277111	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496100002
J	Demontis, F; Dahmann, C				Demontis, Fabio; Dahmann, Christian			Characterization of the Drosophila Ortholog of the Human Usher Syndrome Type 1G Protein Sans	PLOS ONE			English	Article								Background: The Usher syndrome (USH) is the most frequent deaf-blindness hereditary disease in humans. Deafness is attributed to the disorganization of stereocilia in the inner ear. USH1, the most severe subtype, is associated with mutations in genes encoding myosin VIIa, harmonin, cadherin 23, protocadherin 15, and sans. Myosin VIIa, harmonin, cadherin 23, and protocadherin 15 physically interact in vitro and localize to stereocilia tips in vivo, indicating that they form functional complexes. Sans, in contrast, localizes to vesicle-like structures beneath the apical membrane of stereocilia-displaying hair cells. How mutations in sans result in deafness and blindness is not well understood. Orthologs of myosin VIIa and protocadherin 15 have been identified in Drosophila melanogaster and their genetic analysis has identified essential roles in auditory perception and microvilli morphogenesis, respectively. Principal Findings: Here, we have identified and characterized the Drosophila ortholog of human sans. Drosophila Sans is expressed in tubular organs of the embryo, in lens-secreting cone cells of the adult eye, and in microvilli-displaying follicle cells during oogenesis. Sans mutants are viable, fertile, and mutant follicle cells appear to form microvilli, indicating that Sans is dispensable for fly development and microvilli morphogenesis in the follicle epithelium. In follicle cells, Sans protein localizes, similar to its vertebrate ortholog, to intracellular punctate structures, which we have identified as early endosomes associated with the syntaxin Avalanche. Conclusions: Our work is consistent with an evolutionary conserved function of Sans in vesicle trafficking. Furthermore it provides a significant basis for further understanding of the role of this Usher syndrome ortholog in development and disease.	[Demontis, Fabio; Dahmann, Christian] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Demontis, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	dahmann@mpi-cbg.de	Dahmann, Christian/B-5841-2017	Demontis, Fabio/0000-0002-8698-9555	Deutsche Forschungsgemeinschaft [DA586/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant DA586/4-1 of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; D'Alterio C, 2005, J CELL BIOL, V171, P549, DOI 10.1083/jcb.200507072; DeRosier DJ, 2000, J CELL BIOL, V148, P1; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Fung S, 2008, J COMP NEUROL, V506, P469, DOI 10.1002/cne.21539; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Johnston AM, 2004, GENES CELLS, V9, P967, DOI 10.1111/j.1365-2443.2004.00776.x; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; Kikkawa Y, 2003, HUM MOL GENET, V12, P453, DOI 10.1093/hmg/ddg042; LASKO PF, 1988, GENETICS, V120, P495; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pignoni F, 1997, DEVELOPMENT, V124, P271; Reiners J, 2005, MOL VIS, V11, P347; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; Schlichting K, 2005, DEV BIOL, V279, P142, DOI 10.1016/j.ydbio.2004.12.008; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Spradling Allan C., 1993, P1; Todi SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002115; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; WU CT, 1991, MOL CELL BIOL, V11, P3940, DOI 10.1128/MCB.11.8.3940; Zartman JJ, 2009, GENE EXPR PATTERNS, V9, P31, DOI 10.1016/j.gep.2008.09.001	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4753	10.1371/journal.pone.0004753	http://dx.doi.org/10.1371/journal.pone.0004753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270738	gold, Green Published, Green Submitted			2022-12-27	WOS:000265495900020
J	Broedl, UC; Lebherz, C; Lehrke, M; Stark, R; Greif, M; Becker, A; von Ziegler, F; Tittus, J; Reiser, M; Becker, C; Goke, B; Parhofer, KG; Leber, AW				Broedl, Uli C.; Lebherz, Corinna; Lehrke, Michael; Stark, Renee; Greif, Martin; Becker, Alexander; von Ziegler, Franz; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Goeke, Burkhard; Parhofer, Klaus G.; Leber, Alexander W.			Low Adiponectin Levels Are an Independent Predictor of Mixed and Non-Calcified Coronary Atherosclerotic Plaques	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PLASMA ADIPONECTIN; ARTERY-DISEASE; COMPUTED-TOMOGRAPHY; ATHEROGENIC DYSLIPIDEMIA; ANGIOGRAPHIC PROGRESSION; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; HEART-DISEASE	Background: Atherosclerosis is the primary cause of coronary artery disease (CAD). There is increasing recognition that lesion composition rather than size determines the acute complications of atherosclerotic disease. Low serum adiponectin levels were reported to be associated with coronary artery disease and future incidence of acute coronary syndrome (ACS). The impact of adiponectin on lesion composition still remains to be determined. Methodology/Principal Findings: We measured serum adiponectin levels in 303 patients with stable typical or atypical chest pain, who underwent dual-source multi-slice CT-angiography to exclude coronary artery stenosis. Atherosclerotic plaques were classified as calcified, mixed or non-calcified. In bivariate analysis adiponectin levels were inversely correlated with total coronary plaque burden (r = -0.21, p = 0.0004), mixed (r = -0.20, p = 0.0007) and non-calcified plaques (r = -0.18, p = 0.003). No correlation was seen with calcified plaques (r = -0.05, p = 0.39). In a fully adjusted multivariate model adiponectin levels remained predictive of total plaque burden (estimate: -0.036, 95% CI: -0.052 to -0.020, p < 0.0001), mixed (estimate: -0.087, 95% CI: -0.132 to -0.042, p = 0.0001) and non-calcified plaques (estimate: -0.076, 95% CI: -0.115 to -0.038, p = 0.0001). Adiponectin levels were not associated with calcified plaques (estimate: -0.021, 95% CI: -0.043 to -0.001, p = 0.06). Since the majority of coronary plaques was calcified, adiponectin levels account for only 3% of the variability in total plaque number. In contrast, adiponectin accounts for approximately 20% of the variability in mixed and non-calcified plaque burden. Conclusions/Significance: Adiponectin levels predict mixed and non-calcified coronary atherosclerotic plaque burden. Low adiponectin levels may contribute to coronary plaque vulnerability and may thus play a role in the pathophysiology of ACS.	[Broedl, Uli C.; Lehrke, Michael; Goeke, Burkhard; Parhofer, Klaus G.] Univ Munich, Dept Internal Med 2, Munich, Germany; [Lebherz, Corinna; Greif, Martin; Becker, Alexander; von Ziegler, Franz; Tittus, Janine; Leber, Alexander W.] Univ Munich, Dept Internal Med 1, Munich, Germany; [Stark, Renee] Helmholtz Zent, Munich, Germany; [Reiser, Maximilian; Becker, Christoph] Univ Munich, Dept Radiol, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Broedl, UC (corresponding author), Univ Munich, Dept Internal Med 2, Munich, Germany.	uli.broedl@med.uni-muenchen.de	Lehrke, Michael/AAY-7558-2021	Becker, Hans-Christoph/0000-0001-6059-4937	Deutsche Forschungsgemeinschaft [BR 2151/4-1, LE 1350/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants BR 2151/4-1 (UCB) and LE 1350/2-1 (ML) from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Gorter PM, 2008, ATHEROSCLEROSIS, V197, P896, DOI 10.1016/j.atherosclerosis.2007.08.016; Hattori Y, 2003, DIABETOLOGIA, V46, P1543, DOI 10.1007/s00125-003-1224-3; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Koenig W, 2006, J AM COLL CARDIOL, V48, P1369, DOI 10.1016/j.jacc.2006.06.053; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Leber AW, 2008, INT J CARDIOVAS IMAG, V24, P423, DOI 10.1007/s10554-007-9278-9; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Maahs DM, 2005, CIRCULATION, V111, P747, DOI 10.1161/01.CIR.0000155251.03724.A5; Marso SP, 2008, DIABETES CARE, V31, P989, DOI 10.2337/dc07-2024; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Ng TWK, 2005, DIABETES, V54, P795, DOI 10.2337/diabetes.54.3.795; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Otake H, 2008, AM J CARDIOL, V101, P1, DOI 10.1016/j.amjcard.2007.07.041; Otsuka F, 2006, J AM COLL CARDIOL, V48, P1155, DOI 10.1016/j.jacc.2006.05.054; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pasterkamp G, 2000, J AM COLL CARDIOL, V36, P13, DOI 10.1016/S0735-1097(00)00677-X; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Pischon T, 2007, CIRCULATION, V115, pE322, DOI 10.1161/CIRCULATIONAHA.106.666677; Pundziute G, 2007, J AM COLL CARDIOL, V49, P62, DOI 10.1016/j.jacc.2006.07.070; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Selcuk MT, 2008, CORONARY ARTERY DIS, V19, P79, DOI 10.1097/MCA.0b013e3282f3c40b; Son BK, 2008, ENDOCRINOLOGY, V149, P1646, DOI 10.1210/en.2007-1021; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tan KCB, 2004, J CLIN ENDOCR METAB, V89, P765, DOI 10.1210/jc.2003-031012; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Eynatten M, 2008, EUR HEART J, V29, P1307, DOI 10.1093/eurheartj/ehn135; von Eynatten M, 2006, J AM COLL CARDIOL, V47, P2124, DOI 10.1016/j.jacc.2006.02.033; Wolk R, 2007, EUR HEART J, V28, P292, DOI 10.1093/eurheartj/ehl361; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Zhao T, 2005, CELL IMMUNOL, V238, P19, DOI 10.1016/j.cellimm.2005.12.002	46	50	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4733	10.1371/journal.pone.0004733	http://dx.doi.org/10.1371/journal.pone.0004733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266101	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490800013
J	Sun, W; Xie, W; Xu, F; Grunstein, M; Li, KC				Sun, Wei; Xie, Wei; Xu, Feng; Grunstein, Michael; Li, Ker-Chau			Dissecting Nucleosome Free Regions by a Segmental Semi-Markov Model	PLOS ONE			English	Article							HIGH-RESOLUTION MAP; PREFERENTIAL ACCESSIBILITY; SACCHAROMYCES-CEREVISIAE; CHROMATIN-STRUCTURE; YEAST; PROMOTER; TRANSCRIPTION; IDENTIFICATION; OCCUPANCY; POSITIONS	Background: Nucleosome free regions (NFRs) play important roles in diverse biological processes including gene regulation. A genome-wide quantitative portrait of each individual NFR, with their starting and ending positions, lengths, and degrees of nucleosome depletion is critical for revealing the heterogeneity of gene regulation and chromatin organization. By averaging nucleosome occupancy levels, previous studies have identified the presence of NFRs in the promoter regions across many genes. However, evaluation of the quantitative characteristics of individual NFRs requires an NFR calling method. Methodology: In this study, we propose a statistical method to identify the patterns of NFRs from a genome-wide measurement of nucleosome occupancy. This method is based on an appropriately designed segmental semi-Markov model, which can capture each NFR pattern and output its quantitative characterizations. Our results show that the majority of the NFRs are located in intergenic regions or promoters with a length of about 400-600bp and varying degrees of nucleosome depletion. Our quantitative NFR mapping allows for an investigation of the relative impacts of transcription machinery and DNA sequence in evicting histones from NFRs. We show that while both factors have significant overall effects, their specific contributions vary across different subtypes of NFRs. Conclusion: The emphasis of our approach on the variation rather than the consensus of nucleosome free regions sets the tone for enabling the exploration of many subtler dynamic aspects of chromatin biology.	[Sun, Wei] Univ N Carolina, Dept Biostat, Carolina Ctr Genome Sci, Chapel Hill, NC 27515 USA; [Sun, Wei] Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC USA; [Xie, Wei; Xu, Feng; Grunstein, Michael] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Xie, Wei; Li, Ker-Chau] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90024 USA; [Li, Ker-Chau] Acad Sinica, Genom Res Ctr, Inst Stat Sci, Taipei, Taiwan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Academia Sinica - Taiwan	Sun, W (corresponding author), Univ N Carolina, Dept Biostat, Carolina Ctr Genome Sci, Chapel Hill, NC 27515 USA.	mg@mbi.ucla.edu; kcli@stat.ucla.edu	Li, Ker-Chau/AAQ-4886-2021	Xu, Feng/0000-0003-2016-7521	NIH; NSF [DMS-0201005, DMS-0406091, DMS-0707160]; MIB, Institute of Statistical Science, Academia Sinica [NSC95-3114-P-002-005-Y, NSC97-2627-P001-003]; United States Environmental protection Agency [RD833825]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); MIB, Institute of Statistical Science, Academia Sinica(Academia Sinica - Taiwan); United States Environmental protection Agency(United States Environmental Protection Agency)	This work is supported by NIH grants to M.G. and by NSF grants DMS-0201005, DMS-0406091, and DMS-0707160 to K.C.L. K.C.L.'s work is also supported in part by MIB, Institute of Statistical Science, Academia Sinica and grant NSC95-3114-P-002-005-Y and NSC97-2627-P001-003. W.S.'s work is also supported in part by the United States Environmental protection Agency grant (RD833825). However, the research described in this article has not been subjected to the Agency's peer review and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FASCHER KD, 1993, J MOL BIOL, V231, P658, DOI 10.1006/jmbi.1993.1317; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LEE MS, 1992, P NATL ACAD SCI USA, V89, P9166, DOI 10.1073/pnas.89.19.9166; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li W, 2005, BIOINFORMATICS, V21, pI274, DOI 10.1093/bioinformatics/bti1046; Mai X, 2000, MOL CELL BIOL, V20, P6668, DOI 10.1128/MCB.20.18.6668-6676.2000; MORSE RH, 1992, MOL CELL BIOL, V12, P4015, DOI 10.1128/MCB.12.9.4015; Newton MA, 1998, STAT MED, V17, P1425, DOI 10.1002/(SICI)1097-0258(19980715)17:13<1425::AID-SIM861>3.0.CO;2-V; Ostendorf M, 1996, IEEE T SPEECH AUDI P, V4, P360, DOI 10.1109/89.536930; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Sakaki K, 2003, J BIOCHEM, V134, P373, DOI 10.1093/jb/mvg155; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	34	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4721	10.1371/journal.pone.0004721	http://dx.doi.org/10.1371/journal.pone.0004721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266098	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490800003
J	Uzan, B; Figeac, F; Portha, B; Movassat, J				Uzan, Benjamin; Figeac, Florence; Portha, Bernard; Movassat, Jamileh			Mechanisms of KGF Mediated Signaling in Pancreatic Duct Cell Proliferation and Differentiation	PLOS ONE			English	Article								Background: Keratinocyte growth factor (KGF; palifermin) is a growth factor with a high degree of specificity for epithelial cells. KGF is an important effector of epithelial growth and tissue homeostasis in various organs including the pancreas. Here we investigated the intracellular signaling pathways involved in the mediation of pancreatic ductal cell proliferation and differentiation induced by exogenous KGF during beta-cell regeneration in diabetic rat. Methodology and Results: In vitro and in vivo duct cell proliferation was measured by BrdU incorporation assay. The implication of MAPK-ERK1/2 in the mediation of KGF-induced cell proliferation was determined by inactivation of this pathway, using the pharmacological inhibitor or antisense morpholino-oligonucleotides against MEK1. In vivo KGF-induced duct cell differentiation was assessed by the immunolocalization of PDX1 and Glut2 in ductal cells and the implication of PI3K/AKT in this process was investigated. We showed that KGF exerted a potent mitogenic effect on ductal cells. Both in vitro and in vivo, its effect on cell proliferation was mediated through the activation of ERK1/2 as evidenced by the abolition of duct cell proliferation in the context of MEK/ERK inactivation. In vivo, KGF treatment triggered ductal cell differentiation as revealed by the expression of PDX1 and Glut2 in a subpopulation of ductal cells via a PI3K-dependent mechanism. Conclusion: Here we show that KGF promotes beta-cell regeneration by stimulating duct cell proliferation in vivo. Moreover, we demonstrated for the first time that KGF directly induces the expression of PDX1 in some ductal cells thus inducing beta-cell neogenesis. We further explored the molecular mechanisms involved in these processes and showed that the effects of KGF on duct cell proliferation are mediated by the MEK-ERK1/2 pathway, while the KGF-induced cell differentiation is mediated by the PI3K/AKT pathway. These findings might have important implications for the in vivo induction of duct-to-beta cell neogenesis in patients with beta-cell deficiency.	[Uzan, Benjamin; Figeac, Florence; Portha, Bernard; Movassat, Jamileh] Univ Paris 07, CNRS, Dept Life Sci, Lab Pathophysiol Nutr,UMR 7059, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Uzan, B (corresponding author), Univ Paris 07, CNRS, Dept Life Sci, Lab Pathophysiol Nutr,UMR 7059, Paris, France.	movassat@paris7.jussieu.fr	Portha, Bernard/AAW-3021-2021	UZAN, Benjamin/0000-0001-6323-5737	Centre National de la Recherche Scientifique/CNRS; Ministere de lEnseignement Superieur et de la Recherche [fellowship]	Centre National de la Recherche Scientifique/CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de lEnseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	The authors are supported by grants from the Centre National de la Recherche Scientifique/CNRS. Florence Figeac is a recipient of a fellowship from the Ministere de lEnseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Anastasi E, 1999, EUR J ENDOCRINOL, V141, P644, DOI 10.1530/eje.0.1410644; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Bouwens L, 1996, VIRCHOWS ARCH, V427, P553; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; Bouwens L, 1998, J PATHOL, V184, P234; BROCKENBROUGH JS, 1988, DIABETES, V37, P232, DOI 10.2337/diabetes.37.2.232; Bulotta A, 2002, J MOL ENDOCRINOL, V29, P347, DOI 10.1677/jme.0.0290347; Cho K, 2007, AM J PATHOL, V170, P1964, DOI 10.2353/ajpath.2007.060935; Edlund H, 1999, CURR OPIN CELL BIOL, V11, P663, DOI 10.1016/S0955-0674(99)00033-2; Elghazi L, 2002, P NATL ACAD SCI USA, V99, P3884, DOI 10.1073/pnas.062321799; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; GU DL, 1993, DEVELOPMENT, V118, P33; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Habener JF, 1998, P ASSOC AM PHYSICIAN, V110, P12; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; Ishiwata T, 1998, AM J PATHOL, V153, P213, DOI 10.1016/S0002-9440(10)65562-9; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaji H, 1999, CANCER RES, V59, P5097; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; Krakowski ML, 1999, AM J PATHOL, V154, P683, DOI 10.1016/S0002-9440(10)65315-1; Kumar M, 2003, CURR OPIN GENET DEV, V13, P401, DOI 10.1016/S0959-437X(03)00089-3; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Kurokawa M, 2008, INT J NEUROSCI, V118, P693, DOI 10.1080/00207450701555714; Lardon J, 2004, VIRCHOWS ARCH, V444, P61, DOI 10.1007/s00428-003-0930-z; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Lupfer C, 2008, ARCH VIROL, V153, P929, DOI 10.1007/s00705-008-0067-0; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Mei CL, 2005, NEPHROL DIAL TRANSPL, V20, P2368, DOI 10.1093/ndt/gfi040; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Miyatsuka T, 2007, BIOCHEM BIOPH RES CO, V362, P905, DOI 10.1016/j.bbrc.2007.08.076; Morisset J, 1999, AM J PHYSIOL-GASTR L, V277, pG953, DOI 10.1152/ajpgi.1999.277.5.G953; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Movassat J, 2003, DIABETOLOGIA, V46, P822, DOI 10.1007/s00125-003-1117-5; Movassat J, 2007, J ENDOCRINOL, V195, P333, DOI 10.1677/JOE-07-0098; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Plachot C, 2001, HISTOCHEM CELL BIOL, V116, P131; Rescan C, 2005, LAB INVEST, V85, P65, DOI 10.1038/labinvest.3700204; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rutter W J, 1980, Monogr Pathol, V21, P30; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Taniguchi F, 2003, J CLIN ENDOCR METAB, V88, P773, DOI 10.1210/jc.2002-021062; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Wang RN, 1996, DIABETOLOGIA, V39, P548, DOI 10.1007/BF00403301; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Watanabe H, 2008, BIOCHEM BIOPH RES CO, V370, P33, DOI 10.1016/j.bbrc.2008.03.012; Watanabe H, 2008, PANCREAS, V36, P153, DOI 10.1097/MPA.0b013e318157753e; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; YI ES, 1994, AM J PATHOL, V145, P80	61	34	35	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4734	10.1371/journal.pone.0004734	http://dx.doi.org/10.1371/journal.pone.0004734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266047	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490800014
J	Kranjc, A; Grillo, FW; Rievaj, J; Boccaccio, A; Pietrucci, F; Menini, A; Carloni, P; Anselmi, C				Kranjc, Agata; Grillo, Federico W.; Rievaj, Juraj; Boccaccio, Anna; Pietrucci, Fabio; Menini, Anna; Carloni, Paolo; Anselmi, Claudio			Regulation of Bestrophins by Ca2+: A Theoretical and Experimental Study	PLOS ONE			English	Article								Bestrophins are a recently discovered family of Cl- channels, for which no structural information is available. Some family members are activated by increased intracellular Ca2+ concentration. Bestrophins feature a well conserved Asp-rich tract in their COOH terminus (Asp-rich domain), which is homologous to Ca2+-binding motifs in human thrombospondins and in human big-conductance Ca2+- and voltage-gated K+ channels (BKCa). Consequently, the Asp-rich domain is also a candidate for Ca2+ binding in bestrophins. Based on these considerations, we constructed homology models of human bestrophin-1 (Best1) Asp-rich domain using human thrombospondin-1 X-ray structure as a template. Molecular dynamics simulations were used to identify Asp and Glu residues binding Ca2+ and to predict the effects of their mutations to alanine. We then proceeded to test selected mutations in the Asp-rich domain of the highly homologous mouse bestrophin-2. The mutants expressed in HEK-293 cells were investigated by electrophysiological experiments using the whole-cell voltage-clamp technique. Based on our molecular modeling results, we predicted that Asp-rich domain has two defined binding sites and that D301A and D304A mutations may impact the binding of the metal ions. The experiments confirmed that these mutations do actually affect the function of the protein causing a large decrease in the Ca2+-activated Cl- current, fully consistent with our predictions. In addition, other studied mutations (E306A, D312A) did not decrease Ca2+-activated Cl- current in agreement with modeling results.	[Kranjc, Agata; Grillo, Federico W.; Rievaj, Juraj; Boccaccio, Anna; Pietrucci, Fabio; Menini, Anna; Carloni, Paolo; Anselmi, Claudio] SISSA ISAS, Trieste, Italy; [Boccaccio, Anna; Menini, Anna; Carloni, Paolo] SISSA, IIT, Trieste, Italy; [Carloni, Paolo; Anselmi, Claudio] CNR, INFM, DEMOCRITOS Model Ctr Res Atomist Simulat, Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Kranjc, A (corresponding author), SISSA ISAS, Trieste, Italy.	claudio.anselmi@mpibp-frankfurt.mpg.de	Pietrucci, Fabio/AAS-7018-2020; Boccaccio, Anna/H-6816-2012; Carloni, Paolo/H-8736-2013; Pietrucci, Fabio/C-2326-2009; Anselmi, Claudio/D-6244-2012	Pietrucci, Fabio/0000-0002-4892-2667; Boccaccio, Anna/0000-0002-6219-2285; Pietrucci, Fabio/0000-0002-4892-2667; Anselmi, Claudio/0000-0002-3017-5085; Grillo, Federico/0000-0002-9097-1091; Menini, Anna/0000-0001-9304-0412	Italian Institute of Technology (IIT)	Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT)	This work was supported by Italian Institute of Technology (IIT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boccaccio A, 2007, J NEUROPHYSIOL, V98, P153, DOI 10.1152/jn.00270.2007; Bulo RE, 2007, MACROMOLECULES, V40, P3437, DOI 10.1021/ma062467l; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Duta V, 2004, FEBS LETT, V577, P551, DOI 10.1016/j.febslet.2004.10.068; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HORLING F, 2006, VMD2 DATABASE; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Kranjc A, 2007, COMPUT PHYS COMMUN, V177, P21, DOI 10.1016/j.cpc.2007.02.006; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marchant D, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044511; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Milenkovic VM, 2007, J BIOL CHEM, V282, P1313, DOI 10.1074/jbc.M607383200; MISENHEIMER TM, 1995, J BIOL CHEM, V270, P1729, DOI 10.1074/jbc.270.4.1729; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Piskorowski R, 2002, NATURE, V420, P499, DOI 10.1038/nature01199; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2006, FEBS LETT, V580, P2141, DOI 10.1016/j.febslet.2006.03.025; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Slawson EE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r15; SORIA RB, 2006, J BIOL CHEM; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torrance JW, 2008, PROTEINS, V71, P813, DOI 10.1002/prot.21741; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; White K, 2000, HUM MUTAT, V15, P301, DOI 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N; YANG YD, 2008, NATURE; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301	64	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4672	10.1371/journal.pone.0004672	http://dx.doi.org/10.1371/journal.pone.0004672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262692	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490600005
J	Menzel, R				Menzel, Randolf			Serial Position Learning in Honeybees	PLOS ONE			English	Article							MEMORY DYNAMICS; APIS-MELLIFERA; BEES; NAVIGATION; INFORMATION; HIPPOCAMPUS; STRATEGIES; RETRIEVAL; LANDMARKS; COGNITION	Learning of stimulus sequences is considered as a characteristic feature of episodic memory since it contains not only a particular item but also the experience of preceding and following events. In sensorimotor tasks resembling navigational performance, the serial order of objects is intimately connected with spatial order. Mammals and birds develop episodic(like) memory in serial spatio-temporal tasks, and the honeybee learns spatio-temporal order when navigating between the nest and a food source. Here I examine the structure of the bees' memory for a combined spatio-temporal task. I ask whether discrimination and generalization are based solely on simple forms of stimulus-reward learning or whether they require sequential configurations. Animals were trained to fly either left or right in a continuous T-maze. The correct choice was signaled by the sequence of colors (blue, yellow) at four positions in the access arm. If only one of the possible 4 signals is shown (either blue or yellow), the rank order of position salience is 1, 2 and 3 (numbered from T-junction). No learning is found if the signal appears at position 4. If two signals are shown, differences at positions 1 and 2 are learned best, those at position 3 at a low level, and those at position 4 not at all. If three or more signals are shown these results are corroborated. This salience rank order again appeared in transfer tests, but additional configural phenomena emerged. Most of the results can be explained with a simple model based on the assumption that the four positions are equipped with different salience scores and that these add up independently. However, deviations from the model are interpreted by assuming stimulus configuration of sequential patterns. It is concluded that, under the conditions chosen, bees rely most strongly on memories developed during simple forms of associative reward learning, but memories of configural serial patterns contribute, too.	Free Univ Berlin, Inst Biol, Berlin, Germany	Free University of Berlin	Menzel, R (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	menzel@neurobiologie.fu-berlin.de						Agster KL, 2002, J NEUROSCI, V22, P5760; [Anonymous], [No title captured]; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BRANNON EM, 2008, COGNITIVE ANIMAL EMP, P197; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Cheng K, 2006, ANIM COGN, V9, P141, DOI 10.1007/s10071-005-0012-5; CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; CHITTKA L, 1995, ANIM BEHAV, V50, P23, DOI 10.1006/anbe.1995.0217; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Collett TS, 2006, ADV STUD BEHAV, V36, P123, DOI 10.1016/S0065-3454(06)36003-2; COLLETT TS, 1993, J COMP PHYSIOL A, V172, P693, DOI 10.1007/BF00195395; Collett TS, 1997, J COMP PHYSIOL A, V181, P47, DOI 10.1007/s003590050092; COUVILLON PA, 1983, J COMP PSYCHOL, V97, P154, DOI 10.1037/0735-7036.97.2.154; CROWDER RG, 1968, J EXP PSYCHOL, V76, P497, DOI 10.1037/h0025691; DACKE M, 2008, ANIM COGN EARLY ELEC; De Marco R, 2005, J EXP BIOL, V208, P3885, DOI 10.1242/jeb.01832; Deisig N, 2003, LEARN MEMORY, V10, P199, DOI 10.1101/lm.55803; DEMARCO R, 2008, LEARNING MEMORY COMP, V1; DEVENPORT LD, 1994, ANIM BEHAV, V47, P787, DOI 10.1006/anbe.1994.1111; Ebbinghaus, 1885, GEDACHTNIS; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Fulop A, 2000, ANIM BEHAV, V60, P657, DOI 10.1006/anbe.2000.1492; Gallistel C. R., 1990, ORG LEARNING; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GIL M, 2007, LEARNING RE IN PRESS; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GIURFA M, 2001, P 28 GOTT NEUR C GOT, P685; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; GROSSMANN K E, 1970, Zeitschrift fuer Tierpsychologie, V27, P553; Hauser MD, 2000, TRENDS COGN SCI, V4, P127, DOI 10.1016/S1364-6613(00)01473-X; HEALY AF, 2008, SERIAL LEARNING, P53; HEALY AF, 1975, J VERB LEARN VERB BE, V14, P495; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; MENZEL R, 1969, Z VERGL PHYSIOL, V63, P290, DOI 10.1007/BF00298164; Menzel R, 2007, EVOLUTION NERVOUS SY, V2, P403; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Prabhu C, 2008, BEHAV ECOL SOCIOBIOL, V63, P11, DOI 10.1007/s00265-008-0631-3; Shettleworth, 2010, COGNITION EVOLUTION; Skorupski P, 2006, CURR BIOL, V16, pR851, DOI 10.1016/j.cub.2006.08.069; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Srinivasan MV, 1997, J EXP BIOL, V200, P2513; STARKEY P, 1990, COGNITION, V36, P97, DOI 10.1016/0010-0277(90)90001-Z; TULVING E, 1972, ANNU REV PSYCHOL, V53, P1; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wright AA, 1999, J COMP PSYCHOL, V113, P74, DOI 10.1037/0735-7036.113.1.74; Wright AA, 2007, J EXP ANAL BEHAV, V88, P405, DOI 10.1901/jeab.2007.88-405; Zar JH., 1999, BIOSTAT ANAL; Zhang SW, 2005, P NATL ACAD SCI USA, V102, P5250, DOI 10.1073/pnas.0501440102; Zhang SW, 2000, LEARN MEMORY, V7, P363, DOI 10.1101/lm.32900; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069	59	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4694	10.1371/journal.pone.0004694	http://dx.doi.org/10.1371/journal.pone.0004694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MB	19259265	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490500012
J	Fontana, P; Cestaro, A; Velasco, R; Formentin, E; Toppo, S				Fontana, Paolo; Cestaro, Alessandro; Velasco, Riccardo; Formentin, Elide; Toppo, Stefano			Rapid Annotation of Anonymous Sequences from Genome Projects Using Semantic Similarities and a Weighting Scheme in Gene Ontology	PLOS ONE			English	Article							PROTEIN FUNCTION PREDICTION; GO; TOOL	Background: Large-scale sequencing projects have now become routine lab practice and this has led to the development of a new generation of tools involving function prediction methods, bringing the latter back to the fore. The advent of Gene Ontology, with its structured vocabulary and paradigm, has provided computational biologists with an appropriate means for this task. Methodology: We present here a novel method called ARGOT (Annotation Retrieval of Gene Ontology Terms) that is able to process quickly thousands of sequences for functional inference. The tool exploits for the first time an integrated approach which combines clustering of GO terms, based on their semantic similarities, with a weighting scheme which assesses retrieved hits sharing a certain number of biological features with the sequence to be annotated. These hits may be obtained by different methods and in this work we have based ARGOT processing on BLAST results. Conclusions: The extensive benchmark involved 10,000 protein sequences, the complete S. cerevisiae genome and a small subset of proteins for purposes of comparison with other available tools. The algorithm was proven to outperform existing methods and to be suitable for function prediction of single proteins due to its high degree of sensitivity, specificity and coverage.	[Fontana, Paolo; Cestaro, Alessandro; Velasco, Riccardo] FEM IASMA Res Ctr, San Michele All Adige, TN, Italy; [Formentin, Elide] Univ Padua, Dept Biol, I-35100 Padua, Italy; [Toppo, Stefano] Univ Padua, Dept Biol Chem, I-35100 Padua, Italy	Fondazione Edmund Mach; University of Padua; University of Padua	Fontana, P (corresponding author), FEM IASMA Res Ctr, San Michele All Adige, TN, Italy.	stefano.toppo@unipd.it	Velasco, Riccardo/G-8710-2011; Toppo, Stefano/Z-5479-2019	Toppo, Stefano/0000-0002-0246-3119; Velasco, Riccardo/0000-0002-8760-5031; Cestaro, Alessandro/0000-0003-1439-5165	Autonomous Province of Trento	Autonomous Province of Trento(Autonomous Province of Trento)	This work was supported by the Autonomous Province of Trento as part of the "Grapevine genome sequencing" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Enault F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-247; Friedberg I, 2006, NUCLEIC ACIDS RES, V34, pW379, DOI 10.1093/nar/gkl045; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Godzik A, 2007, CELL MOL LIFE SCI, V64, P2505, DOI 10.1007/s00018-007-7211-y; Groth D, 2004, NUCLEIC ACIDS RES, V32, pW313, DOI 10.1093/nar/gkh406; Guo X, 2006, BIOINFORMATICS, V22, P967, DOI 10.1093/bioinformatics/btl042; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Hill DP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S2; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Jiang J.J., 1997, SEMANTIC SIMILARITY, P19; Jones CE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-272; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Joshi T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-222; Kimura M, 2004, NUCLEIC ACIDS RES, V32, P6706, DOI 10.1093/nar/gkh1000; King OD, 2003, GENOME RES, V13, P896, DOI 10.1101/gr.440803; Leacock C, 1998, LANG SPEECH & COMMUN, P265; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Lee Vivian, 2005, In Silico Biology, V5, P5; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIND, 1998, P 15 INT C MACH LEAR, P296; LORD P, 2003, PAC S BIOCOMPUT, V8, P601; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Majer F, 2002, J BACTERIOL, V184, P1234, DOI 10.1128/JB.184.5.1234-1243.2002; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; Mulder Nicola, 2007, V396, P59; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Park JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S7; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rodrigues APC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S1; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; Sasson O, 2006, PROTEIN SCI, V15, P1557, DOI 10.1110/ps.062185706; Tao Y, 2007, BIOINFORMATICS, V23, pI529, DOI 10.1093/bioinformatics/btm195; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Tosatto SCE, 2006, CURR PHARM DESIGN, V12, P2067, DOI 10.2174/138161206777585238; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Verspoor K, 2006, PROTEIN SCI, V15, P1544, DOI 10.1110/ps.062184006; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; NUCL ACIDS RES, V36, pD440	48	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4619	10.1371/journal.pone.0004619	http://dx.doi.org/10.1371/journal.pone.0004619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247487	Green Published, gold			2022-12-27	WOS:000265487800002
J	Kumar, RA; Marshall, CR; Badner, JA; Babatz, TD; Mukamel, Z; Aldinger, KA; Sudi, J; Brune, CW; Goh, G; KaraMohamed, S; Sutcliffe, JS; Cook, EH; Geschwind, DH; Dobyns, WB; Scherer, SW; Christian, SL				Kumar, Ravinesh A.; Marshall, Christian R.; Badner, Judith A.; Babatz, Timothy D.; Mukamel, Zohar; Aldinger, Kimberly A.; Sudi, Jyotsna; Brune, Camille W.; Goh, Gerald; KaraMohamed, Samer; Sutcliffe, James S.; Cook, Edwin H.; Geschwind, Daniel H.; Dobyns, William B.; Scherer, Stephen W.; Christian, Susan L.			Association and Mutation Analyses of 16p11.2 Autism Candidate Genes	PLOS ONE			English	Article								Background: Autism is a complex childhood neurodevelopmental disorder with a strong genetic basis. Microdeletion or duplication of a similar to 500-700-kb genomic rearrangement on 16p11.2 that contains 24 genes represents the second most frequent chromosomal disorder associated with autism. The role of common and rare 16p11.2 sequence variants in autism etiology is unknown. Methodology/Principal Findings: To identify common 16p11.2 variants with a potential role in autism, we performed association studies using existing data generated from three microarray platforms: Affymetrix 5.0 (777 families), Illumina 550 K (943 families), and Affymetrix 500 K (60 families). No common variants were identified that were significantly associated with autism. To look for rare variants, we performed resequencing of coding and promoter regions for eight candidate genes selected based on their known expression patterns and functions. In total, we identified 26 novel variants in autism: 13 exonic (nine non-synonymous, three synonymous, and one untranslated region) and 13 promoter variants. We found a significant association between autism and a coding variant in the seizure-related gene SEZ6L2 (12/1106 autism vs. 3/1161 controls; p = 0.018). Sez6l2 expression in mouse embryos was restricted to the spinal cord and brain. SEZ6L2 expression in human fetal brain was highest in post-mitotic cortical layers, hippocampus, amygdala, and thalamus. Association analysis of SEZ6L2 in an independent sample set failed to replicate our initial findings. Conclusions/Significance: We have identified sequence variation in at least one candidate gene in 16p11.2 that may represent a novel genetic risk factor for autism. However, further studies are required to substantiate these preliminary findings.	[Kumar, Ravinesh A.; Babatz, Timothy D.; Sudi, Jyotsna; Goh, Gerald; KaraMohamed, Samer; Dobyns, William B.; Christian, Susan L.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dobyns, William B.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Dobyns, William B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Badner, Judith A.] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; [Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Inst Juvenile Res, Dept Psychiat, Chicago, IL 60680 USA; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Ctr Applied Genom, Dept Mol & Med Genet, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON, Canada; [Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN USA; [Mukamel, Zohar; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Program Neurogenet, Los Angeles, CA 90024 USA; [Mukamel, Zohar; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Res & Treatment, Los Angeles, CA 90024 USA; [Aldinger, Kimberly A.] Univ Chicago, Committee Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Vanderbilt University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Kumar, RA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	schrist@bsd.uchicago.edu	Sutcliffe, James S/C-1348-2012; Goh, Gerald/E-9158-2014; Dobyns, William/AAI-2768-2020; Goh, Gerald/N-1684-2015; Aldinger, Kimberly/ABB-1561-2020; Scherer, Stephen W./B-3785-2013; Dobyns, William Brian/ABC-6525-2021	Sutcliffe, James S/0000-0001-5200-6007; Goh, Gerald/0000-0002-3832-6466; Dobyns, William/0000-0002-7681-2844; Goh, Gerald/0000-0002-3832-6466; Aldinger, Kimberly/0000-0002-5406-8911; Scherer, Stephen W./0000-0002-8326-1999; Cook, Edwin/0000-0002-5848-5114	National Alliance for Autism Research; National Institute of Neurological Diseases and Stroke [1R01 NS51812]; National Institute of Mental Health [MH64547, MH081754, MH60233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, R37MH060233, R01MH060233, R56MH060233, R01MH064547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051812] Funding Source: NIH RePORTER	National Alliance for Autism Research; National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants to Susan L. Christian from the National Alliance for Autism Research and the National Institute of Neurological Diseases and Stroke (1R01 NS51812), as well as to Daniel H. Geschwind (PI) from the National Institute of Mental Health (MH64547), National Institute of Mental Health (MH081754) and the Method to Extend Research in Time (MERIT) from the National Institute of Mental Health (MH60233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BORK P, 1991, FEBS LETT, V282, P9, DOI 10.1016/0014-5793(91)80433-4; Chizhikov VV, 2004, J NEUROSCI, V24, P5694, DOI 10.1523/JNEUROSCI.0758-04.2004; CHRISTIAN SL, 2008, BIOL PSYCHIAT; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fombonne E., 2006, UNDERSTANDING AUTISM, P25; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P940, DOI 10.1001/jama.297.9.940; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lecavalier L, 2006, J AUTISM DEV DISORD, V36, P1101, DOI 10.1007/s10803-006-0147-5; Levick SE, 2007, CLONING STEM CELLS, V9, P33, DOI 10.1089/clo.2006.0087; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin Christa Lese, 2007, Curr Psychiatry Rep, V9, P141; Miyazaki T, 2006, FEBS LETT, V580, P4057, DOI 10.1016/j.febslet.2006.06.043; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SHIMIZUNISHIKAWA K, 1995, BIOCHEM BIOPH RES CO, V216, P382, DOI 10.1006/bbrc.1995.2635; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; XU J, 2004, CURR GENOMICS, V5, P1; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; Zafeiriou DI, 2007, BRAIN DEV-JPN, V29, P257, DOI 10.1016/j.braindev.2006.09.003	47	72	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4582	10.1371/journal.pone.0004582	http://dx.doi.org/10.1371/journal.pone.0004582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242545	gold, Green Submitted, Green Published			2022-12-27	WOS:000265487500004
J	Elliott, DB; Vale, A; Whitaker, D; Buckley, JG				Elliott, David B.; Vale, Anna; Whitaker, David; Buckley, John G.			Does My Step Look Big In This? A Visual Illusion Leads To Safer Stepping Behaviour	PLOS ONE			English	Article							MULLER-LYER; STAIR DESCENT; REAL-TIME; PERCEPTION; VISION; DISSOCIATION; OBSTACLE; FOOT; EYE	Background: Tripping is a common factor in falls and a typical safety strategy to avoid tripping on steps or stairs is to increase foot clearance over the step edge. In the present study we asked whether the perceived height of a step could be increased using a visual illusion and whether this would lead to the adoption of a safer stepping strategy, in terms of greater foot clearance over the step edge. The study also addressed the controversial question of whether motor actions are dissociated from visual perception. Methodology/Principal Findings: 21 young, healthy subjects perceived the step to be higher in a configuration of the horizontal-vertical illusion compared to a reverse configuration (p = 0.01). During a simple stepping task, maximum toe elevation changed by an amount corresponding to the size of the visual illusion (p<0.001). Linear regression analyses showed highly significant associations between perceived step height and maximum toe elevation for all conditions. Conclusions/Significance:The perceived height of a step can be manipulated using a simple visual illusion, leading to the adoption of a safer stepping strategy in terms of greater foot clearance over a step edge. In addition, the strong link found between perception of a visual illusion and visuomotor action provides additional support to the view that the original, controversial proposal by Goodale and Milner (1992) of two separate and distinct visual streams for perception and visuomotor action should be re-evaluated.	[Elliott, David B.; Vale, Anna; Whitaker, David] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Buckley, John G.] Univ Bradford, Sch Engn Design & Technol, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford	Elliott, DB (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	d.elliott1@bradford.ac.uk	Elliott, David/B-1806-2009; Buckley, John/A-1463-2010	Elliott, David/0000-0001-9959-6841; Buckley, John/0000-0002-4085-4743	College of Optometrists; RCUK	College of Optometrists; RCUK(UK Research & Innovation (UKRI))	Anna Vale was supported by a College of Optometrists studentship and John Buckley by a RCUK Fellowship. The hinders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; AVERY GC, 1969, J EXP PSYCHOL, V81, P376, DOI 10.1037/h0027737; BAKER SP, 1985, CLIN GERIATR MED, V4, P501; Bruno N, 2001, TRENDS COGN SCI, V5, P379, DOI 10.1016/S1364-6613(00)01725-3; Carey DP, 2001, TRENDS COGN SCI, V5, P109, DOI 10.1016/S1364-6613(00)01592-8; Chaudhury S, 2004, EXP BRAIN RES, V159, P360, DOI 10.1007/s00221-004-1961-7; Dassonville P, 2004, PLOS BIOL, V2, P1936, DOI 10.1371/journal.pbio.0020364; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; Franz VH, 2000, PSYCHOL SCI, V11, P20, DOI 10.1111/1467-9280.00209; Franz VH, 2001, TRENDS COGN SCI, V5, P457, DOI 10.1016/S1364-6613(00)01772-1; Fuller GF, 2000, AM FAM PHYSICIAN, V61, P2159; Ganel T, 2008, CURR BIOL, V18, pR599, DOI 10.1016/j.cub.2008.04.052; Gentilucci M, 1996, NEUROPSYCHOLOGIA, V34, P369, DOI 10.1016/0028-3932(95)00128-X; Glover S, 2004, EXP BRAIN RES, V154, P504, DOI 10.1007/s00221-003-1687-y; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale MA, 2008, PERCEPTION, V37, P355, DOI 10.1068/p5876; Haffenden AM, 2000, VISION RES, V40, P1597, DOI 10.1016/S0042-6989(00)00056-0; Haffenden AM, 2001, CURR BIOL, V11, P177, DOI 10.1016/S0960-9822(01)00023-9; Hamel KA, 2005, GAIT POSTURE, V21, P135, DOI 10.1016/j.gaitpost.2004.01.006; Heasley K, 2005, INVEST OPHTH VIS SCI, V46, P3584, DOI 10.1167/iovs.05-0059; Heasley K, 2004, INVEST OPHTH VIS SCI, V45, P2122, DOI 10.1167/iovs.03-1199; Johnson L, 2008, J AM GERIATR SOC, V56, P178, DOI 10.1111/j.1532-5415.2007.01485.x; Johnson L, 2007, INVEST OPHTH VIS SCI, V48, P1466, DOI 10.1167/iovs.06-0586; Li WX, 2005, VISION RES, V45, P533, DOI 10.1016/j.visres.2004.09.026; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P210; MacLellan MJ, 2006, EXP BRAIN RES, V173, P531, DOI 10.1007/s00221-006-0398-6; Marotta JJ, 1998, NEUROPSYCHOLOGIA, V36, P491, DOI 10.1016/S0028-3932(97)00154-1; McCarville EM, 2006, EXP BRAIN RES, V171, P405, DOI 10.1007/s00221-005-0284-7; Meegan DV, 2004, EXP BRAIN RES, V155, P37, DOI 10.1007/s00221-003-1702-3; Milner D, 2003, TRENDS COGN SCI, V7, P10, DOI 10.1016/S1364-6613(02)00004-9; NELSON RC, 1996, EMERG MED CLIN N AM, V8, P309; Otto-de Haart EG, 1999, NEUROPSYCHOLOGIA, V37, P1437, DOI 10.1016/S0028-3932(99)00070-6; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Patla AE, 2002, EXP BRAIN RES, V142, P551, DOI 10.1007/s00221-001-0948-x; Pavani F, 1999, EXP BRAIN RES, V127, P95, DOI 10.1007/s002210050777; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Reynolds RF, 2005, J PHYSIOL-LONDON, V569, P677, DOI 10.1113/jphysiol.2005.095869; Robinson J. O, 1972, PSYCHOL VISUAL ILLUS; SCUFFLIAM P, 2003, J EPIDEMIOL COMMUNIT, V57, P710; SIMONEAU GG, 1991, J GERONTOL, V46, pM188, DOI 10.1093/geronj/46.6.M188; Templer J.A., 1992, STAIRCASE STUDIES HA; Towner, 1999, ACCIDENTAL FALLS FAT; Vale A, 2008, OPHTHAL PHYSL OPT, V28, P135, DOI 10.1111/j.1475-1313.2008.00543.x; Vishton PM, 1999, J EXP PSYCHOL HUMAN, V25, P1659, DOI 10.1037/0096-1523.25.6.1659; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518; Wraga M, 2000, PSYCHOL SCI, V11, P239, DOI 10.1111/1467-9280.00248	47	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4577	10.1371/journal.pone.0004577	http://dx.doi.org/10.1371/journal.pone.0004577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601TH	19240790	Green Submitted, gold, Green Published			2022-12-27	WOS:000278086700004
J	Mair, W; Panowski, SH; Shaw, RJ; Dillin, A				Mair, William; Panowski, Siler H.; Shaw, Reuben J.; Dillin, Andrew			Optimizing Dietary Restriction for Genetic Epistasis Analysis and Gene Discovery in C. elegans	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; ACTIVATED PROTEIN-KINASE; NEMATODE CAENORHABDITIS-ELEGANS; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; MEDIATES LONGEVITY; REPRODUCTION; PATHWAY; GROWTH	Dietary restriction (DR) increases mammalian lifespan and decreases susceptibility to many age-related diseases. Lifespan extension due to DR is conserved across a wide range of species. Recent research has focused upon genetically tractable model organisms such as C. elegans to uncover the genetic mechanisms that regulate the response to DR, in the hope that this information will provide insight into the mammalian response and yield potential therapeutic targets. However, no consensus exists as to the best protocol to apply DR to C. elegans and potential key regulators of DR are protocol-specific. Here we define a DR method that better fulfills criteria required for an invertebrate DR protocol to mirror mammalian studies. The food intake that maximizes longevity varies for different genotypes and informative epistasis analysis with another intervention is only achievable at this 'optimal DR' level. Importantly therefore, the degree of restriction imposed using our method can easily be adjusted to determine the genotype-specific optimum DR level. We used this protocol to test two previously identified master regulators of DR in the worm. In contrast to previous reports, we find that DR can robustly extend the lifespan of worms lacking the AMP-activated protein kinase catalytic subunit AAK2 or the histone deacetylase SIR-2.1, highlighting the importance of first optimizing DR to identify universal regulators of DR mediated longevity.	[Mair, William; Panowski, Siler H.; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Mair, William; Panowski, Siler H.; Dillin, Andrew] Howard Hughes Med Inst, La Jolla, CA USA	Salk Institute; Howard Hughes Medical Institute	Mair, W (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mair@salk.edu; dillin@salk.edu		Mair, William/0000-0002-0661-1342	George E. Hewitt Foundation for Medical Research; National Institutes of Health (NIH) [UCSD CMG Training Grant, R01 DK080425, P01 CA120964]; NIH/NIA; The Ellison Medical Foundation; American Diabetes Association; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); The Ellison Medical Foundation(Lawrence Ellison Foundation); American Diabetes Association(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WM is funding by the George E. Hewitt Foundation for Medical Research, SP is funded by the National Institutes of Health (NIH) UCSD CMG Training Grant, RS is funded by the NIH R01 DK080425 and P01 CA120964 and AD is supported by grants from the NIH/NIA, The Ellison Medical Foundation, the American Diabetes Association and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Arantes-Oliveira N, 2003, SCIENCE, V302, P611, DOI 10.1126/science.1089169; AVERY L, 1993, GENETICS, V133, P897; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Boivin A, 2008, MECH AGEING DEV, V129, P714, DOI 10.1016/j.mad.2008.09.011; BRENNER S, 1974, GENETICS, V77, P71; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Dirkswager E., 2002, TEACHERS OWNERS KEY; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 1998, GENETICS, V150, P129; Gems D, 2000, GENETICS, V154, P1597; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; HOLEHAN AM, 1985, MECH AGEING DEV, V33, P19, DOI 10.1016/0047-6374(85)90106-X; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; HOPE IA, 1999, C ELEGANS; HOSONO R, 1989, EXP GERONTOL, V24, P251, DOI 10.1016/0531-5565(89)90016-8; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jolly CA, 2007, CURR OPIN LIPIDOL, V18, P53, DOI 10.1097/MOL.0b013e3280115416; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; KAEBERLEIN TL, 2006, AGING CELL; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; LEE GD, 2006, AGING CELL; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wang XM, 2006, GLOBAL ENVIRON CHANG, V16, P48, DOI 10.1016/j.gloenvcha.2005.06.006; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Weindruch R., 1988, RETARDATION AGING DI; Yamawaki TM, 2008, GENETICS, V178, P513, DOI 10.1534/genetics.107.083253	61	60	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4535	10.1371/journal.pone.0004535	http://dx.doi.org/10.1371/journal.pone.0004535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229346	Green Submitted, gold, Green Published			2022-12-27	WOS:000265486200012
J	Sutherland, GT; Matigian, NA; Chalk, AM; Anderson, MJ; Silburn, PA; Mackay-Sim, A; Wells, CA; Mellick, GD				Sutherland, Greg T.; Matigian, Nicholas A.; Chalk, Alistair M.; Anderson, Matthew J.; Silburn, Peter A.; Mackay-Sim, Alan; Wells, Christine A.; Mellick, George D.			A Cross-Study Transcriptional Analysis of Parkinson's Disease	PLOS ONE			English	Article								The study of Parkinson's disease (PD), like other complex neurodegenerative disorders, is limited by access to brain tissue from patients with a confirmed diagnosis. Alternatively the study of peripheral tissues may offer some insight into the molecular basis of disease susceptibility and progression, but this approach still relies on brain tissue to benchmark relevant molecular changes against. Several studies have reported whole-genome expression profiling in post-mortem brain but reported concordance between these analyses is lacking. Here we apply a standardised pathway analysis to seven independent case-control studies, and demonstrate increased concordance between data sets. Moreover data convergence increased when the analysis was limited to the five substantia nigra (SN) data sets; this highlighted the down regulation of dopamine receptor signaling and insulin-like growth factor 1 (IGF1) signaling pathways. We also show that case-control comparisons of affected post mortem brain tissue are more likely to reflect terminal cytoarchitectural differences rather than primary pathogenic mechanisms. The implementation of a correction factor for dopaminergic neuronal loss predictably resulted in the loss of significance of the dopamine signaling pathway while axon guidance pathways increased in significance. Interestingly the IGF1 signaling pathway was also over-represented when data from non-SN areas, unaffected or only terminally affected in PD, were considered. Our findings suggest that there is greater concordance in PD whole-genome expression profiling when standardised pathway membership rather than ranked gene list is used for comparison.	[Sutherland, Greg T.; Matigian, Nicholas A.; Chalk, Alistair M.; Anderson, Matthew J.; Silburn, Peter A.; Mackay-Sim, Alan; Wells, Christine A.; Mellick, George D.] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Silburn, Peter A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Mellick, George D.] Princess Alexandra Hosp, Dept Neurol, Brisbane, Qld, Australia; [Mellick, George D.] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia	Griffith University; University of Queensland; Royal Brisbane & Women's Hospital	Mellick, GD (corresponding author), Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia.	g.mellick@griffith.edu.au	Mellick, George D./A-7650-2010; Wells, Christine A/A-5071-2010; Matigian, Nicholas A/A-4935-2009; Chalk, Alistair/O-3522-2019; Sutherland, Greg T/C-8674-2015; Matigian, Nicholas/AAF-9390-2020; Mackay-Sim, Alan/C-3431-2008; Sutherland, Greg/Q-5582-2019; Silburn, Peter A/A-3614-2011	Mellick, George D./0000-0002-7211-4651; Wells, Christine A/0000-0003-3133-3628; Matigian, Nicholas A/0000-0001-7735-9415; Chalk, Alistair/0000-0002-9630-6236; Sutherland, Greg T/0000-0003-2493-9736; Matigian, Nicholas/0000-0001-7735-9415; Mackay-Sim, Alan/0000-0003-4446-5371; Sutherland, Greg/0000-0003-2493-9736; 	Australian Federal Government Department of Health and Ageing; Queensland State Government Smartstate Programme; National Health and Medical	Australian Federal Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Queensland State Government Smartstate Programme; National Health and Medical	The authors kindly acknowledge funding provided by the Australian Federal Government Department of Health and Ageing (AMS), the Queensland State Government Smartstate Programme (CAW, AMS), National Health and Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Barcia C, 2005, J NEURAL TRANSM, V112, P1237, DOI 10.1007/s00702-004-0256-2; Beckert S, 2006, BIOCHEM BIOPH RES CO, V341, P67, DOI 10.1016/j.bbrc.2005.12.148; BOSSERS K, 2008, BRAIN PATHOL; Braak H, 2006, J NEURAL TRANSM-SUPP, P89; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Comella CL, 2007, MOVEMENT DISORD, V22, pS367, DOI 10.1002/mds.21682; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GIBB WRG, 1991, EUR NEUROL, V31, P48, DOI 10.1159/000116721; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hawkes C, 2006, ADV OTO-RHINO-LARYNG, V63, P133, DOI 10.1159/000093759; Hubbard PS, 2007, J ANAT, V211, P117, DOI 10.1111/j.1469-7580.2007.00748.x; Hughes AJ, 1997, EUR NEUROL, V38, P13, DOI 10.1159/000113471; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hwang KB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-159; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalaitzakis ME, 2008, ACTA NEUROPATHOL, V116, P125, DOI 10.1007/s00401-008-0381-3; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Marcotte ER, 2003, PHARMACOL THERAPEUT, V100, P63, DOI 10.1016/S0163-7258(03)00086-X; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Miele C, 2000, J BIOL CHEM, V275, P21695, DOI 10.1074/jbc.M000805200; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Miller RM, 2005, NEUROSCIENTIST, V11, P539, DOI 10.1177/1073858405278330; Mirza B, 2000, NEUROSCIENCE, V95, P425; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; MURRELL W, 2008, STEM CELLS; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Preece P, 2003, MOL BRAIN RES, V116, P7, DOI 10.1016/S0169-328X(03)00208-0; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Rezak M, 2007, DM-DIS MON, V53, P259, DOI 10.1016/j.disamonth.2007.02.003; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Sutherland G, 2008, AM J MED GENET B, V147B, P495, DOI 10.1002/ajmg.b.30633; Vogt IR, 2006, EXP NEUROL, V199, P465, DOI 10.1016/j.expneurol.2006.01.008; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Ziemssen T, 2007, PARKINSONISM RELAT D, V13, P323, DOI 10.1016/j.parkreldis.2006.12.014	51	68	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4955	10.1371/journal.pone.0004955	http://dx.doi.org/10.1371/journal.pone.0004955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305504	Green Submitted, Green Published, gold			2022-12-27	WOS:000265498800008
J	Guo, TQ; Jou, W; Chanturiya, T; Portas, J; Gavrilova, O; McPherron, AC				Guo, Tingqing; Jou, William; Chanturiya, Tatyana; Portas, Jennifer; Gavrilova, Oksana; McPherron, Alexandra C.			Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity	PLOS ONE			English	Article								Myostatin (Mstn) is a secreted growth factor expressed in skeletal muscle and adipose tissue that negatively regulates skeletal muscle mass. Mstn(-/-) mice have a dramatic increase in muscle mass, reduction in fat mass, and resistance to diet-induced and genetic obesity. To determine how Mstn deletion causes reduced adiposity and resistance to obesity, we analyzed substrate utilization and insulin sensitivity in Mstn(-/-) mice fed a standard chow. Despite reduced lipid oxidation in skeletal muscle, Mstn(-/-) mice had no change in the rate of whole body lipid oxidation. In contrast, Mstn(-/-) mice had increased glucose utilization and insulin sensitivity as measured by indirect calorimetry, glucose and insulin tolerance tests, and hyperinsulinemic-euglycemic clamp. To determine whether these metabolic effects were due primarily to the loss of myostatin signaling in muscle or adipose tissue, we compared two transgenic mouse lines carrying a dominant negative activin IIB receptor expressed specifically in adipocytes or skeletal muscle. We found that inhibition of myostatin signaling in adipose tissue had no effect on body composition, weight gain, or glucose and insulin tolerance in mice fed a standard diet or a high-fat diet. In contrast, inhibition of myostatin signaling in skeletal muscle, like Mstn deletion, resulted in increased lean mass, decreased fat mass, improved glucose metabolism on standard and high-fat diets, and resistance to diet-induced obesity. Our results demonstrate that Mstn(-/-) mice have an increase in insulin sensitivity and glucose uptake, and that the reduction in adipose tissue mass in Mstn(-/-) mice is an indirect result of metabolic changes in skeletal muscle. These data suggest that increasing muscle mass by administration of myostatin antagonists may be a promising therapeutic target for treating patients with obesity or diabetes.	[Guo, Tingqing; Portas, Jennifer; McPherron, Alexandra C.] NIDDK, Genet Dev & Dis Branch, Natl Inst Hlth, Bethesda, MD USA; [Jou, William; Chanturiya, Tatyana; Gavrilova, Oksana] NIDDK, Mouse Metabol Core Lab, Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Guo, TQ (corresponding author), NIDDK, Genet Dev & Dis Branch, Natl Inst Hlth, Bethesda, MD USA.	mcpherrona@niddk.nih.gov		McPherron, Alexandra/0000-0002-5875-9154	Intramural Research Program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056022, Z01DK056020, Z01DK056022, Z01DK070002, ZIADK056020, ZICDK070002] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research is supported by the Intramural Research Program of the NIH, NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kim HS, 2001, BIOCHEM BIOPH RES CO, V281, P902, DOI 10.1006/bbrc.2001.4435; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mitchell MD, 2006, J CLIN ENDOCR METAB, V91, P1434, DOI 10.1210/jc.2005-2361; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Patel K, 2005, NEUROMUSCULAR DISORD, V15, P117, DOI 10.1016/j.nmd.2004.10.018; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Stolz LE, 2008, DIABETES OBES METAB, V10, P135, DOI 10.1111/j.1463-1326.2006.00672.x; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	49	271	293	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4937	10.1371/journal.pone.0004937	http://dx.doi.org/10.1371/journal.pone.0004937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295913	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496700010
J	Dahlberg, CL; Nguyen, EZ; Goodlett, D; Kimelman, D				Dahlberg, Caroline Lund; Nguyen, Elizabeth Z.; Goodlett, David; Kimelman, David			Interactions between Casein Kinase I epsilon (CKI epsilon) and Two Substrates from Disparate Signaling Pathways Reveal Mechanisms for Substrate-Kinase Specificity	PLOS ONE			English	Article							BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; WNT; PROTEIN; FAMILY; BINDING; DELTA; DEGRADATION	Background: Members of the Casein Kinase I (CKI) family of serine/threonine kinases regulate diverse biological pathways. The seven mammalian CKI isoforms contain a highly conserved kinase domain and divergent amino- and carboxy-termini. Although they share a preferred target recognition sequence and have overlapping expression patterns, individual isoforms often have specific substrates. In an effort to determine how substrates recognize differences between CKI isoforms, we have examined the interaction between CKI epsilon and two substrates from different signaling pathways. Methodology/Principal Findings: CKI epsilon, but not CKI alpha, binds to and phosphorylates two proteins: Period, a transcriptional regulator of the circadian rhythms pathway, and Disheveled, an activator of the planar cell polarity pathway. We use GSTpull-down assays data to show that two key residues in CKI alpha's kinase domain prevent Disheveled and Period from binding. We also show that the unique C-terminus of CKI epsilon does not determine Dishevelled's and Period's preference for CKI epsilon nor is it essential for binding, but instead plays an auxillary role in stabilizing the interactions of CKI epsilon with its substrates. We demonstrate that autophosphorylation of CKI epsilon's C-terminal tail prevents substrate binding, and use mass spectrometry and chemical crosslinking to reveal how a phosphorylation-dependent interaction between the C-terminal tail and the kinase domain prevents substrate phosphorylation and binding. Conclusions/Significance: The biochemical interactions between CKI epsilon and Disheveled, Period, and its own C-terminus lead to models that explain CKI epsilon's specificity and regulation.	[Dahlberg, Caroline Lund; Kimelman, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Nguyen, Elizabeth Z.; Goodlett, David] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dahlberg, CL (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	kimelman@u.washington.edu	Dahlberg, Caroline/AAP-1285-2021	Nguyen, Elizabeth/0000-0002-6495-7827	NIH [T32-GM07270]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH HD27262 (to DK) T32-GM07270 (to CLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albornoz A, 2007, BIOL RES, V40, P251, DOI 10.4067/S0716-97602007000200015; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Burzio V, 2002, J CELL BIOCHEM, V86, P805, DOI 10.1002/jcb.10263; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Green CL, 1998, GENE, V216, P189, DOI 10.1016/S0378-1119(98)00291-1; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Ishida Y, 2001, J NEUROSCI RES, V64, P612, DOI 10.1002/jnr.1114; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu F, 2002, J BIOL CHEM, V277, P45393, DOI 10.1074/jbc.M204499200; Longenecker KL, 1998, ACTA CRYSTALLOGR D, V54, P473, DOI 10.1107/S0907444997011724; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; Loudon ASI, 2007, COLD SPRING HARB SYM, V72, P261, DOI 10.1101/sqb.2007.72.073; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mackey SR, 2007, COLD SPRING HARB SYM, V72, P7, DOI 10.1101/sqb.2007.72.060; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Matsubayashi H, 2004, MOL CELL BIOL, V24, P2012, DOI 10.1128/MCB.24.5.2012-2024.2004; McKay RM, 2001, DEV BIOL, V235, P378, DOI 10.1006/dbio.2001.0307; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Miyazaki K, 2004, BIOCHEM J, V380, P95, DOI 10.1042/BJ20031308; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Penton A, 2002, GENETICS, V161, P747; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Pulgar V, 1999, EUR J BIOCHEM, V260, P520, DOI 10.1046/j.1432-1327.1999.00195.x; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; SINGH P, 2008, ANAL CHEM; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Takano A, 2004, NEUROPSYCHOPHARMACOL, V29, P1901, DOI 10.1038/sj.npp.1300503; Takano A, 2000, FEBS LETT, V477, P106, DOI 10.1016/S0014-5793(00)01755-5; Trang LTD, 2006, J BIOL RHYTHM, V21, P335, DOI 10.1177/0748730406291734; Vielhaber E, 2001, IUBMB LIFE, V51, P73, DOI 10.1080/15216540152122049; Vielhaber EL, 2001, J BIOL CHEM, V276, P45921, DOI 10.1074/jbc.M107726200; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yin HS, 2006, BIOCHEMISTRY-US, V45, P5297, DOI 10.1021/bi052354e; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang L, 2006, DEV BIOL, V299, P221, DOI 10.1016/j.ydbio.2006.07.025	67	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4766	10.1371/journal.pone.0004766	http://dx.doi.org/10.1371/journal.pone.0004766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274088	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000006
J	Gaeta, RT; Yoo, SY; Pires, JC; Doerge, RW; Chen, ZJ; Osborn, TC				Gaeta, Robert T.; Yoo, Suk-Young; Pires, J. C.; Doerge, R. W.; Chen, Z. Jeffrey; Osborn, Thomas C.			Analysis of Gene Expression in Resynthesized Brassica napus Allopolyploids Using Arabidopsis 70mer Oligo Microarrays	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; CYTOSINE METHYLATION; POLYPLOIDY; TRANSCRIPTOME; EVOLUTION; HYBRIDIZATION; MECHANISMS; REARRANGEMENTS; PATTERNS; SENECIO	Background: Studies in resynthesized Brassica napus allopolyploids indicate that homoeologous chromosome exchanges in advanced generations (S-5:6) alter gene expression through the loss and doubling of homoeologous genes within the rearrangements. Rearrangements may also indirectly affect global gene expression if homoeologous copies of gene regulators within rearrangements have differential affects on the transcription of genes in networks. Methodology/Principal Findings: We utilized Arabidopsis 70mer oligonucleotide microarrays for exploring gene expression in three resynthesized B. napus lineages at the S-0:1 and S-5:6 generations as well as their diploid progenitors B. rapa and B. oleracea. Differential gene expression between the progenitors and additive (midparent) expression in the allopolyploids were tested. The S-5:6 lines differed in the number of genetic rearrangements, allowing us to test if the number of genes displaying nonadditive expression was related to the number of rearrangements. Estimates using per-gene and common variance ANOVA models indicated that 6-15% of 26,107 genes were differentially expressed between the progenitors. Individual allopolyploids showed nonadditive expression for 1.6-32% of all genes. Less than 0.3% of genes displayed nonadditive expression in all S-0:1 lines and 0.1-0.2% were nonadditive among all S-5:6 lines. Differentially expressed genes in the polyploids were over-represented by genes differential between the progenitors. The total number of differentially expressed genes was correlated with the number of genetic changes in S-5:6 lines under the common variance model; however, there was no relationship using a per-gene variance model, and many genes showed nonadditive expression in S-0:1 lines. Conclusions/Significance: Few genes reproducibly demonstrated nonadditive expression among lineages, suggesting few changes resulted from a general response to polyploidization. Furthermore, our microarray analysis did not provide strong evidence that homoeologous rearrangements were a determinant of genome-wide nonadditive gene expression. In light of the inherent limitations of the Arabidopsis microarray to measure gene expression in polyploid Brassicas, further studies are warranted.	[Gaeta, Robert T.; Pires, J. C.; Osborn, Thomas C.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Yoo, Suk-Young; Doerge, R. W.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Chen, Z. Jeffrey] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX USA	University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Texas A&M University System; Texas A&M University College Station	Gaeta, RT (corresponding author), Univ Missouri, Dept Biol Sci, Columbia, MO 65211 USA.	gaetar@missouri.edu	Pires, J. Chris/O-5122-2014	Pires, J. Chris/0000-0001-9682-2639	National Science Foundation Plant Genome Program [0077774, 0501712]	National Science Foundation Plant Genome Program(National Science Foundation (NSF))	We acknowledge funding from the National Science Foundation Plant Genome Program (0077774 and 0501712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Albertin W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-56; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Chen ZJ, 2007, NEW PHYTOL, V174, P717, DOI 10.1111/j.1469-8137.2007.02084.x; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chen ZJ, 2004, BIOL J LINN SOC, V82, P689, DOI 10.1111/j.1095-8312.2004.00351.x; Clarke JD, 2006, PLANT J, V45, P630, DOI 10.1111/j.1365-313X.2006.02668.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Dudoit S, 2002, STAT SINICA, V12, P111; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gottlieb LD, 2003, HEREDITY, V91, P91, DOI 10.1038/sj.hdy.6800317; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Hegarty MJ, 2005, MOL ECOL, V14, P2493, DOI 10.1111/j.1365-294X.2005.02608.x; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Hudson ME, 2007, CROP SCI, V47, pS96, DOI 10.2135/cropsci2006.12.0758tpg; Kashkush K, 2002, GENETICS, V160, P1651; Kovarik A, 2004, BIOL J LINN SOC, V82, P615, DOI 10.1111/j.1095-8312.2004.00345.x; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Meyers LA, 2006, EVOLUTION, V60, P1198, DOI 10.1111/j.0014-3820.2006.tb01198.x; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Poole R, 2007, FUNCT INTEGR GENOMIC, V7, P207, DOI 10.1007/s10142-007-0046-7; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; SAS Institute, 2006, SAS STAT US GUID; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; Udall JA, 2006, GENETICS, V173, P1823, DOI 10.1534/genetics.106.058271; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang JL, 2005, METHOD ENZYMOL, V395, P570, DOI 10.1016/S0076-6879(05)95030-1; Wilson Ian D., 2005, Functional & Integrative Genomics, V5, P144, DOI 10.1007/s10142-005-0137-2; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z	45	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4760	10.1371/journal.pone.0004760	http://dx.doi.org/10.1371/journal.pone.0004760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274085	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496000002
J	Al-Ejeh, F; Darby, JM; Brown, MP				Al-Ejeh, Fares; Darby, Jocelyn M.; Brown, Michael P.			Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors	PLOS ONE			English	Article								Background: To date, inefficient delivery of therapeutic doses of radionuclides to solid tumors limits the clinical utility of radioimmunotherapy. We aim to test the therapeutic utility of Yttrium-90 (Y-90)-radio-conjugates of a monoclonal antibody, which we showed previously to bind specifically to the abundant intracellular La ribonucleoprotein revealed in dead tumor cells after DNA-damaging treatment. Methodology/Principal Findings: Immunoconjugates of the DAB4 clone of the La-specific monoclonal antibody, APOMAB (R), were prepared using the metal chelator, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and then radiolabeled with Y-90. Mice bearing established subcutaneous tumors were treated with Y-90-DOTA-DAB4 alone or after chemotherapy. Non-radiosensitizing cyclophosphamide/etoposide chemotherapy was used for the syngeneic EL4 lymphoma model. Radiosensitizing cisplatin/gemcitabine chemotherapy was used for the syngeneic Lewis Lung carcinoma (LL2) model, and for the xenograft models of LNCaP prostatic carcinoma and Panc-1 pancreatic carcinoma. We demonstrate the safety, specificity, and efficacy of Y-90-DOTA-DAB4-radioimmunotherapy alone or combined with chemotherapy. EL4 lymphoma-bearing mice either were cured at higher doses of radioimmunotherapy alone or lower doses of radioimmunotherapy in synergy with chemotherapy. Radioimmunotherapy alone was less effective in chemo-and radio-resistant carcinoma models. However, radioimmunotherapy synergized with radiosensitizing chemotherapy to retard significantly tumor regrowth and so prolong the survival of mice bearing LL2, LNCaP, or Panc-1 subcutaneous tumor implants. Conclusions/Significance: We report proof-of-concept data supporting a unique form of radioimmunotherapy, which delivers bystander killing to viable cancer cells after targeting the universal cancer antigen, La, created by DNA-damaging treatment in neighboring dead cancer cells. Subsequently we propose that DAB4-targeted ionizing radiation induces additional cycles of tumor cell death, which further augments DAB4 binding to produce a tumor-lethal 'genotoxic chain reaction'. Clinically, this approach may be useful as consolidation treatment after a drug-induced cell death among (small-volume) metastatic deposits, the commonest cause of cancer death. This article is part II of a two-part series providing proof-of-concept for the diagnostic and therapeutic use of the DAB4 clone of the La-specific monoclonal antibody, APOMAB (R).	[Al-Ejeh, Fares; Darby, Jocelyn M.; Brown, Michael P.] Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia; [Brown, Michael P.] Univ Adelaide, Royal Adelaide Hosp, Dept Med Oncol, Adelaide, SA 5005, Australia; [Brown, Michael P.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia	Hanson Institute; Royal Adelaide Hospital; University of Adelaide; University of Adelaide	Al-Ejeh, F (corresponding author), Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia.	michael.brown@health.sa.gov.au	Al-Ejeh, Fares/M-7032-2016; Brown, Michael/C-2081-2014	Al-Ejeh, Fares/0000-0002-1553-0077; Brown, Michael/0000-0002-5796-1932; Darby, Jocelyn/0000-0002-1819-6000	Oncaidia Ltd; National Health and Medical Research Council Research [ID511303]	Oncaidia Ltd; National Health and Medical Research Council Research	Oncaidia Ltd funded the salary of FA for 2007, the salary of JMD as well as equipment and research. National Health and Medical Research Council Research also supplied funding through Project Grant ID511303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5519S, DOI 10.1158/1078-0432.CCR-07-0964; Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; ALEJEH F, NUCL MED BI IN PRESS; Ayukawa K, 2000, J BIOL CHEM, V275, P34465, DOI 10.1074/jbc.M003673200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Chang J, 2000, CANCER-AM CANCER SOC, V89, P2145, DOI 10.1002/1097-0142(20001201)89:11<2145::AID-CNCR1>3.0.CO;2-S; Chen SL, 2005, J CLIN ONCOL, V23, P1538, DOI 10.1200/JCO.2005.06.108; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; Davis DW, 2003, CLIN CANCER RES, V9, P955; Deb N, 1996, CLIN CANCER RES, V2, P1289; EPSTEIN AL, 1988, CANCER RES, V48, P5842; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Goldenberg DM, 2006, Q J NUCL MED MOL IM, V50, P248; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoeppner Luke H, 2006, Cancer Immun, V6, P1; Koppe MJ, 2004, J NUCL MED, V45, P1224; Kovtun YV, 2006, CANCER RES, V66, P3214, DOI 10.1158/0008-5472.CAN-05-3973; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Lang D, 1998, ONCOGENE, V16, P1593, DOI 10.1038/sj.onc.1201665; Lawrence TS, 2003, SEMIN RADIAT ONCOL, V13, P13, DOI 10.1053/srao.2003.50002; Lee CH, 2007, HUM GENE THER, V18, P27, DOI 10.1089/hum.2005.239; Leers MPG, 2002, CELL MOL LIFE SCI, V59, P1358, DOI 10.1007/s00018-002-8513-8; Liu S, 2001, BIOCONJUGATE CHEM, V12, P7, DOI 10.1021/bc000070v; Mayer A, 2006, CLIN CANCER RES, V12, P6509, DOI 10.1158/1078-0432.CCR-06-0769; McArthur C, 2002, ARCH ORAL BIOL, V47, P443, DOI 10.1016/S0003-9969(02)00025-0; Milas L, 1999, CANCER RES, V59, P107; MILLER BK, 1993, HOOSIER FARMLAND WIL, V1, P2; Milowsky MI, 2004, J CLIN ONCOL, V22, P2522, DOI 10.1200/JCO.2004.09.154; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Rokhlin OW, 2000, ONCOGENE, V19, P1959, DOI 10.1038/sj.onc.1203453; SCHMIDBERGER H, 1991, CANCER RES, V51, P1883; Sgouros G, 2008, CANCER BIOTHER RADIO, V23, P74, DOI 10.1089/cbr.2007.0408; Shewach DS, 2007, J CLIN ONCOL, V25, P4043, DOI 10.1200/JCO.2007.11.5287; Smith-Jones PM, 2003, J NUCL MED, V44, P610; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; THIERRY B, ADV MAT IN PRESS; Tran HB, 2002, ARTHRITIS RHEUM, V46, P202, DOI 10.1002/1529-0131(200201)46:1<202::AID-ART10062>3.0.CO;2-Y; Truksa J, 2003, CELL PROLIFERAT, V36, P199, DOI 10.1046/j.1365-2184.2003.00280.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wood W, 2000, DEVELOPMENT, V127, P5245; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241	49	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4630	10.1371/journal.pone.0004630	http://dx.doi.org/10.1371/journal.pone.0004630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247485	Green Published, gold			2022-12-27	WOS:000265487800012
J	Robinet, C; Roques, A; Pan, HY; Fang, GF; Ye, JR; Zhang, YZ; Sun, JH				Robinet, Christelle; Roques, Alain; Pan, Hongyang; Fang, Guofei; Ye, Jianren; Zhang, Yanzhuo; Sun, Jianghua			Role of Human-Mediated Dispersal in the Spread of the Pinewood Nematode in China	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; BURSAPHELENCHUS-XYLOPHILUS; BIOLOGICAL INVASIONS; WILT DISEASE; SAWYER; COLEOPTERA; DIFFUSION; PORTUGAL; PATTERNS; SUCCESS	Background: Intensification of world trade is responsible for an increase in the number of alien species introductions. Human-mediated dispersal promotes not only introductions but also expansion of the species distribution via long-distance dispersal. Thus, understanding the role of anthropogenic pathways in the spread of invading species has become one of the most important challenges nowadays. Methodology/Principal Findings: We analysed the invasion pattern of the pinewood nematode in China based on invasion data from 1982 to 2005 and monitoring data on 7 locations over 15 years. Short distance spread mediated by long-horned beetles was estimated at 7.5 km per year. Infested sites located further away represented more than 90% of observations and the mean long distance spread was estimated at 111-339 km. Railways, river ports, and lakes had significant effects on the spread pattern. Human population density levels explained 87% of the variation in the invasion probability (P<0.05). Since 2001, the number of new records of the nematode was multiplied by a factor of 5 and the spread distance by a factor of 2. We combined a diffusion model to describe the short distance spread with a stochastic, individual based model to describe the long distance jumps. This combined model generated an error of only 13% when used to predict the presence of the nematode. Under two climate scenarios (stable climate or moderate warming), projections of the invasion probability suggest that this pest could expand its distribution 40-55% by 2025. Conclusions/Significance: This study provides evidence that human-induced dispersal plays a fundamental role in the spread of the pinewood nematode, and appropriate control measures should be taken to stop or slow its expansion. This model can be applied to Europe, where the nematode had been introduced later, and is currently expanding its distribution. Similar models could also be derived for other species that could be accidentally transported by humans.	[Robinet, Christelle; Roques, Alain] INRA, UR Zool Forestiere 633, Orleans, France; [Pan, Hongyang; Fang, Guofei] State Forest Adm, Gen Forest Pest Control Stn, Shenyang, Peoples R China; [Ye, Jianren] Nanjing Forest Univ, Nanjing, Peoples R China; [Zhang, Yanzhuo; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Manage Pest Insects & Rod, Beijing 100864, Peoples R China	INRAE; Nanjing Forestry University; Chinese Academy of Sciences; Institute of Zoology, CAS	Robinet, C (corresponding author), INRA, UR Zool Forestiere 633, Orleans, France.	sunjh@ioz.ac.cn	Zhang, Yanzhuo/E-8902-2011	sun, jianghua/0000-0002-9465-3672; Robinet, Christelle/0000-0002-4933-4656	National Natural Science Foundation of China [30730074, 30525009]; Partenariat Hubert Curien of the programme de recherches avancees franco-chinois [AHH610548C]; EU [ALARM GOCE-CT-2003-506675, PRATIQUE KBBE-2007-212459]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Partenariat Hubert Curien of the programme de recherches avancees franco-chinois; EU(European Commission)	We greatly acknowledge support for this work from the National Natural Science Foundation of China (30730074 and 30525009), a French grant from the "Partenariat Hubert Curien of the programme de recherches avancees franco-chinois" (phc pra AHH610548C- INVACHINE ), and the EU projects ALARM GOCE-CT-2003-506675 (FP6 Integrated Project, Assessing large-scale environmental risks with tested methods; www.alarmproject.net [69]) and PRATIQUE KBBE-2007-212459 (FP7 Project, Enhancements of pest risk analysis techniques). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MC, 2004, RISK ANAL, V24, P893, DOI 10.1111/j.0272-4332.2004.00487.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; Christensen J.H., 2007, CLIMATE CHANGE 2007; DOMROES M, 1988, CLIMATE CHINA; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; FU LG, 1999, PINACEAE FLORA CHINA, V4; Fujioka H., 1993, B AKITA PREFECTURE F, V2, P40; GAO TY, 1987, PLANT QUARANTINE, V1, P215; Gilbert M, 2005, J APPL ECOL, V42, P805, DOI 10.1111/j.1365-2664.2005.01074.x; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hu ZZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003651; IDO N, 1977, STUDIES CONTROL PINE, P87; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; JARVIS A, 2006, HOLE FILLED SEAMLESS; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Ma RY, 2006, ANN FOREST SCI, V63, P449, DOI 10.1051/forest:2006025; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; Murray J. D., 2002, MATH BIOL; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Perez G., 2008, V17, P269, DOI 10.1007/978-1-4020-8343-3_15; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piskunov, 1937, B MGU A, V1, P1, DOI DOI 10.1016/B978-0-08-092523-3.50014-9; R Development Core Team, 2007, R LANG ENV STAT COMP; REGO A, 2008, PROTOCOLO COLABORACA; RODRIGUES J, 2006, INT S 10 14 JUL LISB; ROQUES A, 2006, EPPO B, V36, P490, DOI DOI 10.1111/J.1365-2338.2006.01049.X; Roques Alain, 2009, V3, P63; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; Shigesada N., 1997, BIOL INVASIONS THEOR; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; SMITH I M, 1985, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V33, P159; SONG YS, 2001, INTEGRATED MANAGEMEN; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Sun Jie, 2008, Nanjing Nongye Daxue Xuebao, V31, P55; Suzuki K., 2002, Dendrobiology, V48, P71; Takasu Fugo, 2000, Biological Invasions, V2, P141, DOI 10.1023/A:1010048725497; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Vieira P., 2008, PINE WILT DIS WORLDW; Vieira P, 2007, J NEMATOL, V39, P118; WAN FH, 2002, INT WORKSH BIOD MAN, P77; [王峰 Wang Feng], 2002, [云南农业大学学报, Journal of Yunnan Agricultural University], V17, P421; WANG MX, 2001, FOR PEST DIS, V2, P42; WANG YA, 1987, RES REGIONALIZATION; WANG YY, 1988, FOR PEST DIS, V1, P45; Ward DF, 2005, SOCIOBIOLOGY, V45, P401; Weber E, 2008, BIOSCIENCE, V58, P437, DOI 10.1641/B580511; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; YANG BJ, 1989, CAN J FOREST RES, V19, P1527, DOI 10.1139/x89-232; YANG BJ, 1995, EPIDEMICS MANAGEMENT, P263; YING TS, 2004, ATLAS GYMNOSPERMS CH, P70; Yoshimura A, 1999, ECOLOGY, V80, P1691, DOI 10.2307/176557; Zhao LL, 2007, CAN J FOREST RES, V37, P1867, DOI 10.1139/X07-049; [No title captured], DOI DOI 10.1111/J.1365-2338.1996.TB00594.X	69	88	99	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4646	10.1371/journal.pone.0004646	http://dx.doi.org/10.1371/journal.pone.0004646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247498	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800026
J	Teacher, AGF; Garner, TWJ; Nichols, RA				Teacher, Amber G. F.; Garner, Trenton W. J.; Nichols, Richard A.			Evidence for Directional Selection at a Novel Major Histocompatibility Class I Marker in Wild Common Frogs (Rana temporaria) Exposed to a Viral Pathogen (Ranavirus)	PLOS ONE			English	Article							NATURAL-SELECTION; COMPLEX LOCI; MHC; VARIABILITY; ORGANIZATION; VERTEBRATES; POPULATION; PATTERNS; SYSTEM; GENES	Whilst the Major Histocompatibility Complex (MHC) is well characterized in the anuran Xenopus, this region has not previously been studied in another popular model species, the common frog (Rana temporaria). Nor, to date, have there been any studies of MHC in wild amphibian host-pathogen systems. We characterise an MHC class I locus in the common frog, and present primers to amplify both the whole region, and specifically the antigen binding region. As no more than two expressed haplotypes were found in over 400 clones from 66 individuals, it is likely that there is a single class I locus in this species. This finding is consistent with the single class I locus in Xenopus, but contrasts with the multiple loci identified in axolotls, providing evidence that the diversification of MHC class I into multiple loci likely occurred after the Caudata/Anura divergence (approximately 350 million years ago) but before the Ranidae/Pipidae divergence (approximately 230 mya). We use this locus to compare wild populations of common frogs that have been infected with a viral pathogen (Ranavirus) with those that have no history of infection. We demonstrate that certain MHC supertypes are associated with infection status (even after accounting for shared ancestry), and that the diseased populations have more similar supertype frequencies (lower F-ST) than the uninfected. These patterns were not seen in a suite of putatively neutral microsatellite loci. We interpret this pattern at the MHC locus to indicate that the disease has imposed selection for particular haplotypes, and hence that common frogs may be adapting to the presence of Ranavirus, which currently kills tens of thousands of amphibians in the UK each year.	[Teacher, Amber G. F.; Nichols, Richard A.] Univ London, Sch Biol & Chem Sci, London, England; [Teacher, Amber G. F.; Garner, Trenton W. J.] Zool Soc London, Inst Zool, London NW1 4RY, England	University of London; Zoological Society of London	Teacher, AGF (corresponding author), Univ London, Sch Biol & Chem Sci, London, England.	amber.teacher@ioz.ac.uk	Nichols, Richard/B-7732-2008; Teacher, Amber/G-9107-2012; Nichols, Richard Alan/T-4773-2019; Garner, Trenton WJ/D-6873-2011	Nichols, Richard/0000-0002-4801-9312; Garner, Trenton WJ/0000-0002-0336-9706; Griffiths, Amber/0000-0002-7455-6795	Natural Environment Research Council; Herpetofauna Consultants International Ltd.; University of London; Universities Federation for Animal Welfare; British Wildlife Health Association; Zoological Society of London	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Herpetofauna Consultants International Ltd.; University of London; Universities Federation for Animal Welfare; British Wildlife Health Association; Zoological Society of London	This work was funded by a Natural Environment Research Council studentship, with CASE support from Herpetofauna Consultants International Ltd. Additional funds were received from the University of London Central Research Fund, the Universities Federation for Animal Welfare, the British Wildlife Health Association and the Zoological Society of London. No funders played any role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Berlin S, 2000, MOL ECOL, V9, P1938, DOI 10.1046/j.1365-294x.2000.01093-12.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Consuegra S, 2005, IMMUNOGENETICS, V57, P16, DOI 10.1007/s00251-004-0765-z; Cunningham A. A., 2001, INVESTIGATIONS MASS; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; Doherty P C, 1975, Nature, V256, P50; FLAJNIK MF, 1993, EMBO J, V12, P4385, DOI 10.1002/j.1460-2075.1993.tb06123.x; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; FLAJNIK MF, 1999, J IMMUNOLOGY, V163; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jensen LF, 2008, HEREDITY, V100, P79, DOI 10.1038/sj.hdy.6801067; KUMAR S, 2001, MEGA2 MOL EVOLUTIONA; Maniero GD, 2006, DEV COMP IMMUNOL, V30, P649, DOI 10.1016/j.dci.2005.09.007; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nonaka M, 1997, P NATL ACAD SCI USA, V94, P5789, DOI 10.1073/pnas.94.11.5789; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Ohtsuka M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-178; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Robert J, 2005, VIROLOGY, V332, P667, DOI 10.1016/j.virol.2004.12.012; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammut B, 1999, EUR J IMMUNOL, V29, P2897, DOI 10.1002/(SICI)1521-4141(199909)29:09<2897::AID-IMMU2897>3.0.CO;2-2; Seddon JM, 2004, P ROY SOC B-BIOL SCI, V271, P2283, DOI 10.1098/rspb.2004.2869; SHUM BP, 1993, J IMMUNOL, V151, P5376; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; [No title captured]	39	78	82	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4616	10.1371/journal.pone.0004616	http://dx.doi.org/10.1371/journal.pone.0004616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240796	Green Published, Green Submitted, gold			2022-12-27	WOS:000278086700021
J	Wu, XS; Jin, L; Xiong, MM				Wu, Xuesen; Jin, Li; Xiong, Momiao			Mutual Information for Testing Gene-Environment Interaction	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; RHEUMATOID-ARTHRITIS; POLYMORPHISMS; SMOKING; EPISTASIS; HLA-DRB1; DESIGNS; CANCER	Despite current enthusiasm for investigation of gene-gene interactions and gene-environment interactions, the essential issue of how to define and detect gene-environment interactions remains unresolved. In this report, we define gene-environment interactions as a stochastic dependence in the context of the effects of the genetic and environmental risk factors on the cause of phenotypic variation among individuals. We use mutual information that is widely used in communication and complex system analysis to measure gene-environment interactions. We investigate how gene-environment interactions generate the large difference in the information measure of gene-environment interactions between the general population and a diseased population, which motives us to develop mutual information-based statistics for testing gene-environment interactions. We validated the null distribution and calculated the type 1 error rates for the mutual information-based statistics to test gene-environment interactions using extensive simulation studies. We found that the new test statistics were more powerful than the traditional logistic regression under several disease models. Finally, in order to further evaluate the performance of our new method, we applied the mutual information-based statistics to three real examples. Our results showed that P-values for the mutual information-based statistics were much smaller than that obtained by other approaches including logistic regression models.	[Wu, Xuesen; Jin, Li; Xiong, Momiao] Fudan Univ, Sch Life Sci, Theoret Syst Biol Lab, Shanghai 200433, Peoples R China; [Wu, Xuesen; Jin, Li; Xiong, Momiao] Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China; [Jin, Li] Chinese Acad Sci, SIBS, Inst Computat Biol, MPG, Shanghai, Peoples R China; [Xiong, Momiao] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX USA; [Wu, Xuesen] Bengbu Med Coll Bengbu, Dept Epidemiol & Stat, Anhua, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Bengbu Medical College	Wu, XS (corresponding author), Fudan Univ, Sch Life Sci, Theoret Syst Biol Lab, Shanghai 200433, Peoples R China.	momiao@gmail.com	Jin, Li/M-5063-2019; Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Institutes of Health NIAMS [P01 AR052915-01A1, P50 AR054144-01 CORT, HL74735, ES09912]; National Institutes of Health Tech Research and Development Program of China 863 [2007AA02Z312]; Shanghai Commission of Science and Technology [04dz14003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052915, P50AR054144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health Tech Research and Development Program of China 863(National High Technology Research and Development Program of China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant from National Institutes of Health NIAMS P01 AR052915-01A1, NIAMS P50 AR054144-01 CORT, HL74735, and ES09912, and Grant from Hi- Grant from National Institutes of Health Tech Research and Development Program of China 863) (2007AA02Z312), Shanghai Commission of Science and Technology Grant (04dz14003) and Shanghai Commission of Science and Technology (04dz14003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Andrieu N, 1998, EPIDEMIOL REV, V20, P137, DOI 10.1093/oxfordjournals.epirev.a017976; Ay N, 2002, NEURAL COMPUT, V14, P2959, DOI 10.1162/089976602760805368; Brillinger DR., 2004, BRAZ J PROBAB STAT, V18, P163; Bush WS, 2006, BIOINFORMATICS, V22, P2173, DOI 10.1093/bioinformatics/btl347; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; CHEVERUD JM, 1995, GENETICS, V139, P1455; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Cover T. M., 1991, ELEMENTS INFORM THEO; Dandara C, 2006, CARCINOGENESIS, V27, P791, DOI 10.1093/carcin/bgi257; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Goldstein AM, 2006, INT J EPIDEMIOL, V35, P1067, DOI 10.1093/ije/dyl048; GOODMAN M, 2006, PEDIAT BLOOD CANC; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Jakulin A, 2003, LECT NOTES ARTIF INT, V2780, P229; Jakulin A., 2005, THESIS U LJUBLJANA S; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Liberman U, 2007, THEOR POPUL BIOL, V71, P230, DOI 10.1016/j.tpb.2006.10.002; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Liu X, 2004, CURR OPIN GENET DEV, V14, P241, DOI 10.1016/j.gde.2004.04.011; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Matsuda H, 2000, PHYS REV E, V62, P3096, DOI 10.1103/PhysRevE.62.3096; MCGILL WJ, 1954, PSYCHOMETRIKA, V19, P97; Nakahara H, 2003, BIOINFORMATICS, V19, P1124, DOI 10.1093/bioinformatics/btg098; NOTHNAGEL M, 2002, AM J HUM GENET S, V71; Ottman R, 1996, PREV MED, V25, P764, DOI 10.1006/pmed.1996.0117; Puniyani A, 2004, THEOR POPUL BIOL, V66, P317, DOI 10.1016/j.tpb.2004.05.001; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Winslow RL, 2003, CIRC RES, V92, P953, DOI 10.1161/01.RES.0000072475.04373.07; Yoon Y, 2003, CLIN CHEM LAB MED, V41, P529, DOI 10.1515/CCLM.2003.080; Zhou W, 2002, CANCER RES, V62, P1377	39	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4578	10.1371/journal.pone.0004578	http://dx.doi.org/10.1371/journal.pone.0004578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238204	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487400010
J	Jessup, DA; Miller, MA; Ryan, JP; Nevins, HM; Kerkering, HA; Mekebri, A; Crane, DB; Johnson, TA; Kudela, RM				Jessup, David A.; Miller, Melissa A.; Ryan, John P.; Nevins, Hannah M.; Kerkering, Heather A.; Mekebri, Abdou; Crane, David B.; Johnson, Tyler A.; Kudela, Raphael M.			Mass Stranding of Marine Birds Caused by a Surfactant-Producing Red Tide	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; DOMOIC ACID; TOXICITY; BREVETOXICOSIS; DINOFLAGELLATE; COCHLODINIUM	In November-December 2007 a widespread seabird mortality event occurred in Monterey Bay, California, USA, coincident with a massive red tide caused by the dinoflagellate Akashiwo sanguinea. Affected birds had a slimy yellow-green material on their feathers, which were saturated with water, and they were severely hypothermic. We determined that foam containing surfactant-like proteins, derived from organic matter of the red tide, coated their feathers and neutralized natural water repellency and insulation. No evidence of exposure to petroleum or other oils or biotoxins were found. This is the first documented case of its kind, but previous similar events may have gone undetected. The frequency and amplitude of red tides have increased in Monterey Bay since 2004, suggesting that impacts on wintering marine birds may continue or increase.	[Jessup, David A.; Miller, Melissa A.; Nevins, Hannah M.] MWVCRC, Calif Dept Fish & Game, Santa Cruz, CA USA; [Ryan, John P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Nevins, Hannah M.] Moss Landing Marine Lab, Moss Landing, CA USA; [Kerkering, Heather A.] Monterey Bay Aquarium Res Inst, CeNCOOS Program, Moss Landing, CA USA; [Mekebri, Abdou; Crane, David B.] Calif Dept Fish & Game, Water Pollut Control Lab, Rancho Cordova, CA USA; [Johnson, Tyler A.; Kudela, Raphael M.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Johnson, Tyler A.; Kudela, Raphael M.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	Monterey Bay Aquarium Research Institute; Moss Landing Marine Laboratories; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Jessup, DA (corresponding author), MWVCRC, Calif Dept Fish & Game, Santa Cruz, CA USA.	Kudela@ucsc.edu		Ryan, John Phillip/0000-0001-7954-5369	NOAA Monitoring and Event Response for Harmful Algal Blooms program [NA04NOS4780239]	NOAA Monitoring and Event Response for Harmful Algal Blooms program	Partial funding was provided by the NOAA Monitoring and Event Response for Harmful Algal Blooms program (NA04NOS4780239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Bejarano AC, 2008, HUM ECOL RISK ASSESS, V14, P544, DOI 10.1080/10807030802074220; Benson JM, 2005, TOXICON, V45, P691, DOI 10.1016/j.toxicon.2005.01.004; Benson JM, 2005, ENVIRON HEALTH PERSP, V113, P626, DOI 10.1289/ehp.7497; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; BURKHOLDER JM, 1992, NATURE, V358, P407, DOI 10.1038/358407a0; Cloern JE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023321; DOUCETTE G, 2005, MARINE ECOLOGY PROGR, V306, P303; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FUDGE A, 1999, LAB MED AVIAN EXOTIC, P178; Glibert Patricia M., 2005, Oceanography, V18, P136; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Gower J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029638; Hampton Steve, 2003, Marine Ornithology, V31, P35; HARVEY J, 2005, BEACH COMBERS COASTA; Horner RA, 1997, LIMNOL OCEANOGR, V42, P1076, DOI 10.4319/lo.1997.42.5_part_2.1076; Jester R, 2009, HARMFUL ALGAE, V8, P291, DOI 10.1016/j.hal.2008.07.001; Kim CS, 1999, J PLANKTON RES, V21, P2105, DOI 10.1093/plankt/21.11.2105; Kreuder C, 2005, AM J VET RES, V66, P289, DOI 10.2460/ajvr.2005.66.289; KREUDER C, 2006, J ZOO WILDLIFE MED; Kudela RM, 2008, HARMFUL ALGAE, V7, P278, DOI 10.1016/j.hal.2007.12.016; Kvitek R, 2005, MAR ECOL PROG SER, V293, P303, DOI 10.3354/meps293303; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lefebvre KA, 2002, TOXICON, V40, P971, DOI 10.1016/S0041-0101(02)00093-4; Litchman E, 2002, LIMNOL OCEANOGR, V47, P86, DOI 10.4319/lo.2002.47.1.0086; Ryan JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034081; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Twiner MJ, 2000, J PLANKTON RES, V22, P1961, DOI 10.1093/plankt/22.10.1961; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	30	118	123	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4550	10.1371/journal.pone.0004550	http://dx.doi.org/10.1371/journal.pone.0004550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234604	Green Submitted, Green Published, gold			2022-12-27	WOS:000265487200006
J	Fenyo, EM; Heath, A; Dispinseri, S; Holmes, H; Lusso, P; Zolla-Pazner, S; Donners, H; Heyndrickx, L; Alcami, J; Bongertz, V; Jassoy, C; Malnati, M; Montefiori, D; Moog, C; Morris, L; Osmanov, S; Polonis, V; Sattentau, Q; Schuitemaker, H; Sutthent, R; Wrin, T; Scarlatti, G				Fenyo, Eva Maria; Heath, Alan; Dispinseri, Stefania; Holmes, Harvey; Lusso, Paolo; Zolla-Pazner, Susan; Donners, Helen; Heyndrickx, Leo; Alcami, Jose; Bongertz, Vera; Jassoy, Christian; Malnati, Mauro; Montefiori, David; Moog, Christiane; Morris, Lynn; Osmanov, Saladin; Polonis, Victoria; Sattentau, Quentin; Schuitemaker, Hanneke; Sutthent, Ruengpung; Wrin, Terri; Scarlatti, Gabriella			International Network for Comparison of HIV Neutralization Assays: The NeutNet Report	PLOS ONE			English	Article								Background: Neutralizing antibody assessments play a central role in human immunodeficiency virus type-1 (HIV-1) vaccine development but it is unclear which assay, or combination of assays, will provide reliable measures of correlates of protection. To address this, an international collaboration (NeutNet) involving 18 independent participants was organized to compare different assays. Methods: Each laboratory evaluated four neutralizing reagents (TriMab, 447-52D, 4E10, sCD4) at a given range of concentrations against a panel of 11 viruses representing a wide range of genetic subtypes and phenotypes. A total of 16 different assays were compared. The assays utilized either uncloned virus produced in peripheral blood mononuclear cells (PBMCs) (virus infectivity assays, VI assays), or their Env-pseudotyped (gp160) derivatives produced in 293T cells (PSV assays) from molecular clones or uncloned virus. Target cells included PBMC and genetically-engineered cell lines in either a single-or multiple-cycle infection format. Infection was quantified by using a range of assay read-outs that included extracellular or intracellular p24 antigen detection, RNA quantification and luciferase and beta-galactosidase reporter gene expression. Findings: PSV assays were generally more sensitive than VI assays, but there were important differences according to the virus and inhibitor used. For example, for TriMab, the mean IC50 was always lower in PSV than in VI assays. However, with 4E10 or sCD4 some viruses were neutralized with a lower IC50 in VI assays than in the PSV assays. Inter-laboratory concordance was slightly better for PSV than for VI assays with some viruses, but for other viruses agreement between laboratories was limited and depended on both the virus and the neutralizing reagent. Conclusions: The NeutNet project demonstrated clear differences in assay sensitivity that were dependent on both the neutralizing reagent and the virus. No single assay was capable of detecting the entire spectrum of neutralizing activities. Since it is not known which in vitro assay correlates with in vivo protection, a range of neutralization assays is recommended for vaccine evaluation.	[Fenyo, Eva Maria] Lund Univ, Dept Microbiol Dermatol & Infect, Lund, Sweden; [Alcami, Jose] Inst Salud Carlos III, Unidad Immunopatol SIDA, Madrid, Spain; [Bongertz, Vera] Fdn Oswaldo Crusz, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil; [Dispinseri, Stefania; Scarlatti, Gabriella] Ist Sci San Raffaele, Viral Evolut & Transmission Unit, Milan, Italy; [Donners, Helen; Heyndrickx, Leo] Inst Trop Med, Dept Microbiol, Virol Unit, Antwerp, Belgium; [Heath, Alan; Holmes, Harvey] Natl Inst Biol Standards & Control, Potters Bar, Herts, England; [Jassoy, Christian] Univ Leipzig, Inst Virol, Leipzig, Germany; [Lusso, Paolo; Malnati, Mauro] Ist Sci San Raffaele, Unit Human Virol, Milan, Italy; [Montefiori, David] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27706 USA; [Moog, Christiane] Univ Louis Pasteur, F-67070 Strasbourg, France; [Morris, Lynn] Natl Inst Communicable Dis, Johannesburg, South Africa; [Osmanov, Saladin] WHO, IVR HVI, Geneva, Switzerland; [Polonis, Victoria] Henry Jackson Fdn Advancement Military Med, Dept Vaccine Res, Rockville, MD USA; [Sattentau, Quentin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England; [Schuitemaker, Hanneke] Univ Amsterdam, Academ Med Ctr, CINIMA, Dept Expt Immunol, Landsteiner Lab, NL-1012 WX Amsterdam, Netherlands; [Sutthent, Ruengpung] Mahidol Univ, Siriraj Hosp, Natl HIV Repository & Bioinformat Ctr, Fac Microbiol, Bangkok, Thailand; [Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA; [Zolla-Pazner, Susan] NYU, Sch Med, New York, NY USA	Lund University; Instituto de Salud Carlos III; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institute of Tropical Medicine (ITM); National Institute for Biological Standards & Control; Leipzig University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Duke University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institute for Communicable Diseases (NICD); World Health Organization; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; Mahidol University; New York University	Fenyo, EM (corresponding author), Lund Univ, Dept Microbiol Dermatol & Infect, Lund, Sweden.	scarlatti.gabriella@hsr.it	Alcami, Pepe/T-2242-2018; Malnati, Mauro/AAN-4207-2020; Zolla-Pazner, Susan/S-1864-2019; scarlatti, gabriella/H-1482-2018; Morris, Lynn/V-3941-2018; C, Moog/E-3962-2016; Dispinseri, Stefania/I-9972-2018	Alcami, Pepe/0000-0003-0023-7377; Zolla-Pazner, Susan/0000-0002-0750-2666; scarlatti, gabriella/0000-0003-2316-2689; Morris, Lynn/0000-0003-3961-7828; C, Moog/0000-0002-0916-156X; Dispinseri, Stefania/0000-0003-1495-6778; Malnati, mauro/0000-0001-5355-1680	EC [LSSP-CT-2004-012190]; WHO/UNAIDS HIV Vaccine Initiative; EUROPRISE Network of Excellence of the EU [LSHP CT-2006-037611]; MS-Brasil PN DST/AIDS [188/04]; Instituto de Salud Carlos III [RETIC RD06/0006]; FIPSE Foundation [36536/05]; Fund for Scientific Research in Belgium (FWO-Vlaanderen) [G.0346.03]; Istituto Superiore di Sanita -VI Programma Nazionale [45G.35, 40G.56]; Swedish Research Council; Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); The Bill and Melinda Gates Foundation; Collaboration for AIDS vaccine discovery (CAVD); International AIDS Vaccine Initiative (IAVI); Neutralizing Antibody Consortium (NAC); NIH [AI 27742]; MRC [G0000635] Funding Source: UKRI; Medical Research Council [G0000635] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027742] Funding Source: NIH RePORTER	EC(European CommissionEuropean Commission Joint Research Centre); WHO/UNAIDS HIV Vaccine Initiative(World Health Organization); EUROPRISE Network of Excellence of the EU; MS-Brasil PN DST/AIDS; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FIPSE Foundation; Fund for Scientific Research in Belgium (FWO-Vlaanderen)(FWO); Istituto Superiore di Sanita -VI Programma Nazionale; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); The Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Collaboration for AIDS vaccine discovery (CAVD); International AIDS Vaccine Initiative (IAVI); Neutralizing Antibody Consortium (NAC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project "NeutNet: Standardisation of HIV neutralisation assays to be used in vaccine research and clinical trials" was sponsored by EC grant number LSSP-CT-2004-012190. The WHO/UNAIDS HIV Vaccine Initiative provided partial support for the conduct of the project, including the activities of the Repository, preparation and shipment of reagents. Additional support was received from EUROPRISE Network of Excellence of the EU, grant number LSHP CT-2006-037611; MS-Brasil PN DST/AIDS 188/04; Instituto de Salud Carlos III (RETIC RD06/0006) and FIPSE Foundation (36536/05); the Fund for Scientific Research in Belgium (FWO-Vlaanderen, grant number G.0346.03); the Istituto Superiore di Sanita -VI Programma Nazionale (grant numbers 45G.35 and 40G.56); the Swedish Research Council and the Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); The Bill and Melinda Gates Foundation Collaboration for AIDS vaccine discovery (CAVD) and the International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium (NAC). Antibody 447-52D was prepared through the auspices of the NIH-sponsored New York University Center for AIDS Research supported by grant AI 27742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayneh SA, 2008, AIDS RES HUM RETROV, V24, P447, DOI 10.1089/aid.2007.0216; Achkar JM, 2000, J ACQ IMMUN DEF SYND, V24, P203; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P10164, DOI 10.1073/pnas.89.21.10164; BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P475, DOI 10.1001/jama.272.6.475; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Carotenuto P, 1998, AIDS, V12, P1591, DOI 10.1097/00002030-199813000-00005; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Davis D, 2003, J MED VIROL, V71, P332, DOI 10.1002/jmv.10490; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; DSOUZA MP, 1991, AIDS, V5, P1061, DOI 10.1097/00002030-199109000-00001; Esparza J, 2003, CURR MOL MED, V3, P183, DOI 10.2174/1566524033479825; Fenyo E M, 1996, AIDS, V10 Suppl A, pS97, DOI 10.1097/00002030-199601001-00014; Gantlett KE, 2007, ANTIVIR RES, V75, P188, DOI 10.1016/j.antiviral.2007.03.004; Garcia-Perez J, 2008, HIV MED, V9, P160, DOI 10.1111/j.1468-1293.2007.00540.x; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Holl V, 2004, J IMMUNOL, V173, P6274, DOI 10.4049/jimmunol.173.10.6274; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Jarmy G, 2001, J MED VIROL, V64, P223, DOI 10.1002/jmv.1040; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; McCarthy M, 2003, LANCET, V361, P755, DOI 10.1016/S0140-6736(03)12669-4; McElrath MJ, 2000, AIDS RES HUM RETROV, V16, P907, DOI 10.1089/08892220050042846; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nordqvist Anna, 2005, Methods Mol Biol, V304, P273; Nyambi PN, 1996, J VIROL, V70, P6235, DOI 10.1128/JVI.70.9.6235-6243.1996; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1325, DOI 10.1089/aid.1994.10.1325; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Polonis VR, 2001, AIDS RES HUM RETROV, V17, P69, DOI 10.1089/088922201750056807; Quakkelaar ED, 2007, J VIROL, V81, P8533, DOI 10.1128/JVI.02816-06; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; ROBERTGUROFF M, 1988, AIDS RES HUM RETROV, V4, P343, DOI 10.1089/aid.1988.4.343; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Shi Y, 2002, AIDS RES HUM RETROV, V18, P957, DOI 10.1089/088922202760265623; Weber J, 1996, J VIROL, V70, P7827, DOI 10.1128/JVI.70.11.7827-7832.1996; Zhang YJ, 1997, J INFECT DIS, V176, P1180, DOI 10.1086/514111; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; NATURE, V449, P390	51	103	108	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4505	10.1371/journal.pone.0004505	http://dx.doi.org/10.1371/journal.pone.0004505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229336	Green Published, Green Submitted, gold			2022-12-27	WOS:000265486200002
J	Jeong, M; Kwon, YS; Park, SH; Kim, CY; Jeun, SS; Song, KW; Ko, Y; Robbins, PD; Billiar, TR; Kim, BM; Seol, DW				Jeong, Moonsup; Kwon, Yong-Sam; Park, Soon-Hye; Kim, Chae-Young; Jeun, Sin-Soo; Song, Kang-Won; Ko, Yong; Robbins, Paul D.; Billiar, Timothy R.; Kim, Byong-Moon; Seol, Dai-Wu			Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL	PLOS ONE			English	Article								Malignant gliomas are the most common primary brain tumors. Despite intensive clinical investigation and many novel therapeutic approaches, average survival for the patients with malignant gliomas is only about 1 year. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown potent and cancer-selective killing activity and drawn considerable attention as a promising therapy for cancers, but concerns over delivery and toxicity have limited progress. We have developed a secretable trimeric TRAIL (stTRAIL) and here evaluated the therapeutic potential of this stTRAIL-based gene therapy in brain tumors. An adenovirus (Ad-stTRAIL) delivering stTRAIL was injected into intra-cranial human glioma tumors established in nude mice and tumor growth monitored using the magnetic resonance imaging (MRI). Ad-stTRAIL gene therapy showed potent tumor suppressor activity with no toxic side effects at therapeutically effective doses. When compared with 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU), a conventional therapy for malignant gliomas, Ad-stTRAIL suppressed tumor growth more potently. The combination of Ad-stTRAIL and BCNU significantly increased survival compared to the control mice or mice receiving Ad-stTRAIL alone. Our data indicate that Ad-stTRAIL, either alone or combined with BCNU, has promise as a novel therapy for malignant gliomas.	[Jeong, Moonsup; Kwon, Yong-Sam; Park, Soon-Hye; Kim, Chae-Young; Kim, Byong-Moon] Dong A Pharmaceut Co Ltd, Biopharmaceut Res Labs, Kyonggi Do, South Korea; [Jeong, Moonsup; Jeun, Sin-Soo] Catholic Univ Korea, Dept Neurosurg, Seoul, South Korea; [Song, Kang-Won; Ko, Yong] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea; [Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15260 USA; [Billiar, Timothy R.; Seol, Dai-Wu] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Seol, Dai-Wu] Kyungwon Univ, Dept Life Sci, Kyonggi Do, South Korea; [Seol, Dai-Wu] Kyungwon Univ, Gachon BioNano Res Inst, Kyonggi Do, South Korea	Catholic University of Korea; Hanyang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Gachon University; Gachon University	Jeong, M (corresponding author), Dong A Pharmaceut Co Ltd, Biopharmaceut Res Labs, Kyonggi Do, South Korea.	bmkim@donga.co.kr; seold@kyungwon.ac.kr	Kim, Chaeyoung/GPW-6531-2022		Korean Science and Engineering Foundation (KOSEF) of the Korean Ministry of Education, Science and Technology (MEST) [2007-04347]; Korean Ministry of Commerce, Industry and Energy [1007404]	Korean Science and Engineering Foundation (KOSEF) of the Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorea Science and Engineering Foundation); Korean Ministry of Commerce, Industry and Energy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported in part by a grant (2007-04347 to DWS) from the Korean Science and Engineering Foundation (KOSEF) of the Korean Ministry of Education, Science and Technology (MEST) and a grant (#1007404) from the Korean Ministry of Commerce, Industry and Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Denault JB, 1996, FEBS LETT, V379, P113, DOI 10.1016/0014-5793(95)01487-X; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Kim CY, 2006, GENE THER, V13, P330, DOI 10.1038/sj.gt.3302658; Kim MH, 2004, BIOCHEM BIOPH RES CO, V321, P930, DOI 10.1016/j.bbrc.2004.07.046; Kim Y, 2003, MOL CELLS, V15, P283; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Seol DW, 2000, CANCER RES, V60, P3152; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	20	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4545	10.1371/journal.pone.0004545	http://dx.doi.org/10.1371/journal.pone.0004545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229339	Green Accepted, Green Published, gold			2022-12-27	WOS:000265486200016
J	Pickard, GE; Baver, SB; Ogilvie, MD; Sollars, PJ				Pickard, Gary E.; Baver, Scott B.; Ogilvie, Malcolm D.; Sollars, Patricia J.			Light-Induced Fos Expression in Intrinsically Photosensitive Retinal Ganglion Cells in Melanopsin Knockout (Opn4(-/-)) Mice	PLOS ONE			English	Article								Retinal ganglion cells that express the photopigment melanopsin are intrinsically photosensitive (ipRGCs) and exhibit robust synaptically driven ON-responses to light, yet they will continue to depolarize in response to light when all synaptic input from rod and cone photoreceptors is removed. The light-evoked increase in firing of classical ganglion cells is determined by synaptic input from ON-bipolar cells in the proximal sublamina of the inner plexiform layer. OFF-bipolar cells synapse with ganglion cell dendrites in the distal sublamina of the inner plexiform layer. Of the several types of ipRGC that have been described, M1 ipRGCs send dendrites exclusively into the OFF region of the inner plexiform layer where they stratify near the border of the inner nuclear layer. We tested whether M1 ipRGCs with dendrites restricted to the OFF sublamina of the inner plexiform layer receive synaptic ON-bipolar input by examining light-induced gene expression in vivo using melanopsin knockout mice. Mice in which both copies of the melanopsin gene (opn4) have been replaced with the tau-lacZ gene (homozygous tau-lacZ(+/+) knockin mice) are melanopsin knockouts (opn4(-/-)) but M1 ipRGCs are specifically identified by their expression of beta-galactosidase. Approximately 60% of M1 ipRGCs in Opn4(-/-) mice exposed to 3 hrs of light expressed c-Fos; no beta-galactosidase-positive RGCs expressed c-Fos in the dark. Intraocular application of L-AP4, a compound which blocks transmission of visual signals between photoreceptors and ON-bipolar cells significantly reduced light-evoked c-Fos expression in M1 ipRGCs compared to saline injected eyes (66% saline vs 27% L-AP4). The results are the first description of a light-evoked response in an ipRGC lacking melanopsin and provide in vivo confirmation of previous in vitro observations illustrating an unusual circuit in the retina in which ganglion cells sending dendrites to the OFF sublamina of the inner plexiform layer receive excitatory synaptic input from ON-bipolar cells.	[Pickard, Gary E.; Baver, Scott B.; Ogilvie, Malcolm D.; Sollars, Patricia J.] Colorado State Univ, Dept Biomed Sci, Div Neurosci, Ft Collins, CO 80523 USA	Colorado State University	Pickard, GE (corresponding author), Colorado State Univ, Dept Biomed Sci, Div Neurosci, Ft Collins, CO 80523 USA.	gpickard2@unl.edu			NIH [R01 EY017809, R01 NS035615]; NATIONAL EYE INSTITUTE [R01EY017809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grants R01 EY017809 and R01 NS035615 to GEP and PJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CHAMBILLE I, 1993, BRAIN RES, V612, P138, DOI 10.1016/0006-8993(93)91654-B; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DOLAN RP, 1994, VISUAL NEUROSCI, V11, P23, DOI 10.1017/S095252380001107X; Dowling J. E., 1987, RETINA APPROACHABLE; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; Hanzlicek BW, 2004, VISUAL NEUROSCI, V21, P873, DOI 10.1017/S0952523804216078; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Haverkamp S, 2004, J COMP NEUROL, V468, P251, DOI 10.1002/cne.10962; Huerta JJ, 1997, NEUROSCI LETT, V232, P143, DOI 10.1016/S0304-3940(97)00595-8; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KOISTINAHO J, 1995, MOL BRAIN RES, V29, P53, DOI 10.1016/0169-328X(94)00218-4; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NUMURA A, 1994, CELL, V77, P361; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; RODIECK RW, 1973, VERTEBRATE RETINA PR; ROHRER B, 1995, BRAIN RES, V686, P169, DOI 10.1016/0006-8993(95)00370-6; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Snellman J, 2008, PROG RETIN EYE RES, V27, P450, DOI 10.1016/j.preteyeres.2008.03.003; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; VINEY TJ, 2007, CURR BIOL, V13, P1290; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; WONG KY, 2008, SOC NEUROSCI; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	43	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4984	10.1371/journal.pone.0004984	http://dx.doi.org/10.1371/journal.pone.0004984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319185	Green Published, gold			2022-12-27	WOS:000265499200015
J	Conroy, A; Serghides, L; Finney, C; Owino, SO; Kumar, S; Gowda, DC; Liles, WC; Moore, JM; Kain, KC				Conroy, Andrea; Serghides, Lena; Finney, Constance; Owino, Simon O.; Kumar, Sanjeev; Gowda, D. Channe; Liles, W. Conrad; Moore, Julie M.; Kain, Kevin C.			C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental Malaria	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; COMPLEMENT ACTIVATION; PROINFLAMMATORY RESPONSES; HUMAN SYNCYTIOTROPHOBLAST; IMMUNE-RESPONSES; PREGNANCY; INNATE; GLYCOSYLPHOSPHATIDYLINOSITOL; EXPRESSION	Background: Placental malaria (PM) is a leading cause of maternal and infant mortality. Although the accumulation of parasitized erythrocytes (PEs) and monocytes within the placenta is thought to contribute to the pathophysiology of PM, the molecular mechanisms underlying PM remain unclear. Based on the hypothesis that excessive complement activation may contribute to PM, in particular generation of the potent inflammatory peptide C5a, we investigated the role of C5a in the pathogenesis of PM in vitro and in vivo. Methodology and Principal Findings: Using primary human monocytes, the interaction between C5a and malaria in vitro was assessed. CSA- and CD36-binding PEs induced activation of C5 in the presence of human serum. Plasmodium falciparum GPI (pfGPI) enhanced C5a receptor expression (CD88) on monocytes, and the co-incubation of monocytes with C5a and pfGPI resulted in the synergistic induction of cytokines (IL-6, TNF, IL-1 beta, and IL-10), chemokines (IL-8, MCP-1, MIP1 alpha, MIP1 beta) and the antiangiogenic factor sFlt-1 in a time and dose-dependent manner. This dysregulated response was abrogated by C5a receptor blockade. To assess the potential role of C5a in PM, C5a plasma levels were measured in malaria-exposed primigravid women in western Kenya. Compared to pregnant women without malaria, C5a levels were significantly elevated in women with PM. Conclusions and Significance: These results suggest that C5a may contribute to the pathogenesis of PM by inducing dysregulated inflammatory and angiogenic responses that impair placental function.	[Conroy, Andrea; Serghides, Lena; Finney, Constance; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [Conroy, Andrea; Kain, Kevin C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Owino, Simon O.; Moore, Julie M.] Univ Georgia, Ctr Trop & Emerging Glob Dis, Athens, GA 30602 USA; [Owino, Simon O.; Moore, Julie M.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Owino, Simon O.] Kenya Govt Med Res Ctr, Ctr Glob Hlth Res, Kisumu, Kenya; [Kumar, Sanjeev; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Liles, W. Conrad; Kain, Kevin C.] Univ Hlth Network, Toronto Gen Hosp, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Kenya Medical Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Conroy, A (corresponding author), Univ Toronto, Toronto Gen Hosp, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.on.ca	Conroy, Andrea/AAA-8356-2020; Serghides, Lena/C-7968-2018; Conroy, Andrea/ABC-5715-2020	Conroy, Andrea/0000-0002-5328-6511; Serghides, Lena/0000-0002-2817-6134; Conroy, Andrea/0000-0002-5328-6511; Finney, Constance AM/0000-0002-8459-8462; Kumar, Sanjeev/0000-0002-4454-9914; Gowda, Channe/0000-0002-6860-5108; Kain, Kevin/0000-0001-6068-1272	CIHR [Canada Research Chairs]; Ontario Genomics Institute; NIH [RO1050240];  [MT-13721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050240] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by CIHR Team Grant in Malaria (KCK), operating grant MT-13721 (KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chairs (KCK; WCL). Recruitment of women in Kenya was supported by NIH RO1050240 (JMM) and could not have been possible without the invaluable participation of parturient women and dedicated Kenyan staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Albrecht EA, 2004, CURR ALLERGY ASTHM R, V4, P359, DOI 10.1007/s11882-004-0084-3; Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Caucheteux SM, 2003, IMMUNITY, V18, P169, DOI 10.1016/S1074-7613(03)00028-1; Chaisavaneeyakorn S, 2005, INFECT IMMUN, V73, P3287, DOI 10.1128/IAI.73.6.3287-3293.2005; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Charnock-Jones DS, 2000, BEST PRACT RES CL OB, V14, P953, DOI 10.1053/beog.2000.0137; CHENOWETH DE, 1978, P NATL ACAD SCI USA, V75, P3943, DOI 10.1073/pnas.75.8.3943; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Diagne N, 1997, T ROY SOC TROP MED H, V91, P166, DOI 10.1016/S0035-9203(97)90209-1; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GILLES HM, 1969, ANN TROP MED PARASIT, V63, P245, DOI 10.1080/00034983.1969.11686625; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hawlisch H, 2004, MOL IMMUNOL, V41, P123, DOI 10.1016/j.molimm.2004.03.019; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; HUNT JS, 1989, J REPROD IMMUNOL, V16, P1, DOI 10.1016/0165-0378(89)90002-8; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Leopardi O, 1996, PATHOL RES PRACT, V192, P892, DOI 10.1016/S0344-0338(96)80068-9; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lucchi NW, 2007, J REPROD IMMUNOL, V73, P20, DOI 10.1016/j.jri.2006.05.005; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Lucchi NW, 2006, PLACENTA, V27, P384, DOI 10.1016/j.placenta.2005.04.009; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Muehlenbachs A, 2008, P NATL ACAD SCI USA, V105, P14488, DOI 10.1073/pnas.0803657105; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Muehlenbachs A, 2007, J IMMUNOL, V179, P557, DOI 10.4049/jimmunol.179.1.557; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Roestenberg M, 2007, T ROY SOC TROP MED H, V101, P643, DOI 10.1016/j.trstmh.2007.02.023; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Serghides L, 2006, J INFECT DIS, V194, P133, DOI 10.1086/504721; SMEDEGARD G, 1989, AM J PATHOL, V135, P489; SOLOMKIN JS, 1981, SURGERY, V90, P319; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417; YAMADA M, 1989, AM J TROP MED HYG, V41, P161, DOI 10.4269/ajtmh.1989.41.161; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	67	56	58	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4953	10.1371/journal.pone.0004953	http://dx.doi.org/10.1371/journal.pone.0004953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308263	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499000006
J	Jandu, N; Ho, NKL; Donato, KA; Karmali, MA; Mascarenhas, M; Duffy, SP; Tailor, C; Sherman, PM				Jandu, Narveen; Ho, Nathan K. L.; Donato, Kevin A.; Karmali, Mohamed A.; Mascarenhas, Mariola; Duffy, Simon P.; Tailor, Chetankumar; Sherman, Philip M.			Enterohemorrhagic Escherichia coli O157:H7 Gene Expression Profiling in Response to Growth in the Presence of Host Epithelia	PLOS ONE			English	Article								Background: The pathogenesis of enterohemorrhagic Escherichia coli (EHEC) O157:H7 infection is attributed to virulence factors encoded on multiple pathogenicity islands. Previous studies have shown that EHEC O157:H7 modulates host cell signal transduction cascades, independent of toxins and rearrangement of the cytoskeleton. However, the virulence factors and mechanisms responsible for EHEC-mediated subversion of signal transduction remain to be determined. Therefore, the purpose of this study was to first identify differentially regulated genes in response to EHEC O157:H7 grown in the presence of epithelial cells, compared to growth in the absence of epithelial cells (that is, growth in minimal essential tissue culture medium alone, minimal essential tissue culture medium in the presence of 5% CO(2), and Penassay broth alone) and, second, to identify EHEC virulence factors responsible for pathogen modulation of host cell signal transduction. Methodology/Principal Findings: Overnight cultures of EHEC O157:H7 were incubated for 6 hr at 37 degrees C in the presence or absence of confluent epithelial (HEp-2) cells. Total RNA was then extracted and used for microarray analyses (Affymetrix E. coli Genome 2.0 gene chips). Relative to bacteria grown in each of the other conditions, EHEC O157:H7 cultured in the presence of cultured epithelial cells displayed a distinct gene-expression profile. A 2.0-fold increase in the expression of 71 genes and a 2.0-fold decrease in expression of 60 other genes were identified in EHEC O157:H7 grown in the presence of epithelial cells, compared to bacteria grown in media alone. Conclusion/Significance: Microarray analyses and gene deletion identified a protease on O-island 50, gene Z1787, as a potential virulence factor responsible for mediating EHEC inhibition of the interferon (IFN)-gamma-Jak1,2-STAT-1 signal transduction cascade. Up-regulated genes provide novel targets for use in developing strategies to interrupt the infectious process.	[Jandu, Narveen] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Jandu, Narveen; Ho, Nathan K. L.; Donato, Kevin A.; Duffy, Simon P.; Tailor, Chetankumar; Sherman, Philip M.] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Karmali, Mohamed A.; Mascarenhas, Mariola] Publ Hlth Agcy Canada, Lab Foodborne Zoonosis, Guelph, ON, Canada	Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Public Health Agency of Canada	Jandu, N (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	philip.sherman@sickkids.ca		Karmali, Mohamed/0000-0001-7308-6085; Duffy, Simon/0000-0002-1301-6031; Sherman, Philip/0000-0002-4733-6690	Canadian Institutes of Health Research (CIHR) [STP-53877]; CIHR/Canadian Digestive Health Foundation Doctoral Research Award; University of Toronto [Open Fellowship Award]; Canada Research Chair in Gastrointestinal Disease	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Canadian Digestive Health Foundation Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Canada Research Chair in Gastrointestinal Disease	This research was supported by an operating grant from the Canadian Institutes of Health Research (CIHR). NJ is the recipient of a CIHR/Canadian Digestive Health Foundation Doctoral Research Award, a CIHR Cell Signals Strategic Training Program STP-53877 Trainee Award and an Open Fellowship Award from the University of Toronto. PMS is the recipient of a Canada Research Chair in Gastrointestinal Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Ceponis PJM, 2003, INFECT IMMUN, V71, P1396, DOI 10.1128/IAI.71.3.1396-1404.2003; Dahan S, 2004, INFECT IMMUN, V72, P5452, DOI 10.1128/IAI.72.9.5452-5459.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dowd SE, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-30; Fitzmaurice J, 2004, MOL CELL PROBE, V18, P123, DOI 10.1016/j.mcp.2003.10.004; Gadgil M, 2005, BIOTECHNOL PROGR, V21, P689, DOI 10.1021/bp049630l; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Grys TE, 2006, J BACTERIOL, V188, P4646, DOI 10.1128/JB.01806-05; Gutierrez-Rios RM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-53; Haghjoo E, 2007, MOL MICROBIOL, V64, P1549, DOI 10.1111/j.1365-2958.2007.05754.x; Hain T, 2006, J BIOTECHNOL, V126, P37, DOI 10.1016/j.jbiotec.2006.03.047; Hancock V, 2007, INFECT IMMUN, V75, P966, DOI 10.1128/IAI.01748-06; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HONG YQ, 1992, CLIN IMMUNOL IMMUNOP, V62, P133, DOI 10.1016/0090-1229(92)90065-V; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; Jandu N, 2006, INFECT IMMUN, V74, P1809, DOI 10.1128/IAI.74.3.1809-1818.2006; Jandu N, 2007, MICROB PATHOGENESIS, V42, P62, DOI 10.1016/j.micpath.2006.10.005; Kaper JB, 2008, P NATL ACAD SCI USA, V105, P4535, DOI 10.1073/pnas.0801435105; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Kida Y, 2008, CELL MICROBIOL, V10, P1491, DOI 10.1111/j.1462-5822.2008.01142.x; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Noller AC, 2003, J CLIN MICROBIOL, V41, P675, DOI 10.1128/JCM.41.2.675-679.2003; Ogura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r138; PARMELY M, 1990, INFECT IMMUN, V58, P3009, DOI 10.1128/IAI.58.9.3009-3014.1990; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rashid RA, 2006, INFECT IMMUN, V74, P4142, DOI 10.1128/IAI.00299-06; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schramm G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-149; Serna A, 2008, CURR OPIN GASTROEN, V24, P38, DOI 10.1097/MOG.0b013e3282f2dfb8; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tarr PI, 2000, J BACTERIOL, V182, P6183, DOI 10.1128/JB.182.21.6183-6191.2000; Thompson A, 2006, CURR OPIN MICROBIOL, V9, P109, DOI 10.1016/j.mib.2005.12.010; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Willenbrock H, 2006, J BACTERIOL, V188, P7713, DOI 10.1128/JB.01043-06; Wladyka B, 2008, CELL MOL BIOL LETT, V13, P212, DOI 10.2478/s11658-007-0048-4; Wu CF, 2003, BIOSENS BIOELECTRON, V19, P1, DOI 10.1016/S0956-5663(03)00118-0; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121	50	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4889	10.1371/journal.pone.0004889	http://dx.doi.org/10.1371/journal.pone.0004889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293938	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496600009
J	Aliferis, CF; Statnikov, A; Tsamardinos, I; Schildcrout, JS; Shepherd, BE; Harrell, FE				Aliferis, Constantin F.; Statnikov, Alexander; Tsamardinos, Ioannis; Schildcrout, Jonathan S.; Shepherd, Bryan E.; Harrell, Frank E., Jr.			Factors Influencing the Statistical Power of Complex Data Analysis Protocols for Molecular Signature Development from Microarray Data	PLOS ONE			English	Article								Background: Critical to the development of molecular signatures from microarray and other high-throughput data is testing the statistical significance of the produced signature in order to ensure its statistical reproducibility. While current best practices emphasize sufficiently powered univariate tests of differential expression, little is known about the factors that affect the statistical power of complex multivariate analysis protocols for high-dimensional molecular signature development. Methodology/Principal Findings: We show that choices of specific components of the analysis (i.e., error metric, classifier, error estimator and event balancing) have large and compounding effects on statistical power. The effects are demonstrated empirically by an analysis of 7 of the largest microarray cancer outcome prediction datasets and supplementary simulations, and by contrasting them to prior analyses of the same data. Conclusions/Significance: The findings of the present study have two important practical implications: First, high-throughput studies by avoiding under-powered data analysis protocols, can achieve substantial economies in sample required to demonstrate statistical significance of predictive signal. Factors that affect power are identified and studied. Much less sample than previously thought may be sufficient for exploratory studies as long as these factors are taken into consideration when designing and executing the analysis. Second, previous highly-cited claims that microarray assays may not be able to predict disease outcomes better than chance are shown by our experiments to be due to under-powered data analysis combined with inappropriate statistical tests.	[Aliferis, Constantin F.] NYU, Ctr Hlth Informat & Bioinformat, New York, NY 10003 USA; [Aliferis, Constantin F.; Statnikov, Alexander; Tsamardinos, Ioannis] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN USA; [Aliferis, Constantin F.; Schildcrout, Jonathan S.; Shepherd, Bryan E.; Harrell, Frank E., Jr.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Tsamardinos, Ioannis] Univ Crete, Dept Comp Sci, Iraklion, Greece	New York University; Vanderbilt University; Vanderbilt University; University of Crete	Aliferis, CF (corresponding author), NYU, Ctr Hlth Informat & Bioinformat, New York, NY 10003 USA.	constantin.aliferis@nyumc.org			 [2R56LM007948-04A1]; NATIONAL LIBRARY OF MEDICINE [R56LM007948] Funding Source: NIH RePORTER	; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work was in part supported by grant 2R56LM007948-04A1. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2006, CANCER INFORM, V2, P133; Baldi P, 2002, DNA MICROARRAYS GENE; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Casella G., 2002, STAT INFERENCE, V2nd; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Dobbin KK, 2007, BIOSTATISTICS, V8, P101, DOI 10.1093/biostatistics/kxj036; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan R., 2005, J MACHINE LEARNING R, V6, P1918; Freidlin B, 2000, AM STAT, V54, P161, DOI 10.2307/2685584; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Good P, 2000, PERMUTATION TESTS PR; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Jiang WY, 2007, STAT MED, V26, P5320, DOI 10.1002/sim.2968; Kohavi R, 1995, P 14 INT JOINT C ART, V2, P1137; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Ling C., 2003, P 18 INT JOINT C ART; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; MUKHERJEE S, 2003, 2003019 MIT AI; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Saerens M, 2002, NEURAL COMPUT, V14, P21, DOI 10.1162/089976602753284446; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Statnikov A, 2005, INT J MED INFORM, V74, P491, DOI 10.1016/j.ijmedinf.2005.05.002; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V., 1998, STAT LEARNING THEORY; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	50	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4922	10.1371/journal.pone.0004922	http://dx.doi.org/10.1371/journal.pone.0004922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290050	Green Submitted, gold, Green Published			2022-12-27	WOS:000265496500016
J	de Mendibil, IO; Vizmanos, JL; Novo, FJ				Ortiz de Mendibil, Inigo; Vizmanos, Jose L.; Novo, Francisco J.			Signatures of Selection in Fusion Transcripts Resulting From Chromosomal Translocations in Human Cancer	PLOS ONE			English	Article							STRAND BREAK REPAIR; CHRONIC MYELOID-LEUKEMIA; GENE FUSIONS; IDENTIFICATION; ABERRATIONS; REARRANGEMENTS; ORGANIZATION; GENERATION; STABILITY; PARTNER	Background: The recurrence and non-random distribution of translocation breakpoints in human tumors are usually attributed to local sequence features present in the vicinity of the breakpoints. However, it has also been suggested that functional constraints might contribute to delimit the position of translocation breakpoints within the genes involved, but a quantitative analysis of such contribution has been lacking. Methodology: We have analyzed two well-known signatures of functional selection, such as reading-frame compatibility and non-random combinations of protein domains, on an extensive dataset of fusion proteins resulting from chromosomal translocations in cancer. Conclusions: Our data provide strong experimental support for the concept that the position of translocation breakpoints in the genome of cancer cells is determined, to a large extent, by the need to combine certain protein domains and to keep an intact reading frame in fusion transcripts. Additionally, the information that we have assembled affords a global view of the oncogenic mechanisms and domain architectures that are used by fusion proteins. This can be used to assess the functional impact of novel chromosomal translocations and to predict the position of breakpoints in the genes involved.	[Ortiz de Mendibil, Inigo; Vizmanos, Jose L.; Novo, Francisco J.] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain	University of Navarra	de Mendibil, IO (corresponding author), Univ Navarra, Dept Genet, E-31080 Pamplona, Spain.	fnovo@unav.es	Novo, Francisco/M-7596-2015; Vizmanos, José L./G-2833-2012	Novo, Francisco/0000-0003-4961-3097; Vizmanos, José L./0000-0001-7416-3679	Institute of Health Carlos III [FIS PI040037]; Spanish Ministry of Education and Science [SAF 2007-62473]; PIUNA Program of the University of Navarra; Caja Navarra Foundation [10.830]; Government of Navarra [Jeronimo de Ayanz award]	Institute of Health Carlos III(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); PIUNA Program of the University of Navarra; Caja Navarra Foundation; Government of Navarra	This work has been funded with the help of the Institute of Health Carlos III (FIS PI040037), Spanish Ministry of Education and Science (SAF 2007-62473), the PIUNA Program of the University of Navarra and the Caja Navarra Foundation through the Program You choose, you decide (Project 10.830). F.J.N is the recipient of a Jeronimo de Ayanz award from the Government of Navarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2007, LEUKEMIA, V21, P352, DOI 10.1038/sj.leu.2404503; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; Aplan PD, 2006, DNA REPAIR, V5, P1265, DOI 10.1016/j.dnarep.2006.05.034; Ashur-Fabian O, 2008, LEUKEMIA, V22, P200, DOI 10.1038/sj.leu.2404991; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Bizarro S, 2007, CANCER GENET CYTOGEN, V178, P61, DOI 10.1016/j.cancergencyto.2007.05.023; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Catalano A, 2007, BLOOD, V110, P4073, DOI 10.1182/blood-2007-06-095554; Chinen Y, 2008, ONCOGENE, V27, P2249, DOI 10.1038/sj.onc.1210857; Esteyries S, 2008, LEUKEMIA, V22, P663, DOI 10.1038/sj.leu.2404930; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Gorello P, 2008, LEUKEMIA, V22, P216, DOI 10.1038/sj.leu.2404894; Grand FH, 2007, EXP HEMATOL, V35, P1723, DOI 10.1016/j.exphem.2007.07.002; HAMPTON OA, 2008, GENOME RES      1209; Hoglund M, 2006, ONCOGENE, V25, P2674, DOI 10.1038/sj.onc.1209290; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mirault ME, 2006, AM J HUM GENET, V79, P779, DOI 10.1086/507791; Mitelman F, 2005, GENE CHROMOSOME CANC, V43, P350, DOI 10.1002/gcc.20212; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Moller E, 2008, GENE CHROMOSOME CANC, V47, P21, DOI 10.1002/gcc.20501; Nebral K, 2007, BRIT J HAEMATOL, V139, P269, DOI 10.1111/j.1365-2141.2007.06731.x; Novo FJ, 2006, TRENDS GENET, V22, P193, DOI 10.1016/j.tig.2006.02.001; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pan Q, 2008, ONCOGENE, V27, P3414, DOI 10.1038/sj.onc.1210999; Raphael BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r59; Rowe D, 2007, HAEMATOLOGICA, V92, P1433, DOI 10.3324/haematol.11536; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Struski S, 2008, HAEMATOLOGICA, V93, P467, DOI 10.3324/haematol.11988; Sung PA, 2006, DNA REPAIR, V5, P1109, DOI 10.1016/j.dnarep.2006.05.018; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Walz C, 2007, HAEMATOLOGICA, V92, P163, DOI 10.3324/haematol.10980; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020; Zhong CH, 2008, LEUKEMIA, V22, P723, DOI 10.1038/sj.leu.2405084	47	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4805	10.1371/journal.pone.0004805	http://dx.doi.org/10.1371/journal.pone.0004805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279687	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496200002
J	Gusti, A; Baumberger, N; Nowack, M; Pusch, S; Eisler, H; Potuschak, T; De Veylder, L; Schnittger, A; Genschik, P				Gusti, Andi; Baumberger, Nicolas; Nowack, Moritz; Pusch, Stefan; Eisler, Herfried; Potuschak, Thomas; De Veylder, Lieven; Schnittger, Arp; Genschik, Pascal			The Arabidopsis thaliana F-Box Protein FBL17 Is Essential for Progression through the Second Mitosis during Pollen Development	PLOS ONE			English	Article							CELL-CYCLE; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; PROLIFERATION; PHOSPHORYLATION; DEGRADATION; PROTEOLYSIS; DIVISION; COMPLEX; CDKA,1	In fungi and metazoans, the SCF-type Ubiquitin protein ligases (E3s) play a critical role in cell cycle regulation by degrading negative regulators, such as cell cycle-dependent kinase inhibitors (CKIs) at the G1-to-S-phase checkpoint. Here we report that FBL17, an Arabidopsis thaliana F-box protein, is involved in cell cycle regulation during male gametogenesis. FBL17 expression is strongly enhanced in plants co-expressing E2Fa and DPa, transcription factors that promote S-phase entry. FBL17 loss-of-function mutants fail to undergo pollen mitosis II, which generates the two sperm cells in mature A. thaliana pollen. Nonetheless, the single sperm cell-like cell in fbl17 mutants is functional but will exclusively fertilize the egg cell of the female gametophyte, giving rise to an embryo that will later abort, most likely due to the lack of functional endosperm. Seed abortion can, however, be overcome by mutations in FIE, a component of the Polycomb group complex, overall resembling loss-of-function mutations in the A. thaliana cyclin-dependent kinase CDKA;1. Finally we identified ASK11, as an SKP1-like partner protein of FBL17 and discuss a possible mechanism how SCFFBL17 may regulate cell division during male gametogenesis.	[Gusti, Andi; Baumberger, Nicolas; Eisler, Herfried; Potuschak, Thomas; Schnittger, Arp; Genschik, Pascal] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France; [Nowack, Moritz; Pusch, Stefan; Schnittger, Arp] Univ Cologne, Max Planck Inst Zuchtungsforschung, Max Delbruck Lab, Lehrstuhl Botan 3, D-5000 Cologne, Germany; [De Veylder, Lieven] VIB, Dept Plant Syst Biol, Ghent, Belgium; [De Veylder, Lieven] Univ Ghent, Dept Mol Genet, Ghent, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society; University of Cologne; Flanders Institute for Biotechnology (VIB); Ghent University	Gusti, A (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France.	pascal.genschik@ibmp-ulp.u-strasbg.fr	Schnittger, Arp/F-8989-2010; Pusch, Stefan/H-3152-2019; de veylder, lieven/AAM-9909-2020; Schnittger, Arp/AAO-6920-2020	Schnittger, Arp/0000-0001-7067-0091; Pusch, Stefan/0000-0002-3407-4249; de veylder, lieven/0000-0003-1150-4426; Schnittger, Arp/0000-0001-7067-0091; GENSCHIK, Pascal/0000-0002-4107-5071; Potuschak, Thomas/0000-0002-2632-4981; gusti, andi/0000-0003-1988-9260; Nowack, Moritz/0000-0001-8918-7577	CNRS; EU NoE [LSHG-CT-2005-018683]; VW foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); EU NoE; VW foundation(Volkswagen)	Funding was provided by the CNRS to P.G and A.S., the EU NoE (Rubicon LSHG-CT-2005-018683) to P.G. and the VW foundation to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Baroux C, 2007, CURR OPIN GENET DEV, V17, P473, DOI 10.1016/j.gde.2007.09.004; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; del Pozo JC, 2002, PLANT CELL, V14, P3057, DOI 10.1105/tpc.006791; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dissmeyer N, 2007, PLANT CELL, V19, P972, DOI 10.1105/tpc.107.050401; Doelling JH, 2007, PLANT PHYSIOL, V145, P801, DOI 10.1104/pp.106.095323; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; GENSCHIK P, 2007, ANN PLANT REV, P87; Grini PE, 2002, GENETICS, V162, P1911; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; Hengst L, 2004, NAT CELL BIOL, V6, P1153, DOI 10.1038/ncb1204-1153; Howden R, 1998, GENETICS, V149, P621; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Jakoby MJ, 2006, PLANT PHYSIOL, V141, P1293, DOI 10.1104/pp.106.081406; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim HJ, 2008, NATURE, V455, P1134, DOI 10.1038/nature07289; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu FQ, 2004, PLANT CELL, V16, P5, DOI 10.1105/tpc.017772; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Marrocco K, 2006, PLANT J, V45, P423, DOI 10.1111/j.1365-313X.2005.02635.x; Marrocco K, 2003, PLANT MOL BIOL, V52, P715, DOI 10.1023/A:1025056008926; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; PREUSS D, 1994, SCIENCE, V264, P1458, DOI 10.1126/science.8197459; Ren H, 2008, PLANT J, V53, P705, DOI 10.1111/j.1365-313X.2007.03370.x; Serralbo O, 2006, P NATL ACAD SCI USA, V103, P13250, DOI 10.1073/pnas.0602410103; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Verkest A, 2005, PLANT CELL, V17, P1723, DOI 10.1105/tpc.105.032383; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang H, 1997, NATURE, V386, P451, DOI 10.1038/386451a0; WANG H, 2007, ANN PLANT REV, P62; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Zhao DH, 2003, PLANT MOL BIOL, V53, P163, DOI 10.1023/B:PLAN.0000009273.81702.b5	59	110	114	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4780	10.1371/journal.pone.0004780	http://dx.doi.org/10.1371/journal.pone.0004780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277118	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496100011
J	Mullenders, J; Fabius, AWM; Madiredjo, M; Bernards, R; Beijersbergen, RL				Mullenders, Jasper; Fabius, Armida W. M.; Madiredjo, Mandy; Bernards, Rene; Beijersbergen, Roderick L.			A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway	PLOS ONE			English	Article								Background: The p53 tumor suppressor gene is mutated in about half of human cancers, but the p53 pathway is thought to be functionally inactivated in the vast majority of cancer. Understanding how tumor cells can become insensitive to p53 activation is therefore of major importance. Using an RNAi-based genetic screen, we have identified three novel genes that regulate p53 function. Results: We have screened the NKI shRNA library targeting 8,000 human genes to identify modulators of p53 function. Using the shRNA barcode technique we were able to quickly identify active shRNA vectors from a complex mixture. Validation of the screening results indicates that the shRNA barcode technique can reliable identify active shRNA vectors from a complex pool. Using this approach we have identified three genes, ARNTL, RBCK1 and TNIP1, previously unknown to regulate p53 function. Importantly, ARNTL (BMAL1) is an established component of the circadian regulatory network. The latter finding adds to recent observations that link circadian rhythm to the cell cycle and cancer. We show that cells having suppressed ARNTL are unable to arrest upon p53 activation associated with an inability to activate the p53 target gene p21(CIP1). Conclusions: We identified three new regulators of the p53 pathway through a functional genetic screen. The identification of the circadian core component ARNTL strengthens the link between circadian rhythm and cancer.	[Mullenders, Jasper; Fabius, Armida W. M.; Madiredjo, Mandy; Bernards, Rene; Beijersbergen, Roderick L.] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands; [Mullenders, Jasper; Fabius, Armida W. M.; Madiredjo, Mandy; Bernards, Rene; Beijersbergen, Roderick L.] Netherlands Canc Inst, Canc Genom Ctr, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Mullenders, J (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands.	r.bijersbergen@nki.nl	Mullenders, Jasper/J-2398-2015	Mullenders, Jasper/0000-0003-3737-6901; Beijersbergen, Roderick/0000-0003-0116-4130; Bernards, Rene/0000-0001-8677-3423	Dutch Cancer Society; EU 6th framework program TRANSFOG	Dutch Cancer Society(KWF Kankerbestrijding); EU 6th framework program TRANSFOG	This research was funded by the Dutch Cancer Society (KWF) and by the EU 6th framework program TRANSFOG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayle J, 2006, FEBS LETT, V580, P2609, DOI 10.1016/j.febslet.2006.03.093; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qian XZ, 2008, INT J CANCER, V122, P1400, DOI 10.1002/ijc.23243; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Tatematsu K, 2005, J BIOL CHEM, V280, P22937, DOI 10.1074/jbc.M413476200; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	47	103	111	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4798	10.1371/journal.pone.0004798	http://dx.doi.org/10.1371/journal.pone.0004798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277210	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496100017
J	Sayyed-Ahmad, A; Kaznessis, YN				Sayyed-Ahmad, Abdallah; Kaznessis, Yiannis N.			Determining the Orientation of Protegrin-1 in DLPC Bilayers Using an Implicit Solvent-Membrane Model	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ANTIMICROBIAL PEPTIDE; LIPID-BILAYERS; BROAD-SPECTRUM; STABILITY; ENERGY; ELECTROSTATICS; DEFENSINS; MUTATIONS; INSERTION	Continuum models that describe the effects of solvent and biological membrane molecules on the structure and behavior of antimicrobial peptides, holds a promise to improve our understanding of the mechanisms of antimicrobial action of these peptides. In such methods, a lipid bilayer model membrane is implicitly represented by multiple layers of relatively low dielectric constant embedded in a high dielectric aqueous solvent, while an antimicrobial peptide is accounted for by a dielectric cavity with fixed partial charge at the center of each one of its atoms. In the present work, we investigate the ability of continuum approaches to predict the most probable orientation of the beta-hairpin antimicrobial peptide Protegrin-1 (PG-1) in DLPC lipid bilayers by calculating the difference in the transfer free energy from an aqueous environment to a membrane-water environment for multiple orientations. The transfer free energy is computed as a sum of two terms; polar/electrostatic and non-polar. They both include energetic and entropic contributions to the free energy. We numerically solve the Poisson-Boltzmann equation to calculate the electrostatic contribution to the transfer free energy, while the non-polar contribution to the free energy is approximated using a linear solvent accessible surface area relationships. The most probable orientation of PG-1 is that with the lowest relative transfer free energy. Our simulation results indicate that PG-1 assumes an oblique orientation in DLPC lipid bilayers. The predicted most favorable orientation was with a tilt angle of 19 degrees, which is in qualitative agreement with the experimentally observed orientations derived from solid-state NMR data.	[Sayyed-Ahmad, Abdallah; Kaznessis, Yiannis N.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Sayyed-Ahmad, Abdallah; Kaznessis, Yiannis N.] Univ Minnesota, Digital Technol Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sayyed-Ahmad, A (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	yiannis@cems.umn.edu	, Asa/W-3080-2019; Kaznessis, Yiannis N/H-1795-2015	, Asa/0000-0003-2415-8403; Kaznessis, Yiannis/0000-0002-5088-1104	NIH [GM 070989]; National Computational Science Alliance [TG-MCA04N033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Computational Science Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIH (GM 070989). The authors gratefully acknowledge the computational support from the Minnesota Supercomputing Institute. This work also was partially supported by the National Computational Science Alliance under TG-MCA04N033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT RG, 1981, BIOCHIM BIOPHYS ACTA, V643, P191, DOI 10.1016/0005-2736(81)90232-7; Baker N, 2000, J COMPUT CHEM, V21, P1343, DOI 10.1002/1096-987X(20001130)21:15<1343::AID-JCC2>3.0.CO;2-K; Bechor D, 2001, BIOPHYS J, V80, P643, DOI 10.1016/S0006-3495(01)76045-6; Berneche S, 1998, BIOPHYS J, V75, P1603, DOI 10.1016/S0006-3495(98)77604-0; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Bransburg-Zabary S, 2002, BIOCHEMISTRY-US, V41, P6946, DOI 10.1021/bi0120704; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Choi HS, 2006, BIOMACROMOLECULES, V7, P403, DOI 10.1021/bm050579z; Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3; Gidalevitz D, 2003, P NATL ACAD SCI USA, V100, P6302, DOI 10.1073/pnas.0934731100; Haider S, 2005, BIOPHYS J, V88, P3310, DOI 10.1529/biophysj.104.052019; Harwig SSL, 1996, EUR J BIOCHEM, V240, P352, DOI 10.1111/j.1432-1033.1996.0352h.x; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Khandelia H, 2005, PEPTIDES, V26, P2037, DOI 10.1016/j.peptides.2005.03.058; Khandelia H, 2007, BBA-BIOMEMBRANES, V1768, P509, DOI 10.1016/j.bbamem.2006.11.015; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; Langham AA, 2006, MOL SIMULAT, V32, P193, DOI 10.1080/08927020600612205; Langham AA, 2006, BIOPOLYMERS, V84, P219, DOI 10.1002/bip.20397; Lazaridis T, 2005, PROTEINS, V58, P518, DOI 10.1002/prot.20358; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; ORSOLYA T, 2005, J PEPT SCI, V80, P717; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Sansom MSP, 1997, BIOPHYS J, V73, P2404, DOI 10.1016/S0006-3495(97)78269-9; Sayyed-Ahmad A, 2004, J COMPUT CHEM, V25, P1068, DOI 10.1002/jcc.20039; SEIICHIRO T, 2005, J CHEM PHYS, V122; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Sengupta D, 2005, PROTEINS, V58, P913, DOI 10.1002/prot.20383; Shepherd CM, 2003, BIOCHEM J, V370, P233, DOI 10.1042/BJ20021255; Sitkoff D, 1996, J PHYS CHEM-US, V100, P2744, DOI 10.1021/jp952986i; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Steinstraesser L, 2001, CRIT CARE MED, V29, P1431, DOI 10.1097/00003246-200107000-00022; Tanizaki S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1865992; Ulmschneider MB, 2007, BIOPHYS J, V92, P2338, DOI 10.1529/biophysj.106.081810; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Yamaguchi S, 2002, BIOCHEMISTRY-US, V41, P9852, DOI 10.1021/bi0257991; YECHIEL S, 2002, J PEPT SCI, V66, P236; Zanetti M, 2002, CURR PHARM DESIGN, V8, P779, DOI 10.2174/1381612023395457; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	45	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4799	10.1371/journal.pone.0004799	http://dx.doi.org/10.1371/journal.pone.0004799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277199	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496100018
J	Foteinou, PT; Calvano, SE; Lowry, SF; Androulakis, IP				Foteinou, Panagiota T.; Calvano, Steve E.; Lowry, Stephen F.; Androulakis, Ioannis P.			In Silico Simulation of Corticosteroids Effect on an NFkB-Dependent Physicochemical Model of Systemic Inflammation	PLOS ONE			English	Article								Background: During the onset of an inflammatory response signaling pathways are activated for "translating" extracellular signals into intracellular responses converging to the activation of nuclear factor (NF)-kB, a central transcription factor in driving the inflammatory response. An inadequate control of its transcriptional activity is associated with the culmination of a hyper-inflammatory response making it a desired therapeutic target. Predicated upon the nature of the response, a systems level analysis might provide rational leads for the development of strategies that promote the resolution of the response. Methodology and Findings: A physicochemical host response model is proposed to integrate biological information in the form of kinetic rules and signaling cascades with pharmacokinetic models of drug action for the modulation of the response. The unifying hypothesis is that the response is triggered by the activation of the NFkB signaling module and corticosteroids serve as a template for assessing anti-inflammatory strategies. The proposed in silico model is evaluated through its ability to predict and modulate uncontrolled responses. The pre-exposure of the system to hypercortisolemia, i.e. 6 hr before or simultaneously with the infectious challenge "reprograms" the dynamics of the host towards a balanced inflammatory response. However, if such an intervention occurs long before the inflammatory insult a symptomatic effect is observed instead of a protective relief while a steroid infusion after inducing inflammation requires much higher drug doses. Conclusions and Significance: We propose a reversed engineered inflammation model that seeks to describe how the system responds to a multitude of external signals. Timing of intervention and dosage regimes appears to be key determinants for the protective or symptomatic effect of exogenous corticosteroids. Such results lie in qualitative agreement with in vivo human studies exposed both to LPS and corticosteroids under various time intervals thus improving our understanding of how interacting modules generate a behavior.	[Foteinou, Panagiota T.; Androulakis, Ioannis P.] Rutgers State Univ, Piscataway, NJ 08854 USA; [Calvano, Steve E.; Lowry, Stephen F.] UMDNJ, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Foteinou, PT (corresponding author), Rutgers State Univ, Piscataway, NJ 08854 USA.	yannis@rci.rutgers.edu			NSF [0519563]; EPA [GAD R 832721-010-RRA]; Busch Biomedical Research; USPHS [GM34695]; National Institute of General Medical Sciences [2-U54-GM062119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034695, R01GM034695, U54GM062119] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); Busch Biomedical Research; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PTF and IPA acknowledge support from NSF grant 0519563, EPA grant GAD R 832721-010-RRA and a Busch Biomedical Research Grant. SEC and SFL are supported, in part, from USPHS Grant GM34695. The investigators acknowledge the contribution of the Inflammation and the Host Response to Injury Large-Scale Collaborative Project Award # 2-U54-GM062119 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; Almon RR, 2007, ENDOCRINOLOGY, V148, P2209, DOI 10.1210/en.2006-0790; Almon RR, 2005, AAPS J, V7, pE156, DOI 10.1208/aapsj070117; Almon RR, 2005, AM J PHYSIOL-ENDOC M, V289, pE870, DOI 10.1152/ajpendo.00196.2005; Almon RR, 2002, J PHARMACOKINET PHAR, V29, P103, DOI 10.1023/A:1019762323576; Annane D, 2004, BMJ-BRIT MED J, V329, P480, DOI 10.1136/bmj.38181.482222.55; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002243.pub2, DOI 10.1002/14651858.CD002243.PUB2]; ARZT E, 1994, ENDOCRINOLOGY, V134, P672, DOI 10.1210/en.134.2.672; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BARBER AE, 1993, J IMMUNOL, V150, P1999; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bornstein SR, 2003, AM J RESP CRIT CARE, V167, P485, DOI 10.1164/rccm.2211010; Briegel J, 2001, J AM SOC NEPHROL, V12, pS70; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; DUBOIS DC, 1995, J STEROID BIOCHEM, V54, P237, DOI 10.1016/0960-0760(95)00139-Q; FOTEINOU P, 2007, J CRITICAL CARE, V22, P337; FOTEINOU PT, 2008, TRANSLATION IN PRESS; FOTEINOU PT, 2008, MODELING EN IN PRESS; HAWES AS, 1992, INFECT IMMUN, V60, P2641, DOI 10.1128/IAI.60.7.2641-2647.1992; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Ihekwaba A. E. C., 2004, Systems Biology, V1, P93, DOI 10.1049/sb:20045009; Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256; JUSKO WJ, 1994, PROG CLIN BIOL RES, V387, P261; JUSKO WJ, 2005, J PHARMACOKIN PHARMA; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Klaitman V, 2003, ISRAEL MED ASSOC J, V5, P51; KLINKE DJ, 2008, BIOPHYS J BIOFAST; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Krzyzanski W, 1997, J PHARMACOKINET BIOP, V25, P107, DOI 10.1023/A:1025723927981; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Kumar R, 2008, SHOCK, V29, P104, DOI 10.1097/SHK.0b013e318067da56; LAUFFENBURGER DA, 1981, MATH BIOSCI, V53, P189, DOI 10.1016/0025-5564(81)90018-3; LEFERING R, 1995, CRIT CARE MED, V23, P1294, DOI 10.1097/00003246-199507000-00021; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Mager DE, 2003, DRUG METAB DISPOS, V31, P510, DOI 10.1124/dmd.31.5.510; MAHONY DSO, 2008, INT J MED SCI, V5, P1; Marshall JC, 2002, CRIT CARE, V6, P342, DOI 10.1186/cc1522; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Nystrom PO, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.suppl_1.1; Post TM, 2005, PHARM RES-DORDR, V22, P1038, DOI 10.1007/s11095-005-5641-5; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Ramakrishnan R, 2002, J PHARMACOKINET PHAR, V29, P1, DOI 10.1023/A:1015765201129; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; RICHARDSON RP, 1989, ANN SURG, V210, P239, DOI 10.1097/00000658-198908000-00018; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; RIFKIND D, 1967, J BACTERIOL, V93, P1463, DOI 10.1128/JB.93.4.1463-1464.1967; Romaschin Alexander D, 1998, Sepsis (Boston), V2, P119, DOI 10.1023/A:1009769923763; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Sato N, 2002, ANN SURG, V236, P184, DOI 10.1097/00000658-200208000-00006; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Senftleben U, 2003, INTENS CARE MED, V29, P1873, DOI 10.1007/s00134-003-1932-7; Shin HJ, 2007, MOL CELLS, V24, P119; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sun YN, 1998, J PHARMACOKINET BIOP, V26, P289, DOI 10.1023/A:1023233409550; Tetta C, 2005, Crit Care Resusc, V7, P32; Tschaikowsky K, 1998, J PHARMACOL EXP THER, V285, P800; vanderPoll T, 1996, J CLIN ENDOCR METAB, V81, P3604, DOI 10.1210/jc.81.10.3604; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; Xu ZX, 1995, J PHARMACOKINET BIOP, V23, P163, DOI 10.1007/BF02354270; Yang E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-10; Zurakowski R, 2006, J THEOR BIOL, V238, P368, DOI 10.1016/j.jtbi.2005.05.004	75	42	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4706	10.1371/journal.pone.0004706	http://dx.doi.org/10.1371/journal.pone.0004706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274080	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496000001
J	Masataka, N; Koda, H; Urasopon, N; Watanabe, K				Masataka, Nobuo; Koda, Hiroki; Urasopon, Nontakorn; Watanabe, Kunio			Free-Ranging Macaque Mothers Exaggerate Tool-Using Behavior when Observed by Offspring	PLOS ONE			English	Article								The population-level use of tools has been reported in various animals. Nonetheless, how tool use might spread throughout a population is still an open question. In order to answer that, we observed the behavior of inserting human hair or human-hair-like material between their teeth as if they were using dental floss in a group of long-tailed macaques (Macaca fascicularis) in Thailand. The observation was undertaken by video-recording the tool-use of 7 adult females who were rearing 1-year-old infants, using the focal-animal-sampling method. When the data recorded were analyzed separately according to the presence/absence of the infant of the target animal in the target animal's proximity, the pattern of the tool-using action of long-tailed adult female macaques under our observation changed in the presence of the infant as compared with that in the absence of the infant so that the stream of tool-using action was punctuated by more pauses, repeated more often, and performed for a longer period during each bout in the presence of the infant. We interpret this as evidence for the possibility that they exaggerate their action in tool-using so as to facilitate the learning of the action by their own infants.	[Masataka, Nobuo; Koda, Hiroki; Watanabe, Kunio] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Urasopon, Nontakorn] Ubon Rajathanee Univ, Fac Agr, Dept Anim Sci, Bangkok, Thailand	Kyoto University	Masataka, N (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	masataka@pri.kyoto-u.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [Grant-in-Aid]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A Grant-in-Aid for the Global COE Research Program from the Ministry of Education, Science, Sports and Culture, Japan (A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand RJ, 2008, DEVELOPMENTAL SCI, V11, P853, DOI 10.1111/j.1467-7687.2008.00734.x; Brand RJ, 2007, INFANCY, V11, P203, DOI 10.1111/j.1532-7078.2007.tb00223.x; Brand RJ, 2002, DEVELOPMENTAL SCI, V5, P72, DOI 10.1111/1467-7687.00211; CHAUVIN C, 2004, MACAQUE SOC MODEL ST, P209; Ducoing AM, 2005, ANIM COGN, V8, P103, DOI 10.1007/s10071-004-0240-0; Goodall J., 1963, S ZOOL SOC LOND, V10, P39; MASATAKA N, 1992, INFANT BEHAV DEV, V15, P453, DOI 10.1016/0163-6383(92)80013-K; Nagai Y., 2007, P 4 INT S IM AN ART, P299; Rohlfing KJ, 2006, ADV ROBOTICS, V20, P1183, DOI 10.1163/156855306778522532; Visalberghi E., 1990, P247, DOI 10.1017/CBO9780511665486.011; Watanabe K, 2007, AM J PRIMATOL, V69, P940, DOI 10.1002/ajp.20403; Zukow-Goldring P., 1997, EVOLVING EXPLANATION, P199, DOI DOI 10.1037/10265-006	12	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4768	10.1371/journal.pone.0004768	http://dx.doi.org/10.1371/journal.pone.0004768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274074	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000008
J	Couthouis, J; Rebora, K; Immel, F; Berthelot, K; Castroviejo, M; Cullin, C				Couthouis, Julien; Rebora, Karine; Immel, Francoise; Berthelot, Karine; Castroviejo, Michel; Cullin, Christophe			Screening for Toxic Amyloid in Yeast Exemplifies the Role of Alternative Pathway Responsible for Cytotoxicity	PLOS ONE			English	Article								The relationship between amyloid and toxic species is a central problem since the discovery of amyloid structures in different diseases. Despite intensive efforts in the field, the deleterious species remains unknown at the molecular level. This may reflect the lack of any structure-toxicity study based on a genetic approach. Here we show that a structure-toxicity study without any biochemical prerequisite can be successfully achieved in yeast. A PCR mutagenesis of the amyloid domain of HET-s leads to the identification of a mutant that might impair cellular viability. Cellular and biochemical analyses demonstrate that this toxic mutant forms GFP-amyloid aggregates that differ from the wild-type aggregates in their shape, size and molecular organization. The chaperone Hsp104 that helps to disassemble protein aggregates is strictly required for the cellular toxicity. Our structure-toxicity study suggests that the smallest aggregates are the most toxic, and opens a new way to analyze the relationship between structure and toxicity of amyloid species.	[Couthouis, Julien; Rebora, Karine; Immel, Francoise; Berthelot, Karine; Cullin, Christophe] Univ Bordeaux 2 Victor Segalen, CNRS, UMR 5095, IBGC, Bordeaux, France; [Castroviejo, Michel] Univ Bordeaux 2 Victor Segalen, CNRS, UMR 5097, REGER, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Couthouis, J (corresponding author), Univ Bordeaux 2 Victor Segalen, CNRS, UMR 5095, IBGC, Bordeaux, France.	Christophe.Cullin@ibgc.u-bordeaux2.fr	Immel, Françoise/GNP-4167-2022; cullin, christophe/AAM-2179-2020; BERTHELOT, Karine V.J./A-5546-2011; Immel, Françoise/N-7079-2019; COUTHOUIS, Julien/G-3895-2012	Immel, Françoise/0000-0002-2028-902X; cullin, christophe/0000-0003-4110-4677; BERTHELOT, Karine V.J./0000-0003-0809-4921; COUTHOUIS, Julien/0000-0002-2378-4595	GIS; ANR [06-MRAR-011-01]; University Bordeaux2	GIS(Agency for Science Technology & Research (A*STAR)); ANR(French National Research Agency (ANR)); University Bordeaux2	The work was supported by grants from GIS "Maladie rares" and ANR Projet ANR-06-MRAR-011-01 AMYLOI. KR was supported by an ATER position provided by the University Bordeaux2. KB was supported by ANR and the "Conseil Regional d'Aquitaine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; BERTHELOT K, 2009, FASEB J IN PRESS; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Chacinska A, 2000, MOL CELL BIOL, V20, P7220, DOI 10.1128/MCB.20.19.7220-7229.2000; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; CULLIN C, 1994, YEAST, V10, P105, DOI 10.1002/yea.320100110; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Jeter C, 2005, MOL PLANT MICROBE IN, V18, P1235, DOI 10.1094/MPMI-18-1235; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; WANG Y, 2008, FASEB J; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4539	10.1371/journal.pone.0004539	http://dx.doi.org/10.1371/journal.pone.0004539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262694	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490600001
J	Norscia, I; Antonacci, D; Palagi, E				Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta			Mating First, Mating More: Biological Market Fluctuation in a Wild Prosimian	PLOS ONE			English	Article							MALE VERREAUXS SIFAKA; PROPITHECUS-VERREAUXI; SCENT-MARKING; GROOMING RECIPROCITY; BEHAVIOR; REPRODUCTION; KIRINDY; COUNTERMARKING; STRATEGIES; SUCCESS	In biology, economics, and politics, distributive power is the key for understanding asymmetrical relationships and it can be obtained by force (dominance) or trading (leverage). Whenever males cannot use force, they largely depend on females for breeding opportunities and the balance of power tilts in favour of females. Thus, males are expected not only to compete within their sex-class but also to exchange services with the opposite sex. Does this mating market, described for humans and apes, apply also to prosimians, the most ancestral primate group? To answer the question, we studied a scent-oriented and gregarious lemur, Propithecus verreauxi (sifaka), showing female dominance, promiscuous mating, and seasonal breeding. We collected 57 copulations involving 8 males and 4 females in the wild (Berenty Reserve, South Madagascar), and data (all occurrences) on grooming, aggressions, and marking behaviour. We performed the analyses via exact Spearman and matrix correlations. Male mating priority rank correlated with the frequency of male countermarking over female scents but not with the proportion of fights won by males over females. Thus, males competed in an olfactory tournament more than in an arena of aggressive encounters. The copulation frequency correlated neither with the proportion of fights won by males nor with the frequency of male countermarking on female scents. Male-to-female grooming correlated with female-to-male grooming only during premating. Instead, in the mating period male-to-female grooming correlated with the copulation frequency. In short, the biological market underwent seasonal fluctuations, since males bargained grooming for sex in the mating days and grooming for itself in the premating period. Top scent-releasers gained mating priority (they mated first) and top groomers ensured a higher number of renewed copulations (they mated more). In conclusion, males maximize their reproduction probability by adopting a double tactic and by following market fluctuations.	[Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Territ, Calci, PI, Italy	University of Pisa	Norscia, I (corresponding author), Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Territ, Calci, PI, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett Louise, 2001, P119, DOI 10.1017/CBO9780511752421.009; BLAUSTEIN AR, 1981, AM NAT, V117, P1006, DOI 10.1086/283786; Brockman DK, 1999, INT J PRIMATOL, V20, P375, DOI 10.1023/A:1020500804442; Brockman DK, 1996, AM J PHYS ANTHROPOL, V100, P57; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; DAHL RA, 1957, BEHAV SCI, V2, P201, DOI 10.1002/bs.3830020303; De Waal, 1989, PEACEMAKING PRIMATES; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; Fisher HS, 2003, BEHAV ECOL SOCIOBIOL, V53, P123, DOI 10.1007/s00265-002-0552-5; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Hemelrijk C., 2007, HDB PALEOANTHROPOL 2, P1321; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Heymann EW, 2006, AM J PRIMATOL, V68, P650, DOI 10.1002/ajp.20258; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; JOLLY A, 1972, FOLIA PRIMATOL, V17, P335, DOI 10.1159/000155454; Jolly Alison, 2006, P3; Jordan NR, 2007, ANIM BEHAV, V74, P531, DOI 10.1016/j.anbehav.2006.12.015; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lazaro-Perea C, 1999, BEHAV ECOL SOCIOBIOL, V46, P313, DOI 10.1007/s002650050625; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; Lewis RJ, 2005, AM J PRIMATOL, V67, P347, DOI 10.1002/ajp.20187; Lewis RJ, 2005, AM J PHYS ANTHROPOL, V128, P389, DOI 10.1002/ajpa.20206; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Mooring MS, 2004, BIOL J LINN SOC, V81, P17, DOI 10.1111/j.1095-8312.2004.00273.x; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; NOE R, 1991, ETHOLOGY, V87, P97; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Noe Ronald, 2001, P93, DOI 10.1017/CBO9780511752421.008; Norscia I, 2008, INT J PRIMATOL, V29, P1099, DOI 10.1007/s10764-008-9259-4; Norscia I, 2006, INT J PRIMATOL, V27, P1001, DOI 10.1007/s10764-006-9056-x; Nunn Charles L., 2001, P42, DOI 10.1017/CBO9780511752421.005; Palagi E, 2004, INT J PRIMATOL, V25, P1019, DOI 10.1023/B:IJOP.0000043349.23082.c0; Paoli T, 2008, DEV PRIMATOL-PROG PR, P39, DOI 10.1007/978-0-387-74787-3_3; Pochron ST, 2003, BEHAV ECOL SOCIOBIOL, V54, P285, DOI 10.1007/s00265-003-0634-z; Port M, 2009, ANIM BEHAV, V77, P29, DOI 10.1016/j.anbehav.2008.08.032; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Rasmussen HB, 2008, BEHAV ECOL, V19, P9, DOI 10.1093/beheco/arm093; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RICHARD AF, 1992, J HUM EVOL, V22, P395, DOI 10.1016/0047-2484(92)90067-J; Russell B., 1938, POWER NEW SOCIAL ANA; Stopka P, 1999, ETHOLOGY, V105, P969, DOI 10.1046/j.1439-0310.1999.00485.x; Stopka Pavel, 2001, Animal Behaviour Forum, V61, pF19; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Wilson E.O., 1975, P1; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31	56	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4679	10.1371/journal.pone.0004679	http://dx.doi.org/10.1371/journal.pone.0004679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MC	19262737	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490600010
J	Kandimalla, KK; Scott, OG; Fulzele, S; Davidson, MW; Poduslo, JF				Kandimalla, Karunya K.; Scott, Olenych G.; Fulzele, Smita; Davidson, Michael W.; Poduslo, Joseph F.			Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid beta Protein	PLOS ONE			English	Article								Alzheimer's disease (AD) is characterized by significant neurodegeneration in the cortex and hippocampus; intraneuronal tangles of hyperphosphorylated tau protein; and accumulation of beta-amyloid (A beta) proteins 40 and 42 in the brain parenchyma as well as in the cerebral vasculature. The current understanding that AD is initiated by the neuronal accumulation of A beta proteins due to their inefficient clearance at the blood-brain-barrier (BBB), places the neurovascular unit at the epicenter of AD pathophysiology. The objective of this study is to investigate cellular mechanisms mediating the internalization of A beta proteins in the principle constituents of the neurovascular unit, neurons and BBB endothelial cells. Laser confocal micrographs of wild type (WT) mouse brain slices treated with fluorescein labeled A beta 40 (F-A beta 40) demonstrated selective accumulation of the protein in a subpopulation of cortical and hippocampal neurons via nonsaturable, energy independent, and nonendocytotic pathways. This groundbreaking finding, which challenges the conventional belief that A beta proteins are internalized by neurons via receptor mediated endocytosis, was verified in differentiated PC12 cells and rat primary hippocampal (RPH) neurons through laser confocal microscopy and flow cytometry studies. Microscopy studies have demonstrated that a significant proportion of F-A beta 40 or F-A beta 42 internalized by differentiated PC12 cells or RPH neurons is located outside of the endosomal or lysosomal compartments, which may accumulate without degradation. In contrast, BBME cells exhibit energy dependent uptake of F-A beta 40, and accumulate the protein in acidic cell organelle, indicative of endocytotic uptake. Such a phenomenal difference in the internalization of A beta 40 between neurons and BBB endothelial cells may provide essential clues to understanding how various cells can differentially regulate Ab proteins and help explain the vulnerability of cortical and hippocampal neurons to A beta toxicity.	[Kandimalla, Karunya K.; Fulzele, Smita] Florida A&M Univ, Dept Basic Pharmaceut Sci, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Scott, Olenych G.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Scott, Olenych G.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Kandimalla, Karunya K.; Poduslo, Joseph F.] Mayo Clin, Coll Med, Dept Neurol Neurosci & Biochem Mol Biol, Mol Neurobiol Lab, Rochester, MN USA	State University System of Florida; Florida A&M University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Mayo Clinic	Kandimalla, KK (corresponding author), Florida A&M Univ, Dept Basic Pharmaceut Sci, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	karunya.kandimalla@famu.edu			NIH/NIGMS/MBRS [3S06GM008111-35S1]; NIH/NCRR/RCMI [G12RR03020]; NIH [R01 AG22034]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022034] Funding Source: NIH RePORTER	NIH/NIGMS/MBRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH/NIGMS/MBRS 3S06GM008111-35S1, NIH/NCRR/RCMI G12RR03020, and NIH R01 AG22034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attems J, 2007, J NEUROL SCI, V257, P49, DOI 10.1016/j.jns.2007.01.013; Bateman DA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-29; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; COLLINGRIDGE GL, 1995, J NEUROSCI METH, V59, P5, DOI 10.1016/0165-0270(94)00187-L; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Fukuda M, 2004, J BIOCHEM, V136, P245, DOI 10.1093/jb/mvh116; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gredell JA, 2004, BRIT J ANAESTH, V93, P810, DOI 10.1093/bja/aeh272; Gregory GC, 2005, NEUROTOX RES, V7, P29, DOI 10.1007/BF03033774; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Ji SR, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1283, DOI 10.1023/A:1021361607611; Kakio A, 2004, J PEPT SCI, V10, P612, DOI 10.1002/psc.570; Kandimalla KK, 2006, J PHARMACOL EXP THER, V318, P17, DOI 10.1124/jpet.105.095711; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Morelli L, 1999, CELL TISSUE RES, V298, P225, DOI 10.1007/s004419900109; Muller WE, 2001, BIOCHEM SOC T, V29, P617, DOI 10.1042/BST0290617; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Oshima K, 2006, ACTA NEUROPATHOL, V111, P510, DOI 10.1007/s00401-006-0070-z; Poduslo JF, 2001, NEUROBIOL DIS, V8, P555, DOI 10.1006/nbdi.2001.0402; Rensink AAM, 2003, BRAIN RES REV, V43, P207, DOI 10.1016/j.brainresrev.2003.08.001; SAAVEDRA L, 2007, J BIOL CHEM; Schmidt MC, 1998, BIOCHEMISTRY-US, V37, P16582, DOI 10.1021/bi981219h; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tashima Y, 2004, J BIOL CHEM, V279, P17587, DOI 10.1074/jbc.M308622200; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Waschuk SA, 2001, J BIOL CHEM, V276, P33561, DOI 10.1074/jbc.M103598200; Weller RO, 2005, ANN NEUROL, V58, P348, DOI 10.1002/ana.20622; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Xu HX, 1996, P NATL ACAD SCI USA, V93, P4081, DOI 10.1073/pnas.93.9.4081; YAO JK, NEUROCHEM R IN PRESS; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	47	58	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4627	10.1371/journal.pone.0004627	http://dx.doi.org/10.1371/journal.pone.0004627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247480	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487800009
J	Emtage, L; Chang, H; Tiver, R; Rongo, C				Emtage, Lesley; Chang, Howard; Tiver, Rebecca; Rongo, Christopher			MAGI-1 Modulates AMPA Receptor Synaptic Localization and Behavioral Plasticity in Response to Prior Experience	PLOS ONE			English	Article								It is well established that the efficacy of synaptic connections can be rapidly modified by neural activity, yet how the environment and prior experience modulate such synaptic and behavioral plasticity is only beginning to be understood. Here we show in C. elegans that the broadly conserved scaffolding molecule MAGI-1 is required for the plasticity observed in a glutamatergic circuit. This mechanosensory circuit mediates reversals in locomotion in response to touch stimulation, and the AMPA-type receptor (AMPAR) subunits GLR-1 and GLR-2, which are required for reversal behavior, are localized to ventral cord synapses in this circuit. We find that animals modulate GLR-1 and GLR-2 localization in response to prior mechanosensory stimulation; a specific isoform of MAGI-1 (MAGI-1L) is critical for this modulation. We show that MAGI-1L interacts with AMPARs through the intracellular domain of the GLR-2 subunit, which is required for the modulation of AMPAR synaptic localization by mechanical stimulation. In addition, mutations that prevent the ubiquitination of GLR-1 prevent the decrease in AMPAR localization observed in previously stimulated magi-1 mutants. Finally, we find that previously-stimulated animals later habituate to subsequent mechanostimulation more rapidly compared to animals initially reared without mechanical stimulation; MAGI-1L, GLR-1, and GLR-2 are required for this change in habituation kinetics. Our findings demonstrate that prior experience can cause long-term alterations in both behavioral plasticity and AMPAR localization at synapses in an intact animal, and indicate a new, direct role for MAGI/S-SCAM proteins in modulating AMPAR localization and function in the wake of variable sensory experience.	[Emtage, Lesley; Chang, Howard; Tiver, Rebecca; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Emtage, L (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08854 USA.	rongo@waksman.rutgers.edu		Chang, Howard/0000-0003-4310-8890	Pew Scholar in the Biomedical Sciences; NIH [R01 NS42023]; American Heart Association [0525968T]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	Pew Scholar in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	C.R. is a Pew Scholar in the Biomedical Sciences. Funding was provided by the NIH (to C.R.; R01 NS42023) and the American Heart Association (to L.E.; 0525968T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK CDO, 1995, LEARN MEMORY, V2, P161, DOI 10.1101/lm.2.3-4.161; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chang HCH, 2005, J CELL SCI, V118, P1945, DOI 10.1242/jcs.02320; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Giles AC, 2005, INT REV NEUROBIOL, V69, P37, DOI 10.1016/S0074-7742(05)69002-2; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; IIDA J, 2007, MOL CELL BIOL; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Mendoza-Topaz C, 2008, J NEUROSCI, V28, P304, DOI 10.1523/JNEUROSCI.4395-07.2008; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rose JK, 2003, J NEUROSCI, V23, P9595; Rose JK, 2002, LEARN MEMORY, V9, P130, DOI 10.1101/lm.46802; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Walker CS, 2006, P NATL ACAD SCI USA, V103, P10781, DOI 10.1073/pnas.0604482103; WHITE JG, 1984, PHILOS T R SOC LON B, V314, P1; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	46	33	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4613	10.1371/journal.pone.0004613	http://dx.doi.org/10.1371/journal.pone.0004613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242552	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487500015
J	Sukhorukov, VM; Bereiter-Hahn, J				Sukhorukov, Valerii M.; Bereiter-Hahn, Juergen			Anomalous Diffusion Induced by Cristae Geometry in the Inner Mitochondrial Membrane	PLOS ONE			English	Article								Diffusion of inner membrane proteins is a prerequisite for correct functionality of mitochondria. The complicated structure of tubular, vesicular or flat cristae and their small connections to the inner boundary membrane impose constraints on the mobility of proteins making their diffusion a very complicated process. Therefore we investigate the molecular transport along the main mitochondrial axis using highly accurate computational methods. Diffusion is modeled on a curvilinear surface reproducing the shape of mitochondrial inner membrane (IM). Monte Carlo simulations are carried out for topologies resembling both tubular and lamellar cristae, for a range of physiologically viable crista sizes and densities. Geometrical confinement induces up to several-fold reduction in apparent mobility. IM surface curvature per se generates transient anomalous diffusion (TAD), while finite and stable values of projected diffusion coefficients are recovered in a quasi-normal regime for short- and long-time limits. In both these cases, a simple area-scaling law is found sufficient to explain limiting diffusion coefficients for permeable cristae junctions, while asymmetric reduction of the junction permeability leads to strong but predictable variations in molecular motion rate. A geometry-based model is given as an illustration for the time-dependence of diffusivity when IM has tubular topology. Implications for experimental observations of diffusion along mitochondria using methods of optical microscopy are drawn out: a non-homogenous power law is proposed as a suitable approach to TAD. The data demonstrate that if not taken into account appropriately, geometrical effects lead to significant misinterpretation of molecular mobility measurements in cellular curvilinear membranes.	[Sukhorukov, Valerii M.; Bereiter-Hahn, Juergen] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany	Goethe University Frankfurt	Sukhorukov, VM (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany.	sukhorukov@kizefo.de	Sukhorukov, Valerii M/F-9735-2013		EU Integrated Project MiMage CT [2004-512020]	EU Integrated Project MiMage CT	This work has been financially supported by the EU Integrated Project MiMage CT 2004-512020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; BALAKRISHNAN V, 1995, PHYSICA A, V217, P1, DOI 10.1016/0378-4371(95)00083-J; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gustafsson S, 1997, J CHEM PHYS, V106, P1880, DOI 10.1063/1.473326; Hac AE, 2005, BIOPHYS J, V88, P317, DOI 10.1529/biophysj.104.040444; Halle B, 1997, PHYS REV E, V55, P680, DOI 10.1103/PhysRevE.55.680; HAUS JW, 1987, PHYS REP, V150, P263, DOI 10.1016/0370-1573(87)90005-6; HAVLIN S, 1987, ADV PHYS, V36, P695, DOI 10.1080/00018738700101072; Holyst R, 1999, PHYS REV E, V60, P302, DOI 10.1103/PhysRevE.60.302; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; KARP G, 2005, CELL MOL BIOL CONCEP; Kowald A, 2005, AGING CELL, V4, P273, DOI 10.1111/j.1474-9726.2005.00169.x; LENAZ G, 1988, J MEMBRANE BIOL, V104, P193, DOI 10.1007/BF01872322; MANNELLA CA, 1994, MICROSC RES TECHNIQ, V27, P278, DOI 10.1002/jemt.1070270403; More J. J., 1980, ANL8074, VIII; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; NAGLE JF, 1992, BIOPHYS J, V63, P366, DOI 10.1016/S0006-3495(92)81602-8; Naji A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2739526; PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Perkins GA, 2003, MOL VIS, V9, P60; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; REVATHI S, 1993, PHYS REV E, V47, P916, DOI 10.1103/PhysRevE.47.916; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Saxton MJ, 2008, BIOPHYS J, V94, P760, DOI 10.1529/biophysj.107.114074; Saxton MJ, 2007, BIOPHYS J, V92, P1178, DOI 10.1529/biophysj.106.092619; SAXTON MJ, 1987, BIOPHYS J, V52, P989, DOI 10.1016/S0006-3495(87)83291-5; SAXTON MJ, 1989, BIOPHYS J, V55, P21, DOI 10.1016/S0006-3495(89)82776-6; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sbalzarini IF, 2006, BIOPHYS J, V90, P878, DOI 10.1529/biophysj.105.073809; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; SCHNEIDER H, 1982, J BIOL CHEM, V257, P789; SJOSTRAND FS, 1956, INT REV CYTOL, V5, P455, DOI 10.1016/S0074-7696(08)62578-4; SOWERS AE, 1981, P NATL ACAD SCI-BIOL, V78, P6246, DOI 10.1073/pnas.78.10.6246; SOWERS E, 1985, BIOCHIM BIOPHYS ACTA, V821, P85; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; WEISS GH, 1986, PHYSICA A, V134, P474, DOI 10.1016/0378-4371(86)90060-9; Weiss M, 2003, BIOPHYS J, V84, P4043, DOI 10.1016/S0006-3495(03)75130-3; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012	51	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4604	10.1371/journal.pone.0004604	http://dx.doi.org/10.1371/journal.pone.0004604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242541	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487500009
J	Joo, YE; Karrasch, T; Muhlbauer, M; Allard, B; Narula, A; Herfarth, HH; Jobin, C				Joo, Young-Eun; Karrasch, Thomas; Muehlbauer, Marcus; Allard, Brigitte; Narula, Acharan; Herfarth, Hans H.; Jobin, Christian			Tomato Lycopene Extract Prevents Lipopolysaccharide-Induced NF-kappa B Signaling but Worsens Dextran Sulfate Sodium-Induced Colitis in NF-kappa B-EGFP Mice	PLOS ONE			English	Article								Background: The impact of tomato lycopene extract (TLE) on intestinal inflammation is currently unknown. We investigated the effect of TLE on lipopolysaccharide (LPS)-induced innate signaling and experimental colitis. Methodology/Principal Findings: Mice were fed a diet containing 0.5 and 2% TLE or isoflavone free control (AIN-76). The therapeutic efficacy of TLE diet was assessed using dextran sulfate sodium (DSS) exposed mice and IL-10(-/-); NF-kappa B-EGFP mice, representing an acute and spontaneous chronic colitis model respectively. A mini-endoscope was used to determine the extent of macroscopic mucosal lesions. Murine splenocytes and intestinal epithelial cells were used to determine the in vitro impact of TLE on LPS-induced NF-kappa B signaling. In vitro, TLE blocked LPS-induced IkB alpha degradation, RelA translocation, NFkB transcriptional activity and MIP-2 mRNA accumulation in IEC-18 cells. Moreover, LPS-induced IL-12p40 gene expression was dose-dependently inhibited in TLE-treated splenocytes. Interestingly, DSS-induced acute colitis worsened in TLE-fed NF-kappa B-EGFP mice compared to control diet as measured by weight loss, colonoscopic analysis and histological scores. In contrast, TLE-fed IL-10(-/-); NF-kappa B-EGFP mice displayed decreased colonic EGFP expression compared to control diet. IL-6, TNF alpha, and MCP-1 mRNA expression were increased in the colon of TLE-fed, DSS-exposed NF-kappa B-EGFP mice compared to the control diet. Additionally, caspase-3 activation and TUNEL positive cells were enhanced in TLE diet-fed, DSS-exposed mice as compared to DSS control mice. Conclusions/Significance: These results indicate that TLE prevents LPS-induced proinflammatory gene expression by blocking of NF-kappa B signaling, but aggravates DSS-induced colitis by enhancing epithelial cell apoptosis.	[Joo, Young-Eun; Karrasch, Thomas; Muehlbauer, Marcus; Allard, Brigitte; Herfarth, Hans H.; Jobin, Christian] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Joo, Young-Eun; Karrasch, Thomas; Muehlbauer, Marcus; Allard, Brigitte; Herfarth, Hans H.; Jobin, Christian] Univ N Carolina, Ctr Gastrointest Biol & Dis, Chapel Hill, NC USA; [Narula, Acharan] Narula Res, Chapel Hill, NC USA; [Jobin, Christian] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Joo, YE (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	job@med.unc.edu	Herfarth, Hans/K-7547-2019		NIH [ROI DK 47700, P30 DK034987]; American Institute of Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, P30DK034987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute of Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH ROI DK 47700 and the American Institute of Cancer Research grants to C. Jobin; by NIH P30 DK034987 to CGIBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, Drug Metabol Drug Interact, V17, P189; Agarwal S, 1998, LIPIDS, V33, P981, DOI 10.1007/s11745-998-0295-6; Arab L, 2000, AM J CLIN NUTR, V71, p1691S, DOI 10.1093/ajcn/71.6.1691S; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Giovannucci E, 2002, EXP BIOL MED, V227, P852, DOI 10.1177/153537020222701003; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heber D, 2002, EXP BIOL MED, V227, P920, DOI 10.1177/153537020222701013; Jobin C, 1997, J IMMUNOL, V158, P226; Jobin C, 1999, J IMMUNOL, V163, P3474; Karrasch T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000596; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; KENNEDY TA, 1992, J BIOL CHEM, V267, P4658; Kim GY, 2004, IMMUNOLOGY, V113, P203, DOI 10.1111/j.1365-2567.2004.01945.x; Kim JS, 2005, IMMUNOLOGY, V115, P375, DOI 10.1111/j.1365-2567.2005.02156.x; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Nguyen ML, 1999, FOOD TECHNOL-CHICAGO, V53, P38; Paul G, 2005, CLIN EXP IMMUNOL, V140, P547, DOI 10.1111/j.1365-2249.2005.02775.x; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rao AV, 1998, NUTR CANCER, V31, P199, DOI 10.1080/01635589809514703; Rao AVR, 2000, J AM COLL NUTR, V19, P563, DOI 10.1080/07315724.2000.10718953; Reifen R, 2004, J GASTROENTEROL, V39, P514, DOI 10.1007/s00535-003-1336-z; Roberfroid MB, 2000, AM J CLIN NUTR, V71, p1696S; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Stahl W, 1998, FEBS LETT, V427, P305, DOI 10.1016/S0014-5793(98)00434-7; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; Tordoff MG, 2002, J NUTR, V132, P2288, DOI 10.1093/jn/132.8.2288; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	34	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4562	10.1371/journal.pone.0004562	http://dx.doi.org/10.1371/journal.pone.0004562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234608	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487200016
J	Kostal, V; Tollarova-Borovanska, M				Kostal, Vladimir; Tollarova-Borovanska, Michaela			The 70 kDa Heat Shock Protein Assists during the Repair of Chilling Injury in the Insect, Pyrrhocoris apterus	PLOS ONE			English	Article								Background: The Pyrrhocoris apterus (Insecta: Heteroptera) adults attain high levels of cold tolerance during their overwintering diapause. Non-diapause reproducing adults, however, lack the capacity to express a whole array of cold-tolerance adaptations and show relatively low survival when exposed to sub-zero temperatures. We assessed the competence of non-diapause males of P. apterus for responding to heat-and cold-stresses by up-regulation of 70 kDa heat shock proteins (Hsps) and the role of Hsps during repair of heat-and cold-induced injury. Principal Findings: The fragments of P. apterus homologues of Hsp70 inducible (PaHsp70) and cognate forms (PaHsc70) were cloned and sequenced. The abundance of mRNA transcripts for the inducible form (qPCR) and corresponding protein (Western blotting) were significantly up-regulated in response to high and low temperature stimuli. In the cognate form, mRNA was slightly up-regulated in response to both stressors but very low or no up-regulation of protein was apparent after heat-or cold-stress, respectively. Injection of 695 bp-long Pahsp70 dsRNA (RNAi) caused drastic suppression of the heat-and cold-stress-induced Pahsp70 mRNA response and the up-regulation of corresponding protein was practically eliminated. Our RNAi predictably prevented recovery from heat shock and, in addition, negatively influenced repair of chilling injuries caused by cold stress. Cold tolerance increased when the insects were first exposed to a mild heat shock, in order to trigger the up-regulation of PaHsp70, and subsequently exposed to cold stress. Conclusion: Our results suggest that accumulation of PaHsp70 belongs to a complex cold tolerance adaptation in the insect Pyrrhocoris apterus.	[Kostal, Vladimir; Tollarova-Borovanska, Michaela] Acad Sci Czech Republ, Inst Entomol, Biol Ctr ASCR, CR-37005 Ceske Budejovice, Czech Republic; [Kostal, Vladimir; Tollarova-Borovanska, Michaela] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Kostal, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Biol Ctr ASCR, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	kostal@entu.cas.cz	Kostal, Vladimir/G-6688-2014; Borovanska, Michaela/D-1263-2016	Kostal, Vladimir/0000-0002-4994-5123; 	Czech Science Foundation [206/07/0269]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Czech Science Foundation Grant No. 206/07/0269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Chen B, 2006, J BIOCHEM MOL BIOL, V39, P749; CRAIG EA, 1994, CELL, V78, P365, DOI 10.1016/0092-8674(94)90416-2; Danks HV, 1996, EUR J ENTOMOL, V93, P383; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Goto SG, 1998, J INSECT PHYSIOL, V44, P1233, DOI 10.1016/S0022-1910(98)00101-2; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; HODEK I, 1968, ACTA ENTOMOL BOHEMOS, V65, P422; Hodkova M, 1997, CRYOBIOLOGY, V34, P70, DOI 10.1006/cryo.1996.1985; Hodkova M, 2002, J INSECT PHYSIOL, V48, P1009, DOI 10.1016/S0022-1910(02)00188-9; HOLMSTRUP M, 1994, J COMP PHYSIOL B, V164, P312, DOI 10.1007/BF00346448; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2004, PHYSIOL ENTOMOL, V29, P344, DOI 10.1111/j.0307-6962.2004.00396.x; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kostal V, 2001, COMP BIOCHEM PHYS B, V130, P365, DOI 10.1016/S1096-4959(01)00441-9; Kostal V, 2000, J INSECT PHYSIOL, V46, P1321, DOI 10.1016/S0022-1910(00)00056-1; Kostal V, 2008, J INSECT PHYSIOL, V54, P77, DOI 10.1016/j.jinsphys.2007.08.004; Lee R.E. Jr, 1991, P17; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Liang P, 1997, J CELL SCI, V110, P1431; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podrabsky JE, 2007, CELL STRESS CHAPERON, V12, P199, DOI 10.1379/CSC-280.1; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; Renault D, 2002, CRYOLETTERS, V23, P217; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Schill RO, 2006, J EXP ZOOL PART A, V305A, P449, DOI 10.1002/jez.a.281; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Sejerkilde M, 2003, J INSECT PHYSIOL, V49, P719, DOI 10.1016/S0022-1910(03)00095-7; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; Slachta M, 2002, EUR J ENTOMOL, V99, P181, DOI 10.14411/eje.2002.026; SLAMA K, 1964, J INSECT PHYSIOL, V10, P283, DOI 10.1016/0022-1910(64)90013-7; SOCHA R, 1992, PHYSIOL ENTOMOL, V17, P370, DOI 10.1111/j.1365-3032.1992.tb01034.x; Storey K.B., 1991, P64; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Tsai CJ, 2002, CRIT REV BIOCHEM MOL, V37, P55, DOI 10.1080/10409230290771456; Yocum GD, 2006, J INSECT PHYSIOL, V52, P1113, DOI 10.1016/j.jinsphys.2006.07.010; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; [No title captured]	57	117	127	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4546	10.1371/journal.pone.0004546	http://dx.doi.org/10.1371/journal.pone.0004546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229329	Green Published, gold, Green Submitted			2022-12-27	WOS:000265486200017
J	Boggio, PS; Fregni, F; Valasek, C; Ellwood, S; Chi, R; Gallate, J; Pascual-Leone, A; Snyder, A				Boggio, Paulo S.; Fregni, Felipe; Valasek, Claudia; Ellwood, Sophie; Chi, Richard; Gallate, Jason; Pascual-Leone, Alvaro; Snyder, Allan			Temporal Lobe Cortical Electrical Stimulation during the Encoding and Retrieval Phase Reduces False Memories	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DC BRAIN POLARIZATION; HUMAN MOTOR CORTEX; SEMANTIC DEMENTIA; FUTURE; EXCITABILITY; BEHAVIOR; ATROPHY; LESIONS; HUMANS	A recent study found that false memories were reduced by 36% when low frequency repetitive transcranial magnetic stimulation (rTMS) was applied to the left anterior temporal lobe after the encoding (study) phase. Here we were interested in the consequences on a false memory task of brain stimulation throughout the encoding and retrieval task phases. We used transcranial direct current stimulation (tDCS) because it has been shown to be a useful tool to enhance cognition. Specifically, we examined whether tDCS can induce changes in a task assessing false memories. Based on our preliminary results, three conditions of stimulation were chosen: anodal left/cathodal right anterior temporal lobe (ATL) stimulation ("bilateral stimulation''); anodal left ATL stimulation (with a large contralateral cathodal electrode - referred as "unilateral stimulation'') and sham stimulation. Our results showed that false memories were reduced significantly after the two active conditions (unilateral and bilateral stimulation) as compared with sham stimulation. There were no significant changes in veridical memories. Our findings show that false memories are reduced by 73% when anodal tDCS is applied to the anterior temporal lobes throughout the encoding and retrieval stages, suggesting a possible strategy for improving certain aspects of learning.	[Fregni, Felipe; Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Dept Neurol,Med Sch, Boston, MA 02215 USA; [Boggio, Paulo S.; Valasek, Claudia] Univ Prebiteriana Mackenzie, Cognitive Neurosci Lab, Sao Paulo, Brazil; [Boggio, Paulo S.; Valasek, Claudia] Univ Prebiteriana Mackenzie, Ctr Hlth & Biol Sci, Dev Disorders Program, Sao Paulo, Brazil; [Ellwood, Sophie; Chi, Richard; Gallate, Jason; Snyder, Allan] Univ Sydney, Ctr Mind, Sydney, NSW 2006, Australia	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; University of Sydney	Boggio, PS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Dept Neurol,Med Sch, Boston, MA 02215 USA.	boggio@mackenzie.br; ffregni@bidmc.harvard.edu	Boggio, Paulo S/K-6272-2012; Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Boggio, Paulo S/0000-0002-6109-0447; Pascual-Leone, Alvaro/0000-0001-8975-0382; Ellwood, Sophie/0000-0002-9530-7253; Fregni, Felipe/0000-0001-9359-8643	Harvard Club of Australia foundation; CNPQ	Harvard Club of Australia foundation; CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	There was limited partial support to this study - from (i) Harvard Club of Australia foundation that funded the trip of F.F. to A.S. laboratory as to finalize this paper and (2) support for research assistant from CNPQ - Brazilian funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2004, NEUROREPORT, V15, P2491, DOI 10.1097/00001756-200411150-00012; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Beversdorf DQ, 2000, P NATL ACAD SCI USA, V97, P8734, DOI 10.1073/pnas.97.15.8734; Brainerd CJ, 2007, PSYCHOL SCI, V18, P442, DOI 10.1111/j.1467-9280.2007.01919.x; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; FRITH U, 2003, AUTISM MIND BRAIN; Gainotti G, 2007, NEUROPSYCHOLOGIA, V45, P1591, DOI 10.1016/j.neuropsychologia.2006.12.013; Gallate J, 2009, NEUROSCI LETT, V449, P151, DOI 10.1016/j.neulet.2008.11.021; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Holliday RE, 2006, MEMORY, V14, P624, DOI 10.1080/09658210600736525; Hou C, 2000, NEUROPSY NEUROPSY BE, V13, P29; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Loftus E, 2003, NAT REV NEUROSCI, V4, P231, DOI 10.1038/nrn1054; McDermott KB, 1999, MEMORY, V7, P661; Miller BL, 1998, NEUROLOGY, V51, P978, DOI 10.1212/WNL.51.4.978; Mummery CJ, 2000, ANN NEUROL, V47, P36; NITSCHE M, 2008, BRAIN STIMUL, P206; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pobric G, 2008, J COGNITIVE NEUROSCI, V20, P170, DOI 10.1162/jocn.2008.20005; Pobric G, 2007, P NATL ACAD SCI USA, V104, P20137, DOI 10.1073/pnas.0707383104; Rosso SM, 2001, J NEUROL, V248, P965, DOI 10.1007/s004150170049; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Snyder Allan, 2004, Journal of Integrative Neuroscience, V3, P31, DOI 10.1142/S0219635204000361; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001	33	76	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4959	10.1371/journal.pone.0004959	http://dx.doi.org/10.1371/journal.pone.0004959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PK	19319182	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499200008
J	Zinner, D; Arnold, ML; Roos, C				Zinner, Dietmar; Arnold, Michael L.; Roos, Christian			Is the New Primate Genus Rungwecebus a Baboon?	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MITOCHONDRIAL PHYLOGENY; HYBRIDIZATION PATTERNS; UPPER MIOCENE; DNA; EVOLUTION; KIPUNJI; AFFINITIES; INFERENCE; CLIMATE	Background: In 2005, a new primate species from Tanzania, the kipunji, was described and recognized as a member of the mangabey genus Lophocebus. However, molecular investigations based upon a number of papionins, including a limited sample of baboons of mainly unknown geographic origin, identified the kipunji as a sister taxon to Papio and not as a member of Lophocebus. Accordingly, the kipunji was separated into its own monotypic genus, Rungwecebus. Methodology/Principal Findings: We compare available mitochondrial and nuclear sequence data from the voucher specimen of Rungwecebus to other papionin lineages, including a set of geographically proximal (parapatric) baboon samples. Based on mitochondrial sequence data the kipunji clusters with baboon lineages that lie nearest to it geographically, i.e. populations of yellow and chacma baboons from south-eastern Africa, and thus does not represent a sister taxon to Papio. Nuclear data support a Papio+Rungwecebus clade, but it remains questionable whether Rungwecebus represents a sister taxon to Papio, or whether it is nested within the genus as depicted by the mitochondrial phylogeny. Conclusions/Significance: Our study clearly supports a close relationship between Rungwecebus and Papio and might indicate that the kipunji is congeneric with baboon species. However, due to its morphological and ecological uniqueness Rungwecebus more likely represents a sister lineage to Papio and experienced later introgressive hybridization. Presumably, male (proto-)kipunjis reproduced with sympatric female baboons. Subsequent backcrossing of the hybrids with kipunjis would have resulted in a population with a nuclear kipunji genome, but which retained the yellow/chacma baboon mitochondrial genome. Since only one kipunji specimen was studied, it remains unclear whether all members of the new genus have been impacted by intergeneric introgression or rather only some populations. Further studies with additional Rungwecebus samples are necessary to elucidate the complete evolutionary history of this newly-described primate genus.	[Zinner, Dietmar; Roos, Christian] Deutsch Primatenzentrum GmbH, Gottingen, Germany; [Arnold, Michael L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Deutsches Primatenzentrum (DPZ); University System of Georgia; University of Georgia	Zinner, D (corresponding author), Deutsch Primatenzentrum GmbH, Gottingen, Germany.	dzinner@gwdg.de			German Science Foundation [DFG ZI 548/3-1]; National Science Foundation [DEB-0345123]	German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	German Science Foundation Grant (DFG ZI 548/3-1) supported DZ. National Science Foundation Grant DEB-0345123 supported MLA. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2001, AM J PRIMATOL, V53, P139, DOI 10.1002/ajp.1; [Anonymous], 2006, THESIS U TEXAS AUSTI; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Arnold ML, 2008, RETICULATE EVOLUTION AND HUMANS: ORIGINS AND ECOLOGY, P1, DOI 10.1093/acprof:oso/9780199539581.001.0001; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; BURRELL A, 2008, PHYLOGENETICS POPULA; Chakraborty D, 2007, MOL PHYLOGENET EVOL, V44, P838, DOI 10.1016/j.ympev.2007.04.007; Davenport TRB, 2008, ORYX, V42, P352, DOI 10.1017/S0030605308000422; Davenport TRB, 2006, SCIENCE, V312, P1378, DOI 10.1126/science.1125631; DELSON E, 1993, THEROPITHECUS, P157, DOI 10.1017/CBO9780511565540.006; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUNBAR RIM, 1974, J HUM EVOL, V3, P187, DOI 10.1016/0047-2484(74)90176-6; Ehardt Carloyn L., 2006, Primate Conservation, V21, P81, DOI 10.1896/0898-6207.21.1.81; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Gautier-Hion A., 1999, HIST NATURELLE PRIMA; Goossens Benoit, 2000, Conservation Genetics, V1, P157, DOI 10.1023/A:1026535006318; Groves C.P., 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Harris EE, 1998, MOL BIOL EVOL, V15, P892, DOI 10.1093/oxfordjournals.molbev.a025993; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holliday TW, 2003, CURR ANTHROPOL, V44, P653, DOI 10.1086/377663; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jablonski N.G., 1993, THEROPITHECUS RISE F; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Jolly CJ, 1997, INT J PRIMATOL, V18, P597, DOI 10.1023/A:1026367307470; Jones T, 2005, SCIENCE, V308, P1161, DOI 10.1126/science.1109191; Karanth KP, 2005, P NATL ACAD SCI USA, V102, P5090, DOI 10.1073/pnas.0408354102; Kingdon J., 1997, KINGDON FIELDGUIDE A; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lorenz JG, 2005, PHILOS T R SOC B, V360, P1869, DOI 10.1098/rstb.2005.1718; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Newman TK, 2004, AM J PHYS ANTHROPOL, V124, P17, DOI 10.1002/ajpa.10340; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Olson LE, 2008, MOL PHYLOGENET EVOL, V48, P789, DOI 10.1016/j.ympev.2008.04.031; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; RAMBAUT A, 2006, FIGREE TREE FIGURE D; RAMBAUT A, 2005, TRACER V1 3 MCMC TRA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2008, MOL PHYLOGENET EVOL, V47, P629, DOI 10.1016/j.ympev.2008.03.006; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Singleton M, 2009, J HUM EVOL, V56, P25, DOI 10.1016/j.jhevol.2008.07.012; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tattersall I, 1999, P NATL ACAD SCI USA, V96, P7117, DOI 10.1073/pnas.96.13.7117; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; Tung J, 2008, MOL ECOL, V17, P1998, DOI 10.1111/j.1365-294X.2008.03723.x; Turner A, 1999, HUMAN EVOLUT SER, P76; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wildman DE, 2004, MOL PHYLOGENET EVOL, V32, P287, DOI 10.1016/j.ympev.2003.12.014; ZINNER D, 2001, MITOCHONDRIAL UNPUB; ZINNER D, PRIMATES GA IN PRESS; Zinner Dietmar, 2008, Zoologische Garten, V77, P303, DOI 10.1016/j.zoolgart.2008.05.002	63	59	62	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4859	10.1371/journal.pone.0004859	http://dx.doi.org/10.1371/journal.pone.0004859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OL	19295908	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496700002
J	Kilner, JM; Marchant, JL; Frith, CD				Kilner, James M.; Marchant, Jennifer L.; Frith, Chris D.			Relationship between Activity in Human Primary Motor Cortex during Action Observation and the Mirror Neuron System	PLOS ONE			English	Article							CORTICAL OSCILLATORY ACTIVITY; S-R COMPATIBILITY; PREMOTOR CORTEX; FACILITATION; IMITATION; MODULATION; MOVEMENT; REPRESENTATIONS; LATERALIZATION; PERCEPTION	The attenuation of the beta cortical oscillations during action observation has been interpreted as evidence of a mirror neuron system (MNS) in humans. Here we investigated the modulation of beta cortical oscillations with the viewpoint of an observed action. We asked subjects to observe videos of an actor making a variety of arm movements. We show that when subjects were observing arm movements there was a significant modulation of beta oscillations overlying left and right sensorimotor cortices. This pattern of attenuation was driven by the side of the screen on which the observed movement occurred and not by the hand that was observed moving. These results are discussed in terms of the firing patterns of mirror neurons in F5 which have been reported to have similar properties.	[Kilner, James M.; Marchant, Jennifer L.; Frith, Chris D.] Wellcome Trust Ctr Neuroimaging, London, England; [Frith, Chris D.] Univ Aarhus, CFIN, Niels Bohr Project Interacting Minds, DK-8000 Aarhus, Denmark	University of London; University College London; Aarhus University	Kilner, JM (corresponding author), Wellcome Trust Ctr Neuroimaging, London, England.	j.kilner@fil.ion.ucl.ac.uk	Kilner, James M/A-2040-2010; Frith, Chris/A-2171-2009	Kilner, James/0000-0002-6632-6797; Frith, Chris/0000-0002-8665-0690	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	This work was funded by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2003, EXP BRAIN RES, V148, P17, DOI 10.1007/s00221-002-1255-x; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GATTIS M, 2002, IMITATIVE MIND DEV E, P183, DOI DOI 10.1017/CBO9780511489969; GAZZOLA V, 2008, CEREB CORTE IN PRESS; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Heyes C, 2004, PSYCHON B REV, V11, P703, DOI 10.3758/BF03196623; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kiebel S, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P211, DOI 10.1016/B978-012372560-8/50016-4; Kilner J, 2005, EUR J NEUROSCI, V21, P2547, DOI 10.1111/j.1460-9568.2005.04069.x; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kilner JM, 2007, NEUROREPORT, V18, P619, DOI 10.1097/WNR.0b013e3281139ed0; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Kilner JM, 2003, NEUROIMAGE, V18, P67, DOI 10.1006/nimg.2002.1322; Kilner JM, 2000, J NEUROSCI, V20, P8838; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Morin O, 2008, NEUROPHYSIOL CLIN, V38, P189, DOI 10.1016/j.neucli.2008.02.005; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257	51	71	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4925	10.1371/journal.pone.0004925	http://dx.doi.org/10.1371/journal.pone.0004925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290052	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496500019
J	Koestler, SA; Rottner, K; Lai, F; Block, J; Vinzenz, M; Small, V				Koestler, Stefan A.; Rottner, Klemens; Lai, Frank; Block, Jennifer; Vinzenz, Marlene; Small, Victor			F- and G-Actin Concentrations in Lamellipodia of Moving Cells	PLOS ONE			English	Article								Cells protrude by polymerizing monomeric (G) into polymeric (F) actin at the tip of the lamellipodium. Actin filaments are depolymerized towards the rear of the lamellipodium in a treadmilling process, thereby supplementing a G-actin pool for a new round of polymerization. In this scenario the concentrations of F- and G-actin are principal parameters, but have hitherto not been directly determined. By comparing fluorescence intensities of bleached and unbleached regions of lamellipodia in B16-F1 mouse melanoma cells expressing EGFP-actin, before and after extraction with Triton X-100, we show that the ratio of F- to G-actin is 3.2+/-0.9. Using electron microscopy to determine the F- actin content, this ratio translates into F- and G-actin concentrations in lamellipodia of approximately 500 mu M and 150 mu M, respectively. The excess of G-actin, at several orders of magnitude above the critical concentrations at filament ends indicates that the polymerization rate is not limited by diffusion and is tightly controlled by polymerization/ depolymerization modulators.	[Koestler, Stefan A.; Vinzenz, Marlene; Small, Victor] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Rottner, Klemens; Lai, Frank; Block, Jennifer] Helmholtz Ctr Infect Res HZI, Cytoskeleton Dynam Grp, Braunschweig, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Helmholtz Association; Helmholtz-Center for Infection Research	Small, V (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria.	vic.small@imba.oeaw.ac.at		Rottner, Klemens/0000-0003-4244-4198; Koestler, Stefan/0000-0002-7223-8291	Human Frontier Science Program Organisation (HFSPO); The Vienna Science Research and Technology Fund (WWTF); The City of Vienna/Zentrum fur Innovation und Technologie; Deutsche Forschungsgemeinschaft [FOR629]	Human Frontier Science Program Organisation (HFSPO)(Human Frontier Science Program); The Vienna Science Research and Technology Fund (WWTF); The City of Vienna/Zentrum fur Innovation und Technologie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Human Frontier Science Program Organisation (HFSPO); The Vienna Science Research and Technology Fund (WWTF); The City of Vienna/Zentrum fur Innovation und Technologie via the Spot of Excellence grant Center of Molecular and Cellular Nanostructure. KR was supported in part by the Deutsche Forschungsgemeinschaft (FOR629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1970, EXP CELL RES, V59, P393, DOI 10.1016/0014-4827(70)90646-4; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; BLIKSTAD I, 1978, CELL, V15, P935, DOI 10.1016/0092-8674(78)90277-5; BRAY D, 1976, J MOL BIOL, V105, P527, DOI 10.1016/0022-2836(76)90233-3; CHEN WT, 1981, J CELL BIOL, V90, P187, DOI 10.1083/jcb.90.1.187; Dunn GA, 1980, CELL ADHESION MOTILI, P409; FECHHEIMER M, 1983, CELL MOTIL CYTOSKEL, V3, P349, DOI 10.1002/cm.970030406; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; HEACOCK CS, 1984, EXP CELL RES, V153, P402, DOI 10.1016/0014-4827(84)90609-8; Hoglund A S, 1980, J Muscle Res Cell Motil, V1, P127, DOI 10.1007/BF00711795; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; MOSELARSEN P, 1982, CELL, V31, P681, DOI 10.1016/0092-8674(82)90323-3; Novak IL, 2008, BIOPHYS J, V95, P1627, DOI 10.1529/biophysj.108.130096; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	25	87	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4810	10.1371/journal.pone.0004810	http://dx.doi.org/10.1371/journal.pone.0004810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277198	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496100027
J	Machado, ES; Afonso, AO; Nissley, DV; Lemey, P; Cunha, SM; Oliveira, RH; Soares, MA				Machado, Elizabeth S.; Afonso, Adriana O.; Nissley, Dwight V.; Lemey, Philippe; Cunha, Silvia M.; Oliveira, Ricardo H.; Soares, Marcelo A.			Emergency of Primary NNRTI Resistance Mutations without Antiretroviral Selective Pressure in a HAART-Treated Child	PLOS ONE			English	Article								Objective: The use of antiretrovirals (ARV) during pregnancy has drastically reduced the rate of the human immunodeficiency virus perinatal transmission (MTCT). As a consequence of widespread ARV use, transmission of drug resistant strains from mothers to their babies is increasing. Ultra-sensitive PCR techniques have permitted the quantification of minority viral populations, but little is known about the transmission of drug-resistant HIV-1 minority population in the setting of MTCT. Methodology/Principal Findings: We describe the case of a female child born to an HIV-infected mother, which had not taken any ARV during the pregnancy. The child's first genotype demonstrated a minor non-nucleoside reverse transcriptase inhibitor (K101E), and during her treatment with reverse transcriptase and protease inhibitors full resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI) emerged (G190A). Phenotypic/genotypic analysis of variant quasispecies through yeast TyHRT assay was conducted to characterize minority resistant viral strains circulating in both mother and child. Maximum likelihood and Bayesian MCMC phylogenetic analyses were performed with samples from the pair to assess genetic relatedness among minor viral strains. The analysis showed that the child received a minor NNRTI resistant variant, containing the mutation K101E that was present in less than 1% of the mother's quasispecies. Phylogenetic analyses have suggested common ancestry between the mother's virus strain carrying K101E with the viral sequences from the child. Conclusion: This is the first documentation of MTCT of a minority resistant strain of HIV-1. The transmission of minor resistant variants carries the threat of emergence of multi-drug primary mutations without identified specific selective pressures.	[Machado, Elizabeth S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil; [Machado, Elizabeth S.; Afonso, Adriana O.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Nissley, Dwight V.] NCI, NIH, Gene Regulat & Chromosome Biol Lab, Frederick, MD USA; [Nissley, Dwight V.] NCI, SAIC Frederick Inc, NIH, Basic Sci Program, Frederick, MD USA; [Lemey, Philippe] Univ Oxford, Dept Zool, Oxford OX1 2JD, England; [Cunha, Silvia M.; Oliveira, Ricardo H.] Univ Fed Rio de Janeiro, Inst Puericult Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Soares, Marcelo A.] Inst Nacl Canc, Div Genet, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Oxford; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Machado, ES (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.	masoares@biologia.ufrj.br	Soares, Marcelo A/G-5662-2010; Lemey, Philippe/C-3755-2018	Lemey, Philippe/0000-0003-2826-5353	National Institutes of Health [R01 HD37780-01]; Brazilian Ministry of Health; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); National Cancer Institute, National Institutes of Health [N01-CO-12400]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazilian Ministry of Health; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study has been funded by grants of the National Institutes of Health R01 HD37780-01 (U.S.A.), by the Brazilian Ministry of Health and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Research Grant to ESM. This project has been also partly funded with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacheler L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001; Bauer GR, 2006, AIDS, V20, P1707, DOI 10.1097/01.aids.0000242816.80462.81; Colgrove RC, 1998, AIDS, V12, P2281, DOI 10.1097/00002030-199817000-00009; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Iglesias-Ussel MD, 2002, J GEN VIROL, V83, P93, DOI 10.1099/0022-1317-83-1-93; Johnson VA, 2001, J INFECT DIS, V183, P1688, DOI 10.1086/320697; Kamkamidze G, 2001, J CLIN VIROL, V22, P143, DOI 10.1016/S1386-6532(01)00178-0; Karchava M, 2006, JAIDS-J ACQ IMM DEF, V42, P614, DOI 10.1097/01.qai.0000225871.87456.e7; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Llibre JM, 2008, J ANTIMICROB CHEMOTH, V62, P909, DOI 10.1093/jac/dkn297; Martinson NA, 2007, JAIDS-J ACQ IMM DEF, V44, P148, DOI 10.1097/QAI.0b013e31802b920e; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Nissley DV, 1998, P NATL ACAD SCI USA, V95, P13905, DOI 10.1073/pnas.95.23.13905; NISSLEY DV, 1996, NATURE, V380, P330; Schmitz T, 2006, PEDIATR INFECT DIS J, V25, P275, DOI 10.1097/01.inf.0000202142.34502.5e; WANG J, 2007, 14 C RETR OPP INF LO	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4806	10.1371/journal.pone.0004806	http://dx.doi.org/10.1371/journal.pone.0004806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277127	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496100023
J	Stauch, D; Dernier, A; Marchese, ES; Kunert, K; Volk, HD; Pratschke, J; Kotsch, K				Stauch, Diana; Dernier, Annelie; Marchese, Elizabeth Sarmiento; Kunert, Kristina; Volk, Hans-Dieter; Pratschke, Johann; Kotsch, Katja			Targeting of Natural Killer Cells by Rabbit Antithymocyte Globulin and Campath-1H: Similar Effects Independent of Specificity	PLOS ONE			English	Article								T cell depleting strategies are an integral part of immunosuppressive regimens widely used in the hematological and solid organ transplant setting. Although it is known to induce lymphocytopenia, little is known about the effects of the polyclonal rabbit antithymocyte globulin (rATG) or the monoclonal anti-CD52 antibody alemtuzumab on Natural Killer (NK) cells in detail. Here, we demonstrate that induction therapy with rATG following kidney/pancreas transplantation results in a rapid depletion of NK cells. Treatment of NK cells with rATG and alemtuzumab in vitro leads to impairment of cytotoxicity and induction of apoptosis even at a 10-fold lower concentration (0.1 mu g/ml) compared with T and B cells. By generating Fc-parts of rATG and alemtuzumab we illustrate that their ligation to Fc gamma RIII (CD16) is sufficient for the significant induction of degranulation, apoptosis and inflammatory cytokine release (FasL, TNF alpha and IFN gamma) exclusively in CD3(-)CD56(dim) NK cells whereas application of rATG and alemtuzumab F(ab) fragments abolishes these effects. These findings are of general importance as our data suggest that NK cells are also mediators of the clinically relevant cytokine release syndrome and that their targeting by therapeutic antibodies should be considered as they are functionally relevant for the effective clearance of opportunistic viral infections and anti-tumor activity posttransplantation.	[Stauch, Diana; Dernier, Annelie; Kunert, Kristina; Volk, Hans-Dieter; Kotsch, Katja] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Marchese, Elizabeth Sarmiento] Hosp Gen Univ Gregorio Maranon, Dept Immunol, Madrid, Spain; [Pratschke, Johann] Charite Universitatsmed, Dept Surg, Campus Virchow, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; General University Gregorio Maranon Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stauch, D (corresponding author), Charite, Inst Med Immunol, Campus Mitte, D-13353 Berlin, Germany.	katja.kotsch@charite.de	Kotsch, Katja/AAG-2597-2021; volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Sarmiento, Elizabeth/0000-0001-8435-8912; Stauch, Diana/0000-0002-3922-4250	Genzyme; Deutsche Forschungsgemeinschaft [PR 578/2-3]; Instituto de Salud Carlos III, Madrid, Spain	Genzyme(Sanofi-AventisGenzyme Corporation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III)	This study was supported in part by research funding from Genzyme to K.K. and a grant from the Deutsche Forschungsgemeinschaft (DFG PR 578/2-3) to J.P. E.S. was funded by the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bloom DD, 2008, AM J TRANSPLANT, V8, P793, DOI 10.1111/j.1600-6143.2007.02134.x; BONNEFOYBERARD N, 1991, TRANSPLANTATION, V51, P669, DOI 10.1097/00007890-199103000-00024; Buggins AGS, 2002, BLOOD, V100, P1715, DOI 10.1182/blood.V100.5.1715.h81702001715_1715_1720; Calistri E, 2006, AM J HEMATOL, V81, P355, DOI 10.1002/ajh.20560; Chakrabarti S, 2002, BLOOD, V99, P4357, DOI 10.1182/blood.V99.12.4357; Chiossone L, 2007, BLOOD, V109, P3767, DOI 10.1182/blood-2006-07-037846; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cohen-Solal JLF, 2004, IMMUNOL LETT, V92, P199, DOI 10.1016/j.imlet.2004.01.012; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Eischen CM, 1996, J IMMUNOL, V156, P2693; Esposito L, 2005, TRANSPL P, V37, P785, DOI 10.1016/j.transproceed.2004.12.200; Feng XM, 2008, BLOOD, V111, P3675, DOI 10.1182/blood-2008-01-130146; Fischer L, 2006, EXP HEMATOL, V34, P753, DOI 10.1016/j.exphem.2006.02.015; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Genestier L, 1998, BLOOD, V91, P2360, DOI 10.1182/blood.V91.7.2360.2360_2360_2368; Gillet-Hladky S, 2006, TRANSPLANTATION, V82, P965, DOI 10.1097/01.tp.0000235549.47976.d0; Guttmann RD, 1997, TRANSPLANT P, V29, pS24, DOI 10.1016/S0041-1345(97)00627-1; Haidinger M, 2007, TRANSPLANTATION, V84, P117, DOI 10.1097/01.tp.0000266677.45428.80; Hale G, 2002, BONE MARROW TRANSPL, V30, P797, DOI 10.1038/sj.bmt.1703733; Hardinger KL, 2004, TRANSPLANTATION, V78, P136, DOI 10.1097/01.TP.0000132329.67611.3F; Kaufman DB, 2006, AM J TRANSPLANT, V6, P331, DOI 10.1111/j.1600-6143.2005.01166.x; Kaufman DB, 2005, AM J TRANSPLANT, V5, P2539, DOI 10.1111/j.1600-6143.2005.01067.x; Knechtle SJ, 2004, SURGERY, V136, P754, DOI 10.1016/j.surg.2004.06.015; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; MCSWEENEY PA, BLOOD, V100, P1602; Michallet MC, 2003, TRANSPLANTATION, V75, P657, DOI 10.1097/01.TP.0000053198.99206.E6; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Moreau T, 1996, Mult Scler, V1, P357; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Morris EC, 2003, BLOOD, V102, P404, DOI 10.1182/blood-2002-09-2687; Muller TF, 1997, TRANSPLANTATION, V64, P1432; Nashan B, 2005, BIODRUGS, V19, P39, DOI 10.2165/00063030-200519010-00005; Naujokat C, 2007, TRANSPLANTATION, V83, P485, DOI 10.1097/01.tp.0000251975.81281.22; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nuckel H, 2005, EUR J PHARMACOL, V514, P217, DOI 10.1016/j.ejphar.2005.03.024; Oertel M, 2002, TRANSPL INT, V15, P463, DOI 10.1111/j.1432-2277.2002.tb00201.x; Penack O, 2007, TRANSPL IMMUNOL, V18, P85, DOI 10.1016/j.trim.2007.05.001; PERUSSIA B, 1984, J IMMUNOL, V133, P180; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Regan JF, 2001, TRANSPL IMMUNOL, V9, P29, DOI 10.1016/S0966-3274(01)00048-X; Remberger M, 1999, BONE MARROW TRANSPL, V24, P823, DOI 10.1038/sj.bmt.1701991; Remberger M, 2001, CLIN TRANSPLANT, V15, P147, DOI 10.1034/j.1399-0012.2001.150301.x; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruzek MC, 2008, BLOOD, V111, P1726, DOI 10.1182/blood-2007-08-106526; Scheinberg P, 2007, BLOOD, V109, P3219, DOI 10.1182/blood-2006-09-045625; Sentman CL, 2006, ADV CANCER RES, V95, P249, DOI 10.1016/S0065-230X(06)95007-6; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; van Esser JWJ, 2001, BLOOD, V98, P972, DOI 10.1182/blood.V98.4.972; Wang H, 2007, BLOOD, V110, P1530, DOI 10.1182/blood-2006-10-048173; Wing MG, 1996, J CLIN INVEST, V98, P2819, DOI 10.1172/JCI119110; XIA MQ, 1993, BIOCHEM J, V293, P633, DOI 10.1042/bj2930633; Zand MS, 2006, BLOOD, V107, P2895, DOI 10.1182/blood-2005-06-2269	55	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4709	10.1371/journal.pone.0004709	http://dx.doi.org/10.1371/journal.pone.0004709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19266059	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490600020
J	Limesand, KH; Said, S; Anderson, SM				Limesand, Kirsten H.; Said, Sherif; Anderson, Steven M.			Suppression of Radiation-Induced Salivary Gland Dysfunction by IGF-1	PLOS ONE			English	Article							PAROTID-GLAND; ACINAR-CELLS; APOPTOSIS; DAMAGE; IRRADIATION; MOUSE; DELTA; AKT	Background: Radiation is a primary or secondary therapeutic modality for treatment of head and neck cancer. A common side effect of irradiation to the neck and neck region is xerostomia caused by salivary gland dysfunction. Approximately 40,000 new cases of xerostomia result from radiation treatment in the United States each year. The ensuing salivary gland hypofunction results in significant morbidity and diminishes the effectiveness of anti-cancer therapies as well as the quality of life for these patients. Previous studies in a rat model have shown no correlation between induction of apoptosis in the salivary gland and either the immediate or chronic decrease in salivary function following gamma-radiation treatment. Methodology/Principal Finding: A significant level of apoptosis can be detected in the salivary glands of FVB mice following gamma-radiation treatment of the head and neck and this apoptosis is suppressed in transgenic mice expressing an activated mutant of Akt (myr-Akt1). Importantly, this suppression of apoptosis in myr-Akt1 mice preserves salivary function, as measured by saliva output, three and thirty days after gamma-radiation treatment. In order to translate these studies into a preclinal model we found that intravenous injection of IGF1 stimulated activation of endogenous Akt in the salivary glands in vivo. A single injection of IGF1 prior to exposure to gamma-radiation diminishes salivary acinar cell apoptosis and completely preserves salivary gland function three and thirty days following irradiation. Conclusions/Significance: These studies suggest that apoptosis of salivary acinar cells underlies salivary gland hypofunction occurring secondary to radiation of the head and neck region. Targeted delivery of IGF1 to the salivary gland of patients receiving head and neck irradiation may be useful in reducing or eliminating xerostomia and restoring quality of life to these patients.	[Limesand, Kirsten H.; Said, Sherif; Anderson, Steven M.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	Steve.Anderson@ucdenver.edu			NIH [PO1 DE12798, R01 DE016354, F32 DE 14315]; University of Colorado Cancer Center; State of Colorado; University of Colorado Technology Transfer Office; Sjogren's Syndrome Foundation [PN0101-097]; K22 award [DE 16096]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE014315, P01DE012798, K22DE016096, R01DE016354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center; State of Colorado; University of Colorado Technology Transfer Office; Sjogren's Syndrome Foundation; K22 award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the NIH grants PO1 DE12798 and R01 DE016354 to SMA, University of Colorado Cancer Center Translational Grant, and State of Colorado and University of Colorado Technology Transfer Office Bioscience Discovery Grant. KHL has received support from the Sjogren's Syndrome Foundation (PN0101-097) and NIH (F32 DE 14315). KHL is the current recipient of a K22 award DE 16096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA JL, 2008, INT J RAD, V73, P523; Baum B J, 1985, Spec Care Dentist, V5, P274, DOI 10.1111/j.1754-4505.1985.tb00593.x; BERGONIE J, 1911, ARCH ELECTR MED, V19, P241; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Coffer PJ, 1998, BIOCHEM J, V335, P1; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; HIRAMATSU Y, 1994, ARCH ORAL BIOL, V39, P77, DOI 10.1016/0003-9969(94)90038-8; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KASHIMA HK, 1965, AMER J ROENTGENOL RA, V94, P271; KOHN WG, 1992, J ORAL PATHOL MED, V21, P134, DOI 10.1111/j.1600-0714.1992.tb00997.x; Lee AV, 2003, HORM METAB RES, V35, P651; Limesand KH, 2003, IN VITRO CELL DEV-AN, V39, P170; Limesand KH, 2003, CELL DEATH DIFFER, V10, P345, DOI 10.1038/sj.cdd.4401153; Lin AL, 2001, ARCH ORAL BIOL, V46, P1085, DOI 10.1016/S0003-9969(01)00063-2; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; O'Connell AC, 1999, RADIAT RES, V151, P150, DOI 10.2307/3579765; Paardekooper GMRM, 1998, INT J RADIAT BIOL, V73, P641, DOI 10.1080/095530098141898; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Schwertfeger KL, 2001, MOL ENDOCRINOL, V15, P867, DOI 10.1210/me.15.6.867; SHIP JA, 1991, J AM DENT ASSOC, V122, P63, DOI 10.14219/jada.archive.1991.0098; SHOLLEY MM, 1974, LAB INVEST, V31, P340; WRIGHT WE, 1987, J DENT RES, V66, P699, DOI 10.1177/00220345870660S216; Zeilstra LJW, 2000, INT J RADIAT BIOL, V76, P419, DOI 10.1080/095530000138763	30	62	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4663	10.1371/journal.pone.0004663	http://dx.doi.org/10.1371/journal.pone.0004663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252741	gold, Green Published, Green Submitted			2022-12-27	WOS:000265489900006
J	Schmiedeberg, L; Skene, P; Deaton, A; Bird, A				Schmiedeberg, Lars; Skene, Pete; Deaton, Aimee; Bird, Adrian			A Temporal Threshold for Formaldehyde Crosslinking and Fixation	PLOS ONE			English	Article								Background: Formaldehyde crosslinking is in widespread use as a biological fixative for microscopy and molecular biology. An assumption behind its use is that most biologically meaningful interactions are preserved by crosslinking, but the minimum length of time required for an interaction to become fixed has not been determined. Methodology: Using a unique series of mutations in the DNA binding protein MeCP2, we show that in vivo interactions lasting less than 5 seconds are invisible in the microscope after formaldehyde fixation, though they are obvious in live cells. The stark contrast between live cell and fixed cell images illustrates hitherto unsuspected limitations to the fixation process. We show that chromatin immunoprecipitation, a technique in widespread use that depends on formaldehyde crosslinking, also fails to capture these transient interactions. Conclusions/Significance: Our findings for the first time establish a minimum temporal limitation to crosslink chemistry that has implications for many fields of research.	[Schmiedeberg, Lars; Skene, Pete; Deaton, Aimee; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Schmiedeberg, L (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	a.bird@ed.ac.uk		Deaton, Aimee/0000-0003-0365-3077; Bird, Adrian/0000-0002-8600-0372	Wellcome Trust; European Union "Epigenetics" Network of Excellence	Wellcome Trust(Wellcome TrustEuropean Commission); European Union "Epigenetics" Network of Excellence	This work was funded by the Wellcome Trust and an European Union "Epigenetics" Network of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Cherukuri S, 2008, MOL BIOL CELL, V19, P1816, DOI 10.1091/mbc.E07-10-1018; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; GILMOUR DS, 1991, METHOD CELL BIOL, V35, P369; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; KLOSE RJ, 2004, J BIOL CHEM; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nan XS, 1996, MOL CELL BIOL, V16, P414; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2	18	84	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4636	10.1371/journal.pone.0004636	http://dx.doi.org/10.1371/journal.pone.0004636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247482	Green Published, gold			2022-12-27	WOS:000265487800018
J	Gibbs, SJ; Barren, B; Beck, KE; Proft, J; Zhao, XX; Noskova, T; Braun, AP; Artemyev, NO; Braun, JEA				Gibbs, Sarah J.; Barren, Brandy; Beck, Katy E.; Proft, Juliane; Zhao, Xiaoxi; Noskova, Tatiana; Braun, Andrew P.; Artemyev, Nikolai O.; Braun, Janice E. A.			Hsp40 Couples with the CSP alpha Chaperone Complex upon Induction of the Heat Shock Response	PLOS ONE			English	Article								In response to a conditioning stress, the expression of a set of molecular chaperones called heat shock proteins is increased. In neurons, stress-induced and constitutively expressed molecular chaperones protect against damage induced by ischemia and neurodegenerative diseases, however the molecular basis of this protection is not known. Here we have investigated the crosstalk between stress-induced chaperones and cysteine string protein (CSP alpha). CSP alpha is a constitutively expressed synaptic vesicle protein bearing a J domain and a cysteine rich "string'' region that has been implicated in the long term functional integrity of synaptic transmission and the defense against neurodegeneration. We have shown previously that the CSP alpha chaperone complex increases isoproterenol-mediated signaling by stimulating GDP/GTP exchange of G alpha(s). In this report we demonstrate that in response to heat shock or treatment with the Hsp90 inhibitor geldanamycin, the J protein Hsp40 becomes a major component of the CSP alpha complex. Association of Hsp40 with CSP alpha decreases CSP alpha-CSP alpha dimerization and enhances the CSP alpha-induced increase in steady state GTP hydrolysis of G alpha(s). This newly identified CSP alpha-Hsp40 association reveals a previously undescribed coupling of J proteins. In view of the crucial importance of stress-induced chaperones in the protection against cell death, our data attribute a role for Hsp40 crosstalk with CSP alpha in neuroprotection.	[Gibbs, Sarah J.; Beck, Katy E.; Proft, Juliane; Zhao, Xiaoxi; Noskova, Tatiana; Braun, Janice E. A.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada; [Gibbs, Sarah J.; Beck, Katy E.; Proft, Juliane; Zhao, Xiaoxi; Noskova, Tatiana; Braun, Janice E. A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Braun, Andrew P.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 1N4, Canada; [Braun, Andrew P.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; [Barren, Brandy; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Iowa	Gibbs, SJ (corresponding author), Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada.	braunj@ucalgary.ca	Beck, Katy/C-7990-2011; Proft, Juliane/H-6549-2014	Proft, Juliane/0000-0003-0980-8930	Canadian Institute of Health Research [MOP74713]; National Institute of Health [RO1 EY-12682]; Alberta Heritage Foundation for Medical Research [Senior Scholars]; NATIONAL EYE INSTITUTE [R01EY012682] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funding from the Canadian Institute of Health Research (MOP74713) to JEAB and National Institute of Health (RO1 EY-12682) to NOS. JEAB and APB are Senior Scholars of the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNDT V, 2007, CELL MOL LIFE SCI; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Bai LP, 2007, BIOCHEM BIOPH RES CO, V352, P123, DOI 10.1016/j.bbrc.2006.10.178; Barclay JW, 2002, J COMP PHYSIOL A, V188, P71, DOI 10.1007/s00359-002-0279-9; Bechtold DA, 2000, J NEUROCHEM, V74, P641, DOI 10.1046/j.1471-4159.2000.740641.x; Beck KE, 2006, BIOCHEM BIOPH RES CO, V346, P866, DOI 10.1016/j.bbrc.2006.05.185; Bowyer JF, 1999, ANN NY ACAD SCI, V890, P314, DOI 10.1111/j.1749-6632.1999.tb08009.x; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Brown I. R., 2007, ANN N Y ACAD SCI; Chai YH, 1999, J NEUROSCI, V19, P10338; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Cordeiro ML, 2000, J NEUROCHEM, V75, P2622, DOI 10.1046/j.1471-4159.2000.0752622.x; Cordeiro ML, 2003, J NEUROSCI RES, V73, P865, DOI 10.1002/jnr.10707; Cordeiro ML, 2000, J NEUROCHEM, V74, P2365, DOI 10.1046/j.1471-4159.2000.0742365.x; DAUGAARD M, 2007, FEBS LETT; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; KOBAYASHI N, 2008, SOLUTION STRUCTURE J; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Miller LC, 2003, J CELL SCI, V116, P2967, DOI 10.1242/jcs.00595; MORANO KA, 2007, ANN N Y ACAD SCI; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nie ZP, 1999, J NEUROSCI, V19, P10270; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Swayne LA, 2006, BIOCHEM BIOPH RES CO, V348, P83, DOI 10.1016/j.bbrc.2006.07.033; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Yamada M, 2001, NEUROSCI LETT, V301, P183, DOI 10.1016/S0304-3940(01)01638-X; Zhang W, 2002, BIOCHEM BIOPH RES CO, V291, P1038, DOI 10.1006/bbrc.2002.6555; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	53	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4595	10.1371/journal.pone.0004595	http://dx.doi.org/10.1371/journal.pone.0004595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242542	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487500006
J	Liu, WC; Vives-Bauza, C; Acin-Perez, R; Yamamoto, A; Tan, YC; Li, YP; Magrane, J; Stavarache, MA; Shaffer, S; Chang, S; Kaplitt, MG; Huang, XY; Beal, MF; Manfredi, G; Li, CJ				Liu, Wencheng; Vives-Bauza, Cristofol; Acin-Perez, Rebeca; Yamamoto, Ai; Tan, Yingcai; Li, Yanping; Magrane, Jordi; Stavarache, Mihaela A.; Shaffer, Sebastian; Chang, Simon; Kaplitt, Michael G.; Huang, Xin-Yun; Beal, M. Flint; Manfredi, Giovanni; Li, Chenjian			PINK1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit and alpha-Synuclein Aggregation in Cell Culture Models of Parkinson's Disease	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; RICH REPEAT KINASE-2; OXIDATIVE STRESS; MUTATIONS; PHOSPHORYLATION; DEGRADATION; DJ-1; DROSOPHILA-PINK1; PHOSPHOPROTEINS; DEGENERATION	Mutations in PTEN induced kinase 1 (PINK1), a mitochondrial Ser/Thr kinase, cause an autosomal recessive form of Parkinson's disease (PD), PARK6. Here, we report that PINK1 exists as a dimer in mitochondrial protein complexes that co-migrate with respiratory chain complexes in sucrose gradients. PARK6 related mutations do not affect this dimerization and its associated complexes. Using in vitro cell culture systems, we found that mutant PINK1 or PINK1 knock-down caused deficits in mitochondrial respiration and ATP synthesis. Furthermore, proteasome function is impaired with a loss of PINK1. Importantly, these deficits are accompanied by increased alpha-synclein aggregation. Our results indicate that it will be important to delineate the relationship between mitochondrial functional deficits, proteasome dysfunction and alpha-synclein aggregation.	[Liu, Wencheng; Vives-Bauza, Cristofol; Acin-Perez, Rebeca; Li, Yanping; Magrane, Jordi; Shaffer, Sebastian; Chang, Simon; Beal, M. Flint; Manfredi, Giovanni; Li, Chenjian] Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA; [Stavarache, Mihaela A.; Kaplitt, Michael G.] Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; [Tan, Yingcai; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA; [Yamamoto, Ai] Columbia Univ, Judith P Sulzberger MD Columbia Genome Ctr, New York, NY 10027 USA; [Yamamoto, Ai] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA	Cornell University; Cornell University; Cornell University; Columbia University; Columbia University	Liu, WC (corresponding author), Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA.	gim2004@mail.med.cornell.edu; chl2011@med.cornell.edu	li, yan/GTI-4638-2022; Magrané, Jordi/AAJ-2967-2020; Vives-Bauza, Cristofol/N-7044-2015; Vives-Bauza, Cristofol/AAS-1301-2021; Acin-Perez, Rebeca/H-6160-2015; Acin-Perez, Rebeca/AAU-4913-2020; Yamamoto, Ai/D-1100-2011	Magrané, Jordi/0000-0002-6785-2166; Vives-Bauza, Cristofol/0000-0001-5735-8335; Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; 	NIH/NINDS [NS054773]; Department of Defense; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054773, R01NS050199] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported partially by grants to CJL (NIH/NINDS NS054773), MFB (Department of Defense), and to MAS (Parkinson's Disease Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hatano Y, 2004, ANN NEUROL, V56, P603, DOI 10.1002/ana.20299; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Li CJ, 2005, P NATL ACAD SCI USA, V102, P16535, DOI 10.1073/pnas.0508350102; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; MURAKAMI T, 2007, J NEUROL NEUROSURG P; O'Carroll SJ, 2000, BIOTECHNIQUES, V28, P408, DOI 10.2144/00283bm03; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Sardanelli AM, 1995, FEBS LETT, V377, P470, DOI 10.1016/0014-5793(95)01407-1; SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; Thomson M, 2002, CELL MOL LIFE SCI, V59, P213, DOI 10.1007/s00018-002-8417-7; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056	54	109	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4597	10.1371/journal.pone.0004597	http://dx.doi.org/10.1371/journal.pone.0004597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242547	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487500007
J	Clement, CR; Santos, RP; Desmouliere, SJM; Ferreira, EJL; Neto, JTF				Clement, Charles R.; Santos, Ronaldo P.; Desmouliere, Sylvain J. M.; Ferreira, Evandro J. L.; Neto, Joao Tome Farias			Ecological Adaptation of Wild Peach Palm, Its In Situ Conservation and Deforestation-Mediated Extinction in Southern Brazilian Amazonia	PLOS ONE			English	Article							GENETIC-STRUCTURE; BACTRIS-GASIPAES; PLANT DIVERSITY; CLIMATE-CHANGE; MATING SYSTEM; MICROSATELLITE; POPULATIONS; FUTURE	Background: The Arc of Fire across southern Amazonia seasonally attracts worldwide attention as forests are cut and burned for agricultural expansion. These forests contain numerous wild relatives of native South American crops, such as peach palm. Methodology/Principal Findings: Our prospecting expeditions examined critical areas for wild peach palm in the Arc of Fire in Mato Grosso, Para, Maranhao and Tocantins, as well as areas not previously examined in Amazonas and Amapa states. Recent digitization of the RADAM Brasil project permitted comparison among RADAM's parataxonomists' observations, previous botanical collections and our prospecting. Mapping on soils and vegetation types enabled us to hypothesize a set of ecological preferences. Wild peach palm is best adapted to Ultisols (Acrisols) in open forests across the Arc of Fire and westward into the more humid western Amazonia. Populations are generally small (fewer than 10 plants) on slopes above watercourses. In northern Mato Grosso and southern Para soybean fields and pastures now occupy numerous areas where RADAM identified wild peach palm. The controversial BR-163 Highway is already eroding wild peach palm as deforestation expands. Conclusions/Significance: Many of these populations are now isolated by increasing forest fragmentation, which will lead to decreased reproduction via inbreeding depression and eventual extinction even without complete deforestation. Federal conservation areas are less numerous in the Arc of Fire than in other parts of Brazilian Amazonia, although there are indigenous lands; these conservation areas contain viable populations of wild peach palm and require better protection than they are currently receiving. Ex situ conservation of these populations is not viable given the relative lack of importance of domesticated peach palm and the difficulty of maintaining even economically interesting genetic resources.	[Clement, Charles R.; Desmouliere, Sylvain J. M.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Santos, Ronaldo P.] Inst Nacl Colonizacao Reforma Agraria, Manaus, Amazonas, Brazil; [Ferreira, Evandro J. L.] Inst Nacl de Pesquisas da Amazonia, Rio Branco, Acre, Brazil; [Neto, Joao Tome Farias] Embrapa Amazonia Oriental, Belem, Para, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Clement, CR (corresponding author), Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.	cclement@inpa.gov.br	Clement, Charles Roland/G-6081-2010	Clement, Charles Roland/0000-0002-8421-1029; Linhares Ferreira, Evandro Jose/0000-0001-9591-9615	Brazilian Program on Biological Diversity (ProBio); Brazilian Environment Ministry; National Council for Scientific and Technological Development (CNPq) [fellowship]; Foundation to Support Research in Amazonas State (Fapeam) [scholarship]	Brazilian Program on Biological Diversity (ProBio); Brazilian Environment Ministry; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation to Support Research in Amazonas State (Fapeam)	This study was financed primarily by the Brazilian Program on Biological Diversity (ProBio), coordinated by the Brazilian Environment Ministry, for the project: Pupunha - racas primitivas e parentes silvestres {Peach palm - landraces and wild populations} and lead by CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CC has a fellowship (bolsa de produtividade) from the National Council for Scientific and Technological Development (CNPq). SD has a scholarship from the Foundation to Support Research in Amazonas State (Fapeam).	Allem AC, 1999, EUPHYTICA, V107, P123, DOI 10.1023/A:1026422229054; Bianchetti L, 2005, FUNDAMENTOS COLETA G, P355; Clement C. R., 1988, Advances in Economic Botany, V6, P155; CLEMENT C R, 1989, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V5, P39; Clement C.R., 1984, ACTA AMAZON, V14, P337; Clement C.R., 2008, ENCY FRUIT NUTS, P93; Clement CR, 2006, HIST ECOL SER, P165; Clement Charles R., 1999, Acta Botanica Venezuelica, V22, P29; Clement Charles R., 1990, Acta Amazonica, V20, P399; Clement CR, 2004, AGROFOREST SYST, V61-2, P195, DOI 10.1023/B:AGFO.0000028999.84655.17; CLEMENT CR, 1995, IPGRI WORKSH FIELD G; Conte R, 2008, J HERED, V99, P476, DOI 10.1093/jhered/esn055; CORADIN L, PARENTES SILVESTRES; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; EGUIARTE LE, 1992, HEREDITY, V69, P217, DOI 10.1038/hdy.1992.119; Erickson CL, 2000, NATURE, V408, P190, DOI 10.1038/35041555; Fearnside Philip M., 2006, Acta Amaz., V36, P395, DOI 10.1590/S0044-59672006000300018; Ferreira E, 1999, MEM NEW YORK BOTAN G, V83, P225; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Gaiotto FA, 2003, J HERED, V94, P399, DOI 10.1093/jhered/esg087; Heckenberger MJ, 2007, PHILOS T R SOC B, V362, P197, DOI 10.1098/rstb.2006.1979; HENDERSON A, 1995, FIELD GUIDE PALMS AM; HENDERSON A, 2000, FLORA NEOTROPICA MON, V79; Ugalde JAH, 2008, REV BIOL TROP, V56, P217; Huber J, 1904, B MUS PARANESE HIST, V4, P474; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA - IBGE, 1992, MAN TECN VEG BRAS; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jordan C.F., 1985, KEY ENV AMAZONIA, P83; KAHN F, 1986, BIOTROPICA, V18, P214, DOI 10.2307/2388487; KAHN F, 1997, PALMS ELDORADO; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Leeuwen J. van, 2005, Agrociencia (Montevideo), V9, P61; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; *MMA, 2006, PLAN DES REG SUST AR; Morcote-Rios G, 2001, BOT REV, V67, P309, DOI 10.1007/BF02858098; NAMKOONG G, 1991, FOREST TREES MANAGIN; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Parssinen M., 2003, W AMAZONIA AMAZONIA, P97; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Pires JM, 1985, KEY ENV AMAZONIA, P109; *RADAM, 1973, LEV REC NAT GEOL GEO; Rodrigues DP, 2004, GENET RESOUR CROP EV, V51, P871, DOI 10.1007/s10722-005-0774-2; Rodrigues DP, 2007, THESIS U FEDERAL AMA; RODRIGUES JB, 1903, SERTUM PALMARUM BRAS; SALDIASPAZ M, 1993, 4 C INT BIOL AGR IND, P115; Salm Rodolfo, 2004, Acta Amaz., V34, P435, DOI 10.1590/S0044-59672004000300009; Scariot A, 1999, J ECOL, V87, P66, DOI 10.1046/j.1365-2745.1999.00332.x; Schaal BA, 2006, DARWINS HARVEST NEW, P269, DOI [10.7312/motl13316, DOI 10.7312/MOTL13316]; Schultes RE, 1984, PAP PEABODY MUS, V76, P19; SILVA JBF, 2005, ACTA BOT BRAS, V19, P283; URPI JM, 1999, PALMITO PEJIBAYE, P17; URPI JM, 1997, PEACH PALM, V20; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; van Leeuwen J, 2005, AGROCIENCIAS, V9, P67; van Vuuren DP, 2006, ECOL SOC, V11; Veloso H.P., 1991, CLASSIFICACAO VEGETA; VIVAN JL, 2008, THESIS U FEDERAL DE	57	15	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4564	10.1371/journal.pone.0004564	http://dx.doi.org/10.1371/journal.pone.0004564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238213	Green Published, Green Submitted, gold			2022-12-27	WOS:000265487400002
J	van Eijk, M; Aten, J; Bijl, N; Ottenhoff, R; van Roomen, CPAA; Dubbelhuis, PF; Seeman, I; Ghauharali-van der Vlugt, K; Overkleeft, HS; Arbeeny, C; Groen, AK; Aerts, JMFG				van Eijk, Marco; Aten, Jan; Bijl, Nora; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Dubbelhuis, Peter F.; Seeman, Ingar; Ghauharali-van der Vlugt, Karen; Overkleeft, Hermen S.; Arbeeny, Cynthia; Groen, Albert K.; Aerts, Johannes M. F. G.			Reducing Glycosphingolipid Content in Adipose Tissue of Obese Mice Restores Insulin Sensitivity, Adipogenesis and Reduces Inflammation	PLOS ONE			English	Article							MACROPHAGE INFILTRATION; GANGLIOSIDE GM3; RESISTANCE; FAT; INHIBITION; CERAMIDE; ADIPONECTIN; ADIPOCYTES; RECEPTOR; TOLL-LIKE-RECEPTOR-4	Adipose tissue is a critical mediator in obesity-induced insulin resistance. Previously we have demonstrated that pharmacological lowering of glycosphingolipids and subsequently GM3 by using the iminosugar AMP-DNM, strikingly improves glycemic control. Here we studied the effects of AMP-DNM on adipose tissue function and inflammation in detail to provide an explanation for the observed improved glucose homeostasis. Leptin-deficient obese (Lep(Ob)) mice were fed AMP-DNM and its effects on insulin signalling, adipogenesis and inflammation were monitored in fat tissue. We show that reduction of glycosphingolipid biosynthesis in adipose tissue of Lep(Ob) mice restores insulin signalling in isolated ex vivo insulin-stimulated adipocytes. We observed improved adipogenesis as the number of larger adipocytes was reduced and expression of genes like peroxisome proliferator-activated receptor (PPAR) gamma, insulin responsive glucose transporter (GLUT)-4 and adipsin increased. In addition, we found that adiponectin gene expression and protein were increased by AMP-DNM. As a consequence of this improved function of fat tissue we observed less inflammation, which was characterized by reduced numbers of adipose tissue macrophages (crown-like structures) and reduced levels of the macrophage chemo attractants monocyte-chemoattractant protein-1 (Mcp-1/Ccl2) and osteopontin (OPN). In conclusion, pharmacological lowering of glycosphingolipids by inhibition of glucosylceramide biosynthesis improves adipocyte function and as a consequence reduces inflammation in adipose tissue of obese animals.	[van Eijk, Marco; Bijl, Nora; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Dubbelhuis, Peter F.; Seeman, Ingar; Ghauharali-van der Vlugt, Karen; Groen, Albert K.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Overkleeft, Hermen S.] Leiden Univ, Gorleaus Inst, Dept Organ Chem, Leiden, Netherlands; [Arbeeny, Cynthia] Genzyme Corp, Framingham, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; Sanofi-Aventis; Genzyme Corporation	van Eijk, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.c.vaneijk@amc.uva.nl	Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112; Overkleeft, Herman/0000-0001-6976-7005	Dutch Diabetes Foundation [2007.11.017]	Dutch Diabetes Foundation	This work was supported by the Dutch Diabetes Foundation by grant 2007.11.017. The Dutch Diabetes foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gray SL, 2007, NUTR REV, V65, pS7, DOI [10.1111/j.1753-4887.2007.tb00331.x, 10.1301/nr.2007.jun.S7-S12]; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kundu S K, 1981, Methods Enzymol, V72, P174; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Shen C, 2004, INT IMMUNOPHARMACOL, V4, P939, DOI 10.1016/j.intimp.2004.04.008; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Tian L, 2009, ATHEROSCLEROSIS, V202, P152, DOI 10.1016/j.atherosclerosis.2008.04.011; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Vlugt KGVD, 2008, CLIN CHIM ACTA, V389, P109, DOI 10.1016/j.cca.2007.12.001; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	57	90	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4723	10.1371/journal.pone.0004723	http://dx.doi.org/10.1371/journal.pone.0004723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305508	Green Published, Green Submitted, gold			2022-12-27	WOS:000265498800001
J	Hacini-Rachinel, F; Gheit, H; Le Luduec, JB; Dif, F; Nancey, S; Kaiserlian, D				Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Dif, Fariel; Nancey, Stephane; Kaiserlian, Dominique			Oral Probiotic Control Skin Inflammation by Acting on Both Effector and Regulatory T Cells	PLOS ONE			English	Article								Probiotics are believed to alleviate allergic and inflammatory skin disorders, but their impact on pathogenic effector T cells remains poorly documented. Here we show that oral treatment with the probiotic bacteria L. casei (DN-114 001) alone alleviates antigen-specific skin inflammation mediated by either protein-specific CD4(+) T cells or hapten-specific CD8(+) T cells. In the model of CD8(+) T cell-mediated skin inflammation, which reproduces allergic contact dermatitis in human, inhibition of skin inflammation by L. casei is not due to impaired priming of hapten-specific IFN gamma-producing cytolytic CD8(+) effector T cells. Alternatively, L. casei treatment reduces the recruitment of CD8(+) effector T cells into the skin during the elicitation (i.e. symptomatic) phase of CHS. Inhibition of skin inflammation by L. casei requires MHC class II-restricted CD4(+) T cells but not CD1d-restricted NK-T cells. L casei treatment enhanced the frequency of FoxP3(+) Treg in the skin and increased the production of IL-10 by CD4(+)CD25(+) regulatory T cells in skin draining lymph nodes of hapten-sensitized mice. These data demonstrate that orally administered L. casei (DN-114 001) efficiently alleviate T cell-mediated skin inflammation without causing immune suppression, via mechanisms that include control of CD8(+) effector T cells and involve regulatory CD4(+) T cells. L. casei (DN-114 001) may thus represent a probiotic of potential interest for immunomodulation of T cell-mediated allergic skin diseases in human.	[Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Nancey, Stephane; Kaiserlian, Dominique] Univ Lyon, Lyon, France; [Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Nancey, Stephane; Kaiserlian, Dominique] INSERM, U851, Lyon, France; [Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Nancey, Stephane; Kaiserlian, Dominique] Univ Lyon 1, IFR128, Lyon, France; [Dif, Fariel] Danone Res, Palaiseau, France; [Nancey, Stephane] Ctr Hosp Lyon Sud, Serv Gastroenterol, Hospices Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Danone Nutricia; CHU Lyon	Hacini-Rachinel, F (corresponding author), Univ Lyon, Lyon, France.	dominique.kaiserlian@inserm.fr	KAISERLIAN, Dominique/G-3325-2013; NANCEY, STEPHANE/Y-5093-2019	KAISERLIAN, Dominique/0000-0001-6252-4916; NANCEY, STEPHANE/0000-0003-2088-1442; LE LUDUEC, Jean-Benoit/0000-0002-1046-2941	INSERM; Danone Research Center Palaiseau, France; DANONE	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Danone Research Center Palaiseau, France(Danone Nutricia); DANONE(Danone Nutricia)	This work was supported by institutional grant from INSERM (infrastructure charges), and from grant from Danone Research Center (Palaiseau, France). F. Hacini-Rachinel is the recipient of a CIFRE this grant from DANONE. Danone as a private company has no role in study design, data collection or interpretation. The authors have no financial conflict of interest.	Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Cavani A, 2003, J IMMUNOL, V171, P5760, DOI 10.4049/jimmunol.171.11.5760; Cavani A, 1998, J INVEST DERMATOL, V111, P621, DOI 10.1046/j.1523-1747.1998.00334.x; Chapat L, 2004, EUR J IMMUNOL, V34, P2520, DOI 10.1002/eji.200425139; Chen JP, 2005, EUR J IMMUNOL, V35, P690, DOI 10.1002/eji.200425577; Desvignes C, 2000, J IMMUNOL, V164, P2515, DOI 10.4049/jimmunol.164.5.2515; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dubois B, 2003, BLOOD, V102, P3295, DOI 10.1182/blood-2003-03-0727; ENK AH, 1995, J INVEST DERMATOL, V105, P80; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Krasteva M, 1998, J IMMUNOL, V160, P1181; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mahnke K, 2007, EUR J IMMUNOL, V37, P2117, DOI 10.1002/eji.200636841; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Nancey S, 2006, GASTROENTEROLOGY, V131, P485, DOI 10.1053/j.gastro.2006.05.018; Okazaki F, 2002, J DERMATOL, V29, P699, DOI 10.1111/j.1346-8138.2002.tb00206.x; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Ring S, 2006, EUR J IMMUNOL, V36, P2981, DOI 10.1002/eji.200636207; Roelofs-Haarhuis K, 2004, J IMMUNOL, V173, P1043, DOI 10.4049/jimmunol.173.2.1043; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schultz M, 2005, J MICROBIOL METH, V61, P389, DOI 10.1016/j.mimet.2005.01.007; Sheil B, 2004, GUT, V53, P694, DOI 10.1136/gut.2003.027789; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	35	78	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4903	10.1371/journal.pone.0004903	http://dx.doi.org/10.1371/journal.pone.0004903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300508	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496800005
J	Williams, C; Shai, RM; Wu, YC; Hsu, YH; Sitzer, T; Spann, B; McCleary, C; Mo, Y; Miller, CA				Williams, Celia; Shai, Ruty Mehrian; Wu, Yongchun; Hsu, Ya-Hsuan; Sitzer, Traci; Spann, Bryan; McCleary, Carol; Mo, Yi; Miller, Carol A.			Transcriptome Analysis of Synaptoneurosomes Identifies Neuroplasticity Genes Overexpressed in Incipient Alzheimer's Disease	PLOS ONE			English	Article								In Alzheimer's disease (AD), early deficits in learning and memory are a consequence of synaptic modification induced by toxic beta-amyloid oligomers (oA beta). To identify immediate molecular targets downstream of oA beta binding, we prepared synaptoneurosomes from prefrontal cortex of control and incipient AD (IAD) patients, and isolated mRNAs for comparison of gene expression. This novel approach concentrates synaptic mRNA, thereby increasing the ratio of synaptic to somal mRNA and allowing discrimination of expression changes in synaptically localized genes. In IAD patients, global measures of cognition declined with increasing levels of dimeric A beta (dA beta). These patients also showed increased expression of neuroplasticity related genes, many encoding 3'UTR consensus sequences that regulate translation in the synapse. An increase in mRNA encoding the GluR2 subunit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) was paralleled by elevated expression of the corresponding protein in IAD. These results imply a functional impact on synaptic transmission as GluR2, if inserted, maintains the receptors in a low conductance state. Some overexpressed genes may induce early deficits in cognition and others compensatory mechanisms, providing targets for intervention to moderate the response to dA beta.	[Williams, Celia; Mo, Yi; Miller, Carol A.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Sitzer, Traci; Spann, Bryan; McCleary, Carol; Miller, Carol A.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Miller, Carol A.] Univ So Calif, Keck Sch Med, Program Neurosci, Los Angeles, CA 90033 USA; [Wu, Yongchun] Univ So Calif, Keck Sch Med, Norris Med Lib, Los Angeles, CA 90033 USA; [Shai, Ruty Mehrian; Hsu, Ya-Hsuan] Univ So Calif, Keck Sch Med, Inst Genet Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Williams, C (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	carolmil@usc.edu			Alzheimer's Disease Research Center [2P50 AG005142]; California Alzheimer's Disease program research [04-35517]; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	Alzheimer's Disease Research Center; California Alzheimer's Disease program research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Alzheimer's Disease Research Center (2P50 AG005142) and the California Alzheimer's Disease program research (04-35517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Bell KFS, 2006, NEUROBIOL AGING, V27, P1644, DOI 10.1016/j.neurobiolaging.2005.09.034; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Chow N, 1998, P NATL ACAD SCI USA, V95, P9620, DOI 10.1073/pnas.95.16.9620; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; EDGAR R, 2002, GENE EXPRESSION OMNI, P207; Fischbach GD, 2006, NAT MED, V12, P734, DOI 10.1038/nm0706-734; Gabel LA, 2004, J NEUROSCI, V24, P10579, DOI 10.1523/JNEUROSCI.2185-04.2004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hazlett EA, 1998, NEUROBIOL AGING, V19, P437, DOI 10.1016/S0197-4580(98)00075-X; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; HUNG AY, 1993, ACTIVATION PROTEIN K, P22959; JAFFREY SR, 2001, SCIENCE, P9; Jimenez CR, 2002, J NEUROCHEM, V81, P735, DOI 10.1046/j.1471-4159.2002.00873.x; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin L, 1999, P NATL ACAD SCI USA, V96, P12108, DOI 10.1073/pnas.96.21.12108; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Liolitsa D, 2002, J NEUROL NEUROSUR PS, V73, P261, DOI 10.1136/jnnp.73.3.261; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Matsuoka Y, 2002, NEUROSCI RES, V42, P299, DOI 10.1016/S0168-0102(02)00010-X; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Mufson EJ, 2006, PROG BRAIN RES, V158, P197, DOI 10.1016/S0079-6123(06)58010-0; Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7; MUSLIMOV IA, 2004, DENDRITIC TRANSPORT, P52613; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Parameshwaran K, 2007, SYNAPSE, V61, P367, DOI 10.1002/syn.20386; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Poling A, 2008, BEHAV BRAIN RES, V193, P230, DOI 10.1016/j.bbr.2008.06.001; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006; Quattrone A, 2001, P NATL ACAD SCI USA, V98, P11668, DOI 10.1073/pnas.191388398; RAO A, 1991, J NEUROSCI, V11, P2881; Ryan MM, 2004, BIOL PSYCHIAT, V55, P329, DOI 10.1016/j.biopsych.2003.10.016; Sala C, 2003, J NEUROSCI, V23, P6327; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Senda Takao, 2005, Anatomical Science International, V80, P121, DOI 10.1111/j.1447-073x.2005.00106.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Shimomura A, 2005, NEUROSCI LETT, V375, P81, DOI 10.1016/j.neulet.2004.10.074; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sung YJ, 2004, MOL BRAIN RES, V126, P81, DOI 10.1016/j.molbrainres.2004.03.013; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Teter B, 2004, J MOL NEUROSCI, V23, P167, DOI 10.1385/JMN:23:3:167; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Watt TJ, 2005, BIOTECHNIQUES, V38, P109, DOI 10.2144/05381RR03; WEIQIN Z, 2008, ALZHEIMERS DEMENT, V4, pT197; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8	94	88	89	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4936	10.1371/journal.pone.0004936	http://dx.doi.org/10.1371/journal.pone.0004936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295912	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496700009
J	Bozek, K; Relogio, A; Kielbasa, SM; Heine, M; Dame, C; Kramer, A; Herzel, H				Bozek, Katarzyna; Relogio, Angela; Kielbasa, Szymon M.; Heine, Markus; Dame, Christof; Kramer, Achim; Herzel, Hanspeter			Regulation of Clock-Controlled Genes in Mammals	PLOS ONE			English	Article							ERYTHROPOIETIN MESSENGER-RNA; CIRCADIAN TRANSCRIPTION; BINDING SITES; E-BOX; NF-Y; EXPRESSION; MECHANISM; PROTEINS; PROMOTER; MOUSE	The complexity of tissue-and day time-specific regulation of thousands of clock-controlled genes (CCGs) suggests that many regulatory mechanisms contribute to the transcriptional output of the circadian clock. We aim to predict these mechanisms using a large scale promoter analysis of CCGs. Our study is based on a meta-analysis of DNA-array data from rodent tissues. We searched in the promoter regions of 2065 CCGs for highly overrepresented transcription factor binding sites. In order to compensate the relatively high GC-content of CCG promoters, a novel background model to avoid a bias towards GC-rich motifs was employed. We found that many of the transcription factors with overrepresented binding sites in CCG promoters exhibit themselves circadian rhythms. Among the predicted factors are known regulators such as CLOCK:BMAL1, DBP, HLF, E4BP4, CREB, ROR alpha and the recently described regulators HSF1, STAT3, SP1 and HNF-4 alpha. As additional promising candidates of circadian transcriptional regulators PAX-4, C/EBP, EVI-1, IRF, E2F, AP-1, HIF-1 and NF-Y were identified. Moreover, GC-rich motifs (SP1, EGR, ZF5, AP-2, WT1, NRF-1) and AT-rich motifs (MEF-2, HMGIY, HNF-1, OCT-1) are significantly overrepresented in promoter regions of CCGs. Putative tissue-specific binding sites such as HNF-3 for liver, NKX2.5 for heart or Myogenin for skeletal muscle were found. The regulation of the erythropoietin (Epo) gene was analysed, which exhibits many binding sites for circadian regulators. We provide experimental evidence for its circadian regulated expression in the adult murine kidney. Basing on a comprehensive literature search we integrate our predictions into a regulatory network of core clock and clock-controlled genes. Our large scale analysis of the CCG promoters reveals the complexity and extensiveness of the circadian regulation in mammals. Results of this study point to connections of the circadian clock to other functional systems including metabolism, endocrine regulation and pharmacokinetics.	[Bozek, Katarzyna; Relogio, Angela; Herzel, Hanspeter] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Bozek, Katarzyna] Max Planck Inst Informat, Saarbrucken, Germany; [Kielbasa, Szymon M.] Max Planck Inst Mol Genet, Berlin, Germany; [Heine, Markus; Kramer, Achim] Universitasmed Berlin, Lab Chronobiol, Berlin, Germany; [Dame, Christof] Universitatsmed Berlin, Klin Charite, Dept Neonatol, Campus Virchow, Berlin, Germany	Humboldt University of Berlin; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Herzel, H (corresponding author), Humboldt Univ, Inst Theoret Biol, Berlin, Germany.	h.herzel@biologie.hu-berlin.de	Relógio, Angela/M-4959-2016; Kiełbasa, Szymon M./K-2792-2019; Kiełbasa, Szymon/G-1636-2018	Relógio, Angela/0000-0002-9165-2439; Kiełbasa, Szymon/0000-0003-2805-6535; Kramer, Achim/0000-0001-9671-6078	Deutsche Forschungsgemeinschaft [SFB 618]; EU; 6th European Framework program EUCLOCK	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); 6th European Framework program EUCLOCK	The Deutsche Forschungsgemeinschaft (SFB 618) and the EU (BIOSIM network) are acknowledged for financial support. Research in A.K.'s lab is supported by the 6th European Framework program EUCLOCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozek K, 2007, GENOME INFORM SER, V18, P65; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Chen W, 2000, MOL BRAIN RES, V81, P43, DOI 10.1016/S0169-328X(00)00160-1; Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Csernus V, 2003, NEUROENDOCRINOL LETT, V24, P404; Dame C, 1998, BLOOD, V92, P3218, DOI 10.1182/blood.V92.9.3218; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Haus E, 2007, ADV DRUG DELIVER REV, V59, P985, DOI 10.1016/j.addr.2007.01.001; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hrushesky WJM, 2000, JPN J CLIN ONCOL, V30, P529, DOI 10.1093/jjco/hyd134; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kielbasa SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-237; Kim JH, 2001, J BIOL CHEM, V276, P18153, DOI 10.1074/jbc.M101661200; Klausen T, 1996, EUR J APPL PHYSIOL O, V72, P297, DOI 10.1007/BF00599688; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Leclerc GM, 2005, ENDOCRINOLOGY, V146, P2782, DOI 10.1210/en.2005-0100; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Nicolas M, 2003, BIOCHEM J, V371, P265, DOI 10.1042/BJ20021166; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pasqualetti P, 1996, Riv Eur Sci Med Farmacol, V18, P91; Ptitsyn AA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S15; RAHMANN S, 2003, STAT APPL GENET MOL, V22; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; TAN CC, 1992, AM J PHYSIOL, V263, pF474, DOI 10.1152/ajprenal.1992.263.3.F474; TEBOUL M, 2008, MOL ENDOCRINOL; Tokita K, 2007, CANCER SCI, V98, P1752, DOI 10.1111/j.1349-7006.2007.00597.x; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WIDE L, 1989, BRIT J HAEMATOL, V72, P85, DOI 10.1111/j.1365-2141.1989.tb07657.x; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	59	180	187	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4882	10.1371/journal.pone.0004882	http://dx.doi.org/10.1371/journal.pone.0004882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287494	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496400021
J	Kim, MK; Shin, JM; Eun, HC; Chung, JH				Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho			The Role of p300 Histone Acetyltransferase in UV-Induced Histone Modifications and MMP-1 Gene Transcription	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; MATRIX METALLOPROTEINASES; ULTRAVIOLET-B; EXPRESSION; P53; ACETYLATION; ACTIVATION; SKIN; INHIBITION; INDUCTION	Matrix metalloproteinase (MMP)-1 promotes ultraviolet (UV)-triggered long-term detrimental effects such as cancer formation and premature skin aging. Although histone modifications may play a crucial role in the transcriptional regulation of MMP-1, the relationship between UV-induced histone modification and MMP-1 expression is not completely understood. Here, we identify regulators of histone acetylation that may link UV-mediated DNA damage and MMP-1 induction by UV in cultured human dermal fibroblasts (HDFs) in vitro. UV irradiation of HDFs induced MMP-1 expression and increased the level of phosphorylation of H2AX (gamma-H2AX), p53 and the acetylation of histone H3 (acetyl-H3). Total histone deacetylase (HDAC) enzymatic activity was decreased by UV irradiation, while histone acetyltransferase (HAT) activity was increased. Suppression of p300 histone acetyltransferase (p300HAT) activity by the p300HAT inhibitor anacardic acid (AA) or by down-regulation of p300 by siRNA prevented UV-induced MMP-1 expression and inhibited UV-enhanced gamma-H2AX, p53 level, and acetyl-H3. Using chromatin immunoprecipitation assays, we observed that gamma-H2AX, p53, acetyl-H3, p300 and gamma-Jun were consistently recruited by UV to a distinct region (-2067/-1768) adjacent to the p300 binding site (-1858/-1845) in the MMP-1 promoter. In addition, these recruitments of gamma-H2AX, p53, acetyl-H3, p300 and c-Jun to the p300-2 site were significantly abrogated by post-treatment with AA. Furthermore, overexpression of p300 increased the basal and UV-induced MMP-1 promoter activity. Our results suggest that p300HAT plays a critical role in the transcriptional regulation of MMP-1 by UV.	[Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho] Seoul Natl Univ Hosp, Clin Res Inst, Lab Cutaneous Aging Res, Seoul, South Korea; [Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho] Seoul Natl Univ, Inst Dermatol Sci, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Chung, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea.	jhchung@snu.ac.kr	Eun, Hee Chul/J-5568-2012; Chung, Jin Ho/C-3604-2011		Korean Government;  [KRF-2005-015-E00166]	Korean Government(Korean Government); 	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, KRF-2005-015-E00166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Davidson SM, 2005, CHEMBIOCHEM, V6, P162, DOI 10.1002/cbic.200400246; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Fuchs B, 2003, FEBS LETT, V553, P104, DOI 10.1016/S0014-5793(03)00984-0; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Kim HH, 2006, J LIPID RES, V47, P921, DOI 10.1194/jlr.M500420-JLR200; LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Mai A, 2006, J MED CHEM, V49, P6897, DOI 10.1021/jm060601m; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Nelson KK, 2006, J BIOL CHEM, V281, P14100, DOI 10.1074/jbc.M601820200; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Ravanti L, 1999, J BIOL CHEM, V274, P37292, DOI 10.1074/jbc.274.52.37292; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Seo JY, 2003, MECH AGEING DEV, V124, P903, DOI 10.1016/S0047-6374(03)00150-7; Seo JY, 2001, J INVEST DERMATOL, V116, P915, DOI 10.1046/j.1523-1747.2001.01358.x; Shan B, 2003, J BIOL CHEM, V278, P44009, DOI 10.1074/jbc.M302671200; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Terp GE, 2000, J BIOMOL STRUCT DYN, V17, P933, DOI 10.1080/07391102.2000.10506582; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Yu YC, 2005, CELL CYCLE, V4, P1043, DOI 10.4161/cc.4.8.1928; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	42	55	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4864	10.1371/journal.pone.0004864	http://dx.doi.org/10.1371/journal.pone.0004864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287485	Green Published, gold			2022-12-27	WOS:000265496400013
J	Mai, PL; Chatterjee, N; Hartge, P; Tucker, M; Brody, L; Struewing, JP; Wacholder, S				Mai, Phuong L.; Chatterjee, Nilanjan; Hartge, Patricia; Tucker, Margaret; Brody, Lawrence; Struewing, Jeffery P.; Wacholder, Sholom			Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma	PLOS ONE			English	Article							KIN-COHORT; SURVIVAL; RISK; PENETRANCE; WOMEN	Background: Although the increase in risk of developing breast, ovarian, and prostate cancer in BRCA1 and BRCA2 mutation carriers has been studied extensively, its impact on mortality is not well quantified. Further, possible effect of BRCA mutations on non-cancer mortality risk has not been examined. Methodology/Principal Findings: Using mortality data from the relatives of 5,287 genotyped participants, of whom 120 carried a BRCA Ashkenazi Jewish founder mutation, in a community-based study of the Ashkenazi Jewish population in the Washington D. C area, we examined the association between the three Ashkenazi BRCA founder mutations and risk of overall and non-cancer mortality. To examine risks beyond the established effects of these mutations, we analyzed the data excluding both deaths and follow-up times after reported diagnosis of melanoma and cancer of the breast, ovary, prostate, and pancreas. Using an extension of the kin-cohort method that accounts for informative censoring, we estimated that, in the absence of breast, ovarian, and pancreatic cancers, and melanoma, female carriers had a life expectancy that was 6.8 years lower (95% CI: 1.2-10.5) than non-carriers. In male mutation carriers, the reduction in life expectancy, in the absence of prostate and pancreatic cancers and melanoma, was 3.7 (95% CI: -0.4, 6.8) years. When deaths and follow-up times after any cancer diagnosis were excluded, the difference in life expectancy was 5.7 years for women (95% CI: -0.1, 10.4) and 3.7 years for men (95% CI: -0.4, 6.9). An overall test of association for men and women together showed a statistically significant association between BRCA1/2 mutations and increased non-cancer mortality (p=0.024). Conclusions/Significance: These findings suggest that there may be unknown effects of BRCA1/2 mutations on nonneoplastic diseases that cause death at older ages.	[Mai, Phuong L.] NCI, Clin Genet Branch, Rockville, MD USA; [Chatterjee, Nilanjan; Wacholder, Sholom] NCI, Biostat Branch, Rockville, MD USA; [Hartge, Patricia] NCI, Off Director Biostat & Epidemiol Program, Rockville, MD USA; [Tucker, Margaret] NCI, Div Canc Epidemiol & Genet, Genet Epidemiol Branch, Rockville, MD USA; [Brody, Lawrence; Struewing, Jeffery P.] Natl Human Genome Res Inst, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Mai, PL (corresponding author), NCI, Clin Genet Branch, Rockville, MD USA.	maip@mail.nih.gov	Struewing, Jeffery P/I-7502-2013; Tucker, Margaret A/B-4297-2015	Struewing, Jeffery P/0000-0002-4848-3334; 	Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000120] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Byrd LM, 2008, CANCER EPIDEM BIOMAR, V17, P1535, DOI 10.1158/1055-9965.EPI-07-2792; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chatterjee N, 2003, GENET EPIDEMIOL, V25, P303, DOI 10.1002/gepi.10269; Chatterjee N, 2001, BIOMETRICS, V57, P245, DOI 10.1111/j.0006-341X.2001.00245.x; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Dizin E, 2006, J BIOL CHEM, V281, P24236, DOI 10.1074/jbc.M602176200; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gail MH, 1999, GENET EPIDEMIOL, V16, P15, DOI 10.1002/(SICI)1098-2272(1999)16:1<15::AID-GEPI3>3.0.CO;2-8; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lee JS, 1999, JNCI-J NATL CANCER I, V91, P259, DOI 10.1093/jnci/91.3.259; Liebens FP, 2007, EUR J CANCER, V43, P238, DOI 10.1016/j.ejca.2006.07.019; Moller P, 2007, INT J CANCER, V121, P1017, DOI 10.1002/ijc.22789; Moore DF, 2001, GENET EPIDEMIOL, V20, P210, DOI 10.1002/1098-2272(200102)20:2<210::AID-GEPI4>3.0.CO;2-I; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Shukla V, 2006, CANCER RES, V66, P7151, DOI 10.1158/0008-5472.CAN-05-4570; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Wacholder S, 1998, AM J EPIDEMIOL, V148, P623, DOI 10.1093/aje/148.7.623	31	43	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4812	10.1371/journal.pone.0004812	http://dx.doi.org/10.1371/journal.pone.0004812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277124	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496100029
J	Jansen, PAM; Rodijk-Olthuis, D; Hollox, EJ; Kamsteeg, M; Tjabringa, GS; de Jongh, GJ; van Vlijmen-Willems, IMJJ; Bergboer, JGM; van Rossum, MM; de Jong, EMGJ; den Heijer, M; Evers, AWM; Bergers, M; Armour, JAL; Zeeuwen, PLJM; Schalkwijk, J				Jansen, Patrick A. M.; Rodijk-Olthuis, Diana; Hollox, Edward J.; Kamsteeg, Marijke; Tjabringa, Geuranne S.; de Jongh, Gys J.; van Vlijmen-Willems, Ivonne M. J. J.; Bergboer, Judith G. M.; van Rossum, Michelle M.; de Jong, Elke M. G. J.; den Heijer, Martin; Evers, Andrea W. M.; Bergers, Mieke; Armour, John A. L.; Zeeuwen, Patrick L. J. M.; Schalkwijk, Joost			beta-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin	PLOS ONE			English	Article								Background: Previous studies have extensively documented antimicrobial and chemotactic activities of beta-defensins. Human beta-defensin-2 (hBD-2) is strongly expressed in lesional psoriatic epidermis, and recently we have shown that high beta-defensin genomic copy number is associated with psoriasis susceptibility. It is not known, however, if biologically and pathophysiologically relevant concentrations of hBD-2 protein are present in vivo, which could support an antimicrobial and proinflammatory role of beta-defensins in lesional psoriatic epidermis. Methodology/Principal Findings: We found that systemic levels of hBD-2 showed a weak but significant correlation with beta defensin copy number in healthy controls but not in psoriasis patients with active disease. In psoriasis patients but not in atopic dermatitis patients, we found high systemic hBD-2 levels that strongly correlated with disease activity as assessed by the PASI score. Our findings suggest that systemic levels in psoriasis are largely determined by secretion from involved skin and not by genomic copy number. Modelling of the in vivo epidermal hBD-2 concentration based on the secretion rate in a reconstructed skin model for psoriatic epidermis provides evidence that epidermal hBD-2 levels in vivo are probably well above the concentrations required for in vitro antimicrobial and chemokine-like effects. Conclusions/Significance: Serum hBD-2 appears to be a useful surrogate marker for disease activity in psoriasis. The discrepancy between hBD-2 levels in psoriasis and atopic dermatitis could explain the well known differences in infection rate between these two diseases.	[Jansen, Patrick A. M.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; Tjabringa, Geuranne S.; de Jongh, Gys J.; van Vlijmen-Willems, Ivonne M. J. J.; Bergboer, Judith G. M.; van Rossum, Michelle M.; de Jong, Elke M. G. J.; Bergers, Mieke; Zeeuwen, Patrick L. J. M.; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Jansen, Patrick A. M.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; Tjabringa, Geuranne S.; de Jongh, Gys J.; van Vlijmen-Willems, Ivonne M. J. J.; Bergboer, Judith G. M.; van Rossum, Michelle M.; de Jong, Elke M. G. J.; Bergers, Mieke; Zeeuwen, Patrick L. J. M.; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands; [Evers, Andrea W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, Nijmegen, Netherlands; [Armour, John A. L.] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England	Radboud University Nijmegen; Radboud University Nijmegen; University of Leicester; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Nottingham	Jansen, PAM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands.	j.schalkwijk@ncmls.ru.nl	Evers, A.W.M./L-4299-2015; Rossum, M.M./L-4614-2015; de Jong, Elke M. G. J./L-4418-2015; Zeeuwen, Patrick/N-1779-2013; Kamsteeg, M./L-4422-2015; van Vlijmen-Willems, Ivonne MJJ/P-5336-2015; Jansen, Patrick AM/P-5602-2015; Schalkwijk, Joost/R-7509-2019; Schalkwijk, Joost/N-1774-2013; Evers, Andrea/GWV-9705-2022; den Heijer, Martin/J-8036-2015	de Jong, Elke M. G. J./0000-0003-3872-5704; Zeeuwen, Patrick/0000-0002-6878-2438; van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; Schalkwijk, Joost/0000-0002-1308-1319; den Heijer, Martin/0000-0003-3620-5617; Hollox, Edward/0000-0002-0115-2298; Armour, John/0000-0002-8558-8506	Radboud University Nijmegen Medical Centre; Netherlands Organization for Scientific Research; VENI [902.11.092]; ZONMW alternatives to animal experiments programme [114000084]	Radboud University Nijmegen Medical Centre; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); VENI(Netherlands Organization for Scientific Research (NWO)); ZONMW alternatives to animal experiments programme	This work was supported by grants from the Radboud University Nijmegen Medical Centre, the Netherlands Organization for Scientific Research, VENI grant 902.11.092 to P.Z., and the ZONMW alternatives to animal experiments programme, grant 114000084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKEMADE HAC, 1995, J INVEST DERMATOL, V104, P189, DOI 10.1111/1523-1747.ep12612749; ALKEMADE HAC, 1993, AM J PATHOL, V143, P1679; ANDERSON KS, 2008, BR J DERMATOL; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Di Nardo A, 2007, J IMMUNOL, V178, P1829, DOI 10.4049/jimmunol.178.3.1829; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; GALLAGHER WH, 1989, BIOPOLYMERS, V28, P2001, DOI 10.1002/bip.360281115; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Howell MD, 2006, CLIN IMMUNOL, V121, P332, DOI 10.1016/j.clim.2006.08.008; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; LAURENT MR, 1981, ANN RHEUM DIS, V40, P66, DOI 10.1136/ard.40.1.66; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MENSSEN A, 1995, J IMMUNOL, V155, P4078; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Niyonsaba F, 2002, INT IMMUNOL, V14, P421, DOI 10.1093/intimm/14.4.421; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; SCHALKWIJK J, 2006, Patent No. 2007073151; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Tjabringa G, 2008, AM J PATHOL, V173, P815, DOI 10.2353/ajpath.2008.080173; van Riel PLCM, 2001, BEST PRACT RES CL RH, V15, P67, DOI 10.1053/berh.2000.0126; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zeeuwen PLJM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002301	51	137	148	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4725	10.1371/journal.pone.0004725	http://dx.doi.org/10.1371/journal.pone.0004725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266104	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490800006
J	Garcia-Espana, A; Mares, R; Sun, TT; DeSalle, R				Garcia-Espana, Antonio; Mares, Roso; Sun, Tung-Tien; DeSalle, Rob			Intron Evolution: Testing Hypotheses of Intron Evolution Using the Phylogenomics of Tetraspanins	PLOS ONE			English	Article							SPLICEOSOMAL INTRONS; EXTRACELLULAR DOMAIN; LARGE-SCALE; PROTEIN; GENE; SUPERFAMILY; POSITIONS; GAIN; GENOME; WEB	Background: Although large scale informatics studies on introns can be useful in making broad inferences concerning patterns of intron gain and loss, more specific questions about intron evolution at a finer scale can be addressed using a gene family where structure and function are well known. Genome wide surveys of tetraspanins from a broad array of organisms with fully sequenced genomes are an excellent means to understand specifics of intron evolution. Our approach incorporated several new fully sequenced genomes that cover the major lineages of the animal kingdom as well as plants, protists and fungi. The analysis of exon/intron gene structure in such an evolutionary broad set of genomes allowed us to identify ancestral intron structure in tetraspanins throughout the eukaryotic tree of life. Methodology/Principal Findings: We performed a phylogenomic analysis of the intron/exon structure of the tetraspanin protein family. In addition, to the already characterized tetraspanin introns numbered 1 through 6 found in animals, three additional ancient, phase 0 introns we call 4a, 4b and 4c were found. These three novel introns in combination with the ancestral introns 1 to 6, define three basic tetraspanin gene structures which have been conserved throughout the animal kingdom. Our phylogenomic approach also allows the estimation of the time at which the introns of the 33 human tetraspanin paralogs appeared, which in many cases coincides with the concomitant acquisition of new introns. On the other hand, we observed that new introns (introns other than 1-6, 4a, b and c) were not randomly inserted into the tetraspanin gene structure. The region of tetraspanin genes corresponding to the small extracellular loop (SEL) accounts for only 10.5% of the total sequence length but had 46% of the new animal intron insertions. Conclusions/Significance: Our results indicate that tests of intron evolution are strengthened by the phylogenomic approach with specific gene families like tetraspanins. These tests add to our understanding of genomic innovation coupled to major evolutionary divergence events, functional constraints and the timing of the appearance of evolutionary novelty.	[Garcia-Espana, Antonio; Mares, Roso] Univ Rovira & Virgili, Unitat Recerca, Hosp Joan 23, Inst Invest Sanit Rovira & Virgili IISPV, Tarragona, Spain; [Garcia-Espana, Antonio] Univ Rovira & Virgili, CIBERDEM, Tarragona, Spain; [Sun, Tung-Tien] NYU, Sch Med, Dept Cell Biol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Urol, New York, NY USA; [DeSalle, Rob] American Museum Nat Hist, Sackler Inst Comparative Genom, New York, NY USA	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; New York University; New York University; New York University; New York University; American Museum of Natural History (AMNH)	Garcia-Espana, A (corresponding author), Univ Rovira & Virgili, Unitat Recerca, Hosp Joan 23, Inst Invest Sanit Rovira & Virgili IISPV, Tarragona, Spain.	agarciae.hj23.ics@gencat.cat; desalle@amnh.org	garcia-españa, antonio/I-4756-2015; Sun, Tung-Tien/J-4425-2015	garcia-españa, antonio/0000-0002-9957-3161; Sun, Tung-Tien/0000-0002-6841-1063; mares, Roso/0000-0002-7339-0172	NIH [DK39753, DK52206];  [FIS 02/3003];  [PI070789]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039753, P01DK052206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH Grants DK39753 and DK52206 (T.T.S.), FIS 02/3003 and PI070789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bouchard P, 2001, ORG DIVERS EVOL, V1, P17, DOI 10.1078/1439-6092-00003; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Boudet N, 2001, GENOME RES, V11, P2101, DOI 10.1101/gr.200801; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Carmel L, 2007, GENOME RES, V17, P1045, DOI 10.1101/gr.5978207; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Contreras-Moreira B, 2003, J MOL BIOL, V333, P1045, DOI 10.1016/j.jmb.2003.09.023; CRAIK CS, 1983, SCIENCE, V220, P1125, DOI 10.1126/science.6344214; De Kee DW, 2007, MOL BIOL EVOL, V24, P2158, DOI 10.1093/molbev/msm151; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Goldberg AFX, 2006, INT REV CYTOL, V253, P131, DOI 10.1016/S0074-7696(06)53004-9; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; Kumar S, 2005, CELL, V123, P1182, DOI 10.1016/j.cell.2005.12.007; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Lee JH, 2003, CANCER RES, V63, P7247; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Logsdon JM, 2004, P NATL ACAD SCI USA, V101, P11195, DOI 10.1073/pnas.0404148101; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; MADDISON DR, 2002, MACCLADE4 VERSION 4; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Robb L, 2001, BBA-GENE STRUCT EXPR, V1522, P31, DOI 10.1016/S0167-4781(01)00306-2; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Rogozin IB, 2000, TRENDS GENET, V16, P430, DOI 10.1016/S0168-9525(00)02096-5; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2005, P NATL ACAD SCI USA, V102, P713, DOI 10.1073/pnas.0408274102; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sato Y, 1999, GENE, V238, P93, DOI 10.1016/S0378-1119(99)00321-2; Saxonov S, 2000, NUCLEIC ACIDS RES, V28, P185, DOI 10.1093/nar/28.1.185; Schmidt EE, 2007, BIOESSAYS, V29, P262, DOI 10.1002/bies.20546; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stoltzfus A, 1997, P NATL ACAD SCI USA, V94, P10739, DOI 10.1073/pnas.94.20.10739; Todres E, 2000, INSECT MOL BIOL, V9, P581, DOI 10.1046/j.1365-2583.2000.00222.x; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430	66	24	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4680	10.1371/journal.pone.0004680	http://dx.doi.org/10.1371/journal.pone.0004680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262691	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490600011
J	Martin, S; Henley, JM; Holman, D; Zhou, M; Wiegert, O; van Spronsen, M; Joels, M; Hoogenraad, CC; Krugers, HJ				Martin, Stephane; Henley, Jeremy M.; Holman, David; Zhou, Ming; Wiegert, Olof; van Spronsen, Myrrhe; Joels, Marian; Hoogenraad, Casper C.; Krugers, Harmen J.			Corticosterone Alters AMPAR Mobility and Facilitates Bidirectional Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GLUCOCORTICOID-RECEPTOR; DENDRITIC SPINES; STRESS; ACTIVATION; TRANSMISSION; TRAFFICKING; HIPPOCAMPUS; ENDOCYTOSIS; DIFFUSION	Background: The stress hormone corticosterone has the ability both to enhance and suppress synaptic plasticity and learning and memory processes. However, until today there is very little known about the molecular mechanism that underlies the bidirectional effects of stress and corticosteroid hormones on synaptic efficacy and learning and memory processes. In this study we investigate the relationship between corticosterone and AMPA receptors which play a critical role in activity-dependent plasticity and hippocampal-dependent learning. Methodology/Principal Findings: Using immunocytochemistry and live cell imaging techniques we show that corticosterone selectively increases surface expression of the AMPAR subunit GluR2 in primary hippocampal cultures via a glucocorticoid receptor and protein synthesis dependent mechanism. In agreement, we report that corticosterone also dramatically increases the fraction of surface expressed GluR2 that undergo lateral diffusion. Furthermore, our data indicate that corticosterone facilitates NMDAR-invoked endocytosis of both synaptic and extra-synaptic GluR2 under conditions that weaken synaptic transmission. Conclusion/Significance: Our results reveal that corticosterone increases mobile GluR2 containing AMPARs. The enhanced lateral diffusion properties can both facilitate the recruitment of AMPARs but under appropriate conditions facilitate the loss of synaptic AMPARs (LTD). These actions may underlie both the facilitating and suppressive effects of corticosteroid hormones on synaptic plasticity and learning and memory and suggest that these hormones accentuate synaptic efficacy.	[Martin, Stephane; Henley, Jeremy M.; Holman, David] Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TH, Avon, England; [Zhou, Ming; Wiegert, Olof; Joels, Marian; Krugers, Harmen J.] Univ Amsterdam, SILS, CNS, NL-1012 WX Amsterdam, Netherlands; [van Spronsen, Myrrhe; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Martin, Stephane] CNRS, IN2M IPMC, F-06560 Valbonne, France	University of Bristol; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Hoogenraad, CC (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	c.hoogenraad@erasmusmc.nl; h.krugers@uva.nl	Hoogenraad, Casper/B-8866-2011; Martin, Stéphane/G-5954-2012; Joëls, Marian/P-6415-2016	Hoogenraad, Casper/0000-0002-2666-0758; Martin, Stéphane/0000-0001-6771-7645; Joels, Marian/0000-0002-4826-6209; Henley, Jeremy/0000-0003-3589-8335	EU [GRIPPANT, PL 005320]; MRC; Wellcome Trust; Netherlands Organization for Scientific Research [051.02.010]; NWO-ZonMw-VIDI award; Dutch Brain foundation [13F05(2)]; Royal Dutch Academy of Arts and Sciences [05CDP013]; Human Frontier Science Program Career Development Award; European Science Foundation European Young Investigators award; MRC [G9629038, G0601810] Funding Source: UKRI; Medical Research Council [G9629038, G0601810] Funding Source: researchfish	EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO-ZonMw-VIDI award; Dutch Brain foundation; Royal Dutch Academy of Arts and Sciences; Human Frontier Science Program Career Development Award; European Science Foundation European Young Investigators award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dr. Morgan Sheng for GluR1-2 C-terminal antibodies and useful comments, Nanda Keijzer, Yasuko Nakamura and Samantha Spangler for preparing hippocampal cultures. This work was supported by grants from the EU (GRIPPANT, PL 005320), the MRC and the Wellcome Trust to JMH; the Netherlands Organization for Scientific Research (NWO Cognition program 051.02.010 to H.K. and NWO-ZonMw-VIDI award to C.C.H); the Dutch Brain foundation (13F05(2) to H.K.); the Royal Dutch Academy of Arts and Sciences (05CDP013) to H.K. and M.Z., the Human Frontier Science Program Career Development Award (HFSP-CDA to C.C.H) and the European Science Foundation European Young Investigators award (ESF-EURYI to C.C.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarez Deborah N., 2006, CNS & Neurological Disorders-Drug Targets, V5, P521, DOI 10.2174/187152706778559345; Alfarez DN, 2002, NEUROSCIENCE, V115, P1119, DOI 10.1016/S0306-4522(02)00483-9; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Coussens CM, 1997, J NEUROPHYSIOL, V78, P1; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Holman D, 2007, J NEUROSCI METH, V160, P302, DOI 10.1016/j.jneumeth.2006.09.018; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Jaskolski F, 2009, NEUROSCIENCE, V158, P19, DOI 10.1016/j.neuroscience.2008.01.075; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Stein V, 2003, J NEUROSCI, V23, P5503; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiegert O, 2005, NEUROSCIENCE, V135, P403, DOI 10.1016/j.neuroscience.2005.05.039; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204	34	96	97	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4714	10.1371/journal.pone.0004714	http://dx.doi.org/10.1371/journal.pone.0004714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19305644	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490600024
J	Ma, WJ; Zhou, X; Ross, LA; Foxe, JJ; Parra, LC				Ma, Wei Ji; Zhou, Xiang; Ross, Lars A.; Foxe, John J.; Parra, Lucas C.			Lip-Reading Aids Word Recognition Most in Moderate Noise: A Bayesian Explanation Using High-Dimensional Feature Space	PLOS ONE			English	Article							AUDIOVISUAL SPEECH-PERCEPTION; MULTISENSORY INTEGRATION; VISUAL SPEECH; SUPERIOR COLLICULUS; LEXICAL DISTINCTIVENESS; CONSONANT RECOGNITION; SPATIAL LOCALIZATION; AUDITORY DETECTION; POPULATION CODES; HEARING LIPS	Watching a speaker's facial movements can dramatically enhance our ability to comprehend words, especially in noisy environments. From a general doctrine of combining information from different sensory modalities (the principle of inverse effectiveness), one would expect that the visual signals would be most effective at the highest levels of auditory noise. In contrast, we find, in accord with a recent paper, that visual information improves performance more at intermediate levels of auditory noise than at the highest levels, and we show that a novel visual stimulus containing only temporal information does the same. We present a Bayesian model of optimal cue integration that can explain these conflicts. In this model, words are regarded as points in a multidimensional space and word recognition is a probabilistic inference process. When the dimensionality of the feature space is low, the Bayesian model predicts inverse effectiveness; when the dimensionality is high, the enhancement is maximal at intermediate auditory noise levels. When the auditory and visual stimuli differ slightly in high noise, the model makes a counterintuitive prediction: as sound quality increases, the proportion of reported words corresponding to the visual stimulus should first increase and then decrease. We confirm this prediction in a behavioral experiment. We conclude that auditory-visual speech perception obeys the same notion of optimality previously observed only for simple multisensory stimuli.	[Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zhou, Xiang; Parra, Lucas C.] CUNY City Coll, Dept Biomed Engn, New York, NY USA; [Ross, Lars A.; Foxe, John J.] CUNY City Coll, Dept Psychol, Program Cognitive Neurosci, New York, NY USA; [Ross, Lars A.; Foxe, John J.] Nathan S Kline Inst Psychiat Res, Cognitive Neurosci Lab, Program Cognitive Neurosci & Schizophrenia, Orangeburg, NY USA; [Foxe, John J.] City Univ New York, Queens Coll, Dept Psychol, Program Neuropsychol, Flushing, NY USA	Baylor College of Medicine; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Nathan Kline Institute for Psychiatric Research; City University of New York (CUNY) System; Queens College NY (CUNY)	Ma, WJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	wjma@bcm.edu	Zhou, Xiang/D-9614-2011	Foxe, John/0000-0002-4300-3098; Ma, Wei Ji/0000-0002-9835-9083				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Auer ET, 1997, J ACOUST SOC AM, V102, P3704, DOI 10.1121/1.420402; Auer ET, 2002, PSYCHON B REV, V9, P341, DOI 10.3758/BF03196291; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Bernstein L. E., 2004, HDB MULTISENSORY PRO, P203; Bernstein LE, 2000, PERCEPT PSYCHOPHYS, V62, P233, DOI 10.3758/BF03205546; BERNSTEIN LE, 2008, BRAIN RES; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; BINNIE CA, 1974, J SPEECH HEAR RES, V17, P619, DOI 10.1044/jshr.1704.619; Bolognini N, 2005, NEUROPSYCHOLOGIA, V43, P1655, DOI 10.1016/j.neuropsychologia.2005.01.015; BRAIDA LD, 1991, Q J EXP PSYCHOL-A, V43, P647, DOI 10.1080/14640749108400991; Brouwer AM, 2007, J VISION, V7, DOI 10.1167/7.5.6; BUUS S, 1985, J ACOUST SOC AM, V78, P1958, DOI 10.1121/1.392652; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; CALVERT GA, 2004, HEMODYNAMIC STUDIES; CAMPBELL R, 1998, SCAND AUDIOL S, V49; CAMPBELL R, 2007, PHILOS T R SOC LON B; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; ERBER NP, 1975, J SPEECH HEAR DISORD, V40, P481, DOI 10.1044/jshd.4004.481; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FISHER CG, 1968, J SPEECH HEAR RES, V11, P796, DOI 10.1044/jshr.1104.796; GHAHRAMANI Z, 1995, COMPUTATIONAL PSYCHO; Gillmeister H, 2007, BRAIN RES, V1160, P58, DOI 10.1016/j.brainres.2007.03.041; Gordon PC, 1997, J ACOUST SOC AM, V102, P2276, DOI 10.1121/1.419600; Grant KW, 1996, J ACOUST SOC AM, V100, P2415, DOI 10.1121/1.417950; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Grant KW, 2001, J ACOUST SOC AM, V109, P2272, DOI 10.1121/1.1362687; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Hall DA, 2005, J COGNITIVE NEUROSCI, V17, P939, DOI 10.1162/0898929054021175; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HOLMES NP, 2007, NEUROPSYCHOLOGIA; Iverson P, 1998, SPEECH COMMUN, V26, P45, DOI 10.1016/S0167-6393(98)00049-1; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jiang JT, 2007, PERCEPT PSYCHOPHYS, V69, P1070, DOI 10.3758/BF03193945; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.7.5; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2003, VISION RES, V43, P831, DOI 10.1016/S0042-6989(03)00003-8; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kucera H., 1967, COMPUTATIONAL ANAL P; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Lebib R, 2003, NEUROSCI LETT, V341, P185, DOI 10.1016/S0304-3940(03)00131-9; LEHNSCHIOLER T, THESIS; Lidestam B, 2001, SCAND AUDIOL, V30, P89, DOI 10.1080/010503901300112194; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacEachern MR, 2000, J PHONETICS, V28, P367, DOI 10.1006/jpho.2000.0119; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; Massaro D.W., 1998, PERCEIVING TALKING F; MASSARO DW, 1993, J PHONETICS, V21, P445, DOI 10.1016/S0095-4470(19)30230-X; Massaro DW, 1987, SPEECH PERCEPTION EA; Mattys SL, 2002, PERCEPT PSYCHOPHYS, V64, P667, DOI 10.3758/BF03194734; MCCORMICK B, 1979, CLIN OTOLARYNGOL, V4, P355, DOI 10.1111/j.1365-2273.1979.tb01764.x; MCGRATH M, 1985, J ACOUST SOC AM, V77, P678, DOI 10.1121/1.392336; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1986, BRAIN RES, V365, P350; MILLER GA, 1951, J EXP PSYCHOL, V41, P329, DOI 10.1037/h0062491; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Rach S, 2006, EXP BRAIN RES, V173, P514, DOI 10.1007/s00221-006-0452-4; Reale RA, 2007, NEUROSCIENCE, V145, P162, DOI 10.1016/j.neuroscience.2006.11.036; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; ROSEN SM, 1981, NATURE, V291, P150, DOI 10.1038/291150a0; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Rowland B, 2007, EXP BRAIN RES, V180, P153, DOI 10.1007/s00221-006-0847-2; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Schwartz JL, 2004, COGNITION, V93, pB69, DOI 10.1016/j.cognition.2004.01.006; Sekiyama K, 1997, PERCEPT PSYCHOPHYS, V59, P73, DOI 10.3758/BF03206849; Serino A, 2007, NEUROPSYCHOLOGIA, V45, P1101, DOI 10.1016/j.neuropsychologia.2006.09.013; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stein BE., 1993, MERGING SENSES; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Thomas SM, 2004, J EXP PSYCHOL HUMAN, V30, P873, DOI 10.1037/0096-1523.30.5.873; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; WANG MD, 1978, J SPEECH HEAR RES, V21, P5, DOI 10.1044/jshr.2101.05; WANG MD, 1973, J ACOUST SOC AM, V54, P1248, DOI 10.1121/1.1914417	92	123	123	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4638	10.1371/journal.pone.0004638	http://dx.doi.org/10.1371/journal.pone.0004638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MB	19259259	Green Published, gold			2022-12-27	WOS:000265490500005
J	Ganatra, HA; Bhurgri, H; Channa, R; Bawany, FA; Zafar, SN; Chaudhry, RI; Batool, SH; Basit, A; Asghar, M; Saleem, S; Naqvi, H				Ganatra, Hammad Ashraf; Bhurgri, Hadi; Channa, Roomasa; Bawany, Fauzia Ahmad; Zafar, Syed Nabeel; Chaudhry, Rafia Ishfaq; Batool, Syeda Hina; Basit, Abdul; Asghar, Mehmood; Saleem, Sarah; Naqvi, Haider			Educating and Informing Patients Receiving Psychopharmacological Medications: Are Family Physicians in Pakistan up to the Task?	PLOS ONE			English	Article							PSYCHOTROPIC-DRUGS; RISK-FACTORS; HEALTH-CARE; DEPRESSION; PRACTITIONERS; PSYCHOTHERAPY; PRESCRIPTION; DISEASE; BURDEN	Introduction: Studies have shown a high prevalence of psychiatric illnesses among patients in primary health care settings. Family physicians have a fundamental role in managing psychiatric illness with psychopharmacological medications. Providing information about the disease, its management and the potential adverse effects of the medications is an important part of the management of mental illnesses. Our objective was to determine if patients who were prescribed psychopharmacological drugs by family physicians at a community health center in Karachi, Pakistan were provided adequate education about their disease and its management. Methods: A cross-sectional study was conducted at the Community Health Centre (CHC), Aga Khan University Hospital Karachi, Pakistan. Details about the prescriptions and patient education were acquired from the patients after their consultations. Results: A total of 354 adult patients were interviewed during 3 days. Among them, 73 (20.6%) were prescribed psychopharmacological medications. Among patients receiving psychopharmacological medicines, 37 (50.7%) did not know their diagnosis; 50 (68.5%) were unaware of the disease process; 52 (71.2%) were unaware of alternative treatments; 63 (86.3%) were not cautioned about the potential adverse effects of the drugs; 24 (32.9%) were unaware of the duration of treatment and in 60 (82.2%) of the participants an appropriate referral had not been discussed. For all aspects of education, patients prescribed psychopharmacological medications knew less as compared to those patients that were prescribed other medications. Discussion: The practice of imparting information to patients who receive psychopharmacological medications seems to be inadequate in Pakistan. We have hypothesized about the possible reasons for our findings, and identified a need for further research to determine the cause for such findings and to address them accordingly. At the same time there is a need to educate family physicians in Pakistan about the special importance of providing adequate information to such patients.	[Ganatra, Hammad Ashraf; Bhurgri, Hadi; Channa, Roomasa; Bawany, Fauzia Ahmad; Zafar, Syed Nabeel; Chaudhry, Rafia Ishfaq; Batool, Syeda Hina; Basit, Abdul; Asghar, Mehmood] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Naqvi, Haider] Aga Khan Univ, Dept Psychiat, Karachi, Pakistan	Aga Khan University; Aga Khan University; Aga Khan University	Ganatra, HA (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	hammadganatra@gmail.com	Ganatra, Hammad A/P-8652-2019; C, Roomasa/AAK-5176-2020	Ganatra, Hammad A/0000-0001-9534-2780; Zafar, Syed Nabeel/0000-0003-3843-9687				BELLANTUONO C, 1989, SOC PSYCH PSYCH EPID, V24, P212; Biggs JSG, 2008, JCPSP-J COLL PHYSICI, V18, P58, DOI 01.2008/JCPSP.5863; de Maat SM, 2007, EUR PSYCHIAT, V22, P1, DOI 10.1016/j.eurpsy.2006.10.008; Hansen Hanne Vibe, 2007, Expert Rev Neurother, V7, P57, DOI 10.1586/14737175.7.1.57; Hartley D, 1998, ARCH FAM MED, V7, P139, DOI 10.1001/archfami.7.2.139; JOUKAMAA M, 1995, ACTA PSYCHIAT SCAND, V92, P359, DOI 10.1111/j.1600-0447.1995.tb09597.x; Khan MM, 2006, PSYCHIATR BULL, V30, P85, DOI 10.1192/pb.30.3.85; Kisely S, 2000, PSYCHOL MED, V30, P1217, DOI 10.1017/S0033291799002743; Linden M, 1999, J CLIN PSYCHOPHARM, V19, P132, DOI 10.1097/00004714-199904000-00007; Linden M, 2008, J GEN INTERN MED, V23, P1567, DOI 10.1007/s11606-008-0648-3; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mirza I, 2006, SOC SCI MED, V63, P593, DOI 10.1016/j.socscimed.2006.01.028; Molenaar PJ, 2007, DEPRESS ANXIETY, V24, P553, DOI 10.1002/da.20254; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naqvi Haider A, 2006, J Coll Physicians Surg Pak, V16, P438; NEESHAT MQ, 2007, PHARMAGUIDE QUICK RE; O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28; SABOOH SM, 2001, JCPSP-J COLL PHYSICI, V11, P232; Salzman C, 1998, PSYCHIAT QUART, V69, P251, DOI 10.1023/A:1022125929946; Syed EU, 2008, ACAD PSYCHIATR, V32, P160, DOI 10.1176/appi.ap.32.2.160; Thaver IH, 1998, SOC SCI MED, V46, P1441, DOI 10.1016/S0277-9536(97)10134-4; Upshur Carole, 2008, Prim Care Companion J Clin Psychiatry, V10, P182; Ziegler DK, 2001, ARCH INTERN MED, V161, P706, DOI 10.1001/archinte.161.5.706	24	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4620	10.1371/journal.pone.0004620	http://dx.doi.org/10.1371/journal.pone.0004620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247488	gold, Green Submitted, Green Published			2022-12-27	WOS:000265487800003
J	Hoa, N; Myers, MP; Douglass, TG; Zhang, JG; Delgado, C; Driggers, L; Callahan, LL; VanDeusen, G; Pham, JTH; Bhakta, N; Ge, LS; Jadus, MR				Hoa, Neil; Myers, Michael P.; Douglass, Thomas G.; Zhang, Jian Gang; Delgado, Christina; Driggers, Lara; Callahan, Linda L.; VanDeusen, Gerald; Pham, Jimmy T. H.; Bhakta, Nirav; Ge, Lisheng; Jadus, Martin R.			Molecular Mechanisms of Paraptosis Induction: Implications for a Non-Genetically Modified Tumor Vaccine	PLOS ONE			English	Article								Paraptosis is the programmed cell death pathway that leads to cellular necrosis. Previously, rodent and human monocytes/macrophages killed glioma cells bearing the membrane macrophage colony stimulating factor (mM-CSF) through paraptosis, but the molecular mechanism of this killing process was never identified. We have demonstrated that paraptosis of rat T9 glioma cells can be initiated through a large potassium channel (BK)-dependent process initiated by reactive oxygen species. Macrophage mediated cytotoxicity upon the mM-CSF expressing T9-C2 cells was not prevented by the addition of the caspase inhibitor, zVAD-fmk. By a combination of fluorescent confocal and electron microscopy, flow cytometry, electrophysiology, pharmacology, and genetic knock-down approaches, we demonstrated that these ion channels control cellular swelling and vacuolization of rat T9 glioma cells. Cell lysis is preceded by a depletion of intracellular ATP. Six-hour exposure to BK channel activation caused T9 cells to over express heat shock proteins (Hsp 60, 70, 90 and gp96). This same treatment forced HMGB1 translocation from the nuclear region to the periphery. These last molecules are "danger signals'' that can stimulate immune responses. Similar inductions of mitochondrial swelling and increased Hsp70 and 90 expressions by BK channel activation were observed with the non-immunogenic F98 glioma cells. Rats injected with T9 cells which were killed by prolonged BK channel activation developed immunity against the T9 cells, while the injection of x-irradiated apoptotic T9 cells failed to produce the vaccinating effect. These results are the first to show that glioma cellular death induced by prolonged BK channel activation improves tumor immunogenicity; this treatment reproduces the vaccinating effects of mM-CSF transduced cells. Elucidation of strategies as described in this study may prove quite valuable in the development of clinical immunotherapy against cancer.	[Hoa, Neil; Zhang, Jian Gang; Delgado, Christina; Driggers, Lara; Ge, Lisheng; Jadus, Martin R.] Vet Affairs Med Ctr, Diagnost & Mol Med Healthcare Grp, Long Beach, CA USA; [Zhang, Jian Gang; Jadus, Martin R.] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Zhang, Jian Gang; Jadus, Martin R.] Univ Calif Irvine, Lab Med, Irvine, CA 92717 USA; [Myers, Michael P.; VanDeusen, Gerald; Pham, Jimmy T. H.; Bhakta, Nirav] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Callahan, Linda L.] Calif State Univ Long Beach, Nursing Dept, Long Beach, CA 90840 USA; [Douglass, Thomas G.] Calif State Univ Long Beach, Biol Dept, Long Beach, CA 90840 USA; [Jadus, Martin R.] Univ Calif Irvine, Chao Comprehensive Canc Ctr, Neuro Oncol Program, Irvine, CA 92717 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State University Long Beach; California State University System; California State University Long Beach; California State University System; California State University Long Beach; University of California System; University of California Irvine	Hoa, N (corresponding author), Vet Affairs Med Ctr, Diagnost & Mol Med Healthcare Grp, Long Beach, CA USA.	martin.jadus@med.va.gov	Ge, Li/T-3955-2018; Pham, Jimmy Tam Huy/D-1537-2013	Ge, Li/0000-0002-1824-8034; Pham, Jimmy Tam Huy/0000-0003-0527-9832	Veterans Affairs Merit Review; AVon Breast Cancer Foundation; Howard Hughes Medical Institute; Research Corporation; CSUPERB	Veterans Affairs Merit Review(US Department of Veterans Affairs); AVon Breast Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Research Corporation(Research Corporation for Science Advancement); CSUPERB	Veterans Affairs Merit Review and AVon Breast Cancer Foundation: MRJ. Howard Hughes Medical Institute and Research Corporation and CSUPERB: MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; CASSEL D, 1986, J BIOL CHEM, V261, P5460; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen YJ, 2002, BLOOD, V100, P1373, DOI 10.1182/blood-2002-01-0174; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; Dan QH, 2001, MOL THER, V4, P427, DOI 10.1006/mthe.2001.0477; Delgado C, 2007, CYTOKINE, V38, P165, DOI 10.1016/j.cyto.2007.06.003; Eguchi Y, 1997, CANCER RES, V57, P1835; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; GABAI VL, 1994, EXP MOL PATHOL, V60, P88, DOI 10.1006/exmp.1994.1008; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Graf MR, 1999, J IMMUNOL, V163, P5544; Jadus MR, 1996, BLOOD, V87, P5232, DOI 10.1182/blood.V87.12.5232.bloodjournal87125232; Jadus MR, 1998, J IMMUNOL, V160, P361; Jadus MR, 2003, CANCER GENE THER, V10, P411, DOI 10.1038/sj.cgt.7700583; JADUS MR, 1999, RECENT RES DEV IMMUN, V1, P267; Jeffes EWB, 2005, J IMMUNOL, V174, P2533, DOI 10.4049/jimmunol.174.5.2533; Kabakov AE, 2002, AM J PHYSIOL-CELL PH, V283, pC521, DOI 10.1152/ajpcell.00503.2001; Kim JH, 2004, MACROMOL RES, V12, P53, DOI 10.1007/BF03218995; Kuppner MC, 2001, EUR J IMMUNOL, V31, P1602, DOI 10.1002/1521-4141(200105)31:5<1602::AID-IMMU1602>3.0.CO;2-W; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lipinski KS, 2006, CANCER IMMUNOL IMMUN, V55, P347, DOI 10.1007/s00262-005-0014-9; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; MYERS MP, 1999, ELECTRON J BIOTECHN, V2, P3; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; Nicotera P, 2000, BRAIN PATHOL, V10, P276, DOI 10.1111/j.1750-3639.2000.tb00261.x; Ransom CB, 2001, J NEUROPHYSIOL, V85, P790, DOI 10.1152/jn.2001.85.2.790; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sanchez R, 2002, CELL IMMUNOL, V215, P1, DOI 10.1016/S0008-8749(02)00011-4; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schneider D, 2004, CELL DEATH DIFFER, V11, P760, DOI 10.1038/sj.cdd.4401377; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; T Hoa N, 2007, LAB INVEST, V87, P115, DOI 10.1038/labinvest.3700506; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Williams CC, 2001, MOL THER, V3, P216, DOI 10.1006/mthe.2001.0253; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Zakhartchenko VA, 2001, BIOTECHNIQUES, V31, P676, DOI 10.2144/01313dd06	43	51	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4631	10.1371/journal.pone.0004631	http://dx.doi.org/10.1371/journal.pone.0004631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247476	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487800013
J	El-Talatini, MR; Taylor, AH; Elson, JC; Brown, L; Davidson, AC; Konje, JC				El-Talatini, Mona R.; Taylor, Anthony H.; Elson, Janine C.; Brown, Laurence; Davidson, Allan C.; Konje, Justin C.			Localisation and Function of the Endocannabinoid System in the Human Ovary	PLOS ONE			English	Article								Background: Although anandamide (AEA) had been measured in human follicular fluid and is suggested to play a role in ovarian follicle and oocyte maturity, its exact source and role in the human ovary remains unclear. Methods and Findings: Immunohistochemical examination of normal human ovaries indicated that the endocannabinoid system was present and widely expressed in the ovarian medulla and cortex with more intense cannabinoid receptor 2 (CB2) than CB1 immunoreactivity in the granulosa cells of primordial, primary, secondary, tertiary follicles, corpus luteum and corpus albicans. The enzymes, fatty acid amide hydrolase (FAAH) and N-acyclphosphatidylethanolamine-phospholipase D (NAPE-PLD), were only found in growing secondary and tertiary follicles and corpora lutea and albicantes. The follicular fluid (FF) AEA concentrations of 260 FF samples, taken from 37 infertile women undergoing controlled ovarian hyperstimulation for in vitro fertilisation and intracytoplasmic sperm injection with embryo transfer, were correlated with ovarian follicle size (P = 0.03). Significantly higher FF AEA concentrations were also observed in mature follicles (1.43 +/- 0.04 nM; mean +/- SEM) compared to immature follicles (1.26 +/- 60.06 nM), P = 0.0142 and from follicles containing morphologically assessed mature oocytes (1.56 +/- 0.11 nM) compared to that containing immature oocytes (0.99 +/- 60.09 nM), P = 0.0011. ROC analysis indicated that a FF AEA level of 1.09 nM could discriminate between mature and immature oocytes with 72.2% sensitivity and 77.14% specificity, whilst plasma AEA levels and FF AEA levels on oocyte retrieval day were not significantly different (P = 0.23). Conclusions: These data suggest that AEA is produced in the ovary, is under hormonal control and plays a role in folliculogenesis, preovulatory follicle maturation, oocyte maturity and ovulation.	[El-Talatini, Mona R.; Taylor, Anthony H.; Konje, Justin C.] Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Endocannabinoid Res Grp, Leicester, Leics, England; [Elson, Janine C.; Davidson, Allan C.] Univ Hosp Leicester, NHS Trust, Leicester Royal Infirmary, Assisted Concept Unit, Leicester, Leics, England; [Brown, Laurence] Univ Hosp Leicester, NHS Trust, Leicester Royal Infirmary, Dept Pathol, Leicester, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester	El-Talatini, MR (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Endocannabinoid Res Grp, Leicester, Leics, England.	jck4@le.ac.uk		Taylor, Anthony/0000-0002-5746-9091	British United Provident Association (BUPA); Perkin-Elmer; Miscellaneous Research Income of the Endocannabinoid Research Group, University of Leicester	British United Provident Association (BUPA); Perkin-Elmer; Miscellaneous Research Income of the Endocannabinoid Research Group, University of Leicester	This work was supported in part by a British United Provident Association (BUPA) grant, generous funding from Perkin-Elmer, with additional funding provided from the Miscellaneous Research Income of the Endocannabinoid Research Group, University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADASHI EY, 1983, AM J PHYSIOL, V244, pE177, DOI 10.1152/ajpendo.1983.244.2.E177; Arslan M, 2005, FERTIL STERIL, V84, P555, DOI 10.1016/j.fertnstert.2005.02.053; AYALON D, 1977, NEUROENDOCRINOLOGY, V23, P31, DOI 10.1159/000122652; Braude P, 2003, BMJ-BRIT MED J, V327, P852, DOI 10.1136/bmj.327.7419.852; Brown TT, 2002, J CLIN PHARMACOL, V42, p90S, DOI 10.1002/j.1552-4604.2002.tb06008.x; CAHILL DJ, 1994, BRIT J OBSTET GYNAEC, V101, P999, DOI 10.1111/j.1471-0528.1994.tb13047.x; Chang CL, 2002, HUM REPROD, V17, P1724, DOI 10.1093/humrep/17.7.1724; Childers SR, 1998, DRUG ALCOHOL DEPEN, V51, P173, DOI 10.1016/S0376-8716(98)00075-1; Costa LOB, 2004, BRAZ J MED BIOL RES, V37, P1747, DOI 10.1590/S0100-879X2004001100021; Cutting Rachel, 2008, Hum Fertil (Camb), V11, P131, DOI 10.1080/14647270802302629; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Ebner T, 2003, HUM REPROD UPDATE, V9, P251, DOI 10.1093/humupd/dmg021; ELTALATINI MR, 2008, 18 ANN S INT CANN RE; ELTALATINI MR, 2007, 2 SGI INT SUMMIT REP; Erickson GF, 2000, MENOPAUSE BIOL PATHO, P13; Fowler CJ, 2007, BRIT J PHARMACOL, V152, P594, DOI 10.1038/sj.bjp.0707379; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Habayeb OMH, 2002, LIFE SCI, V70, P1963, DOI 10.1016/S0024-3205(01)01539-9; Habayed OM, 2008, ENDOCRINOLOGY, V9, P5052; Kenney SP, 1999, AM J OBSTET GYNECOL, V181, P491, DOI 10.1016/S0002-9378(99)70583-1; Klonoff-Cohen HS, 2006, AM J OBSTET GYNECOL, V194, P369, DOI 10.1016/j.ajog.2005.08.020; Lam PMW, 2008, ANAL BIOCHEM, V380, P195, DOI 10.1016/j.ab.2008.05.033; Lass A, 2003, FERTIL STERIL, V80, P80, DOI 10.1016/S0015-0282(03)00558-2; MENDELSON JH, 1986, J PHARMACOL EXP THER, V237, P862; Mueller B A, 1990, Epidemiology, V1, P195, DOI 10.1097/00001648-199005000-00003; NIR I, 1973, NATURE, V244, P470, DOI 10.1038/243470a0; Parolaro D, 2002, PROSTAG LEUKOTR ESS, V66, P319, DOI 10.1054/plef.2001.0355; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; ROSS HM, 2003, HISTOLOGY TEXT ATLAS, P773; Salha O, 1998, HUM REPROD, V13, P1901, DOI 10.1093/humrep/13.7.1901; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; SMITH CG, 1979, FERTIL STERIL, V31, P335; Strehler E, 2001, FERTIL STERIL, V75, P332, DOI 10.1016/S0015-0282(00)01696-4; Tarin J J, 1992, Ann Acad Med Singap, V21, P492; Taylor AH, 2007, HUM REPROD UPDATE, V13, P501, DOI 10.1093/humupd/dmm018; Taylor AH, 2005, HISTOCHEM CELL BIOL, V123, P463, DOI 10.1007/s00418-004-0748-z; Taylor AH, 2000, J MOL ENDOCRINOL, V24, P145, DOI 10.1677/jme.0.0240145; TYREY L, 1980, J PHARMACOL EXP THER, V213, P306; Wang HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003320; Wu YT, 2007, HUM REPROD, V22, P1526, DOI 10.1093/humrep/dem029	43	119	121	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4579	10.1371/journal.pone.0004579	http://dx.doi.org/10.1371/journal.pone.0004579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238202	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487400011
J	Damy, T; Kirsch, M; Khouzami, L; Caramelle, P; Le Corvoisier, P; Roudot-Thoraval, F; Dubois-Rande, JL; Hittinger, L; Pavoine, C; Pecker, F				Damy, Thibaud; Kirsch, Matthias; Khouzami, Lara; Caramelle, Philippe; Le Corvoisier, Philippe; Roudot-Thoraval, Francoise; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pavoine, Catherine; Pecker, Francoise			Glutathione Deficiency in Cardiac Patients Is Related to the Functional Status and Structural Cardiac Abnormalities	PLOS ONE			English	Article								Background: The tripeptide glutathione (L-gamma-glutamyl-cysteinyl-glycine) is essential to cell survival, and deficiency in cardiac and systemic glutathione relates to heart failure progression and cardiac remodelling in animal models. Accordingly, we investigated cardiac and blood glutathione levels in patients of different functional classes and with different structural heart diseases. Methods: Glutathione was measured using standard enzymatic recycling method in venous blood samples obtained from 91 individuals, including 15 healthy volunteers and 76 patients of New York Heart Association (NYHA) functional class I to IV, undergoing cardiac surgery for coronary artery disease, aortic stenosis or terminal cardiomyopathy. Glutathione was also quantified in right atrial appendages obtained at the time of surgery. Results: In atrial tissue, glutathione was severely depleted (-58%) in NYHA class IV patients compared to NYHA class I patients (P = 0.002). In patients with coronary artery disease, this depletion was related to the severity of left ventricular dysfunction (P = 0.006). Compared to healthy controls, blood glutathione was decreased by 21% in NYHA class I patients with structural cardiac disease (P<0.01), and by 40% in symptomatic patients of NYHA class II to IV (P<0.0001). According to the functional NYHA class, significant depletion in blood glutathione occurred before detectable elevation in blood sTNFR1, a marker of symptomatic heart failure severity, as shown by the exponential relationship between these two parameters in the whole cohort of patients (r = 0.88). Conclusions: This study provides evidence that cardiac and systemic glutathione deficiency is related to the functional status and structural cardiac abnormalities of patients with cardiac diseases. These data also suggest that blood glutathione test may be an interesting new biomarker to detect asymptomatic patients with structural cardiac abnormalities.	[Damy, Thibaud; Kirsch, Matthias; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pecker, Francoise] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Chirurg Cardiaque, Creteil, France; [Damy, Thibaud; Khouzami, Lara; Caramelle, Philippe; Le Corvoisier, Philippe; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pavoine, Catherine; Pecker, Francoise] INSERM, U955, Creteil, France; [Damy, Thibaud; Kirsch, Matthias; Khouzami, Lara; Caramelle, Philippe; Le Corvoisier, Philippe; Roudot-Thoraval, Francoise; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pavoine, Catherine; Pecker, Francoise] Univ Paris 12, Fac Med, UMR S955, F-94010 Creteil, France; [Le Corvoisier, Philippe] INSERM, Ctr Investigat Clin 006, Creteil, France; [Le Corvoisier, Philippe] Grp Hosp Henri Mondor Albert Chenevier, Creteil, France; [Roudot-Thoraval, Francoise] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Rech Clin Sante Publ, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Damy, T (corresponding author), Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Chirurg Cardiaque, Creteil, France.	francoise.pecker@inserm.fr	Pavoine, Catherine/N-4405-2018; le corvoisier, philippe/AAO-2862-2020	Pavoine, Catherine/0000-0002-0598-5545; Le Corvoisier, Philippe/0000-0003-0402-9591; Hittinger, Luc/0000-0003-1933-5815	Institut National de la Sante et de la Recherche Medicale; Assistance Publique des Hopitaux de Paris; Universite Paris 12; Association Francaise contre les Myopathies	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique des Hopitaux de Paris; Universite Paris 12; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The funders for the present work were: Institut National de la Sante et de la Recherche Medicale, the Assistance Publique des Hopitaux de Paris (as a Contrat d'Interface to F.P.), the Universite Paris 12 and the Association Francaise contre les Myopathies (as an aide aux etudes to L.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Amadou A, 2002, AM J PHYSIOL-CELL PH, V282, pC1339, DOI 10.1152/ajpcell.00471.2001; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; Cailleret M, 2004, CIRCULATION, V109, P406, DOI 10.1161/01.CIR.0000109499.00587.FF; Carnes CA, 2007, J BIOL CHEM, V282, P28063, DOI 10.1074/jbc.M704893200; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Deswal A, 2001, CIRCULATION, V103, P2055; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; FERRARI R, 1995, CIRCULATION, V92, P1479, DOI 10.1161/01.CIR.92.6.1479; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Haddad JJ, 2005, MOL IMMUNOL, V42, P987, DOI 10.1016/j.molimm.2004.09.029; Hill MF, 1997, CIRCULATION, V96, P2414; Isaac DL, 2008, CURR OPIN CARDIOL, V23, P127, DOI 10.1097/HCO.0b013e3282f43039; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; Lang CA, 2000, J LAB CLIN MED, V135, P402, DOI 10.1067/mlc.2000.105977; Maisel A, 2004, J AM COLL CARDIOL, V44, P1328, DOI 10.1016/j.jacc.2004.06.015; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Nishii M, 2008, J AM COLL CARDIOL, V51, P2329, DOI 10.1016/j.jacc.2007.11.085; Nozaki N, 1997, JPN CIRC J, V61, P657, DOI 10.1253/jcj.61.657; Ozaydin M, 2008, EUR HEART J, V29, P625, DOI 10.1093/eurheartj/ehn011; Pfister R, 2004, EUR J HEART FAIL, V6, P289, DOI 10.1016/j.ejheart.2003.12.012; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rauchhaus M, 2000, CIRCULATION, V102, P3060; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Tang WHW, 2007, CIRCULATION, V116, pE99, DOI 10.1161/CIRCULATIONAHA.107.185267; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yucel D, 1998, CLIN CHEM, V44, P148	37	73	73	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4871	10.1371/journal.pone.0004871	http://dx.doi.org/10.1371/journal.pone.0004871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319187	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499200002
J	Chang, YW; Ko, TP; Lee, CD; Chang, YC; Lin, KA; Chang, CS; Wang, AHJ; Wang, TF				Chang, Yu-Wei; Ko, Tzu-Ping; Lee, Chien-Der; Chang, Yuan-Chih; Lin, Kuei-Ann; Chang, Chia-Seng; Wang, Andrew H. -J.; Wang, Ting-Fang			Three New Structures of Left-Handed RadA Helical Filaments: Structural Flexibility of N-Terminal Domain Is Critical for Recombinase Activity	PLOS ONE			English	Article							DOUBLE-STRANDED DNA; PROTEIN BINDS DNA; CRYSTAL-STRUCTURE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; METHANOCOCCUS-VOLTAE; SURFACE; DMC1; LONG; ADP	RecA family proteins, including bacterial RecA, archaeal RadA, and eukaryotic Dmc1 and Rad51, mediate homologous recombination, a reaction essential for maintaining genome integrity. In the presence of ATP, these proteins bind a single-strand DNA to form a right-handed nucleoprotein filament, which catalyzes pairing and strand exchange with a homologous double-stranded DNA (dsDNA), by as-yet unknown mechanisms. We recently reported a structure of RadA left-handed helical filament, and here present three new structures of RadA left-handed helical filaments. Comparative structural analysis between different RadA/Rad51 helical filaments reveals that the N-terminal domain (NTD) of RadA/Rad51, implicated in dsDNA binding, is highly flexible. We identify a hinge region between NTD and polymerization motif as responsible for rigid body movement of NTD. Mutant analysis further confirms that structural flexibility of NTD is essential for RadA's recombinase activity. These results support our previous hypothesis that ATP-dependent axial rotation of RadA nucleoprotein helical filament promotes homologous recombination.	[Chang, Yu-Wei; Lee, Chien-Der; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Chang, Yu-Wei; Ko, Tzu-Ping; Lin, Kuei-Ann; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chang, Yuan-Chih; Chang, Chia-Seng] Acad Sinica, Inst Phys, Taipei, Taiwan; [Lee, Chien-Der; Wang, Ting-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Chang, YW (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; tfwang@gate.sinica.edu.tw	CHANG, Yuan-Chih/J-2609-2016; Chang, Chia-Seng/AAP-8155-2021; Wang, Ting-Fang/ABI-3818-2020	CHANG, Yuan-Chih/0000-0002-0289-3768; Wang, Ting-Fang/0000-0001-6306-9505	Academia Sincia [Investigator Award, AS96IBC3]; National Science Council [NSC96-2321-B-001-019]; National Core Facility of High-Throughput Protein Crystallography [NSC97-3112-B-001-011-Y]	Academia Sincia; National Science Council(Ministry of Science and Technology, Taiwan); National Core Facility of High-Throughput Protein Crystallography	This work was supported by Academia Sincia (Investigator Award Grant to TFW and AS96IBC3 to AHJW), National Science Council (NSC96-2321-B-001-019 to TFW) and a National Core Facility of High-Throughput Protein Crystallography Grant (NSC97-3112-B-001-011-Y to AHJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Aihara H, 1997, J MOL BIOL, V274, P213, DOI 10.1006/jmbi.1997.1403; Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000858; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Egelman EH, 2008, BIOESSAYS, V30, P791, DOI 10.1002/bies.20791; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2006, BIOCHEMISTRY-US, V45, P13537, DOI 10.1021/bi060938q; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Kurumizaka H, 1996, J BIOL CHEM, V271, P33515, DOI 10.1074/jbc.271.52.33515; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Lee MH, 2004, BIOCHEM BIOPH RES CO, V323, P845, DOI 10.1016/j.bbrc.2004.08.163; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; Rehrauer WM, 1996, J BIOL CHEM, V271, P11996, DOI 10.1074/jbc.271.20.11996; Sheng DH, 2008, EXTREMOPHILES, V12, P147, DOI 10.1007/s00792-007-0113-y; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; STORY RM, 1993, SCIENCE, V259, P1892, DOI 10.1126/science.8456313; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Wang TF, 2008, BIOESSAYS, V30, P1254, DOI 10.1002/bies.20850; Wang TF, 2008, BIOESSAYS, V30, P48, DOI 10.1002/bies.20694; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; YU X, 1990, BIOPHYS J, V57, P555, DOI 10.1016/S0006-3495(90)82571-6	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4890	10.1371/journal.pone.0004890	http://dx.doi.org/10.1371/journal.pone.0004890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295907	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496700004
J	Flores, I; Blasco, MA				Flores, Ignacio; Blasco, Maria A.			A p53-Dependent Response Limits Epidermal Stem Cell Functionality and Organismal Size in Mice with Short Telomeres	PLOS ONE			English	Article								Telomere maintenance is essential to ensure proper size and function of organs with a high turnover. In particular, a dwarf phenotype as well as phenotypes associated to premature loss of tissue regeneration, including the skin (hair loss, hair graying, decreased wound healing), are found in mice deficient for telomerase, the enzyme responsible for maintaining telomere length. Coincidental with the appearance of these phenotypes, p53 is found activated in several tissues from these mice, where is thought to trigger cellular senescence and/or apoptotic responses. Here, we show that p53 abrogation rescues both the small size phenotype and restitutes the functionality of epidermal stem cells (ESC) of telomerase-deficient mice with dysfunctional telomeres. In particular, p53 ablation restores hair growth, skin renewal and wound healing responses upon mitogenic induction, as well as rescues ESCmobilization defects in vivo and defective ESC clonogenic activity in vitro. This recovery of ESC functions is accompanied by a downregulation of senescence markers and an increased proliferation in the skin and kidney of telomerase-deficient mice with critically short telomeres without changes in apoptosis rates. Together, these findings indicate the existence of a p53-dependent senescence response acting on stem/progenitor cells with dysfunctional telomeres that is actively limiting their contribution to tissue regeneration, thereby impinging on tissue fitness.	[Flores, Ignacio; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Flores, I (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain.	mblasco@cnio.es	Flores, Ignacio/E-8304-2016; Blasco, Maria A./M-1694-2014	Flores, Ignacio/0000-0001-8789-6396; Blasco, Maria A./0000-0002-4211-233X	MCyT [SAF2005-00277, GEN2001-4856-C13-08]; Regional Government of Madrid [GR/SAL/0597/2004]; European Union [FIGH-CT-2002-00217, LSHC-CT-2003-506803, FOOD-CT-2003-506850, RISC-RAD FI6R-CT-2003-508842, LSHC-CT-2004-502943]; Spanish Association Against Cancer (AECC)	MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); Spanish Association Against Cancer (AECC)	M. A. Blasco laboratory is funded by the MCyT (SAF2005-00277, GEN2001-4856-C13-08), by the Regional Government of Madrid (GR/SAL/0597/2004), European Union (TELOSENS FIGH-CT-2002-00217, INTACT LSHC-CT-2003-506803, ZINCAGE FOOD-CT-2003-506850, RISC-RAD FI6R-CT-2003-508842, MOL CANCER MED LSHC-CT-2004-502943) and the Spanish Association Against Cancer (AECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; FLORES I, 2008, GENES DEV; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Krishnamurthy Janakiraman, 2007, Cell Stem Cell, V1, P9, DOI 10.1016/j.stem.2007.05.004; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Maser RS, 2004, DNA REPAIR, V3, P979, DOI 10.1016/j.dnarep.2004.05.009; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Siegl-Cachedenier I, 2007, J CELL BIOL, V179, P277, DOI 10.1083/jcb.200704141; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019	46	54	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4934	10.1371/journal.pone.0004934	http://dx.doi.org/10.1371/journal.pone.0004934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295915	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496700008
J	Haley, NJ; Seelig, DM; Zabel, MD; Telling, GC; Hoover, EA				Haley, Nicholas J.; Seelig, Davis M.; Zabel, Mark D.; Telling, Glenn C.; Hoover, Edward A.			Detection of CWD Prions in Urine and Saliva of Deer by Transgenic Mouse Bioassay	PLOS ONE			English	Article								Chronic wasting disease (CWD) is a prion disease affecting captive and free-ranging cervids (e. g. deer, elk, and moose). The mechanisms of CWD transmission are poorly understood, though bodily fluids are thought to play an important role. Here we report the presence of infectious prions in the urine and saliva of deer with chronic wasting disease (CWD). Prion infectivity was detected by bioassay of concentrated, dialyzed urine and saliva in transgenic mice expressing the cervid PrP gene (Tg[CerPrP] mice). In addition, PrPCWD was detected in pooled and concentrated urine by protein misfolding cyclic amplification (PMCA). The concentration of abnormal prion protein in bodily fluids was very low, as indicated by: undetectable PrPCWD levels by traditional assays (western blot, ELISA) and prolonged incubation periods and incomplete TSE attack rates in inoculated Tg(CerPrP) mice (373(+/-)3days in 2 of 9 urine-inoculated mice and 342(+/-)109 days in 8 of 9 saliva-inoculated mice). These findings help extend our understanding of CWD prion shedding and transmission and portend the detection of infectious prions in body fluids in other prion infections.	[Haley, Nicholas J.; Seelig, Davis M.; Zabel, Mark D.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Telling, Glenn C.] Univ Kentucky, Dept Mol Biol & Genet, Lexington, KY 40506 USA	Colorado State University; University of Kentucky	Haley, NJ (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Edward.Hoover@colostate.edu	Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805	NIH/NCRR Ruth L. Kirschstein Institutional [T32 R07072-03]; NIH/NIAID [NO1-AI-25491-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491] Funding Source: NIH RePORTER	NIH/NCRR Ruth L. Kirschstein Institutional(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NCRR Ruth L. Kirschstein Institutional T32 R07072-03 and NIH/NIAID NO1-AI-25491-02 (EAH, GCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskaia O, 2008, J VET DIAGN INVEST, V20, P141, DOI 10.1177/104063870802000201; ARCHIBALD DW, 1990, AIDS RES HUM RETROV, V6, P1425, DOI 10.1089/aid.1990.6.1425; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Gresham A, 2008, VET REC, V162, P525, DOI 10.1136/vr.162.16.525-c; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Hamir AN, 2006, J VET DIAGN INVEST, V18, P110, DOI 10.1177/104063870601800118; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Harnir AN, 2008, CAN J VET RES, V72, P63; Johnson C, 2003, J WILDLIFE DIS, V39, P576, DOI 10.7589/0090-3558-39.3.576; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Nacar A, 2008, RENAL FAILURE, V30, P507, DOI 10.1080/08860220802064713; O'Rourke KI, 2007, NEUROREPORT, V18, P1935, DOI 10.1097/WNR.0b013e3282f1ca2f; OCHERT AS, 1994, PCR METH APPL, V3, P365; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Siso S, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327-b; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105	36	164	167	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4848	10.1371/journal.pone.0004848	http://dx.doi.org/10.1371/journal.pone.0004848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293928	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496600003
J	Graziano, M; Sigman, M				Graziano, Martin; Sigman, Mariano			The Spatial and Temporal Construction of Confidence in the Visual Scene	PLOS ONE			English	Article							ICONIC MEMORY; CONSCIOUSNESS; ERRORS; RECOGNITION; PERCEPTION; RESOLUTION; ATTENTION; AWARENESS; STORAGE	Human subjects can report many items of a cluttered field a few hundred milliseconds after stimulus presentation. This memory decays rapidly and after a second only 3 or 4 items can be stored in working memory. Here we compared the dynamics of objective performance with a measure of subjective report and we observed that 1) Objective performance beyond explicit subjective reports (blindsight) was significantly more pronounced within a short temporal interval and within specific locations of the visual field which were robust across sessions 2) High confidence errors (False beliefs) were largely confined to a small spatial window neighboring the cue. The size of this window did not change in time 3) Subjective confidence showed a moderate but consistent decrease with time, independent of all other experimental factors. Our study allowed us to asses quantitatively the temporal and spatial access to an objective response and to subjective reports.	[Graziano, Martin; Sigman, Mariano] Univ Buenos Aires, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Graziano, M (corresponding author), Univ Buenos Aires, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina.	sigman@df.uba.ar		Graziano, Martin/0000-0002-6876-7211	Human Frontiers Science Program; SECYT, PICT [38366]; National Research Council of Argentina (CONICET) [fellowship]	Human Frontiers Science Program(Human Frontier Science Program); SECYT, PICT(ANPCyTSecretaria de Ciencia y Tecnologia (SECYT)); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by the Human Frontiers Science Program and by the SECYT, PICT 38366. MG has a fellowship of the National Research Council of Argentina (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars B.J., 1989, COGNITIVE THEORY CON; Baldassi S, 2006, PLOS BIOL, V4, P387, DOI 10.1371/journal.pbio.0040056; Block N, 2007, BEHAV BRAIN SCI, V30, P481, DOI 10.1017/S0140525X07002786; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter RM, 2003, P NATL ACAD SCI USA, V100, P1399, DOI 10.1073/pnas.0334049100; CHOW SL, 1991, J GEN PSYCHOL, V118, P147, DOI 10.1080/00221309.1991.9711140; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen L, 1998, BRAIN, V121, P1641, DOI 10.1093/brain/121.9.1641; CORALLO G, 2008, PSYCHOL SCI IN PRESS; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DICK AO, 1969, J EXP PSYCHOL, V82, P279, DOI 10.1037/h0028147; Fang F, 2008, J VISION, V8, DOI 10.1167/8.9.6; FERRAND L, 1994, MEM COGNITION, V22, P431, DOI 10.3758/BF03200868; GEGENFURTNER KR, 1993, J EXP PSYCHOL HUMAN, V19, P845, DOI 10.1037/0096-1523.19.4.845; Graziano M, 2008, J VISION, V8, DOI 10.1167/8.5.9; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; HAGENAAR R, 1995, ACTA PSYCHOL, V88, P89, DOI 10.1016/0001-6918(94)E0062-K; Hagenaar R, 1997, MEM COGNITION, V25, P641, DOI 10.3758/BF03211305; Hazeltine RE, 1997, J EXP PSYCHOL HUMAN, V23, P263; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Koch Christof, 2004, QUEST CONSCIOUSNESS; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; Latimer C, 2000, Q J EXP PSYCHOL-A, V53, P765, DOI 10.1080/027249800410544; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Mack A., 1998, INATTENTIONAL BLINDN; Mattler U, 2005, PERCEPT PSYCHOPHYS, V67, P285, DOI 10.3758/BF03206492; MCKONE E, 1995, J EXP PSYCHOL LEARN, V21, P1108, DOI 10.1037/0278-7393.21.5.1108; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; MEWHORT DJK, 1981, MEM COGNITION, V9, P50, DOI 10.3758/BF03196951; MISHKIN M, 1952, J EXP PSYCHOL, V43, P43, DOI 10.1037/h0061361; Neisser U., 1967, COGNITIVE PSYCHOL; OSTROSKYSOLIS F, 1991, BRAIN COGNITION, V17, P42, DOI 10.1016/0278-2626(91)90065-G; Overgaard M, 2006, CONSCIOUS COGN, V15, P629, DOI 10.1016/j.concog.2006.10.004; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Popple AV, 2007, VISION RES, V47, P2973, DOI 10.1016/j.visres.2007.06.022; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Szczepanowski R, 2007, J VISION, V7, DOI 10.1167/7.4.10; TOWNSEND VM, 1973, J EXP PSYCHOL, V98, P113, DOI 10.1037/h0034309; Watanabe K, 2002, VISION RES, V42, P2645, DOI 10.1016/S0042-6989(02)00296-1; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; WOLFORD G, 1980, PERCEPT PSYCHOPHYS, V27, P409, DOI 10.3758/BF03204459	51	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4909	10.1371/journal.pone.0004909	http://dx.doi.org/10.1371/journal.pone.0004909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290055	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496500010
J	Shao, JL; Xu, D; Tsai, SN; Wang, YF; Ngai, SM				Shao, Jianlin; Xu, Dong; Tsai, Sau-Na; Wang, Yifei; Ngai, Sai-Ming			Computational Identification of Protein Methylation Sites through Bi-Profile Bayes Feature Extraction	PLOS ONE			English	Article							ARGININE METHYLATION; HIV-1 TAT; PREDICTION	Protein methylation is one type of reversible post-translational modifications (PTMs), which plays vital roles in many cellular processes such as transcription activity, DNA repair. Experimental identification of methylation sites on proteins without prior knowledge is costly and time-consuming. In silico prediction of methylation sites might not only provide researches with information on the candidate sites for further determination, but also facilitate to perform downstream characterizations and site-specific investigations. In the present study, a novel approach based on Bi-profile Bayes feature extraction combined with support vector machines (SVMs) was employed to develop the model for Prediction of Protein Methylation Sites (BPB-PPMS) from primary sequence. Methylation can occur at many residues including arginine, lysine, histidine, glutamine, and proline. For the present, BPB-PPMS is only designed to predict the methylation status for lysine and arginine residues on polypeptides due to the absence of enough experimentally verified data to build and train prediction models for other residues. The performance of BPB-PPMS is measured with a sensitivity of 74.71%, a specificity of 94.32% and an accuracy of 87.98% for arginine as well as a sensitivity of 70.05%, a specificity of 77.08% and an accuracy of 75.51% for lysine in 5-fold cross validation experiments. Results obtained from cross-validation experiments and test on independent data sets suggest that BPB-PPMS presented here might facilitate the identification and annotation of protein methylation. Besides, BPB-PPMS can be extended to build predictors for other types of PTM sites with ease. For public access, BPB-PPMS is available at http://www.bioinfo.bio.cuhk.edu.hk/bpbppms.	[Shao, Jianlin; Tsai, Sau-Na; Ngai, Sai-Ming] Chinese Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Ngai, Sai-Ming] Chinese Univ Hong Kong, Inst Plant Mol Biol & Agr Biotechnol, Hong Kong, Peoples R China; [Xu, Dong] Shanghai Normal Univ, Dept Math & Sci Comput, Shanghai, Peoples R China; [Xu, Dong] Shanghai Normal Univ, Key Lab, Shanghai, Peoples R China; [Wang, Yifei] Shanghai Univ, Dept Math, Shanghai 200444, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Shanghai Normal University; Shanghai Normal University; Shanghai University	Shao, JL (corresponding author), Chinese Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	smngai@cuhk.edu.hk	Ngai, Sai Ming/S-4898-2018	Ngai, Sai Ming/0000-0002-4484-2483	University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/B-07/99]	University Grants Committee of the Hong Kong Special Administrative Region, China	The work described in this paper was supported by a grant from the University Grants Committee of the Hong Kong Special Administrative Region, China (Project No. AoE/B-07/99). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; Chang C.-C., LIBSVM LIB SUPPORT V; Chen H, 2006, NUCLEIC ACIDS RES, V34, pW249, DOI 10.1093/nar/gkl233; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Daily KM, 2005, PROCEEDINGS OF THE 2005 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P475; Grant JE, 2007, J PROTEOME RES, V6, P2786, DOI 10.1021/pr070013c; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; Vapnik V., 2013, NATURE STAT LAERNING; Wang CL, 2006, BIOINFORMATICS, V22, P2590, DOI 10.1093/bioinformatics/btl441; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Xie BD, 2003, J VIROL, V77, P1984, DOI 10.1128/JVI.77.3.1984-1991.2003; Yousef M, 2007, BIOINFORMATICS, V23, P2987, DOI 10.1093/bioinformatics/btm484	22	145	145	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4920	10.1371/journal.pone.0004920	http://dx.doi.org/10.1371/journal.pone.0004920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290060	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496500014
J	Lortie, CJ; Munshaw, M; Zikovitz, A; Hierro, J				Lortie, Christopher J.; Munshaw, Michael; Zikovitz, Andrea; Hierro, Jose			Cage Matching: Head to Head Competition Experiments of an Invasive Plant Species from Different Regions as a Means to Test for Differentiation	PLOS ONE			English	Article							STARTHISTLE CENTAUREA-SOLSTITIALIS; YELLOW STARTHISTLE; DYNAMICS; COMMUNITY; DENSITY; POPULATION; RESISTANCE; EVOLUTION; HISTORY; ACHENES	Many hypotheses are prevalent in the literature predicting why some plant species can become invasive. However, in some respects, we lack a standard approach to compare the breadth of various studies and differentiate between alternative explanations. Furthermore, most of these hypotheses rely on 'changes in density' of an introduced species to infer invasiveness. Here, we propose a simple method to screen invasive plant species for potential differences in density effects between novel regions. Studies of plant competition using density series are a fundamental tool applied to virtually every aspect of plant population ecology to better understand evolution. Hence, we use a simple density series with substitution contrasting the performance of Centaurea solstitialis in monoculture (from one region) to mixtures (seeds from two regions). All else being equal, if there is no difference between the introduced species in the two novel regions compared, Argentina and California, then there should be no competitive differences between intra and inter-regional competition series. Using a replicated regression design, seeds of each species were sown in the greenhouse at 5 densities in monoculture and mixed and grown till onset of flowering. Centaurea seeds from California had higher germination while seedlings had significantly greater survival than Argentina. There was no evidence for density dependence in any measure for the California region but negative density dependence was detected in the germination of seeds from Argentina. The relative differences in competition also differed between regions with no evidence of differential competitive effects of seeds from Argentina in mixture versus monoculture while seeds from California expressed a relative cost in germination and relative growth rate in mixtures with Argentina. In the former instance, lack of difference does not mean 'no ecological differences' but does suggest that local adaptation in competitive abilities has not occurred. Importantly, this method successfully detected differences in the response of an invasive species to changes in density between novel regions which suggests that it is a useful preliminary means to explore invasiveness.	[Lortie, Christopher J.; Munshaw, Michael] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Zikovitz, Andrea] Univ Toronto, Toronto, ON, Canada; [Hierro, Jose] Univ La Pampa, Conicet, Santa Rosa, La Pampa, Argentina	York University - Canada; University of Toronto; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lortie, CJ (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	lortie@yorku.ca	lortie, christopher j/F-6241-2014	lortie, christopher j/0000-0002-4291-7023	NSERC [Discovery Grant]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	An NSERC Discovery Grant to Dr. Lortie funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Bakker J, 2001, PLANT ECOL, V157, P117, DOI 10.1023/A:1013972403293; Benefield CB, 2001, WEED SCI, V49, P83, DOI 10.1614/0043-1745(2001)049[0083:RBOYSM]2.0.CO;2; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Carrete M, 2008, OIKOS, V117, P1115, DOI 10.1111/j.0030-1299.2008.16968.x; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; D'Antonio C.M., 1999, ECOSYSTEMOSF DKTURBE, P413; D'Antonio CM, 2001, ECOLOGY, V82, P89, DOI 10.1890/0012-9658(2001)082[0089:FIDOTI]2.0.CO;2; Dyer AR, 2000, ECOL LETT, V3, P523, DOI 10.1046/j.1461-0248.2000.00187.x; Ewel JJ., 1986, ECOLOGY BIOL INVASIO, P214, DOI DOI 10.1007/978-1-4612-4988-7_13; Figueroa ME, 2003, J ECOL, V91, P616, DOI 10.1046/j.1365-2745.2003.00794.x; Genton BJ, 2005, OECOLOGIA, V146, P404, DOI 10.1007/s00442-005-0234-x; GERLACH JD, 2003, ECOLOGICAL APPL, V13; Gibson DJ, 1999, J ECOL, V87, P1, DOI 10.1046/j.1365-2745.1999.00321.x; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hierro JL, 2006, AM NAT, V168, P144, DOI 10.1086/505767; Joley DB, 2003, CAN J BOT, V81, P993, DOI [10.1139/B03-093, 10.1139/b03-093]; JOLEY DB, 1992, WEED SCI, V40, P190, DOI 10.1017/S0043174500057209; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Lortie CJ, 2002, J ECOL, V90, P435, DOI 10.1046/j.1365-2745.2002.00686.x; MacDougall AS, 2006, J VEG SCI, V17, P47, DOI 10.1111/j.1654-1103.2006.tb02422.x; MacDougall AS, 2004, J ECOL, V92, P422, DOI 10.1111/j.0022-0477.2004.00886.x; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; MADDOX DM, 1985, WEED SCI, V33, P315, DOI 10.1017/S0043174500082357; Maron JL, 2004, ECOLOGY, V85, P3243, DOI 10.1890/04-0297; Meirmans PG, 2003, J EVOLUTION BIOL, V16, P343, DOI 10.1046/j.1420-9101.2003.00515.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Pauchard A, 2004, DIVERS DISTRIB, V10, P371, DOI 10.1111/j.1366-9516.2004.00116.x; PITCAIRN MJ, 1998, BIOL CONTROL PROGRAM; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2007, DIVERS DISTRIB, V13, P299, DOI 10.1111/j.1472-4642.2007.00337.x; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; SHELEY RL, 1994, J RANGE MANAGE, V47, P450, DOI 10.2307/4002995; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Von Holle B, 2005, J ECOL, V93, P16, DOI 10.1111/j.0022-0477.2004.00946.x; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; Willis AJ, 2000, ECOL LETT, V3, P275, DOI 10.1046/j.1461-0248.2000.00149.x	42	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4823	10.1371/journal.pone.0004823	http://dx.doi.org/10.1371/journal.pone.0004823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283070	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496300006
J	Lawo, NC; Wackers, FL; Romeis, J				Lawo, Nora C.; Wackers, Felix L.; Romeis, Jorg			Indian Bt Cotton Varieties Do Not Affect the Performance of Cotton Aphids	PLOS ONE			English	Article							HONEYDEW SUGAR COMPOSITION; PROPYLAEA-JAPONICA COLEOPTERA; NONTARGET HERBIVORE; GOSSYPII HOMOPTERA; EXTRAFLORAL NECTAR; NUTRITIONAL STATE; TRANSGENIC CROPS; FOOD SOURCE; PHLOEM SAP; INSECT	Cotton varieties expressing Cry proteins derived from the soil bacterium Bacillus thuringiensis (Bt) are grown worldwide for the management of pest Lepidoptera. To prevent non-target pest outbreaks and to retain the biological control function provided by predators and parasitoids, the potential risk that Bt crops may pose to non-target arthropods is addressed prior to their commercialization. Aphids play an important role in agricultural systems since they serve as prey or host to a number of predators and parasitoids and their honeydew is an important energy source for several arthropods. To explore possible indirect effects of Bt crops we here examined the impact of Bt cotton on aphids and their honeydew. In climate chambers we assessed the performance of cotton aphids, Aphis gossypii Glover (Hemiptera: Aphididae) when grown on three Indian Bt (Cry1Ac) cotton varieties (MECH 12, MECH 162, MECH 184) and their non-transformed near isolines. Furthermore, we examined whether aphids pick up the Bt protein and analyzed the sugar composition of aphid honeydew to evaluate its suitability for honeydew-feeders. Plant transformation did not have any influence on aphid performance. However, some variation was observed among the three cotton varieties which might partly be explained by the variation in trichome density. None of the aphid samples contained Bt protein. As a consequence, natural enemies that feed on aphids are not exposed to the Cry protein. A significant difference in the sugar composition of aphid honeydew was detected among cotton varieties as well as between transformed and non-transformed plants. However, it is questionable if this variation is of ecological relevance, especially as honeydew is not the only sugar source parasitoids feed on in cotton fields. Our study allows the conclusion that Bt cotton poses a negligible risk for aphid antagonists and that aphids should remain under natural control in Bt cotton fields.	[Lawo, Nora C.; Romeis, Jorg] Agroscope Reckenholz Tanikon Res Stn ART Zurich, Zurich, Switzerland; [Wackers, Felix L.] Univ Lancaster, Lancaster LA1 4YW, England	Swiss Federal Research Station Agroscope; Lancaster University	Lawo, NC (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART Zurich, Zurich, Switzerland.	joerg.romeis@art.admin.ch	Romeis, Joerg/J-5360-2013	Romeis, Joerg/0000-0003-3652-8360	Swiss Agency for Development and Cooperation (SDC) in Berne, Switzerland; Department of Biotechnology (DBT) in Delhi, India	Swiss Agency for Development and Cooperation (SDC) in Berne, Switzerland; Department of Biotechnology (DBT) in Delhi, India(Department of Biotechnology (DBT) India)	The study was compiled within the Pulse Network of the Indo-Swiss Collaboration in Biotechnology (ISCB). The study was funded by the Swiss Agency for Development and Cooperation (SDC) in Berne, Switzerland, and the Department of Biotechnology (DBT) in Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 1998, APPL ENTOMOL ZOOL, V33, P357, DOI 10.1303/aez.33.357; Ashford DA, 2000, J INSECT PHYSIOL, V46, P335, DOI 10.1016/S0022-1910(99)00186-9; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bambawale OM, 2004, CURR SCI INDIA, V86, P1628; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Bourguet Denis, 2002, Environmental Biosafety Research, V1, P49, DOI 10.1051/ebr:2002005; Brookes G., 2008, AgBioForum, V11, P21; Burgio G, 2007, B ENTOMOL RES, V97, P211, DOI 10.1017/S0007485307004920; BYRNE DN, 1990, J INSECT PHYSIOL, V36, P433, DOI 10.1016/0022-1910(90)90061-J; Costa HS, 1999, J ENTOMOL SCI, V34, P305, DOI 10.18474/0749-8004-34.3.305; Cui Jinjie, 2000, Acta Phytophylacica Sinica, V27, P141; Davison AC, 1997, BOOTSTRAP METHODS TH; Deng Shu-Dong, 2003, Acta Entomologica Sinica, V46, P1; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; Fadamiro HY, 2001, ANN ENTOMOL SOC AM, V94, P909, DOI 10.1603/0013-8746(2001)094[0909:EOPSDO]2.0.CO;2; Faria CA, 2008, BASIC APPL ECOL, V9, P286, DOI 10.1016/j.baae.2007.02.001; Faria CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000600; Fischer MK, 2002, J INSECT PHYSIOL, V48, P319, DOI 10.1016/S0022-1910(01)00179-2; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Fitt Gary P., 2008, V5, P303, DOI 10.1007/978-1-4020-8373-0_11; FORRESTER NW, 1993, B ENTOMOL RES, pR1; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Head G, 2001, ENTOMOL EXP APPL, V99, P37, DOI 10.1023/A:1018913429026; HENDRIX DL, 1992, COMP BIOCHEM PHYS B, V101, P23, DOI 10.1016/0305-0491(92)90153-I; Hogervorst PAM, 2007, FUNCT ECOL, V21, P936, DOI 10.1111/j.1365-2435.2007.01297.x; Hogervorst PAM, 2007, ENTOMOL EXP APPL, V122, P223, DOI 10.1111/j.1570-7458.2006.00505.x; Hogervorst PAM, 2009, AGR FOREST ENTOMOL, V11, P161, DOI 10.1111/j.1461-9563.2008.00412.x; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Liu XD, 2005, ECOL ENTOMOL, V30, P307, DOI 10.1111/j.0307-6946.2005.00690.x; Lozzia G. C., 1998, Bollettino di Zoologia Agraria e di Bachicoltura, V30, P153; Lumbierres B, 2004, ECOL ENTOMOL, V29, P309, DOI 10.1111/j.0307-6946.2004.00597.x; Mellet MA, 2007, INDIAN J EXP BIOL, V45, P554; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Obrist LB, 2005, ENTOMOL EXP APPL, V115, P409, DOI 10.1111/j.1570-7458.2005.00298.x; Pons X, 2005, EUR J ENTOMOL, V102, P73, DOI 10.14411/eje.2005.010; Qaim M, 2006, REV AGR ECON, V28, P48, DOI 10.1111/j.1467-9353.2006.00272.x; Qaim Matin, 2008, V5, P329, DOI 10.1007/978-1-4020-8373-0_12; Ramirez-Romero R, 2008, PESTIC BIOCHEM PHYS, V91, P110, DOI 10.1016/j.pestbp.2008.01.010; Raps A, 2001, MOL ECOL, V10, P525, DOI 10.1046/j.1365-294x.2001.01236.x; Romeis J, 2009, ENVIRONMENTAL IMPACT OF GENETICALLY MODIFIED CROPS, P165, DOI 10.1079/9781845934095.0165; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2003, OECOLOGIA, V134, P528, DOI 10.1007/s00442-002-1144-9; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Schuler TH, 2005, B ENTOMOL RES, V95, P243, DOI 10.1079/BER2004356; Schuler TH, 2001, MOL ECOL, V10, P1845, DOI 10.1046/j.0962-1083.2001.01309.x; Siekmann G, 2001, OIKOS, V95, P425, DOI 10.1034/j.1600-0706.2001.950307.x; Stapel JO, 1997, ENVIRON ENTOMOL, V26, P617, DOI 10.1093/ee/26.3.617; Steppuhn A, 2004, FUNCT ECOL, V18, P812, DOI 10.1111/j.0269-8463.2004.00920.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Teran-Vargas AP, 2005, J ECON ENTOMOL, V98, P2203, DOI 10.1603/0022-0493-98.6.2203; Torres JB, 2008, TRANSGENIC RES, V17, P345, DOI 10.1007/s11248-007-9109-8; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; Volkl W, 1999, OECOLOGIA, V118, P483, DOI 10.1007/s004420050751; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Wackers FL, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P17, DOI 10.1017/CBO9780511542220.003; Wackers FL, 2004, ECOLOGY, V85, P1512, DOI 10.1890/03-0422; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; WEATHERSBEE AA, 1994, J ECON ENTOMOL, V87, P258, DOI 10.1093/jee/87.1.258; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; Winkler K, 2006, BASIC APPL ECOL, V7, P133, DOI 10.1016/j.baae.2005.06.001; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Xue K, 2008, SCI CHINA SER C, V51, P145, DOI 10.1007/s11427-008-0028-6; Yao I, 2001, OECOLOGIA, V128, P36, DOI 10.1007/s004420100633; Zhang GF, 2006, ENVIRON ENTOMOL, V35, P143, DOI 10.1603/0046-225X-35.1.143; Zhang GF, 2008, ENVIRON ENTOMOL, V37, P1035, DOI 10.1603/0046-225X(2008)37[1035:RBOTNI]2.0.CO;2	72	67	73	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4804	10.1371/journal.pone.0004804	http://dx.doi.org/10.1371/journal.pone.0004804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279684	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496200001
J	Higashi, M; Ishikawa, C; Yu, JY; Toyoda, A; Kawana, H; Kurokawa, K; Matsuda, M; Kitagawa, M; Harigaya, K				Higashi, Morihiro; Ishikawa, Chieko; Yu, Jianyong; Toyoda, Akihiro; Kawana, Hidetada; Kurokawa, Kazuo; Matsuda, Michiyuki; Kitagawa, Motoo; Harigaya, Kenichi			Human Mena Associates with Rac1 Small GTPase in Glioblastoma Cell Lines	PLOS ONE			English	Article								Mammarian enabled (Mena), a member of the Enabled (Ena)/Vasodilator-stimulated phosphoprotein (VASP) family of proteins, has been implicated in cell motility through regulation of the actin cytoskeleton assembly, including lamellipodial protrusion. Rac1, a member of the Rho family GTPases, also plays a pivotal role in the formation of lamellipodia. Here we report that human Mena (hMena) colocalizes with Rac1 in lamellipodia, and using an unmixing assisted acceptor depletion fluorescence resonance energy transfer (u-adFRET) analysis that hMena associates with Rac1 in vivo in the glioblastoma cell line U251MG. Depletion of hMena by siRNA causes cells to be highly spread with the formation of lamellipodia. This cellular phenotype is canceled by introduction of a dominant negative form of Rac1. A Rac activity assay and FRET analysis showed that hMena knock-down cells increased the activation of Rac1 at the lamellipodia. These results suggest that hMena possesses properties which help to regulate the formation of lamellipodia through the modulation of the activity of Rac1.	[Higashi, Morihiro; Ishikawa, Chieko; Yu, Jianyong; Toyoda, Akihiro; Kawana, Hidetada; Kitagawa, Motoo; Harigaya, Kenichi] Chiba Univ, Grad Sch Med, Chiba, Japan; [Kurokawa, Kazuo] RIKEN Discovery Res Inst, Mol Membrane Biol Lab, Wako, Saitama, Japan; [Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan	Chiba University; RIKEN; Kyoto University	Higashi, M (corresponding author), Chiba Univ, Grad Sch Med, Chiba, Japan.	harigaya@faculty.chiba-u.jp	Kurokawa, Kazuo/E-9130-2013; Kitagawa, Motoo/W-8468-2019; Higashi, Morihiro/AAN-3575-2020	Kurokawa, Kazuo/0000-0003-3549-4795; Kitagawa, Motoo/0000-0003-1036-840X; Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science and Technology, Japan [12215018]; Japan Society for the Promotion of Science [13670163]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research Priority Area 12215018 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K.H.) and a Grant-in-Aid for Scientific Research 13670163 from the Japan Society for the Promotion of Science (to K.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di WL, 2005, J CELL SCI, V118, P1505, DOI 10.1242/jcs.01733; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Gambaryan S, 2001, HISTOCHEM CELL BIOL, V116, P535, DOI 10.1007/s00418-001-0353-3; GEIGER B, 1984, J CELL BIOL, V99, pS83, DOI 10.1083/jcb.99.1.83s; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Giesemann T, 2003, J NEUROSCI, V23, P8330; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Machesky LM, 2002, NATURE, V417, P494, DOI 10.1038/417494a; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Ridley AJ, 2001, J CELL SCI, V114, P2713; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	48	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4765	10.1371/journal.pone.0004765	http://dx.doi.org/10.1371/journal.pone.0004765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277120	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496100010
J	Scambi, C; De Franceschi, L; Guarini, P; Poli, F; Siciliano, A; Pattini, P; Biondani, A; La Verde, V; Bortolami, O; Turrini, F; Carta, F; D'Orazio, C; Assael, BM; Faccini, G; Bambara, LM				Scambi, Cinzia; De Franceschi, Lucia; Guarini, Patrizia; Poli, Fabio; Siciliano, Angela; Pattini, Patrizia; Biondani, Andrea; La Verde, Valentina; Bortolami, Oscar; Turrini, Francesco; Carta, Franco; D'Orazio, Ciro; Assael, Baroukh M.; Faccini, Giovanni; Bambara, Lisa M.			Preliminary Evidence for Cell Membrane Amelioration in Children with Cystic Fibrosis by 5-MTHF and Vitamin B12 Supplementation: A Single Arm Trial	PLOS ONE			English	Article								Background: Cystic fibrosis (CF) is one of the most common fatal autosomal recessive disorders in the Caucasian population caused by mutations of gene for the cystic fibrosis transmembrane conductance regulator (CFTR). New experimental therapeutic strategies for CF propose a diet supplementation to affect the plasma membrane fluidity and to modulate amplified inflammatory response. The objective of this study was to evaluate the efficacy of 5-methyltetrahydrofolate (5-MTHF) and vitamin B12 supplementation for ameliorating cell plasma membrane features in pediatric patients with cystic fibrosis. Methodology and Principal Findings: A single arm trial was conducted from April 2004 to March 2006 in an Italian CF care centre. 31 children with CF aged from 3 to 8 years old were enrolled. Exclusion criteria were diabetes, chronic infections of the airways and regular antibiotics intake. Children with CF were supplemented for 24 weeks with 5-methyltetrahydrofolate (5-MTHF, 7.5 mg/day) and vitamin B12 (0.5 mg/day). Red blood cells (RBCs) were used to investigate plasma membrane, since RBCs share lipid, protein composition and organization with other cell types. We evaluated RBCs membrane lipid composition, membrane protein oxidative damage, cation content, cation transport pathways, plasma and RBCs folate levels and plasma homocysteine levels at baseline and after 24 weeks of 5-MTHF and vitamin B12 supplementation. In CF children, 5-MTHF and vitamin B12 supplementation (i) increased plasma and RBC folate levels; (ii) decreased plasma homocysteine levels; (iii) modified RBC membrane phospholipid fatty acid composition; (iv) increased RBC K(+) content; (v) reduced RBC membrane oxidative damage and HSP70 membrane association. Conclusion and Significance: 5-MTHF and vitamin B12 supplementation might ameliorate RBC membrane features of children with CF.	[Scambi, Cinzia; De Franceschi, Lucia; Guarini, Patrizia; Poli, Fabio; Siciliano, Angela; Pattini, Patrizia; Biondani, Andrea; La Verde, Valentina; Bambara, Lisa M.] Univ Verona, Sect Rheumatol & Internal Med, Dept Clin & Expt Med, I-37100 Verona, Italy; [Bortolami, Oscar] Univ Verona, Dept Med & Publ Hlth, Unit Epidemiol & Med Stat, I-37100 Verona, Italy; [Turrini, Francesco] Univ Turin, Dept Genet Biol & Med Chem, Sect Med Chem, I-10124 Turin, Italy; [Carta, Franco] Nurex, Sassari, Italy; [D'Orazio, Ciro; Assael, Baroukh M.] Hosp Verona, Ctr Cystic Fibrosis Care, Verona, Italy; [Faccini, Giovanni] Univ Verona, Dept Biomed & Morphol Sci, Sect Clin Chem, I-37100 Verona, Italy	University of Verona; University of Verona; University of Turin; University of Verona	Scambi, C (corresponding author), Univ Verona, Sect Rheumatol & Internal Med, Dept Clin & Expt Med, I-37100 Verona, Italy.	cinzia.scambi@medicina.univr.it	Bortolami, Oscar/E-9219-2016; DE FRANCESCHI, Lucia/AAB-8652-2022; Bortolami, Oscar/H-6559-2019	Bortolami, Oscar/0000-0002-4346-9672; DE FRANCESCHI, Lucia/0000-0001-7093-777X; Bortolami, Oscar/0000-0002-4346-9672; carta, franco/0000-0001-7776-8243; D'Orazio, Ciro/0000-0001-5259-4371	MIUR (Ministero Ricerca Universitaria)	MIUR (Ministero Ricerca Universitaria)(Ministry of Education, Universities and Research (MIUR))	Supported by MIUR (Ministero Ricerca Universitaria) ex 60% for Lisa Maria Bambara and Lucia De Franceschi. The funder (MIUR)had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EH, 2001, BLOOD CELL MOL DIS, V27, P165, DOI 10.1006/bcmd.2000.0357; Agarwal R, 2002, J CHROMATOGR B, V775, P121, DOI 10.1016/S1570-0232(02)00273-8; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; Barbero G, 2006, ANAL BIOCHEM, V349, P62, DOI 10.1016/j.ab.2005.10.020; Beharry S, 2007, AM J PHYSIOL-GASTR L, V292, pG839, DOI 10.1152/ajpgi.00582.2005; Benabdeslam H, 1999, CLIN CHEM LAB MED, V37, P511, DOI 10.1515/CCLM.1999.082; Bhura-Bandali FN, 2000, J NUTR, V130, P2870, DOI 10.1093/jn/130.12.2870; Bostom AG, 2000, CIRCULATION, V101, P2829, DOI 10.1161/01.CIR.101.24.2829; Boyle MP, 2007, JAMA-J AM MED ASSOC, V298, P1787, DOI 10.1001/jama.298.15.1787; CARBONNEAU MA, 1991, CLIN CHEM, V37, P1423; DAVIS PB, 1986, PEDIATR RES, V2, P1290; Decherf G, 2007, BLOOD CELL MOL DIS, V39, P24, DOI 10.1016/j.bcmd.2007.02.014; DeFranceschi L, 1997, J CLIN INVEST, V100, P1847, DOI 10.1172/JCI119713; DEFRANCESCHI L, 1995, EUR J CLIN INVEST, V25, P762, DOI 10.1111/j.1365-2362.1995.tb01955.x; Durieu I, 2007, J CYST FIBROS, V6, P320, DOI 10.1016/j.jcf.2006.12.005; Eidelman O, 2002, BIOCHEMISTRY-US, V41, P11161, DOI 10.1021/bi020289s; FOUCARD T, 1991, ACTA PAEDIATR SCAND, V80, P57, DOI 10.1111/j.1651-2227.1991.tb11730.x; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; GABRIEL SE, 1993, NATURE, V363, P263, DOI 10.1038/363263a0; Girelli D, 2003, J NUTR, V133, P1281; GIRELLI D, 1992, CLIN CHIM ACTA, V211, P155, DOI 10.1016/0009-8981(92)90191-R; HOFFMAN DR, 1995, INVEST OPHTH VIS SCI, V36, P1009; Innis SM, 2003, J PEDIATR-US, V143, P351, DOI 10.1067/S0022-3476(03)00326-3; Ismailov II, 1996, J BIOL CHEM, V271, P4725; JAMES DR, 1991, CLIN CHIM ACTA, V204, P279, DOI 10.1016/0009-8981(91)90238-8; JOINER CH, 1988, PEDIATR RES, V24, P495, DOI 10.1203/00006450-198810000-00016; KATZ S, 1978, PEDIATR RES, V12, P1033, DOI 10.1203/00006450-197811000-00001; Lagrange-Puget M, 2004, PEDIATR PULM, V38, P43, DOI 10.1002/ppul.20041; Lamers Y, 2006, AM J CLIN NUTR, V84, P156, DOI 10.1093/ajcn/84.1.156; Lange T, 2006, MOL MEMBR BIOL, V23, P317, DOI 10.1080/09687860600738304; Laskowska-Klita T, 2001, ACTA BIOCHIM POL, V48, P283; LEPAGE G, 1986, J LIPID RES, V27, P114; Liang G, 2005, AM J PHYSIOL-HEART C, V288, pH1580, DOI 10.1152/ajpheart.00807.2004; Luczay A, 1997, ACTA PAEDIATR, V86, P245, DOI 10.1111/j.1651-2227.1997.tb08883.x; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Mander A, 2002, AM J RESP CELL MOL, V27, P714, DOI 10.1165/rcmb.4746; MANNU F, 1995, BLOOD, V86, P2014, DOI 10.1182/blood.V86.5.2014.bloodjournal8652014; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Paredi P, 2002, AM J RESP CRIT CARE, V166, pS31, DOI 10.1164/rccm.2206012; Percival SS, 1999, J AM COLL NUTR, V18, P614, DOI 10.1080/07315724.1999.10718896; Peters SA, 1996, J PEDIATR GASTR NUTR, V22, P341, DOI 10.1097/00005176-199605000-00001; Pietrzik K, 2007, AM J CLIN NUTR, V86, P1414, DOI 10.1093/ajcn/86.5.1414; Pita ML, 2000, THROMB HAEMOSTASIS, V84, P420; PUTNAM JC, 1982, AM J CLIN NUTR, V36, P106, DOI 10.1093/ajcn/36.1.106; Rezk BM, 2003, FEBS LETT, V555, P601, DOI 10.1016/S0014-5793(03)01358-9; REZNIK VM, 1986, BIOCHEM BIOPH RES CO, V137, P1021, DOI 10.1016/0006-291X(86)90327-X; Riordan J. R., 1989, SCIENCE, V245, P1066; Rivera A, 2006, AM J PHYSIOL-CELL PH, V291, pC880, DOI 10.1152/ajpcell.00436.2005; Rizvi SI, 2007, ANN NY ACAD SCI, V1100, P373, DOI 10.1196/annals.1395.041; Roncada P, 2005, PROTEOMICS, V5, P2331, DOI 10.1002/pmic.200401272; SALH B, 1989, CLIN CHIM ACTA, V181, P65, DOI 10.1016/0009-8981(89)90318-5; Scambi C, 2006, J CYST FIBROS, V5, P197, DOI 10.1016/j.jcf.2006.01.006; Scott JM, 1999, P NUTR SOC, V58, P441, DOI 10.1017/S0029665199000580; Smulders YM, 2006, BRIT J HAEMATOL, V132, P623, DOI 10.1111/j.1365-2141.2005.05913.x; Steghens JP, 1997, J CHROMATOGR B, V694, P71, DOI 10.1016/S0378-4347(97)00140-0; Sterling KM, 2004, J CELL BIOCHEM, V91, P1174, DOI 10.1002/jcb.20017; Strandvik B, 2004, NEW ENGL J MED, V350, P605, DOI 10.1056/NEJMe038217; Strandvik B, 1996, PROSTAG LEUKOTR ESS, V55, P419, DOI 10.1016/S0952-3278(96)90125-8; Strandvik B, 2001, J PEDIATR-US, V139, P650, DOI 10.1067/mpd.2001.118890; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; TACCONI M, 1985, P NATL ACAD SCI USA, V82, P4828, DOI 10.1073/pnas.82.14.4828; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; ULANE MM, 1994, CLIN CHIM ACTA, V230, P109, DOI 10.1016/0009-8981(94)90263-1; Venn BJ, 2003, AM J CLIN NUTR, V77, P658, DOI 10.1093/ajcn/77.3.658; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WINKLHOFERROOB BM, 1994, ACTA PAEDIATR, V83, P49, DOI 10.1111/j.1651-2227.1994.tb13229.x; Wood LG, 2002, AM J CLIN NUTR, V75, P668, DOI 10.1093/ajcn/75.4.668; Wood LG, 2001, J AM COLL NUTR, V20, P157, DOI 10.1080/07315724.2001.10719028; WU A, 1975, BRIT J HAEMATOL, V29, P469, DOI 10.1111/j.1365-2141.1975.tb01844.x; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102	74	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4782	10.1371/journal.pone.0004782	http://dx.doi.org/10.1371/journal.pone.0004782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277125	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496100012
J	Lai, A; Cairns, MJ; Tran, N; Zhang, HP; Cullen, L; Arndt, GM				Lai, Angela; Cairns, Murray J.; Tran, Nham; Zhang, Hong-Ping; Cullen, Lara; Arndt, Greg M.			RNA Modulators of Complex Phenotypes in Mammalian Cells	PLOS ONE			English	Article								RNA-mediated gene silencing, in the form of RNA interference (RNAi) or microRNAs (miRNAs) has provided novel tools for gene discovery and validation in mammalian cells. Here, we report on the construction and application of a random small RNA expression library for use in identifying small interfering RNA (siRNA) effectors that can modify complex cellular phenotypes in mammalian cells. The library is based in a retroviral vector and uses convergent promoters to produce unique small complementary RNAs. Using this library, we identify a range of small RNA-encoding gene inserts that overcome resistance to 5-fluorouracil (5-FU)-or tumour necrosis factor alpha (TNF-alpha)-induced cell death in colorectal cancer cells. We demonstrate the utility of this technology platform by identifying a key RNA effector, in the form of a siRNA, which overcomes cell death induced by the chemotherapeutic 5-FU. The technology described has the potential to identify both functional RNA modulators capable of altering physiological systems and the cellular target genes altered by these modulators.	[Lai, Angela; Cairns, Murray J.; Tran, Nham; Zhang, Hong-Ping; Cullen, Lara; Arndt, Greg M.] Johnson & Johnson Res Pty Ltd, Eveleigh, NSW, Australia; [Tran, Nham] Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney Head a& Neck Canc Inst, Sydney, NSW 2006, Australia; [Tran, Nham] Univ Sydney, Sydney, NSW 2006, Australia	Johnson & Johnson; University of Sydney; University of Sydney	Lai, A (corresponding author), Johnson & Johnson Res Pty Ltd, Australian Technol Pk, Eveleigh, NSW, Australia.	garndt@its.jnj.com		Cairns, Murray/0000-0003-2490-2538; Tran, Nham/0000-0001-7747-2530	Johnson and Johnson Research Pty Ltd	Johnson and Johnson Research Pty Ltd	Financial support for this work was provided by Johnson and Johnson Research Pty Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chen MH, 2005, P NATL ACAD SCI USA, V102, P2356, DOI 10.1073/pnas.0401549101; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Giordano E, 2002, GENETICS, V160, P637; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CQ, 2008, CHINA FOUNDRY, V5, P28; Guo Q, 2007, BIOCHEM BIOPH RES CO, V358, P272, DOI 10.1016/j.bbrc.2007.04.123; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jian R, 2007, STEM CELLS, V25, P1904, DOI 10.1634/stemcells.2006-0448; Kaykas A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-16; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Puca R, 2008, GYNECOL ONCOL, V109, P403, DOI 10.1016/j.ygyno.2008.02.018; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Schmidt WM, 2004, INT J CANCER, V112, P200, DOI 10.1002/ijc.20401; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Szell M, 2008, SEMIN CANCER BIOL, V18, P141, DOI 10.1016/j.semcancer.2008.01.007; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tran N, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-21; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003171; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wolters NM, 2008, CELL DEATH DIFFER, V15, P809, DOI 10.1038/sj.cdd.4402311; Worthington MT, 2001, ANAL BIOCHEM, V294, P169, DOI 10.1006/abio.2001.5162; Wu HL, 2007, BIOL PROCED ONLINE, V9, P9, DOI 10.1251/bpo129; Zhang JZ, 2006, STEM CELLS, V24, P2661, DOI 10.1634/stemcells.2006-0017; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	50	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4758	10.1371/journal.pone.0004758	http://dx.doi.org/10.1371/journal.pone.0004758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270743	Green Published, gold			2022-12-27	WOS:000265495900025
J	Fatakia, SN; Costanzi, S; Chow, CC				Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.			Computing Highly Correlated Positions Using Mutual Information and Graph Theory for G Protein-Coupled Receptors	PLOS ONE			English	Article							SPECIFICITY-DETERMINING RESIDUES; 2ND EXTRACELLULAR LOOP; A(2A) ADENOSINE RECEPTOR; AMINO-ACID SUBSTITUTIONS; CRYSTAL-STRUCTURE; SEQUENCE-ANALYSIS; HUMAN CA2+; ALLOSTERIC COMMUNICATION; FUNCTIONAL SPECIFICITY; TRANSMEMBRANE DOMAIN	G protein-coupled receptors (GPCRs) are a superfamily of seven transmembrane-spanning proteins involved in a wide array of physiological functions and are the most common targets of pharmaceuticals. This study aims to identify a cohort or clique of positions that share high mutual information. Using a multiple sequence alignment of the transmembrane (TM) domains, we calculated the mutual information between all inter-TM pairs of aligned positions and ranked the pairs by mutual information. A mutual information graph was constructed with vertices that corresponded to TM positions and edges between vertices were drawn if the mutual information exceeded a threshold of statistical significance. Positions with high degree (i.e. had significant mutual information with a large number of other positions) were found to line a well defined inter-TM ligand binding cavity for class A as well as class C GPCRs. Although the natural ligands of class C receptors bind to their extracellular N-terminal domains, the possibility of modulating their activity through ligands that bind to their helical bundle has been reported. Such positions were not found for class B GPCRs, in agreement with the observation that there are not known ligands that bind within their TM helical bundle. All identified key positions formed a clique within the MI graph of interest. For a subset of class A receptors we also considered the alignment of a portion of the second extracellular loop, and found that the two positions adjacent to the conserved Cys that bridges the loop with the TM3 qualified as key positions. Our algorithm may be useful for localizing topologically conserved regions in other protein families.	[Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fatakia, SN (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA.	carsonc@mail.nih.gov	Chow, Carson C/A-7970-2009; Costanzi, Stefano/G-8990-2013	Costanzi, Stefano/0000-0003-3183-7332; Fatakia, Sarosh/0000-0003-0430-3191	NIDDK/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013025, Z01DK013026, Z01DK013025, ZIADK013026] Funding Source: NIH RePORTER	NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural program of NIDDK/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Banerjee R, 2008, BIOCHEMISTRY-US, V47, P7385, DOI 10.1021/bi8006127; Batagelj V, 2004, MATH VIS, P77; Brun R, 1997, NUCL INSTRUM METH A, V389, P81, DOI 10.1016/S0168-9002(97)00048-X; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; CLARKE ND, 1995, PROTEIN SCI, V4, P2269, DOI 10.1002/pro.5560041104; Costanzi S, 2005, J MED CHEM, V48, P8108, DOI 10.1021/jm050911p; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Costanzi S., 2007, FRONT DRUG DES DISCO, V3, P63; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306; Dimmic MW, 2005, BIOINFORMATICS, V21, pI126, DOI 10.1093/bioinformatics/bti1032; Donald JE, 2009, NUCLEIC ACIDS RES, V37, pD191, DOI 10.1093/nar/gkn716; Donald JE, 2005, NUCLEIC ACIDS RES, V33, P4455, DOI 10.1093/nar/gki755; DONALD JE, 2007, THESIS; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Galitsky Boris, 2003, In Silico Biology, V3, P241; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gouldson PR, 2001, PROTEIN ENG, V14, P759, DOI 10.1093/protein/14.10.759; Govindarajan S, 2003, J MOL BIOL, V328, P1061, DOI 10.1016/S0022-2836(03)00357-7; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harris CJ, 2006, DRUG DISCOV TODAY, V11, P880, DOI 10.1016/j.drudis.2006.08.013; Heitman LH, 2008, MOL PHARMACOL, V73, P518, DOI 10.1124/mol.107.039875; Hemmerich C, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/87356; HERZEL H, 1995, PHYSICA A, V216, P518, DOI 10.1016/0378-4371(95)00104-F; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Hu JX, 2006, J BIOL CHEM, V281, P21558, DOI 10.1074/jbc.M603682200; Ivanov AA, 2006, J COMPUT AID MOL DES, V20, P417, DOI 10.1007/s10822-006-9054-2; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Jothi R, 2006, J MOL BIOL, V362, P861, DOI 10.1016/j.jmb.2006.07.072; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kelly JW, 2005, NATURE, V437, P486, DOI 10.1038/437486a; Kim JH, 1996, MOL PHARMACOL, V49, P683; Klabunde T, 2006, E SCHERING RES FDN W, V58, P31; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kleinau G, 2007, EXP CLIN ENDOCR DIAB, V115, pS75; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kundrotas PJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-503; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; LEWYN L, 2003, P NATL ACAD SCI USA, V100, P4463; Lichtarge O, 1997, J MOL BIOL, V274, P325, DOI 10.1006/jmbi.1997.1395; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Litschig S, 1999, MOL PHARMACOL, V55, P453; Liu XB, 2008, INT J COMPUT INT SYS, V1, P24, DOI 10.2991/ijcis.2008.1.1.3; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lopez-Rodriguez ML, 2001, BIOORG MED CHEM LETT, V11, P2807, DOI 10.1016/S0960-894X(01)00517-0; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Moore S, 2006, J MED CHEM, V49, P3888, DOI 10.1021/jm060247s; Moro S, 1999, BIOCHEMISTRY-US, V38, P3498, DOI 10.1021/bi982369v; Nagl S B, 1999, Pac Symp Biocomput, P90; NAGL SB, 2008, BRIEF BIOINFORM, V2, P279; *NAT CTR BIOT INF, 2002, NCBI HDB INT; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029; Ohno S., 1970, EVOLUTION GENE DUPLI; OLAH ME, 1994, J BIOL CHEM, V269, P24692; Oliveira L, 2003, PROTEINS, V52, P544, DOI 10.1002/prot.10490; Oliveira L, 2003, PROTEINS, V52, P553, DOI 10.1002/prot.10489; Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T; Ortiz AR, 2006, CURR TOP MED CHEM, V6, P41, DOI 10.2174/156802606775193338; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pazos F, 1997, COMPUT APPL BIOSCI, V13, P319; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Pritchard L, 2001, PROTEIN ENG, V14, P549, DOI 10.1093/protein/14.8.549; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qi Y, 2004, BIOINFORMATICS, V20, P3697, DOI 10.1093/bioinformatics/bth431; Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Raviscioni M, 2005, J MOL BIOL, V350, P402, DOI 10.1016/j.jmb.2005.04.054; Ray K, 2005, J BIOL CHEM, V280, P37013, DOI 10.1074/jbc.M506681200; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sato T, 1999, BRIT J PHARMACOL, V128, P272, DOI 10.1038/sj.bjp.0702813; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Sjolander K, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P165; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Thomas J, 2008, IEEE ACM T COMPUT BI, V5, P183, DOI 10.1109/TCBB.2007.70225; Thomas MC, 2006, ELEMENTS INFORM THEO; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WILLIAMSON RM, 1995, J THEOR BIOL, V174, P179, DOI 10.1006/jtbi.1995.0090; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Ye K, 2006, PROTEINS, V63, P1018, DOI 10.1002/prot.20899; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584	126	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4681	10.1371/journal.pone.0004681	http://dx.doi.org/10.1371/journal.pone.0004681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262747	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490600012
J	Gaglio, D; Soldati, C; Vanoni, M; Alberghina, L; Chiaradonna, F				Gaglio, Daniela; Soldati, Chiara; Vanoni, Marco; Alberghina, Lilia; Chiaradonna, Ferdinando			Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts	PLOS ONE			English	Article								Background: Oncogene activation plays a role in metabolic reprogramming of cancer cells. We have previously shown that K-ras transformed fibroblasts have a stronger dependence on glycolysis and a reduced oxidative phosphorylation ability as compared to their normal counterparts. Another metabolic adaptation of cancer cells, that has long been established, is their propensity to exhibit increased glutamine consumption, although the effects induced by glutamine deprivation on cancer cells are still controversial. Methodology and Principal Findings: Here, by using nutritional perturbations and molecular physiology, we show that reduction or complete depletion of glutamine availability in K-ras transformed fibroblasts causes a strong decrease of proliferation ability and a slower re-entry of synchronized cells into the cell cycle. The reduced proliferation is accompanied by sustained expression of cyclin D and E, abortive S phase entrance and is dependent on Ras signalling deregulation, since it is rescued by expression of a dominant negative guanine nucleotide exchange factor. The growth potential of transformed cells as well as the ability to execute the G1 to S transition is restored by adding the four deoxyribonucleotides, indicating that the arrest of proliferation of K-ras transformed cells induced by glutamine depletion is largely due to a reduced supply of DNA in the presence of signalling pathways promoting G1 to S transition. Conclusions and Significance: Our results suggest that the differential effects of glutamine and glucose on cell viability are not a property of the transformed phenotype per se, but rather depend on the specific pathway being activated in transformation. For instance, myc-overexpressing cells have been reported to die under glutamine depletion and not under glucose shortage, while the opposite holds for ras-transformed fibroblasts as shown in this paper. These different responses of transformed cells to nutritional stress should be taken into account when designing anti-cancer therapies that aim to exploit metabolic differences between normal and transformed cells.	[Gaglio, Daniela; Soldati, Chiara; Vanoni, Marco; Alberghina, Lilia; Chiaradonna, Ferdinando] Univ Milan, Dept Biosci & Biotechnol, Milan, Italy	University of Milan	Gaglio, D (corresponding author), Univ Milan, Dept Biosci & Biotechnol, Milan, Italy.	ferdinando.chiaradonna@unimib.it	Vanoni, Marco/AAA-3699-2021; CHIARADONNA, Ferdinando/K-4959-2016	Vanoni, Marco/0000-0002-8690-2587; CHIARADONNA, Ferdinando/0000-0001-8529-2732; Alberghina, Lilia/0000-0003-1694-931X	MIUR; Regione Lombardia [INGENIO fellowship]	MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia)	From MIUR to L.A. (FIRB-ITALBIONET), M.V and F.C. (F.A.R.). D.G. and C.S. were supported by an INGENIO fellowship from Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 1999, J BIOL CHEM, V274, P28645, DOI 10.1074/jbc.274.40.28645; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Agarwal MK, 2006, P NATL ACAD SCI USA, V103, P16278, DOI 10.1073/pnas.0607210103; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Bossu P, 2000, ONCOGENE, V19, P2147, DOI 10.1038/sj.onc.1203539; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chang FM, 2001, ONCOGENE, V20, P4354, DOI 10.1038/sj.onc.1204564; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Chiaradonna F, 2006, BBA-BIOENERGETICS, V1757, P1338, DOI 10.1016/j.bbabio.2006.08.001; COLLINS JM, 1978, J BIOL CHEM, V253, P8570; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Drogat B, 2007, J CELL PHYSIOL, V212, P463, DOI 10.1002/jcp.21044; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; ERIKSSON S, 1984, EXP CELL RES, V155, P129, DOI 10.1016/0014-4827(84)90774-2; ERIKSSON S, 1984, ADV EXP MED BIOL, V165, P407; EVERSON WV, 1989, AM J PHYSIOL, V256, pC18, DOI 10.1152/ajpcell.1989.256.1.C18; FILMUS J, 1994, ONCOGENE, V9, P3627; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HIGASHIGUCHI T, 1993, JPEN-PARENTER ENTER, V17, P307, DOI 10.1177/0148607193017004307; KAHN S, 1987, ANTICANCER RES, V7, P639; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kokkinakis DM, 2005, MOL CANCER THER, V4, P1338, DOI 10.1158/1535-7163.MCT-05-0141; Lamb J, 2000, EXP CELL RES, V255, P238, DOI 10.1006/excr.1999.4779; Le Bacquer O, 2001, AM J PHYSIOL-GASTR L, V281, pG1340, DOI 10.1152/ajpgi.2001.281.6.G1340; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; MACLENNAN PA, 1987, FEBS LETT, V215, P187, DOI 10.1016/0014-5793(87)80139-4; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; Mazurek S, 2003, ANTICANCER RES, V23, P1149; MCFATE T, 2008, J BIOL CHEM; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; RATHBONE MP, 1992, IN VITRO CELL DEV-AN, V28A, P529; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; TUROWSKI GA, 1994, CANCER RES, V54, P5974; Vanoni M, 1999, J BIOL CHEM, V274, P36656, DOI 10.1074/jbc.274.51.36656; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wasa M, 1996, ANN SURG, V224, P189, DOI 10.1097/00000658-199608000-00012; YAMAMOTO F, 1984, NUCLEIC ACIDS RES, V12, P8873, DOI 10.1093/nar/12.23.8873; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; ZHUANG Y, 2008, J MOL SIGNAL, P18; ZHUANG Y, 2008, J MOL SIGNAL, P3; ZIELKE HR, 1984, FED PROC, V43, P121	60	106	107	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4715	10.1371/journal.pone.0004715	http://dx.doi.org/10.1371/journal.pone.0004715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262748	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490600025
J	Caporaso, N; Gu, FY; Chatterjee, N; Jin, SC; Yu, K; Yeager, M; Chen, C; Jacobs, K; Wheeler, W; Landi, MT; Ziegler, RG; Hunter, DJ; Chanock, S; Hankinson, S; Kraft, P; Bergen, AW				Caporaso, Neil; Gu, Fangyi; Chatterjee, Nilanjan; Jin Sheng-Chih; Yu, Kai; Yeager, Meredith; Chen, Constance; Jacobs, Kevin; Wheeler, William; Landi, Maria Teresa; Ziegler, Regina G.; Hunter, David J.; Chanock, Stephen; Hankinson, Susan; Kraft, Peter; Bergen, Andrew W.			Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; NICOTINE REPLACEMENT THERAPY; MONOAMINE-OXIDASE; LINKAGE SCAN; LUNG-CANCER; SUSCEPTIBILITY LOCUS; QUANTITATIVE TRAIT; AFRICAN-AMERICANS; CYP2A6 GENOTYPE; RECEPTOR GENES	The contribution of common genetic variation to one or more established smoking behaviors was investigated in a joint analysis of two genome wide association studies (GWAS) performed as part of the Cancer Genetic Markers of Susceptibility (CGEMS) project in 2,329 men from the Prostate, Lung, Colon and Ovarian (PLCO) Trial, and 2,282 women from the Nurses' Health Study (NHS). We analyzed seven measures of smoking behavior, four continuous (cigarettes per day [CPD], age at initiation of smoking, duration of smoking, and pack years), and three binary (ever versus never smoking, <= 10 versus >10 cigarettes per day [CPDBI], and current versus former smoking). Association testing for each single nucleotide polymorphism (SNP) was conducted by study and adjusted for age, cohabitation/marital status, education, site, and principal components of population substructure. None of the SNPs achieved genome-wide significance (p<10(-7)) in any combined analysis pooling evidence for association across the two studies; we observed between two and seven SNPs with p<10(-5) for each of the seven measures. In the chr15q25.1 region spanning the nicotinic receptors CHRNA3 and CHRNA5, we identified multiple SNPs associated with CPD (p<10(-3)), including rs1051730, which has been associated with nicotine dependence, smoking intensity and lung cancer risk. In parallel, we selected 11,199 SNPs drawn from 359 a priori candidate genes and performed individual-gene and gene-group analyses. After adjusting for multiple tests conducted within each gene, we identified between two and five genes associated with each measure of smoking behavior. Besides CHRNA3 and CHRNA5, MAOA was associated with CPDBI (gene-level p<5.4x10(-5)), our analysis provides independent replication of the association between the chr15q25.1 region and smoking intensity and data for multiple other loci associated with smoking behavior that merit further follow-up.	[Caporaso, Neil; Chatterjee, Nilanjan; Yu, Kai; Yeager, Meredith; Landi, Maria Teresa; Ziegler, Regina G.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gu, Fangyi; Chen, Constance; Hunter, David J.; Hankinson, Susan; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA USA; [Jin Sheng-Chih] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21218 USA; [Chanock, Stephen] Brigham and Womens Hosp, Channing Lab, Boston, MA USA; [Yeager, Meredith; Jacobs, Kevin; Hunter, David J.] NCI, NIH, Advanced Technol Ctr, Core Genotyping Facil, Gaithersburg, MD USA; [Jacobs, Kevin] BioInformed LLC, Gaithersburg, MD USA; [Wheeler, William] Informat Management Serv, Inc, Rockville, MD USA; [Bergen, Andrew W.] SRI Int, Ctr Hlth Sci, Mol Genet Program, Menlo Pk, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; SRI International	Caporaso, N (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	caporaso@nih.gov	Gu, Fangyi/I-5957-2014; Yeager, Meredith/AAA-5322-2020	Jin, Sheng Chih/0000-0002-5777-7262; Bergen, Andrew/0000-0002-1237-7644; Kraft, Peter/0000-0002-4472-8103	National Cancer Institute [P01 CA087969, U01 DA020830]; Intramural Research Program of the NIH; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NHS (PK, FG, SH, CC, DHH) is supported by National Cancer Institute grant P01 CA087969. This research was supported also supported in part by the Intramural Research Program of the NIH and the National Cancer Institute. AWB was supported by the Intramural Research Program of the National Cancer Institute and is supported by U01 DA020830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Batra V, 2003, CHEST, V123, P1730, DOI 10.1378/chest.123.5.1730; Benowitz NL, 2006, CLIN PHARMACOL THER, V80, P457, DOI 10.1016/j.clpt.2006.08.011; Bergen AW, 1999, GENET EPIDEMIOL, V17, pS55; Bergen AW, 1999, JNCI-J NATL CANCER I, V91, P1365, DOI 10.1093/jnci/91.16.1365; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2004, AM J MED GENET A, V124A, P19, DOI 10.1002/ajmg.a.20329; BLUM K, 1995, PHARMACOGENETICS, V5, P121, DOI 10.1097/00008571-199506000-00001; Blum K, 1996, J ROY SOC MED, V89, P396, DOI 10.1177/014107689608900711; Blum K, 2000, J PSYCHOACTIVE DRUGS, V32, P1, DOI [10.1080/02791072, DOI 10.1080/02791072, DOI 10.1080/02791072.2000.10736099]; Caporaso NE, 2001, CANCER EPIDEM BIOMAR, V10, P261; Caporaso NE, 2007, CANCER EPIDEM BIOMAR, V16, P365, DOI 10.1158/1055-9965.EPI-07-0142; Chanock SJ, 2008, NATURE, V452, P537, DOI 10.1038/452537a; Checkoway H, 1998, NEUROLOGY, V50, P1458, DOI 10.1212/WNL.50.5.1458; Comings DE, 2000, PROG BRAIN RES, V126, P325; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Ehlers CL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-9; Faraone SV, 2004, HUM HERED, V57, P59, DOI 10.1159/000077543; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Fowler JS, 2005, J NUCL MED, V46, P1414; Fowler JS, 2003, NEUROTOXICOLOGY, V24, P75, DOI 10.1016/S0161-813X(02)00109-2; Fujieda M, 2004, CARCINOGENESIS, V25, P2451, DOI 10.1093/carcin/bgh258; Gauderman WJ, 2001, GENET EPIDEMIOL, V21, pS831, DOI 10.1002/gepi.2001.21.s1.s831; Gelernter J, 2004, AM J MED GENET B, V128B, P94, DOI 10.1002/ajmg.b.30019; Gu QH, 2005, AM J PHYSIOL-LUNG C, V288, pL932, DOI 10.1152/ajplung.00439.2004; Haberl M, 2005, PHARMACOGENET GENOM, V15, P609, DOI 10.1097/01.fpc.0000171517.22258.f1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ito H, 2003, PHARMACOGENETICS, V13, P73, DOI 10.1097/00008571-200302000-00003; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jin Y, 2006, INT J NEUROPSYCHOPH, V9, P557, DOI 10.1017/S1461145705006218; Kamataki T, 2005, BIOCHEM BIOPH RES CO, V338, P306, DOI 10.1016/j.bbrc.2005.08.268; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; Lerman C, 2000, MOL PSYCHIATR, V5, P189, DOI 10.1038/sj.mp.4000672; Lerman C, 1998, CANCER EPIDEM BIOMAR, V7, P253; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Lewis A, 2007, NEUROTOXICOLOGY, V28, P182, DOI 10.1016/j.neuro.2006.05.019; Li MD, 2008, MOL PSYCHIATR, V13, P407, DOI 10.1038/sj.mp.4002038; Li MD, 2007, MOL PSYCHIATR, V12, P462, DOI 10.1038/sj.mp.4001933; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Li Ming D, 2006, Curr Psychiatry Rep, V8, P158, DOI 10.1007/s11920-006-0016-0; Li MD, 2006, AM J HUM GENET, V79, P745, DOI 10.1086/508208; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Lou XY, 2006, HUM GENET, V120, P381, DOI 10.1007/s00439-006-0229-7; Lubin JH, 2007, CANCER EPIDEM BIOMAR, V16, P1852, DOI 10.1158/1055-9965.EPI-07-0018; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; Malaiyandi V, 2005, CLIN PHARMACOL THER, V77, P145, DOI 10.1016/j.clpt.2004.10.011; McKinney EF, 2000, PHARMACOGENETICS, V10, P483, DOI 10.1097/00008571-200008000-00001; Moslehi R, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S97; Munafo MR, 2008, ADDICTION, V103, P893, DOI 10.1111/j.1360-0443.2007.02071.x; Mwenifiumbo JC, 2007, PHARMACOGENOMICS, V8, P1385, DOI 10.2217/14622416.8.10.1385; Nakajima M, 2007, CURR OPIN MOL THER, V9, P538; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; O'Gara C, 2008, J HUM GENET, V53, P239, DOI 10.1007/s10038-007-0243-1; Pomerleau OF, 2007, NICOTINE TOB RES, V9, P955, DOI 10.1080/14622200701541216; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Ragonese P, 2003, NEUROEPIDEMIOLOGY, V22, P297, DOI 10.1159/000071193; Ray R, 2007, NICOTINE TOB RES, V9, P1237, DOI 10.1080/14622200701648367; Rebbeck TR, 2004, NAT REV GENET, V5, P589, DOI 10.1038/nrg1403; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; RONALD M, 1988, HLTH CONSEQUENCES SM; Saccone NL, 2002, ALCOHOL CLIN EXP RES, V26, P603, DOI 10.1111/j.1530-0277.2002.tb02581.x; Saccone SF, 2007, AM J HUM GENET, V80, P856, DOI 10.1086/513703; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Shields PG, 1998, CANCER EPIDEM BIOMAR, V7, P453; Strasser AA, 2007, NICOTINE TOB RES, V9, P511, DOI 10.1080/14622200701239605; Sullivan PF, 2004, AM J MED GENET B, V126B, P23, DOI 10.1002/ajmg.b.20138; Swan GE, 2006, AM J MED GENET B, V141B, P354, DOI 10.1002/ajmg.b.30315; Tan EK, 2003, AM J MED GENET B, V120B, P58, DOI 10.1002/ajmg.b.20035; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tochigi M, 2007, PHARMACOGENET GENOM, V17, P867, DOI 10.1097/FPC.0b013e3282e9a51e; Tyndale RF, 2002, THER DRUG MONIT, V24, P163, DOI 10.1097/00007691-200202000-00026; Vink JM, 2006, BEHAV GENET, V36, P100, DOI 10.1007/s10519-005-9012-0; Vink JM, 2004, PHARMACOGENOMICS J, V4, P274, DOI 10.1038/sj.tpj.6500255; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Whitlock Gary, 2002, Semin Vasc Med, V2, P369, DOI 10.1055/s-2002-36766; Wiesbeck GA, 2006, NEUROPSYCHOBIOLOGY, V53, P181, DOI 10.1159/000093782; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	89	201	203	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4653	10.1371/journal.pone.0004653	http://dx.doi.org/10.1371/journal.pone.0004653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247474	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800032
J	Felice, B; Cattoglio, C; Cittaro, D; Testa, A; Miccio, A; Ferrari, G; Luzi, L; Recchia, A; Mavilio, F				Felice, Barbara; Cattoglio, Claudia; Cittaro, Davide; Testa, Anna; Miccio, Annarita; Ferrari, Giuliana; Luzi, Lucilla; Recchia, Alessandra; Mavilio, Fulvio			Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome	PLOS ONE			English	Article								Gamma-retroviruses and lentiviruses integrate non-randomly in mammalian genomes, with specific preferences for active chromatin, promoters and regulatory regions. Gene transfer vectors derived from gamma-retroviruses target at high frequency genes involved in the control of growth, development and differentiation of the target cell, and may induce insertional tumors or pre-neoplastic clonal expansions in patients treated by gene therapy. The gene expression program of the target cell is apparently instrumental in directing gamma-retroviral integration, although the molecular basis of this phenomenon is poorly understood. We report a bioinformatic analysis of the distribution of transcription factor binding sites (TFBSs) flanking >4,000 integrated proviruses in human hematopoietic and non-hematopoietic cells. We show that gamma-retroviral, but not lentiviral vectors, integrate in genomic regions enriched in cell-type specific subsets of TFBSs, independently from their relative position with respect to genes and transcription start sites. Analysis of sequences flanking the integration sites of Moloney leukemia virus (MLV)- and human immunodeficiency virus (HIV)-derived vectors carrying mutations in their long terminal repeats (LTRs), and of HIV vectors packaged with an MLV integrase, indicates that the MLV integrase and LTR enhancer are the viral determinants of the selection of TFBS-rich regions in the genome. This study identifies TFBSs as differential genomic determinants of retroviral target site selection in the human genome, and suggests that transcription factors binding the LTR enhancer may synergize with the integrase in tethering retroviral pre-integration complexes to transcriptionally active regulatory regions. Our data indicate that gamma-retroviruses and lentiviruses have evolved dramatically different strategies to interact with the host cell chromatin, and predict a higher risk in using gammaretroviral vs. lentiviral vectors for human gene therapy applications.	[Felice, Barbara; Luzi, Lucilla] FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; [Cattoglio, Claudia; Mavilio, Fulvio] Ist Scientifico H San Raffaele, IIT Unit Mol Neurosci, Milan, Italy; [Cittaro, Davide] Cogentech, Milan, Italy; [Testa, Anna; Recchia, Alessandra; Mavilio, Fulvio] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; [Miccio, Annarita; Ferrari, Giuliana] HSR Telethon Inst Gene Therapy, Milan, Italy; [Ferrari, Giuliana] Univ Vita Salute San Raffaele, Milan, Italy; [Luzi, Lucilla] European Inst Oncol, Dept Expt Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Istituto Italiano di Tecnologia - IIT; Universita di Modena e Reggio Emilia; Fondazione Telethon; Vita-Salute San Raffaele University; IRCCS European Institute of Oncology (IEO)	Felice, B (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy.	fulvio.mavilio@unimore.it	Luzi, Lucilla/K-4350-2018; Cittaro, Davide/K-2405-2018; Recchia, Alessandra/B-7954-2015; Miccio, Annarita/H-9585-2017; Ferrari, Giuliana/AAB-5546-2019; MAVILIO, Fulvio/J-6125-2013	Luzi, Lucilla/0000-0002-8746-4179; Cittaro, Davide/0000-0003-0384-3700; Recchia, Alessandra/0000-0002-3467-1094; Miccio, Annarita/0000-0002-3409-9665; Ferrari, Giuliana/0000-0003-0790-3133; Mavilio, Fulvio/0000-0003-0459-4320	Telethon Italy [GGP06101]; Italian Association for Cancer Research (AIRC); Sixth Framework Program of the European Commission; Fondazione Cariplo	Telethon Italy(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Sixth Framework Program of the European Commission(European Commission); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from Telethon Italy (GGP06101 and TIGET), the Italian Association for Cancer Research (AIRC), the Sixth Framework Program of the European Commission (CONSERT and EPITRON consortia), and Fondazione Cariplo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Ambrosi A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000144; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Bushman FD, 2007, J CLIN INVEST, V117, P2083, DOI 10.1172/JCI32949; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Coffin J, 1997, RETROVIRUSES; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Dudley JP, 2003, TRENDS MOL MED, V9, P43, DOI 10.1016/S1471-4914(03)00003-0; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Engelman A, 2005, P NATL ACAD SCI USA, V102, P1275, DOI 10.1073/pnas.0409587101; Faschinger A, 2008, J VIROL, V82, P1360, DOI 10.1128/JVI.02098-07; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Lai LL, 2001, J VIROL, V75, P11365, DOI 10.1128/JVI.75.23.11365-11372.2001; Laufs S, 2004, MOL THER, V10, P874, DOI 10.1016/j.ymthe.2004.08.001; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Lotti F, 2002, J VIROL, V76, P3996, DOI 10.1128/JVI.76.8.3996-4007.2002; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mulder LCF, 2002, J BIOL CHEM, V277, P27489, DOI 10.1074/jbc.M203061200; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Porteus MH, 2006, PLOS GENET, V2, P1285, DOI 10.1371/journal.pgen.0020133; Recchia A, 2006, P NATL ACAD SCI USA, V103, P1457, DOI 10.1073/pnas.0507496103; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Steinrigl A, 2007, VIROLOGY, V362, P50, DOI 10.1016/j.virol.2006.11.037; Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48; Testa A, 2004, J BIOL CHEM, V279, P10523, DOI 10.1074/jbc.M313638200; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wu XL, 2006, VIROLOGY, V344, P292, DOI 10.1016/j.virol.2005.08.047; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	55	77	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4571	10.1371/journal.pone.0004571	http://dx.doi.org/10.1371/journal.pone.0004571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238208	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487400005
J	Koch, R; Ledermann, R; Urwyler, O; Heller, M; Suter, B				Koch, Rafael; Ledermann, Romana; Urwyler, Olivier; Heller, Manfred; Suter, Beat			Systematic Functional Analysis of Bicaudal-D Serine Phosphorylation and Intragenic Suppression of a Female Sterile Allele of BicD	PLOS ONE			English	Article								Protein phosphorylation is involved in posttranslational control of essentially all biological processes. Using mass spectrometry, recent analyses of whole phosphoproteomes led to the identification of numerous new phosphorylation sites. However, the function of most of these sites remained unknown. We chose the Drosophila Bicaudal-D protein to estimate the importance of individual phosphorylation events. Being involved in different cellular processes, BicD is required for oocyte determination, for RNA transport during oogenesis and embryogenesis, and for photoreceptor nuclei migration in the developing eye. The numerous roles of BicD and the available evidence for functional importance of BicD phosphorylation led us to identify eight phosphorylation sites of BicD, and we tested a total of 14 identified and suspected phosphoserine residues for their functional importance in vivo in flies. Surprisingly, all these serines turned out to be dispensable for providing sufficient basal BicD activity for normal growth and development. However, in a genetically sensitized background where the BicD(A40V) protein variant provides only partial activity, serine 103 substitutions are not neutral anymore, but show surprising differences. The S103D substitution completely inactivates the protein, whereas S103A behaves neutral, and the S103F substitution, isolated in a genetic screen, restores BicD(A40V) function. Our results suggest that many BicD phosphorylation events may either be fortuitous or play a modulating function as shown for Ser(103). Remarkably, amongst the Drosophila serines we found phosphorylated, Ser(103) is the only one that is fully conserved in mammalian BicD.	[Koch, Rafael; Ledermann, Romana; Urwyler, Olivier; Suter, Beat] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Koch, R (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	beat.suter@izb.unibe.ch		Heller, Manfred/0000-0002-6364-7325; Koch, Rafael/0000-0001-6105-2638; Urwyler, Olivier/0000-0001-8334-8667	Swiss National Science Foundation; Kanton Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Bern	This work was supported by funds from the Swiss National Science Foundation and the Kanton Bern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya R, 2006, CURR SCI INDIA, V90, P1179; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; Claussen M, 2005, ANN ANAT, V187, P539, DOI 10.1016/j.aanat.2005.07.004; Claussen M, 2006, GENETICS, V174, P1337, DOI 10.1534/genetics.106.063016; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Houalla T, 2005, MECH DEVELOP, V122, P97, DOI 10.1016/j.mod.2004.08.005; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Mancebo R, 2001, MOL CELL BIOL, V21, P3462, DOI 10.1128/MCB.21.10.3462-3471.2001; Mirouse V, 2006, DEVELOPMENT, V133, P4005, DOI 10.1242/dev.02565; MOHLER J, 1986, GENETICS, V112, P803; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oh J, 2000, GENETICS, V154, P713; Pare C, 2000, J CELL SCI, V113, P2119; RAN B, 1994, DEVELOPMENT, V120, P1233; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; SCHRIEFER LA, 1989, J MOL BIOL, V207, P451, DOI 10.1016/0022-2836(89)90267-2; STERN DL, 2000, DROSOPHILA PROTOCOLS, P601; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; TOMLINSON A, 1985, J EMBRYOL EXP MORPH, V89, P313; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a	44	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4552	10.1371/journal.pone.0004552	http://dx.doi.org/10.1371/journal.pone.0004552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234596	gold, Green Published, Green Submitted			2022-12-27	WOS:000265487200008
J	Kannan, S; Huang, H; Seeger, D; Audet, A; Chen, YY; Huang, CH; Gao, HW; Li, SG; Wu, M				Kannan, Shibichakravarthy; Huang, Huang; Seeger, Drew; Audet, Aaron; Chen, Yaoyu; Huang, Canhua; Gao, Hongwei; Li, Shaoguang; Wu, Min			Alveolar Epithelial Type II Cells Activate Alveolar Macrophages and Mitigate P. Aeruginosa Infection	PLOS ONE			English	Article							SRC KINASE LYN; PSEUDOMONAS-AERUGINOSA; DEFICIENT MICE; PHAGOCYTOSIS; HOST; EXPRESSION; SECRETION; PHOSPHORYLATION; RESISTANCE; INHIBITION	Although alveolar epithelial type II cells (AECII) perform substantial roles in the maintenance of alveolar integrity, the extent of their contributions to immune defense is poorly understood. Here, we demonstrate that AECII activates alveolar macrophages (AM) functions, such as phagocytosis using a conditioned medium from AECII infected by P. aeruginosa. AECII-derived chemokine MCP-1, a monocyte chemoattractant protein, was identified as a main factor in enhancing AM function. We proposed that the enhanced immune potency of AECII may play a critical role in alleviation of bacterial propagation and pneumonia. The ability of phagocytosis and superoxide release by AM was reduced by MCP-1 neutralizing antibodies. Furthermore, MCP-1(-/-) mice showed an increased bacterial burden under PAO1 and PAK infection vs. wt littermates. AM from MCP-1(-/-) mice also demonstrated less superoxide and impaired phagocytosis over the controls. In addition, AECII conditioned medium increased the host defense of airway in MCP-1(-/-) mice through the activation of AM function. Mechanistically, we found that Lyn mediated NFkB activation led to increased gene expression and secretion of MCP-1. Consequently Lyn(-/-) mice had reduced MCP-1 secretion and resulted in a decrease in superoxide and phagocytosis by AM. Collectively, our data indicate that AECII may serve as an immune booster for fighting bacterial infections, particularly in severe immunocompromised conditions.	[Kannan, Shibichakravarthy; Huang, Huang; Seeger, Drew; Audet, Aaron; Gao, Hongwei; Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Chen, Yaoyu; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA; [Huang, Canhua; Wu, Min] Sichuan Univ, W China Hosp, State Key Lab Biother, Chengdu, Peoples R China	University of North Dakota Grand Forks; University of Massachusetts System; University of Massachusetts Worcester; Sichuan University	Wu, M (corresponding author), Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA.	minwu@medicine.nodak.edu	chen, yaoyu/A-4236-2011; Seeger, Drew/ABH-5020-2020	Seeger, Drew/0000-0002-9382-2753; Wu, Min/0000-0003-1205-982X; Kannan, Shibichakravarthy/0000-0002-5389-6272	NIH [ES014690, P20 RR017699]; American Heart Association; National Key Basic Research Program of China [2006CB504300]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES014690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH ES014690 and P20 RR017699, American Heart Association Scientist Development Grant (National Office). The work is also supported by National Key Basic Research Program of China (973Program #2006CB504300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Baran CP, 2003, J BIOL CHEM, V278, P38628, DOI 10.1074/jbc.M305021200; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Das A, 2007, AM J PHYSIOL-LUNG C, V292, pL74, DOI 10.1152/ajplung.00103.2006; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Hauser AR, 1999, INFECT IMMUN, V67, P5530, DOI 10.1128/IAI.67.10.5530-5537.1999; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Maresso AW, 2004, J BIOL CHEM, V279, P38402, DOI 10.1074/jbc.M405707200; Mariencheck WI, 1999, AM J PHYSIOL-LUNG C, V277, pL777, DOI 10.1152/ajplung.1999.277.4.L777; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Neff TA, 2005, AM J PATHOL, V166, P685, DOI 10.1016/S0002-9440(10)62290-0; O'Brien AD, 1998, J LAB CLIN MED, V131, P417, DOI 10.1016/S0022-2143(98)90142-1; Preston MJ, 1997, INFECT IMMUN, V65, P3086, DOI 10.1128/IAI.65.8.3086-3090.1997; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Subramanian A, 2006, LEUKEMIA RES, V30, P1141, DOI 10.1016/j.leukres.2006.02.006; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Wisniowski PE, 2000, AM J RESP CRIT CARE, V162, P733, DOI 10.1164/ajrccm.162.2.9808015; Wu M, 2002, ELECTROPHORESIS, V23, P2373, DOI 10.1002/1522-2683(200208)23:15<2373::AID-ELPS2373>3.0.CO;2-W; WU M, 1995, BIOCONJUGATE CHEM, V6, P587, DOI 10.1021/bc00035a013; Wu M, 2001, P NATL ACAD SCI USA, V98, P14589, DOI 10.1073/pnas.251451498; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zhu F, 2006, CELL MOL IMMUNOL, V3, P107	45	65	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4891	10.1371/journal.pone.0004891	http://dx.doi.org/10.1371/journal.pone.0004891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305493	gold, Green Published, Green Submitted			2022-12-27	WOS:000265498800002
J	Smith, IM; Glazer, CA; Mithani, SK; Ochs, MF; Sun, W; Bhan, S; Vostrov, A; Abdullaev, Z; Lobanenkov, V; Gray, A; Liu, C; Chang, SS; Ostrow, KL; Westra, WH; Begum, S; Dhara, M; Califano, J				Smith, Ian M.; Glazer, Chad A.; Mithani, Suhail K.; Ochs, Michael F.; Sun, Wenyue; Bhan, Sheetal; Vostrov, Alexander; Abdullaev, Ziedulla; Lobanenkov, Victor; Gray, Andrew; Liu, Chunyan; Chang, Steven S.; Ostrow, Kimberly L.; Westra, William H.; Begum, Shahnaz; Dhara, Mousumi; Califano, Joseph			Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer	PLOS ONE			English	Article								Background: Epigenetic alterations have been implicated in the pathogenesis of solid tumors, however, proto-oncogenes activated by promoter demethylation have been sporadically reported. We used an integrative method to analyze expression in primary head and neck squamous cell carcinoma (HNSCC) and pharmacologically demethylated cell lines to identify aberrantly demethylated and expressed candidate proto-oncogenes and cancer testes antigens in HNSCC. Methodology/Principal Findings: We noted coordinated promoter demethylation and simultaneous transcriptional upregulation of proto-oncogene candidates with promoter homology, and phylogenetic footprinting of these promoters demonstrated potential recognition sites for the transcription factor BORIS. Aberrant BORIS expression correlated with upregulation of candidate proto-oncogenes in multiple human malignancies including primary non-small cell lung cancers and HNSCC, induced coordinated proto-oncogene specific promoter demethylation and expression in non-tumorigenic cells, and transformed NIH3T3 cells. Conclusions/Significance: Coordinated, epigenetic unmasking of multiple genes with growth promoting activity occurs in aerodigestive cancers, and BORIS is implicated in the coordinated promoter demethylation and reactivation of epigenetically silenced genes in human cancers.	[Smith, Ian M.; Glazer, Chad A.; Sun, Wenyue; Bhan, Sheetal; Gray, Andrew; Liu, Chunyan; Chang, Steven S.; Ostrow, Kimberly L.; Dhara, Mousumi; Califano, Joseph] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Mithani, Suhail K.] Johns Hopkins Med Inst, Dept Surg, Div Plastic & Reconstruct Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Westra, William H.; Begum, Shahnaz] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Vostrov, Alexander; Abdullaev, Ziedulla; Lobanenkov, Victor] Inst Allergy & Infect Dis, NIH, Rockville, MD USA; [Califano, Joseph] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Greater Baltimore Medical Center	Califano, J (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu	Lobanenkov, Victor V./AGQ-8903-2022; Lobanenkov, Victor/ABD-5710-2021	Lobanenkov, Victor/0000-0001-6665-3635; Mithani, Suhail/0000-0002-3762-0831; Sun, Wenyue/0000-0003-1673-0895	NIH [T32 grant]; Flight Attendant Medical Research Institute [Clinical Innovator Award]; National Cancer Institute SPORE [5P50CA096784-05]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001021, ZIAAI000860, Z01AI001021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH T32 grant, Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the National Cancer Institute SPORE (5P50CA096784-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Bolli M, 2005, INT J CANCER, V115, P960, DOI 10.1002/ijc.20953; Cho Hearn J, 2006, Cancer Immun, V6, P12; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteves LID, 2006, INT J MOL MED, V17, P397; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Foldi M, 2007, ONCOL REP, V17, P841; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; HANADA M, 1993, BLOOD, V82, P1820; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu LH, 2007, ANTI-CANCER DRUG, V18, P427, DOI 10.1097/CAD.0b013e328013d99e; *IGC, 2005, EXPO EXPR PROJ ONC; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; MANGUES R, 1995, MOL CARCINOGEN, V14, P94, DOI 10.1002/mc.2940140205; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nagao T, 2003, J BIOL CHEM, V278, P10668, DOI 10.1074/jbc.M206104200; NGUYEN P, 2008, MOL CELL BIOL; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Prawitt D, 2005, NAT GENET, V37, P785, DOI 10.1038/ng0805-785; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Staiger WI, 2006, ONCOL REP, V16, P657; Suzuki T, 2007, ONCOL REP, V18, P329; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; TSAI JR, 2007, LUNG CANC; TSANG WP, 2007, ONCOGENE; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Volker HU, 2007, EUR ARCH OTO-RHINO-L, V264, P1431, DOI 10.1007/s00405-007-0394-x; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548; ZHANG S, 2007, CANC LETT; Zhou H, 2001, ONCOGENE, V20, P6009, DOI 10.1038/sj.onc.1204830	51	83	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4961	10.1371/journal.pone.0004961	http://dx.doi.org/10.1371/journal.pone.0004961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305507	gold, Green Submitted, Green Published			2022-12-27	WOS:000265498800010
J	VanderLeest, HT; Rohling, JHT; Michel, S; Meijer, JH				vanderLeest, Henk Tjebbe; Rohling, Jos H. T.; Michel, Stephan; Meijer, Johanna H.			Phase Shifting Capacity of the Circadian Pacemaker Determined by the SCN Neuronal Network Organization	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; SINGLE-CELL; OSCILLATORS; CLOCK; RHYTHMS; DEFICIENT; AMPLITUDE; BEHAVIOR; SYSTEM	Background: In mammals, a major circadian pacemaker that drives daily rhythms is located in the suprachiasmatic nuclei (SCN), at the base of the hypothalamus. The SCN receive direct light input via the retino-hypothalamic tract. Light during the early night induces phase delays of circadian rhythms while during the late night it leads to phase advances. The effects of light on the circadian system are strongly dependent on the photoperiod to which animals are exposed. An explanation for this phenomenon is currently lacking. Methodology and Principal Findings: We recorded running wheel activity in C57 mice and observed large amplitude phase shifts in short photoperiods and small shifts in long photoperiods. We investigated whether these different light responses under short and long days are expressed within the SCN by electrophysiological recordings of electrical impulse frequency in SCN slices. Application of N-methyl-D-aspartate (NMDA) induced sustained increments in electrical activity that were not significantly different in the slices from long and short photoperiods. These responses led to large phase shifts in slices from short days and small phase shifts in slices from long days. An analysis of neuronal subpopulation activity revealed that in short days the amplitude of the rhythm was larger than in long days. Conclusions: The data indicate that the photoperiodic dependent phase responses are intrinsic to the SCN. In contrast to earlier predictions from limit cycle theory, we observed large phase shifting responses in high amplitude rhythms in slices from short days, and small shifts in low amplitude rhythms in slices from long days. We conclude that the photoperiodic dependent phase responses are determined by the SCN and propose that synchronization among SCN neurons enhances the phase shifting capacity of the circadian system.	[vanderLeest, Henk Tjebbe; Rohling, Jos H. T.; Michel, Stephan; Meijer, Johanna H.] Leiden Univ, Dept Mol Cell Biol, Neurophysiol Lab, Med Ctr, Leiden, Netherlands; [Rohling, Jos H. T.] Leiden Univ, Leiden Inst Advanced Comp Sci, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Meijer, JH (corresponding author), Leiden Univ, Dept Mol Cell Biol, Neurophysiol Lab, Med Ctr, Leiden, Netherlands.	J.H.Meijer@lumc.nl	Rohling, Jos/AAC-3516-2022; Michel, Stephan/ABC-4211-2021	Rohling, Jos H T/0000-0001-5721-2715	Netherlands Organization for Scientific Research (NWO) [805.47. 212]; EUCLOCK program of the EU	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EUCLOCK program of the EU	This research was supported by Netherlands Organization for Scientific Research (NWO), program grant nr 805.47. 212 From Molecule to Cell, and by "Entrainment of the circadian clock" - EUCLOCK program of the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Beersma DGM, 2008, J BIOL RHYTHM, V23, P362, DOI 10.1177/0748730408317992; Bendova Z, 2006, PHYSIOL RES, V55, P623, DOI 10.33549/physiolres.930849; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; Colwell CS, 2005, NAT NEUROSCI, V8, P10, DOI 10.1038/nn0105-10; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Evans JA, 2004, AM J PHYSIOL-REG I, V286, pR539, DOI 10.1152/ajpregu.00456.2003; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Indic P, 2007, J BIOL RHYTHM, V22, P211, DOI 10.1177/0748730407301238; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Mrugala M, 2000, AM J PHYSIOL-REG I, V278, pR987, DOI 10.1152/ajpregu.2000.278.4.R987; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; PITTENDRIGH CS, 1984, CIBA F SYMP, V104, P26; PITTENDRIGH CS, 1991, J BIOL RHYTHM, V6, P299, DOI 10.1177/074873049100600402; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Refinetti R, 2002, INTEGR PHYS BEH SCI, V37, P114, DOI 10.1007/BF02688824; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rohling J, 2006, J BIOL RHYTHM, V21, P301, DOI 10.1177/0748730406290317; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Sumova A, 2003, J BIOL RHYTHM, V18, P134, DOI 10.1177/0748730403251801; Takahashi J. S., 2001, CIRCADIAN CLOCKS; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Welsh DK, 2007, J NEUROPHYSIOL, V97, P1885, DOI 10.1152/jn.00063.2007; Winfree A.T., 2000, GEOMETRY BIOL TIME	38	75	77	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4976	10.1371/journal.pone.0004976	http://dx.doi.org/10.1371/journal.pone.0004976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305510	Green Submitted, Green Published, gold			2022-12-27	WOS:000265498800018
J	Carthagena, L; Bergamaschi, A; Luna, JM; David, A; Uchil, PD; Margottin-Goguet, F; Mothes, W; Hazan, U; Transy, C; Pancino, G; Nisole, S				Carthagena, Laetitia; Bergamaschi, Anna; Luna, Joseph M.; David, Annie; Uchil, Pradeep D.; Margottin-Goguet, Florence; Mothes, Walther; Hazan, Uriel; Transy, Catherine; Pancino, Gianfranco; Nisole, Sebastien			Human TRIM Gene Expression in Response to Interferons	PLOS ONE			English	Article								Background: Tripartite motif (TRIM) proteins constitute a family of proteins that share a conserved tripartite architecture. The recent discovery of the anti-HIV activity of TRIM5 alpha in primate cells has stimulated much interest in the potential role of TRIM proteins in antiviral activities and innate immunity. Principal Findings: To test if TRIM genes are up-regulated during antiviral immune responses, we performed a systematic analysis of TRIM gene expression in human primary lymphocytes and monocyte-derived macrophages in response to interferons (IFNs, type I and II) or following Fc gamma R-mediated activation of macrophages. We found that 27 of the 72 human TRIM genes are sensitive to IFN. Our analysis identifies 9 additional TRIM genes that are up-regulated by IFNs, among which only 3 have previously been found to display an antiviral activity. Also, we found 2 TRIM proteins, TRIM9 and 54, to be specifically up-regulated in Fc gamma R-activated macrophages. Conclusions: Our results present the first comprehensive TRIM gene expression analysis in primary human immune cells, and suggest the involvement of additional TRIM proteins in regulating host antiviral activities.	[Carthagena, Laetitia; Margottin-Goguet, Florence; Hazan, Uriel; Transy, Catherine; Nisole, Sebastien] Univ Paris 05, Inst Cochin, CNRS, Dept Malad Infect,UMR 8104, Paris, France; [Carthagena, Laetitia; Margottin-Goguet, Florence; Hazan, Uriel; Transy, Catherine; Nisole, Sebastien] INSERM, U567, Paris, France; [Bergamaschi, Anna; David, Annie; Pancino, Gianfranco] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Luna, Joseph M.; Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sch Med, Sect Microb Pathogenesis, New Haven, CT 06520 USA; [Hazan, Uriel; Nisole, Sebastien] Univ Paris 07, UFR Sci Vivant, F-75221 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yale University; UDICE-French Research Universities; Universite Paris Cite	Carthagena, L (corresponding author), Univ Paris 05, Inst Cochin, CNRS, Dept Malad Infect,UMR 8104, Paris, France.	sebastien.nisole@inserm.fr	Nisole, Sébastien/ABA-2367-2021; Margottin-Goguet, Florence/F-9272-2013; Pancino, Gianfranco/A-5519-2010	Nisole, Sébastien/0000-0001-9793-419X; Margottin-Goguet, Florence/0000-0002-3124-6690; Luna, Joseph/0000-0003-2415-9203; Uchil, Pradeep/0000-0002-7236-858X	Sidaction; Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS)	Sidaction; Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported by grants from Sidaction and from Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; BERGAMINI A, 1994, BLOOD, V84, P3405; Boekhoudt GH, 2007, J LEUKOCYTE BIOL, V81, P1086, DOI 10.1189/jlb.0906543; Bouazzaoui A, 2006, VIROLOGY, V356, P79, DOI 10.1016/j.virol.2006.07.025; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dauffy J, 2006, J LEUKOCYTE BIOL, V79, P173, DOI 10.1189/jlb.0205083; David A, 2006, J IMMUNOL, V177, P6291, DOI 10.4049/jimmunol.177.9.6291; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; Eng EW, 2007, MOL BIOL CELL, V18, P2389, DOI 10.1091/mbc.e06-12-1128; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; LAVAU C, 1995, ONCOGENE, V11, P871; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyer M, 2003, TISSUE ANTIGENS, V61, P63, DOI 10.1034/j.1399-0039.2003.610105.x; Nakasato N, 2006, BIOCHEM BIOPH RES CO, V351, P540, DOI 10.1016/j.bbrc.2006.10.061; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Orimo A, 2000, GENOMICS, V69, P143, DOI 10.1006/geno.2000.6318; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perez-Bercoff D, 2003, J VIROL, V77, P4081, DOI 10.1128/JVI.77.7.4081-4094.2003; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rhodes DA, 2002, IMMUNOLOGY, V106, P246, DOI 10.1046/j.1365-2567.2002.01417.x; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Stadler M, 1995, ONCOGENE, V11, P2565; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Taylor MW, 2004, J INTERF CYTOK RES, V24, P107, DOI 10.1089/107999004322813354; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Zhang Z, 2006, INT J INF TECH DECIS, V5, P353, DOI 10.1142/S0219622006001976; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	60	194	205	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4894	10.1371/journal.pone.0004894	http://dx.doi.org/10.1371/journal.pone.0004894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290053	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496500009
J	Scholz, J; Triantafyllou, C; Whitfield-Gabrieli, S; Brown, EN; Saxe, R				Scholz, Jonathan; Triantafyllou, Christina; Whitfield-Gabrieli, Susan; Brown, Emery N.; Saxe, Rebecca			Distinct Regions of Right Temporo-Parietal Junction Are Selective for Theory of Mind and Exogenous Attention	PLOS ONE			English	Article							BRAIN; FMRI; THINKING; ANATOMY; TASKS; MRI	In functional magnetic resonance imaging (fMRI) studies, a cortical region in the right temporo-parietal junction (RTPJ) is recruited when participants read stories about people's thoughts ('Theory of Mind'). Both fMRI and lesion studies suggest that a region near the RTPJ is associated with attentional reorienting in response to an unexpected stimulus. Do Theory of Mind and attentional reorienting recruit a single population of neurons, or are there two neighboring but distinct neural populations in the RTPJ? One recent study compared these activations, and found evidence consistent with a single common region. However, the apparent overlap may have been due to the low resolution of the previous technique. We tested this hypothesis using a high-resolution protocol, within-subjects analyses, and more powerful statistical methods. Strict conjunction analyses revealed that the area of overlap was small and on the periphery of each activation. In addition, a bootstrap analysis identified a reliable 6-10 mm spatial displacement between the peak activations of the two tasks; the same magnitude and direction of displacement was observed in within-subjects comparisons. In all, these results suggest that there are neighboring but distinct regions within the RTPJ implicated in Theory of Mind and orienting attention.	[Scholz, Jonathan] Georgia Inst Technol, Sch Comp Sci, Atlanta, GA 30332 USA; [Triantafyllou, Christina; Whitfield-Gabrieli, Susan; Brown, Emery N.; Saxe, Rebecca] Massachusetts Inst Technol, Dept Brain & Cognitive Sci, Cambridge, MA 02139 USA	University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT)	Scholz, J (corresponding author), Georgia Inst Technol, Sch Comp Sci, Atlanta, GA 30332 USA.	saxe@mit.edu	Triantafyllou, Christina/E-7724-2011	Lauwereyns, Jan/0000-0003-0551-2550	John Merck fellowship; Ellison Medical Foundation; Packard Foundation; Simons Foundation;  [R01 DA015644]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015644] Funding Source: NIH RePORTER	John Merck fellowship; Ellison Medical Foundation(Lawrence Ellison Foundation); Packard Foundation(The David & Lucile Packard Foundation); Simons Foundation; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RS was supported by a John Merck fellowship and grants from the Ellison Medical Foundation, the Packard Foundation and the Simons Foundation. EB was supported by R01 DA015644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffermann WF, 2002, NEUROIMAGE, V17, P583, DOI 10.1006/nimg.2002.1223; BAKER N, 2004, J VISION, V4, P88; Bullmore ET, 2000, NEUROIMAGE, V11, P289, DOI 10.1006/nimg.2000.0544; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Huettel SA, 2004, CEREB CORTEX, V14, P165, DOI 10.1093/cercor/bhg115; Lutcke H, 2008, CEREB CORTEX, V18, P508, DOI 10.1093/cercor/bhm090; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Pajevic S, 2003, J MAGN RESON, V161, P1, DOI 10.1016/S1090-7807(02)00178-7; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Perner J, 2006, SOC NEUROSCI-UK, V1, P245, DOI 10.1080/17470910600989896; POSNER MI, 1984, J NEUROSCI, V4, P1863; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Tibshirani R.J., 1993, MONOGRAPHS STAT APPL, VVolume 57, P1; VALLAR G, 1993, BRAIN, V116, P71, DOI 10.1093/brain/116.1.71; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; ZAIICHIK D, 1990, COGNITION, V35, P41	25	158	158	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4869	10.1371/journal.pone.0004869	http://dx.doi.org/10.1371/journal.pone.0004869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290043	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496500006
J	Koseska, A; Zaikin, A; Kurths, J; Garcia-Ojalvo, J				Koseska, Aneta; Zaikin, Alexey; Kurths, Juergen; Garcia-Ojalvo, Jordi			Timing Cellular Decision Making Under Noise via Cell-Cell Communication	PLOS ONE			English	Article							COHERENCE RESONANCE; SYSTEM; AMPLIFICATION; CLOCK	Many cellular processes require decision making mechanisms, which must act reliably even in the unavoidable presence of substantial amounts of noise. However, the multistable genetic switches that underlie most decision-making processes are dominated by fluctuations that can induce random jumps between alternative cellular states. Here we show, via theoretical modeling of a population of noise-driven bistable genetic switches, that reliable timing of decision-making processes can be accomplished for large enough population sizes, as long as cells are globally coupled by chemical means. In the light of these results, we conjecture that cell proliferation, in the presence of cell-cell communication, could provide a mechanism for reliable decision making in the presence of noise, by triggering cellular transitions only when the whole cell population reaches a certain size. In other words, the summation performed by the cell population would average out the noise and reduce its detrimental impact.	[Koseska, Aneta; Kurths, Juergen] Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany; [Zaikin, Alexey] UCL, Dept Math, London WC1E 6BT, England; [Zaikin, Alexey] UCL, Inst Women Hlth, London WC1E 6BT, England; [Kurths, Juergen] Humboldt Univ, Inst Phys, D-1086 Berlin, Germany; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis Engn Nuclear, Terrassa, Spain	University of Potsdam; University of London; University College London; University of London; University College London; Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung; Universitat Politecnica de Catalunya	Koseska, A (corresponding author), Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany.	alexey.zaikin@ucl.ac.uk	Zaikin, Alexey/T-7171-2019; Zaikin, Alexey/K-6581-2017; Garcia-Ojalvo, Jordi/A-4574-2009	Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Garcia-Ojalvo, Jordi/0000-0002-3716-7520	Federal Ministry of Education and Research [0313924]; VW-foundation; CESCA-CEPBA through European ACCESS programm; Ministerio de Educacion y Ciencia Spain [FIS2006-11452]; European Commission (GABA project); Ministerio de Ciencia e Innovacion (Spain); EU through the Network of Excellence BioSim [LSHB-CT-2004-005137]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); VW-foundation(Volkswagen); CESCA-CEPBA through European ACCESS programm; Ministerio de Educacion y Ciencia Spain(Spanish Government); European Commission (GABA project)(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU through the Network of Excellence BioSim	A.K. and J.K. acknowledge the GoFORSYS project funded by the Federal Ministry of Education and Research, Grant Nr. 0313924, A.Z. acknowledges financial support from VW-foundation and CESCA-CEPBA through European ACCESS programm, J.G.O. from the Ministerio de Educacion y Ciencia (Spain, project FIS2006-11452), the European Commission (GABA project), and the I3 program of the Ministerio de Ciencia e Innovacion (Spain), and J.K. from the EU through the Network of Excellence BioSim, Contract No. LSHB-CT-2004-005137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; ENRIGHT JT, 1980, SCIENCE, V209, P1542, DOI 10.1126/science.7433976; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldbach M, 2008, PHYSICA D, V237, P316, DOI 10.1016/j.physd.2007.09.004; Jung P, 2001, EUROPHYS LETT, V56, P29, DOI 10.1209/epl/i2001-00483-y; Koseska A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031916; Kuznetsov A, 2005, SIAM J APPL MATH, V65, P392, DOI 10.1137/S0036139903436029; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Pikovsky A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.050601; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Schmid G, 2001, EUROPHYS LETT, V56, P22, DOI 10.1209/epl/i2001-00482-6; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Tanouchi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000167; Toral R, 2003, EUROPHYS LETT, V61, P162, DOI 10.1209/epl/i2003-00207-5; Wang MS, 2004, CHEMPHYSCHEM, V5, P1602, DOI 10.1002/cphc.200400255; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	25	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4872	10.1371/journal.pone.0004872	http://dx.doi.org/10.1371/journal.pone.0004872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283068	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496300010
J	Kron, K; Pethe, V; Briollais, L; Sadikovic, B; Ozcelik, H; Sunderji, A; Venkateswaran, V; Pinthus, J; Fleshner, N; van der Kwast, T; Bapat, B				Kron, Ken; Pethe, Vaijayanti; Briollais, Laurent; Sadikovic, Bekim; Ozcelik, Hilmi; Sunderji, Alia; Venkateswaran, Vasundara; Pinthus, Jehonathan; Fleshner, Neil; van der Kwast, Theodorus; Bapat, Bharati			Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays	PLOS ONE			English	Article								Background: Promoter and 59 end methylation regulation of tumour suppressor genes is a common feature of many cancers. Such occurrences often lead to the silencing of these key genes and thus they may contribute to the development of cancer, including prostate cancer. Methodology/Principal Findings: In order to identify methylation changes in prostate cancer, we performed a genome-wide analysis of DNA methylation using Agilent human CpG island arrays. Using computational and gene-specific validation approaches we have identified a large number of potential epigenetic biomarkers of prostate cancer. Further validation of candidate genes on a separate cohort of low and high grade prostate cancers by quantitative MethyLight analysis has allowed us to confirm DNA hypermethylation of HOXD3 and BMP7, two genes that may play a role in the development of high grade tumours. We also show that promoter hypermethylation is responsible for downregulated expression of these genes in the DU-145 PCa cell line. Conclusions/Significance: This study identifies novel epigenetic biomarkers of prostate cancer and prostate cancer progression, and provides a global assessment of DNA methylation in prostate cancer.	[Kron, Ken; Pethe, Vaijayanti; Briollais, Laurent; Ozcelik, Hilmi; Sunderji, Alia; Bapat, Bharati] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Sunderji, Alia; Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Sadikovic, Bekim] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON, Canada; [Venkateswaran, Vasundara] Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON, Canada; [Pinthus, Jehonathan] McMaster Univ, Dept Surg, Div Urol, Hamilton, ON L8S 4L8, Canada; [Fleshner, Neil] Univ Toronto, Univ Hlth Network, Dept Surg, Div Urol, Toronto, ON, Canada; [van der Kwast, Theodorus] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Bapat, Bharati] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Kron, K (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	BAPAT@lunenfeld.ca	Pinthus, Jehonathan/AAQ-1667-2021; Briollais, Laurent/A-2941-2013; Ozcelik, Hilmi/A-3952-2011; Bapat, Bharati/B-5839-2014	Van der Kwast, Theodorus/0000-0001-8640-5786	Canadian Prostate Cancer Research Initiative, National Cancer Institute of Canada [18568]; Ontario Student Opportunity Trust Fund; Scace Prostate Cancer Fellowship	Canadian Prostate Cancer Research Initiative, National Cancer Institute of Canada; Ontario Student Opportunity Trust Fund; Scace Prostate Cancer Fellowship	Canadian Prostate Cancer Research Initiative, National Cancer Institute of Canada (#18568). Ontario Student Opportunity Trust Fund, Scace Prostate Cancer Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bryzgunova OE, 2008, ANN NY ACAD SCI, V1137, P222, DOI 10.1196/annals.1448.039; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Hadnagy A, 2008, MOL CANCER THER, V7, P740, DOI 10.1158/1535-7163.MCT-07-2284; Hamada J, 2001, INT J CANCER, V93, P516, DOI 10.1002/ijc.1357; HERMAN JG, 1995, CANCER RES, V55, P4525; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Li LC, 2005, JNCI-J NATL CANCER I, V97, P103, DOI 10.1093/jnci/dji010; Lopez-Beltran A, 2006, VIRCHOWS ARCH, V448, P111, DOI 10.1007/s00428-005-0102-4; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Mehrotra J, 2008, PROSTATE, V68, P152, DOI 10.1002/pros.20675; Meiers I, 2007, PATHOLOGY, V39, P299, DOI 10.1080/00313020701329906; Millar DS, 1999, ONCOGENE, V18, P1313, DOI 10.1038/sj.onc.1202415; Miyazaki YJ, 2002, ONCOGENE, V21, P798, DOI 10.1038/sj.onc.1205126; Okubo Y, 2002, CLIN EXP METASTAS, V19, P503, DOI 10.1023/A:1020346211686; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rodriguez BAT, 2008, CARCINOGENESIS, V29, P1459, DOI 10.1093/carcin/bgn115; Sadikovic B, 2008, J BIOL CHEM, V283, P4051, DOI 10.1074/jbc.M707506200; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; TANIGUCHI Y, 1995, BLOOD, V85, P2786, DOI 10.1182/blood.V85.10.2786.bloodjournal85102786; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yan PS, 2001, CANCER RES, V61, P8375; YANG YH, 2001, NORMALIZATION CDNA M, P141; Ye L, 2008, UROL ONCOL-SEMIN ORI, V26, P190, DOI 10.1016/j.urolonc.2007.03.027; Yu F, 2000, NUCLEIC ACIDS RES, V28, P2201, DOI 10.1093/nar/28.10.2201	44	68	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4830	10.1371/journal.pone.0004830	http://dx.doi.org/10.1371/journal.pone.0004830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283074	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496300008
J	Nguyen, TH; Mai, NL; Le, TP; Ha, V; Nguyen, TC; Tran, TH; Nguyen, TH; Farrar, JJ; Dunstan, SJ				Nguyen Thi Hue; Mai Ngoc Lanh; Le Thi Phuong; Ha Vinh; Nguyen Tran Chinh; Tran Tinh Hien; Nguyen T. Hieu; Farrar, Jeremy J.; Dunstan, Sarah J.			Toll-Like Receptor 4 (TLR4) and Typhoid Fever in Vietnam	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENETIC-CONTROL; SUSCEPTIBILITY; MUTATIONS; INNATE; LIPOPOLYSACCHARIDE; ASSOCIATION; FAMILY; MICE; DISEASE	Understanding the host genetic susceptibility to typhoid fever may provide a better understanding of pathogenesis and help in the development of new therapeutics and vaccines. Here we determine the genetic variation within the human TLR4 gene encoding the principal receptor for bacterial endotoxin recognition in typhoid fever patients. It is possible that genetic variants of TLR4 could detrimentally affect the innate immune response against S. typhi infection. Mutation detection and genotyping of TLR4 was performed on DNA from 414 Vietnamese typhoid fever patients and 372 population controls. dHPLC detected a total of 10 polymorphisms within the upstream and exonic regions of TLR4, of which 7 are novel. Two SNPs, T4025A and C4215G, were more frequent in typhoid cases than in controls however due to their low allele frequencies they showed borderline significance (T4025A: OR 1.9, 95% CI 0.9-4.3, P 0.07 and C4215G: OR 6.7, 95% CI 0.8-307, P 0.04). Six missense mutations were identified, with 5/6 positioned in the ectoplasmic domain. Four missense mutations and one promoter SNP (A-271G) were only present in typhoid cases, albeit at low allele frequencies. Here we determined the extent of genetic variation within TLR4 in a Vietnamese population and suggest that TLR4 may be involved in defense against typhoid fever in this population.	[Nguyen Thi Hue; Farrar, Jeremy J.; Dunstan, Sarah J.] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Nguyen Thi Hue; Ha Vinh; Nguyen Tran Chinh; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Mai Ngoc Lanh; Le Thi Phuong] Dong Thap Provinc Hosp, Dong Thap, Vietnam; [Farrar, Jeremy J.; Dunstan, Sarah J.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX1 2JD, England; [Nguyen T. Hieu] Hung Vuong Hosp, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Nguyen, TH (corresponding author), Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam.	sdunstan@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Dunstan, Sarah/AAO-9597-2020	Farrar, Jeremy/0000-0002-2700-623X; Dunstan, Sarah/0000-0001-7873-933X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	The Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allen A, 2003, PEDIATR INFECT DIS J, V22, P1018, DOI 10.1097/01.inf.0000095431.15606.68; Ameziane N, 2003, ARTERIOSCL THROM VAS, V23, pE61, DOI 10.1161/01.ATV.0000101191.92392.1D; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Bernheiden M, 2001, J ENDOTOXIN RES, V7, P447, DOI 10.1179/096805101101533061; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Child NJA, 2003, BIOCHEM SOC T, V31, P652, DOI 10.1042/bst0310652; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Dunstan SJ, 2005, J INFECT DIS, V191, P1068, DOI 10.1086/428593; Dunstan SJ, 2001, J INFECT DIS, V183, P261, DOI 10.1086/317940; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Gibbs R, 2005, NATURE, V437, P1233, DOI 10.1038/4371233a; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Lazarus R, 2002, IMMUNOL REV, V190, P9, DOI 10.1034/j.1600-065X.2002.19002.x; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Nishiya T, 2006, BIOCHEM BIOPH RES CO, V341, P1128, DOI 10.1016/j.bbrc.2006.01.074; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Smirnova I, 2001, GENETICS, V158, P1657; Smirnova I, 2000, GENOME BIOL, V1; SULTZER BM, 1968, NATURE, V219, P1253, DOI 10.1038/2191253a0; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463	47	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4800	10.1371/journal.pone.0004800	http://dx.doi.org/10.1371/journal.pone.0004800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277200	gold, Green Published			2022-12-27	WOS:000265496100019
J	Ravassard, P; Bricout-Neveu, E; Hazhouz, Y; Pechberty, S; Mallet, J; Czernichow, P; Scharfmann, R				Ravassard, Philippe; Bricout-Neveu, Emilie; Hazhouz, Yasmine; Pechberty, Severine; Mallet, Jacques; Czernichow, Paul; Scharfmann, Raphael			A New Strategy to Generate Functional Insulin-Producing Cell Lines by Somatic Gene Transfer into Pancreatic Progenitors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CELLS; IN-VITRO; LENTIVIRAL VECTOR; ENDOCRINE-CELLS; HUMAN ISLETS; SCID MOUSE; MICE; EXPRESSION; RAT	Background: There is increasing interest in developing human cell lines to be used to better understand cell biology, but also for drug screening, toxicology analysis and future cell therapy. In the endocrine pancreatic field, functional human beta cell lines are extremely scarce. On the other hand, rodent insulin producing beta cells have been generated during the past years with great success. Many of such cell lines were produced by using transgenic mice expressing SV40T antigen under the control of the insulin promoter, an approach clearly inadequate in human. Our objective was to develop and validate in rodent an alternative transgenic-like approach, applicable to human tissue, by performing somatic gene transfer into pancreatic progenitors that will develop into beta cells. Methods and Findings: In this study, rat embryonic pancreases were transduced with recombinant lentiviral vector expressing the SV40T antigen under the control of the insulin promoter. Transduced tissues were next transplanted under the kidney capsule of immuno-incompetent mice allowing insulinoma development from which beta cell lines were established. Gene expression profile, insulin content and glucose dependent secretion, normalization of glycemia upon transplantation into diabetic mice validated the approach to generate beta cell lines. Conclusions: Somatic gene transfer into pancreatic progenitors represents an alternative strategy to generate functional beta cell lines in rodent. Moreover, this approach can be generalized to derive cells lines from various tissues and most importantly from tissues of human origin.	[Ravassard, Philippe; Bricout-Neveu, Emilie; Hazhouz, Yasmine; Mallet, Jacques] Univ Paris 06, INSERM, Inst Cerveau & Moelle,UMRS795, Biotechnol & Biotherapy Grp,Ctr Rech,CNRS,UMR7225, Paris, France; [Bricout-Neveu, Emilie; Hazhouz, Yasmine; Pechberty, Severine; Czernichow, Paul] Endocells, Paris, France; [Pechberty, Severine; Scharfmann, Raphael] Univ Paris 05, Fac Med, INSERM U845, Hop Necker, Ctr Rech Croissance Signalisat, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ravassard, P (corresponding author), Univ Paris 06, INSERM, Inst Cerveau & Moelle,UMRS795, Biotechnol & Biotherapy Grp,Ctr Rech,CNRS,UMR7225, Paris, France.	ravassar@chups.jussieu.fr; raphael.scharfmann@inserm.fr	scharfmann, raphael/L-3296-2017	Scharfmann, Raphael/0000-0001-7619-337X; ravassard, philippe/0000-0002-0393-9262	CNRS; INSERM; Endocells	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Endocells	This work was supported by CNRS, INSERM and Endocells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Basmaciogullari A, 2000, J ENDOCRINOL, V166, P481, DOI 10.1677/joe.0.1660481; Brun T, 2004, J CELL BIOL, V167, P1123, DOI 10.1083/jcb.200405148; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Castaing M, 2005, DIABETOLOGIA, V48, P709, DOI 10.1007/s00125-005-1694-6; Castaing M, 2001, DIABETOLOGIA, V44, P2066, DOI 10.1007/s001250100012; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Delplanque A, 2000, J CELL SCI, V113, P767; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; EFRAT S, 1993, DIABETES, V42, P901, DOI 10.2337/diabetes.42.6.901; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; EFRAT S, 1995, P NATL ACAD SCI USA, V92, P3576, DOI 10.1073/pnas.92.8.3576; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; GUELI N, 1987, J EXP CLIN CANC RES, V6, P281; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Ju Q, 1998, DIABETOLOGIA, V41, P736, DOI 10.1007/s001250050977; Kahan BW, 2003, DIABETES, V52, P2016, DOI 10.2337/diabetes.52.8.2016; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Levy L, 1998, GENE THER, V5, P913, DOI 10.1038/sj.gt.3300689; MARTIN A, 1993, J CLIN ENDOCR METAB, V77, P305, DOI 10.1210/jc.77.2.305; Miralles F, 1998, DEVELOPMENT, V125, P1017; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Scharfmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003559; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; SOLDEVILA G, 1991, J AUTOIMMUN, V4, P381, DOI 10.1016/0896-8411(91)90154-5; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	39	10	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4731	10.1371/journal.pone.0004731	http://dx.doi.org/10.1371/journal.pone.0004731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266046	Green Submitted, Green Published, gold			2022-12-27	WOS:000265490800011
J	Lee, HG; Rohila, S; Han, KA				Lee, Hyun-Gwan; Rohila, Suman; Han, Kyung-An			The Octopamine Receptor OAMB Mediates Ovulation via Ca2+/Calmodulin-Dependent Protein Kinase II in the Drosophila Oviduct Epithelium	PLOS ONE			English	Article								Ovulation is an essential physiological process in sexual reproduction; however, the underlying cellular mechanisms are poorly understood. We have previously shown that OAMB, a Drosophila G-protein-coupled receptor for octopamine (the insect counterpart of mammalian norepinephrine), is required for ovulation induced upon mating. OAMB is expressed in the nervous and reproductive systems and has two isoforms (OAMB-AS and OAMB-K3) with distinct capacities to increase intracellular Ca2+ or intracellular Ca2+ and cAMP in vitro. Here, we investigated tissue specificity and intracellular signals required for OAMB's function in ovulation. Restricted OAMB expression in the adult oviduct epithelium, but not the nervous system, reinstated ovulation in oamb mutant females, in which either OAMB isoform was sufficient for the rescue. Consistently, strong immunoreactivities for both isoforms were observed in the wild-type oviduct epithelium. To delineate the cellular mechanism by which OAMB regulates ovulation, we explored protein kinases functionally interacting with OAMB by employing a new GAL4 driver with restricted expression in the oviduct epithelium. Conditional inhibition of Ca2+/ Calmodulin-dependent protein kinase II (CaMKII), but not protein kinase A or C, in the oviduct epithelium inhibited ovulation. Moreover, constitutively active CaMKII, but not protein kinase A, expressed only in the adult oviduct epithelium fully rescued the oamb female's phenotype, demonstrating CaMKII as a major downstream molecule conveying the OAMB's ovulation signal. This is consistent with the ability of both OAMB isoforms, whose common intracellular signal in vitro is Ca2+, to reinstate ovulation in oamb females. These observations reveal the critical roles of the oviduct epithelium and its cellular components OAMB and CaMKII in ovulation. It is conceivable that the OAMB-mediated cellular activities stimulated upon mating are crucial for secretory activities suitable for egg transfer from the ovary to the uterus.	[Lee, Hyun-Gwan; Han, Kyung-An] Penn State Univ, Huck Inst Genet, Grad Program, University Pk, PA 16802 USA; [Lee, Hyun-Gwan; Rohila, Suman; Han, Kyung-An] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, HG (corresponding author), Penn State Univ, Huck Inst Genet, Grad Program, University Pk, PA 16802 USA.	kxh29@psu.edu			NIH [HD048766]; NSF [IOB-0620056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH (HD048766) and NSF (IOB-0620056) grants to K.-A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Ajonuma LC, 2002, HUM REPROD UPDATE, V8, P255, DOI 10.1093/humupd/8.3.255; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; HELM G, 1982, ACTA PHYSIOL SCAND, V114, P425, DOI 10.1111/j.1748-1716.1982.tb07005.x; HELM G, 1982, J REPROD FERTIL, V64, P233; HELM G, 1982, BIOL REPROD, V26, P553, DOI 10.1095/biolreprod26.4.553; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Kiger JA, 1999, GENETICS, V152, P281; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Leese HJ, 2001, REPRODUCTION, V121, P339, DOI 10.1530/rep.0.1210339; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lung O, 1999, INSECT BIOCHEM MOLEC, V29, P1043, DOI 10.1016/S0965-1748(99)00078-8; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Mardh PA, 2004, CURR OPIN INFECT DIS, V17, P49, DOI 10.1097/00001432-200402000-00010; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Nykamp DA, 2000, J INSECT PHYSIOL, V46, P809, DOI 10.1016/S0022-1910(99)00170-5; ORCHARD I, 1986, J NEUROBIOL, V17, P359, DOI 10.1002/neu.480170502; Ottiger M, 2000, J NEUROBIOL, V44, P57; Park D, 2002, J NEUROBIOL, V52, P24, DOI 10.1002/neu.10066; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Roman G, 1999, BIOTECHNIQUES, V27, P54, DOI 10.2144/99271bm09; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; STROM C, 1986, J NEURAL TRANSM, V66, P209, DOI 10.1007/BF01260915; Wolfner M.F., 2007, P183; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	44	50	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4716	10.1371/journal.pone.0004716	http://dx.doi.org/10.1371/journal.pone.0004716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262750	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490600026
J	Cohen, CR; Montandon, M; Carrico, AW; Shiboski, S; Bostrom, A; Obure, A; Kwena, Z; Bailey, RC; Nguti, R; Bukusi, EA				Cohen, Craig R.; Montandon, Michele; Carrico, Adam W.; Shiboski, Stephen; Bostrom, Alan; Obure, Alfredo; Kwena, Zachary; Bailey, Robert C.; Nguti, Rosemary; Bukusi, Elizabeth A.			Association of Attitudes and Beliefs towards Antiretroviral Therapy with HIV-Seroprevalence in the General Population of Kisumu, Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; MALE CIRCUMCISION; COST-EFFECTIVENESS; POTENTIAL IMPACT; RISK BEHAVIOR; CONDOM USE; PREVENTION; TRANSMISSION; MEN; PREVALENCE	Background: Since antiretroviral therapy (ART) became available in the developed world, the prevalence of unprotected sex and the incidence of sexually transmitted infections (STIs) and HIV have increased. We hypothesized that a similar phenomenon may be occurring in sub-Saharan Africa concomitant with the scale-up of HIV treatment. Methods: We conducted a general population-based survey in Kisumu, Kenya. Participants completed an interview that included demographics as well as ART-related attitudes and beliefs (AB) and then underwent HIV serological testing. Exploratory and confirmatory factor analyses of AB about ART indicated two factors: 1) ART-related risk compensation (increased sexual risk taking now that ART is available); and 2) a perception that HIV is more controllable now that ART is available. Logistic regression was used to determine associations of these factors with HIV-seroprevalence after controlling for age. Findings: 1,655 (90%) of 1,844 people aged 15-49 contacted, including 749 men and 906 women, consented to participate in the study. Most participants (n = 1164; 71%) had heard of ART. Of those who had heard of ART, 23% believed ART was a cure for HIV. ART-related risk compensation (Adjusted (A) OR = 1.45, 95% CI 1.16-1.81), and a belief that ART cures HIV (AOR = 2.14, 95% CI 1.22-3.76) were associated with an increased HIV seroprevalence in men but not women after controlling for age. In particular, ART-related risk compensation was associated with an increased HIV-seroprevalence in young (aged 15-24 years) men (OR = 1.56; 95% CI 1.12-2.19). Conclusions: ART-related risk compensation and a belief that ART cures HIV were associated with an increased HIV seroprevalence among men but not women. HIV prevention programs in sub-Saharan Africa that target the general population should include educational messages about ART and address the changing beliefs about HIV in the era of greater ART availability.	[Cohen, Craig R.; Montandon, Michele; Bukusi, Elizabeth A.] Univ Calif San Francisco, Dept Obstet Gynecol & Reproduct Sci, San Francisco, CA 94143 USA; [Carrico, Adam W.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Shiboski, Stephen; Bostrom, Alan] Univ Calif San Francisco, Ctr Epidemiol & Biostat, San Francisco, CA 94143 USA; [Obure, Alfredo; Kwena, Zachary; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya; [Bailey, Robert C.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60680 USA; [Nguti, Rosemary] Univ Nairobi, Dept Stat, Nairobi, Kenya	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi	Cohen, CR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reproduct Sci, San Francisco, CA 94143 USA.	ccohen@globalhealth.ucsf.edu			Doris Duke Charitable Foundation [ORACTA]; NIAID, Reproductive Infectious Disease Fellowship [D43 TW007388]; FOGARTY INTERNATIONAL CENTER [D43TW007388] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIAID, Reproductive Infectious Disease Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a Doris Duke Charitable Foundation Operations Research on AIDS Care and Treatment in Africa (ORACTA) grant. AWC was supported by the Reproductive Infectious Disease Fellowship (NIAID D43 TW007388). The sponsor had no role in the design, implementaiton or publication of this study.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Ferguson A, 2004, SEX TRANSM INFECT, V80, P435, DOI 10.1136/sti.2004.010462; Global HIV Prevention Working Group, 2004, HIV PREV ER EXP TREA; Gremy I, 2004, AIDS, V18, P805, DOI [10.1097/01.aids.0000111390.02002.f4, 10.1097/00002030-200403260-00013]; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Luke N, 2005, INT FAM PLAN PERSPEC, V31, P6, DOI 10.1363/3100605; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Muthen L. K., 2004, MPLUS USERS GUIDE; Nachega JB, 2005, JAIDS-J ACQ IMM DEF, V38, P196, DOI 10.1097/00126334-200502010-00011; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Orroth KK, 2006, SEX TRANSM DIS, V33, P536, DOI 10.1097/01.olq.0000204667.11192.71; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Shisana O, 2004, B WORLD HEALTH ORGAN, V82, P812; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tabachnick B. G., 2001, USING MULTIVARIATE S; van der Snoek EM, 2006, SEX TRANSM DIS, V33, P193, DOI 10.1097/01.olq.0000194593.58251.8d; van der Straten A, 2000, AIDS, V14, pF47, DOI 10.1097/00002030-200003100-00003; Vanable PA, 2003, J PSYCHOSOM RES, V54, P263, DOI 10.1016/S0022-3999(02)00483-X; Vanable PA, 2000, HEALTH PSYCHOL, V19, P134, DOI 10.1037//0278-6133.19.2.134; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Wilson TE, 2004, AM J PUBLIC HEALTH, V94, P1141, DOI 10.2105/AJPH.94.7.1141; Wools KK, 1998, E AFR MED J, V75, P679; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	41	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4573	10.1371/journal.pone.0004573	http://dx.doi.org/10.1371/journal.pone.0004573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MB	19259267	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490500001
J	Johnson, L; van Jaarsveld, CHM; Emmett, PM; Rogers, IS; Ness, AR; Hattersley, AT; Timpson, NJ; Smith, GD; Jebb, SA				Johnson, Laura; van Jaarsveld, Cornelia H. M.; Emmett, Pauline M.; Rogers, Imogen S.; Ness, Andy R.; Hattersley, Andrew T.; Timpson, Nicholas J.; Smith, George Davey; Jebb, Susan A.			Dietary Energy Density Affects Fat Mass in Early Adolescence and Is Not Modified by FTO Variants	PLOS ONE			English	Article							FOOD-INTAKE; WEIGHT-LOSS; CHILDREN; OBESITY; OVERWEIGHT; ADJUSTMENT; CHILDHOOD; FATNESS; GENE; MEN	Background: Dietary energy density (DED) does not have a simple linear relationship to fat mass in children, which suggests that some children are more susceptible than others to the effects of DED. Children with the FTO (rs9939609) variant that increases the risk of obesity may have a higher susceptibility to the effects of DED because their internal appetite control system is compromised. We tested the relationship between DED and fat mass in early adolescence and its interaction with FTO variants. Methods and Findings: We carried out a prospective analysis on 2,275 children enrolled in the Avon Longitudinal Study of Parents and Children (ALSPAC). Diet was assessed at age 10 y using 3-day diet diaries. DED (kJ/g) was calculated excluding drinks. Children were genotyped for the FTO (rs9939609) variant. Fat mass was estimated at age 13 y using the Lunar Prodigy Dual-energy X-ray Absorptiometry scanner. There was no evidence of interaction between DED at age 10 y and the high risk A allele of the FTO gene in relation to fat mass at age 13 y (beta = 0.005, p = 0.51), suggesting that the FTO gene has no effect on the relation between DED at 10 y and fat mass at 13 y. When DED at 10 y and the A allele of FTO were in the same model they were independently related to fat mass at 13 y. Each A allele of FTO was associated with 0.35+/-0.13 kg more fat mass at 13 y and each 1 kJ/g DED at 10 y was associated with 0.16+/-0.06 kg more fat mass at age 13 y, after controlling for misreporting of energy intake, gender, puberty, overweight status at 10 y, maternal education, TV watching, and physical activity. Conclusions: This study reveals the multi-factorial origin of obesity and indicates that although FTO may put some children at greater risk of obesity, encouraging a low dietary energy density may be an effective strategy to help all children avoid excessive fat gain.	[Johnson, Laura; van Jaarsveld, Cornelia H. M.] UCL, Canc Res UK Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England; [Emmett, Pauline M.] Univ Bristol, Dept Community Based Med, Bristol, Avon, England; [Rogers, Imogen S.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4AT, E Sussex, England; [Hattersley, Andrew T.] Inst Biomed & Clin Sci, Peninsula Med Sch, Exeter, Devon, England; [Ness, Andy R.] Univ Bristol, Dept Oral & Dental Sci, Bristol, Avon, England; [Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, MRC CAiTE Ctr, Dept Social Med, Bristol, Avon, England; [Jebb, Susan A.] MRC Human Nutr Res, Cambridge, England	Cancer Research UK; University of London; University College London; University of Bristol; University of Brighton; University of Exeter; University of Bristol; University of Bristol; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Johnson, L (corresponding author), UCL, Canc Res UK Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England.	l.johnson@public-health.ucl.ac.uk	Berryman, Katie/J-4236-2014; Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016; Johnson, Laura/C-2700-2008; Davey Smith, George/A-7407-2013; Ness, Andy R/M-7612-2013; Emmett, Pauline/AAL-6815-2021; Timpson, Nicholas John/O-7548-2015; Van Jaarsveld, Ellen CHM/A-4632-2016	Davey Smith, George/0000-0002-1407-8314; Ness, Andy R/0000-0003-3548-9523; Timpson, Nicholas John/0000-0002-7141-9189; Van Jaarsveld, Ellen CHM/0000-0002-4269-0041; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Johnson, Laura/0000-0001-8985-3154; Rogers, Imogen/0000-0001-7275-2437; Jebb, Susan/0000-0001-9190-2920; Hattersley, Andrew/0000-0001-5620-473X; s, hema/0000-0002-3440-9475; Emmett, Pauline/0000-0003-1076-4779	UK Medical Research Council; Wellcome Trust; University of Bristol; Cancer Research UK; Medical Research Council [MC_U105960389, G0600705, G9815508] Funding Source: researchfish; MRC [G0600705, MC_U105960389] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council, the Wellcome Trust and the University of Bristol provide core support for the Avon Longitudinal Study of Parents and Children. Laura Johnson is funded by Cancer Research UK. The funding body had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ASHCROFT J, 2007, EUR J CLIN NUTR; Bell EA, 2001, AM J CLIN NUTR, V73, P1010; BESRASTROLLO M, 2008, PROSPECTIVE STUDY DI, P769; Birch LL, 1997, ANN NY ACAD SCI, V819, P194, DOI 10.1111/j.1749-6632.1997.tb51809.x; Black AE, 2000, EUR J CLIN NUTR, V54, P386, DOI 10.1038/sj.ejcn.1600970; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DEIERLEIN AL, 2008, DIETARY ENERGY DENSI, P693; Drewnowski A, 2004, NUTR REV, V62, P403, DOI 10.1111/j.1753-4887.2004.tb00012.x; Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Glynn L, 2005, J HUM NUTR DIET, V18, P7, DOI 10.1111/j.1365-277X.2004.00582.x; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GREGORY J, 2000, NATL DIET NUTR SURVE, V1; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Iqbal SI, 2006, OBESITY, V14, P106, DOI 10.1038/oby.2006.13; Johnson L, 2008, INT J OBESITY, V32, P586, DOI 10.1038/sj.ijo.0803746; JOHNSON L, 2009, OBESITY REV IN PRESS; Johnson SL, 2000, PEDIATRICS, V106, P1429, DOI 10.1542/peds.106.6.1429; JOTANGIA D, 2005, OBESITY CHILDREN 11; Ledikwe JH, 2007, AM J CLIN NUTR, V85, P1212, DOI 10.1093/ajcn/85.5.1212; McCaffrey TA, 2008, AM J CLIN NUTR, V87, P1230, DOI 10.1093/ajcn/87.5.1230; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Ness AR, 2006, INT J PEDIATR OBES, V1, P59, DOI 10.1080/17477160600569339; Northstone K, 2005, EUR J CLIN NUTR, V59, P751, DOI 10.1038/sj.ejcn.1602136; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013; Price GM, 1995, J HUM NUTR DIET, V8, P417, DOI 10.1111/j.1365-277X.1995.tb00337.x; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086; SAVAGE JS, 2008, DIETARY ENERGY DENSI, P677; Stubbs RJ, 1998, INT J OBESITY, V22, P980, DOI 10.1038/sj.ijo.0800715; STUBBS RJ, 1995, AM J CLIN NUTR, V62, P330, DOI 10.1093/ajcn/62.2.330; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Torun B, 2005, PUBLIC HEALTH NUTR, V8, P968, DOI 10.1079/PHN2005791; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; WESTERTERPPLANT.JW, 2004, BR J NUTR S1, V92, pS35	40	53	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4594	10.1371/journal.pone.0004594	http://dx.doi.org/10.1371/journal.pone.0004594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259258	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490500003
J	Khandoga, AG; Khandoga, A; Reichel, CA; Bihari, P; Rehberg, M; Krombach, F				Khandoga, Alexander Georg; Khandoga, Andrej; Reichel, Christoph Andreas; Bihari, Peter; Rehberg, Markus; Krombach, Fritz			In Vivo Imaging and Quantitative Analysis of Leukocyte Directional Migration and Polarization in Inflamed Tissue	PLOS ONE			English	Article								Directional migration of transmigrated leukocytes to the site of injury is a central event in the inflammatory response. Here, we present an in vivo chemotaxis assay enabling the visualization and quantitative analysis of subtype-specific directional motility and polarization of leukocytes in their natural 3D microenvironment. Our technique comprises the combination of i) semi-automated in situ microinjection of chemoattractants or bacteria as local chemotactic stimulus, ii) in vivo near-infrared reflected-light oblique transillumination (RLOT) microscopy for the visualization of leukocyte motility and morphology, and iii) in vivo fluorescence microscopy for the visualization of different leukocyte subpopulations or fluorescence-labeled bacteria. Leukocyte motility parameters are quantified off-line in digitized video sequences using computer-assisted single cell tracking. Here, we show that perivenular microinjection of chemoattractants [macrophage inflammatory protein-1 alpha (MIP-1 alpha/Ccl3), platelet-activating factor (PAF)] or E. coli into the murine cremaster muscle induces target-oriented intravascular adhesion and transmigration as well as polarization and directional interstitial migration of leukocytes towards the locally administered stimuli. Moreover, we describe a crucial role of Rho kinase for the regulation of directional motility and polarization of transmigrated leukocytes in vivo. Finally, combining in vivo RLOT and fluorescence microscopy in Cx3CR1(gfp/gfp) mice (mice exhibiting green fluorescent protein-labeled monocytes), we are able to demonstrate differences in the migratory behavior of monocytes and neutrophils. Taken together, we propose a novel approach for investigating the mechanisms and spatiotemporal dynamics of subtype-specific motility and polarization of leukocytes during their directional interstitial migration in vivo.	[Khandoga, Alexander Georg; Reichel, Christoph Andreas; Bihari, Peter; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, D-80539 Munich, Germany; [Khandoga, Andrej] Univ Munich, Dept Surg Grosshadern, D-80539 Munich, Germany	University of Munich; University of Munich	Khandoga, AG (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany.	alexander.khandoga@med.uni-muenchen.de		Rehberg, Markus/0000-0001-7314-6332	EU [LSHG-CT-2003-502935]	EU(European Commission)	This work was supported by EU FP6 NoE "MAIN" (LSHG-CT-2003-502935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BAE SY, 2007, INT JOF LAB IN PRESS; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Bardi G, 2003, FEBS LETT, V542, P79, DOI 10.1016/S0014-5793(03)00351-X; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Carstanjen D, 2005, J IMMUNOL, V174, P4613, DOI 10.4049/jimmunol.174.8.4613; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hickey MJ, 2000, J IMMUNOL, V165, P7164, DOI 10.4049/jimmunol.165.12.7164; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; MIGLIORISI G, 1988, J LEUKOCYTE BIOL, V44, P485, DOI 10.1002/jlb.44.6.485; Miyazaki S, 2000, INFLAMM RES, V49, P673, DOI 10.1007/s000110050645; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Normark S, 2001, NAT MED, V7, P1182, DOI 10.1038/nm1101-1182; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Reichel CA, 2008, J LEUKOCYTE BIOL, V83, P864, DOI 10.1189/jlb.1007666; Russo TA, 2003, INFECT IMMUN, V71, P6435, DOI 10.1128/IAI.71.11.6435-6445.2003; SCHUSCHKE DA, 1989, AM J PHYSIOL, V257, pH1607, DOI 10.1152/ajpheart.1989.257.5.H1607; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wan MX, 2003, BRIT J PHARMACOL, V138, P698, DOI 10.1038/sj.bjp.0705094; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wegmann F, 2006, J EXP MED, V203, P1671, DOI 10.1084/jem.20060565; Werr J, 1998, J EXP MED, V187, P2091, DOI 10.1084/jem.187.12.2091; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Young RE, 2004, J IMMUNOL, V172, P4493, DOI 10.4049/jimmunol.172.7.4493	41	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4693	10.1371/journal.pone.0004693	http://dx.doi.org/10.1371/journal.pone.0004693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259262	gold, Green Published, Green Submitted			2022-12-27	WOS:000265490500011
J	Maro, GS; Klassen, MP; Shen, K				Maro, Geraldine S.; Klassen, Matthew P.; Shen, Kang			A beta-Catenin-Dependent Wnt Pathway Mediates Anteroposterior Axon Guidance in C. elegans Motor Neurons	PLOS ONE			English	Article							HOX GENE-EXPRESSION; B-CELL DIVISION; SIGNALING PATHWAY; NEURITE OUTGROWTH; NERVOUS-SYSTEM; PROTEIN; RECEPTORS; POLARITY; HOMOLOG; GROWTH	Background: Wnts are secreted glycoproteins that regulate diverse aspects of development, including cell proliferation, cell fate specification and differentiation. More recently, Wnts have been shown to direct axon guidance in vertebrates, flies and worms. However, little is known about the intracellular signaling pathways downstream of Wnts in axon guidance. Methodology/Principal Findings: Here we show that the posterior C. elegans Wnt protein LIN-44 repels the axons of the adjacent D-type motor neurons by activating its receptor LIN-17/Frizzled on the neurons. Moreover, mutations in mig-5/Disheveled, gsk-3, pry-1/Axin, bar-1/beta-catenin and pop-1/TCF, also cause disrupted D-type axon pathfinding. Reduced BAR-1/beta-catenin activity in D-type axons leads to undergrowth of axons, while stabilization of BAR-1/beta-catenin in a lin-23/SCF beta-TrCP mutant results in an overextension phenotype. Conclusions/Significance: Together, our data provide evidence that Wnt-mediated axon guidance can be transduced through a beta-catenin-dependent pathway.	[Maro, Geraldine S.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA; [Klassen, Matthew P.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Maro, GS (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA.	gmaro@stanford.edu; kangshen@stanford.edu			W. M. Keck Foundation; McKnight Endowment Fund; Searle Scholar Award; Human Frontier Science Program post-doctoral fellow	W. M. Keck Foundation(W.M. Keck Foundation); McKnight Endowment Fund; Searle Scholar Award; Human Frontier Science Program post-doctoral fellow	This work was supported by the W. M. Keck Foundation, the McKnight Endowment Fund and the Searle Scholar Award. GSM is a Human Frontier Science Program post-doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hunter CP, 1999, DEVELOPMENT, V126, P805; Jiang LI, 1998, DEVELOPMENT, V125, P2337; Jin YS, 1999, J NEUROSCI, V19, P539; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Maloof JN, 1999, DEVELOPMENT, V126, P37; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Natarajan L, 2004, DEV BIOL, V272, P536, DOI 10.1016/j.ydbio.2004.05.027; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Sato M, 2006, NAT NEUROSCI, V9, P67, DOI 10.1038/nn1604; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schnorrer F, 2004, CURR BIOL, V14, pR19, DOI 10.1016/j.cub.2003.12.016; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Walston T, 2006, DEV BIOL, V298, P485, DOI 10.1016/j.ydbio.2006.06.053; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Wu MF, 2007, DEV BIOL, V303, P650, DOI 10.1016/j.ydbio.2006.12.002; Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006; Zou YM, 2006, NEURON, V49, P787, DOI 10.1016/j.neuron.2006.03.004; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	55	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4690	10.1371/journal.pone.0004690	http://dx.doi.org/10.1371/journal.pone.0004690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259273	Green Published, Green Submitted, gold			2022-12-27	WOS:000265490500009
J	Borlak, J; Niehof, M				Borlak, Juergen; Niehof, Monika			HNF4alpha and HNF1alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Posttransplantation Diabetes Mellitus	PLOS ONE			English	Article								Posttransplantation diabetes mellitus (PTDM) is a frequent complication in immunosuppressive therapy. To better understand the molecular events associated with PTDM we investigated the effect of cyclosporine on expression and activity of hepatic nuclear factor (HNF) 1alpha and 4alpha and on genes coding for glucose metabolism in cultures of the rat insulinoma cell line INS-1E, the human epithelial cell line Caco-2 and with Zucker diabetic fatty (ZDF) rats. In the pancreas of untreated but diabetic animals expression of HNF4alpha, insulin1, insulin2 and of phosphoenolpyruvate carboxykinase was significantly repressed. Furthermore, cyclosporine treatment of the insulinoma-1E cell line resulted in remarkable reduction in HNF4alpha protein and INS1 as well as INS2 gene expression, while transcript expression of HNF4alpha, apolipoprotein C2, glycerolkinase, pyruvatekinase and aldolase B was repressed in treated Caco-2 cells. Furthermore, with nuclear extracts of cyclosporine treated cell lines protein expression and DNA binding activity of hepatic nuclear factors was significantly repressed. As cyclosporine inhibits the calcineurin dependent dephosphorylation of nuclear factor of activated T-cells (NFAT) we also searched for binding sites for NFAT in the pancreas specific P2 promoter of HNF4alpha. Notably, we observed repressed NFAT binding to a novel DNA binding site in the P2 promoter of HNF4alpha. Thus, cyclosporine caused inhibition of DNA binding of two important regulators for insulin signaling, i.e. NFAT and HNF4alpha. We further investigated HNF4alpha transcript expression and observed >200-fold differences in abundance in n = 14 patients. Such variability in expression might help to identify individuals at risk for developing PTDM. We propose cyclosporine to repress HNF4alpha gene and protein expression, DNA-binding to targeted promoters and subsequent regulation of genes coding for glucose metabolism and of pancreatic beta-cell function.	[Borlak, Juergen; Niehof, Monika] Hannover Med Sch, Fraunhofer Inst Toxicol & Expt Med, D-3000 Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Mol Med & Med Biotechnol, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Fraunhofer Gesellschaft; Hannover Medical School; Hannover Medical School; Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Fraunhofer Inst Toxicol & Expt Med, D-3000 Hannover, Germany.	borlak@item.fraunhofer.de			Lower Saxony Ministry of Science and Culture	Lower Saxony Ministry of Science and Culture	JB received an institutional grant from the Lower Saxony Ministry of Science and Culture, but no fund was received specifically for this study. The sponsor did not influence the design or conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, NUCL RECEPTORS GENET; Bartoov-Shifman R, 2002, J BIOL CHEM, V277, P25914, DOI 10.1074/jbc.M201582200; BASADONNA G, 1988, AM J SURG, V156, P191, DOI 10.1016/S0002-9610(88)80064-3; BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dufer M, 2001, MOL PHARMACOL, V60, P873; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohlke Karen L, 2005, Curr Diab Rep, V5, P149, DOI 10.1007/s11892-005-0043-y; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; RIEGEL W, 1989, TRANSPLANT INT, V2, P8; RYFFEL B, 1992, DRUG CHEM TOXICOL, V15, P95, DOI 10.3109/01480549209032293; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Schafer S, 2003, CARDIOVASC RES, V60, P447, DOI 10.1016/S0008-6363(03)00544-3; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Sivathasan C, 2004, TRANSPL P, V36, p346S, DOI 10.1016/j.transproceed.2004.01.072; STEGALL MD, 1989, TRANSPLANTATION, V48, P944, DOI 10.1097/00007890-198912000-00009; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Toriumi C, 2002, ANAL CHEM, V74, P2321, DOI 10.1021/ac020043t; VANSCHILFGAARDE R, 1987, TRANSPLANTATION, V44, P13; Vincenti F, 2005, TRANSPLANT P, V37, P1001, DOI 10.1016/j.transproceed.2004.12.017; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4662	10.1371/journal.pone.0004662	http://dx.doi.org/10.1371/journal.pone.0004662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252740	Green Submitted, gold, Green Published			2022-12-27	WOS:000265489900005
J	Eickel, V; Kahl, B; Reinisch, B; Dubbers, A; Kuster, P; Brandt, C; Spellerberg, B				Eickel, Vera; Kahl, Barbara; Reinisch, Beatrice; Duebbers, Angelika; Kuester, Peter; Brandt, Claudia; Spellerberg, Barbara			Emergence of Respiratory Streptococcus agalactiae Isolates in Cystic Fibrosis Patients	PLOS ONE			English	Article								Streptococcus agalactiae is a well-known pathogen for neonates and immunocompromized adults. Beyond the neonatal period, S. agalactiae is rarely found in the respiratory tract. During 2002-2008 we noticed S. agalactiae in respiratory secretions of 30/185 (16%) of cystic fibrosis (CF) patients. The median age of these patients was 3-6 years older than the median age CF patients not harboring S. agalactiae. To analyze, if the S. agalactiae isolates from CF patients were clonal, further characterization of the strains was achieved by capsular serotyping, surface protein determination and multilocus sequence typing (MLST). We found a variety of sequence types (ST) among the isolates, which did not substantially differ from the MLST patterns of colonizing strains from Germany. However serotype III, which is often seen in colonizing strains and invasive infections was rare among CF patients. The emergence of S. agalactiae in the respiratory tract of CF patients may represent the adaptation to a novel host environment, supported by the altered surfactant composition in older CF patients.	[Eickel, Vera; Reinisch, Beatrice; Spellerberg, Barbara] Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Kahl, Barbara] Univ Clin Munster, Inst Med Microbiol, Munster, Germany; [Duebbers, Angelika] Univ Clin Muenster, Dept Pediat, Munster, Germany; [Kuester, Peter] Clemenshosp Muenster, Dept Pediat, Munster, Germany; [Brandt, Claudia] Univ Hosp Frankfurt, Inst Med Microbiol, Frankfurt, Germany	Ulm University; University of Munster; University of Munster; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Eickel, V (corresponding author), Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany.	barbara.spellerberg@uniklinik-ulm.de	Spellerberg, Barbara/D-3443-2011	Spellerberg, Barbara/0000-0001-7552-8764; Kahl, Barbara/0000-0001-5155-3383	Unversity of Ulm	Unversity of Ulm	Unversity of Ulm. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brimil N, 2006, INT J MED MICROBIOL, V296, P39, DOI 10.1016/j.ijmm.2005.11.001; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; BUUHOI A, 1990, ANTIMICROB AGENTS CH, V34, P985, DOI 10.1128/AAC.34.6.985; CDC, 1999, MMWR-MORBID MORTAL W, V48, P426; Creti R, 2004, J CLIN MICROBIOL, V42, P1326, DOI 10.1128/JCM.42.3.1326-1329.2004; Cummings C G, 1981, J Clin Pathol, V34, P813, DOI 10.1136/jcp.34.7.813-a; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; DOERN GV, 1992, J CLIN MICROBIOL, V30, P2740, DOI 10.1128/JCM.30.10.2740-2742.1992; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; FERRIERI P, 1977, J CLIN MICROBIOL, V6, P136; Fluegge K, 2005, CLIN INFECT DIS, V40, P760, DOI 10.1086/427942; Griese M, 2004, AM J RESP CRIT CARE, V170, P1000, DOI 10.1164/rccm.200405-575oc; Griese M, 1997, EUR RESPIR J, V10, P1983, DOI 10.1183/09031936.97.10091983; Gygax SE, 2006, ANTIMICROB AGENTS CH, V50, P1875, DOI 10.1128/AAC.50.5.1875-1877.2006; Heinrich S, 2006, CURR MED CHEM, V13, P3239, DOI 10.2174/092986706778773112; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kong FR, 2002, J CLIN MICROBIOL, V40, P216, DOI 10.1128/JCM.40.1.216-226.2002; LeVine AM, 1997, J IMMUNOL, V158, P4336; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lopardo HA, 2003, J CLIN MICROBIOL, V41, P4688, DOI 10.1128/JCM.41.10.4688-4694.2003; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; Schoening TE, 2005, CLIN MICROBIOL INFEC, V11, P579, DOI 10.1111/j.1469-0691.2005.01180.x; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08; Wellinghausen N, 2007, J CLIN MICROBIOL, V45, P789, DOI 10.1128/JCM.01856-06; Zwart S, 2000, SCAND J INFECT DIS, V32, P377, DOI 10.1080/003655400750044944	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4650	10.1371/journal.pone.0004650	http://dx.doi.org/10.1371/journal.pone.0004650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247473	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800029
J	Mendonsa, G; Dobrowolska, J; Lin, A; Vijairania, P; Jong, YJI; Baenziger, NL				Mendonsa, Graziella; Dobrowolska, Justyna; Lin, Angela; Vijairania, Pooja; Jong, Y-J. I.; Baenziger, Nancy L.			Molecular Profiling Reveals Diversity of Stress Signal Transduction Cascades in Highly Penetrant Alzheimer's Disease Human Skin Fibroblasts	PLOS ONE			English	Article								The serious and growing impact of the neurodegenerative disorder Alzheimer's disease (AD) as an individual and societal burden raises a number of key questions: Can a blanket test for Alzheimer's disease be devised forecasting long-term risk for acquiring this disorder? Can a unified therapy be devised to forestall the development of AD as well as improve the lot of present sufferers? Inflammatory and oxidative stresses are associated with enhanced risk for AD. Can an AD molecular signature be identified in signaling pathways for communication within and among cells during inflammatory and oxidative stress, suggesting possible biomarkers and therapeutic avenues? We postulated a unique molecular signature of dysfunctional activity profiles in AD-relevant signaling pathways in peripheral tissues, based on a gain of function in G-protein-coupled bradykinin B2 receptor (BKB2R) inflammatory stress signaling in skin fibroblasts from AD patients that results in tau protein Ser hyperphosphorylation. Such a signaling profile, routed through both phosphorylation and proteolytic cascades activated by inflammatory and oxidative stresses in highly penetrant familial monogenic forms of AD, could be informative for pathogenesis of the complex multigenic sporadic form of AD. Comparing stimulus-specific cascades of signal transduction revealed a striking diversity of molecular signaling profiles in AD human skin fibroblasts that express endogenous levels of mutant presenilins PS-1 or PS-2 or the Trisomy 21 proteome. AD fibroblasts bearing the PS-1 M146L mutation associated with highly aggressive AD displayed persistent BKB2R signaling plus decreased ERK activation by BK, correctible by gamma-secretase inhibitor Compound E. Lack of these effects in the homologous PS-2 mutant cells indicates specificity of presenilin gamma-secretase catalytic components in BK signaling biology directed toward MAPK activation. Oxidative stress revealed a JNK-dependent survival pathway in normal fibroblasts lost in PS-1 M146L fibroblasts. Complex molecular profiles of signaling dysfunction in the most putatively straightforward human cellular models of AD suggest that risk ascertainment and therapeutic interventions in AD as a whole will likely demand complex solutions.	[Mendonsa, Graziella; Dobrowolska, Justyna; Lin, Angela; Vijairania, Pooja; Jong, Y-J. I.; Baenziger, Nancy L.] Washington Univ, Dept Anat & Neurobiol, Program Mol Cell Biol, Div Biol & Biomed Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Mendonsa, G (corresponding author), Washington Univ, Dept Anat & Neurobiol, Program Mol Cell Biol, Div Biol & Biomed Sci, St Louis, MO 63130 USA.	baenzign@thalamus.wustl.edu	Zakaria, Justyna Dobrowolska/L-7283-2019	Zakaria, Justyna Dobrowolska/0000-0003-1718-147X	Washington University Alzheimer's Disease Research Center (ADRC) [P50AG005681]; Edith and Alan L. Wolff Charitable Trust; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	Washington University Alzheimer's Disease Research Center (ADRC); Edith and Alan L. Wolff Charitable Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was privately funded via the Edith and Alan L. Wolff Charitable Trust through the infrastructure support of the Washington University Alzheimer's Disease Research Center (ADRC)(P50AG005681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2004, BIOORGAN MED CHEM, V12, P4791, DOI 10.1016/j.bmc.2004.07.022; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BAENZIGER NL, 1992, EUR J CELL BIOL, V58, P71; BAENZIGER NL, 1994, J BIOL CHEM, V269, P14892; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Beales ILP, 2006, MOL CELL ENDOCRINOL, V247, P140, DOI 10.1016/j.mce.2005.12.050; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bellucci C, 2007, MOL MED, V13, P542, DOI 10.2119/2007-00034.Bellucci; BEZPROZVANNY I, 2008, TRENDS NEUROSCI; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Boo JH, 2008, BIOCHEM BIOPH RES CO, V372, P913, DOI 10.1016/j.bbrc.2008.05.153; Borroni B, 2007, CURR MED CHEM, V14, P1171, DOI 10.2174/092986707780598005; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Butterfield DA, 2002, J NUTR BIOCHEM, V13, P444, DOI 10.1016/S0955-2863(02)00205-X; Cecchi C, 2002, FREE RADICAL BIO MED, V33, P1372, DOI 10.1016/S0891-5849(02)01049-3; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; COMBARROS O, 2008, NEUROBIOL AGING; COSTANZI E, 2007, NEUROCHEM RES; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; DIMOS JT, 2008, SCIENCE; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2005, J ALZHEIMERS DIS, V8, P347; FOWLER CJ, 1995, MOL CELL BIOCHEM, V149, P287, DOI 10.1007/BF01076590; Garnier P, 2003, J NEUROSCI, V23, P7967; Gasparini L, 1998, FASEB J, V12, P17, DOI 10.1096/fasebj.12.1.17; Gibson GE, 2002, FREE RADICAL BIO MED, V32, P1061, DOI 10.1016/S0891-5849(02)00802-X; Gu F, 2008, NEUROSCI LETT, V440, P44, DOI 10.1016/j.neulet.2008.05.050; Haddad JJ, 2004, PROG NEUROBIOL, V73, P359, DOI 10.1016/j.pneurobio.2004.06.002; Hardy J, 2007, EMBO REP, V8, P134, DOI 10.1038/sj.embor.7400899; Hashimoto Y, 2004, J NEUROSCI RES, V75, P417, DOI 10.1002/jnr.10861; Hayashi R, 2000, EUR RESPIR J, V16, P452, DOI 10.1034/j.1399-3003.2000.016003452.x; JANICKI S, 2000, NEUROBIOLOGY AGING, V21; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Jong YJI, 2002, INT IMMUNOPHARMACOL, V2, P1833, DOI 10.1016/S1567-5769(02)00168-6; Jong YJI, 2003, FASEB J, V17, P2319, DOI 10.1096/fj.02-1147fje; Jong YJI, 1996, IMMUNOPHARMACOLOGY, V33, P9, DOI 10.1016/0162-3109(96)00075-6; JONG YJI, 1993, P NATL ACAD SCI USA, V90, P10994, DOI 10.1073/pnas.90.23.10994; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Khan TK, 2006, P NATL ACAD SCI USA, V103, P13203, DOI 10.1073/pnas.0605411103; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lanni C, 2008, MOL PSYCHIATR, V13, P641, DOI 10.1038/sj.mp.4002060; Lanni C, 2007, J ALZHEIMERS DIS, V12, P93; LEE JM, 2008, CLIN CHEM; Li Y, 2008, NEUROBIOL DIS, V29, P293, DOI 10.1016/j.nbd.2007.09.001; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu B, 2006, J CELL BIOCHEM, V97, P1104, DOI 10.1002/jcb.20709; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Malik B, 2008, CELL CYCLE, V7, P637, DOI 10.4161/cc.7.5.5427; Marchesi VT, 2005, P NATL ACAD SCI USA, V102, P9093, DOI 10.1073/pnas.0503181102; Matsuzawa A, 2005, ANTIOXID REDOX SIGN, V7, P472, DOI 10.1089/ars.2005.7.472; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McCarthy JV, 2005, BIOCHEM SOC T, V33, P568, DOI 10.1042/BST0330568; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mukherjee O, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-3; Nakajima M, 2001, J NEUROCHEM, V78, P807, DOI 10.1046/j.1471-4159.2001.00478.x; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pratico D, 2005, NEUROBIOL AGING, V26, P581, DOI 10.1016/j.neurobiolaging.2004.09.020; Quinn J, 2008, NEUROLOGY, V71, P78, DOI 10.1212/01.wnl.0000316808.21277.69; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shaw RW, 2006, FASEB J, V20, pA898, DOI 10.1096/fj.05-4055fje; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Tan YZ, 1998, BBA-MOL BASIS DIS, V1407, P69, DOI 10.1016/S0925-4439(98)00031-3; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Turner JH, 2007, BBA-MOL CELL RES, V1773, P391, DOI 10.1016/j.bbamcr.2006.12.003; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Velez-Pardo C, 2002, NEUROTOXICOLOGY, V23, P351, DOI 10.1016/S0161-813X(02)00081-5; Wilhelm M, 2007, J BIOL CHEM, V282, P1288, DOI 10.1074/jbc.M607038200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4; Zhao WQ, 2002, NEUROBIOL DIS, V11, P166, DOI 10.1006/nbdi.2002.0520; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012; Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6	96	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4655	10.1371/journal.pone.0004655	http://dx.doi.org/10.1371/journal.pone.0004655			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247475	gold, Green Published			2022-12-27	WOS:000265487800034
J	Amonkar, SD; Bertenshaw, GP; Chen, TH; Bergstrom, KJ; Zhao, JH; Seshaiah, P; Yip, P; Mansfield, BC				Amonkar, Suraj D.; Bertenshaw, Greg P.; Chen, Tzong-Hao; Bergstrom, Katharine J.; Zhao, Jinghua; Seshaiah, Partha; Yip, Ping; Mansfield, Brian C.			Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer	PLOS ONE			English	Article							SERUM; BENIGN; CA-125; WOMEN; ANTIGEN-125; BIOMARKERS; MULTIPLE; MARKERS; RISK	Background: Most women with a clinical presentation consistent with ovarian cancer have benign conditions. Therefore methods to distinguish women with ovarian cancer from those with benign conditions would be beneficial. We describe the development and preliminary evaluation of a serum-based multivariate assay for ovarian cancer. This hypothesis-driven study examined whether an informative pattern could be detected in stage I disease that persists through later stages. Methodology/Principal Findings: Sera, collected under uniform protocols from multiple institutions, representing 176 cases and 187 controls from women presenting for surgery were examined using high-throughput, multiplexed immunoassays. All stages and common subtypes of epithelial ovarian cancer, and the most common benign ovarian conditions were represented. A panel of 104 antigens, 44 autoimmune and 56 infectious disease markers were assayed and informative combinations identified. Using a training set of 91 stage I data sets, representing 61 individual samples, and an equivalent number of controls, an 11-analyte profile, composed of CA-125, CA 19-9, EGF-R, C-reactive protein, myoglobin, apolipoprotein A1, apolipoprotein CIII, MIP-1 alpha, IL-6, IL-18 and tenascin C was identified and appears informative for all stages and common subtypes of ovarian cancer. Using a testing set of 245 samples, approximately twice the size of the model building set, the classifier had 91.3% sensitivity and 88.5% specificity. While these preliminary results are promising, further refinement and extensive validation of the classifier in a clinical trial is necessary to determine if the test has clinical value. Conclusions/Significance: We describe a blood-based assay using 11 analytes that can distinguish women with ovarian cancer from those with benign conditions. Preliminary evaluation of the classifier suggests it has the potential to offer approximately 90% sensitivity and 90% specificity. While promising, the performance needs to be assessed in a blinded clinical validation study.	[Amonkar, Suraj D.; Bertenshaw, Greg P.; Chen, Tzong-Hao; Bergstrom, Katharine J.; Zhao, Jinghua; Seshaiah, Partha; Yip, Ping; Mansfield, Brian C.] Correlog Syst Inc, Rockville, MD USA		Amonkar, SD (corresponding author), Correlog Syst Inc, Rockville, MD USA.	bmansfield@correlogic.com		Mansfield, Brian/0000-0002-8533-2789; Bertenshaw, Greg/0000-0003-4903-3412	Correlogic Systems, Inc.	Correlogic Systems, Inc.	All authors are employed by Correlogic Systems, Inc.	*ACS, 2008, CANC FACTS FIG 2008; Andersen MR, 2008, CANCER-AM CANCER SOC, V113, P484, DOI 10.1002/cncr.23577; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buamah P, 2000, J SURG ONCOL, V75, P264, DOI 10.1002/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q; FIORETTI P, 1988, European Journal of Gynaecological Oncology, V9, P291; FUNG ET, 2006, NOVEL BIOMARKERS AID; Goff BA, 2007, CANCER-AM CANCER SOC, V109, P2031, DOI 10.1002/cncr.22604; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Greene MH, 2008, CANCER EPIDEM BIOMAR, V17, P594, DOI 10.1158/1055-9965.EPI-07-2703; Im SS, 2005, OBSTET GYNECOL, V105, P35, DOI 10.1097/01.AOG.0000149159.69560.ef; Kalantri Y, 2007, INDIAN J MED RES, V125, P25; KLUG TL, 1984, CANCER RES, V44, P1048; LAX DA, 1985, J AM STAT ASSOC, V80, P736, DOI 10.2307/2288493; LEEJONES L, 2003, ATLAS GENET CYTOGENE; MCGOWAN L, 1985, OBSTET GYNECOL, V65, P568; McSorley MA, 2007, OBSTET GYNECOL, V109, P933, DOI 10.1097/01.AOG.0000257126.68803.03; Miralles C, 2003, ANN SURG ONCOL, V10, P150, DOI 10.1245/ASO.2003.05.015; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; MYERS ER, 2006, MANAGEMENT ADNEXAL M, P1; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Oei AL, 2006, BRIT J CANCER, V94, P814, DOI 10.1038/sj.bjc.6603015; Palmer C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002633; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Ries LAG, 2007, SEER CANC STAT REV 1; Rose PG, 1998, J CLIN ONCOL, V16, P1494, DOI 10.1200/JCO.1998.16.4.1494; SCHILTHUIS MS, 1987, BRIT J OBSTET GYNAEC, V94, P202; Skates SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091; Skates Steven J, 2003, J Clin Oncol, V21, p206s, DOI 10.1200/JCO.2003.02.955; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Van Calster B, 2007, JNCI-J NATL CANCER I, V99, P1706, DOI 10.1093/jnci/djm199; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569	33	47	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4599	10.1371/journal.pone.0004599	http://dx.doi.org/10.1371/journal.pone.0004599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240799	Green Published, gold, Green Submitted			2022-12-27	WOS:000278086700013
J	Pfeiffer, T; Rand, DG; Dreher, A				Pfeiffer, Thomas; Rand, David G.; Dreher, Anna			Decision-Making in Research Tasks with Sequential Testing	PLOS ONE			English	Article							PUBLISHED RESEARCH; INFORMATION; DIAGNOSTICITY	Background: In a recent controversial essay, published by JPA loannidis in PLoS Medicine, it has been argued that in some research fields, most of the published findings are false. Based on theoretical reasoning it can be shown that small effect sizes, error-prone tests, low priors of the tested hypotheses and biases in the evaluation and publication of research findings increase the fraction of false positives. These findings raise concerns about the reliability of research. However, they are based on a very simple scenario of scientific research, where single tests are used to evaluate independent hypotheses. Methodology/Principal Findings: In this study, we present computer simulations and experimental approaches for analyzing more realistic scenarios. In these scenarios, research tasks are solved sequentially, i.e. subsequent tests can be chosen depending on previous results. We investigate simple sequential testing and scenarios where only a selected subset of results can be published and used for future rounds of test choice. Results from computer simulations indicate that for the tasks analyzed in this study, the fraction of false among the positive findings declines over several rounds of testing if the most informative tests are performed. Our experiments show that human subjects frequently perform the most informative tests, leading to a decline of false positives as expected from the simulations. Conclusions/Significance: For the research tasks studied here, findings tend to become more reliable over time. We also find that the performance in those experimental settings where not all performed tests could be published turned out to be surprisingly inefficient. Our results may help optimize existing procedures used in the practice of scientific research and provide guidance for the development of novel forms of scholarly communication.	[Pfeiffer, Thomas; Rand, David G.; Dreher, Anna] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.] Harvard Univ, Dept Syst Biol, Cambridge, MA 02138 USA; [Dreher, Anna] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden	Harvard University; Harvard University; Stockholm School of Economics	Pfeiffer, T (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	pfeiffer@fas.harvard.edu	Pfeiffer, Thomas/R-1339-2019; Rand, David G./B-3716-2009; Dreber, Anna/D-8709-2010	Pfeiffer, Thomas/0000-0002-0592-577X; Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783	Society in Science; National Science Foundation; Jan Wallander and Tom Hedelius Foundation	Society in Science; National Science Foundation(National Science Foundation (NSF)); Jan Wallander and Tom Hedelius Foundation	TP is supported by Society in Science - The Branco Weiss Fellowship. DR is supported by the National Science Foundation Graduate Research Fellowship Program. AD is supported by the Jan Wallander and Tom Hedelius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LR, 1997, AM ECON REV, V87, P847; BIKHEHANIDANI S, 2001, IMF STUFF PAPERS, V17, P279; Campbell H, 2007, INT J EPIDEMIOL, V36, P445, DOI 10.1093/ije/dym055; Csada RD, 1996, OIKOS, V76, P591, DOI 10.2307/3546355; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Goodman S, 2007, ASSESSING UNRELIABIL; GOODMAN SN, 1988, AM J PUBLIC HEALTH, V78, P1568, DOI 10.2105/AJPH.78.12.1568; Hanson R., 1995, SOC EPISTEMOL, V9, P3, DOI [10.1080/02691729508578768, DOI 10.1080/02691729508578768]; HENRION M, 1986, AM J PHYS, V54, P791, DOI 10.1119/1.14447; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; LINDLEY DV, 1956, ANN MATH STAT, V27, P986, DOI 10.1214/aoms/1177728069; Nelson JD, 2005, PSYCHOL REV, V112, P979, DOI 10.1037/0033-295X.112.4.979; Palmer AR, 2000, ANNU REV ECOL SYST, V31, P441, DOI 10.1146/annurev.ecolsys.31.1.441; Pfeiffer T, 2007, P NATL ACAD SCI USA, V104, P12052, DOI 10.1073/pnas.0701315104; Pfeiffer T, 2006, CURR BIOL, V16, pR946, DOI 10.1016/j.cub.2006.10.011; Rzhetsky A, 2006, P NATL ACAD SCI USA, V103, P4940, DOI 10.1073/pnas.0600591103; SLOWIACZEK LM, 1992, MEM COGNITION, V20, P392, DOI 10.3758/BF03210923; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Urbach P., 1993, SCI REASONING BAYESI, V2; WASON PC, 1968, Q J EXP PSYCHOL, V20, P273, DOI 10.1080/14640746808400161; WELLS GL, 1980, PSYCHOL BULL, V88, P776, DOI 10.1037/0033-2909.88.3.776; Zimmerman C, 2000, DEV REV, V20, P99, DOI 10.1006/drev.1999.0497	28	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4607	10.1371/journal.pone.0004607	http://dx.doi.org/10.1371/journal.pone.0004607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601TH	19240797	Green Published, Green Submitted, gold			2022-12-27	WOS:000278086700018
J	Walther, T; Albrecht, D; Becker, M; Schubert, M; Kouznetsova, E; Wiesner, B; Maul, B; Schliebs, R; Grecksch, G; Furkert, J; Sterner-Kock, A; Schultheiss, HP; Becker, A; Siems, WE				Walther, Thomas; Albrecht, Doris; Becker, Matthias; Schubert, Mania; Kouznetsova, Elena; Wiesner, Burkard; Maul, Bjoern; Schliebs, Reinhard; Grecksch, Gisela; Furkert, Jens; Sterner-Kock, Anja; Schultheiss, Heinz-Peter; Becker, Axel; Siems, Wolf-Eberhard			Improved Learning and Memory in Aged Mice Deficient in Amyloid beta-Degrading Neutral Endopeptidase	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RAT LATERAL AMYGDALA; HIPPOCAMPAL AREA CA1; A-BETA; ALZHEIMERS-DISEASE; HORIZONTAL SLICES; NEPRILYSIN; PEPTIDE; DEPOSITION; BRAIN	Background: Neutral endopeptidase, also known as neprilysin and abbreviated NEP, is considered to be one of the key enzymes in initial human amyloid-beta (A beta) degradation. The aim of our study was to explore the impact of NEP deficiency on the initial development of dementia-like symptoms in mice. Methodology/Principal Findings: We found that while endogenous A beta concentrations were elevated in the brains of NEP-knockout mice at all investigated age groups, immunohistochemical analysis using monoclonal antibodies did not detect any AI deposits even in old NEP knockout mice. Surprisingly, tests of learning and memory revealed that the ability to learn was not reduced in old NEP-deficient mice but instead had significantly improved, and sustained learning and memory in the aged mice was congruent with improved long-term potentiation (LTP) in brain slices of the hippocampus and lateral amygdala. Our data suggests a beneficial effect of pharmacological inhibition of cerebral NEP on learning and memory in mice due to the accumulation of peptides other than A beta degradable by NEP. By conducting degradation studies and peptide measurements in the brain of both genotypes, we identified two neuropeptide candidates, glucagon-like peptide 1 and galanin, as first potential candidates to be involved in the improved learning in aged NEP-deficient mice. Conclusions/Significance: Thus, the existence of peptides targeted by NEP that improve learning and memory in older individuals may represent a promising avenue for the treatment of neurodegenerative diseases.	[Walther, Thomas; Schultheiss, Heinz-Peter] Charite, Dept Cardiol, D-13353 Berlin, Germany; [Walther, Thomas] Hull York Med Sch, Ctr Biomed Res, Kingston Upon Hull, N Humberside, England; [Albrecht, Doris; Schubert, Mania] Charite, Inst Neurophysiol, Berlin, Germany; [Becker, Matthias; Wiesner, Burkard; Maul, Bjoern; Furkert, Jens; Siems, Wolf-Eberhard] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Kouznetsova, Elena; Schliebs, Reinhard] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Grecksch, Gisela; Becker, Axel] Otto VonGuericke Univ Magdegurg, Inst Pharmacol & Toxicol, D-39016 Magdeburg, Germany; [Sterner-Kock, Anja] Free Univ Berlin, D-1000 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hull; University of York - UK; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Leipzig University; Otto von Guericke University; Free University of Berlin	Walther, T (corresponding author), Charite, Dept Cardiol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	thomas.walther@hyms.ac.uk	Schubert, Manja/AAJ-9575-2021; Becker, Axel/G-1808-2013	Schubert, Manja/0000-0003-3592-2470; Becker, Axel/0000-0002-3406-3558; Becker, Matthias/0000-0001-9965-6648	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG) [SI 483/3-2, WA1441/18-1]	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG), Grant: SI 483/3-2; Grant WA1441/18-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; Brewer A, 2005, NEUROPEPTIDES, V39, P323, DOI 10.1016/j.npep.2004.12.007; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Carvajal CC, 2004, BEHAV BRAIN RES, V153, P471, DOI 10.1016/j.bbr.2004.01.004; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Drephal C, 2006, NEUROBIOL LEARN MEM, V85, P272, DOI 10.1016/j.nlm.2005.11.004; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; EICHENBAUM H, 1995, NATURE, V378, P131, DOI 10.1038/378131a0; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Fischer HS, 2002, J MOL NEUROSCI, V18, P129, DOI 10.1385/JMN:18:1-2:129; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hadjiivanova Christina, 2003, Acta Physiol Pharmacol Bulg, V27, P83; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; HUPESODMANN K, 1995, REGUL PEPTIDES, V58, P149, DOI 10.1016/0167-0115(95)00063-H; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kalueff A, 1996, Depress Anxiety, V4, P100, DOI 10.1002/(SICI)1520-6394(1996)4:3<100::AID-DA2>3.0.CO;2-K; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kaschel T, 2004, SYNAPSE, V53, P141, DOI 10.1002/syn.20045; Lanahan A, 1997, J NEUROSCI, V17, P2876; LARSON J, 1988, BRAIN RES, V441, P111, DOI 10.1016/0006-8993(88)91388-1; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Martin JR, 1998, J PHARMACOL EXP THER, V286, P913; Mataro M, 2003, J NEUROL NEUROSUR PS, V74, P1272, DOI 10.1136/jnnp.74.9.1272; Mohajeri MH, 2004, FEBS LETT, V562, P16, DOI 10.1016/S0014-5793(04)00169-3; MOORE CI, 1993, HIPPOCAMPUS, V3, P57, DOI 10.1002/hipo.450030106; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Mouri A, 2006, BEHAV BRAIN RES, V168, P83, DOI 10.1016/j.bbr.2005.10.014; NJUNGE K, 1991, BRIT J PHARMACOL, V104, P105, DOI 10.1111/j.1476-5381.1991.tb12392.x; POPOV N, 1973, ACTA BIOL MED GER, V31, P51; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Siems WE, 2000, EUR J PHARMACOL, V397, P327, DOI 10.1016/S0014-2999(00)00222-3; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tucker HM, 2004, NEUROSCI LETT, V368, P285, DOI 10.1016/j.neulet.2004.07.011; Turner AJ, 2004, ANN NY ACAD SCI, V1035, P1, DOI 10.1196/annals.1332.001; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WATANABE Y, 1995, NEUROSCI RES, V21, P317, DOI 10.1016/0168-0102(94)00867-F; Zou LB, 2006, J PHARMACOL EXP THER, V317, P334, DOI 10.1124/jpet.105.095687	56	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4590	10.1371/journal.pone.0004590	http://dx.doi.org/10.1371/journal.pone.0004590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240795	gold, Green Published, Green Submitted			2022-12-27	WOS:000278086700008
J	Chan, CX; Darling, AE; Beiko, RG; Ragan, MA				Chan, Cheong Xin; Darling, Aaron E.; Beiko, Robert G.; Ragan, Mark A.			Are Protein Domains Modules of Lateral Genetic Transfer?	PLOS ONE			English	Article								Background: In prokaryotes and some eukaryotes, genetic material can be transferred laterally among unrelated lineages and recombined into new host genomes, providing metabolic and physiological novelty. Although the process is usually framed in terms of gene sharing (e. g. lateral gene transfer, LGT), there is little reason to imagine that the units of transfer and recombination correspond to entire, intact genes. Proteins often consist of one or more spatially compact structural regions (domains) which may fold autonomously and which, singly or in combination, confer the protein's specific functions. As LGT is frequent in strongly selective environments and natural selection is based on function, we hypothesized that domains might also serve as modules of genetic transfer, i.e. that regions of DNA that are transferred and recombined between lineages might encode intact structural domains of proteins. Methodology/Principal Findings: We selected 1,462 orthologous gene sets representing 144 prokaryotic genomes, and applied a rigorous two-stage approach to identify recombination breakpoints within these sequences. Recombination breakpoints are very significantly over-represented in gene sets within which protein domain-encoding regions have been annotated. Within these gene sets, breakpoints significantly avoid the domain-encoding regions (domons), except where these regions constitute most of the sequence length. Recombination breakpoints that fall within longer domons are distributed uniformly at random, but those that fall within shorter domons may show a slight tendency to avoid the domon midpoint. As we find no evidence for differential selection against nucleotide substitutions following the recombination event, any bias against disruption of domains must be a consequence of the recombination event per se. Conclusions/Significance: This is the first systematic study relating the units of LGT to structural features at the protein level. Many genes have been interrupted by recombination following inter-lineage genetic transfer, during which the regions within these genes that encode protein domains have not been preferentially preserved intact. Protein domains are units of function, but domons are not modules of transfer and recombination. Our results demonstrate that LGT can remodel even the most functionally conservative modules within genomes.	[Chan, Cheong Xin; Darling, Aaron E.; Beiko, Robert G.; Ragan, Mark A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Chan, Cheong Xin; Darling, Aaron E.; Beiko, Robert G.; Ragan, Mark A.] ARC Ctr Excellence Bioinformat, Brisbane, Qld, Australia; [Beiko, Robert G.] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 3J5, Canada	University of Queensland; Dalhousie University	Chan, CX (corresponding author), Univ Iowa, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA.	m.ragan@imb.uq.edu.au	Chan, Cheong Xin/A-7005-2008; Darling, Aaron/G-8119-2017; Ragan, Mark A/A-9825-2014	Chan, Cheong Xin/0000-0002-3729-8176; Ragan, Mark A/0000-0003-1672-7020; Darling, Aaron/0000-0003-2397-7925	Australian Research Council [CE0348221]; NSF;  [DBI-0630765]	Australian Research Council(Australian Research Council); NSF(National Science Foundation (NSF)); 	This study was supported by Australian Research Council grant CE0348221 to MAR. AED was supported by NSF grant DBI-0630765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Beiko RG, 2005, BIOINFORMATICS, V21, P2230, DOI 10.1093/bioinformatics/bti335; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; BORK P, 1991, FEBS LETT, V286, P47, DOI 10.1016/0014-5793(91)80937-X; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; Chan CX, 2007, S AFR COMPUT J, V38, P20; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Harlow TJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-45; Inagaki Y, 2006, P NATL ACAD SCI USA, V103, P4528, DOI 10.1073/pnas.0600744103; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Kunin V, 2005, GENOME RES, V15, P954, DOI 10.1101/gr.3666505; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Lin CH, 2008, MOL BIOL EVOL, V25, P549, DOI 10.1093/molbev/msm282; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Omelchenko MV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r55; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	32	46	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4524	10.1371/journal.pone.0004524	http://dx.doi.org/10.1371/journal.pone.0004524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229333	Green Published, Green Submitted, gold			2022-12-27	WOS:000265486200009
J	Sassi-Messai, S; Gibert, Y; Bernard, L; Nishio, SI; Lagneau, KFF; Molina, J; Andersson-Lendahl, M; Benoit, G; Balaguer, P; Laudet, V				Sassi-Messai, Sana; Gibert, Yann; Bernard, Laure; Nishio, Shin-Ichi; Lagneau, Karine F. Ferri; Molina, Jose; Andersson-Lendahl, Monika; Benoit, Gerard; Balaguer, Patrick; Laudet, Vincent			The Phytoestrogen Genistein Affects Zebrafish Development through Two Different Pathways	PLOS ONE			English	Article								Background: Endocrine disrupting chemicals are widely distributed in the environment and derive from many different human activities or can also be natural products synthesized by plants or microorganisms. The phytoestrogen, genistein (49, 5, 7-trihydroxy-isoflavone), is a naturally occurring compound found in soy products. Genistein has been the subject of numerous studies because of its known estrogenic activity. Methodology/Principal Findings: We report that genistein exposure of zebrafish embryos induces apoptosis, mainly in the hindbrain and the anterior spinal cord. Timing experiments demonstrate that apoptosis is induced during a precise developmental window. Since adding ICI 182,780, an ER antagonist, does not rescue the genistein-induced apoptosis and since there is no synergistic effect between genistein and estradiol, we conclude that this apoptotic effect elicited by genistein is estrogen-receptors independent. However, we show in vitro, that genistein binds and activates the three zebrafish estrogen receptors ER alpha, ER beta-A and ER beta-B. Furthermore using transgenic ERE-Luciferase fish we show that genistein is able to activate the estrogen pathway in vivo during larval stages. Finally we show that genistein is able to induce ectopic expression of the aromatase-B gene in an ER-dependent manner in the anterior brain in pattern highly similar to the one resulting from estrogen treatment at low concentration. Conclusion/Significance: Taken together these results indicate that genistein acts through at least two different pathways in zebrafish embryos: (i) it induces apoptosis in an ER-independent manner and (ii) it regulates aromatase-B expression in the brain in an ER-dependent manner. Our results thus highlight the multiplicity of possible actions of phytoestrogens, such as genistein. This suggests that the use of standardized endpoints to study the effect of a given compound, even when this compound has well known targets, may carry the risk of overlooking interesting effects of this compound.	[Sassi-Messai, Sana; Gibert, Yann; Bernard, Laure; Nishio, Shin-Ichi; Benoit, Gerard; Laudet, Vincent] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France; [Lagneau, Karine F. Ferri] Univ Lyon 1, CNRS, Apoptosis & Oncogenesis Lab, Inst Biol Chim Proteines, Inst Fed Biosci Gerland Lyon Sud, F-69365 Lyon, France; [Andersson-Lendahl, Monika] Karolinska Inst, Dept Biosci & Nutr, Lab Med Nutr, Stockholm, Sweden; [Molina, Jose; Balaguer, Patrick] Inst Rech Cancerol Montpellier IRCM, Equipe INSERM, U896, Montpellier, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Sassi-Messai, S (corresponding author), Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France.	Vincent.Laudet@ens-lyon.fr	Molina-Molina, José Manuel/F-1055-2017; Andersson Lendahl, Monika/ABE-5981-2021; Balaguer, Patrick/I-2973-2016	Molina-Molina, José Manuel/0000-0002-3657-1548; Andersson Lendahl, Monika/0000-0002-5690-8515; BENOIT, Gerard/0000-0001-9462-6570	European Community; French Ministry of Research (MENRT); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon; association pour la Recherche contre le Cancer (ARC) [fellowship]	European Community(European Commission); French Ministry of Research (MENRT)(Ministry of Research, France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by the European Community (CASCADE network of excellence), French Ministry of Research (MENRT) , Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure de Lyon and an association pour la Recherche contre le Cancer (ARC) fellowship to YG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Bennetau-Pelissero C, 2001, GEN COMP ENDOCR, V121, P173, DOI 10.1006/gcen.2000.7585; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Burvall K, 2004, LIFE SCI, V75, P2733, DOI 10.1016/j.lfs.2004.03.037; Cai QY, 1996, NUTR CANCER, V25, P1, DOI 10.1080/01635589609514423; Carvan Michael J. III, 2000, Annals of the New York Academy of Sciences, V919, P133; Chan WH, 2007, ACTA PHARMACOL SIN, V28, P238, DOI 10.1111/j.1745-7254.2007.00498.x; Chen H, 2007, CHINESE MED J-PEKING, V120, P898, DOI 10.1097/00029330-200705020-00009; Choi EJ, 2004, LIFE SCI, V75, P499, DOI 10.1016/j.lfs.2004.01.010; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Detrich HW, 1999, METHODS CELL BIOL, V59, P3, DOI 10.1016/S0091-679X(08)61816-6; Eggert US, 2006, CURR OPIN CHEM BIOL, V10, P232, DOI 10.1016/j.cbpa.2006.04.010; Ellis PA, 1997, INT J CANCER, V72, P608, DOI 10.1002/(SICI)1097-0215(19970807)72:4<608::AID-IJC10>3.0.CO;2-7; Escande A, 2006, BIOCHEM PHARMACOL, V71, P1459, DOI 10.1016/j.bcp.2006.02.002; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Fukutake M, 1996, FOOD CHEM TOXICOL, V34, P457, DOI 10.1016/0278-6915(96)87355-8; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gross-Sorokin MY, 2006, ENVIRON HEALTH PERSP, V114, P147, DOI 10.1289/ehp.8068; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Henley DV, 2006, ENDOCRINOLOGY, V147, pS25, DOI 10.1210/en.2005-1117; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hsieh RW, 2006, J BIOL CHEM, V281, P17909, DOI 10.1074/jbc.M513684200; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Ismail IA, 2007, EUR J PHARMACOL, V575, P12, DOI 10.1016/j.ejphar.2007.07.039; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306; Kazeto Y, 2004, AQUAT TOXICOL, V69, P25, DOI 10.1016/j.aquatox.2004.04.008; Kime DE, 1999, SCI TOTAL ENVIRON, V225, P3, DOI 10.1016/S0048-9697(98)00328-3; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kiparissis Y, 2003, ENVIRON HEALTH PERSP, V111, P1158, DOI 10.1289/ehp.5928; Kiparissis Y, 2001, ENVIRON SCI TECHNOL, V35, P2423, DOI 10.1021/es001679+; Kishida M, 2001, ENDOCRINOLOGY, V142, P740, DOI 10.1210/en.142.2.740; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lawry J, 2004, METH MOLEC MED, V88, P183; Le Page Y, 2006, ENVIRON HEALTH PERSP, V114, P752, DOI 10.1289/ehp.8141; Legler J, 2000, ENVIRON SCI TECHNOL, V34, P4439, DOI 10.1021/es0000605; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; Lewis JG, 2005, STEROIDS, V70, P974, DOI 10.1016/j.steroids.2005.06.008; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MAKELA S, 1994, ENVIRON HEALTH PERSP, V102, P572, DOI 10.1289/ehp.94102572; MAKELA S, 1995, P SOC EXP BIOL MED, V208, P51; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; Margueron R, 2004, J MOL ENDOCRINOL, V32, P583, DOI 10.1677/jme.0.0320583; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Panzica G, 2005, DOMEST ANIM ENDOCRIN, V29, P436, DOI 10.1016/j.domaniend.2005.02.010; Patisaul HB, 2005, J NEUROENDOCRINOL, V17, P57, DOI 10.1111/j.1365-2826.2005.01268.x; PELISSERO C, 1991, J STEROID BIOCHEM, V38, P293, DOI 10.1016/0960-0760(91)90100-J; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Polkowski K, 2000, Acta Pol Pharm, V57, P135; Potter SM, 1998, AM J CLIN NUTR, V68, p1375S, DOI 10.1093/ajcn/68.6.1375S; Sarkar FH, 2002, CANCER METAST REV, V21, P265, DOI 10.1023/A:1021210910821; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Strauss L, 1998, TOXICOL LETT, V103, P349, DOI 10.1016/S0378-4274(98)00332-4; Tchoudakova A, 2001, J STEROID BIOCHEM, V78, P427, DOI 10.1016/S0960-0760(01)00120-0; THISSE C, 1993, DEVELOPMENT, V119, P1203; Valachovicova T, 2004, MINI-REV MED CHEM, V4, P881, DOI 10.2174/1389557043403387; Waring RH, 2005, MOL CELL ENDOCRINOL, V244, P2, DOI 10.1016/j.mce.2005.02.007; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498; Zhang LL, 2002, COMP BIOCHEM PHYS C, V132, P203, DOI 10.1016/S1532-0456(02)00067-4; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	70	53	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4935	10.1371/journal.pone.0004935	http://dx.doi.org/10.1371/journal.pone.0004935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319186	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499200005
J	Willard, FS; Willard, MD; Kimple, AJ; Soundararajan, M; Oestreich, EA; Li, XY; Sowa, NA; Kimple, RJ; Doyle, DA; Der, CJ; Zylka, MJ; Snider, WD; Siderovski, DP				Willard, Francis S.; Willard, Melinda D.; Kimple, Adam J.; Soundararajan, Meera; Oestreich, Emily A.; Li, Xiaoyan; Sowa, Nathaniel A.; Kimple, Randall J.; Doyle, Declan A.; Der, Channing J.; Zylka, Mark J.; Snider, William D.; Siderovski, David P.			Regulator of G-Protein Signaling 14 (RGS14) Is a Selective H-Ras Effector	PLOS ONE			English	Article								Background: Regulator of G-protein signaling (RGS) proteins have been well-described as accelerators of G alpha-mediated GTP hydrolysis ("GTPase-accelerating proteins'' or GAPs). However, RGS proteins with complex domain architectures are now known to regulate much more than G alpha GTPase activity. RGS14 contains tandem Ras-binding domains that have been reported to bind to Rap-but not Ras GTPases in vitro, leading to the suggestion that RGS14 is a Rap-specific effector. However, more recent data from mammals and Drosophila imply that, in vivo, RGS14 may instead be an effector of Ras. Methodology/Principal Findings: Full-length and truncated forms of purified RGS14 protein were found to bind indiscriminately in vitro to both Rap-and Ras-family GTPases, consistent with prior literature reports. In stark contrast, however, we found that in a cellular context RGS14 selectively binds to activated H-Ras and not to Rap isoforms. Co-transfection /co-immunoprecipitation experiments demonstrated the ability of full-length RGS14 to assemble a multiprotein complex with components of the ERK MAPK pathway in a manner dependent on activated H-Ras. Small interfering RNA-mediated knockdown of RGS14 inhibited both nerve growth factor-and basic fibrobast growth factor-mediated neuronal differentiation of PC12 cells, a process which is known to be dependent on Ras-ERK signaling. Conclusions/Significance: In cells, RGS14 facilitates the formation of a selective Ras? GTP-Raf-MEK-ERK multiprotein complex to promote sustained ERK activation and regulate H-Ras-dependent neuritogenesis. This cellular function for RGS14 is similar but distinct from that recently described for its closely-related paralogue, RGS12, which shares the tandem Ras-binding domain architecture with RGS14.	[Willard, Francis S.; Willard, Melinda D.; Kimple, Adam J.; Oestreich, Emily A.; Kimple, Randall J.; Der, Channing J.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Li, Xiaoyan; Sowa, Nathaniel A.; Zylka, Mark J.; Snider, William D.; Siderovski, David P.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC USA; [Kimple, Randall J.; Der, Channing J.; Siderovski, David P.] Univ N Carolina, Lineberger Comprehensive Canc Ctr, Chapel Hill, NC USA; [Soundararajan, Meera; Doyle, Declan A.] Univ Oxford, Struct Genom Consortium, Oxford, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford	Willard, FS (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	willardfs@lilly.com; dsiderov@med.unc.edu	Kimple, Randall/L-6460-2019; Siderovski, David Peter/AAA-9603-2019	Kimple, Randall/0000-0001-8336-8000; Siderovski, David Peter/0000-0002-0688-8210; Soundararajan, Meera/0000-0003-4687-0151; Kimple, Adam/0000-0003-1670-8401; Der, Channing/0000-0002-7751-2747	U.S. National Institutes of Health [R01CA127152, R01NS060725, R01GM074268]; Wellcome Trust [1097737]; Novartis Research Foundation; GlaxoSmithKline; Merck & Co., Inc; Ontario Genomics Institute; Canadian Institutes of Health Research; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Canadian Foundation for Innovation; VINNOVA; Swedish Agency for Innovation Systems; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Karolinska Institute; PhRMA Foundation [predoctoral fellowship]; NATIONAL CANCER INSTITUTE [R01CA127152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Novartis Research Foundation; GlaxoSmithKline(GlaxoSmithKline); Merck & Co., Inc(Merck & Company); Ontario Genomics Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Foundation for Innovation(Canada Foundation for Innovation); VINNOVA(Vinnova); Swedish Agency for Innovation Systems(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institute(Karolinska Institutet); PhRMA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants to C.J.D. [R01CA127152], M.J.Z. and W.D.S. [R01NS060725], and D.P.S. [R01GM074268]. The Structural Genomics Consortium is a registered charity [#1097737] funded by the Wellcome Trust, the Novartis Research Foundation, GlaxoSmithKline, Merck & Co., Inc., Genome Canada through the Ontario Genomics Institute, the Canadian Institutes of Health Research, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, the Canadian Foundation for Innovation, VINNOVA, the Swedish Agency for Innovation Systems, the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research, and the Karolinska Institute. M.D.W. was supported by a PhRMA Foundation predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altin JG, 1991, GROWTH FACTORS, V4, P145, DOI 10.3109/08977199109000265; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Goldfinger LE, 2008, MOL BIOSYST, V4, P293, DOI 10.1039/b716887j; Hains MD, 2004, METHOD ENZYMOL, V389, P71; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; James P, 1996, GENETICS, V144, P1425; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Martin-McCaffrey L, 2005, CELL CYCLE, V4, P953, DOI 10.4161/cc.4.7.1787; Martin-McCaffrey L, 2004, DEV CELL, V7, P763, DOI 10.1016/j.devcel.2004.10.004; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mittal V, 2006, BIOCHEM J, V394, P309, DOI 10.1042/BJ20051086; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; NG NFL, 1993, J BIOL CHEM, V268, P25329; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Peterson SN, 1996, J BIOL CHEM, V271, P29903, DOI 10.1074/jbc.271.47.29903; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Snow BE, 2002, METHOD ENZYMOL, V344, P740; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Soundararajan M, 2007, BIOCHEM J, V401, P679, DOI 10.1042/BJ20060555; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; VAN AL, 1993, P NATL ACAD SCI USA, V90, P6213; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Willard FS, 2004, METHOD ENZYMOL, V389, P320; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048	57	32	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4884	10.1371/journal.pone.0004884	http://dx.doi.org/10.1371/journal.pone.0004884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319189	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499200003
J	Chen, JH; Martin-Gronert, MS; Tarry-Adkins, J; Ozanne, SE				Chen, Jian-Hua; Martin-Gronert, Malgorzata S.; Tarry-Adkins, Jane; Ozanne, Susan E.			Maternal Protein Restriction Affects Postnatal Growth and the Expression of Key Proteins Involved in Lifespan Regulation in Mice	PLOS ONE			English	Article								We previously reported that maternal protein restriction in rodents influenced the rate of growth in early life and ultimately affected longevity. Low birth weight caused by maternal protein restriction followed by catch-up growth (recuperated animals) was associated with shortened lifespan whereas protein restriction and slow growth during lactation (postnatal low protein: PLP animals) increased lifespan. We aim to explore the mechanistic basis by which these differences arise. Here we investigated effects of maternal diet on organ growth, metabolic parameters and the expression of insulin/IGF1 signalling proteins and Sirt1 in muscle of male mice at weaning. PLP mice which experienced protein restriction during lactation had lower fasting glucose (P = 0.038) and insulin levels (P = 0.046) suggesting improved insulin sensitivity. PLP mice had higher relative weights (adjusted by body weight) of brain (P = 0.0002) and thymus (P = 0.031) compared to controls suggesting that enhanced functional capacity of these two tissues is beneficial to longevity. They also had increased expression of insulin receptor substrate 1 (P = 0.021) and protein kinase C zeta (P = 0.046). Recuperated animals expressed decreased levels of many insulin signalling proteins including P13 kinase subunits p85 alpha (P = 0.018), p110 beta (P = 0.048) and protein kinase C zeta (P = 0.006) which may predispose these animals to insulin resistance. Sirt1 protein expression was reduced in recuperated offspring. These observations suggest that maternal protein restriction can affect major metabolic pathways implicated in regulation of lifespan at a young age which may explain the impact of maternal diet on longevity.	[Chen, Jian-Hua; Martin-Gronert, Malgorzata S.; Tarry-Adkins, Jane; Ozanne, Susan E.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chen, JH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England.	jhc36@cam.ac.uk		Ozanne, Susan/0000-0001-8753-5144	BBSRC; European Union; British Heart Foundation; Parthenon Trust; BBSRC [BB/E00797X/1, BB/E002161/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002161/1, BB/E00797X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); British Heart Foundation(British Heart Foundation); Parthenon Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BBSRC, the European Union, the British Heart Foundation and the Parthenon Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri M, 2008, EXP GERONTOL, V43, P74, DOI 10.1016/j.exger.2007.06.003; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bartke A, 2008, AGING CELL, V7, P285, DOI 10.1111/j.1474-9726.2008.00387.x; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; FRIEDMAN DB, 1988, GENETICS, V118, P75; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Holzenberger M, 2004, HORM RES, V62, P89, DOI 10.1159/000080765; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsieh CC, 2002, MECH AGEING DEV, V123, P1245, DOI 10.1016/S0047-6374(02)00037-4; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Liu LZ, 2006, BIOCHEMISTRY-MOSCOW+, V71, P701, DOI 10.1134/S0006297906070017; Longo VD, 2009, EXP GERONTOL, V44, P70, DOI 10.1016/j.exger.2008.06.005; Martin-Gronert MS, 2006, BIOCHEM SOC T, V34, P779, DOI 10.1042/BST0340779; Martin-Gronert MS, 2008, AM J PHYSIOL-REG I, V294, pR494, DOI 10.1152/ajpregu.00530.2007; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202; Masternak MM, 2005, EXP GERONTOL, V40, P679, DOI 10.1016/j.exger.2005.06.003; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ozanne SE, 2006, DIABETOLOGIA, V49, P2993, DOI 10.1007/s00125-006-0466-2; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2004, SEMIN PERINATOL, V28, P81, DOI 10.1053/j.semperi.2003.10.015; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Paolisso G, 1996, AM J PHYSIOL-ENDOC M, V270, pE890, DOI 10.1152/ajpendo.1996.270.5.E890; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447	54	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4950	10.1371/journal.pone.0004950	http://dx.doi.org/10.1371/journal.pone.0004950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308256	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499000005
J	Power, KA; McRedmond, JP; de Stefani, A; Gallagher, WM; Gaora, PO				Power, Karen A.; McRedmond, James P.; de Stefani, Andreas; Gallagher, William M.; Gaora, Peadar O.			High-Throughput Proteomics Detection of Novel Splice Isoforms in Human Platelets	PLOS ONE			English	Article							MESSENGER-RNA; DATABASE; SURFACE; POLYMORPHISMS; EXPRESSION; PEPTIDES; MODEL; VIEW; ASD	Alternative splicing (AS) is an intrinsic regulatory mechanism of all metazoans. Recent findings suggest that 100% of multiexonic human genes give rise to splice isoforms. AS can be specific to tissue type, environment or developmentally regulated. Splice variants have also been implicated in various diseases including cancer. Detection of these variants will enhance our understanding of the complexity of the human genome and provide disease-specific and prognostic biomarkers. We adopted a proteomics approach to identify exon skip events - the most common form of AS. We constructed a database harboring the peptide sequences derived from all hypothetical exon skip junctions in the human genome. Searching tandem mass spectrometry (MS/MS) data against the database allows the detection of exon skip events, directly at the protein level. Here we describe the application of this approach to human platelets, including the mRNA-based verification of novel splice isoforms of ITGA2, NPEPPS and FH. This methodology is applicable to all new or existing MS/MS datasets.	[Power, Karen A.; McRedmond, James P.; Gallagher, William M.; Gaora, Peadar O.] Univ Coll Dublin, UCD Conway Inst, Dublin 2, Ireland; [Power, Karen A.; McRedmond, James P.; Gallagher, William M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland; [de Stefani, Andreas] NovaUCD, Belfield Innovat Pk, Dublin, Ireland; [Gaora, Peadar O.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Med & Med Sci, Dublin, Ireland	University College Dublin; University College Dublin; University College Dublin	Power, KA (corresponding author), Univ Coll Dublin, UCD Conway Inst, Dublin 2, Ireland.	peadar.ogaora@ucd.ie	O'Gaora, Peadar/F-9400-2011	O'Gaora, Peadar/0000-0002-6417-7054; Gallagher, William/0000-0002-4307-5999	InnoMed; University College Dublin; Higher Education Authority of Ireland; Science Foundation Ireland [04/BR/B0527]; Strategic Research Cluster, Network of Excellence of Functional Biomaterials	InnoMed; University College Dublin; Higher Education Authority of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Strategic Research Cluster, Network of Excellence of Functional Biomaterials(Science Foundation Ireland)	Funding is acknowledged from the EU FP6 Integrated Project, InnoMed (in particular, the PredTox subgroup; http://www.innomed-predtox.com), as well as University College Dublin under its Research Demonstratorship scheme (for part-support of KAP). The UCD Conway Institute is funded by the Programme for Research in Third Level Institutions, as administered by the Higher Education Authority of Ireland. The work was also supported by funding from Science Foundation Ireland (04/BR/B0527) to JMcR and the Strategic Research Cluster, Network of Excellence of Functional Biomaterials, to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Censarek P, 2007, THROMB HAEMOSTASIS, V98, P1309, DOI 10.1160/TH07-05-0346; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matarin M, 2008, J CEREBR BLOOD F MET, V28, P81, DOI 10.1038/sj.jcbfm.9600508; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Mo F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-537; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Newland SA, 2007, BLOOD, V109, P4806, DOI 10.1182/blood-2006-09-047449; Ozelo MC, 2004, THROMB HAEMOSTASIS, V92, P384, DOI 10.1160/TH03-12-0744; Rustin P, 2002, NAT GENET, V30, P352, DOI 10.1038/ng0402-352; Santoro SA, 1999, BLOOD, V93, P3575, DOI 10.1182/blood.V93.11.3575.411a45_3575_3577; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Sugnet C W, 2004, Pac Symp Biocomput, P66; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Tress ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r162; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	43	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e5001	10.1371/journal.pone.0005001	http://dx.doi.org/10.1371/journal.pone.0005001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308253	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499000013
J	Hennah, W; Porteous, D				Hennah, William; Porteous, David			The DISC1 Pathway Modulates Expression of Neurodevelopmental, Synaptogenic and Sensory Perception Genes	PLOS ONE			English	Article								Background: Genetic and biological evidence supports a role for DISC1 across a spectrum of major mental illnesses, including schizophrenia and bipolar disorder. There is evidence for genetic interplay between variants in DISC1 and in biologically interacting loci in psychiatric illness. DISC1 also associates with normal variance in behavioral and brain imaging phenotypes. Methodology: Here, we analyze public domain datasets and demonstrate correlations between variants in the DISC1 pathway genes and levels of gene expression. Genetic variants of DISC1, NDE1, PDE4B and PDE4D regulate the expression of cytoskeletal, synaptogenic, neurodevelopmental and sensory perception proteins. Interestingly, these regulated genes include existing targets for drug development in depression and psychosis. Conclusions: Our systematic analysis provides further evidence for the relevance of the DISC1 pathway to major mental illness, identifies additional potential targets for therapeutic intervention and establishes a general strategy to mine public datasets for insights into disease pathways.	[Hennah, William; Porteous, David] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hennah, W (corresponding author), Natl Publ Hlth Inst, FIMM Inst Mol Med Finland, Dept Mol Med, Helsinki, Finland.	william.hennah@ed.ac.uk	Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Hennah, William/0000-0002-4462-4208	EMBO [research fellow]; UK Medical Research Council; MRC [G0600214, G0902166, G0100266] Funding Source: UKRI; Medical Research Council [G0600214, G9900991B, G0700704B, G0902166, G0100266] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Hennah is a long term EMBO research fellow. This work was funded in part by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BRADSHAW NJ, 2008, BIOCH BIOPHYS RES CO; Bray NJ, 2008, SCHIZOPHRENIA BULL, V34, P412, DOI 10.1093/schbul/sbn013; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HEDRICK PW, 1987, GENETICS, V117, P331; HENNAH W, 2008, MOL PSYCHIAT; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Pickard BS, 2007, PSYCHIAT GENET, V17, P129, DOI 10.1097/YPG.0b013e328014492b; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Takao T, 2007, EUR NEUROPSYCHOPHARM, V17, P273, DOI 10.1016/j.euroneuro.2006.09.002; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	33	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4906	10.1371/journal.pone.0004906	http://dx.doi.org/10.1371/journal.pone.0004906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300510	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496800007
J	Joucla, S; Yvert, B				Joucla, Sebastien; Yvert, Blaise			Improved Focalization of Electrical Microstimulation Using Microelectrode Arrays: A Modeling Study	PLOS ONE			English	Article								Extracellular electrical stimulation (EES) of the central nervous system (CNS) has been used empirically for decades, with both fundamental and clinical goals. Currently, microelectrode arrays (MEAs) offer new possibilities for CNS microstimulation. However, although focal CNS activation is of critical importance to achieve efficient stimulation strategies, the precise spatial extent of EES remains poorly understood. The aim of the present work is twofold. First, we validate a finite element model to compute accurately the electrical potential field generated throughout the extracellular medium by an EES delivered with MEAs. This model uses Robin boundary conditions that take into account the surface conductance of electrode/medium interfaces. Using this model, we determine how the potential field is influenced by the stimulation and ground electrode impedances, and by the electrical conductivity of the neural tissue. We confirm that current-controlled stimulations should be preferred to voltage-controlled stimulations in order to control the amplitude of the potential field. Second, we evaluate the focality of the potential field and threshold-distance curves for different electrode configurations. We propose a new configuration to improve the focality, using a ground surface surrounding all the electrodes of the array. We show that the lower the impedance of this surface, the more focal the stimulation. In conclusion, this study proposes new boundary conditions for the design of precise computational models of extracellular stimulation, and a new electrode configuration that can be easily incorporated into future MEA devices, either in vitro or in vivo, for a better spatial control of CNS microstimulation.	[Joucla, Sebastien; Yvert, Blaise] Univ Bordeaux, CNRS, Ctr Neurosci Integrat & Cognit, UMR Talence, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Joucla, S (corresponding author), Univ Bordeaux, CNRS, Ctr Neurosci Integrat & Cognit, UMR Talence, Bordeaux, France.	b.yvert@cnic.u-bordeaux1.fr	Yvert, Blaise/E-9052-2016	Yvert, Blaise/0000-0002-8850-7935	French ministry for research and technology [03J489, 2003541]; French National Research Agency [ANR06BLAN035601, ANR07TECSAN01404]; Fyssen and FRM foundations (Paris); Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Region Aquitaine [20030301201A, 20040301202A]	French ministry for research and technology; French National Research Agency(French National Research Agency (ANR)); Fyssen and FRM foundations (Paris); Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Region Aquitaine(Region Nouvelle-Aquitaine)	This work was supported in part by the French ministry for research and technology (RMNT Neurocom project No 03J489 and ACI Neurosciences Integratives et Computationnelles No 2003541), the French National Research Agency (ANR - Programme Blanc No ANR06BLAN035601 and Programme TecSan No ANR07TECSAN01404), the Fyssen and FRM foundations (Paris), the Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME), and the Region Aquitaine (No 20030301201A and 20040301202A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN KW, 1988, MED BIOL ENG COMPUT, V26, P466, DOI 10.1007/BF02441913; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; BILLOINT O, 2007, C P IEEE ENG MED BIO, V1, P6069; Borkholder DA, 1997, J NEUROSCI METH, V77, P61, DOI 10.1016/S0165-0270(97)00112-X; Buitenweg JR, 2002, IEEE T BIO-MED ENG, V49, P1591, DOI 10.1109/TBME.2002.804504; Butson CR, 2006, CLIN NEUROPHYSIOL, V117, P447, DOI 10.1016/j.clinph.2005.10.007; Cantrell DR, 2008, J NEURAL ENG, V5, P54, DOI 10.1088/1741-2560/5/1/006; CHARVET G, 2007, SOC NEUR 37 ANN M SA; CHURCH P, 1984, J APPL PHYS, V56, P1, DOI 10.1063/1.333752; EDELL DJ, 1995, Patent No. 5411540; Fromherz P, 2002, EUR BIOPHYS J BIOPHY, V31, P228, DOI 10.1007/s00249-002-0213-7; Gaunt RA, 2006, PROG BRAIN RES, V152, P163, DOI 10.1016/S0079-6123(05)52011-9; GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537; Gimsa J, 2005, J NEUROSCI METH, V142, P251, DOI 10.1016/j.jneumeth.2004.09.001; Gimsa U, 2006, J NEUROSCI METH, V150, P212, DOI 10.1016/j.jneumeth.2005.06.013; GROSS GW, 1982, J NEUROSCI METH, V5, P13, DOI 10.1016/0165-0270(82)90046-2; Grumet AE, 2000, J NEUROSCI METH, V101, P31, DOI 10.1016/S0165-0270(00)00246-6; Heuschkel M.O., 2001, FABRICATION MULTIELE; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holsheimer J, 1997, MED BIOL ENG COMPUT, V35, P493, DOI 10.1007/BF02525529; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; JOUCLA S, 2006, SOC NEUR ABSTR; JOUCLA S, 2009, BIOPHYS J IN PRESS; Lertmanorat Z, 2004, J NEURAL ENG, V1, P202, DOI 10.1088/1741-2560/1/4/003; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; MCHARDY J, 1977, ANN BIOMED ENG, V5, P144, DOI 10.1007/BF02364014; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; MEIER JH, 1992, IEEE T BIO-MED ENG, V39, P122, DOI 10.1109/10.121643; Miller CA, 2003, HEARING RES, V175, P200, DOI 10.1016/S0378-5955(02)00739-6; Moulin C, 2008, IEEE T BIO-MED ENG, V55, P683, DOI 10.1109/TBME.2007.903522; Nam Y, 2006, J NEUROSCI METH, V155, P296, DOI 10.1016/j.jneumeth.2006.01.014; NOVAK JL, 1988, J NEUROSCI METH, V23, P149, DOI 10.1016/0165-0270(88)90187-2; PLONSEY R, 1969, MCGRAW HILL SERIES B; Pudenz R H, 1975, Surg Neurol, V4, P389; RANCK JB, 1965, EXP NEUROL, V11, P451, DOI 10.1016/0014-4886(65)90059-2; RANCK JB, 1963, EXP NEUROL, V7, P144, DOI 10.1016/S0014-4886(63)80005-9; Rattay F, 2004, IEEE T BIO-MED ENG, V51, P1659, DOI 10.1109/TBME.2004.828044; Rattay F, 2007, IEEE T BIO-MED ENG, V54, P158, DOI 10.1109/TBME.2006.883730; Rauschecker JP, 2002, SCIENCE, V295, P1025, DOI 10.1126/science.1067796; Schnabel V, 2001, IEEE T BIO-MED ENG, V48, P1027, DOI 10.1109/10.942593; STRUIJK JJ, 1993, IEEE T BIO-MED ENG, V40, P632, DOI 10.1109/10.237693; SUGIHARA H, 2000, Patent No. 6151519; Theodore WH, 2005, NAT CLIN PRACT NEURO, V1, P64, DOI 10.1038/ncpneuro0051; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Winfree Christopher J, 2005, Curr Surg, V62, P476; Yvert B, 2004, J NEUROPHYSIOL, V91, P2101, DOI 10.1152/jn.01095.2003; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	53	44	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4828	10.1371/journal.pone.0004828	http://dx.doi.org/10.1371/journal.pone.0004828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279677	Green Published, gold			2022-12-27	WOS:000265496200008
J	Nadai, Y; Eyzaguirre, LM; Sill, A; Cleghorn, F; Nolte, C; Charurat, M; Collado-Chastel, S; Jack, N; Bartholomew, C; Pape, JW; Figueroa, P; Blattner, WA; Carr, JK				Nadai, Yuka; Eyzaguirre, Lindsay M.; Sill, Anne; Cleghorn, Farley; Nolte, Claudine; Charurat, Manhattan; Collado-Chastel, Santiago; Jack, Noreen; Bartholomew, Courtenay; Pape, Jean W.; Figueroa, Peter; Blattner, William A.; Carr, Jean K.			HIV-1 Epidemic in the Caribbean Is Dominated by Subtype B	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTION; AFRICA	Background: The molecular epidemiology of HIV-1 in the Caribbean has been described using partial genome sequencing; subtype B is the most common subtype in multiple countries. To expand our knowledge of this, nearly full genome amplification, sequencing and analysis was conducted. Methodology/Principal Findings: Virion RNA from sera collected in Haiti, Dominican Republic, Jamaica and Trinidad and Tobago were reverse transcribed, PCR amplified, sequenced and phylogenetically analyzed. Nearly full genomes were completed for 15 strains; partial pol was done for 67 strains. All but one of the 67 strains analyzed in pol were subtype B; the exception was a unique recombinant of subtypes B and C collected in the Dominican Republic. Of the nearly full genomes of 14 strains that were subtype B in pol, all were subtype B from one end of the genome to the other and not inter-subtype recombinants. Surprisingly, the Caribbean subtype B strains clustered significantly with each other and separate from subtype B from other parts of the pandemic. Conclusions: The more complete analysis of HIV-1 from 4 Caribbean countries confirms previous research using partial genome analysis that the predominant subtype in circulation was subtype B. The Caribbean strains are phylogenetically distinct from other subtype B strains although the biological meaning of this finding is unclear.	[Nadai, Yuka; Eyzaguirre, Lindsay M.; Sill, Anne; Cleghorn, Farley; Charurat, Manhattan; Bartholomew, Courtenay; Blattner, William A.; Carr, Jean K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Nolte, Claudine; Pape, Jean W.] Cornell Univ, Weill Med Coll, New York, NY USA; [Nolte, Claudine; Pape, Jean W.] GHESKIO, Port au Prince, Haiti; [Collado-Chastel, Santiago] Inst Biomed Studies, Santo Domingo, Dominican Rep; [Jack, Noreen] Med Res Fdn, Port Spain, Trinidad Tobago; [Figueroa, Peter] Minist Hlth, Kingston, Jamaica	University System of Maryland; University of Maryland Baltimore; Cornell University	Nadai, Y (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	jecarr@ihv.umaryland.edu			National Institute of Allergy and Infectious Disease [1R21 A1057084-02]; Institute of Human Virology, University of Maryland, Baltimore; AITRP in Brazil, Caribbean and Nigeria; NIH [5K43TW001041]; FOGARTY INTERNATIONAL CENTER [D43TW001041] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute of Human Virology, University of Maryland, Baltimore; AITRP in Brazil, Caribbean and Nigeria; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by 1R21 A1057084-02 from the National Institute of Allergy and Infectious Disease (PI: F Cleghorn, then WA Blattner) and also by the Institute of Human Virology, University of Maryland, Baltimore, AITRP in Brazil, Caribbean and Nigeria, NIH grant # 5K43TW001041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila MM, 2002, J ACQ IMMUN DEF SYND, V29, P422, DOI 10.1097/00126334-200204010-00015; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; Casado G, 2005, JAIDS-J ACQ IMM DEF, V40, P532, DOI 10.1097/01.qai.0000186363.27587.c0; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; Gittens MV, 2003, AIDS RES HUM RETROV, V19, P313, DOI 10.1089/088922203764969519; Heslop OD, 2005, W INDIAN MED J, V54, P279; INCIARDI JA, 2005, AIDS CARE S, V17; Jensen Mark A., 2003, AIDS Reviews, V5, P104; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mastro TD, 1997, AIDS, V11, P113, DOI 10.1097/00002030-199701000-00017; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Nadai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001420; REITZ MS, 1992, AIDS RES HUM RETROV, V8, P1950; *UNAIDS, 2007, 2007 AIDS EP UPD REG; *UNAIDS, 2006, 2006 AIDS EP UPD; Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120; WHEELER VW, 1994, INT J STD AIDS, V5, P79, DOI 10.1177/095646249400500201	17	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4814	10.1371/journal.pone.0004814	http://dx.doi.org/10.1371/journal.pone.0004814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279683	Green Submitted, Green Published, gold			2022-12-27	WOS:000265496200003
J	Petersen, J; Poulsen, L; Birgens, H; Dufva, M				Petersen, Jesper; Poulsen, Lena; Birgens, Henrik; Dufva, Martin			Microfludic Device for Creating Ionic Strength Gradients over DNA Microarrays for Efficient DNA Melting Studies and Assay Development	PLOS ONE			English	Article							ALLELE-SPECIFIC HYBRIDIZATION; REVEALS; CHIP	The development of DNA microarray assays is hampered by two important aspects: processing of the microarrays is done under a single stringency condition, and characteristics such as melting temperature are difficult to predict for immobilized probes. A technical solution to these limitations is to use a thermal gradient and information from melting curves, for instance to score genotypes. However, application of temperature gradients normally requires complicated equipment, and the size of the arrays that can be investigated is restricted due to heat dissipation. Here we present a simple microfluidic device that creates a gradient comprising zones of defined ionic strength over a glass slide, in which each zone corresponds to a subarray. Using this device, we demonstrated that ionic strength gradients function in a similar fashion as corresponding thermal gradients in assay development. More specifically, we noted that (i) the two stringency modulators generated melting curves that could be compared, (ii) both led to increased assay robustness, and (iii) both were associated with difficulties in genotyping the same mutation. These findings demonstrate that ionic strength stringency buffers can be used instead of thermal gradients. Given the flexibility of design of ionic gradients, these can be created over all types of arrays, and encompass an attractive alternative to temperature gradients, avoiding curtailment of the size or spacing of subarrays on slides associated with temperature gradients.	[Petersen, Jesper; Birgens, Henrik] Copenhagen Univ Hosp, Dept Haematol, Herlev, Denmark; [Poulsen, Lena; Dufva, Martin] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Petersen, J (corresponding author), Copenhagen Univ Hosp, Dept Haematol, Herlev, Denmark.	martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012	Dufva, Martin/0000-0001-5449-0189; Petersen, Jesper/0000-0001-6116-5114	Danish Government	Danish Government	The study was financed by a Danish Government PhD-study grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2003, BIOTECHNIQUES, V34, P1082, DOI 10.2144/03345dd05; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Drobyshev AL, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng001; Dufva M, 2004, BIOTECHNIQUES, V37, P286, DOI 10.2144/04372MT02; Dufva M, 2006, ANAL BIOCHEM, V352, P188, DOI 10.1016/j.ab.2006.03.008; Frey BJ, 2005, NAT GENET, V37, P991, DOI 10.1038/ng1630; Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270; Jobs M, 2003, GENOME RES, V13, P916, DOI 10.1101/gr.801103; Kajiyama T, 2003, GENOME RES, V13, P467, DOI 10.1101/gr.790603; Lee HH, 2006, LAB CHIP, V6, P1163, DOI 10.1039/b605507a; Liu WT, 2005, APPL ENVIRON MICROB, V71, P6453, DOI 10.1128/AEM.71.10.6453-6457.2005; Mao HB, 2002, ANAL CHEM, V74, P5071, DOI 10.1021/ac025851z; Marcy Y, 2008, BIOTECHNIQUES, V44, P913, DOI 10.2144/000112758; Matsuoka M, 2004, DICKENSIAN, V100, P111; Noerholm M, 2004, LAB CHIP, V4, P28, DOI 10.1039/b311991b; Petersen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1081; Poulsen L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn600; Pozhitkov A, 2005, APPL ENVIRON MICROB, V71, P8663, DOI 10.1128/AEM.71.12.8663-8676.2005; Pozhitkov AE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm154; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; STROMQVIST ML, 2007, J MOL DIAGN, V9, P30; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Vainrub A, 2003, BIOPOLYMERS, V68, P265, DOI 10.1002/bip.10271; Vainrub A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041905; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913; Zhang L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1064	31	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4808	10.1371/journal.pone.0004808	http://dx.doi.org/10.1371/journal.pone.0004808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277213	gold, Green Submitted, Green Published			2022-12-27	WOS:000265496100025
J	Esteve-Puig, R; Canals, F; Colome, N; Merlino, G; Recio, JA				Esteve-Puig, Rosaura; Canals, Francesc; Colome, Nuria; Merlino, Glenn; Angel Recio, Juan			Uncoupling of the LKB1-AMPK alpha Energy Sensor Pathway by Growth Factors and Oncogenic BRAF(V600E)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MELANOMA-CELLS; SOMATIC MUTATIONS; BRAF MUTATIONS; LKB1 KINASE; PHOSPHORYLATION; LKB1/STK11; P53; INHIBITION; APOPTOSIS	Background: Understanding the biochemical mechanisms contributing to melanoma development and progression is critical for therapeutical intervention. LKB1 is a multi-task Ser/Thr kinase that phosphorylates AMPK controlling cell growth and apoptosis under metabolic stress conditions. Additionally, LKB1(Ser428) becomes phosphorylated in a RAS-Erk1/2-p90(RSK) pathway dependent manner. However, the connection between the RAS pathway and LKB1 is mostly unknown. Methodology/Principal Findings: Using the UV induced HGF transgenic mouse melanoma model to investigate the interplay among HGF signaling, RAS pathway and PI3K pathway in melanoma, we identified LKB1 as a protein directly modified by HGF induced signaling. A variety of molecular techniques and tissue culture revealed that LKB1(Ser428) (Ser431 in the mouse) is constitutively phosphorylated in BRAF(V600E) mutant melanoma cell lines and spontaneous mouse tumors with high RAS pathway activity. Interestingly, BRAF(V600E) mutant melanoma cells showed a very limited response to metabolic stress mediated by the LKB1-AMPK-mTOR pathway. Here we show for the first time that RAS pathway activation including BRAF(V600E) mutation promotes the uncoupling of AMPK from LKB1 by a mechanism that appears to be independent of LKB1(Ser428) phosphorylation. Notably, the inhibition of the RAS pathway in BRAF(V600E) mutant melanoma cells recovered the complex formation and rescued the LKB1-AMPK alpha metabolic stress-induced response, increasing apoptosis in cooperation with the pro-apoptotic proteins Bad and Bim, and the down-regulation of Mcl-1. Conclusions/Significance: These data demonstrate that growth factor treatment and in particular oncogenic BRAF(V600E) induces the uncoupling of LKB1-AMPK alpha complexes providing at the same time a possible mechanism in cell proliferation that engages cell growth and cell division in response to mitogenic stimuli and resistance to low energy conditions in tumor cells. Importantly, this mechanism reveals a new level for therapeutical intervention particularly relevant in tumors harboring a deregulated RAS-Erk1/2 pathway.	[Esteve-Puig, Rosaura; Angel Recio, Juan] Vall Hebron Hosp, Vall Hebron Res Inst VHIO, Med Oncol Res Program, Anim Models & Canc Lab, Barcelona, Spain; [Canals, Francesc; Colome, Nuria] Vall Hebron Hosp, Vall Hebron Res Inst VHIO, Med Oncol Res Program, Proteom Lab, Barcelona, Spain; [Merlino, Glenn] NCI, NHI, Lab Canc Biol & Genet, Bethesda, MD USA	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Esteve-Puig, R (corresponding author), Vall Hebron Hosp, Vall Hebron Res Inst VHIO, Med Oncol Res Program, Anim Models & Canc Lab, Barcelona, Spain.	jarecio@ir.vhebron.net	Esteve-Puig, R/N-1402-2017	Esteve-Puig, R/0000-0003-0547-1752; Recio, Juan Angel/0000-0002-7320-3832	Instituto Carlos III; Fondo de Investigaciones Sanitarias [PI050227, PI080653]; Marie Curie [MIRG-CT-2005-029135]; Fundacion Mutua Madrilena (FMM); Fundacion Genoma Espana; Fundacio Institut de Recerca Vall d'Hebron [REP fellowship]; NATIONAL CANCER INSTITUTE [ZIABC008756] Funding Source: NIH RePORTER	Instituto Carlos III(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Marie Curie(European Commission); Fundacion Mutua Madrilena (FMM); Fundacion Genoma Espana; Fundacio Institut de Recerca Vall d'Hebron; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Instituto Carlos III, Fondo de Investigaciones Sanitarias projects PI050227, PI080653, Marie Curie Reintegration Grant MIRG-CT-2005-029135 and Fundacion Mutua Madrilena (FMM). The Proteomics Laboratory at IR-HUVH is a member of the National Spanish Institute for Proteomics (PROTEORED), supported by Fundacion Genoma Espana. REP fellowship was sponsored by Fundacio Institut de Recerca Vall d'Hebron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9112; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; DORFMAN J, 2008, MOL BIOL CELL; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; FOGARTY S, 2008, J BIOL CHEM; Geller AC, 2007, J AM ACAD DERMATOL, V57, P555, DOI 10.1016/j.jaad.2007.06.032; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Leshem Y, 2002, EXP CELL RES, V274, P288, DOI 10.1006/excr.2002.5473; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Marignani PA, 2005, J CLIN PATHOL, V58, P15, DOI 10.1136/jcp.2003.015255; Melnikova VO, 2003, ONCOGENE, V22, P5958, DOI 10.1038/sj.onc.1206595; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Recio JA, 2002, CANCER RES, V62, P6724; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Rowan A, 1999, J INVEST DERMATOL, V112, P509, DOI 10.1046/j.1523-1747.1999.00551.x; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Scott KD, 2007, CANCER RES, V67, P5622, DOI 10.1158/0008-5472.CAN-07-0762; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shen Z, 2002, CLIN CANCER RES, V8, P2085; SHERIDAN C, 2008, J BIOL CHEM; SONG P, 2008, J BIOL CHEM; Spicer J, 2004, CURR BIOL, V14, pR383, DOI 10.1016/j.cub.2004.05.012; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; WILLIAMS T, 2008, TRENDS CELL BIOL; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999	47	93	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4771	10.1371/journal.pone.0004771	http://dx.doi.org/10.1371/journal.pone.0004771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274086	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496000011
J	Koutsonanos, DG; Martin, MD; Zarnitsyn, VG; Sullivan, SP; Compans, RW; Prausnitz, MR; Skountzou, I				Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Zarnitsyn, Vladimir G.; Sullivan, Sean P.; Compans, Richard W.; Prausnitz, Mark R.; Skountzou, Ioanna			Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays	PLOS ONE			English	Article							T-CELLS; STRATUM-CORNEUM; UNITED-STATES; DELIVERY; VIRUS; RESPONSES; ANTIGEN; MEMORY; SKIN; PATCH	Background: Influenza is a contagious disease caused by a pathogenic virus, with outbreaks all over the world and thousands of hospitalizations and deaths every year. Due to virus antigenic drift and short-lived immune responses, annual vaccination is required. However, vaccine coverage is incomplete, and improvement in immunization is needed. The objective of this study is to investigate a novel method for transdermal delivery using metal microneedle arrays (MN) coated with inactivated influenza virus to determine whether this route is a simpler and safer approach than the conventional immunization, capable to induce robust immune responses and confer protection against lethal virus challenge. Methodology/Principal Findings: Inactivated A/Aichi/2/68 (H3N2) influenza virus was coated on metal microneedle arrays and applied to mice as a vaccine in the caudal dorsal skin area. Substantial antibody titers with hemagglutination inhibition activity were detected in sera collected two and four weeks after a single vaccine dose. Challenge studies in mice with 5xLD(50) of mouse adapted Aichi virus demonstrated complete protection. Microneedle vaccination induced a broad spectrum of immune responses including CD4+ and CD8+ responses in the spleen and draining lymph node, a high frequency of antigen-secreting cells in the lung and induction of virus-specific memory B-cells. In addition, the use of MN showed a dose-sparing effect and a strong Th2 bias when compared to an intramuscular (IM) reference immunization. Conclusions/Significance: The present results show that delivery of inactivated influenza virus through the skin using metal microneedle arrays induced strong humoral and cellular immune responses capable of conferring protection against virus challenge as efficiently as intramuscular immunization, which is the standard vaccination route. In view of the convenience of delivery and the potential for self-administration, vaccine-coated metal microneedles may provide a novel and highly effective immunization method.	[Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Zarnitsyn, Vladimir G.; Sullivan, Sean P.; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Koutsonanos, DG (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	prausnitz@gatech.edu; iskount@emory.edu	Skountzou, Ioanna/A-4454-2010; Compans, Richard W/I-4087-2013	Skountzou, Ioanna/0000-0002-6429-244X; Compans, Richard W/0000-0003-2360-335X; Prausnitz, Mark/0000-0002-9076-8448	National Institutes of Health [AI074579, EB006369]; Center for Drug Design, Development and Delivery; Institute for Bioengineering and Bioscience at Georgia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Drug Design, Development and Delivery; Institute for Bioengineering and Bioscience at Georgia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the National Institutes of Health grants AI074579 and EB006369 and carried out in part at the Center for Drug Design, Development and Delivery and the Institute for Bioengineering and Bioscience at Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Baxby D, 2002, VACCINE, V20, P2140, DOI 10.1016/S0264-410X(02)00028-2; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Dean HJ, 2004, VACCINE, V23, P681, DOI 10.1016/j.vaccine.2004.06.041; Deng YP, 1997, J IMMUNOL, V158, P1507; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Frerichs DM, 2008, VACCINE, V26, P2782, DOI 10.1016/j.vaccine.2008.02.070; Garg S, 2007, CLIN VACCINE IMMUNOL, V14, P926, DOI 10.1128/CVI.00450-06; GERHARD W, 1991, J VIROL, V65, P364, DOI 10.1128/JVI.65.1.364-372.1991; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Gill HS, 2007, PHARM RES, V24, P1369, DOI 10.1007/s11095-007-9286-4; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Glenn GM, 2006, CURR TOP MICROBIOL, V304, P247; Glenn GM, 2007, INFECT IMMUN, V75, P2163, DOI 10.1128/IAI.01740-06; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Howard A, 1997, ANN ALLERG ASTHMA IM, V78, P594, DOI 10.1016/S1081-1206(10)63222-X; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Mahalingam S, 2004, TRENDS IMMUNOL, V25, P636, DOI 10.1016/j.it.2004.10.002; Martanto W, 2004, PHARM RES-DORDR, V21, P947, DOI 10.1023/B:PHAM.0000029282.44140.2e; McElhaney JE, 2008, J INFECT DIS, V198, P632, DOI 10.1086/590435; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Mikszta JA, 2002, NAT MED, V8, P415, DOI 10.1038/nm0402-415; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Oosterom R, 1979, Ann N Y Acad Sci, V332, P113, DOI 10.1111/j.1749-6632.1979.tb47104.x; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Skountzou I, 2007, J VIROL, V81, P1083, DOI 10.1128/JVI.01692-06; Skountzou I, 2006, VACCINE, V24, P6110, DOI 10.1016/j.vaccine.2006.05.014; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; Steinhoff M, 2001, CURR OPIN ALLERGY CL, V1, P469, DOI 10.1097/00130832-200110000-00014; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Stingl G, 1989, Curr Probl Dermatol, V18, P22; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; WENIGER BGP, 2008, ALTERNATIVE VACCINE; Who/Cds/Csr/Ncs, 2002, WHO MAN AN INFL DIAG; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049	53	142	149	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4773	10.1371/journal.pone.0004773	http://dx.doi.org/10.1371/journal.pone.0004773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274084	Green Published, gold			2022-12-27	WOS:000265496000013
J	Kulkarni, R; Dhakal, BK; Slechta, ES; Kurtz, Z; Mulvey, MA; Thanassi, DG				Kulkarni, Ritwij; Dhakal, Bijaya K.; Slechta, E. Susan; Kurtz, Zachary; Mulvey, Matthew A.; Thanassi, David G.			Roles of Putative Type II Secretion and Type IV Pilus Systems in the Virulence of Uropathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; OUTER-MEMBRANE BIOGENESIS; PROTEIN SECRETION; AUTOTRANSPORTER TOXIN; EPITHELIAL-CELLS; PATHWAY; BLADDER; GENES; IDENTIFICATION; EPIDEMIOLOGY	Background: Type II secretion systems (T2SS) and the evolutionarily related type IV pili (T4P) are important virulence determinants in many Gram-negative bacterial pathogens. However, the roles of T2SS and T4P in the virulence of extraintestinal pathogenic Escherichia coli have not been determined. Methodology/Principal Findings: To investigate the functions of putative T2SS and T4P gene clusters present in the model uropathogenic E. coli (UPEC) strains UTI89 and CFT073, we deleted the secretin gene present in each cluster. The secretin forms a channel in the outer membrane that is essential for the function of T2SS and T4P systems. We compared the secretin deletion mutants with their wild type counterparts using tissue culture assays and the CBA/J mouse model of ascending urinary tract infection. No deficiencies were observed with any of the mutants in adherence, invasion or replication in human bladder or kidney cell lines, but UTI89 Delta hofQ and UTI89 Delta gspD exhibited approximately 2-fold defects in fluxing out of bladder epithelial cells. In the mouse infection model, each of the knockout mutants was able to establish successful infections in the bladder and kidneys by day one post-infection. However, UTI89 Delta hofQ and a CFT073 Delta hofQ Delta yheF double mutant both exhibited defects in colonizing the kidneys by day seven post-infection. Conclusions/Significance: Based on our results, we propose that the putative T4P and T2S systems are virulence determinants of UPEC important for persistence in the urinary tract, particularly in renal tissues.	[Kulkarni, Ritwij; Kurtz, Zachary; Thanassi, David G.] SUNY Stony Brook, Ctr Infect Dis, Dept Mol Genet & Microbiol, Stony Brook, NY USA; [Dhakal, Bijaya K.; Slechta, E. Susan; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84112 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Utah System of Higher Education; University of Utah	Kulkarni, R (corresponding author), Columbia Univ, Dept Microbiol, New York, NY 10032 USA.	David.Thanassi@stonybrook.edu		Mulvey, Matthew/0000-0002-6016-7510	National Institutes of Health [GM062987, AI055621, DK068585]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055621, T32AI055434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM062987 and AI055621 (DGT), and DK068585 (MAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; BOCK K, 1985, J BIOL CHEM, V260, P8545; Bose N, 2002, J BACTERIOL, V184, P2305, DOI 10.1128/JB.184.8.2305-2309.2002; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JM, 2005, INFECT IMMUN, V73, P5301, DOI 10.1128/IAI.73.9.5301-5310.2005; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; GIRON JA, 1994, MOL MICROBIOL, V12, P71, DOI 10.1111/j.1365-2958.1994.tb00996.x; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Guyer DM, 2002, INFECT IMMUN, V70, P4539, DOI 10.1128/IAI.70.8.4539-4546.2002; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Hales LM, 1999, INFECT IMMUN, V67, P3662, DOI 10.1128/IAI.67.7.3662-3666.1999; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; JIANG B, 1992, MOL MICROBIOL, V6, P1351, DOI 10.1111/j.1365-2958.1992.tb00856.x; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Landraud L, 2004, INT J MED MICROBIOL, V293, P513, DOI 10.1078/1438-4221-00295; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MCTAGGART LA, 1990, J MED MICROBIOL, V32, P135, DOI 10.1099/00222615-32-2-135; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Paranjpye RN, 2005, INFECT IMMUN, V73, P1411, DOI 10.1128/IAI.73.3.1411-1422.2005; Pugsley AP, 1997, GENE, V192, P13, DOI 10.1016/S0378-1119(96)00803-7; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Ronald A, 2002, AM J MED, V113, p14S; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Zalewska-Piatek B, 2008, J BACTERIOL, V190, P5044, DOI 10.1128/JB.00224-08	44	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4752	10.1371/journal.pone.0004752	http://dx.doi.org/10.1371/journal.pone.0004752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270734	gold, Green Published, Green Submitted			2022-12-27	WOS:000265495900019
J	Qi, X; Li, X; Rider, P; Fan, WX; Gu, HW; Xu, LT; Yang, YH; Lu, SW; Wang, H; Liu, FY				Qi, Xian; Li, Xihan; Rider, Paul; Fan, Weixing; Gu, Hongwei; Xu, Longtao; Yang, Yonghua; Lu, Sangwei; Wang, Hua; Liu, Fenyong			Molecular Characterization of Highly Pathogenic H5N1 Avian Influenza A Viruses Isolated from Raccoon Dogs in China	PLOS ONE			English	Article							HIGH VIRULENCE; HONG-KONG; HEMAGGLUTININ; INFECTION; DETERMINANT; ADAPTATION; RECEPTORS; DELETION; TIGERS; CATS	Background: The highly pathogenic avian influenza H5N1 virus can infect a variety of animals and continually poses a threat to animal and human health. While many genotypes of H5N1 virus can be found in chicken, few are associated with the infection of mammals. Characterization of the genotypes of viral strains in animal populations is important to understand the distribution of different viral strains in various hosts. This also facilitates the surveillance and detection of possible emergence of highly pathogenic strains of specific genotypes from unknown hosts or hosts that have not been previously reported to carry these genotypes. Methodology/Principal Findings: Two H5N1 isolates were obtained from lung samples of two raccoon dogs that had died from respiratory disease in China. Pathogenicity experiments showed that the isolates were highly pathogenic to chicken. To characterize the genotypes of these viruses, their genomic sequences were determined and analyzed. The genetic contents of these isolates are virtually identical and they may come from the same progenitor virus. Phylogenetic analysis indicated that the isolates were genetically closely related to genotype V H5N1 virus, which was first isolated in China in 2003, and were distinct from the dominant virus genotypes ( e. g. genotype Z) of recent years. The isolates also contain a multibasic amino acid motif at their HA cleavage sites and have an E residue at position 627 of the PB2 protein similar to the previously-identified avian viruses. Conclusions/Significance: This is the first report that genotype V H5N1 virus is found to be associated with a mammalian host. Our results strongly suggest that genotype V H5N1 virus has the ability to cross species barriers to infect mammalian animals. These findings further highlight the risk that avian influenza H5N1 virus poses to mammals and humans, which may be infected by specific genotypes that are not known to infect these hosts.	[Qi, Xian; Li, Xihan; Gu, Hongwei; Yang, Yonghua; Wang, Hua; Liu, Fenyong] Nanjing Univ, Jiangsu CDC, State Key Lab Pharmaceut Biotechnol, Inst Virol,Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China; [Qi, Xian; Wang, Hua] Jiangsu Ctr Dis Control & Pevent, Nanjing, Peoples R China; [Rider, Paul; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; [Fan, Weixing] China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China; [Xu, Longtao] Qilu Anim Hlth Products Co Ltd, Jinan, Peoples R China	Nanjing University; University of California System; University of California Berkeley; China Animal Health & Epidemiology Center	Qi, X (corresponding author), Nanjing Univ, Jiangsu CDC, State Key Lab Pharmaceut Biotechnol, Inst Virol,Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China.	wh@jscdc.cn; liu_fy@uclink4.berkeley.edu			Research Program of High Technology of Jiangsu Province Science Foundation, China [BG20077035]; US Public Health Services; NIH [RO1-DE016813]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016813] Funding Source: NIH RePORTER	Research Program of High Technology of Jiangsu Province Science Foundation, China; US Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was in part supported by grant no. BG20077035 from the Research Program of High Technology of Jiangsu Province Science Foundation, China, and US Public Health Services (NIH grant RO1-DE016813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Amonsin A, 2007, ARCH VIROL, V152, P1925, DOI 10.1007/s00705-007-1010-5; Amonsin A, 2006, VIROLOGY, V344, P480, DOI 10.1016/j.virol.2005.08.032; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; DE J, 2005, NEW ENGL J MED, V353, P2667; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Giese M, 2008, EMERG INFECT DIS, V14, P308, DOI 10.3201/eid1402.070864; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lipatov AS, 2007, EMERG INFECT DIS, V13, P539, DOI 10.3201/eid1304.061266; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maas R, 2007, EMERG INFECT DIS, V13, P1219, DOI 10.3201/eid1308.070393; Mase M, 2005, MICROBIOL IMMUNOL, V49, P871, DOI 10.1111/j.1348-0421.2005.tb03677.x; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Roberton SI, 2006, P ROY SOC B-BIOL SCI, V273, P1729, DOI 10.1098/rspb.2006.3549; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Thiry E, 2007, VET MICROBIOL, V122, P25, DOI 10.1016/j.vetmic.2006.12.021; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07	55	44	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4682	10.1371/journal.pone.0004682	http://dx.doi.org/10.1371/journal.pone.0004682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270752	Green Submitted, gold, Green Published			2022-12-27	WOS:000265495900001
J	Wallen, H; Thompson, JA; Reilly, JZ; Rodmyre, RM; Cao, JH; Yee, C				Wallen, Herschel; Thompson, John A.; Reilly, J. Zachary; Rodmyre, Rebecca M.; Cao, Jianhong; Yee, Cassian			Fludarabine Modulates Immune Response and Extends In Vivo Survival of Adoptively Transferred CD8 T Cells in Patients with Metastatic Melanoma	PLOS ONE			English	Article								Background: Adoptive T cell therapy involving the use of ex vivo generated antigen-specific cytotoxic T lymphocytes provides a promising approach to immunotherapy. It has become increasingly apparent that anti-tumor efficacy using adoptively transferred T cells is linked to their duration of in vivo persistence and can only be achieved when combined with some form of pre-infusion patient conditioning regimen. An optimal conditioning regimen that provides a positive benefit without serious toxicities has yet to be defined. We have established a unique clinical model that allows for evaluation of a given conditioning regimen on adoptively transferred T cells in humans. In this first-in-human study (FHCRC #1796), we evaluate the use of fludarabine, an FDA-approved reagent with predictable lymphodepleting kinetics and duration of action, as a conditioning regimen that promotes homeostatic upregulation of cytokines and growth signals contributing to in vivo T cell persistence. Methods/Findings: We conducted a phase I study in patients with refractory metastatic melanoma. Patients received two infusions of a single tumor-reactive antigen- specific CTL clone expanded to 10(10)/m(2); the first infusion was given without fludarabine conditioning, and the second CTL infusion was given after a course of fludarabine (25 mg/m(2)/dayx5 days). This design permits intra-patient comparison of in vivo T cell persistence pre- and post-fludarabine. Nineteen CTL infusions were administered to ten patients. No serious toxicities were observed. Three of nine evaluable patients experienced minor response or stable disease for periods of 5.8-11.0 months with two additional patients demonstrating delayed disease stabilization. The median overall survival in this heavily pre- treated population was 9.7 months. Fludarabine led to a 2.9 fold improvement in the in vivo persistence of transferred CTL clones from a median of 4.5 days (range 0-38+) to 13.0 days (range 2-63+) (p < 0.05). Fludarabine lymphodepletion increased plasma levels of the homeostatic cytokines IL-7 and IL-15. Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3. Conclusions/Significance: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.	[Wallen, Herschel; Thompson, John A.; Reilly, J. Zachary; Rodmyre, Rebecca M.; Cao, Jianhong; Yee, Cassian] Fred Hutchinson Canc Res Ctr, Dept Clin Res, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Wallen, H (corresponding author), Fred Hutchinson Canc Res Ctr, Dept Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	hwallen@u.washington.edu	Thompson, John A/T-7985-2019	Thompson, John A/0000-0002-0872-7306	ASCO Young Investigator Award; NIH [5T32-CA09515-21]; Burroughs-Wellcome Fund; Damon Runyon Clinical Investigator Award; NCI [R21CA103214]; Univ. of Washington GCRC [M01-RR-00037]; NATIONAL CANCER INSTITUTE [T32CA009515, R21CA103214] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER	ASCO Young Investigator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Clinical Investigator Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Univ. of Washington GCRC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by ASCO Young Investigator Award and NIH 5T32-CA09515-21 (to H. Wallen); Burroughs-Wellcome Fund, Damon Runyon Clinical Investigator Award, and NCI R21CA103214 (to C. Yee). This work was supported by the Univ. of Washington GCRC: grant #M01-RR-00037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Altman JD, 1998, SCIENCE, V280, P1821; Attia P, 2005, J IMMUNOTHER, V28, P582, DOI 10.1097/01.cji.0000175468.19742.10; BALCH CM, 1998, CUTANEOUS MELANOMA; Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; CHESON BD, 1995, J CLIN ONCOL, V13, P2431, DOI 10.1200/JCO.1995.13.9.2431; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; GREENBERG PD, 1986, J IMMUNOL, V136, P1917; Jaffe CC, 2006, J CLIN ONCOL, V24, P3245, DOI 10.1200/JCO.2006.06.5599; KISH JA, 1991, INVEST NEW DRUG, V9, P105, DOI 10.1007/BF00194559; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Michalek J, 2007, J IMMUNOL, V178, P6789, DOI 10.4049/jimmunol.178.11.6789; North R J, 1987, Prog Clin Biol Res, V244, P345; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Scheibenbogen C, 2000, J IMMUNOL METHODS, V244, P81, DOI 10.1016/S0022-1759(00)00257-X; STANZER S, 2007, J CLIN IMMUNOL; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; VLASVELD LT, 1994, ANN ONCOL, V5, P179, DOI 10.1093/oxfordjournals.annonc.a058774; Weber J, 2007, ONCOLOGIST, V12, P864, DOI 10.1634/theoncologist.12-7-864; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312	32	87	90	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4749	10.1371/journal.pone.0004749	http://dx.doi.org/10.1371/journal.pone.0004749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270751	gold, Green Published, Green Submitted			2022-12-27	WOS:000265495900016
J	Berger, K; Lindh, R; Wierup, N; Zmuda-Trzebiatowska, E; Lindqvist, A; Manganiello, VC; Degerman, E				Berger, Karin; Lindh, Rebecka; Wierup, Nils; Zmuda-Trzebiatowska, Emilia; Lindqvist, Andreas; Manganiello, Vincent C.; Degerman, Eva			Phosphodiesterase 3B Is Localized in Caveolae and Smooth ER in Mouse Hepatocytes and Is Important in the Regulation of Glucose and Lipid Metabolism	PLOS ONE			English	Article							LIVER-REGENERATION; PLASMA-MEMBRANE; RAT-LIVER; CELLS; MICE; PHOSPHORYLATION; IDENTIFICATION; INHIBITORS; ADIPOCYTE; PROTEINS	Cyclic nucleotide phosphodiesterases (PDEs) are important regulators of signal transduction processes mediated by cAMP and cGMP. One PDE family member, PDE3B, plays an important role in the regulation of a variety of metabolic processes such as lipolysis and insulin secretion. In this study, the cellular localization and the role of PDE3B in the regulation of triglyceride, cholesterol and glucose metabolism in hepatocytes were investigated. PDE3B was identified in caveolae, specific regions in the plasma membrane, and smooth endoplasmic reticulum. In caveolin-1 knock out mice, which lack caveolae, the amount of PDE3B protein and activity were reduced indicating a role of caveolin-1/caveolae in the stabilization of enzyme protein. Hepatocytes from PDE3B knock out mice displayed increased glucose, triglyceride and cholesterol levels, which was associated with increased expression of gluconeogenic and lipogenic genes/enzymes including, phosphoenolpyruvate carboxykinase, peroxisome proliferator-activated receptor c, sterol regulatory element-binding protein 1c and hydroxyl-3-methylglutaryl coenzyme A reductase. In conclusion, hepatocyte PDE3B is localized in caveolae and smooth endoplasmic reticulum and plays important roles in the regulation of glucose, triglyceride and cholesterol metabolism. Dysregulation of PDE3B could have a role in the development of fatty liver, a condition highly relevant in the context of type 2 diabetes.	[Berger, Karin; Lindh, Rebecka; Zmuda-Trzebiatowska, Emilia; Degerman, Eva] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Wierup, Nils; Lindqvist, Andreas] Lund Univ, Dept Expt Med Sci, BMC B11, Lund, Sweden; [Zmuda-Trzebiatowska, Emilia; Manganiello, Vincent C.] NHLBI, NIH, Translat Med Branch, Bethesda, MD USA	Lund University; Lund University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Berger, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C11, Lund, Sweden.	karin.berger@med.lu.se			Swedish Research Council; Lund University Diabetes Center (LUDC); Swedish Diabetes Association; Novo Nordisk, Denmark; The Swedish Society of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540, Z01HL002540] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Diabetes Center (LUDC); Swedish Diabetes Association; Novo Nordisk, Denmark(Novo Nordisk); The Swedish Society of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swedish Research Council Project 3362 to E.D; K.B. was supported by Lund University Diabetes Center (LUDC); Grants were obtained from the following foundations: Swedish Diabetes Association; Novo Nordisk, Denmark; The Swedish Society of Medicine, Dr. P. Hakansson, Albert Pahlsson, Fredrik och Ingrid Thuring, Wiberg, Lars Hierta, Ahlan, Tore Nilsson and Magn. Bergvall. The funding agencies did not take any part in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Abdollahi M, 2003, MOL CELL BIOCHEM, V252, P205, DOI 10.1023/A:1025568714217; Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; BIFULCO M, 1995, J BIOL CHEM, V270, P15231, DOI 10.1074/jbc.270.25.15231; BOTTCHER G, 1986, REGUL PEPTIDES, V13, P283, DOI 10.1016/0167-0115(86)90046-7; Calvo M, 2001, HEPATOLOGY, V33, P1259, DOI 10.1053/jhep.2001.23937; CARDELL RR, 1985, J CELL BIOL, V101, P201, DOI 10.1083/jcb.101.1.201; Carlsson L, 1998, ENDOCRINOLOGY, V139, P2699, DOI 10.1210/en.139.6.2699; Choi YH, 2001, BIOCHEM J, V353, P41, DOI 10.1042/0264-6021:3530041; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DEGERMAN E, 2007, CYCLIC NUCLEOTIDE PH, P79; Dohda T, 2004, J BIOCHEM, V135, P631, DOI 10.1093/jb/mvh076; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fleischer S, 1974, Methods Enzymol, V31, P6; Frank PG, 2007, CELL CYCLE, V6, P115, DOI 10.4161/cc.6.2.3722; GARFIELD SA, 1979, DIABETES, V28, P664, DOI 10.2337/diabetes.28.7.664; HAMMAD ESF, 1982, DIGEST DIS SCI, V27, P692, DOI 10.1007/BF01393763; Harndahl L, 2004, J BIOL CHEM, V279, P15214, DOI 10.1074/jbc.M308952200; Komas N., 1996, PHOSPHODIESTERASE IN, P89, DOI [10.1016/b978-012210720-7/50008-3, DOI 10.1016/B978-012210720-7/50008-3]; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Lindh R, 2007, BBA-MOL CELL RES, V1773, P584, DOI 10.1016/j.bbamcr.2007.01.010; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; PYNE NJ, 1987, BIOCHEM J, V242, P33, DOI 10.1042/bj2420033; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Thompson PE, 2007, CURR TOP MED CHEM, V7, P421, DOI 10.2174/156802607779941224; Tietz P, 2005, J LIPID RES, V46, P1426, DOI 10.1194/jlr.M400412-JLR200; Tuma P L, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0302s02; Wierup N, 2005, CELL TISSUE RES, V319, P423, DOI 10.1007/s00441-004-1044-x; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	37	21	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4671	10.1371/journal.pone.0004671	http://dx.doi.org/10.1371/journal.pone.0004671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262749	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490600004
J	Lodeiro, M; Theodoropoulou, M; Pardo, M; Casanueva, FF; Camina, JP				Lodeiro, Maria; Theodoropoulou, Marily; Pardo, Maria; Casanueva, Felipe F.; Camina, Jesus P.			c-Src Regulates Akt Signaling in Response to Ghrelin via beta-Arrestin Signaling-Independent and -Dependent Mechanisms	PLOS ONE			English	Article							RECEPTOR; PHOSPHORYLATION; ACTIVATION; GROWTH; RICTOR; MTOR; IDENTIFICATION; COMPLEX-2; APOPTOSIS; HORMONE	The aim of the present study was to identify the signaling mechanisms to ghrelin-stimulated activation of the serine/threonine kinase Akt. In human embryonic kidney 293 (HEK293) cells transfected with GHS-R1a, ghrelin leads to the activation of Akt through the interplay of distinct signaling mechanisms: an early G(i/o) protein-dependent pathway and a late pathway mediated by beta-arrestins. The starting point is the G(i/o)-protein dependent PI3K activation that leads to the membrane recruitment of Akt, which is phosphorylated at Y by c-Src with the subsequent phosphorylation at A-loop (T308) and HM (S473) by PDK1 and mTORC2, respectively. Once the receptor is activated, a second signaling pathway is mediated by beta-arrestins 1 and 2, involving the recruitment of at least beta-arrestins, c-Src and Akt. This beta-arrestin-scaffolded complex leads to full activation of Akt through PDK1 and mTORC2, which are not associated to the complex. In agreement with these results, assays performed in 3T3-L1 preadipocyte cells indicate that b-arrestins and c-Src are implicated in the activation of Akt in response to ghrelin through the GHS-R1a. In summary this work reveals that c-Src is crucially involved in the ghrelin-mediated Akt activation. Furthermore, the results support the view that b-arrestins act as both scaffolding proteins and signal transducers on Akt activation.	[Lodeiro, Maria; Pardo, Maria; Casanueva, Felipe F.; Camina, Jesus P.] CHUS, Inst Invest Sanit, Lab Mol & Cellular Endocrinol, Santiago De Compostela, Spain; [Lodeiro, Maria; Pardo, Maria; Casanueva, Felipe F.; Camina, Jesus P.] CIBER Fisiopatol Obesidad Nutr, Santiago De Compostela, Spain; [Theodoropoulou, Marily] Max Planck Inst Psychiat, Dept Endocrinol, Munich, Germany; [Pardo, Maria; Casanueva, Felipe F.] Univ Santiago Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Max Planck Society; Universidade de Santiago de Compostela	Lodeiro, M (corresponding author), CHUS, Inst Invest Sanit, Lab Mol & Cellular Endocrinol, Santiago De Compostela, Spain.	jesus.perez@usc.es	Pardo, María/C-5124-2012; Theodoropoulou, Marily/S-9546-2017	Pardo, María/0000-0002-9967-1650; Theodoropoulou, Marily/0000-0002-7378-4374; Lodeiro, Maria/0000-0003-0008-5641	Instituto de Salud Carlos III [PI060239, PI060705, PI070908]; Xunta de Galicia [PGIDIT05BTF20802PR, PGIDIT06PXIB918322PR, PGIDIT06PXIB918360PR]; University of Santiago de Compostela [Pfizer Young Investigator Fellowship]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); University of Santiago de Compostela	This work was supported by grants from Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion: PI060239, PI060705, PI070908), and Xunta de Galicia (PGIDIT05BTF20802PR, PGIDIT06PXIB918322PR, PGIDIT06PXIB918360PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work of M Lodeiro is funded by Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion). The work of M Theodoropoulou was supported by a research fellowship at the University of Santiago de Compostela for the Pfizer Young Investigator Fellowship. The work of JP Camina is funded by the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion) and the Xunta de Galicia (SERGAS) through a research-staff stabilization contract.	Barazzoni R, 2007, OBESITY, V15, P2614, DOI 10.1038/oby.2007.313; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Duxbury MS, 2003, BIOCHEM BIOPH RES CO, V309, P464, DOI 10.1016/j.bbrc.2003.08.024; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Iantorno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE756, DOI 10.1152/ajpendo.00570.2006; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kim MS, 2004, MOL ENDOCRINOL, V18, P2291, DOI 10.1210/me.2003-0459; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Luttrell LM, 2002, J CELL SCI, V115, P455; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Park YJ, 2008, MOL CELL ENDOCRINOL, V285, P19, DOI 10.1016/j.mce.2008.01.003; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Rossi F, 2007, ATHEROSCLEROSIS, V192, P291, DOI 10.1016/j.atherosclerosis.2006.07.021; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; XU X, 2008, ENDOCRINOLO IN PRESS; Zhao H, 2007, BIOCHEM BIOPH RES CO, V362, P677, DOI 10.1016/j.bbrc.2007.08.021	39	60	64	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4686	10.1371/journal.pone.0004686	http://dx.doi.org/10.1371/journal.pone.0004686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262695	Green Published, gold, Green Submitted			2022-12-27	WOS:000265490600014
J	Peterson, BK; Hare, EE; Iyer, VN; Storage, S; Conner, L; Papaj, DR; Kurashima, R; Jang, E; Eisen, MB				Peterson, Brant K.; Hare, Emily E.; Iyer, Venky N.; Storage, Steven; Conner, Laura; Papaj, Daniel R.; Kurashima, Rick; Jang, Eric; Eisen, Michael B.			Big Genomes Facilitate the Comparative Identification of Regulatory Elements	PLOS ONE			English	Article								The identification of regulatory sequences in animal genomes remains a significant challenge. Comparative genomic methods that use patterns of evolutionary conservation to identify non-coding sequences with regulatory function have yielded many new vertebrate enhancers. However, these methods have not contributed significantly to the identification of regulatory sequences in sequenced invertebrate taxa. We demonstrate here that this differential success, which is often attributed to fundamental differences in the nature of vertebrate and invertebrate regulatory sequences, is instead primarily a product of the relatively small size of sequenced invertebrate genomes. We sequenced and compared loci involved in early embryonic patterning from four species of true fruit flies (family Tephritidae) that have genomes four to six times larger than those of Drosophila melanogaster. Unlike in Drosophila, where virtually all non-coding DNA is highly conserved, blocks of conserved non-coding sequence in tephritids are flanked by large stretches of poorly conserved sequence, similar to what is observed in vertebrate genomes. We tested the activities of nine conserved non-coding sequences flanking the even-skipped gene of the teprhitid Ceratis capitata in transgenic D. melanogaster embryos, six of which drove patterns that recapitulate those of known D. melanogaster enhancers. In contrast, none of the three non-conserved tephritid non-coding sequences that we tested drove expression in D. melanogaster embryos. Based on the landscape of non-coding conservation in tephritids, and our initial success in using conservation in tephritids to identify D. melanogaster regulatory sequences, we suggest that comparison of tephritid genomes may provide a systematic means to annotate the non-coding portion of the D. melanogaster genome. We also propose that large genomes be given more consideration in the selection of species for comparative genomics projects, to provide increased power to detect functional non-coding DNAs and to provide a less biased view of the evolution and function of animal genomes.	[Peterson, Brant K.; Hare, Emily E.; Iyer, Venky N.; Storage, Steven; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Peterson, Brant K.; Hare, Emily E.; Eisen, Michael B.] Ernest Orlando Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA USA; [Conner, Laura; Papaj, Daniel R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Kurashima, Rick; Jang, Eric] US Dept Agr, Pacific Basin Agr Res Ctr, Hilo, HI USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Calif Inst Quantitative Biosci, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Ctr Integrative Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Arizona; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Peterson, BK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Conner, Laura/0000-0002-8457-6837; Peterson, Brant/0000-0002-0433-3035; Eisen, Michael/0000-0002-7528-738X	NIH [HG002779]; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Department of Energy's Joint Genome Institute [Community Sequencing Grant]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Department of Energy's Joint Genome Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH grant HG002779 to MBE and by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Sequencing was conducted under a Community Sequencing Grant from the Department of Energy's Joint Genome Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bergman CM, 2001, GENOME RES, V11, P1335, DOI 10.1101/gr.178701; BERGMAN CM, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0086; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Elnitski L, 1997, J BIOL CHEM, V272, P369; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Gallo SM, 2006, BIOINFORMATICS, V22, P381, DOI 10.1093/bioinformatics/bti794; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Gumucio DL, 1996, MOL PHYLOGENET EVOL, V5, P18, DOI 10.1006/mpev.1996.0004; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1991, GENE DEV, V5, P265, DOI 10.1101/gad.5.2.265; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Ross M.T., 1999, CURRENT PROTOCOLS HU; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SMALL S, 1993, DEVELOPMENT, V119, P767; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Wratten NS, 2006, EVOL DEV, V8, P6, DOI 10.1111/j.1525-142X.2006.05070.x	47	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4688	10.1371/journal.pone.0004688	http://dx.doi.org/10.1371/journal.pone.0004688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259274	Green Submitted, gold, Green Published			2022-12-27	WOS:000265490500008
J	Choi, PT; Beattie, WS; Bryson, GL; Paul, JE; Yang, H				Choi, Peter T.; Beattie, W. Scott; Bryson, Gregory L.; Paul, James E.; Yang, Homer			Effects of Neuraxial Blockade May Be Difficult To Study Using Large Randomized Controlled Trials: The PeriOperative Epidural Trial (POET) Pilot Study	PLOS ONE			English	Article								Background: Early randomized controlled trials have suggested that neuraxial blockade may reduce cardiorespiratory complications after non-cardiothoracic surgery, but recent larger trials have been inconclusive. We conducted a pilot study to assess the feasibility of conducting a large multicentre randomized controlled trial in Canada. Methodology/Principal Findings: After Research Ethics Board approvals from the participating institutions, subjects were recruited if they were >= 45 years old, had an expected hospital stay >= 48 hours, were undergoing a noncardiothoracic procedure amenable to epidural analgesia, met one of six risk criteria, and did not have contraindications to neuraxial blockade. After informed consent, subjects were randomly allocated to combined epidural analgesia (epidural group) and neuraxial anesthesia, with or without general anesthesia, or intravenous opioid analgesia (IV group) and general anesthesia. The primary outcomes were the rate of recruitment and the percents of eligible patients recruited, crossed over, and followed completely. Feasibility targets were defined a priori. A blinded, independent committee adjudicated the secondary clinical outcomes. Subjects were followed daily while in hospital and then at 30 days after surgery. Analysis was intention-to-treat. Over a 15-month period, the recruitment rate was 0.5 +/- 0.3 (mean +/- SEM) subjects per week per centre; 112/494 (22.7%) eligible subjects were recruited at four tertiary-care teaching hospitals in Canada. Thirteen (26.5%) of 49 subjects in the epidural group crossed over to the IV group; seven (14.3%) were due to failed or inadequate analgesia or complications from epidural analgesia. Five (9.8%) of 51 subjects in the IV group crossed over to the epidural group but none were due to inadequate analgesia or complications. Ninety-eight (97.0%) of 101 subjects were successfully followed up until 30 days after their surgery. Conclusion/Significance: Of the criteria we defined for the feasibility of a full-scale trial, only the follow-up target was met. The other feasibility outcomes did not meet our preset criteria for success. The results suggest that a large multicentre trial may not be a feasible design to study the perioperative effects of neuraxial blockade.	[Choi, Peter T.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Beattie, W. Scott] Univ Hlth Network, Dept Anaesthesia, Toronto, ON, Canada; [Bryson, Gregory L.; Yang, Homer] Univ Ottawa, Dept Anesthesiol, Ottawa, ON K1N 6N5, Canada; [Paul, James E.] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4L8, Canada	University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; McMaster University	Choi, PT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	petert.choi@vch.ca	Beattie, William Scott/A-4352-2008; Bryson, Gregory Lyle/AAG-5108-2019	Bryson, Gregory Lyle/0000-0003-3583-9802	ISRCTN [35629817]; NCT [0221260]; Canadian Institutes of Health Research [MCT-73644]; VGH and UBC Hospital Foundation; Hamilton Health Sciences Foundation	ISRCTN; NCT(Deutsche KrebshilfeHelmholtz Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); VGH and UBC Hospital Foundation; Hamilton Health Sciences Foundation	This study (ISRCTN 35629817; ClinicalTrials.gov NCT 0221260) was funded by grants from the Canadian Institutes of Health Research (MCT-73644) to Drs. Peter T. Choi and W. Scott Beattie, from the VGH and UBC Hospital Foundation to Dr. Peter T. Choi, and from the Hamilton Health Sciences Foundation to Dr. James Paul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Anesthesiologists, ASA PHYS STAT CLASS; Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Ballantyne JC, 1998, ANESTH ANALG, V86, P598, DOI 10.1097/00000539-199803000-00032; Beattie WS, 2001, ANESTH ANALG, V93, P853, DOI 10.1097/00000539-200110000-00010; Beattie WS, 2003, ANESTH ANALG, V97, P919, DOI 10.1213/01.ANE.0000074660.05733.10; Bland JM, 1998, BRIT MED J, V316, P129; Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064; CALLUM KG, 2002, 2002 REPORT NATL CON; Carli F, 2002, ANESTHESIOLOGY, V97, P540, DOI 10.1097/00000542-200209000-00005; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2006, AM HEART J, V152, P223, DOI 10.1016/j.ahj.2006.05.019; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P779, DOI 10.1503/cmaj.050316; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Katz J, 2003, ANESTHESIOLOGY, V98, P1449, DOI 10.1097/00000542-200306000-00023; Lawrence VA, 2006, ANN INTERN MED, V144, P596, DOI 10.7326/0003-4819-144-8-200604180-00011; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019; Liu SS, 2007, ANESTH ANALG, V104, P689, DOI 10.1213/01.ane.0000255040.71600.41; MANGANO DT, 1999, BAILLIERE CLIN ANAES, V13, P335; Norris EJ, 2001, ANESTHESIOLOGY, V95, P1054, DOI 10.1097/00000542-200111000-00006; Oliver MF, 1999, ANESTHESIOLOGY, V91, P951, DOI 10.1097/00000542-199910000-00014; Park WY, 2001, ANN SURG, V234, P560; Popping DM, 2008, ARCH SURG-CHICAGO, V143, P990, DOI 10.1001/archsurg.143.10.990; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Salomons TV, 2002, CAN J ANAESTH, V49, P583, DOI 10.1007/BF03017386; Steinberg RB, 2002, J CLIN ANESTH, V14, P571, DOI 10.1016/S0952-8180(02)00451-8; vandenBerg L, 1997, EUR J ANAESTH, V14, P287, DOI 10.1046/j.1365-2346.1997.00125.x; Wijeysundera DN, 2003, AM J MED, V114, P742, DOI 10.1016/S0002-9343(03)00165-7; Wijeysundera DN, 2003, ANESTH ANALG, V97, P634, DOI 10.1213/01.ANE.0000081732.51871.D2; Wijeysundera DN, 2008, CAN J ANAESTH, V55, P670, DOI 10.1007/BF03017742; Zutshi M, 2005, AM J SURG, V189, P268, DOI 10.1016/j.amjsurg.2004.11.012	35	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4644	10.1371/journal.pone.0004644	http://dx.doi.org/10.1371/journal.pone.0004644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247497	Green Published, gold, Green Submitted			2022-12-27	WOS:000265487800024
J	Xiao, WF; Liu, HB; Li, Y; Li, XH; Xu, CG; Long, MY; Wang, SP				Xiao, Wenfei; Liu, Hongbo; Li, Yu; Li, Xianghua; Xu, Caiguo; Long, Manyuan; Wang, Shiping			A Rice Gene of De Novo Origin Negatively Regulates Pathogen-Induced Defense Response	PLOS ONE			English	Article							BACTERIAL-BLIGHT RESISTANCE; DISEASE RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; MOLECULAR PHYLOGENY; DROSOPHILA-YAKUBA; EXPRESSION; EVOLUTION; SEQUENCES; DNA	How defense genes originated with the evolution of their specific pathogen-responsive traits remains an important problem. It is generally known that a form of duplication can generate new genes, suggesting that a new gene usually evolves from an ancestral gene. However, we show that a new defense gene in plants may evolve by de novo origination, resulting in sophisticated disease-resistant functions in rice. Analyses of gene evolution showed that this new gene, OsDR10, had homologs only in the closest relative, Leersia genus, but not other subfamilies of the grass family; therefore, it is a rice tribe-specific gene that may have originated de novo in the tribe. We further show that this gene may evolve a highly conservative rice-specific function that contributes to the regulation difference between rice and other plant species in response to pathogen infections. Biologic analyses including gene silencing, pathologic analysis, and mutant characterization by transformation showed that the OsDR10-suppressed plants enhanced resistance to a broad spectrum of Xanthomonas oryzae pv. oryzae strains, which cause bacterial blight disease. This enhanced disease resistance was accompanied by increased accumulation of endogenous salicylic acid (SA) and suppressed accumulation of endogenous jasmonic acid (JA) as well as modified expression of a subset of defense-responsive genes functioning both upstream and downstream of SA and JA. These data and analyses provide fresh insights into the new biologic and evolutionary processes of a de novo gene recruited rapidly.	[Xiao, Wenfei; Liu, Hongbo; Li, Yu; Li, Xianghua; Xu, Caiguo; Wang, Shiping] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Huazhong Agricultural University; University of Chicago	Xiao, WF (corresponding author), Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	swang@mail.hzau.edu.cn			National Program of High Technology Development of China; National Program on the Development of Basic Research in China; National Natural Science Foundation of China	National Program of High Technology Development of China(National High Technology Research and Development Program of China); National Program on the Development of Basic Research in China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Program of High Technology Development of China, the National Program on the Development of Basic Research in China, and the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Begun DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/genetics.106.069245; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Chen HL, 2002, PHYTOPATHOLOGY, V92, P750, DOI 10.1094/PHYTO.2002.92.7.750; Chen ST, 2007, PLOS GENET, V3, P1131, DOI 10.1371/journal.pgen.0030107; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; CHU Z, 2007, GENETICS IMPROVEMENT, P349; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Ge S, 2002, AM J BOT, V89, P1967, DOI 10.3732/ajb.89.12.1967; Gozzo F, 2003, J AGR FOOD CHEM, V51, P4487, DOI 10.1021/jf030025s; Guo YL, 2005, AM J BOT, V92, P1548, DOI 10.3732/ajb.92.9.1548; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Hsiao C, 1999, AUST SYST BOT, V11, P667, DOI 10.1071/SB97012; Hu KM, 2008, MOL PLANT, V1, P786, DOI 10.1093/mp/ssn039; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; LEE HI, 1995, P NATL ACAD SCI USA, V92, P4076, DOI 10.1073/pnas.92.10.4076; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Long M., 2007, NATURE, V449, P511; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; MULLER A, 2002, PLANTA, V216, P14; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; SILVERMAN P, 1995, PLANT PHYSIOL, V108, P633, DOI 10.1104/pp.108.2.633; SUEL B, 2002, GENOME RES, V12, P17; Sun X, 2003, THEOR APPL GENET, V106, P683, DOI 10.1007/s00122-002-1117-8; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WAU J, 2007, GENETICS IMPROVEMENT, P173; White SE, 1999, GENETICS, V153, P1455; Yuan B, 2007, PLANTA, V226, P953, DOI 10.1007/s00425-007-0541-z; Zhang JW, 2005, PLANT J, V42, P772, DOI 10.1111/j.1365-313X.2005.02408.x; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhou B, 2002, SCI CHINA SER C, V45, P449, DOI 10.1360/02yc9050; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	43	79	81	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4603	10.1371/journal.pone.0004603	http://dx.doi.org/10.1371/journal.pone.0004603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240804	Green Published, gold, Green Submitted			2022-12-27	WOS:000278086700017
J	Burns, DM; Ying, WH; Kauppinen, TM; Zhu, KQ; Swanson, RA				Burns, David M.; Ying, Weihai; Kauppinen, Tiina M.; Zhu, Keqing; Swanson, Raymond A.			Selective Down-Regulation of Nuclear Poly(ADP-Ribose) Glycohydrolase	PLOS ONE			English	Article								Background: The formation of ADP-ribose polymers on target proteins by poly(ADP-ribose) polymerases serves a variety of cell signaling functions. In addition, extensive activation of poly(ADP-ribose) polymerase-1 (PARP-1) is a dominant cause of cell death in ischemia-reperfusion, trauma, and other conditions. Poly(ADP-ribose) glycohydrolase (PARG) degrades the ADP-ribose polymers formed on acceptor proteins by PARP-1 and other PARP family members. PARG exists as multiple isoforms with differing subcellular localizations, but the functional significance of these isoforms is uncertain. Methods/Principal Findings: Primary mouse astrocytes were treated with an antisense phosphorodiamidate morpholino oligonucleotide (PMO) targeted to exon 1 of full-length PARG to suppress expression of this nuclear-specific PARG isoform. The antisense-treated cells showed down-regulation of both nuclear PARG immunoreactivity and nuclear PARG enzymatic activity, without significant alteration in cytoplasmic PARG activity. When treated with the genotoxic agent MNNG to induced PARP-1 activation, the antisense-treated cells showed a delayed rate of nuclear PAR degradation, reduced nuclear condensation, and reduced cell death. Conclusions/Significance: These results support a preferentially nuclear localization for full-length PARG, and suggest a key role for this isoform in the PARP-1 cell death pathway.	[Burns, David M.; Ying, Weihai; Kauppinen, Tiina M.; Zhu, Keqing; Swanson, Raymond A.] VA Med Ctr, San Francisco, CA USA; [Burns, David M.; Ying, Weihai; Kauppinen, Tiina M.; Zhu, Keqing; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Burns, DM (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	raymond.swanson@ucsf.edu	Kauppinen, Tiina/I-1009-2019	Swanson, Raymond/0000-0002-3664-5359; Kauppinen, Tiina/0000-0001-7219-9862	U.S. Dept. of Veterans Affairs; NIH [RO1 NS41421]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041421] Funding Source: NIH RePORTER	U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. Dept. of Veterans Affairs and by the NIH (RO1 NS41421; RAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Ame JC, 1999, MOL CELL BIOCHEM, V193, P75, DOI 10.1023/A:1006912210439; Bakondi E, 2004, EXP DERMATOL, V13, P170, DOI 10.1111/j.0906-6705.2004.0150.x; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Cozzi A, 2006, J CEREBR BLOOD F MET, V26, P684, DOI 10.1038/sj.jcbfm.9600222; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; FORMENTINI L, 2008, BR J PHARM; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Haince JF, 2006, BBA-MOL CELL RES, V1763, P226, DOI 10.1016/j.bbamcr.2005.11.015; HERTZER NR, 1985, J VASC SURG, V2, P661, DOI 10.1067/mva.1985.avs0020661; Hwang JJ, 2002, J NEUROCHEM, V82, P894, DOI 10.1046/j.1471-4159.2002.01040.x; Jaiswal AS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-3; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Lu XCM, 2003, BRAIN RES, V978, P99, DOI 10.1016/S0006-8993(03)02774-4; MENARD L, 1987, BIOCHEM CELL BIOL, V65, P668, DOI 10.1139/o87-088; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Purrello VS, 2002, MECH AGEING DEV, V123, P511, DOI 10.1016/S0047-6374(01)00354-2; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scortegagna M, 2000, NEUROCHEM RES, V25, P861, DOI 10.1023/A:1007577710066; Sevigny MB, 2003, MOL BRAIN RES, V117, P213, DOI 10.1016/S0169-328X(03)00325-5; Sheline CT, 2003, EUR J NEUROSCI, V18, P1402, DOI 10.1046/j.1460-9568.2003.02865.x; St-Laurent JF, 2007, DNA REPAIR, V6, P329, DOI 10.1016/j.dnarep.2006.10.027; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; TANUMA SI, 1986, J BIOL CHEM, V261, P965; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZAHRADKA P, 1982, EUR J BIOCHEM, V127, P579	40	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4896	10.1371/journal.pone.0004896	http://dx.doi.org/10.1371/journal.pone.0004896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319190	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499200004
J	Grosskinsky, S; Schott, M; Brenner, C; Cutler, SJ; Kraiczy, P; Zipfel, PF; Simon, MM; Wallich, R				Grosskinsky, Sonja; Schott, Melanie; Brenner, Christiane; Cutler, Sally J.; Kraiczy, Peter; Zipfel, Peter F.; Simon, Markus M.; Wallich, Reinhard			Borrelia recurrentis Employs a Novel Multifunctional Surface Protein with Anti-Complement, Anti-Opsonic and Invasive Potential to Escape Innate Immunity	PLOS ONE			English	Article								Borrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of B. recurrentis, termed HcpA, and demonstrate that it binds human complement regulators, Factor H, CFHR-1, and simultaneously, the host protease plasminogen. Cell surface bound factor H was found to retain its activity and to confer resistance to complement attack. Moreover, ectopic expression of HcpA in a B. burgdorferi B313 strain, deficient in Factor H binding proteins, protected the transformed spirochetes from complement-mediated killing. Furthermore, HcpA-bound plasminogen/plasmin endows B. recurrentis with the potential to resist opsonization and to degrade extracellular matrix components. Together, the present study underscores the high virulence potential of B. recurrentis. The elucidation of the molecular basis underlying the versatile strategies of B. recurrentis to escape innate immunity and to persist in human tissues, including the brain, may help to understand the pathological processes underlying louse-borne relapsing fever.	[Grosskinsky, Sonja; Schott, Melanie; Brenner, Christiane; Wallich, Reinhard] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany; [Cutler, Sally J.] Univ E London, Sch Hlth & Biosci, Stratford, England; [Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Zipfel, Peter F.] Leibniz Inst Nat Products Res, Dept Infect Biol, Jena, Germany; [Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, Freiburg, Germany	Ruprecht Karls University Heidelberg; University of East London; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Max Planck Society	Grosskinsky, S (corresponding author), Univ Heidelberg, Inst Immunol, Neuenheimer Feld 305, D-6900 Heidelberg, Germany.	wallich@uni-hd.de	Cutler, Sally/AAT-3350-2020		Deutsche Forschungsgemeinschaft [Wa 533/7-1, Wa 533/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by the Deutsche Forschungsgemeinschaft to RW (Wa 533/7-1 and Wa 533/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1982, J EXP MED, V156, P1312, DOI 10.1084/jem.156.5.1312; Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; BARBOUR AG, 1991, MOL MICROBIOL, V5, P489, DOI 10.1111/j.1365-2958.1991.tb02132.x; BARBOUR AG, 1990, ANNU REV MICROBIOL, V44, P155, DOI 10.1146/annurev.mi.44.100190.001103; BRISSETTE CA, 2008, BORRELIA BURGDORFERI, DOI DOI 10.1128/IAI.01133-08; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Coleman AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003010; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; CUTLER SJ, 2001, MOL MED MICROBIOLOGY, P2093; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Houhamdi L, 2005, J INFECT DIS, V191, P1898, DOI 10.1086/429920; Hovis KM, 2006, INFECT IMMUN, V74, P4519, DOI 10.1128/IAI.00377-06; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Kraiczy P, 2004, INT J MED MICROBIOL, V293, P152, DOI 10.1016/S1433-1128(04)80029-9; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, INT IMMUNOPHARMACOL, V1, P393, DOI 10.1016/S1567-5769(00)00041-2; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; KRAMER MD, 1990, IMMUNOBIOLOGY, V181, P357, DOI 10.1016/S0171-2985(11)80504-8; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; KUHN S, 1995, J IMMUNOL, V155, P5663; McDowell JV, 2003, J CLIN MICROBIOL, V41, P3905, DOI 10.1128/JCM.41.8.3905-3910.2003; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Neeleman C, 1999, INFECT IMMUN, V67, P4517, DOI 10.1128/IAI.67.9.4517-4524.1999; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Ras NM, 2000, RES MICROBIOL, V151, P5, DOI 10.1016/S0923-2508(00)00133-9; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rossmann E, 2008, INT J MED MICROBIOL, V298, P272, DOI 10.1016/j.ijmm.2008.02.003; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Scott JC, 2005, EMERG INFECT DIS, V11, P1722, DOI 10.3201/eid1111.050483; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Siegel C, 2008, J BIOL CHEM, V283, P34855, DOI 10.1074/jbc.M805844200; SKERKA C, 1991, J BIOL CHEM, V266, P12015; SOUTHERN PM, 1969, MEDICINE, V48, P129, DOI 10.1097/00005792-196903000-00002; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; SUNDNES KO, 1993, LANCET, V342, P1213, DOI 10.1016/0140-6736(93)92190-5; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004	51	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4858	10.1371/journal.pone.0004858	http://dx.doi.org/10.1371/journal.pone.0004858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308255	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000265499000003
J	Cattoli, G; Monne, I; Fusaro, A; Joannis, TM; Lombin, LH; Aly, MM; Arafa, AS; Sturm-Ramirez, KM; Couacy-Hymann, E; Awuni, JA; Batawui, KB; Awoume, KA; Aplogan, GL; Sow, A; Ngangnou, AC; Hamza, IMEN; Gamatie, D; Dauphin, G; Domenech, JM; Capua, I				Cattoli, Giovanni; Monne, Isabella; Fusaro, Alice; Joannis, Tony M.; Lombin, Lami H.; Aly, Mona M.; Arafa, Abdel S.; Sturm-Ramirez, Katharine M.; Couacy-Hymann, Emmanuel; Awuni, Joseph A.; Batawui, Komla B.; Awoume, Kodzo A.; Aplogan, Gilbert L.; Sow, Adama; Ngangnou, Andre C.; Hamza, Iman M. El Nasri; Gamatie, Djibo; Dauphin, Gwenaelle; Domenech, Joseph M.; Capua, Ilaria			Highly Pathogenic Avian Influenza Virus Subtype H5N1 in Africa: A Comprehensive Phylogenetic Analysis and Molecular Characterization of Isolates	PLOS ONE			English	Article							A VIRUSES; NEURAMINIDASE INHIBITORS; PCR ASSAY; HEMAGGLUTININ; EVOLUTION; BINDING; INTRODUCTIONS; MUTATIONS; NIGERIA; H7	Highly pathogenic avian influenza virus A/H5N1 was first officially reported in Africa in early 2006. Since the first outbreak in Nigeria, this virus spread rapidly to other African countries. From its emergence to early 2008, 11 African countries experienced A/H5N1 outbreaks in poultry and human cases were also reported in three of these countries. At present, little is known of the epidemiology and molecular evolution of A/H5N1 viruses in Africa. We have generated 494 full gene sequences from 67 African isolates and applied molecular analysis tools to a total of 1,152 A/H5N1 sequences obtained from viruses isolated in Africa, Europe and the Middle East between 2006 and early 2008. Detailed phylogenetic analyses of the 8 gene viral segments confirmed that 3 distinct sublineages were introduced, which have persisted and spread across the continent over this 2-year period. Additionally, our molecular epidemiological studies highlighted the association between genetic clustering and area of origin in a majority of cases. Molecular signatures unique to strains isolated in selected areas also gave us a clearer picture of the spread of A/H5N1 viruses across the continent. Mutations described as typical of human influenza viruses in the genes coding for internal proteins or associated with host adaptation and increased resistance to antiviral drugs have also been detected in the genes coding for transmembrane proteins. These findings raise concern for the possible human health risk presented by viruses with these genetic properties and highlight the need for increased efforts to monitor the evolution of A/H5N1 viruses across the African continent. They further stress how imperative it is to implement sustainable control strategies to improve animal and public health at a global level.	[Cattoli, Giovanni; Monne, Isabella; Fusaro, Alice; Capua, Ilaria] Ist Zooprofilatt Sperle Venezie, OIE FAO Reference Lab Avian Influenza & Newcastle, Legnaro, PD, Italy; [Joannis, Tony M.; Lombin, Lami H.] Natl Vet Res Inst, Vom, Nigeria; [Aly, Mona M.; Arafa, Abdel S.] Natl Lab Qual Control Poultry Product, Cairo, Egypt; [Sturm-Ramirez, Katharine M.] Fogarty Int Ctr, NIH, Bethesda, MD USA; [Couacy-Hymann, Emmanuel] Lab Cent Pathol Anim, Bingerville, Cote Ivoire; [Awuni, Joseph A.] Accra Vet Lab, Accra, Ghana; [Batawui, Komla B.; Awoume, Kodzo A.] Lab Cent Vet, Lome, Togo; [Aplogan, Gilbert L.] Lab Diagnost Vet Serosurveillance, Parakou, Benin; [Sow, Adama] Lab Natl Elevage, Ouagadougou, Burkina Faso; [Ngangnou, Andre C.] Lab Natl Vet, Garoua, Cameroon; [Hamza, Iman M. El Nasri] Cent Vet Res Lab, Khartoum, Sudan; [Gamatie, Djibo] Direct Lab Vet, Niamey, Niger; [Dauphin, Gwenaelle; Domenech, Joseph M.] Food & Agr Org UN, AGAH Div, Rome, Italy	IZS delle Venezie; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Food & Agriculture Organization of the United Nations (FAO)	Cattoli, G (corresponding author), Ist Zooprofilatt Sperle Venezie, OIE FAO Reference Lab Avian Influenza & Newcastle, Legnaro, PD, Italy.	gcattoli@izsvenezie.it	Monne, Isabella/K-7652-2016; Fusaro, Alice/J-4538-2019; Arafa, Abdelsatar/L-2724-2013	Monne, Isabella/0000-0002-6564-4689; Fusaro, Alice/0000-0002-8213-5472; Arafa, Abdelsatar/0000-0001-6370-2526; Awuni, Joseph Agebase/0000-0003-0940-9462	Food and Agricultural Organization of the United Nations (UN-FAO); EU-projects EPIZONE; FLUTRAIN	Food and Agricultural Organization of the United Nations (UN-FAO); EU-projects EPIZONE; FLUTRAIN	The Food and Agricultural Organization of the United Nations (UN-FAO) financially supported part of this project and facilitated samples collection and submission. The EU-projects EPIZONE (Network of excellence for epizootic disease diagnosis and control) and FLUTRAIN (Training and technology transfer of avian influenza diagnostics and disease management skills) also contributed to the realization of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1981, AVIAN PATHOL, V10, P281, DOI 10.1080/03079458108418477; Bertolotti L, 2007, VIROLOGY, V360, P143, DOI 10.1016/j.virol.2006.10.030; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; *EUR COMM, 2005, OFFICIAL J EUROPEA L, V10; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Joannis T, 2006, VET REC, V158, P309, DOI 10.1136/vr.158.9.309-b; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Monne I, 2008, EMERG INFECT DIS, V14, P637, DOI 10.3201/eid1404.071178; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; SAAD MD, 2007, DETECTION OSELTAMIVI; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Swan S., 2004, SMALL SCALE POULTRY; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; *WHO, CUM NUMB CONF HUM GA; *WHO WORLD ORG AN, 2008, EMERG INFECT DIS JUL; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Zhou JJ, 2007, ARCH VIROL, V152, P1515, DOI 10.1007/s00705-007-0985-2	34	86	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4842	10.1371/journal.pone.0004842	http://dx.doi.org/10.1371/journal.pone.0004842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290041	Green Submitted, gold, Green Published			2022-12-27	WOS:000265496500002
J	Wu, DM; Pang, YH; Ke, YH; Yu, JX; He, Z; Tautz, L; Mustelin, T; Ding, S; Huang, ZW; Feng, GS				Wu, Dongmei; Pang, Yuhong; Ke, Yuehai; Yu, Jianxiu; He, Zhao; Tautz, Lutz; Mustelin, Tomas; Ding, Sheng; Huang, Ziwei; Feng, Gen-Sheng			A Conserved Mechanism for Control of Human and Mouse Embryonic Stem Cell Pluripotency and Differentiation by Shp2 Tyrosine Phosphatase	PLOS ONE			English	Article							SELF-RENEWAL; DIVERGENT PATHS; SUPPRESSION; PROLIFERATION; MAINTENANCE; ACTIVATION; MAINTAIN; DELETION; STAT3; MICE	Recent studies have suggested distinctive biological properties and signaling mechanisms between human and mouse embryonic stem cells (hESCs and mESCs). Herein we report that Shp2, a protein tyrosine phosphatase with two SH2 domains, has a conserved role in orchestration of intracellular signaling cascades resulting in initiation of differentiation in both hESCs and mESCs. Homozygous deletion of Shp2 in mESCs inhibited differentiation into all three germ layers, and siRNA-mediated knockdown of Shp2 expression in hESCs led to a similar phenotype of impaired differentiation. A small molecule inhibitor of Shp2 enzyme suppressed both hESC and mESC differentiation capacity. Shp2 modulates Erk, Stat3 and Smad pathways in ES cells and, in particular, Shp2 regulates BMP4-Smad pathway bi-directionally in mESCs and hESCs. These results reveal a common signaling mechanism shared by human and mouse ESCs via Shp2 modulation of overlapping and divergent pathways.	[Wu, Dongmei; Pang, Yuhong; Ke, Yuehai; Yu, Jianxiu; He, Zhao; Tautz, Lutz; Mustelin, Tomas; Huang, Ziwei; Feng, Gen-Sheng] Burnham Inst Med Res, Program Signal Transduct, La Jolla, CA USA; [Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute	Wu, DM (corresponding author), Burnham Inst Med Res, Program Signal Transduct, La Jolla, CA USA.	gfeng@burnham.org	he, zhao/S-4989-2019; Yu, Jianxiu/A-7214-2012; Tautz, Lutz/M-9989-2014	Tautz, Lutz/0000-0002-4075-6238; Mustelin, Tomas/0000-0001-5912-8840	NIH [R01CA78606, P20GM075059]; California Institute of Regenerative Medicine (CIRM) [postdoctoral fellowship]; NATIONAL CANCER INSTITUTE [R01CA078606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01CA78606 and a pilot project of P20GM075059 to G.S.F.. Y.P. is a recipient of a postdoctoral fellowship from California Institute of Regenerative Medicine (CIRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2003, BLOOD, V102, P2074, DOI 10.1182/blood-2003-04-1171; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Lai LA, 2004, TOP CURR GENET, V5, P275; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sumi T, 2004, STEM CELLS, V22, P861, DOI 10.1634/stemcells.22-5-861; Tautz L, 2005, J BIOL CHEM, V280, P9400, DOI 10.1074/jbc.M413122200; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	43	45	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4914	10.1371/journal.pone.0004914	http://dx.doi.org/10.1371/journal.pone.0004914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290061	Green Submitted, gold, Green Published			2022-12-27	WOS:000265496500013
J	Abraham, A; von Cramon, DY				Abraham, Anna; von Cramon, D. Yves			Reality = Relevance? Insights from Spontaneous Modulations of the Brain's Default Network when Telling Apart Reality from Fiction	PLOS ONE			English	Article							WANDERING MINDS; NEURAL SYSTEMS; MEMORY; SELF; ACTIVATION; METAANALYSIS; HIPPOCAMPUS; PERCEPTION; THINKING; CONTEXT	Background: Although human beings regularly experience fictional worlds through activities such as reading novels and watching movies, little is known about what mechanisms underlie our implicit knowledge of the distinction between reality and fiction. The first neuroimaging study to address this issue revealed that the mere exposure to contexts involving real entities compared to fictional characters led to engagement of regions in the anterior medial prefrontal and posterior cingulate cortices (amPFC, PCC). As these core regions of the brain's default network are involved during self-referential processing and autobiographical memory retrieval, it was hypothesized that real entities may be conceptually coded as being more personally relevant to us than fictional characters. Methodology/Principal Findings: In the present functional magnetic resonance imaging (fMRI) study, we directly test the hypothesis that entity-associated personal relevance is the critical factor underlying the differential engagement of these brain regions by comparing the brain's response when processing contexts involving family or friends (high relevance), famous people (medium relevance), or fictional characters (low relevance). In line with predictions, a gradient pattern of activation was observed such that higher entity-associated personal relevance was associated with stronger activation in the amPFC and the PCC. Conclusions/Significance: The results of the study have several important implications. Firstly, they provide informed grounds for characterizing the dynamics of reality-fiction distinction. Secondly, they provide further insights into the functions of the amPFC and the PCC. Thirdly, in view of the current debate related to the functional relevance and specificity of brain's default network, they reveal a novel approach by which the functions of this network can be further explored.	[Abraham, Anna; von Cramon, D. Yves] Max Planck Inst Human Brain & Cognit Sci, Dept Cognit Neurol, Leipzig, Germany; [Abraham, Anna] Univ Giessen, Dept Clin Psychol, D-35390 Giessen, Germany; [von Cramon, D. Yves] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	Max Planck Society; Justus Liebig University Giessen; Max Planck Society	Abraham, A (corresponding author), Max Planck Inst Human Brain & Cognit Sci, Dept Cognit Neurol, Leipzig, Germany.	abraham@cbs.mpg.de			Max Planck Gesellschaft	Max Planck Gesellschaft(Max Planck Society)	The study was funded by the Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2008, BRAIN RES, V1233, P106, DOI 10.1016/j.brainres.2008.07.084; Abraham A, 2008, J COGNITIVE NEUROSCI, V20, P965, DOI 10.1162/jocn.2008.20059; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2007, HIPPOCAMPUS, V17, P420, DOI 10.1002/hipo.20287; BARGH JA, 1982, J PERS SOC PSYCHOL, V43, P425, DOI 10.1037/0022-3514.43.3.425; Boyer P, 1997, CHILD DEV, V68, P1012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Chaminade T, 2007, SOC COGN AFFECT NEUR, V2, P206, DOI 10.1093/scan/nsm017; Eichenbaum HB, 1998, HIPPOCAMPUS, V8, P197, DOI 10.1002/(SICI)1098-1063(1998)8:3<197::AID-HIPO1>3.0.CO;2-H; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fitzsimons GM, 2003, J PERS SOC PSYCHOL, V84, P148, DOI 10.1037/0022-3514.84.1.148; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Gillath O, 2006, PERS SOC PSYCHOL B, V32, P1375, DOI 10.1177/0146167206290339; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mar RA, 2007, SOC COGN AFFECT NEUR, V2, P199, DOI 10.1093/scan/nsm011; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mason MF, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1141078; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Moscovitch M, 2008, CAN J EXP PSYCHOL, V62, P62, DOI 10.1037/1196-1961.62.1.62; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; ROSENGREN KS, 1994, CHILD DEV, V65, P1605, DOI 10.2307/1131283; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schmitz TW, 2006, NEUROIMAGE, V30, P1050, DOI 10.1016/j.neuroimage.2005.10.030; Skolnick D., 2006, ARCHITECTURE IMAGINA, P73, DOI [DOI 10.1093/ACPROF:OSO/9780199275731.001.0001, DOI 10.1093/ACPROF:OSO/9780199275731.003.0005]; Skolnick D, 2006, COGNITION, V101, pB9, DOI 10.1016/j.cognition.2005.10.001; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Spreng RN, 2008, J COGN NEUROSCI; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Szpunar KK, 2008, CONSCIOUS COGN, V17, P330, DOI 10.1016/j.concog.2007.04.006; Talairach J., 1988, COPLANAR STEREOTAXIC; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; van den Bos W, 2007, COGN AFFECT BEHAV NE, V7, P337, DOI 10.3758/CABN.7.4.337; Woolley JD, 2007, DEVELOPMENTAL SCI, V10, P681, DOI 10.1111/j.1467-7687.2007.00612.x; Woolley JD, 2006, CHILD DEV, V77, P1778, DOI 10.1111/j.1467-8624.2006.00973.x; Woolley JD, 1997, CHILD DEV, V68, P991, DOI 10.2307/1132282; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	53	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4741	10.1371/journal.pone.0004741	http://dx.doi.org/10.1371/journal.pone.0004741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OF	19277108	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000265496100008
J	Altermatt, F; Pajunen, VI; Ebert, D				Altermatt, Florian; Pajunen, V. Ilmari; Ebert, Dieter			Desiccation of Rock Pool Habitats and Its Influence on Population Persistence in a Daphnia Metacommunity	PLOS ONE			English	Article								Habitat instability has an important influence on species' occurrence and community composition. For freshwater arthropods that occur in ephemeral rock pools, the most drastic habitat instabilities are droughts and the intermittent availability of water. However, although the desiccation of a rock pool is detrimental for planktonic populations, it may also bring certain benefits: the exclusion of predators or parasites, for example, or the coexistence of otherwise competitively exclusive species. The commonness of drought resistant resting stages in many aquatic organisms shows the ecological significance of droughts. We measured daily evaporation in 50 rock pools inhabited by three Daphnia species D. magna, D. longispina and D. pulex over one summer. Daily evaporation and ultimately desiccation showed significantly seasonally influenced correlation with pool surface area, presence of vegetation, ambient temperature, wind and standardized evaporation measures. We used the estimates from this analysis to develop a simulation model to predict changes in the water level in 530 individual pools on a daily basis over a 25-year period. Eventually, hydroperiod lengths and desiccation events could be predicted for all of these rock pools. We independently confirmed the validity of this simulation by surveying desiccation events in the 530 rock pools over a whole season in 2006. In the same 530 rock pools, Daphnia communities had been recorded over the 25 years the simulation model considered. We correlated pool-specific occupation lengths of the three species with pool-specific measures of desiccation risk. Occupation lengths of all three Daphnia species were positively correlated with maximum hydroperiod length and negatively correlated with the number of desiccation events. Surprisingly, these effects were not species-specific.	[Altermatt, Florian; Ebert, Dieter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Altermatt, Florian; Pajunen, V. Ilmari; Ebert, Dieter] Tvarminne Zool STN, Hango, Finland; [Pajunen, V. Ilmari] Univ Helsinki, Dept Ecol & System, Div Populat Biol, FIN-00014 Helsinki, Finland	University of Basel; University of Helsinki	Altermatt, F (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	faltermatt@bluewin.ch	Ebert, Dieter/B-5502-2009; Ebert, Dieter/P-6134-2019	Ebert, Dieter/0000-0003-2653-3772; Ebert, Dieter/0000-0003-2653-3772; Altermatt, Florian/0000-0002-4831-6958	Swiss National Science Foundation; Basler Stiftung fur experimentelle Zoologie; Freiwillige Akademische Gesellschaft; Emilia Guggenheim-Schnurr-Stiftung; Tvarminne Zoological Station [97524006]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Basler Stiftung fur experimentelle Zoologie; Freiwillige Akademische Gesellschaft; Emilia Guggenheim-Schnurr-Stiftung; Tvarminne Zoological Station	The study was supported by the Swiss National Science Foundation. F.A. thanks the Basler Stiftung fur experimentelle Zoologie, the Freiwillige Akademische Gesellschaft, and the Emilia Guggenheim-Schnurr-Stiftung for financial support during the field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is part of project nr 97524006 at Tvarminne Zoological Station.	Altermatt F, 2008, OECOLOGIA, V157, P441, DOI 10.1007/s00442-008-1080-4; Altermatt F, 2008, GLOBAL CHANGE BIOL, V14, P1209, DOI 10.1111/j.1365-2486.2008.01588.x; Altermatt F, 2007, EVOL ECOL, V21, P561, DOI 10.1007/s10682-006-9136-6; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Bengtsson J, 1998, OECOLOGIA, V115, P213, DOI 10.1007/s004420050510; BENGTSSON J, 1986, J ANIM ECOL, V55, P641, DOI 10.2307/4745; BENGTSSON J, 1993, OIKOS, V67, P451, DOI 10.2307/3545357; BENGTSSON J, 1989, NATURE, V340, P713, DOI 10.1038/340713a0; Bengtsson J., 1988, ACTA U UPSAL, V142, P1; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crawley M. J, 2002, STAT COMPUTING INTRO; Ebert D, 2001, ECOLOGY, V82, P3417; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Ellenberg H., 1974, ZEIGERWERTE GEFASSPF; FUENTES ER, 1995, MEDITERRANEAN TYPE E, P186; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Gilpin M.E., 1991, METAPOPULATION DYNAM; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; HANSKI I, 1983, J ANIM ECOL, V52, P263, DOI 10.2307/4599; Hulsmans A, 2008, ECOSYSTEMS, V11, P89, DOI 10.1007/s10021-007-9110-3; HUTCHISON GE, 1958, CONCLUDING REMARKS, V22, P415; LAGERSPETZ KARL, 1955, ARCH SOC ZOOL BOT FENNICAE VANAMO", V9, P138; Lass S, 2006, P ROY SOC B-BIOL SCI, V273, P199, DOI 10.1098/rspb.2005.3310; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Pajunen VI, 2007, HYDROBIOLOGIA, V592, P291, DOI 10.1007/s10750-007-0769-4; Pajunen VI, 2003, ECOGRAPHY, V26, P731; PAJUNEN VI, 1986, ANN ZOOL FENN, V23, P131; Pyke CR, 2004, ECOL MODEL, V173, P109, DOI 10.1016/j.ecolmodel.2003.08.014; R Development Core Team, 2007, R LANG ENV STAT COMP; RANTA E, 1979, ARCH HYDROBIOL, V87, P205; RANTA E, 1982, ANN ZOOL FENN, V19, P337; Scherrer B, 1984, BIOSTATISTIQUE; Schneider DW, 1996, J N AM BENTHOL SOC, V15, P64, DOI 10.2307/1467433; SCHWOERBEL J, 1971, EINFUHRUNG LIMNOLOGI; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Spencer M, 1999, ECOL LETT, V2, P157; Therriault TW, 2001, ISR J ZOOL, V47, P477, DOI 10.1560/BWWA-DTXB-LBJK-5GV5; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Venables WN., 2002, MODERN APPL STAT S 4; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	46	34	36	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4703	10.1371/journal.pone.0004703	http://dx.doi.org/10.1371/journal.pone.0004703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277113	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496100007
J	Brader, P; Kelly, K; Gang, S; Shah, JP; Wong, RJ; Hricak, H; Blasberg, RG; Fong, Y; Gil, Z				Brader, Peter; Kelly, Kaitlyn; Gang, Sheng; Shah, Jatin P.; Wong, Richard J.; Hricak, Hedvig; Blasberg, Ronald G.; Fong, Yuman; Gil, Ziv			Imaging of Lymph Node Micrometastases Using an Oncolytic Herpes Virus and [F-18]FEAU PET	PLOS ONE			English	Article								Background: In patients with melanoma, knowledge of regional lymph node status provides important information on outlook. Since lymph node status can influence treatment, surgery for sentinel lymph node (SLN) biopsy became a standard staging procedure for these patients. Current imaging modalities have a limited sensitivity for detection of micrometastases in lymph nodes and, therefore, there is a need for a better technique that can accurately identify occult SLN metastases. Methodology/Principal Findings: B16-F10 murine melanoma cells were infected with replication-competent herpes simplex virus (HSV) NV1023. The presence of tumor-targeting and reporter-expressing virus was assessed by [F-18]-2'-fluoro-2'-deoxy-1-beta-D-beta-arabinofuranosyl-5-ethyluracil ([F-18] FEAU) positron emission tomography (PET) and confirmed by histochemical assays. An animal foot pad model of melanoma lymph node metastasis was established. Mice received intratumoral injections of NV1023, and 48 hours later were imaged after i.v. injection of [F-18] FEAU. NV1023 successfully infected and provided high levels of lacZ transgene expression in melanoma cells. Intratumoral injection of NV1023 resulted in viral trafficking to melanoma cells that had metastasized to popliteal and inguinal lymph nodes. Presence of virus-infected tumor cells was successfully imaged with [F-18]FEAU-PET, that identified 8 out of 8 tumor-positive nodes. There was no overlap between radioactivity levels (lymph node to surrounding tissue ratio) of tumor-positive and tumor-negative lymph nodes. Conclusion/Significance: A new approach for imaging SLN metastases using NV1023 and [F-18]FEAU-PET was successful in a murine model. Similar studies could be translated to the clinic and improve the staging and management of patients with melanoma.	[Brader, Peter; Hricak, Hedvig] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Kelly, Kaitlyn; Gang, Sheng; Shah, Jatin P.; Wong, Richard J.; Fong, Yuman; Gil, Ziv] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY USA; [Blasberg, Ronald G.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY USA; [Gil, Ziv] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Lab Appl Canc Res, IL-69978 Tel Aviv, Israel; [Brader, Peter] Med Univ Graz, Dept Radiol, Graz, Austria	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Medical University of Graz	Brader, P (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA.	ziv@baseofskull.org		Shah, Jatin/0000-0002-6444-6592; Hricak, Hedvig/0000-0003-2240-9694	NIH [R25-CA096945]; America-Israel Binational Science Foundation; Israeli Science Foundation; Israeli Cancer Association; NATIONAL CANCER INSTITUTE [R25CA096945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); America-Israel Binational Science Foundation; Israeli Science Foundation(Israel Science Foundation); Israeli Cancer Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by grants from NIH R25-CA096945, the America-Israel Binational Science Foundation (ZG, YF, RW), the Israeli Science Foundation (ZG) and the Israeli Cancer Association (ZG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2006, J THORAC CARDIOV SUR, V132, P1179, DOI 10.1016/j.jtcvs.2006.07.005; Adusumilli PS, 2006, FASEB J, V20, P726, DOI 10.1096/fj.05-5316fje; Alauddin MM, 2007, EUR J NUCL MED MOL I, V34, P822, DOI 10.1007/s00259-006-0305-1; Bennett JJ, 2001, NAT MED, V7, P859, DOI 10.1038/89991; Blasberg RG, 1999, Q J NUCL MED, V43, P163; Brader P, 2008, CLIN CANCER RES, V14, P2295, DOI 10.1158/1078-0432.CCR-07-4254; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Chang SS, 2008, CA-CANCER J CLIN, V58, P54, DOI 10.3322/CA.2007.0002; Cochran AJ, 2000, LANGENBECK ARCH SURG, V385, P252, DOI 10.1007/s004230000143; De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4; Diaz LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001007; Eisenberg DP, 2006, ANN SURG, V243, P824, DOI 10.1097/01.sla.0000219738.56896.c0; Faries MB, 2007, SEMIN ONCOL, V34, P498, DOI 10.1053/j.seminoncol.2007.09.010; Gambhir SS, 2000, NEOPLASIA, V2, P118, DOI 10.1038/sj.neo.7900083; Gambhir SS, 1998, J NUCL MED, V39, P2003; Garbe C, 2008, MELANOMA RES, V18, P152, DOI 10.1097/CMR.0b013e3282f702bf; Gil Z, 2008, NEOPLASIA, V10, P347, DOI 10.1593/neo.07981; Gil Z, 2007, CLIN CANCER RES, V13, P6479, DOI 10.1158/1078-0432.CCR-07-1639; Gil Z, 2007, HEAD NECK-J SCI SPEC, V29, P537, DOI 10.1002/hed.20545; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hecht JR, 2003, CLIN CANCER RES, V9, P555; Hovels AM, 2008, CLIN RADIOL, V63, P387, DOI 10.1016/j.crad.2007.05.022; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Jacobs A, 2001, LANCET, V358, P727, DOI 10.1016/S0140-6736(01)05904-9; Jacobs A, 2001, J NUCL MED, V42, P467; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Kelly K, 2008, FASEB J, V22, P1839, DOI 10.1096/fj.07-097808; Kelly KJ, 2009, INT J CANCER, V124, P911, DOI 10.1002/ijc.24037; Kemeny N, 2006, HUM GENE THER, V17, P1214, DOI 10.1089/hum.2006.17.1214; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Labow D, 2000, HUM GENE THER, V11, P759, DOI 10.1089/10430340050015653; MacKie RM, 2001, LANCET, V357, P525, DOI 10.1016/S0140-6736(00)04048-4; Margolis DJA, 2007, RADIOLOGY, V245, P333, DOI 10.1148/radiol.2452061117; McKee TD, 2006, CANCER RES, V66, P2509, DOI 10.1158/0008-5472.CAN-05-2242; MEIGNIER B, 1990, J INFECT DIS, V162, P313, DOI 10.1093/infdis/162.2.313; Min Jung-Joon, 2008, V185, P277, DOI 10.1007/978-3-540-77496-9_12; MOORE AE, 1949, CANCER, V2, P516, DOI 10.1002/1097-0142(194905)2:3<516::AID-CNCR2820020316>3.0.CO;2-P; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Schmidt Gerwin P, 2007, Top Magn Reson Imaging, V18, P193, DOI 10.1097/RMR.0b013e318093e6bo; Schoder H, 2006, CANCER METAST REV, V25, P185, DOI 10.1007/s10555-006-8498-0; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Soghomonyan SA, 2005, CANCER GENE THER, V12, P101, DOI 10.1038/sj.cgt.7700779; SPRECHER E, 1989, ARCH VIROL, V107, P191, DOI 10.1007/BF01317916; Stiles BM, 2006, CANCER GENE THER, V13, P53, DOI 10.1038/sj.cgt.7700860; Stiles BM, 2003, SURGERY, V134, P357, DOI 10.1067/msy.2003.244; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; Tjuvajev JG, 1998, CANCER RES, V58, P4333; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Varghese S, 2007, CANCER RES, V67, P9371, DOI 10.1158/0008-5472.CAN-07-0674; Vidal-Sicart S, 2003, EUR J NUCL MED MOL I, V30, P362, DOI 10.1007/s00259-002-1051-7; Vogl Thomas, 2007, Top Magn Reson Imaging, V18, P303, DOI 10.1097/RMR.0b013e3181570c5b; Watanabe D, 2008, J DERMATOL SCI, V50, P185, DOI 10.1016/j.jdermsci.2007.12.001; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wong RJ, 2004, CLIN CANCER RES, V10, P251, DOI 10.1158/1078-0432.CCR-0197-3; Wong RJ, 2002, HUM GENE THER, V13, P1213, DOI 10.1089/104303402320138998; Wu L, 2001, GENE THER, V8, P1416, DOI 10.1038/sj.gt.3301549; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459; Yu ZK, 2008, CLIN CANCER RES, V14, P1897, DOI 10.1158/1078-0432.CCR-07-4615; Yu ZK, 2007, MOL THER, V15, P103, DOI 10.1038/sj.mt.6300009; Zell JA, 2008, J CLIN ONCOL, V26, P66, DOI 10.1200/JCO.2007.12.3604	62	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4789	10.1371/journal.pone.0004789	http://dx.doi.org/10.1371/journal.pone.0004789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274083	Green Published, Green Submitted, gold			2022-12-27	WOS:000265496000025
J	Takishita, K; Yamaguchi, H; Maruyama, T; Inagaki, Y				Takishita, Kiyotaka; Yamaguchi, Haruyo; Maruyama, Tadashi; Inagaki, Yuji			A Hypothesis for the Evolution of Nuclear-Encoded, Plastid-Targeted Glyceraldehyde-3-Phosphate Dehydrogenase Genes in "Chromalveolate" Members	PLOS ONE			English	Article								Eukaryotes bearing red alga-derived plastids - photosynthetic alveolates (dinoflagellates plus the apicomplexan Toxoplasma gondii plus the chromerid Chromera velia), photosynthetic stramenopiles, haptophytes, and cryptophytes possess unique plastid-targeted glyceraldehyde-3-phosphate dehydrogenases (henceforth designated as "GapC1"). Pioneering phylogenetic studies have indicated a single origin of the GapC1 enzymes in eukaryotic evolution, but there are two potential idiosyncrasies in the GapC1 phylogeny: Firstly, the GapC1 tree topology is apparently inconsistent with the organismal relationship among the "GapC1-containing" groups. Secondly, four stramenopile GapC1 homologues are consistently paraphyletic in previously published studies, although these organisms have been widely accepted as monophyletic. For a closer examination of the above issues, in this study GapC1 gene sampling was improved by determining/identifying nine stramenopile and two cryptophyte genes. Phylogenetic analyses of our GapC1 dataset, which is particularly rich in the stramenopile homologues, prompt us to propose a new scenario that assumes multiple, lateral GapC1 gene transfer events to explain the incongruity between the GapC1 phylogeny and the organismal relationships amongst the "GapC1-containing" groups. Under our new scenario, GapC1 genes uniquely found in photosynthetic alveolates, photosynthetic stramenopiles, haptophytes, and cryptopyhytes are not necessarily a character vertically inherited from a common ancestor.	[Takishita, Kiyotaka; Maruyama, Tadashi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kanagawa, Japan; [Yamaguchi, Haruyo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Inagaki, Yuji] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 305, Japan; [Inagaki, Yuji] Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tsukuba; University of Tsukuba; University of Tsukuba	Takishita, K (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kanagawa, Japan.	takishitak@jamstec.go.jp		Inagaki, Yuji/0000-0003-0101-8483	Study for Understanding of Function and Structure of the Marine Ecosystems in the Earth Systems of JAMSTEC	Study for Understanding of Function and Structure of the Marine Ecosystems in the Earth Systems of JAMSTEC	This work was supported by the project 'Study for Understanding of Function and Structure of the Marine Ecosystems in the Earth Systems' of JAMSTEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Ben Ali A, 2002, PROTIST, V153, P123, DOI 10.1078/1434-4610-00091; Bodyl A, 2005, J PHYCOL, V41, P712, DOI 10.1111/j.1529-8817.2005.00091.x; Bodyl A, 2006, EUR J PHYCOL, V41, P435, DOI 10.1080/09670260600961080; BRINKMANN H, 1989, PLANT MOL BIOL, V13, P81, DOI 10.1007/BF00027337; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Fagan T, 1998, J MOL EVOL, V47, P633, DOI 10.1007/PL00006420; Fast NM, 2002, J EUKARYOT MICROBIOL, V49, P30, DOI 10.1111/j.1550-7408.2002.tb00336.x; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Figge RM, 1999, MOL BIOL EVOL, V16, P429, DOI 10.1093/oxfordjournals.molbev.a026125; Figge RM, 2001, MOL BIOL EVOL, V18, P2240, DOI 10.1093/oxfordjournals.molbev.a003770; Grauvogel C, 2007, J MOL EVOL, V65, P725, DOI 10.1007/s00239-007-9053-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Iida K, 2007, MOL PHYLOGENET EVOL, V45, P227, DOI 10.1016/j.ympev.2007.05.003; Liaud MF, 1997, J MOL EVOL, V44, pS28, DOI 10.1007/PL00000050; LIAUD MF, 1994, J MOL EVOL, V38, P319, DOI 10.1007/BF00163149; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; Matsuzaki M, 2008, MOL BIOL EVOL, V25, P1167, DOI 10.1093/molbev/msn064; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Nosenko T, 2006, MOL BIOL EVOL, V23, P2026, DOI 10.1093/molbev/msl074; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Petersen J, 2006, MOL BIOL EVOL, V23, P1109, DOI 10.1093/molbev/msj123; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Puerta MV, 2008, J PHYCOL, V44, P1097, DOI 10.1111/j.1529-8817.2008.00559.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stelter K, 2007, PROTIST, V158, P119, DOI 10.1016/j.protis.2006.09.003; Takishita K, 2004, PROTIST, V155, P447, DOI 10.1078/1434461042650325; Takishita K, 2003, PROTIST, V154, P443, DOI 10.1078/143446103322454176; TAKISHITA K, 2008, GENE IN PRESS   0310, DOI DOI 10.1016/J.GENE.2008.03.001; Takishita K, 2008, GENE, V410, P26, DOI 10.1016/j.gene.2007.11.008; Teles-Grilo ML, 2007, EUR J PROTISTOL, V43, P163, DOI 10.1016/j.ejop.2007.02.002; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4737	10.1371/journal.pone.0004737	http://dx.doi.org/10.1371/journal.pone.0004737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270733	Green Published, Green Submitted, gold			2022-12-27	WOS:000265495900006
J	Wong, KKL; Kelso, RM; Worthley, SG; Sanders, P; Mazumdar, J; Abbott, D				Wong, Kelvin Kian Loong; Kelso, Richard Malcolm; Worthley, Stephen Grant; Sanders, Prashanthan; Mazumdar, Jagannath; Abbott, Derek			Theory and Validation of Magnetic Resonance Fluid Motion Estimation Using Intensity Flow Data	PLOS ONE			English	Article							BLOOD-FLOW; VELOCITY; ULTRASOUND; HEART; MRI	Background: Motion tracking based on spatial-temporal radio-frequency signals from the pixel representation of magnetic resonance (MR) imaging of a non-stationary fluid is able to provide two dimensional vector field maps. This supports the underlying fundamentals of magnetic resonance fluid motion estimation and generates a new methodology for flow measurement that is based on registration of nuclear signals from moving hydrogen nuclei in fluid. However, there is a need to validate the computational aspect of the approach by using velocity flow field data that we will assume as the true reference information or ground truth. Methodology/Principal Findings: In this study, we create flow vectors based on an ideal analytical vortex, and generate artificial signal-motion image data to verify our computational approach. The analytical and computed flow fields are compared to provide an error estimate of our methodology. The comparison shows that the fluid motion estimation approach using simulated MR data is accurate and robust enough for flow field mapping. To verify our methodology, we have tested the computational configuration on magnetic resonance images of cardiac blood and proved that the theory of magnetic resonance fluid motion estimation can be applicable practically. Conclusions/Significance: The results of this work will allow us to progress further in the investigation of fluid motion prediction based on imaging modalities that do not require velocity encoding. This article describes a novel theory of motion estimation based on magnetic resonating blood, which may be directly applied to cardiac flow imaging.	[Wong, Kelvin Kian Loong; Mazumdar, Jagannath; Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Wong, Kelvin Kian Loong; Mazumdar, Jagannath; Abbott, Derek] Univ Adelaide, Sch Electr & Electron Engn, Adelaide, SA, Australia; [Kelso, Richard Malcolm] Univ Adelaide, Sch Mechan Engn, Adelaide, SA, Australia; [Wong, Kelvin Kian Loong; Worthley, Stephen Grant; Sanders, Prashanthan; Mazumdar, Jagannath] Univ Adelaide, Sch Med, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide	Wong, KKL (corresponding author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia.	kelvin.wong@adelaide.edu.au	Abbott, Derek/E-8352-2011; Sanders, Prashanthan/D-7641-2013; Wong, Kelvin/AAL-8636-2021; Wong, Kelvin Kian Loong/ABA-3915-2021	Abbott, Derek/0000-0002-0945-2674; Sanders, Prashanthan/0000-0003-3803-8429; Wong, Kelvin Kian Loong/0000-0002-8600-1105				ALAHYARI A, 1994, EXP FLUIDS, V17, P434, DOI 10.1007/BF01877047; Barron J. L., 2005, 2004012 TIN; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; BERGEN JR, 1992, P EUR C COMP VIS, P237; Bouguet J.-Y., 2000, PYRAMIDAL IMPLEMENTA; Cariteau B, 2006, NONLINEAR PROC GEOPH, V13, P641, DOI 10.5194/npg-13-641-2006; Carr JC, 2001, RADIOLOGY, V219, P828, DOI 10.1148/radiology.219.3.r01jn44828; CHEN Q, 2001, P INT SOC MAG RESON, V9; Corpetti T, 2006, EXP FLUIDS, V40, P80, DOI 10.1007/s00348-005-0048-y; Cuzol A, 2007, INT J COMPUT VISION, V75, P329, DOI 10.1007/s11263-007-0037-0; Efros A. A., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1033, DOI 10.1109/ICCV.1999.790383; Elkins CJ, 2004, INT J HEAT FLUID FL, V25, P702, DOI 10.1016/j.ijheatfluidflow.2004.05.017; Fuchs F, 2003, EUR J RADIOL, V46, P28, DOI 10.1016/S0720-048X(02)00330-3; Fyrenius A, 2001, HEART, V86, P448, DOI 10.1136/heart.86.4.448; GLOBITS S, 1995, AM HEART J, V129, P369, DOI 10.1016/0002-8703(95)90020-9; HATLE L, 1982, DOPPLER ULTRASOUND C; HERBORN CU, 2002, P INT SOC MAG RESON, V10; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Jung B, 2004, J CARDIOVASC MAGN R, V6, P777, DOI 10.1081/JCMR-200036116; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; KELLMAN P, 2004, P ISMRM 12 ANN M KYO, P310; KUETHE DO, 1989, PHYS REV A, V40, P4542, DOI 10.1103/PhysRevA.40.4542; LAWSON MA, 1999, BUMC P, V12, P115; LEE VS, 2005, CARDIOVACULAR MRI PH; Loevstakken L, 2004, ULTRASON, P602; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; MAIER SE, 1989, RADIOLOGY, V171, P487, DOI 10.1148/radiology.171.2.2649924; Markl M, 2003, J MAGN RESON IMAGING, V17, P499, DOI 10.1002/jmri.10272; Meunier P, 2005, CR PHYS, V6, P431, DOI 10.1016/j.crhy.2005.06.003; *PHIL MED SYST CLI, 1984, BAS PRINC MR IM; Powell AJ, 2000, PEDIATR CARDIOL, V21, P104, DOI 10.1007/s002469910014; Raffel M., 1998, EXP FLUID MECH; Ruhnau P, 2005, EXP FLUIDS, V38, P21, DOI 10.1007/s00348-004-0880-5; Saffman P., 1992, VORTEX DYNAMICS; Seitz J, 2001, J NEUROIMAGING, V11, P121, DOI 10.1111/j.1552-6569.2001.tb00021.x; STAVENS D, 2008, OPENCV LIB COMPUTING; Tang AM, 2007, P ANN INT IEEE EMBS, P2603, DOI 10.1109/IEMBS.2007.4352862; Weng WG, 2001, ACTA MECH SINICA, V17, P332, DOI 10.1007/BF02487460; WOLBARST AB, 1999, LOOKING XRAY CT MRI; WORTHLEY SG, 2001, THESIS U ADELAIDE; Yu Q, 2003, CHINESE MED J-PEKING, V116, P116	41	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4747	10.1371/journal.pone.0004747	http://dx.doi.org/10.1371/journal.pone.0004747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270756	Green Published, gold			2022-12-27	WOS:000265495900015
J	Prabakaran, M; Ho, HT; Prabhu, N; Velumani, S; Szyporta, M; He, F; Chan, KP; Chen, LM; Matsuoka, Y; Donis, RO; Kwang, J				Prabakaran, Mookkan; Ho, Hui-Ting; Prabhu, Nayana; Velumani, Sumathy; Szyporta, Milene; He, Fang; Chan, Kwai-Peng; Chen, Li-Mei; Matsuoka, Yumiko; Donis, Ruben O.; Kwang, Jimmy			Development of Epitope-Blocking ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; AVIAN INFLUENZA; HEMAGGLUTININ; SERUM; NUCLEOPROTEIN; DIAGNOSIS; MICE; HA	Background: Human infections with highly pathogenic H5N1 avian influenza viruses have generally been confirmed by molecular amplification or culture-based methods. Serologic surveillance has potential advantages which have not been realized because rapid and specific serologic tests to detect H5N1 infection are not widely available. Methodology/Principal Findings: Here we describe an epitope-blocking ELISA to detect specific antibodies to H5N1 viruses in human or animal sera. The assay relies on a novel monoclonal antibody (5F8) that binds to an epitope comprising amino acid residues 274 -281 (CNTKCQTP) in the HA1 region of H5 hemagglutinin. Database search analysis of publicly available sequences revealed that this epitope is conserved in 100% of the 163 H5N1 viruses isolated from humans. The sensitivity and specificity of the epitope-blocking ELISA for H5N1 were evaluated using chicken antisera to multiple virus clades and other influenza subtypes as well as serum samples from individuals naturally infected with H5N1 or seasonal influenza viruses. The epitope-blocking ELISA results were compared to those of hemagglutinin inhibition (HI) and microneutralization assays. Antibodies to H5N1 were readily detected in immunized animals or convalescent human sera by the epitopeblocking ELISA whereas specimens with antibodies to other influenza subtypes yielded negative results. The assay showed higher sensitivity and specificity as compared to HI and microneutralization. Conclusions/Significance: The epitope-blocking ELISA based on a unique 5F8 mAb provided highly sensitive and 100% specific detection of antibodies to H5N1 influenza viruses in human sera.	[Prabakaran, Mookkan; Ho, Hui-Ting; Prabhu, Nayana; Velumani, Sumathy; Szyporta, Milene; He, Fang; Kwang, Jimmy] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Chan, Kwai-Peng] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Chen, Li-Mei; Matsuoka, Yumiko; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Kwang, Jimmy] Natl Univ Singapore, Fac Med, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; Singapore General Hospital; Centers for Disease Control & Prevention - USA; National University of Singapore	Prabakaran, M (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg	Subramaniam, Velumani/X-8679-2018	Subramaniam, Velumani/0000-0002-0998-7900; Prabhu, Nayana/0000-0002-2350-6552; Prabakaran, Mookkan/0000-0002-9816-5908	Temasek Life Sciences Laboratory, Singapore	Temasek Life Sciences Laboratory, Singapore	This work was supported by Temasek Life Sciences Laboratory, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Ameri-Mahabadi M, 2005, J VET DIAGN INVEST, V17, P61, DOI 10.1177/104063870501700112; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Blitvich BJ, 2003, J CLIN MICROBIOL, V41, P1041, DOI 10.1128/JCM.41.3.1041-1047.2003; *CDCP US, 1999, BIOS MICR BIOM LAB; Chen YC, 2008, AVIAN DIS, V52, P124, DOI 10.1637/8076-071807-Reg; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Fevereiro M, 1999, J VIROL METHODS, V81, P101, DOI 10.1016/S0166-0934(99)00061-0; GALLGHER S, 2004, CURRENT PROTOCOLS MO; Govorkova EA, 1997, ACTA VIROL, V41, P251; Gut-Winiarska M, 2000, J VIROL METHODS, V88, P63, DOI 10.1016/S0166-0934(00)00178-6; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; HALL RA, 1995, J VIROL METHODS, V51, P201, DOI 10.1016/0166-0934(94)00105-P; He QG, 2007, CLIN VACCINE IMMUNOL, V14, P617, DOI 10.1128/CVI.00444-06; JULKUNEN I, 1985, J VIROL METHODS, V10, P75, DOI 10.1016/0166-0934(85)90091-6; Kuck D, 2007, J VIROL METHODS, V140, P17, DOI 10.1016/j.jviromet.2006.10.005; MASSICOT J, 1977, J INFECT DIS, V136, pS472, DOI 10.1093/infdis/136.Supplement_3.S472; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Prabakaran M, 2008, VIROLOGY, V380, P412, DOI 10.1016/j.virol.2008.08.002; PROFETA ML, 1986, ARCH VIROL, V90, P355, DOI 10.1007/BF01317384; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Singh BK, 2004, VET RES COMMUN, V28, P437, DOI 10.1023/B:VERC.0000034996.18533.90; Stelzer-Braid S, 2008, J CLIN VIROL, V43, P241, DOI 10.1016/j.jcv.2008.06.012; Velumani S, 2008, J VIROL METHODS, V147, P219, DOI 10.1016/j.jviromet.2007.09.004; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; *WHO, 2007, H5N1 AV INFL TIM MAJ; *WHO, 2007, ANT GEN CHAR H5N1 VI; WHO, 2021, CUM NUMB CONF HUM CA; WHO, AV INFL SIT IND UPD; WHO, 2007, REC LAB PROC DET AV; WHO (World Health Organization), 2008, H5N1 AV INFL TIM MAJ; World Health Organization, 2004, LAB BIOS MAN, V3rd; YOKOYAMA WM, 2004, CURRENT PROTOCOLS IM; 1995, ANN I SUPER SANITA, V31, P1	38	55	61	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4566	10.1371/journal.pone.0004566	http://dx.doi.org/10.1371/journal.pone.0004566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238211	Green Submitted, gold, Green Published			2022-12-27	WOS:000265487400003
J	Bollen, J; Van de Sompel, H; Hagberg, A; Bettencourt, L; Chute, R; Rodriguez, MA; Balakireva, L				Bollen, Johan; Van de Sompel, Herbert; Hagberg, Aric; Bettencourt, Luis; Chute, Ryan; Rodriguez, Marko A.; Balakireva, Lyudmila			Clickstream Data Yields High-Resolution Maps of Science	PLOS ONE			English	Article							SCIENTIFIC LITERATURE; PUBLICATION DELAYS; USAGE STATISTICS; WEB; IMPACT	Background: Intricate maps of science have been created from citation data to visualize the structure of scientific activity. However, most scientific publications are now accessed online. Scholarly web portals record detailed log data at a scale that exceeds the number of all existing citations combined. Such log data is recorded immediately upon publication and keeps track of the sequences of user requests (clickstreams) that are issued by a variety of users across many different domains. Given these advantages of log datasets over citation data, we investigate whether they can produce high-resolution, more current maps of science. Methodology: Over the course of 2007 and 2008, we collected nearly 1 billion user interactions recorded by the scholarly web portals of some of the most significant publishers, aggregators and institutional consortia. The resulting reference data set covers a significant part of world-wide use of scholarly web portals in 2006, and provides a balanced coverage of the humanities, social sciences, and natural sciences. A journal clickstream model, i.e. a first-order Markov chain, was extracted from the sequences of user interactions in the logs. The clickstream model was validated by comparing it to the Getty Research Institute's Architecture and Art Thesaurus. The resulting model was visualized as a journal network that outlines the relationships between various scientific domains and clarifies the connection of the social sciences and humanities to the natural sciences. Conclusions: Maps of science resulting from large-scale clickstream data provide a detailed, contemporary view of scientific activity and correct the underrepresentation of the social sciences and humanities that is commonly found in citation data.	[Bollen, Johan; Van de Sompel, Herbert; Chute, Ryan; Balakireva, Lyudmila] Los Alamos Natl Lab, Res Lib, Digital Lib Res & Prototyping Team, Los Alamos, NM 87545 USA; [Hagberg, Aric; Bettencourt, Luis; Rodriguez, Marko A.] Los Alamos Natl Lab, Theoretical Div, Math Modeling & Anal Grp, Los Alamos, NM 87545 USA; [Hagberg, Aric; Bettencourt, Luis; Rodriguez, Marko A.] Los Alamos Natl Lab, Ctr Nonlinear Stud, Los Alamos, NM 87545 USA; [Bettencourt, Luis] Santa Fe Inst, Santa Fe, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute	Bollen, J (corresponding author), Los Alamos Natl Lab, Res Lib, Digital Lib Res & Prototyping Team, Los Alamos, NM 87545 USA.	jbollen@lanl.gov	Balakireva, Lyudmila/AAX-9674-2020; Bettencourt, Luis/R-9861-2019	Balakireva, Lyudmila/0000-0002-3919-3634; Van de Sompel, Herbert/0000-0002-0715-6126	Andrew W. Mellon Foundation	Andrew W. Mellon Foundation	This research was funded as part of the MESUR project (http://www.mesur.org/) by the Andrew W. Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar E., 2000, Q J ELECT COMMERCE, V1, P203; AGGARWAL CC, 1998, IEEE DATA ENG B, V21; Aizen J, 2004, P NATL ACAD SCI USA, V101, P5254, DOI 10.1073/pnas.0307539100; BETTENCOURT LMA, 2008, SCIENTOMETR IN PRESS; Bianchini M., 2005, ACM Transactions on Internet Technology, V5, P92, DOI 10.1145/1052934.1052938; Bollen J., 2008, JOINT C DIG LIB JCDL; Bollen J, 2006, SCIENTOMETRICS, V69, P227, DOI 10.1007/s11192-006-0151-8; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Boyack KW, 2002, J AM SOC INF SCI TEC, V53, P764, DOI 10.1002/asi.10066; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; CHEN C, 2007, IEEE ACM JOINT C DIG, P19; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Davis PM, 2006, J AM SOC INF SCI TEC, V57, P1243, DOI 10.1002/asi.20405; DEMOYAANEGON F, 2007, J AM SOC INFORM SCI, V58; Egghe L, 2000, J AM SOC INFORM SCI, V51, P158, DOI 10.1002/(SICI)1097-4571(2000)51:2<158::AID-ASI7>3.0.CO;2-X; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; GARFIELD E, 1970, NATURE, V227, P669, DOI 10.1038/227669a0; HARRIS E, 2006, NATURE, V444, P985; Huberman B.A., 2001, LAWS WEB PATTERNS EC; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; J. Paul Getty Trust, ART ARCH THES; Kleinberg J., 2008, DATA STREAM MANAGEME; Kurtz MJ, 2005, J AM SOC INF SCI TEC, V56, P36, DOI 10.1002/asi.20095; LEYDESDORFF L, 1994, SCIENTOMETRICS, V31; Luwel M, 1998, SCIENTOMETRICS, V41, P29, DOI 10.1007/BF02457964; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Pirolli P. L. T., 1999, World Wide Web, V2, P29, DOI 10.1023/A:1019288403823; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	31	221	224	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4803	10.1371/journal.pone.0004803	http://dx.doi.org/10.1371/journal.pone.0004803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OF	19562078	gold, Green Published, Green Submitted			2022-12-27	WOS:000265496100022
J	Zhang, C; Yang, N; Yang, CH; Ding, HS; Luo, C; Zhang, Y; Wu, MJ; Zhang, XW; Shen, X; Jiang, HL; Meng, LH; Ding, J				Zhang, Chao; Yang, Na; Yang, Chun-hao; Ding, Hua-sheng; Luo, Cheng; Zhang, Yu; Wu, Mao-jiang; Zhang, Xiong-wen; Shen, Xu; Jiang, Hua-Liang; Meng, Ling-hua; Ding, Jian			S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton	PLOS ONE			English	Article								Background: Deregulation of the phosphatidylinositol 3-kinases (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway plays a central role in tumor formation and progression, providing validated targets for cancer therapy. S9, a hybrid of alpha-methylene-gamma-lactone and 2-phenyl indole compound, possessed potent activity against this pathway. Methodology/Principal Findings: Effects of S9 on PI3K-Akt-mTOR pathway were determined by Western blot, immunofluorescence staining and in vitro kinas assay. The interactions between tubulin and S9 were investigated by polymerization assay, CD, and SPR assay. The potential binding modes between S9 and PI3K, mTOR or tubulin were analyzed by molecular modeling. Anti-tumor activity of S9 was evaluated in tumor cells and in nude mice bearing human cancer xenografts. S9 abrogated EGF-activated PI3K-Akt-mTOR signaling cascade and Akt translocation to cellular membrane in human tumor cells. S9 possessed inhibitory activity against both PI3K and mTOR with little effect on other tested 30 kinases. S9 also completely impeded hyper-phosphorylation of Akt as a feedback of inhibition of mTOR by rapamycin. S9 unexpectedly arrested cells in M phase other than G1 phase, which was distinct from compounds targeting PI3K-Akt-mTOR pathway. Further study revealed that S9 inhibited tubulin polymerization via binding to colchicine-binding site of tubulin and resulted in microtubule disturbance. Molecular modeling indicated that S9 could potentially bind to the kinase domains of PI3K p110 alpha subunit and mTOR, and shared similar hydrophobic interactions with colchicines in the complex with tubulin. Moreover, S9 induced rapid apoptosis in tumor cell, which might reflect a synergistic cooperation between blockade of both PI3-Akt-mTOR signaling and tubulin cytoskeleton. Finally, S9 displayed potent antiproliferative activity in a panel of tumor cells originated from different tissue types including drug-resistant cells and in nude mice bearing human tumor xenografts. Conclusions/Significance: Taken together, S9 targets both PI3K-Akt-mTOR signaling and microtubule cytoskeleton, which combinatorially contributes its antitumor activity and provides new clues for anticancer drug design and development.	[Zhang, Chao; Yang, Na; Zhang, Xiong-wen; Meng, Ling-hua; Ding, Jian] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China; [Yang, Chun-hao; Ding, Hua-sheng; Wu, Mao-jiang] Chinese Acad Sci, Shanghai Inst Mat Med, Div Organ Synthesis, Shanghai 200031, Peoples R China; [Luo, Cheng; Zhang, Yu; Shen, Xu; Jiang, Hua-Liang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Shen, Xu; Jiang, Hua-Liang] East China Univ Sci & Technol, Sch Pharm, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology	Zhang, C (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China.	lhmeng@mail.shcnc.ac.cn; jding@mail.shcnc.ac.cn	Zhang, Yu/J-5225-2014; meng, linghua/Y-8110-2019		Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-YW-R-25]; National Natural Science Foundation of China [30721005, 90713034]; Science and Technology Commission of Shanghai Municipality Pujiang Talent Program [08PJ14114, 07dz05906]	Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Pujiang Talent Program(Science & Technology Commission of Shanghai Municipality (STCSM))	Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R-25), National Natural Science Foundation of China (30721005, 90713034), Science and Technology Commission of Shanghai Municipality Pujiang Talent Program (08PJ14114), Grant 07dz05906. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Ding HS, 2005, BIOORG MED CHEM LETT, V15, P4799, DOI 10.1016/j.bmcl.2005.07.050; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gastpar R, 1998, J MED CHEM, V41, P4965, DOI 10.1021/jm980228l; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P1091; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Maira SM, 2008, EXPERT OPIN THER TAR, V12, P223, DOI 10.1517/14728222.12.2.223 ; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NOBES CD, 1995, J CELL SCI, V108, P225; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; PANDA HPM, RAPID TREADMILLING B; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Tong YG, 2006, MOL PHARMACOL, V69, P1226, DOI 10.1124/mol.105.020537; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wipf P, 2005, ORG BIOMOL CHEM, V3, P2053, DOI 10.1039/B504418a; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang C, 2006, BRIT J PHARMACOL, V148, P741, DOI 10.1038/sj.bjp.0706741; Zhang LH, 2006, CANCER RES, V66, P951, DOI 10.1158/0008-5472.CAN-05-2083	33	85	94	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4881	10.1371/journal.pone.0004881	http://dx.doi.org/10.1371/journal.pone.0004881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293927	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496600007
J	Treadway, MT; Grant, MM; Ding, ZH; Hollon, SD; Gore, JC; Shelton, RC				Treadway, Michael T.; Grant, Merida M.; Ding, Zhaohua; Hollon, Steven D.; Gore, John C.; Shelton, Richard C.			Early Adverse Events, HPA Activity and Rostral Anterior Cingulate Volume in MDD	PLOS ONE			English	Article							HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; DEPRESSION; AMYGDALA; WOMEN; GYRUS; MRI	Background: Prior studies have independently reported associations between major depressive disorder (MDD), elevated cortisol concentrations, early adverse events and region-specific decreases in grey matter volume, but the relationships among these variables are unclear. In the present study, we sought to evaluate the relationships between grey matter volume, early adverse events and cortisol levels in MDD. Methods/Results: Grey matter volume was compared between 19 controls and 19 individuals with MDD using voxel-based morphometry. A history of early adverse events was assessed using the Childhood Trauma Questionnaire. Subjects also provided salivary cortisol samples. Depressed patients showed decreased grey matter volume in the rostral ACC as compared to controls. Rostral ACC volume was inversely correlated with both cortisol and early adverse events. Conclusions: These findings suggest a key relationship between ACC morphology, a history of early adverse events and circulating cortisol in the pathophysiology of MDD.	[Treadway, Michael T.; Grant, Merida M.; Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Ding, Zhaohua; Gore, John C.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Dept Radiol & Radiol Sci, Nashville, TN USA; [Shelton, Richard C.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Treadway, MT (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	merida.grant@vanderbilt.edu	Ding, Zhaohua/AHC-7551-2022; Treadway, Michael/O-9056-2017	Ding, Zhaohua/0000-0002-1805-2955; 	NIMH [K01 MH073092, K02 MH01697, R01 MH60713]; National Center for Research Resources, National Institutes of Health [M01 RR-00095]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060713, K01MH073092, K02MH001697] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an NIMH career development award K01 MH073092 to M.M.G., an NIMH career development award K02 MH01697 to S.D.H. and grant R01 MH60713 to S.D.H. and R.C.S. and grant M01 RR-00095 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; AHIMA RS, 1990, NEUROSCIENCE, V39, P579, DOI 10.1016/0306-4522(90)90244-X; Akana SF, 2001, J NEUROENDOCRINOL, V13, P625, DOI 10.1046/j.1365-2826.2001.00676.x; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Campbell S, 2006, CURR OPIN PSYCHIATR, V19, P25, DOI 10.1097/01.yco.0000194371.47685.f2; Cerqueira JJ, 2005, J PSYCHIATR RES, V39, P451, DOI 10.1016/j.jpsychires.2005.01.003; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; DIORIO D, 1993, J NEUROSCI, V13, P3839; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matsuo K, 2007, MOL PSYCHIATR, V12, P158, DOI 10.1038/sj.mp.4001894; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MAYBERG HS, 2003, BR MED B, V265, P193; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; SALVADORE G, 2008, BIOL PSYCHIAT   0924; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHONING S, 2008, HUM BRAIN MAPP  1211; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1999, J NEUROSCI, V19, P5034; Thase ME, 2002, HANDBOOK OF DEPRESSION, P192; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wagner G, 2006, BIOL PSYCHIAT, V59, P958, DOI 10.1016/j.biopsych.2005.10.025	36	268	271	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4887	10.1371/journal.pone.0004887	http://dx.doi.org/10.1371/journal.pone.0004887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325704	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499400001
J	Kang, Y; Choi, M; Lee, J; Koh, GY; Kwon, K; Choi, C				Kang, Yujung; Choi, Myunghwan; Lee, Jungsul; Koh, Gou Young; Kwon, Kihwan; Choi, Chulhee			Quantitative Analysis of Peripheral Tissue Perfusion Using Spatiotemporal Molecular Dynamics	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; INDOCYANINE GREEN; IN-VIVO; PHOTODYNAMIC THERAPY; CONTRAST; PATHOPHYSIOLOGY; ARTERIOGENESIS; ANGIOGENESIS; INJECTION	Background: Accurate measurement of peripheral tissue perfusion is challenging but necessary to diagnose peripheral vascular insufficiency. Because near infrared (NIR) radiation can penetrate relatively deep into tissue, significant attention has been given to intravital NIR fluorescence imaging. Methodology/Principal Findings: We developed a new optical imaging-based strategy for quantitative measurement of peripheral tissue perfusion by time-series analysis of local pharmacokinetics of the NIR fluorophore, indocyanine green (ICG). Time-series NIR fluorescence images were obtained after injecting ICG intravenously in a murine hindlimb ischemia model. Mathematical modeling and computational simulations were used for translating time-series ICG images into quantitative pixel perfusion rates and a perfusion map. We could successfully predict the prognosis of ischemic hindlimbs based on the perfusion profiles obtained immediately after surgery, which were dependent on the preexisting collaterals. This method also reflected increases in perfusion and improvements in prognosis of ischemic hindlimbs induced by treatment with vascular endothelial growth factor and COMP-angiopoietin-1. Conclusions/Significance: We propose that this novel NIR-imaging-based strategy is a powerful tool for biomedical studies related to the evaluation of therapeutic interventions directed at stimulating angiogenesis.	[Kang, Yujung; Choi, Myunghwan; Lee, Jungsul; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Koh, Gou Young; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon, South Korea; [Koh, Gou Young; Choi, Chulhee] Korea Adv Inst Sci & Technol, Taejon, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Sch Med, Dept Cardiol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Ewha Womans University	Kang, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	cchoi@kaist.ac.kr	Koh, Gou Young/C-1615-2011; Choi, Chulhee/C-1642-2011; Lee, Jungsul/A-7851-2013; Maunsell, John/G-5702-2010	Choi, Chulhee/0000-0001-5542-9136; Lee, Jungsul/0000-0002-8600-5851; Lauwereyns, Jan/0000-0003-0551-2550; Lee, Joonyeol/0000-0001-9929-6080; Maunsell, John/0000-0003-0018-4439; Choi, Myunghwan (Mark)/0000-0002-4235-7003	Chung Moon Soul Center for BioInformation and BioElectronics, KAIST	Chung Moon Soul Center for BioInformation and BioElectronics, KAIST	This work was supported by the Chung Moon Soul Center for BioInformation and BioElectronics, KAIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels C, 2004, PHOTOCH PHOTOBIO SCI, V3, P765, DOI 10.1039/b314241h; Buschmann I, 2000, J PATHOL, V190, P338, DOI 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7; Cai QY, 2007, INVEST RADIOL, V42, P797, DOI 10.1097/RLI.0b013e31811ecdcd; CARSON ER, 1979, NEW ENGL J MED, V300, P1078, DOI 10.1056/NEJM197905103001904; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Crescenzi E, 2004, MOL CANCER THER, V3, P537; El-Desoky A, 1999, BRIT J SURG, V86, P1005, DOI 10.1046/j.1365-2168.1999.01186.x; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gora F, 2002, J NEUROSURG ANESTH, V14, P218, DOI 10.1097/00008506-200207000-00008; Henneman MM, 2006, BRIT MED BULL, V79-80, P187, DOI 10.1093/bmb/ldl014; Keller E, 2001, J NEUROSURG ANESTH, V13, P43, DOI 10.1097/00008506-200101000-00008; LEITGEB RA, 2007, C P IEEE ENG MED BIO, V1, P530; Leung TS, 2007, APPL OPTICS, V46, P1604, DOI 10.1364/AO.46.001604; Leung TS, 2004, PEDIATR RES, V55, P134, DOI 10.1203/01.PDR.0000099775.87684.FB; Liddell RP, 2005, J VASC INTERV RADIOL, V16, P991, DOI 10.1097/01.RVI.0000161381.48445.48; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; PORTER TR, 1995, J AM COLL CARDIOL, V25, P509, DOI 10.1016/0735-1097(94)00376-2; Ryu JK, 2006, MOL THER, V13, P705, DOI 10.1016/j.ymthe.2005.10.016; Schmidt-Erfurth U, 2005, OPHTHALMOLOGY, V112, P2061, DOI 10.1016/j.ophtha.2005.09.007; Scholz D, 2006, CELL TISSUE RES, V324, P395, DOI 10.1007/s00441-005-0072-5; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Wang XD, 2004, OPT LETT, V29, P730, DOI 10.1364/OL.29.000730; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; WHEELER HO, 1958, P SOC EXP BIOL MED, V99, P11; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006; Ziv K, 2004, MAGN RESON MED, V51, P304, DOI 10.1002/mrm.10687	30	70	74	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4275	10.1371/journal.pone.0004275	http://dx.doi.org/10.1371/journal.pone.0004275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19247494	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482800005
